PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Alnawmasi, MM; Chakraborty, A; Dalton, K; Quaid, P; Dunkley, BT; Thompson, B				Alnawmasi, Mohammed M.; Chakraborty, Arijit; Dalton, Kristine; Quaid, Patrick; Dunkley, Benjamin T.; Thompson, Benjamin			The effect of mild traumatic brain injury on the visual processing of global form and motion	BRAIN INJURY			English	Article						Mild TBI; ventral stream; dorsal stream; form perception; motion perception	CONTRAST SENSITIVITY; PERCEPTION; ACUITY; VISION; AUTISM; EPIDEMIOLOGY; CONCUSSION; COHERENCE; PATTERNS; CHILDREN	Cortical visual processing involves the ventral stream (form perception) and the dorsal stream (motion perception). We assessed whether mild traumatic brain injury (TBI) differentially affects these two streams. Eleven adults with mild TBI (28 +/- 9 yrs, 17 +/- 5 months post injury) and 25 controls (25 +/- 5 yrs) participated. Participants completed tests of global processing involving Glass patterns (form) and random dot kinematograms (motion), measurement of contrast thresholds for motion direction discrimination, a comprehensive vision screening and the Post-Concussion Symptom Inventory (PCSI). Our results showed that the mild TBI group had significantly higher (worse) global form (mean +/- SD: TBI 25 +/- 6%, control 21 +/- 5%) and motion (TBI 14 +/- 7%, control 11 +/- 3%) coherence thresholds than controls. The magnitude of the mild TBI group deficit did not differ between the two tasks. Contrast thresholds for motion direction discrimination did not differ between the groups, but were positively correlated with PCSI score (r(2) = 0.51. p = 0.01) in the mild TBI group. The mild TBI group had worse outcomes than controls for all clinical measurements of vision except distance visual acuity. In conclusion, mild TBI affects processing in both the dorsal and ventral cortical processing streams equally. In addition, spatiotemporal contrast sensitivity may be related to the symptoms of mild TBI.	[Alnawmasi, Mohammed M.; Chakraborty, Arijit; Dalton, Kristine; Quaid, Patrick; Dunkley, Benjamin T.; Thompson, Benjamin] Univ Waterloo, Sch Optometry & Vis Sci, 200 Univ Ave West, Waterloo, ON, Canada; [Alnawmasi, Mohammed M.] Qassim Univ, Dept Optometry, Coll Appl Med Sci, Buraydah, Saudi Arabia; [Quaid, Patrick] Guelph Vis Therapy Ctr, VUE Cubed Vis Rehabil Clin, Guelph, ON, Canada; [Dunkley, Benjamin T.] Univ Toronto, Hosp Sick Children, Diagnost Imaging, Toronto, ON, Canada; [Dunkley, Benjamin T.] Univ Toronto, Neurosci & Mental Hlth, Hosp Sick Children, Res Inst, Toronto, ON, Canada; [Dunkley, Benjamin T.] Univ Toronto, Med Imaging, Toronto, ON, Canada		Alnawmasi, MM (corresponding author), Univ Waterloo, Sch Optometry & Vis Sci, 200 Univ Ave West, Waterloo, ON, Canada.	malnawmasi@uwaterloo.ca		Dunkley, Ben/0000-0001-6173-1171; Quaid, Patrick/0000-0001-7318-6350; Alnawmasi, Mohammed/0000-0001-7433-3957	Saudi Arabian Cultural Bureau; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC) [RPIN-05394, RGPAS-477166]	This study was supported by funding from the Saudi Arabian Cultural Bureau to MA and NSERC grants [RPIN-05394 and RGPAS-477166] to BT.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Atkinson J, 1997, NEUROREPORT, V8, P1919, DOI 10.1097/00001756-199705260-00025; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braddick O, 2003, NEUROPSYCHOLOGIA, V41, P1769, DOI 10.1016/S0028-3932(03)00178-7; Braddick OJ, 2000, CURR BIOL, V10, P731, DOI 10.1016/S0960-9822(00)00540-6; Brady ST, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P1; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Chakraborty A, 2017, VISION RES, V135, P16, DOI 10.1016/j.visres.2017.04.005; Chakraborty A, 2015, VISION RES, V115, P83, DOI 10.1016/j.visres.2015.08.007; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Chen NH, 2016, P NATL ACAD SCI USA, V113, P5724, DOI 10.1073/pnas.1524160113; Ciuffreda KJ, 1996, J BEHAV OPTOM, V7, P29; Ciufredda KJ, 2009, OPTOM VIS DEV, V40, P16; CORNELISSEN P, 1995, VISION RES, V35, P1483, DOI 10.1016/0042-6989(95)98728-R; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dennis RJ, 2004, OPTOMETRY VISION SCI, V81, P516, DOI 10.1097/00006324-200407000-00013; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodale MA, 2011, VISION RES, V51, P1567, DOI 10.1016/j.visres.2010.07.027; Green W, 2010, OPTOMETRY, V81, P129, DOI 10.1016/j.optm.2009.07.015; Hazel CA, 2002, OPTOMETRY VISION SCI, V79, P788, DOI 10.1097/00006324-200212000-00011; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hoffer ME, 2018, NEUROSENSORY DISORDE; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Khawam EA, 2006, CLEV CLIN J MED, V73, P351, DOI 10.3949/ccjm.73.4.351; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lotan E, 2018, AM J NEURORADIOL, V39, P1222, DOI 10.3174/ajnr.A5688; Mantyjarvi M, 2001, J CATARACT REFR SURG, V27, P261, DOI 10.1016/S0886-3350(00)00562-9; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McGovern DP, 2012, J VISION, V12, DOI 10.1167/12.11.4; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; MICHAEL CR, 1988, P NATL ACAD SCI USA, V85, P4914, DOI 10.1073/pnas.85.13.4914; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Neri P, 2005, J NEUROPHYSIOL, V93, P1823, DOI 10.1152/jn.01068.2004; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Pellicano E, 2008, NEUROPSYCHOLOGIA, V46, P2593, DOI 10.1016/j.neuropsychologia.2008.04.008; Polat U, 2009, VISION RES, V49, P2566, DOI 10.1016/j.visres.2009.06.005; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schmidtmann G, 2017, INVEST OPHTH VIS SCI, V58, P2630, DOI 10.1167/iovs.17-21845; Spencer J, 2000, NEUROREPORT, V11, P2765, DOI 10.1097/00001756-200008210-00031; Spiegel DP, 2016, VISION RES, V122, P43, DOI 10.1016/j.visres.2016.03.004; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wattam-Bell J, 2010, CURR BIOL, V20, P411, DOI 10.1016/j.cub.2009.12.020; Wesemann W, 2002, KLIN MONATSBL AUGENH, V219, P660, DOI 10.1055/s-2002-35168; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9; Wilson HR, 1998, VISION RES, V38, P2933, DOI 10.1016/S0042-6989(98)00109-6	65	4	4	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2019	33	10					1354	1363		10.1080/02699052.2019.1641842		JUL 2019	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM5YC	WOS:000476285700001	31317788				2022-02-06	
J	Kapeliotis, M; Musigazi, GU; Famaey, N; Depreitere, B; Kleiven, S; Vander Sloten, J				Kapeliotis, Markos; Musigazi, Gracia Umuhire; Famaey, Nele; Depreitere, Bart; Kleiven, Svein; Vander Sloten, Jos			The sensitivity to inter-subject variability of the bridging vein entry angles for prediction of acute subdural hematoma	JOURNAL OF BIOMECHANICS			English	Article						Head impact; Acute subdural hematoma; Bridging vein rupture; CT angiogram; Bridging vein position; Finite element head model		Acute subdural hematoma (ASDH) is one of the most frequent traumatic brain injuries (TBIs) with high mortality rate. Bridging vein (BV) ruptures is a major cause of ASDH. The KTH finite element head model includes bridging veins to predict acute subdural hematoma due to BV rupture. In this model, BVs were positioned according to Oka et al. (1985). The aim of the current study is to investigate whether the location and entry angles of these BVs could be modelled using data from a greater statistical sample, and what the impact of this improvement would be on the model's predictive capability of BV rupture. From the CT angiogram data of 78 patients, the relative position of the bridging veins and their entry angles along the superior sagittal sinus was determined. The bridging veins were repositioned in the model accordingly. The performance of the model, w.r.t. BV rupture prediction potential was tested on simulations of full body cadaver head impact experiments. The experiments were simulated on the original version of the model and on three other versions which had updated BV positions according to mean, maximum and minimum entry angles. Even though the successful prediction rate between the models stayed the same, the location of the rupture site significantly improved for the model with the mean entry angles. Moreover, the models with maximum and minimum entry angles give an insight of how BV biovariability can influence ASDH. In order to further improve the successful prediction rate, more biofidelic data are needed both with respect to bridging vein material properties and geometry. Furthermore, more experimental data are needed in order to investigate the behaviour of FE head models in depth. (C) 2019 Elsevier Ltd. All rights reserved.	[Kapeliotis, Markos; Famaey, Nele; Vander Sloten, Jos] Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium; [Musigazi, Gracia Umuhire; Depreitere, Bart] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Neurosurg, Leuven, Belgium; [Kleiven, Svein] KTH Royal Inst Technol, Neuron Engn, Stockholm, Sweden		Kapeliotis, M (corresponding author), Celestijnenlaan 300 Box 2419, B-3001 Leuven, Belgium.	markos.kapeliotis@kuleuven.be	Depreitere, Bart/AAA-9846-2020	Depreitere, Bart/0000-0002-7458-0648; Famaey, Nele/0000-0002-7374-8912	European UnionEuropean Commission [642662]; FWOFWO [PDO/12]	This work was supported by the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement No. 642662 for HEADS ITN and by a personal FWO fellowship (PDO/12).	Cui Z. Y, 2017, COMPUT METHODS BIOME, V5842; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven S, 2007, STAPP CAR CRASH  SEP; Ls-dyna R, 2015, USERS MANUAL, VI; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Musigazi G. U, 2015, EUR ASS NEUR SOC ANN; Oka K, 1985, FORENSIC SCI INT, V17; Takhounts E. G, 2003, INT J CRASHWORTHINES, V52; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B	12	4	4	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUL 19	2019	92						6	10		10.1016/j.jbiomech.2019.05.016			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	IL0DE	WOS:000476965500002	31201011	Green Accepted			2022-02-06	
J	Totikov, A; Boltzmann, M; Schmidt, SB; Rollnik, JD				Totikov, Alan; Boltzmann, Melanie; Schmidt, Simone B.; Rollnik, Jens D.			Influence of paroxysmal sympathetic hyperactivity (PSH) on the functional outcome of neurological early rehabilitation patients: a case control study	BMC NEUROLOGY			English	Article						Neurological early rehabilitation; Paroxysmal sympathetic hyperactivity (PSH); Outcome; Case control study	TRAUMATIC BRAIN-INJURY; MECHANICAL VENTILATION; DYSAUTONOMIA; OVERRESPONSIVENESS	Background: Paroxysmal Sympathetic Hyperactivity (PSH) is a frequently observed condition among critically ill patients on intensive care units. According to different studies, PSH is associated with worse recovery and increased mortality in acute-care facilities. In this monocentric, retrospective case-control study, we investigated whether this association also applies to post-acute neurological early rehabilitation. Methods: The study included n=387 patients, admitted to an intensive care or intermediate care unit within 1 year (2016). Among these, 97 patients showed clinical signs of PSH. For each patient with PSH, a patient without PSH was identified, controlling for age, gender, functional and respiratory status upon admission. However, for 25 patients with PSH, there was no suitable control patient fulfilling all defined matching criteria. Primary outcome was type of discharge, dichotomized into favorable (follow-up rehabilitation) and unfavorable outcome (all others). Secondary outcome measures were functional and respiratory status, number of secondary diagnoses, duration of treatment interruptions and length of stay at discharge. Results: About 25% of neurological early rehabilitation patients showed clinical signs of PSH. A young age (OR=0.94; CI=0.91-0.97) and less severe PSH symptoms (OR=0.79; CI=0.69-0.90) were independent predictors of a favorable outcome. In addition, severity of PSH symptoms was associated with weaning duration, while the occurrence of PSH symptoms alone had no influence on most secondary outcome variables. The treatment on intermediate care units proved to be longer for patients with PSH symptoms, only. Conclusions: Patients with PSH represent a large group of neurological early rehabilitation patients. Overall, we did not find PSH-related differences in most of the examined outcome measures. However, severe PSH symptoms seem to be associated with poorer outcome and longer treatment on intermediate care units, in order to prevent possible complications.	[Totikov, Alan; Boltzmann, Melanie; Schmidt, Simone B.; Rollnik, Jens D.] Hannover Med Sch, BDH Clin Hessisch Oldendorf, Inst Neurorehabil Res, Associated Inst, Greitstr 18-28, D-31840 Hessisch Oldendorf, Germany		Boltzmann, M (corresponding author), Hannover Med Sch, BDH Clin Hessisch Oldendorf, Inst Neurorehabil Res, Associated Inst, Greitstr 18-28, D-31840 Hessisch Oldendorf, Germany.	a.totikov@nkho.de; m.boltzmann@nkho.de					Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; MAHONEY F I, 1965, Md State Med J, V14, P61; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Oehmichen F, 2012, NERVENARZT, V83, P1300, DOI 10.1007/s00115-012-3600-z; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Pohl M, 2016, NERVENARZT, V87, P634, DOI 10.1007/s00115-016-0093-1; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rollnik JD, 2017, NERVENARZT, V88, P652, DOI 10.1007/s00115-017-0332-0; Rollnik JD, 2014, AKTUEL NEUROL, V41, P328, DOI 10.1055/s-0034-1370228; Rollnik JD, 2010, AKTUEL NEUROL, V37, P316, DOI 10.1055/s-0030-1248595; Schmidt SB, 2018, EUR J PHYS REHAB MED, V54, P939, DOI 10.23736/S1973-9087.18.05100-6; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; Schonle PW., 2000, INT HDB NEUROPSYCHOL, P327, DOI [10.1007/978-1-4757-5569-5_22, DOI 10.1007/978-1-4757-5569-5_22]; Turner MS, 2003, ACT NEUR S, V87, P81	25	4	5	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	JUL 17	2019	19								162	10.1186/s12883-019-1399-y			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IJ5LE	WOS:000475943800005	31315589	Green Published, gold			2022-02-06	
J	Vosa, L; Whiteneck, GG; Ngan, E; Novelo, LL; Harik, LM; Sherer, M				Vosa, Leia; Whiteneck, Gale G.; Ngan, Esther; Novelo, Luis Leon; Harik, Lindsey M.; Sherer, Mark			Comparison of the Neurobehavioral Symptom Inventory and the Rivermead Postconcussion Symptoms Questionnaire	BRAIN INJURY			English	Article						Traumatic brain injury; post-concussive; Neurobehavioral Symptom Inventory; Rivermead Postconcussion Questionnaire	POST-CONCUSSION SYMPTOMS; TRAUMATIC BRAIN-INJURY; CONSTRUCT-VALIDITY; HEAD-INJURY; MODERATE; TBI	Objective: This study sought to determine the similarity of constructs measured by the Neurobehavioral Symptom Inventory (NSI) and Rivermead Postconcussive Symptoms Questionnaire (RPQ) and the potential for interchangeability of scores from the two scales. Setting: Three acute inpatient rehabilitation hospitals in the USA. Participants: 497 community dwelling persons with traumatic brain injury (TBI) who completed the NSI and the RPQ during the same assessment. Inclusion criteria were (a) medical documentation of TBI, (b) age 18 to 64 years, (c) capacity to give informed consent, (d) resides in the community, (e) ability to complete all study measures in English, (f) absence of interfering medical or psychiatric condition. Design: Prospective cohort observational study Main Measures: NSI; RPQ Results: Scores from the NSI and RPQ showed a strong association (Spearman's r = 0.89). Exploratory factor analysis showed that items from the two measures loaded on similar factors. A crosswalk between the two measures was created by equating scores from the scales based on percentile ranks. Conclusion: Results indicate substantial conceptual and empirical overlap between the NSI and RPQ. The percentile crosswalk developed from this dataset may allow combined analysis of post-concussive symptoms from datasets that include either the NSI or the RPQ.	[Vosa, Leia; Harik, Lindsey M.; Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Vosa, Leia; Harik, Lindsey M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Vosa, Leia] Clement J Zablocki VA Med Ctr Milwaukee, Milwaukee, WI USA; [Whiteneck, Gale G.] Craig Hosp, Res Dept, Englewood, CO USA; [Ngan, Esther; Novelo, Luis Leon] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA		Vosa, L (corresponding author), Clement J Zablocki VA Med Ctr, 5000 W Natl Ave, Milwaukee, WI 53295 USA.	Leia.Vos@va.gov	Vos, Leia/AAJ-8364-2020		Administration for Community Living National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) [90RT5007, 90DP0028, 90DP0084]	This work was supported by the Administration for Community Living National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) 90RT5007, 90DP0028, and 90DP0084.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; [Anonymous], 2015, C TRAUM BRAIN INJ US; [Anonymous], 2017, TRAUMATIC BRAIN INJU; Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; Barker-Collo S, 2016, JSM BURNS TRAUMA, V1, P1006; Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bomyea J, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000278; Brickell TA, 2014, MIL MED, V179, P839, DOI 10.7205/MILMED-D-14-00016; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Cicerone K, 1994, ARCH PHYS MED REHAB, V75, P723; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Department of the Army, 2014, NEUR SYMPT INV NSI R; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stephens JP, 1992, APPL MULTIVARIATE ST; Sullivan KA, 2017, APPL NEUROPSYCH-ADUL, V24, P522, DOI 10.1080/23279095.2016.1216433; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	37	4	4	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2019	33	9					1165	1172		10.1080/02699052.2019.1637024		JUL 2019	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IO0TH	WOS:000476369300001	31304774				2022-02-06	
J	Driver, S; Juengst, S; Reynolds, M; McShan, E; Kew, CL; Vega, M; Bell, K; Dubiel, R				Driver, Simon; Juengst, Shannon; Reynolds, Megan; McShan, Evan; Kew, Chung Lin; Vega, Marlene; Bell, Kathleen; Dubiel, Randi			Healthy lifestyle after traumatic brain injury: a brief narrative	BRAIN INJURY			English	Article						Traumatic brain injury; health lifestyle; well-being; physical activity; nutrition; sleep; substance abuse; participation; managing stress	BODY-MASS INDEX; PHYSICAL-ACTIVITY; WEIGHT-LOSS; ACUTE REHABILITATION; DECISION-MAKING; ADULT PATIENTS; UNITED-STATES; PUBLIC-HEALTH; FOLLOW-UP; INDIVIDUALS	Individuals living with traumatic brain injury (TBI) are at an increased risk for developing chronic conditions such as diabetes, heart disease, and hypertension compared to the non-injured population. Furthermore, TBI-specific challenges such as physical limitations, pain, mood, and impaired cognition make it difficult to live a healthy lifestyle. Key health behaviors that contribute to overall health and well-being after TBI include physical activity and healthy eating, sleep, participation, eliminating substance abuse, and managing stress. The objectives of this narrative are to (1) describe the key components of a healthy lifestyle for individuals with a TBI, (2) identify the challenges that individuals with TBI face when attempting to establish these health behaviors, and (3) discuss approaches and supports to achieve these health behaviors after TBI, including the role of self-management.	[Driver, Simon; Reynolds, Megan; McShan, Evan; Dubiel, Randi] Baylor Scott & White Inst Rehabil, North Texas TBI Model Syst, Dallas, TX USA; [Juengst, Shannon; Kew, Chung Lin; Vega, Marlene; Bell, Kathleen] Univ Texas Southwestern, North Texas TBI Model Syst, Dallas, TX USA		Driver, S (corresponding author), Baylor Scott & White Inst Rehabil, Dallas, TX 75246 USA.	sjdriver@bswrehab.com	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X; driver, simon/0000-0003-2356-432X; Bell, Kathleen/0000-0002-0928-2046; Kew, Novelle/0000-0003-1720-4459	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB0013]	This work was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research: [Grant Number 90DPTB0013].	Affairs UDoV, 2016, WHOL HLTH LIF; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Barshikar S, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0792-4; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Brenner LA, 2012, J HEAD TRAUMA REHAB, V27, pE57, DOI 10.1097/HTR.0b013e318273414c; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Brown RM, 2018, BRAIN INJURY, V32, P986, DOI 10.1080/02699052.2018.1468575; Centers for Disease Control and Prevention, 2010, PROM PHYS ACT GUID C; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2017, TBI GET FACTS 2016; Chang T, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2852; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Corrigan J, 1999, SUBSTANCE ABUSE BRAI; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Devine JM, 2016, ARCH PHYS MED REHAB, V97, P1392, DOI 10.1016/j.apmr.2016.04.015; Dicianno BE, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7335; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Dobkin BH, 2016, CURR OPIN NEUROL, V29, P693, DOI 10.1097/WCO.0000000000000380; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Dreer LE, 2018, J HEAD TRAUMA REHAB, V33, P246, DOI 10.1097/HTR.0000000000000408; Driver S, 2018, J HEAD TRAUMA REHAB, V33, pE36, DOI 10.1097/HTR.0000000000000327; Driver S, 2017, BRAIN INJURY, V31, P1612, DOI 10.1080/02699052.2017.1346286; Driver S, 2012, BRAIN INJURY, V26, P1482, DOI 10.3109/02699052.2012.694568; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Dunn D., 2015, SOCIAL PSYCHOL DISAB; Duraski SA, 2014, REHABIL NURS, V39, P140, DOI 10.1002/rnj.138; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Faul M, 2010, TRAUMATIC BRAIN INJU; Frosch S, 1997, BRAIN INJURY, V11, P891; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gordon Wayne A, 2015, Handb Clin Neurol, V127, P423, DOI 10.1016/B978-0-444-52892-6.00027-1; Gosling J, 1999, BRAIN INJURY, V13, P785; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Grandner MA, 2016, CURR OPIN CARDIOL, V31, P551, DOI 10.1097/HCO.0000000000000324; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Guercio J, 1999, BRAIN INJURY, V13, P729; Hamilton M, 2015, BRAIN INJURY, V29, P1572, DOI 10.3109/02699052.2015.1075145; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hawley L, 2018, ARCH PHYS MED REHAB, V99, P1441, DOI 10.1016/j.apmr.2018.02.012; Hedden, 2015, BEHAV HLTH TRENDS US; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; High Jr WM, 2005, REHABILITATION TRAUM; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Institute of Medicine, ACCELERATING PROGR O; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Joice Sara, 2012, Nurs Stand, V26, P39; Jones TM, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0039-x; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Juengst SB, 2019, CURR TOP PHYS MED RE, V7; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; Juengst SB, 2014, REHABIL PSYCHOL, V59, P242, DOI 10.1037/a0036294; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Kolotkin RL, 2017, CLIN OBES, V7, P273, DOI 10.1111/cob.12203; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lee H, 2015, BRIT J SPORT MED, V49, P500, DOI 10.1136/bjsports-2013-092930; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Luxton DD, 2011, TELEMED E-HEALTH, V17, P50, DOI 10.1089/tmj.2010.0091; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Masel B., 2014, UNDERSTANDING TRAUMA, P28; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Monden KR, 2016, REHABIL PSYCHOL, V61, P44, DOI 10.1037/rep0000075; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; National Institute of Health   National Institute of Neurological Disorders and Stroke, 2016, TRAUM BRAIN INJ HOP; Norup A, 2015, BRAIN INJURY, V29, P822, DOI 10.3109/02699052.2015.1016451; Office of Disease P Health P, 2010, HLTH PEOPL 2020 ACT; Oyesanya TO, 2016, HEALTH CARE WOMEN IN, V37, P45, DOI 10.1080/07399332.2015.1005307; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Prevention CfDCa, 2017, DIS HLTH HLTH LIV; Promotion OoDPaH, 2014, DIS HLTH; Rao V, 2015, PSYCHIAT TIMES, V32, P30; Rath JF, 2011, REHABIL PSYCHOL, V56, P320, DOI 10.1037/a0025817; Ravesloot CH, 2007, HEALTH EDUC RES, V22, P522, DOI 10.1093/her/cyl114; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Reynolds M, 2018, BRAIN INJURY, V32, P1450, DOI 10.1080/02699052.2018.1496480; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rochon J, 2011, J GERONTOL A-BIOL, V66, P97, DOI 10.1093/gerona/glq168; Roehrs T, 2006, SLEEP, V29, P145, DOI 10.1093/sleep/29.2.145; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Salisbury DB, 2017, ARCH PHYS MED REHAB, V98, P425, DOI 10.1016/j.apmr.2016.09.117; Sallis RE, 2009, BRIT J SPORT MED, V43, P3, DOI 10.1136/bjsm.2008.054825; Sander AM, 2016, ARCH PHYS MED REHAB, V97, P753, DOI 10.1016/j.apmr.2016.01.009; Schieb LJ, 2013, MMWR-MORBID MORTAL W, V62, P721; Schippers M, 2017, OBES REV, V18, P450, DOI 10.1111/obr.12492; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Timmons SD, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.2.FOCUS1888; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Turner AP, 2003, ARCH PHYS MED REHAB, V84, P358, DOI 10.1053/apmr.2003.50107; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Vungkhanching M, 2007, J HEAD TRAUMA REHAB, V22, P167, DOI 10.1097/01.HTR.0000271117.19652.98; Wadden TA, 2006, OBESITY, V14, P737; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Watling J, 2017, BEHAV SLEEP MED, V15, P394, DOI 10.1080/15402002.2016.1141770; Weber M, 2013, J SLEEP DISORD THER, V2, P110, DOI DOI 10.4172/2167-0277.1000110; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; WHO, 1999, HLTH LIV WHAT IS HLT; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Williamson DA, 2017, OBESITY, V25, P1867, DOI 10.1002/oby.21914; Wing RR, 2004, OBES RES, V12, P1426; World Health Organization, 2007, INT CLASS FUNCT DIS; Wulf G, 2016, PSYCHON B REV, V23, P1382, DOI 10.3758/s13423-015-0999-9; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002	142	4	4	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2019	33	10					1299	1307		10.1080/02699052.2019.1641623		JUL 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM5YC	WOS:000476286500001	31296066				2022-02-06	
J	Rojas, N; Lague-Beauvais, M; Belisle, A; Lamoureux, J; AlSideiri, G; Marcoux, J; Maleki, M; Alturki, AY; Anchouche, S; Alquraini, H; Feyz, M; de Guise, E				Rojas, Natalia; Lague-Beauvais, Maude; Belisle, Arielle; Lamoureux, Julie; AlSideiri, Ghusn; Marcoux, Judith; Maleki, Mohammed; Alturki, Abdulrahman Y.; Anchouche, Sonia; Alquraini, Hanan; Feyz, Mitra; de Guise, Elaine			Frontal assessment battery (FAB) performance following traumatic brain injury hospitalized in an acute care setting	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Acute care; executive functions; frontal assessment battery (FAB); outcome; traumatic brain injury	HEAD-INJURY; EXECUTIVE FUNCTIONS; COGNITIVE RESERVE; NEUROPSYCHOLOGICAL ASSESSMENT; ALZHEIMERS-DISEASE; RATING-SCALE; COMA; ASSOCIATION; PREDICTORS; DIAGNOSIS	The Frontal Assessment Battery (FAB) has been shown to be useful in several clinical settings. The aim of the present study was to examine the performance of patients with traumatic brain injury (TBI) on the FAB and to predict their acute outcome. The FAB was administered to 89 patients with mild (27 = uncomplicated and 39 = complicated) and moderate (n = 23) TBI during hospitalization in an acute care setting. The length of stay in days (LOS), Glasgow Outcome Scale-Revised score (GOSE) and Disability Rating Scale (DRS) score were collected. Results showed no significant differences between the three groups on the FAB score, but age and education were significantly associated with the FAB score. Parietal lesions were associated with lower total FAB score, and with the Similarities, Motor series and Conflicting instructions subscales, while frontal lesions were associated with lower performance on the Motor series and Conflicting instructions subscales. Total FAB score was significantly correlated with all outcome measures, and together the FAB total score and the Glasgow Coma Scale (GCS) score explained 30.8% of the variance in the DRS score. The FAB may be useful clinically to acutely assess frontal and parietal lobe functions at bedside in patients with TBI and, in combination with the GCS score to measure TBI severity, can enable clinicians to predict early outcome.	[Rojas, Natalia; Belisle, Arielle; de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Rojas, Natalia; Belisle, Arielle; de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Lague-Beauvais, Maude; Feyz, Mitra] McGill Univ, Traumat Brain Injury Program, Hlth Ctr, Montreal, PQ, Canada; [Lague-Beauvais, Maude; AlSideiri, Ghusn; Marcoux, Judith; Maleki, Mohammed; Alturki, Abdulrahman Y.; Anchouche, Sonia; Alquraini, Hanan] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Lamoureux, Julie] Univ Montreal, Dept Prevent Med, Montreal, PQ, Canada; [Alturki, Abdulrahman Y.] King Fahad Med City, Dept Neurosurg, Natl Neurosci Inst, Riyadh, Saudi Arabia; [de Guise, Elaine] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada		de Guise, E (corresponding author), Univ Montreal, Campus Laval,1700 Rue Jacques Tetreault,Bur 6230, Laval, PQ H7N 0B6, Canada.	elaine.de.guise@umontreal.ca			Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support.	ALBERT MS, 1990, PSYCHOL AGING, V5, P94, DOI 10.1037/0882-7974.5.1.94; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Boban M, 2012, J GERIATR PSYCH NEUR, V25, P201, DOI 10.1177/0891988712464821; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Chevignard M., 2008, Annales de Readaptation et de Medecine Physique, V51, P74, DOI 10.1016/j.annrmp.2007.10.008; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; de Guise E, 2017, BRAIN INJURY, V31, P1061, DOI 10.1080/02699052.2017.1297485; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Finnanger T. G., 2015, BEHAV NEUROL, V329241, P19; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Ghawami H, 2017, APPL NEUROPSYCH-ADUL, V24, P299, DOI 10.1080/23279095.2016.1157078; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Graver CJ, 2011, APPL NEUROPSYCHOL, V18, P278, DOI 10.1080/09084282.2011.595454; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hawkins ML, 2003, AM SURGEON, V69, P497; Ivarone A., 2011, AGING CLIN EXP RES, V23, P5; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kopp B, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-179; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Lagarde J, 2015, BRAIN, V138, P456, DOI 10.1093/brain/awu359; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lima C, 2008, J NEUROL, V255, P1756, DOI 10.1007/s00415-008-0024-6; Livny A, 2017, J NEUROTRAUM, V34, P1466, DOI 10.1089/neu.2016.4598; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Molleis G. M. C. S., 2013, ARQUIVOS NEUROPSIQUI, V71, P380; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Packard Russell C, 2005, Curr Pain Headache Rep, V9, P59, DOI 10.1007/s11916-005-0076-6; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Paviour DC, 2005, NEUROCASE, V11, P274, DOI 10.1080/13554790590962933; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plumet J, 2005, NEUROPSYCHOLOGY, V19, P566, DOI 10.1037/0894-4105.19.5.566; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Regard M., 1981, THESIS; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Soble JR, 2013, APPL NEUROPSYCH-ADUL, V20, P257, DOI 10.1080/09084282.2012.713056; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vaughan L, 2010, PSYCHOL AGING, V25, P343, DOI 10.1037/a0017729; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; Wong A, 2007, J CLIN EXP NEUROPSYC, V29, P160, DOI 10.1080/13803390600582453; Wright J, 2000, DISABILITY RATING SC; Zanto TP, 2013, TRENDS COGN SCI, V17, P602, DOI 10.1016/j.tics.2013.10.001	68	4	4	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JUL 4	2019	26	4					319	330		10.1080/23279095.2017.1422506			12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IL0AC	WOS:000476957400003	29351381				2022-02-06	
J	Liew, TYS; Ng, JX; Jayne, CHZ; Ragupathi, T; Teo, CKA; Yeo, TT				Liew, Terence Yi Song; Ng, Jun Xuan; Jayne, Chan Hui Zhen; Ragupathi, Tharun; Teo, Colin Kok Ann; Yeo, Tseng Tsai			Changing Demographic Profiles of Patients With Traumatic Brain Injury: An Aging Concern	FRONTIERS IN SURGERY			English	Article						demographics; traumatic brain injury; socio-economic burden; elderly; healthcare planning	LONG-TERM SURVIVAL; MORTALITY; EPIDEMIOLOGY; POPULATION; ACCIDENTS; COSTS; RISK	Background: Trauma continues to be a common cause of mortality in Singapore. By understanding the epidemiology of Traumatic Brain Injury (TBI), healthcare professionals can be better equipped to tackle the increasing socioeconomic burden of disease, adopting better strategies in healthcare planning. Methodology: A retrospective review of 367 patients admitted with TBI to a tertiary medical institution from January to December 2014 was performed, studying demographic profiles, injury details and outcomes of these patients. Data was retrieved from the National Trauma Registry and the institution's database. Results: Two hundred thirty-four of the 367 patients included in this study fell into two age groups-19 to 40 years and >= 65 years. 58% of the TBI population were aged >60. Predominant mechanism of injuries in these groups were road traffic accidents and unwitnessed falls respectively. 39% of the Elderly group were on antiplatelet/anticoagulant agents (p < 0.001). While aggressive surgical intervention was more common in younger patients (p < 0.001), the elderly group had significantly longer lengths of hospital stay (p < 0.001). Though Glasgow Outcome Scale (GOS) scores at discharge were not significantly different between the two groups, elderly patients showed greater percentages of post-injury improvement subsequently. Conclusion: The demographics of TBI patients appears to have shifted toward an older population as compared to a decade ago, with an increased incidence of falls, highlighting a huge healthcare concern. We hope that this study will drive further nationwide studies in future, looking at the incidence and prevalence of TBI, and with the focus on tackling preventable causes of TBI.	[Liew, Terence Yi Song; Teo, Colin Kok Ann; Yeo, Tseng Tsai] Univ Surg Cluster, Natl Univ Hosp, Div Neurosurg, Singapore, Singapore; [Ng, Jun Xuan; Jayne, Chan Hui Zhen; Ragupathi, Tharun] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore		Liew, TYS (corresponding author), Univ Surg Cluster, Natl Univ Hosp, Div Neurosurg, Singapore, Singapore.	liew.yisong.terence@gmail.com	Liew, Terence/AAT-6992-2021	Liew, Terence/0000-0002-4307-1429			Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P994, DOI 10.1016/j.apmr.2015.02.003; Buchele G, 2016, J AM MED DIR ASSOC, V17, P609, DOI 10.1016/j.jamda.2016.02.032; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; EISENBERG MG, 1985, PARAPLEGIA, V23, P335, DOI 10.1038/sc.1985.53; Fuller GW, 2016, NEUROEPIDEMIOLOGY, V47, P1, DOI 10.1159/000445997; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Gilasi HR, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.22925; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Kasmaei VM, 2015, EMERGENCY, V3, P141; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Kica J, 2014, J SAFETY RES, V51, P49, DOI 10.1016/j.jsr.2014.09.003; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Lee K. K., 2006, SMJ Singapore Medical Journal, V47, P31; Leong M, 2003, J EMERGENCY MED, V10, P88, DOI DOI 10.1177/102490790301000205; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Lui SK, 2014, REHABIL RES PRACT, V2014, DOI 10.1155/2014/950183; Majdan M, 2013, EUR J PUBLIC HEALTH, V23, P682, DOI 10.1093/eurpub/cks074; Mujuru P, 2006, AM J IND MED, V49, P1039, DOI 10.1002/ajim.20389; Naumann Rebecca B, 2015, N C Med J, V76, P70; Olsen Cody S, 2016, Inj Epidemiol, V3, P8; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Salem AMO, 2013, OCCUP MED-OXFORD, V63, P358, DOI 10.1093/occmed/kqt037; Schoeneberg C, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0045-3; Servadei F, 2015, WORLD NEUROSURG, V83, P732, DOI 10.1016/j.wneu.2015.01.031; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Wee JZ, 2016, SINGAP MED J, V57, P491, DOI 10.11622/smedj.2015162; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008; Yeo YYC, 2009, SINGAP MED J, V50, P278; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	40	4	4	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-875X			FRONT SURG	Front. Surg.	JUL 3	2019	6								37	10.3389/fsurg.2019.00037			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	IH5CA	WOS:000474508900001	31334245	Green Published, gold			2022-02-06	
J	Trsinski, D; Tadinac, M; Bakran, Z; Klepo, I				Trsinski, Dubravko; Tadinac, Meri; Bakran, Zarko; Klepo, Ivana			Utility of the Croatian translation of the community integration questionnaire-revised in a sample of adults with moderate to severe traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Community Integration Questionnaire-Revised; Croatian translation; validity; traumatic brain injury; posttraumatic amnesia	POSTTRAUMATIC AMNESIA DURATION; INTERNATIONAL CLASSIFICATION; PSYCHOMETRIC PROPERTIES; OUTCOME MEASURES; HEAD-INJURY; INDIVIDUALS; PARTICIPATION; DISABILITY; HEALTH; REHABILITATION	Purpose: To examine the utility of the Community Integration Questionnaire-Revised, translated into Croatian, in a sample of adults with moderate to severe traumatic brain injury. Method: The Community Integration Questionnaire-Revised was administered to a sample of 88 adults with traumatic brain injury and to a control sample matched by gender, age and education. Participants with traumatic brain injury were divided into four subgroups according to injury severity. Results: The internal consistency of the Community Integration Questionnaire-Revised was satisfactory. The differences between the group with traumatic brain injury and the control group were statistically significant for the overall Community Integration Questionnaire-Revised score, as well as for all the subscales apart from the Home Integration subscale. The community Integration Questionnaire-Revised score varied significantly for subgroups with different severity of traumatic brain injury. Conclusions: The results show that the Croatian translation of the Community Integration Questionnaire-Revised is useful in assessing participation in adults with traumatic brain injury and confirm previous findings that severity of injury predicts community integration. Results of the new Electronic Social Networking scale indicate that persons who are more active on electronic social networks report better results for other domains of community integration, especially social activities.	[Trsinski, Dubravko; Bakran, Zarko; Klepo, Ivana] Hosp Med Rehabil, Dept Neurol, Krapinske Toplice, Croatia; [Tadinac, Meri] Univ Zagreb, Dept Psychol, Fac Humanities & Social Sci, Zagreb, Croatia		Trsinski, D (corresponding author), Hosp Med Rehabil, Gajeva 2, HR-49210 Krapinske Toplice, Croatia.	trsinski1@gmail.com	Trsinski, Dubravko/AAC-1519-2021	Trsinski, Dubravko/0000-0002-7379-2446; Tadinac, Meri/0000-0002-3770-9000; Klepo, Ivana/0000-0002-9450-9670			Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Callaway L., 2014, COMMUNITY INTEGRATIO; Callaway L, 2016, AUST OCCUP THER J, V63, P143, DOI 10.1111/1440-1630.12284; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Fortune DG, 2016, INT J REHABIL RES, V39, P234, DOI 10.1097/MRR.0000000000000175; Friedland D, 2016, J NEUROL NEUROSUR PS, V87, P1068, DOI 10.1136/jnnp-2015-312193; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Kratz AL, 2015, J SPINAL CORD MED, V38, P446, DOI 10.1179/2045772313Y.0000000182; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Laxe S, 2012, CLIN NEUROL NEUROSUR, V114, P645, DOI 10.1016/j.clineuro.2011.12.038; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lombardi F., 1997, G IT MED RIAB, V11, P23; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Migliorini C, 2016, BRAIN INJURY, V30, P1201, DOI 10.1080/02699052.2016.1175666; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Negahban H, 2013, DISABIL REHABIL, V35, P1453, DOI 10.3109/09638288.2012.741653; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Publications Office of the European Union, 2015, BEING YOUNG EUR TOD; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Roberts CM, 2016, J HEAD TRAUMA REHAB, V31, pE71, DOI 10.1097/HTR.0000000000000154; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saeki S, 2006, J REHABIL MED, V38, P333, DOI 10.1080/16501970600780245; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sandhaug M, 2015, BRAIN INJURY, V29, P915, DOI 10.3109/02699052.2015.1022880; Fraga-Maia HMS, 2015, CIENC SAUDE COLETIVA, V20, P1340, DOI 10.1590/1413-81232015205.08312014; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stein SC, 1996, NEUROTRAUMA; Steiner Emanuel, 2016, J Trauma Manag Outcomes, V10, P5, DOI 10.1186/s13032-016-0035-8; TEASDALE G, 1974, LANCET, V2, P81; Tomaszewski R, 2016, DISABIL REHABIL, V38, P1016, DOI 10.3109/09638288.2015.1070296; Tsaousides T, 2011, BRAIN INJURY, V25, P1155, DOI 10.3109/02699052.2011.613086; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization, 1993, INT CLASS IMP DIS HA; World Health Organization, 2007, INT CLASS FUNCT DIS	55	4	4	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUL 3	2019	41	14					1711	1718		10.1080/09638288.2018.1443349			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HZ1LN	WOS:000468608300012	29475385				2022-02-06	
J	Deng-Bryant, Y; Leung, LY; Madathil, S; Flerlage, J; Yang, FZ; Yang, WH; Gilsdorf, J; Shear, D				Deng-Bryant, Ying; Leung, Lai Yee; Madathil, Sindhu; Flerlage, Jesse; Yang, Fangzhou; Yang, Weihong; Gilsdorf, Janice; Shear, Deborah			Chronic Cognitive Deficits and Associated Histopathology Following Closed-Head Concussive Injury in Rats	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; concussion; cognition; neurobehavior; neurodegeneration	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY DEFICITS; WATER-MAZE; MODEL; NAVIGATION	Close-head concussive injury, as one of the most common forms of traumatic brain injury (TBI), has been shown to induce cognitive deficits that are long lasting. A concussive impact model was previously established in our lab that produces clinically relevant signs of concussion and induced acute pathological changes in rats. To evaluate the long-term effects of repeated concussions in this model, we utilized a comprehensive Morris water maze (MWM) paradigm for cognitive assessments at 1 and 6 months following repeated concussive impacts in rats. As such, adult Sprague-Dawley rats received either anesthesia (sham) or repeated concussive impacts (4 consecutive impacts at 1 h interval). At 1 month post-injury, results of the spatial learning task showed that the average latencies to locate the hidden "escape" platform were significantly longer in the injured rats over the last 2 days of the MWM testing compared to sham controls (p < 0.05). In the memory retention task, rats subjected to repeated concussive impacts also spent significantly less time in the platform zone searching for the missing platform during the probe trial (p < 0.05). On the working memory task, the injured rats showed a trend toward worse performance, but this failed to reach statistical significance compared to sham controls (p = 0.07). At 6 months post-injury, no differences were detected between the injured group and sham controls in either the spatial learning or probe trials. However, rats with repeated concussive impacts exhibited significantly worsened working memory performance compared to sham controls (p < 0.05). In addition, histopathological assessments for axonal neurodegeneration using silver stain showed that repeated concussive impacts induced significantly more axonal degeneration in the corpus callosum compared to sham controls (p < 0.05) at 1 month post-injury, whereas such difference was not observed at 6 months post-injury. Overall, the results show that repeated concussive impacts in our model produced significant cognitive deficits in both spatial learning abilities and in working memory abilities in a time-dependent fashion that may be indicative of progressive pathology and warrant further investigation.	[Deng-Bryant, Ying; Leung, Lai Yee; Madathil, Sindhu; Flerlage, Jesse; Yang, Fangzhou; Yang, Weihong; Gilsdorf, Janice; Shear, Deborah] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Leung, Lai Yee] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Deng-Bryant, Y (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	ying.d.bryant@gmail.com	Madathil, Sindhu K/E-9407-2012		Combat Casualty Care Research Program, United States Army Medical Research and Materiel Command	This project was funded by Combat Casualty Care Research Program, United States Army Medical Research and Materiel Command.	BADDELEY A, 1992, J COGNITIVE NEUROSCI, V4, P281, DOI 10.1162/jocn.1992.4.3.281; Bertisch H, 2019, J HEAD TRAUMA REHAB, V34, P36, DOI 10.1097/HTR.0000000000000399; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Deng-Bryant Y, 2016, METHODS MOL BIOL, V1462, P539, DOI 10.1007/978-1-4939-3816-2_29; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Funahashi S, 2006, NEUROSCIENCE, V139, P251, DOI 10.1016/j.neuroscience.2005.07.003; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Leung LY, 2014, ANN BIOMED ENG, V42, P1618, DOI 10.1007/s10439-014-1014-8; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Pineau H, 2015, BEHAV SCI-BASEL, V5, P43, DOI 10.3390/bs5010043; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016	36	4	4	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 2	2019	10								699	10.3389/fneur.2019.00699			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IG3BQ	WOS:000473675700001	31312174	Green Published, gold			2022-02-06	
J	Baker, M; Quesnele, J; Baldisera, T; Kenrick-Rochon, S; Laurence, M; Grenier, S				Baker, Matthew; Quesnele, Jairus; Baldisera, Tara; Kenrick-Rochon, Shannon; Laurence, Michelle; Grenier, Sylvain			Exploring the role of cervical spine endurance as a predictor of concussion risk and recovery following sports related concussion	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Concussion; Neck; Cervical; Endurance; Injury; Risk	NECK FLEXOR ENDURANCE; VISUAL DISTURBANCES; NORMATIVE DATA; PAIN; RELIABILITY; WHIPLASH; MUSCLES; DIZZINESS; STRENGTH; HOCKEY	Background: Concussions have become a significant public health concern with rising incidence rates. Concussions have been shown to occur concurrently with neck injuries, such as whiplash-associated-disorder, therefore, understanding the role of the neck in concussions is important. Objectives: To determine if there is a relationship between cervical muscle endurance and either concussion incidence, or concussion recovery in university athletes. Specifically, the primary aim was to investigate a relationship between pre-season deep neck flexor endurance test (DNFET) time in those who sustained an in-season injury versus those who did not. The secondary aim is to determine correlation in DNFET times and concussion recovery. Design: Longitudinal observational study. Methods: Pre-season DNFET was performed on university athletes. In the event of a concussion, cervical endurance and neuromuscular adaptation was re-assessed with the DNFET. Rehabilitative exercises were prescribed, as required, and DNFET was measured at subsequent treatments. Results: There was no significant difference between pre-season DNFET times and concussion incidence (p = 0.55). However, there was a moderate correlation between DNFET times and concussion recovery (R = 0.47, p = 0.001) whereby DNFET times improved predictively throughout rehabilitation. Conclusions: While no statistically significant relationship was found between DNFET and concussion incidence, a significant clinical relationship was present with recovery. The validity of the DNFET test as a means for assessing risk or measuring recovery requires additional research.	[Baker, Matthew; Laurence, Michelle; Grenier, Sylvain] Laurentian Univ, Sch Human Kinet, Sudbury, ON, Canada; [Quesnele, Jairus; Baldisera, Tara; Kenrick-Rochon, Shannon] Northern Ontario Sch Med, Sudbury, ON, Canada		Grenier, S (corresponding author), 935 Ramsey Lake Rd, Sudbury, ON, Canada.	sgrenier@laurentian.ca		Baker, Matthew/0000-0001-7974-3365	Northern Ontario Academic Medicine Association, Clinical Opportunities Fund [C-17-2]	The Northern Ontario Academic Medicine Association, Clinical Opportunities Fund, C-17-2 provided funding for this study.	Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Craton N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7090119; de Koning CHP, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-142; Domenech MA, 2011, PM&R, V3, P105, DOI 10.1016/j.pmrj.2010.10.023; Edmondston SJ, 2008, J MANIP PHYSIOL THER, V31, P348, DOI 10.1016/j.jmpt.2008.04.010; Ellis M., 2014, PHYSL VESTIBULO OCUL, P29, DOI [10.3109/02699052.2014.965207, DOI 10.3109/02699052.2014.965207]; Ellis M. J., 2018, CERVICAL SPINE DYSFU, DOI [10.1097/HTR.0000000000000411, DOI 10.1097/HTR.0000000000000411]; Falla DL, 2004, SPINE, V29, P2108, DOI 10.1097/01.brs.0000141170.89317.0e; Gabriel DA, 2006, SPORTS MED, V36, P133, DOI 10.2165/00007256-200636020-00004; Ghamkhar L, 2018, J MANIP PHYSIOL THER, V41, P129, DOI 10.1016/j.jmpt.2017.08.006; Grimmer K, 1994, Aust J Physiother, V40, P251, DOI 10.1016/S0004-9514(14)60461-X; Harris KD, 2005, PHYS THER, V85, P1349, DOI 10.1093/ptj/85.12.1349; Hedayatpour N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/193741; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Ischebeck BK, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1284-4; Jarman NF, 2017, PM&R, V9, P969, DOI 10.1016/j.pmrj.2017.02.002; Jull G, 2004, MANUAL THER, V9, P89, DOI 10.1016/S1356-689X(03)00086-9; Jull G, 2016, MANUAL THER, V25, P43, DOI 10.1016/j.math.2016.05.336; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Juul T, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-339; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Leslie O, 2013, CLIN J SPORT MED, V23, P331, DOI 10.1097/JSM.0b013e318295bbb1; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Martins F, 2018, PM&R, V10, P183, DOI 10.1016/j.pmrj.2017.06.024; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; O'Leary S, 2007, J ORTHOP SPORT PHYS, V37, P3, DOI 10.2519/jospt.2007.2237; Olson LE, 2006, J MANIP PHYSIOL THER, V29, P134, DOI 10.1016/j.jmpt.2005.12.009; Panjabi MM, 2006, EUR SPINE J, V15, P668, DOI 10.1007/s00586-005-0925-3; Parazza S, 2014, CHIROPR MAN THER, V22, DOI 10.1186/2045-709X-22-10; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Piper A., 2009, VERGLEICH AUSDAUERLE, V18, P202; PLACZEK JD, 1999, J MAN MANIP THER, V7, P33, DOI [DOI 10.1179/106698199790811924, DOI 10.1179/]; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Streissguth M, 2019, AMER MADE MUSIC SER, P1, DOI 10.2519/jospt.2019.8582; Team RC, 2014, R LANG ENV STAT COMP; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Treleaven J, 2011, SPINE, V36, pS211, DOI 10.1097/BRS.0b013e3182387f78; Treleaven J, 2011, MANUAL THER, V16, P252, DOI 10.1016/j.math.2010.11.002; Velikonja D., 2017, STANDARDS POSTCONCUS, V93; Zumsteg D, 2006, CAN J NEUROL SCI, V33, P379, DOI 10.1017/S0317167100005333	53	4	4	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	JUL	2019	42						193	197		10.1016/j.msksp.2019.04.002			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	IC2BJ	WOS:000470764100026	31047873				2022-02-06	
J	Borland, ML; Dalziel, SR; Phillips, N; Lyttle, MD; Bressan, S; Oakley, E; Hearps, SJC; Kochar, A; Furyk, J; Cheek, JA; Neutze, J; Gilhotra, Y; Dalton, S; Babl, FE				Borland, Meredith L.; Dalziel, Stuart R.; Phillips, Natalie; Lyttle, Mark D.; Bressan, Silvia; Oakley, Ed; Hearps, Stephen J. C.; Kochar, Amit; Furyk, Jeremy; Cheek, John A.; Neutze, Jocelyn; Gilhotra, Yuri; Dalton, Sarah; Babl, Franz E.		Paediat Res Emergency Dept Int Col	Delayed Presentations to Emergency Departments of Children With Head Injury: A PREDICT Study	ANNALS OF EMERGENCY MEDICINE			English	Article							COMPUTED-TOMOGRAPHY; 24 H	Study objective: Existing clinical decision rules guide management for head-injured children presenting 24 hours or sooner after injury, even though some may present greater than 24 hours afterward. We seek to determine the prevalence of traumatic brain injuries for patients presenting to emergency departments greater than 24 hours after injury and identify symptoms and signs to guide management. Methods: This was a planned secondary analysis of the Australasian Paediatric Head Injury Rule Study, concentrating on first presentations greater than 24 hours after injury, with Glasgow Coma Scale scores 14 and 15. We sought associations with predictors of traumatic brain injury on computed tomography (CT) and clinically important traumatic brain injury. Results: Of 19,765 eligible children, 981 (5.0%) presented greater than 24 hours after injury, and 465 injuries (48.5%) resulted from falls less than 1 m and 37 (3.8%) involved traffic incidents. Features associated significantly with presenting greater than 24 hours after injury in comparison with presenting within 24 hours were nonfrontal scalp hematoma (20.8% versus 18.1%), headache (31.6% versus 19.9%), vomiting (30.0% versus 16.3%), and assault with nonaccidental injury concerns (1.4% versus 0.4%). Traumatic brain injury on CT occurred in 37 patients (3.8%), including suspicion of depressed skull fracture (8 [0.8%]) and intracranial hemorrhage (31 [3.8%]). Clinically important traumatic brain injury occurred in 8 patients (0.8%), with 2 (0.2%) requiring neurosurgery, with no deaths. Suspicion of depressed skull fracture was associated with traumatic brain injury on CT consistently, with the only other significant factor being nonfrontal scalp hematoma (odds ratio 19.0; 95% confidence interval 8.2 to 43.9). Clinically important traumatic brain injury was also associated with nonfrontal scalp hematoma (odds ratio 11.7; 95% confidence interval 2.4 to 58.6) and suspicion of depressed fracture (odds ratio 19.7; 95% confidence interval 2.1 to 182.1). Conclusion: Delayed presentation after head injury, although infrequent, is significantly associated with traumatic brain injury. Evaluation of delayed presentations must consider identified factors associated with this increased risk.	[Borland, Meredith L.] Perth Childrens Hosp, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia; [Dalziel, Stuart R.] Univ Auckland, Starship Childrens Hlth & Liggins Inst, Auckland, New Zealand; [Phillips, Natalie; Gilhotra, Yuri] Lady Cilento Childrens Hosp, Brisbane, Qld, Australia; [Phillips, Natalie] Univ Queensland, Sch Med, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Lyttle, Mark D.; Bressan, Silvia; Oakley, Ed; Hearps, Stephen J. C.; Cheek, John A.; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Lyttle, Mark D.] Bristol Royal Hosp Children, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Acad Dept Emergency Care, Bristol, Avon, England; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Oakley, Ed; Cheek, John A.; Babl, Franz E.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Melbourne, Vic, Australia; [Kochar, Amit] Womens & Childrens Hosp, Adelaide, SA, Australia; [Furyk, Jeremy] Townsville Hosp, Townsville, Qld, Australia; [Neutze, Jocelyn] KidzFirst Middlemore Hosp, Auckland, New Zealand; [Dalton, Sarah] Childrens Hosp Westmead, Sydney, NSW, Australia		Borland, ML (corresponding author), Perth Childrens Hosp, Perth, WA, Australia.; Borland, ML (corresponding author), Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia.; Borland, ML (corresponding author), Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia.	meredith.borland@health.wa.gov.au	Hearps, Stephen/L-6853-2016	Lyttle, Mark/0000-0002-8634-7210; Hearps, Stephen/0000-0003-2984-1172	National Health and Medical Research Council, Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727]; National Health and Medical Research Council (Centre of Research Excellence for Paediatric Emergency Medicine), Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation, Auckland, New Zealand [3112011]; AthornTrust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Royal Children's Hospital Foundation; Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia; NHMRC, Canberra, AustraliaNational Health and Medical Research Council of Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the AthornTrust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; and the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia. The study was supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. Dr. Babl's time was partly funded by a grant from the Royal Children's Hospital Foundation and the Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia, and an NHMRC Practitioner Fellowship, Canberra, Australia. Dr. Dalziel's time was partly funded by the Health Research Council of New Zealand (HRC13/556).	Babl FE, 2005, J PAEDIATR CHILD H, V41, P614, DOI 10.1111/j.1440-1754.2005.00733_6.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Barrow A, 2012, EMERG MED J, V29, P983, DOI 10.1136/emermed-2011-200523; Borczuk P, 1997, ACAD EMERG MED, V4, P342; Christiansen T, 2010, EPIDATA COMPREHENSIV, V3.1; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gelernter R, 2018, INJURY, V49, P82, DOI 10.1016/j.injury.2017.09.012; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hemphill RR, 1999, ACAD EMERG MED, V6, P957, DOI 10.1111/j.1553-2712.1999.tb01248.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lockie FD, 2013, EMERG MED AUSTRALAS, V25, P75, DOI 10.1111/1742-6723.12019; Marincowitz C, 2016, EMERG MED J, V33, P538, DOI 10.1136/emermed-2015-205370; Marincowitz C, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0154-8; Oakley E, 2017, EMERG MED AUSTRALAS, V29, P192, DOI 10.1111/1742-6723.12732; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; RCH, 2017, HEAD INJ GEN ADV; Sellin JN, 2017, CHILD NERV SYST, V33, P647, DOI 10.1007/s00381-016-3332-7; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395	21	4	4	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	JUL	2019	74	1					1	10		10.1016/j.annemergmed.2018.11.035			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IE8BF	WOS:000472598200006	30655017	Bronze			2022-02-06	
J	Connolly, EJ; McCormick, BF				Connolly, Eric J.; McCormick, Brandon F.			Mild Traumatic Brain Injury and Psychopathology in Adolescence: Evidence From the Project on Human Development in Chicago Neighborhoods	JOURNAL OF ADOLESCENT HEALTH			English	Article						Mild traumatic brain injury; Psychopathology; Adolescents; At-risk youth	HEAD-INJURIES; DELINQUENCY; CHILDHOOD; OUTCOMES; AGE	Purpose: Emerging scientific evidence and media accounts document an association between mild traumatic brain injury (mTBI) and deleterious mental health outcomes in adulthood. This study focuses on exploring the relationship between mTBI and increased risk for psychopathology in a sample of adolescent youth. Methods: Longitudinal data from adolescent youth aged 10-18 years (n = 1,827) from the Project on Human Development in Chicago Neighborhoods are analyzed. Multivariate negative binomial regression models are calculated to examine the relationship between mTBI and aggressive behavior, anxiety/depression, attention problems, somatic symptoms, and delinquency. Results: Participants with a mTBI were significantly more likely to demonstrate an increase in symptoms of aggressive behavior, anxiety/depression, and delinquency while controlling for several confounders and prior levels of psychopathology. Conclusions: Our results suggest that mTBI is an important environmental risk factor for increases in psychopathology during adolescence. Health professionals should begin to consider screening children for mTBI to better address the influence of this type of victimization experience on the emergence of symptoms for internalizing and externalizing problems during adolescence. (C) 2019 Society for Adolescent Health and Medicine. All rights reserved.	[Connolly, Eric J.] Sam Houston State Univ, Coll Criminal Justice, Huntsville, TX 77340 USA; [McCormick, Brandon F.] Sam Houston State Univ, Dept Psychol & Philosophy, Huntsville, TX 77340 USA		Connolly, EJ (corresponding author), Sam Houston State Univ, Coll Criminal Justice, Dept Criminal Justice & Criminol, Huntsville, TX 77340 USA.	ejc025@shsu.edu		Connolly, Eric/0000-0003-4714-6739; McCormick, Brandon/0000-0002-3819-1768			Achenbach T. M., MANUAL CHILD BEHAV C; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Bland JM, 1997, BMJ-BRIT MED J, V314, P372; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Earls F, 1997, TECHNICAL REPORT; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Epstein M, 2016, KIDNEY INT SUPPL, V6, P1, DOI 10.1016/j.kisu.2016.01.001; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Gerritsen H, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020364; Kenny DT, 2007, CRIME JUSTICE B, V107, P15; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Leventhal T, 2006, CHILD DEV, V77, P1359, DOI 10.1111/j.1467-8624.2006.00940.x; Leventhal T, 2011, DEV PSYCHOL, V47, P1680, DOI 10.1037/a0025314; Mclnnes K, 2017, PLOS ONE, V12, P1; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; O'Hare W, 2003, GROWING NUMBER KIDS; Orr L., 2003, MOVING OPPORTUNITY I; Peters DJ, 2009, INT REGIONAL SCI REV, V32, P19, DOI 10.1177/0160017608325795; Sampson R.J., 2012, GREAT AMERICAN CITY; Sampson RJ, 2005, AM J PUBLIC HEALTH, V95, P224, DOI 10.2105/AJPH.2004.037705; Sampson RJ, 2008, P NATL ACAD SCI USA, V105, P845, DOI 10.1073/pnas.0710189104; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Schwartz JA, 2019, CURR OPIN PSYCHOL, V27, P67, DOI 10.1016/j.copsyc.2018.09.006; Schwartz JA, 2018, J CRIM JUST, V56, P70, DOI 10.1016/j.jcrimjus.2017.08.004; Schwartz JA, 2017, J RES CRIME DELINQ, V54, P869, DOI 10.1177/0022427817710287; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; StataCorp, 2017, STATA STAT SOFTWARE; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; U.S. Census Bureau, 1995, STAT BRIEF POV AR; Wechsler D., 1974, WECHSLER INTELLIGENC; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wilson William Julius, 1987, TRULY DISADVANTAGED	38	4	4	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	JUL	2019	65	1					79	85		10.1016/j.jadohealth.2018.12.023			7	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	ID9OK	WOS:000472016500016	30879882				2022-02-06	
J	Dayani, Y; Stierwalt, J; White, A; Chen, Y; Arnaud, F; Jefferson, MA; Goforth, C; Malone, D; Scultetus, AH				Dayani, Yaron; Stierwalt, Joshua; White, Andrea; Chen, Ye; Arnaud, Francoise; Jefferson, Michelle A.; Goforth, Carl; Malone, Debra; Scultetus, Anke H.			Hypobaria during aeromedical evacuation exacerbates histopathological injury and modifies inflammatory response in rats exposed to blast overpressure injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	32nd Annual Scientific Assembly of the Eastern-Association-for-Surgery-of-Trauma (EAST)	JAN 15-19, 2019	Austin, TX	Eastern Assoc Surg Trauma		Aeromedical evacuation; blast; TBI; hypobaria	DAMAGE CONTROL; MONOCYTE CHEMOATTRACTANT; OXIDATIVE STRESS; GOLDEN HOUR; CHEMOKINES; LEUKOCYTES; CASUALTIES; SURVIVAL; INCREASE; HYPOXIA	BACKGROUND Aeromedical evacuation (AE) is often used as a rapid and effective way to evacuate patients. However, little is known about the possible effects of AE on patients with blast and traumatic brain injury. In the current study, we used blast overpressure (BOP) as a method to introduce traumatic brain injury in rats and investigated the effects of hypobaria during AE on histology and inflammatory response. METHODS Animals were exposed to a 12-hour flight 2 days after BOP and euthanized 48 hours after flight. Control animals were kept at normobaria. RESULTS Overall, BOP animals exposed to flight demonstrated higher histopathologic injury scores as compared to control animals in lungs, brain, kidney, heart, and intestine. The BOP animals exposed to normobaria exhibited a proinflammatory response compared to those that were not blasted, an observation that was not seen in BOP animals exposed to hypobaria. CONCLUSION These data suggest that AE 48 hours post blast may lead to impairment in the inflammatory process and worsening of long-term outcomes. Copyright (c) 2019 Wolters Kluwer Health, Inc. All rights reserved.	[Dayani, Yaron; Stierwalt, Joshua; White, Andrea; Chen, Ye; Arnaud, Francoise; Goforth, Carl; Malone, Debra; Scultetus, Anke H.] Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Dayani, Yaron; White, Andrea; Chen, Ye; Arnaud, Francoise; Malone, Debra; Scultetus, Anke H.] Uniformed Serv Univ Hlth Sci, Henry M Jackson Fdn Advancement Mil Med, Bethesda, MD 20814 USA; [Stierwalt, Joshua] Uniformed Serv Univ Hlth Sci, Sch Med, Bethesda, MD 20814 USA; [Arnaud, Francoise; Goforth, Carl; Malone, Debra; Scultetus, Anke H.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Jefferson, Michelle A.; Malone, Debra] Walter Reed Army Inst Res, Dept Pathol, Silver Spring, MD USA		Dayani, Y (corresponding author), Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	yaron.dayani.ctr@mail.mil		Harris, Andrea/0000-0001-5812-3108			Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Butler FK, 1996, MIL MED, V161, P3, DOI 10.1093/milmed/161.suppl_1.3; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Choi M, 2018, J TRAUMA ACUTE CARE, V85, pS68, DOI 10.1097/TA.0000000000001909; Clarke JE, 2012, MIL MED, V177, P1261, DOI 10.7205/MILMED-D-11-00120; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; CrockettTorabi E, 1996, EUR J ANAESTH, V13, P235, DOI 10.1046/j.1365-2346.1996.00982.x; Galvagno SM, 2014, MIL MED, V179, P612, DOI 10.7205/MILMED-D-13-00474; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Johnson JW, 2001, J TRAUMA, V51, P261, DOI 10.1097/00005373-200108000-00007; Kotwal RS, 2018, MIL MED, V183, P134, DOI 10.1093/milmed/usx211; Kotwal RS, 2016, JAMA SURG, V151, P15, DOI 10.1001/jamasurg.2015.3104; Kotwal Russ S, 2013, J Spec Oper Med, V13, P85; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Kragh John F Jr, 2011, US Army Med Dep J, P38; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; MEEHAN RT, 1987, ANN EMERG MED, V16, P974, DOI 10.1016/S0196-0644(87)80743-6; Morris M, 1992, J Air Med Transp, V11, P9, DOI 10.1016/S1046-9095(05)80391-5; Nessen SC, 2018, J TRAUMA ACUTE CARE, V85, pS4, DOI 10.1097/TA.0000000000001969; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Proctor JL, 2017, J TRAUMA ACUTE CARE, V83, pS35, DOI 10.1097/TA.0000000000001478; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; SaiRam M, 1998, INT J BIOMETEOROL, V42, P55, DOI 10.1007/s004840050084; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; Scultetus AH, 2016, J TRAUMA ACUTE CARE, V81, P101, DOI 10.1097/TA.0000000000001048; Shapiro MB, 2000, J TRAUMA, V49, P969, DOI 10.1097/00005373-200011000-00033; Skovira JW, 2016, J NEUROTRAUM, V33, P1292, DOI 10.1089/neu.2015.4189; TSAN MF, 1992, AM J PHYSIOL, V263, pL22, DOI 10.1152/ajplung.1992.263.1.L22; Wang Y, 2017, J NEUROTRAUM, V34, P952, DOI 10.1089/neu.2016.4465; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3	40	4	4	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2019	87	1					205	213		10.1097/TA.0000000000002337			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	IH6VR	WOS:000474640900032	31033888				2022-02-06	
J	Furmanski, O; Nieves, MD; Doughty, ML				Furmanski, Orion; Nieves, Michael D.; Doughty, Martin L.			Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Developmental Biology; Issue 149; Traumatic brain injury; cortex; craniectomy; sensorimotor; transplantation; stem cell	MICE; NEURONS; MECHANISMS; DISEASE	Traumatic brain injury (TBI) is a leading cause of morbidity and mortality worldwide. Disease pathology due to TBI progresses from the primary mechanical insult to secondary injury processes, including apoptosis and inflammation. Animal modeling has been valuable in the search to unravel injury mechanisms and evaluate potential neuroprotective therapies. This protocol describes the controlled cortical impact (CCI) model of focal, open-head TBI. Specifically, parameters for producing a mild unilateral cortical injury are described. Behavioral consequences of CCI are analyzed using the adhesive tape removal test of bilateral sensorimotor integration. Regarding experimental therapy for TBI pathology, this protocol also illustrates a process for transplanting cultured cells into the brain. Neural cell cultures derived from human induced pluripotent stem cells (hiPSCs) were chosen for their potential to show superior functional restoration in human TBI patients. Chronic survival of hiPSCs in the host mouse brain tissue is detected using a modified DAB immunohistochemical process.	[Furmanski, Orion; Nieves, Michael D.; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Furmanski, Orion; Nieves, Michael D.; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Nieves, Michael D.; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, Bethesda, MD 20814 USA		Doughty, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.; Doughty, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.; Doughty, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, Bethesda, MD 20814 USA.	martin.doughty@usuhs.edu			Center for Neuroscience and Regenerative Medicine (CNRM)United States Department of Defense [G170244014]	This work was supported by a grant from the Center for Neuroscience and Regenerative Medicine (CNRM, grant number G170244014). We appreciate the assistance of Mahima Dewan and Clara Selbrede in adhesive removal pilot studies. Kryslaine Radomski performed preliminary brain injury and cell transplantation surgeries. Amanda Fu and Laura Tucker of the USU CNRM Preclinical Studies core laboratory provided valuable advice on animal surgeries and behavior testing, respectively.	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Al-Ali H, 2017, J NEUROSCI, V37, P7079, DOI 10.1523/JNEUROSCI.0931-17.2017; ANDERSEN AB, 1990, PHYSIOL BEHAV, V47, P1045, DOI 10.1016/0031-9384(90)90351-4; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fleming SM, 2013, JOVE-J VIS EXP, DOI 10.3791/50303; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/NMETH.1500, 10.1038/nmeth.1500]; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kikuchi T, 2017, NATURE, V548, P592, DOI 10.1038/nature23664; Kondo T, 2014, STEM CELL REP, V3, P242, DOI 10.1016/j.stemcr.2014.05.017; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Lischka FW, 2018, GLIA, V66, P725, DOI 10.1002/glia.23278; Lundell TG, 2009, DEV DYNAM, V238, P3310, DOI 10.1002/dvdy.22165; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Piltti KM, 2015, STEM CELL RES, V15, P341, DOI 10.1016/j.scr.2015.07.001; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Radomski KL, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-142; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tong LM, 2014, J NEUROSCI, V34, P9506, DOI 10.1523/JNEUROSCI.0693-14.2014; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	37	4	4	0	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUL	2019		149							e59561	10.3791/59561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IN6QT	WOS:000478806500018	31355806				2022-02-06	
J	Harmon, LA; Haase, DJ; Kufera, JA; Adnan, S; Cabral, D; Lottenberg, L; Cunningham, KW; Bonne, S; Burgess, J; Rehbein, JL; Semon, G; Noorbakhsh, MR; Cragun, BN; Agrawal, V; Truitt, M; Marcotte, J; Goldenberg, A; Behbahaninia, M; Keric, N; Hammer, PM; Nahmias, J; Grigorian, A; Turay, D; Chakravarthy, V; Lalchandani, P; Kim, D; Chapin, T; Dunn, J; Portillo, V; Schroeppel, T; Stein, DM				Harmon, Laura A.; Haase, Daniel J.; Kufera, Joseph A.; Adnan, Sakib; Cabral, Donna; Lottenberg, Lawrence; Cunningham, Kyle W.; Bonne, Stephanie; Burgess, Jessica; Rehbein, Jennifer L.; Semon, Gregory; Noorbakhsh, Matthew R.; Cragun, Benjamin N.; Agrawal, Vaidehi; Truitt, Michael; Marcotte, Joseph; Goldenberg, Anna; Behbahaninia, Milad; Keric, Natasha; Hammer, Peter M.; Nahmias, Jeffry; Grigorian, Areg; Turay, Dave; Chakravarthy, Vikram; Lalchandani, Priti; Kim, Dennis; Chapin, Trinette; Dunn, Julie; Portillo, Victor; Schroeppel, Thomas; Stein, Deborah M.			Infection after penetrating brain injury-An Eastern Association for the Surgery of Trauma multicenter study oral presentation at the 32nd annual meeting of the Eastern Association for the Surgery of Trauma, January 15-19, 2019, in Austin, Texas	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	32nd Annual Scientific Assembly of the Eastern-Association-for-Surgery-of-Trauma (EAST)	JAN 15-19, 2019	Austin, TX	Eastern Assoc Surg Trauma		Penetrating brain injury; infection; antibiotics; intervention	RISK-FACTORS; EPIDEMIOLOGY; OUTCOMES; WOUNDS	BACKGROUND Fatality rates following penetrating traumatic brain injury (pTBI) are extremely high and survivors are often left with significant disability. Infection following pTBI is associated with worse morbidity. The modern rates of central nervous system infections (INF) in civilian survivors are unknown. This study sought to determine the rate of and risk factors for INF following pTBI and to determine the impact of antibiotic prophylaxis. METHODS Seventeen institutions submitted adult patients with pTBI and survival of more than 72 hours from 2006 to 2016. Patients were stratified by the presence or absence of infection and the use or omission of prophylactic antibiotics. Study was powered at 85% to detect a difference in infection rate of 5%. Primary endpoint was the impact of prophylactic antibiotics on INF. Mantel-Haenszel chi(2) and Wilcoxon's rank-sum tests were used to compare categorical and nonparametric variables. Significance greater than p = 0.2 was included in a logistic regression adjusted for center. RESULTS Seven hundred sixty-three patients with pTBI were identified over 11 years. 7% (n = 51) of patients developed an INF. Sixty-six percent of INF patients received prophylactic antibiotics. Sixty-two percent of all patients received one dose or greater of prophylactic antibiotics and 50% of patients received extended antibiotics. Degree of dural penetration did not appear to impact the incidence of INF (p = 0.8) nor did trajectory through the oropharynx (p = 0.18). Controlling for other variables, there was no statistically significant difference in INF with the use of prophylactic antibiotics (p = 0.5). Infection was higher in patients with intracerebral pressure monitors (4% vs. 12%; p = <0.001) and in patients with surgical intervention (10% vs. 3%; p < 0.001). CONCLUSION There is no reduction in INF with prophylactic antibiotics in pTBI. Surgical intervention and invasive intracerebral pressure monitoring appear to be risk factors for INF regardless of prophylactic use. Copyright (c) 2019 Wolters Kluwer Health, Inc. All rights reserved.)	[Harmon, Laura A.] Univ Colorado, Anschutz Med Ctr, Dept Surg, Aurora, CO USA; [Haase, Daniel J.; Kufera, Joseph A.; Stein, Deborah M.] Univ Maryland, Sch Med, Dept Surg, Trauma,R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Adnan, Sakib] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Cabral, Donna; Lottenberg, Lawrence] Florida Atlantic Univ, Charles E Schmidt Sch Med, St Marys Med Ctr, Boca Raton, FL 33431 USA; [Cunningham, Kyle W.] Carolinas Med Ctr, Dept Surg, Charlotte, NC 28203 USA; [Bonne, Stephanie] Rutgers State Univ, Dept Surg, Div Trauma, Newark, NJ USA; [Burgess, Jessica; Rehbein, Jennifer L.] Eastern Virginia Med Sch, Dept Surg, Div Trauma, Richmond, VA USA; [Semon, Gregory] Wright State Boonshoft Sch Med, Dept Surg, Beavercreek, OH USA; [Noorbakhsh, Matthew R.; Cragun, Benjamin N.] Allegheny Gen Hosp, Dept Surg, Div Trauma, Pittsburgh, PA 15212 USA; [Agrawal, Vaidehi; Truitt, Michael] Methodist Hosp, Dept Surg, Div Trauma, Dallas, TX USA; [Marcotte, Joseph; Goldenberg, Anna] Cooper Hlth, Div Trauma, Dept Surg, Camden, NJ USA; [Behbahaninia, Milad; Keric, Natasha] Banner Hlth Syst, Phoenix, AZ USA; [Hammer, Peter M.] Indiana Univ Sch Med, Dept Surg, Div Trauma, Indianapolis, IN 46202 USA; [Nahmias, Jeffry; Grigorian, Areg] Univ Calif Irvine, Dept Surg, Div Trauma, Orange County, CA USA; [Turay, Dave; Chakravarthy, Vikram] Loma Linda Med Ctr, Dept Surg, Div Trauma, Loma Linda, CA USA; [Lalchandani, Priti; Kim, Dennis] LA Cty Harbor UCLA Med Ctr, Dept Surg, Div Trauma, Los Angeles, CA USA; [Chapin, Trinette; Dunn, Julie] UC Hlth Northern Colorado, Dept Surg, Div Trauma, Loveland, CO USA; [Portillo, Victor] Med City Plano Hosp, Plano, TX USA; [Schroeppel, Thomas] Univ Colorado Hlth, Dept Surg, Div Trauma, Colorado Springs, CO USA		Harmon, LA (corresponding author), Univ Colorado, Anschutz Med Campus,Rm 6203,12631 E 17th Ave, Aurora, CO 80045 USA.	lauraharmon@yahoo.com	Agrawal, Vaidehi/B-8282-2019; Etheridge, James/K-5609-2019; Nahmias, Jeffry/ABA-1850-2020	Agrawal, Vaidehi/0000-0002-1958-630X; Etheridge, James/0000-0002-7807-7812; Nahmias, Jeffry/0000-0003-0094-571X; Cunningham, Kyle/0000-0002-6526-183X; Haase, Daniel/0000-0001-8950-1933; Schroeppel, Thomas/0000-0001-9164-5004			Alvis-Miranda Hernando Raphael, 2016, Bull Emerg Trauma, V4, P65; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; Bertisch H, 2017, ARCH PHYS MED REHAB, V98, P2288, DOI 10.1016/j.apmr.2017.04.006; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cushing H, 1918, Br Med J, V1, P221; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Fang Raymond, 2015, J Trauma Acute Care Surg, V79, pS181, DOI 10.1097/TA.0000000000000769; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; LEVI L, 1990, ISRAEL J MED SCI, V26, P555; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Jimenez CM, 2013, WORLD NEUROSURG, V79, P749, DOI 10.1016/j.wneu.2012.06.025; Marion DW, 2006, NEUROSURGERY, V58, P655; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Tunkel AR, 2017, CLIN INFECT DIS, V64, pE34, DOI 10.1093/cid/ciw861; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; Van Wyck D.W., 2015, J NEUROL NEUROPHYSIO, V6, P336; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179	21	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2019	87	1					61	67		10.1097/TA.0000000000002327			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	IH6VR	WOS:000474640900009					2022-02-06	
J	Ma, H; Lam, PK; Tong, CSW; Lo, KKY; Wong, GKC; Poon, WS				Ma, Hui; Lam, Ping Kuen; Tong, Cindy See Wai; Lo, Kin Ki Yan; Wong, George Kwok Chu; Poon, Wai Sang			The neuroprotection of hypoxic adipose tissue-derived mesenchymal stem cells in experimental traumatic brain injury	CELL TRANSPLANTATION			English	Article						Traumatic brain injury; mesenchymal stem cells; hypoxia; topical application	PATHOPHYSIOLOGY; MECHANISMS	Traumatic brain injury is one of the leading causes of mortality and morbidity worldwide. At present there is no effective treatment. Previous studies have demonstrated that topical application of adipose tissue-derived mesenchymal stem cells can improve functional recovery in experimental traumatic brain injury. In this study, we evaluated whether hypoxic preconditioned mesenchymal stem cells could enhance the recovery from traumatic brain injury. Traumatic brain injury was induced with an electromagnetically controlled cortical impact device. Two million mesenchymal stem cells derived from the adipose tissue of transgenic green fluorescent protein Sprague-Dawley rats were cultured under either hypoxic (2.5% O-2 for 18 hours) (N = 30) or normoxic (18% O-2) (N = 30) conditions, then topically applied to the exposed cerebral cortex within 1 hour after traumatic brain injury. A thin layer of fibrin was used to fix the cells in position. No treatment was given to the animals with traumatic brain injury (N = 30). Animals that underwent craniectomy without traumatic brain injury were treated as the sham group (N = 15). Neurological functions were evaluated with water maze, Roto-rod and gait analysis. Animals were sacrificed at days 3, 7, and 14 for microscopic examinations and real-time polymerase chain reaction analysis. The rats treated with hypoxic mesenchymal stem cells showed the greatest improvement in neurological function recovery. More green fluorescent protein-positive cells were found in the injured brain parenchyma treated with hypoxic mesenchymal stem cells that co-expressed glial fibrillary acidic protein, Nestin, and NeuN. Moreover, there was early astrocytosis triggered by the infiltration of more glial fibrillary acidic protein-positive cells and microgliosis was suppressed with fewer ionized calcium binding adapter molecule 1-positive cells in the penumbra region of hypoxic mesenchymal stem cells group at day 3. Compared with normoxic mesenchymal stem cells and traumatic brain injury only groups, there was significantly (p < 0.05) less neuronal death in both the hippocampus and penumbral regions in sections treated with hypoxic mesenchymal stem cells as determined by Cresyl violet and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling staining respectively. The expression of pro-inflammatory genes (interleukin 6, interleukin 1a, interleukin 1b, tumor necrosis factor alpha) was upregulated and apoptotic gene (Caspase-3) expression was suppressed at day 3. Anti-inflammatory (interleukin 10) and anti-apoptotic (BCL2 associated agonist of cell death) gene expression was upregulated at days 7 and 14. Our study showed that a hypoxic precondition enhanced the beneficial effects of mesenchymal stem cells on neurological recovery after traumatic brain injury.	[Ma, Hui; Lam, Ping Kuen; Tong, Cindy See Wai; Lo, Kin Ki Yan; Wong, George Kwok Chu; Poon, Wai Sang] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China; [Ma, Hui; Lam, Ping Kuen; Wong, George Kwok Chu; Poon, Wai Sang] Chow Tai Fook Cheng Yu Tung Surg Stem Cell Res Ct, Dept Surg, Hong Kong, Peoples R China		Poon, WS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Neurosurg,Shatin, Hong Kong, Peoples R China.	wpoon@surgery.cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Wong, George Kwok Chu/L-4344-2016				Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Ejtehadifar M, 2015, ADV PHARM BULL, V5, P141, DOI 10.15171/apb.2015.021; Fotia C, 2015, CYTOTECHNOLOGY, V67, P1073, DOI 10.1007/s10616-014-9731-2; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Lam PK, 2013, J CLIN NEUROSCI, V20, P300, DOI 10.1016/j.jocn.2012.03.028; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mastro-Martinez I, 2015, BRAIN INJURY, V29, P1497, DOI 10.3109/02699052.2015.1053525; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Paquet J, 2015, STEM CELL TRANSL MED, V4, P809, DOI 10.5966/sctm.2014-0180; Rasmussen JG, 2011, CYTOTHERAPY, V13, P318, DOI 10.3109/14653249.2010.506505; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106	20	4	5	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.	JUL	2019	28	7					874	884		10.1177/0963689719855624			11	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	IU5ZQ	WOS:000483666600009	31185737	Green Published, gold			2022-02-06	
J	MacLaughlin, KJ; Barton, GP; Braun, RK; Eldridge, MW				MacLaughlin, Kent J.; Barton, Gregory P.; Braun, Rudolf K.; Eldridge, Marlowe W.			Effect of intermittent hyperoxia on stem cell mobilization and cytokine expression	MEDICAL GAS RESEARCH			English	Article						hyperbaric oxygen; intermittent hyperoxia; inflammation; stem cell; CD133; TNF; leptin; MIP-1 alpha	HYPERBARIC-OXYGEN THERAPY; INFLAMMATORY GENE-EXPRESSION; TRAUMATIC BRAIN-INJURY; BYPASS GRAFT-SURGERY; DIABETIC FOOT; PRECONDITIONING PROTECTS; BONE; MECHANISMS; DIFFERENTIATION; SYMPTOMS	The best known form of oxygen therapy is hyperbaric oxygen (HBO) therapy, which increases both concentration and atmospheric pressure. HBO supports tissue regeneration and is indicated in an increasing number of pathologies. Less known but still showing some promising effects is normobaric oxygen (NBO) therapy, which provides some advantages over HBO including eliminating barotrauma risk, increased ease of administration and a significant cost reduction. However, still little is known about differences and similarities in treatment effects between HBO and NBO. Therefore we tested whether NBO induces a biological response comparable to HBO with a focus on stem progenitor cell mobilization and changes in serum cytokine concentration. We randomly assigned Sprague-Dawley rats into an NBO treatment group (n = 6), and a room air control group (n = 6). The NBO treatment group was exposed to 42% oxygen for 2 hours a day for 10 days. The room air group was concurrently kept at 20.9% oxygen. The frequency and number of stem progenitor cells in peripheral blood were analyzed by flow cytometry. Plasma cytokine expression was analyzed by cytokine array enzyme linked immunosorbent assay. All analyses were performed 24 hours after the final exposure to control for transient post treatment effects. The NBO treatment group showed an increase in circulating CD133(+)/CD45(+) stem progenitor cell frequency and number compared to the room air control group. This rise was largely caused by CD34(-) stem progenitor cells (CD133(+)/CD34(-)/CD45(+)) without changes in the CD34(+) population. The plasma cytokine levels tested were mostly unchanged with the exception of tumor necrosis factor-alpha which showed a decrease 24 hours after the last NBO exposure. These findings support our hypothesis that NBO induces a biological response similar to HBO, affecting serum stem progenitor cell populations and tumor necrosis factor-alpha concentration.	[MacLaughlin, Kent J.; Barton, Gregory P.; Braun, Rudolf K.; Eldridge, Marlowe W.] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; [MacLaughlin, Kent J.; Barton, Gregory P.; Braun, Rudolf K.; Eldridge, Marlowe W.] Univ Wisconsin, John Rankin Lab Pulm Med, Madison, WI 53706 USA		MacLaughlin, KJ (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.; MacLaughlin, KJ (corresponding author), Univ Wisconsin, John Rankin Lab Pulm Med, Madison, WI 53706 USA.	kmaclaughlin@pediatrics.wisc.edu	Barton, Greg/AAS-7503-2021	Barton, Gregory/0000-0001-7471-5488	DODUnited States Department of Defense [N00024-17-C-4318]; NIH-NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL115061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL115061] Funding Source: NIH RePORTER	This work was supported by funding from the DOD, N00024-17-C-4318 (Eldridge), NIH-NHLBI R01 HL115061 (to MWE).	Al Hadi H, 2015, J DENT, V43, P382, DOI 10.1016/j.jdent.2014.10.006; Allen MW, 2015, UNDERSEA HYPERBAR M, V42, P107; Balestra C, 2006, J APPL PHYSIOL, V100, P512, DOI 10.1152/japplphysiol.00964.2005; Boussi-Gross R, 2015, NEUROPSYCHOLOGY, V29, P610, DOI 10.1037/neu0000149; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Camporesi EM, 2014, UNDERSEA HYPERBAR M, V41, P247; Chen XS, 2017, UNDERSEA HYPERBAR M, V44, P235; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Danesh-Sani SA, 2012, J CRANIOFAC SURG, V23, pE483, DOI 10.1097/SCS.0b013e3182668777; Dequanter D, 2013, UNDERSEA HYPERBAR M, V40, P381; Deuchar GA, 2019, TRANSL STROKE RES, V10, P583, DOI 10.1007/s12975-018-0679-y; Donati A, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0342-2; Dotsenko EA, 2015, B EXP BIOL MED+, V158, P732, DOI 10.1007/s10517-015-2849-1; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Ennis WJ, 2018, ADV WOUND CARE, V7, P397, DOI 10.1089/wound.2018.0855; Fife CE, 2011, PLAST RECONSTR SURG, V127, p142S, DOI 10.1097/PRS.0b013e3181fb5443; Fosen KM, 2014, ANTIOXID REDOX SIGN, V21, P1634, DOI 10.1089/ars.2014.5940; Hadanny A, 2016, UNDERSEA HYPERBAR M, V43, P21; Hadanny A, 2015, RESTOR NEUROL NEUROS, V33, P471, DOI 10.3233/RNN-150517; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Heyboer M, 2014, STEM CELL RES, V12, P638, DOI 10.1016/j.scr.2014.02.005; Hoge CW, 2015, JAMA INTERN MED, V175, P1241, DOI 10.1001/jamainternmed.2015.1051; Hu SL, 2008, ACTA NEUROCHIR SUPPL, V105, P191; Inanmaz ME, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-85; Kamei N, 2013, J NEUROL SCI, V328, P41, DOI 10.1016/j.jns.2013.02.013; Kendall AC, 2013, UNDERSEA HYPERBAR M, V40, P115; Kendall AC, 2012, EXP CELL RES, V318, P207, DOI 10.1016/j.yexcr.2011.10.014; Lam G, 2017, ADV SKIN WOUND CARE, V30, P181, DOI 10.1097/01.ASW.0000513089.75457.22; Li H, 2015, OTOLARYNG HEAD NECK, V153, P606, DOI 10.1177/0194599815589072; Li Y, 2011, J CARDIOTHOR VASC AN, V25, P908, DOI 10.1053/j.jvca.2011.06.017; Liang Y, 2016, ARCH ORAL BIOL, V68, P123, DOI 10.1016/j.archoralbio.2016.04.007; Margolis DJ, 2013, DIABETES CARE, V36, P1961, DOI 10.2337/dc12-2160; Miller RS, 2015, JAMA INTERN MED, V175, P1240, DOI 10.1001/jamainternmed.2015.1048; Milovanova TN, 2008, MOL CELL BIOL, V28, P6248, DOI 10.1128/MCB.00795-08; Milovanova TN, 2009, J APPL PHYSIOL, V106, P711, DOI 10.1152/japplphysiol.91054.2008; Muhonen A, 2004, INT J ORAL MAX SURG, V33, P173, DOI 10.1054/ijom.2003.0489; Nagatomo F, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/381763; Nakanishi M, 2009, ANN PLAS SURG, V63, P331, DOI 10.1097/SAP.0b013e3181934951; Niyibizi E, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0553-5; Sawai T, 1996, J ORAL MAXIL SURG, V54, P975, DOI 10.1016/S0278-2391(96)90396-1; Shi M, 2009, STEM CELLS, V27, P949, DOI 10.1002/stem.4; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Tal S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00508; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Thom SR, 2016, DIABETES, V65, P486, DOI 10.2337/db15-0517; Thom SR, 2011, WOUND REPAIR REGEN, V19, P149, DOI 10.1111/j.1524-475X.2010.00660.x; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Undersea and Hyperbaric Medicine Society (UHMS), IND HYP OX THER; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Wu N, 2018, AM J TRANSL RES, V10, P4082; Xu B, 2018, J CARDIOVASC TRANSL, V11, P285, DOI 10.1007/s12265-018-9817-x; Yu M, 2015, J PHYS THER SCI, V27, P3271, DOI 10.1589/jpts.27.3271; Yu QH, 2016, BIOCHEM BIOPH RES CO, V478, P93, DOI 10.1016/j.bbrc.2016.07.087; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zhao D, 2017, CLIN THER, V39, P2088, DOI 10.1016/j.clinthera.2017.08.014; Zhou BC, 2016, NEURAL REGEN RES, V11, P1445, DOI 10.4103/1673-5374.191218	59	4	4	0	5	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	JUL-SEP	2019	9	3					139	144		10.4103/2045-9912.266989			6	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	JA1BV	WOS:000487553200007	31552878	Green Published			2022-02-06	
J	Morte, D; Lammers, D; Bingham, J; Kuckelman, J; Eckert, M; Martin, M				Morte, Douglas; Lammers, Daniel; Bingham, Jason; Kuckelman, John; Eckert, Matthew; Martin, Matthew			Tranexamic acid administration following head trauma in a combat setting: Does tranexamic acid result in improved neurologic outcomes?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	32nd Annual Scientific Assembly of the Eastern-Association-for-Surgery-of-Trauma (EAST)	JAN 15-19, 2019	Austin, TX	Eastern Assoc Surg Trauma		Tranexamic acid; military; trauma; hemorrhage; TBI; neurologic outcomes	BRAIN-INJURY; ACUTE COAGULOPATHY; HEMORRHAGE; RESUSCITATION; MORTALITY; REGISTRY; PLACEBO; SHOCK	BACKGROUND Tranexamic acid (TXA) has been shown to decrease mortality and blood product requirements in severely injured patients. Tranexamic acid has also been hypothesized to prevent secondary brain injury in patients with traumatic brain injury. While prior studies have demonstrated improved neurologic outcomes associated with TXA administration in severely injured pediatric patients, no such studies have been performed in adults. METHODS A retrospective review of all adult trauma admissions to North Atlantic Treaty Organization hospitals in Iraq and Afghanistan between 2008 and 2015. Univariate and multivariate analysis was used to identify factors associated with TXA administration. Patients without a documented head Abbreviated Injury Scale (AIS) were excluded. Patients were propensity matched based on demographics, mechanism of injury, Injury Severity Score (AIS/ISS), presenting Glasgow Coma Scale (GCS) score, initial vitals/laboratory values, and initial transfusion requirement. Primary outcomes were in-hospital mortality and neurologic outcomes measured by discharge GCS scores. Secondary outcomes were respiratory failure and rates of thromboembolic events. RESULTS Four thousand four hundred seventy-six injured patients 18 years or older were evaluated. Two hundred sixty-five (5.9%) of these patients required a massive transfusion in the first 24 hours, and 174 (3.9%) received TXA. The TXA patients had significantly higher ISS, more penetrating injuries, lower presenting GCS, higher incidence of severe head injury (AIS > 3), and higher transfusion requirements. Ninety-two patients were included in the propensity matched cohort. Of these, patients who received TXA had significantly lower mortality rate (0% vs. 10.1%, p = 0.02) and improvement of GCS score to 14 to 15, irrespective of admission GCS compared with patients who did not receive TXA (100% vs. 87%, p = 0.01). There were no significant differences in number of thromboembolic events recorded between the two groups. CONCLUSION The TXA administration in adult combat trauma patients was independently associated with decreased mortality and improved neurologic outcomes, with no increase in thromboembolic events. Further study of the possible mechanisms and effect of TXA on brain injury and neurologic outcomes is warranted. Copyright (c) 2019 Wolters Kluwer Health, Inc. All rights reserved.	[Morte, Douglas; Lammers, Daniel; Bingham, Jason; Kuckelman, John; Eckert, Matthew; Martin, Matthew] Madigan Army Med Ctr, Def Hlth Agcy, Dept Gen Surg, Tacoma, WA 98431 USA		Martin, M (corresponding author), US Army, Madigan ArmyMed Ctr, Dept Surg, Med Corps, 9040A Jackson Ave, Joint Base Lewis Mcchord, WA 98431 USA.	traumadoc22@gmail.com		Lammers, Daniel/0000-0002-9489-3633			Alarhayem AQ, 2016, AM J SURG, V212, P1101, DOI 10.1016/j.amjsurg.2016.08.018; Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Derickson MJ, 2018, J TRAUMA ACUTE CARE, V85, pS44, DOI 10.1097/TA.0000000000001861; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eckert MJ, 2014, J TRAUMA ACUTE CARE, V77, P852, DOI 10.1097/TA.0000000000000443; Estcourt LJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009733.pub3; Fakharian E, 2018, WORLD NEUROSURG, V109, pE748, DOI 10.1016/j.wneu.2017.10.075; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Ker K, 2013, BRIT J SURG, V100, P1271, DOI 10.1002/bjs.9193; Ker K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub4; Kuckelman J, 2018, J TRAUMA ACUTE CARE, V85, P91, DOI 10.1097/TA.0000000000001942; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Mahmood A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2073-6; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Stanworth SJ, 2016, BRIT J SURG, V103, P357, DOI 10.1002/bjs.10052; Swendsen H, 2013, J TRAUMA TREAT, V2, P179; Therien SP, 2011, J TRAUMA, V71, pS103, DOI 10.1097/TA.0b013e3182218fd7; Watts S, 2015, SHOCK, V44, P138, DOI 10.1097/SHK.0000000000000409; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023	25	4	4	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2019	87	1					125	129		10.1097/TA.0000000000002269			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	IH6VR	WOS:000474640900019	30908452				2022-02-06	
J	Otto, JL; Peters, ZJ; O'Gallagher, KG; Stewart, LT; Campbell, MS; Bush, N; Belsher, BE; Evatt, DP				Otto, Jean L.; Peters, Zach J.; O'Gallagher, Kevin G.; Stewart, Lindsay T.; Campbell, Marjorie S.; Bush, Nigel; Belsher, Brad E.; Evatt, Daniel P.			Evaluating measures of combat deployment for US Army personnel using various sources of administrative data	ANNALS OF EPIDEMIOLOGY			English	Article						Combat deployment; Measure validation; Administrative data	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; GENDER-DIFFERENCES; MILITARY SERVICE; ACCIDENT DEATH; RISK-FACTORS; IRAQ; AFGHANISTAN; VETERANS; SUPPORT	Purpose: This study's purpose is to inform future research decisions about optimal measures for identifying combat deployments. We aim to evaluate four commonly utilized measures available in population-level administrative data to identify combat deployments in recent military operations among active duty Army personnel. Methods: We compare these measures in three ways: (1) agreement (assessing the extent to which soldiers were differentially identified as combat deployed via each measure); (2) validity (calculating the sensitivity of each measure against a criterion measure); and (3) corroboration (examining how each measure predicted subsequent incidence of traumatic brain injury and post-traumatic stress disorder). Results: We found that using personnel records to identify deployments to Iraq, Afghanistan, and/or Kuwait captured over 98% of combat-related deployments identified via self-reported measures. The addition of Kuwait allowed for detection of nearly 100% of battle injuries, improving sensitivity from 94.5% to 99.8%. However, self-reported combat exposure measures showed the largest differential in subsequent incidence of traumatic brain injury and post-traumatic stress disorder. Completeness and accuracy of different combat deployment measures varied significantly. Conclusions: Using personnel records to identify deployment to Iraq, Afghanistan, and/or Kuwait was the most valid and comprehensive measure of combat deployment. However, self-reported combat exposure measures were more predictive of combat-related outcomes. (C) 2019 Elsevier Inc. All rights reserved.	[Otto, Jean L.; Peters, Zach J.; O'Gallagher, Kevin G.; Stewart, Lindsay T.; Campbell, Marjorie S.; Bush, Nigel; Belsher, Brad E.; Evatt, Daniel P.] Def Hlth Agcy, Psychol Hlth Ctr Excellence, 1335 East West Highway, Silver Spring, MD 20910 USA		Otto, JL (corresponding author), Def Hlth Agcy, Psychol Hlth Ctr Excellence, 1335 East West Highway, Silver Spring, MD 20910 USA.	jean.l.otto.ctr@mail.mil	O'Gallagher, Kevin/AAI-6686-2021	O'Gallagher, Kevin/0000-0003-2692-1521; Bush, Nigel/0000-0002-8137-7998			Abraham JH, 2012, J OCCUP ENVIRON MED, V54, P740, DOI 10.1097/JOM.0b013e318252969a; Armed Forces Health Surveillance Center (AFHSC), 2011, MSMR, V18, P2; [Anonymous], 2004, MSMR, V10, P6; Baiocchi D., 2013, MEASURING ARMY DEPLO; Belasco Amy, 2009, TROOP LEVELS AFGHAN; Bollinger MJ, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0040-6; Bonds T., 2010, ARMY DEPLOYMENTS OIF; Booth-Kewley S, 2012, J NERV MENT DIS, V200, P749, DOI 10.1097/NMD.0b013e318266b7e7; Bullman TA, 2017, TRAFFIC INJ PREV, V18, P369, DOI 10.1080/15389588.2016.1206201; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Fox AB, 2016, PSYCHOL TRAUMA-US, V8, P135, DOI 10.1037/tra0000033; Hannah Fischer, 2015, GUIDE US MILITARY CA; Hoge CW, 2008, AM J EPIDEMIOL, V168, P1095, DOI 10.1093/aje/kwn261; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Internal Revenue Service, 2012, ARM FORC TAX GUID US; Internal Revenue Service, 2014, ARM FORC TAX GUID US; Internal Revenue Service, 2013, ARM FORC TAX GUID US; Ippolito AC, 2017, WOMEN HEALTH ISS, V27, P356, DOI 10.1016/j.whi.2016.12.012; Jacobson IG, 2012, J TRAUMA STRESS, V25, P616, DOI 10.1002/jts.21753; Jones KA, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/741267; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Larson MJ, 2016, MIL MED, V181, P334, DOI 10.7205/MILMED-D-15-00110; MacGregor AJ, 2017, J WOMENS HEALTH, V26, P338, DOI 10.1089/jwh.2014.5130; Maguen S, 2012, J PSYCHIATR RES, V46, P311, DOI 10.1016/j.jpsychires.2011.11.007; Maguen S, 2011, J ANXIETY DISORD, V25, P563, DOI 10.1016/j.janxdis.2011.01.003; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434; McCutchan PK, 2016, ANN EPIDEMIOL, V26, P122, DOI 10.1016/j.annepidem.2015.12.001; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Muralidharan A, 2016, J TRAUMA STRESS, V29, P273, DOI 10.1002/jts.22104; Mustillo SA, 2015, MIL MED, V180, P419, DOI 10.7205/MILMED-D-14-00335; Porter B, 2018, J TRAUMA STRESS, V31, P296, DOI 10.1002/jts.22273; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Reinhard MJ, 2014, MED CARE, V52, pS45, DOI 10.1097/MLR.0000000000000229; Schell TL, 2016, AIR FORCE DEPLOYMENT; Schneider KG, 2014, EVALUATION DEPLOYMEN; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Schoenfeld AJ, 2013, SPINE, V38, P1770, DOI 10.1097/BRS.0b013e31829ef226; Schultz M, 2014, COMPR PSYCHIAT, V55, P1654, DOI 10.1016/j.comppsych.2014.06.003; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Shen Yu-Chu, 2017, BMC Psychol, V5, P32, DOI 10.1186/s40359-017-0201-4; Shen YC, 2010, MIL MED, V175, P763, DOI 10.7205/MILMED-D-10-00086; Smith B, 2007, ANN EPIDEMIOL, V17, P976, DOI 10.1016/j.annepidem.2007.07.102; Smith B, 2009, AM J EPIDEMIOL, V170, P1433, DOI 10.1093/aje/kwp287; Smith TC, 2008, AM J EPIDEMIOL, V168, P1094, DOI 10.1093/aje/kwn262; Smith TC, 2009, ANN EPIDEMIOL, V19, P603, DOI 10.1016/j.annepidem.2009.05.002; Vanneman ME, 2015, MIL MED, V180, P1052, DOI 10.7205/MILMED-D-14-00682; Vasterling JJ, 2016, AM J EPIDEMIOL, V184, P796, DOI 10.1093/aje/kww151; Vaughn-Coaxum R, 2015, PSYCHOL SERV, V12, P241, DOI 10.1037/ser0000026; Vie LL, 2015, BIG DATA-US, V3, P67, DOI 10.1089/big.2014.0055; Vie LL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00934; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Wojcik BE, 2015, MIL MED, V180, P216, DOI 10.7205/MILMED-D-14-00061; Wojcik BE, 2009, MIL MED, V174, P1010, DOI 10.7205/MILMED-D-01-6108	53	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1047-2797	1873-2585		ANN EPIDEMIOL	Ann. Epidemiol.	JUL	2019	35						66	72		10.1016/j.annepidem.2019.04.001			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	IK4SH	WOS:000476576100011	31078385				2022-02-06	
J	Pozdnyakov, DI; Miroshnichenko, KA; Voronkov, AV; Kovaleva, TG				Pozdnyakov, Dmitry I.; Miroshnichenko, Kirill A.; Voronkov, Andey V.; Kovaleva, Tat'yana G.			The Administration of the New Pyrimidine Derivative-4-{2-[2-(3,4-Dimethoxyphenyl)-Vinyl]-6-Ethyl-4-Oxo-5-Phenyl-4H-Pyrimidine-1-Il}Benzsulfamide Restores the Activity of Brain Cells in Experimental Chronic Traumatic Encephalopathy by Maintaining Mitochondrial Function	MEDICINA-LITHUANIA			English	Article						chronic traumatic encephalopathy; pyrimidine derivatives; mitochondrial function	NEUROPATHOLOGY; DYSFUNCTION; MODEL	Background and objectives: To evaluate the effect of a new pyrimidine derivative on the change of mitochondrial function in experimental chronic traumatic encephalopathy. Materials and methods: The study was performed on male mice of the BALB/c line (acute toxicity was assessed) and male rats of the Wistar line, which were modeled chronic traumatic encephalopathy by the method of free fall of the load (weight 150 g from a 50 cm height). The injury to rats was reproduced once a day for 7 days. Further, cognitive functions, changes in sensorimotor deficiency, cerebral blood flow, neuron-specific enolase(NSE), S100 beta, glial fibrillary acidic protein (GFAP) (in blood serum) and beta-amyloid, adenosine triphosphate (ATP) (in brain tissue supernatant) were evaluated. Mitochondrial respiration was also measured. Choline alfoscerate (100 mg/kg) was used as a reference drug. Results: The study found that the use of a new pyrimidine derivative contributed to the preservation of the mitochondrial respirometric function and cognitive functions in rats. In addition, against the administration of test-object marked increase in the concentration of ATP, the velocity of cerebral blood flow was 4.2 times (p < 0.05) and 35.6% (p < 0.05), respectively, as well as reduced concentration and GFAP, NSE, S100 beta, beta-amyloid and sensorimotor deficit at 2.7 (p < 0.05) times; 2 times (p < 0.05); 2.4 times (p < 0.05); of 30.4% (p < 0.05 and 46.5% (p < 0.05), respectively. The LD50 (per os) for the test-object was 4973.56 +/- 573.72 mg/kg. Conclusion: Based on the obtained data, high therapeutic efficacy and low systemic toxicity of the application are assumed 4-{2-[ 2-(3,4-dimethoxyphenyl)-vinyl]-6-ethyl-4-oxo-5-phenyl-4H-pyrimidine-1-Il} benzsulfamide in chronic traumatic encephalopathy.	[Pozdnyakov, Dmitry I.; Miroshnichenko, Kirill A.; Voronkov, Andey V.; Kovaleva, Tat'yana G.] Volgograd State Med Univ, Pyatigorsk Med & Pharmaceut Inst, Pyatigorsk 357532, Russia		Pozdnyakov, DI (corresponding author), Volgograd State Med Univ, Pyatigorsk Med & Pharmaceut Inst, Pyatigorsk 357532, Russia.	pozdniackow.dmitry@yandex.ru	Dmitry, Pozdnyakov/AAN-3278-2020	Dmitry, Pozdnyakov/0000-0002-5595-8182; Voronkov, Andrey/0000-0001-6638-6223			[Anonymous], 2011, TRITON REP; Cantu R., 2019, EXPERT REV NEUROTHER, V27, P1; Decuypere Jean-Paul, 2012, Cells, V1, P284, DOI 10.3390/cells1030284; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Finney DJ., 1952, PROBIT ANAL STAT TRE; Fleming SM, 2013, JOVE-J VIS EXP, DOI 10.3791/50303; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Surguchov A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00003; Sysoev Yu. I, 2018, BIOMEDITSINA, V2, P95; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00223; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Voronkov A. V., 2016, MOD PROBL SCI ED, V5; Voronkov A. V., 2019, INT J ADV RES, V7, P799; Voronkov AV, 2018, RES RESULTS PHARM, V4, P1, DOI [10.3897/rrpharmacology.4.26519, 10.3897/ rrpharmacology.4.26519]; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	29	4	5	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1010-660X	1648-9144		MEDICINA-LITHUANIA	Med. Lith.	JUL	2019	55	7							386	10.3390/medicina55070386			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IQ3NK	WOS:000480658200073	31319603	gold, Green Published			2022-02-06	
J	Safaee, MM; Morshed, RA; Spatz, J; Sankaran, S; Berger, MS; Aghi, MK				Safaee, Michael M.; Morshed, Ramin A.; Spatz, Jordan; Sankaran, Sujatha; Berger, Mitchel S.; Aghi, Manish K.			Interfacility neurosurgical transfers: an analysis of nontraumatic inpatient and emergency department transfers with implications for improvements in care	JOURNAL OF NEUROSURGERY			English	Article						interfacility; neurosurgery; transfer; tertiary care	INTERHOSPITAL TRANSFER; COST; VOLUME; HEMORRHAGE; CENTERS	OBJECTIVE Interfacility neurosurgical transfers to tertiary care centers are driven by a number of variables, including lack of on-site coverage, limited available technology, insurance factors, and patient preference. The authors sought to assess the timing and necessity of surgery and compared transfers to their institution from emergency departments (ED) and inpatient units at other hospitals. METHODS Adult neurosurgical patients who were transferred to a single tertiary care center were analyzed over 12 months. Patients with traumatic injuries or those referred from skilled nursing facilities or rehabilitation centers were excluded. RESULTS A total of 504 transferred patients were included, with mean age 55 years (range 19-92 years); 53% of patients were women. Points of origin were ED in 54% cases and inpatient hospital unit in 46%, with a mean distance traveled for most patients of 119 miles. Broad diagnosis categories included brain tumors (n = 142, 28%), vascular lesions, including spontaneous and hypertensive intracerebral hemorrhage (n = 143, 28%), spinal lesions (n = 126, 25%), hydrocephalus (n = 45, 9%), wound complications (n = 29, 6%), and others (n = 19, 4%). Patients transferred from inpatient units had higher rates of surgical intervention (75% vs 57%, p < 0.001), whereas patients transferred from the ED had higher rates of urgent surgery (20% vs 8%, p < 0.001) and shorter mean time to surgery (3 vs 5 days, p < 0.001). Misdiagnosis rates were higher among ED referrals (11% vs 4%, p = 0.008). Across the same timeframe, patients undergoing elective admission (n = 1986) or admission from the authors' own ED (n = 248) had significantly shorter lengths of stay (p < 0.001) and ICU days (p < 0.001) than transferred patients, as well as a significantly lower total cost ($44,412, $46,163, and $72,175, respectively; p < 0.001). CONCLUSIONS The authors present their 12-month experience from a single tertiary care center without Level I trauma designation. In this cohort, 65% of patients required surgery, but the rates were higher among inpatient referrals, and misdiagnosis rates were higher among ED transfers. These data suggest that admitting nonemergency patients to local hospitals may improve diagnostic accuracy of patients requiring urgent care, more precisely identify patients in need of transfer, and reduce costs. Referring facilities may lack necessary resources or expertise, and the Emergency Medical Treatment and Active Labor Act (EMTALA) obligates tertiary care centers to accept these patients under those circumstances. Telemedicine and integration of electronic medical records may help guide referring hospitals to pursue additional workup, which may eliminate the need for unnecessary transfer and provide additional cost savings.	[Safaee, Michael M.; Morshed, Ramin A.; Spatz, Jordan; Sankaran, Sujatha; Berger, Mitchel S.; Aghi, Manish K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA		Safaee, MM (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	michael.safaee@ucsf.edu					Alaraj A, 2017, NEUROSURGERY, V81, P240, DOI 10.1093/neuros/nyx012; Bekelis K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121191; Byrne RW, 2008, NEUROSURGERY, V62, P709, DOI 10.1227/01.neu.0000317320.79106.7e; Cross DT, 2003, J NEUROSURG, V99, P810, DOI 10.3171/jns.2003.99.5.0810; Dunn LT, 1997, INJURY, V28, P427, DOI 10.1016/S0020-1383(97)00051-X; Holland CM, 2015, NEUROSURGERY, V77, P200, DOI 10.1227/NEU.0000000000000752; Johnston SC, 2000, STROKE, V31, P111, DOI 10.1161/01.STR.31.1.111; Kuhn EN, 2016, NEUROSURGERY, V79, P541, DOI 10.1227/NEU.0000000000001378; Langabeer JR, 2017, J TELEMED TELECARE, V23, P747, DOI 10.1177/1357633X16680541; Lawton MT, 2005, NEUROSURGERY, V57, P9, DOI 10.1227/01.NEU.0000163082.20941.EF; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Lind CRP, 2005, ANZ J SURG, V75, P858, DOI 10.1111/j.1445-2197.2005.03574.x; Madiraju SK, 2017, J SURG RES, V218, P261, DOI 10.1016/j.jss.2017.05.102; McLaughlin N, 2012, NEUROSURGERY, V71, P916, DOI 10.1227/NEU.0b013e31826d5d06; Medford-Davis LN, 2018, AM J EMERG MED, V36, P797, DOI 10.1016/j.ajem.2017.10.024; Menchine MD, 2008, ACAD EMERG MED, V15, P329, DOI 10.1111/j.1553-2712.2008.00071.x; Missios S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092057; Nahed BV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039237; Nakagawa K, 2015, AM J EMERG MED, V33, P512, DOI 10.1016/j.ajem.2015.01.001; Vedantam A, 2016, J NEUROSURG-PEDIATR, V18, P638, DOI 10.3171/2016.5.PEDS16155	20	4	5	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2019	131	1					281	289		10.3171/2018.3.JNS173224			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IJ3XR	WOS:000475838400035	30074453	Bronze			2022-02-06	
J	Satchell, EK; Friedman, SD; Bompadre, V; Poliakov, A; Oron, A; Jinguji, TM				Satchell, Emma K.; Friedman, Seth D.; Bompadre, Viviana; Poliakov, Andrew; Oron, Assaf; Jinguji, Thomas M.			Use of diffusion tension imaging in the evaluation of pediatric concussions	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Sports related concussion; DTI; MRI imaging	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; SYMPTOMS	Objective: To evaluate whether quantitative metrics of white matter fractional anisotropy (FA) and mean diffusivity (MD) were different in patients presenting to our clinic with persistent symptoms after a concussion. Design: Matched control retrospective study. Setting: Primary not-for-profit Institution. Patients: Consecutive patients seen at a primary care institution's Sports Concussion Clinic for sport-related concussion that underwent diffusion tensor imaging. Interventions (Independent variables): Type of sports, days from Injury, number of symptoms, weeks out when Magnetic Resonance Imaging (MRI) ordered, history of psychological issues, length of symptoms, age, sex, MRI imaging data. Main outcome measure: Difference in white matter FA and MD. Results: Seventeen concussion patients, ages 9 and 17 (average = 12.5 years; median = 13 years, 11 males and 6 females), were matched with age and gender controls who had an MRI following a complaint of headache. Patients reported an average of 11.5 concussion symptoms, out of a total possible 22 and were seen at an average of 30 days post injury. No region met tract based spatial statistics criteria for significant differences between concussed and healthy control groups (all p > 0.05). Similarly, when comparing group averages from the atlas based regional summaries, no region met the 0.2 false discovery rate (FDR) threshold for significant differences (the smallest unadjusted p-values were 0.02 for MD and 0.14 for FA). Conclusions: Our results did not show measurable diffusion tensor imaging (DTI) changes with standard clinical data acquisition and quantitative processing for the individual patient. At this time DTI should not be considered a technique that can diagnose concussion within an individual subject.	[Satchell, Emma K.] Tulane Univ, New Orleans, LA 70118 USA; [Friedman, Seth D.; Bompadre, Viviana; Poliakov, Andrew; Jinguji, Thomas M.] Seattle Childrens Hosp, 4800 Sand Point Way NE,M-S 0A-9-120, Seattle, WA 98105 USA; [Oron, Assaf] Inst Dis Modeling, Bellevue, WA USA; [Jinguji, Thomas M.] Univ Washington, Seattle, WA 98195 USA		Bompadre, V (corresponding author), Seattle Childrens Hosp, 4800 Sand Point Way NE,M-S 0A-9-120, Seattle, WA 98105 USA.	viviana.bompadre@seattlechildrens.org			Center for Clinical and Translational Clinical Research Pediatric Pilot Fund Program, Seattle Children's Institute	Center for Clinical and Translational Clinical Research Pediatric Pilot Fund Program, Seattle Children's Institute.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Jones D.K., 2005, CLIN MR NEUROIMAGING, P54; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; Wolfers T, 2018, JAMA PSYCHIAT, V75, P1146, DOI 10.1001/jamapsychiatry.2018.2467; Wu T, 2018, BRAIN IMAGING BEHAV, V12, P962, DOI 10.1007/s11682-017-9752-5; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	23	4	4	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	JUL	2019	42						162	165		10.1016/j.msksp.2019.05.002			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	IC2BJ	WOS:000470764100022	31085066				2022-02-06	
J	Neto, ARS; Valenca, MM				Silva Neto, Angelo R.; Valenca, Marcelo M.			Transcalvarial brain herniation volume as a predictor of posttraumatic hydrocephalus after decompressive craniectomy	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Decompressive craniectomy; Hydrocephalus; Posttraumatic hydrocephalus; Traumatic brain injury	INTRACRANIAL-PRESSURE; INTERHEMISPHERIC HYGROMA; INJURY; HEMICRANIECTOMY	Objectives: In patients undergoing decompressive craniectomy for traumatic brain injury(TBI) there has been reported an incidence of hydrocephalus between 0-45%. There are several radiological and clinical features described in association with development of hydrocephalus. For study the influence of these factors we conducted a retrospective observational single-center cohort study in a tertiary care center with special attention to the transcalvarial herniation(TCH) volume after decompressive craniectomy. Patients and methods: We selected 50 patients that underwent decompressive craniectomy after closed head injury between january 2014 and January 2015. Hydrocephalus was defined as a modified frontal horn index greater than 33%, presence of Gudeman CT scan criteria or insertion of ventriculoperitoneal Shunt. Variables analyzed were: age, post-resuscitation Glasgow coma scale (GCS) score, pupil reactivity, Zunkeller index, presence of hygroma, TCH volume, craniectomy diameter and distance of craniectomy from midline. Logistic regression was used with hydrocephalus as the primary outcome measure. Results: 17 patients developed hydrocephalus (34%). TCH volume after decompression(p < 0.01), subdural hygroma (p < 0.01), lower admission Glasgow Coma Scale score (p = 0.015), unilateral pupil reactivity (p = 0.042) and higher Zumkeller index(p = 0.044) were significant risk factors for hydrocephalus. Logistic regression analysis showed that factors independently associated with the development of hydrocephalus was the TCH volume (odds ratio 11.08; 95%CI 2.10, 58.4; p = 0.0046), and presence of hygroma (odds ratio 49.59; 95%IC 4.1, 459; p = 0.002). Conclusions: There was a clear association between severity of TBI, TCH volume and subdural hygroma with the development of hydrocephalus. Clinicians should follow closely patients with those findings in order to avoid late deterioration.	[Silva Neto, Angelo R.; Valenca, Marcelo M.] Univ Fed Pernambuco, Dept Neuropsychiat, Recife, PE, Brazil; [Silva Neto, Angelo R.] Univ Fed Rio Grande do Norte, Dept Integrated Med, 620 Av Nilo Pecanha, BR-59012300 Natal, RN, Brazil		Neto, ARS (corresponding author), Univ Fed Rio Grande do Norte, Dept Integrated Med, 620 Av Nilo Pecanha, BR-59012300 Natal, RN, Brazil.	angelo.silva@isd.org.br	Neto, Angelo Silva/AAJ-6783-2020; Valenca, Marcelo/A-4302-2013	Neto, Angelo Silva/0000-0002-3819-8951; Valenca, Marcelo/0000-0003-0678-3782			Andrews PJD, 2004, INTENS CARE MED, V30, P1730, DOI 10.1007/s00134-004-2376-4; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; BULLOCK MR, 2006, NEUROSURGERY S, V58; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2011, NEUROSURGERY, V68, pE1777, DOI 10.1227/NEU.0b013e31821787b6; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; GREITZ D, 1993, ACTA RADIOL, V34, P321; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kaufman H H, 1978, Neurosurgery, V2, P136; Liao CC, 2015, MED HYPOTHESES, V84, P183, DOI 10.1016/j.mehy.2014.12.018; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Rekate HL, 2008, J NEUROSURG-PEDIATR, V2, P1, DOI 10.3171/PED/2008/2/7/001; Tanrikulu L, 2015, CLIN NEUROL NEUROSUR, V135, P15, DOI 10.1016/j.clineuro.2015.04.019; Unnerback M, 2018, ACTA NEUROCHIR, V160, P219, DOI 10.1007/s00701-017-3435-2; Valenca MM, 2010, J NEUROSURG, V113, P982, DOI 10.3171/2009.11.JNS09674; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Wang QP, 2016, NEUROSCIENCES, V21, P10, DOI 10.17712/nsj.2016.1.20150543; Wani AA, 2013, PEDIATR NEUROSURG, V49, P287, DOI 10.1159/000363701; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	32	4	4	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2019	182						73	78		10.1016/j.clineuro.2019.05.003			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IF1BT	WOS:000472812800015	31096109				2022-02-06	
J	Suehiro, E; Fujiyama, Y; Kiyohira, M; Haji, K; Ishihara, H; Nomura, S; Suzuki, M				Suehiro, Eiichi; Fujiyama, Yuichi; Kiyohira, Miwa; Haji, Kouhei; Ishihara, Hideyuki; Nomura, Sadahiro; Suzuki, Michiyasu		Japan Neurotrauma Data Bank Comm	Risk of Deterioration of Geriatric Traumatic Brain Injury in Patients Treated with Antithrombotic Drugs	WORLD NEUROSURGERY			English	Article						Antithrombotic drugs; Deterioration; Geriatric traumatic brain injury; Reversal of antithrombotic drugs	PROTHROMBIN COMPLEX CONCENTRATE; PLATELET TRANSFUSION; INTRACRANIAL HEMORRHAGE; ANTICOAGULATED PATIENTS; ANTIPLATELET; REVERSAL; COAGULOPATHY; THERAPY	OBJECTIVE: Developed countries have rapidly aging populations and the use of antithrombotic drugs is increasing. We investigated the effects of antithrombotic drugs and reversal of these drugs in patients with geriatric traumatic brain injury (TBI). METHODS: Age, sex, mechanism of injury, Glasgow Coma Scale on admission, head computed tomography findings, antithrombotic therapy, acute exacerbation, and outcomes at discharge were examined in 711 patients with geriatric TBI, complicated with traumatic intracranial hemorrhage using data from the Japan Neurotrauma Data Bank Project 2015 (JNTDB P2015). These items were compared between patients who did and did not receive antithrombotic therapy. We also conducted a questionnaire survey of reversal of antithrombotic therapy at hospitals participating in the JNTDB P2015. Acute exacerbation was compared in hospitals that did and did not regularly use reversal of this therapy. RESULTS: The major cause of injury was a fall. In head computed tomography, acute subdural hematoma was found in 65.7% of the subjects. Antithrombotic therapy was performed in 30.4% of subjects, and these subjects were significantly older than those who did not receive this therapy; many had a fall as the mechanism of injury, and the level of consciousness was significantly exacerbated with this therapy. In hospitals that performed regular reversal, late exacerbation of the level of consciousness was suppressed. CONCLUSIONS: Patients with geriatric TBI who are given antithrombotic drugs have a risk for late exacerbation, even if initially diagnosed with mild TBI. Therefore, there is a possibility that reversal of antithrombotic drugs is important to suppress the risk of deterioration of patients with TBI.	[Suehiro, Eiichi; Fujiyama, Yuichi; Kiyohira, Miwa; Haji, Kouhei; Ishihara, Hideyuki; Nomura, Sadahiro; Suzuki, Michiyasu] Yamaguchi Univ, Dept Neurosurg, Sch Med, Ube, Yamaguchi, Japan; [Suehiro, Eiichi; Suzuki, Michiyasu; Japan Neurotrauma Data Bank Comm] Japan Neurotrauma Data Bank Comm, Japan Soc Neurotraumatol, Tokyo, Japan		Suehiro, E (corresponding author), Yamaguchi Univ, Dept Neurosurg, Sch Med, Ube, Yamaguchi, Japan.; Suehiro, E (corresponding author), Japan Neurotrauma Data Bank Comm, Japan Soc Neurotraumatol, Tokyo, Japan.	suehiro-nsu@umin.ac.jp		Ishihara, Hideyuki/0000-0002-0208-2412			Akamatsu Yosuke, 2017, No Shinkei Geka, V45, P771, DOI 10.11477/mf.1436203591; Altman J., 2015, ACAD EMERG MED, V22, pS255; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Cabinet Office of Japan, 2017, ANN REP AG SOC; Campiglio L, 2017, NEUROL-CLIN PRACT, V7, P296, DOI 10.1212/CPJ.0000000000000375; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Choi PA, 2017, NEUROSURGERY, V80, P98, DOI 10.1227/NEU.0000000000001401; Cohn B, 2014, J EMERG MED, V46, P410, DOI 10.1016/j.jemermed.2013.08.107; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; Jehan F, 2019, J SURG RES, V236, P224, DOI 10.1016/j.jss.2018.11.050; NAGATA K, 1987, NEURORADIOLOGY, V29, P327, DOI 10.1007/BF00348909; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Shabani S, 2016, WORLD NEUROSURG, V96, P66, DOI 10.1016/j.wneu.2016.08.075; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Steiner T, 2016, LANCET NEUROL, V15, P566, DOI 10.1016/S1474-4422(16)00110-1; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Suehiro Eiichi, 2018, No Shinkei Geka, V46, P1127, DOI 10.11477/mf.1436203880; Toyoda K, 2009, CEREBROVASC DIS, V27, P151, DOI 10.1159/000177924; Uccella L, 2018, WORLD NEUROSURG, V110, pE339, DOI 10.1016/j.wneu.2017.10.173; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Verschoof MA, 2018, J NEUROL, V265, P315, DOI 10.1007/s00415-017-8701-y; Watson VL, 2017, NEUROSURGERY, V81, P899, DOI 10.1093/neuros/nyx072; Yanamadala V, 2014, J CLIN NEUROSCI, V21, P1881, DOI 10.1016/j.jocn.2014.05.001; Yokobori S, 2016, WORLD NEUROSURG, V86, P127, DOI 10.1016/j.wneu.2015.09.105	30	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2019	127						E1221	E1227		10.1016/j.wneu.2019.04.108			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IF5NH	WOS:000473128300153	31009773				2022-02-06	
J	Toney, NA; Bell, MJ; Belle, SH; Hardison, RM; Rodriguez-Baez, N; Loomes, KM; Vodovotz, Y; Zamora, R; Squires, RH; Bukauskas, K; Schulte, M; Narkewicz, MR; Hite, M; Rand, EB; Piccoli, D; Kawchak, D; Seidman, C; Romero, R; Karpen, S; de la Cruz-Tracy, L; Ng, V; Hunt, K; Subbarao, GC; Klipsch, A; Munson, S; Alonso, EM; Sorenson, L; Kelly, S; Neighbors, K; Rosenthal, PJ; Fleck, S; Leonis, MA; Bucuvalas, J; Horning, T; Baez, NR; Montanye, S; Cowie, M; Horslen, SP; Murray, K; Young, M; Nielson, H; Klein, J; Rudnick, DA; Shepherd, RW; Harris, K; Karpen, SJ; De La Torre, A; Olio, DD; Kelly, D; Lloyd, C; Lobritto, SJ; Bakhsh, S; Jonas, M; Elifoson, SA; Raza, R; Schwarz, KB; Karnsakul, WW; Alford, MK; Dhawan, A; Fitzpatrick, E; Kerkar, NN; Haydel, B; Narayanappa, S; Lopez, MJ; Shieck, V				Toney, Nicole A.; Bell, Michael J.; Belle, Steven H.; Hardison, Regina M.; Rodriguez-Baez, Norberto; Loomes, Kathleen M.; Vodovotz, Yoram; Zamora, Ruben; Squires, Robert H.; Bukauskas, Kathryn; Schulte, Madeline; Narkewicz, Michael R.; Hite, Michelle; Rand, Elizabeth B.; Piccoli, David; Kawchak, Deborah; Seidman, Christa; Romero, Rene; Karpen, Saul; de la Cruz-Tracy, Liezl; Ng, Vicky; Hunt, Kelsey; Subbarao, Girish C.; Klipsch, Ann; Munson, Sarah; Alonso, Estella M.; Sorenson, Lisa; Kelly, Susan; Neighbors, Katie; Rosenthal, Philip J.; Fleck, Shannon; Leonis, Mike A.; Bucuvalas, John; Horning, Tracie; Baez, Norberto Rodriguez; Montanye, Shirley; Cowie, Margaret; Horslen, Simon P.; Murray, Karen; Young, Melissa; Nielson, Heather; Klein, Jani; Rudnick, David A.; Shepherd, Ross W.; Harris, Kathy; Karpen, Saul J.; De La Torre, Alejandro; Olio, Dominic Dell; Kelly, Deirdre; Lloyd, Carla; Lobritto, Steven J.; Bakhsh, Sumerah; Jonas, Maureen; Elifoson, Scott A.; Raza, Roshan; Schwarz, Kathleen B.; Karnsakul, Wikrom W.; Alford, Mary Kay; Dhawan, Anil; Fitzpatrick, Emer; Kerkar, Nanda N.; Haydel, Brandy; Narayanappa, Sreevidya; Lopez, M. James; Shieck, Victoria		Pediat Acute Liver Failure Study G	Hepatic Encephalopathy in Children With Acute Liver Failure: Utility of Serum Neuromarkers	JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION			English	Article						acute liver failure; hepatic encephalopathy; inflammatory markers; neuromarkers; pediatric acute liver failure	NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID; BRAIN; S100B; PROTEIN; S-100B; NSE; BIOMARKERS; OUTCOMES; INJURY	Background: Pediatric acute liver failure (PALF) is a public heath burden, often requiring prolonged hospitalization and liver transplantation. Hepatic encephalopathy (HE) is a complication of PALF with limited diagnostic tools to predict outcomes. Serum neurological markers (neuron-specific enolase, S100 beta, and myelin basic protein) can be elevated in traumatic or ischemic brain injury. We hypothesized that these neuromarkers would be associated with the development of HE in PALF. Methods: PALF study participants enrolled between May 2012 and December 2014 by 12 participating centers were the subjects of this analysis. Daily HE assessments were determined by study investigators. Neurological and inflammatory markers were measured using enzyme-linked immunosorbent assay and MILLIPLEX techniques, respectively. To model encephalopathy, these markers were log(2) transformed and individually examined for association with HE using a generalized linear mixed model with a logit link and random intercept. Results: Eighty-two children had neurological and inflammatory marker levels and HE assessments recorded, with the majority having assessments for 3 days during their illness. An indeterminate diagnosis (29%) was most common and the median age was 2.9 years. Significant associations were observed for HE with S100 beta (odds ratio 1.16, 95% confidence interval [1.03-1.29], P = 0.04) and IL-6 (odds ratio 1.24 [1.11-1.38], P = 0.006). Conclusions: Serum S100 beta and IL-6 are associated with HE in children with PALF. Measuring these markers may assist in assessing neurological injury in PALF, impacting clinical decisions.	[Toney, Nicole A.; Bell, Michael J.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA USA; [Belle, Steven H.; Hardison, Regina M.] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Rodriguez-Baez, Norberto] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Childrens Hlth, Div Gastroenterol Hepatol & Nutr, Dallas, TX USA; [Loomes, Kathleen M.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat,Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Vodovotz, Yoram; Zamora, Ruben] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Squires, Robert H.] Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh,UPMC,Div Gastroenterol, Pittsburgh, PA 15261 USA; [Squires, Robert H.; Bukauskas, Kathryn; Schulte, Madeline] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Narkewicz, Michael R.; Hite, Michelle] Childrens Hosp Colorado, Aurora, CO USA; [Loomes, Kathleen M.; Rand, Elizabeth B.; Piccoli, David; Kawchak, Deborah; Seidman, Christa] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Romero, Rene; Karpen, Saul; de la Cruz-Tracy, Liezl] Emory Univ, Atlanta, GA 30322 USA; [Ng, Vicky; Hunt, Kelsey] Hosp Sick Children, Toronto, ON, Canada; [Subbarao, Girish C.; Klipsch, Ann; Munson, Sarah] Indiana Univ, Riley Hosp, Indianapolis, IN 46204 USA; [Alonso, Estella M.; Sorenson, Lisa; Kelly, Susan; Neighbors, Katie] Lurie Childrens Hosp Chicago, Chicago, IL USA; [Rosenthal, Philip J.; Fleck, Shannon] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Leonis, Mike A.; Bucuvalas, John; Horning, Tracie] Univ Cincinnati, Cincinnati, OH USA; [Baez, Norberto Rodriguez; Montanye, Shirley; Cowie, Margaret] Univ Texas Southwestern, Dallas, TX USA; [Horslen, Simon P.; Murray, Karen; Young, Melissa; Nielson, Heather; Klein, Jani] Univ Washington, Seattle, WA 98195 USA; [Rudnick, David A.; Shepherd, Ross W.; Harris, Kathy] Washington Univ, St Louis, MO 63110 USA; [Karpen, Saul J.; De La Torre, Alejandro] Baylor Coll Med, Houston, TX 77030 USA; [Olio, Dominic Dell; Kelly, Deirdre; Lloyd, Carla] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Lobritto, Steven J.; Bakhsh, Sumerah] Columbia Univ, New York, NY USA; [Jonas, Maureen; Elifoson, Scott A.; Raza, Roshan] Harvard Med Sch, Boston, MA 02115 USA; [Schwarz, Kathleen B.; Karnsakul, Wikrom W.; Alford, Mary Kay] Johns Hopkins Univ, Baltimore, MD USA; [Dhawan, Anil; Fitzpatrick, Emer] Kings Coll Hosp London, London, England; [Kerkar, Nanda N.; Haydel, Brandy; Narayanappa, Sreevidya] Mt Sinai Sch Med, New York, NY USA; [Lopez, M. James; Shieck, Victoria] Univ Michigan, Ann Arbor, MI 48109 USA		Squires, RH (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Gastroenterol Hepatol & Nutr, 4401 Penn Ave,Fac Pavil Room 6116, Pittsburgh, PA 15224 USA.	squiresr@upmc.edu	Horslen, Simon/ABB-9076-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	The authors are also grateful for support from the National Institutes of Health (Edward Doo, MD, Director Liver Disease Research Program, and Averell H. Sherker, MD, Scientific Advisor, Viral Hepatitis and Liver Diseases, DDDN-NIDDK) and for assistance from members of the Data Coordinating Center at the University of Pittsburgh (directed by Steven H. Belle, PhD, MScHyg).	Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Butterworth RF, 2015, J CLIN EXP HEPATOL, V5, pS96, DOI 10.1016/j.jceh.2014.02.004; Butterworth RF, 2011, NEUROCHEM INT, V59, P830, DOI 10.1016/j.neuint.2011.07.014; Chastre A, 2014, LIVER INT, V34, P353, DOI 10.1111/liv.12252; Ciocca M, 2008, ARCH DIS CHILD, V93, P48, DOI 10.1136/adc.2006.115113; Cochran JB, 2007, PEDIATR EMERG CARE, V23, P129, DOI 10.1097/PEC.0b013e3180308f4b; CONN HO, 1977, GASTROENTEROLOGY, V72, P573; D'Agostino Daniel, 2012, Curr Gastroenterol Rep, V14, P262, DOI 10.1007/s11894-012-0260-x; Dennis CV, 2014, METAB BRAIN DIS, V29, P1027, DOI 10.1007/s11011-013-9469-0; Hussain E, 2014, J PEDIATR GASTR NUTR, V58, P449, DOI 10.1097/MPG.0000000000000271; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Isobe-Harima Y, 2008, LIVER INT, V28, P146, DOI 10.1111/j.1478-3231.2007.01604.x; KIMURA T, 1986, ACTA NEUROPATHOL, V70, P17, DOI 10.1007/BF00689509; Ng VL, 2016, J PEDIATR GASTR NUTR, V63, P357, DOI 10.1097/MPG.0000000000001178; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Saleh A., 2007, Eastern Mediterranean Health Journal, V13, P1114; Shiotani S, 2004, TRANSPL P, V36, P2713, DOI 10.1016/j.transproceed.2004.09.030; Soares HD, 2003, J NEUROTRAUM, V20, P1080; Sorensen LG, 2015, J PEDIATR GASTR NUTR, V60, P75, DOI 10.1097/MPG.0000000000000575; Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051; Srivastava A, 2011, J GASTROEN HEPATOL, V26, P979, DOI 10.1111/j.1440-1746.2011.06706.x; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Strauss GI, 2001, LIVER TRANSPLANT, V7, P964, DOI 10.1053/jlts.2001.28742; Studer M, 2015, BRAIN INJURY, V29, P1667, DOI 10.3109/02699052.2015.1075250; Treem William R., 2002, JPGN Journal of Pediatric Gastroenterology and Nutrition, V35, pS33, DOI 10.1097/00005176-200207001-00009; Tsai CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128437; USUI A, 1994, J NEUROL SCI, V123, P134, DOI 10.1016/0022-510X(94)90215-1; Vaquero J, 2003, LIVER TRANSPLANT, V9, P887, DOI 10.1053/jlts.2003.50172; Varrica A, 2015, CNS NEUROL DISORD-DR, V14, P85, DOI 10.2174/1871527314666150116122318; Whitington PFAA, 2003, PAEDIAT LIVER DIS, P107; Wijdicks EFM, 2016, NEW ENGL J MED, V375, P1660, DOI 10.1056/NEJMra1600561; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016; Zamora R, 2016, MOL MED, V22, P821, DOI 10.2119/molmed.2016.00183; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	37	4	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-2116	1536-4801		J PEDIATR GASTR NUTR	J. Pediatr. Gastroenterol. Nutr.	JUL	2019	69	1					108	115		10.1097/MPG.0000000000002351			8	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics	JT6YF	WOS:000501132000024	31058776	Green Accepted			2022-02-06	
J	Brown, J; Thiessen, A; Freeland, T; Brewer, CH				Brown, Jessica; Thiessen, Amber; Freeland, Tonya; Brewer, Chung Hwa			Visual processing patterns of adults with traumatic brain injury when viewing image-based grids and visual scenes	AUGMENTATIVE AND ALTERNATIVE COMMUNICATION			English	Article						Eye-tracking; gist reasoning; attention; working memory	ATTENTION PATTERNS; EYE-MOVEMENTS; ALTERNATIVE COMMUNICATION; SELECTIVE ATTENTION; HUMAN ENGAGEMENT; PEOPLE; AGE; SURVIVORS; MEMORY; IDIOSYNCRASY	Many individuals with traumatic brain injury (TBI) rely on augmentative and alternative communication (AAC) supports to meet functional communication needs. The use of images to display message content may be advantageous for this population, given deficits in literacy, visual processing, and cognition. Grid and visual scene displays are two options for presenting images within AAC systems. Eye-tracking technology was utilized to evaluate the visual processing patterns of 13 adults with a history of TBI and 13 adults without TBI when interpreting themes depicted in grid and visual scene displays. Results indicated that differential processing and effort was required when interpreting the two display types. Both groups of participants required significantly more visual fixation time and exhibited patterns consistent with greater cognitive effort when identifying themes depicted in grids compared to visual scenes (i.e., greater numbers of short fixations). The participants with TBI were overall less efficient than those without TBI when identifying themes presented in both AAC display types. These results add to the growing body of evidence indicating that visual scenes may more effectively represent complex concepts than decontextualized, grid-based images for individuals with TBI. Additional clinical implications are discussed.	[Brown, Jessica] Univ Arizona, Speech Language & Hearing Sci, 1131 E 2nd St, Tucson, AZ 85721 USA; [Thiessen, Amber] Univ Houston, Dept Commun Sci & Disorders, Houston, TX USA; [Freeland, Tonya] Harris Hlth Syst, Houston, TX USA; [Brewer, Chung Hwa] Eden Home Hlth, Bellingham, WA USA		Brown, J (corresponding author), Univ Arizona, Speech Language & Hearing Sci, 1131 E 2nd St, Tucson, AZ 85721 USA.	jessicabrown@email.arizona.edu					ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Ball LJ, 2003, Q J EXP PSYCHOL-A, V56, P1053, DOI 10.1080/02724980244000729; Blackstone S, 2004, AUGMENTATIVE COMMUNI, V16, P1; Brown J, 2015, AUGMENT ALTERN COMM, V31, P15, DOI 10.3109/07434618.2014.995224; Brown JA, 2015, DISABIL REHABIL-ASSI, V10, P378, DOI 10.3109/17483107.2014.921250; Burke R, 2004, BRAIN INJURY, V18, P497, DOI 10.1080/02699050310001645784; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Casey M, 2004, AUGMENTATIVE ALTERNA, DOI DOI 10.1080/07434610410001655553; Chapman S.B, 1995, TRAUMATIC HEAD INJUR, P95; Cook LG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00087; Cowan N, 2010, DEV NEUROPSYCHOL, V35, P447, DOI 10.1080/87565641.2010.494985; Davies D. R., 1984, VARIETIES ATTENTION, P395; Drager KDR, 2004, J SPEECH LANG HEAR R, V47, P1133, DOI 10.1044/1092-4388(2004/084); DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Evans KK, 2011, WIRES COGN SCI, V2, P503, DOI 10.1002/wcs.127; Fager S, 2006, AUGMENT ALTERN COMM, V22, P37, DOI 10.1080/07434610500243990; Fager S. K., 2007, AUGMENTATIVE COMMUNI, P131; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried-Oken M., 1992, J HEAD TRAUMA REHAB, V9, DOI [DOI 10.1097/00001199-199209000-00008, 10.1097/00001199-199209000-00008]; Fried-Oken M, 2012, ASSIST TECHNOL, V24, P56, DOI 10.1080/10400435.2011.648713; Garrett K.L., 1988, AUGMENTATIVE ALTERNA, V4, P104, DOI [10.1080/07434618812331274687, DOI 10.1080/07434618812331274687]; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; Goldberg JH, 1999, INT J IND ERGONOM, V24, P631, DOI 10.1016/S0169-8141(98)00068-7; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hornof AJ, 2002, BEHAV RES METH INS C, V34, P592, DOI 10.3758/BF03195487; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; Kertesz A., 2006, W APHASIA BATTERY RE; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LIGHT J, 1991, AUGMENT ALTERN COMM, V7, P186, DOI DOI 10.1080/07434619112331275893; Light J, 2012, ASSIST TECHNOL, V24, P34, DOI 10.1080/10400435.2011.648717; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Manor BR, 2003, J NEUROSCI METH, V128, P85, DOI 10.1016/S0165-0270(03)00151-1; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; McKelvey ML, 2010, AM J SPEECH-LANG PAT, V19, P22, DOI 10.1044/1058-0360(2009/08-0021); Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; NEISSER U, 1975, COGNITIVE PSYCHOL, V7, P480, DOI 10.1016/0010-0285(75)90019-5; Neisser U., 1967, COGNITIVE PSYCHOL; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Pinto Y, 2013, J VISION, V13, DOI 10.1167/13.3.16; Poole A., 2006, ENCY HUMAN COMPUTER, V1, P211; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; ROEBUCK J, 1979, J SOC HIST, V12, P416, DOI 10.1353/jsh/12.3.416; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Snyder C, 2000, J MED SPEECH-LANG PA, V8, P187; Sohlberg MM, 2001, ANN NY ACAD SCI, V931, P359; Thiessen A, 2019, AM J SPEECH-LANG PAT, V28, P664, DOI 10.1044/2018_AJSLP-18-0086; Thiessen A, 2017, J COMMUN DISORD, V69, P58, DOI 10.1016/j.jcomdis.2017.07.001; Thiessen A, 2017, AM J SPEECH-LANG PAT, V26, P428, DOI 10.1044/2016_AJSLP-16-0024; Thiessen A, 2016, J SPEECH LANG HEAR R, V59, P290, DOI 10.1044/2015_JSLHR-L-14-0115; Thiessen A, 2014, AUGMENT ALTERN COMM, V30, P120, DOI 10.3109/07434618.2014.905798; Thistle JJ, 2013, AUGMENT ALTERN COMM, V29, P235, DOI 10.3109/07434618.2013.815800; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; TYLER SW, 1979, J EXP PSYCHOL-HUM L, V5, P607, DOI 10.1037/0278-7393.5.6.607; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Wallace SE, 2010, PERSPECT AUGMENT ALT, V19, P79; Weiss-Kapp S., 2008, VISUAL LANGUAGE AUTI; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Wilkinson K.M., 2004, AUGMENT ALTERN COMM, V20, P123, DOI 10.1080/07434610410001699717; Wilkinson KM, 2014, J SPEECH LANG HEAR R, V57, P455, DOI 10.1044/2013_JSLHR-L-12-0159; Wilkinson KM, 2012, AUGMENT ALTERN COMM, V28, P137, DOI 10.3109/07434618.2012.704522; Yoon D., 2004, P EYE TRACK RES APPL, P77, DOI DOI 10.1145/968363.968382; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	68	4	4	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0743-4618	1477-3848		AUGMENT ALTERN COMM	Augment. Altern. Commun.	JUL 3	2019	35	3					229	239		10.1080/07434618.2019.1609578		JUN 2019	11	Audiology & Speech-Language Pathology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Rehabilitation	IQ2WB	WOS:000473960300001	31257929				2022-02-06	
J	Viot, S; Camara-Costa, H; Laurence, W; Francillette, L; Toure, H; Brugel, D; Laurent-Vannier, A; Dellatolas, G; Gillibert, A; Meyer, P; Cheyignard, M				Viot, Solene; Camara-Costa, Hugo; Laurence, Watier; Francillette, Leila; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Dellatolas, Georges; Gillibert, Andre; Meyer, Philippe; Cheyignard, Mathilde			Assessment of memory functioning over two years following severe childhood traumatic brain injury: results of the TGE cohort	BRAIN INJURY			English	Article						Severe traumatic brain injury; memory; outcome; longitudinal cohort study; child; adolescent; educational outcome	WORKING-MEMORY; COGNITIVE PREDICTORS; RESOURCE UTILIZATION; HEAD-INJURY; CHILDREN; RECOVERY; SCORE; AGE; OUTCOMES; PERFORMANCE	The aims of this study were (1) to prospectively measure memory functioning following severe childhood Traumatic Brain Injury (TBI), and its evolution over 2 years; (2) to assess demographic and medical factors associated with memory function and recovery; (3) to explore relations between memory and other TBI outcomes. Methods: Children (aged 0-15 years; n= 65) consecutively admitted in a single trauma center over a 3-year period, who survived severe non-inflicted TBI, were included in a prospective longitudinal study. Memory was assessed in 38 children aged 5-15 years at injury, using the Children's Memory Scale at 3, 12, and 24 months post-injury. Results: Mean general memory score was low at 3 months (M = 90.2, SD = 20.3) but within the normal range at 12 and 24 months (M = 100.6, SD = 23.1 and M = 108.6, SD = 24.1, respectively), with high variability. Improvement was stronger for immediate visual memory than for other memory indices. Lower general memory score was associated with higher injury severity, lower intellectual ability and functional status, higher overall disability, and ongoing education. Conclusion: Memory functioning is highly variable following severe childhood TBI, related to injury severity and functional, cognitive and educational outcomes; improvement is significant during the first-year post-injury, but varies according to the type of memory.	[Viot, Solene; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Cheyignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Brain Injury, 14 Rue Val dOsne, F-94410 St Maurice, France; [Viot, Solene; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Cheyignard, Mathilde] Hop St Maurice, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [Camara-Costa, Hugo; Dellatolas, Georges] Univ Paris Sud, Univ Paris Saclay, INSERM, UVSQ,CESP, Paris, France; [Camara-Costa, Hugo; Francillette, Leila; Cheyignard, Mathilde] Sorbonne Univ, LIB, Paris, France; [Laurence, Watier] Univ Paris Saclay, Inst Pasteur, INSERM UVSQ, Biostat Biomath Pharmacoepidemiol & Infect Dis B2, Paris, France; [Gillibert, Andre] Rouen Univ Hosp, Biostat Dept, Rouen, France; [Gillibert, Andre] Univ Paris Sud, CESP, INSERM UMR 1178, Fac Med Paris Sud, Le Kremlin Bicetre, France; [Meyer, Philippe] Hop Necker Enfants Malad, Pediat Anesthesiol Dept, Paris, France; [Meyer, Philippe] Univ Paris 05, Fac Med Rene Descartes, Paris, France; [Cheyignard, Mathilde] Sorbonne Univ, Grp Rech Clin Handicap Cognitif & Readaptat HanCR, Paris, France		Cheyignard, M (corresponding author), Hop St Maurice, Rehabil Dept Children Acquired Brain Injury, 14 Rue Val dOsne, F-94410 St Maurice, France.	mathilde.chevignard@ght94n.fr	Meyer, Philippe/ABE-4242-2020; Dellatolas, Georges/AAW-1377-2021	Meyer, Philippe/0000-0002-3829-6631; Camara-Costa, Hugo/0000-0002-3739-7190	Departement de la Recherche Clinique et du Developpement, AP-HP (Paris) [PHRC 2003, AOM 03018]; French Ministry of Health (Direction Generale de la Sante); French Speaking Society of Research in Children with Disabilities (SFERHE); French Traumatic Brain Injury Society (France Traumatisme Cranien - FTC); French Speaking Society of Physical Medicine and Rehabilitation (SOFMER)	The initial data collection for the initiation of the cohort study was funded by the Departement de la Recherche Clinique et du Developpement, AP-HP (Paris, No. PHRC 2003; AOM 03018). In depth data analyses and manuscript preparation were funded thanks to a co-funding of the French Ministry of Health (Direction Generale de la Sante); studies, assessment and statistics by the national fund for health insurance of salaried workers, the national fund for health insurance of independent workers, the national fund for solidarity and autonomy, and by the National Institute for Prevention and Education for Health, in the call for research projects launched by the IReSP in 2011, and by two grants awarded to Hugo Camara-Costa: one from the French Speaking Society of Research in Children with Disabilities (SFERHE, www.sferhe.org) and one joint grant from the French Traumatic Brain Injury Society (France Traumatisme Cranien -FTC) and the French Speaking Society of Physical Medicine and Rehabilitation (SOFMER, www.sofmer.com).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Castello FV, 1999, CRIT CARE MED, V27, P985, DOI 10.1097/00003246-199905000-00041; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Chevignard M, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000295; Chevignard MP, 2010, CURR OPIN NEUROL, V23, P695, DOI 10.1097/WCO.0b013e328340296f; Cohen M. J., 2001, CMS ECHELLE MEMOIRE; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; de Kloet AJ, 2015, BRAIN INJURY, P1; DeMaster D, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.832; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Gioia GA, 2014, BRIEF INVENTAIRE EVA; Gorman S, 2017, DEV NEUROPSYCHOL, V42, P127, DOI 10.1080/87565641.2017.1315581; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Hawks C, 2016, PEDIATR NEUROL, V61, P46, DOI 10.1016/j.pediatrneurol.2016.05.004; HOLM S, 1979, SCAND J STAT, V6, P65; Johnson D, 2017, APPL NEUROPSYCH-CHIL, V14, P1; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; KAUFMANN CR, 1990, JAMA-J AM MED ASSOC, V263, P69, DOI 10.1001/jama.263.1.69; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Krasny-Pacini A, 2017, DEV NEUROREHABIL, V20, P456, DOI 10.1080/17518423.2016.1265605; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Lah S, 2018, J NEUROTRAUM, V35, P2036, DOI 10.1089/neu.2017.5250; Lah S, 2019, J NEUROPSYCHOL, V13, P253, DOI 10.1111/jnp.12141; Lah S, 2011, BRAIN INJURY, V25, P44, DOI 10.3109/02699052.2010.531693; Lambregts SAM, 2018, BRAIN INJURY, V32, P230, DOI 10.1080/02699052.2017.1406990; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Mazeau M., 2016, NEUROPSYCHOLOGIE TRO; McCauley SR, 2011, J CLIN EXP NEUROPSYC, V33, P639, DOI 10.1080/13803395.2010.547844; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCauley SR, 2010, J INT NEUROPSYCH SOC, V16, P335, DOI 10.1017/S135561770999138X; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; Monahan MC, 2001, ARCH CLIN NEUROPSYCH, V16, P193, DOI 10.1016/S0887-6177(99)00064-5; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Patteau G, 2014, REANIMATION, V23, P507, DOI 10.1007/s13546-014-0920-y; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; R Core Team, 2014, R LANG ENV STAT COMP; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; SAS Institute Inc, 2004, SAS STAT 9 1 US GUID; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Silberg T, 2016, CHILD NEUROPSYCHOL, V22, P600, DOI 10.1080/09297049.2015.1028348; SLATE JR, 1995, PSYCHOL REP, V76, P299, DOI 10.2466/pr0.1995.76.1.299; Streri A, 2013, BEHAV SCI, V3, P154, DOI 10.3390/bs3010154; Tavano A, 2014, BRAIN INJURY, V28, P900, DOI 10.3109/02699052.2014.890742; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; TULVING E, 1987, HUM NEUROBIOL, V6, P67; Tulving E, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p327A; Tulving Endel, 1995, P839; Van Heugten CM, 2006, BRAIN INJURY, V20, P895, DOI 10.1080/02699050600832015; Verger K, 2000, BRAIN INJURY, V14, P495; Verger K, 2001, REV NEUROLOGIA, V33, P30, DOI 10.33588/rn.3301.2001103; Volpe DSJ, 2017, BRAIN INJURY, V31, P1689, DOI 10.1080/02699052.2017.1358398; Wechsler D, 2001, MEM 3 ECHELLE CLIN M; Wechsler D., 2002, ECHELLE INTELLIGENCE; Wechsler D., 1996, ECHELLE INTELLIGENCE; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yvon E, 2018, DEV NEUROREHABIL, V21, P83, DOI 10.1080/17518423.2016.1247923	77	4	4	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2019	33	9					1208	1218		10.1080/02699052.2019.1631485		JUN 2019	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IO0TH	WOS:000473352100001	31237456				2022-02-06	
J	Vik, BMD; Skeie, GO; Specht, K				Vik, Berit Marie Dykesteen; Skeie, Geir Olve; Specht, Karsten			Neuroplastic Effects in Patients With Traumatic Brain Injury After Music-Supported Therapy	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						social interaction; emotional control; neuroplasticity; mTBI; orbitofrontal cortex; music-supported therapy; dynamic causal modeling	CONNECTIVITY; PLASTICITY; DEFICITS	Damage to the orbitofrontal cortex (OFC) often occurs following a traumatic brain injury (TBI) and can lead to complex behavioral changes, including difficulty with attention and concentration. We investigated the effects of musical training on patients with behavioral and cognitive deficits following a mild traumatic brain injury (mTBI) and found significant functional neuro-plastic changes in the OFC's networks. The results from neuropsychological tests revealed an improved cognitive performance. Moreover, six out of seven participants in this group returned to work post intervention and reported improved well-being and social behavior. In this study, we explore the functional changes in OFC following music-supported intervention in reference to connecting networks that may be responsible for enhanced social interaction. Furthermore, we discuss the factor of dopamine release during playing as an element providing a possible impact on the results. The intervention consisted of playing piano, two sessions per week in 8 weeks, 30 min each time, with an instructor. Additional playing was required with a minimum of 15 min per day at home. Mean time playing piano in reference to participant's report was 3 h per week during the intervention period. Three groups participated, one mTBI group (n = 7), two control groups consisting of healthy participants, one with music training (n = 11), and one baseline group without music training (n = 12). Participants in the clinical group had received standardized cognitive rehabilitation treatment during hospitalization without recovering from their impairments. The intervention took place 2 years post injury. All participants were assessed with neuropsychological tests and with both task and resting-state functional magnetic resonance imaging (fMRI) pre-post intervention. The results demonstrated a significant improvement of neuropsychological tests in the clinical group, consistent with fMRI results in which there were functional changes in the orbitofrontal networks (OFC). These changes were concordantly seen both in a simple task fMRI but also in resting-state fMRI, which was analyzed with dynamic causal modeling (DCM). We hypothesized that playing piano, as designed in the training protocol, may provide a positive increase in both well-being and social interaction. We suggest that the novelty of the intervention may have clinical relevance for patients with behavioral problems following a TBI.	[Vik, Berit Marie Dykesteen; Specht, Karsten] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Skeie, Geir Olve] Haukeland Univ Hosp Bergen, Dept Neurol, Bergen, Norway; [Skeie, Geir Olve] Univ Bergen, Grieg Acad Res Ctr Mus Therapy GAMUT, Bergen, Norway; [Specht, Karsten] UiT Arctic Univ Norway, Dept Educ, Tromso, Norway; [Specht, Karsten] Haukeland Univ Hosp Bergen, Mohn Med Imaging & Visualizat Ctr, Bergen, Norway		Vik, BMD (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.	vikmusic@online.no			Research Council of NorwayResearch Council of Norway [217932]	The study was supported by a grant to KS from the Research Council of Norway (217932: It's time for some music).	Agnestig C.-B., 1958, VI SPILLER PIANO; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Brodal HP, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00153; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Christopher L, 2014, BRAIN, V137, P565, DOI 10.1093/brain/awt337; Clark D. L., 2018, BRAIN BEHAV; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Deutsch D., 1982, PSYCHOL MUSIC, P99; Drapeau J, 2017, BRAIN INJURY, V31, P221, DOI 10.1080/02699052.2016.1208846; Friston KJ, 2014, NEUROIMAGE, V94, P396, DOI 10.1016/j.neuroimage.2013.12.009; Goldberg E., 2009, EXECUTIVE BRAIN FRON; Hebb D. O., 1961, BRAIN MECH LEARNING, P37, DOI DOI 10.5962/BHL.TITLE.7220; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; Herholz SC, 2016, CEREB CORTEX, V26, P3125, DOI 10.1093/cercor/bhv138; Heskestad B., 2017, THESIS; Hugdahl K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00430; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Kandilarova S, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00083; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Lehrer J., 2011, NEUROSCIENCE MUSIC; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Ockelford A., 1999, COGNITION ORDER MUSI; Owesson-White C, 2016, J NEUROSCI, V36, P6011, DOI 10.1523/JNEUROSCI.0393-16.2016; Pantos C, 2009, THYROID AND HEART FAILURE: FROM PATHOPHYSIOLOGY TO CLINICS, P131, DOI 10.1007/978-88-470-1143-4_13; Parsons LM, 2005, NEUROPSYCHOLOGIA, V43, P199, DOI 10.1016/j.neuropsychologia.2004.11.007; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Razi A, 2015, NEUROIMAGE, V106, P1, DOI 10.1016/j.neuroimage.2014.11.027; Rolls ET, 2014, EMOTION DECISION MAK; Rudebeck PH, 2013, NEURON, V80, P1519, DOI 10.1016/j.neuron.2013.09.036; Sarkamo T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00245; Schlaug G., 2009, OXFORD HDB MUSIC PSY, P197; Schlaug G., 2009, NEUROSCIENCE MUSIC 3, P372; Sigurdardottir S., 2010, PROSPECTIVE STUDY TR; Sihvonen AJ, 2017, LANCET NEUROL, V16, P648, DOI 10.1016/S1474-4422(17)30168-0; Stewart L, 2008, CLIN MED, V8, P304, DOI 10.7861/clinmedicine.8-3-304; Thaut MH, 2010, MUSIC PERCEPT, V27, P281, DOI 10.1525/MP.2010.27.4.281; Tramo MJ, 2001, SCIENCE, V291, P54, DOI 10.1126/SCIENCE.1056899; Vik BMD, 2018, BRAIN INJURY, V32, P634, DOI 10.1080/02699052.2018.1431842; Vikane E., 2016, THESIS; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zald D. H., 2010, ORBITOFRONTAL CORTEX, DOI [10.1093/acprof:oso/9780198565741.001.0001, DOI 10.1093/ACPROF:OSO/9780198565741.001.0001]; Zatorre R., 2007, COGNITIVE NEUROSCIEN, P231	48	4	4	6	23	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JUN 25	2019	13								177	10.3389/fnhum.2019.00177			11	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IF6BN	WOS:000473166200001	31293405	Green Published, gold			2022-02-06	
J	Fernando, DT; Berecki-Gisolf, J; Newstead, S; Ansari, Z				Fernando, Dasamal Tharanga; Berecki-Gisolf, Janneke; Newstead, Stuart; Ansari, Zahid			Complications, burden and in-hospital death among hospital treated injury patients in Victoria, Australia: a data linkage study	BMC PUBLIC HEALTH			English	Article						Burden; Complications; Death; Hospital-admitted; Injury; Linkage; Outcome; Readmission	CHARLSON COMORBIDITY INDEX; TRAUMATIC BRAIN-INJURY; LENGTH-OF-STAY; PREEXISTING CONDITIONS; DISCHARGE DESTINATION; RISK-FACTORS; DIABETES-MELLITUS; SEVERITY-SCORE; MORTALITY; READMISSIONS	BackgroundA wide range of outcome measures can be calculated for hospital-treated injury patients. These include mortality, use of critical care services, complications, length of stay, treatment costs, readmission and nursing care after discharge. Each address different aspects and phases of injury recovery and can yield vastly different results. This study aims to: (1) measure and report this range of outcomes in hospital-treated injury patients in a defined population; and (2) describe the associations between injury characteristics, socio-demographics and comorbidities and the various outcomes.MethodsA retrospective analysis was conducted of injury-related hospital admissions from July 2012 to June 2014 (152,835 patients) in Victoria, Australia. The admission records were linked within the dataset, enabling follow-up, to assess the outcomes of in-hospital death, burden, complications and 30-day readmissions. Associations between factors and outcomes were determined using univariate regression analysis.ResultsThe proportion of patients who died in hospital was 0.9%, while 26.8% needed post-discharge care. On average patients had 2.4 complications (confidence interval (CI) 2.4-2.5) related to their initial injury, the mean cost of treating a patient was Australian dollars 7013 (CI 6929-7096) and the median length of stay was one day (inter quartile range 1-3). Intensive-care-unit-stay was recorded in 3% of the patients. All-cause 30-day readmissions occurred in 12.3%, non-planned 30-day readmissions in 7.9%, while potentially avoidable 30-day readmissions were observed in 3.2% of the patients. Increasing age was associated with all outcomes. The need for care post-discharge from hospital was highest among children and the oldest age group (85years and over). Injury severity was associated with all adverse outcomes. Increasing number of comorbidities increased the likelihood of all outcomes. Overall, outcomes are shown to differ by age, gender, comorbidities, body region injured, injury type and injury severity, and to a lesser extent by socio-economic areas.ConclusionsOutcomes and risk factors differ depending on the outcome measured, and the method used for measuring the outcome. Similar outcomes measured in different ways produces varying results. Data linkage has provided a valuable platform for a comprehensive overview of outcomes, which can help design and target secondary and tertiary preventive measures.	[Fernando, Dasamal Tharanga; Berecki-Gisolf, Janneke; Newstead, Stuart] Monash Univ, Accid Res Ctr, Clayton Campus,21 Alliance Lane, Clayton, Vic 3800, Australia; [Ansari, Zahid] Victorian Agcy Hlth Informat, 50 Lonsdale St, Melbourne, Vic 3000, Australia		Fernando, DT (corresponding author), Monash Univ, Accid Res Ctr, Clayton Campus,21 Alliance Lane, Clayton, Vic 3800, Australia.	tara.fernando@monash.edu		Fernando, Dasamal/0000-0003-2423-3784	Victorian Injury Surveillance Unit - Victorian Government	This paper is part of a PhD Thesis which is supported by the Victorian Injury Surveillance Unit funded by the Victorian Government.	Aggarwal R, 2016, ANAESTH INTENSIVE TH, V48, P162, DOI 10.5603/AIT.a2016.0031; Ahmad R, 2007, ARCH SURG-CHICAGO, V142, P613, DOI 10.1001/archsurg.142.7.613; [Anonymous], 2018, INJ RES STAT SER, V110; [Anonymous], 2013, INJ RES STAT SER, V86; [Anonymous], 2016, AUSTR BURD DIS STUD, V3; [Anonymous], 2012, INT STAT CLASS DIS R; [Anonymous], 2014, AGE STANDARD; [Anonymous], 2011, CENS POP HOUS SOC IN; [Anonymous], 2017, AUSTR HOSP STAT HLTH, V75; Ben-Tovim D., 2009, MEASURING REPORTING; Bochicchio GV, 2006, WORLD J SURG, V30, P114, DOI 10.1007/s00268-005-0203-x; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Camilloni L, 2008, INT J INJ CONTROL SA, V15, P25, DOI 10.1080/17457300701800118; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Cryer C, 2008, OFFICIAL STAT RES SE, V3; Curtis K, 2006, INJURY, V37, P626, DOI 10.1016/j.injury.2006.02.006; Curtis K, 2014, AUSTRALAS J AGEING, V33, P264, DOI 10.1111/ajag.12059; Donze J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7171; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Ehsani JP, 2006, MED J AUSTRALIA, V184, P551, DOI 10.5694/j.1326-5377.2006.tb00378.x; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FIFE D, 1987, INJURY, V18, P315, DOI 10.1016/0020-1383(87)90050-7; Gabbe BJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-30; Gabbe BJ, 2005, ANZ J SURG, V75, P650, DOI 10.1111/j.1445-2197.2005.03484.x; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Halfon P, 2002, J CLIN EPIDEMIOL, V55, P573, DOI 10.1016/S0895-4356(01)00521-2; Halfon P, 2006, MED CARE, V44, P972, DOI 10.1097/01.mlr.0000228002.43688.c2; Harrison J., 2008, SURVIVAL RISK RATIOS; Henley G, 2009, INJURY TECHNICAL PAP, V10; Hwabejire JO, 2014, JAMA SURG, V149, P1054, DOI 10.1001/jamasurg.2014.473; Institute SAS, 2002, SAS SOFTW VERS 9 4; Jackson TJ, 2009, MED J AUSTRALIA, V191, P544, DOI 10.5694/j.1326-5377.2009.tb03307.x; Jackson TJ, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-48; Kao LS, 2006, AM J SURG, V192, P710, DOI 10.1016/j.amjsurg.2006.08.031; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; Kuwabara K, 2010, J TRAUMA, V68, P463, DOI 10.1097/TA.0b013e3181a60275; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Lin MF, 2013, INFORM SYST RES, V24, P906, DOI 10.1287/isre.2013.0480; Lustenberger T, 2013, BRAIN INJURY, V27, P281, DOI 10.3109/02699052.2012.743178; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; McIlvennan CK, 2015, CIRCULATION, V131, P1796, DOI 10.1161/CIRCULATIONAHA.114.010270; Michel JL, 2009, HEALTH INF MANAG J, V38, P18, DOI 10.1177/183335830903800304; Mitchell RJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4087-0; Moore L, 2008, ANN EMERG MED, V52, P356, DOI 10.1016/j.annemergmed.2007.09.007; Moore L, 2015, ANN SURG, V262, P1123, DOI 10.1097/SLA.0000000000000963; Moore L, 2014, J TRAUMA ACUTE CARE, V77, P322, DOI 10.1097/TA.0000000000000366; Moore L, 2014, ANN SURG, V259, P374, DOI 10.1097/SLA.0b013e31828b0fae; Morris DS, 2014, INJURY, V45, P56, DOI 10.1016/j.injury.2013.04.029; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Savic G, 2017, SPINAL CORD, V55, P891, DOI 10.1038/sc.2017.64; Senn-Reeves JN, 2015, J TRAUMA NURS, V22, P136, DOI 10.1097/JTN.0000000000000124; Spitz G, 2016, J NEUROL NEUROSUR PS, V87, P173, DOI 10.1136/jnnp-2014-309479; StataCorp, 2015, STAT STAT SOFTW REL; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Thompson HJ, 2010, ANN SURG, V252, P370, DOI 10.1097/SLA.0b013e3181df03d6; Tonelli M, 2015, KIDNEY INT, V88, P859, DOI 10.1038/ki.2015.228; Toson B, 2015, J CLIN EPIDEMIOL, V68, P44, DOI 10.1016/j.jclinepi.2014.09.017; Trentino KM, 2013, MED J AUSTRALIA, V199, P543, DOI 10.5694/mja12.11640; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Wu JS, 2008, AM J EMERG MED, V26, P419, DOI 10.1016/j.ajem.2007.06.032	67	4	4	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2458			BMC PUBLIC HEALTH	BMC Public Health	JUN 21	2019	19								798	10.1186/s12889-019-7080-y			21	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	IE6NE	WOS:000472492100004	31226975	Green Published, gold			2022-02-06	
J	Auclair-Pilote, J; Lalande, D; Tinawi, S; Feyz, M; de Guis, E				Auclair-Pilote, Jennyfer; Lalande, Daniel; Tinawi, Simon; Feyz, Mitra; de Guis, Elaine			Satisfaction of basic psychological needs following a mild traumatic brain injury and relationships with post-concussion symptoms, anxiety, and depression	DISABILITY AND REHABILITATION			English	Article						Mild traumatic brain injury; satisfaction; basic psychological needs; anxiety; depression; post-concussion symptoms	SELF-DETERMINATION THEORY; QUALITY-OF-LIFE; GOOD OLD DAYS; POSTCONCUSSION SYNDROME; COMMUNITY INTEGRATION; ACUTE PREDICTORS; STRESS; COMPETENCE; PROGNOSIS; MODERATE	Purpose: Self-determination theory proposes that the satisfaction of basic psychological needs (competence, autonomy, and relatedness) is essential to psychological well-being. This study aims to explore the acute impact of a mild traumatic brain injury on the perception of need satisfaction as well as to better understand which variables among post-concussion symptoms and mood are associated with the satisfaction of these psychological needs. Material and methods: A total of 179 adults with mild traumatic brain injury were included. The Basic Psychological Needs Satisfaction Scale (BPNS) was completed retrospectively to assess need satisfaction pre-injury and after the injury to assess need satisfaction post-injury. The Rivermead Post Concussion Symptoms Questionnaire as well as the Hospital Anxiety and Depression Scale were also completed post injury. Results: A significant difference between the perception of need satisfaction pre- and post- was found on the total BPNS score, with lower scores on the post-injury evaluation (less satisfaction). Moreover, higher levels of depression and anxiety were associated with less satisfaction. Conclusions: These results suggest that sustaining a mild traumatic brain injury may have a negative impact on the satisfaction of competence, autonomy, and relatedness needs. To conclude, it is recommended that these concepts be included in psychological intervention programs following mild traumatic brain injury.	[Auclair-Pilote, Jennyfer; de Guis, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Auclair-Pilote, Jennyfer; de Guis, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Lalande, Daniel] Univ Quebec Chicoutimi, Dept Psychol, Chicoutimi, PQ, Canada; [Tinawi, Simon; Feyz, Mitra] McGill Univ, Traumat Brain Injury Program, Hlth Ctr, Montreal, PQ, Canada; [de Guis, Elaine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada		de Guis, E (corresponding author), Univ Montreal, Campus Laval,1700 Rue Jacques Tetreault,Bur 6230, Laval, PQ H7N 0B6, Canada.	elaine.de.guise@umontreal.ca					Audrit H, 2014, J READAP MED, V34, P109; Bartholomew KJ, 2011, PERS SOC PSYCHOL B, V37, P1459, DOI 10.1177/0146167211413125; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bay EH, 2012, J MARITAL FAM THER, V38, P556, DOI 10.1111/j.1752-0606.2011.00231.x; Campbell R, 2015, PERS INDIV DIFFER, V77, P199, DOI 10.1016/j.paid.2015.01.003; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cicchetti D., 2016, DEV PSYCHOPATHOL, DOI [https://doi.org/10.1002/9781119125556.devpsy109, DOI 10.1002/9781119125556.DEVPSY109]; Cohen J, 1998, STAT POWER ANAL BEHA; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; Curran T, 2013, J SPORT SCI, V31, P597, DOI 10.1080/02640414.2012.742956; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DECI EL, 1985, J RES PERS, V19, P109, DOI 10.1016/0092-6566(85)90023-6; Deci EL, 1980, J MIND BEHAV, V1, P33; Delmonico R, 2017, ARCH PHYSMED REHAB, V98, pe96, DOI DOI 10.1016/J.APMR.2017.08.309; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dwyer LA, 2011, J SOC CLIN PSYCHOL, V30, P24, DOI 10.1521/jscp.2011.30.1.24; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Ilies R, 2017, APPL PSYCHOL-INT REV, V66, P3, DOI 10.1111/apps.12075; In SJ, 2017, 6 INT TAEKW S JUN 29, V2017, P175; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Milyavskaya M, 2009, PERS SOC PSYCHOL B, V35, P1031, DOI 10.1177/0146167209337036; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Perreault S, 2007, INT J SPORT PSYCHOL, V38, P437; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Quested E, 2011, J SPORT EXERCISE PSY, V33, P828, DOI 10.1123/jsep.33.6.828; Rothschild L, 2015, CRIT REV PHYS REHABI, V27, P2; Ryan RM, 2017, SELF-DETERMINATION THEORY: BASIC PSYCHOLOGICAL NEEDS IN MOTIVATION, DEVELOPMENT, AND WELLNESS, P1, DOI 10.1521/978.14625/28806; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Ryan RM., 2008, EUR HLTH PSYCHOL, V10, P2, DOI DOI 10.1080/17509840701827437; Shankland R., 2014, PSYCHOL POSITIVE, V1; Sheldon KM, 2006, J PERS SOC PSYCHOL, V91, P331, DOI 10.1037/0022-3514.91.2.331; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Strandberg T, 2009, SOC WORK HEALTH CARE, V48, P276, DOI 10.1080/00981380802599240; Strom TQ, 2007, BRAIN INJURY, V21, P1137, DOI 10.1080/02699050701687334; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; Unanue W, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00680; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wei MF, 2005, J COUNS PSYCHOL, V52, P591, DOI 10.1037/0022-0167.52.4.591; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	4	4	3	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	FEB 13	2021	43	4					507	515		10.1080/09638288.2019.1630858		JUN 2019	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	QL6SA	WOS:000472769600001	31230472				2022-02-06	
J	Martin, LJ; Wong, M; Hanaford, A				Martin, Lee J.; Wong, Margaret; Hanaford, Allison			Neonatal Brain Injury and Genetic Causes of Adult-Onset Neurodegenerative Disease in Mice Interact With Effects on Acute and Late Outcomes	FRONTIERS IN NEUROLOGY			English	Article						neonatal brain damage; traumatic brain injury; ALS; synuclein oligomerization; Parkinson's disease	MOTOR-NEURON DEGENERATION; PERMEABILITY TRANSITION PORE; TRANSGENIC MOUSE MODEL; PARKINSONS-DISEASE; HYPOXIA-ISCHEMIA; OXIDATIVE STRESS; SPINAL MOTONEURONS; CEREBRAL-PALSY; RISK-FACTORS; DNA-DAMAGE	Neonatal brain damage and age-related neurodegenerative disease share many common mechanisms of injury involving mitochondriopathy, oxidative stress, excitotoxicity, inflammation, and neuronal cell death. We hypothesized that genes causing adult-onset neurodegeneration can influence acute outcome after CNS injury at immaturity and on the subsequent development of chronic disability after early-life brain injury. In two different transgenic (Tg) mouse models of adult-onset neurodegenerative disease, a human A53T-alpha-synuclein (h alpha Syn) model of Parkinson's disease (PD) and a human G93A-superoxide dismutase-1 (hSOD1) model of amyotrophic lateral sclerosis (ALS), mortality and survivor morbidity were significantly greater than non-Tg mice and a Tg mouse model of Alzheimer's disease after neonatal traumatic brain injury (TBI). Acutely after brain injury, h alpha Syn neonatal mice showed a marked enhancement of protein oxidative damage in forebrain, brain regional mitochondrial oxidative metabolism, and mitochondriopathy. Extreme protein oxidative damage was also observed in neonatal mutant SOD1 mice after TBI. At 1 month of age, neuropathology in forebrain, midbrain, and brainstem of h alpha Syn mice with neonatal TBI was greater compared to sham h alpha Syn mice. Surviving h alpha Syn mice with TBI showed increased h alpha Syn aggregation and nitration and developed adult-onset disease months sooner and died earlier than non-injured h alpha Syn mice. Surviving hSOD1 mice with TBI also developed adult-onset disease and died sooner than non-injured hSOD1 mice. We conclude that mutant genes causing PD and ALS in humans have significant impact on mortality and morbidity after early-life brain injury and on age-related disease onset and proteinopathy in mice. This study provides novel insight into genetic determinants of poor outcomes after acute injury to the neonatal brain and how early-life brain injury can influence adult-onset neurodegenerative disease during aging.	[Martin, Lee J.; Wong, Margaret] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Martin, Lee J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Martin, Lee J.; Hanaford, Allison] Johns Hopkins Univ, Sch Med, Pathobiol Grad Training Program, Baltimore, MD 21218 USA		Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA.; Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Pathobiol Grad Training Program, Baltimore, MD 21218 USA.	martinl@jhmi.edu			U.S. Public Health Service NIH-NINDS [NS052098]	This work was supported by a grant from the U.S. Public Health Service NIH-NINDS (NS052098).	Al-Abdulla NA, 1998, AM J PATHOL, V153, P447, DOI 10.1016/S0002-9440(10)65588-5; Beghi E, 2010, AMYOTROPH LATERAL SC, V11, P289, DOI 10.3109/17482960903384283; Bendotti C, 2001, J NEUROL SCI, V191, P25, DOI 10.1016/S0022-510X(01)00627-X; Beretta S, 2003, LANCET NEUROL, V2, P656, DOI 10.1016/S1474-4422(03)00579-9; Bi D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-100; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brambrink AM, 1999, EXP TOXICOL PATHOL, V51, P151, DOI 10.1016/S0940-2993(99)80089-X; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Burnsed JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118889; Calkavur S, 2011, J INT MED RES, V39, P1744, DOI 10.1177/147323001103900517; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chang Q, 2016, NEUROBIOL DIS, V93, P78, DOI 10.1016/j.nbd.2016.04.009; Chang Q, 2011, J NEUROSCI, V31, P2815, DOI 10.1523/JNEUROSCI.2475-10.2011; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Choudhry F, 2012, NEUROBIOL AGING, V33, P960, DOI 10.1016/j.neurobiolaging.2010.07.008; Chuang PY, 2010, J NEUROTRAUM, V27, P999, DOI 10.1089/neu.2009.1129; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Dickson DW, 2004, AM J PATHOL, V164, P1143, DOI 10.1016/S0002-9440(10)63202-6; Esih K, 2016, EUR J PAEDIATR NEURO, V20, P704, DOI 10.1016/j.ejpn.2016.05.018; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Gallek MJ, 2009, BIOL RES NURS, V10, P205, DOI 10.1177/1099800408323221; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; HUBBLE JP, 1993, NEUROLOGY, V43, P1693, DOI 10.1212/WNL.43.9.1693; Ischiropoulos H, 2003, ANN NY ACAD SCI, V991, P93; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Junn E, 2002, NEUROSCI LETT, V320, P146, DOI 10.1016/S0304-3940(02)00016-2; Koehler RC, 2018, J CEREBR BLOOD F MET, V38, P2092, DOI 10.1177/0271678X18797328; Kopp VJ, 2013, ANESTH ANALG, V117, P1023, DOI 10.1213/ANE.0b013e3182a231b5; Kumar S, 2018, J GENET, V97, P625, DOI 10.1007/s12041-018-0953-5; LaClair KD, 2016, ACTA NEUROPATHOL, V132, P859, DOI 10.1007/s00401-016-1637-y; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martin LJ, 2007, J NEUROPATH EXP NEUR, V66, P1002, DOI 10.1097/nen.0b013e318158822b; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Martin LJ, 2018, J NEUROPATH EXP NEUR, V77, P636, DOI 10.1093/jnen/nly040; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839; Martin LJ, 2009, EXP NEUROL, V218, P333, DOI 10.1016/j.expneurol.2009.02.015; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Martin LJ, 2003, J NEUROCHEM, V85, P234, DOI 10.1046/j.1471-4159.2003.01659.x; Martin LJ, 1997, J COMP NEUROL, V377, P262, DOI 10.1002/(SICI)1096-9861(19970113)377:2<262::AID-CNE8>3.0.CO;2-1; Martin LJ, 2000, NEUROBIOL DIS, V7, P169, DOI 10.1006/nbdi.2000.0282; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Mueller D, 2005, J NEUROSCI RES, V82, P592, DOI 10.1002/jnr.20673; Mueller-Burke D, 2008, INT J DEV NEUROSCI, V26, P67, DOI 10.1016/j.ijdevneu.2007.08.015; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Natale JE, 2002, NEUROSCIENCE, V112, P665, DOI 10.1016/S0306-4522(02)00098-2; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Perez SE, 2007, NEUROBIOL DIS, V28, P3, DOI 10.1016/j.nbd.2007.06.015; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rajatileka S, 2018, MOL NEUROBIOL, V55, P2013, DOI 10.1007/s12035-017-0462-1; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Scarmeas N, 2002, NEUROLOGY, V59, P773, DOI 10.1212/WNL.59.5.773; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Tabrizi SJ, 2000, HUM MOL GENET, V9, P2683, DOI 10.1093/hmg/9.18.2683; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; van Zundert B, 2012, J CELL BIOCHEM, V113, P3301, DOI 10.1002/jcb.24234; Wang MD, 2017, NEUROTOXICOLOGY, V61, P101, DOI 10.1016/j.neuro.2016.06.015; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Wu D, 2019, J CEREBR BLOOD F MET, V39, P1336, DOI 10.1177/0271678X18759859; Wu YW, 2009, ANN NEUROL, V66, P663, DOI 10.1002/ana.21766; Xu GL, 2002, ALZ DIS ASSOC DIS, V16, P196, DOI 10.1097/00002093-200207000-00011	78	4	4	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 18	2019	10								635	10.3389/fneur.2019.00635			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ID8KU	WOS:000471933800002	31275228	gold, Green Published			2022-02-06	
J	Armstead, WM; Vavilala, MS				Armstead, William M.; Vavilala, Monica S.			Improving Understanding and Outcomes of Traumatic Brain Injury Using Bidirectional Translational Research	JOURNAL OF NEUROTRAUMA			English	Article						age; brain injury; cerebral autoregulation; histopathology; sex; signal transduction; vasopressor	CEREBRAL-BLOOD-FLOW; CONTROLLED CORTICAL IMPACT; ROTATIONAL HEAD-INJURY; DIFFUSE AXONAL INJURY; PERFUSION-PRESSURE; HIPPOCAMPAL NECROSIS; CARDIAC DYSFUNCTION; ANIMAL-MODELS; AGE-DIFFERENCES; PIGLET BRAIN	Recent clinical trials in traumatic brain injury (TBI) have failed to demonstrate therapeutic effects even when there appears to be good evidence for efficacy in one or more appropriate pre-clinical models. While existing animal models mimic the injury, difficulties in translating promising therapeutics are exacerbated by the lack of alignment of discrete measures of the underlying injury pathology between the animal models and human subjects. To address this mismatch, we have incorporated reverse translation of bedside experience to inform pre-clinical studies in a large animal (pig) model of TBI that mirror practical clinical assessments. Cerebral autoregulation is impaired after TBI, contributing to poor outcome. Cerebral perfusion pressure (CPP) is often normalized by use of vasoactive agents to increase mean arterial pressure (MAP) and thereby limit impairment of cerebral autoregulation and neurological deficits. Vasoactive agents clinically used to elevate MAP to increase CPP after TBI, such as phenylephrine (Phe), dopamine (DA), norepinephrine (NE), and epinephrine (EPI), however, have not been compared sufficiently regarding effect on CPP, autoregulation, and survival after TBI, and clinically, current vasoactive agent use is variable. The cerebral effects of these clinically commonly used vasoactive agents are not known. This review will emphasize pediatric work and will describe bidirectional translational studies using a more human-like animal model of TBI to identify better therapeutic strategies to improve outcome post-injury. These studies in addition investigated the mechanism(s) involved in improvement of outcome in the setting of TBI.	[Armstead, William M.] Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS090998, R21NS095321]	This work was supported by NIH R01 NS090998 and R21NS095321.	Aaslid R, 2007, STROKE, V38, P1465, DOI 10.1161/STROKEAHA.106.473462; Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Armstead W.M., 2014, VASCULAR MECH CNS TR, P269; Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead WM, 2017, J NEUROTRAUM, V34, P1666, DOI 10.1089/neu.2016.4770; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Armstead WM, 2016, PEDIATR CRIT CARE ME, V17, pe130, DOI 10.1097/PCC.0000000000000603; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2012, J NEUROTRAUM, V29, P1483, DOI 10.1089/neu.2011.2248; Armstead WM, 2011, J NEUROTRAUM, V28, P105, DOI 10.1089/neu.2010.1581; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1999, BRAIN RES, V816, P158, DOI 10.1016/S0006-8993(98)01146-9; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Atlan L.S., 2018, CLIN BIOMECH; Bahloul M, 2006, AM J CRIT CARE, V15, P462; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; Carey ME, 1990, J NEUROTRAUM, V7, P13, DOI 10.1089/neu.1990.7.13; Carmignoto G, 2010, BRAIN RES REV, V63, P138, DOI 10.1016/j.brainresrev.2009.11.007; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00128; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Curvello V, 2017, BRAIN RES, V1670, P118, DOI 10.1016/j.brainres.2017.06.010; Curvello V, 2017, PEDIATR RES, V82, P108, DOI 10.1038/pr.2017.83; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Dobbing J., 1981, SCI F PAEDIATRICS, P744; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Finnie JW, 2013, J CLIN NEUROSCI, V20, P1759, DOI 10.1016/j.jocn.2013.03.010; FINNIE JW, 1993, J COMP PATHOL, V108, P93, DOI 10.1016/S0021-9975(08)80231-9; Finnie JW, 2002, AUST VET J, V80, P67, DOI 10.1111/j.1751-0813.2002.tb12840.x; Finnie JW, 2001, AUST VET J, V79, P628, DOI 10.1111/j.1751-0813.2001.tb10785.x; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Friess SH, 2012, CRIT CARE MED, V40, P2400, DOI 10.1097/CCM.0b013e31825333e6; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Georgoff PE, 2017, J NEUROTRAUM, V34, P2167, DOI 10.1089/neu.2016.4859; Grimmelt AC, 2011, CENT EUR NEUROSURG, V72, P120, DOI 10.1055/s-0031-1271732; GUISADO R, 1976, NEUROLOGY, V26, P69, DOI 10.1212/WNL.26.1.69; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Ishikawa S, 2009, ANESTH ANALG, V108, P1631, DOI 10.1213/ane.0b013e31819d94e3; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS24, DOI 10.1097/PCC.0b013e31823f4450; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Krishnamoorthy Vijay, 2015, Int J Crit Illn Inj Sci, V5, P103, DOI 10.4103/2229-5151.158409; Krishnamoorthy V, 2015, PEDIATR CRIT CARE ME, V16, pE107, DOI 10.1097/PCC.0000000000000397; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Mandera M, 2002, CHILD NERV SYST, V18, P124, DOI 10.1007/s00381-002-0572-5; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; MARTINS AN, 1978, STROKE, V9, P509, DOI 10.1161/01.STR.9.5.509; McBryde FD, 2017, ACTA PHYSIOL, V219, P274, DOI 10.1111/apha.12706; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Olson E, 2016, J NEUROTRAUM, V33, P734, DOI 10.1089/neu.2015.4085; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; PAPPIUS HM, 1969, ARCH NEUROL-CHICAGO, V20, P207, DOI 10.1001/archneur.1969.00480080107013; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Reinhard M, 2006, J NEUROL SCI, V250, P103, DOI 10.1016/j.jns.2006.07.011; Rhee CJ, 2018, PEDIATR RES, V84, P602, DOI 10.1038/s41390-018-0141-6; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stubbe HD, 2006, CRIT CARE MED, V34, P2651, DOI 10.1097/01.CCM.0000239196.17999.B7; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Vink R, 2010, NEUROTHERAPEUTICS, V7, P1, DOI 10.1016/j.nurt.2009.12.001; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	108	4	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2020	37	22					2372	2380		10.1089/neu.2018.6119		JUN 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	OP2MH	WOS:000475224600001	30834818	Green Published			2022-02-06	
J	Ben Forry, J; Ashaba, S; Rukundo, GZ				Ben Forry, Jimmy; Ashaba, Scholastic; Rukundo, Godfrey Zari			Prevalence and associated factors of mental disorders among prisoners in Mbarara municipality, southwestern Uganda: a cross-sectional study	BMC PSYCHIATRY			English	Article						Crime; Mental disorders; Mental health; Prisoners; Uganda	ILLNESS	BackgroundResearch in high income countries reports higher prevalence of mental disorders among prisoners than in the general population. Lack of published data from low resource settings affects planning and eventual service provision to the prisoners. This study aimed to determine the burden of mental disorders and associated factors among prisoners in Mbarara municipality in southwestern Uganda.MethodsThis was a prison facility based crosssectional study among 414 inmates in Mbarara municipality. We consecutively enrolled them by simple random sampling from 3 prison facilities. Participants completed a sociodemographic and clinical factor questionnaire, and the M.I.N.I. Version 6.0. Data were analyzed using STATA 12.0. Univariate, bivariate and multivariate logistic regression analyses were conducted to determine the prevalence, and associated factors using the individual odds ratios with their 95% Confidence Intervals and P-values as a measure of association, clinical and statistical significance respectively.ResultsA total of 354 (86%) prison-inmates met criteria for a psychiatric disorder. Of these, 338 (95%) had one or more diagnoses. Major depression was the most common diagnosis (44%). Factors associated with mental disorders included history of traumatic brain injury (OR=2.57; 95% CI=1.22-5.42; P-value=0.01), low income status (OR=0.32; 95% CI=0.16-0.63; P-value=0.001) and authoritarian parenting (OR=0.37; 95% CI=0.18-0.75; P-value=0.006).ConclusionsThere is a high prevalence of psychiatric illness among prisoners in Mbarara municipality with most of them having more than one diagnosis. Majority of the prisoners with mental illness go undiagnosed and untreated.	[Ben Forry, Jimmy; Ashaba, Scholastic; Rukundo, Godfrey Zari] Mbarara Univ Sci & Technol, Dept Psychiat, Fac Med, POB 1410, Mbarara, Southwestern Ug, Uganda; [Ben Forry, Jimmy; Ashaba, Scholastic] Kampala Int Univ, Dept Mental Hlth & Psychiat, Fac Med, POB 71, Bushenyi, Southwestern Ug, Uganda; [Ben Forry, Jimmy] Mubende Reg Referral Hosp, POB 4, Mubende, Central Uganda, Uganda		Ben Forry, J (corresponding author), Mbarara Univ Sci & Technol, Dept Psychiat, Fac Med, POB 1410, Mbarara, Southwestern Ug, Uganda.; Ben Forry, J (corresponding author), Kampala Int Univ, Dept Mental Hlth & Psychiat, Fac Med, POB 71, Bushenyi, Southwestern Ug, Uganda.	bforry@must.ac.ug	Rukundo, Godfrey Zari/Z-1528-2018; Forry, Jimmy Ben/AAX-2916-2021; Rukundo, Godfrey Zari/AAG-3176-2020	Rukundo, Godfrey Zari/0000-0002-3739-1426; Forry, Jimmy Ben/0000-0002-6556-8452; Rukundo, Godfrey Zari/0000-0002-3739-1426	PAIKO foundation; Mbarara University of Science and Technology	PAIKO foundation provided the funds that enabled the completion of this study by way of a scholarship in conjunction with Mbarara University of Science and Technology. The study was a prerequisite for the award of a master's degree in medicine specializing in psychiatry. The foundation did not influence or participate in the designing of the study, collection of data and their management, interpretation of the results nor in the authoring of the manuscript for publication.	Aishatu Y, 2013, PREVALENCE PSYCHIAT; Ayhan G, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1320-4; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Baillargeon J, 2010, ADM POLICY MENT HLTH, V37, P367, DOI 10.1007/s10488-009-0252-9; Bureau of Democracy, 2013, UG 2013 HUM RIGHTS R; Dadi AF, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0792-y; Davis M. R, 2007, IDENTIFICATION MENTA; El-Gilany A, 2016, East Asian Arch Psychiatry, V26, P30; Eman M, 2014, WORLD J MED SCI, V11, P228; Erickson CD, 2012, AM J COMMUN PSYCHOL, V49, P404, DOI 10.1007/s10464-011-9484-4; Eytan A, 2010, INT J LAW PSYCHIAT, P1; Fantom N., 2016, WORLD BANKS CLASSIFI; Fazel S., 2012, British Journal of Psychiatry, V200, P364, DOI 10.1192/bjp.bp.111.096370; Fazel S, 2016, LANCET PSYCHIAT, V3, P871, DOI 10.1016/S2215-0366(16)30142-0; Goncalves LC, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0803-z; Goss JR, 2002, PSYCHIAT SERV; Kasoro S, 2002, INT J SOC PSYCHIATR, V48, P29, DOI 10.1177/002076402128783064; Kief Christine, 2007, MENTALLY DISORDERED; Kigozi F, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-1; Kish L, 1965, SURVEY SAMPLING; Kwon S-R, 2011, EVEN DEAD BODIES MUS; López M., 2016, Rev. esp. sanid. penit., V18, P76; Marín-Basallote N., 2012, Rev. esp. sanid. penit., V14, P80, DOI [10.4321/s1575-06202012000300002, 10.4321/S1575-06202012000300002]; Naidoo S, 2012, AFR J PSYCHIATRY, V15, P30, DOI [10.4314/ajpsy.v15i1.4, http://dx.doi.org/10.4314/ajpsy.v15i1.4]; Sepehrmanesh Z, 2014, IRAN RED CRESCENT ME, V16; Statistics A. B, 2008, NAT SURV MENT HLTH W; U. B. o. Statistics, 2015, STAT ABSTR UBO STAT; Walmsley, 2009, WORLD PRISON POPULAT; Walmsley R., WORLD PRISON POPULAT; Zabala-Baños M.C., 2016, Rev. esp. sanid. penit., V18, P13, DOI 10.4321/S1575-06202016000100003	30	4	4	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-244X			BMC PSYCHIATRY	BMC Psychiatry	JUN 11	2019	19								178	10.1186/s12888-019-2167-7			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	IC9WR	WOS:000471335800004	31185947	gold, Green Published			2022-02-06	
J	Thibeault, CM; Thorpe, S; Canac, N; Wilk, SJ; Hamilton, RB				Thibeault, Corey M.; Thorpe, Samuel; Canac, Nicolas; Wilk, Seth J.; Hamilton, Robert B.			Sex-Based Differences in Transcranial Doppler Ultrasound and Self-Reported Symptoms After Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						sex differences; traumatic brain injury; vascular reactivity; CBF autoregulation; blood flow	SPORTS-RELATED CONCUSSION; CEREBRAL-BLOOD-FLOW; GENDER-DIFFERENCES; HIGH-SCHOOL; RECOVERY; OUTCOMES	The possibility of sex-related differences in mild traumatic brain injury (mTBI) severity and recovery remains a controversial subject. With some studies showing that female subjects suffer a longer period of symptom recovery, while others have failed to demonstrate differences. In this study, we explored the sex-related effects of mTBI on self-reported symptoms and transcranial Doppler ultrasound (TCD) measured features in an adolescent population. Fifty-eight subjects were assessed-at different points post-injury-after suffering an mTBI. Subjects answered a series of symptom questions before the velocity from the middle cerebral artery was measured. Subjects participated in breath-holding challenges to evaluate cerebrovascular reactivity. The Pulsatility Index (PI), the ratio of the first peaks (P2R), and the Breath-Hold Index (BHI), were computed. Linear mixed effects models were developed to explore the interactions between measured features, sex, and time since injury while accounting for within subject variation. Over the first 10 days post-injury, the female group had significant interactions between sex and time since injury that was not present in the TCD features. This is the first study to compare sex-related differences in self-reported symptoms and TCD measurements in adolescents suffering an mTBI. It illustrates the pitfalls clinicians face when relying on subjective measures alone during diagnosis and tracking of mTBI patients. In addition, it highlights the need for more focused research on sex-related differences in concussion pathophysiology.	[Thibeault, Corey M.; Thorpe, Samuel; Canac, Nicolas; Wilk, Seth J.; Hamilton, Robert B.] Neural Analyt Inc, Los Angeles, CA 90064 USA		Thibeault, CM (corresponding author), Neural Analyt Inc, Los Angeles, CA 90064 USA.	corey@neuralanalytics.com			National Institute Of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R43NS092209-01, 2R44NS092209-02]	This work was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under award numbers 1R43NS092209-01 and 2R44NS092209-02.	Albalawi T, 2017, J NEUROTRAUM, V34, P2700, DOI 10.1089/neu.2017.5060; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Esposito G, 1996, J NUCL MED, V37, P559; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hamilton R, 2012, J APPL PHYSIOL, V113, P1560, DOI 10.1152/japplphysiol.00357.2012; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kim S, 2013, IEEE T BIO-MED ENG, V60, P1126, DOI 10.1109/TBME.2012.2227477; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kriz PK, 2016, J PEDIATR-US, V171, P234, DOI 10.1016/j.jpeds.2015.12.006; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Makowski D., 2018, J OPEN SOURCE SOFTW, V3, P470, DOI [10.21105/joss.00470, DOI 10.21105/JOSS.00470]; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Seabold S., 2010, STATSMODELS ECONOMET; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	42	4	4	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 11	2019	10								590	10.3389/fneur.2019.00590			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC8TP	WOS:000471255000001	31244755	Green Published, gold			2022-02-06	
J	Berger-Estilita, J; Granja, C; Goncalves, H; Dias, CC; Aragao, I; Costa-Pereira, A; Orwelius, L				Berger-Estilita, Joana; Granja, Cristina; Goncalves, Hernani; Dias, Claudia Camila; Aragao, Irene; Costa-Pereira, Altamiro; Orwelius, Lotti			A new global health outcome score after trauma (GHOST) for disability, cognitive impairment, and health-related quality of life: data from a prospective cross-sectional observational study	BRAIN INJURY			English	Article						EQ-5D; GOSE; MMS; cognitive dysfunction; TBI; follow-up	MINI-MENTAL-STATE; BRAIN-INJURY; LONG-TERM; FUNCTIONAL OUTCOMES; INTENSIVE-CARE; MAJOR TRAUMA; EPIDEMIOLOGY; PREDICTORS; SEVERITY; MODERATE	Background:Trauma patients experience morbidity related to disability and cognitive impairment that negatively impact their health-related quality of life (HRQoL). We assessed the impact of trauma on disability, cognitive impairment and HRQoL after intensive care in patients with and without traumatic brain injury (TBI) and created a predictive score to identify patients with worse outcome. Methods:We identified 262 patients with severe trauma (ISS>15) admitted to the emergency room of a level 1 trauma center. Patients above 13 years were included. After 6 months, patients were assessed for disability, cognitive impairment, and HRQoL. A global health outcome score after trauma (GHOST) was obtained through the combination of these domains. Logistic regression analysis was considered for the effect of demographic, trauma and hospital factors on global outcome. p > 0.05. Statistics performed with SPSS 23.0. Results:Patients with the worst outcomes were older and had a longer length of Intensive Care Unit (ICU) stay. The effect of gender was found in all "GHOST dimensions". TBI was not significantly associated with worse outcome. Conclusions:No significant differences were seen on disability, cognitive impairment and decreased HRQoL in patients with or without TBI. Our GHOST score showed that female gender, older age, and longer ICU stay were significantly associated with the worst outcome.	[Berger-Estilita, Joana; Granja, Cristina; Goncalves, Hernani; Dias, Claudia Camila; Costa-Pereira, Altamiro; Orwelius, Lotti] Univ Porto, CINTESIS Ctr Hlth Technol & Serv Res, Fac Med, Porto, Portugal; [Berger-Estilita, Joana; Granja, Cristina] Algarve Univ Hosp Ctr, Dept Emergency & Intens Care Med, Faro, Portugal; [Granja, Cristina] Univ Algarve, Dept Biomed Sci & Med, Faro, Portugal; [Goncalves, Hernani; Dias, Claudia Camila; Costa-Pereira, Altamiro] Univ Porto, Dept Community Med Informat & Hlth Decis Sci, Fac Med, Porto, Portugal; [Aragao, Irene] Santo Antonio Porto Univ Hosp Ctr, Intens Care Unit, Porto, Portugal; [Orwelius, Lotti] Cty Council Ostergotland, Dept Intens Care, Linkoping, Sweden; [Orwelius, Lotti] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden		Berger-Estilita, J (corresponding author), Univ Porto, CINTESIS Ctr Hlth Technol & Serv Res, Fac Med, Porto, Portugal.	joana.berger-estilita@insel.ch	Goncalves, Hernani/B-2379-2008; Dias, Claudia Camila/N-7130-2014; Goncalves, Hernani/AAY-8719-2021; Berger-Estilita, Joana/AAB-4497-2021; Costa-Pereira, Altamiro/I-5987-2012	Goncalves, Hernani/0000-0001-6558-8966; Dias, Claudia Camila/0000-0001-9356-3272; Goncalves, Hernani/0000-0001-6558-8966; Berger-Estilita, Joana/0000-0002-8695-4264; Aragao, Irene/0000-0001-5750-2739; Costa-Pereira, Altamiro/0000-0001-8467-6398			Ahmed W, 2017, CLIN REHABIL, V31, P1646, DOI 10.1177/0269215517712044; [Anonymous], 2011, WORLD REP DIS; Azevedo L, 2007, CRIT CARE MED, V35, pA172; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Chico-Fernandez M, 2016, MED INTENSIVA, V40, P327, DOI 10.1016/j.medin.2015.07.011; de Boer C, 2014, GERIATR GERONTOL INT, V14, P880, DOI 10.1111/ggi.12183; de Guise E, 2013, BRAIN INJURY, V27, P1428, DOI 10.3109/02699052.2013.835867; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; Gomes E, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-1; Gomes E, 2008, EUR J TRAUMA EMERG S, V34, P561, DOI 10.1007/s00068-007-6189-3; Granja C, 2002, INTENS CARE MED, V28, P898, DOI 10.1007/s00134-002-1345-z; Gutacker N, 2013, MED DECIS MAKING, V33, P804, DOI 10.1177/0272989X13482523; Hoffman K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103082; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Kosty JA, 2013, NEUROL RES, V35, P277, DOI 10.1179/1743132813Y.0000000168; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; NAUGLE RI, 1989, CLEV CLIN J MED, V56, P277, DOI 10.3949/ccjm.56.3.277; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Organization W.H, 2008, GLOBAL BURDEN DIS 20; Orwelius L, 2012, J TRAUMA ACUTE CARE, V72, P504, DOI 10.1097/TA.0b013e31821a416a; Orwelius L, 2010, CRIT CARE, V14, DOI 10.1186/cc8967; Palmer CS, 2017, INJURY, V48, P591, DOI 10.1016/j.injury.2017.01.006; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Santos F., BASE DADOS PORTUGAL; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Soreide K, 2009, BRIT J SURG, V96, P697, DOI 10.1002/bjs.6643; Stenberg M, 2017, BRAIN INJURY, V31, P351, DOI 10.1080/02699052.2016.1261303; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; van Delft-Schreurs CCHM, 2014, INJURY, V45, P320, DOI 10.1016/j.injury.2013.02.025; Wad MS, 2018, INJURY, V49, P191, DOI 10.1016/j.injury.2017.10.001; Weber KT, 2016, ARQ NEURO-PSIQUIAT, V74, P409, DOI 10.1590/0004-282X20160053; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	43	4	4	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2019	33	7					922	931		10.1080/02699052.2019.1581257			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OM5BT	WOS:000586040800012	30810390				2022-02-06	
J	Vassel-Hitier, J; Verdier, V; Rasquier, S; Chalard, A; Laurent-Vannier, A; Chevignard, M				Vassel-Hitier, Jeanne; Verdier, Valentine; Rasquier, Stephanie; Chalard, Anais; Laurent-Vannier, Anne; Chevignard, Mathilde			Language, intellectual and educational outcomes after moderate-to-severe traumatic brain injury sustained before the age of 18 months	BRAIN INJURY			English	Article						Traumatic brain injury; child; language; cognitive; long-term outcome	COGNITIVE PREDICTORS; ACADEMIC OUTCOMES; YOUNG-CHILDREN; RECOVERY; MEMORY; TBI	Objective: The aim of this study was to assess long-term outcomes in terms of oral language, intellectual ability, education, following very early moderate-to-severe TBI. Methods: Children who had been hospitalized in rehabilitation after moderate-to-severe TBI sustained before 18 months of age were contacted once they had reached school age. Detailed oral language and intellectual ability assessment were performed, and information on ongoing education was collected. Results: 52 children met inclusion criteria; 21 (40.4%) participated [13 males, mean age 7.5 years (SD = 1.9), age at injury 0.7 years (SD = 0.5), time since injury 6.8 years (SD = 1.8)]. Performance was in the clinical range (<-2SD) for: syntactic comprehension (67%; mean z-scores -2.6; SD = 3.1), syntactic expression (62%; -2.1; SD = 1.3), lexical stock extent (57%; -1.5; SD = 1.5), lexical access skills (48%; -1.9; SD = 2), and semantic organization (32%; -0.9; SD = 1.2). Full-scale IQ was <90 for 91%. Only eight children followed mainstream education without adaptations. Performance on all language tests (except lexical stock extent) was significantly poorer for children with a personal school aid or those in specialized education. Conclusions: Early moderate-to-severe TBI causes significant delayed language (especially syntactic aspects of language) and cognitive disabilities, with consequences on long-term educational outcome. These children require long-term follow-up and timely interventions.	[Vassel-Hitier, Jeanne; Rasquier, Stephanie; Chalard, Anais; Laurent-Vannier, Anne; Chevignard, Mathilde] St Maurice Hosp, Rehabil Dept Children & Adolescents Acquired Neur, St Maurice, France; [Verdier, Valentine; Laurent-Vannier, Anne; Chevignard, Mathilde] St Maurice Hosp, Outreach Team Children & Adolescents Acquired Bra, 14 Rue Val dOsne, F-94410 St Maurice, France; [Chevignard, Mathilde] Sorbonne Univ, CNRS, INSERM, LIB, Paris, France; [Chevignard, Mathilde] Sorbonne Univ, GRC HanCRe 18, Paris, France		Chevignard, M (corresponding author), St Maurice Hosp, Outreach Team Children & Adolescents Acquired Bra, 14 Rue Val dOsne, F-94410 St Maurice, France.	mathilde.chevignard@ght94n.fr					Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Chevignard MP, 2014, PEDIATR RADIOL, V44, P548, DOI 10.1007/s00247-014-3169-8; Chevignard MP, 2010, CURR OPIN NEUROL, V23, P695, DOI 10.1097/WCO.0b013e328340296f; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coquet F, 2010, ORTHOEDITION; Crowe LM, 2014, J HEAD TRAUMA REHAB, V29, P217, DOI 10.1097/HTR.0b013e31829babfd; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; De Agostini M, 1998, REV NEUROPSYCHOL, V8, P319; Deltour JJ, 1987, TEST CLOSURE GRAMMAT; Dunn Lloyd M, 1993, ECHELLE VOCABULAIRE; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Haarbauer-Krupa J, 2018, NEUROREHABILITATION, V42, P259, DOI 10.3233/NRE-172410; Haute Autorite de Sante, 2011, REC SANT PUBL REC BO; Karandikar S., 2004, CHILD ABUSE REV, V13, P178, DOI DOI 10.1002/CAR.850; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Khomsi A, 1987, EPREUVE EVALUATION S, VO-52; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Lind K, 2016, CHILD ABUSE NEGLECT, V51, P358, DOI 10.1016/j.chiabu.2015.08.001; Morse S, 1999, Pediatr Rehabil, V3, P139; Pomerleau G, 2012, J PEDIATR REHAB MED, V5, P89, DOI 10.3233/PRM-2012-0200; Raghubar KP, 2013, J INT NEUROPSYCH SOC, V19, P254, DOI 10.1017/S1355617712001312; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Van der Horst L, 2010, ARCH PEDIATRIE, V17, P319, DOI 10.1016/j.arcped.2009.09.019; Vas Asha K, 2015, Handb Clin Neurol, V128, P497, DOI 10.1016/B978-0-444-63521-1.00031-5; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081	38	4	5	2	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2019	33	8					1105	1115		10.1080/02699052.2019.1623420		JUN 2019	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM6FW	WOS:000471400200001	31165657				2022-02-06	
J	Piana, LE; Garvey, KD; Kroshus, E; Brook, EM; Matzkin, EG				Piana, Lauren E.; Garvey, Kirsten D.; Kroshus, Emily; Brook, Emily M.; Matzkin, Elizabeth G.			Implementation and effect of concussion education in collegiate women's ice hockey	PHYSICIAN AND SPORTSMEDICINE			English	Article						Concussion; NCAA concussion education mandate; women's ice hockey; concussion reporting	RECURRENT CONCUSSION; INJURY; EPIDEMIOLOGY	Objective: This study aimed to determine whether collegiate women's ice hockey players are receiving pre-season concussion education and evaluate the nature and delivery of this education. Secondarily, we aimed to assess whether players who recall receiving this education have greater knowledge about concussion or are more likely to have reported suspected concussions than their peers. Methods: An anonymous survey was completed by 459 NCAA women's ice hockey players. Players self-reported receipt of pre-season concussion education, year in school, division of competition, player position, and average length of ice hockey career. Players also completed scales assessing concussion knowledge, attitudes and prior reporting behavior for suspected concussions. Results: 65.3% of athletes affirmed that they received pre-season concussion education. Lecture by an athletic trainer was the most common modality. There were no differences in concussion knowledge or attitudes by concussion education status, NCAA division of competition, or year in school. Players with higher knowledge scores were more likely than their peers to have experienced a suspected concussion and to have not reported it (p = 0.056). Conclusions: Not all NCAA women's ice hockey players are receiving (or recall receiving) mandated concussion education from their institution. The inverse association between concussion knowledge and concussion reporting behavior, while not statistically significant, is concerning and warrants further study. More work is needed to develop educational materials about concussion that are acceptable and memorable to this population, and that help increase concussion care-seeking behaviors.	[Piana, Lauren E.; Garvey, Kirsten D.; Brook, Emily M.; Matzkin, Elizabeth G.] Brigham & Womens Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA; [Piana, Lauren E.] Univ Tennessee, Coll Med, Memphis, TN USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Matzkin, EG (corresponding author), Brigham & Womens Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA.	ematzkin@bwh.harvard.edu					[Anonymous], 2016, IEEE ASME T MECHATRO, VPP, P1; [Anonymous], 1981, NCAA SPORTS SPONS PA; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Brook EM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117714445; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, P3; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2013, J ATHL TRAINING, DOI [10.1080/00364827.1988.10420676, DOI 10.1080/00364827.1988.10420676]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Rosene JM, 2017, AM J SPORTS MED, VXX; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	25	4	4	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	JAN 2	2020	48	1					46	52		10.1080/00913847.2019.1624657		JUN 2019	7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	KO4TF	WOS:000471500700001	31131669				2022-02-06	
J	Akel, BS; Sahin, S; Huri, M; Akyuz, C				Akel, Burcu S.; Sahin, Sedef; Huri, Meral; Akyuz, Canan			Cognitive rehabilitation is advantageous in terms of fatigue and independence in pediatric cancer treatment: a randomized-controlled study	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						cognitive rehabilitation; fatigue; occupational therapy; pediatric cancer	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CHILDHOOD-CANCER; ADULT SURVIVORS; CHILDREN; OUTCOMES; BEHAVIOR; SCALE; IMAGE	This study aimed to investigate the effect of task-oriented inpatient cognitive rehabilitation on fatigue perception and independence in daily activities. Forty (22 males, 18 females) children with pediatric cancer were randomized to either study [n=22; 10.81 (1.33) years] or control [n=18; 10.16 (1.24) years] groups. The study group received a cognitive rehabilitation intervention in addition to a routine therapy program, and the control group received a routine therapy program for 15 sessions. Cognitive status, fatigue, and daily life activity outcomes were assessed by blinded assessors in before and after interventions in the hospital setting. The study group showed a significant decrease in fatigue (P values for fatigue before, during, and after activity: P<0.001) and in the control group (P values for fatigue only in during and post activity: P<0.05). A statistically significant improvement was found in functional independence for the study group in all activities of daily living areas areas (P<0.001), whereas no differences were found in the control group. Cognitive rehabilitation appears to provide beneficial effects in decreasing fatigue, improving functional status in activities of daily living, and increasing cognitive skills at the early stages in inpatient rehabilitation of pediatric cancer. Copyright (C) 2019 Wolters Kluwer Health, Inc. All rights reserved.	[Akel, Burcu S.; Sahin, Sedef; Huri, Meral] Hacettepe Univ, Fac Hlth Sci, Dept Occupat Therapy, TR-06610 Ankara, Turkey; [Akyuz, Canan] Hacettepe Univ, Fac Med Sci, Dept Pediat Oncol, Ankara, Turkey		Sahin, S (corresponding author), Hacettepe Univ, Fac Hlth Sci, Dept Occupat Therapy, TR-06610 Ankara, Turkey.	sedefkarayazgan88@hotmail.com.tr	Akel, Burcu/AAZ-5954-2020; Huri, Meral/AAM-6057-2020; SAHIN, SEDEF/ABH-2312-2020	SAHIN, SEDEF/0000-0002-6483-072X			Adler C, 2014, NEUROPEDIATRICS, V45, P341, DOI 10.1055/s-0034-1382824; Al-Gamal E, 2016, J CLIN NURS, V25, P3391, DOI 10.1111/jocn.13467; Argyriou AA, 2011, J PAIN SYMPTOM MANAG, V41, P126, DOI 10.1016/j.jpainsymman.2010.04.021; Berger AM, 2015, J NATL COMPR CANC NE, V13, P1012, DOI 10.6004/jnccn.2015.0122; Boman KK, 2013, J NEURO-ONCOL, V112, P99, DOI 10.1007/s11060-012-1039-5; Butler RW, 2005, J PEDIATR PSYCHOL, V30, P65, DOI 10.1093/jpepsy/jsi017; Campbell LK, 2009, J PEDIATR PSYCHOL, V34, P317, DOI 10.1093/jpepsy/jsn080; Carey ME, 2008, AM J NEURORADIOL, V29, P792, DOI 10.3174/ajnr.A0904; Collins JJ, 2000, J PAIN SYMPTOM MANAG, V19, P363, DOI 10.1016/S0885-3924(00)00127-5; de Raaf PJ, 2013, PSYCHO-ONCOLOGY, V22, P1919, DOI 10.1002/pon.3225; Enskar K, 2010, CANCER NURS, V33, pE18, DOI 10.1097/NCC.0b013e3181b6365a; Gurney JG, 2009, J CLIN ONCOL, V27, P2390, DOI 10.1200/JCO.2008.21.1458; Henry-Amar M, 2016, LANCET ONCOL, V17, P1351, DOI 10.1016/S1470-2045(16)30156-5; Hutchinson AD, 2012, CANCER TREAT REV, V38, P926, DOI 10.1016/j.ctrv.2012.05.002; Jain M, 2005, INDIAN PEDIATR, V42, P907; Jervaeus A, 2014, J PEDIATR ONCOL NURS, V31, P245, DOI 10.1177/1043454214524026; Katz N, 2007, AM J OCCUP THER, V61, P41, DOI 10.5014/ajot.61.1.41; Khanna D, 2008, J RHEUMATOL, V35, P2339, DOI 10.3899/jrheum.080375; Kreissl S, 2016, LANCET ONCOL, V17, P1453, DOI 10.1016/S1470-2045(16)30093-6; Leon-Pizarro C, 2007, PSYCHO-ONCOLOGY, V16, P971, DOI 10.1002/pon.1171; Moore BD, 2005, J PEDIATR PSYCHOL, V30, P51, DOI 10.1093/jpepsy/jsi016; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Ng AH, 2017, J REHABIL MED, V49, P758, DOI 10.2340/16501977-2270; Ostensjo S, 2008, DEV NEUROREHABIL, V11, P252, DOI 10.1080/17518420802525500; Park HY, 2015, OCCUP THER INT, V22, P104, DOI 10.1002/oti.1389; Sahin S., 2017, OCCUPATIONAL THERAPY, P207; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Stout NL, 2018, JNCI-J NATL CANCER I, V110, P815, DOI 10.1093/jnci/djy108; Yeh CH, 2011, CANCER NURS, V34, P3, DOI 10.1097/NCC.0b013e3181e4553c; Yilmaz HB, 2010, J PEDIATR ONCOL NURS, V27, P330, DOI 10.1177/1043454210377176; Yu WH, 2004, USE DYNAMIC OCCUPATI	31	4	5	3	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2019	42	2					145	151		10.1097/MRR.0000000000000340			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	IQ3XH	WOS:000480684600008	30741725				2022-02-06	
J	Andrews, GJ				Andrews, Gavin J.			Spinning, hurting, still, afraid: Living life spaces with Type I Chiari Malformation	SOCIAL SCIENCE & MEDICINE			English	Article						Chiari Malformation; Geography; Chronic illness; Brain; Space	TRAUMATIC BRAIN-INJURY; OBSESSIVE-COMPULSIVE DISORDER; THERAPEUTIC LANDSCAPES; MEDICAL GEOGRAPHY; STROKE MORTALITY; ENABLING PLACES; UNITED-STATES; HEALTH-CARE; SLEEP-APNEA; EXPERIENCE	Human geography's varied engagement with the brain has involved considerations of the way people know and respond to their environments, and their place-based experiences with emotions, mental illnesses and disorders, intellectual disabilities and particular neurological conditions. This paper argues however that this scholarship could be augmented by, and existing expertise be directed towards, considering physical brain abnormalities and injuries. As a case in point it considers the spatial experience of living with Type 1 Chiari Malformation. Through interviews with four sufferers, the research articulates three domains that they have had to re-negotiate - home space, social space and medical space- emphasizing supportive and challenging aspects of each, as well as meaningful and affective qualities to encounters. The paper concludes with some pointers towards the future study of physical brain abnormalities and injuries and the kinds of knowledge it might create to increase awareness and inform care.	[Andrews, Gavin J.] Mc Master Univ, Dept Hlth Aging & Soc, Hamilton, ON, Canada		Andrews, GJ (corresponding author), Mc Master Univ, Dept Hlth Aging & Soc, Hamilton, ON, Canada.	andrews@mcmaster.ca					ABOULEZZ AO, 1985, J COMPUT ASSIST TOMO, V9, P1033, DOI 10.1097/00004728-198511000-00005; AITKEN SC, 1988, PROF GEOGR, V40, P54, DOI 10.1111/j.0033-0124.1988.00054.x; Anderson K, 2001, T I BRIT GEOGR, V26, P7, DOI 10.1111/1475-5661.00002; Andrews G.J., 2018, NONREPRESENTATIONAL; Andrews GJ, 2007, GEOGR ANN B, V89B, P307, DOI 10.1111/j.1468-0467.2007.00263.x; Andrews GJ, 2014, SOC SCI MED, V108, P210, DOI 10.1016/j.socscimed.2014.02.037; Andrews Gavin J, 2012, Complement Ther Clin Pract, V18, P43, DOI 10.1016/j.ctcp.2011.08.009; Andrews GJ, 2011, HEALTH PLACE, V17, P875, DOI 10.1016/j.healthplace.2011.04.012; Andrews GJ, 2010, SOC SCI MED, V71, P1804, DOI 10.1016/j.socscimed.2010.08.010; Andrews GJ, 2004, AREA, V36, P307, DOI 10.1111/j.0004-0894.2004.00228.x; ANDREWS GJ, 2014, SOUNDSCAPES WELLBEIN; Baxter J, 1997, T I BRIT GEOGR, V22, P505, DOI 10.1111/j.0020-2754.1997.00505.x; BEATTY WW, 1989, B PSYCHONOMIC SOC, V27, P473; Bell SL, 2017, SOC CULT GEOGR, V18, P831, DOI 10.1080/14649365.2016.1228116; Bell SL, 2016, SOC SCI MED, V166, P177, DOI 10.1016/j.socscimed.2016.08.025; BELL WO, 1987, J NEUROSURG, V66, P812, DOI 10.3171/jns.1987.66.6.0812; BINDAL AK, 1995, NEUROSURGERY, V37, P1069, DOI 10.1227/00006123-199512000-00005; Bissell D., 2011, STILLNESS MOBILE WOR; Bissell D, 2011, ENVIRON PLANN A, V43, P2649, DOI 10.1068/a43589; Bissell D, 2010, TAKING-PLACE: NON-REPRESENTATIONAL THEORIES AND GEOGRAPHY, P79; Bissell D, 2009, ENVIRON PLANN A, V41, P911, DOI 10.1068/a40309; Bondi L, 2005, T I BRIT GEOGR, V30, P433, DOI 10.1111/j.1475-5661.2005.00183.x; Bondi L, 1999, PROF GEOGR, V51, P11, DOI 10.1111/0033-0124.00141; Brownlow A, 2005, GEOFORUM, V36, P581, DOI 10.1016/j.geoforum.2004.11.005; Bunck AC, 2012, EUR RADIOL, V22, P1860, DOI 10.1007/s00330-012-2457-7; CAHAN LD, 1982, J NEUROSURG, V57, P24, DOI 10.3171/jns.1982.57.1.0024; Campbell R, 2013, NEW ZEAL GEOGR, V69, P83, DOI 10.1111/nzg.12011; Chacko E, 2007, GEOJOURNAL, V68, P131, DOI 10.1007/s10708-007-9078-8; Chiapparini L, 2011, NEUROL SCI, V32, P283, DOI 10.1007/s10072-011-0695-0; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Colls R, 2012, T I BRIT GEOGR, V37, P430, DOI 10.1111/j.1475-5661.2011.00477.x; Connell J, 2006, TOURISM MANAGE, V27, P1093, DOI 10.1016/j.tourman.2005.11.005; Conradson D., 2007, THERAPEUTIC LANDSCAP; CRANG P, 1991, ENVIRON PLANN D, V9, P91, DOI 10.1068/d090091; Crooks VA, 2006, HEALTH PLACE, V12, P345, DOI 10.1016/j.healthplace.2005.02.006; Crooks VA, 2007, DISABIL REHABIL, V29, P1107, DOI 10.1080/09638280600948193; Crooks VA, 2011, SOC SCI MED, V72, P726, DOI 10.1016/j.socscimed.2010.12.022; Crooks VA, 2008, SOC SCI MED, V67, P1837, DOI 10.1016/j.socscimed.2008.07.025; Curtis S, 2010, SPACE PLACE MENTAL H; Darghouth S, 2006, CULT MED PSYCHIAT, V30, P271, DOI 10.1007/s11013-006-9021-3; Davidson, 2003, PHOBIC GEOGRAPHIES P; Davidson J., 2012, EMOTIONAL GEOGRAPHIE; Davidson J, 2010, CAN GEOGR-GEOGR CAN, V54, P462, DOI 10.1111/j.1541-0064.2010.00309.x; Davidson J, 2010, SOC CULT GEOGR, V11, P155, DOI 10.1080/14649360903525240; Davidson J, 2010, SOC SCI MED, V70, P305, DOI 10.1016/j.socscimed.2009.10.017; Davis KK, 2004, SOC SCI MED, V59, P103, DOI 10.1016/j.socscimed.2003.10.008; Dear Michael., 1987, LANDSCAPES DESPAIR D; DeVerteuil G, 2009, POLIT GEOGR, V28, P463, DOI 10.1016/j.polgeo.2009.11.002; DOHERTY MJ, 1995, THORAX, V50, P690, DOI 10.1136/thx.50.6.690; DORN M, 1994, PROF GEOGR, V46, P106, DOI 10.1111/j.0033-0124.1994.00106.x; Draus PJ, 2010, SOC CULT GEOGR, V11, P663, DOI 10.1080/14649365.2010.508564; Driedger SM, 2004, CAN GEOGR-GEOGR CAN, V48, P119, DOI 10.1111/j.0008-3658.2004.00051.x; Duff C., 2014, ASSEMBLAGES HLTH DEL; DURE LS, 1989, J PEDIATR-US, V115, P573, DOI 10.1016/S0022-3476(89)80283-5; DYCK I, 1995, SOC SCI MED, V40, P307, DOI 10.1016/0277-9536(94)E0091-6; Dyck I, 1995, GEOFORUM, V26, P247, DOI 10.1016/0016-7185(95)00025-9; Erdogan E, 2010, TURK NEUROSURG, V20, P303, DOI 10.5137/1019-5149.JTN.2648-09.2; Eule JM, 2002, SPINE, V27, P1451, DOI 10.1097/00007632-200207010-00015; Evans B, 2010, T I BRIT GEOGR, V35, P21, DOI 10.1111/j.1475-5661.2009.00363.x; Evans GW, 2006, ANNU REV PSYCHOL, V57, P423, DOI 10.1146/annurev.psych.57.102904.190057; Evans J, 2015, HEALTH PLACE, V33, P118, DOI 10.1016/j.healthplace.2015.02.011; Evans JD, 2009, SOC SCI MED, V69, P716, DOI 10.1016/j.socscimed.2009.06.040; Fenton N, 2016, PRACTICING QUALITATI; Fleuret S, 2007, NEW ZEAL GEOGR, V63, P106, DOI 10.1111/j.1745-7939.2007.00093.x; Fujita M, 2007, REG SCI URBAN ECON, V37, P482, DOI 10.1016/j.regsciurbeco.2007.04.004; Garland EM, 2001, AM J MED, V111, P546, DOI 10.1016/S0002-9343(01)00922-6; GARLING T, 1993, UNDERSTANDING BEHAV, P00001; GASTALDO D, 2004, CRIT PUBL HLTH, V14, P157; Golledge RG, 2008, GEOGR ANAL, V40, P239, DOI 10.1111/j.1538-4632.2008.00724.x; Gorman R, 2017, SOC CULT GEOGR, V18, P315, DOI 10.1080/14649365.2016.1180424; Green Alison J, 2003, Pediatr Nurs, V29, P331; Greenlee JDW, 2002, PEDIATRICS, V110, P1212, DOI 10.1542/peds.110.6.1212; Gregory D., 2007, VIOLENT GEOGRAPHIES; Hall E, 2005, HEALTH PLACE, V11, P107, DOI 10.1016/j.healthplace.2004.10.007; Hall E, 2004, AREA, V36, P298, DOI 10.1111/j.0004-0894.2004.00227.x; Hall E, 2000, AREA, V32, P21, DOI 10.1111/j.1475-4762.2000.tb00111.x; Hall E, 2010, J INTELL DISABIL RES, V54, P48, DOI 10.1111/j.1365-2788.2009.01237.x; Hall E, 2001, HEALTH PLACE, V7, P237, DOI 10.1016/S1353-8292(01)00007-7; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Herron RV, 2017, SOC SCI MED, V173, P81, DOI 10.1016/j.socscimed.2016.11.041; Hertzman Clyde, 2010, Healthc Q, V14 Spec No 1, P32; Ineichen B, 1998, HEALTH PLACE, V4, P383, DOI 10.1016/S1353-8292(98)00027-6; Iskandar BJ, 2004, J NEUROSURG, V101, P169, DOI 10.3171/ped.2004.101.2.0169; Jones J, 2010, QUAL HEALTH RES, V20, P942, DOI 10.1177/1049732310365501; KEARNS RA, 1993, PROF GEOGR, V45, P139, DOI 10.1111/j.0033-0124.1993.00139.x; Kearns RA, 1997, HEALTH PLACE, V3, P171, DOI 10.1016/S1353-8292(97)00011-7; Kingsbury P., 2016, PSYCHOANALYTIC GEOGR; Kitchin RM, 1997, ENVIRON BEHAV, V29, P554, DOI 10.1177/001391659702900406; LANSKA DJ, 1995, STROKE, V26, P1145, DOI 10.1161/01.STR.26.7.1145; Latham A, 2003, ENVIRON PLANN A, V35, P1993, DOI 10.1068/a3587; Lea J, 2015, CULT GEOGR, V22, P49, DOI 10.1177/1474474014536519; LIBEN LS, 1989, ADV CHILD DEV BEHAV, V22, P145; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Longhurst R, 1997, PROG HUM GEOG, V21, P486, DOI 10.1191/030913297668704177; LONGHURST R, 1995, GENDER PLACE CULTURE, V0002, P00097; Longhurst R., 1994, AUST GEOGR STUD, V32, P214; MacKian S, 2000, HEALTH PLACE, V6, P95, DOI 10.1016/S1353-8292(00)00006-X; Maddrell A, 2009, SOC CULT GEOGR, V10, P675, DOI 10.1080/14649360903068126; MARINPADILLA M, 1981, J NEUROL SCI, V50, P29, DOI 10.1016/0022-510X(81)90040-X; McCormack D., 2013, REFRAINS MOVING BODI; Mcnally RJQ, 2008, ANN EPIDEMIOL, V18, P108, DOI 10.1016/j.annepidem.2007.07.104; McNally RJQ, 2002, BRIT J CANCER, V86, P1070, DOI [10.1038/sj.bjc.6600228, 10.1038/sj/bjc/6600228]; Mehta V, 2002, NEUROSURGERY, V51, P365, DOI 10.1227/01.NEU.0000019779.27789.AC; Meijering L, 2016, HEALTH PLACE, V37, P35, DOI 10.1016/j.healthplace.2015.11.006; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Milhorat TH, 2010, ACTA NEUROCHIR, V152, P1117, DOI 10.1007/s00701-010-0636-3; Montello DR, 2009, GEOGR COMPASS, V3, P1824, DOI 10.1111/j.1749-8198.2009.00273.x; Morgan D, 2011, MATURITAS, V68, P17, DOI 10.1016/j.maturitas.2010.09.008; Moss P, 1996, ENVIRON PLANN D, V14, P737, DOI 10.1068/d140737; MOSS P, 1999, ANTIPODE, V31, P372, DOI DOI 10.1111/1467-8330.00110; MOSS P, 2003, WOMEN BODY ILLNESS S; Munshi I, 2000, NEUROSURGERY, V46, P1384, DOI 10.1097/00006123-200006000-00018; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nanninga CS, 2015, DISABIL REHABIL, V37, P1125, DOI 10.3109/09638288.2014.955136; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Painter J., 2016, WELLBEING PLACE; Panigrahi M, 2004, CHILD NERV SYST, V20, P336, DOI 10.1007/s00381-003-0881-3; Parr H, 2002, PROG HUM GEOG, V26, P240, DOI 10.1191/0309132502ph367pr; Parr H., 2008, MENTAL HLTH SOCIAL S; PAUL KS, 1983, J NEUROSURG, V58, P183, DOI 10.3171/jns.1983.58.2.0183; Peer M, 2014, EPILEPSY BEHAV, V41, P149, DOI 10.1016/j.yebeh.2014.09.055; Pfaffenrath V, 2009, CEPHALALGIA, V29, P48, DOI 10.1111/j.1468-2982.2008.01699.x; Philo C, 2005, HEALTH PLACE, V11, P77, DOI 10.1016/j.healthplace.2004.10.005; Philo C, 2003, SOC CULT GEOGR, V4, P283, DOI 10.1080/14649360309074; Philo C, 2015, J MED HUMANIT, V36, P35, DOI 10.1007/s10912-014-9315-3; Philo C, 1997, HEALTH PLACE, V3, P73, DOI 10.1016/S1353-8292(97)00002-6; PILLAY PK, 1991, NEUROSURGERY, V28, P639, DOI 10.1227/00006123-199105000-00001; Raghuram P, 2009, GEOFORUM, V40, P25, DOI 10.1016/j.geoforum.2008.03.005; RUFF ME, 1987, PEDIATRICS, V80, P231; RUSHTON G, 1979, ANN ASSOC AM GEOGR, V69, P463, DOI 10.1111/j.1467-8306.1979.tb01269.x; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sadie B., 1995, NEUROSURGERY, V37, P214; SAEZ RJ, 1976, J NEUROSURG, V45, P416, DOI 10.3171/jns.1976.45.4.0416; SAHUQUILLO J, 1994, NEUROSURGERY, V35, P874, DOI 10.1227/00006123-199411000-00011; Segrott J, 2004, SOC CULT GEOGR, V5, P597, DOI 10.1080/1464936042000317721; Sergent AW, 2014, J CHIROPR MED, V13, P192, DOI 10.1016/j.jcm.2014.07.004; Shaffer N, 2011, NEUROL RES, V33, P247, DOI 10.1179/016164111X12962202723805; Sibley D, 2003, SOC CULT GEOGR, V4, P391, DOI 10.1080/14649360309070; Siegel A W, 1975, Adv Child Dev Behav, V10, P9, DOI 10.1016/S0065-2407(08)60007-5; Smith N, 2012, SOC CULT GEOGR, V13, P339, DOI 10.1080/14649365.2012.683806; Sternberg R, 1996, GEOFORUM, V27, P205, DOI 10.1016/0016-7185(96)00007-3; Stevenson O, 2016, SOC CULT GEOGR, V17, P153, DOI 10.1080/14649365.2016.1152396; TANNER CM, 1989, NEUROLOGY, V39, P660, DOI 10.1212/WNL.39.5.660; Thomas ME, 2010, PROF GEOGR, V62, P478, DOI 10.1080/00330124.2010.501249; Thrift NJ, 2008, NONREPRESENTATIONAL; Tubbs RS, 2011, J NEUROSURG-PEDIATR, V7, P248, DOI 10.3171/2010.12.PEDS10379; Tubbs RS, 2003, J NEUROSURG, V99, P291, DOI 10.3171/jns.2003.99.2.0291; VALENTINE G, 1989, AREA, V21, P385; Valentine Gill., 1995, MAPPING DESIRE GEOGR; Van Acker V, 2010, TRANSPORT REV, V30, P219, DOI 10.1080/01441640902943453; Vannini P., 2015, NONREPRESENTATIONAL; Whitehead M, 2016, SOC CULT GEOGR, V17, P553, DOI 10.1080/14649365.2015.1089590; Williams A, 2002, SOC SCI MED, V55, P141, DOI 10.1016/S0277-9536(01)00209-X; WILLIS A, 2009, EMOTION SPACE SOC, V2, P86, DOI DOI 10.1016/J.EMOSPA.2009.09.001; Wilton R, 2014, T I BRIT GEOGR, V39, P291, DOI 10.1111/tran.12023; Wolch J, 2000, HEALTH PLACE, V6, P137, DOI 10.1016/S1353-8292(00)00019-8; Yang DY, 2004, NEUROEPIDEMIOLOGY, V23, P118, DOI 10.1159/000075954; Yantzi NM, 2007, HEALTH SOC CARE COMM, V15, P45, DOI 10.1111/j.1365-2524.2006.00663.x; Ziebland S, 2012, MILBANK Q, V90, P219, DOI 10.1111/j.1468-0009.2012.00662.x; [No title captured]; [No title captured]; [No title captured]; [No title captured]	164	4	4	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	JUN	2019	231				SI		13	21		10.1016/j.socscimed.2018.01.030			9	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	IH4YN	WOS:000474498100003	29395547				2022-02-06	
J	Baig, MR; Wilson, JL; Lemmer, JA; Beck, RD; Peterson, AL; Roache, JD				Baig, Muhammad R.; Wilson, Jennifer L.; Lemmer, Jennifer A.; Beck, Robert D.; Peterson, Alan L.; Roache, John D.			Enhancing Completion of Cognitive Processing Therapy for Posttraumatic Stress Disorder with Quetiapine in Veterans with Mild Traumatic Brain Injury: a Case Series	PSYCHIATRIC QUARTERLY			English	Article						Psychopharmacology; Evidence-based psychotherapy: Posttraumatic stress disorder; Mild traumatic brain injury	PROLONGED EXPOSURE THERAPY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PHARMACOLOGICAL MANAGEMENT; ANTIPSYCHOTIC-DRUGS; INTRANASAL OXYTOCIN; FEAR EXTINCTION; PTSD; EFFICACY; PAROXETINE	To evaluate the outcomes of the antiarousal medications valproate, risperidone, and quetiapine on completion of treatment of cognitive processing therapy (CPT) for PTSD. A case series of fifty treatment-seeking adult (18years) veterans with mild traumatic brain injury and combat-related PTSD who had unsuccessful trials of 2 or more first-line agents and previously declined treatment with trauma-focused therapy, seen at the psychiatric outpatient services of the local Polytrauma Rehabilitation Center from January 1, 2014, through December 31, 2017. Patients were prescribed valproate (n=8), risperidone (n=17), or quetiapine (n=25) and were referred for individual weekly treatment with CPT. Outcome measurements of interest were measures of engagement and completion rate of CPT, PTSD Checklist total score (range, 0-80; higher scores indicate greater PTSD severity) and arousal subscale score (range, 0-24; higher scores indicate greater arousal severity), and clinical observations of sleep variables. Of the 50 patients included in the study, 48 (96%) were men; mean (SD) age was 36 (8)years. Eighteen (86%) patients initially receiving quetiapine and none taking valproate or risperidone became adequately engaged in and completed CPT. Among patients who completed CPT, the mean decrease in the PTSD Checklist score was 25 [95% CI, 30 to 20] and 9 (50%) patients no longer met criteria for PTSD. These preliminary findings support quetiapine as an adjunctive medication to facilitate CPT. A pragmatic trial is needed to evaluate the efficacy, safety, and feasibility of quetiapine to improve engagement in and completion rate of CPT.	[Baig, Muhammad R.; Wilson, Jennifer L.; Lemmer, Jennifer A.; Beck, Robert D.; Peterson, Alan L.] South Texas Vet Healthcare Syst, Mental Hlth, San Antonio, TX 78284 USA; [Baig, Muhammad R.; Wilson, Jennifer L.; Lemmer, Jennifer A.; Beck, Robert D.] South Texas Vet Healthcare Syst, Polytrauma Rehabil Ctr, San Antonio, TX 78284 USA; [Baig, Muhammad R.; Roache, John D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Peterson, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, Div Behav Med, San Antonio, TX 78229 USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Roache, John D.] Univ Texas Hlth San Antonio, Dept Pharmacol, San Antonio, TX USA		Baig, MR (corresponding author), South Texas Vet Healthcare Syst, Mental Hlth, San Antonio, TX 78284 USA.; Baig, MR (corresponding author), South Texas Vet Healthcare Syst, Polytrauma Rehabil Ctr, San Antonio, TX 78284 USA.; Baig, MR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.	muhammad.baig@va.gov		Roache, John/0000-0002-7010-8119			Acheson D, 2013, PSYCHOPHARMACOLOGY, V229, P199, DOI 10.1007/s00213-013-3099-4; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2014, TREATM POSTTR STRESS; Asnis GM, 2004, DRUGS, V64, P383, DOI 10.2165/00003495-200464040-00004; Becker CB, 2004, BEHAV RES THER, V42, P277, DOI 10.1016/S0005-7967(03)00138-4; Borison RL, 1996, J CLIN PSYCHOPHARM, V16, P158, DOI 10.1097/00004714-199604000-00008; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; Davis LL, 2008, J CLIN PSYCHOPHARM, V28, P84, DOI [10.1097/jcp.0b013e318160f83b, 10.1097/JCP.0b013e318160f83b]; Deacon B, 2013, BEHAV RES THER, V51, P588, DOI 10.1016/j.brat.2013.06.006; Dold M, 2013, INT J NEUROPSYCHOPH, V16, P557, DOI 10.1017/S1461145712000740; Duff J, 2011, WORLDV EVID-BASED NU, V8, P30, DOI 10.1111/j.1741-6787.2010.00209.x; Echiverri-Cohen A, 2016, J CONSULT CLIN PSYCH, V84, P415, DOI 10.1037/ccp0000080; El-Khalili N, 2010, INT J NEUROPSYCHOPH, V13, P917, DOI 10.1017/S1461145710000015; Flanagan JC, 2018, J PSYCHIATR RES, V98, P64, DOI 10.1016/j.jpsychires.2017.12.014; Foa EB, 2011, DEPRESS ANXIETY, V28, P1043, DOI 10.1002/da.20907; Galovski TE, 2016, J CONSULT CLIN PSYCH, V84, P167, DOI 10.1037/ccp0000059; Ghodke-Puranik Y, 2013, PHARMACOGENET GENOM, V23, P236, DOI 10.1097/FPC.0b013e32835ea0b2; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; Hembree EA, 2003, J TRAUMA STRESS, V16, P555, DOI 10.1023/B:JOTS.0000004078.93012.7d; Hing Matthew, 2012, J Spec Oper Med, V12, P23; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; Imel ZE, 2013, J CONSULT CLIN PSYCH, V81, P394, DOI 10.1037/a0031474; Jaeger J., 2009, INT J BEHAV CONSULT, V5, P294; Jeffreys MD, 2014, J ANXIETY DISORD, V28, P108, DOI 10.1016/j.janxdis.2013.04.010; Jerud AB, 2016, BEHAV RES THER, V77, P62, DOI 10.1016/j.brat.2015.12.002; Jun JJ, 2013, DEPRESS ANXIETY, V30, P607, DOI 10.1002/da.22119; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kilpatrick D.G, 1984, BEHAV THERAPY SOME C, V15, P4; Krystal JH, 2017, BIOL PSYCHIAT; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Lund BC, 2012, J CLIN PSYCHIAT, V73, P292, DOI 10.4088/JCP.10m06775; Matsumoto Y, 2013, PSYCHOPHARMACOLOGY, V229, P51, DOI 10.1007/s00213-013-3078-9; Murphy D, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1398001; Patricia A, 2014, COGNITIVE PROCESSING; PITMAN RK, 1991, J CLIN PSYCHIAT, V52, P17; Pitman RK, 1996, COMPR PSYCHIAT, V37, P419, DOI 10.1016/S0010-440X(96)90025-5; Popiel A, 2015, J BEHAV THER EXP PSY, V48, P17, DOI 10.1016/j.jbtep.2015.01.002; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Rauch SAM, 2004, J TRAUMA STRESS, V17, P461, DOI 10.1007/s10960-004-5794-8; Robert S, 2005, J CLIN PSYCHOPHARM, V25, P387, DOI 10.1097/01.jcp.0000169624.37819.60; Rothbaum BO, 2014, AM J PSYCHIAT, V171, P640, DOI 10.1176/appi.ajp.2014.13121625; Sachs G, 2004, BIPOLAR DISORD, V6, P213, DOI 10.1111/j.1399-5618.2004.00115.x; Schneier FR, 2012, AM J PSYCHIAT, V169, P80, DOI 10.1176/appi.ajp.2011.11020321; Simon NM, 2008, J CLIN PSYCHIAT, V69, P400, DOI 10.4088/JCP.v69n0309; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Tarrier N, 1999, J CONSULT CLIN PSYCH, V67, P13, DOI 10.1037/0022-006X.67.1.13; Tsan JY, 2012, PSYCHOL SERV, V9, P336, DOI 10.1037/a0028308; Villarreal G, 2016, AM J PSYCHIAT, V173, P1205, DOI 10.1176/appi.ajp.2016.15070967; Viola J, 1997, MIL MED, V162, P616, DOI 10.1093/milmed/162.9.616; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wiegand MH, 2008, PSYCHOPHARMACOLOGY, V196, P337, DOI 10.1007/s00213-007-0968-8	57	4	5	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-2720	1573-6709		PSYCHIAT QUART	Psychiatr. Q.	JUN	2019	90	2					431	445		10.1007/s11126-019-09638-z			15	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	HY6AR	WOS:000468211100016	31054021				2022-02-06	
J	Bi, BB; Choi, HP; Hyeon, SJ; Sun, SN; Su, N; Liu, YG; Lee, J; Kowall, NW; McKee, AC; Yang, JH; Ryu, H				Bi, Baibin; Choi, Han-Pil; Hyeon, Seung Jae; Sun, Shengnan; Su, Ning; Liu, Yuguang; Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Yang, Jing-Hua; Ryu, Hoon			Quantitative Proteomic Analysis Reveals Impaired Axonal Guidance Signaling in Human Postmortem Brain Tissues of Chronic Traumatic Encephalopathy	EXPERIMENTAL NEUROBIOLOGY			English	Article						Chronic traumatic encephalopathy (CTE); Quantitative proteomics; Axonal guidance; Oligodendrocyte; Neuron; Neurodegeneration	AMYLOID-BETA ACCUMULATION; HEAD-INJURY; ALZHEIMERS-DISEASE; RISK-FACTOR; STRETCH-INJURY; TAU; PROTEINS; AXOTOMY; IMPACT; EPIDEMIOLOGY	Chronic traumatic encephalopathy (CTE) is a distinct neurodegenerative disease that associated with repetitive head trauma. CTE is neuropathologically defined by the perivascular accumulation of abnormally phosphorylated tau protein in the depths of the sulci in the cerebral cortices. In advanced CTE, hyperphosphorylated tau protein deposits are found in widespread regions of brain, however the mechanisms of the progressive neurodegeneration in CTE are not fully understood. In order to identify which proteomic signatures are associated with CTE, we prepared RIPA-soluble fractions and performed quantitative proteomic analysis of postmortem brain tissue from individuals neuropathologically diagnosed with CTE. We found that axonal guidance signaling pathway-related proteins were most significantly decreased in CTE. Immunohistochemistry and Western blot analysis showed that axonal signaling pathway-related proteins were down regulated in neurons and oligodendrocytes and neuron-specific cytoskeletal proteins such as TUBB3 and CFLI were reduced in the neuropils and cell body in CTE. Moreover, oligodendrocyte-specific proteins such as MAG and TUBB4 were decreased in the neuropils in both gray matter and white matter in CTE, which correlated with the degree of axonal injury and degeneration. Our findings indicate that deregulation of axonal guidance proteins in neurons and oligodendrocytes is associated with the neuropathology in CTE. Together, altered axonal guidance proteins may be potential pathological markers for CTE.	[Bi, Baibin; Su, Ning; Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Yang, Jing-Hua; Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Bi, Baibin; Su, Ning; Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Yang, Jing-Hua; Ryu, Hoon] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Bi, Baibin; Su, Ning; Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Yang, Jing-Hua; Ryu, Hoon] Boston Univ, Sch Med, Dept Surg, Boston, MA 02118 USA; [Bi, Baibin; Sun, Shengnan; Yang, Jing-Hua] Shandong Univ, Canc Res Ctr, Sch Med, Jinan 250012, Shandong, Peoples R China; [Bi, Baibin; Liu, Yuguang] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan 250012, Shandong, Peoples R China; [Choi, Han-Pil; Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Yang, Jing-Hua; Ryu, Hoon] VA Boston Healthcare Syst, Prote Lab, Boston, MA 02130 USA; [Hyeon, Seung Jae; Ryu, Hoon] Korea Inst Sci & Technol, Ctr Neuromed, Brain Sci Inst, Seoul 04535, South Korea; [Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Ryu, Hoon] Boston Univ, Sch Med, BU ADC, Boston, MA 02118 USA; [Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Ryu, Hoon] Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA		McKee, AC; Yang, JH; Ryu, H (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.; McKee, AC; Yang, JH; Ryu, H (corresponding author), Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA.; McKee, AC; Yang, JH; Ryu, H (corresponding author), Boston Univ, Sch Med, Dept Surg, Boston, MA 02118 USA.; Yang, JH (corresponding author), Shandong Univ, Canc Res Ctr, Sch Med, Jinan 250012, Shandong, Peoples R China.; McKee, AC; Yang, JH; Ryu, H (corresponding author), VA Boston Healthcare Syst, Prote Lab, Boston, MA 02130 USA.; Ryu, H (corresponding author), Korea Inst Sci & Technol, Ctr Neuromed, Brain Sci Inst, Seoul 04535, South Korea.; McKee, AC; Ryu, H (corresponding author), Boston Univ, Sch Med, BU ADC, Boston, MA 02118 USA.; McKee, AC; Ryu, H (corresponding author), Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA.	amckee@bu.edu; jyang@bu.edu; hoonryu@bu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS067283]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659-01]; Department of Veterans Affairs, the Veterans Affairs Biorepository [CSP 501]; Concussion Legacy Foundation; Korea Institute of Science and TechnologyKorea Institute of Science & Technology (KIST) [2E29221, 2E29230]; National Research Foundation of Korea from the Ministry of Science, ICT and Future Planning [NRF-2015M3A9A8030034, NRF-2016M3C7A1904233]; National Research Council of Science & Technology (NST) Grant from the Korean government (MSIP) [CRC-15-04-KIST]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER	This study was supported by NIH R01 NS067283 (H.R.), NINDS (U01NS086659-01) (A.C.M.), Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501) (A.C.M.), and the Concussion Legacy Foundation. This work was also supported by the Grant (2E29221 and 2E29230) from Korea Institute of Science and Technology. This study was also supported by the National Research Foundation of Korea Grant (NRF-2015M3A9A8030034 and NRF-2016M3C7A1904233) from the Ministry of Science, ICT and Future Planning, and the National Research Council of Science & Technology (NST) Grant (No. CRC-15-04-KIST) from the Korean government (MSIP).	Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Baas PW, 2013, NEURON, V78, P3, DOI 10.1016/j.neuron.2013.03.012; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cherry JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185541; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Demer JL, 2010, INVEST OPHTH VIS SCI, V51, P4600, DOI 10.1167/iovs.10-5438; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Marner L, 2003, J COMP NEUROL, V462, P144, DOI 10.1002/cne.10714; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Pomicter AD, 2013, NEUROCHEM RES, V38, P2490, DOI 10.1007/s11064-013-1162-5; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Seo JS, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.56; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Su N, 2016, J UROLOGY, V195, P515, DOI 10.1016/j.juro.2015.09.079; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Takase H, 2018, BEHAV BRAIN RES, V340, P205, DOI 10.1016/j.bbr.2016.10.042; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011	61	4	4	2	5	KOREAN SOC BRAIN & NEURAL SCIENCE, KOREAN SOC NEURODEGENERATIVE DISEASE	SEOUL	EXPERIMENTAL NEUROBIOLOGY,  SEOUL NATL UNIV, RM 410, BLDG 152-1, SEOUL, 151-742, SOUTH KOREA	1226-2560	2093-8144		EXP NEUROBIOL	Exp. Neurobiol.	JUN	2019	28	3					362	375		10.5607/en.2019.28.3.362			14	Medicine, Research & Experimental; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	IH4MJ	WOS:000474466200006	31308796	gold, Green Submitted, Green Published			2022-02-06	
J	Citerio, G; Prisco, L; Oddo, M; Meyfroidt, G; Helbok, R; Stocchetti, N; Taccone, F; Vincent, JL; Robba, C; Elli, F; Sala, E; Vargiolu, A; Lingsma, H				Citerio, Giuseppe; Prisco, Lara; Oddo, Mauro; Meyfroidt, Geert; Helbok, Raimund; Stocchetti, Nino; Taccone, Fabio; Vincent, Jean-Louis; Robba, Chiara; Elli, Francesca; Sala, Elisa; Vargiolu, Alessia; Lingsma, Hester			International prospective observational study on intracranial pressure in intensive care ( ICU): the SYNAPSE-ICU study protocol	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; MANAGEMENT; GUIDELINES; HYPERTENSION; MORTALITY; BURDEN; IMPACT	Introduction Intracranial pressure (ICP) monitoring is commonly used in neurocritical care patients with acute brain injury (ABI). Practice about indications and use of ICP monitoring in patients with ABI remains, however, highly variable in high-income countries, while data on ICP monitoring in low and middle-income countries are scarce or inconsistent. The aim of the SYNAPSE-ICU study is to describe current practices of ICP monitoring using a worldwide sample and to quantify practice variations in ICP monitoring and management in neurocritical care ABI patients. Methods and analysis The SYNAPSE-ICU study is a large international, prospective, observational cohort study. From March 2018 to March 2019, all patients fulfilling the following inclusion criteria will be recruited: age > 18 years; diagnosis of ABI due to primary haemorrhagic stroke (subarachnoid haemorrhage or intracranial haemorrhage) or traumatic brain injury; Glasgow Coma Score (GCS) with no eye opening (Eyes response=1) and Motor score <= 5 (not following commands) at ICU admission, or neuro-worsening within the first 48 hours with no eye opening and a Motor score decreased to <= 5. Data related to clinical examination (GCS, pupil size and reactivity, Richmond Agitation-Sedation Scale score, neuroimaging) and to ICP interventions (Therapy Intensity Levels) will be recorded on admission, and at day 1, 3 and 7. The Glasgow Outcome Scale Extended (GOSE) will be collected at discharge from ICU and from hospital and at 6-month follow-up. The impact of ICP monitoring and ICPdriven therapy on GOSE will be analysed at both patient and ICU level. Ethics and dissemination The study has been approved by the Ethics Committee 'Brianza' at the Azienda Socio Sanitaria Territoriale (ASST)-Monza (approval date: 21 November 2017). Each National Coordinator will notify the relevant ethics committee, in compliance with the local legislation and rules. Data will be made available to the scientific community by means of abstracts submitted to the European Society of Intensive Care Medicine annual conference and by scientific reports and original articles submitted to peer-reviewed journals.	[Citerio, Giuseppe; Elli, Francesca; Sala, Elisa; Vargiolu, Alessia] Univ Milano Bicocca, Scuola Med Chirurg, Monza, Italy; [Prisco, Lara] John Radcliffe Hosp, Neurosci Intens Care Unit, Oxford, England; [Prisco, Lara] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Oddo, Mauro] CHU Vaudois, Lausanne Univ Hosp, Dept Intens Care Med, Lausanne, Switzerland; [Meyfroidt, Geert] Univ Hosp, Dept Intens Care Med, Leuven, Belgium; [Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurocrit Care Unit, Innsbruck, Austria; [Stocchetti, Nino] Univ Milan, Dept Physiopathol & Transplant, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Taccone, Fabio; Vincent, Jean-Louis] Univ Libre Bruxelles, Dept Intens Care, Hop Erasme, Brussels, Belgium; [Robba, Chiara] Addenbrookes Hosp, Neurocrit Care Unit, Cambridge, England; [Robba, Chiara] Policlin San Martino IRCCS Oncol & Neurosci, Anesthesia & Intens Care, Genoa, Italy; [Lingsma, Hester] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands		Citerio, G (corresponding author), Univ Milano Bicocca, Scuola Med Chirurg, Monza, Italy.	giuseppe.citerio@unimib.it	Robba, Chiara/AAS-7421-2020; Prisco, Lara/X-9310-2018; Prisco, Lara/I-9267-2019; Helbok, Raimund/AAA-8361-2021	Prisco, Lara/0000-0001-6727-7870; sala, elisa/0000-0001-8603-3839; Vincent, Jean-Louis/0000-0001-6011-6951			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Citerio G, 2007, INTENS CARE MED, V33, P1580, DOI 10.1007/s00134-007-0700-5; Cnossen MC, 2018, CLIN EPIDEMIOL, V10, P841, DOI 10.2147/CLEP.S154500; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Helbok R, 2014, NEUROCRIT CARE S2, pS85; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hendrickson P, 2018, WORLD NEUROSURG, V110, pE952, DOI 10.1016/j.wneu.2017.11.142; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Magni F, 2015, STROKE, V46, P2464, DOI 10.1161/STROKEAHA.115.010219; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Meyfroidt G, 2017, NEUROSURGERY, V81, pE1, DOI 10.1093/neuros/nyx144; Shutter LA, 2016, NEW ENGL J MED, V375, P1183, DOI 10.1056/NEJMe1609722; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zoerle T, 2015, CRIT CARE MED, V43, P168, DOI 10.1097/CCM.0000000000000670	27	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2019	9	4							e026552	10.1136/bmjopen-2018-026552			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IC7MA	WOS:000471157200194	31005932	Green Published, gold			2022-02-06	
J	Dodd, JN; Murphy, S; Bosworth, C				Dodd, Jonathan N.; Murphy, Samantha; Bosworth, Christopher			Sensitivity of the Memory Validity Profile (MVP): Raising the bar	CHILD NEUROPSYCHOLOGY			English	Article						Pediatric; brain injury; performance validity; memory validity profile	TRAUMATIC BRAIN-INJURY; MALINGERING TOMM; PERFORMANCE; CHILDREN; CONCUSSION	The Memory Validity Profile (MVP) is a performance validity test (PVT) designed specifically for pediatric populations and utilizes specific cut-points for identifying noncredible performance at different ages. This study aims to evaluate the MVP using a known-groups design to determine optimal cut-off scores for detecting noncredible performance in youths with mild traumatic brain injury (mTBI) across different age-groups. Participants were 114 youths (age 5-17) with mTBI who were referred for neuropsychological evaluation in a hospital-based concussion clinic. All participants were administered the Nonverbal-Medical Symptom Validity Test (NV-MSVT) and the MVP. Participants who failed the NV-MSVT were also administered the TOMM. Participants who failed both the NV-MSVT and the TOMM comprised the criterion group (i.e., the "Failed two PVTs" group). Participants who failed only one PVT were excluded from the analysis. ROC curve analyses revealed good discriminability (AUC = .844: 95%, CI = 676-1.0, p = .001) with acceptable sensitivity (.73) and specificity (.91) for an optimal MVP Total score cut-off <= 31. There were no differences in MVP Total scores across age-groups. In conclusion, adopting stricter cut-points for non-credible performance and applying these consistently across all age groups in a mTBI population increases the clinical utility of the MVP.	[Dodd, Jonathan N.] WellStar Med Grp, Psychol Serv, Marietta, GA 30060 USA; [Murphy, Samantha] Southern Illinois Univ, Dept Psychol, Edwardsville, IL 62026 USA; [Bosworth, Christopher] Washington Univ, St Louis Childrens Hosp, Dept Psychol, St Louis, MO 63110 USA		Dodd, JN (corresponding author), WellStar Med Grp, Psychol Serv, Marietta, GA 30060 USA.	drdodd@gatewayneuro.com	Murphy, Samantha/ABC-9110-2020	Murphy, Samantha/0000-0002-8765-6111			Anderson V., 1995, NEUROPSYCHOLOGICAL A; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brooks BL, 2019, APPL NEUROPSYCH-CHIL, V8, P319, DOI 10.1080/21622965.2018.1476865; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Conners K.C., 2014, CONNERS CONTINUOUS P; Connery AK, 2016, CLIN NEUROPSYCHOL, V30, P579, DOI 10.1080/13854046.2016.1177596; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Green P.J.E., 2008, MANUAL NONVERBAL MED; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Korkman M., 2007, DEV NEUROPSYCHOLOGIC, V2; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; March J.S., 2013, MULTIDIMENSIONAL ANX; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Reynolds C.R., 2015, BEHAV ASSESSMENT SYS, V3rd; Schneider HE, 2014, CLIN NEUROPSYCHOL, V28, P1133, DOI 10.1080/13854046.2014.960004; Sherman EMS, 2015, MEMORY VALIDITY PROF; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Weschler D., 2013, WESCHLER INTELLIGENC; Weschler D., 2008, WESCHLER ADULT INTEL; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	33	4	4	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JAN 2	2020	26	1					137	144		10.1080/09297049.2019.1620714		JUN 2019	8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OM4UA	WOS:000472274100001	31145035				2022-02-06	
J	Ellis, MJ; Bauman, S; Cowle, S; Fuselli, P; Tator, CH				Ellis, Michael J.; Bauman, Shannon; Cowle, Stephanie; Fuselli, Pamela; Tator, Charles H.			Primary care management of concussion in Canada	PAEDIATRICS & CHILD HEALTH			English	Article						Canada; Canadian Guideline on Concussion in Sport; Concussion; Primary care; Public health		Concussion has emerged as an important public health issue affecting thousands of Canadians annually. Health care providers including paediatricians, family and emergency medicine physicians, nurses, and nurse practitioners are commonly tasked with the responsibility of providing primary care to patients with acute concussion and those with persistent post-concussion symptoms. In July 2017, Parachute, in collaboration with the Public Health Agency of Canada and Sport Canada released the Canadian Guideline on Concussion in Sport that outlines a standardized and evidence-based approach to the recognition, diagnosis, and management of youth and adults with suspected concussion. In this report, we provide a brief overview of the important roles of primary care providers in the medical assessment, management, and prevention of concussion as outlined in this national best practice guideline.	[Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Dept Surg & Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Ellis, Michael J.] Pan Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada; [Bauman, Shannon] Royal Victoria Reg Hlth Care Ctr, Dept Surg, Barrie, ON, Canada; [Bauman, Shannon] Royal Victoria Reg Hlth Care Ctr, Dept Family Med, Barrie, ON, Canada; [Bauman, Shannon] Univ Toronto, Dept Community & Family Med, Toronto, ON, Canada; [Bauman, Shannon] Concuss North, Barrie, ON, Canada; [Cowle, Stephanie; Fuselli, Pamela] Parachute Canada, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Tator, Charles H.] Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada		Ellis, MJ (corresponding author), Pan Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com					Canadian Concussion Collaborative, 2017, 4 CHAR GOOD CONC CLI; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Chung S, 2011, J TRAUMA, V70, P873, DOI 10.1097/TA.0b013e3182108823; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C; Ontario Neurotrauma Foundation, 2017, GUID CONC MTBI PERS; Ontario Neurotrauma Foundation, 2017, STAND POSTC CAR DIAG; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Russell K, 2017, CAN J NEUROL SCI, V44, P225, DOI 10.1017/cjn.2016.423; Stiell IG, 2010, CAN MED ASSOC J, V182, P1173, DOI 10.1503/cmaj.091430; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	23	4	4	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	JUN	2019	24	3					137	142		10.1093/pch/pxy171			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	IA8KD	WOS:000469806700005	31110450	Green Published			2022-02-06	
J	Eriksen, N; Pakkenberg, B; Rostrup, E; Okonkwo, DO; Mathern, B; Shutter, LA; Strong, AJ; Woitzik, J; Pahl, C; Dreier, JP; Martus, P; Lauritzen, MJ; Fabricius, M; Hartings, JA				Eriksen, Nina; Pakkenberg, Bente; Rostrup, Egill; Okonkwo, David O.; Mathern, Bruce; Shutter, Lori A.; Strong, Anthony J.; Woitzik, Johannes; Pahl, Clemens; Dreier, Jens P.; Martus, Peter; Lauritzen, Martin J.; Fabricius, Martin; Hartings, Jed A.			Neurostereologic Lesion Volumes and Spreading Depolarizations in Severe Traumatic Brain Injury Patients: A Pilot Study	NEUROCRITICAL CARE			English	Article						Cortical spreading depression; Brain contusion; Subdural hematoma; Subarachnoid hemorrhage; Electroencephalography; Computed tomography volume	SUBARACHNOID HEMORRHAGE; DEPRESSION; STROKE; PREDICTION; ISCHEMIA; CT	BackgroundSpreading depolarizations (SDs) occur in 50-60% of patients after surgical treatment of severe traumatic brain injury (TBI) and are independently associated with unfavorable outcomes. Here we performed a pilot study to examine the relationship between SDs and various types of intracranial lesions, progression of parenchymal damage, and outcomes.MethodsIn a multicenter study, fifty patients (76% male; median age 40) were monitored for SD by continuous electrocorticography (ECoG; median duration 79h) following surgical treatment of severe TBI. Volumes of hemorrhage and parenchymal damage were estimated using unbiased stereologic assessment of preoperative, postoperative, and post-ECoG serial computed tomography (CT) studies. Neurologic outcomes were assessed at 6months by the Glasgow Outcome Scale-Extended.ResultsPreoperative volumes of subdural and subarachnoid hemorrhage, but not parenchymal damage, were significantly associated with the occurrence of SDs (P's<0.05). Parenchymal damage increased significantly (median 34ml [Interquartile range (IQR) -2, 74]) over 7 (5, 8) days from preoperative to post-ECoG CT studies. Patients with and without SDs did not differ in extent of parenchymal damage increase [47ml (3, 101) vs. 30ml (-2, 50), P=0.27], but those exhibiting the isoelectric subtype of SDs had greater initial parenchymal damage and greater increases than other patients (P's<0.05). Patients with temporal clusters of SDs (3 in 2h; n=10 patients), which included those with isoelectric SDs, had worse outcomes than those without clusters (P=0.03), and parenchymal damage expansion also correlated with worse outcomes (P=0.01). In multivariate regression with imputation, both clusters and lesion expansion were significant outcome predictors.ConclusionsThese results suggest that subarachnoid and subdural blood are important primary injury factors in provoking SDs and that clustered SDs and parenchymal lesion expansion contribute independently to worse patient outcomes. These results warrant future prospective studies using detailed quantification of TBI lesion types to better understand the relationship between anatomic and physiologic measures of secondary injury.	[Eriksen, Nina; Pakkenberg, Bente] Bispebjerg Frederiksberg Hosp, Res Lab Stereol & Neurosci, Copenhagen, Denmark; [Pakkenberg, Bente] Univ Copenhagen, Fac Hlth, Inst Clin Med, Copenhagen, Denmark; [Rostrup, Egill] Univ Copenhagen, Glostrup Hosp, Dept Diagnost, Copenhagen, Denmark; [Rostrup, Egill; Lauritzen, Martin J.] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Lauritzen, Martin J.] Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Lauritzen, Martin J.] Univ Copenhagen, Dept Neurosci, Copenhagen, Denmark; [Strong, Anthony J.; Pahl, Clemens] Kings Coll Hosp London, Dept Clin Neurosci, London, England; [Woitzik, Johannes] Charite, Dept Neurosurg, Berlin, Germany; [Mathern, Bruce] Virginia Commonwealth Univ Med Coll Virginia, Dept Neurosurg, Richmond, VA USA; [Okonkwo, David O.; Shutter, Lori A.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Shutter, Lori A.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Shutter, Lori A.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Fabricius, Martin] Univ Copenhagen, Dept Neurophysiol, Rigshosp, Copenhagen, Denmark; [Martus, Peter] Univ Tubingen, Inst Clin Epidemiol & Appl Biostat, Tubingen, Germany; [Woitzik, Johannes; Dreier, Jens P.] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Woitzik, Johannes; Dreier, Jens P.] Free Univ Berlin, Berlin Inst Hlth, Humboldt Univ Berlin, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Dreier, Jens P.] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Dreier, Jens P.] Einstein Ctr Neurosci Berlin, Berlin, Germany; [Hartings, Jed A.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [Hartings, Jed A.] UC Gardner Neurosci Inst, Cincinnati, OH 45229 USA		Hartings, JA (corresponding author), Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA.; Hartings, JA (corresponding author), UC Gardner Neurosci Inst, Cincinnati, OH 45229 USA.	jed.hartings@uc.edu	Shutter, Lori A/G-2957-2013; Rostrup, Egill/D-8622-2017	pakkenberg, bente/0000-0003-3851-6494; Rostrup, Egill/0000-0001-5015-5244; Lauritzen, Martin/0000-0002-1517-1131; Shutter, Lori/0000-0002-1390-0628; Woitzik, Johannes/0000-0002-1865-4606	US Army CDMRP PH/TBI Research Program [W81XWH-08-2-0016]; Agnes and Poul Friis Foundation; Aase and Ejnar Danielsens Foundation; Dagmar Marshall's Foundation; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [DR 323/5-1]; Bundesministerium fur Bildung und Forschung (BMBF)Federal Ministry of Education & Research (BMBF) [CSB 01 EO 0801]; FP7 CENTER-TBI [602150]	Research was supported by the US Army CDMRP PH/TBI Research Program (Contract No. W81XWH-08-2-0016), the Agnes and Poul Friis Foundation, the Aase and Ejnar Danielsens Foundation, the Dagmar Marshall's Foundation, Deutsche Forschungsgemeinschaft (DFG DR 323/5-1), Bundesministerium fur Bildung und Forschung (BMBF CSB 01 EO 0801) and FP7 No. 602150 CENTER-TBI.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Clatterbuck RE, 1997, NEUROSURGERY, V40, P339, DOI 10.1097/00006123-199702000-00019; de Crespigny A, 1998, J CEREBR BLOOD F MET, V18, P1008, DOI 10.1097/00004647-199809000-00010; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dreier J. P., 2017, NEUROPHARMACOLOGY; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Eriksen N, 2010, BRIT J RADIOL, V83, P307, DOI 10.1259/bjr/18575224; Eriksen N, 2018, NEUROLOGY; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2017, BRAIN, V140, P2673, DOI 10.1093/brain/awx214; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1550, DOI 10.1177/0271678X16677764; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hartings JA, 2009, J NEUROPHYSIOL, V102, P2563, DOI 10.1152/jn.00345.2009; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Hinzman JM, 2014, BRAIN; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jimenez-Roldan L, 2013, J NEUROSURG, V118, P84, DOI 10.3171/2012.8.JNS12100; Karabiyikoglu M, 2005, NEUROSURGERY, V57, P565, DOI 10.1227/01.NEU.0000170435.47739.AE; Krenzlin H, 2019, J NEUROTRAUM, V36, P395, DOI 10.1089/neu.2018.5657; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lapilover EG, 2012, NEUROBIOL DIS, V48, P495, DOI 10.1016/j.nbd.2012.06.024; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Luckl J, 2018, BRAIN, V141, P1734, DOI 10.1093/brain/awy102; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Risher WC, 2012, GLIA, V60, P1709, DOI 10.1002/glia.22390; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	47	4	4	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2019	30	3					557	568		10.1007/s12028-019-00692-w			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HY2EM	WOS:000467930300009	30972614				2022-02-06	
J	Ewing-Cobbs, L; DeMaster, D; Watson, CG; Prasad, MR; Cox, CS; Kramer, LA; Fischer, JT; Duque, G; Swank, PR				Ewing-Cobbs, Linda; DeMaster, Dana; Watson, Christopher G.; Prasad, Mary R.; Cox, Charles S., Jr.; Kramer, Larry A.; Fischer, Jesse T.; Duque, Gerardo; Swank, Paul R.			Post-Traumatic Stress Symptoms after Pediatric Injury: Relation to Pre-Frontal Limbic Circuitry	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; diffusion tensor imaging; injury; limbic; post-traumatic stress; pre-frontal	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INTEGRITY; CHILDHOOD MALTREATMENT; CORPUS-CALLOSUM; BEHAVIOR RELATIONSHIPS; VENTRAL STRIATUM; LIFE-SPAN; AMYGDALA; CHILDREN; DISORDER	Pre-frontal limbic circuitry is vulnerable to effects of stress and injury. We examined microstructure of pre-frontal limbic circuitry after traumatic brain injury (TBI) or extracranial injury (EI) and its relation to post-traumatic stress symptoms (PTSS). Participants aged 8 to 15 years who sustained mild to severe TBI (n = 53) or EI (n = 26) in motor vehicle incidents were compared with healthy children (n = 38) in a prospective longitudinal study. At the seven-week follow-up, diffusion tensor imaging was obtained in all groups; injured children completed PTSS ratings using a validated scale. Using probabilistic diffusion tensor tractography, pathways were seeded from bilateral amygdalae and hippocampi to estimate the trajectory of white matter connecting them to each other and to targeted pre-frontal cortical (PFC) regions. Microstructure was estimated using fractional anisotropy (FA) in white matter and mean diffusivity (MD) in gray matter. Pre-frontal limbic microstructure was similar across groups, except for reduced FA in the right hippocampus to orbital PFC pathway in the injured versus healthy group. We examined microstructure of components of pre-frontal limbic circuitry with concurrently obtained PTSS cluster scores in the injured children. Neither microstructure nor PTSS scores differed significantly in the TBI and EI groups. Across PTSS factors, specific symptom clusters were related positively to higher FA and MD. Higher hyperarousal, avoidance, and re-experiencing symptoms were associated with higher FA in amygdala to pre-frontal and hippocampus to amygdala pathways. Higher hippocampal MD had a central role in hyperarousal and emotional numbing symptoms. Age moderated the relation of white and gray matter microstructure with hyperarousal scores. Our findings are consistent with models of traumatic stress that implicate disrupted top-down PFC and hippocampal moderation of overreactive subcortical threat arousal systems. Alterations in limbic pre-frontal circuitry and PTSS place children with either brain or body injuries at elevated risk for both current and future psychological health problems.	[Ewing-Cobbs, Linda; DeMaster, Dana; Watson, Christopher G.; Prasad, Mary R.; Duque, Gerardo] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX 77030 USA; [Ewing-Cobbs, Linda; DeMaster, Dana; Watson, Christopher G.; Prasad, Mary R.; Duque, Gerardo] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Swank, Paul R.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Kramer, Larry A.] Univ Texas Hlth Sci Ctr Houston, Dept Intervent Radiol, Houston, TX 77030 USA; [Fischer, Jesse T.] Univ Houston, Dept Psychol, Houston, TX USA		Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Sch Med, Childrens Learning Inst, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.; Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Sch Med, Dept Pediat, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.	Linda.ewing-cobbs@uth.tmc.edu	Watson, Christopher G./P-5707-2018	Watson, Christopher G./0000-0002-7082-7631	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS046308]; Nicole and Evan Katz Pediatric Neurodevelopmental Fund	This work was funded by the National Institutes of Health R01 NS046308 awarded to LEC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting institute. Support was also provided by the Nicole and Evan Katz Pediatric Neurodevelopmental Fund.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Akiki TJ, 2018, NEUROIMAGE, V176, P489, DOI 10.1016/j.neuroimage.2018.05.005; Allwood MA, 2011, J CLIN CHILD ADOLESC, V40, P659, DOI 10.1080/15374416.2011.597081; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; [Anonymous], 2016, WEB BAS INJ STAT QUE; Arnsten AFT, 2015, NEUROBIOL STRESS, V1, P89, DOI 10.1016/j.ynstr.2014.10.002; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Biederman J, 2002, AM J PSYCHIAT, V159, P1556, DOI 10.1176/appi.ajp.159.9.1556; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Brosbe MS, 2011, J PEDIATR PSYCHOL, V36, P718, DOI 10.1093/jpepsy/jsq115; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Carrion VG, 2008, DEPRESS ANXIETY, V25, P514, DOI 10.1002/da.20346; Casey BJ, 2015, ANNU REV PSYCHOL, V66, P295, DOI 10.1146/annurev-psych-010814-015156; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DeMaster D, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.832; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Ewing-Cobbs L, 2017, PSYCHONEUROENDOCRINO, V84, P66, DOI 10.1016/j.psyneuen.2017.06.003; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Faber J, 2016, BRAIN INJURY, V30, P1635, DOI 10.1080/02699052.2016.1199910; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Gabard-Durnam LJ, 2014, NEUROIMAGE, V95, P193, DOI 10.1016/j.neuroimage.2014.03.038; Goodrich-Hunsaker NJ, 2018, J NEUROSCI RES, V96, P626, DOI 10.1002/jnr.24142; Hendrickson RC, 2016, EXP NEUROL, V284, P181, DOI 10.1016/j.expneurol.2016.05.014; Herringa RJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0825-3; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Juranek J, 2012, BRAIN IMAGING BEHAV, V6, P36, DOI 10.1007/s11682-011-9140-5; Kassam-Adams N, 2010, J AM ACAD CHILD PSY, V49, P616, DOI 10.1016/j.jaac.2010.02.011; Keding TJ, 2015, NEUROPSYCHOPHARMACOL, V40, P537, DOI 10.1038/npp.2014.239; Kenardy J, 2012, J CLIN CHILD ADOLESC, V41, P5, DOI 10.1080/15374416.2012.632348; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Leh SE, 2017, J NEUROTRAUM, V34, P1402, DOI 10.1089/neu.2016.4591; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Max JE, 2015, J PEDIATR REHAB MED, V8, P345, DOI 10.3233/PRM-150352; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McEwen BS, 2015, NEUROBIOL STRESS, V1, P1, DOI 10.1016/j.ynstr.2014.09.001; Milani ACC, 2017, PSYCHIAT CLIN NEUROS, V71, P154, DOI 10.1111/pcn.12473; Morawetz C, 2017, SOC COGN AFFECT NEUR, V12, P569, DOI 10.1093/scan/nsw169; Morey RA, 2016, NEUROPSYCHOPHARMACOL, V41, P791, DOI 10.1038/npp.2015.205; Nicholson AA, 2017, HUM BRAIN MAPP, V38, P541, DOI 10.1002/hbm.23402; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Ohashi K, 2017, NEUROIMAGE, V150, P50, DOI 10.1016/j.neuroimage.2017.02.037; Paquola C, 2017, J PSYCHIATR RES, V91, P149, DOI 10.1016/j.jpsychires.2017.03.019; Patriat R, 2016, J AM ACAD CHILD PSY, V55, P319, DOI 10.1016/j.jaac.2016.01.010; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Price J, 2016, J PEDIATR PSYCHOL, V41, P86, DOI 10.1093/jpepsy/jsv074; Puetz VB, 2017, HUM BRAIN MAPP, V38, P855, DOI 10.1002/hbm.23423; Qin SZ, 2012, P NATL ACAD SCI USA, V109, P7941, DOI 10.1073/pnas.1120408109; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rinne-Albers MAW, 2016, EUR CHILD ADOLES PSY, V25, P869, DOI 10.1007/s00787-015-0805-2; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Saygin ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125170; Scheibel RS, 2011, SOC NEUROSCI-UK, V6, P582, DOI 10.1080/17470919.2011.588844; Scherf KS, 2013, HORM BEHAV, V64, P298, DOI 10.1016/j.yhbeh.2013.05.011; Schreier H, 2005, J TRAUMA, V58, P353, DOI 10.1097/01.TA.0000152537.15672.B7; Seckfort DL, 2008, BRAIN IMAGING BEHAV, V2, P49, DOI 10.1007/s11682-007-9015-y; Shirtcliff EA, 2008, DEV PSYCHOBIOL, V50, P690, DOI 10.1002/dev.20336; Silvers JA, 2017, DEV COGN NEUROS-NETH, V25, P128, DOI 10.1016/j.dcn.2016.06.005; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stover CS, 2018, CLIN PSYCHOL REV, V64, P77, DOI 10.1016/j.cpr.2016.11.002; Suo XL, 2017, RADIOLOGY, V282, P826, DOI 10.1148/radiol.2016160907; TEASDALE G, 1974, LANCET, V2, P81; Teicher MH, 2018, NEUROIMAGE, V169, P443, DOI 10.1016/j.neuroimage.2017.12.055; Teicher MH, 2016, NAT REV NEUROSCI, V17, P652, DOI 10.1038/nrn.2016.111; Tottenham N, 2016, NEUROSCI BIOBEHAV R, V70, P217, DOI 10.1016/j.neubiorev.2016.07.030; Weems C.F., 2018, J CHILD PSYCHOL PSYC; Weems CF, 2017, DEV REV, V46, P44, DOI 10.1016/j.dr.2017.08.001; Weis C.N., 2018, CHRONIC STRESS; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wolf RC, 2016, NEUROPSYCHOPHARMACOL, V41, P822, DOI 10.1038/npp.2015.209; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	95	4	4	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1738	1751		10.1089/neu.2018.6071			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600004	30672379	Green Published			2022-02-06	
J	Fair, RC; Champa, C				Fair, Ray C.; Champa, Christopher			Estimated Costs of Contact in College and High School Male Sports	JOURNAL OF SPORTS ECONOMICS			English	Article						sports injuries; collegiate sports; high school sports	CONCUSSION RATES; UNITED-STATES; EPIDEMIOLOGY; INJURIES; HEAD; COHORT; HEALTH; TRENDS; LIFE	Injury rates in 12 U.S. men's college sports and 5 U.S. boys' high school sports are examined in this article. The sports are categorized as "contact" or "noncontact," and differences in injury rates between the two are examined. Injury rates in the contact sports are considerably higher than those in the noncontact sports, and they are on average more severe. Estimates are presented of the injury savings that would result if the contact sports were changed to have injury rates similar to those in the noncontact sports. The estimated college savings are 48,100 fewer injuries per year and 5,900 fewer healthy years lost-to-injury per year. The estimated high school savings are 568,600 fewer injuries per year and 92,000 fewer healthy years lost-to-injury per year. For concussions, the savings are 6,900 per year for college and 161,400 per year for high school. The estimated dollar value (in 2015 dollars) of the total injury savings is between US$433 million and US$1.5 billion per year for college and between US$5.1 billion and US$18.4 billion per year for high school.	[Fair, Ray C.] Yale Univ, 30 Hillhouse Ave, New Haven, CT 06520 USA; [Champa, Christopher] Anal Grp, Boston, MA USA		Fair, RC (corresponding author), Yale Univ, 30 Hillhouse Ave, New Haven, CT 06520 USA.	ray.fair@yale.edu					Abelson P, 2003, ECON REC, V79, pS2, DOI 10.1111/1475-4932.00087; Abelson Peter, 2004, ECON PAPERS, V23, P129; Aldy JE, 2008, REV ECON STAT, V90, P573, DOI 10.1162/rest.90.3.573; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Comstock R. D., 2011, SUMMARY REPORT HIGH; Cutler David M., 2004, YOUR MONEY YOUR LIFE; DALTON S, 2016, JOURNAL OF SPORTS ME, V4, P3, DOI DOI 10.1177/2325967116632692; Dalton SL, 2015, AM J SPORT MED, V43, P2671, DOI 10.1177/0363546515599631; Gardner EC, 2015, AM J SPORT MED, V43, P2027, DOI 10.1177/0363546515588175; Hibberd EE, 2016, AM J SPORT MED, V44, P2667, DOI 10.1177/0363546516643721; Kerr ZY, 2016, J ATHL TRAINING, V51, P57, DOI 10.4085/1062-6050-51.1.10; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lynall RC, 2016, BRIT J SPORT MED, V50, P1211, DOI 10.1136/bjsports-2015-095360; Lynall RC, 2016, J ORTHOP SPORT PHYS, V46, P96, DOI 10.2519/jospt.2016.6315; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mathers C., 1999, BURDEN DIS INJURY AU; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Misra A., 2014, CONT MECH THERMODYNA, P1; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Murphy KM, 2006, J POLIT ECON, V114, P871, DOI 10.1086/508033; National Safety Council, 2017, EST COSTS UN INJ; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Yang Jingzhen, 2018, Inj Epidemiol, V5, P2, DOI 10.1186/s40621-018-0132-4	28	4	4	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1527-0025	1552-7794		J SPORT ECON	J. Sport. Econ.	JUN	2019	20	5					690	717		10.1177/1527002518798681			28	Economics; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Business & Economics; Social Sciences - Other Topics	HW1EK	WOS:000466425700004		Green Submitted			2022-02-06	
J	Farr, SA; Niehoff, ML; Kumar, VB; Roby, DA; Morley, JE				Farr, Susan A.; Niehoff, Michael L.; Kumar, Vijaya B.; Roby, Deborah A.; Morley, John E.			Inhibition of Glycogen Synthase Kinase 3 beta as a Treatment for the Prevention of Cognitive Deficits after a Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						antisense; GSK-3 beta; memory; TBI	ALZHEIMERS-DISEASE; EXPRESSION; HIPPOCAMPUS; DECREASES; TARGET; MEMORY; SAMP8; MAZE	Traumatic brain injury (TBI) has many long-term consequences, including impairment in memory and changes in mood. Glycogen synthase kinase 3 beta (GSK-3 beta) in its phosphorylated form (p-GSK-3 beta) is considered to be a major contributor to memory problems that occur post-TBI. We have developed an antisense that targets the GSK-3 beta ((G)AO) gene. Using a model of closed-head concussive TBI, we subjected mice to TBI and injected (G)AO or a random antisense ((R)AO) 15 min post-injury. One week post-injury, mice were tested in object recognition with 24 h delay. At 4 weeks post- injury, mice were tested with a T-maze foot shock avoidance memory test and a second object recognition test with 24 h delay using different objects. Mice that received (G)AO show improved memory in both object recognition and T-maze compared with (R)AO- treated mice that were subjected to TBI. Next, we verified that (G)AO blocked the surge in phosphorylated GSK-3 beta post-TBI. Mice were subjected to TBI and injected with antisense 15 min post-TBI with (G)AO or (R)AO. Mice were euthanized at 4 and 72 h post-TBI. Analysis of p-ser9GSK-3 beta, p-tyr216GSK-3 beta, and phospho-tau (p-tau)(404) showed that mice that received a TBI+(R)AO had significantly higher p-ser9GSK-3 beta, p-tyr216GSK-3 beta, and p-tau(404) levels than the mice that received TBI+(G)AO and the Sham+(R)AO mice. The current finding suggests that inhibiting GSK-3 beta increase after TBI with an antisense directed at GSK-3 beta prevents learning and memory impairments.	[Farr, Susan A.; Niehoff, Michael L.; Kumar, Vijaya B.; Morley, John E.] St Louis Univ, Sch Med, Res & Dev Serv, VA Med Ctr,Div Geriatr Med, 1402 South Grand Blvd,Room M238, St Louis, MO 63104 USA; [Roby, Deborah A.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol, St Louis, MO 63104 USA		Farr, SA (corresponding author), St Louis Univ, Sch Med, Res & Dev Serv, VA Med Ctr,Div Geriatr Med, 1402 South Grand Blvd,Room M238, St Louis, MO 63104 USA.	susan.farr@health.slu.edu		Farr, Susan/0000-0002-0481-2570			Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Evers M.M., 2015, ADV DRUG DELIV REV, pRev; Farr SA, 2000, BRAIN RES, V872, P242, DOI 10.1016/S0006-8993(00)02495-1; Farr SA, 2014, FREE RADICAL BIO MED, V67, P387, DOI 10.1016/j.freeradbiomed.2013.11.014; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fiorini A, 2013, FREE RADICAL BIO MED, V65, P1, DOI 10.1016/j.freeradbiomed.2013.06.017; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Galvez V, 2015, BRAIN STIMUL, V8, P486, DOI 10.1016/j.brs.2014.12.012; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hedya S.A., 2018, STATPEARLS; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Jiang L, 2017, BRAIN RES, V1660, P1, DOI 10.1016/j.brainres.2017.01.031; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; Kumar VB, 2000, PEPTIDES, V21, P1769, DOI 10.1016/S0196-9781(00)00339-9; Leeds PR, 2014, ACS CHEM NEUROSCI, V5, P422, DOI 10.1021/cn500040g; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Malik R, 2011, EXPERT OPIN DRUG DIS, V6, P507, DOI 10.1517/17460441.2011.565744; Dominguez JM, 2012, J BIOL CHEM, V287, P893, DOI 10.1074/jbc.M111.306472; Martin Antonio, 2011, Int J Alzheimers Dis, V2011, P865432, DOI 10.4061/2011/280502; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Morimoto K, 2011, J ALZHEIMERS DIS, V25, P59, DOI 10.3233/JAD-2011-101815; O'Leary O, 2015, CNS DRUGS, V29, P1, DOI 10.1007/s40263-014-0213-z; Rampa A, 2017, CURR TOP MED CHEM, V17, P3361, DOI [10.2174/1568026618666180112161406, 10.1174/1568016618666180111161406]; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Schoch KM, 2017, NEURON, V94, P1056, DOI 10.1016/j.neuron.2017.04.010; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Wu XM, 2013, INT J CLIN EXP PATHO, V6, P1282; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	37	4	4	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1869	1875		10.1089/neu.2018.5999			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600017	30704365				2022-02-06	
J	Grosgurin, O; Gayet-Ageron, A; Suppan, L; Simon, J; Villar, A; Trombert, V; Marti, C; Sarasin, FP; Rutschmann, OT				Grosgurin, Olivier; Gayet-Ageron, Angele; Suppan, Laurent; Simon, Josette; Villar, Adolfo; Trombert, Veronique; Marti, Christophe; Sarasin, Francois P.; Rutschmann, Olivier T.			Reliability and performance of the Swiss Emergency Triage Scale used by paramedics	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						computerized simulator; emergency medical service; emergency triage scale; paramedics; prehospital	TRAUMATIC BRAIN-INJURY; PREHOSPITAL TRIAGE; MEDICAL-SERVICES; CANADIAN TRIAGE; SEVERITY INDEX; STROKE SCALE; ACUITY SCALE; ACCURACY; CENTERS; NURSES	Objectives No general emergency department triage scale has been evaluated for prehospital triage. The objective of this study was to evaluate the reliability and the performance of the Swiss Emergency Triage Scale (SETS) used by paramedics to determine the emergency level and orientation of simulated patients. Patients and methods In a prospective cross-sectional study, 23 paramedics evaluated 28 clinical scenarios with the SETS using interactive computerized triage software simulating real-life triage. The primary outcome was inter-rater reliability regarding the triage level among participants measured by intraclass correlation coefficient (ICC). Secondary outcomes were the accuracy of triage level and the reliability and accuracy of orientation of patients of at least 75 years to a dedicated geriatric emergency centre. Results Twenty-three paramedics completed the evaluation of the 28 scenarios (644 triage decisions). Overall, ICC for triage level was 0.84 (95% confidence interval: 0.77-0.99). Correct emergency level was assigned in 89% of cases, overtriage rate was 4.8%, and undertriage was 6.2%. ICC regarding orientation in the subgroup of simulated patients of at least 75 years was 0.76 (95% confidence interval: 0.61-0.89), with 93% correct orientation. Conclusion Reliability of paramedics rating simulated emergency situations using the SETS was excellent, and the accuracy of their rating was very high. This suggests that in Switzerland, the SETS could be safely used in the prehospital setting by paramedics to determine the level of emergency and guide patients to the most appropriate hospital. Copyright (C) 2017 The Author(s). Published by Wolters Kluwer Health, Inc.	[Grosgurin, Olivier; Suppan, Laurent; Simon, Josette; Villar, Adolfo; Marti, Christophe; Sarasin, Francois P.; Rutschmann, Olivier T.] Geneva Univ Hosp, Fac Med, Dept Community Primary Care & Emergency Med, Div Emergency Med, Gabrielle Perret Gentil 2, CH-1205 Geneva, Switzerland; [Gayet-Ageron, Angele] Geneva Univ Hosp, Fac Med, Dept Epidemiol, Geneva, Switzerland; [Trombert, Veronique] Geneva Univ Hosp, Fac Med, Dept Gen Internal Med Rehabil & Geriatr, Geneva, Switzerland		Grosgurin, O (corresponding author), Geneva Univ Hosp, Fac Med, Dept Community Primary Care & Emergency Med, Div Emergency Med, Gabrielle Perret Gentil 2, CH-1205 Geneva, Switzerland.	olivier.grosgurin@hcuge.ch	grosgurin, olivier/AAT-5605-2021; Suppan, Laurent/AAU-1562-2020	Suppan, Laurent/0000-0001-6989-6421; Gayet-Ageron, Angele/0000-0002-6164-9693			Buschhorn HM, 2013, J EMERG NURS, V39, pE55, DOI 10.1016/j.jen.2011.11.003; Dalwai MK, 2014, SAMJ S AFR MED J, V104, P372, DOI [10.7196/SAMJ.7604, 10.7196/samj.7604]; Ebrahimi M, 2015, WORLD J EMERG MED, V6, P94, DOI 10.5847/wjem.j.1920-8642.2015.02.002; Esmailian M, 2014, EMERGENCY, V2, P158; Farrohknia N, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-42; Fuller G, 2016, EUR J EMERG MED, V23, P61, DOI 10.1097/MEJ.0000000000000327; Hasegawa Y, 2013, J STROKE CEREBROVASC, V22, P514, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.007; Mirhaghi A, 2015, N AM J MED SCI, V7, P299, DOI 10.4103/1947-2714.161243; Mirhaghi Amir, 2015, Sultan Qaboos Univ Med J, V15, pe71; Newgard CD, 2014, PREHOSP EMERG CARE, V18, P461, DOI 10.3109/10903127.2014.912707; Nissen L, 2014, EUR J EMERG MED, V21, P37, DOI 10.1097/MEJ.0b013e32836397d9; Parenti N, 2014, INT J NURS STUD, V51, P1062, DOI 10.1016/j.ijnurstu.2014.01.013; Prabhakaran S, 2013, JAMA NEUROL, V70, P1126, DOI 10.1001/jamaneurol.2013.293; Rutschmann OT, 2006, J CLIN EPIDEMIOL, V59, P615, DOI 10.1016/j.jclinepi.2005.11.003; Rutschmann OT, 2009, B MED SUISSES, V90, P1789, DOI [10.4414/bms.2009.14760, DOI 10.4414/BMS.2009.14760]; Rutschmann OT, 2017, EUR J EMERG MED; Sanossian N, 2015, STROKE, V46, P2886, DOI 10.1161/STROKEAHA.115.010264; Shoukri MM, 2004, STAT METHODS MED RES, V13, P251, DOI 10.1191/0962280204sm365ra; Smith DT, 2015, J EMERG NURS, V41, P489, DOI 10.1016/j.jen.2015.03.006; Tirschwell DL, 2002, STROKE, V33, P2801, DOI 10.1161/01.STR.0000044166.28481.BC; Vicente V, 2014, J AM GERIATR SOC, V62, P1281, DOI 10.1111/jgs.12888; Vigil JM, 2017, PAIN, V158, P377, DOI 10.1097/j.pain.0000000000000725; Wasserman EB, 2015, PREHOSP EMERG CARE, V19, P202, DOI 10.3109/10903127.2014.959225	23	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	JUN	2019	26	3					188	193		10.1097/MEJ.0000000000000530			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IQ3WZ	WOS:000480683800009	29252610	Green Published, hybrid			2022-02-06	
J	Gupta, A; Summerville, G; Senter, C				Gupta, Anjali; Summerville, Greg; Senter, Carlin			Treatment of Acute Sports-Related Concussion	CURRENT REVIEWS IN MUSCULOSKELETAL MEDICINE			English	Article						Sports-related concussion (SRC); Return to learn; Return to play; Concussion treatment	TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCES; EARLY INTERVENTION; ACTIVITY LEVEL; EXERCISE; MANAGEMENT; ASSOCIATION; VOLUNTARY; STATEMENT; SYMPTOMS	Purpose of ReviewHere, we summarize the current scientific literature on the management of sports-related concussion (SRC) in the acute period (<6weeks post-injury) with a focus on rest, return to learn, return to play, and emerging treatments.Recent FindingsWhile relative rest is recommended for the first 24-48h following acute SRC, the most recent guidelines highlight the lack of evidence for complete rest and in fact show that prolonged cognitive and physical rest can be detrimental. Gradual return to learn and play is recommended. Return to sport should only occur once the patient is symptom free. While there are no FDA-approved medications for acute treatment of concussion, there is preclinical data for the benefit of omega 3 fatty acids. Evidence is limited around the benefits of treating sleep disorders, vestibular-ocular dysfunction, and neck pain in the acute period.SummaryAfter 24-48h of rest, SRC patients may gradually resume cognitive and physical activity. More research is needed to determine if any supplements, medications, and/or physical therapy are indicated in the management in acute SRC.	[Gupta, Anjali] Stanfonl OConnor Hosp, Permanence Med Grp, Emergency Med, Sports Med, 2105 Forest Ave, San Jose, CA 95128 USA; [Summerville, Greg] Kaiser South San Francisco Med Ctr, Permanente Med Grp, Sports Med, 1200 El Camino Real, San Francisco, CA 94080 USA; [Senter, Carlin] Univ Calif San Francisco, UCSF Orthoped Inst, Primary Care Sports Med, 1500 Owens St, San Francisco, CA 94158 USA		Gupta, A (corresponding author), Stanfonl OConnor Hosp, Permanence Med Grp, Emergency Med, Sports Med, 2105 Forest Ave, San Jose, CA 95128 USA.	Docgupta@stanford.edu; Gregory.B.Summerville@kp.org; Carlin.Senter@ucsf.edu					Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bica D, HIGH DOSE OMEGA 3 FA; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grady MF, 2017, PEDIATR ANN, V46, pE93, DOI 10.3928/19382359-20170220-04; Graves JM, 2018, J AM ASSOC NURSE PRA, V30, P499, DOI 10.1097/JXX.0000000000000070; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Kalmbach DA, 2018, SLEEP, V1, P41; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Korley F, OPTIMA TBI PILOT STU; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2018, ANN INTERN MED, V169, pITC1, DOI 10.7326/AITC201807030; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miller S, DHA TREATMENT PEDIAT; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Riechers Ronald G 2nd, 2015, Handb Clin Neurol, V128, P567, DOI 10.1016/B978-0-444-63521-1.00036-4; Saini RK, 2018, LIFE SCI, V203, P255, DOI 10.1016/j.lfs.2018.04.049; Salberg S, 2017, NEUROSCIENCE, V365, P146, DOI 10.1016/j.neuroscience.2017.09.053; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Stroth S, 2009, NEUROPSYCHOL REHABIL, V19, P223, DOI 10.1080/09602010802091183; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thau-Zuchman O, 2019, J NEUROTRAUM, V36, P25, DOI 10.1089/neu.2017.5579; The Aspen Institute, 2017, STAT PLAY 2017 TREND; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Walker JM, 2018, SLEEP MED, V51, P66, DOI 10.1016/j.sleep.2018.06.006; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041	53	4	4	2	11	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1935-973X	1935-9748		CURR REV MUSCULOSKE	Curr. Rev. Musculoskelet. Med.	JUN	2019	12	2					117	123		10.1007/s12178-019-09545-7			7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	IA8NP	WOS:000469815900007	30887284	Green Published			2022-02-06	
J	Huang, JL; Woehrle, TA; Conway, P; McCarty, CA; Eyer, MM; Eyer, SD				Huang, Jing Li; Woehrle, Theo A.; Conway, Pat; McCarty, Catherine A.; Eyer, Madeline M.; Eyer, Steven D.			Evaluation of a protocol for early detection of delayed brain hemorrhage in head injured patients on warfarin	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Warfarin; Delayed hemorrhage	TRAUMATIC INTRACRANIAL HEMORRHAGE; ORAL ANTICOAGULANT-THERAPY; COMPLICATIONS; MANAGEMENT; RESUMPTION; REVERSAL; STROKE; RISK	PurposeIn 2007, Essentia Health St. Mary's Medical Center (SMMC), a Level II trauma center in northeastern Minnesota, implemented a protocol for patients who presented with blunt head trauma and were receiving warfarin for anticoagulation. The purpose of this study was to determine the incidence and risk factors of early delayed, warfarin-associated intracranial hemorrhage (ICH).MethodsAdult patients with signs and symptoms of head injury on warfarin who were admitted by protocol to SMMC between March 2007 and June 2015 were included. Patients were observed for neurologic change and received a follow-up head CT scan within 24h after an initial negative scan.ResultsAmong the 232 episodes of care studied, there were 204 patients. The average age was 71; 51% of patients were female. Most patients presented with Glasgow Coma Scale score of 15 and had signs of head trauma. The majority of patients (63%) had a therapeutic International Normalized Ratio (INR) for their indicated condition, but 19% of patients had a supratherapeutic INR and 19% had a subtherapeutic INR. The incidence of early delayed ICH was 1.7%; none of these cases required operative intervention or were fatal.ConclusionsFor patients who were anticoagulated with warfarin and had sustained minor traumatic brain injury, implementation of our protocol showed low incidence of early delayed ICH in the first 24h. We believe withholding warfarin for several days and careful follow-up regarding its resumption is warranted, especially in the setting of supratherapeutic INR.	[Huang, Jing Li] Univ Minnesota, Minneapolis, MN USA; [Woehrle, Theo A.; Conway, Pat; McCarty, Catherine A.; Eyer, Madeline M.] Essentia Inst Rural Hlth, Duluth, MN USA; [McCarty, Catherine A.] Univ Minnesota, Sch Med, Duluth, MN 55812 USA; [Eyer, Steven D.] Essentia Hlth St Marys Med Ctr, 407 E 3rd St, Duluth, MN 55805 USA		Eyer, SD (corresponding author), Essentia Hlth St Marys Med Ctr, 407 E 3rd St, Duluth, MN 55805 USA.	jingx014@umn.edu; theo.woehrle@essentiahealth.org; pat.conway@eirh.org; cmccarty@eirh.org; maddieeyer@creighton.edu; steven.eyer@essentiahealth.org			Essentia Health Duluth Clinic Foundation	The project was funded in part by a Grant from Essentia Health Duluth Clinic Foundation.	Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; [Anonymous], 1996, J Neurosurg Sci, V40, P11; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hodgkinson S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g104; Horton JD, 1999, AM FAM PHYSICIAN, V59, P635; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kujovich JL, 2011, GENET MED, V13, P1, DOI 10.1097/GIM.0b013e3181faa0f2; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; MUELLER RL, 1994, CIRCULATION, V89, P432, DOI 10.1161/01.CIR.89.1.432; New South Wales Institute of Trauma and Injury Management, AD TRAUM CLIN PRACT; Nielsen PB, 2015, CHEST, V147, P1651, DOI 10.1378/chest.14-2099; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Scantling D, 2017, EUR J TRAUMA EMERG S, V24, P1; Schoonman GG, 2014, EUR J NEUROL, V21, P1021, DOI 10.1111/ene.12429; Shlevin EL, 1944, ANN INTERN MED, V21, P332, DOI 10.7326/0003-4819-21-2-332; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	33	4	4	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2019	45	3					481	487		10.1007/s00068-018-0924-9			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	ID8IO	WOS:000471927600015	29541804				2022-02-06	
J	Kerr, ZY; Roos, KG; Lincoln, AE; Morris, S; Yeargin, SW; Grant, J; Covassin, T; Dodge, T; Nittoli, VC; Mensch, J; Quetant, SL; Wasserman, EB; Dompier, TP; Caswell, SV				Kerr, Zachary Y.; Roos, Karen G.; Lincoln, Andrew E.; Morris, Sarah; Yeargin, Susan W.; Grant, Jon; Covassin, Tracey; Dodge, Thomas; Nittoli, Vincent C.; Mensch, James; Quetant, Sara L.; Wasserman, Erin B.; Dompier, Thomas P.; Caswell, Shane V.			Injury Incidence in Youth, High School, and NCAA Men's Lacrosse	PEDIATRICS			English	Article							UNITED-STATES; SURVEILLANCE SYSTEM; RISK-FACTORS; EPIDEMIOLOGY; CONCUSSION; SPORTS; PREVENTION; GIRLS; BOYS; EDUCATION	BACKGROUND:We compared injury incidence and mechanisms among youth, high school (HS), and National Collegiate Athletic Association (NCAA) boys' and men's lacrosse athletes for the 2014-2015 to 2016-2017 lacrosse seasons.METHODS:Multiple injury surveillance systems were used to capture 21 youth boys', 22 HS boys', and 20 NCAA men's lacrosse team-seasons of data during the 2014-2015 to 2016-2017 seasons. Athletic trainers reported game and practice injuries and athlete exposures (AEs). Injuries included those occurring during a game and/or practice and requiring evaluation from an athletic trainer and/or physician. Injury counts, rates per 1000 AEs, and injury rate ratios (IRRs) with 95% confidence intervals (CIs) were calculated.RESULTS:The injury rate in youth was higher than those reported in HS (10.3 vs 5.3 per 1000 AEs; IRR = 2.0; 95% CI: 1.6-2.4) and the NCAA (10.3 vs 4.7 per 1000 AEs; IRR = 2.2; 95% CI: 1.9-2.5). When considering time loss injuries only (restricted participation of >= 24 hours), the injury rate in youth was lower than those reported in HS (2.0 vs 2.9 per 1000 AEs; IRR = 0.7; 95% CI: 0.5-0.95) and the NCAA (2.0 vs 3.3 per 1000 AEs; IRR = 0.6; 95% CI: 0.4-0.8). The concussion rate in youth was higher than those in HS (0.7 vs 0.3 per 1000 AEs; IRR = 2.4, 95% CI: 1.1-5.2) and the NCAA (0.7 vs 0.3 per 1000 AEs; IRR = 2.1, 95% CI: 1.2-3.7). Injuries at the youth, HS, and NCAA levels were most commonly associated with stick contact, inflammatory conditions (including bursitis, tendonitis, and other unspecified inflammation), and noncontact mechanisms, respectively.CONCLUSIONS:Although the time loss injury rate was lowest in youth boys' lacrosse, the concussion rate was the highest. Injury prevention approaches should be specific to the mechanisms associated with each level of play (eg, equipment skill development in youth).	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA; [Roos, Karen G.] Calif State Univ Long Beach, Dept Kinesiol, Long Beach, CA 90840 USA; [Lincoln, Andrew E.] MedStar Sports Med Hlth Res Ctr, Baltimore, MD USA; [Morris, Sarah; Yeargin, Susan W.; Quetant, Sara L.; Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Yeargin, Susan W.; Mensch, James] Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Grant, Jon; Nittoli, Vincent C.] St Vincent Sports Performance, Indianapolis, IN USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Dodge, Thomas] Springfield Coll, Springfield, MA USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Lebanon, PA USA; [Caswell, Shane V.] George Mason Univ, Sports Med Assessment Res & Testing Lab, Manassas, VA USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878	National Operating Committee on Standards for Athletic Equipment [501(c)]; National Operating Committee on Standards for Athletic; Datalys Center for Sports Injury Research and Prevention - National Collegiate Athletic Association; National Athletic Trainers' Association Research and Education Foundation; Central Indiana Corporate Partnership Foundation; BioCrossroads	This study, inclusive of the youth lacrosse surveillance component, was funded by the National Operating Committee on Standards for Athletic Equipment. National Operating Committee on Standards for Athletic Equipment is an independent, nonprofit 501(c)(3) organization funded primarily through licensing fees that it charges to equipment manufacturers who want to have their equipment certified or recertified to National Operating Committee on Standards for Athletic Equipment standards. Its board of directors serves without compensation and includes representation from organizations such as the American Academy of Pediatrics. The funding received from National Operating Committee on Standards for Athletic Equipment did not solely originate from lacrosse equipment manufacturers. The National Collegiate Athletic Association Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the National Collegiate Athletic Association. The National Athletic Treatment, Injury, and Outcomes Network was funded by the National Athletic Trainers' Association Research and Education Foundation and the Central Indiana Corporate Partnership Foundation in cooperation with BioCrossroads. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Chappell JD, 2008, AM J SPORT MED, V36, P1081, DOI 10.1177/0363546508314425; Dick R, 2007, J ATHL TRAINING, V42, P255; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Green L., 2014, LEGAL PERSPECTIVES R; Hagel BE, 2003, AM J EPIDEMIOL, V157, P825, DOI 10.1093/aje/kwg050; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jayanthi N, 2013, SPORTS HEALTH, V5, P251, DOI 10.1177/1941738112464626; Kerr ZY, 2018, MED SCI SPORT EXER, V50, P284, DOI 10.1249/MSS.0000000000001422; Kerr ZY, 2017, NEUROL CLIN, V35, P409, DOI 10.1016/j.ncl.2017.03.001; Kerr Zachary Y, 2017, Inj Epidemiol, V4, P6, DOI 10.1186/s40621-017-0104-0; Kerr Zachary Y, 2016, Inj Epidemiol, V3, P3; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; McCulloch PC, 2007, ORTHOPEDICS, V30, P29, DOI 10.3928/01477447-20070101-05; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Mclean SG, 2009, MED SCI SPORT EXER, V41, P1661, DOI 10.1249/MSS.0b013e31819ca07b; Mihata LCS, 2006, AM J SPORT MED, V34, P899, DOI 10.1177/0363546505285582; Myer GD, 2011, CURR SPORT MED REP, V10, P157, DOI 10.1249/JSR.0b013e31821b1442; National Collegiate Athletic Association, NCAA SPORTS SPONS PA; National Federation of High Schools, 2017, 2016 17 HIGH SCH ATH; Powell JW, 2004, J ATHL TRAINING, V39, P56; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Roos KG, 2016, ATHL TRAIN SPORTS HL, V8, P122; Sanna G, 2008, CLIN BIOMECH, V23, P946, DOI 10.1016/j.clinbiomech.2008.03.065; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; The National Collegiate Athletic Association, 2014, 2014 15 NCAA SPORTS, V25th; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; US Lacrosse, 2016, PART SURV 2016; US Lacrosse, 2017, LAXPREP; US Lacrosse, 2017, ATHL DEV MOD; US Lacrosse, 2017, COACH DEV PROGR; US Lacrosse, 2017, EQUIPMENT; US Lacrosse, 2018, 2018 YOUTH BOYS RUL; US Lacrosse, 2016, PEARL GUARD NAM OFF; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Vincent HK, 2015, SPORTS HEALTH, V7, P448, DOI 10.1177/1941738114552990; Webb M, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114543444; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507	49	4	4	1	10	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	2019	143	6							e20183482	10.1542/peds.2018-3482			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	II0WG	WOS:000474925600028	31076542	Bronze			2022-02-06	
J	Koncan, D; Gilchrist, M; Vassilyadi, M; Hoshizaki, TB				Koncan, David; Gilchrist, Michael; Vassilyadi, Michael; Hoshizaki, Thomas Blaine			A three-dimensional finite element model of a 6-year-old child for simulating brain response from physical reconstructions of head impacts	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Finite element modelling; brain injury; biomechanics; concussion; head impact; child	DYNAMIC-RESPONSE; CONCUSSION; INJURY; TISSUE; VALIDATION; PREDICTORS; THRESHOLD; HELMETS; GENDER; MASS	Despite young children being a high-risk population for sustaining concussive injuries in sport, few studies have investigated head impact biomechanics from sporting impacts using physical models and finite element models of the brain. Physical reconstructions are often used in concussive research, using the recorded kinematics to load finite element models of the brain to obtain better information of real-life head injuries. For children, scaling adult models is a common method used to study the youth population. However, this method does not capture age-dependent material properties or the unique geometry of the developing brain. To address these deficiencies, a novel three-dimensional finite element model of a 6-year-old child was developed and compared to a scaled adult model, for use with physical reconstructions. With the lack of intracranial validation data for the youth population, adult cadaveric data for brain motion was used for comparison. The new brain model showed unique responses in motion and strain compared to the scaled adult model. Using the normalized integral square error method, the new model was classified to have 'fair' to 'excellent' biofidelity. The new model is proposed as more appropriate for conducting concussion and brain injury research in young children near 6 years of age.	[Koncan, David; Hoshizaki, Thomas Blaine] Univ Ottawa, Sch Human Kinet, 200 Lees Ave, Ottawa, ON K1N 6N5, Canada; [Gilchrist, Michael] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada		Koncan, D (corresponding author), Univ Ottawa, Sch Human Kinet, 200 Lees Ave, Ottawa, ON K1N 6N5, Canada.	dkonc074@uottawa.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; National Operating Committee on Standards for Athletic Equipment	The authors would like to thank the two granting agencies, the Natural Sciences and Engineering Research Council of Canada and the National Operating Committee on Standards for Athletic Equipment.	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Cui SH, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/529729; Dawson L., 2016, THESIS, P57; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; Donnelly BR, 1983, STAPP CAR CRASH J, P299; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Forte AE, 2017, BIOMECH MODEL MECHAN, V16, P907, DOI 10.1007/s10237-016-0860-8; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giordano C., 2016, IRCOBI C, P288; Giordano C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187916; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Hardy W, 2007, THESIS; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Ibrahim NG, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000956; Karton CM, 2014, AM SOC TEST MATER, V1552, P23, DOI 10.1520/STP155220120175; King AI, 2003, IRCOBI C 2003 LISB 2; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koncan D, 2017, IRCOBI C 2017 ANTW 1, P201; Koncan DA, 2016, PROCEDIA ENGINEER, V147, P578, DOI 10.1016/j.proeng.2016.06.243; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Li ZG, 2013, COMPUT METH PROG BIO, V112, P309, DOI 10.1016/j.cmpb.2013.05.008; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; Loyd A.M., 2011, THESIS; Loyd Andre M, 2010, Stapp Car Crash J, V54, P167; MacManus DB, 2017, ACTA BIOMATER, V57, P384, DOI 10.1016/j.actbio.2017.05.022; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Oeur RA, INT J CRASHWORTHINES, DOI [10.1080/13588265.2018.1441617, DOI 10.1080/13588265.2018.1441617.]; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Post A, 2014, IRCOBI C 2014 BERL 1; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Post A, 2017, J NEUROSURG-PEDIATR, V19, P502, DOI 10.3171/2016.10.PEDS16449; Post A, 2016, COMPUT METHOD BIOMEC, V19, P366, DOI 10.1080/10255842.2015.1029921; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Prange M T, 2000, Stapp Car Crash J, V44, P205; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Rousseau P., 2015, THESIS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Uchiyama HT, 2013, BRAIN DEV-JPN, V35, P228, DOI 10.1016/j.braindev.2012.04.005; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005	70	4	4	1	10	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	JUN	2019	233	2					277	291		10.1177/1754337118822940			15	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	IA9LX	WOS:000469879800011					2022-02-06	
J	Leung, J; King, C; Fereday, S				Leung, Joan; King, Clayton; Fereday, Sarah			Effectiveness of a programme comprising serial casting, botulinum toxin, splinting and motor training for contracture management: a randomized controlled trial	CLINICAL REHABILITATION			English	Article						Acquired brain injury; contracture; splinting; botulinum toxin; stretch; spasticity; casting; joint range	TRAUMATIC BRAIN-INJURY; INTERRATER RELIABILITY; WRIST CONTRACTURE; DAILY STRETCH; SPASTICITY; STROKE; WALKING; ADULTS	Objective: To determine the effectiveness of a programme comprising serial casting, botulinum toxin, splinting and motor training in contracture management. Design: A randomized trial with concealed allocation and assessor blinding, a deferred treatment cross-over design within the control group, was conducted. Setting: Inpatient Brain Injury Unit of a rehabilitation centre. Subjects: A total of 10 patients with severe acquired brain injury (13 ankles). Interventions: The intervention group received botulinum toxin and then serial casting. The control group was placed on a wait list for six weeks (control phase) and then received the same interventions as the intervention group (intervention phase). Both groups received splinting and motor training following serial casting. Main measures: The primary outcome was passive ankle dorsiflexion range. Secondary outcomes included spasticity, ankle dorsiflexor strength, Functional Independence Measure score for the walking item and walking speed. Results: The mean between-group difference for passive ankle dorsiflexion range at completion of casting was 26 degrees (95% confidence interval (CI): 17-35); at Week 2, after casting was 24 degrees (95% CI: 14-33). The mean within-group differences for passive ankle dorsiflexion at completion of casting, Week 2 after casting and Week 8 after casting were 26 degrees (95% CI: 20-31), 26 degrees (95% CI: 18-33) and 24 degrees (95% CI: 19-30), respectively. These improvements were sustained at Week 2 and Week 8 after casting. Conclusions: A programme for contracture management comprising serial casting, botulinum toxin, motor training and splinting can be useful in improving joint range.	[Leung, Joan; King, Clayton; Fereday, Sarah] Royal Rehab, Brain Injury Unit, 235 Morrison Rd, Sydney, NSW 2112, Australia		Leung, J (corresponding author), Royal Rehab, Brain Injury Unit, 235 Morrison Rd, Sydney, NSW 2112, Australia.	joan.leung@royalrehab.com.au	Leung, Joan/AAC-8623-2019	Leung, Joan/0000-0003-0888-558X			Ada L, 2006, DISABIL REHABIL, V28, P891, DOI 10.1080/09638280500535165; Banky M, 2017, BRAIN INJURY, V31, P440, DOI 10.1080/02699052.2016.1271455; de Sousa DG, 2018, J PHYSIOTHER, V64, P210, DOI 10.1016/j.jphys.2018.08.004; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Esquenazi A, 2008, AM J PHYS MED REHAB, V87, P305, DOI 10.1097/PHM.0b013e318168d36c; Foley N, 2013, ARCH PHYS MED REHAB, V94, P977, DOI 10.1016/j.apmr.2012.12.006; Haesler E., 2014, PREV TREATM PRESS UL; Harvey LA, 2000, ARCH PHYS MED REHAB, V81, P1340, DOI 10.1053/apmr.2000.9168; Harvey LA, 2003, AUST J PHYSIOTHER, V49, P176, DOI 10.1016/S0004-9514(14)60237-3; Horsley SA, 2007, AUST J PHYSIOTHER, V53, P239, DOI 10.1016/S0004-9514(07)70004-1; Johnson CA, 2004, ARCH PHYS MED REHAB, V85, P902, DOI 10.1016/j.apmr.2003.08.081; Katalinic OM, 2011, PHYS THER, V91, P11, DOI 10.2522/ptj.20100265; Kendall FP, 1993, MUSCLES TESTING FUNC, V4th; Lannin NA, 2003, ARCH PHYS MED REHAB, V84, P297, DOI 10.1053/apmr.2003.50031; Lannin NA, 2007, STROKE, V38, P111, DOI 10.1161/01.STR.0000251722.77088.12; Leung J, 2018, PHYSIOTHER CAN, V70, P152, DOI 10.3138/ptc.2016-76; Leung J, 2013, PHYSIOTHER CAN, V65, P223, DOI 10.3138/ptc.2012-29; Moseley A, 1991, Aust J Physiother, V37, P175, DOI 10.1016/S0004-9514(14)60540-7; Moseley AM, 1997, PHYS THER, V77, P240, DOI 10.1093/ptj/77.3.240; Moseley AM, 2008, CLIN REHABIL, V22, P406, DOI 10.1177/0269215507083795; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; TARDIEU G, 1954, REV NEUROL, V91, P143; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Verplancke D, 2005, CLIN REHABIL, V19, P117, DOI 10.1191/0269215505cr827oa; Wu T, 2016, TOP STROKE REHABIL, V23, P217, DOI 10.1080/10749357.2016.1139294	25	4	6	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JUN	2019	33	6					1035	1044		10.1177/0269215519831337			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	IG0VA	WOS:000473507300008	30813776				2022-02-06	
J	Lincoln, Y; Lanford, M				Lincoln, Yvonna; Lanford, Michael			Life History's Second Life	QUALITATIVE INQUIRY			English	Article						life history; marginalized lives; neoliberalism; postmodernism; social media	DISABILITY; EDUCATION; AGENCY	New and revisited insights, theoretical developments, and the emanation of a new political landscape-coupled with the influence of new technologies and social media-suggest that life histories might be considerably more complicated to conduct today than a short generation ago. For example, at least three developments-the rise of a neoliberal, ultra-capitalist, political-economic environment; new technologies, particularly the rise of social media and the shifting social relationships such technologies have engendered; and the Enlightenment counter in posthumanism-have given rise to a postmodern "saturated self." This "saturated self" is both more situated in the new era and, at the same time, less intimately connected with a surrounding community. This article will explore the critical junctures and concussions of life history with new theoretical, political, and social pressures on the individual and on the practice of creating biography from life history.	[Lincoln, Yvonna] Texas A&M Univ, Educ Adm & Dev, College Stn, TX USA; [Lanford, Michael] Univ Southern Calif, Pullias Ctr Higher Educ, Los Angeles, CA USA		Lincoln, Y (corresponding author), Texas A&M Univ, Coll Educ & Human Dev, 801 Harrington Tower, College Stn, TX 77843 USA.	ysl@tamu.edu		Lanford, Michael/0000-0002-4513-725X			Acemoglu D., 2017, W23285 NBER; Adriansen HK., 2012, QUALITATIVE STUDIES, V3, P40, DOI [10.7146/qs.v3i1.6272, DOI 10.7146/QS.V3I1.6272]; Apple M.W., 2000, GLOBALIZATION ED CRI, P57; Atkinson R., 1998, LIFE STORY INTERVIEW; BERGER RJ, 1995, SOCIOL QUART, V36, P15, DOI 10.1111/j.1533-8525.1995.tb02318.x; Berger RJ, 2008, SOCIOL QUART, V49, P309, DOI 10.1111/j.1533-8525.2008.00117.x; Bogotch I, 2017, INT J QUAL STUD EDUC, V30, P1013, DOI 10.1080/09518398.2017.1312591; Bolton RN, 2013, J SERV MANAGE, V24, P245, DOI 10.1108/09564231311326987; Castells M, 2004, NETWORK SOCIETY: A CROSS-CULTURAL PERSPECTIVE, P1; Clemens R. F., 2016, QUALITATIVE REPORT, V21, P2044; Cohen G, 2015, POLIT STUD REV, V13, P506, DOI 10.1111/1478-9302.12033; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Crouch C, 2017, POLIT QUART, V88, P221, DOI 10.1111/1467-923X.12321; Davies D, 2002, QUAL HEALTH RES, V12, P279, DOI 10.1177/104973230201200211; Dhunpath R., 2000, INT J QUAL STUD EDUC, V13, P543, DOI [https://doi.org/10.1080/09518390050156459, DOI 10.1080/09518390050156459]; Dhunpath R., 2009, LIFE HIST RES EPISTE; Dustmann C, 2017, ECON POLICY, V32, P497, DOI 10.1093/epolic/eix008; Forrest R, 2009, INT J URBAN REGIONAL, V33, P998, DOI 10.1111/j.1468-2427.2009.00903.x; Frey CB, 2017, TECHNOL FORECAST SOC, V114, P254, DOI 10.1016/j.techfore.2016.08.019; Gergen K.J., 1991, SATURATED SELF DILEM; Goodson I., 2011, COUNTERPOINTS, V386, P35; GOODSON I., 2001, IDENTITY, V1, P129; Goodson I.F., 1991, CAMB J EDUC, V21, P35, DOI [10.1080/0305764910210104, DOI 10.1080/0305764910210104]; Gramling LF, 2004, NURS RES, V53, P207, DOI 10.1097/00006199-200405000-00008; Gunn A, 2013, J HIGH EDUC POLICY M, V35, P179, DOI 10.1080/1360080X.2013.775926; HELLING I, 1988, STUDIES SYMBOLIC INT, V9, P211; Isenberg Nancy, 2016, WHITE TRASH 400 YEAR; Kakuru D. M., 2007, Gender and Development, V15, P287, DOI 10.1080/13552070701391581; Kathard H., 2009, LIFE HIST RES EPISTE, P19; Knowles, 2001, LIVES CONTEXT ART LI; Koro-Ljungberg M, 2012, QUAL INQ, V18, P808, DOI 10.1177/1077800412453014; Lanford M., 2016, PALGRAVE HDB ASIA PA, P157; Lutz H, 2016, MIGRATION DOMESTIC W; Manyika J., 2014, GLOBAL FLOWS DIGITAL; Marshall K., 2002, LIFE STORIES INTELLE; Marshall K, 2013, ETHICS SOC WELF, V7, P400, DOI 10.1080/17496535.2013.842304; McAfee A., 2014, 2 MACHINE AGE WORK P; Moss T, 2013, INT J QUAL STUD EDUC, V26, P1004, DOI 10.1080/09518398.2012.725139; Oleksiyenko A, 2015, HIGH EDUC POLICY, V28, P197, DOI 10.1057/hep.2014.5; Olive J. L., 2014, FORUM QUAL SOC RES, V15; Rhee N., 2015, CONTINUING RETIREMEN; Rhue L, 2014, SOC NETWORKS, V36, P40, DOI 10.1016/j.socnet.2012.06.007; Schumpeter J.A., 2008, CAPITALISM SOCIALISM, V1st; Shams F, 2016, STUD HIGH EDUC, V41, P955, DOI 10.1080/03075079.2014.966669; Slaughter S, 2001, HIGH EDUC, V41, P389, DOI 10.1023/A:1017505525288; Stromquist N.P., 2014, GLOBALIZATION ED INT; Tierney W. G., 2018, SAGE ENCY SOCIAL RES; Tierney W. G., 2011, HDB QUALITATIVE RES, P265; Tierney WG, 2014, QUAL INQ, V20, P95, DOI 10.1177/1077800413508524; Vance JD., 2016, HILLBILLY ELEGY MEMO; Waterston A, 2006, AM ETHNOL, V33, P397, DOI 10.1525/ae.2006.33.3.397; Watson L. C., 1985, INTERPRETING LIFE HI; Willis JW, 2007, FDN QUALITATIVE RES; Wisniewski R., 1995, LIFE HIST NARRATIVE, P89, DOI DOI 10.1080/0951839950080109	54	4	4	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1077-8004	1552-7565		QUAL INQ	Qual. Inq.	JUN	2019	25	5			SI		464	470		10.1177/1077800418817835			7	Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Social Sciences - Other Topics	HW1BD	WOS:000466416300002					2022-02-06	
J	Lu, LH; Mao, HJ				Lu, Lihong; Mao, Haojie			Quantifying the Effect of Repeated Impacts and Lateral Tip Movements on Brain Responses during Controlled Cortical Impact	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; finite element mouse brain model; lateral tip movements; repeated impacts	INJURY MODEL; MOUSE MODEL; NEUROTRAUMA; RATS	Controlled cortical impact (CCI) is a widely used laboratory neurotrauma model to study traumatic brain injury. During CCI, the brain is damaged by an impactor tip, which travels along its axial direction to a pre-defined depth at a pre-set speed. A recent study, however, using high-speed imaging analysis demonstrated that the impactor tip of an electromagnetically driven CCI device experienced repeated impacts and lateral movements, rather than a single axial impact. How these repeated impacts and lateral movements affect internal brain stresses/strains-which are the direct cause of neuronal damage and affect the accuracy and reproducibility of CCI-remains unknown. We use a previously validated, highly detailed three-dimensional finite element (FE) mouse brain model to investigate the effect of repeated impacts and lateral movements on brain responses during CCI. We also measured tip movements of an in-house pneumatically driven CCI and conducted FE simulations. We found that the repeated impacts had minimal effect on peak strains. The lateral movements of the tip, however, greatly increased brain strains and affected large brain regions. Hence, it is necessary to monitor and control lateral movements to ensure the accuracy and reproducibility of CCI.	[Lu, Lihong; Mao, Haojie] Western Univ, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada		Mao, HJ (corresponding author), Western Univ, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada.	hmao8@uwo.ca			Canada Research Chairs programCanada Research Chairs [X2281B63]; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC) [R5748A04]	We acknowledge the Canada Research Chairs program (X2281B63) and NSERC (R5748A04) for support. We acknowledge Dr. Kathy Xu and Dr. Arthur Brown for the support with the pneumatic CCI device. We acknowledge Mr. Steven Jevnikar and Dr. Kamran Siddiqui for the support of the high-speed camera. Last, we thank Mr. Kewei Bian for his help in taking high-speed videos.	Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DEFORD S, 2000, J NEUROTRAUM, V19, P427; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kim YH, 2018, J NEUROSCI RES, V96, P501, DOI 10.1002/jnr.24099; King A. I., 2003, IRCOBI C LISB PORT; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Osier N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070088; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vonder Haar C, 2013, BEHAV BRAIN RES, V240, P153, DOI 10.1016/j.bbr.2012.11.029; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69	44	4	5	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1828	1835		10.1089/neu.2018.5929			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600013	30421649				2022-02-06	
J	Mooney, SJ; Lee, B; O'Connor, AW				Mooney, Stephen J.; Lee, Bella; O'Connor, Allyson W.			Free-Floating Bikeshare and Helmet Use in Seattle, WA	JOURNAL OF COMMUNITY HEALTH			English	Article						Helmet; Injury prevention; Bicycling; Free-floating bike share	BICYCLE SHARE PROGRAMS	Wearing a helmet when bicycling prevents traumatic brain injury in the event of a crash. Most cyclists nationwide use helmets when riding. However, the growth of free-floating bike sharing systems, which offer short-term access to bicycles but not helmets, may erode helmet-wearing norms among cyclists. We counted cyclists over several hours at four locations in Seattle, WA. We categorized each rider according to whether he or she was wearing a helmet and to whether or not he or she was riding a bike share bike. Whereas 91% of riders of private bikes wore helmets, only 20% of bike share riders wore helmets. Moreover, in locations where a greater proportion of riders were on bikes hare bikes, fewer riders of private bicycles wore helmets (r=-0.96, p=0.04). The impact of bike sharing programs on helmet wearing norms among private bike riders warrants further exploration.	[Mooney, Stephen J.; Lee, Bella; O'Connor, Allyson W.] Univ Washington, Harborview Injury Prevent & Res Ctr, 401 Broadway,4th Floor, Seattle, WA 98122 USA; [Mooney, Stephen J.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [O'Connor, Allyson W.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA		Mooney, SJ (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, 401 Broadway,4th Floor, Seattle, WA 98122 USA.; Mooney, SJ (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	sjm2186@uw.edu			Eunice Kennedy Shiver National Institute for Child Health and Human Development [T32HD057822]; Better Bike Share Partnership; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER	This work was supported by a grant from the Eunice Kennedy Shiver National Institute for Child Health and Human Development (T32HD057822) and a research grant from the Better Bike Share Partnership.	Basch CH, 2014, J COMMUN HEALTH, V39, P503, DOI 10.1007/s10900-013-9785-7; City of Seattle, 2018, FREE FLOATING BIKE S; Cowling K, 2014, AM J PUBLIC HEALTH, V104, pE6, DOI 10.2105/AJPH.2014.302166; Fishman E, 2016, TRANSPORT REV, V36, P92, DOI 10.1080/01441647.2015.1033036; Friedman SM, 2016, CAN J EMERG MED, V18, P28, DOI 10.1017/cem.2015.22; Graves JM, 2014, AM J PUBLIC HEALTH, V104, pE106, DOI 10.2105/AJPH.2014.302012; Hirsch J. A., ROADMAP FREE FLOATIN; Huybers S, 2017, J COMMUN HEALTH, V42, P83, DOI 10.1007/s10900-016-0233-3; JOSHI MS, 1994, ARCH DIS CHILD, V71, P536, DOI 10.1136/adc.71.6.536; Kett P, 2016, J COMMUN HEALTH, V41, P1160, DOI 10.1007/s10900-016-0197-3; Kraemer John D, 2012, Am J Public Health, V102, pe23, DOI 10.2105/AJPH.2012.300794; Mooney SJ, 2019, J TRANSP GEOGR, V74, P91, DOI 10.1016/j.jtrangeo.2018.11.009; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Wolfe ES, 2016, J TRAUMA NURS, V23, P119, DOI 10.1097/JTN.0000000000000202; Zanotto M, 2017, AM J PREV MED, V53, P465, DOI 10.1016/j.amepre.2017.04.013; Zavareh MF, 2018, TRANSPORT RES F-TRAF, V54, P248, DOI 10.1016/j.trf.2018.02.003	16	4	4	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0094-5145	1573-3610		J COMMUN HEALTH	J. Community Health	JUN	2019	44	3					577	579		10.1007/s10900-018-00599-1			3	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	HX0VI	WOS:000467107800020	30539328	Green Accepted			2022-02-06	
J	Pitt, W; Chou, LS				Pitt, Will; Chou, Li-Shan			Reliability and practical clinical application of an accelerometer-based dual-task gait balance control assessment	GAIT & POSTURE			English	Article						Brain concussion; Gait; Postural balance; Sports medicine; Inertial measurement unit; Dual-task	ERROR SCORING SYSTEM; DIVIDED ATTENTION; BRAIN; STABILITY; VALIDITY; RETURN	Background: Gait balance control assessment using whole body center of mass (COM) kinematic measures in concussed individuals reveals persistent balance deficits up to two months post-injury. A reliable and clinically practical gait balance control assessment leveraging similar kinematic measures is necessary to improve concussion assessment and management. Research question: Can peak accelerations collected during a dual-task (DT) gait assessment from a single low back placed accelerometer be measured reliably on different days, by different raters, in different environments, and be practically applied in a Division One (Dl) athletics program? Methods: A single accelerometer placed on the low back over the L5 vertebra was utilized with a DT gait analysis protocol. Twenty (10 F) healthy participants performed the assessment in a laboratory and non-laboratory environment, on two separate days, and with two different raters. Eight gait event specific peak accelerations along three orthogonal axes were collected. In addition, data were collected from a cohort of 14 D1 female soccer players during a single assessment to explore the practical clinical application. Results: Cronbach's alpha values for the eight metrics ranged from 0.881 to 0.980 and ICC values from 0.868 to 0.987. Average assessment time for the 14 Dl female athletes was 8.50 +/- 0.58 min, and significant differences between walking conditions were identified for Vert Accel 1 (p < .01), Vert Accel 2 (p = .01), and A-P Accel (p < .01). Significance: High Cronbach's a and ICC values coupled with a short assessment time and sensitivity to differences in gait balance control indicate our testing apparatus and protocol are both reliable and clinically practical. Additionally, gait event specific peak accelerations from a single accelerometer can detect subtle changes in gait balance control and may facilitate improvements in sport-related concussion diagnosis and return to activity decision making.	[Pitt, Will; Chou, Li-Shan] Univ Oregon, Dept Human Physiol, Mot Anal Lab, Eugene, OR 97403 USA		Chou, LS (corresponding author), Dept Human Physiol, 122 Esslinger Hall,1240 Univ Oregon, Eugene, OR 97403 USA.	chou@uoregon.edu			United States Army Medical Department Long Term Health Education Training Program; United States Army Medical Department Advanced Medical Technologies Initiative [W911QY-16-A-0014-0016]	The authors would like to acknowledge Emma Silverman and Michael Utter for their assistance in data collection. The primary author is supported by the United States Army Medical Department Long Term Health Education Training Program. This work was supported in part by the United States Army Medical Department Advanced Medical Technologies Initiative [W911QY-16-A-0014-0016].	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Allseits E, 2017, J BIOMECH, V55, P27, DOI 10.1016/j.jbiomech.2017.02.016; Bugane F, 2012, COMPUT METH PROG BIO, V108, P129, DOI 10.1016/j.cmpb.2012.02.003; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Floor-Westerdijk MJ, 2012, IEEE T BIO-MED ENG, V59, P2080, DOI 10.1109/TBME.2012.2197211; Fujimoto M, 2012, J BIOMECH, V45, P543, DOI 10.1016/j.jbiomech.2011.11.037; Hahn ME, 2003, CLIN BIOMECH, V18, P737, DOI 10.1016/S0268-0033(03)00139-6; Howell D.R., 2017, J SCI MED SPORT, P1; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; McCrory P, 2017, BR J SPORTS MED; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; MORGAN ALR, 1989, BRAIN LANG, V36, P592, DOI 10.1016/0093-934X(89)90088-6; Myklebust H, 2015, J APPL BIOMECH, V31, P492, DOI 10.1123/jab.2015-0081; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Purcell JJ, 2011, NEUROIMAGE, V55, P750, DOI 10.1016/j.neuroimage.2010.11.042; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	26	4	4	2	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	JUN	2019	71						279	283		10.1016/j.gaitpost.2019.05.014			5	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	ID9QF	WOS:000472021500045	31125835				2022-02-06	
J	Qureshi, KL; Upthegrove, R; Toman, E; Sawlani, V; Davies, DJ; Belli, A				Qureshi, Kasim L.; Upthegrove, Rachel; Toman, Emma; Sawlani, Vijay; Davies, David James; Belli, Antonio			Post-traumatic stress disorder in UK civilians with traumatic brain injury: an observational study of TBI clinic attendees to estimate PTSD prevalence and its relationship with radiological markers of brain injury severity	BMJ OPEN			English	Article							HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; PSYCHOMETRIC PROPERTIES; COMORBIDITY; DEPRESSION; EPIDEMIOLOGY; PREDICTORS; STRATEGIES; CHECKLIST; RISK	Objectives To estimate the prevalence of post-traumatic stress disorder (PTSD) in a large civilian population with traumatic brain injury (TBI), and to assess whether brain injury severity is correlated with PTSD symptoms. Design Observational, cross-sectional study. Setting and participants Outpatient clinic in a major UK trauma centre and secondary care hospital. Estimates of PTSD prevalence are based on 171 sampled individuals attending TBI clinic within an 18-month period. Analysis of the relationship between TBI severity and PTSD was performed on the subset of 127 patients for whom injury severity data were also available. Methods Civilian TBI clinic attendees completed validated self-report questionnaires assessing PTSD (PTSD Checklist Civilian Version (PCL-C)) and other psychiatric symptoms. From this, the prevalence of PTSD was estimated in our cohort. Postresuscitation Glasgow Coma Score and Marshall grade on CT brain scan were recorded as indicators of brain injury severity. A hierarchical regression explored whether TBI severity may predict PTSD scores. Results A high prevalence of PTSD was estimated (21% with PCL-C score >50). Higher Marshall grading displayed a slight negative correlation with PTSD symptoms. This statistically significant relationship persisted after confounding factors such as depression and postconcussion symptoms were controlled for. Conclusions PTSD and TBI frequently coexist, share antecedents and overlap in their resultant symptoms. This complexity has given rise to conflicting hypotheses about relationships between the two. This research reveals that PTSD is common in civilians with TBI (adding to evidence drawn from military populations). The analysis indicated that more severe brain injury may exert a slight protective influence against the development of PTSD-potentially by disrupting implicit access to traumatic memories, or via overlapping neuropsychiatric symptoms that impede diagnosis. The association suggests that further research is warranted to explore the reuse of routine clinical and neuroimaging data-investigating its potential to predict risk of psychiatric morbidity.	[Qureshi, Kasim L.; Upthegrove, Rachel] Univ Birmingham, Sch Psychol, Dept Psychiat, Birmingham, W Midlands, England; [Qureshi, Kasim L.; Upthegrove, Rachel] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Toman, Emma; Davies, David James] Queen Elizabeth Hosp, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Sawlani, Vijay] Queen Elizabeth Hosp, Dept Radiol, Birmingham, W Midlands, England; [Belli, Antonio] Univ Birmingham, Inst Inflammat & Aging, Birmingham, W Midlands, England		Qureshi, KL (corresponding author), Univ Birmingham, Sch Psychol, Dept Psychiat, Birmingham, W Midlands, England.; Qureshi, KL (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.	klq552@alumni.bham.ac.uk	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Upthegrove, Rachel/0000-0001-8204-5103			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Finset A, 2000, BRAIN INJURY, V14, P887; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Hidalgo RB, 2000, J CLIN PSYCHIAT, V61, P5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holeva V, 2001, BEHAV THER, V32, P65, DOI 10.1016/S0005-7894(01)80044-7; KEANE TM, 1990, J APPL SOC PSYCHOL, V20, P1776, DOI 10.1111/j.1559-1816.1990.tb01511.x; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kilpatrick DG, 2003, J CONSULT CLIN PSYCH, V71, P692, DOI 10.1037/0022-006X.71.4.692; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Qureshi Adnan I, 2015, J Vasc Interv Neurol, V8, P42; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tarrier N, 2004, SOC PSYCH PSYCH EPID, V39, P927, DOI 10.1007/s00127-004-0828-3; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; World Health Organization, 1992, ICD 10 CLASSIFICATIO	35	4	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2019	9	2							e021675	10.1136/bmjopen-2018-021675			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IC7AO	WOS:000471124600011	30782864	gold, Green Published			2022-02-06	
J	Root, JM; McNamara, B; Ledda, M; Madati, PJ				Root, Jeremy M.; McNamara, Brittany; Ledda, Matt; Madati, Ponda J.			Pediatric Patient Compliance With Recommendations for Acute Concussion Management	CLINICAL PEDIATRICS			English	Article						concussion; compliance; rest	INTERNATIONAL-CONFERENCE; 2ND IMPACT; SPORT; SYMPTOMS; CHILDREN; REST; STATEMENT; AGREEMENT; INJURY	Emerging evidence supports an active approach for acute pediatric concussion management. The current practices of pediatric emergency providers following acute concussions has not been well studied. We prospectively enrolled 134 pediatric patients with an acute concussion. Providers completed a real-time survey to assess their recommendations for time off from school and sports. Seven to 10 days post-injury, patient compliance with provider recommendations was assessed. Forty-seven (35.1%) providers recommended moderate time off from school. In this cohort (n = 44), 14 (31.8%) patients took more than 2 days off from school. When minimal rest was prescribed (n = 80), 26 (32.5%) patients took more than 2 days off from school, P = .94. One third of our pediatric emergency providers are still recommending moderate time off from school. Regardless of physician prescriptions, patients took a similar amount of time off from school. Our study questions the influence of physician recommendations on management of acute pediatric concussions.	[Root, Jeremy M.; McNamara, Brittany; Ledda, Matt; Madati, Ponda J.] Childrens Natl Hlth Syst, Washington, DC USA; [McNamara, Brittany] GW Med Fac Associates, Washington, DC USA; [Ledda, Matt] Johns Hopkins Univ, Washington, DC USA		Root, JM (corresponding author), Childrens Natl Med Ctr, Div Emergency Med, 111 Michigan Ave NW, Washington, DC 20010 USA.	jeremyroot1@gmail.com		Root, Jeremy/0000-0003-2650-6889			Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Belson K., 2017, NY TIMES; Bey T, 2009, WEST J EMERG MED, V10, P6; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Carey B., 2016, NY TIMES; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Emanuel D, 2017, CNN; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Hohler B., 2009, BOSTON GLOBE; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Rowe BH, 2018, J EMERG MED, V54, P774, DOI 10.1016/j.jemermed.2018.02.013; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schutzman S., 2016, FLEISHER LUDWIGS TXB, V7th ed, P247; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Tharmaratnam T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00445; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Ward J., 2017, NY TIMES; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	35	4	4	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JUN	2019	58	7					731	737		10.1177/0009922819839230			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HZ7AO	WOS:000469004100002	30931591				2022-02-06	
J	Snedden, TR; Pierpoint, LA; Currie, DW; Comstock, RD; Grubenhoff, JA				Snedden, Traci R.; Pierpoint, Lauren A.; Currie, Dustin W.; Comstock, R. Dawn; Grubenhoff, Joseph A.			Postconcussion Academic Support in Children Who Attend a Primary Care Provider Follow-up Visit after Presenting to the Emergency Department	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; PEDIATRIC CONCUSSION; UNITED-STATES; SYMPTOMS; SCHOOL; SEX; RECOMMENDATIONS; EDUCATION; OUTCOMES; DEATHS	Objective To examine whether a primary care provider (PCP) follow-up visit after emergency department evaluation of concussion improved the children's likelihood of receiving academic support. Study design This was a prospective cohort study. Concussed children, aged 8-18 years, presenting to a regional pediatric trauma center emergency department (n = 160) were contacted 7 and 30 days after injury to gather data on PCP follow-up, symptoms, quality of life, and receipt of academic support instituted after and because of the concussion. Bivariate comparisons of demographics, concussion characteristics, quality of life, and symptoms were made between children who did and did not receive support using independent samples t tests, Wilcoxon rank sum tests, or chi(2) tests. ORs and 95% CIs were calculated using multivariable logistic regression with backwards elimination to test the association between attending an outpatient follow-up visit and the receipt of academic support for variables where P < .2 in bivariate comparisons. Results Overall, 51.3% (n = 82) received academic support; of these, 84.2% attended a follow-up visit compared with 71.8% of 78 children who attended a follow-up visit but did not receive support (P = .06). Children who received support were more likely to have commercial insurance; experience a sports-related injury mechanism; have parents whose primary language was English; suffer from learning disabilities and migraines; and be non-Hispanic (P < .05). There was no association between attending a follow-up visit and receipt of academic support (adjusted OR 1.83; 95% CI 0.75-4.45). Conclusions Although the majority of children received academic support postconcussion, accommodations were associated with several demographic, medical history, and injury characteristics, but not attending a PCP follow-up visit.	[Snedden, Traci R.] Univ Wisconsin, Sch Nursing, 701 Highland Ave, Madison, WI 53705 USA; [Pierpoint, Lauren A.; Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Comstock, R. Dawn; Grubenhoff, Joseph A.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA		Snedden, TR (corresponding author), Univ Wisconsin, Sch Nursing, 701 Highland Ave, Madison, WI 53705 USA.	tsnedden@wisc.edu	Grubenhoff, Joseph A/H-9994-2019	Grubenhoff, Joseph A/0000-0001-5072-4064; Snedden, Traci/0000-0002-1550-2340	Colorado Department of Human Services (CDHS) Traumatic Brain Injury Program [4600]; National Institutes of Health (NIH)/National Center for Research Resources Colorado CTSI grant [UL1 RR025780]	Supported by a grant from the Colorado Department of Human Services (CDHS) Traumatic Brain Injury Program (#4600). CDHS did not contribute to the study design, data acquisition or analysis, drafting or review of the manuscript, or the decision to submit for publication. The use of the REDCap database hosted by the Colorado Clinical and Translational Sciences Institute was supported by National Institutes of Health (NIH)/National Center for Research Resources Colorado CTSI grant Number UL1 RR025780. This paper's contents are the authors' sole responsibility and do not represent official views of the NIH. The authors declare no conflicts of interest.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Brook EM, 2016, PHYSICIAN SPORTSMED, V44, P20, DOI 10.1080/00913847.2016.1142834; Collins C. L., 2014, INJURY EPIDEMIOLOGY, V1, P1; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Currie DE, J HEAD TRAUMA REHABI; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kroshus E, HLTH PROMOT PRACT; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Popoli DM, 2014, CLIN PEDIAT PHILA, V133, P635; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zamarripa A, 2017, J PEDIATR-US, V181, P229, DOI 10.1016/j.jpeds.2016.10.071; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	39	4	4	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JUN	2019	209						168	175		10.1016/j.jpeds.2019.01.041			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HZ1OA	WOS:000468615300031	30853206				2022-02-06	
J	van der Wal, SJ; Gorter, R; Reijnen, A; Geuze, E; Vermetten, E				van der Wal, Sija J.; Gorter, Rosalie; Reijnen, Alieke; Geuze, Elbert; Vermetten, Eric			Cohort profile: the Prospective Research In Stress-Related Military Operations (PRISMO) study in the Dutch Armed Forces	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; SELF-RATING INVENTORY; PSYCHOMETRIC PROPERTIES; GLUCOCORTICOID SENSITIVITY; LANGUAGE VERSION; HEALTH SURVEY; DEPLOYMENT; VALIDATION; SYMPTOMS; PTSD	Purpose The Prospective Research in Stress-Related Military Operations (PRISMO) study was initiated to gain a better understanding of the long-term impact of military deployment on mental health, and to map the different biological and psychological factors that contribute to the development of stress-related mental health symptoms. Participants The PRISMO cohort consists of a convenience sample of Dutch military personnel deployed to Afghanistan between 2005 and 2008. Baseline data collection resulted in the recruitment of 1032 military men and women. Combat troops as well as non-combat support troops were recruited to increase the representativeness of the sample to the population as a whole. Findings to date The prevalence of various mental health symptoms increases after deployment in PRISMO cohort members, but symptom progression over time appears to be specific for various mental health symptoms. For post-traumatic stress disorder, we found a short-term symptom increase within 6 months after deployment (8.2%), and a long-term symptom increase at 5 years after deployment (12.9%). Several biological vulnerability factors associated with the development of stress-related conditions after deployment were identified, including predeployment glucocorticoid receptor sensitivity and predeployment testosterone level. Thus far, 34 publications have resulted from the cohort. Future plans Various analyses are planned that will include the prevalence of mental health symptoms at 10 years postdeployment, as well as trajectory analyses that capture the longitudinal development of symptoms. Furthermore, we will use a machine learning approach to develop predictive and network models for several mental health symptoms, incorporating biological, psychological and social factors.	[van der Wal, Sija J.; Gorter, Rosalie; Reijnen, Alieke; Geuze, Elbert; Vermetten, Eric] Minist Def, Res Ctr Mil Mental Healthcare, Utrecht, Netherlands; [van der Wal, Sija J.; Reijnen, Alieke; Vermetten, Eric] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [van der Wal, Sija J.; Gorter, Rosalie; Reijnen, Alieke; Geuze, Elbert; Vermetten, Eric] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Vermetten, Eric] Arq Psychotrauma Expert Grp, Diemen, Netherlands		van der Wal, SJ (corresponding author), Minist Def, Res Ctr Mil Mental Healthcare, Utrecht, Netherlands.; van der Wal, SJ (corresponding author), Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands.; van der Wal, SJ (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	s.j.vanderwal@umcutrecht.nl	Vermetten, Eric/B-1335-2008	Vermetten, Eric/0000-0003-0579-4404; van der Wal, Sija/0000-0002-3064-3934; Gorter, Rosalie/0000-0002-2451-9953	Dutch Ministry of Defence	The PRISMO study is financially supported by the Dutch Ministry of Defence.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Babor TF, 2001, AUDIT ALCOHOL USE DI; Baker DG, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110134; BAREFOOT JC, 1989, PSYCHOSOM MED, V51, P46, DOI 10.1097/00006842-198901000-00005; Blais AR, 2009, MIL PSYCHOL, V21, P365, DOI 10.1080/08995600902914727; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boks MP, 2016, NEUROPSYCHOPHARMACOL, V41, P1350, DOI 10.1038/npp.2015.286; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Bridges KR, 2002, PSYCHOL REP, V90, P1055, DOI 10.2466/PR0.90.3.1055-1058; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; Currier JM, 2015, CLIN PSYCHOL PSYCHOT, V22, P54, DOI 10.1002/cpp.1866; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Duijsens IJ, 2002, VTCI HANDLEIDING NED; Eekhout I, 2016, LANCET PSYCHIAT, V3, P58, DOI 10.1016/S2215-0366(15)00368-5; Engelhard IM, 2007, BRIT J PSYCHIAT, V191, P140, DOI 10.1192/bjp.bp.106.034884; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Geuze E, 2012, PSYCHONEUROENDOCRINO, V37, P1837, DOI 10.1016/j.psyneuen.2012.03.017; Hakkaart-van Roijen L, 2010, HANDLEIDING SHORT FO; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holi MM, 1998, ACTA PSYCHIAT SCAND, V97, P42, DOI 10.1111/j.1600-0447.1998.tb09961.x; HOVENS JE, 1994, ACTA PSYCHIAT SCAND, V90, P172, DOI 10.1111/j.1600-0447.1994.tb01574.x; Hovens JE, 2002, PERCEPT MOTOR SKILL, V94, P996, DOI 10.2466/PMS.94.3.996-1008; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lievaart M, 2016, J CLIN PSYCHOL, V72, P263, DOI 10.1002/jclp.22253; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; Mooren T, 2009, PSYCHOL GEZONDH, V37, P101, DOI 10.1007/BF03080375; Pinder RJ, 2012, INT J EPIDEMIOL, V41, P1272, DOI 10.1093/ije/dyr096; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reijnen A, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.05.003; Reijnen A, 2018, BIOL PSYCHOL, V134, P72, DOI 10.1016/j.biopsycho.2018.02.008; Reijnen A, 2017, J PSYCHIATR RES, V94, P88, DOI 10.1016/j.jpsychires.2017.06.010; Reijnen A, 2015, PSYCHONEUROENDOCRINO, V51, P525, DOI 10.1016/j.psyneuen.2014.07.017; Roelofs J, 2005, STRESS HEALTH, V21, P17, DOI 10.1002/smi.1032; Rutten BPF, 2018, MOL PSYCHIATR, V23, P1145, DOI 10.1038/mp.2017.120; Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Spielberger CD., 1999, STAXI 2 STATE TRAIT; Stimpson NJ, 2003, BRIT J PSYCHIAT, V182, P391, DOI 10.1192/bjp.182.5.391; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Van Dierendonck, 2000, HANDLEIDING UTRECHTS; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Van Sonderen E., 2012, METEN SOCIALE STEUN; van Wingen GA, 2011, MOL PSYCHIATR, V16, P664, DOI 10.1038/mp.2010.132; van Wingen GA, 2012, P NATL ACAD SCI USA, V109, P15508, DOI 10.1073/pnas.1206330109; van Zuiden M, 2015, PSYCHONEUROENDOCRINO, V51, P513, DOI 10.1016/j.psyneuen.2014.09.014; van Zuiden M, 2012, PSYCHONEUROENDOCRINO, V37, P1822, DOI 10.1016/j.psyneuen.2012.03.018; van Zuiden M, 2011, AM J PSYCHIAT, V168, P89, DOI 10.1176/appi.ajp.2010.10050706; vanRoijen L, 1996, INT J TECHNOL ASSESS, V12, P405, DOI 10.1017/S0266462300009764; Vasterling JJ, 2016, AM J EPIDEMIOL, V184, P796, DOI 10.1093/aje/kww151; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Worm-Smeitink M, 2017, J PSYCHOSOM RES, V98, P40, DOI 10.1016/j.jpsychores.2017.05.007	60	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2019	9	3							e026670	10.1136/bmjopen-2018-026670			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IC7HO	WOS:000471144900289	30842118	Green Published, gold			2022-02-06	
J	Yip, PK; Chapman, GE; Sillito, RR; Ip, THR; Akhigbe, G; Beckek, SC; Price, AW; Michael-Titus, AT; Armstrong, JD; Tremoleda, JL				Yip, Ping K.; Chapman, George E.; Sillito, Rowland R.; Ip, T. H. Richard; Akhigbe, Georgia; Beckek, Stephanie C.; Price, Anthony W.; Michael-Titus, Adina T.; Armstrong, J. Douglas; Tremoleda, Jordi L.			Studies on long term behavioural changes in group-housed rat models of brain and spinal cord injury using an automated home cage recording system	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Neurotrauma; Behaviour; Traumatic brain injury; Spinal cord injury; 3Rs	SOCIAL-BEHAVIOR; RODENT MODELS; PREVALENCE; DEPRESSION; CONTUSION; DEFICITS; MOUSE; MICE	Background: Neurotrauma patients face major neurological sequelae. The failure in the preclinical-to-clinical translation of candidate therapies could be due to poor evaluation of rodent behaviours after neurotrauma. New Method: A home cage automated system was used to study the long term behaviour of individual rats with traumatic brain injury (TBI), spinal cord injury (SCI) and non-CNS injured controls, whilst group-housed in their home cages. Naive rats were used as baseline controls. Automated locomotor activity and body temperature recordings were carried out 24 h /day for 3 days/week during 12 weeks post-injury. Behavioural patterns, including aggression, rearing, grooming, feeding and drinking were analysed from automated video recordings during week 1, 6 and 12. Results: SCI animals showed a lower locomotor activity compared to TBI or control animals during light and dark phases. TBI animals showed a higher aggression during the dark phase in the first week post-injury compared to SCI or control animals. Individual grooming and rearing were reduced in SCI animals compared to TBI and control animals in the first week post-injury during the dark phase. No differences in drinking or feeding were detected between groups. Locomotor activity did not differ between naive male and female rats, but body temperature differ between light and dark phases for both. Standard methods: Injury severity was compared to standard SCI and TBI behaviour scores (BBB and mNSS, respectively) and histological analysis. Conclusions: This study demonstrates the practical benefits of using a non-intrusive automated home cage recording system to observe long term individual behaviour of group-housed SCI and TBI rats.	[Yip, Ping K.; Chapman, George E.; Ip, T. H. Richard; Akhigbe, Georgia; Beckek, Stephanie C.; Michael-Titus, Adina T.; Tremoleda, Jordi L.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Neurosci Surg & Trauma, Ctr Trauma Sci,Blizard Inst, 4 Newark St, London E1 2AT, England; [Sillito, Rowland R.; Armstrong, J. Douglas] Actual Analyt Ltd, Edinburgh, Midlothian, Scotland; [Price, Anthony W.; Tremoleda, Jordi L.] Queen Mary Univ London, Biol Serv, London, England; [Armstrong, J. Douglas] Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland		Tremoleda, JL (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Neurosci Surg & Trauma, Ctr Trauma Sci,Blizard Inst, 4 Newark St, London E1 2AT, England.	j.lopez-tremoleda@qmul.ac.uk		Chapman, George/0000-0001-7874-0314; Armstrong, Douglas/0000-0002-5397-3864; lopez tremoleda, jordi/0000-0002-8846-9043	National Centre for the Replacement, Refinement and Reduction of Animals in ResearchUK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs) [NC/C012201/1] Funding Source: Medline		ADAMS RD, 1991, NEUROL CLIN, V9, P605, DOI 10.1016/S0733-8619(18)30270-6; Anderson KB, 2016, THER HYPOTHERMIA TEM, V6, P169, DOI 10.1089/ther.2016.0003; Bains RS, 2018, J NEUROSCI METH, V300, P37, DOI 10.1016/j.jneumeth.2017.04.014; Bains RS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00106; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Burnett J, 2006, J ELDER ABUSE NEGL, V18, P25, DOI 10.1300/J084v18n04_04; Chen K, 2016, J NEUROTRAUM, V33, P1667, DOI 10.1089/neu.2015.4218; Duggan Colette, 2016, Top Spinal Cord Inj Rehabil, V22, P99, DOI 10.1310/sci2202-99; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Everds NE, 2013, TOXICOL PATHOL, V41, P560, DOI 10.1177/0192623312466452; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; GRANT E. C, 1963, BEHAVIOUR, V21, P246, DOI 10.1163/156853963X00185; HUDECKI MS, 1993, RES COMMUN CHEM PATH, V79, P45; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; James ND, 2011, J NEUROSCI, V31, P18543, DOI 10.1523/JNEUROSCI.4306-11.2011; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KOLB B, 1974, J COMP PHYSIOL PSYCH, V87, P466, DOI 10.1037/h0036969; Liu Z. H., 2017, J NEUROTRAUMA; Luedtke K, 2014, J NEUROTRAUM, V31, P1107, DOI 10.1089/neu.2013.3204; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Miczek K., 2004, BEHAV LAB RAT HDB TE; Mohit AA, 2016, SPINE, V41, pA28, DOI 10.1097/BRS.0000000000001434; Molina J, 2008, HUM MOL GENET, V17, P2486, DOI 10.1093/hmg/ddn148; Muir GD, 2000, EUR J NEUROSCI, V12, P3079, DOI 10.1046/j.1460-9568.2000.00205.x; Onifer SM, 2011, NEUROTHERAPEUTICS, V8, P283, DOI 10.1007/s13311-011-0034-4; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Qu WR, 2016, NEURAL REGEN RES, V11, P248, DOI 10.4103/1673-5374.177732; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Redfern WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181068; Richardson CA, 2015, APPL ANIM BEHAV SCI, V163, P19, DOI 10.1016/j.applanim.2014.11.018; Richardson CA, 2012, ATLA-ALTERN LAB ANIM, V40, pP7, DOI 10.1177/026119291204000513; Rossignol S, 2009, PHYSIOLOGY, V24, P127, DOI 10.1152/physiol.00042.2008; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Takahashi Aki, 2014, Curr Top Behav Neurosci, V17, P3, DOI 10.1007/7854_2013_263; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tremoleda JL, 2016, EUR J NUCL MED MOL I, V43, P1710, DOI 10.1007/s00259-016-3391-8; Vu PA, 2018, BRAIN RES, V1700, P138, DOI 10.1016/j.brainres.2018.08.034; Wells J. N., 2015, VIDEO 24 7 AUTOMATED; Williams R, 2015, ARCH PHYS MED REHAB, V96, P133, DOI 10.1016/j.apmr.2014.08.016; Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689	49	4	4	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JUN 1	2019	321						49	63		10.1016/j.jneumeth.2019.04.005			15	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HY6PE	WOS:000468251400006	30991030	Green Submitted			2022-02-06	
J	Powell, MA; Black, RT; Smith, TL; Reeves, TM; Phillips, LL				Powell, Melissa A.; Black, Raiford T.; Smith, Terry L.; Reeves, Thomas M.; Phillips, Linda L.			Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						metalloproteinase; olfactory bulb; osteopontin; synaptogenesis	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; MATRIX METALLOPROTEINASES; CELL-ADHESION; EXTRACELLULAR-MATRIX; FUNCTIONAL RECOVERY; SENSORY NEURONS; GLIAL SCAR; EXPRESSION; CD44	Olfactory receptor axons reinnervate the olfactory bulb (OB) after chemical or transection lesion. Diffuse brain injury damages the same axons, but the time course and regulators of OB reinnervation are unknown. Gelatinases (matrix metalloproteinase [MMP]2, MMP9) and their substrate osteopontin (OPN) are candidate mediators of synaptogenesis after central nervous system (CNS) insult, including olfactory axon damage. Here, we examined the time course of MMP9, OPN, and OPN receptor CD44 response to diffuse OB injury. FVBV/NJ mice received mild midline fluid percussion insult (mFPI), after which MMP9 activity and both OPN and CD44 protein expression were measured. Diffuse mFPI induced time-dependent increase in OB MMP9 activity and elevated the cell signaling 48-kD OPN fragment. This response was bimodal at 1 and 7 days post-injury. MMP9 activity was also correlated with 7-day reduction in a second 32-kD OPN peptide. CD44 increase peaked at 3 days, delayed relative to MMP9/OPN response. MMP9 and OPN immunohistochemistry suggested that deafferented tufted and mitral neurons were the principal sites for these molecular interactions. Analysis of injured MMP9 knockout (KO) mice showed that 48-kD OPN production was dependent on OB MMP9 activity, but with no KO effect on CD44 induction. Olfactory marker protein (OMP), used to identify injured olfactory axons, revealed persistent axon damage in the absence of MMP9. MMP9 KO ultrastructure at 21 days post-injury indicated that persistent OMP reduction was paired with delayed removal of degenerated axons. These results provide evidence that diffuse, concussive brain trauma induces a post-injury interaction between MMP9, OPN, and CD44, which mediates synaptic plasticity and reinnervation within the OB.	[Powell, Melissa A.; Black, Raiford T.; Smith, Terry L.; Reeves, Thomas M.; Phillips, Linda L.] Virginia Commonwealth Univ, Med Ctr, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23298 USA		Phillips, LL (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Campus,POB 980709, Richmond, VA 23298 USA.	Linda.Phillips@vcuhealth.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 044372, NS 056247, NS 057758]; NIH-NCI Cancer Center Grant [P30 CA016059]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056247] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health (grants NS 044372, NS 056247, and NS 057758). Foremost, the authors thank Dr. Richard M. Costanzo for providing MMP9KO mice to establish our working colony and his valuable discussions supporting the project. Additional thanks go to Judy Williamson for expert assistance with TEM tissue preparation and Frances White for guidance on confocal imaging. Microscopy was performed at the VCU Microscopy Facility, supported, in part, by funding from NIH-NCI Cancer Center Grant P30 CA016059.	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Ailane S, 2013, EUR J NEUROSCI, V38, P2468, DOI 10.1111/ejn.12231; Bakos SR, 2011, NEUROREPORT, V22, P539, DOI 10.1097/WNR.0b013e328348ab94; Bakos SR, 2010, CHEM SENSES, V35, P655, DOI 10.1093/chemse/bjq056; Baliga SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014568; BOURGUIGNON L, 2001, J NEUROCHEM, V101, P1002; Campo GM, 2012, GENE, V494, P24, DOI 10.1016/j.gene.2011.11.064; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Choi JS, 2007, BRAIN RES, V1151, P195, DOI 10.1016/j.brainres.2007.03.016; Copin JC, 2005, EUR J NEUROSCI, V22, P1597, DOI 10.1111/j.1460-9568.2005.04367.x; Costanzo RM, 2008, NEUROREPORT, V19, P327, DOI 10.1097/WNR.0b013e3282f50c7b; Costanzo RM, 2006, NEUROREPORT, V17, P1787, DOI 10.1097/WNR.0b013e32800fef87; Cummings DM, 2000, J COMP NEUROL, V421, P362; de Castro R, 2000, NEUROREPORT, V11, P3551, DOI 10.1097/00001756-200011090-00029; Desai B, 2009, J CELL BIOCHEM, V108, P272, DOI 10.1002/jcb.22248; Ding Q, 2002, CANCER RES, V62, P5336; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ellison JA, 1998, STROKE, V29, P1698, DOI 10.1161/01.STR.29.8.1698; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Frischknecht R, 2012, ADV EXP MED BIOL, V970, P153, DOI 10.1007/978-3-7091-0932-8_7; Gao YA, 2004, MATRIX BIOL, V23, P457, DOI 10.1016/j.matbio.2004.09.003; GRAZIADEI PPC, 1978, P NATL ACAD SCI USA, V75, P5230, DOI 10.1073/pnas.75.10.5230; GRAZIADEI PPC, 1979, NEUROSCIENCE, V4, P713, DOI 10.1016/0306-4522(79)90002-2; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; HARDING J, 1977, BRAIN RES, V132, P11, DOI 10.1016/0006-8993(77)90703-X; Harris JL, 2011, HIPPOCAMPUS, V21, P81, DOI 10.1002/hipo.20725; Harris L.K., 2012, ANIMAL MODELS ACUTE, V1, P187; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Hill JW, 2012, NEUROSCIENCE, V220, P277, DOI 10.1016/j.neuroscience.2012.06.019; Holbrook EH, 2014, CHEM SENSES, V39, P601, DOI 10.1093/chemse/bju033; Horstmann S, 2006, J NEUROL SCI, V251, P82, DOI 10.1016/j.jns.2006.09.005; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Jin Y, 2014, ACTA BIOMATER, V10, P3126, DOI 10.1016/j.actbio.2014.02.045; Jones LL, 2000, J COMP NEUROL, V426, P468, DOI 10.1002/1096-9861(20001023)426:3<468::AID-CNE9>3.0.CO;2-I; Kaliszewska A, 2012, CEREB CORTEX, V22, P2160, DOI 10.1093/cercor/bhr303; KANG W, 2003, BRAIN RES, V1228, P208; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kelly EA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00369; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kim SY, 2002, MOL CELLS, V13, P429; Kobayashi M, 2018, J NEUROTRAUM, V35, P652, DOI 10.1089/neu.2017.5316; Kosaka K, 2001, J COMP NEUROL, V440, P219, DOI 10.1002/cne.1381; Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004; Li Q, 2017, BEHAV BRAIN RES, V333, P74, DOI 10.1016/j.bbr.2017.06.041; Lindsey ML, 2015, CAN J PHYSIOL PHARM, V93, P879, DOI 10.1139/cjpp-2015-0019; Long P, 2012, EUR J NEUROSCI, V36, P2733, DOI 10.1111/j.1460-9568.2012.08189.x; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Maeda K, 2001, LUNG, V179, P279, DOI 10.1007/s004080000068; Mahmood A, 2014, J NEUROSURG, V120, P1147, DOI 10.3171/2013.12.JNS131362; Miyazaki KI, 2008, INVEST OPHTH VIS SCI, V49, P1367, DOI 10.1167/iovs.07-1007; Mizoguchi H, 2011, J NEUROSCI, V31, P12963, DOI 10.1523/JNEUROSCI.3118-11.2011; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; MORRISON EE, 1995, NEUROSCI LETT, V198, P213, DOI 10.1016/0304-3940(95)11943-Q; Muradashvili N, 2011, BIOCHEM BIOPH RES CO, V413, P509, DOI 10.1016/j.bbrc.2011.07.133; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Noble LJ, 2002, J NEUROSCI, V22, P7526; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; OLEY N, 1975, J COMP PHYSIOL PSYCH, V88, P477, DOI 10.1037/h0076401; Pastrana E, 2006, J NEUROSCI, V26, P5347, DOI 10.1523/JNEUROSCI.1111-06.2006; Phillips LL, 2014, NEURAL REGEN RES, V9, P362, DOI 10.4103/1673-5374.128237; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Powell MA, 2018, NEUROSCIENCE, V371, P106, DOI 10.1016/j.neuroscience.2017.11.045; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2003, J NEUROSCI, V23, P10182; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Sato W, 2012, J IMMUNOL, V189, P5057, DOI 10.4049/jimmunol.1202026; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Shin SL, 1999, NEUROSCI LETT, V273, P73, DOI 10.1016/S0304-3940(99)00516-9; Shin T, 2005, BRAIN RES, V1041, P95, DOI 10.1016/j.brainres.2005.02.019; Shin T, 2012, ACTA HISTOCHEM, V114, P749, DOI 10.1016/j.acthis.2012.08.004; Shubayev VI, 2004, J NEUROSCI RES, V77, P229, DOI 10.1002/jnr.20160; SMITH L, 2001, J BIOL CHEM, V271, P28485; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; Sun SJ, 2016, ONCOTARGET, V7, P55572, DOI 10.18632/oncotarget.10865; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Topkoru BC, 2013, STROKE, V44, P3189, DOI 10.1161/STROKEAHA.113.001574; Van Hove I, 2012, J NEUROCHEM, V123, P203, DOI 10.1111/j.1471-4159.2012.07900.x; Verslegers M, 2013, PROG NEUROBIOL, V105, P60, DOI 10.1016/j.pneurobio.2013.03.004; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; WEBB D, 2000, SCIENCE, V249, P1295; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Wlodarczyk J, 2011, DEV NEUROBIOL, V71, P1040, DOI 10.1002/dneu.20958; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238; Zhang HQ, 2011, J NEUROSCI, V31, P15894, DOI 10.1523/JNEUROSCI.3943-11.2011; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830	102	4	4	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1615	1631		10.1089/neu.2018.5994			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900013	30444175	Green Published			2022-02-06	
J	Cournoyer, J; Hoshizaki, TB				Cournoyer, Janie; Hoshizaki, T. Blaine			Biomechanical comparison of concussions with and without a loss of consciousness in elite American football: implications for prevention	SPORTS BIOMECHANICS			English	Article; Early Access						Severity; brain tissue deformation; head accelerations; return-to-play	FINITE-ELEMENT SIMULATIONS; SPORT-RELATED CONCUSSION; DIFFUSE AXONAL INJURY; PROFESSIONAL FOOTBALL; PROLONGED RECOVERY; CORTICAL IMPACT; VIDEO ANALYSIS; HEAD-INJURY; HIGH-SCHOOL; BRAIN	Loss of consciousness (LOC) associated with concussion is no longer considered an indicator of severity of injury in concussion management protocols. Studies investigating the association between LOC and recovery time or neurophysiological performance have reported ambiguous findings and resulted in a limited understanding of the severity of LOC-inducing head impacts. Concussive injuries with and without LOC from helmet-to-helmet and shoulder collisions and falls in elite American football were reconstructed in laboratory using a hybrid III headform and finite element model to obtain peak linear and rotational acceleration and brain tissue deformation metrics in the cerebral cortex, the cerebral white matter, the corpus callosum, the thalamus and the brainstem. Impact velocity, peak linear and rotational acceleration were significantly greater in the LOC group than the no LOC group. The brain tissue deformation metrics were greater in the LOC group than the no LOC group. The best overall predictor for LOC was impact velocity. Concussions with LOC are characterised by greater magnitudes of brain tissue deformation. This was mainly the result of higher impact velocities in the LOC group providing league decision-makers with an understanding of the importance of managing impact velocity through athlete education and rule enforcement or change.	[Cournoyer, Janie; Hoshizaki, T. Blaine] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada		Cournoyer, J (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada.	jcour016@uottawa.ca					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Karton CM, 2014, AM SOC TEST MATER, V1552, P23, DOI 10.1520/STP155220120175; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1997, P INT RES COUNC BIOM, V24, P35	41	4	4	1	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.												10.1080/14763141.2019.1600004		MAY 2019	17	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	IA7AE	WOS:000469708400001	31099312				2022-02-06	
J	McPherson, JI				McPherson, Jacob, I			Traumatic brain injury among refugees and asylum seekers	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; refugee; asylum seeker; torture	POSTTRAUMATIC-STRESS-DISORDER; HEALTH-CARE ACCESS; HEAD-INJURY; MENTAL-HEALTH; OUTCOMES; TORTURE; DISPARITIES; SURVIVORS	Background: Refugees and asylum seekers face many challenges in their pursuit of a safe home. The journey for displaced individuals can be extremely dangerous and many do not survive or go missing. Survivors face significant risks of injury, abuse, and torture. Traumatic brain injury is one of the most common and disabling injuries sustained by these populations. This already complex condition can have profound implications on these groups and their families due to factors related to mental health, cultural perspectives, and their ability to navigate healthcare systems. Methods: A literature review was performed to investigate the incidence and prevalence of torture and traumatic brain injury in displaced and fleeing populations. Impacts of traumatic brain injury and residency status on outcomes in these individuals were also examined. Results: The incidence and prevalence of torture and traumatic brain injury among refugees and asylum seekers is significant. These populations may access healthcare systems differently than other groups and as a result may experience a unique health-related outcomes following traumatic brain injury. Conclusions: This information should sensitize healthcare providers to a potential history of traumatic brain injury sustained by patients/clients who are refugees or asylum seekers and may serve to guide some clinical encounters.	[McPherson, Jacob, I] Univ Buffalo, Dept Rehabil Sci, Buffalo, NY 14214 USA		McPherson, JI (corresponding author), Univ Buffalo, Buffalo, NY 14214 USA.	jim6@buffalo.edu					Allden K, 1996, AM J PUBLIC HEALTH, V86, P1561, DOI 10.2105/AJPH.86.11.1561; Amnesty International, 2016, WHATS DIFF REF AS SE; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Asgary R, 2011, J HEALTH CARE POOR U, V22, P506, DOI 10.1353/hpu.2011.0047; CALVANI S, 1990, LANCET, V336, P1448, DOI 10.1016/0140-6736(90)93154-H; Crosby SS, 2013, JAMA-J AM MED ASSOC, V310, P519, DOI 10.1001/jama.2013.8788; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Doherty SM, 2016, GLOB MENT HEALTH, V3, DOI 10.1017/gmh.2016.23; Hollifield M, 2002, JAMA-J AM MED ASSOC, V288, P611, DOI 10.1001/jama.288.5.611; Ibrahim H., 2017, IRAQ FRONT PSYCHOL, V8, P1, DOI [10.3389/fpsyg.2017.00241, DOI 10.3389/FPSYG.2017.00241]; International Organization for Migration (IOM), 2017, MIGR FAT WORLDW; Jaranson JM, 2004, AM J PUBLIC HEALTH, V94, P591, DOI 10.2105/AJPH.94.4.591; Kane WG, 2014, J HEAD TRAUMA REHAB, V29, pE10, DOI 10.1097/HTR.0000000000000028; Keatley E, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000103; Keatley E, 2013, J HEAD TRAUMA REHAB, V28, pE8, DOI 10.1097/HTR.0b013e3182776a70; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Mbakile-Mahlanza L, 2017, NEUROPSYCHOL REHABIL, V27, P38, DOI 10.1080/09602011.2015.1053946; Moisander PA, 2003, FORENSIC SCI INT, V137, P133, DOI 10.1016/j.forsciint.2003.07.008; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Motzkin Julian C, 2015, Handb Clin Neurol, V128, P633, DOI 10.1016/B978-0-444-63521-1.00039-X; OXFAM International, 2016, POOR WELC WORLDS WEA; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Reavell J, 2017, J MENT HEALTH, V26, P74, DOI 10.1080/09638237.2016.1222065; Shannon Patricia, 2012, Ment Health Fam Med, V9, P47; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Tang SS, 2001, J NERV MENT DIS, V189, P507, DOI 10.1097/00005053-200108000-00003; UNHCR, 2015, FIG AT A GLANC 2015; Var FA, 2012, INDIAN J PSYCHOL MED, V34, P223, DOI 10.4103/0253-7176.106014; Wagner J, 2013, J IMMIGR MINOR HEALT, V15, P1065, DOI 10.1007/s10903-012-9715-2	31	4	4	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY 8	2019	41	10					1238	1242		10.1080/09638288.2017.1422038			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HU3XK	WOS:000465208200012	29284288				2022-02-06	
J	Stilling, JM; Duszynski, CC; Oni, I; Paxman, E; Dunn, JF; Debert, CT				Stilling, Joan M.; Duszynski, Chris C.; Oni, Ibukunoluwa; Paxman, Eric; Dunn, Jeff F.; Debert, Chantal T.			Using Functional Near-Infrared Spectroscopy to Study the Effect of Repetitive Transcranial Magnetic Stimulation in Concussion: A Two-Patient Case Study	FRONTIERS IN NEUROLOGY			English	Article						concussion; post-concussion symptom; transcranial magnetic stimulation (repetitive); functional Near Infrared Spectroscopy (fNIRS); rehabilitation	TRAUMATIC BRAIN-INJURY; DORSOLATERAL PREFRONTAL CORTEX; CHRONIC MIGRAINE; DIAGNOSTIC-CRITERIA; DOUBLE-BLIND; DEPRESSION; HEADACHE; RTMS; ACTIVATION; SYMPTOMS	Background: Approximately 25% of concussion patients experience persistent post-concussion symptoms (PPCS). Repetitive transcranial magnetic stimulation (rTMS) has been explored as a treatment, and functional near-infrared spectroscopy (fNIRS) may be a cost-effective method for assessing response. Objectives: Evaluate rTMS for the treatment of PPCS and introduce fNIRS as a method of assessing treatment response. Methods: Design : Two-patient case study. Setting: Calgary Brain Injury Program. Participants: 47 and 49 years. male, with PPCS for 1-2 years (headache, cognitive difficulties, nausea, visual difficulties, irritability, anxiety, poor mood, sleep, and fatigue). Intervention: 10 sessions of rTMS therapy to the left dorsolateral prefrontal cortex (DLPFC), at 10Hz (600 pulses) and 70% of resting motor threshold amplitude. Participants completed an 8-week headache diary and a battery of clinical questionnaires prior to each fNIRS session. fNIRS: Hemodynamic changes were recorded over the frontoparietal cortex during rest, finger tapping, and a graded working memory test. fNIRS was completed pre-rTMS, following rTMS (day 14), and at 1-month post-rTMS (day 45). For comparison, two healthy, sex-matched controls were scanned with fNIRS once daily for five consecutive days. Results: Clinical scores improved (headache severity, MoCA, HIT-6, PHQ-9, GAD-7, QOLIBRI, RPSQ, BCPSI) or remained stable (PCL-5, headache frequency) post-rTMS, for both participants. Participant 1 reported moderate symptom burden, and a fNIRS task-evoked hemodynamic response showing increased oxyhemoglobin was observed following a working memory task, as expected. Participant 2 exhibited a high symptom burden pre-treatment, with abnormal fNIRS hemodynamic response where oxyhemoglobin declined, in response to task. One month following rTMS treatment, participant 2 had a normal fNIRS hemodynamic response to task, corresponding to significant improvements in clinical outcomes. Conclusion: This case study suggests fNIRS may be sensitive to physiological changes that accompany rTMS treatment. Further studies exploring fNIRS as a cost-effective technology for monitoring rTMS response in patients with PPCS are suggested.	[Stilling, Joan M.; Duszynski, Chris C.; Oni, Ibukunoluwa; Dunn, Jeff F.; Debert, Chantal T.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Stilling, Joan M.; Duszynski, Chris C.; Oni, Ibukunoluwa; Paxman, Eric; Dunn, Jeff F.; Debert, Chantal T.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Duszynski, Chris C.; Oni, Ibukunoluwa; Dunn, Jeff F.] Univ Calgary, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada		Debert, CT (corresponding author), Hotchkiss Brain Inst, Calgary, AB, Canada.; Debert, CT (corresponding author), Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada.	Chantel.Debert@albertahealthservices.ca		Debert, Chantel/0000-0002-2704-0438; Duszynski, Chris/0000-0001-5050-3608	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR-CPG-140174]; CHRP Grant-Natural Sciences and Engineering Research Council of Canada [NSERC-CHRP/478476-2015]	Canadian Institutes of Health Research project grant (CIHR-CPG-140174) CHRP Grant-Natural Sciences and Engineering Research Council of Canada (NSERC-CHRP/478476-2015). No grant number for Branch Out (Studentship).	Anderson RJ, 2016, CLIN NEUROPHYSIOL, V127, P3394, DOI 10.1016/j.clinph.2016.08.015; [Anonymous], 2017, MMWR-MORBID MORTAL W, V66, P1; Blumberger DM, 2018, LANCET, V391, P1683, DOI 10.1016/S0140-6736(18)30295-2; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Brighina F, 2004, J NEUROL SCI, V227, P67, DOI 10.1016/j.jns.2004.08.008; Brunoni AR, 2017, JAMA PSYCHIAT, V74, P143, DOI 10.1001/jamapsychiatry.2016.3644; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castien RF, 2012, CEPHALALGIA, V32, P710, DOI 10.1177/0333102412449933; Chen WT, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0834-6; Conforto AB, 2014, CEPHALALGIA, V34, P464, DOI 10.1177/0333102413515340; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; George M.S., 1994, DEPRESSION, V2, P59, DOI [10.1002/depr.3050020202, DOI 10.1002/DEPR.3050020202]; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hocke LM, 2018, J NEUROTRAUM, V35, P1224, DOI 10.1089/neu.2017.5365; Hsu JH, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0703-7; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Kalita J, 2016, J NEUROL, V263, P2238, DOI 10.1007/s00415-016-8257-2; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kito S, 2012, BRAIN STIMUL, V5, P547, DOI 10.1016/j.brs.2011.09.004; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Leon-Dominguez U, 2015, BEHAV BRAIN RES, V292, P167, DOI 10.1016/j.bbr.2015.06.002; Leung A, 2018, MOL PAIN, V14, DOI 10.1177/1744806918810297; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Leung A, 2016, NEUROMODULATION, V19, P133, DOI 10.1111/ner.12364; Leung A, 2016, PAIN PHYSICIAN, V19, pE347; Lipton RB, 2010, LANCET NEUROL, V9, P373, DOI 10.1016/S1474-4422(10)70054-5; Lowe B, 2006, PSYCHOSOMATICS, V47, P62, DOI 10.1176/appi.psy.47.1.62; Ma MM, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0876-9; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Misra UK, 2013, J NEUROL, V260, P2793, DOI 10.1007/s00415-013-7072-2; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Paxman Eric, 2018, BMJ Case Rep, V2018, DOI 10.1136/bcr-2018-226698; Reti IM, 2015, BRAIN INJURY, V29, P789, DOI 10.3109/02699052.2015.1009168; Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003; Sacchet MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02062-y; Santosa H, 2018, ALGORITHMS, V11, DOI 10.3390/a11050073; SCHOENEN J, 1995, CEPHALALGIA, V15, P165, DOI 10.1046/j.1468-2982.1995.015003165.x; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Siddiqi SH, 2019, J NEUROTRAUM, V36, P1361, DOI 10.1089/neu.2018.5889; Stilling JM, 2019, HEADACHE, V59, P339, DOI 10.1111/head.13479; Taib S, 2018, J ECT, V34, P79, DOI 10.1097/YCT.0000000000000477; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Wu ZY, 2018, CNS NEUROSCI THER, V24, P539, DOI 10.1111/cns.12811; Yang Q, 2017, HUM BRAIN MAPP, V38, P1815, DOI 10.1002/hbm.23484; 2005, BRAIN, V128, P1964, DOI DOI 10.1093/BRAIN/AWH608	58	4	4	2	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 8	2019	10								476	10.3389/fneur.2019.00476			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HX4EC	WOS:000467346400001	31139136	Green Published, gold			2022-02-06	
J	Chitturi, J; Li, Y; Santhakumar, V; Kannurpatti, SS				Chitturi, Jyothsna; Li, Ying; Santhakumar, Vijayalakshmi; Kannurpatti, Sridhar S.			Consolidated Biochemical Profile of Subacute Stage Traumatic Brain Injury in Early Development	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; mitochondria; metabolomics; glycolysis; lipid metabolism; amino acid metabolism; pediatric; citric acid cycle	PENTOSE-PHOSPHATE PATHWAY; GLUCOSE-METABOLISM; CEREBRAL PERFUSION; FATTY-ACIDS; INHIBITION; MATURATION; HYPOXIA; ENERGY; PATHOPHYSIOLOGY; NEUROPROTECTION	Traumatic brain injury (TBI) in general has varied neuropathological consequences depending upon the intensity and biomechanics of the injury. Furthermore, in pediatric TBI, intrinsic developmental changes add further complexity, necessitating a biochemical dimension for improved TBI characterization. In our earlier study investigating the subacute stage TBI metabolome (72 h post-injury) in a developmental rat model, significant ipsilateral brain biochemical changes occurred across 25 metabolite sets as determined by metabolite set enrichment analysis (MSEA). The broad metabolic perturbation was accompanied by behavioral deficits and neuronal loss across the ipsilateral hemisphere containing the injury epicenter. In order to obtain a consolidated biochemical profile of the TBI assessment, a subgrouping of the 190 identified brain metabolites was performed. Metabolites were divided into seven major subgroups: oxidative energy/mitochondrial, glycolysis/pentose phosphate pathway, fatty acid, amino acid, neurotransmitters/neuromodulators, one-carbon/folate and other metabolites. Subgroups were based on the chemical nature and association with critically altered biochemical pathways after TBI as obtained from our earlier untargeted analysis. Each metabolite subgroup extracted from the ipsilateral sham and TBI brains were modeled using multivariate partial least square discriminant analysis (PLS-DA) with the model accuracy used as a measurable index of TBI neurochemical impact. Volcano plots of each subgroup, corrected for multiple comparisons, determined the TBI neurochemical specificity. The results provide a ranked biochemical profile along with specificity of changes after developmental TBI, enabling a consolidated biochemical template for future classification of different TBI intensities and injury types in animal models.	[Chitturi, Jyothsna; Kannurpatti, Sridhar S.] Univ Med & Dent New Jersey, Dept Radiol, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Li, Ying; Santhakumar, Vijayalakshmi] Univ Med & Dent New Jersey, Dept Pharmacol Physiol & Neurosci, Rutgers Biomed & Hlth Sci, Newark, NJ USA; [Santhakumar, Vijayalakshmi] Univ Calif Riverside, Dept Mol Cell & Syst Biol, Riverside, CA 92521 USA		Kannurpatti, SS (corresponding author), Univ Med & Dent New Jersey, Dept Radiol, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA.	kannursr@njms.rutgers.edu	Chitturi, Jyothsna/AAR-3986-2020	Santhakumar, Vijayalakshmi/0000-0001-6278-4187	New Jersey Commission for Brain injury research [CBIR15IRG010]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097750]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097750] Funding Source: NIH RePORTER	This study was supported by funding from the New Jersey Commission for Brain injury research (CBIR15IRG010; SK) and National Institutes of Health (R01NS097750; VS). Sample preparation and the LC/MS measurements were performed at the Proteomics and Metabolomics Core Facility at Weill Cornell Medicine, NY.	Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; Brain Injury Association of America, 2014, BRAIN INJURY IN CHIL; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; CHIRON C, 1992, J NUCL MED, V33, P696; Chitturi J, 2019, J NEUROTRAUM, V36, P1264, DOI 10.1089/neu.2018.6100; Chitturi J, 2018, NEUROCHEM INT, V120, P75, DOI 10.1016/j.neuint.2018.08.003; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Coppede F, 2010, CURR GENOMICS, V11, P246, DOI 10.2174/138920210791233090; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Ferreira GC, 2017, NEUROCHEM RES, V42, P1661, DOI 10.1007/s11064-017-2288-7; GARLAND PB, 1963, NATURE, V200, P169, DOI 10.1038/200169a0; Goncalves MD, 2018, P NATL ACAD SCI USA, V115, pE743, DOI 10.1073/pnas.1714703115; Hales PW, 2014, J CEREBR BLOOD F MET, V34, P776, DOI 10.1038/jcbfm.2014.17; Hwang IK, 2007, EXP NEUROL, V206, P114, DOI 10.1016/j.expneurol.2007.04.005; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kennedy DO, 2016, NUTRIENTS, V8, DOI [10.1002/HUP.2236, 10.3390/nu8020068]; KIMURA S, 1990, BRAIN DEV-JPN, V12, P436, DOI 10.1016/S0387-7604(12)80079-9; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; LABARTHE DR, 2009, AM J PREV MED S, V37, pS8; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Ma X., 2019, MOL NEUROBIOL; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; Murugan M, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00019; Parent M, 2019, J NEUROTRAUM, V36, P601, DOI 10.1089/neu.2018.5741; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Prins ML, 2017, CHILD NERV SYST, V33, P1711, DOI 10.1007/s00381-017-3518-7; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; RIBELMADSEN A, 2016, PHYSIOL REP, V4; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Sanders Lisa M, 2007, Nutr Today, V42, P181, DOI 10.1097/01.NT.0000286155.55343.fa; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Schonfeld P, 2013, J CEREBR BLOOD F MET, V33, P1493, DOI 10.1038/jcbfm.2013.128; Schuck PF, 2015, AGING DIS, V6, P390, DOI 10.14336/AD.2015.0827; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Tang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096944; Thaipisuttikul Papan, 2012, Clin Pract (Lond), V9, P199; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Winter JD, 2011, PEDIATR RES, V69, P418, DOI 10.1203/PDR.0b013e3182110f7e; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	53	4	4	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 3	2019	13								431	10.3389/fnins.2019.00431			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HX4GC	WOS:000467352100003	31130841	Green Published, gold			2022-02-06	
J	Fadl, SA; Sandstrom, CK				Fadl, Shaimaa A.; Sandstrom, Claire K.			Pattern Recognition: A Mechanism-based Approach to Injury Detection after Motor Vehicle Collisions	RADIOGRAPHICS			English	Article; Proceedings Paper	103rd Scientific Assembly and Annual Meeting of the Radiological-Society-of-North-America (RSNA)	NOV 26-DEC 01, 2017	Chicago, IL	Radiol Soc N Amer			TRAUMATIC LUMBAR HERNIA; SEAT-BELT SIGN; LONG-TERM; THORACOLUMBAR SPINE; IMAGING EVALUATION; THORACIC INJURY; BLUNT RUPTURE; CAR OCCUPANTS; AORTIC INJURY; SIDE IMPACT	Motor vehicle collisions cause substantial mortality, morbidity, and expense worldwide. Certain types of injuries are more likely to result from frontal versus side-impact collisions, and knowledge of these specific patterns and why they occur aids in accurate and efficient diagnosis of traumatic injuries. Although the proper use of seat belts decreases crash-related mortality during frontal impact, certain injury patterns to the torso are directly attributed to restraint use. The spectrum of seat belt-related injuries ranges from mild skin and soft-tissue contusions to traumatic bowel injuries and unstable spine injuries that require surgery. Impact with the steering wheel or windshield during a frontal crash can cause characteristic injuries to the head, neck, torso, and distal upper extremity. Steering wheel deformity is an independent predictor of serious thoracic and abdominal injury among front-seat passengers. Impact of a flexed knee with the dashboard during a frontal collision can cause knee, thigh, and hip injuries. Distal lower extremity injuries are encountered frequently when the floorboard is driven into the foot. Lateral impact crashes often result in traumatic brain, thoracic, abdominal, and pelvic injuries, which are more often fatal to occupants on the side of the impact. The specific mechanism-based injury patterns are reviewed to establish a structured systematic search pattern that enables the radiologist to identify traumatic injuries with greater accuracy and speed, thereby improving the care of patients who experience acute trauma. (C) RSNA, 2019	[Fadl, Shaimaa A.; Sandstrom, Claire K.] Univ Washington, Med Ctr, Dept Radiol, Harborview Med Ctr, Box 359728,325 Ninth Ave, Seattle, WA 98104 USA		Sandstrom, CK (corresponding author), Univ Washington, Med Ctr, Dept Radiol, Harborview Med Ctr, Box 359728,325 Ninth Ave, Seattle, WA 98104 USA.	cks13@uw.edu		Fadl, Shaimaa/0000-0001-9553-7641			Abbas AK, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-18; Abu-Zidan FM, 2015, INJURY, V46, P136, DOI 10.1016/j.injury.2014.10.066; Acierno S, 2004, ACCIDENT ANAL PREV, V36, P761, DOI 10.1016/j.aap.2003.07.001; ARAJARVI E, 1989, J TRAUMA, V29, P37; ARNDT RD, 1975, J TRAUMA, V15, P600, DOI 10.1097/00005373-197507000-00007; Atweh NA, 2004, J TRAUMA, V56, P516; Augenstein J, 2000, Annu Proc Assoc Adv Automot Med, V44, P57; Becker M, 2014, EUR J RADIOL, V83, P142, DOI 10.1016/j.ejrad.2013.10.021; Bedard M, 2002, ACCIDENT ANAL PREV, V34, P717, DOI 10.1016/S0001-4575(01)00072-0; Benirschke SK, 2012, J BONE JOINT SURG AM, V94A, P1326, DOI 10.2106/JBJS.L00413; Bernstein MP, 2006, AM J ROENTGENOL, V187, P859, DOI 10.2214/AJR.05.0145; Bertrand S, 2008, TRAFFIC INJ PREV, V9, P153, DOI 10.1080/15389580701775777; Biswas Seema, 2014, J Emerg Trauma Shock, V7, P295, DOI 10.4103/0974-2700.142764; Burt BM, 2004, J TRAUMA, V57, P1361, DOI 10.1097/01.TA.0000145084.25342.9D; CANALE ST, 1978, J BONE JOINT SURG AM, V60, P143, DOI 10.2106/00004623-197860020-00001; Chen R, 2014, J TRAUMA ACUTE CARE, V76, P1441, DOI 10.1097/TA.0000000000000222; Chokshi FH, 2011, AM J ROENTGENOL, V196, pW309, DOI 10.2214/AJR.10.4548; Creasy JD, 1997, RADIOGRAPHICS, V17, P27, DOI 10.1148/radiographics.17.1.9017797; Cummins JS, 2008, BULL HOSP JT DIS, V66, P290; Dale JD, 2013, AM J ROENTGENOL, V201, P1087, DOI 10.2214/AJR.12.9918; Danelson Kerry A, 2011, Ann Adv Automot Med, V55, P217; de Mestral C, 2012, J VASC SURG, V56, P656, DOI 10.1016/j.jvs.2012.02.027; Desai NK, 2014, AM J NEURORADIOL, V35, P1836, DOI 10.3174/ajnr.A3916; Dhillon RS, 2013, AM SURGEON, V79, P1001; DISCHINGER PC, 1993, J TRAUMA, V35, P454, DOI 10.1097/00005373-199309000-00020; DISCHINGER PC, 1995, ACCIDENT ANAL PREV, V27, P601, DOI 10.1016/0001-4575(95)00002-H; DOERSCH KB, 1968, AM J SURG, V116, P831, DOI 10.1016/0002-9610(68)90451-0; ERB RE, 1995, AM J ROENTGENOL, V165, P1215, DOI 10.2214/ajr.165.5.7572506; Fortin P T, 2001, J Am Acad Orthop Surg, V9, P114; GARRETT J W, 1962, J Trauma, V2, P220, DOI 10.1097/00005373-196205000-00002; GERTZBEIN SD, 1994, SPINE, V19, P626, DOI 10.1097/00007632-199403000-00022; Gharib A, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781450; Gross JA, 2015, RADIOL CLIN N AM, V53, P773, DOI 10.1016/j.rcl.2015.02.005; Groves CJ, 2005, RADIOLOGY, V236, P601, DOI 10.1148/radiol.2362040281; GUERTLER AT, 1988, ANN EMERG MED, V17, P838, DOI 10.1016/S0196-0644(88)80566-3; HAWKINS LG, 1970, J BONE JOINT SURG AM, VA 52, P991, DOI 10.2106/00004623-197052050-00013; HAYES CW, 1991, RADIOGRAPHICS, V11, P23, DOI 10.1148/radiographics.11.1.1996397; Hazarika S, 2007, TRAUMA, V9, P145, DOI 10.1177/1460408607084179; HERRON LD, 1987, SPINE, V12, P398, DOI 10.1097/00007632-198705000-00019; HILLS MW, 1993, J TRAUMA, V35, P55, DOI 10.1097/00005373-199307000-00009; Johnson MC, 2017, AM J SURG, V214, P1175, DOI 10.1016/j.amjsurg.2017.08.041; KEARNEY PA, 1989, ANN EMERG MED, V18, P1326, DOI 10.1016/S0196-0644(89)80270-7; Killeen DL, 2000, AM J ROENTGENOL, V174, P1413, DOI 10.2214/ajr.174.5.1741413; Laberge-Nadeau C, 2009, J SAFETY RES, V40, P427, DOI 10.1016/j.jsr.2009.08.005; Lalancette M, 2006, ANN VASC SURG, V20, P681, DOI 10.1007/s10016-006-9058-3; Linnau KF, 2007, J ORTHOP TRAUMA, V21, P375, DOI 10.1097/BOT.0b013e31809d5983; Lolli V, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150849; Maak TG, 2007, J TRAUMA, V63, P1296, DOI 10.1097/01.ta.0000241237.72420.51; Mandell JC, 2017, RADIOGRAPHICS, V37, P2181, DOI 10.1148/rg.2017170012; Markhardt BK, 2009, RADIOGRAPHICS, V29, P585, DOI 10.1148/rg.292085078; Martin PG, 2000, ACCIDENT ANAL PREV, V32, P541, DOI 10.1016/S0001-4575(99)00076-7; Matlock KA, 2013, AM SURGEON, V79, P589; MAY AK, 1995, J TRAUMA, V38, P587, DOI 10.1097/00005373-199504000-00021; McCartt Anne T, 2007, Traffic Inj Prev, V8, P162, DOI 10.1080/15389580601173875; Melenevsky Y, 2015, RADIOGRAPHICS, V35, P765, DOI 10.1148/rg.2015140156; Minard G, 2004, J TRAUMA, V57, P777; MOAR JJ, 1987, FORENSIC SCI INT, V34, P227, DOI 10.1016/0379-0738(87)90036-3; Munera F, 2012, RADIOLOGY, V263, P645, DOI 10.1148/radiol.12110526; Newgard CD, 2005, ACCIDENT ANAL PREV, V37, P668, DOI 10.1016/j.aap.2005.03.008; Newgard CD, 2005, ANN EMERG MED, V45, P43, DOI 10.1016/j.annemergmed.2004.09.011; NEWMAN KD, 1990, J TRAUMA, V30, P1133, DOI 10.1097/00005373-199009000-00009; Ng ES, 2013, BMJ CASE REP, V2013; Nikolic S, 2006, AM J FOREN MED PATH, V27, P292, DOI 10.1097/01.paf.0000248756.73053.82; Oliver A, 2005, INJURY, V36, P222, DOI 10.1016/j.injury.2004.04.003; Petrone P, 2017, CURR PROB SURG, V54, P11, DOI 10.1067/j.cpsurg.2016.11.001; Pickrell T. M., 812351 DOT HS NAT HI; Rice D, 2002, ANN THORAC SURG, V73, P1950, DOI 10.1016/S0003-4975(01)03506-8; Richter M, 2001, J ORTHOP TRAUMA, V15, P287, DOI 10.1097/00005131-200105000-00009; Rodriguez C, 2002, J TRAUMA, V53, P79, DOI 10.1097/00005373-200207000-00016; Rozycki GS, 2002, J TRAUMA, V52, P618, DOI 10.1097/00005373-200204000-00002; Rutman AM, 2018, RADIOGRAPHICS, V38, P542, DOI 10.1148/rg.2018170140; Saboo SS, 2014, EMERG RADIOL, V21, P325, DOI 10.1007/s10140-013-1193-x; Sanders TG, 2000, RADIOGRAPHICS, V20, pS135, DOI 10.1148/radiographics.20.suppl_1.g00oc19s135; SANTAVIRTA S, 1992, J TRAUMA, V32, P275, DOI 10.1097/00005373-199203000-00001; Sgarlato A, 2010, J FORENSIC SCI, V55, P527, DOI 10.1111/j.1556-4029.2009.01270.x; Shalhub S, 2014, J TRAUMA ACUTE CARE, V77, P879, DOI 10.1097/TA.0000000000000353; Shearer Damon, 2010, J Spec Oper Med, V10, P43; Siddiqui NA, 2014, RADIOGRAPHICS, V34, P514, DOI 10.1148/rg.342125215; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; Siegel JH, 2001, J TRAUMA, V51, P975, DOI 10.1097/00005373-200111000-00024; Smith B R, 2005, Traffic Inj Prev, V6, P156, DOI 10.1080/15389580590931635; Steenburg SD, 2008, RADIOLOGY, V248, P748, DOI 10.1148/radiol.2483071416; Stigson H, 2015, TRAFFIC INJ PREV, V16, pS133, DOI 10.1080/15389588.2015.1014999; Tencer Allan F, 2007, Traffic Inj Prev, V8, P101, DOI 10.1080/15389580600944250; Weaver AA, 2013, ACCIDENT ANAL PREV, V50, P223, DOI 10.1016/j.aap.2012.04.013; Yoganandan N, 2007, J BIOMECH, V40, P227, DOI 10.1016/j.jbiomech.2006.01.002; Yoganandan N, 2007, ACCIDENT ANAL PREV, V39, P22, DOI 10.1016/j.aap.2006.05.014; Zhou S-W, 2010, OPEN MECH ENG J, V4, P29; 2004, J TRAUMA, V56, P512, DOI DOI 10.1097/01.TA.0000114272.37352.21; 1993, J TRAUMA, V35, P454; 2002, J TRAUMA, V52, P618; 2004, J TRAUMA, V57, P760, DOI DOI 10.1097/01.TA.0000174502.50248.C4; 1990, J TRAUMA, V30, P1133; 1993, J TRAUMA, V34, P736	94	4	4	0	12	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0271-5333			RADIOGRAPHICS	Radiographics	MAY-JUN	2019	39	3					857	+		10.1148/rg.2019180063			20	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Radiology, Nuclear Medicine & Medical Imaging	HW8XU	WOS:000466975600021	31059399	Bronze			2022-02-06	
J	Lystad, RP; Cameron, CM; Mitchell, RJ				Lystad, Reidar P.; Cameron, Cate M.; Mitchell, Rebecca J.			Excess Mortality Among Adults Hospitalized With Traumatic Brain Injury in Australia: A Population-Based Matched Cohort Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						comorbidity; data linkage; mortality; survival; traumatic brain injury	AFTER-DISCHARGE; RISK	Objective: To quantify and describe excess mortality attributable to traumatic brain injury (TBI) during the 12 months after hospitalization. Design: Population-based matched cohort study using linked hospital and mortality data. Setting: Australia. Participants: Individuals 18 years and older who were hospitalized with a principal diagnosis of TBI in 2009 (n = 6929) and matched noninjured individuals randomly selected from the electoral roll (n = 6929). Main Measures: Survival distributions were compared using a Kaplan-Meier plot with a log-rank test. Mortality rate ratios (MRRs) were computed using Cox proportional hazard regression with and without controlling for demographic characteristics and preexisting health status. Results: Individuals with TBI experienced significantly worse survival during the 12 months after hospitalization (chi(2) = 640.9, df = 1, P < .001), and were more than 7.5 times more likely to die compared with their noninjured counterparts (adjusted MRR, 7.76; 95% confidence interval, 6.07-9.93). TBI was likely to be a contributory factor in 87% of deaths in the TBI cohort. Excess mortality was higher among males, younger age groups, and those with more severe TBI. Conclusion: Excess mortality is high among individuals hospitalized with TBI and most deaths are attributable to the TBI. Increased primary and secondary preventive efforts are warranted to reduce the mortality burden of TBI.	[Lystad, Reidar P.; Mitchell, Rebecca J.] Macquarie Univ, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia; [Cameron, Cate M.] Queensland Univ Technol, Jamieson Trauma Inst, Royal Brisbane & Womens Hosp, Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia; [Cameron, Cate M.] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia		Lystad, RP (corresponding author), Macquarie Univ, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.	reidar.lystad@mq.edu.au	Mitchell, Rebecca/Z-5476-2019; Lystad, Reidar P./D-1611-2013	Mitchell, Rebecca/0000-0003-1939-1761; Lystad, Reidar P./0000-0003-0506-0902	Population Health Research Network; Australian Government National Collaborative Research Infrastructure StrategyAustralian GovernmentDepartment of Industry, Innovation and Science; New South Wales Ministry of Health	The research was supported by the Population Health Research Network with funding from the Australian Government National Collaborative Research Infrastructure Strategy and the Western Australian Minister for Science and Innovation. R.J.M. was supported by a career fellowship from the New South Wales Ministry of Health under the New South Wales Health Early-Mid Career Fellowships Scheme. The funding sources had no role in study design; acquisition, analysis, or interpretation of data; or preparation of manuscript.	Access Economics , 2009, EC COST SPIN CORD IN; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Australian Bureau of Statistics, 2010, 3101 0 AUSTR DEM STA; Australian Bureau of Statistics, 2013, 1270 0 55 005 AUSTR, V5; Australian Institute of Health and Welfare, 2015, ADM PAT CAR 2013 14; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dayal S., 2008, MAPPING INJURY SEVER; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Miller TR, 2001, ALCOHOL CLIN EXP RES, V25, P54, DOI 10.1111/j.1530-0277.2001.tb02127.x; Mitchell RJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013266; Mitchell RJ, 2014, AUST NZ J PUBL HEAL, V38, P275, DOI 10.1111/1753-6405.12234; National Centre for Classification in Health, 2006, ICD10AM NAT CTR CLAS; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; Peck KA, 2014, J TRAUMA ACUTE CARE, V77, P978, DOI 10.1097/TA.0000000000000356; Preen DB, 2006, J CLIN EPIDEMIOL, V59, P940, DOI 10.1016/j.jclinepi.2005.12.013; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Stephenson S, 2003, DIAGNOSIS BASED INJU; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Wan JJ, 2006, J TRAUMA, V61, P1299, DOI 10.1097/01.ta.0000240460.35245.1a; Woodward M., 2005, EPIDEMIOLOGY STUDY D	31	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2019	34	3			SI		E1	E9		10.1097/HTR.0000000000000445			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IH1KG	WOS:000474249100001	30418322				2022-02-06	
J	Miarka, B; Dal Bello, F; Brito, CJ; Del Vecchio, FB; Amtmann, J; Chamari, K				Miarka, Bianca; Dal Bello, Fabio; Brito, Ciro J.; Del Vecchio, Fabricio B.; Amtmann, John; Chamari, Karim			A 12-Year Cohort Study of Doc-Stoppage in Professional Mixed Martial Arts	INTERNATIONAL JOURNAL OF SPORTS PHYSIOLOGY AND PERFORMANCE			English	Article						epidemiology; trauma; time and motion studies; risk factors; concussion; rehabilitation	TIME-MOTION ANALYSIS; INJURIES; COMPETITION; TAEKWONDO; EPIDEMIOLOGY; SUGGESTIONS; RESPONSES; WORKLOAD; ROUNDS	Purposes: To determine actions during bouts that generate serious enough injury to stop the bout; verifying the injury incidence, types, and prevalence of doctor stoppages (doc-stoppage); and identify potential risk factors by analyzing technical-tactical profiles for injury in sanctioned mixed martial arts bouts taking place over a 12-y period. Methods: This research analyzed 440 paired mixed martial arts matches separated by doc-stoppage (n = 220) and no doc-stoppage (n = 220) from 2002 to 2014. Technical knockouts for doc-stoppage were diagnosed and managed by attending ringside doctors, and the time-motion variables were categorized into total combat time separated by low-or high-intensity activities per round, stand-up, or groundwork actions, P =.05. Results: The main cause of injuries in doc-stoppage situations was due to facial injuries (>90%), with 87.1% occurring after striking actions during the second round. Lacerations were the leading type of injury, which occurred with 80% frequency. The results showed differences between doc-stoppage and no doc-stoppage for standing combat with low-intensity actions (130.6 [8.5] s vs 83.3 [6.9] s for first round; 115.7 [10.5] s vs 100.1 [9.6] s for second round, and 121.5 [19.5] s vs 106.3 [11.7] s for third round) and total strike attempts (34.5, 23.0-51.8 vs 25.0, 12.0-40.8); in standing combat, head strike attempts (21, 10-33 vs 11, 4-21) and body strikes (2.5, 1.0-5.8 vs 1.0-2), and in groundwork combat, head strikes landed (0.0-3.0 vs 0.0-5.0). Conclusions: This research showed higher values of strike attempts with 2 main orientations, namely the head (on the ground and in stand-up actions) and body (in stand-up actions), and may provide important information regarding the technical knockout and when it can be called by officials supervising mixed martial arts bouts.	[Miarka, Bianca] Univ Fed Rio de Janeiro, Sch Phys Educ & Sport, Dept Fights, Rio De Janeiro, Brazil; [Dal Bello, Fabio] Univ Santo Tomas, Phys Act & Sports Sci Master Program, Santiago, Chile; [Del Vecchio, Fabricio B.] Univ Fed Pelotas, Phys Educ Sch, Pelotas, Brazil; [Brito, Ciro J.] Univ Fed Juiz de Fora, Dept Phys Educ, Governador Valadares, Brazil; [Amtmann, John] Univ Montana, Safety Hlth & Ind Hyg Dept, Montana Tech, Butte, MT USA; [Chamari, Karim] Qatar Orthoped & Sports Med Hosp, Aspetar, Athlete Hlth & Performance Res Ctr, Doha, Qatar		Miarka, B (corresponding author), Univ Fed Rio de Janeiro, Sch Phys Educ & Sport, Dept Fights, Rio De Janeiro, Brazil.	miarkasport@hotmail.com	CHAMARI, Karim/AAJ-7938-2021; Brito, Ciro Jose/ABH-2245-2020; Brito, Ciro/AAC-9104-2019; Boscolo, Fabricio/AAU-9456-2020	CHAMARI, Karim/0000-0001-9178-7678; Brito, Ciro Jose/0000-0002-9678-1977; Boscolo, Fabricio/0000-0003-3771-9660	Agency for Improvement of Higher Education Personnel (CAPES); National Council of Scientific and Technologic Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [234243/2014-7]; Brazilian scholarship program Ciencia sem Fronteiras [234243/2014-7]	This research was supported by the Agency for Improvement of Higher Education Personnel (CAPES: www.capes.gov.br) for postdoctoral scholarship PNPD for B.M., who thanks Fightmetric Team. It was also supported by the National Council of Scientific and Technologic Development (CNPq: www.cnpq.br) for postdoctoral scholarship 234243/2014-7 for C.J.B. CAPES PNPD and Brazilian scholarship program Ciencia sem Fronteiras (grant #234243/2014-7).	Amtmann JA, 2008, J STRENGTH COND RES, V22, P645, DOI 10.1519/JSC.0b013e318166018e; Bledsoe GH, 2006, J SPORT SCI MED, V5, P136; Bromley SJ, 2018, BRIT J SPORT MED, V52, P8, DOI 10.1136/bjsports-2016-097313; Chaabene H, 2014, INT J SPORT PHYSIOL, V9, P302, DOI [10.1123/IJSPP.2012-0353, 10.1123/ijspp.2012-0353]; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Drew MK, 2016, BRIT J SPORT MED, V50, P1306, DOI 10.1136/bjsports-2015-095871; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; James LP, 2016, SPORTS MED, V46, P1525, DOI 10.1007/s40279-016-0493-1; Jensen AR, 2017, SPORTS HEALTH, V9, P64, DOI 10.1177/1941738116664860; Karpman S, 2016, CLIN J SPORT MED, V26, P332, DOI 10.1097/JSM.0000000000000235; Kirk C, 2015, INT J PERF ANAL SPOR, V15, P359, DOI 10.1080/24748668.2015.11868798; Lawrence DW, 2014, CLIN J SPORT MED, V24, P397, DOI 10.1097/JSM.0000000000000047; Lystad RP, 2015, BIOL SPORT, V32, P213, DOI 10.5604/20831862.1150303; Lystad RP, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115612416; Lystad RP, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518492; Lystad RP, 2015, AUSTRALAS EPIDEMIOL, V22, P14; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; Menger R, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15615; Miarka B, 2018, J STRENGTH COND RES, V32, P534, DOI 10.1519/JSC.0000000000001804; Miarka B, 2017, INT J PERF ANAL SPOR, V17, P510, DOI 10.1080/24748668.2017.1360103; Miarka B, 2016, INT J PERF ANAL SPOR, V16, P539, DOI 10.1080/24748668.2016.11868907; Miarka B, 2016, J STRENGTH COND RES, V30, P1975, DOI 10.1519/JSC.0000000000001287; Miarka B, 2015, INT J PERF ANAL SPOR, V15, P1189, DOI 10.1080/24748668.2015.11868861; Ngai KM, 2008, BRIT J SPORT MED, V42, P686, DOI 10.1136/bjsm.2007.044891; O'Sullivan DM, 2016, EUR J SPORT SCI, V16, P1219, DOI 10.1080/17461391.2016.1161073; Pieter W, 2010, SCI SPORT, V25, P32, DOI 10.1016/j.scispo.2009.07.001; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; Pieter Willy, 2010, Asian J Sports Med, V1, P117; Pocecco E, 2013, BRIT J SPORT MED, V47, P1139, DOI 10.1136/bjsports-2013-092886; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448	32	4	5	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1555-0265	1555-0273		INT J SPORT PHYSIOL	Int. J. Sport Physiol. Perform.	MAY	2019	14	5					606	611		10.1123/ijspp.2017-0131			6	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	HV7MY	WOS:000466166300009	30427237				2022-02-06	
J	Puffer, RC; Yue, JK; Mesley, M; Billigen, JB; Sharpless, J; Fetzick, AL; Puccio, AM; Diaz-Arrastia, R; Okonkwo, DO				Puffer, Ross C.; Yue, John K.; Mesley, Matthew; Billigen, Julia B.; Sharpless, Jane; Fetzick, Anita L.; Puccio, Ava M.; Diaz-Arrastia, Ramon; Okonkwo, David O.			Recovery Trajectories and Long-Term Outcomes in Traumatic Brain Injury: A Secondary Analysis of the Phase 3 Citicoline Brain Injury Treatment Clinical Trial	WORLD NEUROSURGERY			English	Article						Clinical; Outcomes; Recovery; TBI; Trajectory; Trial	TEMPORAL PROFILE; MORTALITY; SCALE	BACKGROUND: Prospects for recovery after traumatic brain injury (TBI) are often underestimated, potentially leading to withdrawal of care in the comatose TBI patient who may ultimately have a favorable outcome with aggressive care. Outcomes and trajectories of recovery in a large series of patients with TBI were evaluated at 30, 90, and 180 days postinjury. METHODS: A secondary analysis of the phase 3 Citicoline Brain Injury Treatment (COBRIT) trial was performed analyzing recovery trajectories and long-term outcomes at 30, 90, and 180 days postinjury. A Glasgow Outcome Scale-Extended (GOS-E) score of 5 or higher was considered favorable. Pearson chi(2) analysis was used, and a P value of 0.05 was considered significant. A locally weighted, polynomial regression model was used to model recovery trajectories in a nonlinear fashion. RESULTS: Subjects with TBI in the COBRIT trial had high rates of favorable outcome (57% of severe TBI, 86% of moderate TBI, and 93% of complicated mild TBI) at 6-month follow-up. These favorable outcomes often converted from high rates of unfavorable outcome at initial 1-month follow-up (85% of severe TBI, 57% of moderate TBI, and 21% of complicated mild TBI). Recovery trajectories had not plateaued at 6 months, suggesting that further improvement occurs beyond 6 months postinjury. CONCLUSIONS: In this secondary analysis of the COBRIT trial, most patients had favorable outcomes by the GOS-E at 6 months postinjury in all complicated mild and moderate TBI groups, with over half of patients with severe TBI achieving a favorable outcome as well. Of subjects in a vegetative state (GOS-E score 2) at 1 month postinjury, 18% improved to a favorable outcome by 6 months postinjury. There was substantial improvement in all groups from 1 to 6 months, and this improvement may continue beyond 6 months. Clinical trials in TBI should consider recovery curves with repeated measures to assess outcomes because arbitrary single-moment outcome determination likely underestimates treatment effect in TBI care.	[Puffer, Ross C.] Mayo Clin, Dept Neurosurg, Rochester, MN USA; [Yue, John K.; Mesley, Matthew; Billigen, Julia B.; Sharpless, Jane; Fetzick, Anita L.; Puccio, Ava M.; Okonkwo, David O.] UPMC, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Okonkwo, DO (corresponding author), UPMC, Dept Neurosurg, Pittsburgh, PA 15213 USA.	okonkwodo@upmc.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722			CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Dean D, 2015, ACAD EMERG MED, V22, P54, DOI 10.1111/acem.12555; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lilley EJ, 2016, J TRAUMA ACUTE CARE, V80, P998, DOI 10.1097/TA.0000000000001028; Plaisier BR, 2002, AM SURGEON, V68, P159; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vedantam A, 2018, J NEUROSURG, V129, P234, DOI 10.3171/2017.3.JNS162720; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	13	4	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2019	125						E909	E915		10.1016/j.wneu.2019.01.207			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW2CX	WOS:000466491700112	30763755				2022-02-06	
J	Rekand, T; Biering-Sorensen, B; He, J; Vilholm, OJ; Christensen, PB; Ulfarsson, T; Belusa, R; Strom, T; Myrenfors, P; Maisonobe, P; Dalager, T				Rekand, Tiina; Biering-Sorensen, Bo; He, Jun; Vilholm, Ole Jakob; Christensen, Peter Brogger; Ulfarsson, Trandur; Belusa, Roger; Strom, Torbjorn; Myrenfors, Peter; Maisonobe, Pascal; Dalager, Torben			Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity	BMJ OPEN			English	Article							EFFICACY; SAFETY; ABOBOTULINUMTOXINA; LOCALIZATION; INNERVATION; NEUROTOXIN; DYSTONIA; PLACEBO; STROKE; PAIN	Objectives The therapeutic effects of botulinum neurotoxin (BoNT) are well documented in upper limb spasticity. However, several factors may influence treatment efficacy, including targeting of neuromuscular junctions (NMJs). We examined whether NMJ-targeted BoNT injections were non-inferior, in terms of efficacy, to current injection practices. Design Open-label prospective evaluator-blinded study. Setting Conducted across 20 medical centres in Denmark, Finland, Norway and Sweden (24 September 2012 to 11 March 2015). Participants Aged. 18 years with upper limb spasticity (Modified Ashworth Scale [MAS] score of 2 or 3) following stroke or traumatic brain injury, had received >= 2 consecutive BoNT-A treatment cycles (the latest of which was abobotulinumtoxinA [aboBoNT-A]) and needed BoNT-A retreatment (same modality as previous cycle). Patients requiring aboBoNT-A doses >800units were excluded. In total, 88 patients were randomised (intention-to-treat [ITT] population), most were male (n=58/88, 65.9%) and 54/88 (61.4%) completed the study (per protocol [PP] population). Interventions Randomisation (1: 1) to receive a single dose of aboBoNT-A (<= 800 U) according to either current clinical practice (300 U/mL) or as an NMJ-targeted injection (100 U/mL). Primary outcome measure Proportion of patients with a >= 1 level reduction from baseline in MAS score at week 4 post-injection (responders). Results In the ITT population, the proportion of responders at elbow flexors was 72.7% in the current practice group and 56.8% in the NMJ-targeted group (adjusted difference -0.1673 [95% CIs: -0.3630 to 0.0284]; p=0.0986). Similar results were observed in the PP population (69.0% vs 68.0%, respectively, adjusted difference 0.0707 [-0.1948 to 0.3362]; p=0.6052). Conclusions Owing to the limited number of participants, non-inferiority of NMJ-targeted injections could not be determined. However, there was no statistical difference between groups. Larger studies are needed confirm whether the two techniques offer comparable efficacy.	[Rekand, Tiina] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Biering-Sorensen, Bo] Rigshosp Glostrup, Dept Neurol, Spast Clin, Glostrup, Denmark; [He, Jun] Univ Copenhagen Hosp, Dept Neurol, Roskilde Sygehus, Denmark; [Vilholm, Ole Jakob] Vejle Hosp, Dept Neurol, Vejle, Denmark; [Christensen, Peter Brogger] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark; [Ulfarsson, Trandur] Sahlgrens Univ Hosp, Dept Rehabil Med, Gothenburg, Sweden; [Belusa, Roger; Strom, Torbjorn; Myrenfors, Peter; Maisonobe, Pascal] Inst Produits Synthese AB, Med Dept, Stockholm, Sweden; [Maisonobe, Pascal] Ipsen, Ipsen Innovat, Les Ulis, France; [Dalager, Torben] Bispjeberg Hosp, Clin Dystonia, Copenhagen, Denmark		Rekand, T (corresponding author), Haukeland Hosp, Dept Neurol, Bergen, Norway.	tiina.rekand@helse-bergen.no	Rekand, Tiina/A-6201-2008	Rekand, Tiina/0000-0002-2506-9501; Strom, Torbjorn/0000-0002-1692-6508; Christensen, Peter Broegger/0000-0002-0046-5727	IpsenIpsen	The study was sponsored by Ipsen.	Amirali Asif, 2007, J Clin Neuromuscul Dis, V9, P306; AQUILONIUS SM, 1984, MUSCLE NERVE, V7, P287, DOI 10.1002/mus.880070406; Ashford S, 2013, PHYSIOTHER RES INT, V18, P178, DOI 10.1002/pri.1554; Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402; Chan AK, 2017, CLIN REHABIL, V31, P713, DOI 10.1177/0269215516655589; Childers MK, 1998, MUSCLE NERVE, V21, P653, DOI 10.1002/(SICI)1097-4598(199805)21:5<653::AID-MUS15>3.0.CO;2-W; Demetrios M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009689.pub2; Esquenazi A, 2004, AM J PHYS MED REHAB, V83, pS19, DOI 10.1097/01.PHM.0000141127.63160.3E; Gracies JM, 2018, MUSCLE NERVE, V57, P245, DOI 10.1002/mus.25721; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2009, ARCH PHYS MED REHAB, V90, P9, DOI 10.1016/j.apmr.2008.04.030; Grigoriu AI, 2015, ARCH PHYS MED REHAB, V96, P2067, DOI 10.1016/j.apmr.2015.05.002; Guzman-Venegas RA, 2014, J ELECTROMYOGR KINES, V24, P923, DOI 10.1016/j.jelekin.2014.07.012; Hefter H, 2012, INT J REHABIL RES, V35, P227, DOI 10.1097/MRR.0b013e328353e3d4; Hoare BJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003469.pub4; Kaku M, 2016, DRUG DES DEV THER, V10, P1085, DOI 10.2147/DDDT.S80804; Kanovsky P, 2009, CLIN NEUROPHARMACOL, V32, P259, DOI 10.1097/WNF.0b013e3181b13308; Kim MW, 2005, AM J PHYS MED REHAB, V84, P680, DOI 10.1097/01.phm.0000176341.85398.a9; Lamb YN, 2016, DRUGS, V76, P1373, DOI 10.1007/s40265-016-0630-z; Lepage D, 2005, SURG RADIOL ANAT, V27, P420, DOI 10.1007/s00276-005-0012-9; Nott MT, 2014, J REHABIL MED, V46, P864, DOI 10.2340/16501977-1853; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Paracka L, 2015, J NEURAL TRANSM, V122, P1279, DOI 10.1007/s00702-015-1372-x; Parratte B, 2002, SURG RADIOL ANAT, V24, P91, DOI 10.1007/s00276-002-0022-9; Placzek R, 2010, TOXINS, V2, P2258, DOI 10.3390/toxins2092258; Rosales RL, 2012, NEUROREHAB NEURAL RE, V26, P812, DOI 10.1177/1545968311430824; Saitou K, 2000, J Hum Ergol (Tokyo), V29, P35; Santamato A, 2014, J NEUROL SCI, V347, P39, DOI 10.1016/j.jns.2014.09.016; SHAARI CM, 1993, MUSCLE NERVE, V16, P964, DOI 10.1002/mus.880160913; Simpson DM, 2016, NEUROLOGY, V86, P1818, DOI 10.1212/WNL.0000000000002560; Vicente DP, 2005, CLIN ANAT, V18, P186, DOI 10.1002/ca.20057; Wissel J, 2013, NEUROLOGY, V80, pS13, DOI 10.1212/WNL.0b013e3182762448; Wissel J, 2009, J REHABIL MED, V41, P13, DOI 10.2340/16501977-0303; Yelnik AP, 2007, J NEUROL NEUROSUR PS, V78, P845, DOI 10.1136/jnnp.2006.103341	34	4	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAY	2019	9	5							e024340	10.1136/bmjopen-2018-024340			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IC7YG	WOS:000471192800070	31061021	Green Published, gold			2022-02-06	
J	Rosenblatt, AS; Li, RS; Fortier, C; Liu, XY; Fonda, JR; Villalon, A; McGlinchey, RE; Jorge, RE				Rosenblatt, Andrew S.; Li, Ruosha; Fortier, Catherine; Liu, Xiangyu; Fonda, Jennifer R.; Villalon, Audri; McGlinchey, Regina E.; Jorge, Ricardo E.			Latent Factor Structure of PTSD Symptoms in Veterans With a History of Mild Traumatic Brain Injury and Close-Range Blast Exposure	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article						posttraumatic stress disorder; diagnostics; confirmatory factor analysis; mild traumatic brain injury; blast exposure	POSTTRAUMATIC-STRESS-DISORDER; CONFIRMATORY FACTOR-ANALYSIS; DSM-IV; SCALE; RESILIENCE; CHECKLIST; HEALTH; MODEL	Objective: Confirmatory factor analysis (CFA) has previously been employed to examine the latent factor structure of posttraumatic stress disorder (PTSD) symptoms with mixed results. A limited number of studies examined PTSD factor structure among veterans of recent military conflicts. This study examined the relationship between PTSD factor structure and the hallmark conditions of these conflicts, mild traumatic brain injury (mTBI) and close-range blast exposure (CBE). Method: The fit of previously proposed PTSD factor models was compared in a cohort of 387 combat-exposed veterans, with stratified analyses comparing factor structure models between those with a history of military-related mTBI and CBE (n = 106) and those without either of these antecedents (n = 151). CFAs were conducted using criteria from the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV; American Psychiatric Association, 1994). Results: The 4-factor emotional numbing (EN) model yielded the best fit when using a clinician-administered assessment of PTSD symptoms regardless of mTBI/CBE exposure status. However, when using a self-report measure of PTSD symptom severity, the EN model yielded best fit for those with mTBI/CBE exposure history while the 5-factor dysphoric arousal (DA) model was preferable among combat-exposed veterans with no history of mTBI/CBE exposure. Conclusions: Factors including mTBI and blast exposure and type of assessment tools must be considered when determining preferable PTSD latent factor structure models.	[Rosenblatt, Andrew S.] Univ Houston, Dept Psychol, Houston, TX 77004 USA; [Rosenblatt, Andrew S.; Villalon, Audri; Jorge, Ricardo E.] Michael E DeBakey VA Med Ctr, Translat Res Ctr TBI & Stress Disorders TRACTS, Houston, TX 77030 USA; [Li, Ruosha; Liu, Xiangyu] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Fortier, Catherine; Fonda, Jennifer R.; McGlinchey, Regina E.] Vet Affairs Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Fortier, Catherine; Fonda, Jennifer R.; McGlinchey, Regina E.] Vet Affairs Boston Healthcare Syst, GRECC, Boston, MA USA; [Fortier, Catherine; Fonda, Jennifer R.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Villalon, Audri; Jorge, Ricardo E.] Baylor Coll Med, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA		Jorge, RE (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd,Room 2B-122B 153 TBI, Houston, TX 77030 USA.	ricardo.jorge@bcm.edu	Fonda, Jennifer R./ABG-2890-2021; Fortier, Catherine/AAS-2163-2021	Fonda, Jennifer R./0000-0001-9482-2918; Fortier, Catherine/0000-0002-8953-9904	Translational Research Center for TBI and Stress Disorders (TRACTS); Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center [B9254-C]; Veterans AffairsUS Department of Veterans Affairs [I01CX001327] Funding Source: NIH RePORTER	This study was funded by Translational Research Center for TBI and Stress Disorders (TRACTS); Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center (Grant B9254-C).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; [Anonymous], 2012, AN VA HLTH CAR UT OP; Armour C, 2016, CLIN PSYCHOL REV, V44, P60, DOI 10.1016/j.cpr.2015.12.003; Biehn TL, 2012, J ANXIETY DISORD, V26, P480, DOI 10.1016/j.janxdis.2012.01.008; BLAKE DD, 1996, CLIN ADM PTSD SCAL D; Boasso AM, 2016, PSYCHOL TRAUMA-US, V8, P127, DOI 10.1037/tra0000109; Brown T.A, 2014, CONFIRMATORY FACTOR; Bryant RA, 2017, JAMA PSYCHIAT, V74, P135, DOI 10.1001/jamapsychiatry.2016.3470; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Elhai JD, 2011, J ANXIETY DISORD, V25, P340, DOI 10.1016/j.janxdis.2010.10.007; First M.B., 1996, STRUCTURED CLIN INTE; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Green P., 2004, MED SYMPTOM VALIDITY; Haag C, 2017, JAMA PSYCHIAT, V74, P649, DOI 10.1001/jamapsychiatry.2017.0788; Harrington KM, 2012, COMPR PSYCHIAT, V53, P679, DOI 10.1016/j.comppsych.2011.12.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2016, JAMA PSYCHIAT, V73, P750, DOI 10.1001/jamapsychiatry.2016.0647; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Marshall GN, 2013, CLIN PSYCHOL REV, V33, P54, DOI 10.1016/j.cpr.2012.10.004; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Palmieri PA, 2007, J ABNORM PSYCHOL, V116, P329, DOI 10.1037/0021-843X.116.2.329; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Pietrzak RH, 2015, J AFFECT DISORDERS, V174, P522, DOI 10.1016/j.jad.2014.12.007; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rhemtulla M, 2012, PSYCHOL METHODS, V17, P354, DOI 10.1037/a0029315; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Satorra A, 2010, PSYCHOMETRIKA, V75, P243, DOI 10.1007/S11336-009-9135-Y; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; U. S. Department of Defense, 2012, DEM PROF MIL COMM; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Weathers FW, 1991, PCL C FOR DSM 4; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	44	4	4	1	5	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma	MAY	2019	11	4			SI		442	450		10.1037/tra0000399			9	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	HR7ON	WOS:000463344300011	30113187	Green Accepted			2022-02-06	
J	Shelley-Tremblay, JE; Eyer, JC; Hill, BD				Shelley-Tremblay, John E.; Eyer, Joshua C.; Hill, Benjamin D.			A Laboratory Word Memory Test Analogue Differentiates Intentional Feigning from True Responding Using the P300 Event-Related Potential	BRAIN SCIENCES			English	Article						feigning; malingering; event-related potentials; clinical neuropsychology; P300	TRIAL PROTOCOL CTP; COGNITIVELY INTACT; MALINGERING TOMM; SYMPTOM VALIDITY; NORMATIVE DATA; REACTION-TIME; INFORMATION; PERFORMANCE; DECEPTION; COUNTERMEASURES	Symptom exaggeration and feigned cognitive impairment occur commonly in forensic and medicolegal evaluations. As a result, methods to detect feigned cognitive impairment are an indispensable component of neuropsychological assessments. This study reports the results of two neurophysiological experiments using a forced-choice recognition task built from the stimuli of the Word Memory Test and Medical Symptom Validity Test as well as a new linguistically informed stimulus set. Participant volunteers were instructed either to do their best or to feign cognitive impairment consistent with a mild traumatic brain injury while their brain activity was monitored using event-related potentials (ERP). Experiment 1 varied instructions across individuals, whereas Experiment 2 varied instructions within individuals. The target brain component was a positive deflection indicating stimulus recognition that occurs approximately 300 ms after exposure to a stimulus (i.e., the P300). Multimodal comparison (P300 amplitude to behavioral accuracy) allowed the detection of feigned cognitive impairment. Results indicate that, for correct responses, P300s were equivalent for the simulated malingering and good effort conditions. However, for incorrect responses, feigned impairment produced reliable but significantly reduced P300 amplitudes. Although the P300 is an automatic index of recognitioneven when knowledge is hiddenits amplitude appears capable of modulation by feigning strategies. Implications of this finding are discussed for research and clinical applications.	[Shelley-Tremblay, John E.; Hill, Benjamin D.] Univ S Alabama, Dept Psychol, Mobile, AL 36688 USA; [Eyer, Joshua C.] Univ Alabama, Capstone Coll Nursing, Tuscaloosa, AL 35487 USA		Shelley-Tremblay, JE (corresponding author), Univ S Alabama, Dept Psychol, Mobile, AL 36688 USA.	jstremblay@southalabama.edu; joshua.c.eyer@ua.edu; bdhill@southalabama.edu	Shelley-Tremblay, John/AAX-9410-2021; Eyer, Joshua C./AAH-2243-2021; Shelley-Tremblay, Jack/AAN-4477-2020	Shelley-Tremblay, John/0000-0002-5853-1010; Eyer, Joshua C./0000-0002-1668-6268; 			APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Bass C, 2014, LANCET, V383, P1422, DOI 10.1016/S0140-6736(13)62186-8; Ben-Shakhar G, 2003, J APPL PSYCHOL, V88, P131, DOI 10.1037/0021-9010.88.1.131; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Chafetz M, 2005, ARCH CLIN NEUROPSYCH, V20, P889; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Ellwanger J, 1996, INT J PSYCHOPHYSIOL, V23, P9, DOI 10.1016/0167-8760(96)00035-9; Fabiani M., 1987, ADV PSYCHOPHYSIOL, V2, P78; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 1999, SUPPLEMENT CARB WMT; Green P., 2004, MANUAL MED SYMPTOM V; Green P., 1996, WORD MEMORY TEST USE; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Hill BD, 2015, APPL NEUROPSYCH-ADUL, V22, P233, DOI 10.1080/23279095.2014.910215; Hoover S, 2014, INT J PSYCHOPHYSIOL, V91, P139, DOI 10.1016/j.ijpsycho.2013.12.009; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Leamy E., 2006, CHEATING DISABILITY; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LeesHaley PR, 1997, ASSESSMENT, V4, P321, DOI 10.1177/107319119700400402; Luck S.J., 2012, APA HDB RES METHODS, V1, P523; Lui M, 2008, PSYCHOPHYSIOLOGY, V45, P721, DOI 10.1111/j.1469-8986.2008.00683.x; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; Marchand Y, 2013, J CLIN EXP NEUROPSYC, V35, P686, DOI 10.1080/13803395.2013.819837; Meyer AM, 2007, BRAIN RES, V1183, P91, DOI 10.1016/j.brainres.2007.09.007; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Nunez-Pena MI, 2005, INT J PSYCHOPHYSIOL, V56, P45, DOI 10.1016/j.ijpsycho.2004.09.006; Rhodes SM, 2008, PSYCHOPHYSIOLOGY, V45, P50, DOI 10.1111/j.1469-8986.2007.00598.x; Rosenfeld JP, 2008, PSYCHOPHYSIOLOGY, V45, P906, DOI 10.1111/j.1469-8986.2008.00708.x; Rosenfeld JP, 2017, PSYCHOPHYSIOLOGY, V54, P764, DOI 10.1111/psyp.12835; Rosenfeld JP, 2010, PSYCHOPHYSIOLOGY, V47, P1002, DOI 10.1111/j.1469-8986.2010.01024.x; Rosenfeld JP, 2004, PSYCHOPHYSIOLOGY, V41, P205, DOI 10.1111/j.1469-8986.2004.00158.x; Rosenfeld JP, 1999, STUD NEUROPSYCHOL DE, P287; Schneider W, E PRIME USERS GUIDE; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Wang EW, 1997, BEHAV SCI LAW, V15, P469, DOI 10.1002/(SICI)1099-0798(199723/09)15:4<469::AID-BSL279>3.0.CO;2-A; Widows M. R., 2005, STRUCTURED INVENTORY; Woodman GF, 2010, ATTEN PERCEPT PSYCHO, V72, P2031, DOI 10.3758/APP.72.8.2031; Wynkoop T.F., 2001, J FORENSIC NEUROPSYC, V2, P71; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]; [No title captured]	50	4	4	2	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	MAY	2019	9	5							109	10.3390/brainsci9050109			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IE8YP	WOS:000472660100015	31091738	Green Published, gold, Green Submitted			2022-02-06	
J	Talari, HR; Hamidian, Y; Moussavi, N; Fakharian, E; Abedzadeh-kalahroudi, M; Akbari, H; Taher, EB				Talari, Hamid Reza; Hamidian, Yaser; Moussavi, Nooshin; Fakharian, Esmail; Abedzadeh-kalahroudi, Masoumeh; Akbari, Hossein; Taher, Elaheh Baban			The Prognostic Value of Rotterdam Computed Tomography Score in Predicting Early Outcomes Among Children with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Children; Computed tomography; Head injury; Rotterdam scoring system	GLASGOW COMA SCALE; HEAD-INJURY; CT FINDINGS; CLASSIFICATION; MODEL	BACKGROUND: Prediction of traumatic brain injury (TBI) among children is of great importance for accurate clinical decision making. OBJECTIVES: This study aimed to determine the prognostic value of the Rotterdam scoring system in predicting early outcome among children with TBI. METHODS: This study was conducted in 2017 on 506 children with brain injury in Kashan, Iran. A checklist was used to collect demographic and clinical characteristics of patients such as age, sex, mechanism of trauma, Glasgow Coma Scale (GCS) score, need for surgery, and brain injury outcome. Moreover, each participant's computed tomography scan was evaluated and scored using the Rotterdam system. Sensitivity, specificity, positive and negative predictive values, and the best cut-off score were calculated for the Rotterdam system. The relationships of the Rotterdam score with participants' characteristics were examined using the chi(2) test, whereas the predictors of brain injury outcome were identified using the logistic regression analysis. RESULTS: Pediatric death rate was 4.3%. Most deaths were among children who were male, aged < 4, had developed brain injury owing to traffic accidents, had a GCS score of 3-8, suffered from compressed skull fracture and frontal lobe injury, had cerebral edema, and had a Rotterdam score of 5. The sensitivity and specificity of a Rotterdam score 3 were 86.4% and 97.9%, respectively. The logistic regression analysis indicated that only GCS and Rotterdam scores were significant predictors of brain injury outcome. CONCLUSIONS: At a cut-off score of 3, the Rotterdam system can be used to predict TBI outcome among children with acceptable sensitivity and specificity.	[Talari, Hamid Reza; Hamidian, Yaser; Moussavi, Nooshin; Fakharian, Esmail; Abedzadeh-kalahroudi, Masoumeh; Akbari, Hossein; Taher, Elaheh Baban] Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran		Abedzadeh-kalahroudi, M (corresponding author), Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran.	Abedzadeh@kaums.ac.ir	; Abedzadeh-Kalahroudi, Masoumeh/G-4114-2017	Moosavi Buki, Nooshin/0000-0003-0888-0068; Abedzadeh-Kalahroudi, Masoumeh/0000-0002-7318-6294	Deputy of Research, Kashan University of Medical Sciences [96173]	This study was supported by the Deputy of Research, Kashan University of Medical Sciences (Grant no: 96173).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS9; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Centers for Disease Control and Prevention, 1999, WIS QARS LEAD CAUS D; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fujimoto K, 2016, J NEUROSURG, V124, P1640, DOI 10.3171/2015.4.JNS142760; Haque Anwarul, 2018, J Ayub Med Coll Abbottabad, V30, P140; Hirsch W, 2002, PAEDIATR ANAESTH, V12, P337, DOI 10.1046/j.1460-9592.2002.00837.x; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Imran A, 2016, ANN KING EDWARD MED, V22, P232; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P199, DOI 10.1007/s00402-012-1652-y; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pillai SV, 2003, NEUROL INDIA, V51, P345; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; 2007, J PEDIATR SURG, V42, P1903, DOI DOI 10.1016/J.JPEDSURG.2007.07.020; 1992, NEUROSURGERY, V31, P435	30	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2019	125						E139	E145		10.1016/j.wneu.2018.12.221			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW2CX	WOS:000466491700019	30677579				2022-02-06	
J	van Dijck, JTJM; van Essen, TA; Dijkman, MD; Mostert, CQB; Polinder, S; Peul, WC; de Ruiter, GCW				van Dijck, Jeroen T. J. M.; van Essen, Thomas A.; Dijkman, Mark D.; Mostert, Cassidy Q. B.; Polinder, Suzanne; Peul, Wilco C.; de Ruiter, Godard C. W.			Functional and patient-reported outcome versus in-hospital costs after traumatic acute subdural hematoma (t-ASDH): a neurosurgical paradox?	ACTA NEUROCHIRURGICA			English	Article						Acute subdural hematoma; Traumatic brain injury; Treatment; Patient outcome; Healthcare costs	QUALITY-OF-LIFE; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; DECISION-MAKING; RISK-FACTORS; SCALE; CARE; MANAGEMENT; COMA; INTERVENTION	BackgroundThe decision whether to operate or not in patients with a traumatic acute subdural hematoma (t-ASDH) can, in many cases, be a neurosurgical dilemma. There is a general conception that operating on severe cases leads to the survival of severely disabled patients and is associated with relatively high medical costs. There is however little information on the quality of life of patients after operation for t-ASDH, let alone on the cost-effectiveness.MethodsThis study retrospectively investigated patient outcome and in-hospital costs for 108 consecutive patients with a t-ASDH. Patient outcome was assessed using the Glasgow Outcome Score (GOS) and the Traumatic Brain Injury (TBI)-specific QOLIBRI questionnaire. The in-hospital costs were calculated using the Dutch guidelines for costs calculation.ResultsOut of 108 patients, 40 were classified as having sustained a mild (Glasgow Coma Scale (GCS) 13-15), 19 a moderate (GCS 9-12), and 49 a severe (GCS 3-8) TBI. As expected, mortality rates increased with higher TBI severity (23%, 47%, and 61% respectively), whereas the chance for favorable outcome (GOS 4-5) decreased (72%, 47%, and 29%). Interestingly, the mean QOLIBRI scores for survivors were quite similar between the TBI severity groups (61, 61, and 64). Healthcare consumption and in-hospital costs increased with TBI severity. In-hospital costs were relatively high (Euro24,980), especially after emergency surgery (Euro28,670) and when additional ICP monitoring was used (Euro36,580).ConclusionsAlthough this study confirms that outcome is often unfavorable after t-ASDH, it also shows that favorable outcome can be achieved, even in the most severely injured patients. In-hospital treatment costs were substantial and mainly related to TBI severity, with admission and surgery as main cost drivers. These results serve as a basis for necessary future research focusing on the value-based cost-effectiveness of surgical treatment of patients with a t-ASDH.	[van Dijck, Jeroen T. J. M.; van Essen, Thomas A.; Dijkman, Mark D.; Mostert, Cassidy Q. B.; Peul, Wilco C.; de Ruiter, Godard C. W.] Leiden Univ, UNCH, Dept Neurosurg, Med Ctr, Leiden, Netherlands; [van Dijck, Jeroen T. J. M.; van Essen, Thomas A.; Dijkman, Mark D.; Mostert, Cassidy Q. B.; Peul, Wilco C.; de Ruiter, Godard C. W.] Haaglanden Med Ctr, Leiden, Netherlands; [van Dijck, Jeroen T. J. M.; van Essen, Thomas A.; Dijkman, Mark D.; Mostert, Cassidy Q. B.; Peul, Wilco C.; de Ruiter, Godard C. W.] Haga Teaching Hosp, Leiden, Netherlands; [Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands		van Dijck, JTJM (corresponding author), Leiden Univ, UNCH, Dept Neurosurg, Med Ctr, Leiden, Netherlands.; van Dijck, JTJM (corresponding author), Haaglanden Med Ctr, Leiden, Netherlands.; van Dijck, JTJM (corresponding author), Haga Teaching Hosp, Leiden, Netherlands.	j.t.j.m.van_dijck@lumc.nl	van Dijck, Jeroen/AAM-4123-2021; de Ruiter, Godard/ABC-4074-2020	van Dijck, Jeroen/0000-0002-9893-632X; Van Essen, Thomas/0000-0003-4657-5283	European Union Seventh Framework Program for Collaborative European Neuro Trauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) [602150]; Hersenstichting Nederland (Dutch Brain Foundation) for Neurotraumatology Quality Registry (Net-QuRe)	This work was supported by The European Union Seventh Framework Program (grant 602150) for Collaborative European Neuro Trauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) and Hersenstichting Nederland (Dutch Brain Foundation) for Neurotraumatology Quality Registry (Net-QuRe).	Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; Alali AS, 2014, CRIT CARE MED, V42, P2235, DOI 10.1097/CCM.0000000000000500; Albrecht JS, 2017, J HEAD TRAUMA REHAB, V32, pE45, DOI 10.1097/HTR.0000000000000297; [Anonymous], NED ZORG TAR DBC ZOR; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cnossen MC, 2021, J NEUROTRAUM, V38, P1072, DOI 10.1089/neu.2015.4121; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Fountain DM, 2016, BRIT J NEUROSURG, V31, P1, DOI DOI 10.1080/02688697.2016.1244254; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Garcia-Altes A, 2012, NEUROEPIDEMIOLOGY, V39, P103, DOI 10.1159/000338297; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Greene NH, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000306; Hakkaart-van Roijen L, 2015, KOSTENHANDLEIDING ME; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Honeybul S, 2012, J MED ETHICS, V38, P657, DOI 10.1136/medethics-2012-100672; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Keel G, 2017, HEALTH POLICY, V121, P755, DOI 10.1016/j.healthpol.2017.04.013; Kwon H, 2017, J KOREAN NEUROSURG S, V60, P723, DOI 10.3340/jkns.2017.0506.011; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lu J, 2013, J NEUROTRAUM, V30, P1925, DOI 10.1089/neu.2013.2891; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malmivaara K, 2011, EUR J NEUROL, V18, P656, DOI 10.1111/j.1468-1331.2010.03294.x; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Marion DW, 2006, NEUROSURGERY, V58, P655; Nederlandse Zorgautoriteit, OP DAT NED ZORG; Phan K, 2017, WORLD NEUROSURG, V101, P677, DOI 10.1016/j.wneu.2017.03.024; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Porter MF, 2013, HARV BUS REV; Raj R, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2151-5; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Tan SS, 2012, VALUE HEALTH, V15, P81, DOI 10.1016/j.jval.2011.09.007; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; TEASDALE G, 1974, LANCET, V2, P81; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; van Dijck JT, 2018, J NEUROSURG SCI, V62, P153, DOI 10.23736/S0390-5616.17.04255-2; van Essen TA, 2019, J NEUROTRAUM, V36, P1184, DOI 10.1089/neu.2018.5869; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wilson WT, 2017, BRIT J NEUROSURG, V31, P254, DOI 10.1080/02688697.2016.1226259	49	4	4	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2019	161	5					875	884		10.1007/s00701-019-03878-5			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	HV2SK	WOS:000465840200007	30923919	Green Published, hybrid			2022-02-06	
J	Roy, D; Peters, ME; Everett, A; Leoutsakos, JM; Yan, HJ; Rao, V; Bechtold, K; Sair, H; Van Meter, TE; Falk, H; Vassila, A; Hall, A; Ofoche, U; Akbari, F; Lyketsos, CG; Korley, F				Roy, Durga; Peters, Matthew E.; Everett, Allen; Leoutsakos, Jeannie-Marie; Yan, Haijuan; Rao, Vani; Bechtold, Kathleen; Sair, Haris; Van Meter, Timothy E.; Falk, Hayley; Vassila, Alexandra; Hall, Anna; Ofoche, Uju; Akbari, Freshta; Lyketsos, Constantine G.; Korley, Fredrick			Loss of consciousness and altered mental state predicting depressive and post-concussive symptoms after mild traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; neuropsychiatric; prediction	QUALITY-OF-LIFE; HEAD-INJURY; SEVERITY; VALIDITY; OUTCOMES	Objective: Limited studies exist on the association between loss of consciousness (LOC) and altered mental state (AMS) and development of depressive and post-concussive symptoms within six months after mild traumatic brain injury (mTBI). We tested the hypothesis that presence of both LOC and AMS predict the highest risk of symptoms within the first six months post-mTBI compared to either variable alone, and that LOC alone is more strongly associated with these symptoms. Research design: We analyzed data from 407 subjects with mTBI from the Head injury Serum Markers for Assessing Response to Trauma (HeadSMART) cohort, a prospective cohort of patients post-TBI presenting to two urban emergency departments. Results: There were higher rates of depressive (44%) and post-concussive symptoms (54%) at 1 month post-injury, among participants with both LOC and AMS compared to other groups. AMS was associated with depressive symptoms at one and six months (OR = 1.59, p = .038; OR = 1.60; p = .060) and post-concussive symptoms at one month (OR = 1.56, p = .053). LOC was associated only with post-concussive symptoms at one month (OR = 1.55;p = .048). Among those without LOC, AMS was associated with depressive symptoms at one month (OR = 2.24; p = .028). Conclusions: AMS predicts post-mTBI depressive symptoms both in the acute and chronic mTBI phases whereas LOC is a more sensitive predictor of post-concussive symptoms in the acute mTBI period.	[Roy, Durga; Peters, Matthew E.; Leoutsakos, Jeannie-Marie; Yan, Haijuan; Rao, Vani; Lyketsos, Constantine G.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Everett, Allen] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Bechtold, Kathleen; Van Meter, Timothy E.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Sair, Haris] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Van Meter, Timothy E.] ImmunArray Inc, Program Neurol Dis, Richmond, VA USA; [Falk, Hayley; Korley, Fredrick] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA; [Vassila, Alexandra] Theradex Oncol, Crawley, England; [Hall, Anna] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ofoche, Uju] Drexel Univ, Coll Med, Dept Forens Sci, Philadelphia, PA 19104 USA; [Akbari, Freshta] Univ Maryland, Sch Med, Dept Cardiac Surg, Baltimore, MD 21201 USA		Roy, D (corresponding author), Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, 5300 Alpha Commons Dr, Baltimore, MD 21224 USA.	droy4@jhmi.edu			Immunarray USA, Inc.	This study was funded by a grant from Immunarray USA, Inc.	Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; CDC, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention (CDC), 2010, NAT HOSP DISCH SURV; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Inamasu J, 2018, ACTA NEUROCHIR, V160, P1921, DOI 10.1007/s00701-018-3656-z; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Kreutzer JS, 2001, J HEAD TRAUMA REHAB, V16, pV, DOI 10.1097/00001199-200108000-00001; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lees-Haley P. R., 1992, FORENSIC REPORTS, V5, P385; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Peters ME, 2017, BRAIN INJURY, V31, P370, DOI 10.1080/02699052.2016.1231344; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Storzbach D., 2013, VA EVIDENCE BASED SY; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086	31	4	4	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2019	33	8					1064	1069		10.1080/02699052.2019.1606447		APR 2019	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM6FW	WOS:000470441500001	31017017				2022-02-06	
J	Jones, KM; Prah, P; Starkey, N; Theadom, A; Barker-Collo, S; Ameratunga, S; Feigin, VL; McPherson, K; Jones, A; Ao, BT; Kydd, R; Barber, PA; Parag, V; Dowell, A; Kahan, M; Christey, G; Hardaker, N; Brown, P				Jones, Kelly M.; Prah, Philip; Starkey, Nicola; Theadom, Alice; Barker-Collo, Suzanne; Ameratunga, Shanthi; Feigin, Valery L.; McPherson, K.; Jones, A.; Ao, B. Te; Kydd, R.; Barber, P. Alan; Parag, V.; Dowell, A.; Kahan, M.; Christey, G.; Hardaker, N.; Brown, P.		BIONIC Study Grp	Longitudinal patterns of behavior, cognition, and quality of life after mild traumatic brain injury in children: BIONIC study findings	BRAIN INJURY			English	Article						Behaviour; cognition; quality of life; mild brain injury	GENERIC CORE SCALES; GENDER-DIFFERENCES; NEUROCOGNITIVE OUTCOMES; SEX-DIFFERENCES; ADOLESCENTS; RELIABILITY; CHILDHOOD; SYMPTOMS; DEPRESSION; VALIDITY	Background: Research following mild traumatic brain injury (mTBI) during childhood predominantly examines recovery up to 12 months post-injury. Objectives: To determine children's longer-term (4 years) patterns and predictors of recovery. Methods: Parents of 196 children (aged 1-15 years) completed the Behaviour Assessment System for Children and Pediatric Quality of Life Inventory at baseline, 1, 6, 12, and 48 months post-injury. Children aged >= 8 years at each assessment completed a computerized neurocognitive testing battery. At 1 month, parents completed the Hospital Anxiety and Depression Scale. Multilevel modeling accounted for repeated measures. Results: Children had significantly fewer child behavior problems, better adaptability, and improved quality of life after 12 months. Concurrent improvements in overall neurocognitive function were no longer significant once adjusted for age, gender, and socio-economic status. From 12 to 48 months, quality of life reduced significantly while child behavior and neurocognition plateaued. Child behavior problems and worse quality of life were associated with parental anxiety and lower socio-economic status. Conclusions: Children's recovery in the year following mTBI appears to plateau from 12 to 48 months, with a concomitant reduction in quality of life. Identification and treatment of parent mental health issues may reduce the exacerbation of negative child outcomes following mTBI.	[Jones, Kelly M.; Prah, Philip; Theadom, Alice; Feigin, Valery L.] Auckland Univ Technol, Fac Hlth & Environm Studies, Sch Publ Hlth & Psychosocial Studies, Natl Inst Stroke & Appl Neurosci, Auckland 1142, New Zealand; [Starkey, Nicola] Univ Waikato, Fac Arts & Social Sci, Sch Psychol, Hamilton, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland, New Zealand; [Jones, Kelly M.; Theadom, Alice; Barker-Collo, Suzanne; Feigin, Valery L.; McPherson, K.; Jones, A.; Ao, B. Te] Auckland Univ Technol, Auckland, New Zealand; [Ameratunga, Shanthi; Kydd, R.; Barber, P. Alan; Parag, V.] Univ Auckland, Auckland, New Zealand; [Starkey, Nicola] Waikato Univ, Hamilton, New Zealand; [Dowell, A.] Univ Otago, Dunedin, New Zealand; [Kahan, M.; Christey, G.] Waikato Dist Hlth Board, Hamilton, New Zealand; [Hardaker, N.] Accid Compensat Corp, Wellington, New Zealand; [Brown, P.] Univ Calif, Santa Barbara, CA USA		Jones, KM (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Studies, Sch Publ Hlth & Psychosocial Studies, Natl Inst Stroke & Appl Neurosci, Auckland 1142, New Zealand.	kelly.jones@aut.ac.nz	Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740; McPherson, Kath/0000-0003-0487-8497; Barber, P Alan/0000-0003-2469-9023; Te Ao, Braden/0000-0002-1050-200X	Health Research Council of New ZealandHealth Research Council of New Zealand [09/063A, 11/192, 13/408]	This work was funded by the Health Research Council of New Zealand (09/063A, 11/192, 13/408).	Albicini M., 2015, FRESH LOOK ANXIETY D, P199, DOI [10.5772/57353, DOI 10.5772/57353, DOI 10.5772/60426]; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barbu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016407; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chen X, 2007, QUAL LIFE RES, V16, P1239, DOI 10.1007/s11136-007-9230-4; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Eley T. C., 2004, ANXIETY DISORDERS CH, P71; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Endendijk JJ, 2017, CHILD DEV, V88, P299, DOI 10.1111/cdev.12589; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FERGUSSON DM, 1993, J ABNORM CHILD PSYCH, V21, P245, DOI 10.1007/BF00917534; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Gualtieri C Thomas, 2006, J Atten Disord, V9, P534, DOI 10.1177/1087054705283758; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Gualtieri CT, 2006, J CHILD ADOL PSYCHOP, V16, P147, DOI 10.1089/cap.2006.16.147; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Kendler KS, 2008, PSYCHOL MED, V38, P1567, DOI 10.1017/S003329170800384X; Lambregts SAM, 2018, BRAIN INJURY, V32, P230, DOI 10.1080/02699052.2017.1406990; Landry SH, 2003, DEV NEUROPSYCHOL, V24, P559, DOI 10.1207/S15326942DN242&3_04; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Matza LS, 2004, VALUE HEALTH, V7, P79, DOI 10.1111/j.1524-4733.2004.71273.x; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Muller-Nix C, 2004, EARLY HUM DEV, V79, P145, DOI 10.1016/j.earlhumdev.2004.05.002; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Phillips B., 2009, OXFORD LEVELS EVIDEN; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; Pink B.N., 2006, AUSTR NZ STANDARD CL; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Reynolds C. R., 1998, BEHAV ASSESSMENT SYS; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Tanveer S, 2017, PEDIATR NEUROL, V70, P44, DOI 10.1016/j.pediatrneurol.2017.02.001; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, J CLIN OUTCOMES MANA, V6, P33; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; WHO, 1992, INT STAT CLASS DIS R; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	4	4	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2019	33	7					884	893		10.1080/02699052.2019.1606445		APR 2019	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OM5BT	WOS:000470589900001	31010355				2022-02-06	
J	Brooks, BL; Sayers, PQ; Virani, S; Rajaram, AA; Tomfohr-Madsen, L				Brooks, Brian L.; Sayers, Payton Q.; Virani, Shane; Rajaram, Alysha A.; Tomfohr-Madsen, Lianne			Insomnia in Adolescents with Slow Recovery from Concussion	JOURNAL OF NEUROTRAUMA			English	Article						adolescent; brain injury; chronic; mild traumatic brain injury; sleep	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; MULTIPLE PAST CONCUSSIONS; SEVERITY INDEX; POSTCONCUSSION SYMPTOMS; PSYCHOMETRIC PROPERTIES; EMERGENCY-DEPARTMENT; PEDIATRIC-PATIENTS; SLEEP DISTURBANCE	Sleep disruption can occur after brain injury; however, insomnia prevalence and severity in adolescents with persistent post-concussion symptoms have not been investigated. This study examined: 1) some of the psychometric properties of the Insomnia Severity Index (ISI), 2) the prevalence and severity of insomnia symptoms, and 3) associations between insomnia symptoms and clinical measures of post-concussion symptoms, mental health symptoms, and cognitive tests in adolescents with slow recovery from concussion. Participants (N = 121) were adolescents 13-18 years of age (mean = 16.2; standard deviation [SD] = 1.2) and, on average, of 6.4 months (SD = 3.8) post-concussion. This sample rated insomnia (ISI), post-concussion symptoms, symptoms of depression and anxiety, and cognitive complaints, as well as completed cognitive testing. The ISI demonstrated good internal consistency (alpha = 0.87) and a single factor structure. The majority of the sample endorsed at least some insomnia, with 62% being over the clinical cutoff for experiencing clinically significant symptoms of insomnia. Higher insomnia severity was associated with a greater number of previous concussions, worse post-concussion symptoms, more anxiety, and higher depression. Insomnia was significantly associated with more cognitive complaints and higher rates of failure on performance validity tests, but not with actual objectively measured cognitive abilities. Insomnia is common in adolescents with slow recovery from concussion and is associated with worse post-concussion symptoms, anxiety, depression, cognitive complaints, and performance validity concerns. Investigating evidence-based treatments for insomnia should be a priority in this population.	[Brooks, Brian L.; Virani, Shane; Rajaram, Alysha A.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada; [Brooks, Brian L.; Virani, Shane; Tomfohr-Madsen, Lianne] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Brooks, Brian L.; Rajaram, Alysha A.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.; Tomfohr-Madsen, Lianne] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Sayers, Payton Q.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca			Kinsmen Chair of Pediatric Neurosciences; ACHRI Neurotrauma Fund; ACH Neurosciences Program; Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary AwardCanadian Institutes of Health Research (CIHR); Markin Undergraduate Student Research Program (USRP) in Health and Wellness; Vi Riddell Children's Pain and Rehabilitation Program; Integrated Concussion Research Program; Canadian Child Health Clinician Scientist Program	The BrainChild database, which is the centralized digital storage system for all data collected in neuropsychological assessments, was supported by funding from the Kinsmen Chair of Pediatric Neurosciences, the ACHRI Neurotrauma Fund, and the ACH Neurosciences Program (Conny Betuzzi, manager). Brian Brooks acknowledges partial salary funding from the Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary Award. Payton Sayers acknowledges studentship funding by the Markin Undergraduate Student Research Program (USRP) in Health and Wellness. Shane Virani acknowledges salary funding by the Vi Riddell Children's Pain and Rehabilitation Program and the Integrated Concussion Research Program. Lianne Tomfohr-Madsen acknowledges support from the Canadian Child Health Clinician Scientist Program.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Blake M, 2016, J CONSULT CLIN PSYCH, V84, P1039, DOI 10.1037/ccp0000142; Blake MJ, 2017, CLIN CHILD FAM PSYCH, V20, P227, DOI 10.1007/s10567-017-0234-5; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Brevik EJ, 2017, ACTA PSYCHIAT SCAND, V136, P220, DOI 10.1111/acps.12756; Brooks B. L, 2016, VALIDITY TESTING CHI; Brooks BL, 2019, APPL NEUROPSYCH-CHIL, V8, P319, DOI 10.1080/21622965.2018.1476865; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Bub KL, 2011, DEV PSYCHOL, V47, P1504, DOI 10.1037/a0025535; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CDC, 2003, REP C MILD TRAUM BRA; Chahoud M, 2017, eNeurologicalSci, V7, P9, DOI 10.1016/j.ensci.2017.03.003; Chen PY, 2015, SLEEP MED, V16, P598, DOI 10.1016/j.sleep.2014.11.016; Cohen J., 2013, STAT POWER ANAL BEHA; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; De Bruin EJ, 2016, SLEEP, V39, P1571, DOI 10.5665/sleep.6024; de Bruin EJ, 2015, SLEEP, V38, P1913, DOI 10.5665/sleep.5240; de Zambotti M, 2018, SLEEP MED REV, V39, P12, DOI 10.1016/j.smrv.2017.06.009; Dragioti E, 2015, SCAND J PAIN, V9, P22, DOI 10.1016/j.sjpain.2015.06.001; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Epstein R, 1998, SLEEP, V21, P250, DOI 10.1093/sleep/21.3.250; Fallone G, 2002, SLEEP MED REV, V6, P287, DOI 10.1053/smrv.2001.0192; Fernandez-Mendoza J, 2012, SLEEP MED, V13, P207, DOI 10.1016/j.sleep.2011.06.019; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Green P., 2004, MANUAL GREENS MED SY; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hinds Andrea, 2016, Concussion, V1, pCNC15, DOI 10.2217/cnc-2016-0002; Horris H.B., 2017, ATHL TRAIN SPORTS HL, V9, P39, DOI DOI 10.3928/19425864-20160926-01; IBM Corp, 2016, IBM SPSS STAT WIND V; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kamphaus R.W, 2015, BASC 3 BEHAV ASSESSM; Kirk JW, 2014, ASSESSMENT, V21, P562, DOI 10.1177/1073191114520626; Kirkwood M. W, 2016, VALIDITY TESTING CHI; Kirkwood M. W, 2012, PEDIAT FORENSIC NEUR, P136; Koffel E, 2009, J ABNORM PSYCHOL, V118, P183, DOI 10.1037/a0013945; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; MacAllister W. S., 2016, VALIDITY TESTING CHI; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Medic G, 2017, NAT SCI SLEEP, V9, P151, DOI 10.2147/NSS.S134864; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Mollayeva T, 2016, SLEEP MED, V19, P153, DOI 10.1016/j.sleep.2015.05.014; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Moscou-Jackson G, 2016, J HEALTH CARE POOR U, V27, P209, DOI 10.1353/hpu.2016.0010; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Perna RB, 2013, CHILD NEUROPSYCHOL, V19, P438, DOI 10.1080/09297049.2012.731500; Plourde V, 2017, J INT NEUROPSYCH SOC, V23, P304, DOI 10.1017/S1355617717000066; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reid, 2016, ADHD RATING SCALE 5; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sattler J.M., 2001, ASSESSMENT CHILDREN; Savard MH, 2005, PSYCHO-ONCOLOGY, V14, P429, DOI 10.1002/pon.860; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Sherman E.M.S., 2015, CHILD ADOLESCENT MEM; Sherman EMS, 2015, MEMORY VALIDITY PROF; Sherman EMS, 2017, MULTIDIMENSIONAL EVE; Sierra JC, 2008, REV NEUROLOGIA, V47, P566, DOI 10.33588/rn.4711.2008221; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Touchette E, 2007, SLEEP, V30, P1213, DOI 10.1093/sleep/30.9.1213; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Vriend JL, 2013, J PEDIATR PSYCHOL, V38, P1058, DOI 10.1093/jpepsy/jst033; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Yu DSF, 2010, J ADV NURS, V66, P2350, DOI 10.1111/j.1365-2648.2010.05394.x; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	96	4	4	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2391	2399		10.1089/neu.2018.6257		APR 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000465472600001	30887895				2022-02-06	
J	Lajeunesse, A; Potvin, MJ; Audy, J; Paradis, V; Gigure, JF; Rouleau, I				Lajeunesse, Ariane; Potvin, Marie-Julie; Audy, Julie; Paradis, Veronique; Giguere, Jean-Francois; Rouleau, Isabelle			Prospective memory assessment in acute mild traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Mild traumatic brain injury; prospective memory; retrospective memory; executive functions; ecological assessment	CENTER-TASK-FORCE; POST-CONCUSSION SYMPTOMS; COGNITIVE IMPAIRMENT; RISK-FACTORS; RETRIEVAL; MTBI; INTENTIONS; COMPONENT; SEQUELAE	Objective: Prospective memory (PM) is the ability to remember to perform an intention at the appropriate time in the future. It is of primary importance for daily living, and its disruption may impact functional autonomy. To date, few studies have examined PM during the acute phase of mild traumatic brain injury (mTBI), despite the high prevalence of this neurological condition and its potential impact on cognition. Method: Twenty mTBI patients (time since injury ranged from 45 to 73 days) and 15 healthy control participants performed the Ecological Test of Prospective Memory (TEMP), a simulated errand task in which participants were required to execute 10 event-based (EB) and five time-based (TB) tasks. The TEMP separately evaluates PM phases as well as prospective and retrospective components in event- and time-based conditions. Participants also completed a neuropsychological test battery. Correlations were performed between cognitive composite scores and the TEMP. Results: mTBI patients experienced difficulty in learning the content of intentions, retrieving these intentions in the time-based condition (prospective component) and recalling the associated actions in the event- and time-based conditions (retrospective component). Retrospective memory composite score was correlated with the learning and retention phases of the TEMP, whereas attention/working memory and executive composite scores were correlated with the time-based condition and performance on the ongoing task. Conclusion: These results suggest the presence of global PM impairment during the acute phase of mTBI, as well as impairment of retrospective memory, attention/working memory, and executive functions, which are key components for PM performance.	[Lajeunesse, Ariane; Potvin, Marie-Julie; Audy, Julie; Paradis, Veronique; Rouleau, Isabelle] Univ Quebec Montreal, Dept Psychol, CP 8888,Succursale Ctr Ville, Montreal, PQ H3C 3P8, Canada; [Potvin, Marie-Julie; Paradis, Veronique; Giguere, Jean-Francois] Hop Sacre Coeur Montreal, Neurotraumatol Unit, Montreal, PQ, Canada		Rouleau, I (corresponding author), Univ Quebec Montreal, Dept Psychol, CP 8888,Succursale Ctr Ville, Montreal, PQ H3C 3P8, Canada.	rouleau.isabelle@uqam.ca		Potvin, Marie-Julie/0000-0001-5503-8063	Fonds de Recherche du Quebec-Sante scholarships; Natural Sciences and Engineering Research Council of Canada scholarshipNatural Sciences and Engineering Research Council of Canada (NSERC)	This work was supported by Fonds de Recherche du Quebec-Sante scholarships (A.L., and M.-J.P.), and a Natural Sciences and Engineering Research Council of Canada scholarship (M.-J.P.).	Allain P., 2004, NEUROPSYCHOLOGIE TRA; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bedard M, 2018, CLIN NEUROPSYCHOL, V32, P1002, DOI 10.1080/13854046.2017.1404644; BENEDICT R, 1997, BRIEF VISUOSPATIAL M, DOI DOI 10.1016/J.CHB.2013.10.036; Bennett T L, 1997, Appl Neuropsychol, V4, P1, DOI 10.1207/s15324826an0401_1; Blanco-Campal A, 2009, J INT NEUROPSYCH SOC, V15, P154, DOI 10.1017/S1355617708090127; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; BRANDIMONTE MA, 2014, PROSPECTIVE MEMORY T, DOI DOI 10.1016/J.ADOLESCENCE.2016.11.009; Brown S.C., 2000, OXFORD HDB MEMORY, P93, DOI DOI 10.1016/J.ADOLESCENCE.2017.05.018; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; Delis DC., 2001, DELIS KAPLAN EXECUTI; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Einstein, 2007, PROSPECTIVE MEMORY O; Einstein, 2008, PROSPECTIVE MEMORY C, P283; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J., 1996, PROSPECTIVE MEMORY T; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; FIELD A, 2009, DISCOVERING STAT USI, DOI DOI 10.1177/0003122414524573; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guynn MJ, 2007, PSYCHON B REV, V14, P484, DOI 10.3758/BF03194094; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Karantzoulis S, 2009, J INT NEUROPSYCH SOC, V15, P407, DOI 10.1017/S1355617709090596; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; LEZAK MD, 2012, NEUROPSYCHOLOGICAL A, DOI DOI 10.1111/SJOP.12277; Loewenstein D., 2004, PROSPECTIVE MEMORY T; Mackinnon A., 1999, INT J METHODS PSYCHI, V8, P27, DOI [10.1002/mpr.54, DOI 10.1002/MPR.54]; Mantyla T, 2003, MEM COGNITION, V31, P15, DOI 10.3758/BF03196078; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; MESULAM MM, 1985, CONT NEUROLOGY SERIE, V26; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Potvin MJ, 2011, BRAIN INJURY, V25, P192, DOI 10.3109/02699052.2010.541896; Raskin S, 2004, J INT NEUROPSYCHO S1, V10, P110, DOI DOI 10.1017/S1355617704040019; Rau HK, 2018, CLIN NEUROPSYCHOL, V32, P1319, DOI 10.1080/13854046.2017.1381277; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; REY A, 1958, EXAMEN CLIN PSYCHOL, DOI DOI 10.1016/J.JSP.2013.09.002; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P736, DOI 10.1037/a0018971; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Simard M, 2019, CLIN NEUROPSYCHOL, V33, P137, DOI 10.1080/13854046.2018.1435824; SPREEN O, 1977, NEUROSENSORY CTR COM, DOI DOI 10.1037/A0018164; Sullivan K, 2005, ARCH CLIN NEUROPSYCH, V20, P745, DOI 10.1016/j.acn.2005.04.006; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Thompson C, 2010, J INT NEUROPSYCH SOC, V16, P318, DOI 10.1017/S1355617709991354; VANDERLINDEN M, 1992, COGNITIVE NEUROPSYCH, V9, P301, DOI 10.1080/02643299208252063; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; WECHSLER D, 1997, WAIS 3 WECHSLER ADUL, DOI DOI 10.1080/01973533.2010.495645; WECHSLER D, 1991, WISC 3 WECHSLER INTE, DOI DOI 10.1080/15374416.2011.597090; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; WILSON B, 2005, CAMBRIDGE TEST PROSP, DOI DOI 10.1080/15534510.2011.651302; Wilson J. T. L, 1996, RECOVERY TRAUMATIC B, P29; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woods SP, 2014, AGING MENT HEALTH, V18, P745, DOI 10.1080/13607863.2013.875126; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263; ZHOU T, 2012, BEHAV BRAIN FUNCT, V8, DOI DOI 10.1186/1744-9081-8-39	78	4	4	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	OCT 3	2019	33	7					1175	1194		10.1080/13854046.2019.1598500		APR 2019	20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	IU4ZT	WOS:000470445500001	31007154				2022-02-06	
J	Gan, C; Wright, FV				Gan, Caron; Wright, F. Virginia			Development of the family needs questionnaire - pediatric version [FNQ-P] - phase I	BRAIN INJURY			English	Article						Family needs; pediatrics; acquired brain injury; families; children	TRAUMATIC BRAIN-INJURY; DELPHI TECHNIQUE; SUPPORT NEEDS; CHILD; REHABILITATION; CAREGIVERS; OUTCOMES; PARENTS; BURDEN; HEALTH	Objective: To adapt the well-validated 37-item adult Family Needs Questionnaire to make it suitable for families of children and youth with acquired brain injury (ABI). Methods: Measurement construction employed a modified Delphi technique to identify the most relevant content items for the pediatric Family Needs Questionnaire (FNQ-P). The Delphi process involved a panel of 11 ABI-team clinicians and seven family caregivers of children/youth with an ABI and four rounds of anonymous voting on each item's importance. Qualitative responses related to each item's review were incorporated into item content and wording decisions. Cognitive interviews were conducted with three parents after the Delphi to evaluate face and content validity. Results: The outcome of the final Delphi round was a set of 40 items within the original FNQ's original six categories: Health Information (n = 10), Emotional Support (n = 6), Instrumental Support (n = 4), Professional Support (n = 6), Community Support (n = 6), and Involvement with Care (n = 8). Cognitive interviews resulted in changes to formatting, rating scale, and item wording, and culminated in overall consensus about the FNQ-P's face/content validity. Conclusions: Use of the Delphi process with family and clinical partners resulted in content-endorsed pediatric FNQ that is ready for validation work prior to transfer to clinical practice.	[Gan, Caron; Wright, F. Virginia] Bloorview Res Inst, Toronto, ON, Canada; [Gan, Caron] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Wright, F. Virginia] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada		Gan, C (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	cgan@hollandbloorview.ca			[Holland Bloorview Kids Rehabilitation Hospital] Foundation through the Centre for Leadership in Acquired Brain Injury	This project is funded with contributions from the [Holland Bloorview Kids Rehabilitation Hospital] Foundation through the Centre for Leadership in Acquired Brain Injury.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Armstrong Kira, 2002, Pediatr Rehabil, V5, P149, DOI 10.1080/1363849021000039353; Bowen N., 2004, EVIDENCE BASED PRACT, P509; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Conoley J, 2005, J LEARNING DISABILIT, V29, P662, DOI 10.1177/002221949602900610; Drennan J, 2003, J ADV NURS, V42, P57, DOI 10.1046/j.1365-2648.2003.02579.x; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Feinstein AR, 1987, CLINIMETRICS; Gan C, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P621; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Godwin E, 2016, ACAD CERTIFIED BRAIN; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hermans E, 2012, NEUROREHABILITATION, V30, P213, DOI 10.3233/NRE-2012-0747; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hsu CC, 2007, PRACT ASSESS RES EVA, V12; Keeney S, 2001, INT J NURS STUD, V38, P195, DOI 10.1016/S0020-7489(00)00044-4; Keeney S., 2011, DELPHI TECHNIQUE NUR; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2018, J HEAD TRAUMA REHAB, V33, P228, DOI 10.1097/HTR.0000000000000390; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Moules S, 1999, BRAIN INJURY, V13, P983; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; Muscara F, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0519-5; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Stebbins P, 1998, J REHABIL, V64, P15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; WAALAND PK, 1993, BRAIN INJURY, V7, P135, DOI 10.3109/02699059309008167; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303; Woolley ME, 2004, RES SOCIAL WORK PRAC, V14, P191, DOI 10.1177/1049731503257882	34	4	4	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2019	33	5					623	632		10.1080/02699052.2019.1566836			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HR1NT	WOS:000462901200010	30676093				2022-02-06	
J	Juengst, SB; Terhorst, L; Kew, CL; Wagner, AK				Juengst, Shannon B.; Terhorst, Lauren; Kew, Chung Lin; Wagner, Amy K.			Variability in daily self-reported emotional symptoms and fatigue measured over eight weeks in community dwelling individuals with traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; emotions; fatigue; smartphone; ecological momentary assessment	ECOLOGICAL MOMENTARY ASSESSMENT; GENDER-DIFFERENCES; DEPRESSION; VALIDITY; ADULTS; REHABILITATION; PERSONALITY; CONCUSSION; BEHAVIOR	Objective: To investigate within-person variability in daily self-reported emotional and fatigue symptoms and factors associated with high within-person variability among individuals with chronic traumatic brain injury (TBI). Design: This was a prospective descriptive pilot study of n = 18 adults with chronic TBI (2-27 years post-injury) who owned and could independently use an Apple or Android device. Methods: Participants completed daily assessments for 8 weeks via smartphone. Outcome measures included the Positive and Negative Affect Schedule, Patient Health Questionnaire-2, Generalized Anxiety Disorder-2, and a 7-point fatigue rating. We examined within-person variability over time using individual Multilevel Linear Models. We categorized within-person variability as High or Low based on individual standard deviations in relationship to sample standard deviation. Results: Significant temporal within-person variability occurred for all measures. High variability was associated with more symptom reporting versus Low variability, and variability was associated with sex (High variability: 88% women; Low variability 90% men). Conclusions: Symptom measurement at a single time point among adults with chronic TBI may not capture day-to-day symptom fluctuation and may misidentify individuals in need of intervention. Assessing symptom profiles over time to capture temporal and individual variability may provide a more ecologically valid measure for managing long-term symptoms after TBI.	[Juengst, Shannon B.; Kew, Chung Lin] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Juengst, Shannon B.; Kew, Chung Lin] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Terhorst, Lauren] Univ Pittsburgh, Dept Occupat Therapy, Pittsburgh, PA USA; [Terhorst, Lauren] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat, Pittsburgh, PA USA		Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Neurosci Clin & Translat Sci Inst, 3471 Fifth Ave Suite 202, Pittsburgh, PA 15213 USA.	shannon.juengst@utsouthwestern.edu; wagnerak@upmc.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X; Kew, Novelle/0000-0003-1720-4459	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0041]	The National Institute on Disability, Independent Living, and Rehabilitation Research under Grant 90DP0041 supported this work.	Bell Kathleen R, 2015, Arch Phys Med Rehabil, V96, P567, DOI 10.1016/j.apmr.2013.06.010; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carvalho JO, 2013, ASSESSMENT, V20, P632, DOI 10.1177/1073191113492845; COLANTONIO A, 2010, BMC NEUROL, V10, DOI DOI 10.1186/1471-2377-10-114; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Dicianno BE, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7335; DONDERS J, 2013, BRAIN INJURY, V31, P1871, DOI DOI 10.1080/02699052.2017.1358397; DONKER T, 2014, INTERNET, V15; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FRAZIER L, 2018, INTERNET; Grace J., 2001, PSYCHOL ASSESS RESOU; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; John OP., 2008, HDB PERSONAL THEORY, P114; Juengst SB, 2019, CURR TOP PHYS MED RE, V7; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Juengst SB, 2019, DISABIL REHABIL, V41, P1200, DOI 10.1080/09638288.2017.1423403; Juengst SB, 2017, J NEUROPSYCH CLIN N, V29, P260, DOI 10.1176/appi.neuropsych.16100217; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; KLONOFF EA, 1992, J BEHAV MED, V15, P355, DOI 10.1007/BF00844728; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kumar RG, 2017, J HEAD TRAUMA REHABI; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; Ladwig KH, 2000, EUR J EPIDEMIOL, V16, P511, DOI 10.1023/A:1007629920752; MacIntyre S, 1996, SOC SCI MED, V42, P617, DOI 10.1016/0277-9536(95)00335-5; Neuberger G, 2003, ARTHRIT CARE RES, V49, pS175, DOI DOI 10.1002/ART.11405; Perrin PB, 2017, AM J PHYS MED REHAB, V96, P374, DOI 10.1097/PHM.0000000000000644; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Stroup WW, 2012, GEN LINEAR MIXED MOD; Suffoletto B, 2013, J HEAD TRAUMA REHAB, V28, P302, DOI 10.1097/HTR.0b013e3182847468; Terhorst L, 2016, ARCH PHYS MED REHAB, V97, pe145, DOI [10.1016/j.apmr.2016.08.451, DOI 10.1016/J.APMR.2016.08.451]; Terhorst L, 2018, REHABIL PSYCHOL, V63, P468, DOI 10.1037/rep0000214; Terhorst L, 2017, AM J PHYS MED REHAB, V96, P596, DOI 10.1097/PHM.0000000000000690; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; Wagner AK, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0791-5; Wagner AK, 2011, PM&R, V3, pS28, DOI 10.1016/j.pmrj.2011.04.013; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Worthen-Chaudhari L., 2017, BRAIN INJURY, P1; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	51	4	4	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2019	33	5					567	573		10.1080/02699052.2019.1584333			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HR1NT	WOS:000462901200003	30836017				2022-02-06	
J	Wiseman-Hakes, C; Saleem, M; Poulin, V; Nalder, E; Balachandran, P; Gan, C; Colantonio, A				Wiseman-Hakes, Catherine; Saleem, Madiha; Poulin, Valerie; Nalder, Emily; Balachandran, Peraveena; Gan, Caron; Colantonio, Angela			The development of intimate relationships in adolescent girls and women with traumatic brain injury: a framework to guide gender specific rehabilitation and enhance positive social outcomes	DISABILITY AND REHABILITATION			English	Article						Intimacy; cognitive-communication; social communication; females; traumatic brain injury	OF-THE-LITERATURE; SEX-DIFFERENCES; HEALTH; COMMUNICATION; PREDICTORS; CHILDREN; BEHAVIOR; PEOPLE; MEDIA; MODEL	Background: Traumatic brain injury is a neurological disorder of biopsychosocial nature influenced by sex and gender interactions across the lifespan. Traumatic brain injury sustained during adolescence can result in cognitive and social communication impairments that compromise the development and maintenance of intimate social relationships. This can increase both short and long-term vulnerability to poor mental health, social isolation, lack of meaningful friendships, exploitation, and abuse. Females with traumatic brain injury experience greater loss of confidence and have increased risk of victimization, sexual abuse, and violence. This paper aims to provide a framework to inform gender specific rehabilitation of social communication and intimacy, to enhance positive social outcomes for girls and women with Traumatic Brain Injury. Methods: The framework is developed through presentation of a conceptual, multi-dimensional model of intimacy and discussion of current evidence regarding trauma-related cognitive/social-communication impairments and considerations regarding social media. Results: Intimacy is strongly influenced by today's technology-informed "youth culture" and for those with Traumatic Brain Injury, is impacted by cognitive and social communication impairments. Females experience different challenges in recovery and experience of intimacy. There is a need to support girls and women with Traumatic Brain Injury as they develop intimate relationships. Conclusions: This framework can guide the development of female gender-specific rehabilitation and inform future research to promote positive social outcomes.	[Wiseman-Hakes, Catherine; Nalder, Emily; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, 500 Univ Ave Room 160, Toronto, ON M5G 1V7, Canada; [Wiseman-Hakes, Catherine] Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada; [Wiseman-Hakes, Catherine] McMaster Univ, Dept Speech Language Pathol, Hamilton, ON, Canada; [Saleem, Madiha; Nalder, Emily; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Poulin, Valerie] Univ Quebec Trois Rivieres, Dept Ergotherapie, Trois Rivieres, PQ, Canada; [Balachandran, Peraveena] Royal Univ Hosp, Saskatoon Hlth Reg, Dept Occupat Therapy, Saskatoon, SK, Canada; [Gan, Caron] Holland Bloorview Kids Rehabil Hosp Toronto, Bloorview Res Inst, Toronto, ON, Canada		Wiseman-Hakes, C (corresponding author), Univ Toronto, Rehabil Sci Inst, 500 Univ Ave Room 160, Toronto, ON M5G 1V7, Canada.	Catherinew.hakes@utoronto.ca	Wiseman-Hakes, Catherine/AAC-8303-2021	Wiseman-Hakes, Catherine/0000-0001-8441-884X; Colantonio, Angela/0000-0003-2094-4765; Nalder, Emily/0000-0001-9612-9420	Ontario-Neurotrauma Foundation-Quebec Rehabilitation Network (ONF-REPAR)	Financial support for this work was provided through a grant from the Ontario-Neurotrauma Foundation-Quebec Rehabilitation Network (ONF-REPAR).	[Anonymous], 2018, CAMH ONTARIO STUDENT; Baker-Sparr C, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000305; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Choleris E, 2018, NEUROSCI BIOBEHAV R, V85, P126, DOI 10.1016/j.neubiorev.2017.07.005; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Field B, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0172-2; Flori KL, 2006, J GERONTOL B-PSYCHOL, V61, pP25, DOI 10.1093/geronb/61.1.P25; Gan C, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P621; Haag H, 2015, ARCH PHYS MED REHAB, V97, P64; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Haugh M, 2018, DISCOURSE STUD, V20, P246, DOI 10.1177/1461445617734936; Hook MK, 2003, J COUNS DEV, V81, P462, DOI 10.1002/j.1556-6678.2003.tb00273.x; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108167; Kilov AM, 2010, BRAIN INJURY, V24, P1135, DOI 10.3109/02699052.2010.490511; Laurenceau JP, 1998, J PERS SOC PSYCHOL, V74, P1238, DOI 10.1037/0022-3514.74.5.1238; Lindsay S, 2016, ARCH PHYS MED REHAB, V97, pS33, DOI 10.1016/j.apmr.2014.04.032; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; McQuigge M, 2018, NATL POST; Mollayeva Tatyana, 2017, Healthc Q, V20, P6; O'Reilly K, 2018, DISABIL REHABIL, V40, P2331, DOI 10.1080/09638288.2017.1334838; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Primack BA, 2017, AM J PREV MED, V53, P1, DOI 10.1016/j.amepre.2017.01.010; Raymond Marissa, 2007, Adolesc Med State Art Rev, V18, P449; Reichard AA, 2007, J HEAD TRAUMA REHAB, V22, P390, DOI 10.1097/01.HTR.0000300234.36361.b1; Reis H.T., 1988, HDB PERSONAL RELATIO, P367; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Rycroft-Malone J, 2004, J NURS CARE QUAL, V19, P297, DOI 10.1097/00001786-200410000-00002; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Simpson G, 2017, NEUROREHABILITATION, V41, P261, DOI 10.3233/NRE-172197; Stronach ST, 2008, APHASIOLOGY, V22, P1054, DOI 10.1080/02687030701632187; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Tsaousides T, 2011, BRAIN INJURY, V25, P1155, DOI 10.3109/02699052.2011.613086; Turkle S, 2007, INTERACT STUD, V8, P501; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Van Droogenbroeck F, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1591-4; Wiseman-Hakes C, 2018, COGNITIVE REHABILITA; World Health Organization Department of Mental Health and Substance Dependence, 2000, GEND DISP MENT HLTH; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P493, DOI 10.1017/S1355617713000398	50	4	4	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	NOV 19	2020	42	24					3559	3565		10.1080/09638288.2019.1597180		APR 2019	7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	OI6BJ	WOS:000465993000001	30994020				2022-02-06	
J	Yang, J; Zhao, H; Li, G; Ran, QS; Chen, JB; Bai, ZL; Jin, G; Sun, J; Xu, J; Qin, MX; Chen, MS				Yang, Jun; Zhao, Hui; Li, Gen; Ran, Qisheng; Chen, Jingbo; Bai, Zelin; Jin, Gui; Sun, Jian; Xu, Jia; Qin, Mingxin; Chen, Mingsheng			An experimental study on the early diagnosis of traumatic brain injury in rabbits based on a noncontact and portable system	PEERJ			English	Article						Closed cerebral hemorrhage; Traumatic brain injury; Magnetic induction phase shift; Noncontact; Prehospital diagnosis	CEREBRAL-HEMORRHAGE; MURINE MODELS; ANIMAL-MODEL; TIME-COURSE; TOMOGRAPHY; IMPACT; PATHOPHYSIOLOGY; MANAGEMENT; HEMATOMAS; IMPROVE	Closed cerebral hemorrhage (CCH) is a common symptom in traumatic brain injury (TBI) patients who suffer intracranial hemorrhage with the dura mater remaining intact. The diagnosis of CCH patients prior to hospitalization and in the early stage of the disease can help patients get earlier treatments that improve outcomes. In this study, a noncontact, portable system for early TBI-induced CCH detection was constructed that measures the magnetic induction phase shift (MIPS), which is associated with the mean brain conductivity caused by the ratio between the liquid (blood/CSF and the intracranial tissues) change. To evaluate the performance of this system, a rabbit CCH model with two severity levels was established based on the horizontal biological impactor BIM-II, whose feasibility was verified by computed tomography images of three sections and three serial slices. There were two groups involved in the experiments (group 1 with 10 TBI rabbits were simulated by hammer hit with air pressure of 600 kPa by BIM-II and group 2 with 10 TBI rabbits were simulated with 650 kPa). The MIPS values of the two groups were obtained within 30 min before and after injury. In group 1, the MIPS values showed a constant downward trend with a minimum value of -11.17 +/- 2.91 degrees at the 30th min after 600 kPa impact by BIM-II. After the 650 kPa impact, the MIPS values in group 2 showed a constant downward trend until the 25th min, with a minimum value of -16.81 +/- 2.10 degrees. Unlike group 1, the MIPS values showed an upward trend after that point. Before the injury, the MIPS values in both group 1 and group 2 did not obviously change within the 30 min measurement. Using a support vector machine at the same time point after injury, the classification accuracy of the two types of severity was shown to be beyond 90%. Combined with CCH pathological mechanisms, this system can not only achieve the detection of early functional changes in CCH but can also distinguish different severities of CCH.	[Yang, Jun; Chen, Jingbo; Bai, Zelin; Jin, Gui; Sun, Jian; Xu, Jia; Qin, Mingxin; Chen, Mingsheng] Army Med Univ, Coll Biomed Engn, Chongqing, Peoples R China; [Zhao, Hui] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Li, Gen] Chongqing Univ Technol, Dept Biomed Engn, Chongqing, Peoples R China; [Ran, Qisheng] Army Med Ctr, Dept Radiol, Chongqing, Peoples R China		Qin, MX; Chen, MS (corresponding author), Army Med Univ, Coll Biomed Engn, Chongqing, Peoples R China.	qmingxin@tmmu.edu.cn; chenms83@tmmu.edu.cn		Gen, Li/0000-0002-4183-4242	Foundation of the Third Military Medical University [2014XZH03]; National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61801483]	This work were supported by the Foundation of the Third Military Medical University (2014XZH03) and the National Nature Science Foundation of China (61801483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein TJ, 2017, EMERG RADIOL, V24, P39, DOI 10.1007/s10140-016-1440-z; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11107-1; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Di Ieva A, 2013, NEUROSCIENTIST, V19, P592, DOI 10.1177/1073858412474845; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Enciso-Rodriguez FE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068500; Gabriel C, 1996, TISSUE DIELECTRIC PR; Gao JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118843; Giraudet F, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1616-2; Gonzalez CA, 2006, PHYSIOL MEAS, V27, P829, DOI 10.1088/0967-3334/27/9/006; Griffith J, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041022; Griffiths H, 1999, ANN NY ACAD SCI, V873, P335, DOI 10.1111/j.1749-6632.1999.tb09481.x; Hernandez-Maraver D, 2006, BRIT J HAEMATOL, V135, P293, DOI 10.1111/j.1365-2141.2006.06284.x; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Jin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097179; Jin G, 2014, BIOSENS BIOELECTRON, V52, P374, DOI 10.1016/j.bios.2013.09.019; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kellner CP, 2018, J NEUROINTERV SURG, V10, P1079, DOI 10.1136/neurintsurg-2017-013690; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Koessler L, 2017, HUM BRAIN MAPP, V38, P974, DOI 10.1002/hbm.23431; Laufer S, 2012, PHYSIOL MEAS, V33, P997, DOI 10.1088/0967-3334/33/6/997; Li G, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030537; Li G, 2017, SCI REP-UK, V7, DOI 10.1038/srep42842; Lilja-Cyron A, 2018, J NEUROTRAUM, V35, P1578, DOI 10.1089/neu.2017.5589; Liu WJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121250; Manwaring PK, 2013, ANESTH ANALG, V117, P866, DOI 10.1213/ANE.0b013e318290c7b7; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Mobashsher AT, 2014, IEEE T MICROW THEORY, V62, P1826, DOI 10.1109/TMTT.2014.2342669; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nitsch JB, 2015, IEEE T ELECTROMAGN C, V57, P1705, DOI 10.1109/TEMC.2015.2456098; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Oziel M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186381; Pandey S, 2017, INDIAN J SURG, V79, P19, DOI 10.1007/s12262-015-1416-3; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; SAWYER CH, 1954, J COMP NEUROL, V101, P801, DOI 10.1002/cne.901010307; Schwindling L, 2016, J NEUROIMAGING, V26, P489, DOI 10.1111/jon.12355; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Song JL, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9765174; Sun J, 2014, BRAZ J MED BIOL RES, V47, P144, DOI 10.1590/1414-431X20132978; Sun J, 2016, IRANIAN J MED PHYS, V13, P125, DOI [10.22038/IJMP.2016.7458, DOI 10.22038/IJMP.2016.7458]; Tonui PM, 2018, AM SURGEON, V84, P201; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wykes V., 2015, SURG OXFORD, V33, P355, DOI [10.1016/j.mpsur.2015.06.001, DOI 10.1016/J.MPSUR.2015.06.001]; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zeiler FA, 2017, ACTA NEUROCHIR, V159, P2245, DOI 10.1007/s00701-017-3338-2	54	4	4	1	4	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	APR 12	2019	7								e6717	10.7717/peerj.6717			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT1DF	WOS:000464303500006	30997290	Green Published, Green Submitted, gold			2022-02-06	
J	Lee, SH; Kim, M; Seo, HG; Oh, BM; Lee, G; Leigh, JH				Lee, Seung Hak; Kim, Minje; Seo, Han Gil; Oh, Byung-Mo; Lee, Gangpyo; Leigh, Ja-Ho			Assessment of Dysarthria Using One-Word Speech Recognition with Hidden Markov Models	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Automatic Speech Recognitionl; Dysarthria; Hidden Markov Models	VOICE; TELEREHABILITATION; TUTORIAL; STROKE	Background: The gold standard in dysarthria assessment involves subjective analysis by a speech-language pathologist (SLP). We aimed to investigate the feasibility of dysarthria assessment using automatic speech recognition. Methods: We developed an automatic speech recognition based software to assess dysarthria severity using hidden Markov models (HMMs). Word-specific HMMs were trained using the utterances from one hundred healthy individuals. Twenty-eight patients with dysarthria caused by neurological disorders, including stroke, traumatic brain injury, and Parkinson's disease were participated and their utterances were recorded. The utterances of 37 words from the Assessment of Phonology and Articulation for Children test were recorded in a quiet control booth in both groups. Patients were asked to repeat the recordings for evaluating the test-retest reliability. Patients' utterances were evaluated by two experienced SLPs, and the consonant production accuracy was calculated as a measure of dysarthria severity. The trained HMMs were also employed to evaluate the patients' utterances by calculating the averaged log likelihood (aLL) as the fitness of the spoken word to the word-specific HMM. Results: The consonant production accuracy reported by the SLPs strongly correlated r= 0.808) with the aLL, and the aLL showed excellent test-retest reliability (intraclass correlation coefficient, 0.964). Conclusion: This leads to the conclusion that dysarthria assessment using a one-word speech recognition system based on word-specific HMMs is feasible in neurological disorders.	[Lee, Seung Hak; Seo, Han Gil; Oh, Byung-Mo] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Rehabil Med, Coll Med, 101 Dachak Ro, Seoul 03080, South Korea; [Lee, Seung Hak; Lee, Gangpyo; Leigh, Ja-Ho] Incheon Workers Compensat Hosp, Dept Rehabil Med, 226 Munemi Ro, Incheon 21417, South Korea; [Kim, Minje] Indiana Univ, Dept Intelligent Syst Engn, Bloomington, IN USA; [Leigh, Ja-Ho] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Rehabil Med, Incheon, South Korea; [Leigh, Ja-Ho] Seoul Natl Univ Hosp, Inst Publ Hlth & Med Serv, Seoul, South Korea; [Lee, Seung Hak] Univ Ulsan, Dept Rehabil Med, Coll Med, Asan Med Ctr, Seoul, South Korea; [Leigh, Ja-Ho] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul, South Korea		Leigh, JH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Rehabil Med, Coll Med, 101 Dachak Ro, Seoul 03080, South Korea.; Leigh, JH (corresponding author), Incheon Workers Compensat Hosp, Dept Rehabil Med, 226 Munemi Ro, Incheon 21417, South Korea.	jaho.leigh@gmail.com		leigh, Ja-Ho/0000-0003-0465-6392; Oh, Byung-Mo/0000-0001-9353-7541; Seo, Han Gil/0000-0001-6904-7542; Lee, Seung Hak/0000-0002-3017-8497	Korea Workers&apos; Compensation and Welfare Service Funding Source: Medline		Ali M, 2015, INT J STROKE, V10, P400, DOI 10.1111/ijs.12067; Cherney LR, 2012, SEMIN SPEECH LANG, V33, P243, DOI 10.1055/s-0032-1320044; Duffy JR., 2013, MOTOR SPEECH DISORDE; Hasegawa-Johnson M., 2006, 2006 IEEE INT C AC S, V3, pIII; Hill AJ, 2009, TELEMED J E-HEALTH, V15, P840, DOI 10.1089/tmj.2009.0015; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Kayasith P, 2006, LECT NOTES ARTIF INT, V4099, P885; Kent RD, 1999, AM J SPEECH-LANG PAT, V8, P129, DOI 10.1044/1058-0360.0802.129; Kim MJ., 2007, ASSESSMENT PHONOLOGY; Kim YH, 1994, J KOREAN ACAD REHABI, V18, P12; KREIMAN J, 1993, J SPEECH HEAR RES, V36, P21, DOI 10.1044/jshr.3601.21; Mackenzie C, 2011, INT J SPEECH-LANG PA, V13, P125, DOI 10.3109/17549507.2011.524940; McLeod S, 2014, AM J SPEECH-LANG PAT, V23, P708, DOI 10.1044/2014_AJSLP-13-0066; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rampello L, 2016, J NEUROL SCI, V369, P354, DOI 10.1016/j.jns.2016.08.048; Schwamm LH, 2009, STROKE, V40, P2616, DOI 10.1161/STROKEAHA.109.192360; Urban PP, 2006, BRAIN, V129, P767, DOI 10.1093/brain/awh708; Wang YT, 2009, CLIN LINGUIST PHONET, V23, P335, DOI 10.1080/02699200802688604; Wannberg P, 2016, LOGOP PHONIATR VOCO, V41, P159, DOI 10.3109/14015439.2015.1069889; Young V, 2010, ASSIST TECHNOL, V22, P99, DOI 10.1080/10400435.2010.483646	20	4	4	0	6	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	APR 8	2019	34	13							e108	10.3346/jkms.2019.34.e108			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS4GI	WOS:000463819600005	30950253	Green Published, gold, Green Submitted			2022-02-06	
J	Yang, B; Bundkirchen, K; Krettek, C; Relja, B; Neunaber, C				Yang, Bing; Bundkirchen, Katrin; Krettek, Christian; Relja, Borna; Neunaber, Claudia			Traumatic injury pattern is of equal relevance as injury severity for experimental (poly)trauma modeling	SCIENTIFIC REPORTS			English	Article							SOFT-TISSUE TRAUMA; BLUNT THORACIC TRAUMA; HEMORRHAGIC-SHOCK; BRAIN-INJURY; SYSTEMIC INFLAMMATION; PORCINE MODEL; BONE-FRACTURE; CHEST TRAUMA; POLYTRAUMA; DAMAGE	This study aims to elaborate the relevance of trauma severity and traumatic injury pattern in different multiple and/or polytrauma models by comparing five singular trauma to two different polytrauma (PT) models with high and one multiple trauma (MT) model with low injury-severity score (ISS). The aim is to provide a baseline for reducing animal harm according to 3Rs by providing less injury as possible in polytrauma modeling. Mice were randomly assigned to 10 groups: controls (Ctrl; n = 15), Sham (n = 15); monotrauma groups: hemorrhagic shock (HS; n = 15), thoracic trauma (TxT; n = 18), osteotomy with external fixation (Fx; n = 16), bilateral soft tissue trauma (bSTT; n = 16) or laparotomy (Lap; n= 16); two PT groups: PT I (TxT + HS + Fx; ISS =18; n = 18), PT II (TxT + HS + Fx + Lap; ISS = 22; n= 18), and a MT group (TxT + HS + bSTT + Lap, ISS = 13; n= 18). Activity and mortality were assessed. Blood gas analyses and organ damage markers were determined after 6 h. Significant mortality occurred in TxT, PT and MT (11.7%). Activity decreased significantly in TxT, HS, both polytrauma and MT vs. Ctrl/Sham. PT-groups and MT had significantly decreased activity vs. bsTT, Lap or Fx. MT had significantly lower pCO(2) vs. Ctrl/Sham, Lap or bsTT. Transaminases increased significantly in PT-groups and MT vs. Ctrl, Sham or monotrauma. Traumatic injury pattern is of comparable relevance as injury severity for experimental multiple or (poly)trauma modeling.	[Yang, Bing; Bundkirchen, Katrin; Krettek, Christian; Neunaber, Claudia] Hannover Med Sch, Trauma Dept, Hannover, Germany; [Relja, Borna] Goethe Univ, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany		Neunaber, C (corresponding author), Hannover Med Sch, Trauma Dept, Hannover, Germany.	Neunaber.Claudia@mh-hannover.de	Neunaber, Claudia/AAJ-1490-2021; Relja, Borna/B-6642-2016	Neunaber, Claudia/0000-0002-8537-2238; Relja, Borna/0000-0002-5625-8823	China Scholarship CouncilChina Scholarship Council [201508440220]	The research stay of B.Y. in Germany was supported by an Oversea Study Fellowship from the China Scholarship Council, No. 201508440220.	Association T. R. C. o. S. o. E. a. t. B. O., 2000, BETT CAR SEV INJ; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Barkhausen T, 2009, INJURY, V40, P806, DOI 10.1016/j.injury.2008.07.018; Braun CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187327; Bundkirchen K, 2017, CLIN ORTHOP RELAT R, V475, P2783, DOI 10.1007/s11999-017-5473-8; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; Chaudry IH, 1993, PATHOPHYSIOLOGY SHOC, P371; Chen CY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012223; Claes L, 2006, J ORTHOP RES, V24, P1178, DOI 10.1002/jor.20173; Claes L, 2011, ACTA ORTHOP, V82, P223, DOI 10.3109/17453674.2011.570677; de Vries R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190587; Denk S, 2018, SHOCK, V49, P154, DOI 10.1097/SHK.0000000000000925; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Fitschen-Oestern S, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1813-9; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P921, DOI 10.1097/TA.0000000000000199; Gentile LF, 2013, CRIT CARE MED, V41, P1075, DOI 10.1097/CCM.0b013e318275d1f9; Hildebrand F, 2004, INJURY, V35, P678, DOI 10.1016/j.injury.2004.03.004; Hildebrand F, 2012, SHOCK, V38, P664, DOI 10.1097/SHK.0b013e3182709c90; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Holmes RS, 2009, COMPUT BIOL CHEM, V33, P379, DOI 10.1016/j.compbiolchem.2009.07.006; Horst K, 2016, SCI REP-UK, V6, DOI 10.1038/srep39659; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Hunt PA, 2006, INJURY, V37, P1, DOI 10.1016/j.injury.2005.02.014; Kaiser K, 2018, N-S ARCH PHARMACOL, V391, P523, DOI 10.1007/s00210-018-1483-7; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Lansink KWW, 2013, EUR J TRAUMA EMERG S, V39, P375, DOI 10.1007/s00068-013-0278-2; Levy RM, 2006, AM J PHYSIOL-REG I, V291, pR970, DOI 10.1152/ajpregu.00793.2005; Lichte P, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/132451; Luo SH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/412319; Maddali S, 2004, SURGERY, V136, P1038, DOI 10.1016/j.surg.2004.03.001; Marzi I, 2019, UNFALLCHIRURG, V122, P53, DOI 10.1007/s00113-018-0484-9; Matsutani T, 2005, CYTOKINE, V30, P168, DOI 10.1016/j.cyto.2004.12.019; Matsutani T, 2007, AM J SURG, V193, P61, DOI 10.1016/j.amjsurg.2006.07.012; Mattson DL, 2001, AM J HYPERTENS, V14, P405, DOI 10.1016/S0895-7061(00)01285-1; Mira JC, 2018, METHODS MOL BIOL, V1717, P1, DOI 10.1007/978-1-4939-7526-6_1; Moloney JT, 2008, CURR OPIN ANESTHESIO, V21, P41, DOI 10.1097/ACO.0b013e3282f2aadc; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Parry NG, 2015, CURR OPIN CRIT CARE, V21, P544, DOI 10.1097/MCC.0000000000000251; PRETORIUS JP, 1987, J TRAUMA, V27, P1344, DOI 10.1097/00005373-198712000-00005; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091045; Recknagel S, 2013, J TRAUMA ACUTE CARE, V74, P531, DOI 10.1097/TA.0b013e318278956d; Relja B, 2016, INJURY, V47, P640, DOI 10.1016/j.injury.2016.01.016; Relja B, 2018, EUR J TRAUMA EMERG S, V44, P301, DOI 10.1007/s00068-018-0962-3; Relja B, 2018, IMMUNOBIOLOGY, V223, P310, DOI 10.1016/j.imbio.2017.10.037; Relja B, 2009, SHOCK, V32, P509, DOI 10.1097/SHK.0b013e3181a2530d; Reynolds PS, 2018, J TRAUMA ACUTE CARE, V85, pS57, DOI [10.1097/TA.0000000000001844, 10.1097/ta.0000000000001844]; Sakran JV, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-64; Satoh Y, 2010, LASER SURG MED, V42, P313, DOI 10.1002/lsm.20899; Schimunek L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187404; Serve R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00435; Simon DW, 2016, METHODS MOL BIOL, V1462, P393, DOI 10.1007/978-1-4939-3816-2_22; Sobrino Justin, 2013, Proc (Bayl Univ Med Cent), V26, P120; Song Y, 2017, EUR REV MED PHARMACO, V21, P1522; Teranishi K, 2012, INJURY, V43, P585, DOI 10.1016/j.injury.2010.09.042; Thorsen K, 2011, BRIT J SURG, V98, P894, DOI 10.1002/bjs.7497; Tsukamoto T, 2009, SHOCK, V31, P3, DOI 10.1097/SHK.0b013e31817fdabf; Ulger H, 2014, THORAC CARDIOV SURG, V62, P716, DOI 10.1055/s-0034-1394103; Wagner N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192171; Wagner N, 2017, ALCOHOL CLIN EXP RES, V41, P1559, DOI 10.1111/acer.13446; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P489, DOI 10.1097/TA.0b013e31827d5f1b; Weckbach S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/890816; Wichmann MW, 1998, CRIT CARE MED, V26, P1372, DOI 10.1097/00003246-199808000-00024; Working ZM, 2017, INJURY, V48, P1459, DOI 10.1016/j.injury.2017.04.040; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	72	4	4	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 5	2019	9								5706	10.1038/s41598-019-42085-1			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR9LZ	WOS:000463482800045	30952899	gold, Green Published			2022-02-06	
J	Marshall, CM; Chan, N; Tran, P; DeMatteo, C				Marshall, Cameron M.; Chan, Nicole; Tran, Pauline; DeMatteo, Carol			The use of an intensive physical exertion test as a final return to play measure in concussed athletes: a prospective cohort	PHYSICIAN AND SPORTSMEDICINE			English	Article						Brain concussion; secondary prevention; return to sport; physical exertion; brain injuries; traumatic; symptom flare up	METABOLIC BRAIN VULNERABILITY; 2ND IMPACT SYNDROME; TEMPORAL WINDOW; HEAD-INJURY; EXERCISE; RECOVERY; ADOLESCENTS; SYMPTOMS; RISK	Objectives: To examine the utility of a novel physical exertion test developed by the Chicago Blackhawks medical staff as a final return to play (RTP) clearance test in youth and young adult athletes, and to determine the relationship between participant and test variables on RTP within asymptomatic athletes diagnosed with concussion. Methods: Once asymptomatic and following completion of all RTP steps, concussed athletes underwent the Gapski-Goodman Test (GGT) or modified GGT (mGGT) at partnered Complete Concussion Management Inc. (CCMI) clinics as part of RTP decision-making. Prospective data was collected electronically by trained CCMI clinicians utilizing the CCMI Concussion Database System. A review was conducted to examine data collected between January 2016 and February 2017. Participant and test variables were analyzed to determine relationships with pass/fail rate of the GGT/mGGT. Results: A total of 759 athletes performed the GGT/mGGT in the study period. Although all asymptomatic, 14.6% of concussed athletes failed the GGT/mGGT while attempting to achieve RTP clearance. Statistically significant relationships were found between failure of the test and symptom severity score on initial presentation and self-reported history of pre-morbid anxiety. When taken together, sex, age, and pre-morbid anxiety significantly predicted the length of time between injury and RTP clearance. Conclusion: The GGT may identify individuals who are not ready to RTP despite a self-reported asymptomatic status and completion of all RTP steps. These results illustrate that RTP clearance decisions based on self-reported asymptomatic status at rest may be inadequate. Instead, monitored, intensive, sport-specific, physical exertion testing should be utilized to inform clinical RTP decisions.	[Marshall, Cameron M.] Complete Concuss Management Inc, Dept Res, 2655 Bristol Circle, Oakville, ON L6H 7W1, Canada; [Chan, Nicole; Tran, Pauline; DeMatteo, Carol] McMaster Univ, Fac Hlth Sci, Sch Rehabil Sci, Inst Appl Hlth Sci, Hamilton, ON, Canada		Marshall, CM (corresponding author), Complete Concuss Management Inc, Dept Res, 2655 Bristol Circle, Oakville, ON L6H 7W1, Canada.	dr.cmarshall@outlook.com					Baker JG, 2012, REHABIL RES PRACT, V2012, P1; Balasundaram AP, 2017, SCAND J MED SCI SPOR, V27, P2002, DOI 10.1111/sms.12844; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2012, BRAIN INJURY PATHOGE, P501; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Whyte E. F., 2014, J SPORT REHABIL, V24, DOI DOI 10.1123/JSR.2014-0201; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	33	4	4	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	APR 3	2019	47	2					158	166		10.1080/00913847.2018.1542258			9	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	HV6IX	WOS:000466088200004	30372657				2022-02-06	
J	Zuckerman, SL; Kerr, ZY; Pierpoint, L; Kirby, P; Than, KD; Wilson, TJ				Zuckerman, Scott L.; Kerr, Zachary Y.; Pierpoint, Lauren; Kirby, Paul; Than, Khoi D.; Wilson, Thomas J.			An 11-year analysis of peripheral nerve injuries in high school sports	PHYSICIAN AND SPORTSMEDICINE			English	Article						Athletics; brachial plexus; high school; peripheral nerve injuries; stinger	UNITED-STATES; EPIDEMIOLOGY; CONTACT; BURNER; SURVEILLANCE; NEURAPRAXIA; CONCUSSIONS; PLAYER	Introduction: Sports surveillance databases provide valuable information regarding common ailments, yet fewer studies have focused on more rare peripheral nerve injuries. Our objective was to characterize peripheral nerve injuries in high school athletics with respect to incidence, time loss, mechanism, and diagnoses. Methods: Sport-related nerve injury data on high school athletes were collected during the 2005/2006 through 2015/2016 academic years via the High School Reporting Information Online (RIO) database. All injuries were reported by certified athletic trainers (ATs). Descriptive statistics were performed. Results: A total of 588 peripheral nerve injuries were recorded during the 2005/06-2015/16 academic years, with an overall incidence of 1.46/100,000 athlete-exposures (AE; 95%CI: 1.34, 1.58). Boys' football had the majority of injuries (71.3%) and the highest injury rate (5.46/100,000AE; 95%CI: 4.93, 5.98), followed by boys' wrestling (7.1%) and boys' baseball (3.4%). Over half (50.3%) of peripheral nerve injuries resulted in time loss < 1 week, while 9.4% resulting in the athletes prematurely ending their seasons. The most common mechanisms were player contact (67.3%), overuse (10.0%), and surface contact (9.7%). A specific diagnosis was available for 40 (6.8%) injuries, including upper extremity stinger (n = 26), spinal cord neurapraxia (n = 3), subacromial nerve impingement (n = 2) neuroma (n = 2), axillary nerve palsy (n = 1), sciatic nerve impingement (n = 1), femoral nerve impingement (n = 1), tarsal tunnel syndrome (n = 1), peroneal neuropathy (n = 1), thoracic outlet syndrome (n = 1), and ulnar nerve subluxation (n = 1). Discussion: Recognized peripheral nerve injuries are rare among high school athletes, occurring most commonly in boys' football. While most are minor, approximately 1:10 were season-ending. Specific diagnoses were available for 7% of injuries, with upper extremity stingers being the most commonly reported diagnosis. Working with ATs to identify and implement methods to obtain more specific diagnostic information via surveillance will help researchers better understand the epidemiology of peripheral nerve injuries.	[Zuckerman, Scott L.; Kirby, Paul] Vanderbilt Univ, Med Ctr, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Pierpoint, Lauren] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Than, Khoi D.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Wilson, Thomas J.] Stanford Univ, Dept Neurol Surg, Stanford, CA 94305 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack	The content of this report representing data collection by the National High School Sports-Related Injury Surveillance Study (High School Reporting Information Online) was funded in part by the Centers for Disease Control and Prevention grants [R49/CE000674-01 and R49/CE001172-01]. The authors also acknowledge the generous research funding contributions of the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the Centers for Disease Control and Prevention or any of the other institutions that provided financial support for this research.	[Anonymous], 1988, PEDIATRICS, V81, P737; Associations NFoSHS, 2014, 2014 15 HIGH SCH ATH; Beaulieu-Jones BR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117708744; Boden BP, 2017, SPORTS HEALTH, V9, P444, DOI 10.1177/1941738117712425; Charbonneau RME, 2012, CLIN J SPORT MED, V22, P472, DOI 10.1097/JSM.0b013e3182699ed5; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Cramer CR, 1999, J ATHL TRAINING, V34, P390; Drakos MC, 2011, NEUROSURGERY, V68, pE1743, DOI 10.1227/NEU.0b013e31821815af; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Feinberg J H, 2000, Phys Med Rehabil Clin N Am, V11, P771; Feinberg JH, 1997, SPORTS MED, V24, P385, DOI 10.2165/00007256-199724060-00004; Feinberg Joseph H, 2008, HSS J, V4, P87, DOI 10.1007/s11420-007-9064-1; Green J, 2017, RES SPORTS MED, V25, P26, DOI 10.1080/15438627.2016.1258642; Heck JF, 2004, J ATHL TRAINING, V39, P101; Izzi J, 2001, CLIN SPORT MED, V20, P203, DOI 10.1016/S0278-5919(05)70256-8; Joseph AM, 2013, J ATHL TRAINING, V48, P810, DOI 10.4085/1062-6050-48.6.03; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Kerrigan JM, 2017, CHILD NERV SYST, V33, P1669, DOI 10.1007/s00381-017-3537-4; Krivickas LS, 1998, MUSCLE NERVE, V21, P1092, DOI 10.1002/(SICI)1097-4598(199808)21:8<1092::AID-MUS19>3.3.CO;2-Z; Kuhlman GS, 1999, AM FAM PHYSICIAN, V60, P2035; League NF, 2017, OFF NAT FOOTB LEAG R; Levitz CL, 1997, AM J SPORT MED, V25, P73, DOI 10.1177/036354659702500114; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mitchell CH, 2014, AM J ROENTGENOL, V203, P1075, DOI 10.2214/AJR.13.12183; NCAA, 2016, FOOTB; Perlmutter GS, 1998, SPORTS MED, V26, P351, DOI 10.2165/00007256-199826050-00005; Pheasant S, 2016, INT J SPORTS PHYS TH, V11, P980; ROBERTSON WC, 1979, JAMA-J AM MED ASSOC, V241, P1480, DOI 10.1001/jama.241.14.1480; Robinson TW, 2014, PEDIATRICS, V133, P272, DOI 10.1542/peds.2013-2279; Saliba S, 2009, SPORTS HEALTH, V1, P370, DOI 10.1177/1941738109343544; Saper MG, 2017, AM J SPORTS MED; SPEER KP, 1990, AM J SPORT MED, V18, P591, DOI 10.1177/036354659001800606; Standaert CJ, 2009, ARCH PHYS MED REHAB, V90, P402, DOI 10.1016/j.apmr.2008.09.569; Swenson DM, 2013, CLIN J SPORT MED, V23, P190, DOI 10.1097/JSM.0b013e31827d21fe; Tirabassi J, 2016, AM J SPORT MED, V44, P2925, DOI 10.1177/0363546516644604; Toth C, 2009, PHYS MED REHABIL CLI, V20, P77, DOI 10.1016/j.pmr.2008.10.012; Tummala SV, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118756826; US Census Bureau, 2009, CENS REG US	40	4	4	3	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	APR 3	2019	47	2					167	173		10.1080/00913847.2018.1544453			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	HV6IX	WOS:000466088200005	30392428				2022-02-06	
J	Beauchamp, MH; Tang, K; Yeates, KO; Anderson, P; Brooks, BL; Keightley, M; Desire, N; Boutis, K; Gagnon, I; Gravel, J; Dubrovsky, AS; Zemek, R				Beauchamp, Miriam H.; Tang, Ken; Yeates, Keith Owen; Anderson, Peter; Brooks, Brian L.; Keightley, Michelle; Desire, Naddley; Boutis, Kathy; Gagnon, Isabelle; Gravel, Jocelyn; Dubrovsky, Alexander Sasha; Zemek, Roger		5P PERC Concussion Team	Predicting Wellness After Pediatric Concussion	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; children; positive outcome; post-concussive symptoms; quality of life; neuropsychology	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NEUROCOGNITIVE OUTCOMES; MILD; CHILDREN; HEALTH; SYMPTOMS; RESILIENCE; ADOLESCENTS; DIAGNOSIS	Objective: Concussion in children and adolescents is a prevalent problem with implications for subsequent physical, cognitive, behavioral, and psychological functioning, as well as quality of life. While these consequences warrant attention, most concussed children recover well. This study aimed to determine what pre-injury, demographic, and injury-related factors are associated with optimal outcome (wellness) after pediatric concussion. Method: A total of 311 children 6-18 years of age with concussion participated in a longitudinal, prospective cohort study. Pre-morbid conditions and acute injury variables, including post-concussive symptoms (PCS) and cognitive screening (Standardized Assessment of Concussion, SAC), were collected in the emergency department, and a neuropsychological assessment was performed at 4 and 12 weeks post-injury. Wellness, defined by the absence of PCS and cognitive inefficiency and the presence of good quality of life, was the main outcome. Stepwise logistic regression was performed using 19 predictor variables. Results: 41.5% and 52.2% of participants were classified as being well at 4 and 12 weeks post-injury, respectively. The final model indicated that children who were younger, who sustained sports/recreational injuries (vs. other types), who did not have a history of developmental problems, and who had better acute working memory (SAC concentration score) were significantly more likely to be well. Conclusions: Determining the variables associated with wellness after pediatric concussion has the potential to clarify which children are likely to show optimal recovery. Future work focusing on wellness and concussion should include appropriate control groups and document more extensively pre-injury and injury-related factors that could additionally contribute to wellness. (JINS, 2019, 25, 375-389)	[Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ H2V 2S9, Canada; [Beauchamp, Miriam H.; Gravel, Jocelyn] Ste Justine Hosp Res Ctr, Montreal, PQ H3T 1C5, Canada; [Tang, Ken; Zemek, Roger] Childrens Hosp Eastern Ontario Res Inst, Clin Res Unit, Ottawa, ON K1H 5B2, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada; [Yeates, Keith Owen; Brooks, Brian L.; Desire, Naddley] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB T3B 6A8, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON K1H 8L1, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Behav Neurosci & Consultat Liaison Program, Ottawa, ON K1H 8L1, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neuropsychol Serv, Calgary, AB T3B 6A8, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON M4G 1R8, Canada; [Keightley, Michelle] Univ Toronto, Dept Occupat Sci, Toronto, ON M5G 1V7, Canada; [Keightley, Michelle] Univ Toronto, Dept Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Keightley, Michelle] Univ Toronto, Rehabil Sci Inst, Toronto, ON M5G 1V7, Canada; [Boutis, Kathy] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Boutis, Kathy] Univ Toronto, Toronto, ON M5G 1X8, Canada; [Gagnon, Isabelle; Dubrovsky, Alexander Sasha] McGill Univ, Montreal Childrens Hosp, Hlth Ctr, Montreal, PQ H4A 3J1, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3G 1Y5, Canada; [Zemek, Roger] Univ Ottawa, Dept Pediat, Ottawa, ON K1Y 4E9, Canada; [Zemek, Roger] Univ Ottawa, Dept Emergency Med, Ottawa, ON K1Y 4E9, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca	Yeates, Keith/AAJ-4223-2020	Osmond, Martin/0000-0001-8275-8381; Yeates, Keith/0000-0001-7680-2892; Gagnon, Isabelle/0000-0003-2043-1644	University of Calgary Robert and Irene Ward Chair in Pediatric Brain Injury; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293380]; Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec	Brian Brooks receives royalties from the sale of the book, Pediatric Forensic Neuropsychology (2012, Oxford University Press), and three pediatric neuropsychological tests [Child and Adolescent Memory Profile (ChAMP; Sherman and Brooks, 2015; PAR Inc.), Memory Validity Profile (MVP; Sherman and Brooks, 2015; PAR Inc.), and Multidimensional Everyday Memory Ratings for Youth (MEMRY; Sherman and Brooks, 2017; PAR Inc.)]. Keith Yeates is supported by the University of Calgary Robert and Irene Ward Chair in Pediatric Brain Injury. He receives royalties for book sales from Guilford Press and Cambridge University Press, and occasionally serves as a paid expert in forensic cases. Miriam Beauchamp receives royalties for book sales from Guilford Press. This study was supported by project funding from the Canadian Institutes of Health Research (R.Z. 293380) and by a Fonds de la Recherche en Sante du Quebec salary awards to M.H.B. We would like to acknowledge the input and contributions of the entire 5P Study team, with particular thanks to the coordinators and assistants at the neuropsychology substudy sites and to Mary Aglipay for initial assistance with the statistical analyses.	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Archer E, 2019, RFPERMUTE ESTIMATE P; Asarnow R, 1995, TRAUMATIC BRAIN INJU, P117; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Balazs J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01942; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Beauchamp MH, 2018, NEUROPSYCHOLOGY, V32, P495, DOI 10.1037/neu0000419; Beauchamp MH, 2015, J INT NEUROPSYCH SOC, V21, P596, DOI 10.1017/S1355617715000636; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Bezner JR, 2001, ARCH PHYS MED REHAB, V82, P787, DOI 10.1053/apmr.2001.23269; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brown EA, 2016, J PEDIATR PSYCHOL, V41, P244, DOI 10.1093/jpepsy/jsv090; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; DeMatteo CA, 2014, BRAIN INJURY, V28, P114, DOI 10.3109/02699052.2013.848380; Desai AD, 2014, JAMA PEDIATR, V168, P1114, DOI 10.1001/jamapediatrics.2014.1600; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Durish C.L., 2018, J INT NEUROPSYCHOLOG; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Goreth Michelle Borzik, 2018, JBI Database System Rev Implement Rep, V16, P603, DOI 10.11124/JBISRIR-2017-003447; Hanks RA, 2014, ARCH PHYS MED REHAB, V95, P2096, DOI 10.1016/j.apmr.2014.06.017; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; HETTLER B, 1976, 6 DIMENSIONS WELLNES; Huber P., 1967, BEHAV MAXIMUM LIKELI, V1; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Klassen AF, 2004, PEDIATRICS, V114, pE541, DOI 10.1542/peds.2004-0844; Lee YC, 2019, DISABIL REHABIL, V41, P265, DOI 10.1080/09638288.2017.1391338; Little RJA., 2002, STAT ANAL MISSING DA, DOI [10.1002/9781119013563, DOI 10.1002/9781119013563]; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Lovell M.R., 2005, IMPACT IMMEDIATE POS; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Nalder E, 2019, DISABIL REHABIL, V41, P2708, DOI 10.1080/09638288.2018.1474495; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; O'Neill J. A., 2015, J PEDIAT NEUROPSYCHO, V1, P14, DOI [10.1007/s40817-015-0003-7, DOI 10.1007/S40817-015-0003-7]; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Plourde V, 2018, J INT NEUROPSYCH SOC, V24, P540, DOI 10.1017/S1355617718000061; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rubin D.B., 2004, MULTIPLE IMPUTATION; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; Studer M, 2014, J INT NEUROPSYCH SOC, V20, P982, DOI 10.1017/S1355617714000927; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; van Buuren S., 2012, FLEXIBLE IMPUTATION, DOI [DOI 10.1201/B11826, 10.1201/b11826]; Varni JW, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-26; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Waber DP, 2019, J LEARN DISABIL-US, V52, P146, DOI 10.1177/0022219418775119; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; World Health Organization, 1946, PREAMBL CONST WHO AD, P100; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	84	4	4	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2019	25	4					375	389		10.1017/S1355617719000286			15	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	IC9LS	WOS:000471304800005	31050335				2022-02-06	
J	Bierbaum, M; Lystad, RP; Curtis, K; Mitchell, R				Bierbaum, Mia; Lystad, Reidar P.; Curtis, Kate; Mitchell, Rebecca			Incidence and severity of head injury hospitalisations in Australian children over a 10-year period	HEALTH PROMOTION JOURNAL OF AUSTRALIA			English	Article						costs and cost analysis; craniocerebral trauma; hospitalisation; paediatrics; wounds and injuries	NEW-ZEALAND; TRAUMA; TRENDS; RISK; RATES	Issue addressed Child head injuries can cause life-long disability and are a major cause of mortality globally. The incidence and impact of child head injuries in Australia is unknown. This study aimed to quantify the incidence, characteristics and treatment cost and to identify factors associated with the severity of hospitalisations of head injuries in Australian children. Methods Linked hospitalisation and mortality data were used to retrospectively examine hospitalisation trends for head injury in children aged <= 16 years and associated factors, in Australia, from 1 July 2002 to 30 June 2012. Results There were 164 126 hospitalisations of children for head injury during the 10-year period, commonly male (65.5%), or aged <= 5 years (48.3%). The incidence among children aged <1 year and 1-5 years significantly increased by 1.7% (95% CI 0.9-2.6; P < 0.0001) and 1.5% (95% CI 1.1-1.9; P < 0.0001) annually during the study period, respectively. The most common injury mechanisms across all age groups were falls (45.2%) and road trauma (16.0%). Head injury hospitalisations cost $468.9 million, with the higher costs found for children aged 11-16 years, and for the most severe injuries. Conclusion Head injury hospitalisations cost the Australian health system close to half a billion dollars over a 10-year period, with the most serious injuries resulting in lifelong health implications. So what? Targeted health promotion strategies such as the promotion of helmet wearing during scooter use, the introduction of cycleways, and impact absorbing surfaces on playgrounds, need to be implemented to reduce the occurrence of head injuries in children.	[Bierbaum, Mia; Lystad, Reidar P.; Mitchell, Rebecca] Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW, Australia; [Curtis, Kate] Univ Sydney, Sydney Nursing Sch, Sydney, NSW, Australia		Mitchell, R (corresponding author), Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW, Australia.	r.mitchell@mq.edu.au	Mitchell, Rebecca/Z-5476-2019; Lystad, Reidar P./D-1611-2013; Bierbaum, Mia/AAJ-9497-2020	Mitchell, Rebecca/0000-0003-1939-1761; Lystad, Reidar P./0000-0003-0506-0902; Bierbaum, Mia/0000-0002-7037-4708	NSW Health Early-Mid Career Fellowships Scheme; Day of Difference Foundation	NSW Health Early-Mid Career Fellowships Scheme; Day of Difference Foundation	Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; [Anonymous], 2007, NAT HOSP COST DAT CO; Ashby K, 2000, CHILD FALL INJURIES; Australian Bureau of Statistics, 2017, 3101 0 AUSTR DEM STA; Australian Bureau of Statistics, 2011, AUSTR STAT GEOGR STA; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Bierbaum M, 2018, J PAEDIATR CHILD H, V54, P556, DOI 10.1111/jpc.13777; Bressan S, 2016, EMERG MED AUSTRALAS, V28, P425, DOI 10.1111/1742-6723.12617; Campbell H, 1997, Inj Prev, V3, P17, DOI 10.1136/ip.3.1.17; Cassell E., 2014, PREVENTING SERIOUS F; Chapman S, 2001, J PAEDIATR CHILD H, V37, P567, DOI 10.1046/j.1440-1754.2001.00763.x; Cho JH, 2009, J PAEDIATR CHILD H, V45, P505, DOI 10.1111/j.1440-1754.2009.01556.x; Dayal S., 2008, MAPPING INJURY SEVER; Durbin DR, 2005, PEDIATRICS, V115, pE305, DOI 10.1542/peds.2004-1522; Durbin DR, 2003, JAMA-J AM MED ASSOC, V289, P2835, DOI 10.1001/jama.289.21.2835; Faruque AV, 2016, JCPSP-J COLL PHYSICI, V26, P445, DOI 2335; Fitzpatrick DG, 2018, INT J ORAL MAX SURG, V47, P1121, DOI 10.1016/j.ijom.2018.03.005; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; Kaushik R, 2015, INJ EPIDEMIOL, V2, P189; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim KA, 2000, NEUROSURG FOCUS, V8, P189; Kool B, 2013, NEUROEPIDEMIOLOGY, V41, P189, DOI 10.1159/000354782; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Loftis CM, 2017, J PEDIATR ORTHOPED, V37, P521, DOI 10.1097/BPO.0000000000000719; Mack MG, 1997, RES Q EXERCISE SPORT, V68, P368, DOI 10.1080/02701367.1997.10608019; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Marlow R, 2015, ARCH DIS CHILD, V100, P1136, DOI 10.1136/archdischild-2015-308615; Miller CM, 2013, J TRAUMA ACUTE CARE, V75, P250, DOI 10.1097/TA.0b013e3182930fb7; Mitchell Rebecca, 2007, Health Promot J Austr, V18, P98; Mitchell RJ, 2014, AUST NZ J PUBL HEAL, V38, P275, DOI 10.1111/1753-6405.12234; Morrongiello BA, 1998, J PEDIATR PSYCHOL, V23, P33, DOI 10.1093/jpepsy/23.1.33; Mulligan CS, 2017, J PAEDIATR CHILD H, V53, P754, DOI 10.1111/jpc.13568; Munro C., 2017, RESULTS 2017 NATL CY; National Road Transport Commission, 2009, AUSTR ROAD RUL 14; NSW Department of Health, 2009, NSW COSTS CAR STAND; Olivier J, 2013, ACCIDENT ANAL PREV, V50, P1128, DOI 10.1016/j.aap.2012.09.003; Pal'a A, 2015, J CHILD NEUROL, V30, P1153, DOI 10.1177/0883073814554655; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Petridou E, 2002, ACTA PAEDIATR, V91, P691, DOI 10.1080/080352502760069133; Pointer S., 2014, INJURY RES STAT SERI, V91; Powell EC, 2004, AMBUL PEDIATR, V4, P495, DOI 10.1367/A04-074R1.1; Sandler G, 2011, PEDIATR EMERG CARE, V27, P1052, DOI 10.1097/PEC.0b013e318235e9e0; SAS Institute, 2014, SAS STAT SOFTW VERS; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shankar A, 2006, PEDIATR EMERG CARE, V22, P644, DOI 10.1097/01.pec.0000221339.26873.14; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Stephenson S, 2003, DIAGNOSIS BASED INJU; Stephenson SCR, 2002, J TRAUMA, V53, P326, DOI 10.1097/00005373-200208000-00023; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424	49	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1036-1073	2201-1617		HEALTH PROMOT J AUST	Health Promot. J. Aust.	APR	2019	30	2					189	198		10.1002/hpja.186			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HU0UD	WOS:000464986000008	30030878				2022-02-06	
J	Choffat, C; Delhumeau, C; Fournier, N; Schoettker, P				Choffat, Caroline; Delhumeau, Cecile; Fournier, Nicolas; Schoettker, Patrick			Effect of Pre-Hospital Intubation in Patients with Severe Traumatic Brain Injury on Outcome: A Prospective Cohort Study	JOURNAL OF CLINICAL MEDICINE			English	Article						neurotrauma; severe traumatic brain injury; pre-hospital intubation; secondary injury	GLASGOW COMA SCALE; PROGNOSTIC VALUE; SCORE; MORTALITY; IMPACT; MANAGEMENT; COMPONENTS; SURVIVAL; CARE	Secondary injuries are associated with bad outcomes in the case of severe traumatic brain injury (sTBI). Patients with a Glasgow Coma Scale (GCS) < 9 should undergo pre-hospital intubation (PHI). There is controversy about whether PHI is beneficial. The aim of this study was to estimate the effect of PHI in patients after sTBI. A multicenter, prospective cohort study was performed in Switzerland, including 832 adults with sTBI. Outcomes were death and impaired consciousness at 14 days. Associations between risk factors and outcomes were assessed with univariate and multivariate Cox models for survival, and univariate and multivariate regression models for impaired consciousness. Potential risk factors were age, GCS on scene, pupil reaction, Injury Severity Score (ISS), PHI, oxygen administration, and type of admission to trauma center. Age, GCS on scene < 9, abnormal pupil reaction and ISS 25 were associated with mortality. GCS < 9 and ISS 25 were correlated with impaired consciousness. PHI was overall not associated with short-term mortality and consciousness. However, there was a significative interaction with PHI and major trauma. PHI improves outcome from patients with sTBI and an ISS 25.	[Choffat, Caroline; Delhumeau, Cecile; Fournier, Nicolas; Schoettker, Patrick] Univ Hosp Lausanne, Anesthesiol Serv, CH-1011 Lausanne, Switzerland		Choffat, C (corresponding author), Univ Hosp Lausanne, Anesthesiol Serv, CH-1011 Lausanne, Switzerland.	carolinechoffat@gmail.com; cecile.delhumeau@hcuge.ch; nicolas.fournier@gmail.com; patrick.schoettker@chuv.ch	Schoettker, Patrick/AAE-4462-2020	Schoettker, Patrick/0000-0001-5370-048X			Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Bootland D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023307; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COOKE RS, 1995, INJURY, V26, P399, DOI 10.1016/0020-1383(95)00064-G; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Dick WF, 2000, BRIT J ANAESTH, V84, P818, DOI 10.1093/oxfordjournals.bja.a013601; Garner AA, 2015, EMERG MED J, V32, P869, DOI 10.1136/emermed-2014-204390; Haltmeier T, 2017, EUR J TRAUMA EMERG S, V43, P731, DOI 10.1007/s00068-016-0718-x; Hoffmann M, 2017, J NEUROSURG ANESTH, V29, P161, DOI 10.1097/ANA.0000000000000275; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Rossi-Mossuti F, 2016, J NEUROL SURG PART A, V77, P36, DOI 10.1055/s-0035-1563556; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Tuma M, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/135986; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wahlin RR, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00194; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	35	4	4	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2077-0383			J CLIN MED	J. Clin. Med.	APR	2019	8	4								10.3390/jcm8040470			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX6FT	WOS:000467500200055	30959868	Green Published, gold, Green Submitted			2022-02-06	
J	Edgerton, CA; Leon, SM; Hite, MA; Kalhorn, SP; Scott, LA; Eriksson, EA				Edgerton, Colston A.; Leon, Stuart M.; Hite, Melissa A.; Kalhorn, Stephen P.; Scott, Lancer A.; Eriksson, Evert A.			Airway pressure release ventilation does not increase intracranial pressure in patients with traumatic brain injury with poor lung compliance	JOURNAL OF CRITICAL CARE			English	Article						Traumatic Brain injury; Airway pressure release ventilation; Intracranial pressure; Airway compliance	END-EXPIRATORY PRESSURE	The use of Airway Pressure Release Ventilation (APRV) in patients with traumatic brain injury (TBI) remains controversial. Some believe that elevated mean airway pressures transmitted to the thorax may cause clinically significant increases in Central Venous Pressure (CVP) and intracranial pressure (ICP) from venous congestion. We perform a retrospective review from 2009 to 2015 of traumatically injured patients who were transitioned from traditional ventilator modes to APRV and also had an ICP monitor in place. Fifteen patients undergoing 19 transitions to APRV were identified. Prior to transitioning to APRV the average static and dynamic compliance was 22.9 +/- 5.6 and 16.5 +/- 4.12 mL/cm H2O. There was no statistical difference in ICP, MAP, and CPP prior to and after transition to APRV. There was a statistically significant increase in CVP, PaO2, and P:F ratio. Individually, only 4 patients had ICP values >20 in the first hour after transitioning to APRV and the rate of ICP elevations was similar between the two modes of ventilation. These data show that APRV is a viable mode of ventilation in patients with TBI who have low lung compliance. The increased CVP of this mode of ventilation did not affect ICP or hemodynamic parameters. (C) 2018 Elsevier Inc. All rights reserved.	[Edgerton, Colston A.; Leon, Stuart M.; Hite, Melissa A.; Eriksson, Evert A.] Med Univ South Carolina, Dept Surg, Div Trauma & Crit Care, 96 Jonathan Lucas St CSB 416, Charleston, SC 29425 USA; [Kalhorn, Stephen P.] Med Univ South Carolina, Dept Neurosurg, 96 Jonathan Lucas St Room 301 CSB, Charleston, SC 29425 USA; [Scott, Lancer A.] Med Univ South Carolina, Dept Emergency Med, 169 Ashley Ave Room 265 NT, Charleston, SC 29425 USA		Eriksson, EA (corresponding author), Dept Surg, 96 Jonathan Lucas St,CSB 416, Charleston, SC 29425 USA.	edgertoc@musc.edu; leon@musc.edu; hitema@musc.edu; kalhorn@musc.edu; scottlan@musc.edu; evsurgery@gmail.com					Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Daoud EG, 2012, RESP CARE, V57, P282, DOI 10.4187/respcare.01238; Fletcher JJ, 2018, J INTENSIVE CARE MED, V33, P196, DOI 10.1177/0885066616669315; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; Habashi Nader M, 2005, Crit Care Med, V33, pS228, DOI 10.1097/01.CCM.0000155920.11893.37; Marik PE, 2012, NEUROCRIT CARE, V17, P219, DOI 10.1007/s12028-012-9739-4; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; Mireles-Cabodevila E, 2016, RESP CARE, V61, P761, DOI 10.4187/respcare.04653; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; Salim A, 2004, J TRAUMA, V57, P542, DOI 10.1097/01.TA.0000135159.94744.5F; Stock MC, 1987, AIRWAY PRESSURE RELE	11	4	4	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2019	50						118	121		10.1016/j.jcrc.2018.11.034			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HL0HO	WOS:000458375800019	30530262				2022-02-06	
J	Gobert, F; Luaute, J; Raverot, V; Cotton, F; Dallier, F; Claustrat, B; Perrin, F; Gronfier, C				Gobert, Florent; Luaute, Jacques; Raverot, Veronique; Cotton, Francois; Dallier, Frederic; Claustrat, Bruno; Perrin, Fabien; Gronfier, Claude			Is circadian rhythmicity a prerequisite to coma recovery? Circadian recovery concomitant to cognitive improvement in two comatose patients	JOURNAL OF PINEAL RESEARCH			English	Article						biomarkers; circadian rhythm; cognition; coma; hypothalamus; melatonin; traumatic brain injury	VEGETATIVE STATE; MELATONIN; SLEEP; BRAIN; LIGHT; 6-SULPHATOXYMELATONIN; ALERTNESS; PHASE; SUPPRESSION; DISRUPTION	Circadian rhythmicity (CR) is involved in the regulation of all integrated functions, from sleep-wake cycle regulation to metabolic function, mood and cognition. However, the interdependence of CR, cognition and consciousness has been poorly addressed. To clarify the state of CR in coma and to determine the chronological relationship between its recovery and consciousness after brain lesions, we conducted a longitudinal observational study investigating how the state of CR was chronologically related with the recovery of behavioural wakefulness, cognition and/or awareness. Among 16 acute comatose patients, we recruited two 37-year-old patients with a persistent disorder of consciousness, presenting diencephalic lesions caused by severe traumatic brain injuries. Two biological urinary markers of CR were explored every 2 hours during 24 hours (6-sulfatoxymelatonin, free cortisol) with a dedicated methodology to extract the endogenous component of rhythmicity (environmental light recording, near-constant-routine protocol, control of beta-blockers). They presented an initial absence of rhythmic secretions and a recovered CR 7-8 months later. This recovery was not associated with the restoration of behavioural wakefulness, but with an improvement of cognition and awareness (up to the minimally conscious state). MRI showed a lesion pattern compatible with the interruption of either the main hypothalamic-sympathetic pathway or the accessory habenular pathway. These results suggest that CR may be a prerequisite for coma recovery with a potential but still unproven favourable effect on brain function of the resorted circadian melatonin secretion and/or the functional recovery of the suprachiasmatic nucleus (SCN). Assessing circadian functions by urinary melatonin should be further explored as a biomarker of cognition reappearance and investigated to prognosticate functional recovery.	[Gobert, Florent; Dallier, Frederic] Hosp Civils Lyon, Neurol Hosp Pierre Wertheimer, Neurointens Care Unit, Bron, France; [Gobert, Florent; Luaute, Jacques] Univ Claude Bernard Lyon 1, Lyon Neurosci Res Ctr, ImpAct Team Integrat Multisensory Percept Act & C, INSERM U1028,CNRS UMR5292, Bron, France; [Gobert, Florent; Perrin, Fabien] Univ Claude Bernard Lyon 1, Lyon Neurosci Res Ctr, CAP Team Cognit Audit & Psychoacoust, INSERM U1028,CNRS UMR5292, Lyon, France; [Luaute, Jacques] Hosp Civils Lyon, Neurol Hosp Pierre Wertheimer, Neurorehabil Unit, Bron, France; [Raverot, Veronique; Claustrat, Bruno] Hosp Civils Lyon, Neurol Hosp Pierre Wertheimer, Hormone Lab, Bron, France; [Cotton, Francois] Hosp Civils Lyon, Lyon Sud Hosp, Radiol Unit, Pierre Benite, France; [Cotton, Francois] INSERM U630, CNRS UMR 5220, CREATIS LRMN, Villeurbanne, France; [Gronfier, Claude] Univ Claude Bernard Lyon 1, Univ Lyon, Integrat Physiol Brain Arousal Syst Waking Team, INSERM UMRS 1028,CNRS UMR 5292,Lyon Neurosci Res, F-69000 Lyon, France		Gobert, F (corresponding author), Hosp Civils Lyon, Neurol Hosp Pierre Wertheimer, Neurointens Care Unit, Lyon, France.	gobert.flo@gmail.com	Gronfier, Claude/C-1243-2008	Gronfier, Claude/0000-0002-6549-799X; Raverot, Veronique/0000-0003-4336-1271			Abeysuriya RG, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12474; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Auger RR, 2015, J CLIN SLEEP MED, V11, P1199, DOI 10.5664/jcsm.5100; Ayer RE, 2008, J PINEAL RES, V44, P197, DOI 10.1111/j.1600-079X.2007.00508.x; Blume C, 2017, NEUROLOGY, V88, P1933, DOI 10.1212/WNL.0000000000003942; COHEN RA, 1991, NEUROLOGY, V41, P726, DOI 10.1212/WNL.41.5.726; Cortese MD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0455-5; Cruse D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-18; Czeisler CA, 2007, COLD SPRING HARB SYM, V72, P579, DOI 10.1101/sqb.2007.72.064; DAUCH WA, 1990, J NEUROL NEUROSUR PS, V53, P345, DOI 10.1136/jnnp.53.4.345; DEACON SJ, 1994, CLIN ENDOCRINOL, V40, P413; DIJK DJ, 1995, ACTA NEUROPSYCHIATR, V7, P24, DOI 10.1017/S0924270800037467; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Figueiro Mariana G, 2012, BMC Res Notes, V5, P221, DOI 10.1186/1756-0500-5-221; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Frank MG, 2014, TRENDS NEUROSCI, V37, P491, DOI 10.1016/j.tins.2014.06.005; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; Guaraldi P, 2014, CHRONOBIOL INT, V31, P741, DOI 10.3109/07420528.2014.901972; HARTHE C, 1991, CLIN CHEM, V37, P536; Hatonen T, 1999, BIOL PSYCHIAT, V46, P827, DOI 10.1016/S0006-3223(98)00357-6; JEWETT ME, 1991, NATURE, V350, P59, DOI 10.1038/350059a0; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Kripke DF, 2005, CHRONOBIOL INT, V22, P695, DOI 10.1080/07420520500180439; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lockley SW, 2008, J SLEEP RES, V17, P207, DOI 10.1111/j.1365-2869.2008.00656.x; Lockley SW, 2000, J ENDOCRINOL, V164, pR1, DOI 10.1677/joe.0.164R001; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Naccache L, 2018, BRAIN, V141, P949, DOI 10.1093/brain/awx324; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Papp RS, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00034; Perrin F, 2004, CURR BIOL, V14, P1842, DOI 10.1016/j.cub.2004.09.082; Ritzenthaler T, 2013, NEUROSCI LETT, V544, P1, DOI 10.1016/j.neulet.2013.02.073; Ritzenthaler T, 2009, J PINEAL RES, V46, P349, DOI 10.1111/j.1600-079X.2009.00670.x; Roenneberg T, 2016, CURR BIOL, V26, pR432, DOI 10.1016/j.cub.2016.04.011; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Sharma R, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12498; Skene DJ, 1999, CLIN ENDOCRINOL, V50, P715; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Xu H, 2014, J BIOL CHEM, V289, P16374, DOI 10.1074/jbc.M113.539601	43	4	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3098	1600-079X		J PINEAL RES	J. Pineal Res.	APR	2019	66	3							e12555	10.1111/jpi.12555			10	Endocrinology & Metabolism; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology; Physiology	HO0HQ	WOS:000460583700009	30633817				2022-02-06	
J	Kwon, SJ; Barletta, JF; Hall, ST; Mangram, AJ; Dzandu, JK; Abdulhamid, M; Zach, V				Kwon, Samuel J.; Barletta, Jeffrey F.; Hall, Scott T.; Mangram, Alicia J.; Dzandu, James K.; Abdulhamid, Mohamed; Zach, Victor			Lacosamide versus phenytoin for the prevention of early post traumatic seizures	JOURNAL OF CRITICAL CARE			English	Article						Early post traumatic seizures; Lacosamide; Phenytoin; Traumatic brain injury	BRAIN-INJURY; INTRAVENOUS LEVETIRACETAM; STATUS EPILEPTICUS; PROPHYLAXIS; EFFICACY; SAFETY	Purpose: To compare the efficacy and safety of lacosamide versus phenytoin for seizure prophylaxis following TBI. Materials and methods: All TBI patients who received prophylaxis with either phenytoin or lacosamide were retrospectively identified. The incidence of seizures within the first 7 days of injury were compared along with adverse effects requiring drug discontinuation. A planned sub-group analysis was performed for patients with severe TBI (GCS < 9). Results: There were 481 patients (phenytoin, n = 116; lacosamide, n = 365). Demographics were similar but age (50 +/- 21 vs 58 +/- 22 years, P < .001) and initial GCS (11.3 +/- 4.3 vs 12.5 +/- 3.8, P = .010) were lower in the phenytoin group. The need for mechanical ventilation was higher (53% vs 38%, P = .004). Seizures occurred in 0.9% of the phenytoin group and 1.4% of the lacosamide group (P = 1.00). ADEs were significantly higher with phenytoin (5.2% vs 0.5%, P = .003). This difference remained significant upon multivariate analysis [OR(95% CI) = 9.4 (1.8-48.9)]. Subgroup analysis for patients with severe TB! revealed no difference in seizures (phenytoin, 0% vs lacosamide, 1.5%; P = 1.00) but more ADEs with phenytoin (12.5% vs 0%, P = .010). Conclusion: There was no difference between lacosamide and phenytoin in the prevention of early post traumatic seizures in patients following TBI. Lacosamide may have a more tolerable side effect profile. (C) 2018 Elsevier Inc. All rights reserved.	[Kwon, Samuel J.; Hall, Scott T.] HonorHlth John C Lincoln Med Ctr, Dept Pharm Serv, 250 E Dunlap Ave, Phoenix, AZ 85020 USA; [Barletta, Jeffrey F.] Midwestern Univ, Dept Pharm Practice, Coll Pharm Glendale, 19555 N 59th Ave, Glendale, AZ 85308 USA; [Mangram, Alicia J.; Dzandu, James K.] HonorHlth John C Lincoln Med Ctr, Trauma & Acute Care Surg, 250 E Dunlap Ave, Phoenix, AZ 85020 USA; [Abdulhamid, Mohamed] Royal Inst Adv Spine Surg LLC, Neurosurg, 5415 E High St Suite 105, Phoenix, AZ 85054 USA; [Zach, Victor] AT Still Univ, Neurocrit Care, Sch Osteopath Med, 111 E Dunlap Ave 1-279, Phoenix, AZ 85020 USA		Barletta, JF (corresponding author), Midwestern Univ, Dept Pharm Practice, Coll Pharm Glendale, 19555 N 59th Ave, Glendale, AZ 85308 USA.	jbarle@midwestern.edu	Barletta, Jeffrey F./B-2644-2013	Barletta, Jeffrey/0000-0002-9054-8218; Dzandu, James/0000-0002-9283-8542			Backman JT, 1996, EPILEPSIA, V37, P253, DOI 10.1111/j.1528-1157.1996.tb00021.x; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Buckley MS, 2016, ANN PHARMACOTHER, V50, P276, DOI 10.1177/1060028015627468; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cawello W, 2015, CLIN PHARMACOKINET, V54, P901, DOI 10.1007/s40262-015-0276-0; Cherry S, 2012, NEUROCRIT CARE, V16, P294, DOI 10.1007/s12028-011-9662-0; Gabriel WM, 2014, ANN PHARMACOTHER, V48, P1440, DOI 10.1177/1060028014549013; Garvin R, 2017, NEUROCRIT CARE, V27, pS159, DOI 10.1007/s12028-017-0461-0; Goodwin H, 2011, NEUROCRIT CARE, V14, P348, DOI 10.1007/s12028-010-9501-8; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Legros B, 2014, NEUROCRIT CARE, V20, P484, DOI 10.1007/s12028-013-9882-6; Newey CR, 2017, NEUROCRIT CARE, V26, P273, DOI 10.1007/s12028-016-0322-2; Ouchi K, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0006-z; Patanwala AE, 2016, BRAIN INJURY, V30, P156, DOI 10.3109/02699052.2015.1089596; Radic JAE, 2014, NEUROCRIT CARE, V21, P228, DOI 10.1007/s12028-013-9951-x; Spencer DD, 2011, PHARMACOTHERAPY, V31, P934, DOI 10.1592/phco.31.10.934; Sutter R, 2013, CNS DRUGS, V27, P321, DOI 10.1007/s40263-013-0049-y; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Teixeira PGR, 2013, J TRAUMA ACUTE CARE, V75, P717, DOI 10.1097/TA.0b013e31829d27b6; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Wilson CD, 2018, WORLD NEUROSURG, V110, pE901, DOI 10.1016/j.wneu.2017.11.116; Zangbar B, 2016, WORLD J SURG, V40, P2667, DOI 10.1007/s00268-016-3606-y	25	4	4	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2019	50						50	53		10.1016/j.jcrc.2018.11.010			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HL0HO	WOS:000458375800008	30471561				2022-02-06	
J	McCarron, RH; Watson, S; Gracey, F				McCarron, Robyn Henrietta; Watson, Suzanna; Gracey, Fergus			What do Kids with Acquired Brain Injury Want? Mapping Neuropsychological Rehabilitation Goals to the International Classification of Functioning, Disability and Health	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Education; emotions; environment; family; friendships; relationships; participation; social	CHILDHOOD; CHILDREN; YOUTH; OUTCOMES; TBI; PARTICIPATION; DISORDERS; RECOVERY	Objective: To increase understanding of the community neuropsychological rehabilitation goals of young people with acquired brain injuries (ABIs). Method: Three hundred twenty-six neuropsychological rehabilitation goals were extracted from the clinical records of 98 young people with ABIs. The participants were 59% male, 2-19 years old, and 64% had a traumatic brain injury. Goals were coded using the International Classification of Functioning, Disability and Health: Children and Youth Version (ICF-CY). Descriptive statistical analysis was performed to assess the distribution of goals across the ICF-CY. Chi-squared and Cramer's V were used to identify demographic and injury-related associations of goal type. Results: The distribution of goals was 52% activities and participation (AP), 28% body functions (BF), 20% environmental factors (EF), and <1% body structures (BS). The number of EF goals increased with age at assessment (V = .14). Non-traumatic causes of ABIs were associated with more EF goals (V = .12). There was no association between sex or time post-injury and the distribution of goals across the ICF-CY. Conclusions: Young people with ABIs have a wide range of community neuropsychological rehabilitation goals that require an individualized, context-sensitive, and interdisciplinary approach. Community neuropsychological rehabilitation services may wish to ensure they are resourced to focus intervention on AP, with increasing consideration for EF as a young person progresses through adolescence. The findings of this research support models of community neuropsychological rehabilitation that enable wellness by combining direct rehabilitative interventions with attention to social context and systemic working across agencies. (JINS, 2019, 25, 403-412)	[McCarron, Robyn Henrietta; Watson, Suzanna; Gracey, Fergus] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge Ctr Paediat Neuropsychol Rehabil, Cambridge CB2 8AH, Cambs, England; [McCarron, Robyn Henrietta] Univ Cambridge, Dept Psychiat, Cambridge CB2 0SZ, Cambs, England; [Watson, Suzanna; Gracey, Fergus] Natl Inst Hlth Res, Collaborat Leadership Appl Hlth Res & Care East E, Cambridge CB2 8AH, Cambs, England; [Gracey, Fergus] Univ East Anglia, Dept Clin Psychol, Norwich NR4 7TJ, Norfolk, England		McCarron, RH (corresponding author), Cambridge Ctr Paediat Neuropsychol Rehabil, Brookside Clin, 18D Trumpington Rd, Cambridge CB2 8AH, England.	robyn.dudley@cantab.net	McCarron, Robyn/AAZ-3977-2021	McCarron, Robyn/0000-0002-9878-0345; Watson, Suzanna/0000-0002-9225-8919; Gracey, Fergus/0000-0002-1416-7894	National Institute of Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care East of England Programme; University of CambridgeUniversity of Cambridge; Cambridgeshire and Peterborough NHS Foundation Trust	Y We thank the young people and their families who have made this work possible, and the clinical team who have supported them through their neuropsychological rehabilitation journeys. F.G. and S.W. were supported by the National Institute of Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care East of England Programme. R.H.M. was supported by an academic and clinical fellowship in psychiatry jointly funded by the University of Cambridge and Cambridgeshire and Peterborough NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the University of Cambridge, or the Department of Health and Social Care.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; [Anonymous], 2011, WORLD REP DIS; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; British Society of Rehabilitation Medicine, 2015, SPEC NEUR SERV STAND; Byard Katie, 2011, Clin Child Psychol Psychiatry, V16, P165, DOI 10.1177/1359104511403582; Chan V, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0631-2; Ciccia AH, 2015, INT J LANG COMM DIS, V50, P436, DOI 10.1111/1460-6984.12153; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Department for Education, 2014, SEND COD PRACT; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Dunford C, 2013, BRIT J OCCUP THER, V76, P67, DOI 10.4276/030802213X13603244419158; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Foresight Mental Capital and Wellbeing Project, 2008, FOR MIGR GLOB ENV CH; Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; Gracey F., 2015, NEUROPSYCHOL REHABIL, P191; Gracey F., 2014, SOCIAL CARE NEURODIS, V5, P160, DOI DOI 10.1108/SCN-08-2013-0030; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Greenham M, 2015, DEV NEUROPSYCHOL, V40, P348, DOI 10.1080/87565641.2015.1095191; Lewis JK, 2000, J HEAD TRAUMA REHAB, V15, P930, DOI 10.1097/00001199-200006000-00006; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Mbale EW, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0763-y; McCarron R, 2017, CLIN NEUROPSYCHIATR, V14, P195; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; McKinlay A, 2013, INT NEUROTRAUMA LETT; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; National Institute for Health and Care Excellence, 2016, MAJ TRAUM SERV DEL N; NHS England, 2013, 2013 2014 NHS STAND; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Steinberg M, 2008, NY TIMES BK REV, P6; Thompson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157951; Tucker P., 2015, NEUROPSYCHOLOGICAL R, P151, DOI [10.1057/9781137388223_8, DOI 10.1057/9781137388223_8]; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization, 2007, INT CLASS FUNCT DIS; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	45	4	4	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2019	25	4					403	412		10.1017/S1355617719000213			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	IC9LS	WOS:000471304800007	31050334	Green Accepted			2022-02-06	
J	Mori, H; Naito, M; Nakane, A; Tohara, H				Mori, Hiroko; Naito, Mariko; Nakane, Ayako; Tohara, Haruka			Caregivers' Perspectives on the Slight Recovery of Oral Intake of Home-Dwelling Patients Living With a Percutaneous Endoscopic Gastrostomy Tube: A Qualitative Study Using Focus Group Interviews	NUTRITION IN CLINICAL PRACTICE			English	Article						brain injuries; caregivers; enteral nutrition; gastrostomy tube; home enteral nutrition; quality of life	TRAUMATIC BRAIN-INJURY; ENTERAL-NUTRITION; CARERS EXPERIENCES; NECK-CANCER; SWALLOWING THERAPY; STROKE; DYSPHAGIA; HEAD; PREVALENCE; CHALLENGES	Background Swallowing rehabilitation for patients living with a percutaneous endoscopic gastrostomy (PEG) tube for home enteral nutrition (HEN) is poorly documented, and the quality of caregivers' daily lives is also unknown. Methods A qualitative study based on constant comparative analysis was conducted. The study subjects were the caregivers of acquired brain injury survivors residing at home and living with a PEG tube for HEN who had recovered slight oral intake because of swallowing rehabilitation. Interviews were transcribed into anonymous transcripts and analyzed using inductive qualitative analysis. After 2 researchers performed the initial analysis, related concepts were extracted using matrix-based methods. Finally, an audit was conducted to verify the consistency between the data and extracted concepts. Results Of the 22 caregivers (17 stroke cases and 5 traumatic brain injury cases), 21 were female and 1 was male. The psychological impact on caregivers' daily lives because of the patients' slight recovery of oral intake consisted of 4 concepts: (1) reconstructing and/or strengthening a sense of family belonging, (2) combining oral intake and other rehabilitation, (3) reducing the burden of providing care, and (4) relieving social isolation. Additionally, the evaluation of swallowing function using video endoscopy at every visit led to compliance with eating safety to fit patients' swallowing ability. Conclusions Slight recovery of patients' oral intake changed the daily lives of emotionally overwhelmed caregivers. The evaluation of swallowing disabilities using video endoscopy for patients with a PEG tube for HEN may reveal recovery of eating function and increase compliance with eating safety.	[Mori, Hiroko] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Naito, Mariko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral Epidemiol, Hiroshima, Japan; [Nakane, Ayako; Tohara, Haruka] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Gerontol & Gerodontol, Gerodontol & Oral Rehabil, Tokyo, Japan		Mori, H (corresponding author), Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Sakyou Ku, Yoshidakonoe Cho, Kyoto, Kyoto 6068501, Japan.	hmori-kyt@umin.ac.jp	nakane, ayako/AAI-9998-2020; NAITO, Mariko/I-7264-2014; 森, 寛子/AAR-1425-2020	NAITO, Mariko/0000-0003-3794-2643; 森, 寛子/0000-0001-6994-7567	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26460852, 17K09221]	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (26460852, 17K09221).	Alsaeed D, 2018, J CLIN PHARM THER, V43, P359, DOI 10.1111/jcpt.12664; Anis MK, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-37; Asiedu GB, 2018, HEALTH SCI REP-US, V1, DOI 10.1002/hsr2.56; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Denzin N.K., 1994, HDB QUALITATIVE RES; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; GESIS, 2016, ISSP 2012 FAM CHANG; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Jukic NP, 2017, CLIN NUTR, V36, P1062, DOI 10.1016/j.clnu.2016.06.021; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Lee WK, 2016, ANN REHABIL MED-ARM, V40, P432, DOI 10.5535/arm.2016.40.3.432; Lou S, 2017, DISABIL REHABIL, V39, P301, DOI 10.3109/09638288.2016.1140836; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Manor Y, 2013, PARKINSONISM RELAT D, V19, P207, DOI 10.1016/j.parkreldis.2012.10.004; Martin K, 2017, NUTR CLIN PRACT, V32, P712, DOI 10.1177/0884533617701401; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Miles M.B., 1994, QUALITATIVE DATA ANA, V2nd; Ministry of Health Labour and Welfare, LONG TERM CAR INS SY; Moloney J, 2018, DISABIL REHABIL, V40, P1524, DOI 10.1080/09638288.2017.1300948; Mundi MS, 2017, NUTR CLIN PRACT, V32, P799, DOI 10.1177/0884533617718472; Murray J, 2003, BRIT J GEN PRACT, V53, P803; Nund RL, 2014, DYSPHAGIA, V29, P450, DOI 10.1007/s00455-014-9527-8; Ojo O, 2015, NUTRIENTS, V7, P2524, DOI 10.3390/nu7042524; Patterson JM, 2013, PSYCHO-ONCOLOGY, V22, P1815, DOI 10.1002/pon.3226; Penner JL, 2012, J PAIN SYMPTOM MANAG, V44, P563, DOI 10.1016/j.jpainsymman.2011.10.016; Quinn K, 2014, DISABIL REHABIL, V36, P185, DOI 10.3109/09638288.2013.783630; Ritchie J., 2003, QUALITATIVE RES PRAC; Strauss A., 1990, BASICS QUALITATIVE R; Stroke Association, COMPL GUID EM CHANG; Thompson Cheryl W, 2006, Nutr Clin Pract, V21, P557, DOI 10.1177/0115426506021006557; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wilmskoetter J, 2017, NUTR CLIN PRACT, V32, P166, DOI 10.1177/0884533616661012; Winkler MF, 2007, JPEN-PARENTER ENTER, V31, P334, DOI 10.1177/0148607107031004334; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992; Wong A, 2018, CLIN NUTR, V37, P429, DOI 10.1016/j.clnu.2017.06.019; World Health Organization, 2001, DIS HLTH SHORT VERS; Yoon EWT, 2016, DYSPHAGIA, V31, P730, DOI 10.1007/s00455-016-9717-7	38	4	4	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-5336	1941-2452		NUTR CLIN PRACT	Nutr. Clin. Pract.	APR	2019	34	2					272	279		10.1002/ncp.10253			8	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nutrition & Dietetics	HO2YT	WOS:000460784600013	30741499				2022-02-06	
J	Piitulainen, JM; Posti, JP; Vallittu, PK; Aitasalo, KM; Serlo, W				Piitulainen, Jaakko M.; Posti, Jussi P.; Vallittu, Pekka K.; Aitasalo, Kalle M.; Serlo, Willy			A Large Calvarial Bone Defect in a Child: Osseointegration of an Implant	WORLD NEUROSURGERY			English	Article						Bioactive glass; Cranioplasty; Fiber-reinforced composite; Pediatric	FIBER-REINFORCED COMPOSITE; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; EARLY CRANIOPLASTY; STEM-CELLS; RECONSTRUCTION; HYDROXYAPATITE; TITANIUM; DURA	BACKGROUND: This original report describes the outcome of a cranioplasty at long-term follow-up. A large calvarial bone defect of a child was reconstructed with a bioactive and biostable nonmetallic implant. CASE DESCRIPTION: In a child with infantile fibrosarcoma of occipital bone, the malignancy was removed at 2.5 years of age, and the defect site was reconstructed with an onlay glass fiber-reinforced composite-bioactive glass implant. The follow-up examination at 5 years 7 months showed no signs of tumor recurrence. During the follow-up period, the contour of the reconstructed area followed skull anatomic development. Computed tomography demonstrated considerably large areas (approximately 70% of the total area) of bone ongrowth to the peridural surface of the implant. CONCLUSIONS: In the future, a synthetic cranioplasty material that is able to integrate with cranial bone may be considered superior to cryopreserved bone grafts in younger age groups.	[Piitulainen, Jaakko M.; Aitasalo, Kalle M.] Univ Turku, Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, Turku, Finland; [Posti, Jussi P.] Univ Turku, Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland; [Posti, Jussi P.] Univ Turku, Turku Brain Injury Ctr, Turku Univ Hosp, Turku, Finland; [Piitulainen, Jaakko M.; Posti, Jussi P.; Vallittu, Pekka K.; Aitasalo, Kalle M.] Univ Turku, Dept Biomat Sci, Inst Dent, Turku, Finland; [Piitulainen, Jaakko M.; Posti, Jussi P.; Vallittu, Pekka K.; Aitasalo, Kalle M.] Univ Turku, Turku Clin Biomat Ctr, Inst Dent, Turku, Finland; [Vallittu, Pekka K.] City Turku Welf Div, Turku, Finland; [Serlo, Willy] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Serlo, Willy] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Serlo, Willy] Univ Oulu, PEDEGO Res Unit, Oulu, Finland		Piitulainen, JM (corresponding author), Univ Turku, Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, Turku, Finland.; Piitulainen, JM (corresponding author), Univ Turku, Dept Biomat Sci, Inst Dent, Turku, Finland.; Piitulainen, JM (corresponding author), Univ Turku, Turku Clin Biomat Ctr, Inst Dent, Turku, Finland.	jaakko.piitulainen@utu.fi	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Piitulainen, Jaakko/0000-0001-9788-8904			Aitasalo KMJ, 2014, HEAD NECK-J SCI SPEC, V36, P722, DOI 10.1002/hed.23370; Chan DYC, 2017, J CLIN NEUROSCI, V42, P81, DOI 10.1016/j.jocn.2017.04.016; Fong KD, 2003, PLAST RECONSTR SURG, V112, P1312, DOI 10.1097/01.PRS.0000079860.14734.D6; Frassanito P, 2017, CHILD NERV SYST, V33, P1759, DOI 10.1007/s00381-017-3541-8; Fu KJ, 2016, J CRANIOFAC SURG, V27, P593, DOI 10.1097/SCS.0000000000002491; Gosain AK, 2003, PLAST RECONSTR SURG, V112, P515, DOI 10.1097/01.PRS.0000070728.56716.51; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Jin SW, 2016, J KOREAN NEUROSURG S, V59, P192, DOI 10.3340/jkns.2016.59.3.192; Kim BW, 2017, ANN REHABIL MED-ARM, V41, P354, DOI 10.5535/arm.2017.41.3.354; Korhonen TK, 2019, J NEUROSURG, V130, P312, DOI 10.3171/2017.8.JNS171857; Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030; Lindner D, 2017, J NEUROSURG, V126, P175, DOI 10.3171/2015.10.JNS151245; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Piitulainen JM, 2015, ACTA NEUROCHIR, V157, P681, DOI 10.1007/s00701-015-2363-2; Posti JP, 2016, J MECH BEHAV BIOMED, V55, P191, DOI 10.1016/j.jmbbm.2015.10.030; Sarin J, 2012, ANN OTO RHINOL LARYN, V121, P563, DOI 10.1177/000348941212100901; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Shahid AH, 2018, J NEUROSURG, V128, P229, DOI 10.3171/2016.10.JNS16678; Shih YRV, 2014, P NATL ACAD SCI USA, V111, P990, DOI 10.1073/pnas.1321717111; Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901; Thesleff T, 2017, STEM CELL TRANSL MED, V6, P1576, DOI 10.1002/sctm.16-0410; Tuusa SMR, 2008, J BIOMED MATER RES B, V84B, P510, DOI 10.1002/jbm.b.30898; Vallittu PK, 2017, J MATER SCI, V52, P8772, DOI 10.1007/s10853-017-0888-x; Zaccaria L, 2017, CHILD NERV SYST, V33, P343, DOI 10.1007/s00381-016-3327-4; Zegers T, 2017, J CRANIO MAXILL SURG, V45, P82, DOI 10.1016/j.jcms.2016.10.016	28	4	4	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2019	124						282	286		10.1016/j.wneu.2019.01.028			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HR4BE	WOS:000463087800158	30684720	Green Accepted			2022-02-06	
J	Porter, S; Silverberg, ND; Virji-Babul, N				Porter, Shaun; Silverberg, Noah D.; Virji-Babul, Naznin			Cortical activity and network organization underlying physical and cognitive exertion in active young adult athletes: Implications for concussion	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Physical exertion; Cognitive exertion; EEG; ASAT; Graph theory	FALSE-DISCOVERY-RATE; EXERCISE; SYMPTOMS; TASK; CONNECTIVITY; EEG	Objectives: To examine the neurophysiological correlates and brain network organization underlying physical and cognitive exertion in active young adults. Design: Repeated measures. Methods: Thirteen healthy adults completed three exertion tasks in a counterbalanced order: a graded working memory task (anti-saccade and serial addition task (ASAT)), a graded exercise task (cycling on a stationary bicycle) (EX) and a combined graded working memory and exercise task (ASAT + EX). All three tasks were performed under five levels of increasing difficulty. Continuous EEG was recorded in each session. Heart rate, perceived exertion and accuracy on the working memory task were recorded throughout. Power spectrum analysis and graph theoretical analysis was applied to the EEG data. Results: Heart rate and perceived exertion increased with exercise load and in both the EX only and ASAT + EX tasks. Overall accuracy was equally high for the ASAT and ASAT + EX tasks. Analysis of EEG data showed there was an increase in theta power associated with the ASAT + EX task and increase in functional connectivity in the frontal regions of the brain compared with ASAT only task. Accuracy decreased in the last two blocks when the task was most difficult. This decrease in accuracy was associated with a decrease in theta power and a decrease in functional connectivity. Conclusions: Combined physical and mental exertion results in significant changes in perceived exertion, EEG theta power and network organization in healthy adults and will be valuable in revealing residual neurocognitive deficits after sports related concussion. (C) 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Porter, Shaun] Univ British Columbia, Grad Program Rehabil Sci, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Virji-Babul, Naznin] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Virji-Babul, Naznin] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada		Virji-Babul, N (corresponding author), Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada.; Virji-Babul, N (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.	naznin.virji-babul@ubc.ca		Virji-Babul, Naznin/0000-0002-8984-5848			Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Conley AC, 2019, J NEUROTRAUM, V36, P1, DOI 10.1089/neu.2018.5761; Covassin T, 2013, BRAIN INJURY, V27, P1589, DOI 10.3109/02699052.2013.823656; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Enders H, 2016, J NEUROPHYSIOL, V115, P379, DOI 10.1152/jn.00497.2015; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Golubic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092829; Hogan M, 2013, EXP BRAIN RES, V229, P85, DOI 10.1007/s00221-013-3595-0; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Lee H, 2015, J SCI MED SPORT, V18, P245, DOI 10.1016/j.jsams.2014.04.003; Li JN, 2009, J MACH LEARN RES, V10, P475; Li JN, 2008, IEEE ENG MED BIO, P4617, DOI 10.1109/IEMBS.2008.4650242; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Rajabali F, 2013, BC INJ RES PREV UNIT; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West S. G., 1995, STRUCTURAL EQUATION, P56, DOI DOI 10.1037/0008-400X.26.2.210; Zhao XJ, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00215	30	4	4	2	18	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	APR	2019	22	4					397	402		10.1016/j.jsams.2018.09.233			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HQ4YF	WOS:000462416500005	30318265				2022-02-06	
J	Rehman, L; Afzal, A; Aziz, HF; Akbar, S; Abbas, A; Rizvi, R				Rehman, Lal; Afzal, Ali; Aziz, Hafiza Fatima; Akbar, Sana; Abbas, Asad; Rizvi, Raza			Radiological Parameters to Predict Hemorrhagic Progression of Traumatic Contusional Brain Injury	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Brain contusion; intracerebral hematoma; intraparenchymal hematoma; progressive hemorrhagic injury; traumatic brain injury	INTRACEREBRAL HEMORRHAGE; RISK-FACTORS; INTRAPARENCHYMAL HEMORRHAGE; CEREBRAL CONTUSIONS; DERIVATION; SCORE	Introduction: Traumatic intracerebral contusion is a frequent factor culminating in death and disability, and its progression relates to unfavorable outcome. We evaluated the radiological factors associated with hemorrhagic progression of contusions (HPC). Materials and Methods: Two hundred and forty-six patients were enrolled in this prospective cohort over a period of 1 year. Contusion volume was quantified using the "ABC/2" technique, whereas progression was considered as > 30% increase in the initial volume. Univariate and multivariate statistics were used to examine the correlation between the risk factors of interest and HPC. Results: HPC was seen in 110 (44.7%) patients. Binary logistic regression showed in the final adjusted model that multiplicity (relative risk [RR]: 2.24, 95% confidence limit [CL]: 1.00-5.48), bilateral lesions (RR: 2.99, 95% CL: 1.08-8.25), initial volume of contusion (RR: 4.96, 95% CL: 1.87-13.13), frontal location (RR: 1.42, 95% CL: 1.08-3.56), and presence of concomitant intracranial hematoma (extradural-RR: 3.90, 95% CL: 1.51-10.01, subdural-RR: 2.91, 95% CL: 1.26-6.69, and subarachnoid-RR: 2.27, 95% CL: 1.01-5.80) were significantly associated with HPC. The overall mortality was 18.7% and was almost equal among patients with and without HPC. Mortality was significantly associated with Glasgow Coma Scale on admission (adjusted RR: 12.386, 95% CL: 4.789-32.035) and presence of comorbid conditions (adjusted RR: 0.313, 95% CL: 0.114-0.860). Conclusion: Initial computed tomography scan is a good predictor of high-risk group for HPC.	[Rehman, Lal; Afzal, Ali; Aziz, Hafiza Fatima; Akbar, Sana; Abbas, Asad; Rizvi, Raza] Jinnah Postgrad Med Ctr, Dept Neurosurg, Rafiqui Shaheed Rd, Karachi 75510, Pakistan		Abbas, A (corresponding author), Jinnah Postgrad Med Ctr, Dept Neurosurg, Rafiqui Shaheed Rd, Karachi 75510, Pakistan.	asad.abbas@live.com					Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Allison RZ, 2017, NEUROCRIT CARE, V26, P80, DOI 10.1007/s12028-016-0303-5; Bobinski L., 2016, EVOLUTION INTRACRANI; Carnevale J, 2016, NEUROSURGERY S1, V63, P195; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Hilmer Louise Vera, 2018, Asian J Neurosurg, V13, P23, DOI 10.4103/ajns.AJNS_342_16; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Marion DW, 2006, NEUROSURGERY, V58, P655; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Orito K, 2018, J NEUROTRAUM, V35, P760, DOI 10.1089/neu.2017.5247; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Wang Ke, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P410; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	27	4	5	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	APR-JUN	2019	10	2					212	217		10.4103/jnrp.jnrp_335_18			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HR0ME	WOS:000462821600009	31001007	Green Published, gold			2022-02-06	
J	Reizine, F; Asehnoune, K; Roquilly, A; Laviolle, B; Rousseau, C; Arnouat, M; Dahyot-Fizelier, C; Seguin, P				Reizine, Florian; Asehnoune, Karim; Roquilly, Antoine; Laviolle, Bruno; Rousseau, Chloe; Arnouat, Matthieu; Dahyot-Fizelier, Claire; Seguin, Philippe			Effects of antibiotic prophylaxis on ventilator-associated pneumonia in severe traumatic brain injury. A post hoc analysis of two trials	JOURNAL OF CRITICAL CARE			English	Article						Ventilator-associated pneumonia; Traumatic brain injury; Antibiotic prophylaxis	EARLY-ONSET PNEUMONIA; HOSPITAL-ACQUIRED PNEUMONIA; NOSOCOMIAL PNEUMONIA; COMATOSE PATIENTS; HEAD TRAUMA; HYDROCORTISONE	Purpose: To investigate the role of antibiotic prophylaxis (AP) in the incidence of ventilator-associated pneumonia (VAP) in patients suffering from traumatic brain injury (TBI). Materials and methods: This post hoc analysis was conducted based on data from 2 multicentre double-blind studies that aimed to prevent VAP using hydrocortisone or povidone iodine. Data from TBI patients were extracted and pooled. Patients were classified into 2 groups: those who received an AP (AP group) and those who did not (control group). Results: 295 patients were included (AP group, n = 146; control group, n = 149). The incidence of VAP was 145 (49%). VAP incidence was lower in the AP group (39% vs 59%, Relative Risk = 0.33, 95%CI, 0.19-0.56, p = 0.001). Time to VAP occurrence was delayed (Hazard Ratio = 0.50, 95%CI 0.36-0.69, p < 0.001). The incidence of early VAP (>2 and <= 5 days) was lower in the AP group (10% vs 32%; p < 0.001), whereas that of late VAP (>5 days) did not differ (AP group 29% vs control group 28%; p = 0.811). Length of stay and mortality did not differ between the 2 groups. Conclusions: Early use of AP delayed and may prevent the occurrence of VAP in severe TBI patients but did not change length of stay or mortality. (C) 2018 Elsevier Inc All rights reserved.	[Reizine, Florian; Arnouat, Matthieu; Seguin, Philippe] CHU Rennes, Hop Pontchaillou, Serv Reanimat Chirurg, 2 Rue Henri Le Guilloux, F-35000 Rennes, France; [Asehnoune, Karim; Roquilly, Antoine] CHU Nantes, Dept Anesthesie Reanimat, 1 Pl Alexis Ricordeau, F-44000 Nantes, France; [Laviolle, Bruno; Rousseau, Chloe] CHU Rennes, Ctr Invest Clin, 2 Rue Henri Le Guilloux, F-35000 Rennes, France; [Dahyot-Fizelier, Claire] CHU Poitiers, Dept Anesthesie Reanimat, 2 Rue Miletrie, F-16000 Poitiers, France		Seguin, P (corresponding author), Hop Pontchaillou, Serv Anesthesie Reanimat 1, Reanimat Chirurg, 2 Rue Henri Le Guilloux, F-35033 Rennes 9, France.	karim.asehnoune@chu-nantes.fr; antoine.roquilly@chu-nantes.fr; bruno.laviolle@chu-rennes.fr; chloe.rousseau@chu-rennes.fr; matthieu.arnouat@chu-rennes.fr; claire.dahyot-fizelier@chu-rennes.fr; philippe.seguin@chu-rennes.fr	reizine, florian/AAJ-5901-2021; Seguin, Philippe/P-9487-2019	Seguin, Philippe/0000-0002-7774-4257; reizine, florian/0000-0002-9871-636X; Reizine, Florian/0000-0002-7288-7769; Roquilly, Antoine/0000-0002-1029-6242; Laviolle, Bruno/0000-0002-9541-6708			Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Asehnoune K, 2012, ANESTHESIOLOGY, V117, P411, DOI 10.1097/ALN.0b013e31825f018d; Asehnoune K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-228; Bouza E, 2013, INTENS CARE MED, V39, P1547, DOI 10.1007/s00134-013-2997-6; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Hoth JJ, 2003, J TRAUMA, V55, P249, DOI 10.1097/01.TA.0000083334.93868.65; Kallel H, 2005, J TRAUMA, V59, P705, DOI 10.1097/01.ta.0000177749.09844.c6; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC16, DOI 10.7860/JCDR/2016/16390.7294; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Poole D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113676; Righy C, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0291-4; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Seguin P, 2014, CRIT CARE MED, V42, P1, DOI 10.1097/CCM.0b013e3182a2770f; Sirvent JM, 2000, INTENS CARE MED, V26, P1369, DOI 10.1007/s001340000611; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Societe francaise d'anesthesie et de reanimation, 2011, Ann Fr Anesth Reanim, V30, P168, DOI 10.1016/j.annfar.2010.05.012; Valles J, 2013, CHEST, V143, P1219, DOI 10.1378/chest.12-1361	22	4	4	2	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2019	50						221	226		10.1016/j.jcrc.2018.12.010			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HL0HO	WOS:000458375800034	30583121				2022-02-06	
J	Salehi, A; Jullienne, A; Wendel, KM; Hamer, M; Tang, JP; Zhang, JH; Pearce, WJ; DeFazio, RA; Vexler, ZS; Obenaus, A				Salehi, Arjang; Jullienne, Amandine; Wendel, Kara M.; Hamer, Mary; Tang, Jiping; Zhang, John H.; Pearce, William J.; DeFazio, Richard A.; Vexler, Zinaida S.; Obenaus, Andre			A Novel Technique for Visualizing and Analyzing the Cerebral Vasculature in Rodents	TRANSLATIONAL STROKE RESEARCH			English	Article						Analysis; Rodents; Vasculature; Traumatic brain injury; Stroke	BLOOD-VESSELS; BRAIN; FLOW; QUANTIFICATION; DENSITY; MODEL	We introduce a novel protocol to stain, visualize, and analyze blood vessels from the rat and mouse cerebrum. This technique utilizes the fluorescent dye, DiI, to label the lumen of the vasculature followed by perfusion fixation. Following brain extraction, the labeled vasculature is then imaged using wide-field fluorescence microscopy for axial and coronal images and can be followed by regional confocal microscopy. Axial and coronal images can be analyzed using classical angiographic methods for vessel density, length, and other features. We also have developed a novel fractal analysis to assess vascular complexity. Our protocol has been optimized for adult rat, adult mouse, and neonatal mouse studies. The protocol is efficient, can be rapidly completed, stains cerebral vessels with a bright fluorescence, and provides valuable quantitative data. This method has a broad range of applications, and we demonstrate its use to study the vasculature in assorted models of acquired brain injury.	[Salehi, Arjang; Obenaus, Andre] Univ Calif Riverside, Cell Mol & Dev Biol Program, 1140 Bachelor Hall, Riverside, CA 92521 USA; [Salehi, Arjang; Jullienne, Amandine; Hamer, Mary; Obenaus, Andre] Loma Linda Univ, Dept Basic Sci, Loma Linda, CA 92354 USA; [Wendel, Kara M.; Obenaus, Andre] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Hamer, Mary; Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Tang, Jiping; Zhang, John H.; Pearce, William J.] Loma Linda Univ, Dept Physiol & Pharmacol, Sch Med, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Neurosurg, Loma Linda, CA 92350 USA; [Pearce, William J.] Loma Linda Univ, Ctr Perinatal Biol, Loma Linda, CA 92350 USA; [DeFazio, Richard A.] Univ Michigan, Mol & Integrat Physiol, Ann Arbor, MI 48101 USA; [Vexler, Zinaida S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA		Obenaus, A (corresponding author), Univ Calif Riverside, Cell Mol & Dev Biol Program, 1140 Bachelor Hall, Riverside, CA 92521 USA.; Obenaus, A (corresponding author), Loma Linda Univ, Dept Basic Sci, Loma Linda, CA 92354 USA.; Obenaus, A (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.; Obenaus, A (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA.	obenausa@uci.edu	Jullienne, Amandine/H-3081-2019	Jullienne, Amandine/0000-0001-9458-055X; Pearce, William/0000-0002-5331-5677	NIH Program Project grant from the National Institute of Neurological Disorders and Stroke [1P01NS082184, 3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL139685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS082184, R01NS076726, R01NS044025, R01NS103483, R21NS098514] Funding Source: NIH RePORTER	This study was supported by an NIH Program Project grant from the National Institute of Neurological Disorders and Stroke (1P01NS082184, Project 3).	Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Borodinsky LN, 2001, METHODS, V24, P341, DOI 10.1006/meth.2001.1204; CASERTA F, 1995, J NEUROSCI METH, V56, P133, DOI 10.1016/0165-0270(94)00115-W; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; Cipolla M.J., 2009, CEREBRAL CIRCULATION; Di Ieva A, 2015, NEUROSCIENTIST, V21, P30, DOI 10.1177/1073858413513928; Di Ieva A, 2014, NEUROSCIENTIST, V20, P403, DOI 10.1177/1073858413513927; Di Ieva A, 2011, MICROVASC RES, V81, P222, DOI 10.1016/j.mvr.2010.12.006; Fumagalli S, 2014, PROG NEUROBIOL, V121, P36, DOI 10.1016/j.pneurobio.2014.06.005; Gadde SGK, 2016, INVEST OPHTH VIS SCI, V57, P246, DOI 10.1167/iovs.15-18287; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; Hughes S, 2014, METHODS MOL BIOL, V1135, P127, DOI 10.1007/978-1-4939-0320-7_12; Joshi VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088061; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Konno A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09496-4; Krafft PR, 2012, JOVE-J VIS EXP, DOI 10.3791/4289; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Moy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053753; Mu J, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-8; Muoio V, 2014, ACTA PHYSIOL, V210, P790, DOI 10.1111/apha.12250; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Okyere B, 2018, J NEUROSCI METH, V293, P86, DOI 10.1016/j.jneumeth.2017.09.010; Okyere B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159930; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shen Q, 2015, BRAIN RES, V1599, P126, DOI 10.1016/j.brainres.2014.12.049; Suzuki H, 2010, CRIT CARE MED, V38, P612, DOI 10.1097/CCM.0b013e3181c027ae; Taoufik E, 2008, CURR PHARM DESIGN, V14, P3565, DOI 10.2174/138161208786848748; WANG DB, 1992, J CEREBR BLOOD F MET, V12, P935, DOI 10.1038/jcbfm.1992.130; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Zeller K, 1996, DEV BRAIN RES, V91, P200, DOI 10.1016/0165-3806(95)00177-8; Zhang LY, 2018, AGING DIS, V9, P262, DOI 10.14336/AD.2017.0613; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	41	4	4	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	APR	2019	10	2					216	230		10.1007/s12975-018-0632-0			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HP2EQ	WOS:000461481500010	29766452				2022-02-06	
J	Srivastava, AK; Prabhakara, KS; Jkota, D; Bedi, SS; Triolo, F; Brown, KS; Skiles, ML; Brown, HL; Cox, CS; Olson, SD				Srivastava, Amit K.; Prabhakara, Karthik S.; Jkota, Daniel; Bedi, Supinder S.; Triolo, Fabio; Brown, Katherine S.; Skiles, Matthew L.; Brown, Heather L.; Cox, Charles S., Jr.; Olson, Scott D.			Human umbilical cord blood cells restore vascular integrity in injured rat brain and modulate inflammation in vitro	REGENERATIVE MEDICINE			English	Article						blood-brain barrier; cell therapy; cord blood; immunomodulation; inflammation	YOUNG-CHILDREN; STEM-CELLS; TRANSPLANTATION; THERAPY; BARRIER; MODEL; INFUSION; RECOVERY; DEFICITS; STROKE	Aim: Traumatic brain injury is a complex condition consisting of a mechanical injury with neurovascular disruption and inflammation with limited clinical interventions available. A growing number of studies report systemic delivery of human umbilical cord blood (HUCB) as a therapy for neural injuries. Materials & methods: HUCB cells from five donors were tested to improve blood-brain barrier integrity in a traumatic brain injury rat model at a dose of 2.5 x 10(7) cells/kg at 24 or 72 h postinjury and for immunomodulatory activity in vitro. Results & Conclusion: We observed that cells delivered 72 h postinjury significantly restored blood-brain barrier integrity. HUCB cells reduced the amount of TNF-alpha and IFN-gamma released by activated primary rat splenocytes, which correlated with the expression of COX2 and IDO1. Representative coronal sections from experimental groups injured with a sham injury (top left), a controlled cortical impact (top right), or a controlled cortical impact and an infusion with human umbilical cord blood cells (bottom left) 72 h after injury and imaged following intravenous infusion of a large farred fluorescent dye to visualize blood-brain barrier leakage at 96 h after injury. This technique is used to quantitatively measure vascular permeability as a biomarker for injury (bottom right). [GRAPHICS] .	[Srivastava, Amit K.; Prabhakara, Karthik S.; Bedi, Supinder S.; Triolo, Fabio; Cox, Charles S., Jr.; Olson, Scott D.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA; [Jkota, Daniel] Emory Univ, Sch Med, Emory Personalized Immunotherapy Core Labs, Atlanta, GA 30322 USA; [Brown, Katherine S.; Skiles, Matthew L.; Brown, Heather L.] Cbr Syst Inc, San Francisco, CA 94080 USA		Olson, SD (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA.	scott.d.olson@uth.tmc.edu		Srivastava, Amit/0000-0001-7554-7201; Olson, Scott/0000-0001-8032-3755	University of Texas Health Science Center at Houston; Clare A. Glassell Family Pediatric Stem Cell Research Fund; Cbr Systems, Inc.	KS Brown, ML Skiles and HL Brown receive payment as employees of Cbr Systems, Inc. (Cord Blood Registry (R)). Dr. Charles S. Cox, Jr serves on the Scientific and Medical Advisory Board of Cbr Systems, Inc. This study was partially funded through a sponsored research agreement between the University of Texas Health Science Center at Houston and Cbr Systems, Inc. and through the generous support of the Clare A. Glassell Family Pediatric Stem Cell Research Fund. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Badner A, 2016, STEM CELL TRANSL MED, V5, P991, DOI 10.5966/sctm.2015-0295; Ballen K, 2017, STEM CELL TRANSL MED, V6, P1312, DOI 10.1002/sctm.17-0069; Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Barker JN, 2010, BLOOD, V115, P1843, DOI 10.1182/blood-2009-07-231068; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen SH, 2014, CELL TRANSPLANT, V23, P959, DOI 10.3727/096368913X667006; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; Cotten CM, 2014, J PEDIATR-US, V164, P973, DOI 10.1016/j.jpeds.2013.11.036; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Damien P, 2015, BIOL BLOOD MARROW TR, V21, P1545, DOI 10.1016/j.bbmt.2015.05.022; Dawson G, 2017, STEM CELL TRANSL MED, V6, P1332, DOI 10.1002/sctm.16-0474; de la Pena I, 2014, REGEN MED, V9, P409, DOI [10.2217/RME.14.32, 10.2217/rme.14.32]; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Diaz MF, 2017, STEM CELLS, V35, P1259, DOI 10.1002/stem.2587; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Harting MT, 2018, STEM CELLS, V36, P79, DOI 10.1002/stem.2730; Jackson ML, 2017, J SURG RES, V214, P38, DOI 10.1016/j.jss.2017.02.078; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jin XL, 2014, MICROCIRCULATION, V21, P696, DOI 10.1111/micc.12150; Koliatsos VE, 2015, REGEN MED, V10, P917, DOI 10.2217/rme.15.62; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kota DJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04565; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; McDonald CA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1089-5; McGuckin CP, 2008, CELL PROLIFERAT, V41, P31, DOI 10.1111/j.1365-2184.2008.00490.x; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Newman MB, 2003, NEUROTOX RES, V5, P355, DOI 10.1007/BF03033155; Nikiforow S, 2017, CYTOTHERAPY, V19, P272, DOI 10.1016/j.jcyt.2016.10.016; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Pimentel-Coelho PM, 2012, PEDIATR RES, V71, P464, DOI 10.1038/pr.2011.59; Prabhakara KS, 2018, MOL THER, V26, P2152, DOI 10.1016/j.ymthe.2018.06.022; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Savitz SI, 2016, STEM CELLS, V34, P537, DOI 10.1002/stem.2253; Seghatoleslam M, 2012, IRAN J BASIC MED SCI, V15, P860; Shawki S, 2015, MICROBIOL IMMUNOL, V59, P348, DOI 10.1111/1348-0421.12259; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Soares HD, 1995, J NEUROSCI, V15, P8223; Sun JM, 2017, STEM CELL TRANSL MED, V6, P2071, DOI 10.1002/sctm.17-0102; Sydserff S, 2009, BIOCHEM PHARMACOL, V78, P880, DOI 10.1016/j.bcp.2009.07.005; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659	59	4	4	0	1	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1746-0751	1746-076X		REGEN MED	Regen. Med.	APR	2019	14	4					295	308		10.2217/rme-2018-0106			14	Cell & Tissue Engineering; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Engineering	IK4PU	WOS:000476569600005	31074319	hybrid			2022-02-06	
J	Tate, DF; Wade, BSC; Velez, CS; Drennon, AM; Bolzenius, JD; Cooper, DB; Kennedy, JE; Reid, MW; Bowles, AO; Thompson, PM; Gutman, BA; Lewis, JD; Ritter, JL; York, GE; Bigler, ED				Tate, David F.; Wade, Benjamin S. C.; Velez, Carmen S.; Drennon, Ann Marie; Bolzenius, Jacob D.; Cooper, Douglas B.; Kennedy, Jan E.; Reid, Matthew W.; Bowles, Amy O.; Thompson, Paul M.; Gutman, Boris A.; Lewis, Jeffrey D.; Ritter, John L.; York, Gerald E.; Bigler, Erin D.			Subcortical shape and neuropsychological function among US service members with mild traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain Injury; Subcortical structures; Shape analysis; Service Members; Neuropsychological function; Brain behavior relationships	HIPPOCAMPAL VOLUME; WORKING-MEMORY; CAUDATE-NUCLEUS; HEAD-INJURY; CONSCIOUSNESS; MORPHOMETRY; MOTIVATION; RESPONSES; VETERANS; CONNECTIVITY	In a recent manuscript, our group demonstrated shape differences in the thalamus, nucleus accumbens, and amygdala in a cohort of U.S. Service Members with mild traumatic brain injury (mTBI). Given the significant role these structures play in cognitive function, this study directly examined the relationship between shape metrics and neuropsychological performance. The imaging and neuropsychological data from 135 post-deployed United States Service Members from two groups (mTBI and orthopedic injured) were examined. Two shape features modeling local deformations in thickness (RD) and surface area (JD) were defined vertex-wise on parametric mesh-representations of 7 bilateral subcortical gray matter structures. Linear regression was used to model associations between subcortical morphometry and neuropsychological performance as a function of either TBI status or, among TBI patients, subjective reporting of initial concussion severity (CS). Results demonstrated several significant group-by-cognition relationships with shape metrics across multiple cognitive domains including processing speed, memory, and executive function. Higher processing speed was robustly associated with more dilation of caudate surface area among patients with mTBI who reported more than one CS variables (loss of consciousness (LOC), alteration of consciousness (AOC), and/or post-traumatic amnesia (PTA)). These significant patterns indicate the importance of subcortical structures in cognitive performance and support a growing functional neuroanatomical literature in TBI and other neurologic disorders. However, prospective research will be required before exact directional evolution and progression of shape can be understood and utilized in predicting or tracking cognitive outcomes in this patient population.	[Tate, David F.; Wade, Benjamin S. C.; Velez, Carmen S.; Bolzenius, Jacob D.] Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle, Berkeley, MO 63134 USA; [Tate, David F.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wade, Benjamin S. C.; Thompson, Paul M.; Gutman, Boris A.] Univ Southern Calif, Imaging Genet Ctr, Marina Del Rey, CA USA; [Wade, Benjamin S. C.] Univ Calif Los Angeles, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90024 USA; [Drennon, Ann Marie; Kennedy, Jan E.; Reid, Matthew W.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Cooper, Douglas B.] UT Hlth San Antonio, DVBIC, San Antonio, TX USA; [Cooper, Douglas B.] UT Hlth San Antonio, South Texas Vet Hlth Care Syst, Dept Psychiat, San Antonio Polytrauma Rehabil Ctr, San Antonio, TX USA; [Bowles, Amy O.] Brooke Army Med Ctr, Dept Rehabil Med, San Antonio, TX USA; [Lewis, Jeffrey D.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Neurol, Bethesda, MD 20814 USA; [Ritter, John L.] Austin Radiol Assoc, Austin, TX USA; [York, Gerald E.] TBI Imaging & Res, Alaska Radiol Assoc, Anchorage, AK USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA		Tate, DF (corresponding author), Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle, Berkeley, MO 63134 USA.; Tate, DF (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	David.Tate@mimh.edu	Tate, David F/I-3963-2013; Ritter, John/AAG-8899-2020; Thompson, Paul M/C-4194-2018	Tate, David F/0000-0003-0213-1920; Thompson, Paul M/0000-0002-4720-8867; Wade, Benjamin/0000-0003-2461-6101	Defense and Veterans Brain Injury Centers; U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0025]; Chronic Effects of Neurotrauma Consortium (CENC) [PT108802-SC104835]	This work is supported in part by the Defense and Veterans Brain Injury Centers, the U.S. Army Medical Research and Materiel Command (USAMRMC; W81XWH-13-2-0025) and the Chronic Effects of Neurotrauma Consortium (CENC; PT108802-SC104835).	Almeida OP, 2012, EUR HEART J, V33, P1769, DOI 10.1093/eurheartj/ehr467; Arend I, 2008, BRAIN, V131, P2140, DOI 10.1093/brain/awn135; Baldo BA, 2013, NEUROSCI BIOBEHAV R, V37, P1985, DOI 10.1016/j.neubiorev.2013.02.017; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; BARRETT K, 1994, J ACCID EMERG MED, V11, P79; Bergsland N, 2016, MULT SCLER J, V22, P1327, DOI 10.1177/1352458515616204; Bigler E, 2015, NEUROPSYCHOL REV, V25, P224, DOI 10.1007/s11065-015-9290-0; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Brenner LA, 2015, REHABIL PSYCHOL, V60, P277, DOI 10.1037/rep0000048; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Danziger S, 2004, COGN AFFECT BEHAV NE, V4, P89, DOI 10.3758/CABN.4.1.89; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Derauf C, 2012, DEV NEUROSCI-BASEL, V34, P327, DOI 10.1159/000341119; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Harrington DL, 2014, BRAIN BEHAV, V4, P29, DOI 10.1002/brb3.185; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kim GH, 2015, NEUROBIOL AGING, V36, P485, DOI 10.1016/j.neurobiolaging.2014.08.009; Kirouac GJ, 2015, NEUROSCI BIOBEHAV R, V56, P315, DOI 10.1016/j.neubiorev.2015.08.005; Koerte IK, 2016, TRANSLATIONAL RES TR; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Macfarlane MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129692; Machts J, 2015, NEUROLOGY, V85, P1301, DOI 10.1212/WNL.0000000000002017; Martikainen KK, 2011, J NEUROL, V258, P132, DOI 10.1007/s00415-010-5687-0; Miskowiak KW, 2015, BIOL PSYCHIAT, V78, P270, DOI 10.1016/j.biopsych.2014.12.013; Murray RJ, 2014, CORTEX, V60, P10, DOI 10.1016/j.cortex.2014.06.010; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; Phillips AG, 2003, NEUROSCI BIOBEHAV R, V27, P543, DOI 10.1016/j.neubiorev.2003.09.002; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; Postle BR, 2003, COGN AFFECT BEHAV NE, V3, P133, DOI 10.3758/CABN.3.2.133; Primus EA, 1997, BRAIN INJURY, V11, P577; Pujol N, 2014, BRIT J PSYCHIAT, V205, P369, DOI 10.1192/bjp.bp.113.140384; Quigley SJ, 2015, PSYCHIAT RES-NEUROIM, V233, P324, DOI 10.1016/j.pscychresns.2015.05.012; Reuber M, 2016, NEUROLOGY, V87, P625, DOI 10.1212/WNL.0000000000002948; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Spies G, 2016, J NEUROVIROL, V22, P149, DOI 10.1007/s13365-015-0379-2; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vecera SP, 2003, NEUROL CLIN, V21, P575, DOI 10.1016/S0733-8619(02)00103-2; Wade BSC, 2016, NEUROPSYCHOPHARMACOL, V41, P2481, DOI 10.1038/npp.2016.48; Wade BSC, 2015, NEUROIMAGE-CLIN, V9, P564, DOI 10.1016/j.nicl.2015.10.006; Wade BS, 2015, I S BIOMED IMAGING, P971, DOI 10.1109/ISBI.2015.7164033; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; Wang YL, 2010, NEUROIMAGE, V49, P2141, DOI 10.1016/j.neuroimage.2009.10.086; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Xiong KL, 2016, NEURORADIOLOGY, V58, P733, DOI 10.1007/s00234-016-1675-0	60	4	4	2	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2019	13	2			SI		377	388		10.1007/s11682-018-9854-8			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HV7TJ	WOS:000466183200009	29564659				2022-02-06	
J	Tierney, GJ; Gildea, K; Krosshaug, T; Simms, CK				Tierney, Gregory J.; Gildea, Kevin; Krosshaug, Tron; Simms, Ciaran K.			Analysis of ball carrier head motion during a rugby union tackle without direct head contact: A case study	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Biomechanics; concussion; head kinematics; motion analysis	BRAIN WHITE-MATTER; INJURY ASSESSMENT; IMPACTS; RECONSTRUCTION; ACCELERATION; SEASON; SPORT; PLAYERS; TIME	Rugby union players can be involved in many tackles per game. However, little is known of the regular head loading environment associated with tackling in rugby union. In particular, the magnitude and influencing factors for head kinematics during the tackle are poorly understood. Accordingly, the goal of this study was to measure head motion of a visually unaware ball carrier during a real game tackle to the upper trunk with no direct head contact, and compare the kinematics with previously reported concussive events. Model-Based Image-Matching was utilised to measure ball carrier head linear and angular velocities. Ball carrier componential maximum change in head angular velocities of 38.1, 20.6 and 13.5 rad/s were measured for the head local X (coronal plane), Y (sagittal plane) and Z (transverse plane) axes respectively. The combination of a high legal tackle height configuration and visually unaware ball carrier can lead to kinematics similar to average values previously reported for concussive direct head impacts.	[Tierney, Gregory J.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England; [Tierney, Gregory J.; Gildea, Kevin; Simms, Ciaran K.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [Krosshaug, Tron] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Oslo, Norway		Tierney, GJ (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England.	g.tierney@leeds.ac.uk	Krosshaug, Tron/AAT-2390-2021	Tierney, Gregory/0000-0002-4666-4473; Gildea, Kevin/0000-0003-3802-0675	Irish Research CouncilIrish Research Council for Science, Engineering and Technology	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors received funding from the Irish Research Council for this article.	Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Effgen G, 2012, IRCOBI C P DUBL IR 1; Frechede B, 2007, P 21 ESV C STUTTG GE; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; KIM W, 1994, HUM MOVEMENT SCI, V13, P221, DOI 10.1016/0167-9457(94)90038-8; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Krosshaug T, 2005, J BIOMECH, V38, P919, DOI 10.1016/j.jbiomech.2004.04.033; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Mok KM, 2011, GAIT POSTURE, V34, P71, DOI 10.1016/j.gaitpost.2011.03.014; Montgomery C, 2018, BRIT J SPORT MED, V52, P994, DOI 10.1136/bjsports-2016-096425; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Newman J, 2000, IRCOBI C P MONTP FRA; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; Takhounts EG, 2011, P 22 ENH SAF VEH C W; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tierney GJ, 2017, IRCOBI C P ANTW BELG; Tierney GJ, 2015, IRCOBI C P LYON FRAN; Tierney GJ, 2019, J SPORT SCI, V37, P262, DOI 10.1080/02640414.2018.1494952; Tierney GJ, 2018, J SCI MED SPORT, V21, P1210, DOI 10.1016/j.jsams.2018.05.010; Tierney GJ, 2018, J BIOMECH, V72, P29, DOI 10.1016/j.jbiomech.2018.02.023; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P16, DOI 10.1177/1747954117711866; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tierney GJ, 2018, J SCI MED SPORT, V21, P221, DOI 10.1016/j.jsams.2017.06.023; Tierney GJ, 2018, SPORT BIOMECH, V17, P33, DOI 10.1080/14763141.2016.1271905; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P415, DOI 10.1177/1747954117751345; Tierney GJ, 2017, BRAIN INJURY, V31, P1925, DOI 10.1080/02699052.2017.1385853; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883	38	4	4	1	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	APR	2019	14	2					190	196		10.1177/1747954119833477			7	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	HR5ZF	WOS:000463226200008		Green Accepted, Green Submitted			2022-02-06	
J	Bossers, SM; Boer, C; Greuters, S; Bloemers, FW; Den Hartog, D; Van Lieshout, EMM; Hoogerwerf, N; Innemee, G; van der Naalt, J; Absalom, AR; Peerdeman, SM; de Visser, M; Loer, S; Schober, P; Boer, D; Goslings, JC; van Helden, SH; Hesselink, D; van Aken, G; Beishuizen, A; Egberink, RE; ter Bogt, N; de Jongh, MAC; Lansink, K; Roks, G; Joosse, P; Ponsen, KJ; van Spengler, LL; Aspers, S; de Leeuw, MA; Schwarte, LA; Toor, A; Houmes, RJ; van Ditshuizen, J; van Voorden, T; Edwards, MJR; Dercksen, B; Spanjersberg, R; Venema, L; Weelink, E; Reininga, HF				Bossers, Sebastiaan M.; Boer, Christa; Greuters, Sjoerd; Bloemers, Frank W.; Den Hartog, Dennis; Van Lieshout, Esther M. M.; Hoogerwerf, Nico; Innemee, Gerard; van der Naalt, Joukje; Absalom, Anthony R.; Peerdeman, Saskia M.; de Visser, Matthijs; Loer, Stephan; Schober, Patrick; Boer, de; Goslings, J. Carel; van Helden, Sven H.; Hesselink, Danique; van Aken, Gijs; Beishuizen, Albertus; Egberink, Rolf E.; ter Bogt, Nancy; de Jongh, Mariska A. C.; Lansink, Koen; Roks, Gerwin; Joosse, Pieter; Ponsen, Kees J.; van Spengler, Lukas L.; Aspers, Stasja; de Leeuw, Marcel A.; Schwarte, Lothar A.; Toor, Annelies; Houmes, Robert J.; van Ditshuizen, Jan; van Voorden, Tea; Edwards, Michael J. R.; Dercksen, Bert; Spanjersberg, Rob; Venema, Lieneke; Weelink, Ellen; Reininga, H. F.		BRAIN-PROTECT Collaborators	Dutch Prospective Observational Study on Prehospital Treatment of Severe Traumatic Brain Injury: The BRAIN-PROTECT Study Protocol	PREHOSPITAL EMERGENCY CARE			English	Article						(MESH); air ambulances; brain injuries; traumatic; clinical protocols; emergency medical services; treatment outcome	HEAD-INJURY; MANAGEMENT; GUIDELINES; CLASSIFICATION; COMA	Background: Severe traumatic brain injury (TBI) is associated with a high mortality rate and those that survive commonly have permanent disability. While there is a broad consensus that appropriate prehospital treatment is crucial for a favorable neurological outcome, evidence to support currently applied treatment strategies is scarce. In particular, the relationship between prehospital treatments and patient outcomes is unclear. The BRAIN-PROTECT study therefore aims to identify prehospital treatment strategies associated with beneficial or detrimental outcomes. Here, we present the study protocol. Study Protocol: BRAIN-PROTECT is the acronym for BRAin INjury: Prehospital Registry of Outcome, Treatments and Epidemiology of Cerebral Trauma. It is a prospective observational study on the prehospital treatment of patients with suspected severe TBI in the Netherlands. Prehospital epidemiology, interventions, medication strategies, and nonmedical factors that may affect outcome are studied. Multivariable regression based modeling will be used to identify confounder-adjusted relationships between these factors and patient outcomes, including mortality at 30 days (primary outcome) or mortality and functional neurological outcome at 1 year (secondary outcomes). Patients in whom severe TBI is suspected during prehospital treatment (Glasgow Coma Scale score <= 8 in combination with a trauma mechanism or clinical findings suggestive of head injury) are identified by all four helicopter emergency medical services (HEMS) in the Netherlands. Patients are prospectively followed up in 9 participating trauma centers for up to one year. The manuscript reports in detail the objectives, setting, study design, patient inclusion, and data collection process. Ethical and juridical aspects, statistical considerations, as well as limitations of the study design are discussed. Discussion: Current prehospital treatment of patients with suspected severe TBI is based on marginal evidence, and optimal treatment is basically unknown. The BRAIN-PROTECT study provides an opportunity to evaluate and compare different treatment strategies with respect to patient outcomes. To our knowledge, this study project is the first large-scale prospective prehospital registry of patients with severe TBI that also collects long-term follow-up data and may provide the best available evidence at this time to give useful insights on how prehospital care can be improved.	[Bossers, Sebastiaan M.; Boer, Christa; Greuters, Sjoerd; Loer, Stephan; Schober, Patrick; de Leeuw, Marcel A.; Schwarte, Lothar A.] Univ Amsterdam, Med Ctr, Dept Anesthesiol, Locat VUmc, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Greuters, Sjoerd; Schober, Patrick] Helicopter Emergency Med Serv Lifeliner 1, Amsterdam, Netherlands; [Bloemers, Frank W.] Univ Amsterdam, Med Ctr, Dept Surg, Amsterdam, Netherlands; [Den Hartog, Dennis; Van Lieshout, Esther M. M.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Surg, Trauma Res Unit, Rotterdam, Netherlands; [Hoogerwerf, Nico] Radboud Unvers Med Ctr, Dept Anesthesiol, Nijmegen, Netherlands; [Hoogerwerf, Nico] Helicopter Emergency Med Serv Lifeliner 3, Nijmegen, Netherlands; [Innemee, Gerard] Reg Ambulance Serv Gooi & Vechtstreek, Hilversum, Netherlands; [van der Naalt, Joukje] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Absalom, Anthony R.] Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands; [Peerdeman, Saskia M.] Univ Amsterdam, Med Ctr, Dept Neurosurg, Amsterdam, Netherlands; [de Visser, Matthijs] Reg Ambulance Serv Hollands Midden, Leiden, Netherlands; [Boer, de] Univ Amsterdam, Med Ctr, SpoedZorgNet, Amsterdam, Netherlands; [Goslings, J. Carel] OLVG, Dept Surg, Amsterdam, Netherlands; [van Helden, Sven H.] Isala Hosp, Dept Surg, Zwolle, Netherlands; [Hesselink, Danique; van Aken, Gijs] Netwerk Acute Zorg Zwolle, Zwolle, Netherlands; [Beishuizen, Albertus] Med Spectrum Twente, Intens Care Ctr, Enschede, Netherlands; [Egberink, Rolf E.] Acute Zorg Euregio Enschede, Enschede, Netherlands; [ter Bogt, Nancy] Acute Zorg Euregio, Enschede, Netherlands; [de Jongh, Mariska A. C.] Elisabeth TweeSteden Hosp, Netwerk Acute Zorg Brabant, Tilburg, Netherlands; [Lansink, Koen] Elisabeth TweeSteden Hosp, Dept Surg, Tilburg, Netherlands; [Roks, Gerwin] Elisabeth TweeSteden Hosp, Dept Neurol, Tilburg, Netherlands; [Joosse, Pieter; Ponsen, Kees J.] Noordwest Ziekenhuisgrp, Dept Surg, Alkmaar, Netherlands; [van Spengler, Lukas L.; Aspers, Stasja] Traumazorgnetwerk Midden Nederland, Utrecht, Netherlands; [de Leeuw, Marcel A.; Schwarte, Lothar A.] Univ Amsterdam, Med Ctr, HEMS Lifeliner 1, Locat VUmc, Amsterdam, Netherlands; [Toor, Annelies] Netwerk Acute Zorg Noordwest, Amsterdam, Netherlands; [Houmes, Robert J.] Erasmus MC, Dept Anesthesiol, Rotterdam, Netherlands; [Houmes, Robert J.] Erasmus MC, HEMS Lifeliner 2, Rotterdam, Netherlands; [van Ditshuizen, Jan; van Voorden, Tea] Erasmus MC, Trauma Ctr Southwest Netherlands, Rotterdam, Netherlands; [Edwards, Michael J. R.] Radboud Unvers Med Ctr, Dept Surg, Nijmegen, Netherlands; [Dercksen, Bert; Spanjersberg, Rob; Venema, Lieneke; Weelink, Ellen] Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands; [Dercksen, Bert; Venema, Lieneke; Weelink, Ellen] Univ Med Ctr Groningen, HEMS Lifeliner 4, Groningen, Netherlands; [Reininga, H. F.] Emergency Care Network Northern Netherlands AZNN, Groningen, Netherlands		Bossers, SM (corresponding author), Univ Amsterdam, Med Ctr, Dept Anesthesiol, Locat VUmc, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	s.bossers@vumc.nl	Bossers, Sebastiaan/AAE-1085-2020; Bloemers, Frank/P-5436-2019; Schober, Patrick/G-7400-2012; Hoogerwerf, Nico/L-4388-2015	Bossers, Sebastiaan/0000-0002-2396-2777; Bloemers, Frank/0000-0002-8393-4946; Schober, Patrick/0000-0003-0814-081X; Hoogerwerf, Nico/0000-0003-1815-6989; Absalom, Anthony/0000-0001-7563-9157; van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation ("Hersenstichting") [F2010(1)-14]; Achmea Healthcare Foundation ("Stichting Achmea Gezondheidszorg") [Z644]	This work was supported by the Dutch Brain Foundation ("Hersenstichting") under Grant F2010(1)-14; and the Achmea Healthcare Foundation ("Stichting Achmea Gezondheidszorg") under Grant Z644. The funding sources have no role in the design or execution of this study and did not have any role during analysis and interpretation of the data or the decision to submit results.	Ambulancezorg Nederland Landelijk Netwerk Acute Zorg, 2013, MMT INZ CANC; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Berger-Pelleiter E, 2016, CAN J EMERG MED, V18, P112, DOI 10.1017/cem.2016.12; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Bossers SM, 2018, EUR J TRAUMA EMERG S, V44, P889, DOI 10.1007/s00068-017-0861-z; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castren M, 2008, RESUSCITATION, V79, P193, DOI 10.1016/j.resuscitation.2008.07.007; CBS, 2018, DUTCH POP DENS STAT; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cnossen MC, 2019, J NEUROTRAUM, V36, P176, DOI 10.1089/neu.2018.5712; Gennarelli TA., 2008, ABBREVIATED INJURY S; Giannakopoulos GF, 2010, LANGENBECK ARCH SURG, V395, P737, DOI 10.1007/s00423-009-0576-7; Hammell CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1683; Hylands M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017559; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Roberts BW, 2015, RESUSCITATION, V91, P32, DOI 10.1016/j.resuscitation.2015.03.015; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; Schober P, 2018, ANESTH ANALG, V126, P1068, DOI 10.1213/ANE.0000000000002798; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; TEASDALE G, 1974, LANCET, V2, P81; Vetter TR, 2018, ANESTH ANALG, V127, P277, DOI 10.1213/ANE.0000000000003424; Wang K, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0006-8	37	4	4	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	NOV 2	2019	23	6					820	827		10.1080/10903127.2019.1587126		MAR 2019	8	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	JI6YS	WOS:000469065400001	30893571	Green Published, hybrid			2022-02-06	
J	Xu, XM; Jiang, SK; Xu, EY; Wu, X; Zhao, R				Xu, Xiaoming; Jiang, Shukun; Xu, Enyu; Wu, Xu; Zhao, Rui			Inhibition of CB1 receptor ameliorates spatial learning and memory impairment in mice with traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Spatial memory; 2-Arachidonoyl glycerol; Hippocampus	IMPROVES FUNCTIONAL RECOVERY; CLOSED-HEAD INJURY; CANNABINOID RECEPTOR; SYNAPTIC-TRANSMISSION; WORKING-MEMORY; MOUSE MODEL; MILD; DEGRADATION; BARRIER; 2-ARACHIDONOYLGLYCEROL	Traumatic brain injury (TBI) is an increasingly prevalent condition affecting people of all ages and genders. The impairment of spatial learning and memory is one of the most common effects of TBI. Unfortunately, it currently lacks effective therapeutic interventions. The endocannabinoid (EC) system regulates a diverse array of physiological processes. Here, we found a 6.7-fold increase of 2-AG levels at 1 d post-TBI, declining thereafter. After 5 d, the levels were still 3.3-fold higher than in the controls. AM281, a CB1 receptor antagonist, reversed the TBI-reduced NMDA receptor subunits NR2B in the hippocampus and ameliorate the spatial learning and memory impairment at 7 d post-TBI, suggesting CB1 receptor is involved in the TBI-induced hippocampal-dependent spatial learning and memory impairment.	[Xu, Xiaoming; Jiang, Shukun] China Med Univ, Sch Forens Med, Dept Forens Clin Med, Shenyang, Liaoning, Peoples R China; [Xu, Enyu] China Med Univ, Sch Forens Med, Dept Forens Toxicol Anal, Shenyang, Liaoning, Peoples R China; [Wu, Xu; Zhao, Rui] China Med Univ, Sch Forens Med, Dept Forens Pathol, Shenyang, Liaoning, Peoples R China		Xu, XM (corresponding author), China Med Univ, Sch Forens Med, Dept Forens Clin Med, Shenyang, Liaoning, Peoples R China.	cmuxxm@163.com			Education Department [LQNK201736]; innovation project of college students of Liaoning province, Liaoning, China [201610159003]	This work was supported by the grants from the Education Department (LQNK201736) and innovation project of college students (201610159003) of Liaoning province, Liaoning, China.	Bajo M, 2009, J NEUROSCI RES, V87, P766, DOI 10.1002/jnr.21889; Biegon A, 2004, CURR PHARM DESIGN, V10, P2177, DOI 10.2174/1381612043384196; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Fan N, 2010, J NEUROCHEM, V112, P691, DOI 10.1111/j.1471-4159.2009.06489.x; Ford GK, 2015, EUR J PAIN, V19, P1177, DOI 10.1002/ejp.646; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hoffman AF, 2010, J NEUROSCI, V30, P545, DOI 10.1523/JNEUROSCI.4920-09.2010; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Marsicano G, 2006, J Endocrinol Invest, V29, P27; Mauler F, 2003, CNS DRUG REV, V9, P343; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mechoulam R, 2003, SCIENCE, V302, P65, DOI 10.1126/science.1091256; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Savinainen JR, 2001, BRIT J PHARMACOL, V134, P664, DOI 10.1038/sj.bjp.0704297; Serpa A, 2009, EUR J PHARMACOL, V623, P41, DOI 10.1016/j.ejphar.2009.09.020; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Wang H, 2017, PHYSIOL BEHAV, V181, P1, DOI 10.1016/j.physbeh.2017.08.022; Wang X, 2016, BRAIN RES, V1646, P174, DOI 10.1016/j.brainres.2016.05.055; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Xu JY, 2015, NEUROSCIENTIST, V21, P152, DOI 10.1177/1073858414524632; Yang YJ, 2016, NEUROSCIENCE, V335, P170, DOI 10.1016/j.neuroscience.2016.08.033; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P706, DOI 10.1038/jcbfm.2014.247	46	4	4	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 23	2019	696						127	131		10.1016/j.neulet.2018.12.024			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HR4OM	WOS:000463125800020	30576711				2022-02-06	
J	El-Menyar, A; Consunji, R; Asim, M; Mekkodathil, A; Latifi, R; Smith, G; Parchani, A; Al-Thani, H				El-Menyar, Ayman; Consunji, Rafael; Asim, Mohammed; Mekkodathil, Ahammed; Latifi, Rifat; Smith, Gordon; Parchani, Ashok; Al-Thani, Hassan			Traumatic brain injury in patients screened for blood alcohol concentration based on the mechanism of injury	BRAIN INJURY			English	Article						Alcohol; BAC; trauma; brain injury; head; mechanism of injury	GLASGOW COMA SCALE; SERUM ETHANOL LEVELS; MOTOR-VEHICLE CRASH; ASSOCIATION; CONSUMPTION; MODERATE; MORTALITY; SEVERITY; INTOXICATION; SURVIVAL	Introduction: We aimed to investigate in-hospital outcomes of traumatic brain injury (TBI) based on blood alcohol concentration (BAC) and mechanism of injury (MOI). Methods: We conducted a retrospective study for patients admitted with TBI between 2010 and 2014. Based on BAC, patients were classified into [negative (-BAC) and positive (+BAC) group]. Data were analyzed and compared according to the MOI. Results: Out of 8141 trauma patients, 946 (11.6%) were diagnosed with TBI and 681 (72%) were subjected to BAC screening. One out of seven TBI was related to alcohol consumption with a mean age of 32 years. Gender, age, and Injury Severity Scores (ISS) were comparable in the two groups. However, the proportion of patients with polytrauma was significantly higher in -BAC than +BAC group regardless of the MOI except for the fall-related TBI. The median BAC was higher in fall-related followed by pedestrians and MVC victims [55 mmol/L (10-101), 49(9-71), and 31(1-69), respectively], p = 0.001. Overall hospital mortality was comparable between the two groups except for the pedestrian-related TBIs in which (+BAC) had significantly fewer mortality. Conclusions: Screening for BAC among patients with TBI increases substantially regardless of the MOI. The high BAC value in Fall-related TBI needs more attention to set appropriate preventive measures.	[El-Menyar, Ayman; Asim, Mohammed; Mekkodathil, Ahammed] Hamad Gen Hosp, Clin Res Trauma & Vasc Surg, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Clin Med, Doha, Qatar; [Consunji, Rafael] Hamad Gen Hosp, Injury Prevent, Trauma Surg, Doha, Qatar; [Latifi, Rifat] Westchester Med Ctr, Dept Surg, Valhalla, NY USA; [Latifi, Rifat] New York Med Coll, Valhalla, NY 10595 USA; [Smith, Gordon] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Parchani, Ashok; Al-Thani, Hassan] Hamad Gen Hosp, Dept Surg, Trauma Surg, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Gen Hosp, Weill Cornell Med Scholl & Clin Res, Trauma Surg, Doha, Qatar.	aelmenyar@hamad.qa	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; Smith, Gordon/0000-0002-2911-3071; Latifi, Rifat/0000-0003-1091-3682			Al-Anazi Abdulrahman H, 2004, Neurosciences (Riyadh), V9, P265; American College of Surgeons Committee on Trauma, 2006, ALC SCREEN BRIEF INT; Asim Mohammad, 2014, J Emerg Trauma Shock, V7, P88, DOI 10.4103/0974-2700.130878; Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Cherpitel CJ, 2015, ADDICTION, V110, P279, DOI 10.1111/add.12755; Choi Y, 2009, AM J EMERG MED, V27, P956, DOI 10.1016/j.ajem.2008.07.035; Consunji R, 2015, 16 EUR C TRAUM EM SU; Consunji R, 2014, 15 EUR C TRAUM EM SU; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; Department of Transportation (US) National Highway Traffic Safety Administration (NHTSA), 2014, TRAFF SAF FACTS 2013; El-Matbouly M, 2013, SCI WORLD J, DOI 10.1155/2013/354920; El-Menyar A, 2017, MED SCI MONITOR, V23, P6082, DOI 10.12659/MSM.905201; El-Menyar A, 2017, WORLD NEUROSURG, V107, P6, DOI [10.1016/J.WNEU.2017.07.070, 10.1016/j.wneu.2017.07.070]; Fabbri A, 2001, J TRAUMA, V50, P521, DOI 10.1097/00005373-200103000-00018; Hadjibashi AA, 2012, J SURG RES, V173, P212, DOI 10.1016/j.jss.2011.05.029; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Mahmood S, 2017, BRAIN INJURY, V28, P1; Modig F, 2012, ALCOHOL, V46, P75, DOI 10.1016/j.alcohol.2011.06.001; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; Osman OT, 2015, TRAFFIC INJ PREV, V16, P1, DOI 10.1080/15389588.2014.895923; Parchani A, 2014, WORLD NEUROSURG, V82, pE639, DOI 10.1016/j.wneu.2014.06.022; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Plurad D, 2006, J AM COLL SURGEONS, V202, P919, DOI 10.1016/j.jamcollsurg.2006.02.024; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	39	4	4	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					419	426		10.1080/02699052.2018.1553065			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100004	30612471				2022-02-06	
J	Estevez-Baez, M; Machado, C; Garcia-Sanchez, B; Rodriguez, V; Alvarez-Santana, R; Leisman, G; Carrera, JME; Schiavi, A; Montes-Brown, J; Arrufat-Pie, E				Estevez-Baez, Mario; Machado, Calixto; Garcia-Sanchez, Benjamin; Rodriguez, Valia; Alvarez-Santana, Reynaldo; Leisman, Gerry; Estevez Carrera, Jose Mario; Schiavi, Adam; Montes-Brown, Julio; Arrufat-Pie, Eduardo			Autonomic impairment of patients in coma with different Glasgow coma score assessed with heart rate variability	BRAIN INJURY			English	Article						Heart rate variability; coma; autonomic nervous system; Hilbert-Huang transform; Glasgow coma scale	EMPIRICAL MODE DECOMPOSITION; TRAUMATIC BRAIN-INJURY; HIGH-FREQUENCY OSCILLATIONS; POWER SPECTRUM ANALYSIS; RATE MULTISCALE ENTROPY; LIFESAVING INTERVENTIONS; BLOOD-PRESSURE; ATRIAL-FIBRILLATION; SAMPLING FREQUENCY; NONLINEAR-ANALYSIS	Primary objective: The objective of this study is to assess the functional state of the autonomic nervous system in healthy individuals and in individuals in coma using measures of heart rate variability (HRV) and to evaluate its efficiency in predicting mortality. Design and Methods: Retrospective group comparison study of patients in coma classified into two subgroups, according to their Glasgow coma score, with a healthy control group. HRV indices were calculated from 7 min of artefact-free electrocardiograms using the Hilbert-Huang method in the spectral range 0.02-0.6 Hz. A special procedure was applied to avoid confounding factors. Stepwise multiple regression logistic analysis (SMLRA) and ROC analysis evaluated predictions. Results: Progressive reduction of HRV was confirmed and was associated with deepening of coma and a mortality score model that included three spectral HRV indices of absolute power values of very low, low and very high frequency bands (0.4-0.6 Hz). The SMLRA model showed sensitivity of 95.65%, specificity of 95.83%, positive predictive value of 95.65%, and overall efficiency of 95.74%. Conclusions: HRV is a reliable method to assess the integrity of the neural control of the caudal brainstem centres on the hearts of patients in coma and to predict patient mortality.	[Estevez-Baez, Mario; Machado, Calixto] Inst Neurol & Neurosurg, Dept Clin Neurophysiol, Havana, Cuba; [Garcia-Sanchez, Benjamin; Rodriguez, Valia] Cuban Ctr Neurosci, Havana, Cuba; [Alvarez-Santana, Reynaldo] Hermanos Ameijeiras Hosp, Dept Pathol, Havana, Cuba; [Leisman, Gerry] Univ Haifa, Fac Hlth Sci, 199 Abba Khoushy St,Eshkol Tower,Room 910, Haifa, Israel; [Schiavi, Adam] Johns Hopkins Univ Hosp, Neurosci Crit Care Div, Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Montes-Brown, Julio] Univ Sonora, Dept Med & Hlth Sci, Hermosillo, Sonora, Mexico; [Arrufat-Pie, Eduardo] Inst Basic & Preclin Sci Victoria de Giron, Havana, Cuba; [Estevez Carrera, Jose Mario] Luis Diaz Soto Naval Hosp, Biomed Engn, Havana, Cuba		Leisman, G (corresponding author), Univ Haifa, Fac Hlth Sci, 199 Abba Khoushy St,Eshkol Tower,Room 910, Haifa, Israel.	g.leisman@alumni.manchester.ac.uk	Leisman, Gerry/U-3267-2019	Leisman, Gerry/0000-0002-9975-7331; Rodriguez, Valia/0000-0002-6085-285X			Acharya UR, 2014, COMPUT METH PROG BIO, V113, P55, DOI 10.1016/j.cmpb.2013.08.017; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Altan G, 2016, COMPUT METH PROG BIO, V137, P23, DOI 10.1016/j.cmpb.2016.09.003; Amo C, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17050989; Antelmi I, 2004, AM J CARDIOL, V93, P381, DOI 10.1016/j.amjcard.2003.09.065; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Bailon R, 2003, MED BIOL ENG COMPUT, V41, P561, DOI 10.1007/BF02345319; Batchinsky AL, 2007, J TRAUMA, V63, P512, DOI 10.1097/TA.0b013e318142d2f0; BERNARDI L, 1989, J APPL PHYSIOL, V67, P1447, DOI 10.1152/jappl.1989.67.4.1447; BERNARDI L, 1990, CARDIOVASC RES, V24, P969, DOI 10.1093/cvr/24.12.969; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Bravi A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-90; Camm AJ, 1996, EUR HEART J, V17, P354; Cancio LC, 2008, J TRAUMA, V65, P813, DOI 10.1097/TA.0b013e3181848241; Cersosimo M, 2014, HDB CLIN NEUROLOGY A, P117; Chang CC, 2014, PHYSIOL MEAS, V35, P1873, DOI 10.1088/0967-3334/35/9/1873; Chang CC, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-46; Chang CC, 2014, MED BIOL ENG COMPUT, V52, P343, DOI 10.1007/s11517-013-1135-5; Clark MT, 2012, J APPL PHYSIOL, V112, P859, DOI 10.1152/japplphysiol.01152.2011; Clifford GD, 2005, IEEE T BIO-MED ENG, V52, P630, DOI 10.1109/TBME.2005.844028; Colominas MA, 2014, BIOMED SIGNAL PROCES, V14, P19, DOI 10.1016/j.bspc.2014.06.009; Conci F, 2001, J NEUROL NEUROSUR PS, V71, P621, DOI 10.1136/jnnp.71.5.621; Cooke WH, 2006, J TRAUMA, V60, P363, DOI 10.1097/01.ta.0000196623.48952.0e; Corthout J, 2008, IEEE ENG MED BIO, P3608, DOI 10.1109/IEMBS.2008.4649987; Cygankiewicz Iwona, 2013, Handb Clin Neurol, V117, P379, DOI 10.1016/B978-0-444-53491-0.00031-6; Daskalov I, 1997, MED ENG PHYS, V19, P375, DOI 10.1016/S1350-4533(96)00067-7; Ebrahimi F, 2013, COMPUT METH PROG BIO, V112, P47, DOI 10.1016/j.cmpb.2013.06.007; Ellis RJ, 2015, PHYSIOL MEAS, V36, P1827, DOI 10.1088/0967-3334/36/9/1827; Est?vez-B?ez M., 2016, INT J DISABIL HUM DE, V15, P277, DOI [10.1515/ijdhd-2015-0014, DOI 10.1515/IJDHD-2015-0014]; Estevez M, 2017, MATLAB CODE HILBERT; Estevez-Baez M, 2018, ADV EXP MED BIOL, V1070, P49, DOI 10.1007/5584_2018_154; Fathizadeh P, 2004, CRIT CARE MED, V32, P1300, DOI 10.1097/01.CCM.0000127776.78490.E4; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Freitas J, 1996, CLIN AUTON RES, V6, P141, DOI 10.1007/BF02281900; Fugate JE, 2011, NEUROLOGY, V77, P399, DOI 10.1212/WNL.0b013e3182270444; Garcia OD, 1995, DEVEL NEUR, V9, P191; Garcia-Gonzalez MA, 2004, PHYSIOL MEAS, V25, P489, DOI 10.1088/0967-3334/25/2/008; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Gujjar AR, 2004, NEUROCRIT CARE, V1, P347, DOI 10.1385/NCC:1:3:347; Gupta P, 2016, COMPUT BIOL MED, V68, P121, DOI 10.1016/j.compbiomed.2015.11.007; Haji-Michael PG, 2000, CRIT CARE MED, V28, P2578, DOI 10.1097/00003246-200007000-00066; Hildebrandt H, 1998, EUR ARCH PSY CLIN N, V248, P46, DOI 10.1007/s004060050016; Hsu YF, 2011, CLIN NEUROPHYSIOL, V122, P2260, DOI 10.1016/j.clinph.2011.03.027; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang NE, 2013, ADV DATA SCI ADAPT, V5, DOI 10.1142/S1793536913500118; Huang NE, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0206; Huang Z., 2007, Journal of Medical Engineering & Technology, V31, P381, DOI 10.1080/03091900601165314; King DR, 2009, J TRAUMA, V67, P436, DOI 10.1097/TA.0b013e3181ad67de; Korpelainen JT, 1996, ACTA NEUROL SCAND, V94, P337, DOI 10.1111/j.1600-0404.1996.tb07076.x; Kuusela T, 2013, HEART RATE VARIABILITY (HRV) SIGNAL ANALYSIS: CLINICAL APPLICATIONS, P9; Laguna P, 1998, IEEE T BIO-MED ENG, V45, P698, DOI 10.1109/10.678605; Li HL, 2011, IEEE ACM T COMPUT BI, V8, P1557, DOI 10.1109/TCBB.2011.43; Li XL, 2008, CLIN NEUROPHYSIOL, V119, P2465, DOI 10.1016/j.clinph.2008.08.006; Lin YC, 2016, CHAOS, V26, DOI 10.1063/1.4941673; Liu NT, 2015, SHOCK, V43, P549, DOI 10.1097/SHK.0000000000000356; Liu NT, 2014, SHOCK, V42, P108, DOI 10.1097/SHK.0000000000000186; Liu Q, 2017, PHYSIOL MEAS, V38, P116, DOI 10.1088/1361-6579/38/2/116; Liu X., 2009, J GERIATR CARDIOL, V6, P213; Machado C, 2005, CLIN NEUROPHYSIOL, V116, P2859, DOI 10.1016/j.clinph.2005.08.016; Machado Calixto, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-205677; Machado-Ferrer Y, 2013, CLIN NEUROPHYSIOL, V124, P589, DOI 10.1016/j.clinph.2012.09.008; Maestri R, 2007, PHYSIOL MEAS, V28, P1067, DOI 10.1088/0967-3334/28/9/008; Maestri R, 2007, J CARDIOVASC ELECTR, V18, P425, DOI 10.1111/j.1540-8167.2007.00728.x; Maestri R, 2006, BIOMED TECH, V51, P220, DOI 10.1515/BMT.2006.041; Marple SL, 1999, IEEE T SIGNAL PROCES, V47, P2600; Marthol H, 2010, CLIN AUTON RES, V20, P363, DOI 10.1007/s10286-010-0072-8; Mateo J, 2001, COMPUT CARDIOL, V28, P309, DOI 10.1109/CIC.2001.977654; Mateo J, 2001, 23 ANN INT C IEEE EN; Mejaddam AY, 2013, J TRAUMA ACUTE CARE, V75, P607, DOI 10.1097/TA.0b013e31829bb991; MERRI M, 1990, IEEE T BIO-MED ENG, V37, P99, DOI 10.1109/10.43621; Mert A, 2016, PHYSIOL MEAS, V37, P530, DOI 10.1088/0967-3334/37/4/530; Mohebbi M, 2014, MED BIOL ENG COMPUT, V52, P415, DOI 10.1007/s11517-014-1144-z; Monfredi O, 2014, HYPERTENSION, V64, P1334, DOI 10.1161/HYPERTENSIONAHA.114.03782; Montes-Brown J, 2015, DISFUNCION AUTONOMIC; Montes-Brown J, 2016, INT J DISABIL HUM DE, V15, P5, DOI [10.1515/ijdhd-2014-0025, DOI 10.1515/IJDHD-2014-0025]; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Motin MA, 2018, IEEE J BIOMED HEALTH, V22, P766, DOI 10.1109/JBHI.2017.2679108; Naraghi L, 2015, J CRIT CARE, V30, P705, DOI 10.1016/j.jcrc.2015.03.018; Neto EPS, 2004, METHOD INFORM MED, V43, P60; Nieminen T, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.04.050; Norris PR, 2008, J CRIT CARE, V23, P399, DOI 10.1016/j.jcrc.2007.08.001; Norris PR, 2008, SHOCK, V30, P17, DOI 10.1097/SHK.0b013e318164e4d0; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Ozyilmaz I, 2016, ANATOL J CARDIOL, V16, P290, DOI 10.5152/akd.2015.5922; Percival D.B., 1993, SPECTRAL ANAL PHYS A; Pinhas I, 2004, IEEE T BIO-MED ENG, V51, P1774, DOI 10.1109/TBME.2004.831519; Piskorski J, 2010, CENT EUR J PHYS, V8, P386, DOI 10.2478/s11534-009-0101-1; Proctor KG, 2007, J TRAUMA, V63, P33, DOI 10.1097/01.ta.0000251593.32396.df; Rajesh KNVPS, 2017, COMPUT BIOL MED, V87, P271, DOI 10.1016/j.compbiomed.2017.06.006; Rapenne T, 2000, ANESTH ANALG, V91, P329, DOI 10.1097/00000539-200008000-00018; Rickards CA, 2010, CRIT CARE MED, V38, P1666, DOI 10.1097/CCM.0b013e3181e74cab; Riganello F., 2016, BRAIN FUNCTION RESPO, P145, DOI 10.1007/978-3-319-21425-2_11; Riganello F, 2015, J NEUROTRAUM, V32, P1071, DOI 10.1089/neu.2014.3539; Ryan ML, 2011, J TRAUMA, V70, P1371, DOI 10.1097/TA.0b013e31821858e6; Sacha J, 2014, ANN NONINVAS ELECTRO, V19, P207, DOI 10.1111/anec.12148; Sacha J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00306; Sacha J, 2013, INT J CARDIOL, V168, P1660, DOI 10.1016/j.ijcard.2013.03.038; Salisbury JI, 2004, ANN BIOMED ENG, V32, P1348, DOI 10.1114/B:ABME.0000042223.87320.de; Sassi R, 2015, EUROPACE, V17, P1341, DOI 10.1093/europace/euv015; Schiecke K, 2014, IEEE ENG MED BIO, P6377, DOI 10.1109/EMBC.2014.6945087; Schiecke K, 2014, IEEE T BIO-MED ENG, V61, P1798, DOI 10.1109/TBME.2014.2307481; Shafqat K, 2009, IEEE ENG MED BIO, P2244, DOI 10.1109/IEMBS.2009.5335000; Shimomura C., 1991, BRAIN DEV, V23, P26; Sivakumar SS, 2016, J NEUROPHYSIOL, V115, P1988, DOI 10.1152/jn.01120.2015; Sosnowski M, 2011, COMPREHENSIVE ELECTR; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Takahashi ACM, 2012, INTERN EMERG MED, V7, P229, DOI 10.1007/s11739-011-0512-z; Toledo E, 2003, MED BIOL ENG COMPUT, V41, P432, DOI 10.1007/BF02348086; Toledo E, 2002, AM J PHYSIOL-REG I, V282, pR900, DOI 10.1152/ajpregu.00467.2001; Torres ME, 2011, INT CONF ACOUST SPEE, P4144; Vakilian AR, 2011, JCPSP-J COLL PHYSICI, V21, P130, DOI 03.2011/JCPSP.130133; van Roon AM, 2016, HYPERTENSION, V68, pE63, DOI 10.1161/HYPERTENSIONAHA.116.08053; Veerabhadrappa ST, 2013, IEEE ENG MED BIO, P2575, DOI 10.1109/EMBC.2013.6610066; Viola AU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019002; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Winchell RJ, 1997, J TRAUMA, V43, P927, DOI 10.1097/00005373-199712000-00010; Winchell RJ, 1996, J SURG RES, V63, P11, DOI 10.1006/jsre.1996.0214; Yeh JR, 2013, J NEUROSCI METH, V219, P233, DOI 10.1016/j.jneumeth.2013.08.008; Yeh JR, 2010, ANN BIOMED ENG, V38, P1337, DOI 10.1007/s10439-010-9939-z; Yen JL, 1956, T CIRCUIT THEORY, V3, P251, DOI [10.1109/TCT.1956.1086325, DOI 10.1109/TCT.1956.1086325]; Zhang Y, 2016, NEUROSCI LETT, V633, P152, DOI 10.1016/j.neulet.2016.09.037; Zheng JW, 2016, MED ENG PHYS, V38, P671, DOI 10.1016/j.medengphy.2016.02.015; Zheng Y, 2014, CLIN NEUROPHYSIOL, V125, P1104, DOI 10.1016/j.clinph.2013.09.047	128	4	5	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					496	516		10.1080/02699052.2018.1553312			21	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100012	30755043	Green Accepted			2022-02-06	
J	Fraunberger, EA; Shutt, TE; Esser, MJ				Fraunberger, Erik A.; Shutt, Timothy E.; Esser, Michael J.			Sex-dependent and chronic alterations in behavior and mitochondrial function in a rat model of pediatric mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; pediatrics; mitochondrial dysfunction; mitochondrial dynamics; post-concussion syndrome	PITUITARY-RESPONSIVENESS; OXIDATIVE STRESS; GENE-EXPRESSION; MOUSE MODEL; FEMALE RATS; AGE; DYSFUNCTION; CONCUSSION; OUTCOMES; HORMONE	Objective: To determine if chronic changes in mitochondrial function occur following a mild traumatic brain injury in young rats. Research Design: Closed-head, weight drop model was used to cause mTBI by applying rotational forces to the brain without surgery. Behavioral battery was used to assess multiple dimensions of impairment across time. Analysis of brain tissue carried out at three-weeks post-injury represents a chronic time point to complement previous work examining acute time points. Methods and Procedures: Twenty-three male and 22 female rats one month of age were divided equally into sham and mTBI groups with the latter undergoing the weight drop. Multiple behavioral tests in combination with energetic (oxygen consumption), molecular (immunoblotting), and imaging (electron microscopy) characterization of brain mitochondria were performed. Main Outcomes and Results: Mitochondria isolated from sham juvenile female rats had higher basal oxygen consumption compared to juvenile male rats (514.875 +/- 171.091 pmol/min vs. 267 +/- 73.906 pmol/min, p < 0.0001). Chronic sex-dependent differences were observed in females after mTBI in basal (514.875 +/- 171.091 pmol/min vs. 600.688 +/- 124.422 pmol/min, p = 0.0264) and maximal oxygen consumption (298.938 +/- 119.964 pmol/min vs. 403.281 +/- 112.922 pmol/min, p = 0.0001) and proton leak (59.46 +/- 7.807 vs. 84.32 +/- 5.80 pmol/min, p = 0.0001). Conclusions: The juvenile rat brain displays sex differences in mitochondrial function at (1) baseline and (2) in long-term outcomes after mTBI. These results offer new insight into a potential mechanism for persistent, individualized impairments following pediatric mTBI.	[Fraunberger, Erik A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Fraunberger, Erik A.; Shutt, Timothy E.; Esser, Michael J.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Shutt, Timothy E.] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Shutt, Timothy E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Esser, Michael J.] Univ Calgary, Dept Pediat, Calgary, AB, Canada		Esser, MJ (corresponding author), Alberta Childrens Hosp Res Inst, C4-629,2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	michael.esser@ahs.ca	Shutt, Tim/U-9047-2019	Shutt, Tim/0000-0001-5299-2943	CIHRCanadian Institutes of Health Research (CIHR); BranchOut Neurological Foundation; University of Calgary Integrated Concussion Research Program; Alberta Children's Hospital Research Institute; University of Calgary Cumming School of Medicine; Hotchkiss Brain Institute; Alberta Children's Hospital Foundation	This work was supported by the CIHR, BranchOut Neurological Foundation, University of Calgary Integrated Concussion Research Program, Alberta Children's Hospital Research Institute, the University of Calgary Cumming School of Medicine, the Hotchkiss Brain Institute, and the Alberta Children's Hospital Foundation. Additionally, the authors would like to acknowledge Sydney Candy, Younghee Ahn, Irene Ma and Wei-Xiang Dong for their research expertise.	Ahn Y, 2014, DEV NEUROSCI-BASEL, V36, P371, DOI 10.1159/000362645; ANDREWS WW, 1981, ENDOCRINOLOGY, V109, P2032; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arts JWM, 2012, ILAR J, V53, pE82, DOI 10.1093/ilar.53.1.82; Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Cavallucci V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.511; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dai W, 2009, BRAIN RES, V1251, P287, DOI 10.1016/j.brainres.2008.11.034; DEBELJUK L, 1972, ENDOCRINOLOGY, V90, P585, DOI 10.1210/endo-90-2-585; DEBELJUK L, 1972, ENDOCRINOLOGY, V90, P1499, DOI 10.1210/endo-90-6-1499; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; EVANS AM, 1986, BIOL REPROD, V34, P322, DOI 10.1095/biolreprod34.2.322; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Ferger AI, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-45; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Gagnon I, 2017, BRIT J SPORT MED, V51, P11, DOI [10.1136/bjsports-2016-097270.91, DOI 10.1136/BJSPORTS-2016-097270.91]; Gaignard P, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12497; Gaignard P, 2015, ENDOCRINOLOGY, V156, P2893, DOI 10.1210/en.2014-1913; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/bse0470053, 10.1042/BSE0470053]; Jn H, 2015, NEURAL PLAST, V2015; Konkle ATM, 2010, J AM ASSOC LAB ANIM, V49, P427; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Pandya JD, 2016, NEUROBIOL AGING, V42, P25, DOI 10.1016/j.neurobiolaging.2016.02.027; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Satterthwaite TD, 2015, CEREB CORTEX, V25, P2383, DOI 10.1093/cercor/bhu036; Satterthwaite TD, 2014, P NATL ACAD SCI USA, V111, P8643, DOI 10.1073/pnas.1400178111; Satterthwaite TD, 2014, J AM ACAD CHILD PSY, V53, P341, DOI 10.1016/j.jaac.2013.12.002; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Semple BD, 2016, METHODS MOL BIOL, V1462, P325, DOI 10.1007/978-1-4939-3816-2_18; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Ventura-Clapier R, 2017, CLIN SCI, V131, P803, DOI 10.1042/CS20160485; Voloboueva LA, 2007, J NEUROCHEM, V102, P1383, DOI 10.1111/j.1471-4159.2007.04634.x; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Watson William D, 2013, Front Neuroenergetics, V5, P12, DOI 10.3389/fnene.2013.00012; WILSON DF, 1994, MED SCI SPORT EXER, V26, P37; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	77	4	5	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					534	542		10.1080/02699052.2019.1565898			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100015	30663413				2022-02-06	
J	Wayment, HA; Huffman, AH				Wayment, Heidi A.; Huffman, Ann H.			Psychosocial experiences of concussed collegiate athletes: The role of emotional support in the recovery process	JOURNAL OF AMERICAN COLLEGE HEALTH			English	Article						Athletics; health education; mental health	SOCIAL SUPPORT; HEAD-INJURY; REHABILITATION; ANXIETY; GROWTH	Objective: Understand from whom concussed football players seek and receive emotional support, and whether this support is associated with injury perceptions. Participants: Football players (N = 26) from three NCAA Division I programs. Methods: With approval from the head athletic trainer, concussed athletes (2017 season) completed short surveys within 4-6 days of diagnosis and when cleared to return. Results: Concussed athletes perceived their injury as a normal consequence of playing football, not serious, and reported little, if any, depression and anxiety. Athletes reported the most support from athletic trainers; the least from coaches and teammates. Emotional support was associated with fewer adverse psychosocial reactions, more sport-injury related growth, and greater intentions to report future concussion symptoms. Conclusion: Results from this pilot study suggest that emotional support during the concussion recovery process should be understood and fostered by university officials charged with the health and well-being of collegiate football players.	[Wayment, Heidi A.] No Arizona Univ, Dept Psychol Sci, Box 15106, Flagstaff, AZ 86011 USA; [Huffman, Ann H.] No Arizona Univ, Dept Psychol Sci, WA Franke Coll Businesss, Flagstaff, AZ 86011 USA		Wayment, HA (corresponding author), No Arizona Univ, Dept Psychol Sci, Box 15106, Flagstaff, AZ 86011 USA.	heidi.wayment@nau.edu		Wayment, Heidi/0000-0001-5287-5966	National Collegiate Athletic Association (NCAA); U.S. Department of Defense (DoD)United States Department of Defense	This research was supported by the National Collegiate Athletic Association (NCAA) and the U.S. Department of Defense (DoD) on a programmatic research project investigating NCAA football programs' efforts to increase concussion-reporting behavior (Mind Matters). The views expressed in this article are those of the authors and do not necessarily represent the official policy or position of the NCAA or the U.S. DoD.	[Anonymous], NY TIMES; [Anonymous], 2018, CREAT PATHW OPP; Bejar MP, 2016, J SPORT BEHAV, V39, P345; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; BREWER BW, 1995, CLIN J SPORT MED, V5, P241, DOI 10.1097/00042752-199510000-00006; Brock RL, 2009, J FAM PSYCHOL, V23, P181, DOI 10.1037/a0015402; Clement D, 2011, J SPORT REHABIL, V20, P457, DOI 10.1123/jsr.20.4.457; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Cutrona CE., 1990, SOCIAL SUPPORT INTER, P319; Dallal G.V., 1999, LITTLE HDB STAT PRAC LITTLE HDB STAT PRAC; Evans L, 2002, RES Q EXERCISE SPORT, V73, P310, DOI 10.1080/02701367.2002.10609025; Evans L, 2012, J SPORT SCI, V30, P917, DOI 10.1080/02640414.2012.682078; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Johnston LH, 1998, J SPORT REHABIL, V7, P206, DOI 10.1123/jsr.7.3.206; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lininger M, 2017, ATHLETIC TRAIN SPORT, V9, P71, DOI DOI 10.3928/19425864-20161116-01; Mainwaring L, 2017, OXFORD HDB SPORTS RE; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Podlog L, 2007, PSYCHOL SPORT EXERC, V8, P535, DOI 10.1016/j.psychsport.2006.07.008; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Salim J, 2018, J APPL SPORT PSYCHOL, V30, P367, DOI 10.1080/10413200.2017.1417338; Salim J, 2016, J APPL SPORT PSYCHOL, V28, P154, DOI 10.1080/10413200.2015.1086448; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Theodorakis Y, 1997, J SPORT REHABIL, V6, P355, DOI 10.1123/jsr.6.4.355; Tjong VK, 2017, JAAOS GLOB RES REV, V1, DOI 10.5435/JAAOSGlobal-D-17-00070; Tracey J, 2003, J APPL SPORT PSYCHOL, V15, P279, DOI 10.1080/714044197; Udry E, 1997, J SPORT EXERCISE PSY, V19, P368, DOI 10.1123/jsep.19.4.368; Weiner B., 1986, ATTRIBUTIONAL THEORY; Wiese-Bjornstal DM, 1998, J APPL SPORT PSYCHOL, V10, P46, DOI 10.1080/10413209808406377; Yang JZ, 2010, J ATHL TRAINING, V45, P372, DOI 10.4085/1062-6050-45.4.372	35	4	4	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0744-8481	1940-3208		J AM COLL HEALTH	J. Am. Coll. Health	MAY 18	2020	68	4					438	443		10.1080/07448481.2019.1577863		MAR 2019	6	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	LV1KG	WOS:000465680000001	30908165				2022-02-06	
J	Seesen, M; Siviroj, P; Sapbamrer, R; Morarit, S				Seesen, Maturamat; Siviroj, Penprapa; Sapbamrer, Ratana; Morarit, Sompong			High blood alcohol concentration associated with traumatic brain injury among traffic injury patients during New Year festivals in Thailand	TRAFFIC INJURY PREVENTION			English	Article						Blood alcohol concentration; traumatic brain injury; traffic injury; Thailand	GENDER-DIFFERENCES; SEATING POSITION; CONSUMPTION; PATTERNS; ACCIDENTS; SEVERITY; INTOXICATION; DRIVERS; RISK	Objective: Road traffic injury (RTI) is one of the most significant public health problems in Thailand, especially during New Year and Songkran (Thai traditional New Year) holidays, which have the highest traffic density during the entire year. Drunk driving was reported to be one of the leading causes of RTI in Thailand. This study aimed to investigate the prevalence of patients with high blood alcohol concentration (BAC) and the association of BAC and specific organ injury during New Year and Songkran (Thai traditional New Year) holidays. Methods: A cross-sectional study was performed to analyze the database from the Thai Governmental Road Safety Evaluation Project. Patient data on RTIs were collected from 26 main provincial hospitals during the New Year Festival 2003 and 2004 and Songkran Festival in 2003. Patient characteristics, type of organ injured, and BAC levels were mainly analyzed. Results: During those long holidays, 2,642 RTI patients were identified, among whom 1,341 patients had high BAC levels. High BAC levels were associated with motorcycle users, male sex, middle age, teenagers, being riders or drivers, and not using protective devices. Moreover, high BAC levels were associated with brain injury. Conclusion: Excessive alcohol consumption and RTIs occurred on New Year and Songkran Festival in Thailand. Legislation should be strictly used during these long holidays to control driving under the influence of alcohol, particularly among motorcyclists.	[Seesen, Maturamat; Siviroj, Penprapa; Sapbamrer, Ratana] Chiang Mai Univ, Fac Med, Dept Community Med, 110 Inthavaroros, Chiang Mai 50200, Thailand; [Morarit, Sompong] Minist Publ Hlth, Dept Hlth, Hlth Promot Ctr Reg 1, Chiang Mai, Thailand		Siviroj, P (corresponding author), Chiang Mai Univ, Fac Med, Dept Community Med, 110 Inthavaroros, Chiang Mai 50200, Thailand.	psiviroj@gmail.com		Siviroj, Penprapa/0000-0003-4781-4119; Seesen, Mathuramat/0000-0002-4705-2380; Sapbamrer, Ratana/0000-0003-0379-2798	Thai Health Promotion Foundation	We thank the Faculty of Medicine, Chiang Mai University, for providing facilities for this research. In addition, we are grateful to the Thai Health Promotion Foundation for supporting the budget for the Thai Governmental Road Safety Evaluation project, whose database was used in this study.	Ankarath S, 2002, INJURY, V33, P473, DOI 10.1016/S0020-1383(02)00048-7; Assanangkornchai S, 2010, ALCOHOL ALCOHOLISM, V45, P278, DOI 10.1093/alcalc/agq018; Berecki-Gisolf J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120617; Clarke DD, 2005, ACCIDENT ANAL PREV, V37, P523, DOI 10.1016/j.aap.2005.01.007; Creaser JI, 2009, ACCIDENT ANAL PREV, V41, P906, DOI 10.1016/j.aap.2009.04.007; Department of Disease Control, 2012, THAIL REP SIT SEV IN; Digital Government Development Agency, 2018, NUMB REG MOT VEH 31; Ely M, 1999, ALCOHOL ALCOHOLISM, V34, P894, DOI 10.1093/alcalc/34.6.894; EVANS L, 1988, AM J PUBLIC HEALTH, V78, P1456, DOI 10.2105/AJPH.78.11.1456; Fitzharris M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-11; Global Road Safety Partnership, 2007, DRINK DRIV ROAD SAF; Gururaj G, 2004, J Indian Med Assoc, V102, P157; Health Promotion Policy Research Center, 2017, REP ALC DRINK BEH SE; Iamtrakul I., 2003, J E ASIA SOC T STUDI, V5, P147; Institute for Health Metrics and Evaluation, 2016, THAIL HLTH DAT; Junsirimongkol B, 2012, J MENTAL HLTH THAILA, V19, P88; Kasantikul V, 2005, ACCIDENT ANAL PREV, V37, P357, DOI 10.1016/j.aap.2004.07.006; Kasantikul V, 2001, MOTORCYCLE ACCIDENT; Kraus JF, 2002, J TRAUMA, V52, P548, DOI 10.1097/00005373-200203000-00022; Kuppa S, 2009, STAPP CAR CRASH J, V53, P75; Mann B., 2011, EMERG MED INT, V2011, P1; MANNERING F, 1995, ACCIDENT ANAL PREV, V27, P21, DOI 10.1016/0001-4575(94)00041-J; NELSON D, 1992, ANN EMERG MED, V21, P279, DOI 10.1016/S0196-0644(05)80888-1; Plurad D, 2006, J AM COLL SURGEONS, V202, P919, DOI 10.1016/j.jamcollsurg.2006.02.024; Prapongsena P, 2017, TRAFFIC ACCIDENT NAT; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; Smith KM, 2004, ACCIDENT ANAL PREV, V36, P257, DOI 10.1016/S0001-4575(03)00002-2; Sornpaisarn B, 2010, THAILAND ANN REPORT; Stephan K, 2011, ACCIDENT ANAL PREV, V43, P1062, DOI 10.1016/j.aap.2010.12.011; Stubig T, 2012, ALCOHOL, V46, P681, DOI 10.1016/j.alcohol.2012.07.002; Sun SW, 1998, ACCIDENT ANAL PREV, V30, P133, DOI 10.1016/S0001-4575(97)00055-9; Tanaboriboon Y, 2005, IATSS RES, V29, P88, DOI 10.1016/S0386-1112(14)60122-9; Tay R, 2007, J ADV TRANSPORT, V41, P245, DOI 10.1002/atr.5670410303; Thai Road Safety Collaboration, 2018, NEW YEAR SONGKR STAT; United Nations Educational Scientific and Cultural Organization Bangkok, 2018, OV INT MIGR THAIL; Wakabayashi M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2662-9; WHO, 2004, WORLD REPORT ROAD TR; Williams AF, 2003, J SAFETY RES, V34, P5, DOI 10.1016/S0022-4375(02)00075-0; Wilsnack RW, 2000, ADDICTION, V95, P251, DOI 10.1046/j.1360-0443.2000.95225112.x; World Health Organization, 2016, ROAD SAF I LEG ASS T; World Health Organization, 2015, GLOB STAT REP ROAD S; ZARGAR M, 2001, E MEDITERR HEALTH J, V12, P81; Zhou JH, 2008, CHIN J TRAUMATOL, V11, P3, DOI 10.1016/S1008-1275(08)60001-2	44	4	4	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	FEB 17	2019	20	2					115	121		10.1080/15389588.2018.1547379		MAR 2019	7	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	HY7VB	WOS:000461930600001	30892946				2022-02-06	
J	Picetti, E; Maier, RV; Rossi, S; Kirkpatrick, AW; Biffl, WL; Stahel, PF; Moore, EE; Kluger, Y; Baiocchi, GL; Ansaloni, L; Agnoletti, V; Catena, F				Picetti, Edoardo; Maier, Ronald V.; Rossi, Sandra; Kirkpatrick, Andrew W.; Biffl, Walter L.; Stahel, Philip F.; Moore, Ernest E.; Kluger, Yoram; Baiocchi, Gian Luca; Ansaloni, Luca; Agnoletti, Vanni; Catena, Fausto			Preserve encephalus in surgery of trauma: online survey. (PESTO)	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Traumatic brain injury; Polytrauma; Management; Monitoring	INTRAOPERATIVE SECONDARY INSULTS; BRAIN-INJURY; INTRACRANIAL-PRESSURE; DAMAGE CONTROL; INDUCED COAGULOPATHY; MANAGEMENT; RESUSCITATION; MORTALITY; HYPERTENSION; TRANSFUSION	BackgroundTraumatic brain injury (TBI) is a global health problem. Extracranial hemorrhagic lesions needing emergency surgery adversely affect the outcome of TBI. We conducted an international survey regarding the acute phase management practices in TBI polytrauma patients.MethodsA questionnaire was available on the World Society of Emergency Surgery website between December 2017 and February 2018. The main endpoints were the evaluation of (1) intracranial pressure (ICP) monitoring during extracranial emergency surgery (EES), (2) hemodynamic management without ICP monitoring during EES, (3) coagulation management, and (4) utilization of simultaneous multisystem surgery (SMS).ResultsThe respondents were 122 representing 105 trauma centers worldwide. ICP monitoring was utilized in 10-30% of patients at risk of intracranial hypertension (IH) undergoing EES from about a third of the respondents [n=35 (29%)]. The respondents reported that the safest values of systolic blood pressure during EES in patients at risk of IH were 90-100mmHg [n=35 (29%)] and 100-110mmHg [n=35 (29%)]. The safest values of mean arterial pressure during EES in patients at risk of IH were >70mmHg [n=44 (36%)] and >80mmHg [n=32 (26%)]. Regarding ICP placement, a large percentage of respondents considered a platelet (PLT) count >50,000/mm(3) [n=57 (47%)] and a prothrombin time (PT)/activated partial thromboplastin time (aPTT) <1.5 times the normal control [n=73 (60%)] to be the safest parameters. For craniotomy, the majority of respondents considered PLT count >100,000/mm(3) [n=67 (55%)] and a PT/aPTT <1.5 times the normal control [n=76 (62%)] to be the safest parameters. Almost half of the respondents [n=53 (43%)], reported that they transfused red blood cells (RBCs)/plasma (P)/PLTs at a ratio of 1/1/1 in TBI polytrauma patients. SMS was performed in 5-19% of patients, requiring both an emergency neurosurgical operation and EES, by almost half of the respondents [n=49 (40%)].ConclusionsA great variability in practices during the acute phase management of polytrauma patients with severe TBI was identified. These findings may be helpful for future investigations and educational purposes.	[Picetti, Edoardo; Rossi, Sandra] Parma Univ Hosp, Dept Anesthesia & Intens Care, Via Gramsci 14, I-43100 Parma, Italy; [Maier, Ronald V.] Harborview Med Ctr, Dept Surg, Seattle, WA USA; [Kirkpatrick, Andrew W.] Foothills Med Ctr, Dept Gen Acute Care, Calgary, AB, Canada; [Kirkpatrick, Andrew W.] Foothills Med Ctr, Dept Abdominal Wall Reconstruct & Trauma Surg, Calgary, AB, Canada; [Biffl, Walter L.] Scripps Mem Hosp, Div Trauma & Acute Care Surg, La Jolla, CA USA; [Stahel, Philip F.] Rocky Vista Univ, Coll Osteopath Med, Parker, CO USA; [Moore, Ernest E.] Denver Hlth, Dept Trauma Surg, Denver, CO USA; [Kluger, Yoram] Rambam Hlth Campus, Dept Gen Surg, Haifa, Israel; [Baiocchi, Gian Luca] Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy; [Ansaloni, Luca] Bufalini Hosp, Dept Gen & Emergency Surg, Cesena, Italy; [Agnoletti, Vanni] Bufalini Hosp, Dept Anesthesia & Intens Care, Cesena, Italy; [Catena, Fausto] Parma Univ Hosp, Dept Emergency Surg, Parma, Italy		Picetti, E (corresponding author), Parma Univ Hosp, Dept Anesthesia & Intens Care, Via Gramsci 14, I-43100 Parma, Italy.	edoardopicetti@hotmail.com	Ansaloni, Luca/AAP-9134-2020; Pisano, Michele/G-9348-2018; Agnoletti, Vanni/AAC-9854-2022	Ansaloni, Luca/0000-0001-6427-0307; Pisano, Michele/0000-0001-9237-3530; Agnoletti, Vanni/0000-0002-7093-2749; Lostoridis, Eftychios/0000-0002-7843-6838; Rossi, Sandra/0000-0002-9963-8121; BAIOCCHI, Gian Luca/0000-0003-2402-2178			Algarra NN, 2017, J NEUROSURG ANESTH, V29, P228, DOI 10.1097/ANA.0000000000000292; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Cannon JW, 2017, J TRAUMA ACUTE CARE, V82, P605, DOI 10.1097/TA.0000000000001333; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carver D, 2018, ANN SURG; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chovanes J, 2012, SURG CLIN N AM, V92, P859, DOI 10.1016/j.suc.2012.04.002; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Fujita Y, 2014, CHILD NERV SYST, V30, P1201, DOI 10.1007/s00381-014-2353-3; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Gonzalez E, 2017, CRIT CARE CLIN, V33, P119, DOI 10.1016/j.ccc.2016.09.002; Guiza F, 2017, J NEUROTRAUM, V34, P2425, DOI 10.1089/neu.2016.4807; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Kinoshita T, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0218-x; Kinoshita T, 2018, WORLD NEUROSURG, V118, pE792, DOI 10.1016/j.wneu.2018.07.053; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Moore EE, 2018, J TRAUMA ACUTE CARE, V84, pS35, DOI 10.1097/TA.0000000000001797; Moore JM, 2016, CLIN NEUROL NEUROSUR, V148, P13, DOI 10.1016/j.clineuro.2016.06.012; Picetti E, 2017, NEUROSURGERY, V81, pE2, DOI 10.1093/neuros/nyx086; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Servadei F, 2015, WORLD NEUROSURG, V83, P732, DOI 10.1016/j.wneu.2015.01.031; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Weinberger J, 2017, CRIT CARE CLIN, V33, P135, DOI 10.1016/j.ccc.2016.08.005; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205	33	4	4	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	MAR 4	2019	14								9	10.1186/s13017-019-0229-2			8	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	HO0MH	WOS:000460597100001	30873217	Green Published, gold			2022-02-06	
J	Acord-Vira, A; Curtis, R; Davis, D; Wheeler, S				Acord-Vira, Amanda; Curtis, Reagan; Davis, Diana; Wheeler, Steven			Returning to the Classroom Following Sport-Related Concussion: Perspectives of College Student Athletes	JOURNAL OF POSTSECONDARY EDUCATION AND DISABILITY			English	Article						concussion; return to learn; postsecondary; college	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; BASE-LINE; MANAGEMENT; PERCEPTIONS; STATEMENT; EDUCATION; RECOVERY	The purpose of this study was to examine student athlete's perspectives regarding return to learn following sport-related concussion. Data were collected through an online survey from student athletes; a subset of whom had a history of concussion. Student athletes who reported receiving education regarding the effects of concussion on classroom performance were more likely to report a concussion and receive accommodations. Also, student athletes experiencing specific symptoms reported certain accommodations to be more or less beneficial with returning to the classroom following concussion. However, the presence of a return to learn policy at colleges did not improve the odds that student athletes received education on the effects of concussion on academic performance or improve concussion reporting or receiving accommodations while recovering from symptoms of concussion. Returning to the classroom prior to symptom resolution following concussion can have adverse effects on symptom recovery, learning, grades, and ultimately the livelihood of the student athletes. Colleges need to provide education specifically on the effects of concussion on classroom performance to increase the odds of student athletes reporting a suspected concussion to a school official. Student athletes who report a concussion are also more likely to receive accommodations when returning to the classroom that will enhance recovery without exacerbating symptoms.	[Acord-Vira, Amanda; Davis, Diana] West Virginia Univ, Div Occupat Therapy, Morgantown, WV 26506 USA; [Curtis, Reagan] West Virginia Univ, Educ Psychol, Morgantown, WV 26506 USA; [Curtis, Reagan] West Virginia Univ, Dept Learning Sci & Human Dev, Morgantown, WV 26506 USA; [Wheeler, Steven] Univ Cincinnati, Occupat Therapy, Cincinnati, OH 45221 USA		Acord-Vira, A (corresponding author), West Virginia Univ, Div Occupat Therapy, Morgantown, WV 26506 USA.	sacordvira@hsc.wvu.edu; dmdavis@hsc.wvu.edu; steven.wheeler@uc.edu	Wheeler, Steven/AAK-8237-2020; Curtis, Reagan/AAD-3185-2020	Curtis, Reagan/0000-0003-1873-1744			Baker J. G, 2014, INT J CLIN PRACTICE, V68; Baker KQ, 2012, J POSTSECOND EDUC DI, V25, P309; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Bonds G. B, 2014, SPORT J, V19; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Byrnes M, 2008, REM SPEC EDUC, V29, P306, DOI 10.1177/0741932507313017; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Centers for Disease Control and Prevention, 2015, HEADS; Centers for Disease Control and Prevention, 2015, INJ PREV CONTR TRAUM; Covassin T, 2013, SPORT PSYCHOL, V27, P372, DOI 10.1123/tsp.27.4.372; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hadley W. M, 2005, NATL ASS COLL ADMISS, V43, P18; Hall EE, 2015, CLIN J SPORT MED, V25, P291, DOI 10.1097/JSM.0000000000000133; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Interassociation Consensus: Diagnosis and Management of Sport-Related Concussion Best Practices, 2017, INT CONS DIAGN MAN S; Johansson B, 2017, NEUROPSYCHOL REHABIL, V27, P1047, DOI 10.1080/09602011.2017.1292921; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McAvoy K., 2012, COMMUNIQUE, V40, P23; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; National Collegiate Athletic Association, EL TIM; Paddack M, 2016, J ATHL TRAINING, V51, P82, DOI 10.4085/1062-6050-51.2.01; Pennington B., 2008, NEW YORK TIMES; Quinlan MM, 2012, J RES SPEC EDUC NEED, V12, P224, DOI 10.1111/j.1471-3802.2011.01225.x; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Trammell J., 2007, J POSTSECONDARY ED D, V20, P5; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3	45	4	4	0	1	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD	COLUMBUS	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD, COLUMBUS, OH 00000 USA	2379-7762	2328-3343		J POSTSECOND EDUC DI	J. Postsecond. Educ. Disabil.	SPR	2019	32	1					35	48					14	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	IA2XJ	WOS:000469425800004					2022-02-06	
J	Benoit, JS; Hannay, HJ; Yamal, JM; Francis, DJ; Aisiku, I; Robertson, C				Benoit, Julia S.; Hannay, H. Julia; Yamal, Jose-Miguel; Francis, David J.; Aisiku, Imoigele; Robertson, Claudia			Longitudinal Changes in Disability Rating Scale Scores: A Secondary Analysis Among Patients With Severe TBI Enrolled in the Epo Clinical Trial	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Randomized clinical trial; Treatment profiles; Neurotrauma; Functional outcome; DRS; Long-term functional recovery; Injury severity; Longitudinal data analysis	TRAUMATIC BRAIN-INJURY; GLASGOW OUTCOME SCALE; HEAD-INJURY; REHABILITATION; RECOVERY; PROGNOSIS; MODELS	Objectives: Long-term neurological response to treatment after a severe traumatic brain injury (sTBI) is a dynamic process. Failure to capture individual heterogeneity in recovery may impact findings from single endpoint sTBI randomized controlled trials (RCT). The present study re-examined the efficacy of erythropoietin (Epo) and transfusion thresholds through longitudinal modeling of sTBI recovery as measured by the Disability Rating Scale (DRS). This study complements the report of primary outcomes in the Epo sTBI RCT, which failed to detect significant effects of acute treatment at 6 months post-injury. Methods: We implemented mixed effects models to characterize the recovery time-course and to examine treatment efficacy as a function of time post-injury and injury severity. Results: The inter-quartile range (25(th)-75(th) percentile) of DRS scores was 20-28 at week1; 8-24 at week 4; and 3-17 at 6 months. TBI severity group was found to significantly interact with Epo randomization group on mean DRS recovery curves. No significant differences in DRS recovery were found in transfusion threshold groups. Conclusions: This study demonstrated the value of taking a comprehensive view of recovery from sTBI in the Epo RCT as a temporally dynamic process that is shaped by both treatment and injury severity, and highlights the importance of the timing of primary outcome measurement. Effects of Epo treatment varied as a function of injury severity and time. Future studies are warranted to understand the possible moderating influence of injury severity on treatment effects pertaining to sTBI recovery. (JINS, 2019, 25, 293-301)	[Benoit, Julia S.] Univ Houston, TIMES, 4849 Calhoun Rd,STE 373, Houston, TX 77204 USA; [Benoit, Julia S.] Univ Houston, Dept Basic Vis Sci, 4849 Calhoun Rd,STE 373, Houston, TX 77204 USA; [Hannay, H. Julia; Francis, David J.] Univ Houston, Dept Psychol, TIMES, Houston, TX 77204 USA; [Yamal, Jose-Miguel] Univ Texas Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX USA; [Aisiku, Imoigele] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Benoit, JS (corresponding author), Univ Houston, TIMES, 4849 Calhoun Rd,STE 373, Houston, TX 77204 USA.; Benoit, JS (corresponding author), Univ Houston, Dept Basic Vis Sci, 4849 Calhoun Rd,STE 373, Houston, TX 77204 USA.	julia.benoit@times.uh.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660]	This study was supported by National Institute of Neurological Disorders and Stroke (grant #P01-NS38660). Author Disclosure Statement: No competing financial interests exist.	BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; BURCHINAL M, 1991, CHILD DEV, V62, P23, DOI 10.1111/j.1467-8624.1991.tb01512.x; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; DAVIS RA, 1984, SURG GYNECOL OBSTET, V159, P597; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCauley SR, 2001, J INT NEUROPSYCH SOC, V7, P457, DOI 10.1017/S1355617701744025; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zhao HX, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0524-9	31	4	4	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2019	25	3					293	301		10.1017/S1355617718001078			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	HO8ML	WOS:000461206600006	30864534	Green Accepted			2022-02-06	
J	Crowe, A; Murray, CE; Mullen, PR; Lundgren, K; Hunnicutt, G; Olson, L				Crowe, Allison; Murray, Christine E.; Mullen, Patrick R.; Lundgren, Kristine; Hunnicutt, Gwen; Olson, Loreen			Help-Seeking Behaviors and Intimate Partner Violence-Related Traumatic Brain Injury	VIOLENCE AND GENDER			English	Article						traumatic brain injury; intimate partner violence; abuse; help seeking	TERRORISM; SURVIVORS; BARRIERS; STIGMA	Traumatic brain injury (TBI) as a result of intimate partner violence (IPV) has been recognized as a health concern needing more attention from researchers and practitioners. This study explored help-seeking behaviors of IPV survivors who were at risk, as well as those who were not at risk for TBI. Using the HELPS screening tool for TBI and a survey created specifically for this research, results revealed that although many at risk for TBI sought help from a professional, these providers did not discuss TBI with the survivor during office visits. Also, victims who did not seek help for the TBI in particular visited a counselor or therapist, family physician, domestic violence agency, psychiatrist, clergy, or an emergency room. Thus, victims may not be aware of the possibility of a TBI, and many professionals are not inquiring about it. Implications are discussed with particular emphasis given to the issue of assessment and referral for professionals working with survivors of IPV who may be at risk for TBI.	[Crowe, Allison] East Carolina Univ, Dept Interdisciplinary Profess, 225 Ragsdale Bldg Mail Stop 121,1000 E Fifth St, Greenville, NC 27858 USA; [Murray, Christine E.; Lundgren, Kristine; Hunnicutt, Gwen; Olson, Loreen] Univ N Carolina, Dept Commun Sci Disorders & Sociol, CED Dept, UNCG, Greensboro, NC USA; [Murray, Christine E.; Lundgren, Kristine; Hunnicutt, Gwen; Olson, Loreen] Univ N Carolina, UNCG, Commun Studies, Greensboro, NC USA; [Mullen, Patrick R.] Coll William & Mary, Sch Psychol & Counselor Educ, Williamsburg, VA USA		Crowe, A (corresponding author), East Carolina Univ, Dept Interdisciplinary Profess, 225 Ragsdale Bldg Mail Stop 121,1000 E Fifth St, Greenville, NC 27858 USA.	crowea@ecu.edu	Hunnicutt, Gwen/AAS-1272-2020; Mullen, Patrick R/V-1711-2019	Mullen, Patrick/0000-0003-3561-9244			Barrett BJ, 2011, VIOLENCE AGAINST WOM, V17, P47, DOI 10.1177/1077801210394273; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant SA, 2003, J FAM VIOLENCE, V18, P369, DOI 10.1023/A:1026205817132; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, 2017, TBI GET THE FACTS; Centers for Disease Control and Prevention Traumatic Brain Injury & Concussion, 2016, TOOLS FOR PROV; Crowe A, 2015, PARTN ABUSE, V6, P157, DOI 10.1891/1946-6560.6.2.157; Faul M, 2010, TRAUMATIC BRAIN INJU; Fugate M, 2005, VIOLENCE AGAINST WOM, V11, P290, DOI 10.1177/1077801204271959; Gover A, 2015, OXFORD HDB ONLINE ED, DOI 10.1093/oxfordhb/9780199935383.001.0001/oxfordhb-9780199935383-e-58; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; JOHNSON MP, 1995, J MARRIAGE FAM, V57, P283, DOI 10.2307/353683; Kaukinen CE, 2013, J INTERPERS VIOLENCE, V28, P577, DOI 10.1177/0886260512455516; King K, 2017, FAM J, V25, P230, DOI 10.1177/1066480717710656; Leone JM, 2007, FAM RELAT, V56, P427, DOI 10.1111/j.1741-3729.2007.00471.x; Liang B, 2005, AM J COMMUN PSYCHOL, V36, P71, DOI 10.1007/s10464-005-6233-6; Lundgren K, 2016, ARCH PHYS MED REHAB, V97, pe13; Murray CE, 2016, OVERCOMING STIGMA IN; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Murray CE, 2015, PARTN ABUSE, V6, P320, DOI 10.1891/1946-6560.6.3.320; Overstreet NM, 2013, BASIC APPL SOC PSYCH, V35, P109, DOI 10.1080/01973533.2012.746599; Picard M., 1991, HELPS; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Sabina C, 2012, J INTERPERS VIOLENCE, V27, P40, DOI 10.1177/0886260511416460; Sylaska KM, 2014, TRAUMA VIOLENCE ABUS, V15, P3, DOI 10.1177/1524838013496335; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	27	4	4	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2326-7836	2326-7852		VIOLENCE GEND	Violence Gend.	MAR 1	2019	6	1					64	71		10.1089/vio.2018.0003			8	Criminology & Penology	Emerging Sources Citation Index (ESCI)	Criminology & Penology	HS4CF	WOS:000463808700009					2022-02-06	
J	Fama, F; Vita, R; Sindoni, A; Vinci, SL; Giorgianni, G; Grasso, L; Gioffre'-Florio, M; Benvenga, S				Fama, Fausto; Vita, Roberto; Sindoni, Alessandro; Vinci, Sergio Lucio; Giorgianni, Grazia; Grasso, Loredana; Gioffre'-Florio, Maria; Benvenga, Salvatore			High frequency of empty sella, with gender differences, in the early neuroradiology evaluation of patients with traumatic brain injury. A prospective study	JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY			English	Article						Traumatic brain injury; Post-traumatic hypopituitarism; Empty sella; Computed tomography	PITUITARY-HORMONE DEFICIENCY; SUBARACHNOID HEMORRHAGE; HYPOPITUITARISM; DYSFUNCTION	One-hundred four persons aged >= 18 years (62 males and 42 females) who were admitted for traumatic brain injury (TBI) underwent brain computed tomography (CT) scan and assay of serum cortisol, insulin-like growth factor 1 (IGF-1), thyrotropin (TSH) and free thyroxine (FT4). The main purpose was to assess any gender difference and the rate of empty sella (ES). Women were more likely to have empty sella (19/42 [45.2%] vs 19/62 [30.6%], P = 0.15, OR = 1.9), which was more frequently total ES or TES (16/19 [84.2%] vs 3/19 [15.8%], P = 0.0025, OR = 11.6). Neuroradiology was normal in the remaining 65 patients. Patients with TES were approximately 20-30 years older than both patients with partial ES (PES) and normal sella, but only the comparison with normal sella was significant (P = 0.001 all patients, P = 0.005 males). Presumed deficiency of IGF-1, cortisol or TSH occurred in 33 persons (31.7%; 20 Males [32.2%], 13 Females [30.9%]), 14 (13.5%; 10M [16.2%], 4F [9.5%]) or 8 (7.7%; 1M [1.7%], 7F [16.7%]), with only TSH deficiency having significant intergender difference (P = 0.007). The highest or lowest rates of IGF-1 deficiency occurred in men with PES (41.7%) or men with TES (14.3%), of cortisol deficiency in men with PES (33.3%) or women with PES (zero), and TSH deficiency in women with TES (18.7%) or both men and women with PES (zero) and men with normal sella (zero). Within ES, males with no deficiency were older compared to males with at least one hormone deficiency (75.7 +/- 17.4 vs 55.6 +/- 18.9, P = 0.022); in turn, the former males were also older compared with normal sella males having no hormone deficiency (54.1 +/- 25.2, P = 0.023). In conclusion, ES is detectable in almost 40% of persons who undergo CT within 24 h from TBI. A number of intergender differences concerning ES and the hormones evaluated are apparent.	[Fama, Fausto; Gioffre'-Florio, Maria] Univ Messina, Dept Human Pathol Adulthood & Childhood G Barresi, Messina, Italy; [Vita, Roberto; Benvenga, Salvatore] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Sindoni, Alessandro] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Vinci, Sergio Lucio; Giorgianni, Grazia; Grasso, Loredana] Univ Messina, Dept Biomed & Dent Sci, Morphol & Funct Images, Messina, Italy; [Benvenga, Salvatore] Univ Messina, Master Program Childhood Adolescent & Womens Endo, Messina, Italy; [Benvenga, Salvatore] Univ Hosp Messina, Interdept Program Mol & Clin Endocrinol & Womens, I-98125 Messina, Italy		Fama, F (corresponding author), Complesso MITO,Residenza Ginestre F-2, I-98151 Messina, Italy.	famafausto@yahoo.it	Fama', Fausto/L-3071-2015; Sindoni, Alessandro/AAF-6877-2020; Vinci, Sergio Lucio/AAC-4553-2022; Vita, Roberto/K-8639-2016	Fama', Fausto/0000-0002-9017-1991; Vinci, Sergio Lucio/0000-0002-7443-8270; SINDONI, ALESSANDRO/0000-0002-7564-0518; Vita, Roberto/0000-0002-5977-3062			Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Benvenga Salvatore, 2005, Pituitary, V8, P193, DOI 10.1007/s11102-006-6040-6; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; De Marinis L, 2005, J CLIN ENDOCR METAB, V90, P5471, DOI 10.1210/jc.2005-0288; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Foresti M, 1991, Radiol Med, V81, P803; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hari Kumar K V S, 2016, Indian J Endocrinol Metab, V20, P772; Karamouzis I, 2016, ENDOCRINE, V52, P441, DOI 10.1007/s12020-015-0796-2; Klose M, 2018, NAT REV ENDOCRINOL, V14, P57, DOI 10.1038/nrendo.2017.103; Krahulik D, 2017, BIOMED PAP, V161, P80, DOI 10.5507/bp.2016.047; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Leal-Cerro Alfonso, 2009, Endocrinol Nutr, V56, P293, DOI 10.1016/S1575-0922(09)71944-8; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Nemes O, 2016, ACTA NEUROCHIR, V158, P2347, DOI 10.1007/s00701-016-2995-x; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Rabelink NM, 2011, J HEAD TRAUMA REHAB, V26, P90, DOI 10.1097/HTR.0b013e31820367b3; Rani P Radha, 2013, Indian J Endocrinol Metab, V17, pS125, DOI 10.4103/2230-8210.119527; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Scranton RA, 2015, J CLIN MED, V4, P1463, DOI 10.3390/jcm4071463; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Tan CL, 2017, J NEUROL NEUROSUR PS, V88, P971, DOI 10.1136/jnnp-2016-315500; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Zuhur SS, 2014, TURK NEUROSURG, V24, P374, DOI 10.5137/1019-5149.JTN.8671-13.0	27	4	4	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2214-6237			J CLIN TRANSL ENDOCR	J. Clin. Transl. ENdocrinol.	MAR	2019	15						54	61		10.1016/j.jcte.2018.12.008			8	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	HP2GP	WOS:000461486600010	30622899	Green Published, gold			2022-02-06	
J	Grassner, L; Marhold, F; Yousif, M; Grillhosl, A; Ungersboeck, K; Schulz, J; Strowitzki, M				Grassner, Lukas; Marhold, Franz; Yousif, Miron; Grillhoesl, Andreas; Ungersboeck, Karl; Schulz, Joachim; Strowitzki, Martin			Experiences with a temporary synthetic skin substitute after decompressive craniectomy: a retrospective two-center analysis	ACTA NEUROCHIRURGICA			English	Article						Outcome; Edema; Decompressive craniectomy; Brain herniation; Skin replacement	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPERTENSION; CARE; OUTCOMES	BackgroundDecompressive craniectomy is a commonly performed procedure. It reduces intracranial pressure, improves survival, and thus might have a positive impact on several neurosurgical diseases and emergencies. Sometimes primary skin closure is not possible due to cerebral herniation or extensive skin defects. In order to prevent further restriction of the underlying tissue, a temporary skin expansion might be necessary.Methods and materialWe retrospectively reviewed patients in need for a temporary skin substitute because skin closure was not possible after craniectomy without violating brain tissue underneath in a time period of 6years (2011-2016). With this study, we present initial experiences of Epigard (Biovision, Germany) as an artificial temporary skin replacement. We performed this analysis at two level-1 trauma centers (Trauma Center Murnau, Germany; University Hospital of St. Poelten, Austria). Demographic data, injury and surgical characteristics, and complication rates were analyzed via chart review. We identified nine patients within our study period. Six patients suffered from severe traumatic brain injury and developed pronounced cerebral herniation in the acute or subacute phase. Three patients presented with non-traumatic conditions (one atypical intracerebral hemorrhage and two patients with extensive destructive tumors invading the skull and scalp).ResultsA total of 20 Epigard exchanges (range 1-4) were necessary before skin closure was possible. A CSF fistula due to a leaky Epigard at the interface to the skin was observed in two patients (22%). Additional complications were four wound infections, three CNSinfections, and three patients developed a shunt dependency. Three patients died within the first month after injury.ConclusionsTemporary skin closure with Epigard as a substitute is feasible for a variety of neurosurgical conditions. The high complication and mortality rate reflect the complexity of the encountered pathologies and need to be considered when counseling the patient and their families.	[Grassner, Lukas; Yousif, Miron; Schulz, Joachim; Strowitzki, Martin] Trauma Ctr Murnau, Dept Neurosurg, Prof Kuntscher Str 8, D-82418 Murnau, Germany; [Grassner, Lukas] Trauma Ctr Murnau, Ctr Spinal Cord Injuries, Murnau, Germany; [Grassner, Lukas] Paracelsus Med Univ, Inst Mol Regenerat Med, Salzburg, Austria; [Grassner, Lukas] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Marhold, Franz; Ungersboeck, Karl] Univ Hosp St Poelten, Karl Landsteiner Univ Hlth Sci, Dept Neurosurg, St Polten, Austria; [Grillhoesl, Andreas] Trauma Ctr Murnau, Dept Neuroradiol, Murnau, Germany		Grassner, L (corresponding author), Trauma Ctr Murnau, Dept Neurosurg, Prof Kuntscher Str 8, D-82418 Murnau, Germany.; Grassner, L (corresponding author), Trauma Ctr Murnau, Ctr Spinal Cord Injuries, Murnau, Germany.; Grassner, L (corresponding author), Paracelsus Med Univ, Inst Mol Regenerat Med, Salzburg, Austria.; Grassner, L (corresponding author), Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria.	lukas.grassner@googlemail.com		Marhold, Franz/0000-0001-8338-8060			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Aslakson RA, 2014, CRIT CARE MED, V42, P2418, DOI 10.1097/CCM.0000000000000573; BLOMSTEDT GC, 1985, ACTA NEUROCHIR, V78, P81, DOI 10.1007/BF01808684; Crudele A, 2016, J INTENSIVE CARE MED, V31, P587, DOI 10.1177/0885066615601607; Fowler RA, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0852-6; Goedemans T, 2018, WORLD NEUROSURG, V119, pE417, DOI 10.1016/j.wneu.2018.07.177; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061; Holsgrove DT, 2014, ACTA NEUROCHIR SUPPL, V119, P53, DOI 10.1007/978-3-319-02411-0_9; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Karamanos E, 2014, AM J SURG, V208, P363, DOI 10.1016/j.amjsurg.2013.10.026; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Marion DW, 2006, NEUROSURGERY, V58, P655; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Stone H A, 1993, J Foot Ankle Surg, V32, P232; Sundseth J, 2017, ACTA NEUROCHIR, V159, P301, DOI 10.1007/s00701-016-3049-0; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P277, DOI 10.1007/978-3-7091-1434-6_53; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507	22	4	4	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAR	2019	161	3					493	499		10.1007/s00701-018-3748-9			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HO0PZ	WOS:000460607500009	30515616				2022-02-06	
J	Jackson, TC; Kotermanski, SE; Kochanek, PM; Jackson, EK				Jackson, Travis C.; Kotermanski, Shawn E.; Kochanek, Patrick M.; Jackson, Edwin K.			Oxidative stress induces release of 2 '-AMP from microglia	BRAIN RESEARCH			English	Article						2 ',3 '-cAMP; 2 '-AMP; 3 '-AMP; Microglia; Astrocytes; Neurons; Oxidative stress; CNPase	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL-NEURONS; EXPRESSION; MICRODIALYSIS; PROLIFERATION; MITOCHONDRIA; HYPOTHERMIA; 2',3'-CAMP; PROTEINS; SURVIVAL	Background: Microglia metabolize exogenous 2'-AMP and 3'-AMP (non-canonical nucleotides) to adenosine and exogenous 2'-AMP and 3'-AMP (via conversion to adenosine) inhibit the production of inflammatory cytokines by microglia. This suggests that if microglia release endogenous 2'-AMP and/or 3'-AMP in response to injurious stimuli, this would complete an autocrine/paracrine mechanism that attenuates the over-activation of microglia during brain injury. Here we investigated in microglia (and for comparison astrocytes and neurons) the effects of injurious stimuli on extracellular and intracellular levels of 2',3'-cAMP (2'-AMP and 3'-AMP precursor), 2'-AMP, and 3'-AMP. Methods: Experiments were conducted in primary cultures of rat microglia, astrocytes, and neurons. Cells were exposed to oxygen/glucose deprivation, iodoacetate plus 2,4-dinitrophenol (metabolic inhibitors), glutamate, or H2O2 for one hour, and extracellular and intracellular 2',3'-cAMP, 2'-AMP, and 3'-AMP were measured by UPLC-MS/MS. Key results: In microglia, H2O2 increased extracellular levels of 2'-AMP, but not 3'-AMP, by similar to 16-fold (from 0.17 +/- 0.11 to 2.78 +/- 0.27 ng/10(6) cells; n = 13; mean +/- SEM; P < 0.000005). H2O2 also induced oxidative changes in cellular proteins as detected by an increased number of carbonyl groups in protein side chains. In contrast, oxygen/glucose deprivation, metabolic inhibitors, or glutamate had no effect on either extracellular 2' AMP or 3'-AMP levels. In astrocytes and neurons, none of the injurious stimuli increased extracellular 2'-AMP or 3'-AMP. Conclusions: Oxidative stress (but not oxygen/glucose deprivation, energy deprivation, or excitotoxicity) induces microglia (but not astrocytes or neurons) to release 2'-AMP, but not 3'-AMP. The 2',3'-cAMP/2'-AMP/adenosine pathway mechanism may serve to prevent over-activation of microglia in response to oxidative stress.	[Jackson, Travis C.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med,Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Kotermanski, Shawn E.; Jackson, Edwin K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA		Jackson, EK (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	tcj10@pitt.edu; sek128@pitt.edu; kochanekpm@ccm.upmc.edu; edj@pitt.edu		Jackson, Edwin/0000-0002-8101-6009	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS087978, HL109002, DK091190, HL069846, NS105721, DK079307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL069846, R01HL109002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK079307, R01DK068575, R01DK091190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087978, R01NS105721] Funding Source: NIH RePORTER	Supported by grants from the National Institutes of Health [NS087978 (PMK/EKJ), HL109002 (EKJ), DK091190 (EKJ), HL069846 (EKJ), NS105721 (TCJ), and DK079307 (EKJ)].	Azarashvili T, 2010, BIOL CHEM, V391, P619, DOI 10.1515/BC.2010.070; Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cardenas-Rodriguez N, 2009, J BIOCHEM MOL TOXIC, V23, P137, DOI 10.1002/jbt.20278; Du LL, 2017, MOL NEUROBIOL, V54, P1992, DOI 10.1007/s12035-016-9758-9; Han QD, 2014, BRAIN RES, V1542, P176, DOI 10.1016/j.brainres.2013.10.026; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Ishihara Y, 2015, J BIOL CHEM, V290, P22805, DOI 10.1074/jbc.M115.659151; Jackson EK, 2017, J NEUROCHEM, V141, P676, DOI 10.1111/jnc.14018; Jackson EK, 2017, HANDB EXP PHARMACOL, V238, P229, DOI 10.1007/164_2015_40; Jackson EK, 2012, AM J PHYSIOL-RENAL, V303, pF954, DOI 10.1152/ajprenal.00335.2012; Jackson EK, 2011, AM J PHYSIOL-RENAL, V301, pF565, DOI 10.1152/ajprenal.00094.2011; Jackson EK, 2011, J PHARMACOL EXP THER, V337, P444, DOI 10.1124/jpet.110.178137; Jackson EK, 2010, HYPERTENSION, V56, P151, DOI 10.1161/HYPERTENSIONAHA.110.152454; Jackson EK, 2009, J BIOL CHEM, V284, P33097, DOI 10.1074/jbc.M109.053876; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Jackson TC, 2010, J NEUROCHEM, V115, P941, DOI 10.1111/j.1471-4159.2010.06984.x; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Kabba JA, 2018, CELL MOL NEUROBIOL, V38, P53, DOI 10.1007/s10571-017-0504-2; Lei BP, 1997, NEUROSCI LETT, V222, P91, DOI 10.1016/S0304-3940(97)13349-3; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; LIVNAT T, 1993, INT J BIOCHEM, V25, P993, DOI 10.1016/0020-711X(93)90112-R; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Ma J, 2014, BIOCHEM J, V462, P489, DOI 10.1042/BJ20140235; Maines Mahin D., 2010, CURRENT PROTOCOLS TO; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Newell EA, 2015, BRAIN RES, V1594, P27, DOI 10.1016/j.brainres.2014.10.059; Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5; Rao F, 2010, BIOCHEM BIOPH RES CO, V398, P500, DOI 10.1016/j.bbrc.2010.06.107; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Ulland TK, 2015, SEMIN IMMUNOL, V27, P410, DOI 10.1016/j.smim.2016.03.011; Verrier JD, 2013, GLIA, V61, P1595, DOI 10.1002/glia.22523; Verrier JD, 2012, J NEUROCHEM, V122, P115, DOI 10.1111/j.1471-4159.2012.07705.x; Verrier JD, 2011, J NEUROCHEM, V118, P979, DOI 10.1111/j.1471-4159.2011.07392.x; Wieser GL, 2013, GLIA, V61, P869, DOI 10.1002/glia.22480; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wu CY, 2006, NEUROSCIENCE, V142, P333, DOI 10.1016/j.neuroscience.2006.06.030; Yang LJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0148-9; Yin J, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/5150678	42	4	4	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 1	2019	1706						101	109		10.1016/j.brainres.2018.11.002			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM7FZ	WOS:000459644500012	30395838	Green Accepted			2022-02-06	
J	Jolley, DL; Upham, B; Fullerton, L; Annett, RD				Jolley, David Leo; Upham, Bryan; Fullerton, Lynne; Annett, Robert D.			Reduction in Head Computed Tomography Ordering in Pediatric Emergency Patients: Effect of National Publication and Local Availability of Urgent Neurology Appointments	PEDIATRIC EMERGENCY CARE			English	Article						computed tomography; seizure; headache; closed head injury	IMAGE-GENTLY CAMPAIGN; RADIATION RISKS; CT RADIATION; CHILDREN; EPILEPSY	Objective The objective of this study was to evaluate the effect of the Pediatric Emergency Care Applied Research Network (PECARN) blunt head trauma guidelines and implementation of urgent neurology follow-up (UNF) appointments on an observed decline in head computed tomography (CT) use for pediatric emergency department (PED) patients presenting with headache, seizure, and trauma. Methods Patients ages 0 to 18 years presenting to and discharged from an urban tertiary care PED with chief complaint of trauma, headache, and seizure between 2007 and 2013 were retrospectively included. The total number of head CTs obtained in the trauma, headache, and seizure groups was compared before and after the publication of the PECARN guidelines in 2009 and the implementation of urgent UNF within a week from PED discharge in 2011, respectively. Results Between 2007 and 2013, 24,434 encounters were identified with 2762 head CTs performed. Analysis demonstrated a decline in pediatric head CTs for trauma (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.8-2.2) after the publication of the PECARN study on blunt head trauma, for headache (OR, 1.4; 95% CI, 1.1-1.8) and seizure (OR, 1.9; 95% CI, 1.4-2.6) with UNF. However, cross comparison (headache and seizure with PECARN and trauma with UNF) also demonstrated similar significant declines. Conclusions The decline in head CTs observed at our institution demonstrated a strong linear relationship, yet cannot be solely attributed to the PECARN blunt head trauma study or the implementation of UNF.	[Jolley, David Leo; Upham, Bryan; Fullerton, Lynne] Univ New Mexico, Dept Emergency Med, MSC11 6025, Albuquerque, NM 87131 USA; [Annett, Robert D.] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA		Jolley, DL (corresponding author), Univ New Mexico, Dept Emergency Med, MSC11 6025, Albuquerque, NM 87131 USA.	dajolley@salud.unm.edu			University of New Mexico Clinical Data Warehouse - NIH [ULITR0041]	This study received support from the University of New Mexico Clinical Data Warehouse, which is funded by NIH grant number ULITR0041 for the Clinical and Translational Science Center at the University of New Mexico and the generous contributions of Laurie McPherson and Karon Avery.	Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, MED PHYS, V28, P2387, DOI 10.1118/1.1415074; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Broder J, 2007, EMERG RADIOL, V14, P227, DOI 10.1007/s10140-007-0618-9; Broder JS, 2008, PEDIATR RADIOL, V38, pS664, DOI 10.1007/s00247-008-0892-z; Chen JX, 2014, OTOLARYNG HEAD NECK, V151, P554, DOI 10.1177/0194599814542588; Donnelly LF, 2005, AM J ROENTGENOL, V184, P655, DOI 10.2214/ajr.184.2.01840655; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Goske MJ, 2008, PEDIATR RADIOL, V38, P265, DOI 10.1007/s00247-007-0743-3; Goske MJ, 2008, AM J ROENTGENOL, V190, P273, DOI 10.2214/AJR.07.3526; Huang CC, 1998, EPILEPSIA, V39, P960, DOI 10.1111/j.1528-1157.1998.tb01445.x; Huda W, 2009, EMERG RADIOL, V16, P335, DOI 10.1007/s10140-009-0801-2; Kirpalani H, 2008, PEDIATRICS, V121, P449, DOI 10.1542/peds.2007-3394; Kotsopoulos IAW, 2002, EPILEPSIA, V43, P1402, DOI 10.1046/j.1528-1157.2002.t01-1-26901.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Lateef TM, 2009, J CHILD NEUROL, V24, P536, DOI 10.1177/0883073808327831; Lodwick DL, 2015, PEDIATRICS, V136, pE1212, DOI 10.1542/peds.2015-1671; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371; Slovis TL, 2002, RADIOLOGY, V223, P5, DOI 10.1148/radiol.2231012100; Slovis TL, 2003, PEDIATRICS, V112, P971, DOI 10.1542/peds.112.4.971; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Townsend BA, 2010, AM J ROENTGENOL, V194, P1194, DOI 10.2214/AJR.09.3682; Willis Charles E, 2004, Radiol Technol, V76, P150	28	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2019	35	3					199	203		10.1097/PEC.0000000000001757			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	HQ7XY	WOS:000462638500014	30747787				2022-02-06	
J	Kawauchi, S; Okuda, W; Nawashiro, H; Sato, S; Nishidate, I				Kawauchi, Satoko; Okuda, Wataru; Nawashiro, Hiroshi; Sato, Shunichi; Nishidate, Izumi			Multispectral imaging of cortical vascular and hemodynamic responses to a shock wave: observation of spreading depolarization and oxygen supply-demand mismatch	JOURNAL OF BIOMEDICAL OPTICS			English	Article						blast-induced mild traumatic brain injury; multispectral imaging; diffuse reflectance; cortical spreading depolarization; hemodynamics; light scattering	INTRINSIC OPTICAL SIGNALS; TRAUMATIC BRAIN-INJURY; CEREBRAL HEMODYNAMICS; DEPRESSION; RAT; MECHANISMS; MODEL; CONTRACTION; METABOLISM; ACTIVATION	Blast-induced traumatic brain injury has been a recent major concern in neurotraumatology. However, its pathophysiology and mechanism are not understood partly due to insufficient information on the brain pathophysiology during/immediately after shock wave exposure. We transcranially applied a laser-induced shock wave (LISW, similar to 19 Pa . s) to the left frontal region in a rat and performed multispectral imaging of the ipsilateral cortex through a cranial window (n = 4). For the spectral data obtained, we conducted multiple regression analysis aided by Monte Carlo simulation to evaluate vascular diameters, regional hemoglobin concentration (rC(Hb)), tissue oxygen saturation (StO(2)), oxygen extraction fraction, and light-scattering signals as a signature of cortical spreading depolarization (CSD). Immediately after LISW exposure, rC(Hb) and StO(2) were significantly decreased with distinct venular constriction. CSD was then generated and was accompanied by distinct hyperemia/hyperoxemia. This was followed by oligemia with arteriolar constriction, but it soon recovered (within similar to 20 min). However, severe hypoxemia was persistently observed during the post-CSD period (similar to 1 h). These observations indicate that inadequate oxygen supply and/or excessive oxygen consumption continued even after blood supply was restored in the cortex. Such a hypoxemic state and/or a hypermetabolic state might be associated with brain damage caused by a shock wave. (C) The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License.	[Kawauchi, Satoko; Sato, Shunichi] Natl Def Med Coll, Res Inst, Div Bioinformat & Therapeut Syst, Tokorozawa, Saitama, Japan; [Okuda, Wataru; Nishidate, Izumi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo, Japan; [Nawashiro, Hiroshi] Tokorozawa Cent Hosp, Div Neurosurg, Tokorozawa, Saitama, Japan		Kawauchi, S (corresponding author), Natl Def Med Coll, Res Inst, Div Bioinformat & Therapeut Syst, Tokorozawa, Saitama, Japan.	skawauch@ndmc.ac.jp	NISHIDATE, IZUMI/C-8826-2013		Ministry of Defense Research Program for Advanced Defense Medicine; US-ARMY ITC-PAC Research and Development Project [FA5209-15-P-0175, FA5209-16-P-0132]	The authors gratefully acknowledge the financial support of the Ministry of Defense Research Program for Advanced Defense Medicine and US-ARMY ITC-PAC Research and Development Project (FA5209-15-P-0175 and FA5209-16-P-0132). We thank A. Kamoshida for technical support in the use of image acquisition and processing software (LabVIEW) and H. Inose, Y. Muramatsu, and A. Kono for technical assistance in data analysis and histopathological assessments. The present study was performed in a doctoral program of Graduate School of Bio-Applications & Systems Engineering, Tokyo University of Agriculture and Technology.	Abookasis D, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3116709; Agoston D. V., 2015, BRAIN NEUROTRAUMA; Aitken PG, 1999, METHODS, V18, P91, DOI 10.1006/meth.1999.0762; Alley M. D., 2009, THESIS; Andrew RD, 1999, METHODS, V18, P185, DOI 10.1006/meth.1999.0771; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Busija DW, 2008, PROG NEUROBIOL, V86, P379, DOI 10.1016/j.pneurobio.2008.09.008; Chang FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30332; Chen S, 2015, EXP NEUROL, V272, P4, DOI 10.1016/j.expneurol.2015.03.007; Cipolla M. J., 2006, C SERIES INTEGRATED; de Wit C, 2006, BIOL CHEM, V387, P3, DOI 10.1515/BC.2006.002; Dehaes M, 2015, BIOMED OPT EXPRESS, V6, P4749, DOI 10.1364/BOE.6.004749; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dunn AK, 2005, NEUROIMAGE, V27, P279, DOI 10.1016/j.neuroimage.2005.04.024; EDVINSSON L, 1983, J CEREBR BLOOD F MET, V3, P226, DOI 10.1038/jcbfm.1983.30; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gutierrez-Jimenez E, 2018, NEUROBIOL AGING, V62, P82, DOI 10.1016/j.neurobiolaging.2017.10.006; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Hammer DX, 2014, BIOMED OPT EXPRESS, V5, P2823, DOI 10.1364/BOE.5.002823; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horiuchi T, 2002, STROKE, V33, P2692, DOI 10.1161/01.STR.0000034791.52151.6B; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950312; Kawauchi S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.015003; Kohl M, 2000, PHYS MED BIOL, V45, P3749, DOI 10.1088/0031-9155/45/12/317; Kurioka T, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.12.125001; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; Miyazaki H, 2015, ACTA NEUROCHIR, V157, P2111, DOI 10.1007/s00701-015-2613-3; Mourant JR, 1998, APPL OPTICS, V37, P3586, DOI 10.1364/AO.37.003586; MOURANT JR, 2003, BIOMEDICAL PHOTONICS, pCH29; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nielsen AN, 2000, J VASC RES, V37, P513, DOI 10.1159/000054084; Nishidate I, 2017, APPL SPECTROSC, V71, P866, DOI 10.1177/0003702816657569; Niwa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31754; Okuda W, 2014, PROC SPIE, V8928, DOI 10.1117/12.2040899; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Prahl S.A., 1999, TABULATED MOLAR EXTI; Ravin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25713; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Satoh Y, 2010, LASER SURG MED, V42, P313, DOI 10.1002/lsm.20899; Schueler M, 2014, HEADACHE, V54, P996, DOI 10.1111/head.12371; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P99, DOI 10.1007/978-3-7091-1434-6_17; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; TUCHIN VV, 2007, TISSUE OPTICS LIGHT; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Yoshida K, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.051026	59	4	4	0	4	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	MAR	2019	24	3							035005	10.1117/1.JBO.24.3.035005			17	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	HS5BU	WOS:000463886200028	30851013	Green Published, gold			2022-02-06	
J	Larsen, KB; Barber, Z; Squier, W				Larsen, Karen Bonde; Barber, Zoe; Squier, Waney			The pathology and aetiology of subcortical clefts in infants	FORENSIC SCIENCE INTERNATIONAL			English	Article						Cortical tears; Contusions; Trauma; Cerebral venous thrombosis; Subpial bleeding	INFLICTED HEAD-INJURY; DIFFUSE AXONAL INJURY; WHITE-MATTER; CEREBRAL-CORTEX; BRAIN-LESIONS; HEMORRHAGE; THROMBOSIS; TEARS; NEUROPATHOLOGY; MARKER	In infants, traumatic surface contusions of the brain are rare but subcortical clefts or cysts, variously labelled "contusional tears", "contusional clefts", "cortical tears" or "parenchymal lacerations" have been ascribed to trauma, and are even said to be characteristic of shaking and abuse. We describe the pathology of subcortical clefts or haemorrhages in seven infants. In none were the axonal swellings characteristic of traumatic axonal injury seen in relation to the clefts. Subpial bleeding was associated with clefts in all the cases of recent onset. We hypothesize that subcortical clefts are not due to direct mechanical forces of trauma but are part of a secondary cascade caused by impaired venous drainage which may or may not follow trauma. The finding of subcortical and subpial haemorrhages should prompt a search for CVT. We consider the term "contusion" is not accurate and is misleading. (C) 2019 Elsevier B.V. All rights reserved.	[Larsen, Karen Bonde] Copenhagen Univ Hosp, Rigshosp, Dept Pathol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Larsen, Karen Bonde; Squier, Waney] Oxford Univ Hosp, John Radcliffe Hosp, Dept Neuropathol & Ocular Pathol, Oxford, England; [Barber, Zoe] Royal Gwent Hosp, Dept Gen Surg, Newport, Shrops, England		Larsen, KB (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Pathol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	Karen.bonde.larsen.01@regionh.dk			Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Brains for Dementia Research (BDR) (Alzheimer Society); Autistica UKAutistica; NIHR Oxford Biomedical Research CentreNational Institute for Health Research (NIHR); Brains for Dementia Research (BDR) (Alzheimer Research UK)	We acknowledge the Oxford Brain Bank supported by the Medical Research Council (MRC), Brains for Dementia Research (BDR) (Alzheimer Society and Alzheimer Research UK), Autistica UK and the NIHR Oxford Biomedical Research Centre. We are grateful to the parents who have allowed us to examine and study their infants' brains. The authors have stated they had no interests that might be perceived as posing a conflict or bias.	ADAMS JH, 1986, ARCH PATHOL LAB MED, V110, P485; Au-Yong ITH, 2009, BRIT J RADIOL, V82, P735, DOI 10.1259/bjr/81603888; Barnes PD, 2011, RADIOL CLIN N AM, V49, P205, DOI 10.1016/j.rcl.2010.08.001; Berfelo FJ, 2010, STROKE, V41, P1382, DOI 10.1161/STROKEAHA.110.583542; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; CERVOSNAVARRO J, 1994, ACTA NEUROCHIR, P151; Courville C. B., 1937, CNS TRAUMA PATHOLO 4; Delanghe G, 2018, CLIN CASE REP, V6, P407, DOI 10.1002/ccr3.1360; FREYTAG E, 1963, ARCH PATHOL, V75, P402; FRIEDE RL, 1972, J NEUROPATH EXP NEUR, V31, P548, DOI 10.1097/00005072-197207000-00012; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; HAUSDORF G, 1984, NEUROPEDIATRICS, V15, P110, DOI 10.1055/s-2008-1052351; Huang AH, 2004, AM J NEURORADIOL, V25, P469; JASPAN T, 1992, PEDIATR RADIOL, V22, P237, DOI 10.1007/BF02019848; KEIPER MD, 1995, J COMPUT ASSIST TOMO, V19, P527, DOI 10.1097/00004728-199507000-00003; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; KOSTOVIC I, 1974, ANAT REC, V178, P395; Kostovic I, 2014, BRAIN STRUCT FUNCT, V219, P231, DOI 10.1007/s00429-012-0496-0; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; NAKAMURA Y, 1994, J NEUROPATH EXP NEUR, V53, P582, DOI 10.1097/00005072-199411000-00005; Oehmichen M, 2008, ACTA NEUROPATHOL, V116, P317, DOI 10.1007/s00401-008-0356-4; Okudera T, 1999, NEUROPATHOLOGY, V19, P93, DOI 10.1046/j.1440-1789.1999.00215.x; ORDIA IJ, 1981, J NEUROSURG, V54, P696, DOI 10.3171/jns.1981.54.5.0696; Palifka LA, 2016, AM J NEURORADIOL, V37, P163, DOI 10.3174/ajnr.A4519; Ramenghi LA, 2009, SEMIN FETAL NEONAT M, V14, P278, DOI 10.1016/j.siny.2009.07.010; Raybaud C, 2013, NEURORADIOLOGY, V55, P23, DOI 10.1007/s00234-013-1231-0; Squier W., 1993, PATHOLOGY FETAL NEON, P110; Squier W, 2011, EARLY HUM DEV, V87, P421, DOI 10.1016/j.earlhumdev.2011.03.003; Tan M, 2011, PEDIATRICS, V128, pE429, DOI 10.1542/peds.2010-3896; Teksam M, 2008, AM J NEURORADIOL, V29, P1961, DOI 10.3174/ajnr.A1246; VILLRINGER A, 1994, J NEURORADIOLOGY, V21, P72; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; ZHANG ET, 1990, J ANAT, V170, P111	36	4	4	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	MAR	2019	296						115	122		10.1016/j.forsciint.2019.01.011			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	HM0UT	WOS:000459163700017	30711846				2022-02-06	
J	Lu, LH; Cooper, DB; Reid, MW; Khokhar, B; Tsagaratos, JE; Kennedy, JE				Lu, Lisa H.; Cooper, Doug B.; Reid, Matthew W.; Khokhar, Bilal; Tsagaratos, Jennifer E.; Kennedy, Jan E.			Symptom Reporting Patterns of US Military Service Members with a History of Concussion According to Duty Status	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Malingering/symptom validity testing; Assessment	TRAUMATIC BRAIN-INJURY; CLINICAL UTILITY; VALIDITY-10 SCALE; IRAQI FREEDOM; EXAGGERATION; MBIAS; PTSD; TBI; NSI	Objective: To compare symptom reporting patterns of service members with a history of concussion based on work status: full duty, limited duty, or in the Medical Evaluation Board (MEB)/disability process. Methods: Retrospective analysis of 181 service members with a history of concussion (MEB n = 56; limited duty n = 62; full duty n = 63). Neurobehavioral Symptom Inventory (NSI) Validity-10 cutoff (> 22) and Mild Brain Injury Atypical Symptoms Scale (mBIAS) cutoffs (>= 10 and >= 8) were used to evaluate potential over-reporting of symptoms. Results: The MEB group displayed significantly higher NSI scores and significantly higher proportion scored above the mBIAS >= 10 cutoff (MEB = 15%; limited duty = 3%; full duty = 5%). Validity-10 cutoff did not distinguish between groups. Conclusions: MEB but not limited duty status was associated with increased risk of over-reporting symptoms in service members with a history of concussion. Results support the use of screening measures for over-reporting in the MEB/disability samples.	[Lu, Lisa H.; Cooper, Doug B.; Reid, Matthew W.; Tsagaratos, Jennifer E.; Kennedy, Jan E.] Brooke Army Med Ctr, Dept Med, Neurol Serv, Def & Vet Brain Injury Ctr, Joint Base San Antonio, TX 78234 USA; [Khokhar, Bilal] Natl Headquarters, Def & Vet Brain Injury Ctr, Silver Spring, MD USA		Lu, LH (corresponding author), Brooke Army Med Ctr, Dept Med, Neurol Serv, Def & Vet Brain Injury Ctr, Joint Base San Antonio, TX 78234 USA.	Lisa.h.lu.ctr@mail.mil			United States Department of Defense/Department of Health Affairs' Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015 20DEC18]; General Dynamics Health Solutions	This work was supported by the United States Department of Defense/Department of Health Affairs' Defense and Veterans Brain Injury Center, contract #W91YTZ-13-C-0015 20DEC18; General Dynamics Health Solutions.	Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Boisvert JA, 2003, DEPRESS ANXIETY, V17, P19, DOI 10.1002/da.10080; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; DVBIC, 2017, DOD WORLDW NUMB TBI; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Lippa SM, 2016, J CLIN EXP NEUROPSYC, V38, P721, DOI 10.1080/13803395.2016.1161732; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Renshaw KD, 2009, ANXIETY STRESS COPIN, V22, P101, DOI 10.1080/10615800802354000; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e	21	4	4	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2019	34	2					236	242		10.1093/arclin/acy031			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HQ7AR	WOS:000462572200012	29608655	hybrid			2022-02-06	
J	Penttila, N; Korpijaakko-Huuhka, AM; Kent, RD				Penttila, Nelly; Korpijaakko-Huuhka, Anna-Maija; Kent, Raymond D.			Disfluency clusters in speakers with and without neurogenic stuttering following traumatic brain injury	JOURNAL OF FLUENCY DISORDERS			English	Article						Disfluencies; Disfluency clusters; Fluency; Neurogenic stuttering; Traumatic brain injury	DELAYED AUDITORY-FEEDBACK; SPEECH MOTOR CONTROL; SYNTACTIC COMPLEXITY; STROKE; FLUENCY; APRAXIA; ADULTS; CHILDREN; TIME	Purpose: Analyze the characteristics and rate of disfluency clusters in adults with and without neurogenic stuttering after traumatic brain injury (TBI). Method: Twenty adults with TBI participated in this study, including 10 with neurogenic stuttering (Group B) and 10 without-stuttering (Group A). Disfluency clusters in speech samples were classified into three types: Stuttering-like (SLD), other (OD), and mixed (MIX). Results: Speakers with and without neurogenic stuttering produced the same mean number of disfluency clusters. In addition, the mean length of clusters did not differ between these speaker groups although the longest clusters did. The most frequently occurring cluster type for people with neurogenic stuttering was MIX and OD for people without stuttering. Although the speakers in Group A produced stuttering-like disfluencies, these never occurred together to form a SLD type cluster. For Group B, the starter units of the clusters were usually stuttering-like disfluencies, while for Group A, the starter units were mostly interruptions. Conclusions: Compared to non-stuttering speakers, stuttering after TBI did not increase the number of clusters, but rather lengthened them. In speakers with neurogenic stuttering, the number and length of clusters were related to the manifestation of other communication deficits, not to the frequency of stuttering-like disfluencies. Still, SLD clusters occurred only in those people with neurogenic stuttering. These findings raise questions about the nature of both neurogenic stuttering and the dynamics of disfluency clustering.	[Penttila, Nelly; Korpijaakko-Huuhka, Anna-Maija] Univ Tampere, Fac Social Sci, Tampere 33610, Finland; [Kent, Raymond D.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA		Penttila, N (corresponding author), Univ Tampere, Kalevantie 4 Main Bldg Room D227, Tampere 33100, Finland.	nelly.penttila@uta.fi	Kent, Raymond D/AAI-1928-2020	Penttila, Nelly/0000-0002-6086-2310			Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; [Anonymous], 2017, WORKING GROUP APPOIN; Bailey DJ, 2017, AM J SPEECH-LANG PAT, V26, P641, DOI 10.1044/2017_AJSLP-16-0108; Balasubramanian V, 2003, BRAIN COGNITION, V53, P185, DOI 10.1016/S0278-2626(03)00106-4; Balasubramanian V, 2010, J NEUROLINGUIST, V23, P488, DOI 10.1016/j.jneuroling.2009.04.004; Basso A, 2003, APHASIA ITS THERAPY; Baumgartner J., 1997, J MED SPEECH-LANG PA, V5, P75; Bona J, 2019, CLIN LINGUIST PHONET, V33, P393, DOI 10.1080/02699206.2018.1513075; Bortfeld H, 2001, LANG SPEECH, V44, P123, DOI 10.1177/00238309010440020101; Burghaus L, 2006, J NEURAL TRANSM, V113, P625, DOI 10.1007/s00702-005-0341-1; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; Chang S-E., 2018, Neuroscientist; Ciabarra AM, 2000, J NEUROL NEUROSUR PS, V69, P546, DOI 10.1136/jnnp.69.4.546; Code, 2014, SOCIAL COMMUNICATION, P1; COLBURN N, 1985, J FLUENCY DISORD, V10, P51, DOI 10.1016/0094-730X(85)90005-1; Cruz C, 2018, REV NEUROLOGIA, V66, P59, DOI 10.33588/rn.6602.2017151; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; De Nil L., 2009, CLIN MANAGEMENT SENO, P235; De Nil LF, 1999, STUTTERING RESEARCH AND PRACTICE: BRIDGING THE GAP, P85; Deger K, 2002, J PHONETICS, V30, P321, DOI 10.1006/jpho.2001.0163; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Duckworth, 1996, ADV CLIN PHONETICS S, P171; Duffy, 2005, MOTOR SPEECH DISORDE; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Faragasso, 2008, BULGARIAN J COMMUNIC, V2, P10; Goberman AM, 2010, J NEUROLINGUIST, V23, P470, DOI 10.1016/j.jneuroling.2008.11.001; Grant AC, 1999, ARCH NEUROL-CHICAGO, V56, P624, DOI 10.1001/archneur.56.5.624; Guitar B., 2014, STUTTERING INTEGRATE, V4th ed.; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Hamano T, 2005, NEUROLOGY, V64, P1092, DOI 10.1212/01.WNL.0000154472.51190.FB; Harmon TG, 2016, APHASIOLOGY, V30, P922, DOI 10.1080/02687038.2015.1077925; Helm N, 1980, J FLUENCY DISORD, V5, P55; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Hillis AE, 2004, BRAIN, V127, P1479, DOI 10.1093/brain/awh172; Howell P., 2002, CURRENT ISSUES LINGU, P75, DOI [10.1075/cilt.227.08how, DOI 10.1075/CILT.227.08HOW]; HUBBARD CP, 1988, J SPEECH HEAR RES, V31, P228, DOI 10.1044/jshr.3102.228; Jokel R, 2007, J MED SPEECH-LANG PA, V15, P243; Juste FS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199054; Kent RD, 2000, J COMMUN DISORD, V33, P391, DOI 10.1016/S0021-9924(00)00023-X; Kleinow J, 2000, J SPEECH LANG HEAR R, V43, P548, DOI 10.1044/jslhr.4302.548; Kono I, 1998, Rinsho Shinkeigaku, V38, P758; Korpijaakko-Huuhka AM, 2012, J INTERACT RES COM D, V3, P47, DOI 10.1558/jircd.v3i1.47; Krishnan G, 2011, J NEUROLINGUIST, V24, P383, DOI 10.1016/j.jneuroling.2011.01.001; Laine M, 1997, BDAT BOSTONIN DIAGNO; LASALLE LR, 1995, J SPEECH HEAR RES, V38, P965, DOI 10.1044/jshr.3805.965; Launonen, 2008, COMMUNICATION DISORD, P9; Levelt W.J.M., 1989, SPEAKING INTENTION A; Levine AB, 2016, WORLD NEUROSURG, V90, DOI 10.1016/j.wneu.2016.02.085; Logan KJ, 2001, J FLUENCY DISORD, V26, P85, DOI 10.1016/S0094-730X(01)00093-6; Logan KJ, 1999, J SPEECH LANG HEAR R, V42, P80, DOI 10.1044/jslhr.4201.80; Lundgren K, 2010, J NEUROLINGUIST, V23, P447, DOI 10.1016/j.jneuroling.2009.08.008; Lundie M, 2014, S AFR J COMMUN DISOR, V61, DOI 10.4102/sajcd.v61i1.64; Makkonen T, 2018, INT J LANG COMM DIS, V53, P385, DOI 10.1111/1460-6984.12357; Makkonen T, 2016, J COMMUN DISORD, V61, P97, DOI 10.1016/j.jcomdis.2016.04.002; MARSHALL RC, 1987, J FLUENCY DISORD, V12, P355, DOI 10.1016/0094-730X(87)90032-5; Max L., 2004, CONT ISSUES COMMUNIC, V31, P105, DOI 10.1044/cicsd_31_S_105; McDonald S., 2014, SOCIAL COMMUNICATION, P48; Myers FL, 2012, J FLUENCY DISORD, V37, P9, DOI 10.1016/j.jfludis.2011.10.001; Nebel A, 2009, J NEURAL TRANSM, V116, P167, DOI 10.1007/s00702-008-0173-x; Norman RS, 2018, MIL MED, V183, pE526, DOI 10.1093/milmed/usy067; Patterson J., 2017, APHASIA REHABILITATI, P173; Penttila N, 2018, J SPEECH LANG HEAR R, V61, P1086, DOI 10.1044/2018_JSLHR-S-17-0326; Peters HFM, 2000, FOLIA PHONIATR LOGO, V52, P103, DOI 10.1159/000021518; Pietila M.-L, 2005, W APHASIA BATTERY; POSTMA A, 1993, J SPEECH HEAR RES, V36, P472, DOI 10.1044/jshr.3603.472; Prins R, 2004, APHASIOLOGY, V18, P1075, DOI 10.1080/02687030444000534; Robb M, 2009, LOGOP PHONIATR VOCO, V34, P1401; Sawyer J, 2010, J SPEECH LANG HEAR R, V53, P1191, DOI 10.1044/1092-4388(2010/09-0067); Shriberg E. E., 1996, P INT C SPOK LANG PR, P11; SILVERMAN EM, 1973, J SPEECH HEAR RES, V16, P578, DOI 10.1044/jshr.1604.578; Silverman SW, 1997, J SPEECH LANG HEAR R, V40, P95, DOI 10.1044/jslhr.4001.95; Smith A, 2010, J FLUENCY DISORD, V35, P1, DOI 10.1016/j.jfludis.2009.12.001; STILL AW, 1979, J SPEECH HEAR RES, V22, P565, DOI 10.1044/jshr.2203.565; Strasberg S, 2016, AM J EMERG MED, V34, DOI 10.1016/j.ajem.2015.07.056; Tani T, 2011, J FLUENCY DISORD, V36, P1, DOI 10.1016/j.jfludis.2010.12.002; Theys C, 2011, J COMMUN DISORD, V44, P678, DOI 10.1016/j.jcomdis.2011.06.001; Theys C, 2008, J FLUENCY DISORD, V33, P1, DOI 10.1016/j.jfludis.2007.09.001; Theys C, 2013, HUM BRAIN MAPP, V34, P2103, DOI 10.1002/hbm.22052; Tree JEF, 1995, J MEM LANG, V34, P709, DOI 10.1006/jmla.1995.1032; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Van Borsel J, 2003, BRAIN LANG, V85, P185, DOI 10.1016/S0093-934X(03)00061-0; Van Borsel J, 2001, J COMMUN DISORD, V34, P385, DOI 10.1016/S0021-9924(01)00057-0; Van Borsel J, 2014, J NEUROLINGUIST, V27, P41, DOI 10.1016/j.jneuroling.2013.09.003; Van Borsel J, 2010, J NEUROLINGUIST, V23, P479, DOI 10.1016/j.jneuroling.2009.01.001; Van Lieshout PHHM, 2007, CLIN LINGUIST PHONET, V21, P159, DOI 10.1080/02699200600812331; Wambaugh J, 2006, J MED SPEECH-LANG PA, V14, P25; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; WEXLER KB, 1982, J FLUENCY DISORD, V7, P37, DOI 10.1016/0094-730X(82)90036-5; Wingate ME, 2001, J SPEECH LANG HEAR R, V44, P381, DOI 10.1044/1092-4388(2001/031); Yadegari F, 2014, IRAN J NEUROL, V13, P77; Yaruss JS, 1998, AM J SPEECH-LANG PAT, V7, P25, DOI 10.1044/1058-0360.0702.25; Ziegler Wolfram, 2008, Handb Clin Neurol, V88, P269, DOI 10.1016/S0072-9752(07)88013-4	93	4	4	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0094-730X	1873-801X		J FLUENCY DISORD	J. Fluency Disord.	MAR	2019	59						33	51		10.1016/j.jfludis.2019.01.001			19	Audiology & Speech-Language Pathology; Education, Special; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Education & Educational Research; Linguistics; Rehabilitation	HN1NA	WOS:000459952700003	30641458				2022-02-06	
J	Reilly, PL; Khan, T; Lqbal, W				Reilly, Peter L.; Khan, Tariq; Lqbal, Wahid			A survey of prehospital and acute hospital care in three low and middle income countries	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Neurotrauma; Prehospital care; LMIC countries; First responder management	TRAUMATIC BRAIN-INJURY; DEATHS; EMERGENCY; EDUCATION; SYSTEMS	A prospective survey of neurotrauma admitted to neurosurgical units in three low and middle income countries (LMIC) indicated a frequent lack of organised prehospital care. On site care was usually provided by a member of the public. The accident victim was rarely accompanied within an equipped ambulance by trained personnel. Intensive care management and intracranial pressure monitoring was rare. There appeared to be limited rehabilitation in all regions. (C) 2018 Elsevier Ltd. All rights reserved.	[Reilly, Peter L.] Univ Adelaide, Fac Hlth & Med Sci, Neurosurg, Adelaide, SA, Australia; [Khan, Tariq] Northwest Gen Hosp Peshawar, Dept Neurosurg, Peshawar, Pakistan; [Lqbal, Wahid] Northwest Sch Med, Peshawar, Pakistan		Reilly, PL (corresponding author), 81 Queen St, Norwood South, SA 5067, Australia.	p.reilly@adelaide.edu.au		Reilly, Peter/0000-0003-3173-0666			Aekka A, 2015, J SURG RES, V197, P331, DOI 10.1016/j.jss.2015.03.047; [Anonymous], 2007, BRIAN TRAUMA FDN GUI; [Anonymous], 2015, WHO GLOBAL STATUS RE; Bhatti JA, 2015, BMC EMERG MED, V15, DOI 10.1186/1471-227X-15-S2-S12; Callese TE, 2015, J SURG RES, V193, P300, DOI 10.1016/j.jss.2014.09.040; Callese TE, 2014, J SURG RES, V190, P104, DOI 10.1016/j.jss.2014.03.029; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Fayyaz J, 2015, BMC EMERG MED, V15, DOI 10.1186/1471-227X-15-S2-S3; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Husum H, 2003, J TRAUMA, V54, P1188, DOI 10.1097/01.TA.0000073609.12530.19; Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; Obermeyer Z, 2015, B WORLD HEALTH ORGAN, V93, P577, DOI 10.2471/BLT.14.148338; Oliver GJ, 2017, INJURY, V48, P978, DOI 10.1016/j.injury.2017.01.039; Oliver GJ, 2017, INJURY, V48, P985, DOI 10.1016/j.injury.2017.02.026; Olumide AO, 2015, PREHOSP DISASTER MED, V30, P579, DOI 10.1017/S1049023X15005282; Prusty G.K., 2012, TRAUMATIC SPINAL COR, P17, DOI 10.1017/CBO9781139030564.003.; Razzak JA, 2015, EMERG MED J, V32, P207, DOI 10.1136/emermed-2013-202590; Reilly PL, 2012, TRAUMATIC BRAIN SPIN, P1; Reynolds TA, 2017, ANNU REV PUBL HEALTH, V38, P507, DOI 10.1146/annurev-publhealth-032315-021412; Vali Y, 2017, PUBLIC HEALTH, V146, P92, DOI 10.1016/j.puhe.2016.12.006; Wesson HK, 2017, SURGERY, V48, P985	24	4	4	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAR	2019	61						201	204		10.1016/j.jocn.2018.10.030			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO3SY	WOS:000460844400036	30381159				2022-02-06	
J	Rhodes, CS; Zhang, H; Patel, K; Mistry, N; Kwok, Y; D'Souza, WD; Regine, WF; Gullapalli, RP				Rhodes, Chandler Sours; Zhang, Hao; Patel, Kruti; Mistry, Nilesh; Kwok, Young; D'Souza, Warren D.; Regine, William F.; Gullapalli, Rao P.			The Feasibility of Integrating Resting-State fMRI Networks into Radiotherapy Treatment Planning	JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES			English	Article						Radiation therapy treatment plan; resting-state fMRI; default mode network	TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; DEFAULT MODE; CORTEX; SPECTROSCOPY; INFORMATION; METASTASES; AVOIDANCE; MEMORY; HEAD	Background: Functional magnetic resonance imaging (fMRI) presents the ability to selectively protect functionally significant regions of the brain when primary brain tumors are treated with radiation therapy. Previous research has focused on task-based fMRI of language and sensory networks; however, there has been limited investigation on the inclusion of resting-state fMRI into the design of radiation treatment plans. Methods and materials: In this pilot study of 9 patients with primary brain tumors, functional data from the default mode network (DMN), a network supporting cognitive functioning, was obtained from resting-state fMRI and retrospectively incorporated into the design of radiation treatment plans. We compared the dosimetry of these fMRI DMN avoidance treatment plans with standard of care treatment plans to demonstrate feasibility. In addition, we used normal tissue complication probability models to estimate the relative benefit of fMRI DMN avoidance treatment plans over standard of care treatment plans in potentially reducing memory loss, a surrogate for cognitive function. Results: On average, we achieved 20% (P = 0.002) and 12% (P = 0.002) reductions in the mean and maximum doses, respectively, to the DMN without compromising the dose coverage to the planning tumor volume or the dose-volume constraints to organs at risk. Normal tissue complication probability models revealed that when the fMRI DMN was considered during radiation treatment planning, the probability of developing memory loss was lowered by more than 20%. Conclusion: In this pilot study, we demonstrated the feasibility of including rs-MRI data into the design of radiation treatment plans to spare cognitively relevant brain regions during radiation therapy. These results lay the groundwork for future clinical trials that incorporate such treatment planning methods to investigate the long-term behavioral impact of this reduction in dose to the cognitive areas and their neural networks that support cognitive performance.	[Rhodes, Chandler Sours; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA; [Zhang, Hao; Kwok, Young; D'Souza, Warren D.; Regine, William F.] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Patel, Kruti] Greater Baltimore Med Ctr, Radiat Oncol, Towson, MD USA; [Mistry, Nilesh] Siemens Healthcare, Raleigh, NC USA		Gullapalli, RP (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA.	rgullapalli@umm.edu			University of Maryland, Marlene and Stuart Greenebaum Comprehensive Cancer Center in Baltimore	The authors wish to acknowledge the support of the University of Maryland, Marlene and Stuart Greenebaum Comprehensive Cancer Center in Baltimore, and the Core for Translational Research in Imaging @ Maryland for providing imaging services.	Aoyama H, 2004, INT J RADIAT ONCOL, V58, P1177, DOI 10.1016/j.ijrobp.2003.08.034; Bahrami N, 2017, BRAIN CONNECT, V7, P299, DOI 10.1089/brain.2017.0494; Beetz I, 2012, RADIOTHER ONCOL, V105, P86, DOI 10.1016/j.radonc.2011.05.010; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boomsma MJ, 2012, INT J RADIAT ONCOL, V84, pE351, DOI 10.1016/j.ijrobp.2012.05.020; Chang J, 2008, TECHNOL CANCER RES T, V7, P349; Christianen MEMC, 2016, RADIOTHER ONCOL, V118, P298, DOI 10.1016/j.radonc.2015.11.009; Christianen MEMC, 2012, RADIOTHER ONCOL, V105, P107, DOI 10.1016/j.radonc.2011.08.009; Cole AM, 2013, INT J RADIAT ONCOL, V87, P705, DOI 10.1016/j.ijrobp.2013.07.037; Conti A, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12414; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dietrich J, 2008, ONCOLOGIST, V13, P1285, DOI 10.1634/theoncologist.2008-0130; Fink JR, 2015, J NUCL MED, V56, P1554, DOI 10.2967/jnumed.113.131516; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gondi V, 2014, J CLIN ONCOL, V32, P3810, DOI 10.1200/JCO.2014.57.2909; Gondi V, 2010, RADIOTHER ONCOL, V97, P370, DOI 10.1016/j.radonc.2010.09.013; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Greene-Schloesser D, 2012, NEURO-ONCOLOGY, V14, P37, DOI 10.1093/neuonc/nos196; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Huijbers W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017463; Kazda T, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-139; Kovacs A, 2011, J NEURO-ONCOL, V105, P629, DOI 10.1007/s11060-011-0633-2; Langendijk JA, 2013, RADIOTHER ONCOL, V107, P267, DOI 10.1016/j.radonc.2013.05.007; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Narayana A, 2007, BRIT J RADIOL, V80, P347, DOI 10.1259/bjr/65349468; Pantelis E, 2010, INT J RADIAT ONCOL, V78, P257, DOI 10.1016/j.ijrobp.2009.10.064; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Schaake W, 2016, RADIOTHER ONCOL, V119, P381, DOI 10.1016/j.radonc.2016.04.005; Scoccianti S, 2012, J NEURO-ONCOL, V108, P291, DOI 10.1007/s11060-012-0821-8; Sours C, 2015, BRAIN CONNECT, V5, P442, DOI 10.1089/brain.2014.0333; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; SPM8 Statistical parametrice mapping, SPM8 STAT PAR MAPP; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Suh JH, 2014, J CLIN ONCOL, V32, P3789, DOI 10.1200/JCO.2014.58.4367; Tallet AV, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-77; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Wang ML, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0364-1	42	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1939-8654			J MED IMAGING RADIAT	J. Med. Imaging Radiat. Sci.	MAR	2019	50	1					119	128		10.1016/j.jmir.2018.09.003			10	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	HL6OY	WOS:000458856100018	30777232				2022-02-06	
J	Sady, MD; Vaughan, CG; Gioia, GA				Sady, Maegan D.; Vaughan, Christopher G.; Gioia, Gerard A.			Measuring Dynamic Symptom Response in Concussion: Children's Exertional Effects Rating Scale	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive exertion; concussion; momentary symptom assessment; mTBI; pediatric; psychometrics; traumatic brain injury		Objective: To introduce and evaluate a measure of momentary symptom response to cognitive activity, a core feature of concussion. Setting: Concussion clinic at a large regional children's hospital. Participants: Individuals aged 5 to 18 years, comprising 3 clinical groups: uninjured (n = 590), recently concussed but clinically recovered (n = 160), and recently concussed but not yet recovered (n = 570). Design: Participants completed pretest symptom ratings, underwent neurocognitive assessment and completion of questionnaires, and then completed posttest ratings. An exertional effects index was computed by subtracting pretest from posttest ratings. Main Measures: Children's Exertional Effects Rating Scale, which includes 4 symptoms (Headache, Fatigue, Concentration Problems, and Irritability) rated pre- and postactivity. Results: Children's Exertional Effects Rating Scale was found to have adequate reliability and validity. There were negligible differences in ratings (pretest and exertional effects) between the Uninjured and Recovered groups, while individuals who were Not Recovered rated higher levels of pretest and exertional effects. Base rates showed that an exertional effects index of 4 or more points is rare in individuals who do not have a current concussion. Conclusion: Children's Exertional Effects Rating Scale is a psychometrically sound scale for evaluating momentary symptom increase in response to cognitive activity. Clinicians can use this scale as part of a multimodal battery for concussion assessment and treatment.	George Washington Univ, Sch Med, Childrens Natl Hlth Syst, Div Pediat Neuropsychol, Washington, DC USA; George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA; George Washington Univ, Sch Med, Dept Psychiat & Behav Sci, Washington, DC USA		Sady, MD (corresponding author), Childrens Natl Hlth Syst, Div Pediat Neuropsychol, 111 Michigan Ave NW, Washington, DC 20010 USA.	msady@childrensnational.org			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U17/CCU323352]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR020359]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR020359] Funding Source: NIH RePORTER	This work was supported in part by the Centers for Disease Control and Prevention (U17/CCU323352 to G.G.); and the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) (M01RR020359 to G.G.).	Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Covassin T, 2013, BRAIN INJURY, V27, P1589, DOI 10.3109/02699052.2013.823656; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Lee I. A., 2013, CALCULATION TEST DIF; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meyer JE, 2015, DEV NEUROPSYCHOL, V40, P24, DOI 10.1080/87565641.2014.1001065; Ransom DM, 2016, J INT NEUROPSYCH SOC, V22, P1038, DOI 10.1017/S1355617716000916; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187	12	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		E35	E44		10.1097/HTR.0000000000000424			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400004	30169434	Green Accepted			2022-02-06	
J	Schnur, KC; Gill, E; Guerrero, A; Osier, N; Reuter-Rice, K				Schnur, Kaylee C.; Gill, Eliana; Guerrero, Alejandro; Osier, Nicole; Reuter-Rice, Karin			Best Practices for Obtaining Genomic Consent in Pediatric Traumatic Brain Injury Research	NURSING RESEARCH			English	Article						brain injuries; children; human genetics; precision health; trauma	INFORMED-CONSENT; CLINICAL-TRIALS; CHILDREN; RECRUITMENT; PARTICIPATION; CHALLENGES; BIOMARKERS; ATTITUDES	Background Precision health relies on large sample sizes to ensure adequate power, generalizability, and replicability; however, a critical first step to any study is the successful recruitment of participants. Objectives This study seeks to explore how the enrollment strategies used in a parent study contributed to the high consent rates, establish current best practices that can be used in future studies, and identify additional factors that contribute to consent into pediatric traumatic brain injury biobanks. Methods Retrospective secondary analysis of data from a parent study with high consent rates was examined to explore factors affecting consent into biobanking studies. Results Of the 76 subjects who were approached, met the eligibility criteria, and reviewed the consent form, only 16 (21.1%) declined to participate. The consented group (n = 60) represents 64.5% of those who met the eligibility criteria upon initial screening (n = 93) and 78.9% of those with confirmed eligibility (n = 76). Analysis of screening data suggested there were no major barriers to consenting individuals into this pediatric traumatic brain injury biobank. Discussion There were no demographic or research-related characteristics that significantly explained enrollment. Ethically, to obtain true informed consent, parents need to understand only their child's diagnosis, prognosis, and medical care, as well as the purpose of the proposed research and its risks and benefits. Researchers need to implement best practices, including a comprehensive review of census data to identify eligible participants to approach, a prescreening protocol, and effective consenting process to obtain informed consent so that precision care initiatives can be pursued.	[Schnur, Kaylee C.; Osier, Nicole] Univ Texas Austin, Sch Nursing, Austin, TX 78712 USA; [Gill, Eliana] Seton Med Ctr, Austin, TX USA; [Guerrero, Alejandro] Univ Texas Austin, Austin, TX 78712 USA; [Osier, Nicole] Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX 78712 USA; [Reuter-Rice, Karin] Duke Univ, Sch Nursing, DUMC 3322,307 Trent Dr, Durham, NC 27710 USA; [Reuter-Rice, Karin] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA		Reuter-Rice, K (corresponding author), Duke Univ, Sch Nursing, DUMC 3322,307 Trent Dr, Durham, NC 27710 USA.	karin.reuter-rice@duke.edu	Osier, Nico/Q-7913-2017	Osier, Nico/0000-0002-2903-6774; Reuter-Rice, Karin/0000-0003-1501-8994	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Adaptive Leadership for Cognitive Affective Symptom Science ADAPT Institute of Nursing Research Center of Excellence [NINR 1P30 NR014139-01]; Robert Wood Johnson Foundation Nurse Faculty ScholarRobert Wood Johnson Foundation (RWJF) [71244]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [P30NR014139] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institutes of Health, the Adaptive Leadership for Cognitive Affective Symptom Science ADAPT Institute of Nursing Research Center of Excellence under Award Number NINR 1P30 NR014139-01, and the Robert Wood Johnson Foundation Nurse Faculty Scholar under Award Number 71244.	Anderson Emily E, 2017, AJOB Empir Bioeth, V8, P178, DOI 10.1080/23294515.2017.1362488; Au AK, 2017, CURR OPIN NEUROL, V30, P565, DOI 10.1097/WCO.0000000000000504; Axson SA, 2019, NURS ETHICS, V26, P1050, DOI 10.1177/0969733017740175; Barfield RC, 2005, CURR OPIN PEDIATR, V17, P20, DOI 10.1097/01.mop.0000145718.77939.b1; Bernhardt BA, 2015, AM J MED GENET A, V167, P2635, DOI 10.1002/ajmg.a.37256; Burstein MD, 2014, PEDIATRICS, V133, P690, DOI 10.1542/peds.2013-1592; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Daunt DJ, 2003, APPL NURS RES, V16, P189, DOI 10.1016/S0897-1897(03)00042-9; Deines JJ, 2019, J NEUROTRAUM, V36, P135, DOI 10.1089/neu.2017.5577; Dennis EL, 2017, NEUROIMAGE-CLIN, V15, P125, DOI 10.1016/j.nicl.2017.03.014; Dove ES, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-5; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Giesbertz NAA, 2015, EUR J HUM GENET, V23, P1129, DOI 10.1038/ejhg.2014.267; Halbert CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154850; Hudson BF, 2017, PALLIATIVE MED, V31, P419, DOI 10.1177/0269216316663856; Kassam-Adams N, 2005, GEN HOSP PSYCHIAT, V27, P29, DOI 10.1016/j.genhosppsych.2004.08.007; Katz AL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1485; Kraft SA, 2018, AM J BIOETHICS, V18, P3, DOI 10.1080/15265161.2018.1431322; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Leibson T, 2015, PEDIATR DRUGS, V17, P5, DOI 10.1007/s40272-014-0108-y; Lochmuller Hanns, 2009, Biopreserv Biobank, V7, P155, DOI 10.1089/bio.2010.7302; Menon K, 2014, J MED ETHICS, V40, P123, DOI 10.1136/medethics-2012-101075; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Pearl PL, 2013, EPILEPSIA, V54, pe135, DOI 10.1111/epi.12326; Reuter-Rice K, 2018, BIOL RES NURS, V20, P566, DOI 10.1177/1099800418785982; Reuter-Rice K, 2015, ANNU REV NURS RES-SE, V33, P185, DOI 10.1891/0739-6686.33.185; Rogers Joyce, 2011, Journal of the National Cancer Institute Monographs, P32, DOI 10.1093/jncimonographs/lgr010; Salvaterra E, 2014, PATHOBIOLOGY, V81, P304, DOI 10.1159/000362091; Stanley RM, 2017, ACAD EMERG MED, V24, P31, DOI 10.1111/acem.13085; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Susilo AP, 2014, NURS ETHICS, V21, P684, DOI 10.1177/0969733014531524; Tinkler L, 2018, J ADV NURS, V74, P318, DOI 10.1111/jan.13409; Vaewpanich J, 2016, EPILEPSY BEHAV, V62, P225, DOI 10.1016/j.yebeh.2016.07.012; Wilkinson AA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0925-6	36	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-6562	1538-9847		NURS RES	Nurs. Res.	MAR-APR	2019	68	2					E11	E20		10.1097/NNR.0000000000000335			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	HP1RL	WOS:000461444300002	30829926	Green Accepted			2022-02-06	
J	Woods, C; Jones, R; Usher, K				Woods, Cindy; Jones, Rikki; Usher, Kim			The impact of unintentional alcohol-related falls on emergency departments	AUSTRALASIAN EMERGENCY CARE			English	Article						Accidental falls; Alcohol; Emergency department; Injuries; Observational study	INJURY PRESENTATIONS; CONSUMPTION; PATTERNS; ADULTS; RISK	Background: Alcohol is the cause of many injury presentations to the emergency department. There has been little research on alcohol-related falls in the broader adult population, which represent a substantial proportion of the total alcohol-related injury presentations to emergency departments. Methods: A population-based retrospective analysis of public hospital emergency department presentations for Victoria for 2003-2015 was undertaken. Results: Alcohol-related fall presentations have increased by 96% over the 13-year period, a rate of growth exceeding non-alcohol-related falls, all ED presentations, and Victorian population growth. Alcohol-related fall presentations are most prevalent in the 20-24 year age group, and among males. The severity of alcohol-related fall presentations is greater than non-alcohol-related fall presentations, based on triages cale ratings and admission rates, with head injuries being the most frequent type of injury. Conclusions: Public health warnings about the risks of alcohol-related fall injuries and the need to seek medical treatment for head injuries in particular are necessary to raise awareness among younger people. Emergency staff vigilance with neurological assessments is needed for early diagnosis of traumatic brain injury in alcohol-related fall presentations to help prevent adverse outcomes. (C) 2018 Published by Elsevier Ltd on behalf of College of Emergency Nursing Australasia.	[Woods, Cindy; Jones, Rikki; Usher, Kim] Univ New England, Sch Hlth, Armidale, NSW 2351, Australia		Woods, C (corresponding author), Univ New England, Sch Hlth, Armidale, NSW 2351, Australia.	cwood30@une.edu.au	Woods, Cindy E/H-6185-2016; Usher, Kim/ABB-2803-2020	Woods, Cindy E/0000-0001-5790-069X; Usher AM, Kim/0000-0002-9686-5003; Jones, Rikki/0000-0001-6643-1565			Althaus F, 2011, ANN EMERG MED, V58, P41, DOI 10.1016/j.annemergmed.2011.03.007; Australian Bureau of Statistics, 2017, 3101 1 AUSTR BUR STA; Australian Institute of Health and Welfare, 2016, DRUG TREATM SER; Australian Institute of Health and Welfare, 2017, DRUG STAT SER; Australian Institute of Health Welfare, 2016, HLTH SERV SER, V70; Australian Institute of Health Welfare (AIHW), 2004, AIHW DIS EXP DAT; Borges G, 2009, ALCOHOL INJURIES EME; Bunker N, 2017, J CLIN NURS, V26, P157, DOI 10.1111/jocn.13472; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Cherpital C, 2009, ALCOHOL INJURIES EME; FitzGerald G, 2010, POSTGRAD MED J, V86, P502, DOI 10.1136/pgmj.2009.077081rep; Gielen AC, 2015, ANNU REV PUBL HEALTH, V36, P231, DOI 10.1146/annurev-publhealth-031914-122722; Hides L, 2015, DRUG ALCOHOL REV, V34, P177, DOI 10.1111/dar.12218; Hill K, 2004, INTERN MED J, V34, P557, DOI 10.1111/j.1445-5994.2004.00668.x; Hoban Ciara, 2017, Emerg Nurse, V25, P30, DOI 10.7748/en.2017.e1670; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; McDonald EM, 2018, AM J LIFESTYLE MED, V12, P96, DOI 10.1177/1559827616629924; McHale P, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-258; McLeod R, 1999, ADDICTION, V94, P1719, DOI 10.1046/j.1360-0443.1999.941117199.x; Miller TR, 2012, ALCOHOL CLIN EXP RES, V36, P104, DOI 10.1111/j.1530-0277.2011.01593.x; Morris M, 2004, AUST J PHYSIOTHER, V50, P153, DOI 10.1016/S0004-9514(14)60153-7; Mukamal KJ, 2004, J AM GERIATR SOC, V52, P1174, DOI 10.1111/j.1532-5415.2004.52318.x; NSW Ministry of Health, 2015, HOSP DRUG ALC CONS M; NSW Ministry of Health, 2015, HOSP DRUG ALC CONS M; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Orces CH, 2014, CURR GERONTOL GERIAT, V2014, P1; Pointer S., 2015, INJURY RES STAT SERI, V95; Reid D., 2011, NSW I TRAUMA INJURY; Sergeant E, 2013, EPITOOLS EPIDEMIOLOG; Swaminathan M, 2007, FALL RELATED EMERGEN; Victorian Department of Health and Human Services, 2015, ASS INT PERS; Vinson DC, 2003, J STUD ALCOHOL, V64, P358, DOI 10.15288/jsa.2003.64.358; Watt K, 2004, ADDICTION, V99, P1262, DOI 10.1111/j.1360-0443.2004.00823.x; White AM, 2018, ALCOHOL CLIN EXP RES, V42, P352, DOI 10.1111/acer.13559	34	4	4	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2588-994X			AUSTRALAS EMERG CARE	Australas. Emerg. Care	MAR	2019	22	1					22	27		10.1016/j.auec.2018.11.001			6	Emergency Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Nursing	HP1WL	WOS:000461459200004	30998868				2022-02-06	
J	Skop, NB; Singh, S; Antikainen, H; Saqcena, C; Calderon, F; Rothbard, DE; Cho, CH; Gandhi, CD; Levison, SW; Dobrowolski, R				Skop, Nolan B.; Singh, Sweta; Antikainen, Henri; Saqcena, Chaitali; Calderon, Frances; Rothbard, Deborah E.; Cho, Cheul H.; Gandhi, Chirag D.; Levison, Steven W.; Dobrowolski, Radek			Subacute Transplantation of Native and Genetically Engineered Neural Progenitors Seeded on Microsphere Scaffolds Promote Repair and Functional Recovery After Traumatic Brain Injury	ASN NEURO			English	Article						neurotrauma; regenerative medicine; radial glia; multifunctional scaffold; fibroblast growth factor; fibronectin; cell transplantation; neural stem cells; insulin-like growth factor 1; regeneration	MESENCHYMAL STEM-CELLS; COGNITIVE FUNCTION; IGF-I; NEURONAL DIFFERENTIATION; STEM/PROGENITOR CELLS; NEUROLOGICAL MOTOR; RAT MODEL; SURVIVAL; MIGRATION; EXPRESSION	There is intense interest and effort toward regenerating the brain after severe injury. Stem cell transplantation after insult to the central nervous system has been regarded as the most promising approach for repair; however, engrafting cells alone might not be sufficient for effective regeneration. In this study, we have compared neural progenitors (NPs) from the fetal ventricular zone (VZ), the postnatal subventricular zone, and an immortalized radial glia (RG) cell line engineered to conditionally secrete the trophic factor insulin-like growth factor 1 (IGF-1). Upon differentiation in vitro, the VZ cells were able to generate a greater number of neurons than subventricular zone cells. Furthermore, differentiated VZ cells generated pyramidal neurons. In vitro, doxycycline-driven secretion of IGF-1 strongly promoted neuronal differentiation of cells with hippocampal, interneuron and cortical specificity. Accordingly, VZ and engineered RG-IGF-1-hemagglutinin (HA) cells were selected for subsequent in vivo experiments. To increase cell survival, we delivered the NPs attached to a multifunctional chitosan-based scaffold. The microspheres containing adherent NPs were injected subacutely into the lesion cavity of adult rat brains that had sustained controlled cortical impact injury. At 2 weeks posttransplantation, the exogenously introduced cells showed a reduction in stem cell or progenitor markers and acquired mature neuronal and glial markers. In beam walking tests assessing sensorimotor recovery, transplanted RG cells secreting IGF-1 contributed significantly to functional improvement while native VZ or RG cells did not promote significant recovery. Altogether, these results support the therapeutic potential of chitosan-based multifunctional microsphere scaffolds seeded with genetically modified NPs expressing IGF-1 to promote repair and functional recovery after traumatic brain injuries.	[Skop, Nolan B.; Calderon, Frances; Rothbard, Deborah E.; Levison, Steven W.] Univ Med & Dent New Jersey, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Skop, Nolan B.; Cho, Cheul H.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Singh, Sweta; Antikainen, Henri; Saqcena, Chaitali; Dobrowolski, Radek] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07103 USA; [Singh, Sweta] Inst Nucl Med & Allied Sci, Stem Cell & Gene Therapy Res Grp, Delhi, India; [Gandhi, Chirag D.] NY Med Coll, Westchester Med Ctr, Dept Neurosurg, Valhalla, NY USA; [Dobrowolski, Radek] Univ Texas Hlth San Antonio, Dept Cell Syst & Anat, San Antonio, TX USA; [Dobrowolski, Radek] Univ Texas Hlth Sci Ctr San Antonio, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX 78229 USA		Levison, SW (corresponding author), Rutgers State Univ, Rutgers Biomed Hlth Sci, Dept Pharmacol Physiol & Neurosci, H-1226,205 South Orange Ave, Newark, NJ 07103 USA.; Dobrowolski, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, South Texas Res Facil, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	Levisosw@njms.rutgers.edu; dobrowolskir@uthscsa.edu	Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309; Dobrowolski, Radek/0000-0002-1805-5806	New Jersey Commission on Brain Injury Research [08.001. BIR2, CBIR12FEL025, CBIR14PIL001]; International Alzheimer's Association [NIRG-305325]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R15NS087501]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was partially supported by the New Jersey Commission on Brain Injury Research grant numbers 08.001. BIR2 awarded to CDG and SWL, #CBIR12FEL025 awarded to NBS, and #CBIR14PIL001 awarded to R. D. This work also was supported by a grant from the International Alzheimer's Association #NIRG-305325 awarded to R. D. and the National Institutes of Health #1R15NS087501 awarded to C. H. C.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007; Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO;2-5; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Azari MF, 2010, CURR NEUROPHARMACOL, V8, P316, DOI 10.2174/157015910793358204; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Bianchi VE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112441; Bible E, 2012, BIOMATERIALS, V33, P7435, DOI 10.1016/j.biomaterials.2012.06.085; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Goodus MT, 2015, DEV NEUROSCI-BASEL, V37, P29, DOI 10.1159/000367784; Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/j.neulet.2003.07.021; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hasegawa K, 2005, EXP NEUROL, V193, P394, DOI 10.1016/j.expneurol.2004.12.024; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Jinnou H, 2018, CELL STEM CELL, V22, P128, DOI 10.1016/j.stem.2017.11.005; Kazanis I, 2004, EXP NEUROL, V186, P221, DOI 10.1016/j.expneurol.2003.12.004; Lin SY, 2009, EXP NEUROL, V217, P361, DOI 10.1016/j.expneurol.2009.03.021; Liu XF, 2001, J NEUROL SCI, V187, P91, DOI 10.1016/S0022-510X(01)00532-9; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Niimi Y., 2018, PEDIAT RES, V83, P385; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sanberg PR, 2012, BRIT MED BULL, V101, P163, DOI 10.1093/bmb/lds001; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Skop NB, 2016, J TISSUE ENG REGEN M, V10, pE419, DOI 10.1002/term.1832; Skop Nolan B, 2014, Mol Cell Ther, V2, P19, DOI 10.1186/2052-8426-2-19; Skop NB, 2013, ACTA BIOMATER, V9, P6834, DOI 10.1016/j.actbio.2013.02.043; Sun D, 2011, J NEUROTRAUM, V28, P961, DOI 10.1089/neu.2010.1697; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Vergano-Vera E, 2009, NEUROSCIENCE, V162, P39, DOI 10.1016/j.neuroscience.2009.03.033; Vincent AM, 2004, NEUROBIOL DIS, V16, P407, DOI 10.1016/j.nbd.2004.03.001; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wennersten A, 2006, EXP NEUROL, V199, P339, DOI 10.1016/j.expneurol.2005.12.035; Wurmser AE, 2002, NATURE, V416, P485, DOI 10.1038/416485a; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang C, 2005, J NEUROTRAUM, V22, P1456, DOI 10.1089/neu.2005.22.1456; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061; Ziegler AN, 2015, NAT REV ENDOCRINOL, V11, P161, DOI 10.1038/nrendo.2014.208	60	4	4	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	FEB 28	2019	11								1759091419830186	10.1177/1759091419830186			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN2KB	WOS:000460013000001	30818968	Green Published, gold			2022-02-06	
J	de la Cour, FLD; Rasmussen, MA; Foged, EM; Jensen, LS; Schow, T				de la Cour, Frederik Lehman Dornonville; Rasmussen, Morten Arendt; Foged, Eva Meldal; Jensen, Line Svenning; Schow, Trine			Vocational Rehabilitation in Mild Traumatic Brain Injury: Supporting Return to Work and Daily Life Functioning	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; concussion; post-concussive syndrome; vocational rehabilitation; multidisciplinary rehabilitation; return to work; employment; standard operating procedure (SOP)	SYMPTOMS; INTERVENTION; PREDICTORS; EMPLOYMENT; PREVENTION; PROGRAM; STROKE; IMPACT	Persisting post-concussive symptoms are challenging to treat and may delay return-to-work (RTW). The aims of this study were to describe a multidisciplinary and holistic vocational rehabilitation (VR) program for individuals with mild traumatic brain injury (mTBI) and to explore course and predictors of employment outcome during VR. The VR program was described using the Standard Operating Procedures (SOPs) framework. Further, a retrospective, cohort study on individuals with mTBI receiving VR was conducted based on clinical records (n = 32; 22% males; mean age 43.2 years; 1.2 years since injury on average). The primary outcome was difference in hours at work per week from pre- to post-VR, and the secondary outcome was change in a three-level RTW-status. Time since injury, age, sex, and loss of consciousness were investigated as predictors of the outcomes. The VR intervention is individually tailored and targets patients' individual needs. Thus, it may combine a variety of methods based on a biopsychosocial theoretical model. During VR, hours at work, 17.0 +/- 2.2, p < 0.001, and RTW-status, OR = 14.0, p < 0.001, improved significantly with 97% having returned to work after VR. Shorter length of time since injury and male sex were identified as predictors of a greater gain of working hours. Time since injury was the strongest predictor; double the time was associated with a reduction in effect by 4.2 +/- 1.4 h after adjusting for working hours at start of VR. In sum, these results suggest that individuals facing persistent problems following mTBI may still improve employment outcomes and RTW after receiving this multidisciplinary and holistic VR intervention, even years after injury. While results are preliminary and subject to bias due to the lack of a control group, this study warrants further research into employment outcomes and VR following mTBI, including who may benefit the most from treatment.	[de la Cour, Frederik Lehman Dornonville; Foged, Eva Meldal; Jensen, Line Svenning; Schow, Trine] Brain Injury Ctr BOMI, Res & Dev, Roskilde, Denmark; [de la Cour, Frederik Lehman Dornonville] Univ Southern Denmark, Fac Hlth Sci, Dept Psychol, Odense, Denmark; [Rasmussen, Morten Arendt] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood COPS, Copenhagen, Denmark		de la Cour, FLD; Schow, T (corresponding author), Brain Injury Ctr BOMI, Res & Dev, Roskilde, Denmark.; de la Cour, FLD (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Dept Psychol, Odense, Denmark.	frederikldc@bomi.roskilde.dk; trineschow@bomi.roskilde.dk	Rasmussen, Morten/AAE-9517-2020; de la Cour, Frederik Lehman Dornonville/C-6144-2019	Rasmussen, Morten/0000-0001-7431-5206; de la Cour, Frederik Lehman Dornonville/0000-0002-2905-557X	University Library of Southern Denmark; Brain Injury Centre BOMI	Brain Injury Centre BOMI funded the study. The University Library of Southern Denmark funded the Open Access costs.	Bond GR, 2012, WORLD PSYCHIATRY, V11, P32, DOI 10.1016/j.wpsyc.2012.01.005; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dijkers MP, 2014, ARCH PHYS MED REHAB, V95, pS45, DOI 10.1016/j.apmr.2013.05.033; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Hart T, 2014, ARCH PHYS MED REHAB, V95, pS33, DOI 10.1016/j.apmr.2013.05.032; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Hoffer ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146039; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; LeBlanc JM, 2010, AUST J REHABIL COUNS, V16, P36, DOI 10.1375/jrc.16.1.36; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Martelli MF, 1999, REHABIL PSYCHOL NEWS, V23, P8; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; R Core Team, 2018, STATS PACK LANG ENV; Rao T S Sathyanarayana, 2011, Indian J Psychiatry, V53, P1, DOI 10.4103/0019-5545.75542; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Scheenen ME, 2017, CLIN REHABIL, V31, P1019, DOI 10.1177/0269215516687101; Schneider U, 2016, EUR J HEALTH ECON, V17, P629, DOI 10.1007/s10198-015-0707-8; Schow T, 2016, NEUROREHABILITATION, V38, P331, DOI 10.3233/NRE-161324; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Soares de Souza R, 2015, INT ARCH MED, V8, P1, DOI [10.3823/1672, DOI 10.3823/1672]; Stergiou-Kita M, 2012, J OCCUP REHABIL, V22, P166, DOI 10.1007/s10926-011-9332-2; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Waddell G, 2008, VOCATIONAL REHABILIT; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Whyte J, 2006, J HEAD TRAUMA REHAB, V21, P99, DOI 10.1097/00001199-200603000-00003; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D	37	4	4	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 21	2019	10								103	10.3389/fneur.2019.00103			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HM2LR	WOS:000459295300001	30846964	gold, Green Published			2022-02-06	
J	Radoi, A; Poca, MA; Gandara, D; Castro, L; Cevallos, M; Pacios, ME; Sahuquillo, J				Radoi, Andreea; Poca, Maria A.; Gandara, Dario; Castro, Lidia; Cevallos, Mauricio; Pacios, Maria E.; Sahuquillo, Juan			The Sport Concussion Assessment Tool (SCAT2) for evaluating civilian mild traumatic brain injury. A pilot normative study	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; HEAD-INJURY; HOSPITAL ANXIETY; HIGH-SCHOOL; SYMPTOMS; QUESTIONNAIRE; PREVALENCE; CONSENSUS; RECOVERY; SAMPLE	Self-report measures, particularly symptom inventories, are critical tools for identifying patients with persistent post-concussion symptoms and their follow-up. Unlike in military or sports-related assessment, in general civilian settings pre-injury levels of concussion-like symptoms are lacking. Normative data are available in adolescent and college populations, but no reference data exist to guide clinical adult explorations. The purpose of this study was to use the second edition of the Sport Concussion Assessment Tool (SCAT2) to profile a cohort of 60 healthy community volunteers who had not sustained a head injury. Participating volunteers underwent MRI scanning and were evaluated with the Hospital Anxiety and Depression Scale (HADS). Participants reported a median of 3 concussion-like symptoms and the 97.5 percentile score was found at 10.5 symptoms, out of a total of 22. The median severity score was 4.9 points, and 28.9 was the upper limit of the reference interval. Only 10 participants (16.7%) did not endorse any symptom. The most frequently endorsed symptom was feeling difficulty in concentrating, with 41.7% of the sample reporting it. Age, sex and general distress, anxiety and depressive symptoms were not associated with concussion-like symptoms. Our data yielded elevated cut-offs scores for both the number of symptoms and the symptom severity. In conclusion, postconcussive-like symptoms are frequent in the general non-concussed adult population and it should be taken into account in any future models developed for screening patients at risk of developing physical, cognitive, and psychological complaints following mild traumatic injury.	[Radoi, Andreea; Poca, Maria A.; Castro, Lidia; Sahuquillo, Juan] Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain; [Radoi, Andreea; Poca, Maria A.; Castro, Lidia; Sahuquillo, Juan] Univ Autonoma Barcelona, Barcelona, Spain; [Poca, Maria A.; Gandara, Dario; Cevallos, Mauricio; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Pacios, Maria E.] Vall dHebron Univ Hosp, Neurotraumatol Emergency Unit, Barcelona, Spain		Radoi, A (corresponding author), Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain.; Radoi, A (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.	aradoi@neurotrauma.net	Radoi, Andreea/N-5613-2019; Poca, Maria A./B-8475-2008; Sabatini, Dario Fabian Gandara/AAB-6699-2019; Sahuquillo, Juan/B-3577-2008	Radoi, Andreea/0000-0002-0677-3544; Poca, Maria A./0000-0002-3831-0536; Sabatini, Dario Fabian Gandara/0000-0003-1303-9847; Sahuquillo, Juan/0000-0003-0713-5875	Generalitat de CatalunyaGeneralitat de CatalunyaGeneral Electric [SGR 2014-844]; Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)Instituto de Salud Carlos III [FIS PI11/00700, FIS PI13/02397]; European Regional Development Fund (ERDF)European Commission; Fundacio Institut de Recerca VHIR [PRED-VHIR-2012-26]	UNINN is supported by a Grant from the Generalitat de Catalunya (SGR 2014-844, http://agaur.gencat.cat). This work has been supported in part by the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III, https://portalfis.isciii.es) with grants FIS PI11/00700 (J.S.) and grant FIS PI13/02397 (M.A.P.), which were co-financed by the European Regional Development Fund (ERDF). A.R. was a recipient of a pre-doctoral grant from the Fundacio Institut de Recerca VHIR (PRED-VHIR-2012-26, http://en.vhir.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Edmed SL, 2014, BRAIN INJURY, V28, P1277, DOI 10.3109/02699052.2014.915988; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Hastie T, 2001, ELEMENTS STAT LEARNI, Vxvi; Horn PS, 2001, CLIN CHEM, V47, P2137; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Horn PS, 1998, CLIN CHEM, V44, P622; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P1429, DOI 10.1001/jama.2018.1536; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Thomas RE, 2016, BMJ OPEN SPORT EXERC, V2, DOI DOI 10.1136/BMJSEM-2015-000095; Vargo MM, 2016, PM&R, V8, P241, DOI 10.1016/j.pmrj.2015.07.006; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; World Health Organization, 2013, COUNTR PROF NUTR PHY; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212541	10.1371/journal.pone.0212541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	WOS:000459307000068	30785950	Green Submitted, Green Published, gold			2022-02-06	
J	Wei, HT; Pan, TL; Hsu, JW; Huang, KL; Bai, YM; Ko, NY; Su, TP; Li, CT; Tsai, SJ; Lin, WC; Chen, TJ; Chen, MH				Wei Han-Ting; Pan Tai-Long; Hsu Ju-Wei; Huang Kai-Lin; Bai Ya-Mei; Ko Nai-Ying; Su Tung-Ping; Li Cheng-Ta; Tsai Shih-Jen; Lin Wei-Chen; Chen Tzeng-Ji; Chen Mu-Hong			Risks of bipolar disorder, depressive disorder, and traumatic brain injury among siblings of patients with attention-deficit hyperactivity disorder	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Unaffected siblings; ADHD; Unipolar depression; Bipolar disorder; Traumatic brain injury	DEFICIT/HYPERACTIVITY DISORDER; YOUNG-ADULTS; ADHD; ADOLESCENTS; CHILDREN	Background: Previous studies have suggested that the unaffected siblings of patients with attention-deficit hyperactivity disorder (ADHD) experience deficits in attention, impulsivity control, and behavior inhibition, which are associated with health-risk behaviors. However, risks to mental and physical health among the unaffected siblings of ADHD probands have rarely been investigated. Methods: Using the Taiwan National Health Insurance Research Database, 5128 unaffected siblings of ADHD probands born between 1980 and 2000 were included in our study along with 20,512 age-and sex-matched controls, and they were followed from 1996 or birth until the end of 2011. Mental and physical health risks, including affective disorders, traumatic brain injury (TBI), and sexually transmitted infection were identified during the follow-up period. Results: Logistic regression analyses with adjustments for demographic data showed that the unaffected siblings were more likely to develop unipolar depression (odds ratio [OR]: 1.76, 95% confidence interval [CI]: 1.39-2.22), bipolar disorder (OR: 2.10, 95% CI: 1. 09-4.05), and TBI (OR: 1.24, 95% CI: 1.14-1.36) than were the control group. Discussion: The unaffected siblings of patients with ADHD were prone to developing unipolar depression, bipolar disorder, and TBI later in life.	[Wei Han-Ting; Hsu Ju-Wei; Huang Kai-Lin; Bai Ya-Mei; Su Tung-Ping; Li Cheng-Ta; Tsai Shih-Jen; Lin Wei-Chen; Chen Mu-Hong] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Hsu Ju-Wei; Huang Kai-Lin; Bai Ya-Mei; Su Tung-Ping; Li Cheng-Ta; Tsai Shih-Jen; Lin Wei-Chen; Chen Mu-Hong] Natl Yang Ming Univ, Dept Psychiat, Coll Med, Taipei, Taiwan; [Chen Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan; [Su Tung-Ping] Cheng Hsin Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Wei Han-Ting] Taipei City Hosp, Div Psychiat, Kunming Branch, Taipei, Taiwan; [Wei Han-Ting] Taipei City Hosp, Branch Linsen Chinese Med & Kunming, Taipei, Taiwan; [Ko Nai-Ying] Natl Cheng Kung Univ & Hosp, Dept Nursing, Coll Med, Tainan, Taiwan; [Pan Tai-Long] Chang Gung Univ, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Pan Tai-Long] Chang Gung Mem Hosp, Liver Res Ctr, Taoyuan, Taiwan; [Pan Tai-Long] Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Food & Cosmet Safety, Res Ctr Chinese Herbal Med, Taoyuan, Taiwan		Hsu, JW; Chen, MH (corresponding author), Dept Psychiat, 201 Shih Pai Rd,Sect 2, Taipei 11217, Taiwan.	jwhsu@vghtpe.gov.tw; kremer7119@gmail.com	Ko, Monica/AAE-2253-2021; Chen, TJ/AAH-8430-2021; Li, Cheng-Ta/AAI-5759-2021; Chen, Kuan-Lin/AAC-5430-2021; Tsai, Shih-Jen/AAK-7944-2020	Li, Cheng-Ta/0000-0002-0670-1153; Tsai, Shih-Jen/0000-0002-9987-022X; Ko, Nai-Ying/0000-0002-3007-2537	Taipei Veterans General HospitalTaipei Veterans General Hospital [V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181]; Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [107-2314-B-075-063-MY3]	The study was supported by grant from Taipei Veterans General Hospital (V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181) and Ministry of Science and Technology, Taiwan (107-2314-B-075-063-MY3). The funding source had no role in any process of our study.	Asherson P, 2016, LANCET PSYCHIAT, V3, P568, DOI 10.1016/S2215-0366(16)30032-3; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; BIEDERMAN J, 1995, ARCH GEN PSYCHIAT, V52, P464; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Chen MH, 2018, J AM ACAD CHILD PSY, V57, P48, DOI 10.1016/j.jaac.2017.09.438; Chen MH, 2016, DIABETES CARE, V39, P788, DOI 10.2337/dc15-1807; Chen MH, 2015, BRIT J PSYCHIAT, V206, P302, DOI 10.1192/bjp.bp.113.143610; Cheng CM, 2018, MOL PSYCHIATR, V23, P1756, DOI 10.1038/mp.2017.217; Cortese S, 2016, J CLIN PSYCHIAT, V77, pE421, DOI 10.4088/JCP.14m09630; Faraone SV, 1996, J AM ACAD CHILD PSY, V35, P1449, DOI 10.1097/00004583-199611000-00013; Graziano PA, 2015, J ATTEN DISORD, V19, P179, DOI 10.1177/1087054714527792; Hosain GMM, 2012, J WOMENS HEALTH, V21, P463, DOI 10.1089/jwh.2011.2825; King K, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090910; Kuo CF, 2015, JAMA INTERN MED, V175, P1518, DOI 10.1001/jamainternmed.2015.3528; Larsson H, 2013, BRIT J PSYCHIAT, V203, P103, DOI 10.1192/bjp.bp.112.120808; Listug-Lunde L, 2008, J ATTEN DISORD, V12, P239, DOI 10.1177/1087054708316253; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; NadaRaja S, 1997, J AM ACAD CHILD PSY, V36, P515, DOI 10.1097/00004583-199704000-00014; Oerlemans AM, 2015, J CHILD PSYCHOL PSYC, V56, P782, DOI 10.1111/jcpp.12349; Olazagasti MAR, 2013, J AM ACAD CHILD PSY, V52, P153, DOI 10.1016/j.jaac.2012.11.012; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Rommelse NNJ, 2007, J AM ACAD CHILD PSY, V46, P582, DOI 10.1097/chi.0b013e3180335af7; Smith E, 2017, EUR CHILD ADOLES PSY, V26, P123, DOI 10.1007/s00787-016-0876-8; van Dongen EV, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0043-y; Vitola ES, 2017, PSYCHOL MED, V47, P744, DOI 10.1017/S0033291716002853; Yang LK, 2011, CAN J PSYCHIAT, V56, P281, DOI 10.1177/070674371105600507	27	4	4	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	FEB 15	2019	245						335	339		10.1016/j.jad.2018.11.057			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	HI8HR	WOS:000456697100043	30419534				2022-02-06	
J	Yokobori, S; Sasaki, K; Kanaya, T; Igarashi, Y; Nakae, R; Onda, H; Masuno, T; Suda, S; Sowa, K; Nakajima, M; Spurlock, MS; Chieng, LO; Hazel, TG; Johe, K; Gajavelli, S; Fuse, A; Bullock, MR; Yokota, H				Yokobori, Shoji; Sasaki, Kazuma; Kanaya, Takahiro; Igarashi, Yutaka; Nakae, Ryuta; Onda, Hidetaka; Masuno, Tomohiko; Suda, Satoshi; Sowa, Kota; Nakajima, Masataka; Spurlock, Markus S.; Chieng, Lee Onn; Hazel, Tom G.; Johe, Karl; Gajavelli, Shyam; Fuse, Akira; Bullock, M. Ross; Yokota, Hiroyuki			Feasibility of Human Neural Stem Cell Transplantation for the Treatment of Acute Subdural Hematoma in a Rat Model: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; acute subdural hematoma; transplantation; neural stem cell; treatment	TRAUMATIC BRAIN-INJURY; NEURONAL DIFFERENTIATION; HYPOTHERMIA; THERAPY; NEUROPROTECTION; GUIDELINES; DEFICITS; TRIAL	Human neural stem cells (hNSCs) transplantation in several brain injury models has established their therapeutic potential. However, the feasibility of hNSCs transplantation is still not clear for acute subdural hematoma (ASDH) brain injury that needs external decompression. Thus, the aim of this pilot study was to test feasibility using a rat ASDH decompression model with two clinically relevant transplantation methods. Two different methods, in situ stereotactic injection and hNSC-embedded matrix seating on the brain surface, were attempted. Athymic rats were randomized to uninjured or ASDH groups (F344/NJcl-rnu/rnu, n = 7-10/group). Animals in injury group were subjected to ASDH, and received decompressive craniectomy and 1-week after decompression surgery were transplanted with green fluorescent protein (GFP)-transduced hNSCs using one of two approaches. Histopathological examinations at 4 and 8 weeks showed that the GFP-positive hNSCs survived in injured brain tissue, extended neurite-like projections resembling neural dendrites. The in situ transplantation group had greater engraftment of hNSCs than matrix embedding approach. lmmunohistochemistry with doublecortin, NeuN, and GFAP at 8 weeks after transplantation showed that transplanted hNSCs remained as immature neurons and did not differentiate toward to glial cell lines. Motor function was assessed with rotarod, compared to control group (n = 10). The latency to fall from the rotarod in hNSC in situ transplanted rats was significantly higher than in control rats (median, 113 s in hNSC vs. 69 s in control, P = 0.02). This study first demonstrates the robust engraftment of in situ transplanted hNSCs in a clinically-relevant ASDH decompression rat model. Further preclinical studies with longer study duration are warranted to verify the effectiveness of hNSC transplantation in amelioration of TBI induced deficits.	[Yokobori, Shoji; Sasaki, Kazuma; Kanaya, Takahiro; Igarashi, Yutaka; Nakae, Ryuta; Onda, Hidetaka; Masuno, Tomohiko; Fuse, Akira; Yokota, Hiroyuki] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan; [Suda, Satoshi; Sowa, Kota; Nakajima, Masataka] Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Tokyo, Japan; [Spurlock, Markus S.; Chieng, Lee Onn; Gajavelli, Shyam; Bullock, M. Ross] Univ Miami, Sch Med, Dept Neurosurg, Miami, FL USA; [Hazel, Tom G.; Johe, Karl] Neuralstem Inc, Germantown, MD USA		Yokobori, S (corresponding author), Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan.	shoji@nms.ac.jp	a, e c°/AAN-2574-2021; Gajavelli, Shyam/AAI-1374-2019	Gajavelli, Shyam/0000-0002-5947-6973	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [16K15768]	The studies were supported by a Grant-in-Aid for challenging Exploratory Research of Japan Society for the Promotion of Science (Grant No: 16K15768).	Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Di X, 1996, J NEUROSURG, V85, P655, DOI 10.3171/jns.1996.85.4.0655; Feldman EL, 2014, ANN NEUROL, V75, P363, DOI 10.1002/ana.24113; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Giusto E, 2014, EXP NEUROL, V260, P19, DOI 10.1016/j.expneurol.2013.03.009; Houkin K, 2018, STROKE, V49, pE145, DOI 10.1161/STROKEAHA.117.019216; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Inoue T, 2018, NEUROL RES, V40, P18, DOI 10.1080/01616412.2017.1382801; Kim C, 2018, MOL NEUROBIOL, V55, P4870, DOI 10.1007/s12035-017-0683-3; Kobeissy F, 2015, BRAIN NEUROTRAUMA MO; KURODA Y, 1992, NEUROSURGERY, V30, P687; Kwon TH, 2003, J NEUROTRAUM, V20, P337, DOI 10.1089/089771503765172291; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Lin GQ, 2018, NEUROSCI LETT, V674, P11, DOI 10.1016/j.neulet.2018.02.064; Liu WC, 2017, J NEUROSURG, V127, P8, DOI 10.3171/2016.4.JNS152909; Mar J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-46; Pritchett K, 2003, CONT TOPICS LAB ANIM; Spurlock MS, 2017, J NEUROTRAUM, V34, P1981, DOI 10.1089/neu.2016.4602; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; WATZMAN N, 1964, J PHARM SCI, V53, P1429, DOI 10.1002/jps.2600531142; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yokobori S, 2018, BEHAV BRAIN RES, V340, P23, DOI 10.1016/j.bbr.2016.05.055; Yokobori S, 2016, METHODS MOL BIOL, V1462, P413, DOI 10.1007/978-1-4939-3816-2_23; Yokobori S, 2016, WORLD NEUROSURG, V86, P127, DOI 10.1016/j.wneu.2015.09.105; Yokobori S, 2011, THER HYPOTHERMIA TEM, V1, P185, DOI 10.1089/ther.2011.0012; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725	33	4	4	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 12	2019	10								82	10.3389/fneur.2019.00082			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL3GF	WOS:000458600200001	30809187	Green Published, gold			2022-02-06	
J	Carabenciov, ID; Bureau, BL; Cutrer, M; Savica, R				Carabenciov, Ivan D.; Bureau, Britta L.; Cutrer, Michael; Savica, Rodolfo			Amantadine Use for Postconcussion Syndrome	MAYO CLINIC PROCEEDINGS			English	Article								The development of postconcussion syndrome after traumatic brain injury can result in a wide range of potentially debilitating symptoms that includes headaches, cognitive dysfunction, and mood disorders. Unfortunately, data on helpful medications are quite limited, particularly on the treatment of persistent headaches attributed to trauma. This retrospective medical record review used data collected from patients with a diagnosis of postconcussion syndrome in Mayo Clinic's Neurology and Physical Medicine and Rehabilitation outpatient clinics to evaluate the response of postconcussive symptoms to amantadine. A complete trial of amantadine was defined as 100 mg twice per day for 2 months. Thirty-three patients were prescribed amantadine for postconcussive syndrome after traumatic brain injury. One-third of patients discontinued the medication because of adverse effects. However, posttraumatic headaches were improved in 80% of patients who completed a full trial of amantadine. Surprisingly, patients had improvement in headaches even if the medication was prescribed years after the initial trauma. Little improvement was noted in other symptoms such as poor memory, dizziness, and personality changes. Although additional research is certainly needed, amantadine may be a reasonable medication to consider for the treatment of persistent headaches attributed to trauma, even if the initial injury is remote. (C) 2018 Mayo Foundation for Medical Education and Research.	[Carabenciov, Ivan D.; Bureau, Britta L.; Cutrer, Michael; Savica, Rodolfo] Mayo Clin, Dept Neurol, 200 First St SW, Rochester, MN 55905 USA		Savica, R (corresponding author), Mayo Clin, Dept Neurol, 200 First St SW, Rochester, MN 55905 USA.	savica.rodolfo@mayo.edu					Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7	3	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0025-6196	1942-5546		MAYO CLIN PROC	Mayo Clin. Proc.	FEB	2019	94	2					275	277		10.1016/j.mayocp.2018.10.021			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HJ5FB	WOS:000457202800017	30711125				2022-02-06	
J	Cohen-Zimerman, S; Kachian, ZR; Krueger, F; Gordon, B; Grafman, J				Cohen-Zimerman, Shira; Kachian, Zachary R.; Krueger, Frank; Gordon, Barry; Grafman, Jordan			Childhood socioeconomic status predicts cognitive outcomes across adulthood following traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						Socioeconomic status; Traumatic brain injury; Intelligence; Longitudinal study	RECOVERY; POSITION; HOLLINGSHEAD; INTELLIGENCE; DECLINE; VOLUME	Objective: To examine the association between childhood socioeconomic status (SES) and the level and rate of change in intelligence scores throughout adulthood following traumatic brain injury (TBI). Methods: In this longitudinal study we tested 186 patients with TBI and 54 healthy controls from the Vietnam Head Injury Study. Childhood SES was determined for each participant based on parental educational attainment and occupational prestige. General intelligence was initially assessed pre-injury upon induction into the military, and again 15, 35 and 40+ years post-injury. We examined whether childhood SES, total brain volume loss and lesion laterality can predict post-injury intelligence scores and the rate of change in those scores between study phases. Results: For both participants with and without TBI, childhood SES accounted for a significant portion of the variance in intelligence scores pre-injury and in all three post-injury evaluations, however, it was not associated with the rate of cognitive change. Lastly, childhood SES predicted cognitive outcome among patients with left hemisphere damage better than it did for right hemisphere damage patients. Conclusions: These findings provide the first evidence indicating the persistent effects of childhood SES on intelligence scores later in adulthood following a TBI. Childhood SES should be considered when predicting and assessing cognitive recovery following TBI, even when the injury occurred in adulthood.	[Cohen-Zimerman, Shira; Kachian, Zachary R.; Grafman, Jordan] Shirley Ryan AbilityLab, Think Speak Lab, Cognit Neurosci Lab, Chicago, IL 60611 USA; [Krueger, Frank] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Krueger, Frank] Univ Mannheim, Dept Psychol, Mannheim, Germany; [Gordon, Barry] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gordon, Barry] Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Cohen-Zimerman, S (corresponding author), Shirley Ryan AbilityLab, Think Speak Lab, Cognit Neurosci Lab, Chicago, IL 60611 USA.	scohenzime@sralab.org; zkachian@gmail.com; jgrafman@northwestern.edu	Cohen-Zimerman, Shira/X-8330-2019	Cohen-Zimerman, Shira/0000-0001-6098-2550	National Naval Medical Center; Smart Family Foundation of New York; Julius N. Frankel Foundation; Therapeutic Cognitive Neuroscience Fund	The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the U.S. Department of the Navy, the U.S. Department of Defense, or the U.S. government. We thank the National Naval Medical Center for their support and provision of their facilities and the Smart Family Foundation of New York and the Julius N. Frankel Foundation for their financial support. SCZ, JG and BG were supported by the Therapeutic Cognitive Neuroscience Fund. We greatly appreciate the essential contributions made by the Vietnam veterans who enthusiastically agreed to participate in our studies. The authors report no competing financial interests.	[Anonymous], 2015, EC MOBILITY US; Bornstein MH, 2003, MON PARENT, P29; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; Cristofori I, 2015, NEUROLOGY, V84, P1394, DOI 10.1212/WNL.0000000000001446; Duncan GJ, 2003, MON PARENT, P83; Duncan GJ, 2012, WIRES COGN SCI, V3, P377, DOI 10.1002/wcs.1176; Ericsson M, 2017, P NATL ACAD SCI USA, V114, P7001, DOI 10.1073/pnas.1620603114; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Farah MJ, 2017, NEURON, V96, P56, DOI 10.1016/j.neuron.2017.08.034; Fors S, 2009, J GERONTOL B-PSYCHOL, V64, P750, DOI 10.1093/geronb/gbp029; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; GRAFMAN J, 1986, J NEUROSCI, V6, P301; Hackman DA, 2015, DEVELOPMENTAL SCI, V18, P686, DOI 10.1111/desc.12246; Herd P, 2007, J HEALTH SOC BEHAV, V48, P223, DOI 10.1177/002214650704800302; Hoff E, 2003, MON PARENT, P147; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Hollingshead A.A., 1975, UNPUB; Hudson CG, 2005, AM J ORTHOPSYCHIAT, V75, P3, DOI 10.1037/0002-9432.75.1.3; Kaplan GA, 2001, INT J EPIDEMIOL, V30, P256, DOI 10.1093/ije/30.2.256; Lawlor DA, 2006, PAEDIATR PERINAT EP, V20, P148, DOI 10.1111/j.1365-3016.2006.00704.x; Lawson GM, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12529; Lipina S., 2012, FRONT HUM NEUROSCI; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Packard CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-42; Ponders J., 2018, ARCH CLIN NEUROPSYCH; Raizada RDS, 2008, NEUROIMAGE, V40, P1392, DOI 10.1016/j.neuroimage.2008.01.021; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Schaie K. W., 1993, SEATTLE LONGITUDINAL; Semega J. L., 2017, INCOME POVERTY US 20; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; von Stumm S, 2015, INTELLIGENCE, V48, P30, DOI 10.1016/j.intell.2014.10.002	37	4	4	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	FEB	2019	124						1	8		10.1016/j.neuropsychologia.2019.01.001			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	HO5XQ	WOS:000461003000001	30611733				2022-02-06	
J	Cunha, DD; Camargos, S; Passos, VMD; Mello, CD; Vaz, LS; de Lima, LRS				Cunha, Denise de Aquino; Camargos, Sarah; de Azeredo Passos, Valeria Maria; Mello, Carla de Meirelles; Vaz, Luiz Sergio; Soares de Lima, Luciano Romero			Heterotopic Ossification After Stroke: Clinical Profile and Severity of Ossification	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Stroke; heterotopic ossification; risk factors; correlation; prevalence	SPINAL-CORD-INJURY; MINI-MENTAL-STATE; TRAUMATIC BRAIN-INJURY; RISK-FACTORS; MEDICAL COMPLICATIONS; BONE; RELIABILITY; SPASTICITY	Background and purpose: The aim of this study was to evaluate heterotopic ossification (HO) prevalence after stroke, describing clinical features and investigating predictors of HO and its severity. Methods: A cross-sectional study was carried out in 7 rehabilitation centers (Sarah Network) from 2004 to 2013. Results: Among 17,794 stroke cases, 235 patients (1.3%) presented clinical and radiological evidence of HO. A log-binomial model with robust variance estimated the prevalence ratio of 1.3% in 10 years. A multinomial logistic regression was performed to investigate the predictors of HO and its severity. The presence of hemorrhagic stroke (prevalence ratio [PRI = 4.75; 95% confidence interval [CI] PR = 3.38; 6.68) and ischemic stroke with hemorrhagic transformation (PR = 3.08; 95% CI PR = 1.63; 5.81), male sex (PR = 1.60; 95% CI PR = 1.16; 2.22), spasticity (PR = 13.78; 95% CI PR = 8.59; 22.10), and cognitive impairment (PR = 1.88; 95% CI PR = 1.36; 2.60) were independently associated with HO. Patients with HO were younger (P < .0001) and presented a shorter time of disease (P = .013). Young adult patients were more likely to develop severe HO (odds ratio = 2.80, 95% CI 1.09; 7.20) than were elderly patients. Severe HO was also related to heavy alcohol consumption (2.45; 1.03-5.84) and involved 2 or more joints (5.34; 1.85-15.36). There was an association with use of invasive ventilation (6.30; 2.13-18.63) at the acute stroke phase and patients were dependent on activities of daily living after stroke (3.90; 1.00-15.19). Conclusions: Despite the small prevalence of HO after stroke, this 10-year multicenter study was able to identify several associated factors related to the management and severity of stroke as well as the hemorrhagic subtype.	[Cunha, Denise de Aquino; Camargos, Sarah; de Azeredo Passos, Valeria Maria] Univ Fed Minas Gerais, Fac Med, Adult Hlth Sci Post Grad Program, Ave Prof Alfredo Balena 190,Sala 149, BR-30130100 Belo Horizonte, MG, Brazil; [Cunha, Denise de Aquino; Mello, Carla de Meirelles; Vaz, Luiz Sergio; Soares de Lima, Luciano Romero] Sarah Network Rehabil Hosp, Belo Horizonte, MG, Brazil		Camargos, S (corresponding author), Univ Fed Minas Gerais, Fac Med, Adult Hlth Sci Post Grad Program, Ave Prof Alfredo Balena 190,Sala 149, BR-30130100 Belo Horizonte, MG, Brazil.	sarahcamargos@hotmail.com	Passos, Valeria/AAJ-2761-2021; CAMARGOS, SARAH/Y-4071-2019	CAMARGOS, SARAH/0000-0001-9829-6783			Almeida OP, 1998, ARQ NEURO-PSIQUIAT, V56, P605, DOI 10.1590/S0004-282X1998000400014; Atalaia-Silva Kelly Cristina, 2008, Rev. Saúde Pública, V42, P930, DOI 10.1590/S0034-89102008000500020; BERROL S, 1987, ARCH PHYS MED REHAB, V68, P746; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Chiu D, 2010, J STROKE CEREBROVASC, V19, P225, DOI 10.1016/j.jstrokecerebrovasdis.2009.06.002; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Citak M, 2016, SPINAL CORD, V54, P303, DOI 10.1038/sc.2015.182; Citak M, 2012, SPINE, V37, P1953, DOI 10.1097/BRS.0b013e31825ee81b; Coelho CVC, 2009, ARQ NEURO-PSIQUIAT, V67, P382, DOI 10.1590/S0004-282X2009000300002; da Paz AC, 2007, MED HYPOTHESES, V68, P67, DOI 10.1016/j.mehy.2006.06.035; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Genet F, 2015, BRAIN INJURY, V29, P866, DOI 10.3109/02699052.2015.1005133; Gurcay E, 2013, BRAIN INJURY, V27, P1727, DOI 10.3109/02699052.2013.831123; Haas BM, 1996, SPINAL CORD, V34, P560, DOI 10.1038/sc.1996.100; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Leung AWS, 2010, NEUROREHABILITATION, V27, P351, DOI 10.3233/NRE-2010-0619; Lipson DM, 2005, INT J REHABIL RES, V28, P303, DOI 10.1097/00004356-200512000-00002; MAJOR P, 1980, RADIOLOGY, V136, P797, DOI 10.1148/radiology.136.3.6773108; NITRINI R, 1994, ARQ NEURO-PSIQUIAT, V52, P457, DOI 10.1590/S0004-282X1994000400001; Nitrini R, 2004, J INT NEUROPSYCH SOC, V10, P634, DOI 10.1017/S1355617704104062; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Pek CH, 2014, SINGAP MED J, V55, pE119, DOI 10.11622/smedj.2014107; RIGGS BL, 1981, J CLIN INVEST, V67, P328, DOI 10.1172/JCI110039; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Shulman KI., 1986, INT J GERIATR PSYCH, V1, P135, DOI [10.1002/gps.930010209, DOI 10.1002/GPS.930010209]; Silver J R, 1969, Paraplegia, V7, P220; Smith EE, 2009, NEUROLOGY, V73, P709, DOI 10.1212/WNL.0b013e3181b59a6e; Stover SL, 1986, MANAGEMENT SPINAL CO, P284; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; Taly AB, 2001, NEUROL INDIA, V49, P37; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; VARGHESE G, 1991, ARCH PHYS MED REHAB, V72, P1009; VARGHESE G, 1992, PHYS MED REH CLIN N, V3, P407; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955; Zorowitz RD, 2013, NEUROLOGY, V80, pS45, DOI 10.1212/WNL.0b013e3182764c86	44	4	4	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2019	28	2					513	520		10.1016/j.jstrokecerebrovasdis.2018.10.032			8	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Cardiovascular System & Cardiology	HG0IX	WOS:000454628100044	30466894				2022-02-06	
J	Gouttebarge, V; Cowie, C; Goedhart, E; Kemp, SPT; Kerkhoffs, GMMJ; Patricios, J; Stokes, KA				Gouttebarge, Vincent; Cowie, Charlotte; Goedhart, Edwin; Kemp, Simon P. T.; Kerkhoffs, Gino M. M. J.; Patricios, Jon; Stokes, Keith A.			Educational concussion module for professional footballers: from systematic development to feasibility and effect	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article							INJURIES; KNOWLEDGE; PLAYERS	Objectives To describe: (1) how we developed a concussion module and (2) whether the concussion module is feasible (in terms of relevance, added value and suitability) and enhances knowledge and changes attitude of professional footballers about concussion. Developing the concussion module We developed the concussion module based on two structured and systematic processes. First, our needs assessment (questionnaire and interviews) in professional football (especially players) revealed that a 5-10 min concussion module was needed, ideally disseminated during club visits. Second, the objectives were defined (from published literature and by experts) as to disseminate essential information about what concussion is (definition), how to recognise it and the importance of removing a player with (suspected) concussion from the football field. We included an introductory video featuring a high-profile professional footballer and an animated educational component on defining concussion, recognising it and removing affected players from the field. Feasibility and effect A quasiexperimental study (pretest post-test design) was conducted among 61 professional footballers. These players were asked to complete two questionnaires related to knowledge about and attitude towards concussion and feasibility of the module: one before and one after viewing the concussion module. Potential increase in knowledge and attitude was explored by comparing the pretest and post-test scores of the Rosenbaum Concussion Knowledge and AttitudesSurvey with the non-parametric Wilcoxon signedrank test (p<0.05). The mean knowledge score of the participants was stable between tests (Z=213; p=0.16), while mean attitude score increased significantly (Z=331; p=0.01). Nearly all participants (85%-100%) were positive about the relevance, added value, duration and form of the concussion module. Conclusion The developed educational concussion module leads to better attitude of professional footballers towards concussion.	[Gouttebarge, Vincent] World Players Union FIFPro, Hoofddorp, Netherlands; [Gouttebarge, Vincent; Kerkhoffs, Gino M. M. J.] Univ Amsterdam, Dept Orthopaed Surg, Amsterdam UMC, Amsterdam Movement Sci, Meibergdreef 9, Amsterdam, Netherlands; [Gouttebarge, Vincent; Kerkhoffs, Gino M. M. J.] AMC VUmc IOC Res Ctr, Amsterdam Collaborat Hlth & Safety Sports ACHSS, Amsterdam, Netherlands; [Gouttebarge, Vincent] Univ Cape Town, Div Exercise Sci & Sports Med, Cape Town, South Africa; [Cowie, Charlotte] Football Assoc, London, England; [Goedhart, Edwin] Royal Netherlands Football Assoc KNVB, FIFA Med Ctr Excellence, Zeist, Netherlands; [Kemp, Simon P. T.; Stokes, Keith A.] Rugby Football Union, Twickenham, England; [Patricios, Jon] Univ Witwatersrand, Sch Therapeut Sci, Fac Hlth Sci, Johannesburg, South Africa; [Stokes, Keith A.] Univ Bath, Dept Hlth, Bath, Avon, England		Gouttebarge, V (corresponding author), World Players Union FIFPro, Hoofddorp, Netherlands.; Gouttebarge, V (corresponding author), Univ Amsterdam, Dept Orthopaed Surg, Amsterdam UMC, Amsterdam Movement Sci, Meibergdreef 9, Amsterdam, Netherlands.; Gouttebarge, V (corresponding author), AMC VUmc IOC Res Ctr, Amsterdam Collaborat Hlth & Safety Sports ACHSS, Amsterdam, Netherlands.; Gouttebarge, V (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, Cape Town, South Africa.	v.gouttebarge@amc.uva.nl	; Stokes, Keith/C-2605-2009	Kemp, Simon/0000-0002-3250-2713; Stokes, Keith/0000-0002-5049-2838			Bandholm T, 2018, BRIT J SPORT MED, V52, P1407, DOI 10.1136/bjsports-2018-099714; Bartholomew LK, 1998, HEALTH EDUC BEHAV, V25, P545, DOI 10.1177/109019819802500502; Bartholomew LK, 2001, INTERVENTION MAPPING; BOUTER LM, 2018, TXB EPIDEMIOLOGY; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Cross MF, 2017, ESSAYS FR LIT CULT, P11; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Lystad RP, 2018, INJ EPIDEMIOL, V5; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Verhagen E, 2014, BRIT J SPORT MED, V48, P698, DOI 10.1136/bjsports-2013-092241; Walden M, 2013, SCAND J MED SCI SPOR, V23, P424, DOI 10.1111/j.1600-0838.2011.01409.x; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; Woodward M., 2014, EPIDEMIOLOGY STUDY D	20	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	FEB	2019	5	1							e000490	10.1136/bmjsem-2018-000490			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PC2AQ	WOS:000596810500022	30899550	gold, Green Published			2022-02-06	
J	Kilic, O; Hopley, P; Kerkhoffs, GMMJ; Lambert, M; Verhagen, E; Viljoen, W; Wylleman, P; Gouttebarge, V				Kilic, Ozgur; Hopley, Phil; Kerkhoffs, Gino M. M. J.; Lambert, Mike; Verhagen, Evert; Viljoen, Wayne; Wylleman, Paul; Gouttebarge, Vincent			Impact of concussion and severe musculoskeletal injuries on the onset of mental health symptoms in male professional rugby players: a 12-month study	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article							CONSENSUS STATEMENT; PROSPECTIVE COHORT; SLEEP DISTURBANCE; FOOTBALL SOCCER; ALCOHOL-USE; FOLLOW-UP; DISORDERS; UNION; POPULATION; PREVALENCE	Objective This study explored the association between concussion or musculoskeletal injuries, and the onset of mental health symptoms (MHS) in male professional rugby players over a 12-month period. Methods Observational prospective cohort study with three measurements over a follow-up period of 12 months. At baseline, 573 participants provided informed consent. A total of 327 male professional rugby players (62% forwards, 38% backs) completed all follow-up assessments at baseline, 6 months and 12 months. The mean (+/- SD) age, height and weight of the participants at baseline was 25.9 (+/- 4.4) years, 184.9 (+/- 8.7) cm and 101.5 (+/- 14.6) kg, respectively. Number of musculoskeletal injuries and number of confirmed concussions were assessed through single questions. Symptoms of distress, anxiety/depression, sleep disturbance, adverse alcohol use and eating disorders were assessed using validated questionnaires. Results Professional rugby players who sustained a concussion within 12 months of baseline were more likely to develop MHS with ORs ranging from 1.5 (95% CI 1.0 to 2.1) for distress to 2.0 (1.2 to 3.6) for adverse alcohol use. Players who sustained a severe injury within 12 months of baseline were more likely to develop symptoms anxiety/depression with an OR of 1.5 (1.1 to 2.0). There was no significant association in both groups for other MHS. Conclusions Rugby players who sustained concussion or severe injuries are up to two times more likely to develop symptoms of distress, adverse alcohol use or anxiety/depression.	[Kilic, Ozgur; Kerkhoffs, Gino M. M. J.; Gouttebarge, Vincent] Univ Amsterdam, Amsterdam UMC, Amsterdam Movement Sci, Dept Orthopaed Surg, Meibergdreef 9, Amsterdam, Noord Holland, Netherlands; [Kilic, Ozgur; Kerkhoffs, Gino M. M. J.; Verhagen, Evert; Gouttebarge, Vincent] Amsterdam UMC, IOC Res Ctr Excellence, Amsterdam Collaborat Hlth & Safety Sports ACHSS, Amsterdam, Netherlands; [Hopley, Phil] Cognacity, London, England; [Hopley, Phil] Inst Sport & Exercise Hlth, London, England; [Hopley, Phil] UCL, Div Surg, London, England; [Kerkhoffs, Gino M. M. J.; Gouttebarge, Vincent] Amsterdam Movement Sci, Acad Ctr Evidence Based Sports Med ACES, Amsterdam, Netherlands; [Lambert, Mike; Verhagen, Evert; Viljoen, Wayne; Gouttebarge, Vincent] Univ Cape Town, Div Exercise Sci & Sports Med, Cape Town, South Africa; [Verhagen, Evert] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam Movement Sci, Dept Publ & Occupat Hlth, Boelelaan 1117, Amsterdam, Netherlands; [Viljoen, Wayne] South African Rugby Union SARU, Cape Town, South Africa; [Wylleman, Paul] Vrije Univ Brussel, Brussels, Belgium		Gouttebarge, V (corresponding author), Univ Amsterdam, Amsterdam UMC, Amsterdam Movement Sci, Dept Orthopaed Surg, Meibergdreef 9, Amsterdam, Noord Holland, Netherlands.; Gouttebarge, V (corresponding author), Amsterdam UMC, IOC Res Ctr Excellence, Amsterdam Collaborat Hlth & Safety Sports ACHSS, Amsterdam, Netherlands.; Gouttebarge, V (corresponding author), Amsterdam Movement Sci, Acad Ctr Evidence Based Sports Med ACES, Amsterdam, Netherlands.; Gouttebarge, V (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, Cape Town, South Africa.	v.gouttebarge@amsterdamumc.nl	Verhagen, Evert/A-1502-2013	Verhagen, Evert/0000-0001-9227-8234	World Rugby	This research was partly funded by World Rugby.	Braam C, 2009, J OCCUP REHABIL, V19, P231, DOI 10.1007/s10926-009-9178-z; Brown JC, 2017, INT J SPORTS MED, V38, P582, DOI 10.1055/s-0043-103959; Bultmann U, 2002, J PSYCHOSOM RES, V52, P445, DOI 10.1016/S0022-3999(01)00228-8; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Cotton MA, 2003, J GEN INTERN MED, V18, P53, DOI 10.1046/j.1525-1497.2003.20374.x; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Du Preez EJ, 2017, CLIN J SPORT MED, V27, P530, DOI 10.1097/JSM.0000000000000411; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gouttebarge V, 2018, EUR J SPORT SCI, V18, P1004, DOI 10.1080/17461391.2018.1466914; Gouttebarge V, 2017, INT J SPORTS MED, V38, P864, DOI 10.1055/s-0043-114010; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P252, DOI 10.1080/00913847.2017.1338497; Gouttebarge V, 2017, CLIN J SPORT MED, V27, P487, DOI 10.1097/JSM.0000000000000388; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P11, DOI 10.1080/00913847.2017.1248796; Gouttebarge V, 2016, KNEE SURG SPORT TR A, V24, P3934, DOI 10.1007/s00167-015-3729-y; Gouttebarge V, 2016, EUR J SPORT SCI, V16, P595, DOI 10.1080/17461391.2015.1086819; Gouttebarge V, 2015, J SPORT SCI MED, V14, P811; Hainline B, 2019, BRIT J SPORT MED, V53, DOI 10.1136/bjsports-2019-100681; Ivarsson A, 2013, J SPORT REHABIL, V22, P19, DOI 10.1123/jsr.22.1.19; Kilic O, 2018, KNEE SURG SPORT TR A, V26, P946, DOI 10.1007/s00167-017-4644-1; Kilic O, 2017, EUR J SPORT SCI, V17, P1328, DOI 10.1080/17461391.2017.1381768; Korten A, 2000, BRIT J PSYCHIAT, V177, P325, DOI 10.1192/bjp.177.4.325; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Lynge Inge, 2004, Int J Circumpolar Health, V63 Suppl 2, P377; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; Reardon CL, 2019, BRIT J SPORT MED, V53, P667, DOI 10.1136/bjsports-2019-100715; Salama-Younes M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-22; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Terluin B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-34; Verhaak PFM, 2005, BRIT J GEN PRACT, V55, P770; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Whitehouse T, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116634075; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; Woodward M., 2014, EPIDEMIOLOGY STUDY D; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266	39	4	4	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	FEB	2019	5	1							e000693	10.1136/bmjsem-2019-000693			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PC2AQ	WOS:000596810500120	31908840	Green Published, gold			2022-02-06	
J	Kongebro, EK; Jorgensen, LN; Siersma, VD; Meyhoff, CS				Kongebro, Emilie Katrine; Jorgensen, Lars N.; Siersma, Volkert D.; Meyhoff, Christian Sahlholt			Association between perioperative hyperoxia and cerebrovascular complications after laparotomy-A post-hoc follow-up study	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						cerebrovascular events; hyperoxia; laparotomy; oxygen inhalation therapy; perioperative; surgical procedures	INSPIRATORY OXYGEN FRACTION; TRAUMATIC BRAIN-INJURY; LONG-TERM MORTALITY; ABDOMINAL-SURGERY; SUPPLEMENTAL OXYGEN; BLOOD-FLOW; STROKE; REGRESSION	Background Perioperative hyperoxia has been linked to increased long-term mortality. Vasoconstrictive and cellular side effects to hyperoxia have been suggested to increase the risk of coronary and cerebral ischemia. The aim of this post-hoc analysis of a large randomized trial was to compare the effects of 80% vs 30% perioperative oxygen on the long-term risk of stroke or transient cerebral ischemia (TCI) in patients undergoing abdominal surgery. Methods A total of 1386 patients were randomized to 80% or 30% perioperative oxygen during acute or elective open abdominal surgery. Median follow-up was 3.9 years. Primary outcome was a composite of the long-term occurrence of stroke or TCI. Secondary outcomes included long-term mortality without stroke or TCI, and incidences of neurological admission, psychiatric admission, and dementia. Outcomes were analyzed in Cox regression models. Results Stroke or TCI occurred in 20 (3.0%) patients given 80% oxygen vs 22 (3.2%) patients given 30% oxygen with an adjusted hazard ratio (HR) of 0.96 [95% CI 0.52-1.76]. Composite secondary outcome of death, stroke, or TCI had a HR of 1.21 [95% CI 1.00-1.47] for 80% compared to 30% oxygen. HRs for secondary outcomes were HR 1.14 [95% CI 0.79-1.64] for neurological admission, 1.34 [95% CI 0.95-1.88] for psychiatric admission and 0.54 [95% CI 0.16-1.80] for dementia. Conclusion Stroke or TCI did not seem related to perioperative inspiratory oxygen fraction. Due to few events, this study cannot exclude that perioperative hyperoxia increases risk of mortality, stroke, or TCI after abdominal surgery.	[Kongebro, Emilie Katrine; Meyhoff, Christian Sahlholt] Univ Copenhagen, Dept Anaesthesia & Intens Care, Bispebjerg & Frederiksberg Hosp, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark; [Jorgensen, Lars N.] Univ Copenhagen, Digest Dis Ctr, Bispebjerg & Frederiksberg Hosp, Copenhagen, Denmark; [Siersma, Volkert D.] Univ Copenhagen, Res Unit Gen Practice, Copenhagen, Denmark; [Siersma, Volkert D.] Univ Copenhagen, Sect Gen Practice, Dept Publ Hlth, Copenhagen, Denmark		Meyhoff, CS (corresponding author), Univ Copenhagen, Dept Anaesthesia & Intens Care, Bispebjerg & Frederiksberg Hosp, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.	christianmeyhoff@gmail.com	Meyhoff, Christian S./B-4777-2009; Siersma, Volkert/G-6867-2016	Meyhoff, Christian S./0000-0002-4885-4609; Siersma, Volkert/0000-0003-1941-2681; Jorgensen, Lars N/0000-0001-7465-5374			Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Fonnes S, 2016, INT J CARDIOL, V215, P238, DOI 10.1016/j.ijcard.2016.04.104; Habre W, 2014, BRIT J ANAESTH, V113, P26, DOI 10.1093/bja/aeu380; Hafner S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0084-6; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0996-4; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Jeon SB, 2014, J NEUROL NEUROSUR PS, V85, P1301, DOI 10.1136/jnnp-2013-307314; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Lumb Andrew B, 2012, Anesthesiol Clin, V30, P591, DOI 10.1016/j.anclin.2012.07.009; Meyhoff CS, 2014, BRIT J ANAESTH, V113, P74, DOI 10.1093/bja/aeu110; Meyhoff CS, 2012, ANESTH ANALG, V115, P849, DOI 10.1213/ANE.0b013e3182652a51; Meyhoff CS, 2009, JAMA-J AM MED ASSOC, V302, P1543, DOI 10.1001/jama.2009.1452; Meyhoff CS, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-58; Mrkobrada M, 2016, BRIT J ANAESTH, V117, P191, DOI 10.1093/bja/aew179; Narotam PK, 2014, J NEUROTRAUM, V31, P630, DOI 10.1089/neu.2013.3104; O'Driscoll BR, 2017, THORAX, V72, DOI 10.1136/thoraxjnl-2016-209729; Podolyak A, 2016, ANESTH ANALG, V122, P1907, DOI 10.1213/ANE.0000000000001316; Rincon F, 2014, CRIT CARE MED, V42, P387, DOI 10.1097/CCM.0b013e3182a27732; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Roffe C, 2017, JAMA-J AM MED ASSOC, V318, P1125, DOI 10.1001/jama.2017.11463; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rousseau A, 2005, ACTA PHYSIOL SCAND, V183, P231, DOI 10.1111/j.1365-201X.2005.01405.x; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sjoberg F, 2013, J INTERN MED, V274, P505, DOI 10.1111/joim.12139; Thomson AJ, 1985, J APPL PHYSIOL, V2006, P809; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x	30	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	FEB	2019	63	2					164	170		10.1111/aas.13235			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	HG2SP	WOS:000454814700004	30066392				2022-02-06	
J	Kuchler, J; Tronnier, F; Smith, E; Gliemroth, J; Tronnier, VM; Ditz, C				Kuechler, Jan; Tronnier, Franziska; Smith, Emma; Gliemroth, Jan; Tronnier, Volker M.; Ditz, Claudia			The Impact of Intrahospital Transports on Brain Tissue Metabolism in Patients with Acute Brain Injury	NEUROCRITICAL CARE			English	Article						Acute brain injury; Intrahospital transport; Neuromonitoring; Cerebral microdialysis	CRITICALLY-ILL PATIENTS; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; COMPUTED-TOMOGRAPHY; SECONDARY INSULTS; CEREBRAL METABOLISM; ADVERSE EVENTS; MICRODIALYSIS; SAFETY; CHEMISTRY	BackgroundPatients with severe acute brain injury (ABI) often require intrahospital transports (IHTs) for repeated computed tomography (CT) scans. IHTs are associated with serious adverse events (AE) that might pose a risk for secondary brain injury. The goal of this study was to assess IHT-related alterations of cerebral metabolism in ABI patients.MethodsWe included mechanically ventilated patients with ABI who had continuous multimodality neuromonitoring during an 8-h period before and after routine IHT. Intracranial pressure (ICP), cerebral perfusion pressure (CPP), brain tissue oxygenation (PtiO(2)) as well as cerebral and subcutaneous microdialysis parameters (lactate, pyruvate, glycerol, and glutamate) were recorded. Values were compared between an 8-h period before (pre-IHT) and after (post-IHT) the IHT.ResultsA total of 23 IHT for head CT scans in 18 patients were analyzed. Traumatic brain injury (n=7) was the leading cause of ABI, followed by subarachnoid hemorrhage (n=6) and intracerebral hemorrhage (n=5). The analyzed microdialysis parameters in the brain tissue as in the subcutaneous tissue did not show significant changes between the pre-IHT and post-IHT period. In addition, we observed no significant increase in ICP or decrease in CPP and PtiO(2) in the 8-h period after IHT.ConclusionsWhile the occurrence of AE during IHT is a known risk factor for ABI patients, our results demonstrate that IHTs do not alter the brain tissue chemistry in a significant manner. This fact may help assess the risk for routine IHT more accurately.	[Kuechler, Jan; Tronnier, Franziska; Smith, Emma; Gliemroth, Jan; Tronnier, Volker M.; Ditz, Claudia] Univ Lubeck, Dept Neurosurg, Ratzeburger Allee 160, D-23538 Lubeck, Germany		Kuchler, J (corresponding author), Univ Lubeck, Dept Neurosurg, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	jan.kuechler@uksh.de					Adamides AA, 2009, J AM COLL SURGEONS, V209, P531, DOI 10.1016/j.jamcollsurg.2009.05.028; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bergman LM, 2017, CRIT CARE MED, V45, pE1043, DOI 10.1097/CCM.0000000000002653; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brunsveld-Reinders AH, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0938-1; Chaikittisilpa N, 2017, NEUROCRIT CARE, V26, P196, DOI 10.1007/s12028-016-0308-0; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Donovan AL, 2018, CRIT CARE MED, V46, P980, DOI 10.1097/CCM.0000000000003067; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Evans A, 1995, Am J Crit Care, V4, P106; Fanara B, 2010, CRIT CARE, V14, DOI 10.1186/cc9018; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; John S, 2016, J NEUROIMAGING, V26, P5, DOI 10.1111/jon.12319; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kerwin AJ, 2000, J TRAUMA, V48, P878, DOI 10.1097/00005373-200005000-00011; Kleffmann J, 2016, NEUROCRIT CARE, V25, P440, DOI 10.1007/s12028-016-0274-6; Kuchler J, 2017, CLIN NEUROL NEUROSUR, V159, P1, DOI 10.1016/j.clineuro.2017.05.010; Martin M, 2017, NEUROCRIT CARE, V26, P87, DOI 10.1007/s12028-016-0291-5; Nagel A, 2009, J NEUROSURG, V111, P94, DOI 10.3171/2009.1.JNS08587; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; Parmentier-Decrucq E, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-10; Gimenez FMP, 2017, CRIT CARE RES PRACT, V2017, DOI 10.1155/2017/6847124; Reinprecht A, 2003, CRIT CARE MED, V31, P1831, DOI 10.1097/01.CCM.0000063453.93855.0A; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Schwebel C, 2013, CRIT CARE MED, V41, P1919, DOI 10.1097/CCM.0b013e31828a3bbd; Tasneem N, 2017, CRIT CARE RES PRACT, V2017, DOI 10.1155/2017/6097265; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Trofimov A, 2016, ACTA NEUROCHIR SUPPL, V122, P125, DOI 10.1007/978-3-319-22533-3_25; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A	38	4	4	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2019	30	1					216	223		10.1007/s12028-018-0604-y			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HJ8LA	WOS:000457449700026	30203385	Bronze			2022-02-06	
J	Kullberg-Turtiainen, M; Vuorela, K; Huttula, L; Turtiainen, P; Koskinen, S				Kullberg-Turtiainen, Marjo; Vuorela, Kaisa; Huttula, Lilli; Turtiainen, Petri; Koskinen, Sanna			Individualized goal directed dance rehabilitation in chronic state of severe traumatic brain injury: A case study	HELIYON			English	Article						Neurology; Rehabilitation	DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; 3-DIMENSIONAL COMPONENTS; INTRINSIC CONNECTIVITY; COGNITIVE IMPAIRMENT; HIPPOCAMPAL; PLASTICITY; ATTENTION; MEMORY; SELFHOOD	Few long-term studies report late outcomes after severe traumatic brain injury. New rehabilitation techniques are needed for this heterogenous patient group. We present a dance intervention six and half years after an extreme severe TBI including excessive diffuse axonal injury, which disconnects the brain networks. Given the fact, that efficient brain function depends on the integrated operation of large-scale brain networks like default mode network (DMN), we created an intervention with multisensory and multimodal approach and goal-directed behavior. The intervention lasted four months including weekly one-hour dance lessons with the help of a physiotherapist and dance teacher. The measures included functional independence measure (FIM), repeated electroencephalogram (EEG) analysis of three subnets of DMN and clinical evaluations and observations. The results showed clear improvement after the intervention, and FIM stayed in elevated level during several years after the intervention. We present suggestion for further studies using larger patient groups.	[Kullberg-Turtiainen, Marjo] Univ Helsinki, EazyeM Ltd, Helsinki, Finland; [Vuorela, Kaisa] Univ Helsinki, Tmi Kaisa Vuorela, Helsinki, Finland; [Huttula, Lilli] Univ Helsinki, Helsinki, Finland; [Turtiainen, Petri] EazyeM Ltd, Helsinki, Finland; [Koskinen, Sanna] Univ Helsinki, Dept Psychol & Logoped, Fac Med, Helsinki, Finland		Kullberg-Turtiainen, M (corresponding author), Univ Helsinki, EazyeM Ltd, Helsinki, Finland.	marjo.kullberg-turtiainen@helsinki.fi		Koskinen, Sanna/0000-0002-3453-5084			Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Beaty RE, 2015, NEUROSCI BIOBEHAV R, V51, P108, DOI 10.1016/j.neubiorev.2015.01.004; Beaty RE, 2014, NEUROPSYCHOLOGIA, V64, P92, DOI 10.1016/j.neuropsychologia.2014.09.019; Blasing B, 2012, ACTA PSYCHOL, V139, P300, DOI 10.1016/j.actpsy.2011.12.005; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bradt J, 2010, COCHRANE DB SYST REV, V7, P1; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Caravasso CF, 2016, J NEUROTRAUM, V33, P1247, DOI 10.1089/neu.2015.4003; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Elvers P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00002; Ermutlu N, 2015, COGN NEURODYNAMICS, V9, P257, DOI 10.1007/s11571-014-9320-2; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fauvel B, 2014, NEUROIMAGE, V90, P179, DOI 10.1016/j.neuroimage.2013.12.065; Fingelkurts Alexander A, 2016, Open Neuroimag J, V10, P41, DOI 10.2174/1874440001610010041; Fingelkurts AA, 2017, CLIN EEG NEUROSCI, V48, P327, DOI 10.1177/1550059417696180; Fingelkurts AA, 2017, NEUROPSYCHOLOGIA, V99, P30, DOI 10.1016/j.neuropsychologia.2017.02.020; Fingelkurts AA, 2016, SELF IDENTITY, V15, P381, DOI 10.1080/15298868.2015.1136351; Fingelkurts Andrew A, 2012, Open Neuroimag J, V6, P55, DOI 10.2174/1874440001206010055; Fingelkurts AA, 2011, BRAIN COGNITION, V75, P79, DOI 10.1016/j.bandc.2010.11.015; Fingelkurts AA, 2009, NEW MATH NAT COMPUT, V5, P221, DOI 10.1142/S1793005709001258; Fink A, 2009, NEUROIMAGE, V46, P854, DOI 10.1016/j.neuroimage.2009.02.036; Garza-Villarreal EA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01051; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Ham TE, 2013, CEREB CORTEX, V23, P703, DOI 10.1093/cercor/bhs056; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Homann KB, 2010, AM J DANCE THER, V32, P80, DOI 10.1007/s10465-010-9099-6; Hufner K, 2011, HIPPOCAMPUS, V21, P855, DOI 10.1002/hipo.20801; Jola C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033343; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kay BP, 2012, BRAIN RES, V1447, P53, DOI 10.1016/j.brainres.2012.01.064; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Konoike N, 2012, NEUROIMAGE, V63, P328, DOI 10.1016/j.neuroimage.2012.07.002; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Lu JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep11775; Luo C, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/180138; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Magee WL, 2017, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858; Michaelis K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00252; Munzert J, 2008, EXP BRAIN RES, V188, P437, DOI 10.1007/s00221-008-1376-y; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Phillips-Silver J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00026; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Sato K, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/274919; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sepulcre J, 2014, NEUROSCIENTIST, V20, P499, DOI 10.1177/1073858414531657; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sihvonen AJ, 2017, LANCET NEUROL, V16, P648, DOI 10.1016/S1474-4422(17)30168-0; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Thomas JP, 2010, J VISION, V10, DOI 10.1167/10.12.14; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	70	4	4	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	FEB	2019	5	2							e01184	10.1016/j.heliyon.2019.e01184			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN3KM	WOS:000460082200015	30805564	Green Published, gold			2022-02-06	
J	Landless, BM; Walker, MS; Kaimal, G				Landless, Bronwen M.; Walker, Melissa S.; Kaimal, Girija			Using human and computer-based text analysis of clinical notes to understand military service members' experiences with therapeutic writing	ARTS IN PSYCHOTHERAPY			English	Article						Therapeutic writing; Military; Service members; TBI; PTSD; Text analysis; LIWC	INTERVENTION	Background: Therapeutic writing has been shown to improve both physical health and emotional well-being. This paper examines the usefulness of clinical notes as a data source, and presents two different analyses of individual clinical notes of therapeutic writing group sessions: analysis performed by a person and analysis by a computer-based program (Pennebaker et al., 2015). The therapeutic writing sessions were offered during the second week of treatment at the National Intrepid Center of Excellence (NICoE) as part of an integrative care model for service members (SMs) with traumatic brain injury and underlying psychological conditions to include post-traumatic stress disorder (PTSD). Method: Therapeutic writing sessions were facilitated in the art therapy studio at the NICoE. The sessions were documented in the military healthcare system's patient record application by the art therapist and art therapy interns at the NICoE. Clinical notes were informed by SM self-report surveys and clinician observations. Notes from May 2012 to 2015 and were pulled and coded manually for emerging themes, then separately analyzed by a computer software text content analysis program (Pennebaker et al., 2015). Results: Overall, SMs reported more positive than negative, neutral, or mixed emotions during and after the therapeutic writing experience. Some reported a change from negative to positive emotions through the writing process, and many described experiencing relief during and after sessions. SMs wrote on a wide range of topics. Most SMs kept their writing pieces, although some destroyed them or shared them with others, and a few SMs gifted the pieces. Computerized-based analysis (Pennebaker et al., 2015) indicated that work and social were the most prominent content theme areas. It also showed that positive emotions were more evident than negative emotions in the clinical notes and that the focus of the writing pieces was primarily on the present rather than on the past or the future. Implications: Many SMs perceived the therapeutic writing experience as therapeutic, a relevant coping skill, and enjoyable. Some, however, preferred to work on art therapy projects they had begun in previous sessions (such as mask-making) during the writing sessions. The computer-based analysis of the clinical notes took much less time than the human analysis, but it did not produce results of comparable richness or nuance. Computer based analysis of the actual therapeutic writing pieces may provide deeper insights into the content and themes that emerged during this therapeutic intervention.	[Landless, Bronwen M.; Kaimal, Girija] Drexel Univ, Coll Nursing & Hlth Profess, Philadelphia, PA 19104 USA; [Walker, Melissa S.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA		Walker, MS (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA.	melissa.s.walker12.civ@mail.mil			National Endowment for the Arts (NEA) and Creative Forces.: NEA Military Healing Arts Network	We are grateful to Dr. Jesus Caban, Ms. Adele Gonzaga and Ms. Rebekka Dieterich-Hartwell for help data gathering, analysis and various stages of the manuscript, and to Dr. Joshua Smyth for feedback about LIWC. We are also grateful to the National Endowment for the Arts (NEA) and Creative Forces.: NEA Military Healing Arts Network for funding rhis research.	[Anonymous], 2016, DED VERS 7 0 23 WEB; Baddeley JL, 2011, J TRAUMA STRESS, V24, P581, DOI 10.1002/jts.20679; BAKER KC, 2004, J POETRY THER, V17, P141, DOI DOI 10.1080/08893670412331311352; Harrington S. J., 2012, THESIS; Hoyt T, 2011, J SOC CLIN PSYCHOL, V30, P549, DOI 10.1521/jscp.2011.30.6.549; Hunt N., 2014, INT J, V20, P75, DOI [10.1037/h0099377, DOI 10.1037/H0099377]; Levy C. E., 2017, ARTS PSYCHOTHERAPY, V57, P20, DOI [10.1016/j/aip.2017.08.010, DOI 10.1016/J/AIP.2017.08.010]; Lowe G, 2006, HEALTH EDUC, V106, P60, DOI 10.1108/09654280610637201; Mosher CE, 2006, J SOC CLIN PSYCHOL, V25, P1122, DOI 10.1521/jscp.2006.25.10.1122; Nevinski RL, 2013, J POETRY THER, V26, P201, DOI 10.1080/08893675.2013.849044; Pennebaker J.W., 2015, LINGUISTIC INQUIRY W; Sayer NA, 2015, J TRAUMA STRESS, V28, P381, DOI 10.1002/jts.22047; Sloan DM, 2007, BEHAV THER, V38, P155, DOI 10.1016/j.beth.2006.06.005; Sloan DM, 2018, JAMA PSYCHIAT, V75, P233, DOI 10.1001/jamapsychiatry.2017.4249; Sloan DM, 2011, BEHAV RES THER, V49, P299, DOI 10.1016/j.brat.2011.02.001; Sloan DM, 2005, J CONSULT CLIN PSYCH, V73, P549, DOI 10.1037/0022-006X.73.3.549; Smyth J, 2003, J CLIN PSYCHOL, V59, P227, DOI 10.1002/jclp.10144; Smyth JM, 2008, BRIT J HEALTH PSYCH, V13, P85, DOI 10.1348/135910707X250866; Smyth JM, 2008, BRIT J HEALTH PSYCH, V13, P1, DOI 10.1348/135910707X260117; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676	20	4	4	1	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-4556	1873-5878		ART PSYCHOTHER	Arts Psychother.	FEB	2019	62				SI		77	84		10.1016/j.aip.2018.10.002			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	IG5IR	WOS:000473837200013		hybrid			2022-02-06	
J	Roy, S; Smith, LP				Roy, Soham; Smith, Lee P.			Preventing and Managing Operating Room Fires in Otolaryngology-Head and Neck Surgery	OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA			English	Article						Airway fire; Endoscopic surgery; Head and neck surgery; Electrocautery; Coblation; CO2 laser; Fire safety	AIRWAY FIRE; DEVICES; INJURY; CARE	Otolaryngologists are at high risk of surgical fire. During surgery in the head and neck region there is close proximity of 3 essential elements: an ignition source, a fuel, and an oxidizing agent. In this article, the authors highlight the scenarios where fire may occur and offer steps that surgeons can take to minimize risk for their patients. By understanding the elements of the fire triad, otolaryngologists can decrease the risk of surgical fire, through careful control of oxidizers, ignition sources, and potential fuels in the operating room.	[Roy, Soham] Univ Texas Houston, McGovern Med Sch, Dept Otorhinolaryngol, 6431 Fannin St,MSB 5-036, Houston, TX 77401 USA; [Smith, Lee P.] Northwell Hlth Syst, Hofstra Northwell Sch Med, Cohen Childrens Med Ctr, Dept Otolaryngol, 269-01 76th Ave, Queens, NY 11040 USA		Roy, S (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Otorhinolaryngol, 6431 Fannin St,MSB 5-036, Houston, TX 77401 USA.	SOHAM.ROY@UTH.TMC.EDU					Amer Soc Anesthesiologists, 2013, ANESTHESIOLOGY, V118, P271, DOI 10.1097/ALN.0b013e31827773d2; American Society of Anesthesiologists Task Force on Operating Room Fires, 2008, Anesthesiology, V108, P786, DOI 10.1097/01.anes.0000299343.87119.a9; [Anonymous], 1996, Health Devices, V25, P260; Bhananker SM, 2006, ANESTHESIOLOGY, V104, P228, DOI 10.1097/00000542-200602000-00005; Chou A K, 2001, Chang Gung Med J, V24, P393; Day AT, 2018, OTOLARYNG HEAD NECK, V158, P598, DOI 10.1177/0194599817746926; Friedman AD, 2018, ANN OTO RHINOL LARYN, V127, P258, DOI 10.1177/0003489418757549; Jones EL, 2017, J AM COLL SURGEONS, V225, P160, DOI 10.1016/j.jamcollsurg.2017.01.058; Kuo C H, 2001, Acta Anaesthesiol Sin, V39, P53; Landro L., 2009, WALL STREET J; Lin I-Hung, 2005, Chang Gung Med J, V28, P186; Niskanen M, 2007, ACTA ANAESTH SCAND, V51, P509, DOI 10.1111/j.1399-6576.2007.01280.x; Prasad R, 2006, ANESTH ANALG, V102, P172, DOI 10.1213/01.ane.0000183641.09008.f2; REYES RJ, 1995, PLAST RECONSTR SURG, V95, P924, DOI 10.1097/00006534-199595050-00026; Roy S, 2015, OTOLARYNG HEAD NECK, V152, P67, DOI 10.1177/0194599814555853; Roy S, 2015, AM J OTOLARYNG, V36, P63, DOI 10.1016/j.amjoto.2014.10.009; Roy S, 2011, INT J PEDIATR OTORHI, V75, P227, DOI 10.1016/j.ijporl.2010.11.005; Roy S, 2010, AM J OTOLARYNG, V31, P356, DOI 10.1016/j.amjoto.2009.05.006; Smith LP, 2008, AM J OTOLARYNG, V29, P171, DOI 10.1016/j.amjoto.2007.05.006; Smith LP, 2011, AM J OTOLARYNG, V32, P109, DOI 10.1016/j.amjoto.2009.11.004; Varcoe RL, 2004, ANZ J SURG, V74, P507, DOI 10.1111/j.1445-2197.2004.03048.x; 2003, SENTINEL EVENT ALERT	22	4	4	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0030-6665	1557-8259		OTOLARYNG CLIN N AM	Otolaryngol. Clin. N. Am.	FEB	2019	52	1					163	171		10.1016/j.otc.2018.08.011			9	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	HD8PN	WOS:000452819100017	30241765				2022-02-06	
J	Shackelford, JL; Smith, LS; Farrell, CT; Neils-Strunjas, J				Shackelford, Jo L.; Smith, Lynette S.; Farrell, C. Thomas; Neils-Strunjas, Jean			Interrelationships Among Resilience, Posttraumatic Stress Disorder, Traumatic Brain Injury, Depression, and Academic Outcomes in Student Military Veterans	JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES			English	Article							SOCIAL SUPPORT; HEALTH; AFGHANISTAN; PREVALENCE; DEPLOYMENT; VALIDITY; AGE	Resilience, depression, posttraumatic stress disorder (PTSD), and traumatic brain injury (TBI) are important factors to consider as student military Veterans work to reintegrate into society. The impact of these factors on academic success is not fully understood, but is important for rehabilitation professionals, student advisors, and counselors. The current study examined the impact of resilience, depression, PTSD, and TBI on student Veteran academic outcomes, and whether the amount of student Veterans' military experience moderated the effect of these factors on academic performance. Seventy-seven student Veterans completed measures that assessed resilience, grade point average, academic disruptions, and symptoms of depression, PTSD, and TBI. Path analysis was used to determine the manner in which the variables influenced academic performance. Results indicate that student Veterans should not be viewed as a homogeneous group and their needs differ based on level of military experience. Academic disruption among less experienced Veterans was most associated with symptoms of depression, whereas academic disruption among more experienced Veterans was most associated with symptoms of TBI.	[Shackelford, Jo L.; Neils-Strunjas, Jean] Western Kentucky Univ, Dept Commun Sci & Disorders, 1906 Coll Hts Blvd 41030, Bowling Green, KY 42101 USA; [Farrell, C. Thomas] Western Kentucky Univ, Dept Publ Hlth, Bowling Green, KY 42101 USA; [Smith, Lynette S.] Indiana Univ, Sch Nursing, Dept Community & Hlth Syst, Indianapolis, IN 46204 USA		Shackelford, JL (corresponding author), Western Kentucky Univ, Dept Commun Sci & Disorders, 1906 Coll Hts Blvd 41030, Bowling Green, KY 42101 USA.	jo.shackelford@wku.edu			Western Kentucky University College of Health and Human Services Quick Turnaround Grant	The authors have disclosed no potential conflicts of interest, financial or otherwise. This research was supported by a Western Kentucky University College of Health and Human Services Quick Turnaround Grant.	[Anonymous], 2017, PAYING FOR COLLEGE; Basoglu M, 1997, PSYCHOL MED, V27, P1421, DOI 10.1017/S0033291797005679; Campbell R, 2015, J AM COLL HEALTH, V63, P473, DOI 10.1080/07448481.2015.1040408; Cate CA., 2014, STUDENT VETERANS AM, V2, P1; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Durdella NR., 2012, J STUD ED, V2, P109; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kalisch R, 2017, NAT HUM BEHAV, V1, P784, DOI 10.1038/s41562-017-0200-8; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kimerling R., 2009, EXAMINING DIAGNOSTIC; KLEM L, 1995, READING UNDERSTANDIN, P65; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Knight BG, 2000, PSYCHOL AGING, V15, P627, DOI 10.1037/0882-7974.15.4.627; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Preacher K. L., 2006, COMPUTING POWER MINI; Rice V, 2016, WORK, V54, P335, DOI 10.3233/WOR-162301; Rudd MD, 2011, PROF PSYCHOL-RES PR, V42, P354, DOI 10.1037/a0025164; Schwab KA, 2006, NEUROLOGY, V66, pA235; Substance Abuse and Mental Health Services Administration, 2016, KEY SUBST US MENT HL; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Vyas KJ, 2016, MIL MED, V181, P1240, DOI 10.7205/MILMED-D-15-00585; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Whiteman SD, 2013, J COUNS PSYCHOL, V60, P265, DOI 10.1037/a0031650; Zinger Lana, 2010, CONT ISSUES ED RES, V3, P39, DOI DOI 10.19030/CIER.V3I1.160	29	4	4	1	7	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0279-3695	1938-2413		J PSYCHOSOC NURS MEN	J. Psychosoc. Nurs. Ment. Health Serv.	FEB	2019	57	2					35	43		10.3928/02793695-20180924-02			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	HJ6YR	WOS:000457340000006	30272811				2022-02-06	
J	van Rein, EAJ; Jochems, D; Lokerman, RD; van der Sluijs, R; Houwert, RM; Lichtveld, RA; van Es, MA; Leenen, LPH; van Heijl, M				van Rein, E. A. J.; Jochems, D.; Lokerman, R. D.; van der Sluijs, R.; Houwert, R. M.; Lichtveld, R. A.; van Es, M. A.; Leenen, L. P. H.; van Heijl, M.			Diagnostic value of emergency medical services provider judgement in the identification of head injuries among trauma patients	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						head injury; neurotrauma; pre-hospital; trauma; triage	GLASGOW COMA SCALE; BRAIN-INJURY; MOTOR COMPONENT; TRIAGE; MORTALITY; CARE; AGE; MANAGEMENT; TRANSPORT; ACCURACY	Background and purpose Previous studies have reported that many patients with a severe head injury are not transported to a higher-level trauma centre where the necessary round-the-clock neurosurgical care is available. The aim of this study was to analyse the diagnostic value of emergency medical services (EMS) provider judgement in the identification of a head injury. Methods In this multicentre cohort study, all trauma patients aged 16 years and over who were transported with highest priority to a trauma centre were evaluated. The diagnostic value of EMS provider judgement was determined using an Abbreviated Injury Scale score of >= 1 in the head region as reference standard. Results A total of 980 (35.4%) of the 2766 patients who were included had a head injury. EMS provider judgement (Abbreviated Injury Scale score >= 1) had a sensitivity of 67.9% and a specificity of 87.7%. In the cohort, 208 (7.5%) patients had a severe head injury. Of these, 68% were transported to a level I trauma centre. Conclusions Identification of a head injury on-scene is challenging. EMS providers could not identify 32% of the patients with a head injury and 21% of the patients with a severe head injury. Additional education, training and a supplementary protocol with predictors of a severe head injury could help EMS providers in the identification of these patients.	[van Rein, E. A. J.; Jochems, D.; Lokerman, R. D.; van der Sluijs, R.; Houwert, R. M.; Leenen, L. P. H.; van Heijl, M.] Univ Med Ctr Utrecht, Dept Traumatol, Utrecht, Netherlands; [Houwert, R. M.] Trauma Ctr Utrecht, Utrecht, Netherlands; [Lichtveld, R. A.] Reg Ambulance Facil Utrecht, Bilthoven, Netherlands; [van Es, M. A.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [van Heijl, M.] Diakonessenhuis Utrecht Zeist Doorn, Dept Surg, Utrecht, Netherlands		van Rein, EAJ (corresponding author), Univ Med Ctr Utrecht, Suite G04-228,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	evelinevanrein@gmail.com	van+Es, Michael/AAC-5772-2021; Houwert, Roderick/K-7887-2019	Houwert, Roderick/0000-0003-3497-659X; Leenen, Luke/0000-0001-8385-1801; van Es, Michael/0000-0002-7709-5883			Ambulance Zorg Nederland. Landelijk Protocol Ambulancezorg (LPA), 2007, LAND PROT AMB LPA; [Anonymous], 2016, LAND TRAUM 2011 2015; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Barton DJ, 2016, PREHOSP EMERG CARE, V20, P206, DOI 10.3109/10903127.2015.1076101; Beskind DL, 2014, PREHOSP EMERG CARE, V18, P68, DOI 10.3109/10903127.2013.844870; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bossers SM, 2018, EUR J TRAUMA EMERG S, V44, P889, DOI 10.1007/s00068-017-0861-z; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Centers for Disease Control and Prevention (CDC) National Centre for Injury Prevention and Control, 2016, TRAUM BRAIN INJ US F; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Cox S, 2014, INJURY, V45, P1312, DOI 10.1016/j.injury.2014.02.028; Fakhry SM, 2017, BRAIN INJURY, V31, P1486, DOI 10.1080/02699052.2017.1376762; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Flottemesch TJ, 2017, ACAD EMERG MED, V24, P447, DOI 10.1111/acem.13150; Fuller G, 2014, EMERG MED J, V31, P914, DOI 10.1136/emermed-2013-202575; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kupas DF, 2016, ANN EMERG MED, V68, P744, DOI 10.1016/j.annemergmed.2016.06.017; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mans S, 2016, INJURY, V47, P26, DOI 10.1016/j.injury.2015.09.020; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Najafi Z, 2018, INT EMERG NURS, V36, P27, DOI 10.1016/j.ienj.2017.08.003; Newgard CD, 2011, J TRAUMA, V70, P1345, DOI 10.1097/TA.0b013e3182191a1b; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Salottolo K, 2017, J CRIT CARE, V38, P197, DOI 10.1016/j.jcrc.2016.11.034; Scheetz LJ, 2012, J EMERG MED, V43, P1020, DOI 10.1016/j.jemermed.2011.09.036; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Spijkers ATE, 2010, J TRAUMA, V69, P1138, DOI 10.1097/TA.0b013e3181e12526; Voskens FJ, 2018, JAMA SURG, V153, P322, DOI 10.1001/jamasurg.2017.4472; Wasserman EB, 2015, PREHOSP EMERG CARE, V19, P202, DOI 10.3109/10903127.2014.959225	33	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	FEB	2019	26	2					274	280		10.1111/ene.13804			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HH5YE	WOS:000455803800013	30171654				2022-02-06	
J	Zhao, XY; Rangaprakash, D; Denney, TS; Katz, JS; Dretsch, MN; Deshpande, G				Zhao, Xinyu; Rangaprakash, D.; Denney, Thomas S., Jr.; Katz, Jeffrey S.; Dretsch, Michael N.; Deshpande, Gopikrishna			Identifying neuropsychiatric disorders using unsupervised clustering methods: Data and code	DATA IN BRIEF			English	Article; Data Paper						Functional magnetic resonance imaging; Functional connectivity; Effective connectivity; Unsupervised learning; Clustering; Genetic algorithm; Psychiatric disorders		This article provides data for five different neuropsychiatric disorders Attention Deficit Hyperactivity Disorder, Alzheimer's Disease, Autism Spectrum Disorder, Post-Traumatic Stress Disorder, and Post-Concussion Syndrome-along with healthy controls. The data includes clinical diagnostic labels, phenotypic variables, and resting-state functional magnetic resonance imaging connectivity features obtained from individuals. In addition, it provides the source MATLAB codes used for data analyses. Three existing clustering methods have been incorporated into the provided code, which do not require a priori specification of the number of clusters. A genetic algorithm based feature selection method has also been included to find the relevant subset of features and clustering the subset of data simultaneously. Findings from this data set and further detailed interpretations are available in our recent research study (Zhao et al., 2017) [1]. This contribution is a valuable asset for performing unsupervised machine learning on fMRI data to investigate the correspondence of clinical diagnostic grouping with the underlying neurobiological/phenotypic clusters. (C) 2018 The Authors. Published by Elsevier lnc.	[Zhao, Xinyu; Rangaprakash, D.; Denney, Thomas S., Jr.; Katz, Jeffrey S.; Deshpande, Gopikrishna] Auburn Univ, Dept Elect & Comp Engn, AU MRI Res Ctr, Auburn, AL 36849 USA; [Rangaprakash, D.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Denney, Thomas S., Jr.; Katz, Jeffrey S.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Denney, Thomas S., Jr.; Katz, Jeffrey S.; Deshpande, Gopikrishna] Alabama Adv Imaging Consortium, Birmingham, AL USA; [Dretsch, Michael N.] HQ TRADOC, Human Dimens Div, Ft Eustis, VA USA; [Dretsch, Michael N.] US Army Aeromed Res Lab, Ft Rucker, AL USA; [Deshpande, Gopikrishna] Auburn Univ, Ctr Hlth Ecol & Equ Res, Auburn, AL 36849 USA; [Denney, Thomas S., Jr.; Katz, Jeffrey S.; Deshpande, Gopikrishna] Auburn Univ, Ctr Neurosci, Auburn, AL 36849 USA		Deshpande, G (corresponding author), Auburn Univ, 560 Devall Dr,Suite 266D, Auburn, AL 36849 USA.	gopi@auburn.edu					Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Dasgupta S, 2005, J COMPUT SYST SCI, V70, P555, DOI 10.1016/j.jcss.2004.10.006; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Dy JG, 2004, J MACH LEARN RES, V5, P845; Grant MM, 2015, NEUROPSYCHOPHARMACOL, V40, P1782, DOI 10.1038/npp.2015.28; Jia H, 2014, BRAIN CONNECT, V4, P741, DOI 10.1089/brain.2014.0300; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Zhao Xinyu, 2018, Front Appl Math Stat, V4, DOI 10.3389/fams.2018.00025	8	4	4	2	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2352-3409			DATA BRIEF	Data Brief	FEB	2019	22						570	573		10.1016/j.dib.2018.01.080			4	Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	HK6SP	WOS:000458114600079	30627610	gold, Green Published			2022-02-06	
J	Giles, GM; Clark-Wilson, J; Baxter, DM; Tasker, R; Holloway, M; Seymour, S				Giles, Gordon Muir; Clark-Wilson, Jo; Baxter, Doreen M.; Tasker, Ross; Holloway, Mark; Seymour, Stephanie			The interrelationship of functional skills in individuals living in the community, following moderate to severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; brain injury; activities of daily living; self-awareness; executive function	IMPAIRED AWARENESS; SELF-AWARENESS; REHABILITATION; PERSPECTIVES; COMPETENCE; MANAGEMENT; EFFICACY; VALIDITY; INSIGHT; CLIENTS	Objective: The Adaptive Behaviour and Community Competency Scale was used to investigate the interrelationship of 22 basic and instrumental activities of daily living (ADL/IADL) in individuals with moderate to severe traumatic brain injury (TBI). The relationship of self-awareness to task performance was also investigated. Research design: Prospective descriptive study. Method: The profiles of 100 community dwelling individuals were used to compare the degree to which independence in each ADL/IADL was associated with independence in every other ADL/IADL. The interrelationship of these skills was further explored in a factor analysis, and comparisons made between the degree of self-awareness of those who could and could not complete IADL independently. Results: We found evidence of a hierarchy of skills: individuals who were independent in IADL were more able to perform ADL, than vice versa. Factor analysis supported a two-factor solution distinguishing ADL and IADL. Self-awareness was more strongly associated with IADL than with ADL independence. Conclusions: A subset of individuals with moderate to severe TBI are able to perform a range of IADL. This group appears to have higher levels of self-awareness than those who are limited to performing only ADL skills. Implications for the applications of functional retraining interventions are discussed.	[Giles, Gordon Muir] Samuel Merritt Univ, Dept Occupat Therapy, Oakland, CA USA; [Giles, Gordon Muir] Crestwood Treatment Ctr, 2171 Mowry Ave, Fremont, CA USA; [Clark-Wilson, Jo; Baxter, Doreen M.; Tasker, Ross; Holloway, Mark; Seymour, Stephanie] Head First, Grove Mills, Hawkhurst, England; [Holloway, Mark] Univ Nottingham, Sch Sociol & Social Policy, Nottingham, England		Giles, GM (corresponding author), Crestwood Treatment Ctr, FAOTA, OTR L, 2171 Mowry Ave, Fremont, CA 94538 USA.	ggiles@samuelmerritt.edu					Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; American Occupational Therapy Association-AOTA, 2014, AM J OCCUP THER, V68, ps01, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJOT.2014.682006]; [Anonymous], 2010, IBM SPSS STAT WIND V; Bender A, 2014, BRAIN INJURY, V28, P44, DOI 10.3109/02699052.2013.850177; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Clark-Wilson J, 2016, BRAIN INJURY, V30, P872, DOI 10.3109/02699052.2016.1146799; Clark-Wilson J, 2014, BRAIN INJURY, V28, P1646, DOI 10.3109/02699052.2014.946449; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; Giles GM, 2007, BRAIN INJURY, V21, P521, DOI 10.1080/02699050701311067; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Holmqvist K, 2014, BRAIN INJURY, V28, P1365, DOI 10.3109/02699052.2014.919529; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; MAHONEY F I, 1965, Md State Med J, V14, P61; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P2271, DOI 10.1016/j.apmr.2012.06.013; McDonald JH., 2014, HDB BIOL STAT; Morrison MT, 2015, AM J OCCUP THER, V69, P117, DOI 10.5014/ajot.2015.011528; O'Callaghan A, 2012, BRAIN INJURY, V26, P1599, DOI 10.3109/02699052.2012.698788; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Powell JM, 2007, AM J OCCUP THER, V61, P269, DOI 10.5014/ajot.61.3.269; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; R Core Team R, LANG ENV STAT COMP; Reber PJ, 2013, NEUROPSYCHOLOGIA, V51, P2026, DOI 10.1016/j.neuropsychologia.2013.06.019; Schmitter-Edgecombe M, 2011, J INT NEUROPSYCH SOC, V17, P853, DOI 10.1017/S1355617711000865; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SPECTOR WD, 1987, J CHRON DIS, V40, P481, DOI 10.1016/0021-9681(87)90004-X; State University of New York, 1997, GUID UN DAT SET MED; Trevena-Peters J, 2018, J HEAD TRAUMA REHAB, V33, P317, DOI 10.1097/HTR.0000000000000363; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Velikonja D, 2017, BRAIN INJURY, V31, P68, DOI 10.1080/02699052.2016.1212090; World Health Organization, 2007, INT CLASS FUNCT DIS	36	4	4	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2019	33	2					129	136		10.1080/02699052.2018.1539762			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG9RL	WOS:000455346300003	30424682	hybrid			2022-02-06	
J	Ramage, AE; Tate, DF; New, AB; Lewis, JD; Robin, DA				Ramage, Amy E.; Tate, David F.; New, Anneliese B.; Lewis, Jeffrey D.; Robin, Donald A.			Effort and Fatigue-Related Functional Connectivity in Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; fatigue; effort; functional connectivity; fMRI	COGNITIVE-CONTROL; POSTCONCUSSION SYNDROME; INDIVIDUAL-DIFFERENCES; SEVERITY SCALE; MODERATE; CORTEX; ACTIVATION; MECHANISMS; DISORDERS; TONGUE	Mental fatigue in healthy individuals is typically observed under conditions of high cognitive demand, particularly when effort is required to perform a task for a long period of time-thus the concepts of fatigue and effort are closely related. In brain injured individuals, mental fatigue can be a persistent and debilitating symptom. Presence of fatigue after brain injury is prognostic for return to work/school and engagement in activities of daily life. As such, it should be a high priority for treatment in this population, but because there is little understanding of its behavioral and neural underpinnings, the target for such treatment is unknown. Here, the neural underpinnings of fatigue and effort are investigated in active duty military service members with mild traumatic brain injury (mTBI) and demographically-matched orthopedic controls. Participants performed a Constant Effort task for which they were to hold a pre-defined effort level constant for long durations during fMRI scanning. The task allowed for investigation of the neural systems underlying fatigue and their relationship with sense of effort. While brain activation associated with effort and fatigue did not differentiate the mTBI and controls, functional connectivity amongst active brain regions did. The mTBI group demonstrated immediate hyper-connectivity that increased with effort level but diminished quickly when there was a need to maintain effort. Controls, in contrast, demonstrated a similar pattern of hyper-connectivity, but only when maintaining effort over time. Connectivity, particularly between the left anterior insula, rostral anterior cingulate cortex, and right-sided inferior frontal regions, correlated with effort-level and state fatigue in mTBI participants. These connections also correlated with effort level in the Control group, but only the connection between the left insula and superior medial frontal gyrus correlated with fatigue, suggesting a differing pattern of connectivity. These findings align, in part, with the dopamine imbalance, and neural efficiency hypotheses that pose key roles for medial frontal connections with insular or striatal regions in motivating or optimizing performance. Sense of effort and fatigue are closely related. As people fatigue, sense of effort increases systematically. The data propose a complex link between sense of effort, fatigue, and mTBI that is centered in what may be an inefficient neural system due to brain trauma that warrants further investigation.	[Ramage, Amy E.; Robin, Donald A.] Univ New Hampshire, Dept Commun Sci, Durham, NH 03824 USA; [Ramage, Amy E.; Robin, Donald A.] Univ New Hampshire, Interdisciplinary Program Neurosci & Behav, Durham, NH 03824 USA; [Tate, David F.] Univ Missouri St Louis, Missouri Inst Mental Hlth, Berkeley, MO USA; [New, Anneliese B.] TIRR Mem Hermann, Dept Neuropsychol, Houston, TX USA; [Lewis, Jeffrey D.] Uniformed Serv Univ Hlth Sci, Dept Neurol, F Edward Hebert Sch Med, Sch Med, Bethesda, MD 20814 USA		Ramage, AE (corresponding author), Univ New Hampshire, Dept Commun Sci, Durham, NH 03824 USA.; Ramage, AE (corresponding author), Univ New Hampshire, Interdisciplinary Program Neurosci & Behav, Durham, NH 03824 USA.	Amy.ramage@unh.edu	Tate, David F/I-3963-2013; Ramage, Amy/S-9227-2018	Tate, David F/0000-0003-0213-1920; Ramage, Amy/0000-0001-8554-555X	Defense and Veterans Brain Injury Centers, the U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0025]	The authors thank Gerald York for his assistance in neuroimaging data collection. They also thank Elizabeth Kinney and Jenna Campbell for their careful editing and aid in preparing this manuscript. The views, opinions and/or findings contained in this manuscript are those of the authors and should not be construed as an official Department of Defense or Veterans Affairs position, policy or decision unless so designated by other documentation. Research on this article was supported in part by the Defense and Veterans Brain Injury Centers, the U.S. Army Medical Research and Materiel Command (USAMRMC; W81XWH-13-2-0025). In the conduct of this research, the investigators adhered to the policies regarding the protection of human subjects as prescribed by Code of Federal Regulations (CFR) Title 45, Volume 1, Part 46; Title 32, Chapter1, Part 219; and Title 21, Chapter 1, Part 50 (Protection of Human Subjects).	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Berginstrom N, 2018, J HEAD TRAUMA REHAB, V33, P266, DOI 10.1097/HTR.0000000000000340; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chong TTJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002598; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark David Glenn, 2016, Alzheimers Dement (Amst), V2, P113, DOI 10.1016/j.dadm.2016.02.001; Clark H. M., 1995, AM J SPEECH-LANG PAT, V4, P143, DOI DOI 10.1044/1058-0360.0404.143; Cockshell SJ, 2012, J CLIN EXP NEUROPSYC, V34, P679, DOI 10.1080/13803395.2012.668176; Dobryakova E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00052; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Engstrom M, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01071; Fellows LK, 2005, NEUROPSYCHOLOGIA, V43, P1214, DOI 10.1016/j.neuropsychologia.2004.07.018; Gillis MM, 2015, BRAIN IMAGING BEHAV, V9, P801, DOI 10.1007/s11682-014-9337-5; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Head H, 1920, BRAIN, V43, P87, DOI 10.1093/brain/43.2.87; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hoot MR, 2018, BRAIN INJURY, V32, P1169, DOI 10.1080/02699052.2018.1482427; Johansson B, 2015, NEUROREHABILITATION, V36, P195, DOI 10.3233/NRE-151207; Kahneman D., 1973, ATTENTION EFFORT SER; KIRKENDALL DT, 1990, MED SCI SPORT EXER, V22, P444; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kulas JF, 2018, MIL MED, V183, pE114, DOI 10.1093/milmed/usx050; Logan DM, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00397, 10.3389/fnhum.2015.00397]; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Pardini M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02001; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schneider W, 1977, PSYCHOL REV; Sharples SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149026; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Solomon NP, 2005, PARKINSONISM RELAT D, V11, P353, DOI 10.1016/j.parkreldis.2005.06.004; Solomon NP, 1996, J SPEECH HEAR RES, V39, P114, DOI 10.1044/jshr.3901.114; Somodi LB, 1995, BRAIN LANG, V51, P371, DOI 10.1006/brln.1995.1066; Stierwalt J, 1996, TONGUE STRENGTH ENDU; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Treadway MT, 2012, J NEUROSCI, V32, P6170, DOI 10.1523/JNEUROSCI.6459-11.2012; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; Wylie GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08846-6; Wylie GR, 2017, COGN AFFECT BEHAV NE, V17, P838, DOI 10.3758/s13415-017-0515-y; Zald DH, 2002, P NATL ACAD SCI USA, V99, P2450, DOI 10.1073/pnas.042457199	47	4	4	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 18	2019	9								1165	10.3389/fneur.2018.01165			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HH8OV	WOS:000455992600001	30713519	Green Published, gold			2022-02-06	
J	McMillan, TM; Graham, L; Pell, JP; McConnachie, A; Mackay, DF				McMillan, T. M.; Graham, L.; Pell, J. P.; McConnachie, A.; Mackay, D. F.			The lifetime prevalence of hospitalised head injury in Scottish prisons: A population study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ASSOCIATION	Background There is mounting evidence that associates brain injury and offending behaviour, and there is a need to understand the epidemiology of head injury in prisoners in order to plan interventions to reduce associated disability and risk of reoffending. This is the first study to determine the lifetime prevalence of hospitalised head injury (HHI) in a national population of current prison inmates. In addition characteristics of prisoners with HHI and were compared to prisoners without HHI to discover whether those with HI differed demographically. Methods Whole life hospital records of everyone aged 35 years or younger and resident in a prison in Scotland on a census date in 2015 were electronically linked via their unique NHS identifier and checked for ICD-9 and 10 codes for head injury. Using a case-control design, these data were compared with a sample from the general population matched 3: 1 for age, gender and area-based social deprivation. Comparison of demographic variables was made between prisoners with and without HHI. Results HHI was found in 24.7% (1,080/4,374) of prisoners and was significantly more prevalent than found in the matched general population sample (18.2%; 2394/13122; OR 2.10; 95% CI 1.87, 2.16). The prevalence of HHI in prisoners and controls was similar with the exception of a higher risk of HHI in prisoners in lower deprivation quintiles. Having three or more HHI was more common in prisoners (OR 3.04; 95% CI 2.33, 3.97) as were HHI with ICD codes for intracranial injuries (OR 1.81; 95% CI 1.54, 2.11), suggesting that more severe HHI is more prevalent in prisoners than the general population. The distributions within demographic variables and the characteristics of HHI admissions in prisoners with and without a history of HHI were similar. Conclusion Prisoners in Scotland aged 35 years or younger have a higher lifetime prevalence of HHI than the general population and are more likely to have had repeated HI or intracranial injuries. Further work is required to elucidate the correspondence between self-report of HI and hospitalised records and to ascertain persisting effects of HI in prisoners and the need for services to reduce associated disability and risk of reoffending.	[McMillan, T. M.; Pell, J. P.; McConnachie, A.; Mackay, D. F.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Graham, L.] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland		McMillan, TM (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Thomas.mcmillan@glasgow.ac.uk	McMillan, Thomas/K-2055-2015	McMillan, Thomas/0000-0002-5278-9889	NHS Scotland National Prisoner Healthcare Network	Funded by NHS Scotland National Prisoner Healthcare Network.	Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centre for Mental Health, 2016, TRAUM BRAIN INJ OFF; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Farrington D.P., 2006, CRIMINAL CAREERS AGE, V2nd; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HIRSCHI T, 1983, AM J SOCIOL, V89, P552, DOI 10.1086/227905; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; McMillan TM, 2017, NEUROBEHAVIOURAL DIS, P57; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, https://doi.org/10.1300/J076v27n03_01]; Moynan CR, 2018, J HEAD TRAUMA REHAB, V33, P275, DOI 10.1097/HTR.0000000000000354; National Prisoner Healthcare Network, 2016, BRAIN INJ OFF; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Piccolino AL, 2014, J CORRECT HEALTH CAR, V20, P203, DOI 10.1177/1078345814530871; Roworth MA, 1998, COM MED, V10, P327; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Scottish Executive, 2012, SCOTT IND MULT DEPR; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Worthington A, 2017, NEUROBEHAVIOURAL DIS, P3	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210427	10.1371/journal.pone.0210427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	WOS:000456015500038	30653552	Green Published, gold, Green Accepted, Green Submitted			2022-02-06	
J	Prak, RF; van der Naalt, J; Zijdewind, I				Prak, Roeland F.; van der Naalt, Joukje; Zijdewind, Inge			Self-Reported Fatigue After Mild Traumatic Brain Injury Is Not Associated With Performance Fatigability During a Sustained Maximal Contraction	FRONTIERS IN PHYSIOLOGY			English	Article						mTBl; motor task; force decline; voluntary muscle activation; interpolated twitch technique; first dorsal interosseous	MULTIPLE-SCLEROSIS; TASK-PERFORMANCE; MUSCLE; PREDICTORS; ACTIVATION; SYMPTOMS; PATTERNS; RECOVERY; IMPACT; SCALE	Patients with mild traumatic brain injury (mTBI) are frequently affected by fatigue. However, hardly any data is available on the fatigability of the motor system. We evaluated fatigue using the Fatigue Severity Scale (FSS) and Modified Fatigue Impact Scale (MFIS) questionnaires in 20 participants with mTBI (>3 months post injury; 8 females) and 20 age- and sex matched controls. Furthermore, index finger abduction force and electromyography of the first dorsal interosseous muscle of the right hand were measured during brief and sustained maximal voluntary contractions (MVC). Double pulse stimulation (100 Hz) was applied to the ulnar nerve to evoke doublet-forces before and after the sustained contraction. Seven superimposed twitches were evoked during the sustained MVC to quantify voluntary muscle activation. mTBI participants reported higher FSS scores (mTBI: 5.2 +/- 0.8 SD vs. control: 2.8 +/- 0.8 SD; P < 0.01). During the sustained MVC, force declined to similar levels in mTBI (30.0 +/- 9.9% MVC) and control participants (32.7 +/- 9.8% MVC, P = 0.37). The decline in doublet-forces after the sustained MVC (mTBI: to 37.2 +/- 12.1 vs. control: to 41.4 +/- 14.0% reference doublet, P = 0.32) and the superimposed twitches evoked during the sustained MVC (mTBI: median 9.3, range: 2.2-32.9 vs. control: median 10.3, range: 1.9-31.0% doublet(pre), P = 0.34) also did not differ between groups. Force decline was associated with decline in doublet-force (R-2 = 0.50, P < 0.01) for both groups. Including a measure of voluntary muscle activation resulted in more explained variance for mTBI participants only. No associations between self-reported fatigue and force decline or voluntary muscle activation were found in mTBI participants. However, the physical subdomain of the MFIS was associated with the decline in doublet-force after the sustained MVC (R-2 = 0.23, P = 0.04). These results indicate that after mTBI, increased levels of self-reported physical fatigue reflected increased fatigability due to changes in peripheral muscle properties, but not force decline or muscle activation. Additionally, muscle activation was more important to explain the decline in voluntary force (performance fatigability) after mTBI than in control participants.	[Prak, Roeland F.; Zijdewind, Inge] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Groningen, Netherlands; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		Prak, RF; Zijdewind, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Groningen, Netherlands.	r.f.prak@umcg.nl; c.a.t.zijdewind@umcg.nl	Zijdewind, inge/A-7506-2008	Zijdewind, inge/0000-0003-2146-1212; van der Naalt, Joukje/0000-0001-9873-2418; Prak, Roeland/0000-0002-4729-6588	Junior Scientific Masterclass (JSM) of the UMCG	This work was supported by Junior Scientific Masterclass (JSM) of the UMCG to RP.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ALLEN GM, 1994, BRAIN, V117, P661, DOI 10.1093/brain/117.4.661; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Behm DG, 1996, J APPL PHYSIOL, V81, P2267, DOI 10.1152/jappl.1996.81.5.2267; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449, DOI 10.1113/jphysiol.1989.sp017626; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; De Serres SJ, 1998, J APPL PHYSIOL, V84, P284, DOI 10.1152/jappl.1998.84.1.284; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Flachenecker P, 2002, MULT SCLER J, V8, P523, DOI 10.1191/1352458502ms839oa; GANDEVIA SC, 1988, J PHYSIOL-LONDON, V407, P599, DOI 10.1113/jphysiol.1988.sp017434; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Keen DA, 2012, J NEUROPHYSIOL, V108, P3264, DOI 10.1152/jn.01154.2011; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lippold O, 1981, Ciba Found Symp, V82, P234; Lorist MM, 2002, J PHYSIOL-LONDON, V545, P313, DOI 10.1113/jphysiol.2002.027938; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Moller MC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00496; Moller MC, 2014, J CLIN EXP NEUROPSYC, V36, P716, DOI 10.1080/13803395.2014.933779; Multiple Sclerosis Clinical Practice Guidelines, 1998, FATIGUE MULTIPLE SCL; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Post M, 2007, NEUROIMAGE, V35, P16, DOI 10.1016/j.neuroimage.2006.11.050; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Prescott RJ, 2019, GAIT POSTURE, V72, P240, DOI 10.1016/j.gaitpost.2018.06.172; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Sarajuuri J, 2013, J REHABIL MED, V45, P38, DOI 10.2340/16501977-1060; Sars V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00637; Schaart R, 2008, DUTCH STANDARD CLASS; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Schillings ML, 2003, EUR J APPL PHYSIOL, V90, P562, DOI 10.1007/s00421-003-0913-4; Shinohara M, 2003, J APPL PHYSIOL, V94, P966, DOI 10.1152/japplphysiol.00836.2002; Smith A., 1982, SYMBOL DIGIT MODALIT; Steens A, 2012, NEUROREHAB NEURAL RE, V26, P48, DOI 10.1177/1545968311416991; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Duinen H, 2007, J NEUROSCI METH, V164, P247, DOI 10.1016/j.jneumeth.2007.05.005; Wolkorte R, 2015, NEUROREHAB NEURAL RE, V29, P796, DOI 10.1177/1545968314567151; Wolkorte R, 2015, NEUROREHAB NEURAL RE, V29, P424, DOI 10.1177/1545968314552529; Wolkorte R, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00079; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003; Yasen AL, 2017, MED SCI SPORT EXER, V49, P1066, DOI 10.1249/MSS.0000000000001217; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Zijdewind I, 2001, J NEUROPHYSIOL, V85, P1907, DOI 10.1152/jn.2001.85.5.1907	66	4	4	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	JAN 10	2019	9								1919	10.3389/fphys.2018.01919			12	Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Physiology	HH0NA	WOS:000455412300001	30687127	Green Published, gold			2022-02-06	
J	Gooden, JR; Ponsford, JL; Charlton, JL; Ross, P; Marshall, S; Gagnon, S; Bedard, M; Stolwyk, RJ				Gooden, James R.; Ponsford, Jennie L.; Charlton, Judith L.; Ross, Pamela; Marshall, Shawn; Gagnon, Sylvain; Bedard, Michel; Stolwyk, Renerus J.			Self-regulation upon return to driving after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; driving; self-regulation; driving habits	OLDER DRIVERS; ACCIDENT RATE; FOLLOW-UP; BEHAVIORS; ADULTS; PERFORMANCE; AWARENESS; POSTINJURY; PREDICTORS; ABILITIES	The aim of this study was to explore self-reported driving habits and the factors associated with these within the first three months of return to driving following traumatic brain injury (TBI). Participants included 24 individuals with moderate to severe TBI (post-traumatic amnesia duration M = 33.26, SD = 29.69 days) and 28 healthy age, education, and gender-matched controls who completed an on-road assessment. Driving frequency and avoidance questionnaires were administered to assess premorbid driving, anticipated driving upon resuming, and driving at three months post-assessment. There were no differences between groups for premorbid driving frequency or avoidance. Individuals with TBI anticipated greater reductions in driving frequency, t(29.57) = -3.95, p < .001, and increases in avoidance, U = 171.00, z = -2.69, p < .01. On follow up, significant reductions in frequency, t(48) = -3.03, p < .01, but not avoidance, U = 239.00, z = -1.35, p = .18, were observed. Females were more likely to reduce their driving frequency, rs = -.43, p < .05, while increased anxiety was associated with increased avoidance r = .63, p < .05, and reduced frequency r = -.43, p < .05. It was concluded that individuals with TBI anticipated changes in their driving habits upon return to driving, indicating an expectation for post-injury changes to their driving lifestyle. On follow up, many of these intended changes to driving habits, particularly in relation to driving frequency, were reported by individuals with TBI, suggestive of some strategic self-regulation.	[Gooden, James R.; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Gooden, James R.; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia; [Charlton, Judith L.] Monash Univ, Monash Accid Res Ctr, Clayton, Vic, Australia; [Ross, Pamela] Epworth Rehabil, Richmond, Vic, Australia; [Marshall, Shawn] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Gagnon, Sylvain] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Bedard, Michel] Lakehead Univ, Ctr Res & Safe Driving, Thunder Bay, ON, Canada; [Gooden, James R.; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Monash Inst Cognit & Clin Neurosci, 18 Innovat Walk, Clayton, Vic 3800, Australia		Stolwyk, RJ (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, 18 Innovat Walk, Clayton, Vic 3800, Australia.	rene.stolwyk@monash.edu	; Ponsford, Jennie/H-8341-2014	Stolwyk, Renerus/0000-0002-4975-3332; Charlton, Judith/0000-0002-5990-2151; Ponsford, Jennie/0000-0003-0430-125X; Gooden, James/0000-0001-6835-9528	Transport Accident Commission (Victoria, Australia); Ontario Neurotrauma Foundation (Ontario, Canada)	This research project was jointly funded by the Transport Accident Commission (Victoria, Australia) and the Ontario Neurotrauma Foundation (Ontario, Canada).	Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Blanchard RA, 2010, ACCIDENT ANAL PREV, V42, P1213, DOI 10.1016/j.aap.2010.01.013; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Charlton JL, 2006, TRANSPORT RES F-TRAF, V9, P363, DOI 10.1016/j.trf.2006.06.006; Colarusso R.P., 2003, MOTOR FREE VISUAL PE; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cotrell V, 1999, ALZ DIS ASSOC DIS, V13, P151, DOI 10.1097/00002093-199907000-00007; Devlin A, 2014, AUSTRALAS J AGEING, V33, P74, DOI 10.1111/ajag.12061; Eby D.W., 2009, MAINTAINING SAFE MOB; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fleming J., 1995, BRIT J OCCUPATIONAL, V58, P55, DOI [https://doi.org/10.1177/030802269505800204, DOI 10.1177/030802269505800204]; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Gooden J. R., 2016, AUSTR OCCUPATIONAL T, DOI [10.1111/1440-1630.123066, DOI 10.1111/1440-1630.123066]; Gooden JR, 2017, J HEAD TRAUMA REHAB, V32, pE50, DOI 10.1097/HTR.0000000000000212; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gwyther H, 2012, ACCIDENT ANAL PREV, V45, P19, DOI 10.1016/j.aap.2011.11.022; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Labbe DR, 2014, J HEAD TRAUMA REHAB, V29, P185, DOI 10.1097/HTR.0b013e3182795211; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; MacDonald L, 2008, TOP GERIATR REHABIL, V24, P239; Mallon K, 2004, AM J OCCUP THER, V58, P279, DOI 10.5014/ajot.58.3.279; McCarthy DP, 2005, PHYS OCCUP THER GERI, V23, P25, DOI 10.1080/J148v23n02_02; Meng A, 2015, J APPL GERONTOL, V34, pNP62, DOI 10.1177/0733464812463433; Molnar LJ, 2014, TRAFFIC INJ PREV, V15, P262, DOI 10.1080/15389588.2013.808742; Molnar LJ, 2013, TRANSPORT RES F-TRAF, V20, P29, DOI 10.1016/j.trf.2013.05.001; Molnar LJ, 2013, J SAFETY RES, V46, P107, DOI 10.1016/j.jsr.2013.05.001; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; ODENHEIMER GL, 1994, J GERONTOL, V49, pM153, DOI 10.1093/geronj/49.4.M153; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PRIDDY D A, 1990, Brain Injury, V4, P267, DOI 10.3109/02699059009026176; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Reitan R, 1988, HALSTEAD REITAN NEUR; Rike PO, 2014, BRAIN INJURY, V28, P1687, DOI 10.3109/02699052.2014.947632; Ross P, 2016, DISABIL REHABIL, V38, P994, DOI 10.3109/09638288.2015.1074293; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Siren A, 2013, TRANSPORT RES F-TRAF, V17, P88, DOI 10.1016/j.trf.2012.10.004; Smith A., 1991, SYMBOL DIGIT MODALIT; Tabachnick B. G., 2006, USING MULTIVARIATE S, V5th; Vlahodimitrakou Z, 2013, ACCIDENT ANAL PREV, V61, P253, DOI 10.1016/j.aap.2013.03.027; Wong IY, 2012, ACCIDENT ANAL PREV, V49, P316, DOI 10.1016/j.aap.2012.05.031; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	4	4	2	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2019	29	1					92	106		10.1080/09602011.2016.1261716			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GY1HI	WOS:000448276600005	27892821				2022-02-06	
J	Hecimovich, M; King, D; Dempsey, A; Gittins, M; Murphy, M				Hecimovich, Mark; King, Doug; Dempsey, Alasdair; Gittins, Mason; Murphy, Myles			In situ use of the King-Devick eye tracking test and changes seen with sport-related concussion: saccadic and blinks counts	PHYSICIAN AND SPORTSMEDICINE			English	Article						Concussion; head impact; oculomotor; saccades; eye movements; Australian football; children; youth	TRAUMATIC BRAIN-INJURY; SCREENING TOOL; DYSFUNCTION; VISION; MOVEMENTS; SYMPTOMS; WORKLOAD; TASK	Objectives: Sport-related concussion (SRC) can result in impaired oculomotor function. Oculomotor performance, measured utilizing the King-Devick/Eye Tracking test (K-D/ET), is reported to be able to identify sub-optimal brain function. The objectives of the study were to determine the diagnostic accuracy of the K-D/ET in identifying SRC occurring from game participation and to perform a comparative analysis on saccade and blink counts for each K-D card individually and total counts between baseline and post-concussion. Methods: Nineteen male Australian Football players were assessed on the K-D/ET test. Those suspected of having SRC secondary to a head impact were also tested. Results: Participants recorded a slower time on the third (20.2 +/- 4.6 s) screen when compared with the first (p = 0.0424) and second (p = 0.0150) screens. The number of blinks was higher on the third (2.9 +/- 2.9) when compared with the second (p = 0.0057) screen. There was decrease of the K-D/ET total times between pre- and post-game (p = 0.1769). Participants who sustained a head impact recorded slower mean total K-D time (p = 0.7322), fewer mean total saccades (p = 0.0112), and more mean blinks (p = 0.8678) compared with their baseline scores. The assessment of blinks was the most sensitive measure for potential SRC (0.67). The K-D/ET duration was the most specific measure for potential SRC (0.88). An increase in the number of blinks had a fair specificity of 0.69. Conclusion: The rapid number-naming component of the K-D test is an assessment tool which quantifies impairment to oculomotor function and has been validated as a diagnostic tool for SRC. The clinical usefulness of the eye tracking component of the K-D/ET test is that it may be an effective method to assess concussions with the eye tracking component serving as a measure of progression and return to play. However, more research is required at the adult and youth level.	[Hecimovich, Mark] Univ Northern Iowa, Athlet Training, Cedar Falls, IA 50614 USA; [Hecimovich, Mark; Dempsey, Alasdair; Gittins, Mason] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia; [King, Doug] Auckland Univ Technol, Fac Hlth & Environm Sci, Auckland, New Zealand; [King, Doug] Univ New England, Dept Sci & Technol, Armidale, NSW, Australia; [Murphy, Myles] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA, Australia		Hecimovich, M (corresponding author), Univ Northern Iowa, Athlet Training, Cedar Falls, IA 50614 USA.	mark.hecimovich@uni.edu	Murphy, Myles/Q-8313-2017; Dempsey, Alasdair/A-7098-2008	Murphy, Myles/0000-0001-6068-1096; Dempsey, Alasdair/0000-0001-8219-6120			Alfano CA, 2009, DEPRESS ANXIETY, V26, P503, DOI 10.1002/da.20443; Andrieux J, 2000, HISTOIRE, P4; [Anonymous], 2003, MILLER KEANE ENCY DI; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Choi W, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01024; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Deuschl G, 1998, J NEUROL NEUROSUR PS, V64, P320, DOI 10.1136/jnnp.64.3.320; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Doughty MJ, 2001, OPTOMETRY VISION SCI, V78, P712, DOI 10.1097/00006324-200110000-00011; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Hecimovich Mark, 2018, J Sports Med (Hindawi Publ Corp), V2018, P8376030, DOI 10.1155/2018/8376030; Hecimoyich M, 2018, J SCI MED SPORT, V21, P1004, DOI 10.1016/j.jsams.2018.03.011; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Ingre M, 2006, J SLEEP RES, V15, P47, DOI 10.1111/j.1365-2869.2006.00504.x; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Marshall SP, 2007, AVIAT SPACE ENVIR MD, V78, pB165; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Pierrot-Deseilligny C, 2005, ANN NY ACAD SCI, V1039, P239, DOI 10.1196/annals.1325.023; Pierrot-Deseilligny C, 2002, ANN NY ACAD SCI, V956, P216, DOI 10.1111/j.1749-6632.2002.tb02821.x; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Ryu K, 2005, INT J IND ERGONOM, V35, P991, DOI 10.1016/j.ergon.2005.04.005; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Veltman JA, 1998, ERGONOMICS, V41, P656, DOI 10.1080/001401398186829	39	4	4	2	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	JAN 2	2019	47	1					78	84		10.1080/00913847.2018.1525261			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	HJ9CR	WOS:000457496900014	30244636				2022-02-06	
J	Mutlu, B; Duff, M; Turkstra, L				Mutlu, Bilge; Duff, Melissa; Turkstra, Lyn			Social-cue perception and mentalizing ability following traumatic brain injury: A human-robot interaction study	BRAIN INJURY			English	Article						Mentalizing; Theory of Mind (ToM); social cognition; gaze cueing; human-robot interaction	VIRTUAL ENVIRONMENT TECHNOLOGY; EMOTION RECOGNITION; MIND; IMPAIRMENT; COGNITION; ADULTS; INTENTIONS; RESPONSES; DEFICITS; AUTISM	Primary Objective: Research studies and clinical observations of individuals with traumatic brain injury (TBI) indicate marked deficits in mentalizing-perceiving social information and integrating it into judgements about the affective and mental states of others. The current study investigates social-cognitive mechanisms that underlie mentalizing ability to advance our understanding of social consequences of TBI and inform the development of more effective clinical interventions. Research Design: The study followed a mixed-design experiment, manipulating the presence of a mentalizing gaze cue across trials and participant population (TBI vs. healthy comparisons). Methods and Procedures: Participants, 153 adults, 74 with moderate-severe TBI and 79 demographically matched healthy comparison peers, were asked to judge a humanoid robot's mental state based on precisely controlled gaze cues presented by the robot and apply those judgements to respond accurately on the experimental task. Main Outcomes and Results: Results showed that, contrary to our hypothesis, the social cues improved task performance in the TBI group but not the healthy comparison group. Conclusions: Results provide evidence that, in specific contexts, individuals with TBI can perceive, correctly recognize, and integrate dynamic gaze cues and motivate further research to understand why this ability may not translate to day-to-day social interactions.	[Mutlu, Bilge] Univ Wisconsin, Dept Comp Sci, 1210 W Dayton St, Madison, WI 53706 USA; [Duff, Melissa] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN USA; [Turkstra, Lyn] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada		Mutlu, B (corresponding author), 1210 W Dayton St, Madison, WI 53706 USA.	bilge@cs.wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	National Center for Medical Rehabilitation Research [R01 HD071089]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GMO83252]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	This work was supported by the National Center for Medical Rehabilitation Research [R01 HD071089]; National Institute of General Medical Sciences [R25GMO83252];	Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Breazeal C, 2002, TRENDS COGN SCI, V6, P481, DOI 10.1016/S1364-6613(02)02016-8; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Byom Lindsey J, 2013, Front Hum Neurosci, V7, P413, DOI 10.3389/fnhum.2013.00413; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Delis D.C., 2000, CALIFORNIA VERBAL LE; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; FRITH U, 1991, TRENDS NEUROSCI, V14, P433, DOI 10.1016/0166-2236(91)90041-R; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Kertesz A., 2006, W APHASIA BATTERY; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lee KM, 2006, J COMMUN, V56, P754, DOI 10.1111/j.1460-2466.2006.00318.x; Loomis JM, 1999, BEHAV RES METH INS C, V31, P557, DOI 10.3758/BF03200735; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Mutlu B., 2009, P 4 ACM IEEE INT C H; Mutlu B., 2009, THESIS; Nass C, 2000, J SOC ISSUES, V56, P81, DOI 10.1111/0022-4537.00153; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Reeves Byron, 1996, MEDIA EQUATION PEOPL; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Scassellati B, 2005, USING SOCIAL ROBOTS; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Turkstra LS, 2019, NEUROPSYCHOL REHABIL, V29, P789, DOI 10.1080/09602011.2017.1333012; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	41	4	4	1	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2019	33	1			SI		23	31		10.1080/02699052.2018.1531305			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG2RW	WOS:000454812400004	30336070	Green Accepted			2022-02-06	
J	Rochat, L; Manolov, R; Aboulafia-Brakha, T; Berner-Burkard, C; Van der Linden, M				Rochat, Lucien; Manolov, Rumen; Aboulafia-Brakha, Tatiana; Berner-Burkard, Christina; Van der Linden, Martial			Reducing anger outbursts after a severe TBI: a single-case study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; anger; single-case; emotion recognition; implementation intentions	TRAUMATIC BRAIN-INJURY; IMPLEMENTATION INTENTIONS; EMOTION RECOGNITION; AGGRESSIVE-BEHAVIOR; FACIAL EXPRESSION; IMPULSIVITY; MANAGEMENT; INTERVENTION; METAANALYSIS; DEFICITS	Anger outbursts constitute a frequent behavioural issue after a traumatic brain injury (TBI) and have a strong negative impact on the social outcomes resulting from the TBI. However, few studies have examined the efficacy of specific intervention strategies to reduce the frequency and intensity of anger outbursts. We therefore performed a single-case study on this topic by administering two successive and complementary psychological interventions with an AB design with maintenance (first intervention) and an AC design with maintenance plus a one-month follow-up (second intervention) to a patient with a severe TBI. Whereas the first intervention focused on improving the recognition and expression of basic emotions, the second consisted of a self-regulation programme, including various features such as psychoeducation about self-control strategies, relaxation and assertiveness training that aimed to establish adequate behaviours, which were further promoted by an implementation intentions strategy in the patient's daily life. The results indicated that all interventions resulted in a reduced frequency and intensity of anger outbursts, and the data upheld the specificity of these effects. In addition, a meta-analytic integration of the effects of both interventions on the outcomes indicated a medium effect size. Further research is needed on other patients who experience long-standing anger outbursts to examine whether the observed gains can be replicated, sustained on a longer-term basis and improved.	[Rochat, Lucien; Berner-Burkard, Christina; Van der Linden, Martial] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, Geneva, Switzerland; [Rochat, Lucien; Van der Linden, Martial] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Manolov, Rumen] Univ Barcelona, Dept Behav Sci Methods, Barcelona, Spain; [Manolov, Rumen] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Aboulafia-Brakha, Tatiana] Geneva Univ Hosp, Dept Clin Neurosci, Div Neurorehabil, Geneva, Switzerland; [Berner-Burkard, Christina] Inst Lavigny, Neuropsychol & Speech Therapy Unit, Geneva, Switzerland; [Van der Linden, Martial] Univ Liege, Cognit Psychopathol Unit, Liege, Belgium		Rochat, L (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, Cognit Psychopathol & Neuropsychol Unit, Blvd Pont dArve 40, CH-1205 Geneva, Switzerland.	lucien.rochat@unige.ch	Manolov, Rumen/H-8972-2015	Manolov, Rumen/0000-0002-9387-1926; Rochat, Lucien/0000-0002-9992-2720			Aboulafia-Brakha T, 2013, NEUROPSYCHOL REHABIL, V23, P216, DOI 10.1080/09602011.2012.747443; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baddeley A, 1994, DOORS PEOPLE TEST TE; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Benton A., 1994, CONTRIBUTIONS NEUROP; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Brandstatter V, 2001, J PERS SOC PSYCHOL, V81, P946, DOI 10.1037//0022-3514.81.5.946; Brickenkamp R., 1998, D2 TEST ATTENTION; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burkard C, 2014, NEUROPSYCHOL REHABIL, V24, P266, DOI 10.1080/09602011.2014.887023; Burkard C, 2013, ACTA PSYCHOL, V144, P291, DOI 10.1016/j.actpsy.2013.07.008; Churchill S, 2011, PSYCHOL HEALTH, V26, P517, DOI 10.1080/08870441003611536; Churchill S, 2010, BRIT J HEALTH PSYCH, V15, P529, DOI 10.1348/135910709X475423; Cohen A. L., 2008, PROSPECTIVE MEMORY C, P161; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; Ekman P., 1976, PICTURES FACIAL AFFE; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Gollwitzer PM, 2014, MOTIV EMOTION, V38, P305, DOI 10.1007/s11031-014-9416-3; Gollwitzer PeterM., 1993, EUR REV SOC PSYCHOL, V4, P141, DOI [10.1080/14792779343000059, DOI 10.1080/14792779343000059]; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Hedges LV, 2013, RES SYNTH METHODS, V4, P324, DOI 10.1002/jrsm.1086; Howard D, 1992, PYRAMIDS PALM TREES; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kratochwill T. R., 2010, WHAT WORKS CLEARINGH; Lengfelder A, 2001, NEUROPSYCHOLOGY, V15, P80, DOI 10.1037//0894-4105.15.1.80; Lundqvist D., 1998, KAROLINSKA DIRECTED, V91, P630, DOI DOI 10.1037/T27732-000; Mancuso M, 2015, J NERV MENT DIS, V203, P87, DOI 10.1097/NMD.0000000000000245; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; NEZU CM, 1991, RES DEV DISABIL, V12, P371, DOI 10.1016/0891-4222(91)90033-O; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Parker RI, 2006, SCHOOL PSYCHOL QUART, V21, P418, DOI 10.1037/h0084131; Parker RI, 2009, BEHAV THER, V40, P357, DOI 10.1016/j.beth.2008.10.006; R Development Core Team, 2012, R LANG ENV STAT COMP; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rebetez MML, 2015, BRAIN INJURY, V29, P1175, DOI 10.3109/02699052.2015.1035326; Rochat L, 2011, PSYCHOPATHOLOGY, V44, P158, DOI 10.1159/000322454; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Scherer KR, 2011, J NONVERBAL BEHAV, V35, P305, DOI 10.1007/s10919-011-0115-4; Shadish W. R., 2015, NCER201502 US DEP ED; Shadish WR, 2014, J SCHOOL PSYCHOL, V52, P123, DOI 10.1016/j.jsp.2013.11.005; Smith JD, 2012, PSYCHOL METHODS, V17, P510, DOI 10.1037/a0029312; Solanas A, 2010, BEHAV MODIF, V34, P195, DOI 10.1177/0145445510363306; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vannest KJ, 2015, J COUNS DEV, V93, P403, DOI 10.1002/jcad.12038; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wechsler, 1997, WECHSLER ADULT INTEL; White T., 1996, COLOR TRAILS TEST PR; Wieber F., 2015, FRONTIERS HUMAN NEUR, V395; Zimmermann P., 2012, TESTS EVALUATION ATT	66	4	4	0	22	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2019	29	1					107	130		10.1080/09602011.2016.1270837			24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GY1HI	WOS:000448276600006	28007000	Green Submitted, Green Accepted			2022-02-06	
J	Saint-Jean, M; Allain, P; Besnard, J				Saint-Jean, Mathilde; Allain, Philippe; Besnard, Jeremy			A sociocognitive approach to social problem solving in patients with traumatic brain injury: a pilot study	BRAIN INJURY			English	Article						Traumatic brain injury; social problem solving; theory of mind; behavioral disorders	MIND; COGNITION; IMPAIRMENT; RECOGNITION; INFORMATION; DYSFUNCTION; ADULTS	Primary objective: Patients with traumatic brain injury (TBI) have difficulty dealing with the social world and may display inappropriate social behavior that negatively affects their social and occupational rehabilitation. This difficulty may be explained by a social problem-solving (SPS) impairment, but little is yet known about the cognitive processes involved in the ability to solve social problems. Several publications have demonstrated that executive functions are related to social problem solving, but the role of social cognition needs to be confirmed. The present pilot study examined the expected relationships between SPS ability and both social cognition and social behavioral skills. Research design: We compared the performances of 15 patients with TBI on SPS, theory-of-mind and social behavior tasks with those of 25 matched healthy controls. Main outcomes and results: Our results showed for the first time that impaired social problem solving is associated with a theory-of-mind deficit, but surprisingly not with executive impairment. There was no evidence that SPS deficits predict social behavioral disorders. Conclusions: Studying social problem solving in patients with TBI may inform the design of more appropriate methods of social rehabilitation.	[Saint-Jean, Mathilde; Allain, Philippe; Besnard, Jeremy] Univ Angers, Pays de la Loire Psychol Lab, Angers, France; [Allain, Philippe] Angers Univ Hosp, Dept Neurol, Neuropsychol Unit, Angers, France		Allain, P (corresponding author), Ctr Hosp Univ, Unite Neuropsychol, Dept Neurol, 4 Rue Larrey, F-49033 Angers 09, France.	philippe.allain@univ-angers.fr		Besnard, Jeremy/0000-0001-7127-7558; ALLAIN, Philiooe/0000-0003-0668-0986			Achim AM, 2013, PSYCHOL ASSESSMENT, V25, P117, DOI 10.1037/a0029137; Alderman N., 1996, BADS BEHAV ASSESSMEN; Anderson RJ, 2013, BEHAV NEUROSCI, V127, P184, DOI 10.1037/a0030250; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Besnard J, 2017, SOC NEUROSCI-UK, V12, P430, DOI 10.1080/17470919.2016.1182066; Besnard J, 2018, NEUROPSYCHOL REHABIL, V28, P919, DOI 10.1080/09602011.2016.1209420; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Bryson G, 1997, PSYCHIAT RES, V71, P105, DOI 10.1016/S0165-1781(97)00050-4; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Channon S, 1999, NEUROPSYCHOLOGIA, V37, P757, DOI 10.1016/S0028-3932(98)00138-9; Channon S, 2014, COGN NEUROPSYCHIATRY, V19, P149, DOI 10.1080/13546805.2013.809659; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; D'Zurilla T.J., 1990, PSYCHOL ASSESSMENT, V2, P156, DOI DOI 10.1037/1040-3590.2.2.156; D'Zurilla TJ., 2004, SOCIAL PROBLEM SOLVI, P11, DOI [10.1037/10805-001, DOI 10.1037/10805-001]; D'Zurilla TJ, 2002, MANUAL SOCIAL PROBLE; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Francis HM, 2017, BRAIN INJURY, V31, P336, DOI 10.1080/02699052.2016.1250954; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Goodglass H., 1972, ASSESSMENT APHASIA R; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Ivarsson A, 2013, PSYCHOL SPORT EXERC, V14, P97, DOI 10.1016/j.psychsport.2012.07.007; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Leclercq M, 2007, TRAUMATISME CRANIEN; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Mazaux J. M., 1982, BOSTON DIAGNOSTIC AP; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Moran LM, 2015, BRAIN INJURY, V29, P1682, DOI 10.3109/02699052.2015.1075140; Pfeiffer UJ, 2013, NEUROSCI BIOBEHAV R, V37, P2516, DOI 10.1016/j.neubiorev.2013.07.017; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Reitan R., 1979, TRAIL MAKING TEST; Robertson RH, 2008, NEUROPSYCHOL REHABIL, V18, P236, DOI 10.1080/09602010701734438; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Schmidt T, 2016, J CLIN EXP NEUROPSYC, V38, P974, DOI 10.1080/13803395.2016.1180346; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thoma P, 2015, PSYCHIAT RES, V228, P835, DOI 10.1016/j.psychres.2015.05.015; Tlustos SJ, 2016, REHABIL PSYCHOL, V61, P347, DOI 10.1037/rep0000098; Turkstra LS, 2018, NEUROPSYCHOLOGIA, V111, P117, DOI 10.1016/j.neuropsychologia.2018.01.016; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Van der Linden M, 1995, NEUROPSYCHOLOGIE TRA, P65	53	4	4	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2019	33	1			SI		40	47		10.1080/02699052.2018.1531306			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG2RW	WOS:000454812400006	30332550				2022-02-06	
J	Sweeney, JE; Johnson, AM				Sweeney, James Ernest; Johnson, Andrew M.			Halstead-Reitan characteristics of nonimpact and impact mTBI litigants and insurance claimants	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Diagnosis; etiology; Halstead-Reitan tests; impact brain injury; mild traumatic brain injury; neuropsychology; nonimpact brain injury	REACTION-TIME; BRAIN-INJURY; HEAD-INJURY; MILD	The purpose of this study was to investigate possible neuropsychological differences in Halstead-Reitan characteristics between motor vehicle accident litigants and insurance claimants that sustained uncomplicated mild traumatic brain injury (mTBI) and did or did not sustain direct impact to the head (i.e., Impact vs. Nonimpact mTBI), and to compare these clinical groups with a control group that did not suffer mTBI (No mTBI). The Tactile Form Recognition Test (TFR) was the only level of performance test in the Halstead-Reitan Battery (HRB) that generated statistically significant differences. The TFR resembles a complex reaction time test. TFR response time was significantly longer for Nonimpact mTBI patients than for Impact mTBI and No mTBI participants. Frequency comparisons of abnormal score patterns demonstrated that Nonimpact patients produced significantly more aberrant Impairment Index vs. FSIQ score patterns than Impact and No mTBI participants. Given the components of the score pattern, this finding suggests that Nonimpact patients may experience less recovery from neuropsychological deficits than Impact participants. Complex perceptual reaction times and score patterns comparing sensitive and "hold" test results may represent heuristic avenues of future research in the study of compensation-seeking Nonimpact and Impact mTBI patients.	[Johnson, Andrew M.] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada; [Sweeney, James Ernest] 401-242 Rideau St, Ottawa, ON K1N 0B7, Canada		Sweeney, JE (corresponding author), 401-242 Rideau St, Ottawa, ON K1N 0B7, Canada.	jsweeney@neuroinjury.com	Johnson, Andrew M/B-2048-2012	Johnson, Andrew M./0000-0002-7269-3016			ADAMS RL, 1981, J CONSULT CLIN PSYCH, V49, P298, DOI 10.1037/0022-006X.49.2.298; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Boone K.B., 2013, CLIN PRACTICE FORENS; BRAZZELLI M, 1994, CORTEX, V30, P27, DOI 10.1016/S0010-9452(13)80323-1; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; Henry G K, 2000, Appl Neuropsychol, V7, P65, DOI 10.1207/S15324826AN0702_1; Herring S., 1983, THESIS; Hirsch A. E., 1970, IMPACT INJURY CRASH, P352; HORTON AM, 2008, NEUROPSYCHOLOGY HDB, P345; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; HUMMEL TJ, 1971, PSYCHOL BULL, V76, P49, DOI 10.1037/h0031323; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; PARKER RS, 2001, CONCUSSIVE BRAIN TRA; ROSENHAN DL, 1973, SCIENCE, V179, P250, DOI 10.1126/science.179.4070.250; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1983, NEUROPSYCHOLOGIA, V21, P235, DOI 10.1016/0028-3932(83)90040-4; Sweeney J E, 1999, Appl Neuropsychol, V6, P79, DOI 10.1207/s15324826an0602_3; Sweeney JE, 2007, APPL NEUROPSYCHOL, V14, P65, DOI 10.1080/09084280701319763; Sweeney JE, 2017, APPL NEUROPSYCH-ADUL, V24, P446, DOI 10.1080/23279095.2016.1198909; Sweeney JE, 2017, APPL NEUROPSYCH-ADUL, V24, P169, DOI 10.1080/23279095.2015.1119694; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Varney N R, 1995, Appl Neuropsychol, V2, P47, DOI 10.1207/s15324826an0202_1; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wolfson, 1993, HALSTEAD REITAN NEUR	37	4	4	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 2	2019	26	1					65	75		10.1080/23279095.2017.1359783			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HR3RQ	WOS:000463057500007					2022-02-06	
J	Abdollahpour, I; Lizarraga, AA; Nedjat, S; Mansournia, MA; Weinstock-Guttman, B				Abdollahpour, Ibrahim; Lizarraga, Alexis A.; Nedjat, Saharnaz; Mansournia, Mohammad Ali; Weinstock-Guttman, Bianca			Medical History and Multiple Sclerosis: A Population-Based Incident Case-Control Study	NEUROEPIDEMIOLOGY			English	Article						Multiple sclerosis; Population-based incident case-control; Head injury; Autoimmune disease; Comorbidities; Medical history	AUTOIMMUNE-DISEASES; INCREASED RISK; HEAD-INJURY; PREVALENCE; ADOLESCENCE; CONCUSSION; GENETICS; TEHRAN; IRAN	Background: Consistent evidence regarding the potential role of medical history in multiple sclerosis (MS) etiology is lacking. Objective: The association of medical history variables, that is, head injury and 9 autoimmune diseases with MS onset was investigated. Methods: This was a population-based incident case-control study in Iran with 547 incident cases and 1,057 general population controls (August 7, 2013 - February 17, 2015). Multiple logistic regression models were used for estimating the adjusted ORs. Results: Lifetime history of head trauma was not significantly associated with risk of MS after adjustment for well-known confounders (OR 1.24 [0.93-1.66, p = 0.14]). Similarly, there was no statistically significant association between cumulative numbers of head injury and MS (OR 1.02 [0.90-1.15, p = 0.79]). A history of autoimmune disease did not increase the risk of MS (p > 0.1). Similarly, the cumulative number of autoimmune diseases is not significantly associated with the risk of MS (p > 0.70). Conclusion: Lifetime histories of head trauma as well as 9 investigated autoimmune diseases are not associated with increased risk of MS. (C) 2018 S. Karger AG, Basel	[Abdollahpour, Ibrahim] Arak Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Markazi 3818146851, Arak, Iran; [Lizarraga, Alexis A.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Nedjat, Saharnaz] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Weinstock-Guttman, Bianca] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Neurol, Buffalo, NY USA		Abdollahpour, I (corresponding author), Arak Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Markazi 3818146851, Arak, Iran.	ebrahemen@gmail.com	Weinstock-Guttman, Bianca/AAI-4694-2021; Abdollapour, Ibrahim/M-9329-2017	Weinstock-Guttman, Bianca/0000-0001-6732-151X; Abdollapour, Ibrahim/0000-0002-8607-4507	 [93-04-10-240/691]	We would like to sincerely thank Dr. Ingrid van der Mei for her intelligent comments and kind support in this project. The authors appreciate the cooperation of the staff members of the Iranian Multiple Sclerosis Society. This project has been a part of Ibrahim Abdollahpour's PhD dissertation in epidemiology (Dissertation Project Number: 93-04-10-240/691).	Abdollahpour I, 2018, ACTA NEUROL SCAND, V138, P308, DOI 10.1111/ane.12958; Abdollahpour I, 2018, NEUROEPIDEMIOLOGY, V50, P111, DOI 10.1159/000487640; Abdollahpour I, 2017, MULT SCLER J, V23, P1328, DOI 10.1177/1352458516677867; Al-Afasy HH, 2013, NEUROEPIDEMIOLOGY, V40, P30, DOI 10.1159/000341240; Alonso A, 2008, ACTA NEUROL SCAND, V117, P15, DOI 10.1111/j.1600-0404.2007.00898.x; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Charcot J. M., 1879, LECT DIS NERVOUS SYS; Chouhfeh L, 2015, MULT SCLER RELAT DIS, V4, P228, DOI 10.1016/j.msard.2015.02.004; Clagett B, 2013, AM J EPIDEMIOL, V178, P1638, DOI 10.1093/aje/kwt164; Cossburn M, 2011, NEUROLOGY, V77, P573, DOI 10.1212/WNL.0b013e318228bec5; Costelloe L, 2012, EXPERT REV NEUROTHER, V12, P335, DOI [10.1586/ern.12.5, 10.1586/ERN.12.5]; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Elhami SR, 2011, NEUROEPIDEMIOLOGY, V36, P141, DOI 10.1159/000324708; Etemadifar M, 2011, MULT SCLER J, V17, P1022, DOI 10.1177/1352458511401460; Fellner A, 2014, J NEUROL SCI, V338, P226, DOI 10.1016/j.jns.2014.01.003; Goldacre MJ, 2006, J NEUROL NEUROSUR PS, V77, P351, DOI 10.1136/jnnp.2005.077693; Gundersen DA, 2014, AM J EPIDEMIOL, V179, P39, DOI 10.1093/aje/kwt226; HARTGE P, 1984, AM J EPIDEMIOL, V120, P825, DOI 10.1093/oxfordjournals.aje.a113955; Henderson RD, 2000, J CLIN NEUROSCI, V7, P434, DOI 10.1054/jocn.2000.0693; Heydarpour P, 2014, MULT SCLER J, V20, P512, DOI 10.1177/1352458513494496; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kister I, 2012, MULT SCLER J, V18, P90, DOI 10.1177/1352458511416487; Langer-Gould A, 2010, MULT SCLER J, V16, P855, DOI 10.1177/1352458510369146; Lunny CA, 2014, J NEUROL SCI, V336, P13, DOI 10.1016/j.jns.2013.08.011; Marrie RA, 2015, MULT SCLER J, V21, P282, DOI 10.1177/1352458514564490; Milo R, 2010, AUTOIMMUN REV, V9, pA387, DOI 10.1016/j.autrev.2009.11.010; Montgomery S, 2017, ANN NEUROL, V82, P554, DOI 10.1002/ana.25036; Munger KL, 2009, NEUROLOGY, V73, P1543, DOI 10.1212/WNL.0b013e3181c0d6e0; Nielsen NM, 2008, MULT SCLER J, V14, P823, DOI 10.1177/1352458508088936; Patten SB, 2003, NEUROLOGY, V61, P1524, DOI 10.1212/01.WNL.0000095964.34294.B4; Pfleger CCH, 2009, MULT SCLER J, V15, P294, DOI 10.1177/1352458508099475; Pugliatti M, 2012, ACTA NEUROL SCAND, V126, P43, DOI 10.1111/ane.12032; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Rothman K.J., 2008, Modern epidemiology, V3rd; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; Warren SA, 2013, CAN J NEUROL SCI, V40, P168, DOI 10.1017/S0317167100013688; Wijnands JMA, 2017, ANN NEUROL, V82, P651, DOI 10.1002/ana.25061	39	4	4	1	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2019	52	1-2					55	62		10.1159/000494257			8	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	HM5KU	WOS:000459515400007	30476926				2022-02-06	
J	Abrahams, S; Mc Fie, S; Patricios, J; Suter, J; September, AV; Posthumus, M				Abrahams, Shameemah; Mc Fie, Sarah; Patricios, Jon; Suter, Jason; September, Alison V.; Posthumus, Michael			Toxic tau: The TAU gene polymorphisms associate with concussion history in rugby union players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						MAPT; Tau; Sports concussion; Rugby; Genetic association	PARKINSONS-DISEASE; AMYLOID-BETA; PROTEIN; MAPT	Objectives: Concussion is a brain injury that occurs when biomechanical forces are transmitted to the head region resulting in neurological deficits. The accumulation of tau protein in autopsies of athletes with multiple concussions implicates tau in concussion-associated neurodegeneration. The TAU rs2435211 (C > T) and rs2435200 (G >A) polymorphisms are involved in pathological tau expression and neurodegenerative disease risk. The aims of this study were to investigate the associations of TAU (rs2435211, rs2435200) polymorphisms with concussion history and sustaining multiple concussions in rugby. Design: In total, 140 non-concussed controls and 163 previously concussed participants (all cases group, N=163; clinically diagnosed, N =140; multiple concussed, N = 87) were recruited from high school (N =135, junior), club and professional rugby teams (N= 166, senior). Methods: Participants were genotyped for TAU rs2435211 and rs2435200 polymorphisms. Results: In seniors, the rs2435200 AA genotype was significantly over-represented in the control group compared to the multiple concussed subgroup (P = 0.033, control: 25%, N= 16, multiple concussed: 11%, N = 6; OR: 0.34, 95% CI 0.12-0.96). While the AG genotype was significantly under-represented in the control compared to multiple concussed (P = 0.024, control: 45%, N =29, multiple concussed: 63%, N =36; OR: 2.34, 95% CI 1.11-4.95). The inferred TAU (rs2435211 C >T-rs2435200 G >A) T-G haplotype was significantly under-represented in the control (19%, N =12) compared to the all cases group (30%, N = 28, P= 0.031). Conclusions: The TAU-associated neurodegenerative pathway was implicated as a potential pathophysiological mechanism underlying concussion in seniors. In future, the identification of TAU polymorphisms associated with concussion risk may assist clinical management and reduce risk of severe complications. (C) 2018 Published by Elsevier Ltd on behalf of Sports Medicine Australia.	[Abrahams, Shameemah; Mc Fie, Sarah; September, Alison V.; Posthumus, Michael] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med, Rondebosch, South Africa; [Patricios, Jon] Sports Concuss South Africa, Johannesburg, South Africa; [Patricios, Jon] Univ Pretoria, Sect Sports Med, Pretoria, South Africa; [Patricios, Jon] Univ Witwatersrand, Dept Emergency Med, Johannesburg, South Africa; [Suter, Jason] Sports Sci Inst, Cape Sports Med, Cape Town, South Africa		Posthumus, M (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med, Rondebosch, South Africa.	mposthumus@me.com		September, Alison V/0000-0003-0950-286X; Patricios, Jon/0000-0002-6829-4098; Abrahams, Shameemah/0000-0002-1120-678X	South African National Research FoundationNational Research Foundation - South Africa [90942, 93416:2015, 85534:2015]; Deutscher Akademischer Austausch Dienst (DAAD)Deutscher Akademischer Austausch Dienst (DAAD); South African National Research FoundationNational Research Foundation - South Africa; University of Cape Town	We would like to thank all the participants and respective authorities from the high schools, clubs, professional teams and medical practices for their time, effort and participation in our study. This study was funded by the South African National Research Foundation (A.V.S., grant number 90942), (M.P., grant numbers 93416:2015, 85534:2015). The South African National Research Foundation, the Deutscher Akademischer Austausch Dienst (DAAD) and the University of Cape Town funded S.A. and S.M.	Abrahams S, 2018, J SCI MED SPORT, V21, P117, DOI 10.1016/j.jsams.2017.06.004; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Biernacka JM, 2011, PARKINSONISM RELAT D, V17, P730, DOI 10.1016/j.parkreldis.2011.07.001; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Breedlove K.M., 2014, ATHL TRAIN SPORTS HL, V6, P1; Chung SJ, 2011, MOVEMENT DISORD, V26, P280, DOI 10.1002/mds.23376; Elias-Sonnenschein LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059676; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; GUILMETTE TJ, 1995, NEUROPSYCHOLOGY, V9, P338, DOI 10.1037/0894-4105.9.3.338; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Lee AJ, 1996, BRIT J SPORT MED, V30, P213, DOI 10.1136/bjsm.30.3.213; Little J, 2009, GENET EPIDEMIOL, V33, P581, DOI 10.1002/gepi.20410; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Panenka W, 2017, J NEUROTRAUM, V7; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; R Core Team, 2017, R LANG ENV STAT COMP; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Smet-Nocca C, 2008, BIOCHEMISTRY-US, V47, P6519, DOI 10.1021/bi7022283; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013	30	4	4	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JAN	2019	22	1					22	28		10.1016/j.jsams.2018.06.012			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HK3LJ	WOS:000457817700005	30554614				2022-02-06	
J	Alberts, JL; Modic, MT; Udeh, B; Dey, T; Cherian, K; Lu, XY; Figler, R; Russman, A; Linder, SM				Alberts, Jay L.; Modic, Michael T.; Udeh, Belinda; Dey, Tanujit; Cherian, Kay; Lu, Xiaoyang; Figler, Richard; Russman, Andrew; Linder, Susan M.			Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 143; value-based care; care pathway; concussion; mild traumatic brain injury; health economics; care algorithm	STATEMENT; SPORT; QUANTIFICATION	The evidence-informed standardization of care along disease lines is recommended to improve outcomes and reduce healthcare costs. The aim of this project is to 1) describe the development and implementation of the Concussion Carepath, 2) demonstrate the process of integrating technology in the form of a mobile application to enable the carepath and guide clinical decision-making, and 3) present data on the utility of the C3 app in facilitating decision-making throughout the injury recovery process. A multi-disciplinary team of experts in concussion care was formed to develop an evidence-informed algorithm, outlining best practices for the clinical management of concussion along three phases of recovery - acute, subacute, and post-concussive. A custom mobile application, the Cleveland Clinic Concussion (C3) app was developed and validated to provide a platform for the systematic collection of objective, biomechanical outcomes and to provide guidance in clinical decision-making in the field and clinical environments. The Cleveland Clinic Concussion app included an electronic incident report, assessment modules to measure important aspects of cognitive and motor function, and a return to play module to systematically document the six phases of post-injury rehabilitation. The assessment modules served as qualifiers within the carepath algorithm, driving referral for specialty services as indicated. Overall, the carepath coupled with the C3 app functioned in unison to facilitate communication among the interdisciplinary team, prevent stagnant care, and drive patients to the right provider at the right time for efficient and effective clinical management.	[Alberts, Jay L.; Cherian, Kay; Linder, Susan M.] Cleveland Clin Fdn, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Alberts, Jay L.] Cleveland Clin Fdn, Ctr Neurol Restorat, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Alberts, Jay L.; Modic, Michael T.; Udeh, Belinda; Lu, Xiaoyang] Cleveland Clin Fdn, Off Clin Transformat, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Alberts, Jay L.; Figler, Richard; Russman, Andrew; Linder, Susan M.] Cleveland Clin Fdn, Concuss Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Udeh, Belinda] Cleveland Clin Fdn, Neurol Inst Ctr Outcomes Res, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Dey, Tanujit] Cleveland Clin Fdn, Quantitat Hlth Sci, 9500 Euclid Ave, Cleveland, OH 44195 USA		Alberts, JL (corresponding author), Cleveland Clin Fdn, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Alberts, JL (corresponding author), Cleveland Clin Fdn, Ctr Neurol Restorat, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Alberts, JL (corresponding author), Cleveland Clin Fdn, Off Clin Transformat, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Alberts, JL (corresponding author), Cleveland Clin Fdn, Concuss Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.	albertj@ccf.org			Cleveland Clinic Athletic Trainers; Edward F. and Barbara A. Bell Family Endowed Chair	We wish to thank the Jason Cruickshank, Bob Gray, and the Cleveland Clinic Athletic Trainers for their support and assistance with data collection. This study was supported by the Edward F. and Barbara A. Bell Family Endowed Chair to JLA.	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Alberts JL, 2016, BRIDGE LINKING ENG S, V46, P23; Alberts JL., 2015, KINESIOL REV, V4, P39, DOI [10.1123/kr.2014-0080, DOI 10.1123/KR.2014-0080]; Bernstein JP., 2018, APPL NEUROPSYCH-ADUL, V2018, P1, DOI [10.1080/23279095.2017.1416471, DOI 10.1080/23279095.2017.1416471]; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Burke D., 2016, ASSESSMENT; Faul M, 2010, TRAUMATIC BRAIN INJU; Foundation ON, 2018, CONC CAR REC PATHW; Giza CC, 2013, NEUROLOGY; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Katzan IL, 2015, CIRC-CARDIOVASC QUAL, V8, pS179, DOI 10.1161/CIRCOUTCOMES.115.001808; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ozinga SJ, 2014, EXP BRAIN RES, V232, P3861, DOI 10.1007/s00221-014-4069-8; Porter ME, 2013, HARVARD BUS REV, V91, P24; Porter ME, 2013, HEALTH AFFAIR, V32, P516, DOI 10.1377/hlthaff.2012.0961; Rudick R. A., 2014, JOVE-J VIS EXP, V2014; Valovich McLeod, 2017, DEV NEUROPSYCHOL, P1, DOI DOI 10.1007/978-3-319-45438-2; Vander Vegt C., 2018, MED SCI SPORTS EXERC; Vanhaecht K, 2007, HEALTH SERV MANAG RE, V20, P189, DOI 10.1258/095148407781395964	22	4	4	0	3	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JAN	2019		143							e58962	10.3791/58962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK5NC	WOS:000458012000171	30735197				2022-02-06	
S	Alosco, ML; Stern, RA		Dekosky, ST; Asthana, S		Alosco, Michael L.; Stern, Robert A.			The long-term consequences of repetitive head impacts: Chronic traumatic encephalopathy	GERIATRIC NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							ALZHEIMERS ASSOCIATION WORKGROUPS; PROFESSIONAL SOCCER PLAYERS; LIFE COGNITIVE IMPAIRMENT; WHITE-MATTER INTEGRITY; BRAIN-INJURY; NATIONAL INSTITUTE; FOOTBALL PLAYERS; AXONAL INJURY; RECURRENT CONCUSSION; AMYLOID-BETA	Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with exposure to repetitive head impacts (RHI). Although described in boxers for almost a century, scientific and public interest in CTE grew tremendously following a report of postmortem evidence of CTE in the first former professional American football player in 2005. Neuropathologic diagnostic criteria for CTE have been defined, with abnormal perivascular deposition of hyperphosphorylated tau at the sulcal depths as the pathognomonic feature. CTE can currently only be diagnosed postmortem, but clinical research criteria for the in vivo diagnosis of CTE have been proposed. The clinical phenotype of CTE is still ill-defined and there are currently no validated biomarkers to support an in-life diagnosis of "Probable CTE." Many knowledge gaps remain regarding the neuropathologic and clinical make-up of CTE. An increased understanding of CTE is critical given the millions that could potentially be impacted by this disease. This chapter describes the state of the literature on CTE. The historical origins of CTE are first presented, followed by a comprehensive description of the neuropathologic and clinical features. The chapter concludes with discussion on future research directions, emphasizing the importance of diagnosing CTE during life to facilitate development of preventative and intervention strategies.	[Alosco, Michael L.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis Ctr, 72 E Concord St,Suite B7800, Boston, MA 02118 USA; [Alosco, Michael L.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, CTE Ctr, 72 E Concord St,Suite B7800, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA		Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis Ctr, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.; Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Neurol, CTE Ctr, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.	bobstern@bu.edu					Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Alosco ML, 2019, BRAIN IMAGING BEHAV; Armstrong RA, 2017, NEUROPATH APPL NEURO, V43, P154, DOI 10.1111/nan.12323; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beach TG, 2014, J NEUROPATH EXP NEUR, V73, P948, DOI 10.1097/NEN.0000000000000114; Beitz Janice M, 2014, Front Biosci (Schol Ed), V6, P65; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bowman KM, 1940, INJURIES SKULL BRAIN; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Carroll EJ, 1936, AM J MED SCI, V191, P706, DOI 10.1097/00000441-193619150-00014; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Epstein HT, 1999, BRAIN DEV-JPN, V21, P535, DOI 10.1016/S0387-7604(99)00066-2; Erlanger DM, 2015, BRAIN INJURY, V29, P171, DOI 10.3109/02699052.2014.965211; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gandy Sam, 2014, F1000Res, V3, P229, DOI 10.12688/f1000research.5372.1; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Harada R, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010007; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kang JH, 2015, ALZHEIMERS DEMENT, V11, P772, DOI 10.1016/j.jalz.2015.05.003; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Landau SM, 2013, J NUCL MED, V54, P70, DOI 10.2967/jnumed.112.109009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Martland HS, 1943, THER INT DIS, V3, P291; MAWDSLEY C, 1963, LANCET, V2, P795; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363, DOI 10.2174/187152709789541998; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pietrzak RH, 2015, JAMA PSYCHIAT, V72, P284, DOI 10.1001/jamapsychiatry.2014.2476; Pokharel Y, 2014, SOUTH MED J, V107, P633, DOI 10.14423/SMJ.0000000000000173; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Sephton CF, 2012, BIOL CHEM, V393, P589, DOI 10.1515/hsz-2012-0115; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Willeumier K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.67; Wright MJ, 2016, J CLIN EXP NEUROPSYC, V38, P561, DOI 10.1080/13803395.2016.1139057; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	167	4	4	2	2	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-805141-2; 978-0-12-804766-8	HAND CLINIC			2019	167						337	355		10.1016/B978-0-12-804766-8.00018-2			19	Geriatrics & Gerontology; Clinical Neurology	Book Citation Index – Science (BKCI-S)	Geriatrics & Gerontology; Neurosciences & Neurology	BQ8QQ	WOS:000621193100020	31753141				2022-02-06	
J	Bay, E; Chan, RR				Bay, Esther; Chan, Roxane Raffin			Mindfulness-Based Versus Health Promotion Group Therapy After Traumatic Brain Injury	JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES			English	Article							POST-CONCUSSION SYMPTOMS; STRESS REDUCTION; DEPRESSIVE SYMPTOMS; EMERGENCY-DEPARTMENT; SELF-COMPASSION; SEX-DIFFERENCES; ACTIVE CONTROL; MEDITATION; INTERVENTION; CONSEQUENCES	The current pre-and posttest intervention study is designed for individuals with chronic symptoms and stress associated with mild-to-moderate traumatic brain injury (TBI). The researchers' intent was to evaluate whether an 8-week mindfulness-based group therapy compared to health promotion active control group therapy reduces chronic stress, TBI symptoms, and depressive symptoms. Significant mean reductions in chronic stress and TBI depressive and general symptoms for individuals in the mindfulness group compared to the active control group were present, according to paired t test analyses. Further, while controlling for baseline scores, the mindfulness-based intervention group change score was greater compared to the control group using regression analyses. Results suggest that mindfulness-based group intervention for individuals with chronic difficulties after TBI is feasible and effective. Further study of this cost-effective and self-management approach to stress and symptom management is warranted and has the potential to be a broad-based intervention for early therapy after injury.	[Bay, Esther] Univ Michigan, Sch Nursing, 400 N Ingalls St,Room 2351, Ann Arbor, MI 48109 USA; [Chan, Roxane Raffin] Michigan State Univ, Coll Nursing, E Lansing, MI 48824 USA		Bay, E (corresponding author), Univ Michigan, Sch Nursing, 400 N Ingalls St,Room 2351, Ann Arbor, MI 48109 USA.	pdq@umich.edu			Janet Gatherer Boyles Endowment	The authors have disclosed no potential conflicts of interest, financial or otherwise. The authors are grateful for the financial support from the Janet Gatherer Boyles Endowment to the School of Nursing for this endeavor. In addition, they thank the neuropsychologists who provided support for their recruitment processes: Dr. Ned Kirsch and Dr. Denyce Kerner, as well as many students from the School of Nursing who provided technical assistance, and Dr. Janet Larson, who provided mentoring.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Auvergne L, 2016, PSYCHOSOM MED, V78, P68, DOI 10.1097/PSY.0000000000000253; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bay E, 2016, APPL NURS RES, V30, P90, DOI 10.1016/j.apnr.2015.11.003; Bay E, 2012, BRAIN INJURY, V26, P941, DOI 10.3109/02699052.2012.666365; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bay EH, 2014, J NEUROSCI NURS, V46, P142, DOI 10.1097/JNN.0000000000000048; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Bedard Michel, 2012, Adv Mind Body Med, V26, P14; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Berben L, 2012, INT J NURS STUD, V49, P1039, DOI 10.1016/j.ijnurstu.2012.01.015; Bormann Jill E, 2006, J Contin Educ Nurs, V37, P218; Branstrom R, 2011, BRIT J HEALTH PSYCH, V16, P300, DOI 10.1348/135910710X501683; Breines JG, 2012, PERS SOC PSYCHOL B, V38, P1133, DOI 10.1177/0146167212445599; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Centers for Disease Control and Prevention, 2015, HEADS UP HLTH CAR PR; Cohen S, 1995, MEASURING STRESS GUI; Cole MA, 2015, MIL MED, V180, P956, DOI 10.7205/MILMED-D-14-00581; Crawford C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/747694; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Ditto B, 2006, ANN BEHAV MED, V32, P227, DOI 10.1207/s15324796abm3203_9; Doll A, 2016, NEUROIMAGE, V134, P305, DOI 10.1016/j.neuroimage.2016.03.041; Eliyahu L, 2016, ACAD EMERG MED, V23, P531, DOI 10.1111/acem.12924; Fan YX, 2014, STRESS HEALTH, V30, P65, DOI 10.1002/smi.2497; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Grossman P, 2003, J PSYCHOSOM RES, V55, P491, DOI 10.1016/S0022-3999(03)00074-6; Hughes JW, 2013, PSYCHOSOM MED, V75, P721, DOI 10.1097/PSY.0b013e3182a3e4e5; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Kessler D, 2017, J CLIN NURS, V26, P3256, DOI 10.1111/jocn.13701; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lau MA, 2005, CAN J PSYCHIAT, V50, P863, DOI 10.1177/070674370505001310; Leary MR, 2007, J PERS SOC PSYCHOL, V92, P887, DOI 10.1037/0022-3514.92.5.887; Ludman EJ, 2016, PSYCHIAT SERV, V67, P29, DOI 10.1176/appi.ps.201400295; MacCoon DG, 2012, BEHAV RES THER, V50, P3, DOI 10.1016/j.brat.2011.10.011; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Masel BE, 2015, J NEUROTRAUM, V32, P1833, DOI 10.1089/neu.2015.29004.bm; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Musekamp G, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0486-5; Nijjar PS, 2014, INT J CARDIOL, V177, P557, DOI 10.1016/j.ijcard.2014.08.116; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Ogier M, 2017, J NEUROTRAUM, V34, P1645, DOI 10.1089/neu.2016.4741; Ory MG, 2014, HEALTH EDUC BEHAV, V41, p34S, DOI 10.1177/1090198114543008; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Rajesh A, 2017, J NEUROTRAUM, V34, P3280, DOI 10.1089/neu.2017.5047; Ritter PL, 2014, TRANSL BEHAV MED, V4, P398, DOI 10.1007/s13142-014-0277-9; Rosenkranz MA, 2013, BRAIN BEHAV IMMUN, V27, P174, DOI 10.1016/j.bbi.2012.10.013; Ryan P, 2009, NURS OUTLOOK, V57, P217, DOI 10.1016/j.outlook.2008.10.004; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Smith ML, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060638; Tang YY, 2012, TRENDS COGN SCI, V16, P330, DOI 10.1016/j.tics.2012.05.001; Taren AA, 2017, PSYCHOSOM MED, V79, P674, DOI 10.1097/PSY.0000000000000466; Taylor AG, 2010, EXPLORE-NY, V6, P29, DOI 10.1016/j.explore.2009.10.004; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Witkiewitz K, 2013, PSYCHOL ADDICT BEHAV, V27, P351, DOI 10.1037/a0029258	72	4	4	0	18	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0279-3695	1938-2413		J PSYCHOSOC NURS MEN	J. Psychosoc. Nurs. Ment. Health Serv.	JAN	2019	57	1					26	33		10.3928/02793695-20180924-03			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	HH1MN	WOS:000455484100005	30272810				2022-02-06	
J	Bianchi, E; Erba, G; Beghi, E; Giussani, G				Bianchi, Elisa; Erba, Giuseppe; Beghi, Ettore; Giussani, Giorgia			Self-reporting versus clinical scrutiny: the value of adding questionnaires to the routine evaluation of seizure disorders. An exploratory study on the differential diagnosis between epilepsy and psychogenic nonepileptic seizures	EPILEPSY & BEHAVIOR			English	Article						Patient questionnaires; Witness questionnaires; Clinical scrutiny; Epileptic seizures; Psychogenic seizures; Chart review	ACCURACY; MANIFESTATIONS	Questionnaires or symptom lists have proved effective for differentiating epileptic seizures (ES) from psychogenic nonepileptic seizures (PNES). However, monitoring the events, corroborated by medical history gathered by experts, remains the gold standard. We directly compared symptoms and characteristic of the events self-reported by patients/eyewitnesses (Questionnaire A/B) with the information contained in the clinical charts of 50 patients with undefined diagnosis undergoing long-term monitoring. Data extracted from medical records were reformatted to fit the questionnaires' templates (A1/B1) for comparison. Quantitatively, self-reported information was considerably greater and more complete. Calculating sensitivity (SE) and specificity (SP) of all variables in the group with confirmed diagnosis, we identified those above the preset thresholds with the potential to discriminate between ES and PNES. Eight predictive variables were common to both methods: head injury, physical/emotional abuse, chronic fatigue (A): talked out of seizures, eyes closed, apnea, and collapsing (B). Eleven predictive variables were specific to direct questioning: preictal headache, bright light, feeling overwhelmed, heart racing, tingling and numbness, postictal trouble speaking, physical pain, history of gastroesophageal reflux disease (GERD), self-inflicted injuries (A); on/off shaking, and side-to-side head movements (B). Thirteen predictive variables were generated by chart review: sleep deprivation, strong emotions/anxiety, preictal headache (warning), nausea/vomiting, history of PNES, cholecystectomy, depression, medications for behavioral problems (A1), sudden start/sudden stop of shaking, both sides shaking, falling during the seizure, feeling confused and disoriented postictally (B1). Conclusion: Self-reporting and clinical scrutiny are complementary. Structured questionnaires increase the range of predictive variables and should be utilized routinely to facilitate clinicians' quest for the correct diagnosis. (C) 2018 Elsevier Inc. All rights reserved.	[Bianchi, Elisa; Beghi, Ettore; Giussani, Giorgia] IRCCS, Ist Ric Farmacol Mario Negri, Lab Neurol Disorders, Dept Neurosci, Via Giuseppe La Masa 19, I-20156 Milan, Italy; [Erba, Giuseppe] Univ Rochester, Dept Neurol, Rochester, NY USA		Beghi, E (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, Lab Neurol Disorders, Dept Neurosci, Via Giuseppe La Masa 19, I-20156 Milan, Italy.	ettore.beghi@marionegri.it	Giussani, Giorgia/E-8057-2017; Giussani, Giorgia/AAA-8029-2020; Beghi, Ettore/AAA-7426-2020; Bianchi, Elisa/ABF-8173-2020	Giussani, Giorgia/0000-0003-2460-3095; Giussani, Giorgia/0000-0003-2460-3095; Beghi, Ettore/0000-0003-2542-0469; Bianchi, Elisa/0000-0002-0279-0128			Alessi R, 2013, EPILEPSY BEHAV, V26, P91, DOI 10.1016/j.yebeh.2012.10.011; An DM, 2010, EPILEPSY BEHAV, V17, P408, DOI 10.1016/j.yebeh.2010.01.003; Asadi-Pooya AA, 2013, J NEUROL SCI, V332, P66, DOI 10.1016/j.jns.2013.06.016; Cronje G, 2013, EPILEPSY BEHAV, V29, P581, DOI 10.1016/j.yebeh.2013.09.045; De Paola L, 2016, EPILEPSY BEHAV, V54, P40, DOI 10.1016/j.yebeh.2015.10.025; Erba G, 2017, SEIZURE-EUR J EPILEP, V53, P66, DOI 10.1016/j.seizure.2017.11.001; Farghaly WMA, 2013, SEIZURE-EUR J EPILEP, V22, P611, DOI 10.1016/j.seizure.2013.04.010; Besocke AG, 2009, EPILEPSY BEHAV, V16, P551, DOI 10.1016/j.yebeh.2009.09.015; Hingray C, 2018, EPILEPSIA, V59, P203, DOI 10.1111/epi.13952; Kanemoto Kousuke, 2017, Epilepsia Open, V2, P307, DOI 10.1002/epi4.12060; Kerr WT, 2017, EPILEPSIA, V58, P1852, DOI 10.1111/epi.13888; Reuber M, 2004, J NEUROL NEUROSUR PS, V75, P743, DOI 10.1136/jnnp.2003.013821; Reuber M, 2011, EPILEPSIA, V52, P2028, DOI 10.1111/j.1528-1167.2011.03162.x; Rosemergy I, 2013, EPILEPSY BEHAV, V27, P81, DOI 10.1016/j.yebeh.2012.12.024; Rugg-Gunn FJ, 2001, EPILEPSY RES, V43, P193, DOI 10.1016/S0920-1211(00)00209-6; Sharrack S, 2015, NEUROLOGY S14, V84, P5; Syed TU, 2009, NEUROLOGY, V72, P1646, DOI 10.1212/WNL.0b013e3181a55ef7; Syed TU, 2008, EPILEPSIA, V49, P898, DOI 10.1111/j.1528-1167.2007.01456.x; Syed TU, 2011, ANN NEUROL, V69, P997, DOI 10.1002/ana.22345; Thijs RD, 2008, NEUROLOGY, V71, P1713, DOI 10.1212/01.wnl.0000335165.68893.b0	20	4	5	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JAN	2019	90						191	196		10.1016/j.yebeh.2018.11.040			6	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	HI8RF	WOS:000456722900033	30578096				2022-02-06	
J	Biese, KM; Pietrosimone, LE; Andrejchak, M; Lynall, RC; Wikstrom, EA; Padua, DA				Biese, Kevin M.; Pietrosimone, Laura E.; Andrejchak, Morgan; Lynall, Robert C.; Wikstrom, Erik A.; Padua, Darin A.			Preliminary Investigation on the Effect of Cognition on Jump-Landing Performance Using a Clinically Relevant Setup	MEASUREMENT IN PHYSICAL EDUCATION AND EXERCISE SCIENCE			English	Article						Dual-task; healthy; jump-landing; LESS; cognition; clinical	CRUCIATE LIGAMENT INJURY; ERROR SCORING SYSTEM; EXTREMITY MUSCULOSKELETAL INJURY; PREVENTION PROGRAM; POSTURAL CONTROL; CONCUSSION INCREASES; ATTENTIONAL DEMANDS; ASSESSMENT TOOL; WORKING-MEMORY; TASK	Objective: Little is known about cognition's effect on jump-landing movement patterns. Design: Participants completed three baseline cognitive tasks. Then, participants performed three jump-landing trials per condition (dual-task trials (DT)): Stroop Color Word test (SCWT), Symbol Digits Modalities test (SDMT), Brooks Visuospatial task (BVT), and no concurrent cognitive task (singletask). Main Outcome Measures: Total Landing Error Scoring System (LESS) scores were used to evaluate movement patterns. Participant's reaction time (RT) for the jump-landing task was recorded. Results: LESS scores were not different between conditions (F-3, (17) = 1.77, p = 0.16). RT was different between DT-SCWT and single-task (difference = -0.107 sec, SD = 0.095) and DT-SDMT and single-task (difference = -0.164 sec, SD = 0.245). Additionally, correctness on the BVT (t(19) = 2.57, p = 0.019) and SDMT (t(19) = 2.93, p = 0.009) decreased significantly during the dual-task condition relative to baseline task scores. Conclusion: Individuals slowed their RT and were less accurate on the cognitive task during a dual-task condition to create an appropriate jump-landing movement.	[Biese, Kevin M.] Univ Wisconsin, Dept Kinesiol, Madison, WI USA; [Biese, Kevin M.; Pietrosimone, Laura E.; Andrejchak, Morgan; Wikstrom, Erik A.; Padua, Darin A.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27514 USA; [Pietrosimone, Laura E.; Andrejchak, Morgan] Duke Univ, Dept Orthopaed Surg, Durham, NC USA; [Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA		Padua, DA (corresponding author), Univ N Carolina, 101 Student Recreat Ctr 8610, Chapel Hill, NC 27514 USA.	dpadua@email.unc.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640			Bell DR, 2014, J ATHL TRAINING, V49, P435, DOI 10.4085/1062-6050-49.3.21; Boden BP, 2010, J AM ACAD ORTHOP SUR, V18, P520, DOI 10.5435/00124635-201009000-00003; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Can RG, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00871; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; DiStefano LJ, 2009, AM J SPORT MED, V37, P495, DOI 10.1177/0363546508327542; DUFEK JS, 1991, SPORTS MED, V12, P326, DOI 10.2165/00007256-199112050-00005; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Fabri TL, 2017, GAIT POSTURE, V54, P154, DOI 10.1016/j.gaitpost.2017.03.002; Fraizer EV, 2008, GAIT POSTURE, V27, P271, DOI 10.1016/j.gaitpost.2007.04.002; Grabiner Mark D, 2005, J Neuroeng Rehabil, V2, P25, DOI 10.1186/1743-0003-2-25; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Herman DC, 2016, AM J SPORT MED, V44, P2347, DOI 10.1177/0363546516657338; Hwang JH, 2013, ANN REHABIL MED-ARM, V37, P347, DOI 10.5535/arm.2013.37.3.347; Ikeda Y, 2014, MOTOR CONTROL, V18, P76, DOI 10.1123/mc.2012-0108; Khateb A, 2000, NEUROREPORT, V11, P1849, DOI 10.1097/00001756-200006260-00010; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Lin MIB, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00092; Lombard W, 2017, MEAS PHYS EDUC EXERC, V21, P235, DOI 10.1080/1091367X.2017.1354215; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Madehkhaksar F, 2016, GAIT POSTURE, V43, P114, DOI 10.1016/j.gaitpost.2015.09.009; Markbreiter JG, 2015, J SPORT REHABIL, V24, P214, DOI 10.1123/jsr.2013-0135; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mitra S, 2004, HUM MOVEMENT SCI, V23, P1, DOI 10.1016/j.humov.2004.03.003; Motl RW, 2014, GAIT POSTURE, V39, P870, DOI 10.1016/j.gaitpost.2013.11.023; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Padua DA, 2015, J ATHL TRAINING, V50, P589, DOI 10.4085/1062-6050-50.1.10; Padua DA, 2012, AM J SPORT MED, V40, P300, DOI 10.1177/0363546511425474; Padua DA, 2011, J SPORT REHABIL, V20, P145, DOI 10.1123/jsr.20.2.145; Padua DA, 2009, AM J SPORT MED, V37, P1996, DOI 10.1177/0363546509343200; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Perrochon A, 2013, CLIN INTERV AGING, V8, P317, DOI 10.2147/CIA.S38667; Polskaia N, 2016, J MOTOR BEHAV, V48, P482, DOI 10.1080/00222895.2015.1134435; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; SALWAY AFS, 1995, BRIT J PSYCHOL, V86, P253, DOI 10.1111/j.2044-8295.1995.tb02560.x; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Soangra R, 2017, APPL BIONICS BIOMECH, V2017, DOI 10.1155/2017/1014784; Spiegel MA, 2013, J EXP PSYCHOL HUMAN, V39, P1326, DOI 10.1037/a0031398; Sun RP, 2016, EXP BRAIN RES, V234, P1047, DOI 10.1007/s00221-015-4534-z; TAIMELA S, 1990, J SPORT MED PHYS FIT, V30, P194; Talarico MK, 2017, J SPORT SCI, V35, P1118, DOI 10.1080/02640414.2016.1211307; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Yom JP, 2019, SPORT BIOMECH, V18, P414, DOI 10.1080/14763141.2017.1409795; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585	48	4	4	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1091-367X	1532-7841		MEAS PHYS EDUC EXERC	Meas. Phys. Educ. Exerc. Sci.		2019	23	1					78	88		10.1080/1091367X.2018.1518875			11	Education & Educational Research; Hospitality, Leisure, Sport & Tourism; Sport Sciences	Social Science Citation Index (SSCI)	Education & Educational Research; Social Sciences - Other Topics; Sport Sciences	IB0KA	WOS:000469945900009					2022-02-06	
J	Brown, J; Wollersheim, M				Brown, Jessica; Wollersheim, Madeline			Exploring assistive technology use to support cognition in college students with histories of mild traumatic brain injury	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Cognitive supports; mild traumatic brain injury; task execution; person-centred treatment	UNIVERSAL DESIGN; POPULATION; CONCUSSION; STATEMENT; SCHOOL	Purpose: College students with mild traumatic brain injury (mTBI) may experience chronic cognitive deficits necessitating use of external supports for daily task completion. The purpose of this study was to explore cognitive support system selection and use by students with histories of mTBI when completing novel prospective memory tasks. Materials and methods: We implemented a multiple case study, sequential explanatory mixed-methods design with three participants. Participants completed four experimental phases: (1) background history collection, cognitive assessment completion, pre-trial interview, and selection of two external supports for trial phase use; (2) trial Phase 1 (i.e., 10-days); (3) trial Phase 2 (i.e., 10days); and (4) post-trial exit interview. We examined participants' support type and characteristic preferences and evaluated task execution accuracy when implementing differing supports. Results: Participants expressed both collective and unique cognitive aid preferences before trial completion. Trial phase results revealed that task completion accuracy did not alter substantially between trials; however, personal preferences and perceived usefulness of trialled cognitive aid systems appeared to impact support implementation and effectiveness. Themes emerged from post-trial interview relating to the (a) necessity for differing functions of individual systems and (b) importance of trialling devices prior to selection. Conclusions: Results emphasize the necessity of person-centred approaches to treatment due to the variability of performance accuracy and system preferences. The cognitive aid selection and implementation intervention protocol piloted in this study appears beneficial for understanding unique strengths and challenges for college students following mTBI and may be useful for clinicians working with individuals with mTBI.	[Brown, Jessica; Wollersheim, Madeline] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ USA		Brown, J (corresponding author), 1131 E 2nd St, Tucson, AZ 85721 USA.	jessicabrown@email.arizona.edu			Undergraduate Research Opportunity Program at the University of Minnesota	This work was supported in part by the Undergraduate Research Opportunity Program at the University of Minnesota. The award was provided to the second author (i.e., Madeline Wollersheim) for her work on the project.	Aldrich EM, 2012, CAN J SCH PSYCHOL, V27, P291, DOI 10.1177/0829573512455016; ANDRZEJEWSKI SJ, 1991, B PSYCHONOMIC SOC, V29, P304; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; Brown J., 2015, AM SPEECH LANG HEAR; Brown J, 2017, NEUROREHABILITATION, V41, P483, DOI 10.3233/NRE-162065; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P45; Claes C, 2010, INTELLECT DEV DISAB, V48, P432, DOI 10.1352/1934-9556-48.6.432; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Hagner D, 1996, MENT RETARD, V34, P159; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hux K., 2017, CURRENT RES CONCUSSI, V4, pE14, DOI [10.1055/s-0037-1606578, DOI 10.1055/S-0037-1606578]; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Jensen GM, 2000, PHYS THER, V80, P28, DOI 10.1093/ptj/80.1.28; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Krause M, 2014, BRAIN INJURY, V28, P1301, DOI 10.3109/02699052.2014.916416; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Lasker JP, 2001, AAC AUGMENTATIVE ALT, V17, P141, DOI DOI 10.1080/AAC.17.3.141.153; Martella R. C., 2013, UNDERSTANDING INTERP; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Moffatt K, 2004, P SIGCHI C HUM FACT; O'Brien CL, 1997, MENT RETARD, V35, P480; O'Brien CL, 2000, PERSON CTR PLANNING, P2; Pisha B, 2001, REM SPEC EDUC, V22, P197, DOI 10.1177/074193250102200402; Rose D., 2000, J SPEC EDUC TECHNOL, V15, P47; Scott SS, 2003, REM SPEC EDUC, V24, P369, DOI 10.1177/07419325030240060801; Silver P., 1998, EQUITY EXCELLENCE, V31, P47, DOI [https://doi.org/10.1080/1066568980310206, DOI 10.1080/1066568980310206]; Steere DE., 1997, QUALITY LIFE, V2, P5; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Wagner M, 2005, HIGH SCH 1 LOOK POST, P190; [No title captured]	39	4	4	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2019	14	3					255	266		10.1080/17483107.2018.1428371			12	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	HX9ZT	WOS:000467768900008	29350084				2022-02-06	
J	Brown, J; Clark, D; Pooley, A				Brown, Joshua; Clark, Dessie; Pooley, Apryl			Exploring the Use of Neurofeedback Therapy in Mitigating Symptoms of Traumatic Brain Injury in Survivors of Intimate Partner Violence	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Traumatic brain injury; interpersonal violence; neurofeedback therapy; postconcussive syndrome; domestic violence; quantitative EEG; depression; mental health	PEAK ALPHA-FREQUENCY; QUANTITATIVE EEG; BATTERED WOMEN; HEAD-INJURY; BIOFEEDBACK; ASYMMETRY; PTSD; CONSEQUENCE; DEPRESSION; ATTENTION	Traumatic Brain Injury (FBI) is an injury to the brain caused by an acute injury to the head, neck, or face, such as a blunt force trauma. Survivors of Intimate Partner Violence (IPV) are at high risk for TBI, given how frequently they are repeatedly struck in the head. An abundance of evidence indicates that even "mild" TBI can have lifelong impacts, including personality and behavioral changes. TBI often goes undiagnosed in survivors as most do not seek medical treatment for their injuries. Given the lack of diagnoses, these symptoms may often be overlooked or misunderstood. One emerging method for treating the symptoms of TBI is neurofeedback (NF). NF is a type of biofeedback that uses operant conditioning to regulate activity in various regions of the brain. NF can lead to better cognitive performance and emotional self-regulation. Given the potentially high rate of TBI in IPV, it is worth exploring if NF can reduce the symptoms that negatively impact survivors. The current study explores the use of NF to treat IPV survivors who experienced head injury and, as such, probable TBI (N = 32). Survivors participated in a quantitative EEG (qEEG) to locate problem areas of the brain and participated in assessments, before and after treatment, to examine constructs such as depression and Post-Traumatic Stress Disorder (PTSD). Results show significant differences in both the qEEG data and written assessments following the completion of NF. These results suggest NF could mitigate symptoms of probable TBI in IPV survivors.	[Brown, Joshua] Michigan State Univ, Ft Bend Womens Ctr, E Lansing, MI 48824 USA; [Clark, Dessie] Michigan State Univ, Dept Psychol, 316 W Phys Rd, E Lansing, MI 48824 USA; [Pooley, Apryl] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA		Clark, D (corresponding author), Michigan State Univ, Dept Psychol, 316 W Phys Rd, E Lansing, MI 48824 USA.	clarkd53@msu.edu			Texas Health and Human Services Commission [529-15-0006]; George Foundation; Simmons Foundation	This work was supported by the Texas Health and Human Services Commission under grant number [529-15-0006]; The George Foundation; and The Simmons Foundation.	Ackerman RJ, 2003, WOMEN THER, V26, P343, DOI 10.1300/J015v26n03_11; Allen JJB, 2001, PSYCHOPHYSIOLOGY, V38, P685, DOI 10.1111/1469-8986.3840685; Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; Arns M, 2012, APPL PSYCHOPHYS BIOF, V37, P171, DOI 10.1007/s10484-012-9191-4; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Banks ME, 2002, WOMEN THER, V25, P133, DOI 10.1300/J015v25n03_10; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Brewer TL, 2002, RES NURS HEALTH, V25, P269, DOI 10.1002/nur.10045; Burkett SV, 2005, J NEUROTHERAPY, V9, P27, DOI DOI 10.1300/J184v09n02_03; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Clark CR, 2009, CLIN EEG NEUROSCI, V40, P84, DOI 10.1177/155005940904000208; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; Duric NS, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-107; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gordon E, 2010, CLIN EEG NEUROSCI, V41, P178, DOI 10.1177/155005941004100404; Hagemann D, 2001, PSYCHOPHYSIOLOGY, V38, P847, DOI 10.1111/1469-8986.3850847; Hammond DC, 2010, APPL PSYCHOPHYS BIOF, V35, P31, DOI 10.1007/s10484-009-9106-1; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Jackson H, 2004, AP PRA H PS, P233; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kluetsch RC, 2014, ACTA PSYCHIAT SCAND, V130, P123, DOI 10.1111/acps.12229; Koberda JL., 2015, J NEUROL NEUROBIOL, V1, P1, DOI [10.16966/2379-7150.113., DOI 10.16966/2379-7150.113]; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lobo I, 2015, J AFFECT DISORDERS, V183, P210, DOI 10.1016/j.jad.2015.05.015; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Metzger LJ, 2004, J ABNORM PSYCHOL, V113, P324, DOI 10.1037/0021-843X.113.2.324; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Muelleman RL, 1998, AM J EMERG MED, V16, P128, DOI 10.1016/S0735-6757(98)90028-6; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; PASSINI FT, 1977, J CLIN PSYCHOL, V33, P292, DOI 10.1002/1097-4679(197701)33:1+<292::AID-JCLP2270330166>3.0.CO;2-L; Peeters F, 2014, INT J PSYCHOPHYSIOL, V93, P116, DOI 10.1016/j.ijpsycho.2013.06.010; PENISTON EG, 1989, ALCOHOL CLIN EXP RES, V13, P271, DOI 10.1111/j.1530-0277.1989.tb00325.x; Peniston EG, 1999, INTRO QUANTITATIVE E, P157, DOI [10.1016/B978-012243790-8/50008-0, DOI 10.1016/B978-012243790-8/50008-0]; Pigott H. E., 2013, J NEUROTHERAPY, V17, P93, DOI [10.1080/10874208.2013.785178, DOI 10.1080/10874208.2013.785178]; Rhodes KV, 2011, J GEN INTERN MED, V26, P894, DOI 10.1007/s11606-011-1662-4; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Simkin DR, 2014, CHILD ADOL PSYCH CL, V23, P427, DOI 10.1016/j.chc.2014.03.001; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Stevens M.R., 2011, NATL INTIMATE PARTNE; Surmeli T, 2017, CLIN EEG NEUROSCI, V48, P217, DOI 10.1177/1550059416654849; Thatcher R. W., 2003, Journal of Neurotherapy, V7, P87, DOI 10.1300/J184v07n03_05; Thatcher R.W., 2010, J NEUROTHER, V14, P122; Thatcher RW, 2000, CLIN ELECTROENCEPHAL, V31, P38, DOI 10.1177/155005940003100110; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4; van der Kolk BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166752; Wahbeh H, 2013, APPL PSYCHOPHYS BIOF, V38, P57, DOI 10.1007/s10484-012-9208-z; Walker JE, 2010, APPL PSYCHOPHYS BIOF, V35, P25, DOI 10.1007/s10484-009-9107-0; Wigton NL, 2019, J ATTEN DISORD, V23, P398, DOI 10.1177/1087054715577135; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333	55	4	4	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2019	28	6			SI		764	783		10.1080/10926771.2019.1603176			20	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	IM2YW	WOS:000477859700008					2022-02-06	
J	Catharine, V; Helena, V; Ellen, D; Guy, V; Karel, D; Karen, C				Catharine, Vander Linden; Helena, Verhelst; Ellen, Deschepper; Guy, Vingerhoets; Karel, Deblaere; Karen, Caeyenberghs			Exploration of gray matter correlates of cognitive training benefit in adolescents with chronic traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Pediatric traumatic brain injury; Cognitive rehabilitation; Gray matter; Neural plasticity; Executive function; Linear mixed model analyses	HUMAN CEREBRAL-CORTEX; BASAL GANGLIA VOLUME; FALSE DISCOVERY RATE; EXECUTIVE FUNCTION; CORTICAL THICKNESS; LONGITUDINAL CHANGES; INTRACRANIAL VOLUME; SUBCORTICAL VOLUMES; PARENT RATINGS; FAMILY INCOME	Sustaining a traumatic brain injury (FBI) during adolescence has a profound effect on brain development and can result in persistent executive functioning deficits in daily life. Cognitive recovery from pediatric-TBI relies on the potential of neuroplasticity, which can be fostered by restorative training-programs. However the structural mechanisms underlying cognitive recovery in the immature brain are poorly understood. This study investigated gray matter plasticity following 2 months of cognitive training in young patients with TBI. Sixteen adolescents in the chronic stage of moderate-severe-TBI (9 male, mean age = 15y8m +/- 1y7m) were enrolled in a cognitive computerized training program for 8 weeks (5 times/week, 40 min/session). Pre-and post-intervention, and 6 months after completion of the training, participants underwent a comprehensive neurocognitive test-battery and anatomical Magnetic Resonance Imaging scans. We selected 9 cortical-subcortical Regions-Of-Interest associated with Executive Functioning (EF-ROIs) and 3 control regions from the Desikan-Killiany atlas. Baseline analyses showed significant decreased gray matter density in the superior frontal gyri p = 0.033, superior parietal gyri p = 0.015 and thalamus p = 0.006 in adolescents with TBI compared to age and gender matched controls. Linear mixed model analyses of longitudinal volumetric data of the EF-ROI revealed no strong evidence of training-related changes in the group with TBI. However, compared to the change over time in the control regions between post-intervention and 6 months follow-up, the change in the EF-ROIs showed a significant difference. Exploratory analyses revealed a negative correlation between the change on the Digit Symbol Substitution test and the change in volume of the putamen (r = - 0.596, p = 0.015). This preliminary study contributes to the insights of training-related plasticity mechanisms after pediatric-TBI.	[Catharine, Vander Linden] Ghent Univ Hosp, Child Rehabil Ctr K7, Corned Heymanslaan 10, B-9000 Ghent, Belgium; [Helena, Verhelst; Guy, Vingerhoets] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Henri Dunantlaan 2, B-9000 Ghent, Belgium; [Ellen, Deschepper] Univ Ghent, Biostat Unit, Dept Publ Hlth, Comeel Heymanslaan 10, B-9000 Ghent, Belgium; [Karel, Deblaere] Ghent Univ Hosp, Dept Neuroradiol, Comeel Heymanslaan 10, B-9000 Ghent, Belgium; [Karen, Caeyenberghs] Australian Catholic Univ, Mary McKillop Inst Hlth Res, Level 5,215 Spring St, Melbourne, Vic 3000, Australia		Catharine, V (corresponding author), Ghent Univ Hosp, Child Rehabil Ctr K7, Corned Heymanslaan 10, B-9000 Ghent, Belgium.	catharine.vanderlinden@uzgent.be; helena.verhelst@ugent.be; ellen.deschepper@ugent.be; guy.vingerhoets@ugent.be; karel.deblaere@uzgent.be; karen.caeyenberghs@acu.edu.au		Verhelst, Helena/0000-0002-6861-0249	Special Research Fund (BOF) from Ghent University, Belgium [01 N00214]	This research was supported by a grant (01 N00214) from the Special Research Fund (BOF) from Ghent University, Belgium.	Alcauter S, 2014, J NEUROSCI, V34, P9067, DOI 10.1523/JNEUROSCI.0796-14.2014; Anderson V, 2009, DEV NEUROREHABIL, V12, P253, DOI 10.3109/17518420903086899; Andre J, 2016, NEUROIMAGE-CLIN, V12, P940, DOI 10.1016/j.nicl.2015.12.002; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Arsalidou M, 2013, HUM BRAIN MAPP, V34, P3031, DOI 10.1002/hbm.22124; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Bettcher BM, 2016, NEUROPSYCHOLOGIA, V85, P100, DOI 10.1016/j.neuropsychologia.2016.03.001; Breukelaar IA, 2017, HUM BRAIN MAPP, V38, P631, DOI 10.1002/hbm.23401; Brooks SJ, 2016, NEUROIMAGE-CLIN, V12, P478, DOI 10.1016/j.nicl.2016.08.019; Caeyenberghs K, 2018, NEUROREHAB NEURAL RE, V32, P99, DOI 10.1177/1545968317753076; Catani M, 2012, CORTEX, V48, P1262, DOI 10.1016/j.cortex.2012.07.001; Chevignard M, 2016, ANN PHYS REHABIL MED, V59, pe133; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; Dennison M, 2013, DEVELOPMENTAL SCI, V16, P772, DOI 10.1111/desc.12057; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diez-Cirarda M, 2017, BRAIN IMAGING BEHAV, V11, P1640, DOI 10.1007/s11682-016-9639-x; Donders J., 2016, CHILD NEUROPSYCHOL, P1; Donolato E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00663; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Ellis CT, 2018, TRENDS COGN SCI, V22, P375, DOI 10.1016/j.tics.2018.01.005; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Ferguson BR, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01027; Ffytche DH, 2005, PHILOS T R SOC B, V360, P767, DOI 10.1098/rstb.2005.1621; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fryer SL, 2012, ALCOHOL CLIN EXP RES, V36, P1932, DOI 10.1111/j.1530-0277.2012.01811.x; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Goddings AL, 2014, NEUROIMAGE, V88, P242, DOI 10.1016/j.neuroimage.2013.09.073; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Greven CU, 2015, JAMA PSYCHIAT, V72, P490, DOI 10.1001/jamapsychiatry.2014.3162; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Han K., 2014, ARCH PHYS MED REHAB, V95, pe7; Han K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.687; Herting MM, 2018, NEUROIMAGE, V172, P194, DOI 10.1016/j.neuroimage.2018.01.020; Hinton-Bayre A, 2005, PSYCHOL ASSESSMENT, V17, P237, DOI 10.1037/1040-3590.17.2.237; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hsu NS, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00221; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Ialongo C, 2016, BIOCHEM MEDICA, V26, P150, DOI 10.11613/BM.2016.015; Isbell E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00696; Ismail FY, 2017, EUR J PAEDIATR NEURO, V21, P23, DOI 10.1016/j.ejpn.2016.07.007; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Jiang LJ, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00118; Kannan Nithya, 2014, Int J Crit Illn Inj Sci, V4, P131, DOI 10.4103/2229-5151.134152; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kim NY, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00378; Kostering L, 2015, NEUROPSYCHOLOGIA, V75, P646, DOI 10.1016/j.neuropsychologia.2015.07.017; Kolb B, 2017, DEV MED CHILD NEUROL, V59, P1218, DOI 10.1111/dmcn.13546; Kolb Bryan, 2001, Neural Plasticity, V8, P1, DOI 10.1155/NP.2001.1; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Lampit A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00014; Lazaridou A, 2013, INT J MOL MED, V32, P995, DOI 10.3892/ijmm.2013.1476; Lenroot RK, 2009, HUM BRAIN MAPP, V30, P163, DOI 10.1002/hbm.20494; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Levan A, 2016, BRAIN IMAGING BEHAV, V10, P1090, DOI 10.1007/s11682-015-9472-7; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Luciana M, 2009, DEV NEUROPSYCHOL, V34, P461, DOI 10.1080/87565640902964540; Ma LS, 2010, BRAIN RES, V1318, P64, DOI 10.1016/j.brainres.2009.12.073; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malone IB, 2015, NEUROIMAGE, V104, P366, DOI 10.1016/j.neuroimage.2014.09.034; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McDonald JH., 2014, HDB BIOL STAT; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Metzler-Baddeley C, 2016, NEUROIMAGE, V130, P48, DOI 10.1016/j.neuroimage.2016.01.007; Mills KL, 2016, NEUROIMAGE, V141, P273, DOI 10.1016/j.neuroimage.2016.07.044; Narvacan K, 2017, HUM BRAIN MAPP, V38, P3771, DOI 10.1002/hbm.23604; Niemann C, 2014, NEUROSCIENCE, V281, P147, DOI 10.1016/j.neuroscience.2014.09.033; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Nordenskjold R, 2013, NEUROIMAGE, V83, P355, DOI 10.1016/j.neuroimage.2013.06.068; Nowrangi MA, 2014, J NEUROPSYCH CLIN N, V26, P114, DOI 10.1176/appi.neuropsych.12070176; O'Brien LM, 2011, PSYCHIAT RES-NEUROIM, V193, P113, DOI 10.1016/j.pscychresns.2011.01.007; Piccolo LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162511; Piekarski DJ, 2017, BRAIN RES, V1654, P123, DOI 10.1016/j.brainres.2016.08.042; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Roman FJ, 2016, BRAIN STRUCT FUNCT, V221, P4369, DOI 10.1007/s00429-015-1168-7; Rosch KS, 2018, PSYCHIAT RES-NEUROIM, V271, P67, DOI 10.1016/j.pscychresns.2017.10.013; Sachs M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187254; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Snow PJ, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00501; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Swagerman SC, 2014, GENES BRAIN BEHAV, V13, P733, DOI 10.1111/gbb.12182; Syvaoja HJ, 2015, PSYCHOL ASSESSMENT, V27, P698, DOI 10.1037/a0038485; Tamnes CK, 2017, J NEUROSCI, V37, P3402, DOI 10.1523/JNEUROSCI.3302-16.2017; Thomas C, 2013, NEUROIMAGE, V73, P225, DOI 10.1016/j.neuroimage.2012.03.069; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Treit S, 2014, HUM BRAIN MAPP, V35, P4892, DOI 10.1002/hbm.22520; Vander Linden C., 2018, EUROPEAN J PHYS REHA; Velanova K, 2008, CEREB CORTEX, V18, P2505, DOI 10.1093/cercor/bhn012; Verhelst H, 2017, GAMES HEALTH J, V6, P28, DOI 10.1089/g4h.2016.0043; Walhovd KB, 2016, P NATL ACAD SCI USA, V113, P9357, DOI 10.1073/pnas.1524259113; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Ware AL, 2016, NEUROPSYCHOLOGY, V30, P492, DOI 10.1037/neu0000266; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wenger E, 2017, TRENDS COGN SCI, V21, P930, DOI 10.1016/j.tics.2017.09.008; Wenger E, 2017, CEREB CORTEX, V27, P2911, DOI 10.1093/cercor/bhw141; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Young JM, 2015, NEUROIMAGE, V111, P360, DOI 10.1016/j.neuroimage.2015.02.030; Zhou DM, 2015, NEUROIMAGE, V104, P138, DOI 10.1016/j.neuroimage.2014.10.005; Zihl J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084590	113	4	4	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	23								101827	10.1016/j.nicl.2019.101827			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IX6OV	WOS:000485804400020	31005776	Green Published, gold			2022-02-06	
J	Cetin, A; Deveci, E				Cetin, A.; Deveci, E.			Expression of vascular endothelial growth factor and glial fibrillary acidic protein in a rat model of traumatic brain injury treated with honokiol: a biochemical and immunohistochemical study	FOLIA MORPHOLOGICA			English	Article						traumatic brain injury; honokiol; vascular endothelial growth factor; glial fibrillary acidic protein; rat	CEREBRAL-ISCHEMIA-REPERFUSION; INFLAMMATORY REACTION; MAGNOLIA-OFFICINALIS; OXIDATIVE STRESS; INHIBITION; BLOOD; ACTIVATION; BARRIER; DAMAGE; VEGF	Background: Traumatic brain injury (TBI) leads to neuronal damage and neurological dysfunction. The aim of our study was to investigate the antioxidative effect of honokiol on TBI in rats with biochemical, histopathological and immunohistochemical methods. Materials and methods: Sprague-Dawley rats were subjected to TBI with a weight-drop device using 300 g/1 m weight/height impact. Forty-five rats were divided into three groups as control group, TBI group and TBI + honokiol group (5 mg/kg/day, i.p.). Honokiol (5 mg/kg) dissolved in dimethyl sulfoxide (DMSO) was intraperitoneally administered to rats for 7 days after the trauma. At the end of experiment, blood samples were taken from the animals and analysed with various biochemical markers. Results: Histopathological examination of the trauma group revealed some degenerated pyramidal cells, dilatation and congestion in blood vessels, hyperplasia in endothelial cells, inflammatory cell infiltration around the vein and disruptions in glial extensions. In TBI + honokiol group, pyramidal neurons showed a decrease in degeneration, slight dilatation in blood vessels, improvement of endothelial cells towards the lumen, and reduction of inflammatory cells in the vessel. In TBI + honokiol group, vascular endothelial growth factor expression was positive in the endothelial and few inflammatory cells of the mildly dilated blood vessels. In the blood brain barrier deteriorated after trauma, it was observed that the glial foot processes were positive expression and extended to the endothelial cells in the TBI + honokiol group. Conclusions: Glial fibrillary acidic protein expression showed a positive reaction in these processes. Considering the important role of antioxidants and inflammatory responses in cerebral damage induced by traumatic head injury, honokiol is thought to be important in decreasing lipid peroxidation, protecting the membrane structure of blood brain barrier, degeneration of neurons and glial cells.	[Cetin, A.] Univ Hlth Sci, Dept Neurosurg, Gazi Yasargil Educ & Res Hosp, Diyarbakir, Turkey; [Deveci, E.] Dicle Univ, Fac Med, Dept Histol & Embryol, TR-21280 Diyarbakir, Turkey		Deveci, E (corresponding author), Dicle Univ, Fac Med, Dept Histol & Embryol, TR-21280 Diyarbakir, Turkey.	devecie32@hotmail.com					Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Baloglu M, 2019, FOLIA MORPHOL, V78, P17, DOI 10.5603/FM.a2018.0050; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Chao LK, 2010, J AGR FOOD CHEM, V58, P3472, DOI 10.1021/jf904207m; Chiang J, 2009, EUR J PHARMACOL, V610, P119, DOI 10.1016/j.ejphar.2009.03.035; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Chuang DY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-15; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Feng Y, 2016, MOL MED REP, V13, P5248, DOI 10.3892/mmr.2016.5201; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hayashi T, 2005, J CEREBR BLOOD F MET, V25, P41, DOI 10.1038/sj.jcbfm.9600005; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Kim BH, 2008, ACTA PHARMACOL SIN, V29, P113, DOI 10.1111/j.1745-7254.2008.00725.x; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Kuribara H, 1999, J PHARM PHARMACOL, V51, P97; Kuribara H, 2000, PHARMACOL BIOCHEM BE, V67, P597, DOI 10.1016/S0091-3057(00)00401-9; Lee S, 2015, INT J MOL SCI, V16, P19657, DOI 10.3390/ijms160819657; Lenzlinger PM, 2004, RESTOR NEUROL NEUROS, V22, P73; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Lin JW, 2012, NEURO-ONCOLOGY, V14, P302, DOI 10.1093/neuonc/nor217; Lin YR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-94; Liou KT, 2003, EUR J PHARMACOL, V475, P19, DOI 10.1016/S0014-2999(03)02121-6; Liou KT, 2003, BRAIN RES, V992, P159, DOI 10.1016/j.brainres.2003.08.026; Liou KT, 2003, PLANTA MED, V69, P130, DOI 10.1055/s-2003-37707; LO YC, 1994, BIOCHEM PHARMACOL, V47, P549, DOI 10.1016/0006-2952(94)90187-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Missler U, 1999, CLIN CHEM, V45, P138; Munroe ME, 2007, J IMMUNOL, V179, P753, DOI 10.4049/jimmunol.179.2.753; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nakano N, 2017, INT J MOL MED, V39, P253, DOI 10.3892/ijmm.2016.2833; Ou HC, 2006, CHEM-BIOL INTERACT, V161, P1, DOI 10.1016/j.cbi.2006.02.006; Ozevren H, 2017, ANAL QUANT CYTOPATHO, V39, P35; Preston GW, 2016, ANAL BIOANAL CHEM, V408, P2187, DOI 10.1007/s00216-016-9334-1; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sohrab G, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.28551; Stroop R, 1998, ACT NEUR S, V71, P303; Sulakhiya K, 2015, PHARMACOL BIOCHEM BE, V132, P79, DOI 10.1016/j.pbb.2015.02.015; Talarek S, 2017, BIOFACTORS, V43, P760, DOI 10.1002/biof.1385; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Wang HQ, 2014, NEUROPHARMACOLOGY, V86, P9, DOI 10.1016/j.neuropharm.2014.06.018; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018490; Xu Q, 2008, PROG NEURO-PSYCHOPH, V32, P715, DOI 10.1016/j.pnpbp.2007.11.020; Yu HM, 2004, NEUROPATHOLOGY, V24, P136, DOI 10.1111/j.1440-1789.2003.00539.x; Zhang L, 2011, PHARMACOLOGY, V87, P265, DOI 10.1159/000326082; Zhang P, 2013, NEUROSCI LETT, V534, P123, DOI 10.1016/j.neulet.2012.11.052; Zhou PH, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7201549	53	4	4	0	1	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	0015-5659	1644-3284		FOLIA MORPHOL	Folia Morphol.		2019	78	4					684	694		10.5603/FM.a2019.0029			11	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	KH2PR	WOS:000510490300004	30835336	gold			2022-02-06	
J	Charry, JD; Navarro-Parra, S; Solano, J; Moscote-Salazar, L				Charry, Jose D.; Navarro-Parra, Sandra; Solano, Juan; Moscote-Salazar, Luis			Outcomes of traumatic brain injury: the prognostic accuracy of various scores and models	NEUROLOGIA I NEUROCHIRURGIA POLSKA			English	Article						traumatic brain injury; prognosis models; neurological outcome	DECOMPRESSIVE CRANIECTOMY; VALIDATION; IMPACT; CRASH; PREDICTION; CLASSIFICATION; MODERATE; TOOL	Introduction. Traumatic Brain Injury (TBI) is a worldwide health problem, and is a pathology that causes significant mortality and disability in Latin America. Different scores and prognostic models have been developed in order to predict the neurological outcomes of patients. We aimed to test the prognostic accuracy of the Marshall CT classification system, the Rotterdam CT scoring system, and the IMPACT and CRASH models, in predicting 6-month mortality and 6-month unfavourable outcomes in a cohort of trauma patients with TBI in a university hospital in Colombia. Methods. We analysed 309 patients with significant TBI who were treated in a regional trauma centre in Colombia over a two year period. Bivariate and multivariate analyses were undertaken. The discriminatory power of each model, as well as its accuracy and precision, were assessed by logistic regression and AUC. Shapiro Wilks, chi2 and Wilcoxon test were used to compare the actual outcomes in the cohort against the predicted outcomes. Results. The median age was 32 years, and 77.67% were male. All four prognostic models showed good accuracy in predicting outcomes. The IMPACT model had the greatest accuracy in predicting an unfavourable outcome (AUC 0.864; 95% CI 0.819 - 0.909) and in predicting mortality (AUC 0.902; 95% CI 0.862 - 0.943) in patients with TBI. Conclusion. All four prognostic models are applicable to eligible TBI patients in Colombia. The IMPACT model was shown to be more accurate than the other prognostic models, and had a higher sensitivity in predicting 6-month mortality and 6-month unfavourable outcomes in patients with TBI in a university hospital in Colombia.	[Charry, Jose D.; Navarro-Parra, Sandra; Solano, Juan; Moscote-Salazar, Luis] Fdn Univ Navarra UNINAVARRA, Calle 10 6-41, Neiva, Colombia		Charry, JD (corresponding author), Fdn Univ Navarra UNINAVARRA, Calle 10 6-41, Neiva, Colombia.	danielcharry06@gmail.com	Moscote-Salazar, Luis Rafael/K-6307-2012	Moscote-Salazar, Luis Rafael/0000-0002-4180-6962; Pinzon Pinzon, Miguel Angel/0000-0001-5828-9212			Andelic N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/2678081; Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477; De la, 2013, COMPORTAMIENTO HOMIC, V2013, P79; Maia HF, 2013, SALUD COLECT, V9, P335, DOI 10.1590/S1851-82652013000300005; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017; Honeybul S, 2014, J NEUROSURG, V120, P1131, DOI 10.3171/2014.1.JNS131559; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; Egea-Guerrero JJ, 2018, J HEAD TRAUMA REHAB, V33, P46, DOI 10.1097/HTR.0000000000000292; Junque C, 1999, REV NEUROLOGIA, V28, P423, DOI 10.33588/rn.2804.98420; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032	26	4	4	0	0	ELSEVIER URBAN & PARTNER SP Z O O	WROCLAW	UL MIGDALOWA 4, LOK 59, WROCLAW, 02-796, POLAND	0028-3843			NEUROL NEUROCHIR POL	Neurol. Neurochir. Pol.		2019	53	1					55	60		10.5603/PJNNS.a2018.0003			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HT0QP	WOS:000464270000009	30742300	Bronze			2022-02-06	
J	Chow, BH; Stevenson, AM; Burke, JF; Adelman, EE				Chow, Bryan H.; Stevenson, Alyssa M.; Burke, James F.; Adelman, Eric E.			The effect of concussion on batting performance of major league baseball players	OPEN ACCESS JOURNAL OF SPORTS MEDICINE			English	Article						MLB; head injury; professional sports; athletic performance; brain injury	ATTENTION; DEFICITS	Purpose: Previous investigations into concussions' effects on Major League Baseball (MLB) players suggested that concussion negatively impacts traditional measures of batting performance. This study examined whether post-concussion batting performance, as measured by traditional, plate discipline, and batted ball statistics, in MLB players was worse than other post-injury performance. Subjects and methods: MLB players with concussion from 2008 to 2014 were identified. Concussion was defined by placement on the disabled list or missing games due to concussion, post-concussive syndrome, or head trauma. Injuries causing players to be put on the disabled list were matched by age, position, and injury duration to serve as controls. Mixed effects models were used to estimate concussion's influence after adjusting for potential confounders. The primary study outcome measurements were: traditional (eg, average), plate discipline (eg, swing-at-strike rate), and batted ball (eg, ground ball percentage) statistics. Results: There were 85 concussed players and 212 controls included in the analyses. There was no significant difference in performance between concussed players and controls. However, concussed players started at a lower level of performance pre-event than the controls, striking out a 9.2% rate vs 8.2% (P=0.042) with an isolated power of 0.075 vs 0.082 (P=0.035). For concussed players, traditional batting statistics decreased before plate discipline metrics. Conclusion: MLB players' performance was lower after return from concussion, but no more than after return from other injuries. The decreased performance prior to concussion suggests that concussion-related performance declines may not be due exclusively to concussion and perhaps point to risk factors predisposing to concussion.	[Chow, Bryan H.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Stevenson, Alyssa M.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Burke, James F.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Burke, James F.] Ann Arbor VA Healthcare Syst, Dept Vet Affairs, Ann Arbor, MI USA; [Adelman, Eric E.] Univ Wisconsin, Dept Neurol, MFCB 7th Floor,1685 Highland Ave, Madison, WI 53705 USA		Adelman, EE (corresponding author), Univ Wisconsin, Dept Neurol, MFCB 7th Floor,1685 Highland Ave, Madison, WI 53705 USA.	adelman@neurology.wisc.edu		Adelman, Eric/0000-0002-3559-5580			Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Hagen P., MLB; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hutchinson MR., 2014, ANN ORTHOP RHEUMATOL, V2, P1022; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Reams N, 2017, INT J SPORT PHYSIOL, V12, P1100, DOI 10.1123/ijspp.2016-0508; Song A, 2017, P NATL ACAD SCI USA, V114, P1407, DOI 10.1073/pnas.1608847114; Strauss J., ST LOUIS POST DISPAT; The Associated Press, ASS PRESS; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956	17	4	4	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1543			OPEN ACCESS J SPORTS	Open Access J. Sports Med.		2019	10						41	48		10.2147/OAJSM.S192338			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	HQ4CK	WOS:000462356900001	30881155	Green Published, Green Submitted, gold			2022-02-06	
J	Cowee, K; Simon, JE				Cowee, Katlyn; Simon, Janet E.			A History of Previous Severe Injury and Health-Related Quality of Life Among Former Collegiate Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						NCAA; retired athletes; mental health; physical health	RECURRENT CONCUSSION; DEPRESSION; ASSOCIATION; DIAGNOSIS; ACCURACY; SPORT; RISK	Context: Empirical evidence supports the idea that previous severe injuries in former collegiate athletes may adversely affect their ability to participate in daily activities later in life, which may then decrease their health-related quality of life (HRQOL). Objective: To assess the influences of previous severe injuries on the HRQOL of former National Collegiate Athletic Association (NCAA) athletes. Design: Cross-sectional study. Setting: Online survey. Patients or Other Participants: A total of 171 former NCAA collegiate athletes (69 men, 102 women; age = 29.7 +/- 3.9 years, height = 171.5 +/- 10.4 cm, mass = 76.4 +/- 12.9 kg) participated. All individuals completed a demographics questionnaire and the Short Form-36 version 2 (SF-36v2) Health Survey via Qualtrics. Main Outcome Measure(s): The dependent variables were the physical composite and mental composite summary scores and the 8 subscales of the SF-36v2. The independent variable was the presence of previous severe injury (history of a severe injury or no history of a severe injury during collegiate athletics). Two multivariate analyses of variance were conducted. The first multivariate analysis of variance was conducted for the 8 SF-36v2 subscales and the second for the 2 summary scores. Results: For the summary scores and all 8 SF-36v2 subscales, the responses were worse for the 103 former collegiate athletes who sustained a previous severe injury compared with the 68 who did not sustain a severe injury. The largest difference between groups was for the physical composite score, with a mean difference of 15.8 points (1.5 standard deviations worse than the US population); the physical functioning subscale demonstrated a mean difference of 12.9 points (1.3 standard deviations worse than the US population). Conclusions: A majority of the athletes in our sample had experienced a severe injury. Based on these data, previous severe injuries had a negative influence on the HRQOL of former NCAA collegiate athletes.	[Cowee, Katlyn; Simon, Janet E.] Ohio Univ, E150 Grover Ctr, Athens, OH 45701 USA		Simon, JE (corresponding author), Ohio Univ, E150 Grover Ctr, Athens, OH 45701 USA.	simonj1@ohio.edu					Barlow JH, 1998, BRIT J RHEUMATOL, V37, P985; Brooks K., J EXERCISE PHYSL; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; El Fakiri F, 2007, J CLIN EPIDEMIOL, V60, P1271, DOI 10.1016/j.jclinepi.2007.02.014; Friery KB, J EXERCISE PHYSL; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Houston MN, 2016, J ATHL TRAINING, V51, P442, DOI 10.4085/1062-6050-51.7.03; Hurtubise JM, 2015, INT J ATHL THER TRAI, V20, P44, DOI 10.1123/ijatt.2014-0090; Kerr ZY, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114544107; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lam KC, 2017, J ATHL TRAINING, V52, P534, DOI 10.4085/1062-6050-50.5.01; Maglinte GA, 2012, J CLIN EPIDEMIOL, V65, P497, DOI 10.1016/j.jclinepi.2011.09.008; McAllister DR, 2001, AM J SPORT MED, V29, P806, DOI 10.1177/03635465010290062201; McLeod TCV, 2009, J ATHL TRAINING, V44, P603, DOI 10.4085/1062-6050-44.6.603; Meyers S., ESTIMATED PROBABILIT; Parsons JT, 2011, J SPORT REHABIL, V20, P17, DOI 10.1123/jsr.20.1.17; Reider B, 2012, AM J SPORT MED, V40, P2197, DOI 10.1177/0363546512462362; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Simon JE, 2016, J ATHL TRAINING, V51, P205, DOI 10.4085/1062-6050-51.4.05; Simon JE, 2014, AM J SPORT MED, V42, P423, DOI 10.1177/0363546513510393; Sorenson SC, 2014, J ATHL TRAINING, V49, P684, DOI 10.4085/1062-6050-49.3.18; Straus SE, 2002, J GEN INTERN MED, V17, P684, DOI 10.1046/j.1525-1497.2002.20102.x; Ware J.E., 2008, USERS MANUAL SF 36V2; Weigand S, 2013, SPORTS HEALTH, V5, P263, DOI 10.1177/1941738113480464	26	4	4	2	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2019	54	1					64	69		10.4085/1062-6050-377-17			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HO1BA	WOS:000460639000008	30657720	Green Published, gold			2022-02-06	
S	Darwish, H; Hasan, H		Kobeissy, FH		Darwish, Hala; Hasan, Hiba			Y-Shaped Maze to Test Spontaneous Object Recognition and Temporal Order Memory After Traumatic Brain Injury	PSYCHIATRIC DISORDERS: Methods and Protocols	Methods in Molecular Biology		English	Article; Book Chapter						Y-maze; Traumatic brain injury; Temporal order memory; Object recognition memory; Memory deficits	CONTROLLED CORTICAL IMPACT; MILD HEAD-INJURY; PREFRONTAL CORTEX; TERM-MEMORY; RECOLLECTION; FAMILIARITY; MOUSE; NEUROPSYCHOLOGY; MODEL	Traumatic brain injury (TBI) is one of the most frequent causes of brain damage. Cognitive deficits have been reported in the literature after mild-to-severe TBI affecting memory, language, executive functions, attention, and information processing speed. In this chapter, we describe a method to characterize cognitive impairment in rats following TBI of various intensities. The focus will be on spontaneous object recognition and temporal order memory in rats. These tests are performed in a Y-shaped maze. We have previously identified using this method persistent spontaneous object recognition and temporal order memory deficits following mild-to-moderate TBI in the animals up to 35-day postinjury.	[Darwish, Hala] Amer Univ Beirut, Abu Haidar Neurosci Inst, Hariri Sch Nursing, Beirut, Lebanon; [Hasan, Hiba] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon		Darwish, H (corresponding author), Amer Univ Beirut, Abu Haidar Neurosci Inst, Hariri Sch Nursing, Beirut, Lebanon.			Darwish, Hala/0000-0001-5744-6466; hasan, hiba/0000-0001-5316-5480			Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Buffalo EA, 1998, HIPPOCAMPUS, V8, P330, DOI 10.1002/(SICI)1098-1063(1998)8:4<330::AID-HIPO3>3.0.CO;2-L; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Darwish H, 2014, BRAIN INJURY, V28, P211, DOI 10.3109/02699052.2013.862737; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Mitchell JB, 1998, BEHAV BRAIN RES, V97, P107, DOI 10.1016/S0166-4328(98)00032-1; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Skinner EI, 2007, NEUROPSYCHOLOGIA, V45, P2163, DOI 10.1016/j.neuropsychologia.2007.03.007; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Swanson HL, 1999, DEV PSYCHOL, V35, P986, DOI 10.1037/0012-1649.35.4.986; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Wais PE, 2006, NEURON, V49, P459, DOI 10.1016/j.neuron.2005.12.020; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	24	4	4	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-9554-7; 978-1-4939-9553-0	METHODS MOL BIOL	Methods Mol. Biol.		2019	2011						383	392		10.1007/978-1-4939-9554-7_22	10.1007/978-1-4939-9554-7		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Psychiatry	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Psychiatry	BS2ER	WOS:000700605200024	31273711				2022-02-06	
J	Di, GF; Zhang, YH; Liu, H; Jiang, XC; Liu, Y; Yang, K; Chen, J; Liu, HY				Di, Guangfu; Zhang, Yuhai; Liu, Hua; Jiang, Xiaochun; Liu, Yong; Yang, Kun; Chen, Jiu; Liu, Hongyi			Postoperative complications influencing the long-term outcome of head-injured patients after decompressive craniectomy	BRAIN AND BEHAVIOR			English	Article						decompressive craniectomy; outcome; postoperative complications; risk factor; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYDROCEPHALUS; SURGICAL COMPLICATIONS; PROGNOSTIC MODELS; CRANIOPLASTY; HEMICRANIECTOMY; PREDICTION; MANAGEMENT; SECONDARY; SCALE	Objective: Postoperative complications are common in patients who underwent decompressive craniectomy (DC) after traumatic brain injury (TBI). However, little is known about the degree of association between the postoperative complications and the long-term outcome of adult TBI patients after DC. The aim of this study was to evaluate the risk of postoperative complications that influenced the long-term outcome of DC in TBI patients. Method: A total of 121 patients were studied up to 6 months after DC in TBI. The collected data included demographic, clinical and radiological information, postoperative complications, and Glasgow Outcome Scale-Extended (GOSE) scores at follow-up 6 months after DC. Based on their GOSE scores, they were divided into two functional groups: favorable (GOSE = 5-8) or unfavorable outcome (GOSE = 2-4) group. The characteristics of the two groups were compared using statistical analysis. Finally, a regression model was established and a receiver operating characteristic (ROC) curve was applied to analyze its performance power. Results: Of 121 admitted patients, 31 (25.62%) sustained an unfavorable outcome. A logistic regression analysis showed that the presence of Glasgow Coma Scale (GCS) scores on admission (odds ratio [OR] 0.285, p = 0.001), posttraumatic hydrocephalus (PTH) (OR 8.688, p = 0.003), craniectomy site (OR 8.068, p = 0.033), and postoperative progressive hemorrhagic injury (PHI) (OR 6.196, p = 0.026) were independent risk factors that correlated with an unfavorable outcome. Analysis using ROC curves demonstrated that these factors had different accuracies in predicting an unfavorable outcome (AUC = 0.852 for GCS scores on admission; AUC = 0.826 for PTH, AUC = 0.617 for craniectomy site; AUC = 0.616 for postoperative PHI). The performance power of the GCS scores on admission and PTH influenced the patient's outcomes to a similar degree (p = 0.623), and either predicted the outcome better than the craniectomy site or the postoperative PHI (p < 0.05, respectively). Conclusion: These findings suggest that the occurrence of PTH and postoperative PHI were independently associated with an unfavorable long-term outcome after DC in patients with TBI. Early prevention and treatment of PTH and postoperative PHI may be beneficial to improve the long-term outcome, especially in patients with lower admission GCS scores or bilateral DC.	[Di, Guangfu; Zhang, Yuhai; Liu, Hua; Liu, Yong; Yang, Kun; Liu, Hongyi] Nanjing Med Univ, Dept Neurosurg, Affiliated Brain Hosp, Clin Coll 4, Nanjing, Jiangsu, Peoples R China; [Di, Guangfu; Jiang, Xiaochun] Wannan Med Coll, Dept Neurosurg, Affiliated Hosp 1, Wuhu, Peoples R China; [Chen, Jiu] Nanjing Med Univ, Inst Neuropsychiat, Affiliated Brain Hosp, Clin Coll 4, Nanjing, Jiangsu, Peoples R China; [Chen, Jiu] Nanjing Med Univ, Inst Brain Funct Imaging, Nanjing, Jiangsu, Peoples R China		Liu, HY (corresponding author), Nanjing Med Univ, Dept Neurosurg, Affiliated Brain Hosp, Clin Coll 4, Nanjing, Jiangsu, Peoples R China.; Chen, J (corresponding author), Nanjing Med Univ, Inst Neuropsychiat, Affiliated Brain Hosp, Clin Coll 4, Nanjing, Jiangsu, Peoples R China.	ericcst@aliyun.com; hyliu18@126.com		Di, Guangfu/0000-0001-9856-2025; Chen, Jiu/0000-0001-8185-8575	Young and Middle-aged Research Fund Project of Wannan Medical College [WK2017F04]; clinical medical scientific and technologic project of National Health and Family Planning Commission of the People's Republic of China [w201308, H201540, ZKX14044, CXTDA2017050]; Nanjing Commission of Health and Family Planning; medical scientific and technologic development project of Nanjing [YKK12137, ZKX15035]; Innovation team project of 13th Five Year Plan of the Jiangsu provincial Health and Family Planning Commission	Young and Middle-aged Research Fund Project of Wannan Medical College, Grant/Award Number: WK2017F04; clinical medical scientific and technologic project of National Health and Family Planning Commission of the People's Republic of China, Grant/Award Number: w201308, H201540, ZKX14044 and CXTDA2017050; Nanjing Commission of Health and Family Planning; the medical scientific and technologic development project of Nanjing, Grant/Award Number: YKK12137 and ZKX15035; the Innovation team project of 13th Five Year Plan of the Jiangsu provincial Health and Family Planning Commission	Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; Ham HY, 2011, J KOREAN NEUROSURG S, V50, P370, DOI 10.3340/jkns.2011.50.4.370; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; Khalili H, 2016, WORLD NEUROSURG, V94, P120, DOI 10.1016/j.wneu.2016.06.122; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kim H, 2017, J KOREAN NEUROSURG S, V60, P730, DOI 10.3340/jkns.2017.0210; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Lemcke J, 2010, ACTA NEUROCHIR SUPPL, V106, P231, DOI 10.1007/978-3-211-98811-4_43; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Manfiotto M, 2017, CHILD NERV SYST, V33, P1751, DOI 10.1007/s00381-017-3542-7; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Muzevic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010193.pub2; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; SHEFFLER LR, 1994, ARCH PHYS MED REHAB, V75, P338, DOI 10.1016/0003-9993(94)90039-6; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Vedantam A, 2016, J NEUROSURG, V125, P1229, DOI 10.3171/2015.11.JNS151515; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Wen L, 2013, BRAIN INJURY, V27, P286, DOI 10.3109/02699052.2012.743180; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zhang DF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08959-y	34	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JAN	2019	9	1							e01179	10.1002/brb3.1179			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	HM7CY	WOS:000459636100021	30511376	gold, Green Published			2022-02-06	
J	Faheem, M; Jaiswal, M; Ojha, BK; Chandra, A; Singh, SK; Srivastava, C				Faheem, Mohd; Jaiswal, Manish; Ojha, Bal Krishna; Chandra, Anil; Singh, Sunil Kumar; Srivastava, Chhitij			Traumatic Pediatric Extradural Hematoma: An Institutional Study of 228 Patients in Tertiary Care Center	PEDIATRIC NEUROSURGERY			English	Article						Extradural hematoma; Head Injury; Traumatic brain injury; Pediatric head injury	EPIDURAL HEMATOMAS; CHILDREN; EXPERIENCE; MANAGEMENT; PROGNOSIS	Background: Extradural hematoma (EDH) is one of the most common causes of mortality and morbidity after traumatic brain injury in pediatric patients. Early surgical intervention in these patients produces excellent results. Objective: We reviewed surgical experience at our center, examining and presenting symptomatology and outcome analysis. Materials and Methods: A retrospective study of 228 pediatric patients of EDH from July 2007 to August 2017 was performed. Patients were evaluated in terms of demographic profile, clinical features, pupillary size and reaction, computed tomography findings, operative measures, and several other parameters. Neurological status was assessed using motor component (M) of Glasgow Coma Scale score. Best motor response was considered as a criterion to classify severity of traumatic brain injury and for the assessment of outcome. Results: Most of the patients were in the age group of 13-18years (n = 122, 53.5%). Majority of them were male (n = 182, 79.8%). The commonest mode of injury was fall from height (n = 116, 50.9%) followed by road traffic accident (n = 92, 40.4%). Most common site of hematoma was frontal region (n = 66, 28.9%) followed by parietal region (n = 54, 23.7%). The volume of hematoma was between 30 and 50mL in majority of the patients (n = 186, 81.6%), and most of the patients had a motor responses of M5 (n = 88, 38.6%) and M6 (n = 108, 47.4%). The association between hematoma site and volume was not significant (chi(2) = 5.910, p = 0.749), whereas statistically significant association was noted between volume of hematoma and motor response (chi(2) = 93.468, p <= 0.001), volume and age (chi(2) = 7.380, p <= 0.05), and volume to time between trauma and surgery (chi(2) = 8.469, p <= 0.05). Maximum mortality was in patients of low motor (M1-M3) response and who were operated 24 h after injury. Conclusion: Mortality in patients of EDH can be significantly reduced with gratifying results if operated early. Best motor response at presentation, pupillary abnormalities, time between injury to surgery, and location of hematoma have been identified as the important factors determining outcome in patients of EDH.	[Faheem, Mohd] Uttar Pradesh Univ Med Sci, Dept Neurosurg, Etawah, India; [Jaiswal, Manish; Ojha, Bal Krishna; Chandra, Anil; Singh, Sunil Kumar; Srivastava, Chhitij] King Georges Med Univ, Dept Neurosurg, Lucknow 226003, Uttar Pradesh, India		Jaiswal, M (corresponding author), King Georges Med Univ, Dept Neurosurg, Lucknow 226003, Uttar Pradesh, India.	manishjaiswal@kgmcindia.edu	Jaiswal, Manish/J-1591-2019; FAHEEM, MOHD/AAI-2075-2021	Jaiswal, Manish/0000-0002-1300-3716; 	Department of Neurosurgery, King George's Medical University, Lucknow, UP, India; Department of Neurosurgery, Uttar Pradesh University of Medical Sciences, Etawah, Uttar Pradesh, India	This work was supported by the Department of Neurosurgery, King George's Medical University, Lucknow, UP, India and Department of Neurosurgery, Uttar Pradesh University of Medical Sciences, Etawah, Uttar Pradesh, India.	Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Ben Abraham R, 2000, PEDIATR NEUROSURG, V33, P70, DOI 10.1159/000028990; Browne GJ, 2002, PEDIATR EMERG CARE, V18, P86, DOI 10.1097/00006565-200204000-00006; Bullock M Ross, 2006, Neurosurgery, V58, pS7; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Duthie G, 2009, BRIT J NEUROSURG, V23, P596, DOI 10.3109/02688690902978157; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Huda MF, 2004, NEUROL INDIA, V52, P450; Jung SW, 2012, J KOREAN NEUROSURG S, V51, P215, DOI 10.3340/jkns.2012.51.4.215; Kamal R, 2012, NEUROLOGICAL EXAMINA; Mahapatra AK, 1995, NEUROLOGY INDIA S, V43, P64; MAZZA C, 1982, ACTA NEUROCHIR, V65, P67, DOI 10.1007/BF01405443; MOLLOY CJ, 1990, CHILD NERV SYST, V6, P383, DOI 10.1007/BF00302223; Paiva WS, 2010, ARQ NEURO-PSIQUIAT, V68, P888, DOI 10.1590/S0004-282X2010000600011; PILLAY R, 1995, S AFR MED J, V85, P672; Prasad GL, 2015, PEDIATR NEUROSURG, V50, P250, DOI 10.1159/000438488; SAMBASIVAN M, 1995, NEUROL INDIA, V43, P36; Umerani Muhammad Sohail, 2018, Asian J Neurosurg, V13, P681, DOI 10.4103/ajns.AJNS_164_16; Zhong WY, 2013, CHILD NERV SYST, V29, P635, DOI 10.1007/s00381-012-1971-x	20	4	4	1	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2019	54	4					237	244		10.1159/000501043			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	IP8BK	WOS:000480271700004	31288223				2022-02-06	
J	Guldager, R; Willis, K; Larsen, K; Poulsen, I				Guldager, Rikke; Willis, Karen; Larsen, Kristian; Poulsen, Ingrid			Relatives' strategies in subacute brain injury rehabilitation: The warrior, the observer and the hesitant	JOURNAL OF CLINICAL NURSING			English	Article						Bourdieu; decision-making; interdisciplinary team; qualitative research; rehabilitation; relatives; traumatic brain injury	FAMILY-MEMBERS; PEOPLE; PATTERNS; MODERATE	Background Relative involvement is crucial in rehabilitation when patients are incapable of being involved due to cognitive and functional dysfunction. However, studies have shown that this is complex because of differing understandings of the meaning of involvement as well as diverse needs to be involved. Aims and objectives To explore the experience of the rehabilitation process from the perspectives of relatives of patients with a traumatic brain injury. The aim of the study was, through a theoretical-empirical analysis, to identify relatives' strategies and practices in the rehabilitation process as evidenced in meetings with providers. Design A longitudinal study with a qualitative approach, drawing on the theory of Pierre Bourdieu. Methods Data were generated using participant observation and semi-structured interviews. Participants were eleven relatives of patients with a severe traumatic brain injury, followed through in-patient rehabilitation varying from 9-12 weeks. Analysis was undertaken using both an inductive and deductive approach. Findings Drawing on Bourdieu's concept of strategy, three relative positions were identified, the warrior, the observer and the hesitant. These positions illustrate how different relative positions and their related dispositions influence the strategies used by relatives of patients with a severe traumatic brain injury evidenced in how they act, participate and relate to both the patient and the providers during the course of rehabilitation. Conclusions Acknowledging the relatives' positions during the rehabilitation process enables better understanding and support of the relatives in the rehabilitation process to meet their (and thus the patients') diverse needs. Relevance to clinical practice The findings have practical implications in informing how clinicians meet, interact, communicate and involve relatives of adult patients' with traumatic brain injury in decision-making during rehabilitation.	[Guldager, Rikke; Poulsen, Ingrid] Rigshosp, Copenhagen Univ Hosp, RUBRIC Res Unit Brain Injury Rehabil Copenhagen, Traumat Brain Injury Unit,Dept Neurorehabil, Flintevaenget 30, DK-4320 Copenhagen, Denmark; [Guldager, Rikke; Larsen, Kristian] Aalborg Univ, Dept Learning & Philosophy, Aalborg, Denmark; [Willis, Karen] Melbourne Hlth, Allied Hlth, Bundoora, Vic, Australia; [Willis, Karen] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia; [Poulsen, Ingrid] Aarhus Univ, Sect Nursing Sci, Hlth, Aarhus, Denmark		Guldager, R (corresponding author), Rigshosp, Copenhagen Univ Hosp, RUBRIC Res Unit Brain Injury Rehabil Copenhagen, Traumat Brain Injury Unit,Dept Neurorehabil, Flintevaenget 30, DK-4320 Copenhagen, Denmark.	rikke.guldager@regionh.dk	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X; Guldager, Rikke/0000-0003-1491-2556; larsen, kristian/0000-0001-6835-0814; Willis, Karen/0000-0001-8036-8814	Danish Health Confederation and Danish Regions [R26-A1033-B888]	This study was funded by grants from The Danish Health Confederation and Danish Regions (Grant no. R26-A1033-B888).	Asimakopoulou K, 2014, COMMUNITY DENT ORAL, V42, P603, DOI 10.1111/cdoe.12120; Averill JB, 2002, QUAL HEALTH RES, V12, P855, DOI 10.1177/104973230201200611; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Bourdieu P., 1991, LANGUAGE SYMBOLIC PO; Bourdieu P, 1992, INVITATION REFLEXIVE; Bourdieu P., 2010, DISTINCTION SOCIAL C; Collyer FM, 2015, CURR SOCIOL, V63, P685, DOI 10.1177/0011392115590082; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Ferguson PriscillaParkhurst., 1999, WEIGHT WORLD SOCIAL; Fisher A, 2019, DISABIL REHABIL, V41, P854, DOI 10.1080/09638288.2017.1407966; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Holliday RC, 2007, DISABIL REHABIL, V29, P389, DOI 10.1080/09638280600841117; Jumisko E, 2007, DISABIL REHABIL, V29, P1535, DOI 10.1080/09638280601055816; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kuipers P, 2014, NEUROREHABILITATION, V35, P475, DOI 10.3233/NRE-141139; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Lefebvre H, 2012, BRAIN INJURY, V26, P1084, DOI 10.3109/02699052.2012.666364; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Miles M., 2020, QUALITATIVE DATA ANA, V4th ed.; Ministeriet for Sundhed og Forebyggelse, 2014, DIAL OG INDDR PAT PA; MIRR MP, 1991, HEART LUNG, V20, P228; Passeron, 1991, CRAFT SOCIOLOGY EPIS; Polit D.F., 2014, ESSENTIALS NURSING R, V8th; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sekse RJT, 2012, J CLIN NURS, V21, P2626, DOI 10.1111/j.1365-2702.2011.04028.x; Spradley J.P., 2016, PARTICIPANT OBSERVAT; Sundstrom Terje, 2005, Tidsskr Nor Laegeforen, V125, P1310; Videnscenter for Brugerinddragelse i Sundhedsvaesenet (The Danish Knowledge Center for User Involvement in Health Care), 2014, INDDR PAT PAR FORT D; Videnscenter for Brugerinddragelse i Sundhedsvaesenet (The Danish Knowledge Center for User Involvement in Health Care), 2015, TEM PAR; Weber Max, 1968, METHODOLOGY SOCIAL S; [No title captured]	39	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	JAN	2019	28	1-2					289	299		10.1111/jocn.14598			11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	HE3CG	WOS:000453228000027	29964307	Green Published			2022-02-06	
J	Hazay, M; Denes, D; Bojtar, I				Hazay, Mate; Denes, Daniel; Bojtar, Imre			The probability of traumatic brain injuries based on tissue-level reliability analysis	ACTA OF BIOENGINEERING AND BIOMECHANICS			English	Article						traumatic brain injuries; finite element simulations; reliability analysis; Head Injury Criterion; injury risk curves	MECHANICS; STRAIN	Purpose: Motor vehicle crashes are one of the leading causes of traumatic brain injuries. Restraint systems of cars are evaluated by crash tests based on human tolerance data, however, the reliability of data currently used has been questioned several times in the literature due to the neglect of certain types of effects, injury types and uncertainties. Our main goal was to re-evaluate the currently applied risk curve by taking the previously neglected effects into account. Methods: In this paper, the probability of traumatic brain injury was determined by reliability analysis where different types of uncertainties are taken into account. The tissue-level response of the human brain in the case of frontal crashes was calculated by finite element analyses and the injury probability is determined by Monte Carlo simulations. Sensitivity analysis was also performed to identify which effects have considerable contribution to the injury risk. Results: Our results indicate a significantly larger injury risk than it is predicted by current safety standards. Accordingly, a new risk curve was constructed which follows a lognormal distribution with the following parameters: mu(LN) = 6.5445 and sigma(LN) = 1.1993. Sensitivity analysis confirmed that this difference primarily can be attributed to the rotational effects and tissue-level uncertainties. Conclusions: Results of the tissue-level reliability analysis enhance the belief that rotational effects are the primary cause of brain injuries. Accordingly, the use of a solely translational acceleration based injury metric contains several uncertainties which can lead to relatively high injury probabilities even if relatively small translational effects occur.	[Hazay, Mate; Denes, Daniel; Bojtar, Imre] Budapest Univ Technol & Econ, Dept Struct Mech, 1111 Muegyet Rkp 3, Budapest, Hungary		Hazay, M (corresponding author), Budapest Univ Technol & Econ, Dept Struct Mech, 1111 Muegyet Rkp 3, Budapest, Hungary.	hazay.mate@epito.bme.hu			Higher Education Excellence Program of the Ministry of Human Capacities	This work was supported by the Higher Education Excellence Program of the Ministry of Human Capacities in the frame of Biotechnology research area of Budapest University of Technology and Economics (BME FIKP-BIO).	DIMASI F., 1995, 952718 SAE, DOI [10.4271/952718, DOI 10.4271/952718]; EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019; EPPINGER, 2009, P 21 ESV INT TECHN C; Faul M, 2010, TRAUMATIC BRAIN INJU; HAZAY M., 2017, BIOMECH HUNG, V10, P75; Holbourn AHS, 1943, LANCET, V2, P438; Irwin, 2015, ACCIDENTAL INJURY, P83; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.1093/biomet/30.1-2.81; KING A. I., 2000, BIOMEDICAL ENG HDB, P420; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; MERTZ H., 1996, 960099 SOC AUT ENG; Mueller B., 2015, P 24 INT TECHN C ENH; NEWMAN J. A., 1980, 801317 SOC AUT ENG; Nowak AS., 2000, RELIABILITY STRUCTUR; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; PRASAD P., 1985, 851246 SOC AUT ENG; Prasad Priya, 2014, Stapp Car Crash J, V58, P175; Rubinstein R. Y., 1981, SIMULATION MONTE CAR; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; The MathWorks, 2016, MATLAB PROGR FUND; The MathWorks, MATLAB ONL HELP COP; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501	25	4	4	0	0	WROCLAW UNIV TECHNOLOGY, FAC COMPUTER SCIENCE & MANAGEMENT	WROCLAW	WYBRZEZE WYSPIANSKIEGO 27, WROCLAW, 50-370, POLAND	1509-409X			ACTA BIOENG BIOMECH	Acta Bioeng. Biomech.		2019	21	1					141	152		10.5277/ABB-01281-2018-02			12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	IB0HA	WOS:000469937700017	31197278				2022-02-06	
J	Hoffman, JM; Ehde, DM; Dikmen, S; Dillworth, T; Gertz, K; Kincaid, C; Lucas, S; Temkin, N; Sawyer, K; Williams, R				Hoffman, Jeanne M.; Ehde, Dawn M.; Dikmen, Sureyya; Dillworth, Tiara; Gertz, Kevin; Kincaid, Carrie; Lucas, Sylvia; Temkin, Nancy; Sawyer, Kate; Williams, Rhonda			Telephone-delivered cognitive behavioral therapy for veterans with chronic pain following traumatic brain injury: Rationale and study protocol for a randomized controlled trial study	CONTEMPORARY CLINICAL TRIALS			English	Article						Traumatic brain injury, TBI; Cognitive behavioral therapy, CBT; Chronic pain; Pain interventions	POSTTRAUMATIC-STRESS-DISORDER; INTERFERENCE MEASURES; MULTIPLE-SCLEROSIS; SERVICE MEMBERS; POLYTRAUMA; DEPRESSION; HEADACHE; VALIDITY; RELIABILITY; DISTURBANCE	Background and objectives: Chronic pain is a highly prevalent and potentially disabling condition in Veterans who have had a traumatic brain injury (TBI) and access to non-pharmacological pain treatments such as cognitive behavioral therapy is limited and variable. The purpose of this randomized controlled trial (RCT) is to evaluate the efficacy of a telephone-delivered cognitive behavioral therapy (T-CBT) for pain in Veterans with a history of TBI. Methods: Veterans with a history of TBI and chronic pain of at least six months duration (N = 160) will be randomized to either T-CBT or a telephone-delivered pain psychoeducational active control condition (T-Ed). The eight-week T-CBT intervention builds on other efficacious CBT interventions for chronic pain in the general population but is novel in that it is conducted via telephone and adapted for Veterans with a history of TBI. Outcome variables will be collected pre, mid-, and post-treatment, and 6 months following randomization (follow-up). Projected outcomes: In addition to evaluating the effects of the interventions on pain intensity (primary outcome), this study will determine their effects on pain interference, sleep, depression, and life satisfaction. We will also examine potential moderators of treatment outcomes such as cognition, PTSD, and alcohol and drug use. This non-pharmacologic one-on-one therapeutic intervention has the potential to reduce pain and pain related dysfunction, improve access to care, and reduce barriers associated with geography, finances, and stigma, without the negative effects on physical and cognitive performance and potential for addiction as seen with some pharmacologic treatments for pain.	[Hoffman, Jeanne M.; Williams, Rhonda] Univ Washington, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA; [Ehde, Dawn M.; Dikmen, Sureyya; Dillworth, Tiara; Gertz, Kevin; Temkin, Nancy] Univ Washington, Dept Rehabil Med, Box 359612, Seattle, WA 98104 USA; [Kincaid, Carrie; Williams, Rhonda] VA Puget Sound Healthcare Syst, 1660 S Columbian Way,RCS 117, Seattle, WA 98108 USA; [Dikmen, Sureyya; Lucas, Sylvia; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Box 359924, Seattle, WA 98104 USA; [Sawyer, Kate] Western Washington Med Grp, Dept Psychol, 3525 Colby Ave,Suite 200, Everett, WA 98201 USA		Hoffman, JM (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.	jeanneh@uw.edu; ehde@uw.edu; dikmen@uw.edu; tiara@uw.edu; kjgertz@uw.edu; Carrie.Kincaid@va.gov; lucass@uw.edu; temkin@uw.edu; Rhonda.williams1@va.gov	Ehde, Dawn/K-1883-2016	Ehde, Dawn/0000-0002-9555-2347; Temkin, Nancy/0000-0002-6392-5292	Congressionally Directed Medical Research Programs of the Department of Defense [PT110602, W81XWH-12-2-0109]	This study was funded through a cooperative agreement PT110602 (W81XWH-12-2-0109) with the Congressionally Directed Medical Research Programs of the Department of Defense.	Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bombardier CH, 2013, J CONSULT CLIN PSYCH, V81, P89, DOI 10.1037/a0031242; Brown R L, 2001, J Am Board Fam Pract, V14, P95; Brown S, 2011, BRAIN INJURY, V25, P453, DOI 10.3109/02699052.2011.556581; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Clark-Hitt R, 2012, HEALTH COMMUN, V27, P429, DOI 10.1080/10410236.2011.606525; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Ecdeston C., 2009, COCHRANE DB SYST REV, V2; Ehde D., 2010, TELEPHONE INTERVENTI; Ehde D., 2018, ANN REH PSYCH C DALL; Ehde DM, 2015, ARCH PHYS MED REHAB, V96, P1945, DOI 10.1016/j.apmr.2015.07.015; Ehde DM, 2014, AM PSYCHOL, V69, P153, DOI 10.1037/a0035747; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; Finlayson M, 2011, MULT SCLER J, V17, P1130, DOI 10.1177/1352458511404272; Geisser ME, 1996, PAIN, V66, P207, DOI 10.1016/0304-3959(96)03038-2; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Goesling J, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0421-0; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Guy W, 1976, ECDEU ASSESSMENT MAN, P218; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Holroyd KA, 2006, SEMIN NEUROL, V26, P199, DOI 10.1055/s-2006-939920; Jennum P, 2002, SLEEP MED REV, V6, P471, DOI 10.1053/smrv.2001.0223; Jensen MP, 2011, INT J CLIN EXP HYP, V59, P45, DOI 10.1080/00207144.2011.522892; Jensen MP, 2011, HDB PAIN ASSESSMENT, V3rd, P19; Kansagara D., 2013, COMPLICATIONS MILD T; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lake AE, 2001, MED CLIN N AM, V85, P1055, DOI 10.1016/S0025-7125(05)70359-X; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; LEW HL, 2009, J REHABIL RES DEV, V46; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; McBeth J, 2012, ARCH INTERN MED, V172, P48, DOI 10.1001/archinternmed.2011.555; Mohr DC, 2000, J CONSULT CLIN PSYCH, V68, P356, DOI 10.1037//0022-006X.68.2.356; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Osborne TL, 2006, J PAIN SYMPTOM MANAG, V32, P217, DOI 10.1016/j.jpainsymman.2006.03.008; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Raichle KA, 2006, J PAIN, V7, P179, DOI 10.1016/j.jpain.2005.10.007; Saletu-Zyhlarz GM, 2001, NEUROPSYCHOBIOLOGY, V44, P139, DOI 10.1159/000054934; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Sirey JA, 2001, AM J PSYCHIAT, V158, P479, DOI 10.1176/appi.ajp.158.3.479; Strauss E, 1990, COMPENDIUM NEUROPSYC, P776; Symoulakis EK, 2007, BRIT J GEN PRACT, V57, P231; Tatrow K, 2003, APPL PSYCHOPHYS BIOF, V28, P267, DOI 10.1023/A:1027326808356; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Turk DC., 2002, PSYCHOL APPROACHES P, V2nd; Tyler EJ, 2002, ARCH PHYS MED REHAB, V83, P236, DOI 10.1053/apmr.2002.27466; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Victor TW, 2008, CLIN J PAIN, V24, P550, DOI 10.1097/AJP.0b013e31816b1058; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	64	4	4	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2019	76						112	119		10.1016/j.cct.2018.12.004			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	HI9DZ	WOS:000456756800015	30553077				2022-02-06	
J	Holmes, SA; Singh-Saluja, R; Chen, JK; Gagnon, I; Ptito, A				Holmes, Scott A.; Singh-Saluja, Rajeet; Chen, Jen-kai; Gagnon, Isabelle; Ptito, Alain			Evaluating task-based brain network activity in pediatric subjects with an mTBI: mechanisms of functional compensation are symptom-level dependent	BRAIN INJURY			English	Article						mild traumatic brain injury; functional MRI; spatial navigation; adaptation; functional compensation	SPORTS-RELATED CONCUSSION; WORKING-MEMORY; COGNITIVE RESERVE; INJURY; ACTIVATION	The diagnosis of a mild traumatic brain injury (mTBI) places large emphasis on patient-reported symptoms which has restricted our ability to evaluate patients. Task-based functional magnetic resonance imaging has the potential to act as an objective measurement of abnormal brain activity and inform clinical decision-making; however, there is little research evaluating pediatric subjects as a function of mTBI-related symptoms. The objective of this study was to evaluate the extent to which brain activity during a spatial navigation task is different between children with mTBI and a group of healthy controls (HCs) based on symptom reporting. A group of patients with mTBI (n =27) were divided into low- and high-symptom cohorts and compared with HCs (n =27) on a task that required participants to locate specific landmarks. No difference was found in the level of symptoms reported between patients with low-symptom participants and HCs despite the low-symptom group showing increased activity within the frontal and occipital cortices. In participants with high-symptoms, an increase in the number of reported symptoms was found relative to HCs alongside an increase in the number of active brain regions. Findings suggest that persons with an mTBI may display unique symptom-dependent patterns of altered task-related brain activity.	[Holmes, Scott A.; Chen, Jen-kai; Ptito, Alain] McGill Univ, Cognit Neurosci Unit, Montreal, PQ, Canada; [Holmes, Scott A.; Gagnon, Isabelle] Montreal Childrens Hosp, Concuss Res Lab, Montreal, PQ, Canada; [Holmes, Scott A.] Harvard Med Sch, Dept Anesthesia, Boston, MA 02115 USA; [Singh-Saluja, Rajeet; Ptito, Alain] Montreal Gen Hosp, Dept Neurosurg, Montreal, PQ, Canada		Holmes, SA (corresponding author), McGill Univ, Cognit Neurosci Unit, Montreal, PQ, Canada.; Holmes, SA (corresponding author), Montreal Childrens Hosp, Concuss Res Lab, Montreal, PQ, Canada.; Holmes, SA (corresponding author), Harvard Med Sch, Dept Anesthesia, Boston, MA 02115 USA.	scott.holmes@childrens.harvard.edu		Gagnon, Isabelle/0000-0003-2043-1644	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [231257,484706]	This work was supported by the Canadian Institutes of Health Research [231257,484706].	Ballesteros S, 2013, NEUROBIOL AGING, V34, P1254, DOI 10.1016/j.neurobiolaging.2012.09.019; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; FORGY EW, 1965, BIOMETRICS, V21, P768; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Frings L, 2006, EXP BRAIN RES, V173, P661, DOI 10.1007/s00221-006-0408-8; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Grieves RM, 2017, BEHAV PROCESS, V135, P113, DOI 10.1016/j.beproc.2016.12.012; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Li M, 2016, OPEN ACCESS, V1, P1; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; MacQueen J, 1967, P 5 BERKELEY S MATH; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Martinet LE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002045; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Saluja RS, 2015, J NEUROTRAUM, V32, P712, DOI 10.1089/neu.2014.3470; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Tang HL, 2014, NEURON, V83, P736, DOI 10.1016/j.neuron.2014.06.017; Team RC, 2014, R LANG ENV STAT COMP; Wechsler D., 2011, WECHSLER ABBREVIATED; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110	38	4	4	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2019	33	3					383	393		10.1080/02699052.2018.1552023			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM7DB	WOS:000459636400015	30507312				2022-02-06	
J	Huang, W; Johnson, TM; Kutner, NG; Halpin, SN; Weiss, P; Griffiths, PC; Bliwise, DL				Huang, Wei; Johnson, Theodore M., II; Kutner, Nancy G.; Halpin, Sean N.; Weiss, Paul; Griffiths, Patricia C.; Bliwise, Donald L.			Acupuncture for Treatment of Persistent Disturbed Sleep: A Randomized Clinical Trial in Veterans With Mild Traumatic Brain Injury and Posttraumatic Stress Disorder	JOURNAL OF CLINICAL PSYCHIATRY			English	Article						Neurology; Traumatic Brain Injury; Veterans and Military Issues; Sleep	QUALITY INDEX; OLDER-ADULTS; INSOMNIA; PAIN; DISSOCIATION; ACTIGRAPHY; INVENTORY; VALIDITY; OUTCOMES; HEALTH	Objective: To evaluate real, as compared with sham, acupuncture in improving persistent sleep disturbance in veterans with mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD). Methods: This sham-controlled randomized clinical trial at a US Department of Veterans Affairs Medical Center (2010-2015) included 60 veterans aged 24-55 years (mean of 40 years) with history of mTBI of at least 3 months and refractory sleep disturbance. Most of these participants (66.7%) carried a concurrent DSM-IV clinical diagnosis of PTSD. For the present study, they were randomized into 2 groups and stratified by PTSD status using the PTSD Checklist-Military Version. Each participant received up to 10 treatment sessions. The primary outcome measure was change in baseline-adjusted global Pittsburgh Sleep Quality Index (PSQI) score following intervention. Secondary outcomes were wrist-actigraphy-assessed objective sleep measurements. Comorbid PTSD was analyzed as a covariate. Results: Mean (SD) preintervention global PSQI score was 14.3 (3.2). Those receiving real acupuncture had a global PSQI score improvement of 4.4 points (relative to 2.4 points in sham, P =.04) and actigraphically measured sleep efficiency (absolute) improvement of 2.7% (relative to a decrement of 5.3% in sham, P =.0016). Effective blinding for active treatment was maintained in the study. PTSD participants presented with more clinically significant sleep difficulties at baseline; acupuncture was effective for both those with and without PTSD. Conclusions: Real acupuncture, compared with a sham needling procedure, resulted in a significant improvement in sleep measures for veterans with mTBI and disturbed sleep, even in the presence of PTSD. These results indicate that an alternative-medicine treatment modality like acupuncture can provide clinically significant relief for a particularly recalcitrant problem affecting large segments of the veteran population.	[Huang, Wei] Atlanta Vet Affairs Med Ctr, Traumat Brain Injury Geriatr Extended Care & Reha, Decatur, GA 30030 USA; [Huang, Wei; Kutner, Nancy G.] Emory Univ, Sch Med, Dept Rehabil Med, Atlanta, GA USA; [Johnson, Theodore M., II; Griffiths, Patricia C.] Atlanta Vet Affairs Med Ctr, Birmingham Atlanta Vet Affairs GRECC, Decatur, GA USA; [Johnson, Theodore M., II] Emory Univ, Sch Med, Dept Med, Div Gen Med & Geriatr, Atlanta, GA USA; [Halpin, Sean N.] Emory Univ, Rollins Sch Publ Hlth, Emory Prevent Res Ctr, Atlanta, GA 30322 USA; [Weiss, Paul] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Bliwise, Donald L.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Dept Neurol,Emory Sleep Ctr, Atlanta, GA USA		Huang, W (corresponding author), Atlanta Vet Affairs Med Ctr, Traumat Brain Injury Geriatr Extended Care & Reha, Decatur, GA 30030 USA.	whuang4@emory.edu	, Theodore M. Johnson/A-6374-2014	, Theodore M. Johnson/0000-0001-8332-5369	US Department of Veterans Affairs Rehabilitation Research and Development Career Development Award Level II [B6924W]	The work was supported by a US Department of Veterans Affairs Rehabilitation Research and Development Career Development Award Level II (W.H.) (B6924W). The funding provided financial support for both salary (W.H.) and research subjects' participation from 2010 to 2015.	Ahn AC, 2005, ALTERN THER HEALTH M, V11, P40; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beck AT, 1993, BECK ANXIETY INVENTO; Bertisch SM, 2009, J EVAL CLIN PRACT, V15, P14, DOI 10.1111/j.1365-2753.2008.00942.x; Bhatnagar S, 2016, BRAIN RES, V1640, P164, DOI 10.1016/j.brainres.2016.01.021; Blackwell T, 2005, SLEEP, V28, P1599, DOI 10.1093/sleep/28.12.1599; Blackwell T, 2008, SLEEP, V31, P283, DOI 10.1093/sleep/31.2.283; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bonnet MH, 2010, SLEEP MED REV, V14, P9, DOI 10.1016/j.smrv.2009.05.002; Bush AL, 2012, PSYCHIAT RES, V199, P24, DOI 10.1016/j.psychres.2012.03.045; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cabyoglu MT, 2006, INT J NEUROSCI, V116, P115, DOI 10.1080/00207450500341472; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Cheuk DKL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005472.pub3; Cheuk DKL, 2012, COCHRANE DB SYST REV, V9, P1; Ensrud KE, 2012, MENOPAUSE, V19, P848, DOI 10.1097/gme.0b013e3182476099; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang W, 2013, NEUROPSYCHOL REHABIL, V23, P698, DOI 10.1080/09602011.2013.803488; Huang W, 2011, J CLIN SLEEP MED, V7, P95; Huang W, 2009, SLEEP MED REV, V13, P73, DOI 10.1016/j.smrv.2008.04.002; Hwang MY, 1999, JAMA-J AM MED ASSOC, V281, P1056; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; King AC, 2008, J GERONTOL A-BIOL, V63, P997, DOI 10.1093/gerona/63.9.997; Kong J, 2009, NEUROIMAGE, V47, P1066, DOI 10.1016/j.neuroimage.2009.05.087; Kong J, 2009, NEUROIMAGE, V45, P940, DOI 10.1016/j.neuroimage.2008.12.025; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Lee MS, 2008, INT J CLIN PRACT, V62, P1744, DOI 10.1111/j.1742-1241.2008.01876.x; Lequerica A, 2015, ARCH PHYS MED REHAB, V96, P1802, DOI 10.1016/j.apmr.2015.05.011; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Li FZ, 2004, J AM GERIATR SOC, V52, P892, DOI 10.1111/j.1532-5415.2004.52255.x; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Ouslander JG, 2006, J AM GERIATR SOC, V54, P38, DOI 10.1111/j.1532-5415.2005.00562.x; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Quan SF, 2005, J CLIN SLEEP MED, V1, P83; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Schnyer RN, 2002, J ALTERN COMPLEM MED, V8, P623, DOI 10.1089/107555302320825147; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; White P, 2010, ACUPUNCT MED, V28, P120, DOI 10.1136/aim.2009.001768; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; Yeung WF, 2012, SLEEP MED, V13, P971, DOI 10.1016/j.sleep.2012.06.003; ZHANG AZ, 1980, CHINESE MED J-PEKING, V93, P673	51	4	4	0	15	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	JAN-FEB	2019	80	1							18m12235	10.4088/JCP.18m12235			26	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	HM0YR	WOS:000459174400014	30549498				2022-02-06	
J	Lueckel, SN; Teno, JM; Stephen, AH; Benoit, E; Kheirbek, T; Adams, CA; Cioffi, WG; Thomas, KS				Lueckel, Stephanie N.; Teno, Joan M.; Stephen, Andrew H.; Benoit, Eric; Kheirbek, Tareq; Adams, Charles A., Jr.; Cioffi, William G.; Thomas, Kali S.			Population of Patients With Traumatic Brain Injury in Skilled Nursing Facilities: A Decade of Change	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						outcomes; skilled nursing facilities; traumatic brain injury	ELDERLY-PATIENTS; HOME RESIDENTS; UNITED-STATES; TRENDS; MANAGEMENT; MORTALITY; DISCHARGE; RECOVERY; PROTOCOL; CENTERS	Objective: To describe the natural history of patients with traumatic brain injury (TBI) admitted to skilled nursing facilities (SNFs) following hospitalizations. Setting: Between 2005 and 2014. Participants: Adults who had incident admissions to skilled nursing facilities (SNFs) with a diagnosis of TBI. Design: Retrospective review of the Minimum Data Set. Main Measures: Main variables were cognitive and physical function, length of stay, presence of feeding tube, terminal condition, and dementia. Results: Incident admissions to SNFs increased annually from 17 247 patients to 20 787 from 2005 to 2014. The percentage of patients with activities of daily living score 23 or more decreased from 25% to 14% (P < .05). The overall percentage of patients with severe cognitive impairment decreased from 18% to 10% (P < .05). More patients had a diagnosis of dementia in 2014 compared with previous years (P < .05), and the presence of a terminal condition increased from 1% to 1.5% over the 10-year period (P < .05). The percentage of patients who stayed fewer than 30 days was noted to increase steadily over the 10 years, starting with 48% in 2005 and ending with 53% in 2013 (P < .05). Conclusion: Understanding past trends in TBI admissions to SNFs is necessary to guide appropriate discharge and predict future demand, as well as inform SNF policy and practice necessary to care for this subgroup of patients.	[Lueckel, Stephanie N.; Stephen, Andrew H.; Benoit, Eric; Kheirbek, Tareq; Adams, Charles A., Jr.; Cioffi, William G.] Brown Univ, Rhode Isl Hosp, Dept Surg, Warren Alpert Med Sch, Providence, RI 02903 USA; [Teno, Joan M.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA USA; [Thomas, Kali S.] Brown Univ, Sch Publ Hlth, Providence Vet Affairs Med Ctr, Providence, RI 02912 USA		Lueckel, SN (corresponding author), Rhode Isl Hosp, Dept Surg, Providence, RI 02903 USA.	Stephanie_Lueckel@brown.edu	Kheirbek, Tareq/AAL-6616-2020; Adams Jr., Charles A/ABC-8735-2021	Kheirbek, Tareq/0000-0002-6758-9150; Adams Jr., Charles A/0000-0002-9915-4186	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG027296] Funding Source: NIH RePORTER		American Speech Language Hearing Association, TRAUM BRAIN INJ AD; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Bechtold ML, 2016, NUTR CLIN PRACT, V31, P737, DOI 10.1177/0884533616670103; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Bilgin S, 2012, NEURAL REGEN RES, V7, P1978, DOI 10.3969/j.issn.1673-5374.2012.25.009; Brown DL, 2004, CTR MEDICARE MED SER; Buchanan RJ, 2003, BRAIN INJURY, V17, P507, DOI 10.1080/0269905031000070215; Centers for Disease Control and Prevention, MORBIDITY MORTALITY; Centers for Disease Control and Prevention (CDC), TBI GET THE FACTS; Centers for Medicare & Medicaid Services (CMS) HHS, 2016, Fed Regist, V81, P52055; Colantonio A, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-7; Competty B, 2016, TOP 10 DIFFERENCES S; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; EDELMAN TS, 1994, JAMA-J AM MED ASSOC, V272, P1169; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Freedman VA, 2014, J GERONTOL B-PSYCHOL, V69, pS42, DOI 10.1093/geronb/gbu120; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Haring RS, 2015, BRAIN INJURY, V29, P989, DOI 10.3109/02699052.2015.1033014; Hirshson CI, 2013, NEUROREHABILITATION, V32, P225, DOI 10.3233/NRE-130840; Hsia RY, 2011, ARCH SURG-CHICAGO, V146, P585, DOI 10.1001/archsurg.2010.311; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P196, DOI 10.1097/TA.0b013e3182a833ac; Karon SL, 2007, J HEAD TRAUMA REHAB, V22, P350, DOI 10.1097/01.HTR.0000300230.13490.11; Liberman M, 2003, CAN J SURG, V46, P446; Lipschutz L, 2012, DIFFERENCES SNFS LTA; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Mallinson TR, 2008, ARCH PHYS MED REHAB, V89, P2066, DOI 10.1016/j.apmr.2008.05.014; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mor V, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-20; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Saliba D, 2012, J AM MED DIR ASSOC, V13, P611, DOI 10.1016/j.jamda.2012.06.004; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thomas KS, 2018, J AGING SOC POLICY, V30, P93, DOI 10.1080/08959420.2017.1414538; Thomas KS, 2017, MED CARE, V55, pE68, DOI 10.1097/MLR.0000000000000334; Thomas KS, 2017, MED CARE BLOG INTERN; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532; Wysocki A, 2015, J AM MED DIR ASSOC, V16, P470, DOI 10.1016/j.jamda.2014.11.018	42	4	4	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2019	34	1			SI		E39	E45		10.1097/HTR.0000000000000393			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HK0FH	WOS:000457573600011	29863612	Green Accepted			2022-02-06	
J	Qin, P; Dick, BD; Leung, A; Brown, CA				Qin, Pei; Dick, Bruce D.; Leung, Ada; Brown, Cary A.			Effectiveness of hand self-shiatsu to improve sleep following sport-related concussion in young athletes: a proof-of-concept study	JOURNAL OF INTEGRATIVE MEDICINE-JIM			English	Article						Concussion; Insomnia; Youth; Complementary and alternative medicine; Self-management	TRAUMATIC BRAIN-INJURY; QUALITY INDEX; SYMPTOMS; COMPLEMENTARY; ACUPRESSURE; DISTURBANCE; MANAGEMENT; SCALE	Objective: The prevalence of sport-related concussion (SRC) is high and results in a number of serious health consequences. One area that has received minimal research is the relationship between SRC and sleep. The literature shows that sleep deficiency is a frequent negative consequence of SRC. At the same time, sleep deficiency delays recovery from SRC and contributes added risk of symptom recurrence. A 2014 study of chronic pain patients who learned to apply the complementary and alternative medicine intervention hand self-shiatsu (HSS) had promising, sleep-promoting results that warrant further investigation with other populations. This proof-of-concept study explored the feasibility of HSS as an intervention to promote sleep onset and continuity for young adults with SRC. Methods: This study employed a prospective case-series design, where participants act as their own controls. Baseline and follow-up data included standardized self-reported assessment tools and sleep actigraphy. Results: Seven athletes, aged between 18 and 25 years, participated in the study. Although statistically significant improvement in actigraphy sleep scores between baseline and follow-up was not achieved, metrics for sleep quality and daytime fatigue showed significant improvement. Conclusion: These findings support the hypothesis that HSS has the potential to improve sleep and reduce daytime fatigue in young postconcussion athletes. This pilot study provides guidance to refine research protocols and lays a foundation for further, large-sample, controlled studies. Please cite this article as: Qin P, Dick BD, Leung A, Brown CA. Effectiveness of hand self-shiatsu to improve sleep following sport-related concussion in young athletes: a proof-of-concept study. J Integr Med. 2019; 17(1): 24-29. (C) 2018 Shanghai Changhai Hospital. Published by Elsevier B.V. All rights reserved.	[Qin, Pei; Brown, Cary A.] Univ Alberta, Fac Rehabil Med, Edmonton, AB T6E4H4, Canada; [Dick, Bruce D.] Univ Alberta, Fac Med & Dent, Dept Anesthesiol & Pain Med, Edmonton, AB T6E4H4, Canada; [Leung, Ada; Brown, Cary A.] Univ Alberta, Fac Rehabil Med, Dept Occupat Therapy, Edmonton, AB T6E4H4, Canada		Brown, CA (corresponding author), Univ Alberta, Fac Rehabil Med, Edmonton, AB T6E4H4, Canada.	cary.brown@ualberta.ca		Qin, Pei/0000-0001-8169-0549			Adan A, 2006, J SLEEP RES, V15, P125, DOI 10.1111/j.1365-2869.2006.00509.x; Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; Beresford-Cooke C., 2011, SHIATSU THEORY PRACT; Brown CA, 2014, J INTEGR MED-JIM, V12, P94, DOI 10.1016/S2095-4964(14)60010-8; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll L J, 2011, CONCUSSION CRISIS AN; Chen ML, 1999, J GERONTOL A-BIOL, V54, pM389, DOI 10.1093/gerona/54.8.M389; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Ebben MR, 2009, J BEHAV MED, V32, P244, DOI 10.1007/s10865-008-9198-8; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Gradisar M, 2007, J CLIN SLEEP MED, V3, P722; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; Hereford JM, 2014, SLEEP AND REHABILITATION: A GUIDE FOR HEALTH PROFESSIONALS, P1; Higgins DM, 2015, NERVES NERVE INJURIE, P805; Hsu C, 2010, J ALTERN COMPLEM MED, V16, P157, DOI 10.1089/acm.2009.0188; Hyland ME, 2003, COMPLEMENT THER MED, V11, P33, DOI 10.1016/S0965-2299(02)00113-9; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Jiang SH, 2008, CLIN RES APPL ACUPUN; Kooistra B, 2009, J BONE JOINT SURG AM, V91A, P21, DOI 10.2106/JBJS.H.01573; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Laker SR, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0510-3; Long AF, 2003, J ALTERN COMPLEM MED, V9, P539, DOI 10.1089/107555303322284839; Long AF, 2008, J ALTERN COMPLEM MED, V14, P921, DOI 10.1089/acm.2008.0085; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makoto Annica, 2013, Aust Nurs Midwifery J, V21, P51; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Nichols AW, 2006, CLIN J SPORT MED, V16, P232, DOI 10.1097/00042752-200605000-00008; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Reza Hoseinabadi, 2010, Complement Ther Clin Pract, V16, P81, DOI 10.1016/j.ctcp.2009.07.003; Robinson N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-88; Sargent C, 2016, J SCI MED SPORT, V19, P848, DOI 10.1016/j.jsams.2015.12.007; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Sedlmeier P, 2012, PSYCHOL BULL, V138, P1139, DOI 10.1037/a0028168; Song HJ, 2015, COMPLEMENT THER MED, V23, P68, DOI 10.1016/j.ctim.2014.11.002; Styles E. A., 2006, PSYCHOL ATTENTION; Sun JL, 2010, INT J NURS STUD, V47, P798, DOI 10.1016/j.ijnurstu.2009.12.003; Sun JL., 2006, J EVIDENCE BASED NUR, V2, P331; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Titova OE, 2015, SLEEP MED, V16, P87, DOI 10.1016/j.sleep.2014.09.004; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wesensten NJ, 2011, DRUG DISCOV TODAY DI, V8, P139; Yuan SLK, 2013, J MANIP PHYSIOL THER, V36, P436, DOI 10.1016/j.jmpt.2013.05.019; Yuan SLK, 2015, MANUAL THER, V20, P257, DOI 10.1016/j.math.2014.09.003; Zinkhan M, 2014, SLEEP MED, V15, P1107, DOI 10.1016/j.sleep.2014.04.015	49	4	4	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2095-4964			J INTEGR MED-JIM	J. Integr. Med.-JIM	JAN	2019	17	1					24	29		10.1016/j.joim.2018.11.002			6	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	HG5XX	WOS:000455055500006	30482473				2022-02-06	
J	Rached, MAKB; Gaudet, JG; Delhumeau, C; Walder, B				Rached, Mohamed A. K. B.; Gaudet, John G.; Delhumeau, Cecile; Walder, Bernhard			Comparison of two simple models for prediction of short term mortality in patients after severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Head injury; Prognosis; Discrimination; Calibration; Age; Pupil reactivity; Glasgow Coma Scale; Abbreviated Injury Score	GLASGOW COMA SCALE; OLDER-ADULTS; HEAD-INJURY; SCORE; EPIDEMIOLOGY; MODERATE; IMPACT	Introduction: The subscale motor score of Glasgow Coma Scale (msGCS) and the Abbreviated Injury Score of head region (HAIS) are validated prognostic factors in traumatic brain injury (TBI). The aim was to compare the prognostic performance of a HAIS-based prediction model including HAIS, pupil reactivity and age, and the reference prediction model including msGCS in emergency department (ED), pupil reactivity and age. Methods: Secondary analysis of a prospective epidemiological study including patients after severe TBI (HAIS> 3) with follow-up from the time of accident until 14 days or earlier death was performed in Switzerland. Performance of prediction, based on accuracy of discrimination [area under the receiver-operating curve (AUROC)], calibration (Hosmer-Lemeshow test) and validity (bootstrapping with 2000 repetitions to correct) for optimism of the two prediction models were investigated. A non-inferiority approach was performed and an a priori threshold for important differences was established. Results: The cohort included 808 patients [median age 56 {inter-quartile range (IQR) 33-71}, median motor part of GCS in ED 1 (1-6), abnormal pupil reactivity 29.0%] with a death rate of 29.7% at 14 days. The accuracy of discrimination was similar (AUROCHAIS-based prediction model: 0.839; AUROC msGCS-based prediction model: 0.826, difference of the 2 AUROC 0.013 (-0.007 to 0.037). A similar calibration was observed (Hosmer-Lemeshow X-2 11.64, p = 0.168 vs. Hosmer-Lemeshow X-2 8.66, p = 0.372). Internal validity of HAIS-based prediction model was high (optimism corrected AUROC: 0.837). Conclusions: Performance of prediction for short-term mortality after severe TBI with HAIS-based prediction model was non-inferior to reference prediction model using msGCS as predictor. (C) 2018 Elsevier Ltd. All rights reserved.	[Rached, Mohamed A. K. B.; Gaudet, John G.; Delhumeau, Cecile; Walder, Bernhard] Univ Hosp Geneva HUG, Div Anaesthesiol, Geneva, Switzerland		Rached, MAKB (corresponding author), Univ Hosp Geneva, Dept APSI, Div Anaesthesiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.	mohk@hcuge.ch			Swiss Accident Insurance Foundation (SUVA, Switzerland)	The authors have no conflict of interest to declare. This study was partially funded by the Swiss Accident Insurance Foundation (SUVA, Switzerland). The funding agency had no role in the study design, data collection, data analysis, data interpretation or writing of the report.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; [Anonymous], 1971, JAMA, V215, P277; Ashkenazi I, 2016, JAMA SURG, V151, P954, DOI 10.1001/jamasurg.2016.1742; Beskind DL, 2014, PREHOSP EMERG CARE, V18, P68, DOI 10.3109/10903127.2013.844870; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Holmes M, 2014, J AM COLL SURGEONS, V219, P631, DOI 10.1016/j.jamcollsurg.2014.05.014; Hosmer DW, 1997, STAT MED, V16, P965; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Ogundimu EO, 2016, J CLIN EPIDEMIOL, V76, P175, DOI 10.1016/j.jclinepi.2016.02.031; Pepe MS, 2009, STATA J, V9, P1; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Ringdal KG, 2013, INJURY, V44, P691, DOI 10.1016/j.injury.2012.06.032; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Staples JA, 2016, J HEAD TRAUMA REHAB, V31, pE8, DOI 10.1097/HTR.0000000000000195; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	40	4	5	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2019	50	1					65	72		10.1016/j.injury.2018.08.022			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	HG1LR	WOS:000454717700013	30213562				2022-02-06	
J	Rajneesh, CP; Lai, CH; Chen, SC; Hsieh, TH; Chin, HY; Peng, CW				Rajneesh, Chellappan Praveen; Lai, Chien-Hung; Chen, Shih-Ching; Hsieh, Tsung-Hsun; Chin, Hung-Yen; Peng, Chih-Wei			Improved voiding function by deep brain stimulation in traumatic brain-injured animals with bladder dysfunctions	INTERNATIONAL UROLOGY AND NEPHROLOGY			English	Article						Deep brain stimulations; PnO; Traumatic brain injury; Weight drop model; Cystometric analysis	ELECTRICAL-STIMULATION; MECHANISMS; NUCLEUS; MICTURITION; EFFICACY; DISEASE; RAT	ObjectiveTraumatic brain injury (TBI) is a global scenario with high mortality and disability, which does not have an effectual and approved therapy till now. Bladder dysfunction is a major symptom after TBI, and this study deals with the alleviation of bladder function in TBI rats, with the aid of deep brain stimulations (DBS).MethodsTBI was induced by weight drop model (WDM) and standardized with the experimental subjects with variable heights for weight dropping. The rats survived after TBI were considered for bladder dysfunction observations. DBS with variable stimulation parameters like cystometric analysis and MRI studies were also performed.ResultsAfter experimental studies, TBI 2-m-height crash was determined as suitable parameter due to minimal mortality rate and significant reduction in the voiding efficiency from 67 to 28%, whereas DBS significantly reversed the value of voiding efficiency to 65-84%. MRI studies revealed the severity of TBI impact and DBS localization.ConclusionThe results showed profound therapeutic effect of PnO-DBS on voiding functions and bladder control on TBI rats.	[Rajneesh, Chellappan Praveen; Peng, Chih-Wei] Taipei Med Univ, Coll Biomed Engn, Sch Biomed Engn, 250 Wuxing St, Taipei 11031, Taiwan; [Lai, Chien-Hung; Chen, Shih-Ching; Peng, Chih-Wei] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lai, Chien-Hung; Chen, Shih-Ching; Peng, Chih-Wei] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Linkou, Taiwan; [Chin, Hung-Yen] Taipei Med Univ, Dept Obstet & Gynaecol, Taipei, Taiwan; [Chin, Hung-Yen] Taipei Med Univ, Coll Med, Sch Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Optomechatron, Taipei, Taiwan		Peng, CW (corresponding author), Taipei Med Univ, Coll Biomed Engn, Sch Biomed Engn, 250 Wuxing St, Taipei 11031, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Optomechatron, Taipei, Taiwan.	cwpeng@tmu.edu.tw	Hsieh, Tung-Hsun/AAZ-5010-2020; Praveen Rajneesh, Chellappan/O-3179-2018	Hsieh, Tung-Hsun/0000-0002-1794-7941; Peng, Chih-Wei/0000-0001-9744-4094; Praveen Rajneesh, Chellappan/0000-0002-5305-0357; Lai, Chien-Hung/0000-0002-5765-3120	Taiwan Ministry of Science and Technology [MOST106-2221-E-038-010-MY3, MOST107-2811-E-038-001]	This work was supported by the Taiwan Ministry of Science and Technology under the Grant Number MOST106-2221-E-038-010-MY3 and MOST107-2811-E-038-001 to C.W. Peng.	Anderson RJ, 2012, NEUROSCI BIOBEHAV R, V36, P1920, DOI 10.1016/j.neubiorev.2012.06.001; Andersson KE, 2011, NEUROUROL URODYNAM, V30, P636, DOI 10.1002/nau.21108; Benabid AL, 1996, J NEUROSURG, V84, P203, DOI 10.3171/jns.1996.84.2.0203; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; BLAIVAS JG, 1982, J UROLOGY, V127, P958, DOI 10.1016/S0022-5347(17)54147-6; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen CS, 2011, BR J UROL, V109, P1051; Chen JQ, 2014, ASIAN PAC J TROP MED, V7, P991, DOI 10.1016/S1995-7645(14)60174-7; Chew DJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007186; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Denny-Brown D E, 1941, Proc R Soc Med, V34, P691; Dixon EC, 1989, J NEUROSURG, V67, P110; Fan WJ, 2013, AM J PHYSIOL-RENAL, V305, pF1332, DOI 10.1152/ajprenal.00261.2013; Finan DJ, 2018, CLIN BIOMECH; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frederick C, 2018, NEUROBIOL DIS; Fry CH, 2010, AUTON NEUROSCI-BASIC, V154, P3, DOI 10.1016/j.autneu.2009.10.006; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Jang HJ, 2018, INT NEUROUROL J; Jen E, 2018, J MED BIOL ENG, V38, P337, DOI 10.1007/s40846-017-0326-1; Jen E, 2017, NEUROUROL URODYNAM, V36, P1734, DOI 10.1002/nau.23183; Jiang HH, 2013, EXP NEUROL, V240, P57, DOI 10.1016/j.expneurol.2012.11.012; Kadow BT, 2015, CURR BLADDER DYSFUNC, V10, P325, DOI 10.1007/s11884-015-0331-6; Kelly Christopher E, 2004, Rev Urol, V6 Suppl 1, pS32; KHAN Z, 1990, UROLOGY, V35, P265, DOI 10.1016/0090-4295(90)80048-R; KHAN Z, 1981, J UROLOGY, V126, P86, DOI 10.1016/S0022-5347(17)54392-X; Klevmark B, 2002, SCAND J UROL NEPHROL, V36, P6, DOI 10.1080/003655902320765890; Krasmik D, 2014, NEUROUROL URODYNAM, V33, P1202, DOI 10.1002/nau.22486; Kringelbach ML, 2007, NEUROREPORT, V18, P223, DOI 10.1097/WNR.0b013e328010dc3d; KRUSE MN, 1990, BRAIN RES, V532, P182, DOI 10.1016/0006-8993(90)91758-9; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; Marmarou A, 2010, J NEUROSURG, V112, P291; McMurray G, 2006, BRIT J PHARMACOL, V147, pS62, DOI 10.1038/sj.bjp.0706630; Miocinovic S, 2009, EXP NEUROL, V216, P166, DOI 10.1016/j.expneurol.2008.11.024; Montgomery EB, 2000, NEUROL RES, V22, P259; Moody BJ, 2014, NEUROUROL URODYNAM, V33, P1159, DOI 10.1002/nau.22470; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; NOTO H, 1989, BRAIN RES, V492, P99, DOI 10.1016/0006-8993(89)90893-7; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Oostra K, 1996, BRAIN INJURY, V10, P459, DOI 10.1080/026990596124313; Salanova V, 2018, EPILEPSY BEHAV; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Seif C, 2004, ANN NEUROL, V55, P118, DOI 10.1002/ana.10806; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Veerakumar A, 2015, CURR OPIN BEHAV SCI, V4, P48, DOI 10.1016/j.cobeha.2015.02.004; Vitek JL, 2002, STEREOT FUNCT NEUROS, V78, P119, DOI 10.1159/000068959; Wallace BA, 2007, BRAIN, V130, P2129, DOI 10.1093/brain/awm137; WYNDAELE JJ, 1986, PARAPLEGIA, V24, P271, DOI 10.1038/sc.1986.37	50	4	4	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-1623	1573-2584		INT UROL NEPHROL	Int. Urol. Nephrol.	JAN	2019	51	1					41	52		10.1007/s11255-018-2028-1			12	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	HH0JL	WOS:000455402200006	30474784				2022-02-06	
J	Ringdahl, EN; Becker, ML; Hussey, JE; Thaler, NS; Vogel, SJ; Cross, C; Mayfield, J; Allen, DN				Ringdahl, Erik N.; Becker, Megan L.; Hussey, Julia E.; Thaler, Nicholas S.; Vogel, Sally J.; Cross, Chad; Mayfield, Joan; Allen, Daniel N.			Executive Function Profiles in Pediatric Traumatic Brain Injury	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							TEST-CHILDRENS VERSION; INDEX SCORE PATTERNS; COMPREHENSIVE TRAIL; WISC-III; CLUSTER-ANALYSIS; INDIVIDUAL-DIFFERENCES; CRITERION VALIDITY; TEST-PERFORMANCE; MEMORY FUNCTION; WORKING-MEMORY	Traumatic brain injury (TBI) results in heterogeneous patterns of neuropsychological impairment. This study investigated heterogeneity in executive function (EF) using the Comprehensive Trail Making Test (CTMT) to evaluate 121 children and adolescents with TBI and 121 matched normal controls. The TBI group performed approximately two standard deviations below controls. Cluster analyses indicated that a three-cluster solution best classified the TBI group and a four-cluster solution best classified controls. Greater impairment in EF was associated with lower intellectual, achievement, and neuropsychological test performance in the TBI group. Results suggest that EF deficits reflected in CTMT performance may be useful for classifying severity of TBI.	[Ringdahl, Erik N.; Becker, Megan L.; Hussey, Julia E.; Thaler, Nicholas S.; Vogel, Sally J.; Allen, Daniel N.] Univ Nevada, Las Vegas, NV 89154 USA; [Cross, Chad] Univ Nevada, Sch Med, Las Vegas, NV 89154 USA; [Cross, Chad] Univ Nevada, Sch Community Hlth Sci, Las Vegas, NV 89154 USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242; Maietta, Julia/0000-0001-5612-6321; Cross, Chad/0000-0002-8756-5607			Allen DN, 2014, APPL NEUROPSYCH-CHIL, V3, P83, DOI 10.1080/21622965.2012.700531; Allen DN, 2012, PSYCHOL ASSESSMENT, V24, P964, DOI 10.1037/a0028521; Allen DN, 2012, PSYCHOL ASSESSMENT, V24, P556, DOI 10.1037/a0026263; Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Allen DN, 2009, CHILD NEUROPSYCHOL, V15, P543, DOI 10.1080/09297040902748234; Allen DN, 2003, J INT NEUROPSYCH SOC, V9, P56, DOI 10.1017/S135561770391006X; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson VA, 2000, BRAIN INJURY, V14, P679; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Ball G. H., 1971, 5533 SRI; Beale EML, 1969, CLUSTER ANAL; Black, 1992, MULTIVARIATE DATA AN; Blake TM, 2009, CLIN NEUROPSYCHOL, V23, P373, DOI 10.1080/13854040802279691; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Conners C. K., 2000, CONNERS CONTINUOUS P; Cross CL., 2013, CLUSTER ANAL NEUROPS, P13; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Donders J, 1996, CHILD NEUROPSYCHOL, V2, P185, DOI 10.1080/09297049608402251; Donders J, 1995, CHILD NEUROPSYCHOL, V1, P19, DOI 10.1080/09297049508401339; Donders J, 2008, J CLIN EXP NEUROPSYC, V30, P741, DOI 10.1080/13803390701689595; Everitt BS., 2001, CLUSTER ANAL, V4th ed; Fraiman R, 2008, J AM STAT ASSOC, V103, P1294, DOI 10.1198/016214508000000544; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; GNANADESIKAN R, 1995, J CLASSIF, V12, P113, DOI 10.1007/BF01202271; Goldstein G, 1998, J INT NEUROPSYCH SOC, V4, P353, DOI 10.1017/S1355617798003531; Goldstein G.., 2013, CLUSTER ANAL NEUROPS, DOI [10.1007/978-1-4614-6744-1, DOI 10.1007/978-1-4614-6744-1]; Goldstein G, 2008, NEUROPSYCHOLOGY, V22, P301, DOI 10.1037/0894-4105.22.3.301; Goldstein G, 2010, BRAIN INJURY, V24, P625, DOI 10.3109/02699051003670882; Gunstad J, 2006, J GERIATR PSYCH NEUR, V19, P59, DOI 10.1177/0891988705284738; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Johnson M.B., 1989, WOODCOCK JOHNSON PSY; Jonsson CA, 2013, BRAIN INJURY, V27, P831, DOI 10.3109/02699052.2013.775493; Jonsson CA, 2013, J NEUROTRAUM, V30, P76, DOI 10.1089/neu.2012.2592; Kahn DA, 2012, APPL NEUROPSYCH-CHIL, V1, P53, DOI 10.1080/09084282.2011.643954; Kamphaus, 2003, REYNOLDS INTELLECTUA; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; MALEC JF, 1993, CLIN NEUROPSYCHOL, V7, P48, DOI DOI 10.1080/13854049308401887; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Mayfield A. R., NEUROCOGNITIVE CORRE; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; MORRIS R, 1981, Journal of Clinical Neuropsychology, V3, P79, DOI 10.1080/01688638108403115; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Orem DM, 2008, STRESS, V11, P73, DOI 10.1080/10253890701535103; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Palmer BW, 1997, NEUROPSYCHOLOGY, V11, P437, DOI 10.1037/0894-4105.11.3.437; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; REYNOLDS C. R., 2007, TEST MEMORY LEARNING; Reynolds C.R., 1994, TEST MEMORY LEARNING; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; TEASDALE G, 1974, LANCET, V2, P81; TEUBER H-L, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P615; Thaler NS, 2015, APPL NEUROPSYCH-CHIL, V4, P20, DOI 10.1080/21622965.2013.790820; Thaler NS, 2013, ARCH CLIN NEUROPSYCH, V28, P798, DOI 10.1093/arclin/act080; Thaler NS, 2012, ARCH CLIN NEUROPSYCH, V27, P446, DOI 10.1093/arclin/acs042; Thaler NS, 2011, APPL NEUROPSYCHOL, V18, P168, DOI 10.1080/09084282.2011.595443; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Waxman RS, 2006, CHILD NEUROPSYCHOL, V12, P23, DOI 10.1080/09297040500205561; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; Woodcock R. W., 2001, WOODCOCK JOHNSON TES, V3rd	94	4	4	1	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2019	44	2					172	188		10.1080/87565641.2018.1557190			17	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HP3RJ	WOS:000461594600002	30590952	Green Submitted			2022-02-06	
J	Roberts, DJ; Leonard, SD; Stein, DM; Williams, GW; Wade, CE; Cotton, BA				Roberts, Derek J.; Leonard, Samuel D.; Stein, Deborah M.; Williams, George W.; Wade, Charles E.; Cotton, Bryan A.			Can trauma surgeons keep up? A prospective cohort study comparing outcomes between patients with traumatic brain injury cared for in a trauma versus neuroscience intensive care unit	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						intensive care unit; neurocritical care; trauma intensive care unit; polytrauma; traumatic brain injury		Background Although many patients with traumatic brain injury (TBI) are admitted to trauma intensive care units (ICUs), some question whether outcomes would improve if their care was provided in neurocritical care units. We sought to compare characteristics and outcomes of patients with TBI admitted to and cared for in a trauma versus neuroscience ICU. Methods We conducted a prospective cohort study of adult (>= 18 years of age) blunt trauma patients with TBI admitted to a trauma versus neuroscience ICU between May 2015 and December 2016. We used multivariable logistic regression to estimate an adjusted odds ratio (OR) comparing 30-day mortality between cohorts. Results In total, 548 patients were included in the study, including 207 (38%) who were admitted to the trauma ICU and 341 (62%) to the neuroscience ICU. When compared with neuroscience ICU admissions, patients admitted to the trauma ICU were more likely to have sustained their injuries from a high-speed mechanism (71% vs. 34%) and had a higher Injury Severity Score (ISS) (median 25 vs. 16) despite a similar head Abbreviated Injury Scale score (3 vs. 3, p=0.47) (all p<0.05). Trauma ICU patients also had a lower initial Glasgow Coma Scale score (5 vs. 15) and systolic blood pressure (128mm Hg vs. 136mm Hg) and were more likely to have fixed or unequal pupils at admission (13% vs. 8%) (all p<0.05). After adjusting for age, ISS, a high-speed mechanism of injury, fixed or unequal pupils at admission, and field intubation, the odds of 30-day mortality was 70% lower among patients admitted to the trauma versus neuroscience ICU (adjusted OR=0.30, 95% CI 0.11 to 0.82). Conclusions Despite a higher injury burden and worse neurological examination and hemodynamics at presentation, patients admitted to the trauma ICU had a lower adjusted 30-day mortality. This finding may relate to improved care of associated injuries in trauma versus neuroscience ICUs. Level of evidence Prospective comparative study, level II.	[Roberts, Derek J.] Univ Ottawa, Div Vasc & Endovasc Surg, Dept Surg, Ottawa, ON, Canada; [Roberts, Derek J.; Leonard, Samuel D.; Wade, Charles E.; Cotton, Bryan A.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX 77030 USA; [Leonard, Samuel D.; Wade, Charles E.; Cotton, Bryan A.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Surg, Houston, TX 77030 USA; [Stein, Deborah M.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Williams, George W.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Anesthesiol, Houston, TX 77030 USA; [Williams, George W.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurosurg, Houston, TX 77030 USA		Roberts, DJ (corresponding author), Ottawa Hosp, Div Vasc & Endovasc Surg, Civ Campus, Ottawa, ON, Canada.	Derek.Roberts01@gmail.com		Stein, Deborah/0000-0003-3683-3963			Alali AS, 2017, J NEUROTRAUM, V34, P2760, DOI 10.1089/neu.2017.4997; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Azim A, 2017, J TRAUMA ACUTE CARE, V83, P1200, DOI 10.1097/TA.0000000000001611; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Jeong JH, 2017, J INTENSIVE CARE MED, V885066617706675; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Josephson SA, 2010, J NEUROSURG, V112, P626, DOI 10.3171/2009.8.JNS09441; Kramer AH, 2011, NEUROCRIT CARE, V14, P329, DOI 10.1007/s12028-011-9530-y; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lerch C, 2006, NEUROCRIT CARE, V5, P85, DOI 10.1385/NCC:5:2:85; Lombardo S, 2017, J TRAUMA ACUTE CARE, V82, P489, DOI 10.1097/TA.0000000000001361; Lott JP, 2009, AM J RESP CRIT CARE, V179, P676, DOI 10.1164/rccm.200808-1281OC; McCredie V, 2017, NEUROCRIT CARE, V26, P14, DOI 10.1007/s12028-016-0297-z; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; Palminteri J., 2010, NEUROCRIT CARE, V13, pS101; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Samuels O, 2011, NEUROCRIT CARE, V14, P334, DOI 10.1007/s12028-011-9505-z; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Varelas PN, 2004, CRIT CARE MED, V32, P2191, DOI 10.1097/01.CCM.0000146131.03578.21; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	30	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	JAN	2019	4	1							e000229	10.1136/tsaco-2018-000229			6	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	VK2XU	WOS:000672553800010	30899790	Green Published, gold			2022-02-06	
J	Schupper, AJ; Berndtson, AE; Smith, A; Godat, L; Costantini, TW				Schupper, Alexander J.; Berndtson, Allison E.; Smith, Alan; Godat, Laura; Costantini, Todd W.			Respect your elders: effects of ageing on intracranial pressure monitor use in traumatic brain injury	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						traumatic brain injury; intracranial pressure monitor; surgical disparities; age disparities; neurotrauma		BackgroundThe Brain Trauma Foundation recommends intracranial pressure (ICP) monitor placement for patients with severe traumatic brain injury (TBI). Adherence with these guidelines in elderly patients is unknown. We hypothesized that disparities in ICP monitor placement would exist based on patient age.MethodsUsing the National Trauma Data Bank (2010-2014), we identified patients admitted for blunt TBI with admission Glasgow Coma Scale (GCS) scores of 3-8. Patients were excluded if they had a non-Head Abbreviated Injury Scale (AIS) score >= 3, hospital length of stay <24hours or were discharged from the emergency department. Demographic data, ICP monitor placement, GCS, AIS-Head, Injury Severity Score, and outcome measures were collected. Propensity score matching between ICP monitor and non-ICP monitor patients was used for logistic regression and Cox multivariate regression analyses.ResultsOf the 30710 patients with blunt TBI with GCS scores of 3-8 included in our study, 4093 were treated with an ICP monitor. ICP monitor placement rates significantly decreased with increasing age. Multivariable analysis demonstrated that patients treated with an ICP monitor were more likely to be younger, male, have private/commercial insurance, and receive care at an institution with three or more neurosurgeons.ConclusionPatients <greater than or equal to>65 years of age with severe blunt TBI are less likely to be treated with an ICP monitor than younger patients. Age disparities in adherence to Brain Trauma Foundation guidelines may alter the outcomes for patients with severe TBI.Level of evidenceLevel IV.	[Schupper, Alexander J.; Berndtson, Allison E.; Smith, Alan; Godat, Laura; Costantini, Todd W.] Univ Calif San Diego, Sch Med, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, La Jolla, CA 92093 USA		Costantini, TW (corresponding author), Univ Calif San Diego, Sch Med, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, La Jolla, CA 92093 USA.	tcostantini@ucsd.edu					Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dang Q, 2015, J SURG RES, V198, P482, DOI 10.1016/j.jss.2015.03.092; Ekeh AP, 2014, J TRAUMA ACUTE CARE, V76, P286, DOI 10.1097/TA.0000000000000092; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Finkelstein E., 2006, INCIDENCE EC BURDEN; Han JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002827; Lilley EJ, 2018, JAMA SURG, V153, P44, DOI 10.1001/jamasurg.2017.3148; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Sadaka F, 2013, BRAIN INJURY, V27, P600, DOI 10.3109/02699052.2013.772238; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9; Young PJ, 2012, J TRAUMA ACUTE CARE, V73, P431, DOI 10.1097/TA.0b013e318262437b	20	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	JAN	2019	4	1							e000306	10.1136/tsaco-2019-000306			4	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	VK2XU	WOS:000672553800045	31321312	gold, Green Published			2022-02-06	
J	Sharma, B; Nowrouzi-Kia, B; Mollayeva, T; Kontos, P; Grigorovich, A; Liss, G; Gibson, B; Mantis, S; Lewko, J; Colantonio, A				Sharma, Bhanu; Nowrouzi-Kia, Behdin; Mollayeva, Tatyana; Kontos, Pia; Grigorovich, Alisa; Liss, Gary; Gibson, Brian; Mantis, Steve; Lewko, John; Colantonio, Angela			Work-related traumatic brain injury: A brief report on workers perspective on job and health and safety training, supervision, and injury preventability	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article							RETURN-TO-WORK; OCCUPATIONAL-HEALTH; GENDER-DIFFERENCES; SELF-EFFICACY; SEX; CONCUSSION; INSURERS; OUTCOMES; CLIMATE; SCALE	BACKGROUND: Although work-related injuries are on the decline, rates of work-related traumatic brain injury (wrTBI) continue to rise. As even mild wrTBI can result in cognitive, behavioural, and functional impairments that can last for months and even years, injury prevention is a primary research focus. Administrative claims data have provided valuable insights into the mechanisms that cause wrTBI; however, data from the perspective of injured workers on wrTBI prevention is limited. OBJECTIVE: Our study aimed to better understand the factors that precipitate wrTBI, as perceived by injured workers. METHODS: We recruited 101 injured workers from a neurology services clinic with a province-wide catchment area in a large, urban teaching hospital and studied perceived preventability of these injuries from the injured workers' perspective. RESULTS: Key findings were that nearly 80% of injuries were perceived as preventable, and nearly 25% and 50% of workers reported that they did not receive job and health and safety training, respectively. Less than half of all workers reported being regularly supervised, and of those who were supervised, approximately two-thirds reported that supervision was adequate. Moreover, 84% and 77% reported they were advised to rest and take time-off after the injury, respectively. CONCLUSIONS: Our study is the first to show that the vast majority of injured workers consider their wrTBI to be preventable. In addition, we found that training and supervision are two areas that can be targeted by wrTBI prevention strategies. Our study provides valuable and unique perspectives to consider when designing wrTBI prevention initiatives.	[Sharma, Bhanu] McMaster Univ, Hamilton, ON, Canada; [Mollayeva, Tatyana; Kontos, Pia; Grigorovich, Alisa; Mantis, Steve; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Nowrouzi-Kia, Behdin; Lewko, John] Laurentian Univ, Sudbury, ON, Canada; [Kontos, Pia; Gibson, Brian] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Liss, Gary] Univ Toronto, Gage Occupat & Environm Hlth Unit, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada		Sharma, B (corresponding author), Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	sharmb1@mcmaster.ca	, Mollayeva/A-4522-2018	Colantonio, Angela/0000-0003-2094-4765	Ontario Ministry of Labour [13-R-056]; CIHR Research Chair in Gender, Work and Health; Ontario Ministry of Health and Long-Term Care (Ontario Women's Health Scholars Award); Canadian Institutes of Health Research (Health System Impact Fellowship)Canadian Institutes of Health Research (CIHR)	Ontario Ministry of Labour (13-R-056), CIHR Research Chair in Gender, Work and Health; Alisa Grigorovich gratefully acknowledges funding from the Ontario Ministry of Health and Long-Term Care (Ontario Women's Health Scholars Award) and from the Canadian Institutes of Health Research (Health System Impact Fellowship).	Amodio V, 2017, WORK, V56, P563, DOI 10.3233/WOR-172525; [Anonymous], 2014, OCC INJ ILLN FAT OCC; Beus JM, 2016, ORGAN PSYCHOL REV, V6, P352, DOI 10.1177/2041386615626243; Board I., 2013, NUMB 2013 WSIB STAT; Bryson-Campbell M, 2013, WORK, V44, P57, DOI [10.3233/WOR-2012-1561, 10.3233/WOR-2012-01561]; Burke MJ, 2006, AM J PUBLIC HEALTH, V96, P315, DOI 10.2105/AJPH.2004.059840; Bush EJ, 2016, BRAIN INJURY, V30, P422, DOI 10.3109/02699052.2015.1131849; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Dong XW, 2004, J OCCUP ENVIRON MED, V46, P1222, DOI 10.1097/01.jom.0000147268.42094.de; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gahagan J, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0144-4; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Guerriero EN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151462; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Holzberg Emily, 2001, Work, V16, P245; Huang YH, 2006, ACCIDENT ANAL PREV, V38, P425, DOI 10.1016/j.aap.2005.07.002; Islam SS, 2001, AM J IND MED, V39, P84, DOI 10.1002/1097-0274(200101)39:1<84::AID-AJIM8>3.3.CO;2-K; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kilgour E, 2015, J OCCUP REHABIL, V25, P220, DOI 10.1007/s10926-014-9521-x; Kilgour E, 2015, J OCCUP REHABIL, V25, P160, DOI 10.1007/s10926-014-9513-x; Kissinger DB, 2008, WORK, V31, P309; Konda S, 2016, AM J IND MED, V59, P212, DOI 10.1002/ajim.22557; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Laberge M, 2014, SAFETY SCI, V68, P250, DOI 10.1016/j.ssci.2014.04.012; Leung K L, 2005, Work, V25, P333; Liu M, 2011, WORK, V39, P283, DOI 10.3233/WOR-2011-1176; Loeppke RR, 2015, J OCCUP ENVIRON MED, V57, P585, DOI 10.1097/JOM.0000000000000467; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Mansfield E, 2015, BRAIN INJURY, V29, P1362, DOI 10.3109/02699052.2015.1053524; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; McCrory P, 2016, BRIT J SPORT MED, V2017; Mollayeva Tatyana, 2017, Healthc Q, V20, P6; Mollayeva T, 2016, WORK, V54, P415, DOI 10.3233/WOR-162339; Nielsen KJ, 2014, J SAFETY RES, V48, P7, DOI 10.1016/j.jsr.2013.10.003; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Ricci F, 2016, J WORKPLACE LEARN, V28, P355, DOI 10.1108/JWL-11-2015-0087; Robson LS, 2012, SCAND J WORK ENV HEA, V38, P193, DOI 10.5271/sjweh.3259; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seo DC, 2004, J SAFETY RES, V35, P427, DOI 10.1016/j.jsr.2004.04.006; Shapiro CM, 2006, J PSYCHOSOM RES, V60, P595, DOI 10.1016/j.jpsychores.2006.04.012; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	50	4	4	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2019	62	2					319	325		10.3233/WOR-192866			7	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HN3ZQ	WOS:000460124400015	30829642				2022-02-06	
J	Soeker, MS; Darries, Z				Soeker, Mogammad Shaheed; Darries, Zareena			The experiences of women with traumatic brain injury about the barriers and facilitators experienced after vocational rehabilitation in the Western Cape Metropole, South Africa	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Return to work; therapeutic use of self; self-efficacy	OCCUPATIONAL SELF-EFFICACY; CLIENTS; GENDER; MODEL	BACKGROUND: Traumatic Brain Injury (TBI) is a serious global public health problem. Globally and annually, at least 10 million individuals live with TBI that is serious enough to result in death or hospitalisation OBJECTIVE: This study aimed to explore and describe the experiences of women with traumatic brain injury, in their work environments utilising the Model of Occupational Self-efficacy as a vocational rehabilitation approach METHOD: Ten females with mild to moderate traumatic brain injury participated in the study. Semi-structured interviews were conducted and data were analysed utilising a qualitative approach to elucidate themes. Semi-structured interviews were also conducted with two occupational therapists who served as key informants. RESULTS: Two themes emerged depicting the participants' experiences and perceptions of barriers and facilitators which influenced their return to work: (1) Barriers to work participation for women with TBI, 2) Re-establishing a worker identity by means of vocational rehabilitation. CONCLUSION: Both personal and environmental factors emerged as hindrances to returning to work for women with traumatic brain injury. Vocational rehabilitation proved successful in establishing a worker identity amongst participants; however, particular focus should be placed on the function-dysfunction continuum of the process of work place integration to further develop and enhance sustainable return to work programmes for women with traumatic brain injury.	[Soeker, Mogammad Shaheed; Darries, Zareena] Univ Western Cape, Occupat Therapy Dept, Cape Town, South Africa		Soeker, MS (corresponding author), Univ Western Cape, Occupat Therapy Dept, Cape Town, South Africa.	msoeker@uwc.ac.za			University of the Western Cape; National Research Fund (South Africa)	This study was made possible with the support of the University of the Western Cape and the National Research Fund (South Africa).	BANDURA A, 1993, EDUC PSYCHOL, V28, P117, DOI 10.1207/s15326985ep2802_3; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Bradshaw D, 2005, SAMJ S AFR MED J, V95, P496; Coetzee Z, 2001, S AFRICAN J OCCUPATI, V41, P32; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Corring D, 2000, CANADIAN J OCCUPATIO, V67, P15; Creswell J.W., 2007, QUALITATIVE ENQUIRY; De Vos A.S., 2011, RES GRASSROOTS SOCIA, V4th ed.; Denzin N. K., 2005, SAGE HDB QUALITATIVE, V3rd; Dickie V, 2006, J OCCUP SCI, V13, P83, DOI 10.1080/14427591.2006.9686573; Dyck I., 2000, USING QUALITATIVE RE; Guest G., 2012, APPL THEMATIC ANAL; Hammell Karen Whalley, 2008, Can J Occup Ther, V75, P61; Health Western Cape, 2013, HEALTHC 2030 W CAP P; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Kielhofner G., 2008, MODEL HUMAN OCCUPATI; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; LeDoux JE, 2003, SYNAPTIC SELF ARE BR; Lombard LA, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P16; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; MERIANO C, 2008, OCCUPATIONAL THERAPY; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; Norman R, 2007, B WORLD HEALTH ORGAN, V85, P695, DOI 10.2471/BLT.06.037184; Pansford J., 2004, COGNITIVE BEHAV REHA; Robson C., 2002, REAL WORLD RES RESOU; Ross J., 2007, OCCUPATIONAL THERAPY; SCHULTZ S, 2003, WILLARD SPACKMANS OC; Soeker MS, 2012, WORK, V43, P313, DOI 10.3233/WOR-2012-1412; Soeker S, 2016, WORK, V53, P523, DOI 10.3233/WOR-152229; Tesch R., 1990, QUALITATIVE RES ANAL, V337; Townsend Elizabeth, 2004, Can J Occup Ther, V71, P75; Van Niekerk Lana, 2011, S. Afr. j. occup. ther., V41, P85; Wehman P, 2003, SUPPORTED EMPLOYMENT; World Health Organization, SOC DET HLTH WOM GEN	35	4	4	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2019	64	3					477	486		10.3233/WOR-193009			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	JQ2YC	WOS:000498815300008	31658081	Green Published			2022-02-06	
J	Stojanovski, S; Nazeri, A; Lepage, C; Ameis, S; Voineskos, AN; Wheeler, AL				Stojanovski, Sonja; Nazeri, Arash; Lepage, Christian; Ameis, Stephanie; Voineskos, Aristotle N.; Wheeler, Anne L.			Microstructural abnormalities in deep and superficial white matter in youths with mild traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Mild traumatic brain injury; Superficial white matter; Diffusion tensor imaging; Processing speed	AXONAL INJURY; SPATIAL STATISTICS; PSYCHOSIS SPECTRUM; CORPUS-CALLOSUM; DIFFUSION; CHILDREN; NEUROPATHOLOGY; CONNECTIONS; PERFORMANCE; SYSTEM	Background: Diffusion Tensor Imaging (DTI) studies of traumatic brain injury (TBI) have focused on alterations in microstructural features of deep white matter fibers (DWM), though post-mortem studies have demonstrated that injured axons are often observed at the gray-while matter interface where superficial white matter fibers (SWM) mediate local connectivity. Objectives: To examine microstructural alterations in SWM and DWM in youths with a history of mild TBI and examine the relationship between white matter alterations and attention. Methods: Using DTIDWM fractional anisotropy (FA) and SWM FA in youths with mild TBI (TBI, n = 63) were compared to typically developing and psychopathology matched control groups (n = 63 each). Following tract-based spatial statistics, SWM FA was assessed by applying a probabilistic tractography derived SWM mask, and DWM FA was captured with a white matter fiber tract mask. Voxel-wise z-score calculations were used to derive a count of voxels with abnormally high and low FA for each participant. Analyses examined DWM and SWM FA differences between TBI and control groups, the relationship between attention and DWM and SWM FA and the relative susceptibility of SWM compared to DWM FA to alterations associated with mild TBI. Results: Case-based comparisons revealed more voxels with low FA and fewer voxels with high FA in SWM in youths with mild TBI compared to both control groups. Equivalent comparisons in DWM revealed a similar pattern of results, however, no group differences for low FA in DWM were found between mild TBI and the control group with matched psychopathology. Slower processing speed on the attention task was correlated with the number of voxels with low FA in SWM in youths with mild TBI. Conclusions: Within a sample of youths with a history of mild TBI, this study identified abnormalities in SWM microstructure associated with processing speed. The majority of DTI studies of TBI have focused on long-range DWM fiber tracts, often overlooking the SWM fiber type.	[Stojanovski, Sonja; Ameis, Stephanie; Wheeler, Anne L.] Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON, Canada; [Stojanovski, Sonja; Wheeler, Anne L.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Nazeri, Arash] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Lepage, Christian] Toronto Rehabil Inst, Toronto, ON, Canada; [Ameis, Stephanie; Voineskos, Aristotle N.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Ameis, Stephanie] Ctr Addict & Mental Hlth, Margaret & Wallace McCain Ctr Child, Youth & Family Mental Hlth, Toronto, ON, Canada; [Ameis, Stephanie; Voineskos, Aristotle N.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Inst, Toronto, ON, Canada; [Ameis, Stephanie; Voineskos, Aristotle N.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada		Wheeler, AL (corresponding author), Hosp Sick Children, SickKids Reaserch Inst, Neurosci & Mental Hlth Program, 686 Bay St, Toronto, ON M5G 0A4, Canada.	anne.wheeler@sickkids.ca		Nazeri, Arash/0000-0001-6983-0641; Wheeler, Anne/0000-0002-1103-0526; Voineskos, Aristotle/0000-0003-0156-0395	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH089983, MH089924, P50MH096891]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH107703, K23MH098130, R01MH101111, K08MH079364, T32MH065218, K01MH102609, R01NS085211, R01MH099167]; Dowshen Program for Neuroscience; SickKids Foundation; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH101111, R01MH107703, K01MH102609, T32MH065218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS085211] Funding Source: NIH RePORTER	The Philadelphia Neurodevelopmental Cohort is supported by RC2 grants MH089983 and MH089924 and P50MH096891 from the National Institute of Mental Health. Additional support for the Philadelphia Neurodevelopmental Cohort was provided by grants R01MH107703 and K23MH098130 (Dr Satterthwaite), R01MH101111 (Dr. Wolf), K08MH079364 (Dr. Calkins), T32MH065218 (Mr. Vandekar), K01MH102609 (Dr. Roalf), and R01NS085211 (Dr. Shinohara) from the National Institutes of Health, as well as by the Dowshen Program for Neuroscience. We want to thank everyone who has worked to share the PNC data. Funding was provided by the SickKids Foundation (ALW) and the following National Institutes of Health grants: Grant no. R01MH099167 (to AV).	Alexander DC, 2005, LECT NOTES COMPUT SC, V3565, P76; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; BOX GEP, 1982, J AM STAT ASSOC, V77, P209, DOI 10.2307/2287791; Calkins ME, 2015, J CHILD PSYCHOL PSYC, V56, P1356, DOI 10.1111/jcpp.12416; Calkins ME, 2014, WORLD PSYCHIATRY, V13, P296, DOI 10.1002/wps.20152; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Critchleey M., 1953, PARIETAL LOBES; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Dickie EW, 2018, BIOL PSYCHIAT, V84, P278, DOI 10.1016/j.biopsych.2018.02.1174; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Gur RC, 2014, JAMA PSYCHIAT, V71, P366, DOI 10.1001/jamapsychiatry.2013.4190; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Hilbe JM, 2014, MODELING COUNT DATA, P126; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Lambregts SAM, 2018, DEV NEUROREHABIL, V21, P465, DOI 10.1080/17518423.2018.1460770; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Miller R., 2002, CORTICAL AREAS UNITY, DOI DOI 10.1201/9780203299296.CH16; Nazeri A, 2015, NEUROBIOL AGING, V36, P2094, DOI 10.1016/j.neurobiolaging.2015.02.022; Nazeri A, 2013, NEUROPSYCHOPHARMACOL, V38, P1954, DOI 10.1038/npp.2013.93; Oyefiade AA, 2018, HUM BRAIN MAPP, V39, P204, DOI 10.1002/hbm.23836; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Satterthwaite TD, 2014, NEUROIMAGE, V86, P544, DOI 10.1016/j.neuroimage.2013.07.064; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stojanovski S., 2018, BIOL PSYCHIAT; Thomason ME, 2011, ANNU REV CLIN PSYCHO, V7, P63, DOI 10.1146/annurev-clinpsy-032210-104507; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; Weinberger R, 2016, EUR NEUROPSYCHOPHARM, V26, P1610, DOI 10.1016/j.euroneuro.2016.08.003; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Yeterian EH, 2012, CORTEX, V48, P58, DOI 10.1016/j.cortex.2011.03.004	61	4	4	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	24								102102	10.1016/j.nicl.2019.102102			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JY8MY	WOS:000504663800086	31795058	Green Published, gold			2022-02-06	
J	Take, M; Tomori, Y; Sawaizumi, T; Majima, T; Nanno, M; Takai, S				Take, Masaki; Tomori, Yuji; Sawaizumi, Takuya; Majima, Tokifumi; Nanno, Mitsuhiko; Takai, Shinro			Ulnar osteotomy and the ilizarov mini-fixator for pediatric chronic monteggia fracture-dislocations	MEDICINE			English	Article						chronic Monteggia fracture-dislocation; Ilizarov mini-fixator; malunion; opening wedge osteotomy; radial head dislocation	RADIAL HEAD DISLOCATION; ANNULAR LIGAMENT RECONSTRUCTION; OPEN REDUCTION; SURGICAL-TREATMENT; ANCONEUS INTERPOSITION; ANTERIOR DISLOCATION; CLOSED REDUCTION; CHILDREN; LESIONS; MANAGEMENT	Treatment of chronic Monteggia fracture-dislocations remains controversial in skeletally immature patients. The present study aimed to review the clinical outcomes of surgical treatment with an Ilizarov mini-fixator for chronic Monteggia fracture-dislocations in children. From April 2003 to March 2014, 5 pediatric patients (4 males, 1 female) with chronic Monteggia fracture-dislocation were treated with an Ilizarov mini-fixator at our institution. The median age at the time of surgery was 9 years (range 5-14 years), median duration from injury to surgery was 31 months (range 2-125 months), and median duration of follow-up was 12 months (range 11 months-10 years). All patients underwent opening wedge osteotomy of the proximal ulna followed by the application of an Ilizarov mini-fixator. Although closed reduction was attempted after ulnar osteotomy and application of the Ilizarov mini-fixator, open reduction of the radial head was required in all patients. In 4 patients, dense scar tissue in the radiocapitellar joint was excised to enable reduction of the radial head; the remaining patient had traumatic radioulnar synostosis, and underwent separation of the synostosis followed by anconeus interposition arthroplasty. No patient received bone grafting at the ulnar osteotomy site, repair or reconstruction of the annular ligament, or temporary fixation of the radial head with transarticular wire. The median period of external fixation was 10 weeks (range 8-13 weeks). Although there were no severe complications such as deep infection and neurovascular disturbance, asymptomatic radial head subluxation occurred in 2 patients. The patient with traumatic synostosis had residual posterior subluxation with limitation of forearm rotation, and another patient with radial head enlargement had residual anterior subluxation. The median postoperative ranges of motion in pronation, supination, extension, and flexion were 90 degrees, 90 degrees, 0 degrees, and 140 degrees, respectively. The median Kim's elbow performance score was 65 (range 50-75) preoperatively, which improved to 94 (range 80-100) at final follow-up. The outcome was rated as excellent in 4 cases, and good in 1. In pediatric chronic Monteggia fracture-dislocations, ulnar osteotomy followed by the application of an Ilizarov mini-fixator is a viable option that is less invasive than plate fixation.	[Take, Masaki; Tomori, Yuji; Sawaizumi, Takuya; Majima, Tokifumi; Nanno, Mitsuhiko; Takai, Shinro] Nippon Med Sch, Dept Orthopaed Surg, Tokyo, Japan		Tomori, Y (corresponding author), Nippon Med Sch, Dept Orthopaed Surg, Dept Orthopaed & Rheumatism Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	s4064@nms.ac.jp					Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Belangero WD, 2007, INT ORTHOP, V31, P151, DOI 10.1007/s00264-006-0153-4; Bell SN, 1999, J SHOULDER ELB SURG, V8, P621, DOI 10.1016/S1058-2746(99)90101-5; Bhaskar A, 2009, INDIAN J ORTHOP, V43, P389, DOI 10.4103/0019-5413.55978; Bor N, 2015, J PEDIATR ORTHOPED, V35, P7, DOI 10.1097/BPO.0000000000000203; BOYD HB, 1969, CLIN ORTHOP RELAT R, P94; Daluiski A, 2014, J SHOULDER ELB SURG, V23, P1882, DOI 10.1016/j.jse.2014.07.011; Datta T, 2014, J CLIN DIAGN RES, V8, pLC1, DOI 10.7860/JCDR/2014/9891.4409; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; Delpont M, 2014, ORTHOP TRAUMATOL-SUR, V100, P803, DOI 10.1016/j.otsr.2014.06.022; Devnani AS, 1997, INJURY, V28, P131, DOI 10.1016/S0020-1383(96)00160-X; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; Eygendaal D, 2007, STRATEG TRAUMA LIMB, V2, P31, DOI 10.1007/s11751-007-0013-9; FREEDMAN L, 1988, J BONE JOINT SURG BR, V70, P846, DOI 10.1302/0301-620X.70B5.3192599; Goyal T, 2015, J PEDIATR ORTHOP B, V24, P191, DOI 10.1097/BPB.0000000000000147; Gyr BM, 2004, J PEDIATR ORTHOP B, V13, P402, DOI 10.1097/01202412-200411000-00011; Hasler CC, 2005, J BONE JOINT SURG BR, V87B, P88, DOI 10.1302/0301-620X.87B1.14669; HIRAYAMA T, 1987, J BONE JOINT SURG BR, V69, P639, DOI 10.1302/0301-620X.69B4.3611173; Horii E, 2002, J BONE JOINT SURG AM, V84A, P1183, DOI 10.2106/00004623-200207000-00014; Hui JHP, 2005, J PEDIATR ORTHOPED, V25, P501, DOI 10.1097/01.bpo.0000158812.37225.b3; HURST LC, 1983, J PEDIATR ORTHOPED, V3, P227, DOI 10.1097/01241398-198305000-00015; Inoue G, 1998, ACTA ORTHOP SCAND, V69, P73, DOI 10.3109/17453679809002361; Kawoosa Altaf A, 2010, J Med Case Rep, V4, P344, DOI 10.1186/1752-1947-4-344; Kemnitz S, 2000, Acta Orthop Belg, V66, P359; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P583, DOI 10.1097/00004694-200209000-00004; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P591, DOI 10.1097/01.BPO.0000023140.69745.72; Koslowsky TC, 2006, J SHOULDER ELB SURG, V15, P119, DOI 10.1016/j.jse.2004.12.002; Ladermann A, 2007, J CHILD ORTHOP, V1, P237, DOI 10.1007/s11832-007-0039-z; Lu XM, 2017, J PEDIATR ORTHOPED, V37, P20, DOI 10.1097/BPO.0000000000000584; Lu XM, 2013, J PEDIATR ORTHOPED, V33, P398, DOI 10.1097/BPO.0b013e3182812762; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; Nishimura M, 2016, J PEDIATR ORTHOP B, V25, P450, DOI 10.1097/BPB.0000000000000302; Park H, 2017, YONSEI MED J, V58, P829, DOI 10.3349/ymj.2017.58.4.829; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; Seel MJ, 1999, J PEDIATR ORTHOPED, V19, P306, DOI 10.1097/00004694-199905000-00006; Song KS, 2012, J ORTHOP TRAUMA, V26, P597, DOI 10.1097/BOT.0b013e3182548981; STOLL TM, 1992, J BONE JOINT SURG BR, V74, P436, DOI 10.1302/0301-620X.74B3.1587897; TAJIMA T, 1995, J HAND SURG-AM, V20A, pS91, DOI 10.1016/S0363-5023(95)80177-4; Wang MN, 2006, J ORTHOP TRAUMA, V20, P1, DOI 10.1097/01.bot.0000189881.75421.92	39	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN	2019	98	1							e13978	10.1097/MD.0000000000013978			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ3CM	WOS:000462284900058	30608438	Green Published, gold			2022-02-06	
J	Tan, L; Zeng, LL; Wang, N; Deng, MJ; Chen, YS; Ma, TY; Zhang, LH; Xu, ZH				Tan, Li; Zeng, Liling; Wang, Ning; Deng, Meijun; Chen, Yinshi; Ma, Tianyi; Zhang, Luhan; Xu, Zhenhua			Acupuncture to Promote Recovery of Disorder of Consciousness after Traumatic Brain Injury: A Systematic Review and Meta-Analysis	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article								Traumatic brain injury (TBI) has become an economic and social burden for patients and their families. While acupuncture is an effective tool for promoting recovery of disorder of consciousness (DOC) following TBI, there have been no comprehensive meta-analyses and/or systematic reviews addressing this topic. The present systematic review and meta-analysis aimed to assess the therapeutic efficacy of acupuncture for DOC after TBI. All randomized controlled trials (RCTs) incorporating acupuncture, or acupuncture combined with other interventions for DOC after TBI, were included and assessed by two independent investigators. Six outcome indicators were assessed: Glasgow Coma Scale (GCS); Glasgow Outcome Scale (GOS); mortality; efficacy rate; activities of daily living (ADL); and functional comprehensive assessment. Direct comparisons were performed using RevMan 5.3.0 software, with results presented as mean difference (MD) for continuous outcomes and relative risk (RR) for binary outcomes. A total of 3511 patients from 49 trials were included. Pooled analyses indicated that acupuncture may have a superior effect on GCS score (MD-2.03, 95% CI :1.92 2.43, Z-16.54, and P<0.00001); GOS score (RR-1.23, 95%CI: 1.181.35, Z-6.65, and P<0.00001); efficacy rate (RR=1.48, 95%CI: 1.40 1.56, Z=13.49, and P<0.00001); ADL (MD=9.20, 95% CI:8.19 10.21, Z=17.84, and P<0.00001); and mortality (RR=0.50, 95% CI:0.38 0.67, Z=4.70, and P<0.00001). The results demonstrated that the acupuncture group fared better than the control group in the treatment of DOC after TBI. However, studies were generally of poor quality, and publication bias favoring positive studies was obvious. Therefore, rigorous evaluation standards and well-designed studies are necessary in future studies.	[Tan, Li; Zeng, Liling; Deng, Meijun; Chen, Yinshi; Ma, Tianyi; Zhang, Luhan] Guangzhou Univ Chinese Med, Airport Rd, Guangzhou 510405, Guangdong, Peoples R China; [Tan, Li; Xu, Zhenhua] Guangdong Prov Hosp Chinese Med, Yide Rd, Guangzhou 510006, Guangdong, Peoples R China; [Wang, Ning] Zhongshan Univ, Affiliated Hosp 7, Shenzhen 518107, Peoples R China		Xu, ZH (corresponding author), Guangdong Prov Hosp Chinese Med, Yide Rd, Guangzhou 510006, Guangdong, Peoples R China.	xzh197011@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81373800]	This study was supported by the National Natural Science Foundation of China (No. 81373800).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bin T., 2012, MED INNOVATION CHINA, V09, P42; Bin Y., 2018, CLIN RES, V26, P174; BOLY M, 2002, BRAIN CONNECT, V2, P1, DOI DOI 10.1089/BRAIN.2011.0049; Calabria KE, 2016, MED ACUPUNCT, V28, P278, DOI 10.1089/acu.2016.1200; Chen K., 2013, SHANXI MED J, V42, P501; Chen L., 2013, CHINESE MED MODERN D, V11, P62; Chen Q., 2011, J ARTICLE, V32, P1696; Chen XY, 2009, CHINESE ACUPUNCTURE, V29, P619; Chen Y., 2006, J GUANGXI MED U, V23, P942; Cheng J., 2016, SHANDONG MED J, V56, P61; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CORSO P, 2002, PREVENTION, V12, P212, DOI DOI 10.1136/IP.2005.010983; Dan Z., 2017, REHABILITATION MED, V27, P15, DOI [10.3724/SP.J.1329.2017.06015, DOI 10.3724/SP.J.1329.2017.06015]; Dong D., 2015, EFFECT ACUPUNCTURE C; Dongmei Y., 2009, J NANJING U, V5, P17; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feng B., 2012, J TAIYUAN NORMAL U N, V11, P46; Feng R., 2005, CHINESE J TISSUE ENG, V9, P172; Fu Li-Xin, 2008, Zhongguo Zhen Jiu, V28, P473; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Fu Ying-ying, 2009, Zhongguo Zhen Jiu, V29, P107; GBD Disease Injury Incidence Prevalence Collaborators, 2017, GLOB REG NAT INC PRE, V390; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Gu Q., 2010, J EMERGENCY TRADITIO, V19, P1832; Guangtuan X., 2017, J EMERGENCY TRADITIO, V36, P113; Guangtuan X., 2017, J TRADITIONAL CHINES, V36, P113; GUSTAVSSON A, 2002, EUROPE, V21, P718, DOI DOI 10.1016/J.EURONEURO.2011.08.008; He X., 2012, CHINESE J INTEGRATEE, P71; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Jianxia X., 2015, MODERN J INTEGRATED, V24; Li J., 2010, CHINESE J ETHNOMEDIC, V19, P134; [李壮志 Li Zhuangzhi], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P380; Liu Jian-ping, 2010, Zhongguo Zhen Jiu, V30, P206; Liu S., 2006, PRACTICAL CLIN MED, V7, P93; lou M., 2013, CONT MED, V19, P159; lou M., 2013, CHINESE J TRADITIONA, V19, P159; Ma RJ, 2015, J NEUROTRAUM, V32, P1943, DOI 10.1089/neu.2014.3866; Min W., 2016, GUIDE CHINA MED, V14, P189; Ni G. F., 2007, J TRADITIONAL CHINES, V42, P230; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Peng F, 2010, CHINESE ACUPUNCTURE, V30, P465; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Song Y, 2007, SHANGHAI J ACUPUNCT, V26, P11; Spitz G, 2016, J NEUROL NEUROSUR PS, V87, P173, DOI 10.1136/jnnp-2014-309479; STEINMANN HW, 1964, N-S ARCH EX PATH PH, V247, P316, DOI 10.1007/BF02308410; STOCCHETTI N, 2002, THE LANCET NEUROLOGY, V16, P452; Sun X., 2009, INT J TRADITIONAL CH, V31, P341; Tang J., 2016, CLINIAL STUDY ELECTR; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tu Xiao-Hua, 2010, Zhongguo Zhen Jiu, V30, P974; Vos P. E., 2014, TRAUMATIC BRAIN INJU, DOI [10.1002/9781118656303, DOI 10.1002/9781118656303]; Wang J., 2012, CHINESE J INTEGRATED, V19, P119; Wang X. P., 2013, CLIN MED, V33, P120; Wong V, 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007700.PUB3; Yang B., 2011, MODERN DIAGNOSIS TRE, V22, P23; Yang P., 2016, CHINESE J NEUROSURGI, V15, P369; Yang X., 2007, GUANGZHOU U CHINESE; Yang X., 2000, CHINESE MED, V35, P45; Yao W. - P., 2010, J CHINESE INTEGRATIV, V8, P979; You G., 2013, CHINA MED PHARM, V3, P12; Yu M., 2010, CHINESE J NEUROSURGI, V29, P6; Yu M., 2012, CHINESE J INTEGRATIV, V10, P1471; Yuchao Z., 2014, CHINA FOREIGN MED TR, V33, P117; Zha Xiao-xiong, 2015, Journal of South China University of Technology (Natural Science Edition), V43, P92, DOI 10.3969/j.issn.1000-565X.2015.07.013; Zhang BF, 2015, WORLD NEUROSURG, V83, P567, DOI 10.1016/j.wneu.2014.12.010; Zhang X, 2014, WORLD J ACUPUNCT-MOX, V24, P63, DOI 10.1016/S1003-5257(14)60046-5; Zhang Yi-Min, 2013, Zhen Ci Yan Jiu, V38, P158; Zhao H, 2014, J TRADIT CHIN MED, V34, P145, DOI 10.1016/S0254-6272(14)60068-6; 刘淑云, 2006, [激光杂志, Laser Journal], V27, P87	72	4	4	2	8	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.		2019	2019								UNSP 5190515	10.1155/2019/5190515			14	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	HR9MG	WOS:000463483600001	31015851	Green Submitted, gold, Green Published			2022-02-06	
J	Tannen, B; Good, K; Ciuffreda, KJ; Moore, KJ				Tannen, Barry; Good, Kalynn; Ciuffreda, Kenneth J.; Moore, Kelsey J.			Prevalence of esophoria in concussed patients	JOURNAL OF OPTOMETRY			English	Article						Concussion; Esophoria; Convergence excess; Optometry; Post-concussion syndrome		Purpose: To assess the prevalence of esophoria at near in concussed patients in a neuro-optometric private practice setting. Methods: A retrospective analysis was performed involving a chart review in a neuro-optometric, private practice setting of consecutive patients with a medical diagnosis of concussion from January 1st 2016 to December 31st 2016. A total of 71 patients were included in the analysis. All received a comprehensive vision examination, with a near vision emphasis. The near horizontal phoria was assessed with the cover test and the von Graefe test. Results: Approximately 30% of the patients with a medically based diagnosis of concussion exhibited esophoria at near, with good agreement (95%) between the two tests. Mean esophoria was 5.2 (SD =2.8) prism diopters (pd), with a range from 2pd to 14pd of esophoria. Convergence excess was diagnosed in 23%. Discussion: Near esophoria was found in nearly one-third of this practice-based sample of concussed patients. Thus, it was more common than typically believed to be the case. Two proposed oculomotor-based mechanisms related to these symptomatic esophoric patients included phoria decompensation and excessive accommodative vergence. (C) 2018 Spanish General Council of Optometry. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Tannen, Barry] EyeCare Professionals PC, 1777 Kuser Rd,Hamilton Sq, Hamilton Township, NJ 08690 USA; [Ciuffreda, Kenneth J.] SUNY State Coll Optometry, New York, NY USA; [Moore, Kelsey J.] EyeCare Professionals PC, Vis Therapy & Neuro Optometr Rehabil, Hamilton Sq, Hamilton Township, NJ USA		Tannen, B (corresponding author), EyeCare Professionals PC, 1777 Kuser Rd,Hamilton Sq, Hamilton Township, NJ 08690 USA.	btannenod@aol.com					Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Ciuffreda K. J., 2015, VIS DEV REHABIL, V1, P105; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda KJ, 2016, ADV OPHTHALMOL OPTOM, V1, P303; CIUFFREDA KJ, 2011, J BEHAV OPTOM, V82, P61; D'Angelo MD, 2015, OPTOM VIS PERF, V3, P298; Evans B J, 2008, OPTOM PRACT, V9, P63; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Scheiman M, 2001, VISUAL VESTIBULAR CO, P89; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; TAIT EF, 1951, AM J OPHTHALMOL, V34, P1093; Tannen B, 2015, VIS DEV REHAB, V1, P206; Tannen NM, 2016, VIS DEV REHAB, V2, P238; Thiagarajan P, 2014, J REHABIL RES DEV, V51, P175, DOI 10.1682/JRRD.2013.01.0027; Thiagarajan P, 2010, OPTOMETRY VISION SCI, V87, P487, DOI 10.1097/OPX.0b013e3181e19ec2; Wick, 2002, CLIN MANAGEMENT BINO	18	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1888-4296	1989-1342		J OPTOM	J. Optom.	JAN-MAR	2019	12	1					64	68		10.1016/j.optom.2018.02.003			5	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	LY9LB	WOS:000540848500009	29602686	Green Published, gold			2022-02-06	
J	Twamley, EW; Hays, CC; Van Patten, R; Seewald, PM; Orff, HJ; Depp, CA; Olsen, DC; Jak, AJ				Twamley, Elizabeth W.; Hays, Chelsea C.; Van Patten, Ryan; Seewald, P. Michelle; Orff, Henry J.; Depp, Colin A.; Olsen, Donald C.; Jak, Amy J.			Neurocognition, psychiatric symptoms, and lifetime homelessness among veterans with a history of traumatic brain injury	PSYCHIATRY RESEARCH			English	Article						Cognition; Homeless persons; Mental disorders	SAMPLE; GENDER; ADULTS; RISK; IRAQ	We retrospectively investigated archival clinical data, including correlates of lifetime homelessness, in 503 Veterans with a history of traumatic brain injuries (86.5% mild) who completed neuropsychological evaluations and passed performance validity tests. The 471 never-homeless and 32 ever-homeless Veterans were compared on demographic factors, TBI severity, psychiatric diagnosis, subjective symptoms, and neuropsychological functioning. Homelessness history was significantly associated with unemployment, lower disability income, more severe depressive, anxiety, posttraumatic stress disorder, and postconcussive symptoms, and lower performances on two of fifteen neurocognitive tests. In a multiple logistic regression model, current unemployment and substance use disorder remained significantly associated with lifetime homelessness.	[Twamley, Elizabeth W.; Orff, Henry J.; Jak, Amy J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Twamley, Elizabeth W.; Van Patten, Ryan; Orff, Henry J.; Depp, Colin A.; Jak, Amy J.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Seewald, P. Michelle; Orff, Henry J.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Hays, Chelsea C.] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA 92120 USA; [Depp, Colin A.; Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA 92161 USA; [Olsen, Donald C.] Alliant Int Univ, Calif Sch Profess Psychol, 10455 Pomerado Rd, San Diego, CA 92131 USA		Twamley, EW (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr 116A, San Diego, CA 92161 USA.	etwamley@ucsd.edu	Van+Patten, Ryan/AAZ-6757-2021; depp, colin a/D-1264-2009		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32MH019934]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019934] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2RX001512] Funding Source: NIH RePORTER	This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. Ryan Van Patten's effort was supported by NIH grant T32MH019934.	Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Blackstock OJ, 2012, MED CARE, V50, P347, DOI 10.1097/MLR.0b013e318245a738; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Caplan B, 2006, SCHIZOPHR RES, V83, P77, DOI 10.1016/j.schres.2005.11.013; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Veterans Affairs Office of Inspector General, 2012, 1103428173 US DEP VE; Depp CA, 2015, J NERV MENT DIS, V203, P126, DOI 10.1097/NMD.0000000000000248; Edens EL, 2011, AM J ADDICTION, V20, P412, DOI 10.1111/j.1521-0391.2011.00166.x; Kuhn J. H., 2011, 17 ANN PROGR REPORT; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Metraux S, 2013, AM J PUBLIC HEALTH, V103, pS255, DOI 10.2105/AJPH.2013.301432; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rosenheck RA, 2007, PSYCHIAT SERV, V58, P325, DOI 10.1176/appi.ps.58.3.325; Steer, 1990, MANUAL BECK ANXIETY; Stergiopoulos V, 2015, ACTA PSYCHIAT SCAND, V131, P256, DOI 10.1111/acps.12391; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tsai J, 2016, SOC PSYCH PSYCH EPID, V51, P907, DOI 10.1007/s00127-016-1210-y; Tsai J, 2013, ADM POLICY MENT HLTH, V40, P400, DOI 10.1007/s10488-012-0431-y; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkinson G. S, 2006, WRAT4 PSYCH ASS RESO	25	4	4	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	JAN	2019	271						167	170		10.1016/j.psychres.2018.11.049			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	HO1YZ	WOS:000460709900027	30481694				2022-02-06	
J	Voronkov, AV; Pozdnyakov, DI; Nigaryan, SA; Khouri, EI; Miroshnichenko, KA; Sosnovskaya, AV; Olokhova, EA				Voronkov, A. V.; Pozdnyakov, D. I.; Nigaryan, S. A.; Khouri, E. I.; Miroshnichenko, K. A.; Sosnovskaya, A. V.; Olokhova, E. A.			EVALUATION OF THE MITOCHONDRIA RESPIROMETRIC FUNCTION IN THE CONDITIONS OF PATHOLOGIES OF VARIOUS GENESES	PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA			English	Article						cerebral ischemia; myocardial infarction; traumatic brain injury; muscle dysfunction; respirometry	DYSFUNCTION; METABOLISM; MECHANISMS; SYSTEM; CELLS; ROS	The aim of the paper is to assess the change in the mitochondria! respirometric function under conditions of various pathologies. Materials and methods. The study was performed on male Wistar rats. Experimental focal cerebral ischemia, traumatic brain injury, coronary occlusive myocardial infarction and muscle dysfunction were used as pathological models. Focal ischemia was reproduced by the method of irreversible thermocoagulation of the middle cerebra! artery. Traumatic brain injury was modeled by the method of free fall of the load. Experimental myocardial infarction was reproduced by ligating the descending branch of the left coronary artery. Muscle dysfunction was modeled by the method of "forced swimming with a 20% burden". The respiratory function of mitochondria was assessed by the method of respirometry by the change in oxygen consumption when introducing mitochondrial respiration into the medium: Oligomycin, Rotenone and FCCP. Additionally, we evaluated the intensity of the glycolysis process and the activity of respiratory complexes I, II, IV and V In order to comprehensively assess the respiratory function, an ELISA study was conducted to determine the concentration of ATP, mitochondrial ATP synthetase, cytochrome C oxidase and NADP-Oxidase 4. Results. In the course of the study it was established that under conditions of experimental cerebral ischemia, traumatic brain injury, myocardial infarction and muscle dysfunction, the ATP-generating ability of mitochondria the maximum breathing and respiratory capacity deteriorated, herby the decrease in overall respiratory function was accompanied by an increase in glycolysis, which was uncompensated, as well as dysfunction of mitochondria! complexes I, II, IV and V, confirmed by an increase in NADPH oxidase 4 activity and a decrease in cytochrome C oxidases and ATP synthetase. As a result, the observed changes in mitochondrial respiration function contributed to a decrease in ATP concentration under conditions of cerebral ischemia - by 3.2 times (p <0.05), traumatic brain injury - by 2.6 times (p <0.05), myocardial infarction - by 1.8 times (p <0.05) and muscle dysfunction - by 4 times (p <0.05). Conclusion. Basing on the data obtained, we can assume that in conditions of cerebral ischemia, traumatic brain injury, myocardial infarction and muscle dysfunction, there is deterioration of the mitochondrial respirometric function with inhibition of ATP synthesis and increased glycolysis.	[Voronkov, A. V.; Pozdnyakov, D. I.; Nigaryan, S. A.; Khouri, E. I.; Miroshnichenko, K. A.; Sosnovskaya, A. V.] Branch Volgograd State Med Univ, Pyatigorsk Med & Pharmaceut Inst, 11 Kalinin Ave, Pyatigorsk 357532, Russia; [Olokhova, E. A.] Krasnoyarsk State Med Univ, 1 Partizan Zheleznyak Str, Krasnoyarsk 660005, Russia		Voronkov, AV (corresponding author), Branch Volgograd State Med Univ, Pyatigorsk Med & Pharmaceut Inst, 11 Kalinin Ave, Pyatigorsk 357532, Russia.	prohor77@mail.ru; pozdniackow.dmitry@yandex.ru; 79682650210@yandex.ru; elena.belova@hotmail.ru; K220436@yandex.ru; 88misi88@yandex.ru; tabletka@yandex.ru	Voronkov, Andrey/AAD-2684-2019; Dmitry, Pozdnyakov/AAN-3278-2020	Dmitry, Pozdnyakov/0000-0002-5595-8182; Voronkov, Andrey/0000-0001-6638-6223; Nigaran, Siranus/0000-0001-9898-0518			Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bergman O, 2016, CAN J PSYCHIAT, V61, P457, DOI 10.1177/0706743716648290; Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178; Cai Q, 2017, J ALZHEIMERS DIS, V57, P1087, DOI 10.3233/JAD-160726; Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079; Choudhury AR, 2017, SEMIN CANCER BIOL, V47, P125, DOI 10.1016/j.semcancer.2017.05.001; Di Meo S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1245049; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Ferrari D, 1998, J EXP MED, V188, P979, DOI 10.1084/jem.188.5.979; Khacho M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4550; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Lerner CA, 2016, INT J BIOCHEM CELL B, V81, P294, DOI 10.1016/j.biocel.2016.07.026; Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505; Menges S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42942; O-Uchi J, 2014, ANTIOXID REDOX SIGN, V21, P987, DOI 10.1089/ars.2013.5681; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003; Redmann M, 2018, REDOX BIOL, V17, P59, DOI 10.1016/j.redox.2018.04.005; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Shanmugasundaram K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01106-1; Sisakyan AS, 2008, RUSS J CARDIOL, P63; Smith MR, 2016, REDOX BIOL, V8, P136, DOI 10.1016/j.redox.2016.01.002; Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174; Voronkov AV, 2015, FUNDAMENTAL RES, V1-5, P915; Voronkov AV, 2016, MODERN PROBLEMS SCI, V5; Zielonka J, 2017, CHEM REV, V117, P10043, DOI 10.1021/acs.chemrev.7b00042; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	28	4	6	0	0	PYATIGORSKII MEDIKO-FARMATSEVTICHESKII INST	PYATIGORSK	PR-KT KALININA, 11, PYATIGORSK, 357532, RUSSIA	2307-9266	2413-2241		PHARM PHARMACOL-RUSS	Pharm. Pharmacol.		2019	7	1					20	31		10.19163/2307-9266-2019-7-1-20-31			12	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	IJ5XY	WOS:000475977900003		Green Submitted, gold			2022-02-06	
J	Wang, V; Fort, E; Beaudoin-Gobert, M; Ndiaye, A; Fischer, C; Bergeret, A; Charbotel, B; Luaute, J				Wang, V; Fort, E.; Beaudoin-Gobert, M.; Ndiaye, A.; Fischer, C.; Bergeret, A.; Charbotel, B.; Luaute, J.			Indicators of long-term return to work after severe traumatic brain injury: A cohort study	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Return to work; Traumatic brain injury; Occupational outcome; Job stability; Vocational rehabilitation	QUALITY-OF-LIFE; EMPLOYMENT OUTCOME 2; FOLLOW-UP; COMMUNITY INTEGRATION; REHABILITATION; PREDICTORS; MODERATE; HEALTH; PEOPLE	Background: Return to work (RTW) is a major objective in the rehabilitation of individuals with severe traumatic brain injury (TBI). Implications for long-term occupational integration (beyond 5 years) have rarely been studied. Objective: The objective was to assess long-term RTW and the associated factors after severe TBI. Material and methods: Retrospective analysis of a cohort of individuals 16 to 60 years old admitted to hospital after severe TBI from 2005 to 2009 and followed prospectively. Medical and occupational data were collected from medical files and by systematic telephone interview to assess outcome at a minimum of 6 years post-trauma. Factors associated with RTW were investigated by multivariable regression analysis, estimating prevalence ratios (PRs) and 95% confidence intervals (CIs). A proportional hazards model was used to study RTW delay, estimating hazard ratios (HRs). Results: Among the 91 individuals included (mean [SD] age 28.5 [11.3] years; 79% male), 63.7% returned to work after a mean of about 20 months, and 57.1% were still working at the time of the survey. Factors significantly associated with RTW on multivariable analysis were higher educational level (adjusted PR, 1.53; 95% CI, 1.15 to 2.03), absence of motor disability (adjusted PR, 1.82; 1.12 to 2.95) and behavioural disorder (adjusted PR, 1.26; 1.01 to 1.60), as well as disabled worker status (adjusted PR, 1.26; 1.01 to 1.60) (likelihood of the multivariate analysis model 53.1). Delayed RTW was associated with health insurance payments (adjusted HR, 0.40; 95% CI, 0.22 to 0.71), motor disability (adjusted HR, 0.34; 0.15 to 0.76), low educational level (adjusted HR, 2.20; 1.06 to 4.56) and moderate disability on the Extended Glasgow Outcome Scale (adjusted HR, 0.49; 0.27 to 0.91) (likelihood of the multivariate analysis model 335.5). Conclusion: Individuals with the most severe TBI are able to RTW and remain in work. This study highlights the multiple determinants involved in RTW and the role of socioenvironmental factors. (C) 2018 Published by Elsevier Masson SAS.	[Wang, V; Fort, E.; Ndiaye, A.; Bergeret, A.; Charbotel, B.] Claude Bernard Lyon 1 Univ, Univ Lyon, Ifsttar, Umrestte,UMR T 9405, F-69373 Lyon, France; [Beaudoin-Gobert, M.; Luaute, J.] Univ Claude Bernard Lyon 1, Lyon Neurosci Res Ctr CNRS UMR5292, Inserm U1028, IMPACT Team, F-69000 Lyon, France; [Fischer, C.] Hosp Civils Lyon, Neurol Hosp, Funct Neurol & Epileptol Dept, F-69394 Lyon, France; [Bergeret, A.; Charbotel, B.] Hosp Civils Lyon, Lyon Sud Hosp Ctr, Occupat Dis & Occupat Med Dept, F-69495 Pierre Benite, France; [Luaute, J.] Hosp Civils Lyon, Henry Gabrielle Hosp, Phys Med & Rehabil Dept, F-69610 Pierre Benite, France		Beaudoin-Gobert, M (corresponding author), Univ Claude Bernard Lyon 1, Lyon Neurosci Res Ctr CNRS UMR5292, Inserm U1028, IMPACT Team, F-69000 Lyon, France.	maude.beaudoin@isc.cnrs.fr	Fort, Emmanuel/Q-4570-2019; Beaudoin-Gobert, Maude/AAB-5618-2019	Fort, Emmanuel/0000-0003-1419-9914; Beaudoin-Gobert, Maude/0000-0002-3056-2384			Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Bonneterre V., 2013, Annals of Physical and Rehabilitation Medicine, V56, P652, DOI 10.1016/j.rehab.2013.10.001; Bontoux L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P17, DOI 10.1016/j.rehab.2008.12.005; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Czuba C, 2013, ARCH MAL PROF ENVIRO, V74, P515, DOI 10.1016/j.admp.2013.07.186; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Doucet T., 2012, Annals of Physical and Rehabilitation Medicine, V55, P112, DOI 10.1016/j.rehab.2012.01.007; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fleming J, 1999, BRAIN INJURY, V13, P417; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Fort E, 2011, J REHABIL MED, V43, P283, DOI 10.2340/16501977-0670; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Libeson L, 2020, NEUROPSYCHOL REHABIL, V30, P412, DOI 10.1080/09602011.2018.1470987; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Mazaux JM, 2002, ACT NEUR S, V79, P49; Nieuwenhuijsen K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006237.pub3; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Petersson LM, 2013, J OCCUP REHABIL, V23, P391, DOI 10.1007/s10926-012-9402-0; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Saunders SL, 2014, J OCCUP REHABIL, V24, P100, DOI 10.1007/s10926-013-9436-y; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Waddell G, 2016, THE STATIONERY OFFIC; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wasiak R, 2007, J OCCUP REHABIL, V17, P766, DOI 10.1007/s10926-007-9101-4	44	4	4	2	7	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	JAN	2019	62	1					28	34		10.1016/j.rehab.2018.08.003			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HI5WP	WOS:000456525200006	30193993	Green Published, Bronze			2022-02-06	
S	Yang, KH; Mao, HJ		Miller, K		Yang, King H.; Mao, Haojie			Modelling of the Brain for Injury Simulation and Prevention	BIOMECHANICS OF THE BRAIN, 2ND EDITION	Biological and Medical Physics Biomedical Engineering		English	Article; Book Chapter							IMPACT-MEASUREMENT DEVICES; BIOMECHANICAL RESPONSE; PROFESSIONAL FOOTBALL; ELEMENT-ANALYSIS; HEAD-INJURY; STRAIN; TISSUE; CONCUSSION; ACCURACY; EPIDEMIOLOGY		[Yang, King H.] Wayne State Univ, Biomed Engn, Detroit, MI 48202 USA; [Mao, Haojie] Western Univ, London, ON, Canada		Yang, KH (corresponding author), Wayne State Univ, Biomed Engn, Detroit, MI 48202 USA.	aa0007@wayne.edu			Canada Research Chairs programCanada Research Chairs	Dr. Haojie Mao acknowledges the financial support provided by the Canada Research Chairs program.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Allsop D, 1988, P 32 STAPP CAR CRASH; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Atsumi N, 2018, ANN BIOMED ENG, V46, P736, DOI 10.1007/s10439-018-1988-8; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 1994, P 38 STAPP CAR CRASH; Beusenberg MC., 2000, P INT RES C BIOM IMP; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2018, CLIN BIOMECH; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Faul M, 2010, TRAUMATIC BRAIN INJU; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Franklyn M., 2005, 49 STAPP CAR CRASH C; Gehre C., 2009, 21 ESV C JUNE 15 18; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C., 2014, STAPP CAR CRASH J, V58, p14S; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gurdjian E S, 1964, Clin Neurosurg, V12, P112; Gurdjian E.S., 1958, HEAD INJURIES, P62; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1946, SURG GYNECOL OBSTET, V83, P219; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Holbourn AHS, 1943, LANCET, V2, P438; Hughes T.J.R., 1987, FINITE ELEMENT METHO; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Jin X, 2009, THESIS WAYNE STATE U; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; Kabbani H, 2004, AM FAM PHYSICIAN, V69, P2863; Kalra A, 2017, SHOCK WAVES, V27, P947, DOI 10.1007/s00193-017-0760-6; King A.I., 2003, IRCOBI LISBON PORTUG; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Li ZG, 2013, ANN BIOMED ENG, V41, P215, DOI 10.1007/s10439-012-0682-5; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; Macneal R.H., 1985, FINITE ELEM ANAL DES, V1, P3, DOI DOI 10.1016/0168-874X(85)90003-4; Mandelli ML, 2014, J NEUROSURG, V121, P349, DOI 10.3171/2014.4.JNS131160; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Nahum AM, 1977, P 21 STAPP CAR CRASH; Newman J, 1999, NY TIMES BK REV, P17; Nyquist G. W., 1986, P 30 STAPP CAR CRASH; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Raymond D, 2009, J BIOMECH, V42, P2479, DOI 10.1016/j.jbiomech.2009.07.018; Rowson S., 2012, ANN BIOMED ENG, V40, P1; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Ruan J, 2001, Stapp Car Crash J, V45, P395; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sanchez E.J., 2018, CLIN BIOMECH, DOI [10.1016/J.CLINBIOMECH.2018.02.019, DOI 10.1016/J.CLINBI0MECH.2018.02.019]; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; SHENKIN HA, 1982, J NEUROSURG, V57, P254, DOI 10.3171/jns.1982.57.2.0254; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Trosseille X., 1992, P 36 STAPP CAR CRASH; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang F, 2018, BIOMECH MODEL MECHAN, V17, P1165, DOI 10.1007/s10237-018-1021-z; Ward C. C., 1975, P 19 STAPP GAR CRASH; White N.A., 2009, SAE 2009 WORLD C EXP; Williams RM, 2016, SPORTS HEALTH, V8, P270, DOI 10.1177/1941738116641912; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yang K.H, 2017, BASIC FINITE ELEMENT, Vfirst; Yang King H, 2006, Stapp Car Crash J, V50, P429; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan Narayan, 2004, Traffic Inj Prev, V5, P368, DOI 10.1080/15389580490510336; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang L., 2003, P IRCOBI C 2003 LISB; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z; Zhu F, 2016, J NEUROTRAUM, V33, P859, DOI 10.1089/neu.2015.4007; Zhu F, 2016, COMPUT METHOD BIOMEC, V19, P1053, DOI 10.1080/10255842.2015.1091887	112	4	4	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1618-7210	2197-5647	978-3-030-04996-6; 978-3-030-04995-9	BIOL MED PHYS BIOMED	Biol. Med. Phys. Biomed. Eng.		2019							97	133		10.1007/978-3-030-04996-6_5	10.1007/978-3-030-04996-6		37	Engineering, Biomedical; Neurosciences	Book Citation Index – Science (BKCI-S)	Engineering; Neurosciences & Neurology	BO2IP	WOS:000505953200006					2022-02-06	
J	Yu, HY; Dennison, CR				Yu, Henry Y.; Dennison, Christopher R.			A Laboratory Study on Effects of Cycling Helmet Fit on Biomechanical Measures Associated With Head and Neck Injury and Dynamic Helmet Retention	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						Injury biomechanics; helmet; head injury; neck injury; helmet fit	TRAUMATIC BRAIN-INJURY; BICYCLE HELMETS; HYBRID III; EPIDEMIOLOGY; MOTION; BODY	There is a scant biomechanical literature that tests, in a laboratory setting, whether or not determinants of helmet fit affect biomechanical parameters associated with injury. Using conventional cycling helmets and repeatable models of the human head and neck, integrated into a guided drop impact experiment at speeds up to 6 m/s, this study tests the hypothesis that fit affects head kinematics, neck kinetics, and the extent to which the helmet moves relative to the underlying head (an indicator of helmet positional stability). While there were a small subset of cases where head kinematics were statistically significantly altered by fit, when viewed as a whole our measures of head kinematics suggest that fit does not systematically alter kinematics of the head secondary to impact. Similarly, when viewed as a whole, our data suggest that fit does not systematically alter resultant neck compression and resultant moment and associated biomechanical measures. Our data suggest that backward fit helmets exhibit the worst dynamic stability, in particular when the torso is impacted before the helmeted head is impacted, suggesting that the typical certification method of dynamical loading of a helmet to quantify retention may not be representative of highly plausible cycling incident scenarios where impact forces are first applied to the torso leading to loading of the neck prior to the head. Further study is warranted so that factors of fit that affect injury outcome are uncovered in both laboratory and real-world settings.	[Yu, Henry Y.; Dennison, Christopher R.] Univ Alberta, Dept Mech Engn, Biomed Instrumentat Lab, Edmonton, AB T6G 1H9, Canada		Dennison, CR (corresponding author), Univ Alberta, Dept Mech Engn, Biomed Instrumentat Lab, Edmonton, AB T6G 1H9, Canada.	hyyu@ualberta.ca; cdenniso@ualberta.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [435921]; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR [LOF: 32642]; Banting Research Foundation; Department of Mechanical Engineering at the University of AlbertaUniversity of Alberta; Faculty of Engineering at the University of AlbertaUniversity of Alberta;  [458535]	The Natural Sciences and Engineering Research Council of Canada (Discovery Grant 435921).; Research Tools and Instruments: (458535).; The Canada Foundation for Innovation (LOF: 32642).; The Banting Research Foundation (Discovery Award),; The Pashby Sport Safety Fund, The Faculty of Engineering and Department of Mechanical Engineering at the University of Alberta.	Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; ASTM, 2006, F144706 ASTM; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Bland ML, 2018, TRAFFIC INJ PREV, V19, pS158, DOI 10.1080/15389588.2017.1388915; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Butz RC, 2015, J BIOMECH, V48, P3816, DOI 10.1016/j.jbiomech.2015.09.032; Chang L.-T, JSME INT A, V44, P185; CPSC, 1998, US CONS PROD SAF COM; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Dennis J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2674; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; Eppinger R., 2000, SUPPLEMENT DEV IMPRO; Fahlstedt M., 2012, 2012 IRCOBI C P INT, P787, DOI DOI 10.1177/1753193412460139; Feist F, 2016, INT RES COUNC BIOM I; Ghajari M, 2013, ACCIDENT ANAL PREV, V50, P263, DOI 10.1016/j.aap.2012.04.016; Holbourn AHS, 1943, LANCET, V2, P438; Jadischke R, 2012, FOOTBALL HELMET FITM; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; Klug C., 2015, TESTING BICYCLE HELM, P136; Knowles BM, 2017, ANN BIOMED ENG, V45, P2146, DOI 10.1007/s10439-017-1848-y; Lee RS, 2009, INJURY PREV, V15, P125, DOI 10.1136/ip.2008.019695; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Newman J. A, 2000, 200001SC16 SAE; Newman J.A., 1986, P IRCOBI C, P121; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Nightingale RW, 1996, J BONE JOINT SURG AM, V78A, P412, DOI 10.2106/00004623-199603000-00013; NOCSAE, 2013, ND00213M13 NOCSAE; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Parkinson GW, 2003, PEDIATRICS, V112, P320, DOI 10.1542/peds.112.2.320; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Pintar FA, 1995, J BIOMECH ENG-T ASME, V117, P474, DOI 10.1115/1.2794210; Rivara F P, 1999, Inj Prev, V5, P194; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Romanow N. R, CHRONIC DIS INJ CAN, V34, P1; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; SAE International, 2007, J2111 SAE INT; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Snell Memorial Foundations, 2013, B95A SNELL; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Toomey DE, 2014, TRAFFIC INJ PREV, V15, pS223, DOI 10.1080/15389588.2014.931950; Woodcock J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g425; Yu H. Y, 2017, JOVE-J VIS EXP, V127	47	4	4	1	7	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	JAN	2019	141	1							011007	10.1115/1.4040944			13	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	HC7BM	WOS:000451955400007	30098148				2022-02-06	
J	Hill, CS; Menon, DK; Coleman, MP				Hill, Ciaran S.; Menon, David K.; Coleman, Michael P.			P7C3-A20 neuroprotection is independent of Wallerian degeneration in primary neuronal culture	NEUROREPORT			English	Article						axon; P7C3-A20; protection; Wallerian degeneration	TRAUMATIC BRAIN-INJURY; AXONAL DEGENERATION; AMINOPROPYL CARBAZOLES; MOUSE MODEL; EFFICACY; NEUROPATHY; PATHWAY; DISEASE	The antiapoptotic, neuroprotective compound P7C3-A20 reduces neurological deficits when administered to murine in-vivo models of traumatic brain injury. P7C3-A20 is thought to exert its activity through small-molecule activation of the enzyme nicotinamide phosphoribosyltransferase. This enzyme converts nicotinamide to nicotinamide mononucleotide, the precursor to nicotinamide adenine dinucleotide synthesis. Alterations to this bioenergetic pathway have been shown to induce Wallerian degeneration (WD) of the distal neurite following injury. This study aimed to establish whether P7C3-A20, through induction of nicotinamide phosphoribosyltransferase activity, would affect the rate of WD. The model systems used were dissociated primary cortical neurons, dissociated superior cervical ganglion neurons and superior cervical ganglion explants. P7C3-A20 failed to show any protection against WD induced by neurite transection or vincristine administration. Furthermore, there was a concentration-dependent neurotoxicity. These findings are important in understanding the mechanism by which P7C3-A20 mediates its effects - a key step before moving to human clinical trials.	[Hill, Ciaran S.; Coleman, Michael P.] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England; [Hill, Ciaran S.; Menon, David K.] Univ Cambridge, Div Anaesthesia, Dept Med, Cambridge, England; [Menon, David K.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England		Hill, CS (corresponding author), Univ Cambridge, Cambridge CB2 0PY, England.	ciaranhill@gmail.com		Hill, Ciaran/0000-0002-4488-4034	National Institute for Health Research, UK (NIHR); Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre; European Union (CENTER-TBI) [602150]; John and Lucille van Geest Foundation; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/B/000C0433] Funding Source: UKRI	C.S.H. is supported by a Wellcome Trust PhD for Clinicians.; D.K.M. is supported by a Senior Investigator Award from the National Institute for Health Research, UK (NIHR), by the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, and a Framework Program 7 grant from the European Union (CENTER-TBI; Grant no: 602150).; M.P.C. is funded by the John and Lucille van Geest Foundation.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gilley J, 2013, J NEUROSCI, V33, P13410, DOI 10.1523/JNEUROSCI.1534-13.2013; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Milde S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001539; Pieper AA, 2014, CHEM SOC REV, V43, P6716, DOI 10.1039/c3cs60448a; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Wang MS, 2000, J NEUROPATH EXP NEUR, V59, P599, DOI 10.1093/jnen/59.7.599; Watanabe M, 2007, NEUROSCI LETT, V411, P228, DOI 10.1016/j.neulet.2006.09.068; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030	20	4	4	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	DEC 12	2018	29	18					1544	1549		10.1097/WNR.0000000000001146			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA7CO	WOS:000450438900005	30334859	Green Published, hybrid			2022-02-06	
J	Daugherty, J; Sarmiento, K				Daugherty, Jill; Sarmiento, Kelly			Chronic traumatic encephalopathy: what do parents of youth athletes know about it?	BRAIN INJURY			English	Article						Chronic Traumatic Encephalopathy; concussions; youth athletics	UNITED-STATES; BRAIN-INJURY	Introduction/Background: Chronic Traumatic Encephalopathy (CTE) is a neurodegenerative disease thought to be caused by repeated head impacts and associated with deficits in cognition. Despite research and media attention, there is little science-based information available for the public. Also unclear is what the public and particularly parents of youth athletes know about CTE. The U.S. Centers for Disease Control and Prevention (CDC) surveyed parents of young athletes to fill this gap. Methods: CDC analysed 12 CTE-related questions that appeared in Porter Novelli Public Service's 2017 SummerStyles opinion survey. Analyses focused on 674 parents of children who play in a youth sports programme. Results: Half of parents had at least one child who plays contact sports. About one-third of respondents reported being somewhat or very familiar with CTE. Most parents (81.7%) have not received educational materials on CTE from a school or sports programme. Healthcare providers were the preferred source of information about CTE (70%), followed by sports coaches (54%). Discussion/Conclusion: This analysis identified information needs related to CTE among parents of young athletes. These findings can be used by health educators to tailor educational materials to meet information needs. Educational materials that emphasize potential prevention strategies and symptom onset may be beneficial.	[Daugherty, Jill; Sarmiento, Kelly] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 4770 Buford Highway Northeast, Atlanta, GA 30341 USA		Daugherty, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 4770 Buford Highway Northeast, Atlanta, GA 30341 USA.	JDaugherty@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Beaudouin F, 2017, BRIT J SPORT MED, P1; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Boston University Research: CTE Center, 2018, FREQ ASK QUEST CTE; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Burns A.C., 2010, MARKETING RES; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention, 2018, ANSW QUEST CHRON TRA; Concussion Legacy Foundation, 2018, WHAT IS CTE; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Edlow BL, 2018, J NEUROTRAUM, V35, P1604, DOI 10.1089/neu.2017.5457; Enniss Toby M, 2018, Trauma Surg Acute Care Open, V3, pe000153, DOI 10.1136/tsaco-2017-000153; Facts M, 1994, MAIL PANELS VS GEN S; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Goldstein LE, 2012, SCI TRANSL MED, V4; Growth from Knowledge (GfK), 2018, GFK KNOWLEDGEPANEL; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Hornbeck Kimberly, 2017, AMA J Ethics, V19, P686, DOI 10.1001/journalofethics.2017.19.7.pfor1-1707; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mayo Clinic, 2016, CHRON TRAUM ENC; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; National Council of Youth Sports, 2008, REP TRENDS PART ORG; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Pollard WE, 2001, JOINT STAT M SECT HL; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; United States Census Bureau, 2017, CENS REG DIV US; US National Institutes of Health, 2018, TRAUM BRAIN INJ HOP; US National Institutes of Health, 2018, NIH CHRON TRAUM ENC; Waltzman Dana, 2018, J Concussion, V2, P1, DOI 10.1177/2059700218769218; Wikipedia, 2018, CHRON TRAUM ENC; Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020	47	4	4	1	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1773	1779		10.1080/02699052.2018.1530801			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600021	30296176	Green Accepted			2022-02-06	
J	Ettenhofer, ML; Hershaw, JN; Engle, JR; Hungerford, LD				Ettenhofer, Mark L.; Hershaw, Jamie N.; Engle, James R.; Hungerford, Lars D.			Saccadic impairment in chronic traumatic brain injury: examining the influence of cognitive load and injury severity	BRAIN INJURY			English	Article						Eye tracking; saccades; cognitive load; attention; TBI	MILD HEAD-INJURY; EYE-TARGET SYNCHRONIZATION; WORKING-MEMORY; POSTCONCUSSION SYNDROME; SMOOTH-PURSUIT; ATTENTION; DEFICITS; TASK; PERFORMANCE; MOVEMENTS	Objective: Previous research suggests that saccadic eye movements can be uniquely sensitive to impairment in chronic traumatic brain injury (TBI). This study was conducted to examine saccadic eye movements across varying levels of cognitive load and TBI history/severity. We hypothesized that saccadic impairment in chronic mild and moderate-severe TBI would be most pronounced under conditions of high cognitive load. Methods: In total, 61 participants (including n = 20 with chronic mild TBI, n = 15 with chronic moderate-severe TBI, and 26 uninjured controls) completed a battery of conventional neuropsychological tests and the Fusion n-Back Test, which measures manual and saccadic response time (RT) across varying cognitive load and cueing conditions. Results: Consistent with our hypotheses, chronic mild and moderate-severe TBI were associated with substantial saccadic impairment under conditions of high cognitive load. Participants with moderate-severe TBI also demonstrated saccadic impairment at low levels of cognitive load. TBI groups and uninjured controls did not differ significantly on manual metrics or conventional neuropsychological measures. Conclusions: This study provides additional support for the value of eye tracking for enhanced assessment of TBI. Additionally, findings suggest that TBI is associated with greatest susceptibility to oculomotor interference under high levels of cognitive load.	[Ettenhofer, Mark L.; Hungerford, Lars D.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Ettenhofer, Mark L.; Hungerford, Lars D.] Naval Med Ctr San Diego, Dept Phys Med & Rehabil, San Diego, CA USA; [Ettenhofer, Mark L.; Hershaw, Jamie N.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Ettenhofer, Mark L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Hershaw, Jamie N.; Engle, James R.] Henry M Jackson Fdn, Bethesda, MD USA		Ettenhofer, ML (corresponding author), 34730 Bob Wilson Dr,Suite 201, San Diego, CA 92134 USA.	mark.ettenhofer@usuhs.edu	Ettenhofer, Mark L./J-7171-2019	Ettenhofer, Mark L./0000-0001-9381-7578	Medical Research and Materiel Command, Congressionally Directed Medical Research Program [W81XWH-13-1-0095]	This work was supported by the Medical Research and Materiel Command, Congressionally Directed Medical Research Program [W81XWH-13-1-0095].	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Barker F, 2013, TRAUMATIC BRAIN INJU; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Contreras R, 2011, BRAIN RES, V1398, P55, DOI 10.1016/j.brainres.2011.05.004; Contreras R, 2008, J BIOL PHYS, V34, P381, DOI 10.1007/s10867-008-9092-1; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; de Haan B, 2008, BRAIN RES, V1204, P102, DOI 10.1016/j.brainres.2008.01.105; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Ettenhofer ML, 2016, J CLIN EXP NEUROPSYC, V38, P96, DOI 10.1080/13803395.2015.1089978; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Heitger MH, 2005, BRAIN INJURY, V19, P109, DOI 10.1080/02699050410001720095; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Holdnack JA., 2001, WECHSLER TEST ADULT; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kahneman D, 1973, ATTENTION EFFORT, P253; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Klein C, 2010, EXP BRAIN RES, V203, P759, DOI 10.1007/s00221-010-2276-5; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kraus MF, 2010, COGN BEHAV NEUROL, V23, P210, DOI 10.1097/WNN.0b013e3181cefe2e; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mitchell JP, 2002, J COGNITIVE NEUROSCI, V14, P95, DOI 10.1162/089892902317205357; Osaka M., 2007, COGNITIVE NEUROSCIEN, P99; Pierrot-Deseilligny C, 2005, ANN NY ACAD SCI, V1039, P239, DOI 10.1196/annals.1325.023; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rizzo JR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00012; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Safford A, 2015, INT C AUGM COGN; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; Stuyven E, 2000, ACTA PSYCHOL, V104, P69, DOI 10.1016/S0001-6918(99)00054-2; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Unsworth N, 2004, J EXP PSYCHOL LEARN, V30, P1302, DOI 10.1037/0278-7393.30.6.1302; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wechsler D., 2008, WAIS IV TECHNICAL IN; Wechsler D., 2008, WECHSLER ADULT INTEL; WICKENS C. D., 1984, VARIETIES ATTENTION, P63; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	73	4	4	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1740	1748		10.1080/02699052.2018.1511067			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600017	30183381	hybrid			2022-02-06	
J	O'Rourke, C; Linden, MA; Lohan, M				O'Rourke, Conall; Linden, Mark A.; Lohan, Maria			Traumatic brain injury and abuse among female offenders compared to non-incarcerated controls	BRAIN INJURY			English	Article						Traumatic brain injury; prison; abuse; female offender; trauma	TBI IDENTIFICATION METHOD; BEHAVIOR INVENTORY; SALIVARY CORTISOL; SUBSTANCE-ABUSE; SEXUAL-ABUSE; CHILDHOOD; PREVALENCE; MISCONCEPTIONS; ASSOCIATION; PRISONERS	Objective: To examine the prevalence of traumatic brain injury (TBI) and past abuse experienced by adult female offenders. Methods: Twenty-nine female offenders from a UK women's prison and twenty-nine age and gender matched university controls were recruited. In addition to demographic data, the Brain Injury Screening Index was utilized alongside the Childhood Trauma Questionnaire and the Abusive Behaviour Inventory. Results: Approximately 79% (n = 21) of female offenders reported a history of TBI, with 38% (n = 8) reporting six or more injuries. However, only 28.5% of female offenders reporting injury (n = 6) believed they had sustained a brain injury. Prevalence of both childhood (n = 15, 51.7%), and partner (n = 19, 65.5%) abuse was also high among offenders. TBI Index scores correlated with past childhood and past partner physical abuse. Past mental illness, partner physical abuse, and number of convictions were predictive of greater TBI severity. Conclusion: This is the first European study to examine combined TBI and abuse among an exclusively female offender population. It suggests that TBI is as prevalent among incarcerated females as it is among males. The unique presentation of female offenders must be acknowledged if effective rehabilitation programs are to be implemented.	[O'Rourke, Conall; Linden, Mark A.; Lohan, Maria] Queens Univ Belfast, Sch Nursing & Midwifery, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland		Linden, MA (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	m.linden@qub.ac.uk		Lohan, Maria/0000-0003-3525-1283; Linden, Mark/0000-0002-3832-4102			Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth K, 2008, NURS RES, V57, P166, DOI 10.1097/01.NNR.0000319501.97864.d5; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Corston B. J., 2007, CORSTON REPORT REPOR; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Durand E, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.535; Elbogen EB, 2015, J HEAD TRAUMA REHAB, V30, pE3, DOI 10.1097/HTR.0000000000000083; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Friestad C, 2014, INT J SOC PSYCHIATR, V60, P40, DOI 10.1177/0020764012461235; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Grunau RE, 2009, PAIN, V143, P138, DOI 10.1016/j.pain.2009.02.014; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; IBM Corp, 2016, IBM SPSS STAT WINDOW; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Linden MA, 2015, ARCH DIS CHILD, V100, P554, DOI 10.1136/archdischild-2014-307390; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay Audrey, 2016, Concussion, V1, pCNC25, DOI 10.2217/cnc-2016-0011; McKinlay A, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000284; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Minieri AM, 2014, INT J OFFENDER THER, V58, P303, DOI 10.1177/0306624X12472017; Ministry of Justice, 2012, DIST APPR GUID WORK; Ministry of Justice, 2016, WOM CRIM JUST SYST S; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; O'Sullivan M, 2015, AGGRESS VIOLENT BEH, V25, P54, DOI 10.1016/j.avb.2015.07.006; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Postmus JL, 2016, J INTERPERS VIOLENCE, V31, P2867, DOI 10.1177/0886260515581882; Ray B, 2014, J FORENSIC SCI, V59, P1248, DOI 10.1111/1556-4029.12466; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; SHEPARD MF, 1992, J INTERPERS VIOLENCE, V7, P291, DOI 10.1177/088626092007003001; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Swavola E., 2016, OVERLOOKED WOMEN JAI; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tripodi SJ, 2013, INT J LAW PSYCHIAT, V36, P30, DOI 10.1016/j.ijlp.2012.11.005; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	55	4	4	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1787	1794		10.1080/02699052.2018.1539872			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600023	30373402	Green Published			2022-02-06	
J	Aydin, I; Algin, A; Poyraz, MK; Yumrutas, O				Aydin, I.; Algin, A.; Poyraz, M. K.; Yumrutas, O.			Diagnostic value of serum glial fibrillary acidic protein and S100B serum levels in emergency medicine patients with traumatic versus nontraumatic intracerebral hemorrhage	NIGERIAN JOURNAL OF CLINICAL PRACTICE			English	Article						Fracture; glial fibrillary acidic protein; hemorrhage; S100B	INJURY	Background: Glial fibrillary acidic protein (GFAP) is a brain-specific astroglial protein that is released into the blood soon after traumatic brain injury by mature astrocytes. S100B is rapidly released into the cerebrospinal fluid and bloodstream after brain damage. We compared the serum concentrations of these proteins in patients with severe head trauma (bleeding and/or fracture) or nontraumatic intracerebral hemorrhage and healthy individuals. Materials and Methods: The study included 63 patients (33 males and 30 females) with traumatic cerebral hemorrhage and/or cranial bone fractures or nontraumatic cerebral hemorrhage and 30 healthy control subjects. The reasons for attending the emergency department were as follows: fall from a height (n = 32), traffic accident (n = 18), nontraumatic intracerebral hemorrhage (n = 6), animal kick to the head (n = 4), and blow to the head (n = 3). Results: Of the 63 patients included in the study, 33 (52.4%) were male and 30 (47.6%) were female. Of the 30 healthy controls, 12 (40%) were male and 18 (60%) were female. The average age of the patients was 27 years (range, 1 month to 86 years) and the average age of the control group was 21 years (range, 18u30 years). The mean serum GFAP concentrations were 86.37 ng/mL in the patients and 38.07 ng/mL in the controls (P < 0.05). The mean serum S100B concentrations were 428.37 pg/mL in the patients and 103.44 pg/mL in the controls (P < 0.05). Eight (12.7%) patients died in the hospital; of those, the mean GCS score was 4.6, and the mean GFAP and S100B levels were 127.8 ng/mL and 860.6 pg/mL, respectively. Conclusion: The GFAP and S100B concentrations were significantly higher in patients with traumatic or nontraumatic brain injury than in healthy individuals, indicating that serum levels of these biomarkers may provide an alternative to computed tomography for the diagnosis of brain injury.	[Aydin, I.; Algin, A.; Poyraz, M. K.] Adiyaman Univ, Training & Res Hosp, Dept Emergency Med, Adiyaman, Turkey; [Yumrutas, O.] Adiyaman Univ, Training & Res Hosp, Dept Med Biol, Adiyaman, Turkey		Algin, A (corresponding author), Adiyaman Univ, Training & Res Hosp, Dept Emergency Med, Adiyaman, Turkey.	dralgin@hotmail.com	Algin, Abdullah/AAB-5013-2020				Abbasi Mohsen, 2014, Turk J Emerg Med, V14, P147, DOI 10.5505/1304.7361.2014.74317; Akoglu H, 2005, MARMARA MED J, V18, P113; Alpua M, 2014, J FAC MED KOC U, V16, P8; Brunkhorst R, 2010, TRANSL STROKE RES, V1, P246, DOI 10.1007/s12975-010-0040-6; Cikriklar HI, 2014, BOZOK MED J, V4, P6; Duman C, 2008, J TURK CLIN BIOL, V6, P33; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Isik HS, 2011, ULUS TRAVMA ACIL CER, V17, P46, DOI 10.5505/tjtes.2011.57431; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Senn R, 2014, CEREBROVASC DIS, V38, P395, DOI 10.1159/000366470; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149	15	4	5	1	4	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1119-3077			NIGER J CLIN PRACT	Niger. J. Clin. Pract.	DEC	2018	21	12					1645	1650		10.4103/njcp.njcp_431_17			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HF4JH	WOS:000454199000015	30560830				2022-02-06	
J	Bossers, SM; Pol, KM; Ophuis, EPAO; Jacobs, B; Visser, MC; Loer, SA; Boer, C; van der Naalt, J; Schober, P				Bossers, S. M.; Pol, K. M.; Ophuis, E. P. A. Oude; Jacobs, B.; Visser, M. C.; Loer, S. A.; Boer, C.; van der Naalt, J.; Schober, P.			Discrepancy between the initial assessment of injury severity and post hoc determination of injury severity in patients with apparently mild traumatic brain injury: a retrospective multicenter cohort analysis	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Mild traumatic brain injury; Emergency medicalservice; Hospital; Decision support techniques; Prognosis; Risk factors	GLASGOW COMA SCALE; CT HEAD RULE; COMPUTED-TOMOGRAPHY; ELDERLY-PATIENTS; MORTALITY; CLASSIFICATION; CONSCIOUSNESS; PREDICTION; DIAGNOSIS	PurposeTraumatic brain injury (TBI) is a major cause of trauma-related visits to emergency departments (ED). Determination of monitoring requirements of patients with apparently mild TBI is challenging. Patients may turn out to be more severely injured than initially assumed, and failure to identify these patients constitutes a serious threat to patient safety. We, therefore, aimed to identify clinical risk factors for more severe injuries in patients with apparently mild TBI.MethodsIn a retrospective cohort analysis performed at two level I trauma centers, 808 patients aged 16 presenting to the ED with head trauma and a Glasgow Coma Scale (GCS) score 13-15 who received a head CT scan were studied. Discrepancies between the initial TBI severity as determined by GCS and severity as determined post hoc by the Head Abbreviated Injury Score were assessed. Multiple logistic regression was used to identify risk factors of such discrepancies.Results104 (12.9%) patients were more severely injured than initially classified. A GCS<15at presentation (GCS 13: OR 6.2, [95% CI 3.8-9.9]; GCS 14: OR 2.7, [2.0-3.7]), an SpO(2)<90% (OR 5.4, [1.2-23.4]), loss of consciousness (OR 2.3, [1.5-3.5]), absence of equal and reactive pupils (OR 2.1, [1.6-2.7]), transport by ambulance (OR 2.0, [1.7-2.4]), and use of anticoagulant drugs (OR 1.2, [1.1-1.3]) were independent risk factors of more severe injury.ConclusionsSix risk factors of more severe injury in patients presenting with apparently mild TBI were identified. Patients with any of these factors should be thoroughly monitored for signs of neurologic deterioration.	[Bossers, S. M.; Ophuis, E. P. A. Oude; Loer, S. A.; Boer, C.; Schober, P.] VU Univ Amsterdam Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Pol, K. M.; Jacobs, B.; van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Visser, M. C.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands		Schober, P (corresponding author), VU Univ Amsterdam Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	p.schober@vumc.nl	Schober, Patrick/G-7400-2012; Bossers, Sebastiaan/AAE-1085-2020	Schober, Patrick/0000-0003-0814-081X; Bossers, Sebastiaan/0000-0002-2396-2777; Boer, Christa/0000-0002-7781-6951; van der Naalt, Joukje/0000-0001-9873-2418			Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Dutch Society of Neurology, 2010, RICHTL OPV PAT LICHT; Easter JS, 2008, J EMERG MED, V35, P77, DOI 10.1016/j.jemermed.2008.04.002; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Laskowski RA, 2015, BRAIN NEUROTRAUMA MO, P35; Lee Bruce, 2005, NeuroRx, V2, P372; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	25	4	4	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2018	44	6					889	896		10.1007/s00068-017-0861-z			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HB9NV	WOS:000451419500013	29032474	Green Published, hybrid			2022-02-06	
J	de Noriega, FR; Manley, GT; Moscovici, S; Itshayek, E; Tamir, I; Fellig, Y; Abu Shkara, R; Rosenthal, G				de Noriega, Fernando Ramirez; Manley, Geoffrey T.; Moscovici, Samuel; Itshayek, Eyal; Tamir, Idit; Fellig, Yakov; Abu Shkara, Ramiz; Rosenthal, Guy			A swine model of intracellular cerebral edema - Cerebral physiology and intracranial compliance	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Swine model; Cerebral edema; Intracranial pressure; Brain tissue oxygen tension; Intracranial compliance; ICP dose	BRAIN-TISSUE OXYGEN; INSPIRED OXYGEN; ORAL TOLVAPTAN; AXONAL INJURY; PRESSURE; HYPONATREMIA; TENSION; VOLUME; PATHOPHYSIOLOGY; AQUAPORIN-4	Cerebral edema leading to elevated intracranial pressure (ICP) is a fundamental concern after severe traumatic brain injury (TBI), stroke, and severe acute hyponatremia. We describe a swine model of water intoxication and its cerebral histological and physiological sequela. We studied female swine weighing 35-45 kg. Four serum sodium intervals were designated: baseline, mild, moderate, and severe hyponatremia attained by infusing hypotonic saline. Intracranial fluid injections were performed to assess intracranial compliance. At baseline and following water intoxication wedge biopsy was obtained for pathological examination and electron microscopy. We studied 8 swine and found an increase in ICP that was strongly related to the decrease in serum sodium level. Mean ICP rose from a baseline of 6 +/- 2 to 28 +/- 6 mm Hg during severe hyponatremia, while cerebral perfusion pressure (CPP) decreased from 72 +/- 10 to 46 +/- 11 mm Hg. Brain tissue oxygen tension (PbtO(2)) decreased from 18.4 +/- 8.9 to 5.3 +/- 3.0 mm Hg. Electron microscopy demonstrated intracellular edema and astrocytic foot process swelling following water intoxication. With severe hyponatremia, 2 cc intracranial fluid injection resulted in progressively greater ICP dose, indicating a worsening intracranial compliance. Our model leads to graded and sustained elevation of ICP, lower CPP, and decreased PbtO(2), all of which cross clinically relevant thresholds. Intracranial compliance worsens with increased cerebral swelling. This model may serve as a platform to study which therapeutic interventions best improve the cerebral physiological profile in the face of severe brain edema. (C) 2018 Elsevier Ltd. All rights reserved.	[de Noriega, Fernando Ramirez; Moscovici, Samuel; Itshayek, Eyal; Tamir, Idit; Abu Shkara, Ramiz; Rosenthal, Guy] Hadassah Hebrew Univ, Med Ctr, Dept Neurosurg, IL-91120 Jerusalem, Israel; [Manley, Geoffrey T.; Rosenthal, Guy] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Fellig, Yakov] Hadassah Hebrew Univ, Dept Pathol, Jerusalem, Israel		Rosenthal, G (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Neurosurg, IL-91120 Jerusalem, Israel.	rosenthalg@hadassah.org.il		Moscovici, Samuel/0000-0001-6090-2901	Hadassah Keren Klita Grant	This study was supported by a Hadassah Keren Klita Grant (Guy Rosenthal, MD). The authors have no competing financial interests or disclosures.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Bardt TF, 1998, ACT NEUR S, V71, P153; Berl T, 2010, J AM SOC NEPHROL, V21, P705, DOI 10.1681/ASN.2009080857; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Chesnut R, 2014, NEUROCRIT CARE, V21, pS64; Clayton JA, 2006, QJM-INT J MED, V99, P505, DOI 10.1093/qjmed/hcl071; Fraser CL, 1997, AM J MED, V102, P67, DOI 10.1016/S0002-9343(96)00274-4; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; GULLANS SR, 1993, ANNU REV MED, V44, P289, DOI 10.1146/annurev.med.44.1.289; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; HOSSMANN KA, 1971, EXP NEUROL, V32, P163, DOI 10.1016/0014-4886(71)90060-4; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kleindienst A, 2016, J NEUROTRAUM, V33, P615, DOI 10.1089/neu.2015.3981; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Longhi L, 2002, ACT NEUR S, V81, P315; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MATSUOKA Y, 1982, J CEREBR BLOOD F MET, V2, P466, DOI 10.1038/jcbfm.1982.53; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; OLSON JE, 1990, ANN EMERG MED, V19, P1113, DOI 10.1016/S0196-0644(05)81514-8; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Reinert M, 2003, ACTA NEUROCHIR WIEN, V145, P9; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Verbalis JG, 2011, EUR J ENDOCRINOL, V164, P725, DOI 10.1530/EJE-10-1078; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Vink R, 2008, ACTA NEUROCHIR SUPPL, V102, P189, DOI 10.1007/978-3-211-85578-2_37; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan L, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0297-z	50	4	4	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2018	58						192	199		10.1016/j.jocn.2018.10.051			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HD5OS	WOS:000452580400033	30454689				2022-02-06	
J	Ellis, M; Hwang, LS; Ford, NK; Slavin, K				Ellis, Marco; Hwang, Lisa; Ford, Ni-Ka; Slavin, Konstantin			The Role of the Visor Flap in Scalp Reconstruction: A Case Series of 21 Patients	OPERATIVE NEUROSURGERY			English	Article						Full-thickness scalp defects; Scalp reconstruction; Bipedicled scalp advancement flap; Visor flap; Complex scalp wound	MANAGEMENT	BACKGROUND: Full-thickness scalp defects pose a reconstructive problem, especially in the setting of infection, chemotherapy/radiation, and underlying cranial defects. Current options include dermal matrices, skin grafts, and local flaps. Local flaps often fail, requiring subsequent microvascular free flap reconstruction. OBJECTIVE: To describe the visor flap, a novel bipedicled advancement flap design, and its role in reconstruction of scalp defects. METHODS: A retrospective review of 21 adult patients who developed scalp defects reconstructed using the visor flap from 2013 to 2017. The visor flap is a large bipedicled advancement flap design with a triangular extension at the base, which allows redistribution of a large surface area of the scalp. RESULTS: All 21 patients achieved complete and viable soft tissue coverage of the recipient site, but 19.0% developed complications unrelated to flap viability, requiring reoperation (infected bone flap, epidural hematoma, and recurrent glioblastoma with subdural abscess). Only 1 patient required conversion to free flap reconstruction due to cerebrospinal fluid leak. Etiologies included cancer (76.1%), cerebrovascular disease (19.0%), and traumatic brain injury (4.8%). Preoperative radiation (42.9%), bone/hardware exposure (57.1%), and previous craniotomy (85.7%) were widely prevalent. Defect size ranged from 3 to 50 cm(2) (mean, 16.9 cm(2)), and flap size ranged from 90 to 500 cm(2) (mean, 222 cm(2)). CONCLUSION: The visor flap provides an innovative solution for closure of scalp defects. This technique optimizes immediate closure of tissue compromised by infection or chemotherapy/radiation without burning bridges to more complex reconstructive options.	[Ellis, Marco; Hwang, Lisa; Ford, Ni-Ka; Slavin, Konstantin] Univ Illinois, Chicago, IL USA; [Ellis, Marco] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA		Ellis, M (corresponding author), Northwestern Mem Hosp, 675 N St Clair St,Suite 19-250, Chicago, IL 60611 USA.	mellis2@nm.org	Slavin, Konstantin/H-3269-2019	Slavin, Konstantin/0000-0002-7946-8639; Ellis, Marco/0000-0002-4911-3132			Hartzell TL, 2009, PLAST RECONSTR SURG, V124, P167, DOI 10.1097/PRS.0b013e3181a805e4; Hwang LS, 2017, J CRANIOFAC SURG, V28, pE146, DOI 10.1097/SCS.0000000000003332; Iblher N, 2010, PLAST RECONSTR SURG, V126, P450, DOI 10.1097/PRS.0b013e3181e09515; Jadhav CN, 2014, J CRANIOFAC SURG, V25, pE406, DOI 10.1097/SCS.0000000000000886; Kruse-Losler B, 2006, EJSO-EUR J SURG ONC, V32, P1006, DOI 10.1016/j.ejso.2006.05.001; MARTY F, 1986, ANN PLAS SURG, V16, P368, DOI 10.1097/00000637-198605000-00004; Moulton-Barrett R, 2015, J CRANIOFAC SURG, V26, P523, DOI 10.1097/SCS.0000000000002029; NAIR S, 1994, NEUROSURGERY, V34, P103, DOI 10.1227/00006123-199401000-00015	8	4	4	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	DEC	2018	15	6					651	655		10.1093/ons/opy042			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HK0OU	WOS:000457600400031	29554345				2022-02-06	
J	Gernsback, JE; Kolcun, JPG; Richardson, AM; Jagid, JR				Gernsback, Joanna E.; Kolcun, John Paul G.; Richardson, Angela M.; Jagid, Jonathan R.			Patientem Fortuna Adiuvat: The Delayed Treatment of Surgical Acute Subdural Hematomas-A Case Series	WORLD NEUROSURGERY			English	Article						Acute subdural hematoma; Burr hole craniotomy; Conservative management; Traumatic brain injury	LENGTH-OF-STAY; RISK-FACTORS; NONSURGICAL MANAGEMENT; SPONTANEOUS RESOLUTION; CONSERVATIVE TREATMENT; EVACUATION; OUTCOMES; TRAUMA; MORTALITY; DRAINS	BACKGROUND: Current guidelines prescribe emergent decompression of acute subdural hematomas (aSDHs) with width 10 mm or larger or midline shift 5 mm or larger. A subset of patients who meet these criteria, including those with high Glasgow Coma Scale (GCS) scores and coagulopathy because of medication or multiple medical comorbidities, may be treated conservatively until the hematoma can be removed by burr hole drainage. We present a series of conservatively managed surgical patients with aSDH, examining their hospital course and outcomes. METHODS: Patients were included who met guidelines for surgery on admission but who had decompression delayed until it could be accomplished by burr hole drainage. Charts were reviewed for presentation, computed tomography scan findings, and outcomes. Patients were classified according to outcome and whether their eventual surgery was scheduled or emergent. RESULTS: Eighteen patients were included with a mean age of 70.2 years. Average GCS score at presentation was 14.6 +/- 0.6. Most patients were using some form of blood-thinning medication at presentation (72.2%). Admission CT scan revealed aSDH with a mean width of 13.6 mm and midline shift of 6.6 mm. Average total length of stay was 28.4 +/- 17.0 days, of which 14.2 +/- 9.2 days were spent in the intensive care unit. Outcomes were generally acceptable, with an average Glasgow Outcome Scale score at discharge of 3.8 +/- 1.4. There were only 2 deaths, neither of which was related to the initial trauma or a neurologic process. CONCLUSIONS: Delayed treatment of aSDH by burr hole drainage is an effective option in certain patients who are suboptimal craniotomy candidates. Acceptable outcomes may be achievable with this conservative approach, when applied in appropriate patients.	[Gernsback, Joanna E.; Kolcun, John Paul G.; Richardson, Angela M.; Jagid, Jonathan R.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA		Kolcun, JPG (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.	jpk73@med.miami.edu	Richardson, Angela/AAN-8731-2020	Richardson, Angela/0000-0003-2656-7438			Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; CROCE MA, 1994, J TRAUMA, V36, P820, DOI 10.1097/00005373-199406000-00012; De Angelis G, 2010, CLIN MICROBIOL INFEC, V16, P1729, DOI 10.1111/j.1469-0691.2010.03332.x; Feliciano CE, 2008, P R HEALTH SCI J, V27, P220; Fridley J, 2011, J CLIN NEUROSCI, V18, P422, DOI 10.1016/j.jocn.2010.05.004; Guilfoyle MR, 2017, ACTA NEUROCHIR, V159, P903, DOI 10.1007/s00701-017-3095-2; Kapsalaki EZ, 2007, CLIN NEUROL NEUROSUR, V109, P287, DOI 10.1016/j.clineuro.2006.11.005; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kato N, 2001, NEUROL MED-CHIR, V41, P140, DOI 10.2176/nmc.41.140; Kim BJ, 2014, ACTA NEUROCHIR, V156, P1605, DOI 10.1007/s00701-014-2151-4; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Laviv Y, 2014, BRIT J NEUROSURG, V28, P733, DOI 10.3109/02688697.2014.918578; Lee Jong Joo, 2015, Korean J Neurotrauma, V11, P52, DOI 10.13004/kjnt.2015.11.2.52; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Marion DW, 2006, NEUROSURGERY, V58, P655; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Matsuyama T, 1997, SURG NEUROL, V48, P193, DOI 10.1016/S0090-3019(96)00484-3; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Morris NA, 2016, NEUROCRIT CARE, V24, P226, DOI 10.1007/s12028-015-0178-x; Nelson RE, 2015, INFECT CONT HOSP EP, V36, P1089, DOI 10.1017/ice.2015.129; Peng DQ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011402.pub2; Putnam TJ, 1925, ARCH SURG-CHICAGO, V11, P329, DOI 10.1001/archsurg.1925.01120150002001; Regan JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115085; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Shen J, 2013, NEUROL MED-CHIR, V53, P221, DOI 10.2176/nmc.53.221; Shen J, 2013, ACTA NEUROCHIR, V155, P335, DOI 10.1007/s00701-012-1569-9; Shibahashi K, 2017, BRIT J NEUROSURG, V31, P618, DOI 10.1080/02688697.2016.1211251; Son S, 2013, J KOREAN NEUROSURG S, V54, P211, DOI 10.3340/jkns.2013.54.3.211; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stone PW, 2005, AM J INFECT CONTROL, V33, P501, DOI 10.1016/j.ajic.2005.04.246; Weigel R, 2004, BRIT J NEUROSURG, V18, P8, DOI 10.1080/02688690410001660418; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; WILBERGER JE, 1994, J TRAUMA, V36, P826; WONG CW, 1995, ACTA NEUROCHIR, V135, P38, DOI 10.1007/BF02307412	36	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2018	120						E414	E420		10.1016/j.wneu.2018.08.095			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HA9ZO	WOS:000450668300052	30149158				2022-02-06	
J	Gunter, KB; Shields, CJ; Ott, SD; Coronado, RA				Gunter, Kelli B.; Shields, Christopher J.; Ott, Summer D.; Coronado, Rogelio A.			Rehabilitation of an Adolescent Equestrian Athlete With a History of Multiple Concussions: A Case Report Describing an Adapted Return-to-Sport Protocol	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						athletic injuries; concussion; horses; pediatrics; postconcussion syndrome; return to sport	DIAGNOSTIC-ACCURACY; NORMATIVE DATA; HIGH-SCHOOL; INJURY; BALANCE; TESTS; PLAY; RELIABILITY; STATEMENT; ENDURANCE	BACKGROUND: Equestrian riding is a sport with a high risk of concussion. Currently, the literature guiding rehabilitation for concussions in equestrian athletes is limited, especially for directing return to sport. CASE DESCRIPTION: In this case report, a 14-year-old female equestrian athlete presented to physical therapy following her third concussion in 3 years. Her primary complaints were headaches, dizziness, difficulty concentrating, light sensitivity, and neck pain. On examination, the patient demonstrated reproduction of symptoms during testing of the vestibular-ocular reflex, showed a 3-line symptomatic loss on the dynamic visual acuity test, and had impairments in the joint position error test (1/5 correct on the left, 4/5 correct on the right) and a Balance Error Scoring System (BESS) score of 38/60 errors. A return-to-riding protocol was adapted from general return-to-sport guidelines and tailored to meet the unique demands of the patient's equestrian sport. The protocol included phased progression through no activity, light aerobic activity, moderate aerobic activity, sport-specific nonjumping skills, sport-specific jumping skills, full practice, and return to competition. During the protocol, the patient participated in 8 physical therapy sessions over 4 weeks for vestibular training, aerobic conditioning, and cervical and core exercises, as well as equestrian exercises at her stables. OUTCOMES: At the final evaluation, the patient reported no symptoms at rest, with exercise, or when testing vestibular-ocular reflex. Improvements were noted in the dynamic visual acuity test, joint position error, and BESS, with changes in the BESS exceeding minimal detectable change. The patient completed the full return-to-riding protocol in 8 weeks and was able to return to equestrian competition without complaints. DISCUSSION: This case report describes the physical therapy management of an adapted return-to-sport protocol for an equestrian athlete with a history of multiple sport-related concussions.	[Gunter, Kelli B.] C Foster Phys Therapy, 5150 Crenshaw Rd, Pasadena, TX 77505 USA; [Shields, Christopher J.; Ott, Summer D.] Mem Hermann IRONMAN Sports Med Inst, Houston, TX USA; [Ott, Summer D.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Orthoped Surg, Houston, TX 77030 USA; [Coronado, Rogelio A.] Vanderbilt Univ, Med Ctr, Dept Orthopaed Surg & Rehabil, Nashville, TN USA		Gunter, KB (corresponding author), C Foster Phys Therapy, 5150 Crenshaw Rd, Pasadena, TX 77505 USA.	kelli@cfosterrehab.com		Coronado, Rogelio/0000-0002-7112-4903	Rehabilitation Research Career Development Program from the National Institutes of Health (NIH) [K12 HD055929]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055929] Funding Source: NIH RePORTER	Dr Gunter completed this case report during her time as a student physical therapist at the University of Texas Medical Branch. During the time of manuscript development, Dr Coronado was affiliated with the University of Texas Medical Branch and supported by a Rehabilitation Research Career Development Program grant (K12 HD055929) from the National Institutes of Health (NIH). The authors certify that they have no affiliations with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the article.	Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Beynon GJ, 1998, CLIN OTOLARYNGOL, V23, P117; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Edmondston SJ, 2008, J MANIP PHYSIOL THER, V31, P348, DOI 10.1016/j.jmpt.2008.04.010; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hutting N, 2013, PHYS THER, V93, P1686, DOI 10.2522/ptj.20130186; Hutting N, 2013, MANUAL THER, V18, P177, DOI 10.1016/j.math.2012.09.009; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jarman NF, 2017, PM&R, V9, P969, DOI 10.1016/j.pmrj.2017.02.002; Kardouni JR, 2018, J ORTHOP SPORT PHYS, V48, P533, DOI 10.2519/jospt.2018.8053; Kuhl HN, 2014, SPORTS HEALTH, V6, P136, DOI 10.1177/1941738113508073; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lapointe AP, 2018, INT J PSYCHOPHYSIOL, V132, P93, DOI 10.1016/j.ijpsycho.2017.08.003; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; LONGRIDGE NS, 1987, ACTA OTO-LARYNGOL, V103, P273, DOI 10.3109/00016488709107794; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Reneker JC, 2015, BRIT J SPORT MED, V49, P491, DOI 10.1136/bjsports-2014-093634; Rine RM, 2003, INT J PEDIATR OTORHI, V67, P1195, DOI 10.1016/j.ijporl.2003.07.004; Ruchinskas R A, 1997, Appl Neuropsychol, V4, P43, DOI 10.1207/s15324826an0401_5; Schneider KJ, 2016, J ORTHOP SPORT PHYS, V46, P613, DOI 10.2519/jospt.2016.0607; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; SCHNEIDER KJ, 2017, BRIT J SPORT MED, V51; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Srinivasan V, 2014, NEUROL RES, V36, P873, DOI 10.1179/1743132814Y.0000000373; Stewart GW, 2012, INT J SPORTS PHYS TH, V7, P433; Thomas LC, 2011, MANUAL THER, V16, P351, DOI 10.1016/j.math.2010.12.008; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Zuckerman SL, 2015, WORLD NEUROSURG, V83, P1098, DOI 10.1016/j.wneu.2014.12.030; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	50	4	4	0	11	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	DEC	2018	48	12					934	942		10.2519/jospt.2018.8214			9	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	HC4JF	WOS:000451768700005	30053793	Green Accepted			2022-02-06	
J	Hecimovich, M; King, D; Dempsey, A; Gittins, M; Murphy, M				Hecimovich, Mark; King, Doug; Dempsey, Alasdair; Gittins, Mason; Murphy, Myles			Youth Australian Footballers Experience Similar Impact Forces to the Head as Junior- and Senior-League Players: A Prospective Study of Kinematic Measurements	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Australian Football; sports related concussion; bio-mechanics; head impacts	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; CONCUSSION; BIOMECHANICS; ACCELERATION; EXPOSURE; CHILDREN	The aims of this study were to investigate the frequency, magnitude, and distribution of head impacts sustained by youth AF players over a season of games and report subjective descriptions on the mechanism-of-injury and sign and symptoms experienced. A prospective observational cohort study with participants (n = 19) (age range 13-14 yr., mean +/- SD 13.9 +/- 0.3 yr.) wearing a wireless impact measuring device behind their right ear over the mastoid process prior to game participation. Participants completed an individual post-game logbook providing feedback responses on recalling having a direct hit to their head with another player or the surface. Players experienced a mean (SD) of 5 (+/- 4) impacts per-player per-game. The peak linear rotation (PLA) median, (95th percentiles) were 15.2g (45.8g). The median (95th percentile) peak rotational acceleration (PRA) were 183,117 deg/s(2) (594,272 deg/s(2)). Median (95th percentile) Head Impact Telemetry Severity profile were 15.1 (46.1) and Risk Weighted Exposure Combined Probability were 0.0012 (0.7062). Twelve participants reported sustaining a head impact. Players reporting a head impact had a faster mean impact duration (t((25)) = 2.4; p = 0.0025) and had a lower median PLA(g) (F-(23,F-2) = 845.5; p = 0.0012) than those who did not report a head impact. These results show similar measurements to the older junior- (aged 17-19) and senior-league (20+) players. Furthermore, players who reported sustaining a direct or indirect impact during games had similar measurements to those who did not, thus highlighting the difficulty of concussion recognition, at least with youth. Future research may need to establish the relationship between concussion-like symptoms in the absence of an impact and in relation to concussion evaluation assessments such as the King-Devick and SCAT5.	[Hecimovich, Mark] Univ Northern Iowa, Div Athlet Training, Cedar Falls, IA USA; [Hecimovich, Mark; King, Doug; Dempsey, Alasdair; Gittins, Mason] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia; [King, Doug] Univ New England, Dept Sci & Technol, Sydney, NSW, Australia; [Murphy, Myles] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA, Australia; [Murphy, Myles] St John God Hlth Care, SportsMed Subiaco, Subiaco, WA, Australia; [Murphy, Myles] Western Australian Cricket Assoc, Sports Sci Sports Med Dept, East Perth, WA, Australia		Hecimovich, M (corresponding author), Univ Northern Iowa, Human Performance Ctr 003C, Div Athlet Training, Cedar Falls, IA 50614 USA.	mark.hecimovich@uni.edu; dking30@une.edu.au; a.dempsey@murdoch.edu.au; m.gittins@murdoch.edu.au; myles.murphy1@my.nd.edu.au	Murphy, Myles/Q-8313-2017; Dempsey, Alasdair/A-7098-2008	Murphy, Myles/0000-0001-6068-1096; Dempsey, Alasdair/0000-0001-8219-6120			Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco J, 2010, J ATHL TRAINING, V45, P459; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Eckner JT, 2018, AM J SPORT MED, V46, P2253, DOI 10.1177/0363546518777244; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Hecimovich M., 2018, J SPORTS MED, V2018; Hecimovich M., 2016, SPORT J; Hecimovich MD, 2017, J PAEDIATR CHILD H, V53, P246, DOI 10.1111/jpc.13405; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hrysomallis C., 2006, WEIGHT TRAINING AUST; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Orchard J, 1998, J Sci Med Sport, V1, P83, DOI 10.1016/S1440-2440(98)80016-9; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Siegmund GP, 2015, INT IRCOBI C BIOM IN, P182; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Vopat LM, 2015, IOC MANUAL OF EMERGENCY SPORTS MEDICINE, P205; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	48	4	4	0	8	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	DEC	2018	17	4					547	556					10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HA9SG	WOS:000450645700005	30479522				2022-02-06	
J	Jang, SH; Kim, SH; Lee, HD				Jang, Sung Ho; Kim, Seong Ho; Lee, Han Do			Relation Between Memory Impairment and the Fornix Injury in Patients With Mild Traumatic Brain Injury: A Diffusion Tensor Tractography Study	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Diffusion Tensor Tractography; Fornix; Memory; Mild Traumatic Brain Injury	TEMPORAL-LOBE; AXONAL INJURY; DYSFUNCTION; TRACT; TIME	Objective We investigated the relation between memory impairment and the fornix injury in patients with mild traumatic brain injury, using diffusion tensor tractography. Design Eighty-six chronic patients with mild traumatic brain injury and 50 normal control subjects were recruited. Fractional anisotropy and fiber volume were measured for each reconstructed fornix. The patients were classified according to the following three types: type A (47 patients), intact integrity of both fornical crura; type B (27 patients), showed a discontinuation in either fornical crus; and type C (12 patients), discontinuations in both fornical crura. The Memory Assessment Scale was used for evaluation of memory function. Results Fractional anisotropy and fiber volume showed weak positive correlations with global memory of Memory Assessment Scale, respectively (r = 0.303, P = 0.006; r = 0.271, P = 0.014). Significant difference in the global memory of Memory Assessment Scale was observed between type A and B and between type A and C without difference between type B and C (P < 0.05). Conclusion It seems that the diffusion tensor tractography parameters of the fornix and the integrity of fornical crus can be used as a biomarker for axonal injury of the fornix in patients with mild traumatic brain injury.	[Jang, Sung Ho; Lee, Han Do] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea; [Kim, Seong Ho] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu, South Korea		Lee, HD (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.				DGIST R&D Program of the Ministry of Science, ICT, and Future Planning [18-BD-0401]	This work was supported by the DGIST R&D Program of the Ministry of Science, ICT, and Future Planning (18-BD-0401).	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alhilali LM, 2017, AM J NEURORADIOL, V38, P691, DOI 10.3174/ajnr.A5073; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Concha L, 2005, AM J NEURORADIOL, V26, P2267; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Flynn Frederick G, 2010, Continuum (Minneap Minn), V16, P79, DOI 10.1212/01.CON.0000391454.15052.e4; Hong JH, 2010, EUR NEUROL, V63, P252, DOI 10.1159/000277477; Jang SH, 2017, BRAIN INJURY, V31, P1530, DOI 10.1080/02699052.2017.1350997; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE14, DOI 10.1097/PHM.0000000000000390; Jang SH, 2015, AM J PHYS MED REHAB, V94, pE86, DOI 10.1097/PHM.0000000000000317; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee HD, 2014, BRAIN INJURY, V28, P1485, DOI 10.3109/02699052.2014.930178; Lee SK, 2005, RADIOGRAPHICS, V25, P68; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Loring DW, 2000, J CLIN PSYCHOL, V56, P563, DOI 10.1002/(SICI)1097-4679(200004)56:4<563::AID-JCLP9>3.0.CO;2-K; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TUCKER DM, 1988, CORTEX, V24, P465, DOI 10.1016/S0010-9452(88)80010-8; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Williams JM., 1991, MAS MEMORY ASSESSMEN; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x	31	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	2018	97	12					892	896		10.1097/PHM.0000000000000996			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HA6ZJ	WOS:000450430000009	29994793				2022-02-06	
J	Khalenkow, D; Donche, S; Braeckman, K; Vanhove, C; Skirtach, AG				Khalenkow, Dmitry; Donche, Sam; Braeckman, Kim; Vanhove, Christian; Skirtach, Andre G.			Added Value of Microscale Raman Chemical Analysis in Mild Traumatic Brain Injury (TBI): A Comparison with Macroscale MRI	ACS OMEGA			English	Article							LESIONS	Diffuse axonal injury and microhemorrhages, common complications after mild traumatic brain injury (mTBI), can lead to neurodegeneration and disability and have negative socioeconomic consequences. Magnetic resonance imaging (MRI) is conventionally used to study brain injuries in vivo, but microscale damage common in mTBI is challenging to detect. Raman microscopy is an effective diagnostic tool to investigate cells and tissue in a label-free manner, but the scanning mode of Raman microscopy is typically used only in vitro. Here, we show that Raman microscopy complements in vivo MRI, providing the vital information on the structural and molecular changes caused by mTBI in rats. We demonstrate that a method based on Raman microscopy allows us to detect structural damage invisible by conventional MRI and spot molecular changes in protein/lipid concentrations caused by mild TBI.	[Khalenkow, Dmitry; Donche, Sam] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Donche, Sam; Braeckman, Kim; Vanhove, Christian; Skirtach, Andre G.] Univ Ghent, Fac Engn & Architecture, INFINITY Lab, B-9000 Ghent, Belgium; [Donche, Sam] Univ Ghent, Fac Med, B-9000 Ghent, Belgium		Khalenkow, D (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium.; Skirtach, AG (corresponding author), Univ Ghent, Fac Engn & Architecture, INFINITY Lab, B-9000 Ghent, Belgium.	Dmitry.Khalenkow@UGent.be; Andre.Skirtach@UGent.be	Skirtach, Andre G/K-8152-2015	Skirtach, Andre G/0000-0002-4468-7620; Vanhove, Christian/0000-0002-3988-5980; Donche, Sam/0000-0002-5688-6539	Special Research Fund (BOF) of Ghent UniversityGhent University [24J201400010]	This research is supported by the Special Research Fund (BOF) of Ghent University (24J201400010).	Abalde-Cela S, 2010, J R SOC INTERFACE, V7, pS435, DOI 10.1098/rsif.2010.0125.focus; Baker MJ, 2016, FARADAY DISCUSS, V187, P299, DOI 10.1039/C6FD90012G; Beleites C. S. V., 2013, HYPERSPEC PACKAGE HA; Bratashov DN, 2011, J RAMAN SPECTROSC, V42, P1901, DOI 10.1002/jrs.2938; CDC, 2010, INJ PREV CONTR TRAUM; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Diem M, 2013, J BIOPHOTONICS, V6, P855, DOI 10.1002/jbio.201300131; Eilers P.H., 2005, BASELINE CORRECTION; Fateixa S, 2018, ACS OMEGA, V3, P4331, DOI 10.1021/acsomega.7b01983; Gibb S, 2012, BIOINFORMATICS, V28, P2270, DOI 10.1093/bioinformatics/bts447; Jermyn M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2384; Kneipp J, 2008, CHEM SOC REV, V37, P1052, DOI 10.1039/b708459p; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; Ko H, 2008, SMALL, V4, P1980, DOI 10.1002/smll.200800301; Krafft C, 2015, ANAL BIOANAL CHEM, V407, P699, DOI 10.1007/s00216-014-8311-9; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Matthaus C, 2007, BIOPHYS J, V93, P668, DOI 10.1529/biophysj.106.102061; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morisaki S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.116011; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Surmacki JM, 2017, ANALYST, V142, P132, DOI 10.1039/c6an02238c; Tax CMW, 2017, MED IMAGE ANAL, V39, P162, DOI 10.1016/j.media.2017.03.007; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Thurman DJ, 2001, HEAD TRAUMA, P327; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Vistain LF, 2016, CHEM COMMUN, V52, P160, DOI 10.1039/c5cc06565h; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yashchenok A, 2013, SMALL, V9, P351, DOI 10.1002/smll.201201494; Yashchenok AM, 2012, ANN PHYS-BERLIN, V524, P723, DOI 10.1002/andp.201200158	33	4	4	2	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2470-1343			ACS OMEGA	ACS Omega	DEC	2018	3	12					16806	16811		10.1021/acsomega.8b02404			6	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	HF5AJ	WOS:000454244600047		Green Published, gold			2022-02-06	
J	Lazarus, R; Helmick, K; Malik, S; Gregory, E; Agimi, Y; Marion, D				Lazarus, Rachel; Helmick, Katherine; Malik, Saafan; Gregory, Emma; Agimi, Yil; Marion, Donald			Continuum of the United States military's traumatic brain injury care: adjusting to the changing battlefield	NEUROSURGICAL FOCUS			English	Article						Military Health System; Department of Defense; traumatic brain injury; service member; levels of care	HEMORRHAGE	Over the past 8 years, advances in the US Military Health System (MHS) have led to extensive changes in the way combat casualty care is provided to deployed service members with a traumatic brain injury (TBI). Changes include the application of cutting-edge Clinical Practice Guidelines, use of pioneering technologies, and advances in evacuation procedures. Compared with previous engagements, current operations occur on a much smaller scale, and more frequently in austere environments, such that effective medical support is increasingly challenging. In this paper, the authors describe key aspects of the current continuum of TB! care in the US military, from the point of injury through rehabilitation, with an emphasis on how emerging technologies and evidence-based Clinical Practice Guidelines assist MHS clinicians with providing the best clinical care possible in the changing battlefield.	[Lazarus, Rachel; Helmick, Katherine; Malik, Saafan; Gregory, Emma; Agimi, Yil; Marion, Donald] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Lazarus, Rachel; Marion, Donald] Gen Dynam Hlth Solut, Fairfax, VA USA; [Agimi, Yil] Salient CRGT, Fairfax, VA USA		Lazarus, R (corresponding author), Def & Vet Brain Injury Ctr, Res Div, Silver Spring, MD 20910 USA.	rachel.c.lazarus.ctr@mail.mil					[Anonymous], NON TRADITIONAL REF; Bell R, 2017, ID30 CPG DEP DEF CTR; Bell R, 2018, ID68 CPG DEP DEF CTR; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Butler Frank K, 2014, J Spec Oper Med, V14, P13; Cap A, 2018, ID21 CPG DEP DEF CTR; Cubano MA., 2013, EMERGENCY WAR SURG, V4th ed.; Ingalls N, 2014, JAMA SURG, V149, P807, DOI 10.1001/jamasurg.2014.621; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kotwal RS, 2017, WILD ENVIRON MED, V28, pS33, DOI 10.1016/j.wem.2016.11.007; Manley JD., 2017, J SPEC OPER MED, V17, P1; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Young W, 1988, J Neurotrauma, V5, P219, DOI 10.1089/neu.1988.5.219	13	4	4	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2018	45	6							E15	10.3171/2018.9.FOCUS18396			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HD6HR	WOS:000452637400015	30544329	gold			2022-02-06	
J	Lehner, M; Hoffmann, F; Kammer, B; Heinrich, M; Falkenthal, L; Wendling-Keim, D; Kurz, M				Lehner, M.; Hoffmann, F.; Kammer, B.; Heinrich, M.; Falkenthal, L.; Wendling-Keim, D.; Kurz, M.			Reduction of treatment time for children in the trauma room care. Impact of implementation of an interdisciplinary trauma room concept (iTRAP(S))	ANAESTHESIST			German	Article						Trauma room management; Pediatric major trauma; Pediatric emergency management; Pediatric emergencies; Seriously injured patients	BODY COMPUTED-TOMOGRAPHY; MANAGEMENT; SUPPORT; INJURY; ATLS	IntroductionIn addition to infrastructural and conceptual planning, smooth interdisciplinary cooperation is crucial for trauma room care of severely injured children based on time-saving management and aclear set of priorities. The time to computed tomography (CT) is awell-accepted marker for the efficacy of trauma management. Up to now there are no guidelines in the literature for an adapted approach in pediatric trauma room care.MethodsAstep-by-step algorithm for pediatric trauma room care (Interdisciplinary Trauma Room Algorithm in Pediatric Surgery, iTRAP(S)) was developed within the framework of an interdisciplinary team: pediatric surgeons, pediatric anaethesiologists, pediatric intensivists and pediatric radiologists. In two groups of patients from January 2014 to April 2015 (group 1) and from July 2015 to January 2017 (group 2) process quality was monitored by the time required for trauma room treatment until the CT scan was performed and used as asurrogate marker. Inclusion criteria were patients aged 0-16years, who were evaluated in a level 1 pediatric trauma room with an injury severity score (ISS) 8 and the necessity for aCT scan.ResultsBefore (group1) and after (group2) implementation of iTRAP(S) 16patients were included in each group. There were no significant differences between the age and the ISS in the two groups of patients. The required time for trauma room treatment was significantly reduced from an average of 33.6min before to 15.2min after implementation of iTRAP(S) (p<0.01).DiscussionThe required time for the trauma care room treatment could be significantly reduced by more than half after the implementation of iTRAP(S). The reasons were the interdisciplinary organization of the trauma room leadership, reorganization of patient transfer and improved briefing by emergency doctors.ConclusionBesides awell-organized trauma team, it is essential that the trauma room workflow is adapted to the specific structure of the hospital. Despite the limitations of the study the data demonstrate that the trauma room workflow enables an efficient management. By the interdisciplinary reorganization of the pediatric trauma room treatment with improved structures and standardized processes, patient care was more effective with asignificant reduction in the time required for trauma room treatment. The suggested iTRAP(S) concept could be used as aframework to establish individualized workflows for pediatric trauma room treatment in other hospitals. This algorithm should be supplemented by standardized operating procedures (SOPs) for the differentiated radiological diagnostic procedures in areas of traumatic brain injury (TBI), thoracic and abdominal trauma in children.	[Lehner, M.; Heinrich, M.; Falkenthal, L.; Wendling-Keim, D.] Ludwig Maximilians Univ Munchen, Dr von Haunersches Kinderspital, Klin Kinderchirurg, Munich, Germany; [Hoffmann, F.] Ludwig Maximilians Univ Munchen, Kinderklin & Kinderpoliklin, Dr von Haunersches Kinderspital, Kinderintens Stn, Munich, Germany; [Kammer, B.] Ludwig Maximilians Univ Munchen, Kinderradiol Klin & Poliklin Radiol, Dr von Haunersches Kinderspital, Munich, Germany; [Kurz, M.] Ludwig Maximilians Univ Munchen, Klin Anaesthesiol, Munich, Germany; [Lehner, M.] Luzerner Kantonsspital, Kinderspital, Kinderchirurg Klin, Spitalstr 20, CH-6000 Luzern, Switzerland		Lehner, M (corresponding author), Luzerner Kantonsspital, Kinderspital, Kinderchirurg Klin, Spitalstr 20, CH-6000 Luzern, Switzerland.	markus.lehner@luks.ch	Lehner, Markus/B-9955-2019	Lehner, Markus/0000-0002-8176-8067			Appenteng R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201550; Ben-Abraham R, 2000, ISRAEL MED ASSOC J, V2, P513; Bernhard M, 2007, RESUSCITATION, V73, P362, DOI 10.1016/j.resuscitation.2006.09.014; Bouillon B, 2013, CHIRURG, V84, P745, DOI 10.1007/s00104-013-2476-1; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Brown JB, 2017, J TRAUMA ACUTE CARE, V82, P995, DOI 10.1097/TA.0000000000001440; Carter EA, 2013, RESUSCITATION, V84, P66, DOI 10.1016/j.resuscitation.2011.10.032; Chidambaram S, 2017, INJURY, V48, P1784, DOI 10.1016/j.injury.2017.06.003; Chin K, 2016, INSTR COURSE LECT, V65, P345; Cronlein M, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1337-8; Ellsassr G, 2014, BUNDESGESUNDHEITSBLA, V57, P681, DOI 10.1007/s00103-014-1971-y; Franzen Lena, 2003, Eur J Surg Suppl, P3; Fritzsche K, 2013, ANASTH INTENSIV NOTF, V48, P406, DOI 10.1055/s-0033-1349006; Furugori S, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0176-3; Huber-Wagner S, 2018, CURR OPIN CRIT CARE, V24, P55, DOI 10.1097/MCC.0000000000000474; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Johansson J, 2012, RESUSCITATION, V83, P1259, DOI 10.1016/j.resuscitation.2012.02.018; Kanz Karl-Georg, 2010, J Trauma Manag Outcomes, V4, P4, DOI 10.1186/1752-2897-4-4; Keil J, 2015, MONATSSCHR KINDERH, V163, P575, DOI 10.1007/s00112-015-3334-7; Kinoshita T, 2019, ANN SURG, V269, P370, DOI 10.1097/SLA.0000000000002527; Kinoshita T, 2018, WORLD NEUROSURG, V118, pE792, DOI 10.1016/j.wneu.2018.07.053; Koller M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1468-5; Lehner M, 2018, NOTFALL RETTUNGSMED, V21, P90, DOI 10.1007/s10049-017-0385-4; Sanddal TL, 2011, J TRAUMA, V70, P970, DOI 10.1097/TA.0b013e3181fec9ba; Soni KD, 2017, BURNS TRAUMA, V5, DOI 10.1186/s41038-017-0087-7; Stahel PF, 2005, ORTHOPADE, V34, P823, DOI 10.1007/s00132-005-0842-5; Vasilyeva IV, 2013, STUD HEALTH TECHNOL, V190, P59, DOI 10.3233/978-1-61499-276-9-59; Wieck MM, 2018, J TRAUMA ACUTE CARE, V85, P659, DOI 10.1097/TA.0000000000001908; Yousefzadeh-Chabok S, 2016, ULUS TRAVMA ACIL CER, V22, P328, DOI 10.5505/tjtes.2015.83930	29	4	4	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	DEC	2018	67	12					914	921		10.1007/s00101-018-0500-z			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	HD8AK	WOS:000452776000005	30361932				2022-02-06	
J	McKinley, TO; Lei, ZG; Kalbas, Y; White, FA; Shi, ZS; Wu, F; Xu, ZC; Rodgers, RB				McKinley, Todd O.; Lei, Zhigang; Kalbas, Yannik; White, Fletcher A.; Shi, Zhongshan; Wu, Fan; Xu, Zao C.; Rodgers, Richard B.			Blood purification by nonselective hemoadsorption prevents death after traumatic brain injury and hemorrhagic shock in rats	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Military Health System Research Symposium	AUG 27-30, 2017	Orlando, FL			Hemoadsorption; traumatic brain injury; hemorrhagic shock; cytokines; multiple injuries	SHORT-TERM SURVIVAL; ACUTE LUNG INJURY; CYTOKINE REMOVAL; NEUROINFLAMMATORY RESPONSES; INTRACRANIAL-PRESSURE; SECONDARY INSULTS; SERUM BIOMARKERS; HEAD-INJURY; MRC CRASH; IN-VIVO	BACKGROUND: Patients who sustain traumatic brain injury (TBI) and concomitant hemorrhagic shock (HS) are at high risk of high-magnitude inflammation which can lead to poor outcomes and death. Blood purification by hemoadsorption (HA) offers an alternative intervention to reduce inflammation after injury. We tested the hypothesis that HA would reduce mortality in a rat model of TBI and HS. METHODS: Male Sprague Dawley rats were subjected to a combined injury of a controlled cortical impact to their brain and pressure-controlled HS. Animals were subsequently instrumented with an extracorporeal blood circuit that passed through a cartridge for sham or experimental treatment. In experimental animals, the treatment cartridge was filled with proprietary beads (Cytosorbents, Monmouth Junction, NJ) that removed circulating molecules between 5 kDa and 60 kDa. Sham rats had equivalent circulation but no blood purification. Serial blood samples were analyzed with multiplex technology to quantify changes in a trauma-relevant panel of immunologic mediators. The primary outcome was survival to 96 hours postinjury. RESULTS: Hemoadsorption improved survival from 47% in sham-treated rats to 86% in HA-treated rats. There were no treatment-related changes in histologic appearance. Hemoadsorption affected biomarker concentrations both during the treatment and over the ensuing 4 days after injury. Distinct changes in biomarker concentrations were also measured in survivor and nonsurvivor rats from the entire cohort of rats indicating biomarker patterns associated with survival and death after injury. CONCLUSION: Blood purification by nonselective HA is an effective intervention to prevent death in a combined TBI/HS rat model. Hemoadsorption changed circulating concentrations of multiple inmmunologically active mediators during the treatment time frame and after treatment. Hemoadsorption has been safely implemented in human patients with sepsis and may be a treatment option after injury. (Copyright (C) 2018 Wolters Kluwer Health, Inc. CAll rights reserved.)	[McKinley, Todd O.] Indiana Univ Sch Med, Dept Orthopaed Surg, IU Hlth Methodist Hosp, Suite 535 MPC 1, Indianapolis, IN 46202 USA; [McKinley, Todd O.] Indiana Univ Sch Med, Dept Anat, IU Hlth Methodist Hosp, Suite 535 MPC 1, Indianapolis, IN 46202 USA; [McKinley, Todd O.] Indiana Univ Sch Med, Dept Cell Biol, IU Hlth Methodist Hosp, Suite 535 MPC 1, Indianapolis, IN 46202 USA; [Lei, Zhigang; Xu, Zao C.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Kalbas, Yannik] Univ Spital Zurich, Zurich, Switzerland; [White, Fletcher A.] Indiana Univ Sch Med, Dept Anesthesiol, Indianapolis, IN 46202 USA; [Shi, Zhongshan] Jinan Univ, GHM Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China; [Wu, Fan] Guangzhou Med Univ, Dept Pediat, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Rodgers, Richard B.] Indiana Univ Sch Med, Dept Neurosurg, Indianapolis, IN 46202 USA		McKinley, TO (corresponding author), Indiana Univ Sch Med, Dept Orthopaed Surg, IU Hlth Methodist Hosp, Suite 535 MPC 1, Indianapolis, IN 46202 USA.; McKinley, TO (corresponding author), Indiana Univ Sch Med, Dept Anat, IU Hlth Methodist Hosp, Suite 535 MPC 1, Indianapolis, IN 46202 USA.; McKinley, TO (corresponding author), Indiana Univ Sch Med, Dept Cell Biol, IU Hlth Methodist Hosp, Suite 535 MPC 1, Indianapolis, IN 46202 USA.	tmckinley@iuhealth.org	; White, Fletcher/F-3203-2015	Shi, Zhongshan/0000-0002-5802-7332; White, Fletcher/0000-0002-8408-9262	Indiana University Clinical and Translational Sciences Institute, Indianapolis, IN; Veterans AffairsUS Department of Veterans Affairs [I01BX002209] Funding Source: NIH RePORTER	This study was funded by the Indiana University Clinical and Translational Sciences Institute, Indianapolis, IN.	Abboud A, 2016, CRIT CARE MED, V44, pE1074, DOI 10.1097/CCM.0000000000001951; Abdul-Malak O, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7950374; Almahmoud K, 2015, SHOCK, V44, P101, DOI 10.1097/SHK.0000000000000395; An G, 2012, ANN BIOMED ENG, V40, P2414, DOI 10.1007/s10439-012-0565-9; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Bernardi MH, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1270-0; Bonds BW, 2015, J TRAUMA ACUTE CARE, V79, P85, DOI 10.1097/TA.0000000000000698; Bruenger F, 2015, INT J ARTIF ORGANS, V38, P113, DOI 10.5301/ijao.5000382; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Didar TF, 2015, BIOMATERIALS, V67, P382, DOI 10.1016/j.biomaterials.2015.07.046; Edwards P, 2005, LANCET, V365, P1957; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kellum JA, 2004, CRIT CARE MED, V32, P801, DOI 10.1097/01.CCM.0000114997.39857.69; Kogelmann K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1662-9; Lee K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/207247; Lo TYM, 2010, J NEUROTRAUM, V27, P2139, DOI 10.1089/neu.2010.1387; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Namas RA, 2016, J CRIT CARE, V36, P146, DOI 10.1016/j.jcrc.2016.07.002; Namas RA, 2016, ANN SURG, V263, P191, DOI 10.1097/SLA.0000000000001001; Namas RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067419; Namas RA, 2012, MOL MED, V18, P1366, DOI 10.2119/molmed.2012.00106; Peng ZY, 2008, CRIT CARE MED, V36, P1573, DOI 10.1097/CCM.0b013e318170b9a7; Rimmele T, 2013, CRIT CARE, V17, DOI 10.1186/cc12587; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sauaia A, 2017, CRIT CARE CLIN, V33, P167, DOI 10.1016/j.ccc.2016.08.006; Schimunek L, 2018, SHOCK, V49, P259, DOI 10.1097/SHK.0000000000000987; Spruijt NE, 2010, CRIT CARE, V14, DOI 10.1186/cc9218; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tomescu DR, 2016, INT J ARTIF ORGANS, V39, P136, DOI 10.5301/ijao.5000489; Trager K, 2016, INT J ARTIF ORGANS, V39, P141, DOI 10.5301/ijao.5000492; Vodovotz Y, 2010, IMMUNOPHARM IMMUNOT, V32, P181, DOI 10.3109/08923970903369867; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zhang JC, 2015, BLOOD PURIFICAT, V39, P239, DOI 10.1159/000381006	45	4	4	2	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2018	85	6					1063	1071		10.1097/TA.0000000000002069			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	HB9CD	WOS:000451388100006	30211852	Green Submitted			2022-02-06	
J	Duarte, KCN; Soares, TT; Magri, AMP; Garcia, LA; Le Sueur-Maluf, L; Renno, ACM; de Castro, GM				Nunes Duarte, Katherine Chuere; Soares, Thais Torres; Paiva Magri, Angela Maria; Garcia, Livia Assis; Le Sueur-Maluf, Luciana; Muniz Renno, Ana Claudia; de Castro, Glaucia Monteiro			Low-level laser therapy modulates demyelination in mice	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; MOUSE MODEL; MICROGLIAL ACTIVATION; CUPRIZONE MODEL; PHOTOBIOMODULATION THERAPY; TOXIC DEMYELINATION; BEHAVIORAL-CHANGES; CNS REMYELINATION	There are no effective therapies for remyelination. Low-level laser therapy (LLLT) has been found advantageous in neurogenesis promotion, cell death prevention, and modulation of inflammation in central and peripheral nervous system models. The purpose of this study was to analyse LLLT effects on cuprizone-induced demyelination. Mice were randomly distributed into three groups: Control Laser (CTL), Cuprizone (CPZ), and Cuprizone Laser (CPZL). Mice from CPZ and CPZL groups were exposed to a 0.2% cuprizone oral diet for four complete weeks. Six sessions of transcranial laser irradiation were applied on three consecutive days, during the third and fourth weeks, with parameters of 36 J/cm(2), 50 mW, 0.028 cm(2) spot area, continuous wave, 1 J, 20 s, 1.78 W/cm(2) in a single point equidistant between the eyes and ears of CTL and CPZL mice. Motor coordination was assessed by the rotarod test. Twenty-four hours after the last laser session, all animals were euthanized, and brains were extracted. Serum was obtained for lactate dehydrogenase toxicity testing. Histomorphological analyses consisted of Luxol Fast Blue staining and immunohistochemistry. The results showed that laser-treated animals presented motor performance improvement, attenuation of demyelination, increased number of oligodendrocyte precursor cells, modulated microglial and astrocytes activation, and a milder toxicity by cuprizone. Although further studies are required, it is suggested that LLLT represents a feasible therapy for demyelinating diseases.	[Nunes Duarte, Katherine Chuere; Soares, Thais Torres; Paiva Magri, Angela Maria; Garcia, Livia Assis; Le Sueur-Maluf, Luciana; Muniz Renno, Ana Claudia; de Castro, Glaucia Monteiro] Univ Fed Sao Paulo, UNIFESP, Programa Interdisciplinar Ciencias Saude, Av Ana Costa 95, BR-11060001 Santos, SP, Brazil; [Nunes Duarte, Katherine Chuere; Soares, Thais Torres; Paiva Magri, Angela Maria; Garcia, Livia Assis; Le Sueur-Maluf, Luciana; Muniz Renno, Ana Claudia; de Castro, Glaucia Monteiro] Univ Fed Sao Paulo, UNIFESP, Dept Biociencias, Rua Silva Jardim 136, BR-11015020 Santos, SP, Brazil; [Muniz Renno, Ana Claudia] Univ Fed Sao Paulo, UNIFESP, Programa Bioprod & Bioproc, Av Ana Costa 95, BR-11060001 Santos, SP, Brazil		de Castro, GM (corresponding author), Rua Silva Jardim 136,Sala 323, BR-11015020 Santos, SP, Brazil.	glaucia.castro@unifesp.br	Assis, Livia/H-8299-2012; de Castro, Glaucia Monteiro/G-6846-2019; Duarte, Katherine Chuere Nunes/AAO-1909-2021; Magri, Angela Maria Paiva/J-9323-2016; Le Sueur-Maluf, Luciana/Q-5311-2016	Assis, Livia/0000-0002-8343-3375; de Castro, Glaucia Monteiro/0000-0003-1474-1902; Duarte, Katherine Chuere Nunes/0000-0002-4488-5678; Magri, Angela Maria Paiva/0000-0001-5901-7227; Le Sueur-Maluf, Luciana/0000-0002-7274-459X	National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordination for the Improvement of Higher Education Personnel (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Sao Paulo Research Foundation, Sao Paulo, Brazil (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA) [2007/07828-3]	This work was funded by the National Council for Scientific and Technological Development (CNPq), Coordination for the Improvement of Higher Education Personnel (CAPES) and Sao Paulo Research Foundation, Sao Paulo, Brazil (FAPESP- 2007/07828-3).	Acs P, 2013, J NEUROIMMUNOL, V262, P128, DOI 10.1016/j.jneuroim.2013.06.012; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Ando T, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.098002; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Benardais K, 2013, NEUROTOX RES, V24, P244, DOI 10.1007/s12640-013-9380-9; Benetti F, 2010, NEUROTOXICOLOGY, V31, P509, DOI 10.1016/j.neuro.2010.05.008; Blackwell ML, 2009, NEUROIMAGE, V46, P382, DOI 10.1016/j.neuroimage.2009.01.030; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P73, DOI 10.1016/0022-510X(73)90119-6; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Bramow S, 2010, BRAIN, V133, P2983, DOI 10.1093/brain/awq250; Brosnan CF, 2013, GLIA, V61, P453, DOI 10.1002/glia.22443; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; CARLTON WILLIAM W., 1967, LIFE SCI, V6, P11, DOI 10.1016/0024-3205(67)90356-6; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Clarner T, 2015, J IMMUNOL, V194, P3400, DOI 10.4049/jimmunol.1401459; Doan V, 2013, J NEUROSCI RES, V91, P363, DOI 10.1002/jnr.23174; El Massri N, 2016, EXP BRAIN RES, V234, P3225, DOI 10.1007/s00221-016-4720-7; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Falangola MF, 2014, NMR BIOMED, V27, P948, DOI 10.1002/nbm.3140; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2017, NAT REV NEUROSCI, V18, P753, DOI 10.1038/nrn.2017.136; Franklin RJM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020594; Gigo-Benato D, 2010, LASER SURG MED, V42, P673, DOI 10.1002/lsm.20978; Goldmann T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/208093; Goncalves ED, 2016, AUTOIMMUNITY, V49, P132, DOI 10.3109/08916934.2015.1124425; Groebe A, 2009, CEREBELLUM, V8, P163, DOI 10.1007/s12311-009-0099-3; Hagemeyer N, 2012, MOL MED, V18, P628, DOI 10.2119/molmed.2011.00457; Hibbits N, 2012, ASN NEURO, V4, DOI 10.1042/AN20120062; Hibbits N, 2009, ASN NEURO, V1, DOI 10.1042/AN20090032; Holanda VM, 2017, LASER SURG MED, V49, P516, DOI 10.1002/lsm.22628; Hossain S, 2009, NEUROTOXICOLOGY, V30, P544, DOI 10.1016/j.neuro.2009.06.001; Hu JG, 2012, INT J MOL MED, V30, P1113, DOI 10.3892/ijmm.2012.1110; Huang YY, 2013, J BIOPHOTONICS, V6, P829, DOI 10.1002/jbio.201200157; Hwang KH, 2017, J DIGIT IMAGING, V30, P4, DOI 10.1007/s10278-016-9916-7; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Janowska J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020331; Jenkins PA, 2011, PHOTOMED LASER SURG, V29, P785, DOI 10.1089/pho.2011.9895; Kajagar B. M., 2018, J PHOTOCH PHOTOBIO B, V189, P55; Kajagar BM, 2012, INDIAN J SURG, V74, P359, DOI 10.1007/s12262-011-0393-4; KARU TI, 2004, PHOTOCHEM PHOTOBIOL, V3, P211, DOI DOI 10.1039/B306126D; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Koutsoudaki PN, 2009, NEUROSCI LETT, V451, P83, DOI 10.1016/j.neulet.2008.11.058; Krauthausen M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-109; Li ZF, 2015, NEUROSCI BULL, V31, P617, DOI 10.1007/s12264-015-1555-3; Lindner M, 2009, NEUROSCI LETT, V453, P120, DOI 10.1016/j.neulet.2009.02.004; Loers G, 2004, MOL CELL NEUROSCI, V27, P175, DOI 10.1016/j.mcn.2004.06.006; Losy J, 2013, J NEURAL TRANSM, V120, P1459, DOI 10.1007/s00702-013-1079-9; Lu YJ, 2017, NEUROBIOL AGING, V49, P165, DOI 10.1016/j.neurobiolaging.2016.10.003; Luan Q, 2014, INDIAN J DERMATOL VE, V80, DOI 10.4103/0378-6323.129436; Magalon K, 2012, ANN NEUROL, V71, P213, DOI 10.1002/ana.22593; Mason JL, 2000, J NEUROSCI RES, V61, P251, DOI 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W; Ziago EKM, 2017, LASER MED SCI, V32, P369, DOI 10.1007/s10103-016-2126-1; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Meijer DH, 2012, NAT REV NEUROSCI, V13, P819, DOI 10.1038/nrn3386; Meng CB, 2013, J NEUROSCI, V33, P13505, DOI 10.1523/JNEUROSCI.0918-13.2013; Moldovan N, 2015, NEUROTOXICOLOGY, V48, P1, DOI 10.1016/j.neuro.2015.02.009; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Moro C, 2017, EXP BRAIN RES, V235, P3081, DOI 10.1007/s00221-017-5048-7; Muili KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030655; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Patel J, 2012, INT J MOL SCI, V13, P10647, DOI 10.3390/ijms130810647; Pedraza CE, 2014, ASN NEURO, V6, DOI 10.1177/1759091414538134; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Pitzschke A, 2015, PHYS MED BIOL, V60, P2921, DOI 10.1088/0031-9155/60/7/2921; Pott F, 2009, BRAIN RES, V1305, P137, DOI 10.1016/j.brainres.2009.09.084; Potter GB, 2016, J NEUROSCI RES, V94, P1341, DOI 10.1002/jnr.23804; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; Rochkind S, 2002, NEUROL RES, V24, P355, DOI 10.1179/016164102101200131; Salehpour F, 2017, REV NEUROSCIENCE, V28, P441, DOI 10.1515/revneuro-2016-0087; Sancakli E, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0116-5; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; SCHOLTZ CL, 1977, HISTOCHEM J, V9, P759, DOI 10.1007/BF01003070; Shen CC, 2013, J BIOMED MATER RES A, V101, P2763, DOI 10.1002/jbm.a.34581; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Skripuletz T, 2008, AM J PATHOL, V172, P1053, DOI 10.2353/ajpath.2008.070850; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Soleimanpour H, 2014, LASER MED SCI, V29, P1695, DOI 10.1007/s10103-014-1576-6; Song JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00553-6; Song S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-219; Song WY, 2016, IN VITRO CELL DEV-AN, V52, P522, DOI 10.1007/s11626-016-0009-1; Stadelmann C, 2002, BRAIN, V125, P75, DOI 10.1093/brain/awf015; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; Stoffels JMJ, 2013, BRAIN, V136, P116, DOI 10.1093/brain/aws313; Takhtfooladi MA, 2015, LASER MED SCI, V30, P1757, DOI 10.1007/s10103-015-1786-6; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Torkildsen O, 2009, CLIN NUTR, V28, P83, DOI 10.1016/j.clnu.2008.10.015; Tsiperson V, 2015, ASN NEURO, V7, DOI 10.1177/1759091414566878; Varga E, 2018, CELL MOL NEUROBIOL, V38, P1081, DOI 10.1007/s10571-018-0578-5; Vernerey J, 2013, J NEUROSCI, V33, P3240, DOI 10.1523/JNEUROSCI.2579-12.2013; Veronez S, 2017, LASER MED SCI, V32, P343, DOI 10.1007/s10103-016-2120-7; VonDran MW, 2011, J NEUROSCI, V31, P14182, DOI 10.1523/JNEUROSCI.6595-10.2011; Wang RM, 2019, MOL NEUROBIOL, V56, P1852, DOI 10.1007/s12035-018-1191-9; Wang SL, 2008, STROKE, V39, P2348, DOI 10.1161/STROKEAHA.107.509927; Wang YJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004641; Wegener A, 2015, BRAIN, V138, P120, DOI 10.1093/brain/awu375; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Wu XJ, 2009, LASER SURG MED, V41, P36, DOI 10.1002/lsm.20729; Xiao L, 2012, GLIA, V60, P1037, DOI 10.1002/glia.22333; Xing YL, 2014, J NEUROSCI, V34, P14128, DOI 10.1523/JNEUROSCI.3491-13.2014; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yadav A, 2016, J PHOTOCH PHOTOBIO B, V162, P77, DOI 10.1016/j.jphotobiol.2016.06.031; Yang LD, 2018, EXP NEUROL, V299, P86, DOI 10.1016/j.expneurol.2017.10.013; Yang X, 2010, NEUROSCIENCE, V171, P859, DOI 10.1016/j.neuroscience.2010.09.025; Yazdani SO, 2012, J PHOTOCH PHOTOBIO B, V107, P9, DOI 10.1016/j.jphotobiol.2011.11.001; Ye JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054590; Yip KK, 2011, NEUROSCIENCE, V190, P301, DOI 10.1016/j.neuroscience.2011.06.022; Zhang Q, 2014, J CEREBR BLOOD F MET, V34, P1391, DOI 10.1038/jcbfm.2014.95	118	4	4	1	4	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1011-1344	1873-2682		J PHOTOCH PHOTOBIO B	J. Photochem. Photobiol. B-Biol.	DEC	2018	189						55	65		10.1016/j.jphotobiol.2018.09.024			11	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	HF6UW	WOS:000454374800008	30312921				2022-02-06	
J	Ozevren, H; Irtegun, S; Ekingen, A; Tuncer, MC; Ozkorkmaz, EG; Deveci, E; Deveci, S				Ozevren, Huseyin; Irtegun, Sevgi; Ekingen, Arzu; Tuncer, Mehmet Cudi; Ozkorkmaz, Ebru Gokalp; Deveci, Engin; Deveci, Senay			Immunoexpression of Vascular Endothelial Growth Factor, beta-cell Lymphoma 2 and Cluster of Differentiation 68 in Cerebellar Tissue of Rats Treated with Ganoderma lucidum	INTERNATIONAL JOURNAL OF MORPHOLOGY			English	Article						VEGF; beta cl-2; CD68; Ganoderma lucidum; Traumatic brain injury; Cerebellum; Histopathology; Rat	TRAUMATIC BRAIN-INJURY; CEREBRAL CORTICAL-NEURONS; AGED MICE; OXIDATIVE STRESS; BCL-2; POLYSACCHARIDES; DEATH; EXPRESSION; INDUCTION; MICROGLIA	Traumatic brain injury (TBI) can potentially lead to hemorrhages in all areas of the skull, which can damage cells and nerve connections. This study aims to investigate the protective effects of Ganoderma lucidum polysaccharides (GLPS) as a antioxidant on cerebellar cell tissues after traumatic brain injury in rats. Sprague Dawley rats were subjected to TBI with a weight-drop device using 300 g-1m weight-height impact. The groups are consisted of control, trauma, and trauma+Ganoderma lucidum groups. At seven days post-brain injury, experimental rats were decapitated after intraperitoneal administration of ketamine HCL (0.15 ml/100 g body weight). Cereballar samples were taken for histological examination or determination of malondialdehyde (MDA) and glutathione (GSH) levels and myeloperoxidase (MPO) activity. Significant improvement was observed in cells and vascular structures of Ganoderma lucidum treated groups when compared to untreated groups. It is believed that Ganoderma lucidum may have an effect on the progression of traumatic brain injury. Ganoderma lucidum application may affect angiogenetic development in blood vessel endothelial cells, decrease inflammatory cell accumulation by affecting cytokine mechanism and may create apoptotic nerve cells and neuroprotective mechanism in glial cells.	[Ozevren, Huseyin] Dicle Univ, Fac Med, Dept Neurosurg, Diyarbakir, Turkey; [Irtegun, Sevgi] Dicle Univ, Fac Med, Dept Med Biol, Diyarbakir, Turkey; [Ekingen, Arzu] Univ Batman, Vocat Sch Hlth Serv, Batman, Turkey; [Tuncer, Mehmet Cudi] Dicle Univ, Fac Med, Dept Anat, Diyarbakir, Turkey; [Ozkorkmaz, Ebru Gokalp; Deveci, Engin] Dicle Univ, Fac Med, Dept Histol & Embryol, Diyarbakir, Turkey; [Deveci, Senay] Dicle Univ, Ataturk Hlth High Sch, Diyarbakir, Turkey		Tuncer, MC (corresponding author), Dicle Univ, Med Sch, Dept Anat, TR-21280 Diyarbakir, Turkey.	drcudi@hotmail.com	OZKORKMAZ, EBRU GOKALP/Y-2382-2018; ekingen, arzu/ABA-7595-2020; Mumcu, Arzu/AAN-3276-2021; Ozevren, Huseyin/AAC-1236-2021	OZKORKMAZ, EBRU GOKALP/0000-0002-1967-4844; ekingen, arzu/0000-0001-9002-0352; Ozevren, Huseyin/0000-0002-5437-4003			ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Andjelkovic AV, 1998, BRAIN RES, V814, P13, DOI 10.1016/S0006-8993(98)00830-0; Bao XF, 2001, CARBOHYD RES, V332, P67, DOI 10.1016/S0008-6215(01)00075-1; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; BATISTATOU A, 1993, J NEUROSCI, V13, P4422; Beattie MS, 1998, NEUROSCIENTIST, V4, P163, DOI 10.1177/107385849800400312; Cao QZ, 2006, LIFE SCI, V78, P1457, DOI 10.1016/j.lfs.2005.07.017; Chen J, 1996, P NATL ACAD SCI USA, V93, P7042, DOI 10.1073/pnas.93.14.7042; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Cheung WMW, 2000, FEBS LETT, V486, P291, DOI 10.1016/S0014-5793(00)02317-6; Clark RSB, 1997, J NEUROSCI, V17, P9172; Cong Z, 1981, J BEIJING MED COLL, V13, P6; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; D'Ambrosi N, 2000, NEUROPHARMACOLOGY, V39, P1083, DOI 10.1016/S0028-3908(99)00213-0; DeBilbao F, 1996, NEUROSCIENCE, V71, P1111, DOI 10.1016/0306-4522(95)00505-6; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; Fukaya M, 2015, NEW FOOD IND, V57, P1; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Gao YH, 2005, IMMUNOL INVEST, V34, P171, DOI 10.1081/IMM-200055813; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; Gokce EC, 2015, INJURY, V46, P2146, DOI 10.1016/j.injury.2015.08.017; Granholm AC, 1998, REV NEUROSCIENCE, V9, P31; Gumerlock MK, 1996, PRACTICE NEUROSURGER, P4; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hajjaj H, 2005, APPL ENVIRON MICROB, V71, P3653, DOI 10.1128/AEM.71.7.3653-3658.2005; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; HEFTI F, 1986, ANN NEUROL, V20, P275, DOI 10.1002/ana.410200302; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Huang CY, 2010, J AGR FOOD CHEM, V58, P8798, DOI 10.1021/jf1020158; Huang TT, 2012, SEMIN CELL DEV BIOL, V23, P738, DOI 10.1016/j.semcdb.2012.04.003; Kamiuchi S, 2010, JPN J COMPLEMENT ALT, V7, P35; Kamiuchi S, 2014, JPN J COMPLEMENT ALT, V11, P57; Kawahara Y, 2011, JPN J COMPLEMENT ALT, V8, P1; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Lai CSW, 2008, BRAIN RES, V1190, P215, DOI 10.1016/j.brainres.2007.10.103; Liu J, 2004, J ETHNOPHARMACOL, V95, P265, DOI 10.1016/j.jep.2004.07.010; Lu HM, 2003, ONCOL REP, V10, P375; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsuzaki H, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-370; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nakagawa I., 1999, BIOTHERAPY, V13, P513; PERRY VH, 1993, GLIA, V7, P60, DOI 10.1002/glia.440070111; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Preston GW, 2016, ANAL BIOANAL CHEM, V408, P2187, DOI 10.1007/s00216-016-9334-1; Raab S, 2004, THROMB HAEMOSTASIS, V91, P595, DOI 10.1160/TH03-09-0582; Rakic S, 2003, GLIA, V41, P117, DOI 10.1002/glia.10140; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Slemmer JE, 2004, NEUROBIOL DIS, V15, P563, DOI 10.1016/j.nbd.2003.11.027; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sohrab G, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.28551; Sun XZ, 2017, NEURAL REGEN RES, V12, P953, DOI 10.4103/1673-5374.208590; Trajkovic LMH, 2009, NUTR CANCER, V61, P696, DOI 10.1080/01635580902898743; TSAI FY, 1980, J COMPUT ASSIST TOMO, V4, P291, DOI 10.1097/00004728-198006000-00002; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Usui T., 2007, Journal of Japanese Society of Nutrition and Food Science, V60, P249; Wang MF, 2004, INT CONGR SER, V1260, P399, DOI 10.1016/S0531-5131(03)01682-0; Weng CJ, 2009, J AGR FOOD CHEM, V57, P5049, DOI 10.1021/jf900828k; Wong KL, 2004, PHYTOTHER RES, V18, P1024, DOI 10.1002/ptr.1557; Wynne AM, 2010, BRAIN BEHAV IMMUN, V24, P1190, DOI 10.1016/j.bbi.2010.05.011; Zhang HN, 2004, ACTA PHARMACOL SIN, V25, P191; Zhang RP, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep075; Zhang Wei, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P298, DOI 10.3736/jcim20060316; Zhao HB, 2005, LIFE SCI, V76, P1027, DOI 10.1016/j.lfs.2004.08.013; Zhao HB, 2004, J PHARMACOL SCI, V95, P294, DOI 10.1254/jphs.SC0040011; Zhou Y, 2012, EXP TOXICOL PATHOL, V64, P673, DOI 10.1016/j.etp.2010.12.011; Zhou ZY, 2010, J ETHNOPHARMACOL, V131, P154, DOI 10.1016/j.jep.2010.06.023; Zhu XL, 2005, ACTA PHARMACOL SIN, V26, P1130, DOI 10.1111/j.1745-7254.2005.00171.x	70	4	4	3	7	SOC CHILENA ANATOMIA	TEMUCO	CASILLA 54-D, TEMUCO, 00000, CHILE	0717-9502	0717-9367		INT J MORPHOL	Int. J. Morphol.	DEC	2018	36	4					1453	1462		10.4067/S0717-95022018000401453			10	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	HF6HG	WOS:000454335600048		gold			2022-02-06	
J	Proyenzale, JM; Taylor, BA; Wilde, EA; Boss, M; Schneider, W				Proyenzale, James M.; Taylor, Brian A.; Wilde, Elisabeth A.; Boss, Michael; Schneider, Walter			Analysis of variability of fractional anisotropy values at 3T using a novel diffusion tensor imaging phantom	NEURORADIOLOGY JOURNAL			English	Article						Brain; diffusion; fractional anisotropy; imaging; phantom; quantitative	TRAUMATIC BRAIN-INJURY; ADULTS	We employed a novel diffusion tensor imaging phantom to study intra- and interscanner reproducibility on two 3T magnetic resonance (MR) scanners. Using a phantom containing thousands of hollow micron-size tubes in complex arrays, we performed two experiments using a b value of 1000 s/ms(2) on two Siemens 3T Trio scanners. First, we performed 12-direction scans. Second, on one scanner, we performed two 64-direction protocols with different repetition times (TRs). We used a one-way analysis of variance to calculate differences between scanners and the Mann-Whitney U test to assess differences between 12-direction and 64-direction data. We calculated the coefficient of variation (CoV) for intrascanner and interscanner data. For 12-direction protocols, mean fractional anisotropy (FA) was 0.3003 for Scanner 1 (four scans) and 0.3094 for Scanner 2 (three scans). Lowest FA value on Scanner 1 was 2.56 standard deviations below the mean of Scanner 2. For 64-direction scans, mean FA was 0.2640 for 4000 ms TR and 0.2582 for 13,200 ms TR scans. For 12-direction scans, within-scanner CoV was 0.0326 for Scanner 1 and 0.0240 for Scanner 2; between-scanner CoV was 0.032. For 64-direction scans, CoV was 0.056 for TR 4000 ms and 0.0533 for TR 13,200 ms. The difference between median FA values of 12-direction and 64-direction scans was statistically significant (p < 0.001). We found relatively good reproducibility on any single MR scanner. FA values from one scanner were sometimes significantly below the mean FA of another scanner, which has important implications for clinical use of DTI.	[Proyenzale, James M.] Duke Univ, Med Ctr, Dept Radiol, Box 3808, Durham, NC 27516 USA; [Taylor, Brian A.] Virginia Commonwealth Univ, Dept Biomed Engn, Coll Engn, Richmond, VA 23284 USA; [Taylor, Brian A.] Virginia Commonwealth Univ, C Kenneth & Dianne Wright Ctr Clin & Translat Res, Richmond, VA 23284 USA; [Wilde, Elisabeth A.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Boss, Michael] Univ Colorado, Boulder, CO 80309 USA; [Boss, Michael] NIST, Gaithersburg, MD 20899 USA; [Schneider, Walter] Univ Pittsburgh, Pittsburgh, PA 15260 USA		Proyenzale, JM (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Box 3808, Durham, NC 27516 USA.	james.provenzale@duke.edu	Boss, Michael/I-2904-2019	Boss, Michael/0000-0002-9492-767X; Taylor, Brian/0000-0001-9745-1075	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002649] Funding Source: NIH RePORTER		Andersson J, 2007, TR07JA2 OXF U OXF CT; Giannelli M, 2011, MED PHYS, V38, P3205, DOI 10.1118/1.3592013; Giannelli Marco, 2009, J Appl Clin Med Phys, V11, P2927; Guise C, 2016, ACS APPL MATER INTER, V8, P29960, DOI 10.1021/acsami.6b09809; Hakulinen U, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-30; Hasan KM, 2005, J MAGN RESON IMAGING, V21, P735, DOI 10.1002/jmri.20296; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marenco S, 2006, PSYCHIAT RES-NEUROIM, V147, P69, DOI 10.1016/j.pscychresns.2006.01.008; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mirzaalian H, 2015, LECT NOTES COMPUT SC, V9349, P12, DOI 10.1007/978-3-319-24553-9_2; Takao H, 2012, HUM BRAIN MAPP, V33, P466, DOI 10.1002/hbm.21225; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046	15	4	4	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1971-4009	2385-1996		NEURORADIOL J	Neuradiology J.	DEC	2018	31	6					581	586		10.1177/1971400918789383			6	Neuroimaging	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HD4HW	WOS:000452489200006	30037296	Green Published			2022-02-06	
J	Taranto, E; Fishman, M; Garvey, K; Perlman, M; Benjamin, HJ; Ross, LF				Taranto, Eleanor; Fishman, Michael; Garvey, Katherine; Perlman, Meryl; Benjamin, Holly J.; Ross, Lainie Friedman			Pubic Attitudes and Knowledge About Youth Sports Participation and Concussion Risk in an Urban Area	JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION			English	Article						Concussion; Foot ball; Youth sports; Physician counseling; Public attitudes	HIGH-SCHOOL; EMERGENCY-DEPARTMENT; MANAGEMENT; FOOTBALL; PARENTS; EDUCATION; RECOVERY; CHILDREN; PLAYERS; INJURY	Background: Every year, millions of children in the United States participate in youth full-contact sports, which carry concussion risks-the long-term sequelae of which are not well understood. We examined the attitudes and knowledge of adults in Chicago about youth sports participation, concussion risk, and whether physicians should counsel against youth participation in full-contact sports. Methods: An anonymous paper survey featuring 13 attitudinal 13 demographic, and 9 knowledge questions was distributed to a convenience sample of adults >= 18 years in hospitals waling areas and four Chicago parks. Participants were asked to hypothetically consider themselves the parent of a 10-year-old child regarding attitudes towards full-contact sports participation. Results: Between June 13 and July 27, 2016, 1091 partial or complete valid surveys were collected. Almost half (46%) of respondents would not allow a hypothetical 10-year-old son to play tackle football. The majority (74%) of respondents agreed that it was appropriate for physicians to counsel against youth participation in full-contact sports. Respondents obtained information about concussions from, on average, 2-3 sources, although only 34% received information from physicians. Respondents demonstrated a high concussion knowledge level (average: 6.75 of 9 questions). However, only 39% of respondents correctly answered that the following statement was false: "After a mild concussion, there are usually visible changes on medical imaging". Conclusions: Overall, respondents are well-informed about concussions. They are divided about the participation d youth in full-contact sports and are amenable to physician counseling against youth participation in full-contact sports.	[Taranto, Eleanor; Fishman, Michael] Univ Chicago, Pritzker Sch Med, 924 E 57th St, Chicago, IL 60637 USA; [Garvey, Katherine] Icahn Sch Med Mt Sinai, 1 Gustave L Levy Pl, New York, NY 10029 USA; [Perlman, Meryl] Massachusetts Gen Hosp Children, Dept Pediat Gastroenterol & Nutr, 55 Fruit St,6B, Boston, MA 02114 USA; [Benjamin, Holly J.] Univ Chicago, Dept Orthoped Surg & Rehabil Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Benjamin, Holly J.; Ross, Lainie Friedman] Univ Chicago, Dept Pediat, 5841 S Maryland Ave,MC 6082, Chicago, IL 60637 USA; [Ross, Lainie Friedman] Univ Chicago, MacLean Ctr Clin Med Eth, 5841 S Maryland Ave, Chicago, IL 60637 USA		Ross, LF (corresponding author), Univ Chicago, Dept Pediat, 5841 S Maryland Ave,MC 6082, Chicago, IL 60637 USA.	Lross@uchicago.edu		Ross, Lainie/0000-0002-7395-3000	University of Chicago Pritzker School of Medicine Summer Research Project; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Training Grant [T35DK062719-29]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK062719, P30DK042086] Funding Source: NIH RePORTER	Eleanor Taranto and Michael Fishman were supported by the University of Chicago Pritzker School of Medicine Summer Research Project. Eleanor Taranto was also supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Training Grant #T35DK062719-29. No other funding was obtained.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Belson K, 2016, NY TIMES; Bieler D., 2016, WASH POST; Bonesteel M, 2016, WASHINGTON POST; Carone D. A, 2014, OXFORD HDB SPORTS RE, DOI [10.1093/oxfordhb/9780199896585.001.0001, DOI 10.1093/OXFORDHB/9780199896585.001.0001]; Caswell SV, 2015, PEDIATRICS, V135, P26, DOI 10.1542/peds.2014-1451; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Dyck J. J, 2016, CITIZEN ATTITUDES SP; Ennis SR, 2011, HISPANIC POPULATION; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Farrey T, 2016, NON TRADITIONAL REF; Fedor A, 2016, APPL NEUROPSYCH-CHIL, V5, P107, DOI 10.1080/21622965.2014.999770; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Jinguji TM, 2011, PHYS MED REH CLIN N, V22, P565, DOI 10.1016/j.pmr.2011.08.001; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; LaBond Virginia, 2014, NASN Sch Nurse, V29, P194; Landesman P., 2015, CONCUSSION; Laskas J.M., 2015, CONCUSSION; Lax ID, 2015, BRAIN INJURY, V29, P1409, DOI 10.3109/02699052.2015.1043344; Leitch H, 2015, J NATL MED ASSOC, V107, P60, DOI 10.1016/S0027-9684(15)30053-5; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Macdonald I, 2016, J NEUROSCI NURS, V48, P297, DOI 10.1097/JNN.0000000000000212; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Murray M. Poll, 2015, MSNBC           0130; Nowinski C, 2006, HEAD GAMES FOOTBALLS; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Perez A.J., 2018, US TODAY; Quintana LM, 2016, WORLD NEUROSURG, V91, P647, DOI 10.1016/j.wneu.2016.04.035; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Schwarz A., 2016, NY TIMES; Sharing Progress, 2016, PLAYSMART PLAYSAFE; Stein A, 2016, CHICAGO TRIBUNE 0104; Turner RW, 2017, BRAIN INJURY, V31, P1124, DOI 10.1080/02699052.2017.1298003; Washington RL, 2001, PEDIATRICS, V107, P1205; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Zamarripa A, 2017, J PEDIATR-US, V181, P229, DOI 10.1016/j.jpeds.2016.10.071; Zuckerman SL, 2017, J NEUROSURG-PEDIATR, V19, P652, DOI 10.3171/2017.1.PEDS16611	43	4	4	0	15	NATL MED ASSOC	WASHINGON	1012 10TH ST, N W, WASHINGON, DC 20001 USA	0027-9684	1943-4693		J NATL MED ASSOC	J. Natl. Med. Assoc.	DEC	2018	110	6					635	643		10.1016/j.jnma.2018.10.001			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA2SB	WOS:000450091500020	30376961	Green Accepted, Bronze			2022-02-06	
J	Zhou, S; Yin, DP; Wang, Y; Tian, Y; Wang, ZG; Zhang, JN				Zhou, Shuai; Yin, Dong-Pei; Wang, Yi; Tian, Ye; Wang, Zeng-Guang; Zhang, Jian-Ning			Dynamic changes in growth factor levels over a 7-day period predict the functional outcomes of traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; vascular endothelial growth factor; angiopoietin-1; granulocyte-colony stimulating factor; outcomes; secondary brain injuries; blood-brain barrier; brain edema; acute phase; clinical trial; neural regeneration	COLONY-STIMULATING FACTOR; BIOMARKERS; CELLS; ANGIOGENESIS; RECOVERY; PATHWAY; DISEASE; MODEL	Traumatic brain injury (TBI) can result in poor functional outcomes and death, and overall outcomes are varied. Growth factors, such as angiopoietin-1 (Ang-1), vascular endothelial growth factor (VEGF), and granulocyte-colony stimulating factor (G-CSF), play important roles in the neurological functions. This study investigated the relationship between serum growth factor levels and long-term outcomes after TBI. Blood samples from 55 patients were collected at 1, 3 and 7 days after TBI. Blood samples from 39 healthy controls were collected as a control group. Serum Ang-1, G-CSF, and VEGF levels were measured using ELISA. Patients were monitored for 3 months using the Glasgow Outcome Scale-Extended (GOSE). Patients having a GOSE score of > 5 at 3 months were categorized as a good outcome, and patients with a GOSE score of 1-5 were categorized as a bad outcome. Our data demonstrated that TBI patients showed significantly increased growth factor levels within 7 days compared with healthy controls. Serum levels of Ang-1 at 1 and 7 days and G-CSF levels at 7 days were significantly higher in patients with good outcomes than in patients with poor outcomes. VEGF levels at 7 days were remarkably higher in patients with poor outcomes than in patients with good outcomes. Receiver operating characteristic analysis showed that the best cut-off points of serum growth factor levels at 7 days to predict functional outcome were 1,333 pg/mL for VEGF, 447.2 pg/mL for G-CSF, and 90.6 ng/mL for Ang-1. These data suggest that patients with elevated levels of serum Ang-1, G-CSF, and decreased VEGF levels had a better prognosis in the acute phase of TBI (within 7 days).	[Zhou, Shuai] Tianjin Med Univ Gen Hosp, Dept Intens Care Unit, Tianjin, Peoples R China; [Zhou, Shuai; Yin, Dong-Pei; Wang, Yi; Tian, Ye; Wang, Zeng-Guang; Zhang, Jian-Ning] Tianjin Neurol Inst, Tianjin, Peoples R China; [Zhou, Shuai; Yin, Dong-Pei; Wang, Yi; Tian, Ye; Wang, Zeng-Guang; Zhang, Jian-Ning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Zhou, Shuai; Yin, Dong-Pei; Wang, Yi; Tian, Ye; Wang, Zeng-Guang; Zhang, Jian-Ning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Zhou, Shuai; Yin, Dong-Pei; Wang, Yi; Tian, Ye; Wang, Zeng-Guang; Zhang, Jian-Ning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China		Wang, ZG; Zhang, JN (corresponding author), Tianjin Neurol Inst, Tianjin, Peoples R China.; Wang, ZG; Zhang, JN (corresponding author), Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China.; Wang, ZG; Zhang, JN (corresponding author), Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China.; Wang, ZG; Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.	wzgforrest@163.com; jianningzhang@hotmail.com		Dongpei, Yin/0000-0003-2572-3689	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 81501057]; Science AMP; Technology Development Fund of Tianjin Education Commission for Higher Education in China [2016YD02]; Technology Program Fund of Tianjin Health and Family Planning Commission for the Key Field of Traditional Chinese Medicine [2018001]	This study was supported by the National Natural Science Foundation of China, No. 81330029 (to JNZ), 81501057 (to YT); the Science & Technology Development Fund of Tianjin Education Commission for Higher Education in China, No. 2016YD02 (to YW); the Technology Program Fund of Tianjin Health and Family Planning Commission for the Key Field of Traditional Chinese Medicine, No. 2018001 (to ZGW). The funding bodies played no role in the study design, in the collection, analysis and interpretation of data, in the writing of the paper, and in the decision to submit the paper for publication.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Chittiboina Prashant, 2013, Pathophysiology, V20, P15, DOI 10.1016/j.pathophys.2012.02.004; David S, 2010, CRIT CARE, V14, DOI 10.1186/cc9090; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gong DS, 2012, BRAIN INJURY, V26, P291, DOI 10.3109/02699052.2011.648710; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Hart T, 2018, J NEUROSCI RES, V96, P702, DOI 10.1002/jnr.24102; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hirschi R, 2017, NEURAL REGEN RES, V12, P1801, DOI 10.4103/1673-5374.219037; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; JENNETT B, 1975, LANCET, V1, P480; Jin X, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037399; Li J, 2015, AM J EMERG MED, V33, P1191, DOI 10.1016/j.ajem.2015.05.023; Li M, 2016, CLIN NEUROL NEUROSUR, V144, P7, DOI 10.1016/j.clineuro.2016.02.032; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Raghupathi R, 2017, NEURAL REGEN RES, V12, P741, DOI 10.4103/1673-5374.206639; Robciuc MR, 2016, CELL METAB, V23, P712, DOI 10.1016/j.cmet.2016.03.004; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Sobrino T, 2009, J CEREBR BLOOD F MET, V29, P1968, DOI 10.1038/jcbfm.2009.182; SOLAROGLU I, 2016, STROKE, V94, P409; Song SJ, 2016, J NEUROSCI RES, V94, P409, DOI 10.1002/jnr.23714; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Sun DD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00193; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wang Y, 2015, J NEUROL SCI, V356, P72, DOI 10.1016/j.jns.2015.05.038; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zafar MI, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20171089; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang WT, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006960; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073	41	4	5	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	DEC	2018	13	12					2134	+	PMID 30323142	10.4103/1673-5374.241462			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HA4ZK	WOS:000450276000027	30323142	Green Published, gold			2022-02-06	
J	Matveev, R; Sergio, L; Fraser-Thomas, J; Macpherson, AK				Matveev, Roman; Sergio, Lauren; Fraser-Thomas, Jessica; Macpherson, Alison K.			Trends in concussions at Ontario schools prior to and subsequent to the introduction of a concussion policy - an analysis of the Canadian hospitals injury reporting and prevention program from 2009 to 2016	BMC PUBLIC HEALTH			English	Article						Concussion; Policy; Emergency department; Youth	COLLEGIATE; RATES; SPORT; EPIDEMIOLOGY; LEGISLATION; CHILDREN; VISITS; HEALTH	BackgroundConcussion is a preventable injury that can have long-term health consequences for children and youth. In Ontario, the Policy/Program Memorandum # 158 (PPM) was introduced by the Ministry of Education of Ontario in March 2014. The PPM's main purpose is to require each school board in the province to create and implement a concussion policy. The purpose of this paper is to examine trends in school-based concussions prior to and subsequent to the introduction of the PPM.MethodsThis report examined emergency department (ED) visits in 5 Ontario hospitals that are part of the Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP), and compared trends over time in diagnosed concussions, and suspected concussions identified as other head injury in children and youth aged 4-18.ResultsFrom 2009 to 2016 study years, there were 21,094 suspected concussions, including 8934 diagnosed concussions in youth aged 4-18. The average number of diagnosed concussions in the 5years before the PPM was 89 concussions/month, compared to approximately 117 concussions per month after; a 30% increase in the monthly rate of concussions presenting to the ED. The total number of concussion or head injury-related ED visits remained relatively unchanged but the proportion of diagnosed concussions rose from 31% in 2009 to 53% in 2016. The proportion of diagnosed concussions in females also increased from 38% in 2013 to 46% in 2016. The percent of all diagnosed concussions occurring at schools increased throughout the study reaching almost 50% in 2016 with most injuries taking place at the playground (24%), gymnasium (22%) or sports field (20%).ConclusionsThe introduction of the PPM may have contributed to a general increase in concussion awareness and an improvement in concussion identification at the school level in children and youth aged 4-18.	[Matveev, Roman; Sergio, Lauren; Fraser-Thomas, Jessica; Macpherson, Alison K.] York Univ, Sch Kinesiol & Hlth Sci, 4700 Keele St, Toronto, ON M3J 1P3, Canada		Matveev, R (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	roman10m@outlook.com	Sergio, Lauren/AAK-3274-2020		CIHR Chair in Maternal and Child Health Services and Policy Research	Dr. Macpherson holds a CIHR Chair in Maternal and Child Health Services and Policy Research which supported this research. The funding body aided in acquiring the data and supported the primary investigator by partially covering publication costs.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], 2014, 142 APHA ANN M EXP N, P2014; Atlantic Collaborative on Injury Prevention & Child Safety Link, 2016, ATL CAN CHILD YOUTH; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Canadian Institute for Health Information, 2016, HEADS UP SPORT REL B; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Craig M, 2016, GLOBAL NEWS     0727; Crain J, 2016, HEALTH PROMOT CHRON, V36, P112, DOI 10.24095/hpcdp.36.6.02; Daroff R. B., 2014, ENCY NEUROLOGICAL SC; French J, 2015, SASKATOON STARPHOENI; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hall V, 2016, NATL POST; Halton District School Board, ID MAN CONC ADM PROC; Halton Region, 2004 2013 EM DEP VIS; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Herzog MM, 2014 AAP NAT C EXH 2; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Keays G, 2018, CAN J PUBLIC HEALTH, V109, P52, DOI 10.17269/s41997-018-0037-6; Kirwan R, 2013, CMP STUDENT ATHLETE; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrory P, 2017, BR J SPORTS MED; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Ministry of Education of Ontario, 2014, 158 MIN ED ONT; Ministry of Education of Ontario, 2016, ED FACTS; Ontario School Boards' Insurance Exchange, CONC DAT OSB INC REP; Ontario School Boards' Insurance Exchange, ONL INC REP; Public Health Agency of Canada, CAN HOSP INJ REP PRE; Rajabali F, 2016, CONCUSSION CHILDREN; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Snyder M, 2015, WASHINGTON POST; Trojian Thomas, 2015, Inj Epidemiol, V2, P2; Turcotte K., 2013, CONCUSSION CHILDREN; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; You JJ, 2007, DIAGNOSTIC SERVICES; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	45	4	4	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2458			BMC PUBLIC HEALTH	BMC Public Health	NOV 29	2018	18								1324	10.1186/s12889-018-6232-9			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	HC3NQ	WOS:000451709700003	30497446	Green Published, gold			2022-02-06	
J	Walter, A; Herrold, AA; Gallagher, VT; Lee, R; Scaramuzzo, M; Bream, T; Seidenberg, PH; Vandenbergh, D; O'Connor, K; Talavage, TM; Nauman, EA; Slobounov, SM; Breiter, HC				Walter, Alexa; Herrold, Amy A.; Gallagher, Virginia T.; Lee, Rosa; Scaramuzzo, Madeleine; Bream, Tim; Seidenberg, Peter H.; Vandenbergh, David; O'Connor, Kailyn; Talavage, Thomas M.; Nauman, Eric A.; Slobounov, Semyon M.; Breiter, Hans C.			KIAA0319 Genotype Predicts the Number of Past Concussions in a Division I Football Team: A Pilot Study	JOURNAL OF NEUROTRAUMA			English	Article						APOE; BDNF; concussion; genetics; football; KIAA0319; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; CATECHOL-O-METHYLTRANSFERASE; DEFAULT MODE NETWORK; HIGH-SCHOOL; APOLIPOPROTEIN-E; SEX-DIFFERENCES; WHITE-MATTER; MESSENGER-RNA; RISK-FACTORS; GENE	This candidate gene study evaluated the relationship of a past history of concussion with single nucleotide polymorphisms (SNPs) in nine genes in a small cohort (N = 87) of a nationally ranked Division I football team. Genes and SNPs studied were selected based on their published connection to brain injury and brain development, as well as impulsivity. We used multinomial logistic regression analysis (MLRA) to quantify how well genotype predicted the number of previously diagnosed concussions (three categories: none, one, two or more), while covarying race and number of years participating in football. The rs4504469 SNP for KIAA0319 was the only locus that significantly predicted number of previously diagnosed concussions (p = 0.005, meeting Bonferroni correction for multiple comparisons). The KIAA0319 results raise the hypothesis that having the CT or TT genotype of KIAA0319 may be predictive of a lower incidence of previously diagnosed concussion. This finding raises a number of hypotheses for future pre-clinical research, particularly whether alterations in neural organization related to KIAA0319 rs4504469 lead to reduced susceptibility for lasting head trauma, or greater resilience in the face of repeated subconcussive injury.	[Walter, Alexa; Slobounov, Semyon M.] Penn State Univ, Dept Kinesiol, 25 Recreat Hall, University Pk, PA 16802 USA; [Herrold, Amy A.; Gallagher, Virginia T.; Lee, Rosa; O'Connor, Kailyn; Breiter, Hans C.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Warren Wright Adolescent Ctr, 710 N Lake Shore Dr, Chicago, IL 60611 USA; [Herrold, Amy A.] Edward Hines Jr VA Hosp, Hines, IL USA; [Scaramuzzo, Madeleine; Bream, Tim; Seidenberg, Peter H.] Penn State Univ, Athlet Dept, University Pk, PA 16802 USA; [Vandenbergh, David] Penn State Univ, Dept Biobehav Hlth, Mol & Cellular Biosci Program, University Pk, PA 16802 USA; [Vandenbergh, David] Penn State Univ, Inst Neurosci, University Pk, PA 16802 USA; [Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Lab Neuroimaging & Genet, Boston, MA 02114 USA; [Breiter, Hans C.] Florida State Univ, Concuss Neuroimaging Consortium, Tallahassee, FL 32306 USA; [Breiter, Hans C.] Harvard Univ, Cambridge, MA 02138 USA; [Breiter, Hans C.] Michigan State Univ, E Lansing, MI 48824 USA; [Breiter, Hans C.] Northwestern Univ, Evanston, IL 60208 USA; [Breiter, Hans C.] Ohio State Univ, Columbus, OH 43210 USA; [Breiter, Hans C.] Purdue Univ, W Lafayette, IN 47907 USA; [Breiter, Hans C.] Penn State Univ, University Pk, PA 16802 USA; [Breiter, Hans C.] Univ Cent Florida, Orlando, FL 32816 USA; [Breiter, Hans C.] Univ Nebraska, Lincoln, NE 68583 USA		Slobounov, SM (corresponding author), Penn State Univ, Dept Kinesiol, 25 Recreat Hall, University Pk, PA 16802 USA.; Breiter, HC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Warren Wright Adolescent Ctr, 710 N Lake Shore Dr, Chicago, IL 60611 USA.	sms18@psu.edu; h-breiter@northwestern.edu		Talavage, Thomas/0000-0003-4977-6398	Semyon Slobounov's laboratory; Hans Breiter's laboratory; Veterans AffairsUS Department of Veterans Affairs [IK2RX000949] Funding Source: NIH RePORTER	Data collection and initial genetic analysis for this project were entirely funded by Semyon Slobounov's laboratory. Funding for data analysis and manuscript preparation was funded by Hans Breiter's laboratory.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Akil H, 2018, NEUROSCI BIOBEHAV R, V84, P272, DOI 10.1016/j.neubiorev.2017.08.019; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Bekris LM, 2008, J ALZHEIMERS DIS, V13, P255; Bennett E.R., 2016, TRANSLATIONAL RES TR; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chuang PY, 2010, J NEUROTRAUM, V27, P999, DOI 10.1089/neu.2009.1129; Cochrane GD, 2018, CLIN J SPORT MED, V28, P125, DOI 10.1097/JSM.0000000000000443; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Dardiotis E., 2010, NEUROSURGERY FOCUS, V28, P1; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Francks C, 2004, AM J HUM GENET, V75, P1046, DOI 10.1086/426404; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Gardner L, 2004, BIOCHEM BIOPH RES CO, V321, P306, DOI 10.1016/j.bbrc.2004.06.146; GARRIS PA, 1993, J NEUROCHEM, V61, P637; Gasic GP, 2009, AM J MED GENET B, V150B, P762, DOI 10.1002/ajmg.b.30944; Greisenegger S, 2003, THROMB RES, V110, P181, DOI 10.1016/S0049-3848(03)00376-1; Gur RC, 1999, J NEUROSCI, V19, P4065; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Halvorsen K., 2017, NEUROLOGY S16, V88, P167; Hayes JP, 2018, GENES BRAIN BEHAV, V17, P107, DOI 10.1111/gbb.12403; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Horuk R, 1996, J LEUKOCYTE BIOL, V59, P29, DOI 10.1002/jlb.59.1.29; Hulkkonen J, 2001, RHEUMATOLOGY, V40, P656, DOI 10.1093/rheumatology/40.6.656; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jiang P, 2015, CELL REP, V11, P835, DOI 10.1016/j.celrep.2015.04.003; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000162; Lachman HM, 1996, AM J MED GENET, V67, P468, DOI 10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G; Lang SB, 2007, J NEUROSCI, V27, P1097, DOI 10.1523/JNEUROSCI.3590-06.2007; Lehman EJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt188; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Luders E, 2009, J NEUROSCI, V29, P14265, DOI 10.1523/JNEUROSCI.2261-09.2009; LUNDSTROM K, 1995, BBA-PROTEIN STRUCT M, V1251, P1, DOI 10.1016/0167-4838(95)00071-2; Markett S, 2017, CEREB CORTEX, V27, P2166, DOI 10.1093/cercor/bhw059; Martinez A, 1998, J NEUROSCI, V18, P7336; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McCarro SA, 2014, NAT NEUROSCI, V17, P756, DOI 10.1038/nn.3716; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Minten C, 2014, BRAIN, V137, P1454, DOI 10.1093/brain/awu045; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Paus T, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.014.2009; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P882, DOI 10.1001/archgenpsychiatry.2008.3; Perrin JS, 2009, NEUROIMAGE, V45, P1055, DOI 10.1016/j.neuroimage.2009.01.023; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Sanders AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15736-4; Sarnaik AA, 2010, J NEUROTRAUM, V27, P465, DOI 10.1089/neu.2009.1171; SELINGER MJ, 1980, NATURE, V285, P498, DOI 10.1038/285498a0; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Stoltenberg SF, 2012, PROG NEURO-PSYCHOPH, V39, P182, DOI 10.1016/j.pnpbp.2012.06.012; Stoltenberg SF, 2006, PSYCHIAT GENET, V16, P35, DOI 10.1097/01.ypg.0000176528.30362.34; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; SZABO MC, 1995, J BIOL CHEM, V270, P25348, DOI 10.1074/jbc.270.43.25348; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Trakhtenberg EF, 2012, INT REV NEUROBIOL, V106, P105, DOI 10.1016/B978-0-12-407178-0.00005-3; Venkatesh SK, 2013, J HUM GENET, V58, P531, DOI 10.1038/jhg.2013.46; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; YASUKAWA K, 1987, EMBO J, V6, P2939, DOI 10.1002/j.1460-2075.1987.tb02598.x; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67; Zou L, 2012, AM J MED GENET B, V159B, P970, DOI 10.1002/ajmg.b.32102; Zuo Lingjun, 2006, Behav Brain Funct, V2, P13, DOI 10.1186/1744-9081-2-13	108	4	4	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1115	1124		10.1089/neu.2017.5622		NOV 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR6CG	WOS:000451526200001	30351182				2022-02-06	
J	Bedaso, A; Geja, E; Ayalew, M; Oltaye, Z; Duko, B				Bedaso, Asres; Geja, Ephrem; Ayalew, Mohammed; Oltaye, Zewdie; Duko, Bereket			Post-concussion syndrome among patients experiencing head injury attending emergency department of Hawassa University Comprehensive specialized hospital, Hawassa, southern Ethiopia	JOURNAL OF HEADACHE AND PAIN			English	Article						Post-concussion syndrome; Mild traumatic brain injury; Head injury; Hawassa	TRAUMATIC BRAIN-INJURY; SYMPTOMS; QUESTIONNAIRE; DIAGNOSIS; SEQUELAE	IntroductionPost-concussion syndrome (PCS) is defined as the presence of 3 or more of the following signs and symptoms after experiencing head injury such as headache, dizziness, fatigue, irritability, insomnia, difficulty of concentration or memory difficulty. In Ethiopia, even though there was no research conducted on post-concussion syndrome, it is common health problems after experiencing head trauma that affect the productive age group, which directly or indirectly influences the development of the country.ObjectiveTo assess the prevalence and determinants of post-concussion syndrome among patients experiencing head injury attending emergency department of Hawassa University Comprehensive Specialized hospital, Hawassa, Southern Ethiopia.MethodsInstitution based cross sectional study was conducted from November 1, 2017 to March 30, 2018, in Hawassa University Comprehensive Specialized Hospital emergency department, Hawassa, Southern Ethiopia.ResultA total of 275 cases were interviewed during data collection period with response rate of 95.2%. More than half (55.7%) of patients were within age range of 25-34 and Majorities (55.6%) of patients were married. About two-fifths of study participants (41.5%) had at least three symptoms of post-concussion syndrome components. Headache and restlessness were the most symptoms occurring in varying severity while double vision and fatigue were less severe among others. Occupation, cause of injury and location of injury were significant determinants of post-concussion syndrome.ConclusionAbout 41.5% of study participants had at least three symptoms of PCS. Occupation, cause of injury and location of injury were significantly associated with the occurrence of PCS.	[Bedaso, Asres; Geja, Ephrem; Ayalew, Mohammed; Oltaye, Zewdie; Duko, Bereket] Hawassa Univ, Coll Med & Hlth Sci, POB 1560, Hawassa, Ethiopia		Bedaso, A (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, POB 1560, Hawassa, Ethiopia.	asresbedaso@gmail.com	Duko, Bereket/P-8904-2019; Tilahune, Asres Bedaso/AAP-9464-2020; Tilahune, Asres Bedaso/AAP-9118-2020	Duko, Bereket/0000-0002-4419-0016; Tilahune, Asres Bedaso/0000-0001-7859-0264; 			Al J, 2014, J SCI RES REPORTS, V3, P2055; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barker-Collo S, 2016, JSM BURN TRAUMA, V1, P1; Barth JT, 2006, PAIN TBI, V46, P271; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hup CK, 2016, CLIN MED NORTHFIELD, V15, P2016; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Manuals M, 2003, CONCUSSION; McHugh T, 2006, BRAIN COGNITION, V60, P209; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Sivak S, 2005, Cas Lek Cesk, V144, P445; Woldemichael K, 2011, ETHIOP J HEALTH SCI, V21, P155	22	4	4	0	1	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	NOV 21	2018	19								112	10.1186/s10194-018-0945-0			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB4BP	WOS:000450997600001	30463506	Green Published, gold			2022-02-06	
J	Pistarini, C; Maggioni, G				Pistarini, Caterina; Maggioni, Giorgio			Early rehabilitation of Disorders of Consciousness (DOC): management, neuropsychological evaluation and treatment	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Disorders of Consciousness; early rehabilitation; neuropsychological impairments; assessment; comorbidity	COMA RECOVERY SCALE; TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; HETEROTOPIC OSSIFICATION; INPATIENT REHABILITATION; MEDICAL COMPLICATIONS; ITALIAN VERSION; VALIDATION; AWARENESS; AROUSAL	In order to ensure the best possible rehabilitation plan and best outcome for patients with Disorders of Consciousness (DOC), optimal management of the early phase of rehabilitation is fundamental. This includes a correct diagnosis, accurate assessment of the patient's state of alertness and the main comorbidities, appropriate neurophysiological and neuroradiology examinations, and education of the caregiver and family so that they can provide the best assistance. Thirty years ago, specialists first began applying a systematic approach to the rehabilitation of patients with DOC, but still today many problems remain unsolved: the rate of misdiagnosis is still high, and recommendations about the most appropriate mode of rehabilitation are lacking, both as regards the timing of interventions and what the best techniques to use are. In a medical sector where nosography has changed over the last decade and where the documented evidence, though increasing, still remains insufficient, we discuss in this brief review the main assessment tools and disability scales to use and the key issues that need to be considered when a patient with DOC is admitted to the rehabilitation unit and decisions about the early rehabilitation plan are made.	[Pistarini, Caterina] IRCCS I Clin Maugeri, Severe Brain Injury Rehabil Unit, Genoa, Italy; [Maggioni, Giorgio] IRCCS I Clin Maugeri, Rehabil Unit, Veruno, Italy		Maggioni, G (corresponding author), IRCCS I Clin Maugeri, Rehabil Unit, Veruno, Italy.	giorgio.maggioni@icsmaugeri.it	Pistarini, CATERINA/K-5234-2018; Maggioni, Giorgio/K-3148-2016	Pistarini, CATERINA/0000-0001-8925-0484; Maggioni, Giorgio/0000-0002-9246-7008			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; [Anonymous], 2011, BIENN INT C BRAIN IN; Arnaldi D, 2016, CLIN NEUROPHYSIOL, V127, P1445, DOI 10.1016/j.clinph.2015.10.042; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Bender A, 2015, DTSCH ARZTEBL INT, V112, P235, DOI 10.3238/arztebl.2015.0235; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Choate K, 2009, AUST CRIT CARE, V22, P8, DOI 10.1016/j.aucc.2008.10.002; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Ciurleo R, 2013, DRUGS, V73, P1849, DOI 10.1007/s40265-013-0138-8; Cortese MD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0455-5; Cullen N, 2007, BRAIN INJURY, V21, P215, DOI 10.1080/02699050701202027; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Di Perri C, 2014, WORLD J RADIOL, V6, P589, DOI 10.4329/wjr.v6.i8.589; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Formisano R, 2014, J HEAD TRAUMA REHAB, V29, P387, DOI 10.1097/HTR.0000000000000027; Frank U, 2007, DYSPHAGIA, V22, P20, DOI 10.1007/s00455-006-9036-5; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Keren O, 2001, BRAIN INJURY, V15, P531, DOI 10.1080/02699050010007371; La Porta F, 2013, ARCH PHYS MED REHAB, V94, P527, DOI 10.1016/j.apmr.2012.09.035; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Littlewood Keith E, 2005, Respir Care, V50, P516; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Magrassi L, 2016, J NEUROSURG, V125, P972, DOI 10.3171/2015.7.JNS15700; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; Nakase-Richardson R., 2012, J NEUROTRAUM, V28, P1; Naro A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144713; O'Neil-Pirozzi TM, 2003, BRAIN INJURY, V17, P389, DOI 10.1080/0269905031000070251; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; Pickard JD, 2005, NEUROPSYCHOL REHABIL, V15, P224, DOI 10.1080/09602010443000614; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Rafii MS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000548; Sacco S, 2011, BRAIN INJURY, V25, P488, DOI 10.3109/02699052.2011.558043; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Scottish Intercollegiate Guidelines Network (S. I. G. N. ), 2009, EARL MAN PAT HEAD IN; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Stelfox HT, 2009, RESP CARE, V54, P1658; Sterpi I, 2013, PHYSIOL MEAS, V34, P1423, DOI 10.1088/0967-3334/34/11/1423; Taira T, 2009, PROG BRAIN RES, V177, P317, DOI 10.1016/S0079-6123(09)17721-X; Tamashiro M, 2014, BRAIN INJURY, V28, P1744, DOI 10.3109/02699052.2014.947621; Taricco M, 2006, Eura Medicophys, V42, P73; Terre R, 2009, NEUROGASTROENT MOTIL, V21, P361, DOI 10.1111/j.1365-2982.2008.01208.x; Thibaut A, 2015, EUR J PHYS REHAB MED, V51, P389; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Wilson B. A., 2016, PSYCHOL NEUROSCI, V9, P221, DOI [10.1037/pne0000053, DOI 10.1037/PNE0000053]; Wilson BA, 2013, BRAIN IMPAIR, V14, P475, DOI 10.1017/BrImp.2013.34	61	4	5	1	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	NOV 17	2018	28	8			SI		1319	1330		10.1080/09602011.2018.1500920			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	GX2YR	WOS:000447587800011	30033818				2022-02-06	
J	Shankar, C; Karunasree, S; Manesh, A; Veeraraghavan, B				Shankar, Chaitra; Karunasree, Susmitha; Manesh, Abi; Veeraraghavan, Balaji			First Report of Whole-Genome Sequence of Colistin-Resistant Klebsiella quasipneumoniae subsp similipneumoniae Producing KPC-9 in India	MICROBIAL DRUG RESISTANCE			English	Article						Klebsiella quasipneumoniae; KPC-9; India; colistin resistance; ST2957	BETA-LACTAMASE; PNEUMONIAE; CARBAPENEMASE; VARIICOLA; EMERGENCE	Aim:Klebsiella pneumoniae carbapenemase (KPC) is a class A carbapenemase endemic in the United States, China, South America, and Europe but is rarely reported from India. A single report of KPC-9 from K. pneumoniae in Israel has been published. K. pneumoniae has been classified into three phylogenetic groups: group 1 consists of K. pneumoniae and its subspecies, group 2 consists of Klebsiella quasipneumoniae and its subspecies, and group 3 consists of Klebsiella variicola. This is the first report of whole-genome sequencing of colistin-resistant K. quasipneumoniae subsp. similipneumoniae harboring bla(KPC-9) gene. Results: The isolate was obtained from the culture of a respiratory catheter tip from a 41-year-old woman with traumatic brain injury. Whole-genome sequencing showed the presence of bla(OKP-B-3) gene and hence it was identified as K. quasipneumoniae subsp. similipneumoniae. The isolate was resistant to all antimicrobials except tigecycline. Colistin resistance was chromosomally mediated; mcr-1 to mcr-5 genes and their variants were not identified. The isolate belonged to the novel clonal type ST2957. Conclusion: The isolation of KPC-9 from India, a nonendemic region, and in an isolate of K. quasipneumoniae highlights the importance of accurate identification of Klebsiella species and determination of mechanism of resistance. The novel sequence type obtained indicates evolution of the organism and acquisition of plasmid-mediated resistance. The occurrence of KPC in India is a potential public health threat.	[Shankar, Chaitra; Karunasree, Susmitha; Veeraraghavan, Balaji] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore 632004, Tamil Nadu, India; [Manesh, Abi] Christian Med Coll & Hosp, Dept Infect Dis, Vellore, Tamil Nadu, India		Veeraraghavan, B (corresponding author), Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore 632004, Tamil Nadu, India.	vbalaji@cmcvellore.ac.in	SOUNDRARAJAN, JOYSON/I-1779-2019; Shankar, Chaitra/AAN-7324-2021	Shankar, Chaitra/0000-0001-8903-4810			Anandan S, 2015, J CLIN DIAGN RES, V9, pDM1, DOI 10.7860/JCDR/2015/14246.6530; Biberg CA, 2015, BRAZ J MICROBIOL, V46, P501, DOI 10.1590/S1517-838246246220140174; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Chen L, 2014, ANTIMICROB AGENTS CH, V58, P2871, DOI 10.1128/AAC.00120-14; Chen MY, 2016, J BASIC MICROB, V56, P78, DOI 10.1002/jobm.201500415; Clinical and Laboratory Standards Institute, 2016, M100S26 CLSI; De Belder D, 2018, MICROB DRUG RESIST, V24, P958, DOI 10.1089/mdr.2017.0213; Fonseca EL, 2017, DIAGN MICR INFEC DIS, V87, P315, DOI 10.1016/j.diagmicrobio.2017.01.005; Gan HM, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00768-17, 10.1128/genomea.00768-17]; Gartzonika K, 2018, CLIN MICROBIOL INFEC, V24, P558, DOI 10.1016/j.cmi.2017.12.007; Garza-Ramos U, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00475-16; Hidalgo-Grass C, 2012, ANTIMICROB AGENTS CH, V56, P6057, DOI 10.1128/AAC.01156-12; Jain R, 2013, INFECT DIS REP, V5, P16, DOI 10.4081/idr.2013.e5; Kumarasamy K, 2012, J ANTIMICROB CHEMOTH, V67, P243, DOI 10.1093/jac/dkr431; Lee CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00895; Naas T, 2008, ANTIMICROB AGENTS CH, V52, P1257, DOI 10.1128/AAC.01451-07; Nadkarni AS, 2009, AM J INFECT CONTROL, V37, P121, DOI 10.1016/j.ajic.2007.10.013; Ozer EA, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00422-16; Paul D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145823; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Pournaras S, 2009, J ANTIMICROB CHEMOTH, V64, P348, DOI 10.1093/jac/dkp207; Rosenblueth M, 2004, SYST APPL MICROBIOL, V27, P27, DOI 10.1078/0723-2020-00261; Shankar C, 2017, J GLOB ANTIMICROB RE, V9, P30, DOI 10.1016/j.jgar.2017.01.004; Sharma A, 2016, J INFECT DIS THER, V4, P293, DOI DOI 10.4172/2332-0877; Stoesser N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06256-2; Tuon FF, 2015, BRAZ J INFECT DIS, V19, P324, DOI 10.1016/j.bjid.2015.01.003; Veeraraghavan B, 2017, PATHOG GLOB HEALTH, V111, P240, DOI 10.1080/20477724.2017.1340128; Warnock DW, 2010, MANUAL CLIN MICROBIO; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x	30	4	4	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1076-6294	1931-8448		MICROB DRUG RESIST	Microb. Drug Resist.	MAY 1	2019	25	4					489	493		10.1089/mdr.2018.0116		NOV 2018	5	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	HX9QD	WOS:000450065500001	30427763				2022-02-06	
J	Gillingham, SM; Vallesi, A; Pichora-Fuller, MK; Alain, C				Gillingham, Susan M.; Vallesi, Antonino; Pichora-Fuller, M. Kathleen; Alain, Claude			Older Adults With Hearing Loss Have Reductions in Visual, Motor and Attentional Functioning	FRONTIERS IN AGING NEUROSCIENCE			English	Article						attention; visual reaction time; temporal preparation; variable foreperiod; sequential foreperiod; hearing loss in older adults	TRAUMATIC BRAIN-INJURY; SIMPLE REACTION-TIME; AGE-RELATED-CHANGES; NONSPECIFIC PREPARATION; TEMPORAL PREPARATION; COGNITIVE FUNCTIONS; FOREPERIOD; MEMORY; VARIABILITY; DISSOCIATIONS	Evidence from epidemiological, laboratory and clinical research suggests a link between age-related auditory declines and domain-general cognitive declines. Nevertheless, few studies have experimentally compared measures of non-auditory cognitive functions in younger normal hearing adults (YN), older adults with typical hearing thresholds for their age (ONHA) and older adults with clinically significant threshold hearing loss (OHL). The current study investigated the differences between these groups on measures of attentional response selection and execution to visual stimuli. A visual reaction time (RT) paradigm involving four tasks with differing and hierarchical attentional demands was administered. RTs on trials with differing foreperiods (FPs; pre-stimulus waiting times) were analyzed to assess context-related slowing, error commission and related cognitive control and strategic and automatic neural preparatory processes. The OHL group demonstrated a general slowing that was most apparent on the simplest tasks. Although the number of errors was similar when comparing all three groups, the OHL group exhibited less control over recovery from an error compared to the younger and ONHA groups. Unlike the YN and ONHA groups, the OHL group also showed difficulties with both strategic and automatic response preparation, although automatic preparation was more affected across all tasks. This pattern of results suggests that in older adults with hearing loss there is an underlying difficulty in automatic temporal processing that can affect higher order cognitive functions, although there may not be a completely generalized decline in cognitive functioning that is associated with hearing loss.	[Gillingham, Susan M.; Pichora-Fuller, M. Kathleen; Alain, Claude] RRI, Baycrest Hlth Sci, Toronto, ON, Canada; [Gillingham, Susan M.; Pichora-Fuller, M. Kathleen; Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Vallesi, Antonino] Univ Padua, Padova Neurosci Ctr, Padua, Italy; [Vallesi, Antonino] Univ Padua, Dept Neurosci, Padua, Italy; [Vallesi, Antonino] San Camillo Hosp IRCCS, Venice, Italy; [Alain, Claude] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Alain, Claude] Univ Toronto, Fac Mus, Toronto, ON, Canada		Gillingham, SM (corresponding author), RRI, Baycrest Hlth Sci, Toronto, ON, Canada.; Gillingham, SM (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.	sgillingham@research.baycrest.org	Vallesi, Antonino/E-8987-2011	Vallesi, Antonino/0000-0002-4087-2845	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 106619]; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	This research was funded by the Canadian Institutes of Health Research (MOP 106619) and the Natural Sciences and Engineering Research Council of Canada (NSERC).	Albers MW, 2015, ALZHEIMERS DEMENT, V11, P70, DOI 10.1016/j.jalz.2014.04.514; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090594; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; DRAZIN DH, 1961, J EXP PSYCHOL, V62, P43, DOI 10.1037/h0046860; Fogerty D, 2010, J ACOUST SOC AM, V127, P2509, DOI 10.1121/1.3316291; Grassi M, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00059; Guerreiro MJS, 2017, NEUROBIOL AGING, V56, P180, DOI 10.1016/j.neurobiolaging.2017.05.001; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; HASHER L, 1985, J EXP PSYCHOL GEN, V114, P104, DOI 10.1037/0096-3445.114.1.104; HERTEL PT, 1991, J EXP PSYCHOL GEN, V120, P301, DOI 10.1037/0096-3445.120.3.301; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Humes LE, 2016, EAR HEARING, V37, p52S, DOI 10.1097/AUD.0000000000000303; Humes LE, 2013, ATTEN PERCEPT PSYCHO, V75, P508, DOI 10.3758/s13414-012-0406-9; KARLIN L, 1959, J EXP PSYCHOL, V58, P185, DOI 10.1037/h0049152; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kolev V, 2006, NEUROBIOL AGING, V27, P1719, DOI 10.1016/j.neurobiolaging.2005.09.027; KRAMES L, 1985, COGNITIVE THER RES, V9, P561, DOI 10.1007/BF01173009; Li KZH, 2002, NEUROSCI BIOBEHAV R, V26, P777, DOI 10.1016/S0149-7634(02)00073-8; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Lindenberger U, 2009, PSYCHOL AGING, V24, P1, DOI 10.1037/a0014986; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Los SA, 2001, ACTA PSYCHOL, V106, P121, DOI 10.1016/S0001-6918(00)00029-9; Los SA, 2001, J EXP PSYCHOL HUMAN, V27, P370, DOI 10.1037/0096-1523.27.2.370; Martini A, 2014, AUDIOL NEURO-OTOL, V19, P2, DOI 10.1159/000371593; Mudar RA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00828; Naatanen R, 1970, Acta Psychol (Amst), V34, P399, DOI 10.1016/0001-6918(70)90035-1; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Ouda L, 2015, CELL TISSUE RES, V361, P337, DOI 10.1007/s00441-014-2107-2; Pichora-Fuller MK, 2017, SPRINGER HANDB AUDIT, V60, P227, DOI 10.1007/978-3-319-51662-2_9; Pichora-Fuller MK, 2016, EAR HEARING, V37, p5S, DOI 10.1097/AUD.0000000000000312; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; Reitan R, 1985, HALSTEAD REITAN NEUR; Ronnberg J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00326; Ronnberg J, 2011, J SPEECH LANG HEAR R, V54, P705, DOI 10.1044/1092-4388(2010/09-0088); Salthouse T. A., 1985, HDB AGING HDB PSYCHO, P400; STERNBERG S, 1969, AM SCI, V57, P421; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Stuss DT, 2002, NEUROPSYCHOLOGY, V16, P500, DOI 10.1037//0894-4105.16.4.500; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Thomas P, 1999, EUR ARCH PSY CLIN N, V249, P79, DOI 10.1007/s004060050070; Tun PA, 2012, AM J AUDIOL, V21, P344, DOI 10.1044/1059-0889(2012/12-0030); Vallesi A, 2007, J EXP PSYCHOL HUMAN, V33, P1377, DOI 10.1037/0096-1523.33.6.1377; Vallesi A, 2007, NEUROPSYCHOLOGIA, V45, P2755, DOI 10.1016/j.neuropsychologia.2007.04.017; Vallesi A, 2014, COGNITION, V130, P141, DOI 10.1016/j.cognition.2013.10.006; Vallesi A, 2013, COGNITION, V127, P22, DOI 10.1016/j.cognition.2012.11.011; Vaughan N, 2008, J AM ACAD AUDIOL, V19, P533, DOI 10.3766/jaaa.19.7.2; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Welford A. T, 1980, HDB MENTAL HLTH AGIN, P192; Wolfson, 1993, HALSTEAD REITAN NEUR; Woodrow H, 1914, PSYCHOL MONOGR, V17, P1; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131	58	4	4	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	NOV 6	2018	10								351	10.3389/fnagi.2018.00351			15	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	GZ4AL	WOS:000449332200001	30459591	Green Published, gold			2022-02-06	
J	Bang, JY; Kim, SO; Kim, SG; Song, JG; Kang, J; Kim, JW; Ha, S				Bang, Ji-Yeon; Kim, Seon-Ok; Kim, Sae-Gyeol; Song, Jun-Gol; Kang, Jiwon; Kim, Jong-Wook; Ha, Seungil			Impact of the serum albumin level on acute kidney injury after cerebral artery aneurysm clipping	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; BYPASS SURGERY; RAT-KIDNEY; MORTALITY; RISK; HYPOALBUMINEMIA; RESUSCITATION; DYSFUNCTION; CELLS	Background Although hypoalbuminemia is a known risk factor for acute kidney injury (AKI) following surgery, little is known about its effects following aneurysm clipping surgery. We aimed to investigate the predictors of AKI and overall mortality and assessed the relationship between preoperative albumin and postoperative outcomes after aneurysm clipping surgery. Methods This study included 2,339 patients who underwent aneurysm clipping surgery. According to the criteria updated by the Kidney Disease: Improving Global Outcomes (KDIGO), patients were classified into AKI and no AKI group. Independent AKI predictors were analyzed by multivariate methods, and the influence of AKI on the outcome variables was assessed with by propensity score matching analysis. Survival in relation to AKI was analyzed using the Kaplan-Meier method. Results The total proportion of patients who developed AKI was 1.9%. The cutoff value of preoperative albumin for predicting AKI was 3.9 g/dL. Multivariate analyses showed that preoperative albumin <= 3.9 g/dL, aneurysmal subarachnoid hemorrhage, male sex, phenylephrine use, and hemoglobin were associated with postoperative AKI development. In multivariate analysis, mortality was increased in AKI patients (p< 0.01). After propensity score matching, preoperative albumin <= 3.9 g/dL was significantly related to AKI and overall mortality. Conclusion Preoperative albumin <= 3.9 g/dL is associated with postoperative AKI and mortality.	[Bang, Ji-Yeon; Kim, Sae-Gyeol; Song, Jun-Gol; Kang, Jiwon; Kim, Jong-Wook; Ha, Seungil] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Kim, Seon-Ok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea		Ha, S (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	seungilha@amc.seoul.kr		Saratzis, Athanasios/0000-0002-3399-094X			Bellomo R, 2008, CRIT CARE MED, V36, pS179, DOI 10.1097/CCM.0b013e318169167f; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; CONTRERAS AM, 1994, REV INVEST CLIN, V46, P37; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Dixon R, 1999, J AM SOC NEPHROL, V10, P1487; Doi K, 2004, KIDNEY INT, V65, P1714, DOI 10.1111/j.1523-1755.2004.00567.x; Dubois MJ, 2006, CRIT CARE MED, V34, P2536, DOI 10.1097/01.CCM.0000239119.57544.0C; Grams ME, 2016, AM J KIDNEY DIS, V67, P872, DOI 10.1053/j.ajkd.2015.07.022; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Heyman S N, 1995, New Horiz, V3, P597; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Igleslas J, 1999, AM J PHYSIOL-RENAL, V277, pF711, DOI 10.1152/ajprenal.1999.277.5.F711; Jeffcote T, 2010, ANAESTH INTENS CARE, V38, P274, DOI 10.1177/0310057X1003800208; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; KAUFMANN MA, 1995, J PHARMACOL EXP THER, V273, P855; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Kim CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082289; Lee EH, 2016, ANESTHESIOLOGY, V124, P1001, DOI 10.1097/ALN.0000000000001051; Lee EH, 2014, J CARDIOTHOR VASC AN, V28, P936, DOI 10.1053/j.jvca.2013.12.006; Lee EH, 2012, INTENS CARE MED, V38, P1478, DOI 10.1007/s00134-012-2599-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Margarson MP, 1998, ANAESTHESIA, V53, P789, DOI 10.1046/j.1365-2044.1998.00438.x; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Sear JW, 2005, BRIT J ANAESTH, V95, P20, DOI 10.1093/bja/aei018; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Wiedermann CJ, 2010, INTENS CARE MED, V36, P1657, DOI 10.1007/s00134-010-1928-z; Wu HC, 2016, RENAL FAILURE, V38, P330, DOI 10.3109/0886022X.2015.1128790; Zacharia BE, 2009, STROKE, V40, P2375, DOI 10.1161/STROKEAHA.108.545210	30	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206731	10.1371/journal.pone.0206731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	WOS:000449291400045	30395651	Green Submitted, Green Published, gold			2022-02-06	
J	Angulo-Parker, FJ; Adkinson, JM				Angulo-Parker, Francisco J.; Adkinson, Joshua M.			Common Etiologies of Upper Extremity Spasticity	HAND CLINICS			English	Article						Spasticity; Spastic hypertonia; Upper extremity; Motor neuron syndrome; Cerebral palsy; Spinal cord injury; Stroke; Cerebrovascular accident	SPINAL-CORD-INJURY; CEREBRAL-PALSY; PREVALENCE; PATHOPHYSIOLOGY; STROKE; CLASSIFICATION; EPIDEMIOLOGY; ASSOCIATION; IMPAIRMENTS; DEFINITION	Spasticity is a motor disorder that manifests as a component of the upper motor neuron syndrome. It is associated with paralysis and can cause significant disability. The most common causes leading to spasticity include stroke, traumatic brain injury, multiple sclerosis, spinal cord injury, and cerebral palsy. This article discusses the pathophysiology and clinical findings associated with each of the most common etiologies of upper extremity spasticity.	[Angulo-Parker, Francisco J.] Indiana Univ Sch Med, Dept Pediat, Phys Med & Rehabil, 705 Riley Hosp Dr, Indianapolis, IN 46202 USA; [Adkinson, Joshua M.] Indiana Univ Sch Med, Dept Surg, Div Plast Surg, 545 Barnhill Dr,Emerson Hall 232, Indianapolis, IN 46202 USA		Adkinson, JM (corresponding author), Indiana Univ Sch Med, Dept Surg, Div Plast Surg, 545 Barnhill Dr,Emerson Hall 232, Indianapolis, IN 46202 USA.	jadkinso@iu.edu					[Anonymous], LEAD CAUS DEATH; Anson CA, 1996, INT J REHABIL RES, V19, P55, DOI 10.1097/00004356-199603000-00006; Armour BS, 2016, AM J PUBLIC HEALTH, V106, P1855, DOI 10.2105/AJPH.2016.303270; Balakrishnan Sudha, 2013, Handb Clin Neurol, V110, P145, DOI 10.1016/B978-0-444-52901-5.00013-7; Barnes MP, 2003, NEUROREHAB NEURAL RE, V17, P66, DOI 10.1177/0888439002250449; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Bernhard M, 2005, RESUSCITATION, V66, P127, DOI 10.1016/j.resuscitation.2005.03.005; Bryce T, 2011, PHYS MED REHABILITAT, P1293; CDC, FACTS AB STROK; Centers for Disease Control and Prevention, DAT STAT CER PALS; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Dolhun RM, 2011, SPASTICITY: DIAGNOSIS AND MANAGEMENT, P297; Dromerick AW, 2002, CUR CLIN NEUROL, P13; Durkin MS, 2016, PAEDIATR PERINAT EP, V30, P496, DOI 10.1111/ppe.12299; Evans K, 2001, J Obstet Gynaecol, V21, P114, DOI 10.1080/01443610020025967; Gormley ME, 1997, MUSCLE NERVE, pS14; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Harvey RL, 2011, PHYS MED REHABILITAT, P1177; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; James MA, 2007, J HAND SURG-AM, V32A, P154, DOI 10.1016/j.jhsa.2006.11.008; Johnson RL, 1998, SPINAL CORD, V36, P45, DOI 10.1038/sj.sc.3100494; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; Kraft G, 2011, PHYS MED REHABILITAT, P1233; Leclercq C, 2003, HAND CLIN, V19, P557, DOI 10.1016/S0749-0712(03)00059-3; Lundstrom E, 2008, EUR J NEUROL, V15, P533, DOI 10.1111/j.1468-1331.2008.02114.x; Malhotra S, 2008, CLIN REHABIL, V22, P1105, DOI 10.1177/0269215508095089; MAYNARD FM, 1990, ARCH PHYS MED REHAB, V71, P566; McGuire JR, 2011, SPASTICITY: DIAGNOSIS AND MANAGEMENT, P5; McMahon M, 2015, PEDIATRIC REHABILITATION: PRINCIPLES AND PRACTICE, FIFTH EDITION, P336; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; Noreau L, 2000, AM J PHYS MED REHAB, V79, P526, DOI 10.1097/00002060-200011000-00009; Powell A, 2015, PHYS MED REH CLIN N, V26, P109, DOI 10.1016/j.pmr.2014.09.002; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Wagner A, 2011, PHYS MED REHABILITAT, P1133; Walker HW, 2011, SPASTICITY: DIAGNOSIS AND MANAGEMENT, P313; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; Wedekind C, 2005, BRAIN INJURY, V19, P681, DOI 10.1080/02699050400025182; Welmer AK, 2006, CEREBROVASC DIS, V21, P247, DOI 10.1159/000091222; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; Zorowitz R, 2010, PHYS MED REHABILITAT, P40	45	4	4	1	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0712	1558-1969		HAND CLIN	Hand Clin.	NOV	2018	34	4					437	+		10.1016/j.hcl.2018.06.001			8	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	GY5QU	WOS:000448636400002	30286958				2022-02-06	
J	Avery, M; Wattie, N; Holmes, M; Dogra, S				Avery, Michelle; Wattie, Nick; Holmes, Michael; Dogra, Shilpa			SEASONAL CHANGES IN FUNCTIONAL FITNESS AND NEUROCOGNITIVE ASSESSMENTS IN YOUTH ICE-HOCKEY PLAYERS	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						functional movement screen; injury; Y-Balance Test; concussion	Y-BALANCE TEST; TEST-RETEST RELIABILITY; MOVEMENT SCREEN; RISK-FACTORS; FUNDAMENTAL MOVEMENTS; INJURY; CONCUSSION; CHILDREN; SCORES; SOCCER	Deficits in balance and strength combined with differing rates of sensory and motor neural development may increase risk of sports-related injury in youth. This study evaluated changes in functional fitness and concussion status over the course of a competitive season in youth ice-hockey players, and examined the relationship between these variables and injury occurrence. Thirty-six participants (8.9 +/- 1.1 years) completed preseason and postseason assessments including anthropometric measurements, the functional movement screen (FMS), Lower Quarter Y-Balance Test (YBT-LQ), and a computerized neurocognitive assessment (ImPACT). Paired-samples t-tests were used to compare preseason and postseason data. Independent samples t-tests were used to compare FMS, YBT-LQ, and ImPACT scores between injured and uninjured participants at baseline. The mean composite score of the FMS was not statistically different between preseason (15.1 +/- 1.8) and postseason (15.6 +/- 2.3, p < 0.16). The YBT-LQ composite score showed a decrease in reach distance scores between preseason (86.10 +/- 6.00) and postseason (83.20 +/- 5.40, p < 0.001). Neurocognitive assessment scores improved in both the injured and uninjured participants. There were no significant relationships between FMS scores, YBT-LQ, and injury incidence. Results from our study provide insight into changes in functional fitness levels and neurocognitive scores over the course of a season in youth ice-hockey players. These findings provide insight into expected changes over the course of a season and provide context for injury risk monitoring by coaches.	[Avery, Michelle; Wattie, Nick; Dogra, Shilpa] Univ Ontario Inst Technol, Fac Hlth Sci Kinesiol, Hlth & Human Performance Lab, Oshawa, ON, Canada; [Holmes, Michael] Brock Univ, Fac Appl Hlth Sci, St Catharines, ON, Canada		Dogra, S (corresponding author), Univ Ontario Inst Technol, Fac Hlth Sci Kinesiol, Hlth & Human Performance Lab, Oshawa, ON, Canada.	Shilpa.Dogra@uoit.ca	Holmes, Mike/AAA-9582-2019	Holmes, Mike/0000-0002-1918-1695			Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Gonell AC, 2015, INT J SPORTS PHYS TH, V10, P955; Chorba Rita S, 2010, N Am J Sports Phys Ther, V5, P47; Cook G, 2014, INT J SPORTS PHYS TH, V9, P549; Cook G, 2014, INT J SPORTS PHYS TH, V9, P396; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Faigenbaum AD, 2014, INT J SPORTS PHYS TH, V9, P140; Faigenbaum AD, 2013, PEDIATR EXERC SCI, V25, P591, DOI 10.1123/pes.25.4.591; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Forward KE, 2014, PAED CHILD HEALT-CAN, V19, P418, DOI 10.1093/pch/19.8.418; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Garrison M, 2015, INT J SPORTS PHYS TH, V10, P21; Government of Canada, 2013, CAN HER SPORT PART 2; Hockey Development Center for Ontario, 2015, PLAYER INF MED FOR; Kiesel Kyle, 2007, N Am J Sports Phys Ther, V2, P147; Kostka T, 2012, BRIT J SPORT MED, V46, P159, DOI 10.1136/bjsports-2011-090043; KOUTEDAKIS Y, 1995, SPORTS MED, V19, P373, DOI 10.2165/00007256-199519060-00002; Krumrei K, 2014, J SPORT REHABIL, V23, P360, DOI 10.1123/jsr.2013-0027; Lemez S, 2014, SCAND J MED SCI SPOR, V24, P935, DOI 10.1111/sms.12127; MacDonald J, 2015, CLIN J SPORT MED, V25, P43, DOI 10.1097/JSM.0000000000000096; Malina RM, 2004, GROWTH MATURATION PH, P350; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Mckay C, 2013, CLIN J SPORT MED, V23, P216, DOI 10.1097/JSM.0b013e31826a86c9; Moser RS, 2017, APPL NEUROPSYCH-CHIL, V6, P166, DOI 10.1080/21622965.2016.1138310; Parenteau E, 2014, PHYS THER SPORT, V15, P169, DOI 10.1016/j.ptsp.2013.10.001; Quatman-Yates CC, 2012, BRIT J SPORT MED, V46, P649, DOI 10.1136/bjsm.2010.079616; Rossler R, 2016, J SPORT SCI, V34, P549, DOI 10.1080/02640414.2015.1099715; Rowan CP, 2015, J STRENGTH COND RES, V29, P1163, DOI 10.1519/JSC.0000000000000757; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Smith CA, 2015, MED SCI SPORT EXER, V47, P136, DOI 10.1249/MSS.0000000000000380; Sports Medicine Australia, 2015, INJ TRACK FORM; Sprague PA, 2014, J STRENGTH COND RES, V28, P3155, DOI 10.1519/JSC.0000000000000506; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; Washington RL, 2001, PEDIATRICS, V107, P1459; Wattie N, 2007, PEDIATRICS, V120, P142, DOI 10.1542/peds.2006-2672; Wright AA, 2017, PHYSIOTHERAPY, V103, P231, DOI 10.1016/j.physio.2016.06.002; Wu R, 2016, AGE, V38, DOI 10.1007/s11357-016-9921-2; Zech A, 2014, EUR J APPL PHYSIOL, V114, P395, DOI 10.1007/s00421-013-2786-5; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38	43	4	4	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	NOV	2018	32	11					3143	3152		10.1519/JSC.0000000000002399			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HF1ZU	WOS:000454033000021	29239998				2022-02-06	
J	Bailly, N; Llari, M; Donnadieu, T; Masson, C; Arnoux, PJ				Bailly, Nicolas; Llari, Maxime; Donnadieu, Thierry; Masson, Catherine; Arnoux, Pierre-Jean			Numerical Reconstruction of Traumatic Brain Injury in Skiing and Snowboarding	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						SKI; SNOWBOARD; HEAD INJURY; HELMET; IMPACT BIOMECHANICS; STANDARDS TEST	SEVERE HEAD-INJURY; IMPACTS; CONCUSSION; ACCIDENT; SEASONS; SPORTS	Purpose Proper evaluation of ski helmet designs and safety standards should rely on head impact conditions involved in skiing and snowboarding head injuries. To study these impacts, main crash scenarios involving head injuries are numerically replicated. Methods Multibody models of skiers and snowboarders were developed to investigate five common crash scenarios involved in traumatic brain injury: forward and sideways skiing falls, snowboarding backward falls, collisions between users and collisions with obstacles. For each scenario, the influence of crash conditions on head impact (location, speed, linear and rotational accelerations) and risk of injury are evaluated. Crash conditions were initial velocity, user height, position and approach angle, slope steepness, obstacles, and snow stiffness. Results One thousand one hundred forty-nine crashes were simulated and three significant levels of impact conditions were discriminated over the investigated crash scenarios: 1) the smallest normal-to-slope impact velocities (6 kmh(-1); 22 kmh(-1)) and peak linear accelerations (42g; 75g) were obtained during forward and sideways skiing falls; 2) snowboarding backward falls and collisions between users were associated with high normal-to-surface impact velocities (26 kmh(-1); 32 kmh(-1)) and head accelerations (80g; 149g) above one published threshold for mild traumatic brain injury but below the pass/fail criteria of helmet standard tests; 3) collisions with obstacles were associated with high normal-to-surface impact velocities (19 kmh(-1); 35 kmh(-1)) and the highest head accelerations (626g; 1885g). Conclusions Current impact conditions of helmet standard evaluations consistently replicate collisions with obstacles, but need to be revised to better reflect other significant crash scenarios leading to traumatic brain injury.	[Bailly, Nicolas] Ecole Technol Super, Dept Mech Engn, Montreal, PQ, Canada; [Bailly, Nicolas] Sacre Coeur Hosp, Res Ctr, Montreal, PQ, Canada; [Bailly, Nicolas; Arnoux, Pierre-Jean] Associated Int Lab Spine Biomech & Imagery, iLAB Spine, Montreal, PQ, Canada; [Bailly, Nicolas; Llari, Maxime; Masson, Catherine; Arnoux, Pierre-Jean] Univ Mediterranean, IFSTTAR, UMRT24, Lab Biomecan Appl, Marseille, France; [Bailly, Nicolas; Donnadieu, Thierry] Salomon SAS, Annecy, France		Bailly, N (corresponding author), Ctr Rech HSCM 5400, Lab Rech Imagerie & Orthoped, Local K-4075, Montreal, PQ H4J 1C5, Canada.	nicolas1.bailly@gmail.com	ARNOUX, Pierre Jean/AAK-6652-2021	ARNOUX, Pierre Jean/0000-0002-0311-560X			Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; [Anonymous], 2011, F2040 F08 COMM; Association des Medecin de Montagne, 2013, REP EP SNOW SPORT FR; Bailly N, 2017, SCAND J MED SCI SPOR, V27, P964, DOI 10.1111/sms.12699; Bailly N., 2017, SNOW SPORTS TRAUMA S, P163; Bailly N, 2018, WILD ENVIRON MED, V29, P151, DOI 10.1016/j.wem.2017.11.007; Bailly N, 2017, MED SCI SPORT EXER, V49, P1, DOI 10.1249/MSS.0000000000001078; Bourdet N, 2014, INT J CRASHWORTHINES, V19, P222, DOI 10.1080/13588265.2013.805293; Brunner F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132002; Chamarro A, 2009, ACCIDENT ANAL PREV, V41, P197, DOI 10.1016/j.aap.2008.10.012; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dickson TJ, 2017, SCAND J MED SCI SPOR, V27, P236, DOI 10.1111/sms.12642; Dickson TJ, 2011, PROCEDIA ENGINEER, V13, P476, DOI 10.1016/j.proeng.2011.05.117; European Committee for Standardization, 2007, 10772007 EN; Fierz C., 2009, INT CLASSIFICATION S; Gilgien M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118119; Glasson E, 2000, VEH SAF 2000 P INT C; Greve MW, 2009, WILD ENVIRON MED, V20, P234, DOI 10.1580/08-WEME-OR-244R1.1; Kleinberger M, 1998, DEV IMPROVED INJURY; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; Mecham MD, 1999, J APPL BIOMECH, V15, P27, DOI 10.1123/jab.15.1.27; Meyers MC, 2007, SPORTS MED, V37, P485, DOI 10.2165/00007256-200737060-00003; Mills NJ, 2007, POLYMER FOAMS HANDBOOK: ENGINEERING AND BIOMECHANICS APPLICATIONS AND DESIGN GUIDE, P1; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; Nakaguchi H, 2002, J NEUROSURG, V97, P542, DOI 10.3171/jns.2002.97.3.0542; Richards Darrin, 2008, Journal of ASTM International, V5, DOI 10.1520/JAI101406; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Scher I, 2009, SKIING TRAUMA SAFETY, V17th; Scher I, 2006, J ASTM INT, V3, P1; Serre T, 2007, INT J CRASHWORTHINES, V12, P227, DOI 10.1080/13588260701441050; Shealy JE., 2015, SKIING TRAUMA SAFETY, V20th Volume, P22, DOI DOI 10.1520/STP158220140079; Steenstrup SE, 2018, BRIT J SPORT MED, V52, P32, DOI 10.1136/bjsports-2016-097086; Steenstrup SE, 2018, BRIT J SPORT MED, V52, P709, DOI 10.1136/bjsports-2017-098050; Steenstrup SE, 2018, BRIT J SPORT MED, V52, P61, DOI 10.1136/bjsports-2017-098240; Takakuwa T, 1997, J ORTHOP SCI, V2, P367, DOI [10.1007/BF02488923, DOI 10.1007/BF02488923]; van Hoof Jack, 2003, Stapp Car Crash J, V47, P401; Xiang HY, 2003, INJURY, V34, P892, DOI 10.1016/S0020-1383(03)00055-X; Yamazaki J, 2015, MED SCI SPORT EXER, V47, P1113, DOI 10.1249/MSS.0000000000000511; Yang J.K., 2000, J CRASH PREVENTION I, V2, P131, DOI [10.1080/10286580008902559, DOI 10.1080/10286580008902559]; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	43	4	4	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2018	50	11					2322	2329		10.1249/MSS.0000000000001701			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GX2PC	WOS:000447560400017	30048412	Bronze			2022-02-06	
J	Baker, MT; Moring, JC; Hale, WJ; Mintz, J; Young-McCaughan, S; Bryant, RA; Broshek, DK; Barth, JT; Villarreal, R; Lancaster, CL; Malach, SL; Lara-Ruiz, JM; Isler, W; Peterson, AL				Baker, Monty T.; Moring, John C.; Hale, Willie J.; Mintz, Jim; Young-McCaughan, Stacey; Bryant, Richard A.; Broshek, Donna K.; Barth, Jeffrey T.; Villarreal, Robert; Lancaster, Cynthia L.; Malach, Steffany L.; Lara-Ruiz, Jose M.; Isler, William; Peterson, Alan L.		STRONG STAR Consortium	Acute Assessment of Traumatic Brain Injury and Post-Traumatic Stress After Exposure to a Deployment-Related Explosive Blast	MILITARY MEDICINE			English	Article							NEUROPSYCHOLOGICAL ASSESSMENT METRICS; ACUTE CONCUSSION EVALUATION; PSYCHOMETRIC PROPERTIES; REPEATABLE BATTERY; PTSD CHECKLIST; COMBAT DUTY; DISORDER; IRAQ; RELIABILITY; AFGHANISTAN	Introduction: Traumatic brain injury (FBI) and post-traumatic stress disorder (PTSD) are two of the signature injuries in military service members who have been exposed to explosive blasts during deployments to Iraq and Afghanistan. Acute stress disorder (ASD), which occurs within 2-30 d after trauma exposure, is a more immediate psychological reaction predictive of the later development of PTSD. Most previous studies have evaluated service members after their return from deployment, which is often months or years after the initial blast exposure. The current study is the first large study to collect psychological and neuropsychological data from active duty service members within a few days after blast exposure. Materials and Methods: Recruitment for blast-injured TBI patients occurred at the Air Force Theater Hospital, 332nd Air Expeditionary Wing, Joint Base Balad, Iraq. Patients were referred from across the combat theater and evaluated as part of routine clinical assessment of psychiatric and neuropsychological symptoms after exposure to an explosive blast. Four measures of neuropsychological functioning were used: the Military Acute Concussion Evaluation (MACE); the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS); the Headminder Cognitive Stability Index (CSI); and the Automated Neuropsychological Assessment Metrics, Version 4.0 (ANAM4). Three measures of combat exposure and psychological functioning were used: the Combat Experiences Scale (CES); the PTSD Checklist-Military Version (PCL-M); and the Acute Stress Disorder Scale (ASDS). Assessments were completed by a deployed clinical psychologist, clinical social worker, or mental health technician. Results: A total of 894 patients were evaluated. Data from 93 patients were removed from the data set for analysis because they experienced a head injury due to an event that was not an explosive blast (n = 84) or they were only assessed for psychiatric symptoms (n = 9). This resulted in a total of 801 blast-exposed patients for data analysis. Because data were collected in-theater for the initial purpose of clinical evaluation, sample size varied widely between measures, from 565 patients who completed the MACE to 154 who completed the CES. Bivariate correlations revealed that the majority of psychological measures were significantly correlated with each other (ps <= 0.01), neuropsychological measures were correlated with each other (ps <= 0.05), and psychological and neuropsychological measures were also correlated with each other (ps <= 0.05). Conclusions: This paper provides one of the first descriptions of psychological and neuropsychological functioning (and their inter-correlation) within days after blast exposure in a large sample of military personnel. Furthermore, this report describes the methodology used to gather data for the acute assessment of TBI, PTSD, and ASD after exposure to an explosive blast in the combat theater. Future analyses will examine the common and unique symptoms of TBI and PTSD, which will be instrumental in developing new assessment approaches and intervention strategies.	[Baker, Monty T.; Moring, John C.; Hale, Willie J.; Mintz, Jim; Young-McCaughan, Stacey; Villarreal, Robert; Malach, Steffany L.; Lara-Ruiz, Jose M.; Peterson, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, 7550 Interstate Highway 10 West,Suite 1325, San Antonio, TX 78229 USA; [Baker, Monty T.; Isler, William] Wilford Hall Ambulatory Surg Ctr, 2200 Bergquist Dr, San Antonio, TX 78236 USA; [Hale, Willie J.; Lara-Ruiz, Jose M.; Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, One UTSA Circle, San Antonio, TX 78249 USA; [Bryant, Richard A.] Univ New South Wales, Sch Psychol, 11 Bot St, Sydney, NSW 2052, Australia; [Broshek, Donna K.; Barth, Jeffrey T.] Univ Virginia, Sch Med, Dept Psychiat, 1215 Lee St, Charlottesville, VA 22908 USA; [Lancaster, Cynthia L.] Univ Nevada, Dept Psychol, 1664 N Virginia St, Reno, NV 89557 USA; [Malach, Steffany L.] Brooke Army Med Ctr, 3551 Roger Brooke Dr, San Antonio, TX 78219 USA; [Peterson, Alan L.] South Texas Vet Hlth Care Syst, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA		Baker, MT (corresponding author), Wilford Hall Ambulatory Surg Ctr, 2200 Bergquist Dr, San Antonio, TX 78236 USA.		Bryant, Richard/AAA-6479-2019; Broshek, Donna/ABA-4208-2021	Bryant, Richard/0000-0002-9607-819X; Broshek, Donna/0000-0002-7175-7815	United States Air Force Aerospace Medicine and Human Performance Integration Research Program [FA86-50-11-2-6162]; Defense Medical Research and Development Program Applied Research and Advanced Technology Development Awards [D10_I_AR_J6_577]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002646] Funding Source: NIH RePORTER	This study was supported by research grants through the United States Air Force Aerospace Medicine and Human Performance Integration Research Program (FA86-50-11-2-6162), and the Defense Medical Research and Development Program Applied Research and Advanced Technology Development Awards (D10_I_AR_J6_577).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Barth J., 2010, MILITARY NEUROPSYCHO, P127; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2000, PSYCHOL ASSESSMENT, V12, P61, DOI 10.1037/1040-3590.12.1.61; Bryant RA, 1998, J CONSULT CLIN PSYCH, V66, P862, DOI 10.1037/0022-006X.66.5.862; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2015, PSYCHOTHER PSYCHOSOM, V84, P120, DOI 10.1159/000370049; Burgess Paula, 2010, J Emerg Trauma Shock, V3, P164, DOI 10.4103/0974-2700.62120; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Center for the Study of Human Operator Performance, 2007, AUT NEUR ASS METR VE; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Duff K, 2005, J CLIN EXP NEUROPSYC, V27, P565, DOI 10.1080/13803390490918363; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Kane RL, 2005, ARCH CLIN NEUROPS S1, V22, pS115; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Levinson D, 2005, ARCH CLIN NEUROPSYCH, V20, P403, DOI 10.1016/j.acn.2004.09.001; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; McCrea M., 2000, STANDARDIZED ASSESSM; McCrea M, 2014, MIL MED, V179, P990, DOI 10.7205/MILMED-D-13-00349; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050118030; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Owens G. P., 2009, TRAUMATOLOGY, V15, P31, DOI DOI 10.1177/1534765609336361; Peterson AL, 2008, PERSPECT PSYCHIATR C, V44, P146, DOI 10.1111/j.1744-6163.2008.00169.x; Peterson AL, 2008, PERSPECT PSYCHIATR C, V44, P159, DOI 10.1111/j.1744-6163.2008.00170.x; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Weathers FW, 1994, PCL M FOR DSM 4; Wild K, 2008, ALZHEIMERS DEMENT, V4, P428, DOI 10.1016/j.jalz.2008.07.003; Wilk CM, 2004, SCHIZOPHR RES, V70, P175, DOI 10.1016/j.schres.2003.10.009; Woodhouse J, 2013, CLIN NEUROPSYCHOL, V27, P376, DOI 10.1080/13854046.2012.762427	57	4	5	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2018	183	11-12					E555	E563		10.1093/milmed/usy100			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HC4ZP	WOS:000451813600030	29788111	Green Submitted, Green Published, hybrid			2022-02-06	
J	Jang, SH; Kim, SH; Kwon, YH				Jang, Sung Ho; Kim, Seong Ho; Kwon, Young Hyeon			Extensive traumatic axonal injury of brain due to violence A case report	MEDICINE			English	Article						diffusion tensor imaging; traumatic axonal injury; traumatic brain injury; violence	DIFFUSION-TENSOR TRACTOGRAPHY; SPINOTHALAMIC TRACT; CORTICOBULBAR TRACT; CENTRAL PAIN	Rationale: Many studies using diffusion tensor imaging (DTI) have demonstrated traumatic axonal injury (TAI) in patients whose conventional brain magnetic resonance imaging (MRI) results are negative following head trauma. Injury mechanism for TAI in these patients has been mainly associated with motor vehicle accident, whereas very little is known about TAI by violence. Patient concerns: A 42-year-old male patient presented after experiencing head trauma due to violence. His face was hit several times by 2 men, and 1 of the men kicked the right side of the patient's head, after which the patient's left parietal area hit the ground while falling. After the head trauma, he felt mild motor weakness of the left upper and lower extremities and had mild articulation difficulty, cognitive dysfunction including memory impairment, and excessive daytime sleepiness. Diagnoses: The patient was diagnosed as TAI. Interventions: Clinical assessments and DTI were performed at 10 days after the head trauma. Outcomes: He showed mild left hemiparesis (5/4), mild dysarthria, mild cognitive abnormality (Clinical Dementia Rating: 0.5) and mild abnormality on the Epworth Sleepiness Scale (score: 12; cut-off score: 10, maximum score: 24). DTI showed the following configurational abnormalities: right corticospinal tract narrowing, left corticobulbar tract narrowing, discontinuations in the anterior portion of both cingula, discontinuation of the left fornical crus, non-reconstruction of the right dorsolateral prefronto-thalamic tract, and narrowing in both lower ventral ascendin Lessons: Extensive TAI of various neural tracts was demonstrated by performing DTI of a patient with head trauma due to violence. Analysis of the neural tracts via DTI can be useful in detection of TAI in patients who show various neurological features following head trauma due to violence.	[Jang, Sung Ho; Kwon, Young Hyeon] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea; [Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Daegu, South Korea		Kwon, YH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea.	kyh7648764@daum.net			Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Concha L, 2005, AM J NEURORADIOL, V26, P2267; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hughes CP, 1982, BRIT J PSYCHIAT, P6; Jang SH, TRAUMATIC BRAIN INJU, P137; Jang SH, 2016, J NEUROTRAUM, V33, P1790, DOI 10.1089/neu.2015.4298; Jang SH, 2016, BRAIN INJURY, V30, P933, DOI 10.3109/02699052.2016.1146966; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003007; Jang SH, 2016, SLEEP MED, V17, P124, DOI 10.1016/j.sleep.2015.09.020; Jang SH, 2015, NEUROSCI LETT, V590, P80, DOI 10.1016/j.neulet.2015.01.072; Jang SH, 2014, YONSEI MED J, V55, P709, DOI 10.3349/ymj.2014.55.3.709; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Liegeois F, 2013, NEUROLOGY, V80, P926, DOI 10.1212/WNL.0b013e3182840c6d; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; YORK DH, 1987, NEUROSURGERY, V20, P70; 장성호, 2016, [Brain & NeuroRehabilitation, 뇌신경재활], V9, P1	28	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV	2018	97	48							e13315	10.1097/MD.0000000000013315			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD4AE	WOS:000452467000043	30508923	Green Published, gold			2022-02-06	
J	Khanmohammadi, S; Laurido-Soto, O; Eisenman, LN; Kummer, TT; Ching, SN				Khanmohammadi, Sina; Laurido-Soto, Osvaldo; Eisenman, Lawrence N.; Kummer, Terrance T.; Ching, ShiNung			Intrinsic network reactivity differentiates levels of consciousness in comatose patients	CLINICAL NEUROPHYSIOLOGY			English	Article						Consciousness; Traumatic brain injury; Coma; Electroencephalography; Intrinsic dynamics; Intrinsic Network Reactivity Index (INRI)	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; TIME-SERIES; EFFECTIVE CONNECTIVITY; PROLONGED DISORDERS; EEG; COMPLEXITY; SCALE; RECOVERY; SYNCHRONIZATION	Objective: We devise a data-driven framework to assess the level of consciousness in etiologically heterogeneous comatose patients using intrinsic dynamical changes of resting-state Electroencephalogram (EEG) signals. Methods: EEG signals were collected from 54 comatose patients (GCS <= 8) and 20 control patients (GCS > 8). We analyzed the EEG signals using a new technique, termed Intrinsic Network Reactivity Index (INRI), that aims to assess the overall lability of brain dynamics without the use of extrinsic stimulation. The proposed technique uses three sigma EEG events as a trigger for ensuing changes to the directional derivative of signals across the EEG montage. Results: The INRI had a positive relationship with GCS and was significantly different between various levels of consciousness. In comparison, classical band-limited power analysis did not show any specific patterns correlated to GCS. Conclusions: These findings suggest that reaching low variance EEG activation patterns becomes progressively harder as the level of consciousness of patients deteriorate, and provide a quantitative index based on passive measurements that characterize this change. Significance: Our results emphasize the role of intrinsic brain dynamics in assessing the level of consciousness in coma patients and the possibility of employing simple electrophysiological measures to recognize the severity of disorders of consciousness (DOC). (C) 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.	[Khanmohammadi, Sina; Ching, ShiNung] Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63130 USA; [Khanmohammadi, Sina; Laurido-Soto, Osvaldo; Eisenman, Lawrence N.; Kummer, Terrance T.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Ching, ShiNung] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Ching, ShiNung] Washington Univ, Div Biol & Biomed Sci, St Louis, MO 63130 USA		Khanmohammadi, S (corresponding author), Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63130 USA.	s.khanmohammadi@wustl.edu; ojlaur-ido-soto@wustl.edu; leisenman@wustl.edu; kummert@wustl.edu; shinung@wustl.edu	Khanmohammadi, Sina/E-4766-2017	Khanmohammadi, Sina/0000-0003-4023-9078	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R2-1NS096590-01A1, 1R21-EY027590-01, UL1 TR000448]; Air Force Office of Scientific Research (AFOSR)United States Department of DefenseAir Force Office of Scientific Research (AFOSR) [YIP 15RT0189]; National Science FoundationNational Science Foundation (NSF) [NSF CMMI 1537015, NSF ECCS 1509342, NSF CMMI 1653589]; Career Awards at the Scientific Interface (CASI) from Burroughs Wellcome Fund (BWF); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R21EY027590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS096590, K08NS094760] Funding Source: NIH RePORTER	This work is primarily supported by the grant #1R2-1NS096590-01A1 from the National Institutes of Health (NIH). Other sources of support include Air Force Office of Scientific Research (AFOSR YIP 15RT0189), National Science Foundation (NSF CMMI 1537015, NSF ECCS 1509342, and NSF CMMI 1653589), National Institutes of Health (NIH 1R21-EY027590-01, NIH UL1 TR000448), and Career Awards at the Scientific Interface (CASI) from Burroughs Wellcome Fund (BWF).	Andino SLG, 2000, HUM BRAIN MAPP, V11, P46; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Babadi B, 2014, IEEE T BIO-MED ENG, V61, P1555, DOI 10.1109/TBME.2014.2311996; Bagnato S, 2012, CLIN NEUROPHYSIOL, V123, P1937, DOI 10.1016/j.clinph.2012.03.014; Bai Y, 2017, FRONT NEUROL, V8, P1; Binder M, 2017, CLIN NEUROPHYSIOL, V128, P799, DOI 10.1016/j.clinph.2017.02.012; Bishop CM., 2006, PATTERN RECOGN; Blume WT, 2006, J CLIN NEUROPHYSIOL, V23, P306, DOI 10.1097/01.wnp.0000229137.94384.fa; Bodart O, 2017, NEUROIMAGE-CLIN, V14, P354, DOI 10.1016/j.nicl.2017.02.002; Bonfiglio L, 2014, PLOS ONE, V9, P1; Bonfiglio L, 2013, HUM BRAIN MAPP, V34, P2178, DOI 10.1002/hbm.22056; Britton J.W., 2016, ELECTROENCEPHALOGRAP; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Carboncini MC, 2014, RESTOR NEUROL NEUROS, V32, P767, DOI 10.3233/RNN-140426; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Cavinato M, 2011, CLIN NEUROPHYSIOL, V122, P719, DOI 10.1016/j.clinph.2010.08.024; Chennu S, 2017, BRAIN, V140, P2120, DOI 10.1093/brain/awx163; Chennu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003887; Cruse D, 2016, BRAIN FUNCTION RESPO, P105; Cruse D, 2016, CLIN NEUROPHYSIOL, V127, P1001, DOI 10.1016/j.clinph.2015.08.018; Dong P, 2011, CRIT CARE, V15, P179; Estraneo A, 2016, CLIN NEUROPHYSIOL, V127, P2379, DOI 10.1016/j.clinph.2016.03.021; Fell J, 1996, BIOL CYBERN, V75, P85; GALLEZ D, 1991, BIOL CYBERN, V64, P381, DOI 10.1007/BF00224705; Gao JB, 2011, COGN NEURODYNAMICS, V5, P171, DOI 10.1007/s11571-011-9151-3; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Gosseries O, 2011, FUNCT NEUROL, V26, P25; Guerit JM, 2010, CURR OPIN CRIT CARE, V16, P98, DOI 10.1097/MCC.0b013e328337541a; Guyon I, 2006, STUD FUZZ SOFT COMP, V207, P1; Holler Y, 2014, CLIN NEUROPHYSIOL, V125, P1545, DOI 10.1016/j.clinph.2013.12.095; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P1744, DOI 10.1016/j.clinph.2011.02.009; Husain A M, 2017, CONTINUOUS EEG MONIT; JURDJEVIC V., 1997, GEOMETRIC CONTROL TH, V52; Khanmohammadi S, 2017, COMPUT BIOL MED, V91, P80, DOI 10.1016/j.compbiomed.2017.09.022; King JR, 2013, CURR BIOL, V23, P1914, DOI 10.1016/j.cub.2013.07.075; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kotchoubey B, 2017, CONSCIOUS COGN, V54, P155, DOI 10.1016/j.concog.2017.05.002; LaRoche S., 2018, HDB ICU EEG MONITORI; Laureys S, 2005, NAT REV NEUROSCI, V6, P899, DOI 10.1038/nrn1789; Laureys S, 2004, NEUROREHABILITATION, V19, P335; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Leon-Carrion J, 2012, BRAIN RES, V1476, P22, DOI 10.1016/j.brainres.2012.03.055; Marinazzo D, 2014, CLIN EEG NEUROSCI, V45, P33, DOI 10.1177/1550059413510703; McGee J, 2016, NEUROL CLIN, V34, P55, DOI 10.1016/j.ncl.2015.08.004; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Naro A, 2016, J NEUROL SCI, V368, P178, DOI 10.1016/j.jns.2016.07.016; Numan T, 2017, CLIN NEUROPHYSIOL, V128, P914, DOI 10.1016/j.clinph.2017.02.022; OSSELTON JW, 1965, ELECTROEN CLIN NEURO, V19, P527, DOI 10.1016/0013-4694(65)90195-1; Peng CK, 2009, ADV DATA SCI ADAPT, V1, P61, DOI 10.1142/S1793536909000035; Piarulli A, 2016, J NEUROL, V263, P1746, DOI 10.1007/s00415-016-8196-y; Pollonini L, 2010, BRAIN TOPOGR, V23, P221, DOI 10.1007/s10548-010-0139-9; PRADHAN N, 1993, COMPUT BIOL MED, V23, P425, DOI 10.1016/0010-4825(93)90091-E; Ragazzoni A, 2017, CLIN NEUROPHYSIOL, V128, P1629, DOI 10.1016/j.clinph.2017.06.037; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Real RGL, 2016, CLIN NEUROPHYSIOL, V127, P1395, DOI 10.1016/j.clinph.2015.07.020; Risetti M., 2013, FRONT HUM NEUROSCI, V7, P1; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Sanders RD, 2012, ANESTHESIOLOGY, V116, P946, DOI 10.1097/ALN.0b013e318249d0a7; Sara M, 2010, NONLIN DYNAM PSYCHOL, V14, P1; Schartner M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133532; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sebastiano DR, 2015, CLIN NEUROPHYSIOL, V126, P558, DOI 10.1016/j.clinph.2014.07.004; Simmons G. F., 1996, CALCULUS ANAL GEOMET; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stam CJ, 1999, CLIN NEUROPHYSIOL, V110, P1801, DOI 10.1016/S1388-2457(99)00099-1; STERN JM, 2005, ATLAS EEG PATTERNS; Tang L, 2015, CHAOS SOLITON FRACT, V81, P117, DOI 10.1016/j.chaos.2015.09.002; Thul A, 2016, CLIN NEUROPHYSIOL, V127, P1419, DOI 10.1016/j.clinph.2015.07.039; Varotto G, 2014, CLIN NEUROPHYSIOL, V125, P63, DOI 10.1016/j.clinph.2013.06.016; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijnen VJM, 2010, CLIN NEUROPHYSIOL, V121, P992, DOI 10.1016/j.clinph.2010.02.004; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P1956, DOI 10.1016/j.clinph.2011.03.018; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Zhang M, 2017, FRONT IMMUNOL, V8, P1, DOI 10.3389/fimmu.2017.00942	77	4	4	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	NOV	2018	129	11					2296	2305		10.1016/j.clinph.2018.08.004			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GX5EJ	WOS:000447765400011	30240976	Green Accepted			2022-02-06	
J	Kintz, S; Hibbs, V; Henderson, A; Andrews, M; Wright, HH				Kintz, Stephen; Hibbs, Valentyna; Henderson, Amy; Andrews, Morgan; Wright, Heather Harris			Discourse-based treatment in mild traumatic brain injury	JOURNAL OF COMMUNICATION DISORDERS			English	Article						Traumatic brain injury; Discourse; Treatment; Language; Cognition	CLOSED-HEAD INJURY; COGNITIVE REHABILITATION; NARRATIVE DISCOURSE; DEFICITS; LANGUAGE; ADULTS; IMPAIRMENT; PATTERNS; APHASIA; SKILLS	Background: Individuals with traumatic brain injury (TBI) present with numerous discourse deficits associated with impairments to the linguistic system and other cognitive systems. Individuals with TBI may produce discourse that is lacking important information and poorly organized, as well as containing numerous coherence disrupting elements. Yet there are few studies directly addressing discourse deficits in individuals with TBI to guide clinicians. Aims: The purpose of the study was to determine if discourse processing treatment improved the discourse production in individual with TBI. Aims of the study included determining if the discourse processing treatment improved completeness and informativeness in TBI discourse samples. Methods & procedures: The study included three participants with mild-to-moderate TBI. The study utilized an A-B with maintenance design that incorporated components of functional practice, structured cues in the form of comprehension questions and story guide, and meta cognitive and meta-linguistic processes. Discourse samples were obtained for baseline, treatment, and maintenance one-week and one-month post treatment. Stimuli included 12 sequential pictures, as well as a single picture and a recount probe. Outcomes & results: All participants demonstrated small gains in completeness and informativeness for treated items, and 2 of 3 participants demonstrated a medium therapeutic effect for untreated stimuli. Participants also produced discourse with fewer errors for both treated and untreated stimuli after treatment with no therapeutic effect to a small effect for the generalization stimuli. Conclusions: The study demonstrated that the discourse processing treatment is capable of producing small therapeutic effects that persisted one-month post treatment in adults with mild-to moderate TBI.	[Kintz, Stephen; Hibbs, Valentyna; Henderson, Amy; Andrews, Morgan; Wright, Heather Harris] East Carolina Univ, Greenville, NC 27858 USA		Kintz, S (corresponding author), Univ Arkansas, Dept Audiol & Speech Pathol, Coll Educ & Hlth Professionals, Univ Plaza,Suite 600, Little Rock, AR 72204 USA.	sgkintz@ualr.edu		wright, heather/0000-0001-6922-6364			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Beeson PM, 2006, NEUROPSYCHOL REV, V16, P161, DOI 10.1007/s11065-006-9013-7; Beukelman D R, 1998, AUGMENTATIVE ALTERNA; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Biggs J., 1982, EVALUATING QUALITY L; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Gee J.P., 2012, ROUTLEDGE HDB DISCOU; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Golden CJ., 2002, STROOP COLOR WORD TE; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Gordon W. A., 2011, TRAUMATIC BRAIN INJU; Greco T, 2013, HEART LUNG VESSEL, V5, P219; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Kemmerer D., 2015, COGNITIVE NEUROSCIEN; Kertesz A., 1982, W APHASIA BATTERY; Kiran S, 2003, J SPEECH LANG HEAR R, V46, P608, DOI 10.1044/1092-4388(2003/048); Le K., 2011, ASHA LEADER, V16, P18, DOI [10.1044/leader.FTR4.16022011.18, DOI 10.1044/LEADER.FTR4.16022011.18, DOI 10.1044/leader.FTR4.16022011.18]; Loban Walter, 1976, LANGUAGE DEV KINDERG; Logan LR, 2008, DEV MED CHILD NEUROL, V50, P99, DOI 10.1111/j.1469-8749.2007.02005.x; Love T, 2009, J PSYCHOLINGUIST RES, V38, P285, DOI 10.1007/s10936-009-9103-9; MacWhinney B., 2000, CHILDES PROJECT; Marini A, 2005, J PSYCHOLINGUIST RES, V34, P439, DOI 10.1007/s10936-005-6203-z; Marini A., 2016, AGE RELATED EFFECTS; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; McCullagh S., 2011, TRAUMATIC BRAIN INJU; McReynolds L., 1983, SINGLE SUBJECT EXPT; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Penn C, 1997, APHASIOLOGY, V11, P601, DOI 10.1080/02687039708248492; Prigatano GP, 2011, TOP STROKE REHABIL, V18, P30, DOI 10.1310/tsr1801-30; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Rider JD, 2008, AM J SPEECH-LANG PAT, V17, P161, DOI 10.1044/1058-0360(2008/016); Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Schaude B.A., 1986, AM SPEECH LANG HEAR; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Ska B., 2004, ENCY COMMUNICATION D, P302; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Sohlberg M. M., 1994, ATTENTION PROCESS TR; Ulatowska H. K., 2004, MIT ENCY COMMUNICATI, P300; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wiseman-Hakes C, 1998, J HEAD TRAUMA REHAB, V13, P23, DOI 10.1097/00001199-199812000-00005; Wright HH, 2014, AGING NEUROPSYCHOL C, V21, P174, DOI 10.1080/13825585.2013.794894; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; Youse KM, 2009, NEUROREHABILITATION, V24, P355, DOI 10.3233/NRE-2009-0490; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	56	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	NOV-DEC	2018	76						47	59		10.1016/j.jcomdis.2018.08.001			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HE0FC	WOS:000452941200005	30212715				2022-02-06	
J	Kucukboyaci, NE; Long, C; Smith, M; Rath, JF; Bushnik, T				Kucukboyaci, N. Erkut; Long, Coralynn; Smith, Michelle; Rath, Joseph F.; Bushnik, Tamara			Cluster Analysis of Vulnerable Groups in Acute Traumatic Brain Injury Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Health care quality; access and evaluation; Hospitalization; Length of stay; Patient discharge; Quality of health care; Rehabilitation; Vulnerable populations		Objective: To analyze the complex relation between various social indicators that contribute to socioeconomic status and health care barriers. Design: Cluster analysis of historical patient data obtained from inpatient visits. Setting: Inpatient rehabilitation unit in a large urban university hospital. Participants: Adult patients (N=148) receiving acute inpatient care, predominantly for closed head injury. Interventions: Not applicable. Main Outcome Measures: We examined the membership of patients with traumatic brain injury in various "vulnerable group" clusters (eg, homeless, unemployed, racial/ethnic minority) and characterized the rehabilitation outcomes of patients (eg, duration of stay, changes in FIM scores between admission to inpatient stay and discharge). Results: The cluster analysis revealed 4 major clusters (ie, clusters A-D) separated by vulnerable group memberships, with distinct durations of stay and FIM gains during their stay. Cluster B, the largest cluster and also consisting of mostly racial/ethnic minorities, had the shortest duration of hospital stay and one of the lowest FIM improvements among the 4 clusters despite higher FIM scores at admission. In cluster C, also consisting of mostly ethnic minorities with multiple socioeconomic status vulnerabilities, patients were characterized by low cognitive FIM scores at admission and the longest duration of stay, and they showed good improvement in FIM scores. Conclusions: Application of clustering techniques to inpatient data identified distinct clusters of patients who may experience differences in their rehabilitation outcome due to their membership in various "at-risk" groups. The results identified patients (ie, cluster B, with minority patients; and cluster D, with elderly patients) who attain below-average gains in brain injury rehabilitation. The results also suggested that systemic (eg, duration of stay) or clinical service improvements (eg, staff's language skills, ability to offer substance abuse therapy, provide appropriate referrals, liaise with intensive social work services, or plan subacute rehabilitation phase) could be beneficial for acute settings. Stronger recruitment, training, and retention initiatives for bilingual and multiethnic professionals may also be considered to optimize gains from acute inpatient rehabilitation after traumatic brain injury. (C) 2017 by the American Congress of Rehabilitation Medicine.	[Kucukboyaci, N. Erkut] Kessler Fdn, Neuropsychol & Neurosci & TBI Lab, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA; [Long, Coralynn] NYU Langone, Rusk Inst Rehabil, Dept Psychol, New York, NY USA; [Smith, Michelle; Rath, Joseph F.; Bushnik, Tamara] NYU Langone, Rusk Inst Rehabil, Dept Rehabil Med, New York, NY USA		Kucukboyaci, NE (corresponding author), Kessler Fdn, Neuropsychol & Neurosci & TBI Lab, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA.	ekucukboyaci@kesslerfoundation.org	Rath, Joseph F./C-4823-2008	Rath, Joseph F./0000-0003-2933-6299; Bushnik, Tamara/0000-0003-3328-257X	Administration for Community Living, National Institute on Disability, Independent Living, and Rehabilitation Research; Traumatic Brain Injury Model Systems [90AR5014, 90DP0047]	Supported by the Administration for Community Living, National Institute on Disability, Independent Living, and Rehabilitation Research; Advanced Rehabilitation Research Training; and Traumatic Brain Injury Model Systems (grant nos. 90AR5014 and 90DP0047).	Agency for Healthcare Research and Quality, USITC PUBL; Anderberg M., 1973, CLUSTER ANAL APPL; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Glubo H, 2015, NAT MULT C SUMM JAN; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lequerica A, 2014, NEUROREHABILITATION, V34, P645, DOI 10.3233/NRE-141079; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Peterson-Besse JJ, 2014, MED CARE, V52, pS51, DOI 10.1097/MLR.0000000000000195; Roebuck-Spencer T., 2014, HDB NEUROPSYCHOLOGY, P3; Snowden LR, 2007, AM PSYCHOL, V62, P109, DOI 10.1037/0003-066X.62.2.109; Tian Zhang, 1996, SIGMOD Record, V25, P103; Traumatic Brain Injury Model Systems National Data and Statistical Center, STAND OP PROC FORM 1	14	4	4	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2018	99	11					2365	2369		10.1016/j.apmr.2017.11.016			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HB8TD	WOS:000451362700026	29317223	Green Accepted			2022-02-06	
J	Marino, C; Botticello, A; Coyne, JH; Dribbon, M; DeLuca, J				Marino, Cherylynn; Botticello, Amanda; Coyne, Julia H.; Dribbon, Michael; DeLuca, John			The Effect of Admission Functional Independence on Early Recovery in Pediatric Traumatic and Nontraumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; functional outcomes; nontraumatic brain injury; pediatrics; rehabilitation; traumatic brain injury; WeeFIM	UNITED-STATES; CHILDREN; REHABILITATION; OUTCOMES; PLASTICITY; MOBILITY; WEEFIM	Objective: To examine functional independence at admission as a predictor of outcomes during an initial inpatient hospitalization for a pediatric brain injury. Participants: A total of 531 pediatric inpatients with traumatic (n = 298) or nontraumatic (n = 233) brain injuries. Design: Retrospective analysis of data extracted from the Uniform Data System for Medical Rehabilitation. Main Measure: The Functional Independence Measure for Children, a measure of self-care, mobility, and cognitive independence. Results: Logistic regression analyses indicated that children with traumatic brain injury showed greater odds of making large functional gains in comparison with children with nontraumatic brain injury. For both groups, children entering rehabilitation with a moderate level of functional independence had the highest probability of making large gains. Children with a nontraumatic brain injury entering treatment with a high level of functioning made greater gains than those entering with low functioning. The opposite trend emerged for children with traumatic injuries. Conclusions: Level of functioning at admission may be a useful predictor of progress during an inpatient stay for youth with brain injuries. Children with nontraumatic brain injury entering treatment with low functioning are expected to make slower progress during hospitalization.	[Marino, Cherylynn; Botticello, Amanda; Coyne, Julia H.; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [Marino, Cherylynn; Coyne, Julia H.; Dribbon, Michael] Childrens Specialized Hosp, New Brunswick, NJ USA; [Botticello, Amanda; DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Neurol, Newark, NJ USA		Marino, C (corresponding author), Kessler Fdn, 120 Eagle Rock Ave, E Hanover, NJ 07936 USA.	cmarino@kesslerfoundation.org					Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2011, PEDIATR NEUROSURG, V34, P138; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; [Anonymous], 2006, WEEFIM 2 CLIN GUID V; Bilgin S, 2014, EUR J PHYS REHAB MED, V50, P17; Boake C, 2000, PHYS MED REHABILITAT, P1073; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Chen CC, 2004, AM J OCCUP THER, V58, P44, DOI 10.5014/ajot.58.1.44; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Dumas Helene M., 2001, Physical and Occupational Therapy in Pediatrics, V21, P7; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P266, DOI 10.1136/adc.2008.147926; Fragala MA, 2002, BRAIN INJURY, V16, P149, DOI 10.1080/02699050110103328; Gluck MA., 2016, LEARNING MEMORY BRAI, V3rd edn; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; KRAUS JF, 1987, PEDIATRICS, V79, P501; Martinez W, 2011, J PEDIATR PSYCHOL, V36, P878, DOI 10.1093/jpepsy/jsr035; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Ottenbacher KJ, 2000, ARCH PHYS MED REHAB, V81, P1317, DOI 10.1053/apmr.2000.9387; Petrosyan M, 2009, J TRAUMA, V67, pS114, DOI 10.1097/TA.0b013e3181ad3251; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tokcan Gul, 2003, Pediatr Phys Ther, V15, P16, DOI 10.1097/01.PEP.0000050765.71924.6C; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	34	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					E11	E18		10.1097/HTR.0000000000000374			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600002	29385015				2022-02-06	
J	Moir, ME; Balestrini, CS; Abbott, KC; Klassen, SA; Fischer, LK; Fraser, DD; Shoemaker, JK				Moir, M. Erin; Balestrini, Christopher S.; Abbott, Kolten C.; Klassen, Stephen A.; Fischer, Lisa K.; Fraser, Douglas D.; Shoemaker, J. Kevin			An Investigation of Dynamic Cerebral Autoregulation in Adolescent Concussion	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CEREBROVASCULAR FUNCTION; PEDIATRIC; RATE OF REGULATION; SIT-TO-STAND; TRANSCRANIAL DOPPLER ULTRASOUND; TRAUMATIC BRAIN INJURY	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; BLOOD-FLOW; HIGH-SCHOOL; PRESSURE AUTOREGULATION; HEAD-INJURY; CHILDREN; RECOVERY; HUMANS; METABOLISM	Purpose Although cerebrovascular impairments are believed to contribute to concussion symptoms, little information exists regarding brain vasomotor control in adolescent concussion, particularly autoregulatory control that forms a fundamental response mechanism during changes in blood pressure. This research tested the hypothesis that adolescent concussion is marked by impaired dynamic cerebral autoregulation. Methods Nineteen concussed adolescents (15 2 yr, 13 females) and 18 healthy controls (15 2 yr, 9 females) completed two sit-to-stand trials. Brachial artery blood pressure and cerebral blood flow velocity in the right middle cerebral artery were measured continuously. Dynamic rate of regulation was calculated as the rate of change in cerebrovascular resistance relative to the change in arterial blood pressure. The concussed adolescents were followed through their rehabilitation for up to 12 wk. Results At the first visit, the concussed adolescents demonstrated reduced rate of regulation compared with the healthy controls (0.12 +/- 0.04 vs 0.19 +/- 0.06 s(-1), P 0.001). At the concussed adolescents final visit, after symptom resolution, the rate of regulation improved to levels that were not different from the healthy controls (n = 9; 0.15 +/- 0.08 vs 0.19 +/- 0.06 s(-1), P= 0.06). Two distinct groups were observed at the final visit with some individuals experiencing recovery of dynamic cerebral autoregulation and others showing no marked change from the initial visit. Conclusion Adolescents demonstrate an impairment in dynamic cerebral autoregulation after concussion that improves along with clinical symptoms in some individuals and remains impaired in others despite symptom resolution.	[Moir, M. Erin; Klassen, Stephen A.; Fischer, Lisa K.; Shoemaker, J. Kevin] Western Univ, Sch Kinesiol, Room 3159C,Thames Hall,1151 Richmond St, London, ON N6A 5B9, Canada; [Balestrini, Christopher S.] Western Univ, Dept Anat & Cell Biol, London, ON, Canada; [Abbott, Kolten C.; Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Fischer, Lisa K.] Western Univ, Dept Family Med, London, ON, Canada; [Fischer, Lisa K.] Western Univ, Fowler Kennedy Sports Med Clin, London, ON, Canada; [Fraser, Douglas D.] Western Univ, Dept Paediat, London, ON, Canada; [Fraser, Douglas D.; Shoemaker, J. Kevin] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada		Shoemaker, JK (corresponding author), Western Univ, Sch Kinesiol, Room 3159C,Thames Hall,1151 Richmond St, London, ON N6A 5B9, Canada.	kshoemak@uwo.ca	Shoemaker, Joel Kevin/L-2682-2013; Fischer, Lisa K/H-3999-2015	Shoemaker, Joel Kevin/0000-0002-6794-5979; Fischer, Lisa K/0000-0001-5992-0176	Children's Health Foundation	This work was supported generously by a grant from the Children's Health Foundation (www.childhealth.ca). J. Kevin Shoemaker holds a Canadian Research Chair Tier 1 position in the Integrative Physiology of Exercise and Health. The authors gratefully acknowledge Alexandra B. Harriss, Emilie Woehrle, Jennifer R.M. Petrakos, and Arlene Fleischhauer for their support.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Augustine C, 2014, NEUROSCIENCE, V274, P1, DOI 10.1016/j.neuroscience.2014.05.009; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Chacon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108281; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harms MPM, 1999, CLIN SCI, V97, P291, DOI 10.1042/CS19990061; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kim KJ, 2015, J NEUROSCI, V35, P8245, DOI 10.1523/JNEUROSCI.4486-14.2015; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Lang EW, 2003, J CLIN NEUROSCI, V10, P670, DOI 10.1016/S0967-5868(03)00197-8; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Leung J, 2016, J PHYSIOL-LONDON, V594, P2681, DOI 10.1113/JP271056; Lipsitz LA, 2000, STROKE, V31, P1897, DOI 10.1161/01.STR.31.8.1897; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Smielewski P, 1996, STROKE, V27, P2197, DOI 10.1161/01.STR.27.12.2197; Smirl JD, 2014, HYPERTENSION, V64, P1314, DOI 10.1161/HYPERTENSIONAHA.114.04236; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2002, ACTA ANAESTH SCAND, V46, P393, DOI 10.1034/j.1399-6576.2002.460411.x; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	40	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2018	50	11					2192	2199		10.1249/MSS.0000000000001695			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GX2PC	WOS:000447560400002	29927876				2022-02-06	
J	Ore, CLD; Rennert, RC; Schupper, AJ; Gabel, BC; Gonda, D; Peterson, B; Marshall, LF; Levy, M; Meltzer, HS				Ore, Cecilia L. Dalle; Rennert, Robert C.; Schupper, Alexander J.; Gabel, Brandon C.; Gonda, David; Peterson, Bradley; Marshall, Lawrence F.; Levy, Michael; Meltzer, Hal S.			The identification of a subgroup of children with traumatic subarachnoid hemorrhage at low risk of neuroworsening	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						neuroworsening; pediatric; traumatic brain injury; isolated traumatic subarachnoid hemorrhage; trauma	COMPUTED-TOMOGRAPHY; CRITICAL-CARE; BRAIN-INJURY; NEUROLOGICAL DETERIORATION; POSTTRAUMATIC-STRESS; HEAD-INJURY; MULTICENTER; PROGRESSION; PREDICTION; CHILDHOOD	OBJECTIVE Pediatric traumatic subarachnoid hemorrhage (tSAH) often results in intensive care unit (ICU) admission, the performance of additional diagnostic studies, and ICU-level therapeutic interventions to identify and prevent episodes of neuroworsening. METHODS Data prospectively collected in an institutionally specific trauma registry between 2006 and 2015 were supplemented with a retrospective chart review of children admitted with isolated traumatic subarachnoid hemorrhage (tSAH) and an admission Glasgow Coma Scale (GCS) score of 13-15. Risk of blunt cerebrovascular injury (BCVI) was calculated using the BCVI clinical prediction score. RESULTS Three hundred seventeen of 10,395 pediatric trauma patients were admitted with tSAH. Of the 317 patients with tSAH, 51 children (16%, 23 female, 28 male) were identified with isolated tSAH without midline shift on neuroimaging and a GCS score of 13-15 at presentation. The median patient age was 4 years (range 18 days to 15 years). Seven had modified Fisher grade 3 tSAH; the remainder had grade 1 tSAH. Twenty-six patients (51%) had associated skull fractures; 4 involved the petrous temporal bone and 1 the carotid canal. Thirty-nine (76.5%) were admitted to the ICU and 12 (23.5%) to the surgical ward. Four had an elevated BCVI score. Eight underwent CT angiography; no vascular injuries were identified. Nine patients received an imaging-associated general anesthetic. Five received hypertonic saline in the ICU. Patients with a modified Fisher grade 1 tSAH had a significantly shorter ICU stay as compared to modified Fisher grade 3 tSAH (1.1 vs 2.5 days, p = 0.029). Neuroworsening was not observed in any child. CONCLUSIONS Children with isolated tSAH without midline shift and a GCS score of 13-15 at presentation appear to have minimal risk of neuroworsening despite the findings in some children of skull fractures, elevated modified Fisher grade, and elevated BCVI score. In this subgroup of children with tSAH, routine ICU-level care and additional diagnostic imaging may not be necessary for all patients. Children with modified Fisher grade 1 tSAH may be particularly unlikely to require ICU-level admission. Benefits to identifying a subgroup of children at low risk of neuroworsening include improvement in healthcare efficiency as well as decreased utilization of unnecessary and potentially morbid interventions, including exposure to ionizing radiation and general anesthesia.	[Ore, Cecilia L. Dalle; Rennert, Robert C.; Schupper, Alexander J.; Gabel, Brandon C.; Gonda, David; Marshall, Lawrence F.; Levy, Michael; Meltzer, Hal S.] Univ Calif San Diego, Sch Med, Dept Neurosurg, San Diego, CA 92103 USA; [Gonda, David; Levy, Michael; Meltzer, Hal S.] Rady Childrens Hosp, Div Neurosurg, San Diego, CA USA; [Peterson, Bradley] Rady Childrens Hosp, Div Pediat Crit Care, San Diego, CA USA		Meltzer, HS (corresponding author), UCSD Sch Med, Rady Childrens Hosp, San Diego, CA 92103 USA.	hsmeltzer@ucsd.edu	Levy, Michael/AAL-4647-2020				Alhelali I, 2015, J TRAUMA ACUTE CARE, V78, P1155, DOI 10.1097/TA.0000000000000662; Allison RZ, 2017, NEUROCRIT CARE, V26, P80, DOI 10.1007/s12028-016-0303-5; Ament JD, 2017, J NEUROSURG-PEDIATR, V19, P668, DOI 10.3171/2017.2.PEDS16419; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Carrillo EH, 1999, J TRAUMA, V46, P1120, DOI 10.1097/00005373-199906000-00030; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Coopersmith CM, 2012, CRIT CARE MED, V40, P1072, DOI 10.1097/CCM.0b013e31823c8d03; Deepika A, 2013, J HEAD TRAUMA REHAB, V28, P442, DOI 10.1097/HTR.0b013e31825e19e5; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Fan JS, 2012, ACAD EMERG MED, V19, P133, DOI 10.1111/j.1553-2712.2011.01285.x; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Halpern NA, 2009, CURR OPIN CRIT CARE, V15, P591, DOI 10.1097/MCC.0b013e328332f54f; Halstead ME, 2016, SPORTS HEALTH, V8, P50, DOI 10.1177/1941738115622158; Helling TS, 2014, J AM COLL SURGEONS, V218, P723, DOI 10.1016/j.jamcollsurg.2013.12.026; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; HOURIHAN MD, 1984, J NEUROSURG, V60, P1163, DOI 10.3171/jns.1984.60.6.1163; Lee JJ, 2014, J NEUROTRAUM, V31, P595, DOI 10.1089/neu.2013.3152; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Lumba-Brown A, 2014, PEDIATR EMERG CARE, V30, P139, DOI 10.1097/PEC.0000000000000084; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Nahed BV, 2009, J NEUROSURG-PEDIATR, V3, P311, DOI 10.3171/2008.12.PEDS08206; Orser BA, 2018, ANESTH ANALG, V126, P1393, DOI 10.1213/ANE.0000000000002833; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Ratzer M, 2014, HEALTH PSYCHOL BEHAV, V2, P882, DOI 10.1080/21642850.2014.943760; Ravindra VM, 2017, J NEUROTRAUM, V34, P391, DOI 10.1089/neu.2016.4415; Ravindra VM, 2015, J NEUROSURG-PEDIATR, V15, P599, DOI 10.3171/2014.11.PEDS14397; Rubino S, 2014, J NEUROSURG, V121, P944, DOI 10.3171/2014.6.JNS132204; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; Scheetz LJ, 2018, INT EMERG NURS, V37, P29, DOI 10.1016/j.ienj.2016.11.003; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Sundararajan K, 2014, AUST CRIT CARE, V27, P183, DOI 10.1016/j.aucc.2014.04.003; Tunik MG, 2016, ANN EMERG MED, V68, P431, DOI 10.1016/j.annemergmed.2016.04.058; Weber CD, 2018, WORLD J SURG, V42, P2043, DOI 10.1007/s00268-017-4408-6	45	4	4	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2018	22	5					559	566		10.3171/2018.5.PEDS18140			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GY9QH	WOS:000448982800014	30095347	Bronze			2022-02-06	
J	Pruiksma, KE; Fina, B; Dietch, JR; Dondanville, KA; Williams, J; Wright, EC; Molino, A; Hall-Clark, B; Nicholson, KL; Peterson, AL; Taylor, DJ				Pruiksma, Kristi E.; Fina, Brooke; Dietch, Jessica R.; Dondanville, Katherine A.; Williams, Jacob; Wright, Edward C.; Molino, Alma; Hall-Clark, Brittany; Nicholson, Karin L.; Peterson, Alan L.; Taylor, Daniel J.		STRONG STAR Consortium	Special Considerations in the Adaptation of Cognitive Behavioral Therapy for Insomnia With Active-Duty US Army Personnel	COGNITIVE AND BEHAVIORAL PRACTICE			English	Article						insomnia; Cognitive Behavioral Therapy for Insomnia; active-duty military; deployment; treatment	SLEEP RESTRICTION THERAPY; TRAUMATIC BRAIN-INJURY; PRIMARY-CARE; INTERVENTION; METAANALYSIS; DISTURBANCE; VETERANS; PREVALENCE; OPERATIONS; DEPLOYMENT	Insomnia is highly prevalent among active-duty military service members. Cognitive Behavioral Therapy for Insomnia (CBT-I) is a well established and effective treatment; however, research and treatment recommendations have primarily focused on civilian or veteran populations. A multitude of military-specific factors directly impact service members' sleep and the subsequent treatment recommendations. This article provides treatment considerations for the use of CBT-I with active-duty U.S. Army personnel. First, an overview of the theoretical model of insomnia, including military-specific predisposing, precipitating, and perpetuating factors, is presented, followed by a review of common comorbid conditions among service members with insomnia. Finally, discussion focuses on considerations and strategies for implementing components of CBT-I with service members, managing sleep during deployments, and adjusting sleep to accommodate overnight duties. Additional training resources and supplemental video examples (with actors) are provided.	[Pruiksma, Kristi E.; Fina, Brooke; Dondanville, Katherine A.; Williams, Jacob; Wright, Edward C.; Molino, Alma; Hall-Clark, Brittany] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Dietch, Jessica R.; Taylor, Daniel J.; STRONG STAR Consortium] Univ North Texas, Denton, TX 76203 USA; [Nicholson, Karin L.] Carl R Darnall Army Med Ctr, Ft Hood, TX USA; [Peterson, Alan L.] Univ Texas San Antonio, Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, San Antonio, TX USA		Pruiksma, KE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.	Pruiksma@uthscsa.edu	Dietch, Jessica/AAG-2441-2020	Dietch, Jessica/0000-0001-9434-0791	U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs, Psychological Health and Traumatic Brain Injury Research Program award [W81XWH-10-1-0828]	Funding for this work was made possible by the U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs, Psychological Health and Traumatic Brain Injury Research Program award W81XWH-10-1-0828 (Daniel Taylor).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P12; Bertisch SM, 2014, SLEEP, V37, P343, DOI 10.5665/sleep.3410; Bonnet M. H, 2017, CLIN HDB INSOMNIA, P41; Bootzin R., 1973, 80 ANN CONV AM PSYCH; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Bray RM, 2007, ADDICTION, V102, P1092, DOI 10.1111/j.1360-0443.2007.01841.x; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Bryan CJ, 2011, PROF PSYCHOL-RES PR, V42, P16, DOI 10.1037/a0022290; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Casement MD, 2012, CLIN PSYCHOL REV, V32, P566, DOI 10.1016/j.cpr.2012.06.002; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Cranston CC, 2011, J CLIN SLEEP MED, V7, P549, DOI 10.5664/JCSM.1330; Cunnington D, 2013, MED J AUSTRALIA, V199, pS36, DOI 10.5694/mja13.10718; Dolan DC, 2010, BEHAV RES THER, V48, P321, DOI 10.1016/j.brat.2009.12.004; Ebben MR, 2009, J BEHAV MED, V32, P244, DOI 10.1007/s10865-008-9198-8; Epstein DR, 2012, J REHABIL RES DEV, V49, P867, DOI 10.1682/JRRD.2011.06.0114; Foa E.B., 2007, PROLONGED EXPOSURE T; Goodie JL, 2014, COGN BEHAV PRACT, V21, P261, DOI 10.1016/j.cbpra.2014.01.001; Goodie JL, 2009, J CLIN PSYCHOL, V65, P294, DOI 10.1002/jclp.20548; Hao LLJ, 2014, ASEAN J PSYCHIATR, V15, P106; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Harvey CJ, 2014, SLEEP MED REV, V18, P237, DOI 10.1016/j.smrv.2013.11.004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horoho P. D, 2013, US ARMY MED DEP  OCT, V2013, P4; Johnson LA, 2014, MIL MED, V179, P375, DOI 10.7205/MILMED-D-13-00322; Karlin BE, 2013, J CONSULT CLIN PSYCH, V81, P912, DOI 10.1037/a0032554; Lee J, 2015, STUD HEALTH TECHNOL, V210, P458, DOI 10.3233/978-1-61499-512-8-458; Lentino Cynthia V, 2013, US Army Med Dep J, P98; Lichstein KL, 2011, PRACT RESOUR MENT, P45, DOI 10.1016/B978-0-12-381522-4.00004-3; Lichstein KL, 2004, EPIDEMIOLOGY OF SLEEP AGE, GENDER, AND ETHNICITY, P1; Lunasco TK, 2010, MIL MED, V175, P509, DOI 10.7205/MILMED-D-09-00182; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; McCrae CS, 2001, SLEEP MED REV, V5, P47, DOI 10.1053/smrv.2000.0146; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Mental Health Advisory Team-III, 2006, MENT HLTH ADV TEAM 3; Mental Health Advisory Team-VI, 2009, MENT HLTH ADV TEAM 4; Miller CB, 2014, SLEEP MED REV, V18, P415, DOI 10.1016/j.smrv.2014.01.006; Miller NL, 2011, BEHAV SLEEP MED, V9, P53, DOI 10.1080/15402002.2011.533994; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; Morgenthaler T, 2006, SLEEP, V29, P1415; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Morin CM, 2004, AM J PSYCHIAT, V161, P332, DOI 10.1176/appi.ajp.161.2.332; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Ohayon MM, 2001, J PSYCHOSOM RES, V51, P745, DOI 10.1016/S0022-3999(01)00285-9; Okajima I, 2011, SLEEP BIOL RHYTHMS, V9, P24, DOI 10.1111/j.1479-8425.2010.00481.x; Olmsted KLR, 2011, NICOTINE TOB RES, V13, P691, DOI 10.1093/ntr/ntr060; Perlis ML, 2005, PRINCIPLES PRACTICE, P714, DOI DOI 10.1016/B0-72-160797-7/50067-7; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Pigeon WR, 2014, COGN BEHAV PRACT, V21, P252, DOI 10.1016/j.cbpra.2013.10.007; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Posner D, 2011, PRACT RESOUR MENT, P31, DOI 10.1016/B978-0-12-381522-4.00003-1; Riemann D, 2009, SLEEP MED REV, V13, P205, DOI 10.1016/j.smrv.2008.06.001; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Roth T, 2009, AM J MANAG CARE, V15, pS6; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Shay J., 1998, PARAMETERS, V28, P93; Smith MT, 2002, AM J PSYCHIAT, V159, P5, DOI 10.1176/appi.ajp.159.1.5; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; SPIELMAN AJ, 1987, SLEEP, V10, P45; Taylor D, 2014, HDB OF INSOMNIA; Taylor D. J, 2014, AANN M ASS PROF SLEE; Taylor DJ, 2007, SLEEP, V30, P213, DOI 10.1093/sleep/30.2.213; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Taylor DJ, 2016, SLEEP, V39, P1795, DOI 10.5665/sleep.6156; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Taylor DJ, 2010, J CLIN SLEEP MED, V6, P169; Troxel WM, 2015, SLEEP MILITARY PROMO; Vallieres A, 2003, SLEEP, V26, P902, DOI 10.1093/sleep/26.7.902; van de Laar M, 2010, SLEEP MED REV, V14, P61, DOI 10.1016/j.smrv.2009.07.007; Van Den Berg JF, 2008, J SLEEP RES, V17, P295, DOI 10.1111/j.1365-2869.2008.00638.x; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Wu JQ, 2015, JAMA INTERN MED, V175, P1461, DOI 10.1001/jamainternmed.2015.3006; Zayfert C, 2004, J TRAUMA STRESS, V17, P69, DOI 10.1023/B:JOTS.0000014679.31799.e7	77	4	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1077-7229	1878-187X		COGN BEHAV PRACT	Cogn. Behav. Pract.	NOV	2018	25	4					515	530		10.1016/j.cbpra.2017.12.007			16	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GZ5GC	WOS:000449446200005					2022-02-06	
J	Roberts, CM; Spitz, G; Mundy, M; Ponsford, JL				Roberts, Caroline M.; Spitz, Gershon; Mundy, Matthew; Ponsford, Jennie L.			Retrograde Personal Semantic Memory During Post-Traumatic Amnesia and Following Emergence	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Retrograde amnesia; Anterograde amnesia; Autobiographical memory; Traumatic brain injury; Westmead Post-Traumatic Amnesia Scale	DEFAULT MODE NETWORK; TRAUMATIC BRAIN-INJURY; AUTOBIOGRAPHICAL MEMORY; FUNCTIONAL CONNECTIVITY; RECOVERY; SCALE; CONSOLIDATION; ORIENTATION; CONCUSSION; RETRIEVAL	Objectives: Anecdotal reports suggest that following traumatic brain injury (TBI) retrograde memories are initially impaired and recover in order of remoteness. However, there has been limited empirical research investigating whether a negative gradient in retrograde amnesia relative preservation of remote over recent memory exists during post-traumatic amnesia (PTA) compared with the acute phase post-emergence. This study used a repeated-measures design to examine the pattern of personal semantic (PS) memory performance during PTA and within two weeks of emergence to improve understanding of the nature of the memory deficit during PTA and its relationship with recovery. Methods: Twenty patients with moderate-severe TBI and 20 healthy controls (HCs) were administered the Personal Semantic Schedule of the Autobiographical Memory Interview. The TBI group was assessed once during PTA and post-emergence. Analysis of variance was used to compare the gradient across lifetime periods during PTA relative to post-emergence, and between groups. Results: PS memory was significantly lower during PTA than post-emergence from PTA, with no relative preservation of remote memories. The TBI group was still impaired relative to HCs following emergence from PTA. Lower overall PS memory scores during PTA were associated with increased days to emerge from PTA post-interview. Conclusions: These results suggest a global impairment in PS memory across lifetime periods particularly during PTA, but still present within 2 weeks of emergence from PTA. PS memory performance may be sensitive to the diffuse nature of TBI and may, therefore, function as a clinically valuable indicator of the likely time to emerge from PTA.	[Roberts, Caroline M.; Spitz, Gershon; Mundy, Matthew; Ponsford, Jennie L.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Sch Psychol Sci, Melbourne, Vic, Australia; [Roberts, Caroline M.; Spitz, Gershon; Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Epworth Healthcare, Melbourne, Vic, Australia		Roberts, CM (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	caroline.roberts@monash.edu	; Spitz, Gershon/H-7755-2014	Mundy, Matthew/0000-0002-7073-0047; Roberts, Caroline/0000-0003-1200-4415; Spitz, Gershon/0000-0002-7810-1480	Institute for Safety, Compensation and Recovery Research (ISCRR) [089]	This work was supported by the Institute for Safety, Compensation and Recovery Research (ISCRR; Grant number 089). The authors have no conflicts of interest to disclose.	ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; BENSON DF, 1967, J NEUROL NEUROSUR PS, V30, P539, DOI 10.1136/jnnp.30.6.539; Bluck S, 2005, SOC COGNITION, V23, P91, DOI 10.1521/soco.23.1.91.59198; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; BROWN MB, 1974, TECHNOMETRICS, V16, P129, DOI 10.2307/1267501; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Coste C, 2015, NEUROPSYCHOLOGIA, V71, P133, DOI 10.1016/j.neuropsychologia.2015.03.014; Coste C, 2011, CORTEX, V47, P771, DOI 10.1016/j.cortex.2010.07.004; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Greenberg DL, 2010, J INT NEUROPSYCH SOC, V16, P748, DOI 10.1017/S1355617710000676; Greene JDW, 1995, NEUROPSYCHOLOGIA, V33, P1647, DOI 10.1016/0028-3932(95)00046-1; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; Huynh H., 1976, J EDUC STAT, V1, P69, DOI [10.3102/10769986001001069, DOI 10.3102/10769986001001069, 10.2307/1164736]; Irish M, 2011, NEUROPSYCHOLOGIA, V49, P2694, DOI 10.1016/j.neuropsychologia.2011.05.017; Irish M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00027; Kopelman M D, 1994, Memory, V2, P211, DOI 10.1080/09658219408258945; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Leach K, 2006, BRAIN INJURY, V20, P1241, DOI 10.1080/02699050601049874; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Martinelli P, 2013, HUM BRAIN MAPP, V34, P1515, DOI 10.1002/hbm.22008; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Renoult L, 2012, TRENDS COGN SCI, V16, P550, DOI 10.1016/j.tics.2012.09.003; Ribot T., 2010, DISEASES OF MEMORY A; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Roberts CM, 2015, NEUROPSYCHOLOGY, V29, P522, DOI 10.1037/neu0000178; Russell WR, 1935, LANCET, V2, P762; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Solmaz B, 2017, HUM BRAIN MAPP, V38, P2913, DOI 10.1002/hbm.23561; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; SYMONDS C, 1962, LANCET, V1, P1; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; WASTERLAIN CG, 1971, EUR NEUROL, V5, P225, DOI 10.1159/000114074; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Wilson BA., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [DOI 10.1080/09602019208401410, 10.1080/09602019208401410]; Winocur G, 2011, J INT NEUROPSYCH SOC, V17, P766, DOI 10.1017/S1355617711000683	54	4	4	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2018	24	10					1064	1072		10.1017/S1355617718000565			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	HA6XR	WOS:000450425500006	30196802				2022-02-06	
J	Seifi, A; Dengler, B; Martinez, P; Godoy, DA				Seifi, Ali; Dengler, Bradley; Martinez, Paola; Agustin Godoy, Daniel			Pulmonary embolism in severe traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Pulmonary embolism; Deep vein thrombosis; Venous thromboembolism; Prophylaxis; Anticoagulation; Traumatic brain injury	VENOUS THROMBOEMBOLISM; CLINICAL ARTICLE; UNITED-STATES; COAGULOPATHY; PROPHYLAXIS; THROMBOSIS; SAFETY; PROGRESSION; MANAGEMENT; HEMORRHAGE	Introduction: Pulmonary emboli (PE) is a significant source of morbidity and mortality in the trauma patients. The use of chemical prophylaxis to prevent deep venous thrombosis and subsequent PE is still controversial given its risk of increased intracranial hemorrhage expansion. Objective: In the present study, we evaluated the incidence of PE in severe traumatic brain injury. Methods: Retrospective review of patients who were admitted to a Neurosurgery unit from 2011 to 2013 with severe TBI who developed PE. Results: 155 patients met the study criteria. The incidence of PE was 2.58%. The cohort was mainly composed of white (71.6%), male (76.77%) with the mean age of 23.03 +/- 15.79. There was no statistical difference between the patients who developed PE with prophylaxis and without (p = 0.58). Hospital length of stay was significantly increased by the development of a PE (27.82 +/- 21.78 vs. 61.24 +/- 25.74 days, p = 0.01). Conclusion: Our data is limited by a low incidence of PE in this cohort, but does show an increased hospital length of stay. The true incidence of PE is unknown, so large-scale population studies are urgently needed and a high index of suspicion is required for diagnosis. (C) 2018 Elsevier Ltd. All rights reserved.	[Seifi, Ali] Univ Texas Hlth San Antonio, Dept Neurosurg, San Antonio, TX USA; [Dengler, Bradley] Walter Reed Natl Mil Med Ctr, Dept Neurosurg, Bethesda, MD USA; [Martinez, Paola] Univ Texas Hlth San Antonio, Dept Neurol, San Antonio, TX USA; [Agustin Godoy, Daniel] Hosp San Juan, Neurointens Care Unit, Sanatorio Pasteur & Intens Care Unit, Bautista, Catamarca, Argentina		Seifi, A (corresponding author), Univ Texas Hlth San Antonio, Mail Code 7843,7703 Floyd Curl Dr, San Antonio, TX 78299 USA.	seifi@uthscsa.edu	Seifi, Ali/AAR-6163-2020; Dengler, Bradley/AAN-7688-2021				Agnelli G, 2010, NEW ENGL J MED, V363, P266, DOI 10.1056/NEJMra0907731; Bahloul M, 2017, INTENS CARE MED, V43, P1433, DOI 10.1007/s00134-017-4815-z; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; De Oliveira Manoel AL, 2014, NEUROCRIT CARE, V22, P1; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Hoo GWS, 2013, EXPERT REV RESP MED, V7, P171, DOI [10.1586/ers.13.7, 10.1586/ERS.13.7]; Jeremitsky E, 2013, SURGERY, V154, P810, DOI 10.1016/j.surg.2013.04.045; Khaldi A, 2011, J NEUROSURG, V114, P40, DOI 10.3171/2010.8.JNS10332; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Nyquist P, 2016, NEUROCRIT CARE, V24, P47, DOI 10.1007/s12028-015-0221-y; Phelan HA, 2013, SEMIN THROMB HEMOST, V39, P541, DOI 10.1055/s-0033-1343356; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Praeger AJ, 2012, CRIT CARE RESUSC, V14, P10; Raychaudhuri R, 2014, EXPERT REV NEUROTHER, V14, P237, DOI 10.1586/14737175.2014.888652; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2	28	4	4	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2018	57						46	50		10.1016/j.jocn.2018.08.042			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY3YS	WOS:000448494000009	30154000				2022-02-06	
J	Stokes, SM; Scaife, ER; Stevens, AM; Fenton, SJ				Stokes, Sean M.; Scaife, Eric R.; Stevens, Austin M.; Fenton, Stephen J.			Longitudinal analysis of hospital charges following injury in a level 1 pediatric trauma system	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatric; Trauma; Injury; Healthcare costs; Value	UNITED-STATES; BRAIN-INJURY; COST FACTORS; CARE	Background: The treatment of injured children contributes substantially to the financial burden of a health care system. The purpose of this study was to characterize these charges at a level-1 pediatric trauma center. Methods: Financial data for children (<14 years) admitted for traumatic injury from 1/2009 to 12/2014 were analyzed. The charges of the index admission and first two years following discharge were evaluated. Results: 5853 trauma patients were included with average annual charges of $11,128,730. The most common mechanisms of injury were fall (44%), sports (12%), and bike (9%). The median ISS was 6 (IQR 4-10) with a mortality rate of 1.8% and Z-score of 13.04 (p<0.001). The overall total charges per patient during the index admission were $9513. Spinal cord and major abdominal injuries had the greatest charges per patient ($55,560 and $23,618 respectively) primarily owing to hospital LOS. During the first year after discharge, the total charges per patient were $1733, of which spinal cord injury resulted in highest overall ($19,426), owing to inpatient rehabilitation. For all other injury patterns, mean total charges per patient were $2376 (range $791-$3573). Conclusions: The value proposition in health care requires us to define outcomes relative to costs. Injury severity, major injury location, and hospital length of stay are the highest contributors for the financial burden of pediatric traumatic injury, while inpatient readmissions and inpatient rehabilitation drove higher charges in the years following discharge. Type of Study: Clinical Research Paper. (C) 2018 Elsevier Inc All rights reserved.	[Stokes, Sean M.; Stevens, Austin M.] Univ Utah, Sch Med, Dept Surg, Div Gen Surg, 30 N 1900 E, Salt Lake City, UT 84132 USA; [Scaife, Eric R.; Fenton, Stephen J.] Univ Utah, Sch Med, Dept Surg, Div Pediat Surg, 100 North Med Dr,Suite 3800, Salt Lake City, UT 84113 USA		Stokes, SM (corresponding author), Univ Utah, Sch Med, Dept Surg, Div Gen Surg, 30 N 1900 E, Salt Lake City, UT 84132 USA.	Sean.stokes@hsc.utah.edu					Borse Nagesh N., 2012, Morbidity and Mortality Weekly Report, V61, P830; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Burkhardt JH, 1999, RADIOLOGY, V212, P181, DOI 10.1148/radiology.212.1.r99jl46181; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; CHAN BSH, 1989, J TRAUMA, V29, P1540, DOI 10.1097/00005373-198911000-00014; Dueck A, 2001, CAN J SURG, V44, P117; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Gurses D, 2003, CAN J SURG, V46, P441; Harris BH, 1996, J PEDIATR SURG, V31, P78, DOI 10.1016/S0022-3468(96)90323-1; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; PECLET MH, 1990, J PEDIATR SURG, V25, P85, DOI 10.1016/S0022-3468(05)80169-1; Peterson C, 2014, PEDIATRICS, V134, P91, DOI 10.1542/peds.2014-0117; Shwartz M, 1995, INQUIRY-J HEALTH CAR, V32, P476; Skarda DE, 2015, J PEDIATR SURG, V50, P919, DOI 10.1016/j.jpedsurg.2015.03.009; Taira DA, 2003, AM HEART J, V145, P452, DOI 10.1067/mhj.2003.3	15	4	4	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	NOV	2018	53	11					2189	2194		10.1016/j.jpedsurg.2018.02.054			6	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Surgery	GW4KC	WOS:000446881300020	29576401				2022-02-06	
J	Varriano, B; Tomlinson, G; Tarazi, A; Wennberg, R; Tator, C; Tartaglia, MC				Varriano, Brenda; Tomlinson, George; Tarazi, Apameh; Wennberg, Richard; Tator, Charles; Tartaglia, Maria Carmela			Age, Gender and Mechanism of Injury Interactions in Post-Concussion Syndrome	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	Concussion in Women and Girls Symposium	SEP 23, 2017	Toronto, CANADA			Post-concussion syndrome; Gender; Age; Mechanism of Injury	TRAUMATIC-BRAIN-INJURY; SPORTS-RELATED CONCUSSION; MILD HEAD-INJURY; POSTCONCUSSION SYNDROME; SYMPTOMS; RECOVERY; PREDICTORS; PERFORMANCE; WORKING; RISK	Background: Certain factors such as age and gender seem to affect the risk of developing post-concussion syndrome (PCS). We assessed the interactions between age, gender, concussion history and mechanism of injury in PCS patients so that a better understanding could guide the development of targeted prevention strategies. Methods: Demographic data including age, gender, concussion mechanism of injury and concussion history were collected from (1) a prospective study evaluating PCS biomarkers and (2) a retrospective chart review of PCS patients. A total of 437 PCS patients who were assessed at the Canadian Concussion Centre or Toronto Western Hospital, Toronto, ON, were included. Results: Overall, there were more men with PCS; however, a greater percentage of women had PCS after a single concussion. The results showed that age, gender and concussion history are conditionally dependent on the mechanism of injury, and independent of one another. The relative frequency of having PCS was greater in the following instances: (1) being a woman and having had concussion from a fall or motor vehicle collision (MVC), (2) being older and having had concussion from a fall or MVC or (3) having a single concussion with cause being MVC or fall. Conclusion: In patients with PCS, age and gender interact with the mechanism of injury to influence the risk of concussion. Targeted prevention strategies may be essential to prevent injuries leading to PCS.	[Varriano, Brenda; Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 399 Bathurst St WW5-449, Toronto, ON M5T 2S8, Canada; [Tomlinson, George] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Tomlinson, George] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Tomlinson, George] Mt Sinai Hosp, Dept Med, Toronto, ON, Canada; [Tarazi, Apameh; Tator, Charles; Tartaglia, Maria Carmela] Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada; [Tarazi, Apameh; Wennberg, Richard; Tator, Charles; Tartaglia, Maria Carmela] Toronto Western Hosp, Concuss Res Clin, Toronto, ON, Canada; [Tator, Charles] Toronto Western Hosp, Krembil Neurosci Ctr, Div Neurosurg, Toronto, ON, Canada; [Tator, Charles] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Wennberg, Richard; Tartaglia, Maria Carmela] Toronto Western Hosp, Krembil Neurosci Ctr, Div Neurol, Toronto, ON, Canada		Tartaglia, MC (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 399 Bathurst St WW5-449, Toronto, ON M5T 2S8, Canada.	carmela.tartaglia@uhn.ca	Tomlinson, George/L-5432-2016	Tomlinson, George/0000-0002-9328-6399	Toronto Western and General Hospital Foundation; Ontario Brain Institute	The Toronto Western and General Hospital Foundation and Ontario Brain Institute provided funding for the study.	Anderson G., 2004, CHRONIC CONDITIONS M; Association AP, 2000, DIAGN STAT MAN MENT; Association AP, 1994, DIAGN STAT MAN MENT, P143; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Brook EM, 2016, PHYSICIAN SPORTSMED, V44, P20, DOI 10.1080/00913847.2016.1142834; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Camicioli R, 2010, GAIT POSTURE, V32, P87, DOI 10.1016/j.gaitpost.2010.03.013; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen DYT, 2016, RADIOLOGY, V278, P854, DOI 10.1148/radiol.2015150612; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iverson GL, 2016, J ATTEN DISORD; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Li GH, 2003, ACCIDENT ANAL PREV, V35, P227, DOI 10.1016/S0001-4575(01)00107-5; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Ramage-Morin Pamela L, 2008, Health Rep, V19, P45; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Stutts JC, 1998, ACCIDENT ANAL PREV, V30, P337, DOI 10.1016/S0001-4575(97)00108-5; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Tator Charles H, 2014, Neurosurgery, V75 Suppl 4, pS106, DOI 10.1227/NEU.0000000000000484; Team RC, 2017, LANG ENV STAT COMP; Valera E., 2016, TRAUMA BRAIN IMAGING, V11, P1664, DOI DOI 10.1007/s11682-016-9643-1; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Vehicle RSaM Regulation TC, 2011, ROAD SAF CAN; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320	43	4	4	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2018	45	6					636	642		10.1017/cjn.2018.322			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	HA6WM	WOS:000450422100005	30293541	Bronze			2022-02-06	
J	Yakoub, KM; O'Halloran, P; Davies, DJ; Bentley, C; Watson, CN; Forcione, M; Scarpa, U; Bishop, JRB; Toman, E; Hammond, D; Cross, MJ; Stokes, KA; Kemp, SPT; Menon, DK; Di Pietro, V; Belli, A				Yakoub, Kamal M.; O'Halloran, Patrick; Davies, David J.; Bentley, Conor; Watson, Callum N.; Forcione, Mario; Scarpa, Ugo; Bishop, Jonathan R. B.; Toman, Emma; Hammond, Douglas; Cross, Matthew J.; Stokes, Keith A.; Kemp, Simon P. T.; Menon, David K.; Di Pietro, Valentina; Belli, Antonio			Study of Concussion in Rugby Union through MicroRNAs (SCRUM): a study protocol of a prospective, observational cohort study	BMJ OPEN			English	Article						sport concussion; traumatic brain injury; concussion; biomarkers; chronic traumatic encephalopathy; miRNA	TRAUMATIC BRAIN-INJURY; BIOMARKERS; DIAGNOSIS; MILD	Introduction The diagnosis of mild traumatic brain injury or sports-related concussion is a challenge for all clinicians, players, coaches and parents involved in contact sports. Currently, there is no validated objective biomarker available to assess the presence or severity of concussion in sport, and so it is necessary to rely on subjective measures like self-reporting of symptoms which depend on the cooperation of the athlete. There is a significant health risk associated with repetitive injury if the diagnosis is missed, and so there is great value in an objective biomarker to assist diagnostic and prognostic decisions. Objective To establish a panel of non-invasive MicroRNA biomarkers in urine and saliva for the rapid diagnosis of sports-related concussion and investigate the kinetics and clinical utility of these biomarkers in assisting diagnostic, prognostic and return-to-play decisions. Methods and analysis Observational, prospective, multicentre cohort study recruiting between the 2017-2018 and 2018-2019 Rugby Union seasons. Professional rugby players in the two highest tiers of senior professional domestic rugby competition in England will be recruited prospectively to the study. During the season, three groups will be identified: athletes entering the World Rugby Head Injury Assessment (HIA) protocol, uninjured control athletes and control athletes with musculoskeletal injuries. Saliva and urine will be collected from these athletes at multiple timepoints, coinciding with key times in the HIA protocol and return-to-play process. Ethics and dissemination Ethics approval has been obtained. The compiled and analysed results will be presented at national and international conferences concerning the care of patients with traumatic brain injury. Results will also be submitted for peer review and publication in the subject journals/literature.	[Yakoub, Kamal M.; Davies, David J.; Bentley, Conor; Forcione, Mario; Bishop, Jonathan R. B.; Di Pietro, Valentina; Belli, Antonio] Univ Hosp Birmingham NHS Fdn Trust, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Yakoub, Kamal M.; O'Halloran, Patrick; Davies, David J.; Watson, Callum N.; Forcione, Mario; Scarpa, Ugo; Di Pietro, Valentina; Belli, Antonio] Univ Birmingham, Inst Inflammat & Aging, Neurotrauma & Ophthalmol Res Grp, Birmingham, W Midlands, England; [Toman, Emma; Hammond, Douglas] Univ Cent Lancashire, Sch Dent, Fac Clin & Biomed Sci, Head Injury Management Res Grp, Preston, Lancs, England; [Cross, Matthew J.; Stokes, Keith A.] Univ Bath, Dept Hlth, Bath, Avon, England; [Cross, Matthew J.] Premiership Rugby, London, England; [Stokes, Keith A.; Kemp, Simon P. T.] Rugby Football Union, London, England; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Di Pietro, Valentina] Univ Illinois, Beckman Inst Adv Sci & Technol, Champaign, IL USA		Yakoub, KM (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England.; Yakoub, KM (corresponding author), Univ Birmingham, Inst Inflammat & Aging, Neurotrauma & Ophthalmol Res Grp, Birmingham, W Midlands, England.	k.yakoub@bham.ac.uk	Belli, Antonio/I-3799-2015; Stokes, Keith/C-2605-2009; Forcione, Mario/K-2852-2018	Belli, Antonio/0000-0002-3211-9933; O'Halloran, Patrick/0000-0002-1185-3485; Bentley, Conor/0000-0003-3021-4838; Watson, Callum Nicholas/0000-0003-2511-5501; Kemp, Simon/0000-0002-3250-2713; Toman, Emma/0000-0003-2142-1923; Stokes, Keith/0000-0002-5049-2838; Forcione, Mario/0000-0002-4045-8011	Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Biovici Diagnostics Ltd; Rugby Football Union (RFU) [MRC CIC 164132]	This work is supported by funding received from the Medical Research Council (MRC), National Institute for Health Research (NIHR), Biovici Diagnostics Ltd and the Rugby Football Union (RFU), grant number: MRC CIC 164132.	Brett BL, 2018, J INT NEUROPSYCH SOC, V24, P476, DOI 10.1017/S1355617717001321; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; National Institute for Health and Care Excellence (NICE), 2017, HEAD INJ ASS EARL MA; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rugby Football Union, 2017, PROF RUGB INJ SURV P; Toman E, 2016, J ROY ARMY MED CORPS, V162, P103, DOI 10.1136/jramc-2015-000517	20	4	4	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	NOV	2018	8	11							e024245	10.1136/bmjopen-2018-024245			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HG1SL	WOS:000454740400137	30478124	Green Published, gold, Green Accepted			2022-02-06	
J	Yu, XY; Jia, LL; Yin, KQ; Lv, JS; Yu, WL; Du, HY				Yu, Xiangyang; Jia, Lili; Yin, Kuoqi; Lv, Jingshu; Yu, Wenli; Du, Hongyin			Src is Implicated in Hepatic Ischemia Reperfusion-Induced Hippocampus Injury and Long-Term Cognitive Impairment in Young Mice via NMDA Receptor Subunit 2A Activation	NEUROSCIENCE			English	Article						hepatic ischemia reperfusion; hippocampus; Src; NR2A; cognitive function; tyrosine phosphorylation	PERIPHERAL BENZODIAZEPINE-RECEPTORS; PEDIATRIC LIVER-TRANSPLANTATION; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; TYROSINE PHOSPHORYLATION; GLUTAMATE RECEPTORS; INFLAMMATORY CYTOKINES; SYNAPTIC PLASTICITY; HYDROGEN-SULFIDE	Hepatic ischemia reperfusion (HIR) has been found to induce hippocampus injury and cognitive dysfunction. The N-methyl-D-aspartate (NMDA) receptor subunit 2A (NR2A) is an important factor mediating excitotoxicity and neurons injury, and autophosphorylation of Src can up-regulate tyrosine phosphorylation of NR2A to improve its activity. However, the role of Src and NR2A in HIR-induced hippocampus injury in young mice remains unknown. In this study, we found that serum biomarkers of brain injury (S100 beta and NSE) increased significantly and reached highest after reperfusion of 3 days which had the same trend with the levels of p-Src and p-NR2A. Interactions between Src and NR2A or PSD95 were increased after HIR. Hippocampal neuron apoptosis was increased, and long-term cognitive impairment was found after reperfusion of 1 month. Inhibition of Src and NR2A with PP2 and NVP-AAM077 respectively not only down-regulated the levels of p-Src and p-NR2A, but also ameliorated hippocampal neurons apoptosis and long-term cognitive impairment after HIR. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), tumor necrosis factor alpha (TNF-alpha), interferon-gamma (IFN-gamma) and interleukin (IL)-6 were increased after reperfusion of 3 days, while PP2 and NVP-AAM077 treatment didn't attenuate the changes. And no difference was found in serum TNF-alpha, IFN-gamma, IL-6 concentrations as well as the levels of Src, p-Src, NR2A, p-NR2A, PSD95 among the four groups after reperfusion of 1 month. In summary, HIR can lead to hippocampus injury and long-term cognitive dysfunction, and Src-PSD95-NR2A pathway plays an important role in the process. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Yu, Xiangyang; Yin, Kuoqi; Lv, Jingshu] Tianjin Med Univ, Ctr Clin Coll 1, Tianjin, Peoples R China; [Jia, Lili; Yu, Wenli; Du, Hongyin] Tianjin First Ctr Hosp, Dept Anesthesiol, Tianjin, Peoples R China		Yu, WL (corresponding author), Tianjin First Ctr Hosp, Dept Anesthesiol, Tianjin, Peoples R China.	yzxwenliyu@163.com			Key Research Projects of Tianjin Health Industry [13KG105, 16KG101]; Natural Science Foundation of TianjinNatural Science Foundation of Tianjin [17JCYBJC28000, 18JCYBJC27500]; Research Project of Combining Traditional Chinese and Western Medicine of Tianjin Health and Family Planning Committee [2017056]	This work was supported by Key Research Projects of Tianjin Health Industry (13KG105, 16KG101), Natural Science Foundation of Tianjin (17JCYBJC28000), Research Project of Combining Traditional Chinese and Western Medicine of Tianjin Health and Family Planning Committee (2017056) and Natural Science Foundation of Tianjin (18JCYBJC27500).	Ayala Alfred, 2007, Novartis Found Symp, V280, P37; Benedict C, 2014, SLEEP, V37, P195, DOI 10.5665/sleep.3336; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Biegon A, 2002, J NEUROCHEM, V82, P924, DOI 10.1046/j.1471-4159.2002.01050.x; Bucuvalas J, 2013, AM J TRANSPLANT, V13, P2790, DOI 10.1111/ajt.12409; Chen TT, 2016, NEUROPHARMACOLOGY, V107, P411, DOI 10.1016/j.neuropharm.2016.03.028; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Colletti LM, 1996, HEPATOLOGY, V23, P506; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dong N, 2017, EXP THER MED, V13, P3183, DOI 10.3892/etm.2017.4411; Duan ZZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29246; Erol I, 2007, PEDIATR TRANSPLANT, V11, P152, DOI 10.1111/j.1399-3046.2006.00620.x; Fernandez D, 2010, TRANSPLANTATION, V90, P319, DOI 10.1097/TP.0b013e3181e5b7fc; Gong X, 2015, EXP THER MED, V10, P653, DOI 10.3892/etm.2015.2577; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Hou XY, 2007, NEUROSCI LETT, V420, P235, DOI 10.1016/j.neulet.2007.03.048; Jia LL, 2017, BRAIN RES, V1657, P202, DOI 10.1016/j.brainres.2016.12.015; Jung WR, 2010, NEUROSCIENCE, V165, P159, DOI 10.1016/j.neuroscience.2009.10.012; Kaller T, 2013, AM J TRANSPLANT, V13, P2956, DOI 10.1111/ajt.12408; Karimi N, 2017, NEUROSCIENCE, V358, P238, DOI 10.1016/j.neuroscience.2017.06.058; Kasahara M, 2017, PEDIATR SURG INT, V33, P1289, DOI 10.1007/s00383-017-4173-5; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Laube B, 1998, J NEUROSCI, V18, P2954; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; Ma G, 2017, BIOMED PHARMACOTHER, V90, P62, DOI 10.1016/j.biopha.2017.02.094; Macuchova E, 2013, PHYSIOL RES, V62, pS89, DOI 10.33549/physiolres.932598; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Niimura M, 2005, J NEUROCHEM, V92, P1377, DOI 10.1111/j.1471-4159.2005.02977.x; Qiao X, 2017, HYPERTENSION, V69, P154, DOI 10.1161/HYPERTENSIONAHA.116.07947; Rand EB, 2003, GASTROENTEROL CLIN N, V32, P913, DOI 10.1016/S0889-8553(03)00048-7; Raza M, 2004, P NATL ACAD SCI USA, V101, P17522, DOI 10.1073/pnas.0408155101; Reus GZ, 2016, ADV PROTEIN CHEM STR, V103, P169, DOI 10.1016/bs.apcsb.2015.10.003; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Scanlon DP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15220; Shimada S, 2015, SURG TODAY, V45, P892, DOI 10.1007/s00595-014-1064-4; Sonmez A, 2015, NEUROSCI LETT, V597, P137, DOI 10.1016/j.neulet.2015.05.001; Taniguchi S, 2009, EMBO J, V28, P3717, DOI 10.1038/emboj.2009.300; Thornton C, 2003, J BIOL CHEM, V278, P23823, DOI 10.1074/jbc.M302389200; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Tsung A, 2006, AM J PHYSIOL-GASTR L, V290, pG1261, DOI 10.1152/ajpgi.00460.2005; Tu FP, 2016, J SURG RES, V205, P426, DOI 10.1016/j.jss.2016.06.071; Wang YQ, 2014, GENET MOL RES, V13, P5767, DOI 10.4238/2014.July.29.4; Wang Y, 2013, INT J NEUROSCI, V123, P191, DOI 10.3109/00207454.2012.744755; Wang Z, 2017, EXP THER MED, V14, P5851, DOI 10.3892/etm.2017.5265; Wanner GA, 1996, SHOCK, V5, P34, DOI 10.1097/00024382-199601000-00008; Wright Clinton B, 2006, J Stroke Cerebrovasc Dis, V15, P34, DOI 10.1016/j.jstrokecerebrovasdis.2005.08.009; Wu GM, 2010, BRAIN RES, V1343, P186, DOI 10.1016/j.brainres.2010.04.055; Xu Q, 2017, J NEUROL SCI, V376, P166, DOI 10.1016/j.jns.2017.03.027; Yang M, 2001, J NEUROCHEM, V77, P580, DOI 10.1046/j.1471-4159.2001.00255.x; Yang Xiaorong, 2017, Oxid Med Cell Longev, V2017, P2823454, DOI 10.1155/2017/2823454; Zamaraev AV, 2017, TRENDS CELL BIOL, V27, P322, DOI 10.1016/j.tcb.2017.01.003; Zhang F, 2013, STROKE, V44, P170, DOI 10.1161/STROKEAHA.112.667253; Zhang X, 2015, HIPPOCAMPUS, V25, P286, DOI 10.1002/hipo.22372; Zhang Y, 2016, NEUROL SCI, V37, P1039, DOI 10.1007/s10072-016-2546-5	57	4	8	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 1	2018	391						1	12		10.1016/j.neuroscience.2018.08.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GW7UG	WOS:000447176700001	30213765				2022-02-06	
J	van Essen, TA; Dijkman, MD; Cnossen, MC; Moudrous, W; Ardon, H; Schoonman, GG; Steyerberg, EW; Peul, WC; Lingsma, HF; de Ruiter, GCW				van Essen, Thomas A.; Dijkman, Mark D.; Cnossen, Maryse C.; Moudrous, Walid; Ardon, Hilko; Schoonman, Guus G.; Steyerberg, Ewout W.; Peul, Wilco C.; Lingsma, Hester F.; de Ruiter, Godard C. W.			Comparative Effectiveness of Surgery for Traumatic Acute Subdural Hematoma in an Aging Population	JOURNAL OF NEUROTRAUMA			English	Article						acute subdural hematoma; epidemiology; surgery; traumatic brain injury	BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; SURGICAL-MANAGEMENT; MORTALITY; CRANIOTOMY; EVACUATION; GUIDELINES; ADMISSION; OUTCOMES; SCORE	There is uncertainty as to the optimal initial management of patients with traumatic acute subdural hematoma, leading to regional variation in surgical policy. This can be exploited to compare the effect of various management strategies and determine best practices. This article reports such a comparative effectiveness analysis of a retrospective observational cohort of traumatic acute subdural hematoma patients in two geographically distinct neurosurgical departments chosen for their - a-priori defined - diverging treatment preferences. Region A favored a strategy focused on surgical hematoma evacuation, whereas region B employed a more conservative approach, performing primary surgery less often. Region was used as a proxy for preferred treatment strategy to compare outcomes between groups, adjusted for potential confounders using multivariable logistic regression with imputation of missing data. In total, 190 patients were included: 108 from region A and 82 from region B. There were 104 males (54.7%). Matching current epidemiological developments, the median age was relatively high at 68 years (interquartile range [IQR], 54-76). Baseline characteristics were comparable between regions. Primary evacuation was performed in 84% of patients in region A and in 65% of patients in region B (p<0.01). Mortality was lower in region A (37% vs. 45%, p=0.29), as was unfavorable outcome (53% vs. 62%, p=0.23). The strategy favoring surgical evacuation was associated with significantly lower odds of mortality (odds ratio [OR]: 0.43; 95% confidence interval [CI]: 0.21-0.88) and unfavorable outcome (OR: 0.53; 95% CI: 0.27-1.02) 3-9 months post-injury. Therefore, in the aging population of patients with acute subdural hematoma, a treatment strategy favoring emergency hematoma evacuation might be associated with lower odds of mortality and unfavorable outcome.	[van Essen, Thomas A.; Dijkman, Mark D.; Peul, Wilco C.] Leiden Univ, Med Ctr, Dept Neurosurg, Albinusdreef 2,Mailing Zone J-11R, NL-2333 ZA Leiden, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [van Essen, Thomas A.; Peul, Wilco C.; de Ruiter, Godard C. W.] Medial Ctr Haaglanden, Dept Neurosurg, The Hague, Netherlands; [Cnossen, Maryse C.; Steyerberg, Ewout W.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, Rotterdam, Netherlands; [Moudrous, Walid; Schoonman, Guus G.] Elisabeth Tweesteden Hosp, Dept Neurol, Tilburg, Netherlands; [Moudrous, Walid] Elisabeth Tweesteden Hosp, Dept Neurosurg, Tilburg, Netherlands; [Ardon, Hilko] Maasstad Hosp, Dept Neurol, Rotterdam, Netherlands		van Essen, TA (corresponding author), Leiden Univ, Med Ctr, Dept Neurosurg, Albinusdreef 2,Mailing Zone J-11R, NL-2333 ZA Leiden, Netherlands.	t.a.van_essen@lumc.nl	de Ruiter, Godard/ABC-4074-2020	Van Essen, Thomas/0000-0003-4657-5283	European UnionEuropean Commission [602150]; Hersenstichting Nederland (Dutch Brain Foundation) [PS2014-06]	This study was funded by the European Union Seventh Framework Program (grant 602150) for CENTER-TBI and Hersenstichting Nederland (Dutch Brain Foundation, project PS2014-06) for the Neurotraumatology Quality Registry (Net-QuRe). The authors have no industry affiliation.	Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CROCE MA, 1994, J TRAUMA, V36, P820, DOI 10.1097/00005373-199406000-00012; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Feliciano CE, 2008, P R HEALTH SCI J, V27, P220; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; Goslings J Carel, 2009, Ned Tijdschr Geneeskd, V153, P744; Gregson BA, 2015, HEALTH TECHNOL ASSES, V19, DOI 10.3310/hta19700; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hedges JR, 2009, J EMERG MED, V37, P115, DOI 10.1016/j.jemermed.2008.07.001; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; JENNETT B, 1975, LANCET, V1, P480; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Marion DW, 2006, NEUROSURGERY, V58, P655; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Nijboer JMM, 2010, INJURY, V41, P52, DOI 10.1016/j.injury.2009.05.030; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Scotter J, 2015, EMERG MED J, V32, P654, DOI 10.1136/emermed-2014-204260; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Tierney KJ, 2016, J NEUROSURG, V124, P538, DOI 10.3171/2015.4.JNS142440; Timmons SD, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS1296; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019	41	4	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1184	1191		10.1089/neu.2018.5869		OCT 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6CL	WOS:000447597300001	30234429	Green Submitted			2022-02-06	
J	McGeown, JP; Zerpa, C; Lees, S; Niccoli, S; Sanzo, P				McGeown, Joshua P.; Zerpa, Carlos; Lees, Simon; Niccoli, Sarah; Sanzo, Paolo			Implementing a structured exercise program for persistent concussion symptoms: a pilot study on the effects on salivary brain-derived neurotrophic factor, cognition, static balance, and symptom scores	BRAIN INJURY			English	Article						Persistent concussion symptoms; sports-related concussion; active rehabilitation; neuroplasticity; brain-derived neurotrophic factor	SPORT-RELATED CONCUSSION; HEART-RATE-VARIABILITY; ERROR SCORING SYSTEM; AEROBIC EXERCISE; POSTCONCUSSION SYNDROME; ENDURANCE EXERCISE; REHABILITATION; INJURY; NEUROPROTECTION; ADOLESCENTS	Primary objective: Persistent concussion symptoms (PCS) affect 10-30% of individuals after sports-related concussion. This study evaluated the effect of exercise-based rehabilitation on symptom scores, brain-derived neurotrophic factor (BDNF), cognitive functions and static balance in a sample of participants with PCS. Research design: One group pre-test post-test pilot study. Methods and procedure: Nine participants with PCS received a structured exercise-based rehabilitation program. Changes in symptom scores, BDNF, cognitive functions and measures of static balance were used to evaluate the utility of the exercise program. Main outcome and results: The results of this pilot study indicate a significant improvement in symptom scores following treatment, as well as some associated benefits in regards to cognitive function and static balance. BDNF levels in the participants with PCS within this study are notably lower than in a previous study on healthy controls. Conclusions: The preliminary evidence reported in the current pilot study is clinically relevant as our findings suggest exercise-based treatments may improve PCS outcomes in a more favourable manner than rest-based treatment.	[McGeown, Joshua P.; Zerpa, Carlos; Sanzo, Paolo] Lakehead Univ, Sch Kinesiol, Dept Hlth & Behav Sci, Thunder Bay, ON, Canada; [McGeown, Joshua P.] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Mail Code P-1,Private Bag 92006, Auckland 1142, New Zealand; [Lees, Simon; Niccoli, Sarah; Sanzo, Paolo] Lakehead Univ, Med Sci Div, Northern Ontario Sch Med, Thunder Bay, ON, Canada		McGeown, JP (corresponding author), Auckland Univ Technol, Sports Performance Res Inst New Zealand, Mail Code P-1,Private Bag 92006, Auckland 1142, New Zealand.	josh.mcgeown@aut.ac.nz		McGeown, Joshua/0000-0003-0225-4488			Adachi Naoki, 2014, World J Biol Chem, V5, P409, DOI 10.4331/wjbc.v5.i4.409; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Austin MW, 2014, NEUROSCI RES, V87, P8, DOI 10.1016/j.neures.2014.06.007; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Carter JB, 2003, SPORTS MED, V33, P33, DOI 10.2165/00007256-200333010-00003; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2001, J ATHL TRAINING, V36, P228; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hennigan A, 2007, BIOCHEM SOC T, V35, P424, DOI 10.1042/BST0350424; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kent M, 2007, KARVONEN METHOD OXFO, DOI 10. 1093/acref/9780198568506. 001. 0001/acref-9780198568506-e-3771; King ML, 1997, BRAIN INJURY, V11, P445; Koo Jung Hoon, 2013, J Exerc Nutrition Biochem, V17, P151, DOI 10.5717/jenb.2013.17.4.151; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lee TMC, 2014, PSYCHONEUROENDOCRINO, V39, P214, DOI 10.1016/j.psyneuen.2013.09.019; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Mandel AL, 2009, ARCH ORAL BIOL, V54, P689, DOI 10.1016/j.archoralbio.2009.04.005; Mandel AL, 2011, J IMMUNOASS IMMUNOCH, V32, P18, DOI 10.1080/15321819.2011.538625; Mang CS, 2013, PHYS THER, V93, P1707, DOI 10.2522/ptj.20130053; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGeown JP, 2016, RES NEUROSCIENCE, V5, P15, DOI [10.5923/j.neuroscience.20160501.03, DOI 10.5923/J.NEUROSCIENCE.20160501.03]; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Phillips C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00170; Ploughman M, 2005, NEUROSCIENCE, V136, P991, DOI 10.1016/j.neuroscience.2005.08.037; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Quaney BM, 2009, NEUROREHAB NEURAL RE, V23, P879, DOI 10.1177/1545968309338193; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Shih PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078163; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Wells DG, 2002, ENCY AGING; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003	55	4	4	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2018	32	12					1556	1565		10.1080/02699052.2018.1498128			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GX0EO	WOS:000447382800015	30036102				2022-02-06	
J	Mifflin, K; Baker, GB; Kerr, BJ				Mifflin, Katherine; Baker, Glen B.; Kerr, Bradley J.			Effect of voluntary wheel running on neuroactive steroid levels in murine experimental autoimmune encephalomyelitis	NEUROSCIENCE LETTERS			English	Article						Sex dependent differences; EAE; Brain; Neuroactive steroids; Multiple sclerosis; Exercise	SEX-DIMORPHIC CHANGES; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID	Increasing evidence from both clinical and animal research has implicated changes in neuroactive steroids (rapid acting steroids that act as allosteric modulators at NMDA and/or GABA-A receptors) in multiple sclerosis. These changes have been linked to clinical differences in disease severity, prevention of disease development, as well as the disease state (relapsing vs progressive) in patients with multiple sclerosis. Previous research has also linked changes in neuroactive steroid levels to the beneficial effects of exercise in certain disorders such as traumatic brain injury and post-traumatic stress disorder. The present study therefore examined whether voluntary wheel running could modulate any of the reported changes in neuroactive steroids associated with the EAE model of multiple sclerosis. Female mice with EAE who ran were found to have significantly increased levels of brain pregnenolone compared to male EAE mice who ran. In contrast, male mice with EAE were found to have significantly higher levels of brain allopregnanolone compared to female mice with EAE regardless of exercise. Overall, these results indicate that exercise has moderate beneficial effects on brain neuroactive steroid levels in EAE. These changes may be related to other beneficial responses to exercise, such as improvements in disease severity, in EAE and/or multiple sclerosis.	[Mifflin, Katherine; Baker, Glen B.; Kerr, Bradley J.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB T6G 2E1, Canada; [Kerr, Bradley J.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6E 2H7, Canada; [Baker, Glen B.] Univ Alberta, Dept Psychiat NRU, Edmonton, AB T6G 2B7, Canada; [Kerr, Bradley J.] Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB T6G 2G3, Canada		Mifflin, K (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Med Sci Bldg 9-28, Edmonton, AB T6G 2H7, Canada.	mifflin@ualberta.ca		Mifflin, Katherine/0000-0002-6323-4731; Kerr, Bradley/0000-0002-0264-8316	CIHRCanadian Institutes of Health Research (CIHR) [MOP-119338, MOP-86712]; University of AlbertaUniversity of Alberta; MS Society of Canada; Alberta Innovates: Health Solutions trust fund	Funding for this project was provided by operating grants from CIHR MOP-119338 and MOP-86712, the University of Alberta, and the MS Society of Canada. KAM was supported by a scholarship from Alberta Innovates: Health Solutions trust fund. The funding agencies had no role in the study design, data collection, analysis/interpretation of data, the writing of the report or the decision to submit for publication.	Ahboucha S, 2008, NEUROGASTROENT MOTIL, V20, P671, DOI 10.1111/j.1365-2982.2007.01080.x; Baulieu E., 2018, STEROIDS, V65, P605; Caruso D, 2014, J NEUROCHEM, V130, P591, DOI 10.1111/jnc.12745; Caruso D, 2010, J NEUROCHEM, V114, P921, DOI 10.1111/j.1471-4159.2010.06825.x; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; Giatti S, 2010, NEUROCHEM INT, V56, P118, DOI 10.1016/j.neuint.2009.09.009; Melcangi RC, 2011, NEUROSCIENCE, V191, P1, DOI 10.1016/j.neuroscience.2011.06.024; Mifflin KA, 2017, J NEUROIMMUNOL, V305, P135, DOI 10.1016/j.jneuroim.2017.02.005; Noorbakhsh F, 2014, FRONT CELL NEUROSCI, V8, P1, DOI 10.3389/fncel.2014.00134; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Orefice NS, 2016, J STEROID BIOCHEM, V159, P1, DOI 10.1016/j.jsbmb.2016.02.012; Ortona Elena, 2016, Ann Ist Super Sanita, V52, P205, DOI 10.4415/ANN_16_02_12; Rahn EJ, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/2042-6410-5-4; Savettieri G, 2004, J NEUROL, V251, P1208, DOI 10.1007/s00415-004-0508-y; Schule C, 2011, NEUROSCIENCE, V191, P55, DOI 10.1016/j.neuroscience.2011.03.025; Scioli-Salter E, 2016, J REHABIL RES DEV, V53, P95, DOI 10.1682/JRRD.2014.10.0267; Tuem KB, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00442; Wang MD, 2002, J NEUROSCI, V22, P3366	18	4	5	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	OCT 15	2018	685						150	154		10.1016/j.neulet.2018.08.040			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GZ1LF	WOS:000449128900024	30171909				2022-02-06	
J	Aas, RW; Haveraaen, LA; Brouwers, EPM; Skarpaas, LS				Aas, Randi Wago; Haveraaen, Lise Aasen; Brouwers, Evelien P. M.; Skarpaas, Lisebet Skeie			Who among patients with acquired brain injury returned to work after occupational rehabilitation? The rapid-return-to-work-cohort-study	DISABILITY AND REHABILITATION			English	Article						Acquired brain injury; traumatic brain injury; stroke; rapid-RTW-studies; occupational rehabilitation; workplace disability prevention and integration; disability management	VOCATIONAL-REHABILITATION; BACK; EMPLOYMENT; PREDICTORS; EMPLOYEES; STROKE	Background: Acquired brain injury (ABI) is known to be severely disabling. On average, 40% of employees return to work (RTW) within two years after injury. There is, however, limited research on what might contribute to successful RTW. Aim: To examine factors that might impact the time-to first RTW for patients with ABI, participating in a RTW-program. Methods: The study was designed as a cohort study of patients on sick leave due to mild or moderate ABI (n = 137). The mean age of the patients was 51 years, and 58% were men. The most common diagnoses were stroke (75%) and traumatic brain injury (12%). Data were collected through questionnaires, and combined with register data on sickness absence. Survival analyses were used to analyse the effect of different variables on time to first RTW (full or partial), at one- and two-year follow-up. Results: Generally, women (HR = 0.447; CI: 0.239-0.283) had higher RTW-rates than men, and patients with non-comorbid impairments returned to work earlier than patients with multiple impairments. Although not statistically significant, receiving individual consultations and participating in group-sessions were generally associated with a delayed RTW at both follow-up-times. The only service-related factor significantly associated with delayed RTW was meetings with the social insurance office (HR = 0.522; CI: 0.282-0.965), and only at one-year follow-up. Conclusions: Women and patients with non-comorbid impairments returned to work earlier than men and patients with multiple impairments. There seems to be an association between intense and long-lasting participation in the RTW program and prolonged time-to first-RTW, even after controlling for level of cognitive impairments and comorbidity.	[Aas, Randi Wago; Haveraaen, Lise Aasen; Skarpaas, Lisebet Skeie] Presenter Making Sense Sci, Stavanger, Norway; [Aas, Randi Wago; Skarpaas, Lisebet Skeie] Oslo & Akershus Univ Coll Appl Sci, Fac Hlth Sci, Oslo, Norway; [Aas, Randi Wago] Univ Stavanger, Fac Social Sci, Stavanger, Norway; [Brouwers, Evelien P. M.] Tilburg Univ, Tilburg Sch Social & Behav Sci, Tranzo, Tilburg, Netherlands		Aas, RW (corresponding author), Univ Stavanger, N-4021 Stavanger, Norway.	randi.w.aas@uis.no		Aas, Randi W./0000-0003-4391-6142	Norwegian Directorate of Health; South-Eastern Norway Regional Health Authority	This work was funded by The Norwegian Directorate of Health and South-Eastern Norway Regional Health Authority.	Aas RW, 2008, J OCCUP REHABIL, V18, P335, DOI 10.1007/s10926-008-9147-y; Aas RW, 2011, RASKERE TILBAKE ORG; Ballabeni P, 2010, J OCCUPATIONAL REHAB, V21, P43; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; da Silva JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115885; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Doucet T., 2012, Annals of Physical and Rehabilitation Medicine, V55, P112, DOI 10.1016/j.rehab.2012.01.007; Edwards MJ, 2003, DISABIL REHABIL, V25, P405, DOI 10.1080/0963828031000062642; Ellingsen KL, 2010, RAPPORT; Farstad L, 2011, RAPPORT IRIS; Frank JW, 1996, SPINE, V21, P2918, DOI 10.1097/00007632-199612150-00025; Fukuoka Y, 2009, SOC SCI MED, V68, P1875, DOI 10.1016/j.socscimed.2009.02.030; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Haveraaen L, 2017, J OCCUP REHABIL, V27, P623, DOI 10.1007/s10926-016-9693-7; Haveraaen LA, 2016, WORK, V53, P61, DOI 10.3233/WOR-152216; Haveraaen LA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3942-8; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Jacobsen A., 2005, PERSONER MED HJERNES; Johansson G., 2007, ILLNESS FLEXIBILITY; Johansson G, 2006, J OCCUP REHABIL, V16, P185, DOI 10.1007/s10926-006-9020-9; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Koopmans PC, 2010, OCCUP MED-OXFORD, V60, P249, DOI 10.1093/occmed/kqq061; Krause N, 2001, AM J IND MED, V40, P374, DOI 10.1002/ajim.1112; Laine S, 2009, J EPIDEMIOL COMMUN H, V63, P24, DOI 10.1136/jech.2007.071407; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lidwall U, 2005, WORK, V27, P153; Lysaght RM, 2008, WORK, V30, P255; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Mitchell K, 2012, PROF CASE MANAG, V17, P94, DOI 10.1097/NCM.0b013e318244c333; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; Nilsson S, 2013, WORK, V44, P449, DOI 10.3233/WOR-2012-1402; Ntsiea MV, 2015, CLIN REHABIL, V29, P663, DOI 10.1177/0269215514554241; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Post M, 2005, DISABIL REHABIL, V27, P481, DOI 10.1080/09638280400018601; Puhr A, 2011, TIDSSKRIFT NORSK PSY, V48, P774; Roelen CA, 2011, PSYCHO-ONCOLOGY, V20, P1001, DOI 10.1002/pon.1820; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Selander J, 2002, DISABIL REHABIL, V24, P704, DOI 10.1080/09638280210124284; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Skarpaas LS, 2013, DELPHI STUDIE RUNDER; Stoltenberg CDG, 2010, SCAND J PUBLIC HEALT, V38, P299, DOI 10.1177/1403494809357095; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Velzen JMv, 2009, BRAIN INJURY, V23, P473; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; World Health Organization, 2007, INT CLASS FUNCT DIS	52	4	4	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 9	2018	40	21					2561	2570		10.1080/09638288.2017.1354234			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GW1GU	WOS:000446621800011	28724317				2022-02-06	
J	Botchway, EN; Godfrey, C; Anderson, V; Nicholas, CL; Catroppa, C				Botchway, Edith N.; Godfrey, Celia; Anderson, Vicki; Nicholas, Christian L.; Catroppa, Cathy			Outcomes of Subjective Sleep-Wake Disturbances Twenty Years after Traumatic Brain Injury in Childhood	JOURNAL OF NEUROTRAUMA			English	Article						children; sleep-wake disturbances; TBI; young adults	COGNITIVE-BEHAVIORAL THERAPY; INSOMNIA SEVERITY INDEX; STRESS SCALES DASS; QUALITY-OF-LIFE; POOR SLEEP; PSYCHOMETRIC PROPERTIES; OBJECTIVE ASSESSMENT; ADOLESCENTS; CHILDREN; MILD	Sleep-wake disturbances (SWD) are frequent following traumatic brain injury (TBI) in childhood. However, outcomes of SWD following transition into young adulthood remain unknown. This study investigated prevalence and factors associated with subjective sleep quality, insomnia, and excessive daytime sleepiness in young adults with a history of childhood TBI. Participants included 54 young adults with mild (n=14), moderate (n=27), and severe (n=13) TBI (age: mean=27.7, SD=3.3), and 13 typically developing controls (TDC) (age: mean=25.9, SD=2.2). SWD were assessed using the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), and Epworth Sleepiness Scale (ESS). Compared with TDC, young adults with TBI reported a trend toward poorer sleep quality (F[1, 63]=3.85, p=0.054, (2)=0.06), with a higher risk in participants after moderate TBI (mean=2.40, SD=0.56) than after severe TBI (mean=1.89, SD=0.62: p=0.015). However, the groups did not differ on symptoms of insomnia and excessive daytime sleepiness, and SWD were less frequent after severe TBI at 20 years post-injury. Poor sleep quality in young adults with TBI was associated with high levels of anxiety and pain, and pain was also associated with higher risk of insomnia and excessive daytime sleepiness. Our findings indicate that sustaining TBI in childhood can increase risk of SWD in young adulthood, particularly following moderate TBI. Routine assessments and treatment of SWD, as well as anxiety and pain in children with TBI, should therefore continue into adulthood.	[Botchway, Edith N.; Godfrey, Celia; Anderson, Vicki; Nicholas, Christian L.; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Botchway, Edith N.; Godfrey, Celia; Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia; [Botchway, Edith N.; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Anderson, Vicki; Nicholas, Christian L.; Catroppa, Cathy] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Nicholas, Christian L.] Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia		Botchway, EN (corresponding author), Murdoch Childrens Res Inst, Clin Sci, 50 Flemington Rd, Parkville, Vic 3052, Australia.	edith.botchway@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Botchway, Edith N/0000-0002-0075-3382	University of Melbourne International Fee Remission; Melbourne International Research Scholarships; National Health and Medical Research Council Senior Practitioner FellowshipNational Health and Medical Research Council of Australia; Murdoch Children's Research Institute Career Development Award	Edith N. Botchway was funded by the University of Melbourne International Fee Remission and the Melbourne International Research Scholarships, Vicki Anderson was supported by a National Health and Medical Research Council Senior Practitioner Fellowship, and Cathy Catroppa was funded by the Murdoch Children's Research Institute Career Development Award.	Albicini M., 2015, FRESH LOOK ANXIETY D, P199, DOI [10.5772/57353, DOI 10.5772/57353, DOI 10.5772/60426]; Albicini M, 2018, J HEAD TRAUMA REHAB, V33, P191, DOI 10.1097/HTR.0000000000000312; Albicini MS, 2016, INT J REHABIL RES, V39, P77, DOI 10.1097/MRR.0000000000000149; Allan AC, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000222; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson VA, 2000, BRAIN INJURY, V14, P679; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Apostolidis K., 2015, OPEN SCI J CLIN MED, V3, P153; Batailler P, 2014, ACCIDENT ANAL PREV, V71, P267, DOI 10.1016/j.aap.2014.06.001; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Beebe DW, 2010, J ADOLESCENT HEALTH, V47, P523, DOI 10.1016/j.jadohealth.2010.03.005; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Berger Ivona, 2017, Glob Pediatr Health, V4, p2333794X17745973, DOI 10.1177/2333794X17745973; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Catroppa C, 2014, BRAIN INJURY, V28, P252, DOI 10.3109/02699052.2013.860471; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper JM, 2014, J NEUROTRAUM, V31, P713, DOI 10.1089/neu.2013.3101; Daniel A., 1983, POWER PRIVILEGE PRES; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dorris L, 2008, DEV NEUROREHABIL, V11, P95, DOI 10.1080/17518420701860149; Dworkin RH, 2015, J PAIN, V16, P357, DOI 10.1016/j.jpain.2015.01.012; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ekinci O, 2017, INT J PSYCHIAT MED, V52, P72, DOI 10.1177/0091217417703288; Eren S, 2014, SOCIAL CARE NEURODIS, V5, P135, DOI [10.1108/SCN-06-2013-0022, DOI 10.1108/SCN-06-2013-0022]; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fischer JT, 2018, NEUROPSYCHOLOGY, V32, P161, DOI 10.1037/neu0000420; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Huang T., 2015, HINDAWI PUBL CORP BE, V2015, P7; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Kachooei AR, 2015, ARCH BONE JT SURG-AB, V3, P45; Kajeepeta S, 2015, SLEEP MED, V16, P320, DOI 10.1016/j.sleep.2014.12.013; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Koskenvuo K, 2010, SLEEP MED, V11, P17, DOI 10.1016/j.sleep.2009.03.010; Kwan V, 2018, J NEUROTRAUM, V35, P877, DOI 10.1089/neu.2017.5281; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Lovejoy TI, 2012, J PAIN, V13, P1250, DOI 10.1016/j.jpain.2012.09.011; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Nunes ML, 2015, J PEDIAT-BRAZIL, V91, pS26, DOI 10.1016/j.jped.2015.08.006; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ong JC, 2014, SLEEP, V37, P1553, DOI 10.5665/sleep.4010; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Pallant, 2005, SPSS SURVIVAL MANUAL; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Rach AM, 2017, J CANCER SURVIV, V11, P256, DOI 10.1007/s11764-016-0583-y; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SASKIN P, 1986, PSYCHOSOM MED, V48, P319, DOI 10.1097/00006842-198605000-00002; Schiehser DM, 2017, NEUROPSYCHOL REHABIL, V27, P1031, DOI 10.1080/09602011.2016.1215999; Schmidt AT, 2015, COGN BEHAV NEUROL, V28, P53, DOI 10.1097/WNN.0000000000000056; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Schwartz MD, 2015, PSYCHIAT CLIN N AM, V38, P615, DOI 10.1016/j.psc.2015.07.002; Seow LSE, 2018, SLEEP MED, V41, P86, DOI 10.1016/j.sleep.2017.09.015; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Shochat T, 2014, SLEEP MED REV, V18, P75, DOI 10.1016/j.smrv.2013.03.005; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Spielman A., 1991, CASE STUDIES INSOMNI, P1, DOI DOI 10.1007/978-1-4757-9586-8_1; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2013, J PAIN, V14, P1242, DOI 10.1016/j.jpain.2013.05.007; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Thorndike FP, 2011, BEHAV SLEEP MED, V9, P216, DOI 10.1080/15402002.2011.606766; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Waters KA, 2013, MED J AUSTRALIA, V199, pS31, DOI 10.5694/mja13.10621; Yu K, 2018, J NEUROSCI RES, V96, P642, DOI 10.1002/jnr.24087	86	4	4	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					669	678		10.1089/neu.2018.5743		OCT 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000446465200001	30180783				2022-02-06	
J	Ammar, MA; Hussein, NS				Ammar, Mona Ahmed; Hussein, Noha Sayed			Using propranolol in traumatic brain injury to reduce sympathetic storm phenomenon: A prospective randomized clinical trial	SAUDI JOURNAL OF ANAESTHESIA			English	Article						Propranolol; sympathetic storm; traumatic brain injury	ADRENERGIC-BLOCKADE; CEREBRAL PERFUSION; CRITICAL ILLNESS; AGITATION; CATECHOLAMINES; HYPERACTIVITY; MANAGEMENT	Background: Traumatic brain injury (TBI) correlated with increased sympathetic activity on the expense of parasympathetic system due to loss of cortical control after brain injury. Manifestations of sympathetic storm include tachycardia, hypertension, tachypnea, and hyperthermia. The neuroprotective effects via reducing cerebral metabolism and lowering O-2 and glucose consumption are the targets early after trauma. Beta-blockers reduce sympathetic activity. Objectives: We suppose that using propranolol blunts the sympathetic storming phenomenon as it is a nonselective beta inhibitor and has a lipophilic property to steadily penetrate blood-brain barrier. Patients and Methods: Sixty patients allocated randomly into two groups, each consisting of 30 patients. Group A started propranolol and Group B received placebo within first 24 h. Primary outcome was catecholamine levels on day 7, and the secondary outcomes were physiological measures (heart rate [HR], respiratory rate [RR], mean arterial blood pressure [MABP], temperature, random blood sugar, and follow-up Glasgow coma score [GCS] and sedation score). Results: Analysis of outcomes demonstrated that Group A tended to have lower catecholamine levels in comparison to Group B in day 7 (norepinephrine 206.87 +/- 44.44 vs. 529.33 +/- 42.99 pg/ml, P = < 0.001), epinephrine level (69.00 +/- 8.66 vs. 190.73 +/- 16.48 pg/ml, P < 0.001), and dopamine level (32.90 +/- 4.57 vs. 78.00 +/- 3.48 pg/ml P < 0.001). GCS of the patients in Group A improved and was statistically significant compared to Group B in day 7 (13 vs. 10, P = 0.006), with percent change interquartile range (20.0 vs. 8.33, P = 0.006). Regarding hemodynamic parameters between the two groups MABP, HR, RR, and temperature, there was no statistically significant difference on day 1, while on day 7, there is high statistical significance and significant percent change (P < 0.001). Conclusion: Early usage of propranolol after TBI controls hemodynamics and blood sugar with decreased catecholamine levels correlated with the improvement of GCS.	[Ammar, Mona Ahmed; Hussein, Noha Sayed] Ain Shams Univ, Fac Med, Anesthesia Intens Care & Pain Management, Cairo, Egypt		Ammar, MA (corresponding author), 20 Taksim Al Awqaf,Presidential Palace St, Cairo 11646, Egypt.	mona_3mmar@hotmail.com					Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Arthur ML, 2016, AM SOC ANESTHESIOL A, V115, P1; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Faulds M, 2013, BJA EDUC, V13, P75, DOI 10.1093/bjaceaccp/mks063; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P58, DOI 10.1016/j.rehab.2015.11.001; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Schmalbruch IK, 2002, STROKE, V33, P251, DOI 10.1161/hs0102.101233; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shetty S, 2012, ENDOCR PRACT, V18, P363, DOI 10.4158/EP11260.OR; WALTER P, 1982, BRIT MED J, V284, P1661, DOI 10.1136/bmj.284.6330.1661; WOOLF PD, 1988, AM J PHYSIOL, V254, pE287, DOI 10.1152/ajpendo.1988.254.3.E287; WOOLF PD, 1983, J CLIN ENDOCR METAB, V56, P246, DOI 10.1210/jcem-56-2-246	26	4	6	0	5	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1658-354X	0975-3125		SAUDI J ANAESTH	Saudi J. Anaesth.	OCT-DEC	2018	12	4					514	520		10.4103/sja.SJA_33_18			7	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	GV9OS	WOS:000446489400005	30429730				2022-02-06	
J	Carr, C; Kahn, L; Mathkour, M; Biro, E; Bui, CJ; Dumont, AS				Carr, Christopher; Kahn, Lora; Mathkour, Mansour; Biro, Erin; Bui, Cuong J.; Dumont, Aaron S.			The shifting burden of neurosurgical disease: Vietnam and the middle-income nations	NEUROSURGICAL FOCUS			English	Article						Vietnam; neurosurgery; Global Burden of Disease; stroke; traumatic brain injury; back pain	MOTORCYCLE HELMET LAW; GLOBAL BURDEN; DEVELOPING-COUNTRIES; HEALTH-CARE; IMPACT; MORTALITY; OUTCOMES; NEUROINTENSIVIST; IMPLEMENTATION; MARKET	OBJECTIVE The Global Burden of Disease (GBD) is an international collaboration and the largest comprehensive investigation of global health disease burden ever conducted. It has been particularly insightful for understanding disease demographics in middle-income nations undergoing rapid development, such as Vietnam, where 6 of the top 10 causes of death are relevant to the neurosurgeon. The burden of stroke-the number one cause of death in Vietnam-is particularly impressive. Likewise, road injuries, with a disproportionate rate of traumatic brain injury, continue to increase in Vietnam following economic development. Low-back and neck pain is the number one cause of disability. Simultaneously, more patients have access to care, and healthcare spending is increased. METHODS It is imperative that neurosurgical capital and infrastructure keep pace with Vietnam's growth. The authors searched the existing literature for assessments of neurosurgical infrastructure or initiatives to address neurosurgical disease burden. Using GBD data, the authors also abstracted data for death by cause and prevalence of years of life lost due to disability (YLD) for common neurosurgical pathologies for Vietnam and comparison nations. RESULTS Interventions aimed at primary prevention of risk factors for neurosurgical disease and focused on the transference of self-sustainable technical skills were found to be analogous to those that have been successful in other regions. Efforts toward stroke prevention have been focused on causal risk factors. Multiple investigators have found that interventions aimed at increasing helmet use were successful in preventing traumatic brain injury. Government-led reforms and equipment donation programs have improved technical capacity. Nevertheless, Vietnam lags behind other nations in neurosurgeons per capita; cause-attributable death and YLD attributable to neurosurgical disease are considerably higher in Vietnam and middle-income nations compared to both lower-income nations and upper-income nations. CONCLUSIONS More than two-thirds of deaths attributable to neurosurgical pathologies in Vietnam and other middle-income nations were due to stroke, and one-fifth of both cause-attributable death and YLD was associated with neurosurgical pathologies. Vietnam and other middle-income nations continue to assume a global burden of disease profile that ever more closely resembles that of developed nations, with particular cerebrovascular, neurotrauma, and spinal disease burdens, leading to exponentially increased demand for neurosurgeons that threatens to outpace the training of neurosurgeons.	[Carr, Christopher; Kahn, Lora; Mathkour, Mansour] Tulane Univ, Med Ctr, Dept Neurosurg, Ochsner Clin Fdn Program, New Orleans, LA USA; [Biro, Erin; Bui, Cuong J.] Ochsner Hlth Syst, Dept Neurosurg, New Orleans, LA USA; [Dumont, Aaron S.] Tulane Univ, Med Ctr, Dept Neurosurg, New Orleans, LA USA		Carr, C (corresponding author), Tulane Univ Med Ctr Hosp & Clin, New Orleans, LA 70112 USA.	ccarr6@tulane.edu	Mathkour, Mansour/AAW-8837-2020	Mathkour, Mansour/0000-0002-1913-3677			AIP Foundation, 2017, HEAD 1 CAS STUD VIET; Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Asamoto S, 2017, WORLD NEUROSURG, V99, P145, DOI 10.1016/j.wneu.2016.11.079; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Bean JR, 2018, WORLD NEUROSURG, V112, P322, DOI 10.1016/j.wneu.2018.01.167; Bramall A, 2014, WORLD NEUROSURG, V82, P560, DOI 10.1016/j.wneu.2014.05.015; BROOMBERG J, 1994, HEALTH POLICY PLANN, V9, P237, DOI 10.1093/heapol/9.3.237; Budohoski KP, 2018, WORLD NEUROSURG, V113, P436, DOI 10.1016/j.wneu.2018.01.085; Centers for Disease Control and Prevention, SMOK TOB US CURR CIG; Dempsey KE, 2017, WORLD NEUROSURG, V101, P196, DOI 10.1016/j.wneu.2017.01.104; Dempsey RJ, 2013, NEUROSURGERY, V73, P1070, DOI 10.1227/NEU.0000000000000136; Egawa S, 2016, J CRIT CARE, V32, P52, DOI 10.1016/j.jcrc.2015.11.008; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Garbusinski JM, 2005, STROKE, V36, P1388, DOI 10.1161/01.STR.0000170717.91591.7d; Nguyen HT, 2013, INT J INJ CONTROL SA, V20, P192, DOI 10.1080/17457300.2012.706617; Harper C., 2011, VIETNAM NONCOMMUNICA; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hoang Hanh T M, 2008, Cost Eff Resour Alloc, V6, P17, DOI 10.1186/1478-7547-6-17; Hung DV, 2016, INJURY PREV, V12, P409; Institute for Health Metrics and Evaluation, GBD PROFILE VIETNAM; Institute for Health Metrics and Evaluation; Human Development Network; TheWorld Bank, 2013, GLOB BURD DIS GEN EV; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Kaptigau WM, 2016, WORLD J SURG, V40, P251, DOI 10.1007/s00268-015-3268-1; Karras CL, 2017, WORLD NEUROSURG, V105, P122, DOI 10.1016/j.wneu.2017.05.141; Knopf L, 2012, NEUROCRIT CARE, V16, P63, DOI 10.1007/s12028-011-9620-x; Le VT, 1999, REV NEUROL PARIS, P137; Lim J, 2014, GLOBAL HEALTH ACTION, V7, P13, DOI 10.3402/gha.v7.25110; Murray CJL, 2013, LANCET, V381, P628; Nhung NTT, 2014, ASIA-PAC J PUBLIC HE, V26, P527, DOI 10.1177/1010539513510556; Ha NT, 2018, TRAFFIC INJ PREV, V19, P75, DOI 10.1080/15389588.2017.1322203; Pauly MV, 1998, HEALTH SERV RES, V33, P1439; Peden M., 2004, WORLD REPORT ROAD TR; Pervin A, 2009, B WORLD HEALTH ORGAN, V87, P369, DOI 10.2471/BLT.08.057109; Anh PTH, 2016, TOB CONTROL, V25, P96, DOI 10.1136/tobaccocontrol-2014-051821; Poungvarin N, 1998, LANCET SUPPL, V352; Rosenfeld JV, 1997, SURG NEUROL, V48, P307, DOI 10.1016/S0090-3019(96)00397-7; Sekhon MS, 2017, CAN J NEUROL SCI, V44, P350, DOI 10.1017/cjn.2017.25; Servadei F, 2018, WORLD NEUROSURG, V112, P315, DOI 10.1016/j.wneu.2018.01.047; Son PT, 2012, J HUM HYPERTENS, V26, P268, DOI 10.1038/jhh.2011.18; Sugimori Haruhiko, 2012, Nihon Geka Gakkai Zasshi, V113, P252; Takashima K, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0682-z; Tien TV, 2011, HLTH FINANCING REV V; Venturini S, 2018, WORLD NEUROSURG, V109, P98, DOI 10.1016/j.wneu.2017.09.117; Yamanashi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160665	46	4	5	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2018	45	4							E12	10.3171/2018.7.FOCUS18297			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GV6US	WOS:000446253400012	30269588	gold			2022-02-06	
J	Daskal, Y; Alfici, R; Givon, A; Peleg, K; Olsha, O; Kessel, B				Daskal, Yaakov; Alfici, Ricardo; Givon, Adi; Peleg, Kobi; Olsha, Oded; Kessel, Boris		Israel Trauma Grp	Evaluation of differences in injury patterns according to seat position in trauma victims survived traffic accidents	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Traffic accidents; Injury pattern; Seat position	MOTOR-VEHICLE CRASHES; PASSENGERS; CHILDREN; RISK; DRIVERS	Purpose: Investigation of injury patterns epidemiology among car occupants may help to develop different therapeutic approach according to the seat position. The aim of the study was to evaluate and compare differences in the incidence of serious injuries, between occupants in different locations in private cars. Methods: A retrospective study including trauma patients who were involved in motor vehicle accidents and admitted alive to 20 hospitals (6 level I trauma centers and 14 level II trauma centers). We examined the incidence of injures with abbreviated injury score 3 and more, and compared their occurrence between seat locations. Results: The study included 28,653 trauma patients, drivers account for 60.8% (17,417). Front passenger mortality was 0.47% higher than in drivers. Rear seat passengers were at greater risk (10.26%) for traumatic brain injuries than front seat passengers (7.48%) and drivers (7.01%). Drivers are less likely to suffer from serious abdominal injuries (3.84%) compared to the passengers (front passengers - 5.91%, rear passengers - 5.46%). Conclusion: Out of victims who arrived alive to the hospital, highest mortality was found in front seat passengers. The rate of serious chest injuries was higher as well. Rear seat passengers are at greater risk for serious traumatic brain injuries. All passengers have a greater incidence of abdominal injuries. These findings need to be addressed in order to develop "customized" therapeutic policy in trauma victims. (C) 2018 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. Production and hosting by Elsevier B.V.	[Daskal, Yaakov; Alfici, Ricardo] Hillel Yaffe Med Ctr, Surg Div, Hadera, Israel; [Givon, Adi; Peleg, Kobi] Gertner Inst Epidemiol & Hlth Policy Res, Natl Ctr Trauma & Emergency Med Res, Tel Hashomer, Israel; [Olsha, Oded] Shaare Zedek Med Ctr, Surg Dept, Jerusalem, Israel; [Kessel, Boris] Hillel Yaffe Med Ctr, Trauma Unit, Hadera, Israel; [Peleg, Kobi] Tel Aviv Univ, Fac Med, Disaster Med Dept, Tel Aviv, Israel		Daskal, Y (corresponding author), Hillel Yaffe Med Ctr, Surg Div, Hadera, Israel.	kobi_das@me.com		Olsha, Oded/0000-0002-8805-7794; DASKAL, YAAKOV/0000-0002-4123-6787			Bilston LE, 2010, ACCIDENT ANAL PREV, V42, P1974, DOI 10.1016/j.aap.2010.06.002; Brockamp T, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0401-1; Brown J, 2014, TRAFFIC INJ PREV, V15, P462, DOI 10.1080/15389588.2013.833662; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P57, DOI 10.4103/2229-5151.79283; Durbin DR, 2005, PEDIATRICS, V115, pE305, DOI 10.1542/peds.2004-1522; Howard AW, 2002, CAN MED ASSOC J, V167, P769; Kallan MJ, 2008, PEDIATRICS, V121, pE1342, DOI 10.1542/peds.2007-1512; Majdan M, 2015, TRAFFIC INJ PREV, V16, P450, DOI 10.1080/15389588.2014.962133; Mayrose J, 2008, J SAFETY RES, V39, P433, DOI 10.1016/j.jsr.2008.06.003; National Center for Health Statistics (US), 2011, HLTH US 2010 SPEC FE; Ndiaye A, 2009, FORENSIC SCI INT, V184, P21, DOI 10.1016/j.forsciint.2008.11.007; Newgard CD, 2005, ANN EMERG MED, V45, P43, DOI 10.1016/j.annemergmed.2004.09.011; Pedley DK, 2004, EMERG MED J, V21, P197, DOI 10.1136/emj.2003.012369; Ramage-Morin Pamela L, 2008, Health Rep, V19, P45; Smith KM, 2004, ACCIDENT ANAL PREV, V36, P257, DOI 10.1016/S0001-4575(03)00002-2	15	4	4	1	4	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	OCT	2018	21	5					273	276		10.1016/j.cjtee.2018.03.001			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	GZ9EU	WOS:000449800300006	29937380	Green Published, gold			2022-02-06	
J	Eimontaite, I; Goel, V; Raymont, V; Krueger, F; Schindler, I; Grafman, J				Eimontaite, Iveta; Goel, Vinod; Raymont, Vanessa; Krueger, Frank; Schindler, Igor; Grafman, Jordan			Differential roles of polar orbital prefrontal cortex and parietal lobes in logical reasoning with neutral and negative emotional content	NEUROPSYCHOLOGIA			English	Article						Reasoning; Emotional content; Neutral content; Exclusive disjunctions; Polar/orbital PFC; Parietal lobe; Penetrating traumatic brain injury; Logic; Rationality	BELIEF-BIAS; BRAIN; SOFTWARE; LESIONS; ACTIVATIONS; VETERANS; DECISION; MODELS; INJURY; TASK	To answer the question of how brain pathology affects reasoning about negative emotional content, we administered a disjunctive logical reasoning task involving arguments with neutral content (e.g. Either there are tigers or women in NYC, but not both; There are no tigers in NYC; There are women in NYC) and emotionally laden content (e.g. Either there are pedophiles or politicians in Texas, but not both; There are politicians in Texas; There are no pedophiles in Texas) to 92 neurological patients with focal lesions to various parts of the brain. A Voxel Lesion Symptom Mapping (VLSM) analysis identified 16 patients, all with lesions to the orbital polar prefrontal cortex (BA 10 & 11), as being selectively impaired in the emotional reasoning condition. Another 17 patients, all with lesions to the parietal cortex, were identified as being impaired in the neutral content condition. The reasoning scores of these two patient groups, along with 23 matched normal controls, underwent additional analysis to explore the effect of belief bias. This analysis revealed that the differences identified above were largely driven by trials where there was an incongruency between the believability of the conclusion and the validity of the argument (i.e. valid argument/false conclusion or invalid argument/true conclusion). Patients with lesions to polar orbital prefrontal cortex underperformed in incongruent emotional content trials and over performed in incongruent neutral content trials (compared to both normal controls and patients with parietal lobe lesions). Patients with lesions to parietal lobes underperformed normal controls (at a trend level) in neutral trials where there was a congruency between the believability of the conclusion and the validity of the argument (i.e. valid argument/true conclusion or invalid argument/false conclusion). We conclude that lesions to the polar orbital prefrontal cortex (i) prevent these patients from enjoying any emotionally induced cognitive boost, and (ii) block the belief bias processing route in the neutral condition. Lesions to parietal lobes result in a generalized impairment in logical reasoning with neutral content.	[Eimontaite, Iveta; Schindler, Igor] Univ Hull, Dept Psychol, Kingston Upon Hull, N Humberside, England; [Goel, Vinod] York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada; [Raymont, Vanessa] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Raymont, Vanessa] Imperial Coll, Dept Med, London, England; [Krueger, Frank] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Grafman, Jordan] Northwestern Univ, Sch Med, Cognit Neurol & Psychiat & Behav Sci & Phys Med &, Chicago, IL USA		Goel, V (corresponding author), York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	vgoel@yorku.ca			Wellcome TrustWellcome TrustEuropean Commission [089233]; Therapeutic Cognitive Neuroscience Fund	This work was supported, in part, by Wellcome Trust Grant (089233) to Vinod Goel and Jordan Grafman. This research was also partly supported by the Therapeutic Cognitive Neuroscience Fund (J.G.).	Andrade EB, 2009, ORGAN BEHAV HUM DEC, V109, P1, DOI 10.1016/j.obhdp.2009.02.003; Baggio G, 2016, NEUROIMAGE, V135, P300, DOI 10.1016/j.neuroimage.2016.04.061; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Blanchette I, 2004, PSYCHOL SCI, V15, P745, DOI 10.1111/j.0956-7976.2004.00751.x; Blanchette I, 2007, J EXP PSYCHOL-APPL, V13, P47, DOI 10.1037/1076-898X.13.1.47; Blanchette I, 2006, MEM COGNITION, V34, P1112, DOI 10.3758/BF03193257; Blanchette I, 2013, THINK REASONING, V19, P399, DOI 10.1080/13546783.2013.791642; Blanchette I, 2012, J COGN PSYCHOL, V24, P157, DOI 10.1080/20445911.2011.603693; Bonnefond M, 2009, NEUROPSYCHOLOGIA, V47, P3125, DOI 10.1016/j.neuropsychologia.2009.07.014; Brosig J, 2002, J ECON BEHAV ORGAN, V47, P275, DOI 10.1016/S0167-2681(01)00211-6; de Jong PJ, 1997, COGNITIVE THER RES, V21, P647, DOI 10.1023/A:1021856223970; EVANS JST, 1983, MEM COGNITION, V11, P295, DOI 10.3758/BF03196976; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Field A., 2012, DISCOVERING STAT USI; Gangemi A, 2013, J COGN PSYCHOL, V25, P157, DOI 10.1080/20445911.2012.737318; Garcia-Madruga JA, 2001, Q J EXP PSYCHOL-A, V54, P613, DOI 10.1080/02724980042000309; Goel V, 2003, NEUROIMAGE, V20, P2314, DOI 10.1016/j.neuroimage.2003.07.027; Goel V, 1997, NEUROREPORT, V8, P1305, DOI 10.1097/00001756-199703240-00049; Goel V, 2003, COGNITION, V87, pB11, DOI 10.1016/S0010-0277(02)00185-3; Goel V, 2000, NEUROIMAGE, V12, P504, DOI 10.1006/nimg.2000.0636; Goel V, 2007, TRENDS COGN SCI, V11, P435, DOI 10.1016/j.tics.2007.09.003; Goel V, 2017, NEUROPSYCHOLOGIA, V99, P236, DOI 10.1016/j.neuropsychologia.2017.03.006; Goel V, 2011, COGNITION EMOTION, V25, P121, DOI 10.1080/02699931003593942; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Grice Herbert Paul, 1975, LOGIC GRAMMAR, P64; Hu YX, 2015, J RISK RES, V18, P637, DOI 10.1080/13669877.2014.910688; HURFORD JR, 1974, FOUND LANG, V11, P409; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; MEHTA C. R., 2011, IBM SPSS EXACT TESTS; NEWSTEAD SE, 1984, Q J EXP PSYCHOL-A, V36, P611, DOI 10.1080/14640748408402182; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Noveck I. A., 2002, Thinking & Reasoning, V8, P297, DOI 10.1080/13546780244000079; Prado J, 2011, J COGNITIVE NEUROSCI, V23, P3483, DOI 10.1162/jocn_a_00063; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Reverberi C, 2007, NEUROIMAGE, V38, P752, DOI 10.1016/j.neuroimage.2007.07.060; Reverberi C, 2012, NEUROIMAGE, V59, P1752, DOI 10.1016/j.neuroimage.2011.08.027; Reverberi C, 2009, NEUROPSYCHOLOGIA, V47, P1107, DOI 10.1016/j.neuropsychologia.2009.01.004; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Tomczak M, 2014, TRENDS SPORT SCI; Tsujii T, 2010, NEUROPSYCHOLOGIA, V48, P2005, DOI 10.1016/j.neuropsychologia.2010.03.021; Tsujii T, 2009, BRAIN RES, V1287, P118, DOI 10.1016/j.brainres.2009.06.080; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkins M.C., 1929, ARCH PSYCHOL; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004	50	4	4	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	OCT	2018	119						320	329		10.1016/j.neuropsychologia.2018.05.014			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	HA8MM	WOS:000450543800034	29772219	Green Published, hybrid			2022-02-06	
J	Inamasu, J; Nakaya, M; Kujirai, D; Mayanagi, K; Nakatsukasa, M				Inamasu, Joji; Nakaya, Msasato; Kujirai, Dai; Mayanagi, Keita; Nakatsukasa, Masashi			Frequency and characteristics of traumatic brain injury in restrained drivers involved in road traffic accidents	ACTA NEUROCHIRURGICA			English	Article						Driver; Traumatic brain injury; Road traffic accident; Seatbelt; Whole-body computed tomography	COMPUTED-TOMOGRAPHY; CRASH SEVERITY; VEHICLE; ASSOCIATION; PREDICTION; RISK; COMA	Background: While seatbelt is an important device protecting drivers from traumatic brain injury (TBI), it has rarely been reported how often and in what circumstances restrained drivers sustain TBI after road traffic accident (RTA). Whole-body computed tomography (WBCT) for blunt trauma patients may provide a unique opportunity to investigate the frequency and characteristics of TBI sustained by restrained drivers. Methods: A single-center, retrospective observational study was conducted using prospectively acquired data. Between January 2013 and December 2017, 409 restrained drivers (284 men/125 women, mean age of 45.0 +/- 19.1years) whose vehicle had been severely damaged in RTAs underwent WBCT for evaluation of injuries. Multivariate regression analysis was performed to identify variables predictive of TBI. Influence of collision patterns (frontal, lateral or rollover) on the frequency and severity of TBI was evaluated. Relationship between collision patterns and CT findings was also reviewed. Results: Thirty-one restrained drivers (7.6%) sustained TBI after RTA. The distribution of Glasgow Coma Scale (GCS) scores among the 31 drivers was 15 in 9, 13-14 in 9, 9-12 in 4, and <8 in 9, indicating that the majority of TBIs were classifiable as mild. The frequency of TBI in alert and oriented drivers, i.e., those with a GCS score of 15, was 2.9%. Multivariate regression analysis showed that both altered mental status (OR, 4.933; 95% CI, 1.135-21.431) and loss of consciousness (OR, 6.492; 95% CI, 1.669-25.249) were associated with TBI. The frequency of TBI tended to be higher in drivers with rollover collision than those with frontal collision (6 vs. 13%, p=0.07). Interhemispheric acute subdural hematoma and subcortical petechial hemorrhage seemed to be characteristic CT findings in drivers with frontal and lateral collision, respectively. Conclusions: The key finding of this study, i.e., that (1) TBI was observed in 7.6% of restrained drivers with severe vehicular damage, may provide useful information to neurosurgeons who take care of RTA victims. The majority of the TBIs were mild without need for neurosurgical intervention. While association may exist between type of collision and type of brain injury, further studies with prospective design are warranted.	[Inamasu, Joji; Nakaya, Msasato; Mayanagi, Keita; Nakatsukasa, Masashi] Saiseikai Utsunomiya Hosp, Dept Neurosurg, 1-98 Takebayashi, Utsunomiya, Tochigi 3210974, Japan; [Kujirai, Dai] Saiseikai Utsunomiya Hosp, Dept Emergency Med, Utsunomiya, Tochigi, Japan		Inamasu, J (corresponding author), Saiseikai Utsunomiya Hosp, Dept Neurosurg, 1-98 Takebayashi, Utsunomiya, Tochigi 3210974, Japan.	inamasu@fujita-hu.ac.jp	Inamasu, Joji/R-7314-2019		General Insurance Association of Japan	The corresponding author (JI) received a research grant from the General Insurance Association of Japan. The sponsor had no role in the design or conduct of this research.	Abu-Zidan FM, 2015, INJURY, V46, P136, DOI 10.1016/j.injury.2014.10.066; [Anonymous], 1984, VEHICLE DAMAGE SCALE; Bazarian JJ, 2004, ANN EMERG MED, V44, P142, DOI 10.1016/j.annemergmed.2004.03.029; BRAAKMAN R, 1992, ACTA NEUROCHIR, V116, P161, DOI 10.1007/BF01540870; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Cleveland N, 2014, PREHOSP EMERG CARE, V18, P402, DOI 10.3109/10903127.2014.891065; Conroy C, 2006, ACCIDENT ANAL PREV, V38, P835, DOI 10.1016/j.aap.2006.02.002; Croft AC, 2005, MED SCI MONITOR, V11, pRA316; Davies RM, 2016, INJURY, V47, P43, DOI 10.1016/j.injury.2015.08.036; Desapriya Ediriweera, 2005, Int J Inj Contr Saf Promot, V12, P191, DOI 10.1080/1566097042000265782; Hong ZJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004653; Inamasu J, 2007, J NEUROSURG-SPINE, V7, P311, DOI 10.3171/SPI-07/09/311; Inamasu J, 2018, INT J STROKE, V13, P301, DOI 10.1177/1747493017728398; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Kahn J, 2016, ACTA RADIOL, V57, P362, DOI 10.1177/0284185115580839; Kimura A, 2013, J TRAUMA ACUTE CARE, V75, P202, DOI 10.1097/TA.0b013e3182905ef7; Linder F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0199-2; Majdzadeh R, 2008, ACCIDENT ANAL PREV, V40, P17, DOI 10.1016/j.aap.2007.03.019; Newgard CD, 2002, ACAD EMERG MED, V9, P924, DOI 10.1197/aemj.9.9.924; Price SJ, 2003, INJURY, V34, P834, DOI 10.1016/S0020-1383(03)00028-7; Rosi J, 2012, NEUROSURG REV, V35, P437, DOI 10.1007/s10143-012-0379-0; Schulman C I, 2007, Annu Proc Assoc Adv Automot Med, V51, P49; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Vaca FE, 2009, WEST J EMERG MED, V10, P62; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071; Yoganandan N, 2009, J TRAUMA, V66, P309, DOI 10.1097/TA.0b013e3181692104	27	4	4	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2018	160	10					1921	1929		10.1007/s00701-018-3656-z			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GT2ZX	WOS:000444370600007	30116903				2022-02-06	
J	Komlosh, ME; Benjamini, D; Hutchinson, EB; King, S; Haber, M; Avram, AV; Holtzclaw, LA; Desai, A; Pierpaoli, C; Basser, PJ				Komlosh, Michal E.; Benjamini, Dan; Hutchinson, Elizabeth B.; King, Sarah; Haber, Margalit; Avram, Alexandru V.; Holtzclaw, Lynne A.; Desai, Abhishek; Pierpaoli, Carlo; Basser, Peter J.			Using double pulsed-field gradient MRI to study tissue microstructure in traumatic brain injury (TBI)	MICROPOROUS AND MESOPOROUS MATERIALS			English	Article; Proceedings Paper	13th International Bologna Conference of the Division-of-Groupement-Ampere on Magnetic Resonance in Porous Media (MRPM)	SEP 04-08, 2016	Univ Bologna, Sch Engn & Architecture, Bologna, ITALY		Univ Bologna, Sch Engn & Architecture	Anisotropic diffusion; MRI; Microstructure; Diffusion; d-PFG; DDE; DTI; TBI; DAI; CHIMERA	AXONAL INJURY; WHITE-MATTER; DIFFUSION; MODEL; NMR; PFG	Double pulsed-field gradient (dPFG) MRI is proposed as a new sensitive tool to detect and characterize tissue microstructure following diffuse axonal injury. In this study dPFG MRI was used to estimate apparent mean axon diameter in a diffuse axonal injury animal model and in healthy fixed mouse brain. Histological analysis was used to verify the presence of the injury detected by MRI. (C) 2017 Elsevier Inc. All rights reserved.	[Komlosh, Michal E.; Benjamini, Dan; Hutchinson, Elizabeth B.; King, Sarah; Avram, Alexandru V.; Pierpaoli, Carlo; Basser, Peter J.] NICHD, Sect Quantitat Imaging & Tissue Sci, NIH, Bethesda, MD 20892 USA; [Komlosh, Michal E.; Hutchinson, Elizabeth B.; King, Sarah] Uniform Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Haber, Margalit] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Desai, Abhishek] NIAAA, Lab Mol Signaling, NIH, Rockville, MD 20852 USA; [Holtzclaw, Lynne A.] NICHD, Microscopy & Imaging Core, NIH, Bethesda, MD USA		Komlosh, ME (corresponding author), NICHD, Sect Quantitat Imaging & Tissue Sci, NIH, Bethesda, MD 20892 USA.	komloshm@mail.nih.gov	Pierpaoli, Carlo/E-1672-2011	Pierpaoli, Carlo/0000-0001-8558-4428; King, Sarah/0000-0001-8082-826X; Hutchinson, Elizabeth/0000-0002-3374-5469; Benjamini, Dan/0000-0002-9558-7056; Holtzclaw, Lynne/0000-0001-5102-8992	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD000266]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, [HJF) [308049-8.01-60855, 307513-3.01-60855]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD000266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [ZIAEB000089] Funding Source: NIH RePORTER	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development [grant numbers HD000266] and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, [HJF Award Numbers: 308049-8.01-60855 and 307513-3.01-60855].	Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Avram AV, 2013, NEUROIMAGE, V64, P229, DOI 10.1016/j.neuroimage.2012.08.048; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Benjamini D, 2016, NEUROIMAGE, V135, P333, DOI 10.1016/j.neuroimage.2016.04.052; Benjamini D, 2014, J MAGN RESON, V246, P36, DOI 10.1016/j.jmr.2014.06.017; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Faul M., 2010, CTR DIS CONTR PREV; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Grebenkov DS, 2008, CONCEPT MAGN RESON A, V32A, P277, DOI 10.1002/cmr.a.20117; Haber M., 2016, SOC NEUROTRAUMA ANN; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Koch MA, 2011, NMR BIOMED, V24, P1422, DOI 10.1002/nbm.1711; Komlosh ME, 2013, NEUROIMAGE, V78, P210, DOI 10.1016/j.neuroimage.2013.03.074; Komlosh ME, 2011, J MAGN RESON, V208, P128, DOI 10.1016/j.jmr.2010.10.014; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MITRA PP, 1995, PHYS REV B, V51, P15074, DOI 10.1103/PhysRevB.51.15074; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Ozarslan E, 2009, J MAGN RESON, V199, P56, DOI 10.1016/j.jmr.2009.04.002; Ozarslan E, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3082078; Pierpaoli C, 2010, ISMRM 18 ANN M; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Weber T, 2009, MAGN RESON MED, V61, P1001, DOI 10.1002/mrm.21848; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	24	4	4	1	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-1811	1873-3093		MICROPOR MESOPOR MAT	Microporous Mesoporous Mat.	OCT	2018	269				SI		156	159		10.1016/j.micromeso.2017.05.030			4	Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Chemistry; Science & Technology - Other Topics; Materials Science	GM6YD	WOS:000438324000036	30337835	Green Accepted			2022-02-06	
J	Pinto, SM; Yassin, M; Galang, G				Pinto, Shanti M.; Yassin, Mohamed; Galang, Gary			Cost-Effectiveness Analysis of Routine Venous Doppler Ultrasound for Diagnosis of Deep Venous Thrombosis at Admission to Inpatient Rehabilitation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Venous Thromboembolism; Deep Venous Thrombosis; Pulmonary Embolism; Inpatient Rehabilitation; Cost-effectiveness Analysis; Venous Doppler Ultrasound	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; MAJOR ORTHOPEDIC-SURGERY; PULMONARY-EMBOLISM; VEIN THROMBOSIS; MODEL SYSTEMS; ACUTE STROKE; THROMBOEMBOLISM; SURVEILLANCE; PREVENTION	Objective The aims of the study were to identify whether timing of venous thromboembolism diagnosis is associated with differences in patient outcomes and to perform a cost-effectiveness analysis of routine venous Doppler ultrasound at admission to inpatient rehabilitation, taking into account costs associated with prolonged inpatient rehabilitation length of stay, and development of pulmonary embolism. Design This was a retrospective cohort study of 2312 consecutive patient discharges from a single inpatient rehabilitation facility for an 18-mo period. Cost-effectiveness model was built using TreeAge Healthcare Pro. The base case was constructed using probabilities and inpatient rehabilitation length of stay identified from retrospective analysis. Cost of Doppler ultrasound was obtained through the literature, and daily inpatient rehabilitation cost was obtained from the study institution. Results Venous thromboembolism was diagnosed in 6.6% of patients. Asymptomatic patients diagnosed with venous thromboembolism on screening Doppler ultrasound had shorter inpatient rehabilitation length of stay (P = 0.045) and lower rate of pulmonary embolism (P < 0.001) and acute hospital transfer (P = 0.002) than those diagnosed after clinical symptoms developed. Use of routine Doppler ultrasound at inpatient rehabilitation admission was found to be cost-effective, with a total cost of US $20,265 per admission compared with $20,269 per admission without use of Doppler ultrasound at inpatient rehabilitation admission. Conclusions Routine Doppler ultrasound screening for venous thromboembolism at inpatient rehabilitation admission is associated with improved patient outcomes without added cost per admission.	[Pinto, Shanti M.] Carolinas Rehabil, Dept Phys Med & Rehabil, Charlotte, NC USA; [Yassin, Mohamed] Univ Pittsburgh, Dept Med, Div Infect Dis, Med Ctr, Pittsburgh, PA USA; [Galang, Gary] Univ Pittsburgh, Dept Phys Med & Rehabil, Med Ctr, Pittsburgh, PA USA		Pinto, SM (corresponding author), Carolinas Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.						Bandle J, 2013, J TRAUMA ACUTE CARE, V74, P575, DOI 10.1097/TA.0b013e3182789330; Beyer-Westendorf J, 2013, VASA, V42, P40, DOI 10.1024/0301-1526/a000246; Borer DS, 2005, J ORTHOP TRAUMA, V19, P92, DOI 10.1097/00005131-200502000-00004; BROWN M, 1973, JAMA-J AM MED ASSOC, V224, P1493, DOI 10.1001/jama.224.11.1493; Carlile MC, 2006, J HEAD TRAUMA REHAB, V21, P483, DOI 10.1097/00001199-200611000-00003; Chen D, 1999, ARCH PHYS MED REHAB, V80, P1397, DOI 10.1016/S0003-9993(99)90250-2; Cipolle MD, 2002, J TRAUMA, V52, P453, DOI 10.1097/00005373-200203000-00007; Consortium for Spinal Cord Medicine, 2016, PREV VEN THROMB IND; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Fanikos J, 2013, AM J MED, V126, P127, DOI 10.1016/j.amjmed.2012.07.025; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goodacre S, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-6; Greenwald BD, 2013, PM&R, V5, P340, DOI 10.1016/j.pmrj.2013.03.006; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P191, DOI 10.1097/01.PHM.0000113401.47681.A6; Kelly BM, 2010, PM&R, V2, P647, DOI 10.1016/j.pmrj.2010.03.029; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P285, DOI 10.1053/apmr.2003.50116; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; Misra M, 2004, NEUROSURGERY, V54, P1099, DOI 10.1227/01.NEU.0000119352.71531.29; Moed BR, 2012, J TRAUMA ACUTE CARE, V72, P443, DOI 10.1097/TA.0b013e318241090d; OSTER G, 1987, JAMA-J AM MED ASSOC, V257, P203, DOI 10.1001/jama.257.2.203; Pierfranceschi MG, 2013, THROMB HAEMOSTASIS, V109, P34, DOI 10.1160/TH12-06-0390; Pinto SM, 2017, AM J PHYS MED REHAB, V96, P367, DOI 10.1097/PHM.0000000000000643; Schwarcz TH, 2001, J VASC SURG, V34, P447, DOI 10.1067/mva.2001.117146; Segal JB, 2007, ANN FAM MED, V5, P63, DOI 10.1370/afm.648; Selassie AW, 2011, ARCH PHYS MED REHAB, V92, P1534, DOI 10.1016/j.apmr.2011.04.018; VIITANEN M, 1987, ACTA MED SCAND, V222, P401; Wijdicks EFM, 1997, MAYO CLIN PROC, V72, P297; Wilson RA, 2005, ARCH PHYS MED REHAB, V86, P1941, DOI 10.1016/j.apmr.2005.05.009	30	4	4	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	OCT	2018	97	10					747	753		10.1097/PHM.0000000000000961			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GU0UR	WOS:000444968800015	29734231				2022-02-06	
J	Savage, JL; Covassin, T				Savage, Jennifer L.; Covassin, Tracey			The Self-Efficacy of Certified Athletic Trainers in Assessing and Managing Sport-Related Concussions	JOURNAL OF ATHLETIC TRAINING			English	Article						self-confidence; self-assessment; concussion practices	HIGH-SCHOOL; RELIABILITY; MANAGEMENT; VALIDITY; PATTERNS	Context: Diagnostic and return-to-play assessments of athletes with sport-related concussions (SRCs) have changed dramatically over the past decade. Currently, SRC assessment and management has taken a multifaceted approach, with new SRC measures being developed yearly. However, to date, no researchers have examined certified athletic trainers' (ATs') self-efficacy in assessing and managing a patient with an SRC. Objective: To examine the self-efficacy of ATs in assessing and managing athletes with SRCs, with a secondary purpose of examining job setting (high school and college). Design: Cross-sectional study. Setting: Web-based questionnaire. Patients or Other Participants: A total of 94 ATs (high school setting = 54.3%, n = 51; collegiate setting = 45.7%, n = 43) completed an online survey, for a response rate of 9.2%. Main Outcome Measure(s): The survey contained 3 primary subsections: demographics, self-efficacy in assessing SRCs, and self-efficacy in managing SRCs. Possible self-efficacy ratings for SRC assessment and management in the survey ranged from 0 to 100. Multivariate analyses of variance were performed to identify differences in the self-efficacy of high school and collegiate ATs in assessing and managing athletes with SRCs. Results: The self-efficacy of all 94 participants in their assessment of SRCs was 60.34 +/- 14.5 and in their management of SRCs was 55.30 +/- 14.1. Collegiate ATs reported higher self-efficacy in the assessment of SRCs using balance (P < .001) and the King-Devick test (P= .04), and their responses approached significance for vestibular-ocular motor screening (P= .05). Additionally, their self-efficacy in the management of SRCs was greater using balance (P < .001) and vestibular-ocular therapy (P= .01) compared with high school ATs. Conclusions: Athletic trainers had moderate self-efficacy regarding their assessment and management of SRCs. Collegiate ATs had higher self-efficacy in newer SRC assessment and management tools than high school ATs.	[Savage, Jennifer L.; Covassin, Tracey] Michigan State Univ, Dept Kinesiol, 308 West Circle Dr,Room 134, E Lansing, MI 48824 USA		Savage, JL (corresponding author), Michigan State Univ, Dept Kinesiol, 308 West Circle Dr,Room 134, E Lansing, MI 48824 USA.	savage25@msu.edu					BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, SELF EFFICACY EXERCI; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Bradley R., 2010, SPORT J, V13; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Derdall Michele, 2002, Can J Occup Ther, V69, P49; Eddy R, CLIN J SPORT MED; Feltz D.L., 2008, SELF EFFICACY SPORT; Ferrara Michael S., 2001, J Athl Train, V36, P145; Graham S., 1996, HDB ED PSYCHOL, V4, P63; Hecimovich Mark D, 2014, BMC Res Notes, V7, P338, DOI 10.1186/1756-0500-7-338; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Rankin J M, 1992, J Athl Train, V27, P344; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Wallace J, 2018, ATHL TRAIN ED J, V13, P112; Weinberg R, 2015, FDN SPORT EXERCISE P; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	31	4	4	1	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2018	53	10					983	989		10.4085/1062-6050-394-17			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HB9TJ	WOS:000451435400008	30311504	Green Published, gold			2022-02-06	
J	Wall, K; Gorgens, K; Dettmer, J; Davis, TM; Gafford, J				Wall, Kristi; Gorgens, Kim; Dettmer, Judy; Davis, Terri M.; Gafford, Jennifer			Violence-Related Traumatic Brain Injury in Justice-Involved Women	CRIMINAL JUSTICE AND BEHAVIOR			English	Article						violence; TBI; women; incarcerated; probation; justice-involved	INTIMATE PARTNER VIOLENCE; BATTERY-SCREENING MODULE; IDENTIFICATION METHOD; TEST-RATIO; VALIDITY; RELIABILITY; POPULATION; PREVALENCE; VALIDATION; OUTCOMES	The present study investigated gender differences in the prevalence and incidence of violence-related traumatic brain injury (TBI) among justice-involved individuals, as well as potential associations between violence-related TBI and select biopsychosocial variables among women in the sample. Data from 409 justice-involved individuals were analyzed, and men and women were compared for rate of violence-related TBI. Women were grouped by violence-related TBI history and compared on eight biopsychosocial variables. Gender was significantly associated with multiple TBIs and multiple violence-related TBIs. History of violence-related TBI in women was associated with physical health problems and incarceration history. This research revealed a high rate of violence-related multiple TBIs among justice-involved women. Violence-related TBIs were associated with more prevalent physical illness and increased incarceration times. Identification of justice-involved women with these injuries may help clinicians better tailor services to improve inmate outcomes and reduce cost burdens to justice systems.	[Wall, Kristi] Univ Denver, Denver, CO 80208 USA; [Gorgens, Kim] Univ Denver, Grad Sch Profess Psychol, Denver, CO 80208 USA; [Dettmer, Judy] Colorado Dept Human Serv, MINDSOURCE Brain Injury Network, Denver, CO USA; [Davis, Terri M.] Univ Denver, Grad Sch Profess Psychol, Denver, CO 80208 USA; [Davis, Terri M.] Univ Denver, Grad Sch Profess Psychol, PsyD Program, Denver, CO 80208 USA; [Gafford, Jennifer] Denver Sheriff Dept, Denver, CO USA; [Gafford, Jennifer] Denver Sheriff Dept, Correct Behav Hlth, Denver, CO USA		Wall, K (corresponding author), Oklahoma City VA Med Ctr, 921 NE 13th St, Oklahoma City, OK 73104 USA.	Kristi.Wall@va.gov	Gorgens, Kimberly/K-6741-2019	Gorgens, Kimberly/0000-0003-4413-0600			Allely CS, 2016, BRAIN INJURY, V30, P1161, DOI 10.1080/02699052.2016.1191674; [Anonymous], 2015, C TRAUM BRAIN INJ US; [Anonymous], VERS 0 8 5 COMP SOFT; Automated Neuropsychological Assessment Metrics (Version 4) Core Battery [Computer software], 2016, AUT NEUR ASS METR VE; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bureau of Justice Statistics, 2015, 248973 NCJ BUR JUST; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Centers for Disease Control and Prevention, 2016, BAS INF TRAUM BRAIN; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Durand E, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.535; Egeland J, 2007, APPL NEUROPSYCHOL, V14, P113, DOI 10.1080/09084280701319953; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Frederick R. I., 1997, VALIDITY INDICATOR P; Frederick RI, 2000, LAW HUMAN BEHAV, V24, P59, DOI 10.1023/A:1005426803586; Gagnon KL, 2017, J TRAUMA DISSOCIATIO, V18, P635, DOI 10.1080/15299732.2016.1252001; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Glover N, 2018, CRIM JUSTICE BEHAV, V45, P885, DOI 10.1177/0093854818765043; Guy LS, 2004, CRIM JUSTICE BEHAV, V31, P695, DOI 10.1177/0093854804268754; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lipsey, 2005, J EXPT CRIMINOLOGY, V1, P451, DOI [DOI 10.1007/S11292-005-3541-7, 10.1007/s11292-005-3541-7]; Martin TA, 2003, APPL NEUROPSYCHOL, V10, P163, DOI 10.1207/S15324826AN1003_05; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Miller H.A., 2001, MILLER FORENSIC ASSE; Mollayeva Tatyana, 2017, Healthc Q, V20, P6; Moracco KE, 2007, WOMEN HEALTH ISS, V17, P3, DOI 10.1016/j.whi.2006.03.007; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; Ohio Valley Center for Brain Injury Prevention and Rehabilitation, 2017, TRAUM BRAIN INJ ID M; Ray B, 2014, J FORENSIC SCI, V59, P1248, DOI 10.1111/1556-4029.12466; Reeves D. L., 1992, TECHNICAL REPORT; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Sakala L, 2014, BREAKING MASS INCARC; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Schopp LH, 2006, J HEAD TRAUMA REHAB, V21, P213, DOI 10.1097/00001199-200605000-00002; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wall K., 2016, ANN M DIV 18 PSYCH P; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Wolff N, 2007, CRIM JUSTICE BEHAV, V34, P588, DOI 10.1177/0093854806296830; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909; Zust Barbara L, 2009, Issues Ment Health Nurs, V30, P246, DOI 10.1080/01612840802701265	70	4	4	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0093-8548	1552-3594		CRIM JUSTICE BEHAV	Crim. Justice Behav.	OCT	2018	45	10					1588	1605		10.1177/0093854818778082			18	Psychology, Clinical; Criminology & Penology	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology	GT5WJ	WOS:000444580500007					2022-02-06	
J	Williamson, CL; Norte, GE; Broshek, DK; Hart, JM; Resch, JE				Williamson, Chelsea L.; Norte, Grant E.; Broshek, Donna K.; Hart, Joseph M.; Resch, Jacob E.			Return to Learn After Sport-Related Concussion: A Survey of Secondary School and Collegiate Athletic Trainers	JOURNAL OF ATHLETIC TRAINING			English	Article						academic accommodations; concussion management; student-athletes	POSITION STATEMENT CONCUSSION; AMERICAN MEDICAL SOCIETY; ACADEMIC ACCOMMODATIONS; MANAGEMENT; IMPLEMENTATION; PERCEPTIONS; FAMILIARITY; CLASSROOM; SYMPTOMS; CHILDREN	Context: Recent recommendations have emphasized return-to-learn (RTL) protocols to aid athletes in recovery from sport-related concussion (SRC) but have been based primarily on anecdotal evidence. Objective: To investigate the RTL practices of certified athletic trainers (ATs) after an SRC. Design: Cross-sectional study. Setting: Online survey. Patients or Other Participants: A total of 1083 individuals (27%) from a random sample of 4000 ATs in the National Athletic Trainers' Association membership database completed an electronic survey. Participants consisted of 729 self-identified secondary school ATs (SSATs; 67.3%; experience = 14.0 +/- 9.7 years) and 354 self-identified collegiate ATs (CATs; 32.7%; experience = 13.4 +/- 9.7 years). Main Outcome Measure(s): We used chi(2) analyses to assess respondent differences related to current knowledge, current practices, and available resources. Independent t tests were used to compare SSATs and CATs on years of certification and annual number of SRCs evaluated. Results: Of our total respondents, 41.2% (n = 446) correctly indicated the absence of evidence-based RTL guidelines. Whereas most (73.9%, n=800) respondents had an established RTL policy, only 38.1% (n = 413) used such guidelines in their clinical practice. Most (97.1%, n = 708) SSATs and 82.2% (n = 291) of CATs had access to (a) mental health professional(s); however, minorities of SSATs (21.4%, n = 156) and CATs (37.0%, n = 131) never accessed these resources to care for concussed student-athletes. Conclusions: Our results suggested that, despite the absence of empirical evidence, most surveyed ATs incorporated some form of RTL protocol in their SRC management policy. The varying AT knowledge, clinical practices, and resources highlighted by our results should be considered when creating or refining an RTL protocol.	[Williamson, Chelsea L.; Hart, Joseph M.; Resch, Jacob E.] Univ Virginia, Sports Med Program Area, Dept Kinesiol, Charlottesville, VA 22904 USA; [Norte, Grant E.] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22904 USA; [Broshek, Donna K.] Univ Toledo, Sch Exercise & Rehabil Sci, Athlet Training Program, 2801 W Bancroft St, Toledo, OH 43606 USA		Resch, JE (corresponding author), Univ Virginia, Dept Kinesiol, 210 Emmet St S, Charlottesville, VA 22904 USA.	jer6x@virginia.edu	Broshek, Donna/ABA-4208-2021; Norte, Grant/R-5847-2019	Broshek, Donna/0000-0002-7175-7815; Norte, Grant/0000-0001-8052-3642			Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Chan AY, 2018, J NEUROSURG, V128, P258, DOI 10.3171/2016.11.JNS162328; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Gioia G, HEAD UP CONCUSSIONS; Hall EE, 2015, CLIN J SPORT MED, V25, P291, DOI 10.1097/JSM.0000000000000133; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; McNeal Lori, 2017, NASN Sch Nurse, V32, P310, DOI 10.1177/1942602X17698487; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Miyashita TL, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114554549; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; National Collegiate Athletic Association Sport Science Institute, CONC SAF PROT CHECKL; Picciano A, 2013, FAM MED, V45, P501; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879	37	4	4	0	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2018	53	10					990	1003		10.4085/1062-6050-234-17			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HB9TJ	WOS:000451435400009	30398928	gold, Green Published			2022-02-06	
J	Yeargin, SW; Kingsley, P; Mensch, JM; Mihalik, JP; Monsma, EV				Yeargin, Susan W.; Kingsley, Payton; Mensch, Jim M.; Mihalik, Jason P.; Monsma, Eva, V			Anthropometrics and maturity status: A preliminary study of youth football head impact biomechanics	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Pediatric; Obesity; Body Mass Index; Linear acceleration; Rotational acceleration	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; PLAYERS; EXPOSURE; MAGNITUDE; FREQUENCY; LOCATION	Context: There is a paucity of head impact biomechanics research focusing on youth athletes. Little is known about how youth subconcussive head impact tolerances are related to physical size and maturation. Objective: To examine the effects of age, anthropometric and maturational status variability on head impact biomechanics. Design: Cross-sectional. Setting: Outdoor youth football facilities in South Carolina. Participants: Thirty-four male recreational youth football players, 8 to 13 yrs. Interventions: Categorized by CDC standards, independent variables were: age, height, mass, BMI, and estimated peak height velocity (PHV). Participants wore a designated head impact sensor (xPatch) on their mastoid process during practices and games. Main outcome measures: Linear acceleration (g) and rotational acceleration (rad/s(2)). Results: Boys in the older age category had a greater linear (F = 17.72; P < 0.001) and rotational acceleration (F = 10.74; P < 0.001) than those in the younger category. Post-PHV boys had higher linear (F = 9.09, P = 0.002) and rotational (F = 5.57, P = 0.018) accelerations than those who were pre-PHV. Rotational, but not linear acceleration differed by height category with lowest impacts found for the tallest category, whereas both linear and rotational accelerations by mass differences favored average and heavy categories. BMI overweight boys, had the greatest linear (F = 5.25; P = 0.011) and rotational acceleration (F = 4.13; P = 0.260) means. Conclusion: Post-PHV boys who were older, taller and had longer legs, but who were not heavier, had higher impacts perhaps due to the type of impacts sustained. Taller boys' heads are above their peers possibly encouraging hits in the torso region resulting in lower impact accelerations. Obese boys did not have sequential results compared to boys in the other BMI categories probably due to league rules, player position, and lack of momentum produced.	[Yeargin, Susan W.] Univ South Carolina, Dept Exercise Sci, 921 Assembly St,Publ Hlth Res 226, Columbia, SC 29208 USA; [Kingsley, Payton; Mensch, Jim M.] Univ South Carolina, Dept Exercise Sci, Blatt Ctr, 1300 Wheat St, Columbia, SC 29208 USA; [Mihalik, Jason P.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 2201 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27599 USA; [Monsma, Eva, V] Univ South Carolina, Dept Phys Educ, Blatt Ctr, 1300 Wheat St, Columbia, SC 29208 USA; [Kingsley, Payton] Ochsner Sports Med, New Orleans, LA USA		Yeargin, SW (corresponding author), Univ South Carolina, Dept Exercise Sci, 921 Assembly St,Publ Hlth Res 226, Columbia, SC 29208 USA.	syeargin@mailbox.sc.edu; JMENSCH@mailbox.sc.edu; jmihalik@email.unc.edu; EAVADOCZ@mailbox.sc.edu			Datalys Center for Sports Injury Research and Prevention, Indianapolis, IN	This work was supported by the Datalys Center for Sports Injury Research and Prevention, Indianapolis, IN.	[Anonymous], 2011, BMI CHILDR TEENS; [Anonymous], 2010, AGE BASED PEDIAT GRO; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cobb Bryan R, 2014, Biomed Sci Instrum, V50, P285; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Hynes LM, 2008, ACCIDENT ANAL PREV, V40, P1063, DOI 10.1016/j.aap.2007.11.012; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Malina RM, 2004, EUR J APPL PHYSIOL, V91, P555, DOI 10.1007/s00421-003-0995-z; Malina RM, 2007, J PEDIATR-US, V151, P378, DOI 10.1016/j.jpeds.2007.03.044; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Moore SA, 2015, MED SCI SPORT EXER, V47, P1755, DOI 10.1249/MSS.0000000000000588; Munce T. A, 2014, MED SCI SPORTS EXERC; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; National Council of Youth Sports, 2008, REP TRENDS PART ORG; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036	37	4	4	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		87	92		10.1016/j.ijpsycho.2017.09.022			6	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000012	28986327				2022-02-06	
J	Yonekura, S; Anno, T; Kobayashi, N				Yonekura, Satoru; Anno, Takayuki; Kobayashi, Nobuyuki			Posterior Reversible Encephalopathy Syndrome and Guillain-Barre Syndrome after Head Injury: Case Report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						posterior reversible encephalopathy syndrome; Guillain-Barre syndrome; magnetic resonance imaging; head injuary	TRAUMATIC BRAIN-INJURY; INITIAL MANIFESTATION; LEUKOENCEPHALOPATHY; EXPRESSION; FEATURES	We report a case of head injury with posterior reversible encephalopathy syndrome (PRES), followed by Guillain-Barre syndrome (GBS). A 74-year-old man was brought to our hospital after a fall. Computed tomography revealed intracranial hemorrhage. Magnetic resonance imaging showed bilateral reversible intensities with features of vasogenic edema in parietooccipital areas, suggesting PRES. After admission, weakness and areflexia of extremities and respiratory muscles developed gradually, which favored a diagnosis of GBS. Common etiologies of PRES were absent. Concurrent occurrence of PRES and GBS is rare. Given that PRES can be an initial manifestation of GBS, GBS must be considered in head trauma patients with PRES.	[Yonekura, Satoru; Anno, Takayuki; Kobayashi, Nobuyuki] Tochigi Med Ctr Shimotsuga, Dept Neurosurg, Tochigi, Tochigi, Japan		Yonekura, S (corresponding author), Tochigi Med Ctr Shimotsuga, Ohira Machi Kawatsure 420-1, Tochigi, Tochigi 3294498, Japan.	yonechian@gmail.com	Yonekura, Satoru/R-2468-2016	Yonekura, Satoru/0000-0003-4047-3016			Abraham Alon, 2011, J Clin Neuromuscul Dis, V12, P113, DOI 10.1097/CND.0b013e318209ef9a; Ahn KJ, 2004, NEURORADIOLOGY, V46, P978, DOI 10.1007/s00234-004-1276-1; Ay H, 1998, NEUROLOGY, V51, P1369, DOI 10.1212/WNL.51.5.1369; Banakar BF, 2014, J NEUROSCI RURAL PRA, V5, P63, DOI 10.4103/0976-3147.127877; Barbay M, 2013, CAN J NEUROL SCI, V40, P267, DOI 10.1017/S0317167100017510; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1036, DOI 10.3174/ajnr.A0928; Bavikatte G, 2010, J CLIN NEUROSCI, V17, P924, DOI 10.1016/j.jocn.2009.11.009; Burwen DR, 2010, AM J PREV MED, V39, P296, DOI 10.1016/j.amepre.2010.05.022; Chen A, 2015, J CLIN NEUROSCI, V22, P914, DOI 10.1016/j.jocn.2014.11.004; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Dasgupta S, 2017, INT J BIOCHEM CELL B, V82, P41, DOI 10.1016/j.biocel.2016.11.015; Donmez FY, 2010, J NEUROIMAGING, V20, P22, DOI 10.1111/j.1552-6569.2008.00306.x; Doss-Esper CE, 2005, J NEUROIMAGING, V15, P188, DOI 10.1177/1051228404273820; DUNCAN R, 1987, POSTGRAD MED J, V63, P479, DOI 10.1136/pgmj.63.740.479; Elahi A, 2004, NEUROCRIT CARE, V1, P465, DOI 10.1385/NCC:1:4:465; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Fugate JE, 2015, LANCET NEUROL, V14, P914, DOI 10.1016/S1474-4422(15)00111-8; Fugate JE, 2010, MAYO CLIN PROC, V85, P427, DOI 10.4065/mcp.2009.0590; Fugate JE, 2009, NEUROCRIT CARE, V11, P395, DOI 10.1007/s12028-009-9279-8; Hobson EV, 2012, PERITON DIALYSIS INT, V32, P590, DOI 10.3747/pdi.2012.00152; Jia H., 2017, NEUROIMMUNOL NEUROIN, V4, P61, DOI [10.20517/2347-8659.2016.51, DOI 10.20517/2347-8659.2016.51]; Kawanabe T, 2011, NEUROL MED-CHIR, V51, P582, DOI 10.2176/nmc.51.582; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Latronico N, 2008, MINERVA ANESTESIOL, V74, P319; Li H, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-36; Lin TM, 2006, J PLAST RECONSTR AES, V59, P543, DOI 10.1016/j.bjps.2005.10.017; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; Okada T, 1996, ACTA PAEDIATR, V85, P1006, DOI 10.1111/j.1651-2227.1996.tb14204.x; Okada T, 2013, NEUROL MED-CHIR, V53, P520, DOI 10.2176/nmc.53.520; Piccolo G, 2015, FUNCT NEUROL, V30, P67; Rigamonti A, 2012, J PERIPHER NERV SYST, V17, P356, DOI 10.1111/j.1529-8027.2012.00416.x; Rivas S, 2008, J NEUROSURG, V108, P595, DOI 10.3171/JNS/2008/108/3/0595; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Sutter R, 2009, NEUROMUSCULAR DISORD, V19, P709, DOI 10.1016/j.nmd.2009.06.370; Tan IL, 2010, J CLIN NEUROSCI, V17, P1452, DOI 10.1016/j.jocn.2009.11.037; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; Tuttle J, 1997, AM J PUBLIC HEALTH, V87, P2045, DOI 10.2105/AJPH.87.12.2045; Van Diest D, 2007, CLIN NEUROL NEUROSUR, V109, P58, DOI 10.1016/j.clineuro.2006.01.004; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; Yang B, 2016, J NEUROIMMUNOL, V293, P17, DOI 10.1016/j.jneuroim.2016.02.003; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497	42	4	4	0	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	OCT	2018	58	10					453	458		10.2176/nmc.cr.2018-0049			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HF2ED	WOS:000454048300005	30078819	Green Submitted, gold, Green Published			2022-02-06	
J	Yoon, KJ; Kim, DY				Yoon, Kyung Jae; Kim, Dae Yul			Immediate Effects of a Single Exercise on Behavior and Memory in the Early Period of Traumatic Brain Injury in Rats	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Traumatic brain injuries; Exercise; Recovery; Memory; Rehabilitation	FLUID-PERCUSSION MODEL; VOLUNTARY EXERCISE; CEREBRAL-ISCHEMIA; MOTOR CORTEX; EXPRESSION; STIMULATION; STRESS	Objective To evaluate the immediate effect of single exercise on physical performance and memory in the early stage of traumatic brain injury (TBI) in rats. Methods Ninety TBI rats were randomly assigned to T0 (sedentary), T10 (treadmill 10 m/min for 30 minutes), or T20 (treadmill 20 m/min for 30 minutes) groups, on day 3 (D3), D7, and D14 after TBI, respectively. Rotarod (RR), Barnes maze (BM), brain magnetic resonance imaging (MRI) and MR spectroscopy were performed immediately before and 6 hours after exercise. Rats were sacrificed for immunohistochemistry with heat shock protein 70 (Hsp70) and glial fibrillary acidic protein (GFAP). Results On D3, the T10 and T20 groups demonstrated significant improvement in RR (p<0.05). On D7, only the T20 group showed significantly enhanced RR (p<0.05). In BM on D3, the T20 group showed significant deterioration compared with the other groups (p<0.05). Lesion volume did not significantly differ among the groups. MR spectroscopy on D3 showed that only the T20 group had significantly increased choline/creatine and 0.9/creatine (p<0.05). In the perilesional area on D3, only T20 had a significantly higher Hsp70 and GFAP than the T0 group. On D7, Hsp70 was significantly higher in the T20 group than in the T0 group (p<0.05). In the ipsilesional hippocampus on D3, the T20 group showed a significantly higher Hsp70 and GFAP than the T0 group (p<0.05). Conclusion A single session of low-intensity exercise in the early period of TBI improves behavioral performance without inducing cognitive deficits. However, high-intensity exercise can exacerbate cognitive function in the early period after TBI. Therefore, the optimal timing of rehabilitation and exercise intensity are crucial in behavior and memory recovery after TBI.	[Yoon, Kyung Jae] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Phys & Rehabil Med, Seoul, South Korea; [Yoon, Kyung Jae] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Med Res Inst,Regenerat & Neurosci Lab, Seoul, South Korea; [Kim, Dae Yul] Univ Ulsan, Dept Rehabil Med, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea		Kim, DY (corresponding author), Univ Ulsan, Dept Rehabil Med, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.	dykimmart@gmail.com	Yoon, Kyung Jae/ABB-3785-2021		Asan Institute for Life Science [2010-454]; Medical Research Funds from Kangbuk Samsung Hospital, Seoul, Korea	This study was supported and funded by the Asan Institute for Life Science (Task No. 2010-454) and by the Medical Research Funds from Kangbuk Samsung Hospital, Seoul, Korea.	Bernardi C, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/709732; BORER KT, 1992, PHYSIOL BEHAV, V51, P713, DOI 10.1016/0031-9384(92)90106-C; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; DeVries AC, 2001, P NATL ACAD SCI USA, V98, P11824, DOI 10.1073/pnas.201215298; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hansson AC, 2006, J NEUROENDOCRINOL, V18, P104, DOI 10.1111/j.1365-2826.2005.01390.x; Hoffman-Goetz L, 2008, BRAIN BEHAV IMMUN, V22, P195, DOI 10.1016/j.bbi.2007.07.002; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Keeler BE, 2012, BRAIN RES, V1438, P8, DOI 10.1016/j.brainres.2011.12.015; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Li R, 1998, AM J FOREN MED PATH, V19, P129, DOI 10.1097/00000433-199806000-00006; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Qu M, 1998, NEUROSCIENCE, V85, P29, DOI 10.1016/S0306-4522(97)00656-8; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Saur L, 2014, BRAIN STRUCT FUNCT, V219, P293, DOI 10.1007/s00429-012-0500-8; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; VANDERWOLF CH, 1994, BRAIN RES REV, V19, P264, DOI 10.1016/0165-0173(94)90015-9; Yoon KJ, 2012, BRAIN RES, V1452, P61, DOI 10.1016/j.brainres.2012.02.062; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	30	4	5	0	2	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	OCT	2018	42	5					643	651		10.5535/arm.2018.42.5.643			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	GZ5KQ	WOS:000449459700001	30404413	Green Published, gold, Green Submitted			2022-02-06	
J	Butler, O; Herr, K; Willmund, G; Gallinat, J; Zimmermann, P; Kuhn, S				Butler, Oisin; Herr, Kerstin; Willmund, Gerd; Gallinat, Juergen; Zimmermann, Peter; Kuehn, Simone			Neural correlates of response bias: Larger hippocampal volume correlates with symptom aggravation in combat-related posttraumatic stress disorder	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Symptom validity tests; Symptom exaggeration; Malingering; Military; Structural neuroimaging; MRI	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; PREFRONTAL CORTEX; PTSD; VETERANS; SOLDIERS; IRAQ; METAANALYSIS; AFGHANISTAN; PREVALENCE	The diagnosis of posttraumatic stress disorder (PTSD) is vulnerable to the simulation or exaggeration of symptoms as it depends on the individual's self-report of symptoms. The use of symptom validity tests is recommended to detect malingering in PTSD. However, in neuroimaging research, PTSD diagnosis is often taken at face validity. To date, no neuroimaging study has compared credible PTSD patients with those identified as malingering, and the potential impacts of including malingerers along with credible patients on results is unclear. We classified male patients with combat-related PTSD as either credible (n = 37) or malingerers (n = 9) based on the Morel Emotional Numbing Test and compared structural neuroimaging and psychological questionnaire data. Patients identified as malingerers had larger gray matter volumes in the hippocampus, right inferior frontal gyrus and thalamus, and reported higher PTSD symptoms than credible PTSD patients. This is the first structural neuroimaging study to compare credible PTSD patients and malingerers. We find evidence of structural differences between these groups, in regions implicated in PTSD, inhibition and deception. These results emphasize the need for the inclusion of SVTs in neuroimaging studies of PTSD to ensure future findings are not confounded by an unknown mix of valid PTSD patients and malingerers.	[Butler, Oisin; Kuehn, Simone] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Lentzeallee 94, D-14195 Berlin, Germany; [Herr, Kerstin; Willmund, Gerd; Zimmermann, Peter] Mil Hosp Berlin, Ctr Mil Mental Hlth, Scharnhorststr 13, D-10115 Berlin, Germany; [Gallinat, Juergen; Kuehn, Simone] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Martinistr 52, D-20246 Hamburg, Germany		Butler, O (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Lentzeallee 94, D-14195 Berlin, Germany.	butler@mpib-berlin.mpg.de	Kuehn, Simone/P-6145-2014	Kuhn, Simone/0000-0001-6823-7969	German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF); German Science FoundationGerman Research Foundation (DFG); AstraZenecaAstraZeneca; LundbeckLundbeck Corporation; Janssen-CilagJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc; LillyEli Lilly; OtsukaOtsuka Pharmaceutical; Heisenberg grant from the German Science FoundationGerman Research Foundation (DFG) [DFG KU 3322/1-1]; European UnionEuropean Commission [ERC-2016-StG-Self-Control-677804]; Jacobs Foundation [JRF 2016-2018]; Military Medical Academy of German Armed Forces, German Ministry of Defense	We thank Sonali Beckmann, Tobias Gleich, Elizabeth Labuhn, Sarah Polk and Nadine Taube for their helpful contributions. OB received a PhD student stipend from the International Max Planck Research School on the Life Course (LIFE). JG has received research funding from the German Federal Ministry of Education and Research, German Science Foundation, AstraZeneca, and speaker fees from Lundbeck, Janssen-Cilag, Lilly and Otsuka. SK has been funded by a Heisenberg grant from the German Science Foundation(DFG KU 3322/1-1), the European Union (ERC-2016-StG-Self-Control-677804) and the Jacobs Foundation (JRF 2016-2018). KH, GW and PZ are employed by the German Armed Forces. Their employment had no influence on the study design. The study was funded by the Military Medical Academy of German Armed Forces, German Ministry of Defense. Data and Materials will be made available via the Open Science Framework or are otherwise available from the authors on request (with the exception of questionnaire measures subject to third-party copyright or potentially identifying patient information).	APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; BAGBY RM, 1994, J PERS ASSESS, V62, P191, DOI 10.1207/s15327752jpa6202_2; Bedard-Gilligan M, 2008, BEHAV RES THER, V46, P1062, DOI 10.1016/j.brat.2008.06.009; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bremner JD, 2004, ANN NY ACAD SCI, V1032, P154, DOI 10.1196/annals.1314.012; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Burges C, 2001, BRIT J CLIN PSYCHOL, V40, P209, DOI 10.1348/014466501163544; Butler O, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.288; Butler O, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.956; Butler O, 2018, HUM BRAIN MAPP, V39, P2088, DOI 10.1002/hbm.23988; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chao LL, 2014, PSYCHIAT RES-NEUROIM, V222, P119, DOI 10.1016/j.pscychresns.2014.03.005; Charney D.S, 1998, CNS SPECTRUM S2, V3, P6, DOI [10.1017/S1092852900007264, DOI 10.1017/S1092852900007264]; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Evans SC, 2013, INT J PSYCHOL, V48, P177, DOI 10.1080/00207594.2013.804189; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Freeman T, 2008, PSYCHIAT RES, V158, P374, DOI 10.1016/j.psychres.2007.04.002; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Frueh BC, 1997, J PERS ASSESS, V68, P369, DOI 10.1207/s15327752jpa6802_8; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Guriel Jennifer, 2003, Clin Psychol Rev, V23, P881; Hall RCW, 2007, J FORENSIC SCI, V52, P717, DOI 10.1111/j.1556-4029.2007.00434.x; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Howe LLS, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P301, DOI 10.1007/978-1-4614-0442-2_11; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kessler RC, 2014, JAMA PSYCHIAT, V71, P504, DOI 10.1001/jamapsychiatry.2014.28; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Kleinman SB, 2004, PSYCHIAT CLIN N AM, V27, P559, DOI 10.1016/j.psc.2004.03.008; Knoll J, 2006, PSYCHIAT CLIN N AM, V29, P629, DOI 10.1016/j.psc.2006.04.001; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kozel FA, 2005, BIOL PSYCHIAT, V58, P605, DOI 10.1016/j.biopsych.2005.07.040; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Maercker A, 2009, POSTTRAUMATISCHE BEL, VII, DOI [10.1007/978-3-540-79543-8, DOI 10.1007/978-3-540-79543-8]; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Merten T., 2010, GERMAN J PSYCHIAT, V13, P140; Morel K.R, 2008, GER J PSYCHIAT, V22, P128, DOI [10.1007/s12207-013-9151-1, DOI 10.1007/S12207-013-9151-1]; Morel KR, 2013, PSYCHOL INJ LAW, V6, P138, DOI 10.1007/s12207-013-9151-1; Morel KR, 1998, J PERS ASSESS, V70, P299, DOI 10.1207/s15327752jpa7002_8; Pohlack ST, 2012, HUM BRAIN MAPP, V33, P478, DOI 10.1002/hbm.21224; Portas CM, 1998, J NEUROSCI, V18, P8979; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Resnick P.J, 1995, POSTTRAUMATIC STRESS; Rogers, 2009, BRIT J PSYCHIAT, DOI [10.1192/bjp.bp.108.060855, DOI 10.1192/BJP.BP.108.060855]; Rosen GM, 2007, J ANXIETY DISORD, V21, P201, DOI 10.1016/j.janxdis.2006.09.011; Rubin M, 2016, PSYCHIAT RES-NEUROIM, V252, P36, DOI 10.1016/j.pscychresns.2016.05.001; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Spadoni AD, 2015, PSYCHIAT RES-NEUROIM, V233, P367, DOI 10.1016/j.pscychresns.2015.06.007; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stevens A., 2007, PRAXIS RECHTSPSYCHOL, V17, P83; Tanielian T, 2008, INVISIBLE WOUNDS WAR, V60, DOI [10.1176/appi.ps.60.2.273, DOI 10.1176/APPI.PS.60.2.273, 10.1176/appi. ps.60.2.273]; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Taylor S, 2007, J ANXIETY DISORD, V21, P22, DOI 10.1016/j.janxdis.2006.03.016; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Trautmann S, 2017, EPIDEMIOL PSYCH SCI, V26, P199, DOI 10.1017/S204579601600024X; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; van Rooij SJH, 2015, PSYCHOL MED, V45, P2737, DOI 10.1017/S0033291715000707; Whitfield-Gabrieli S, 2009, REGION INTEREST EXTR; Wittchen HU, 2012, DTSCH ARZTEBL INT, V109, P559, DOI 10.3238/arztebl.2012.0559	74	4	4	1	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	SEP 30	2018	279						1	7		10.1016/j.pscychresns.2018.06.010			7	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	GQ6XW	WOS:000441874500001	30014966				2022-02-06	
J	Oernbo, EK; Lykke, K; Steffensen, AB; Tollner, K; Kruuse, C; Rath, MF; Loscher, W; MacAulay, N				Oernbo, Eva Kjer; Lykke, Kasper; Steffensen, Annette Buur; Toellner, Kathrin; Kruuse, Christina; Rath, Martin Fredensborg; Loescher, Wolfgang; MacAulay, Nanna			Cerebral influx of Na+ and Cl- as the osmotherapy-mediated rebound response in rats	FLUIDS AND BARRIERS OF THE CNS			English	Article						Osmotherapy; Rebound effect; Brain edema; Brain barriers; Ion-transporting mechanisms	INCREASED INTRACRANIAL-PRESSURE; CARBONIC-ANHYDRASE INHIBITOR; ARTERY OCCLUSION MODEL; TRAUMATIC BRAIN-INJURY; HYPERTONIC SALINE; CEREBROSPINAL-FLUID; MANNITOL; SODIUM; BUMETANIDE; AMILORIDE	Background: Cerebral edema can cause life-threatening increase in intracranial pressure. Besides surgical craniectomy performed in severe cases, osmotherapy may be employed to lower the intracranial pressure by osmotic extraction of cerebral fluid upon intravenous infusion of mannitol or NaCl. A so-called rebound effect can, however, hinder continuous reduction in cerebral fluid by yet unresolved mechanisms. Methods: We determined the brain water and electrolyte content in healthy rats treated with osmotherapy. Osmotherapy (elevated plasma osmolarity) was mediated by intraperitoneal injection of NaCl or mannitol with inclusion of pharmacological inhibitors of selected ion-transporters present at the capillary lumen or choroidal membranes. Brain barrier integrity was determined by fluorescence detection following intravenous delivery of Na+-fluorescein. Results: NaCl was slightly more efficient than mannitol as an osmotic agent. The brain water loss was only similar to 60% of that predicted from ideal osmotic behavior, which could be accounted for by cerebral Na+ and Cl- accumulation. This electrolyte accumulation represented the majority of the rebound response, which was unaffected by the employed pharmacological agents. The brain barriers remained intact during the elevated plasma osmolarity. Conclusions: A brain volume regulatory response occurs during osmotherapy, leading to the rebound response. This response involves brain accumulation of Na+ and Cl- and takes place by unresolved molecular mechanisms that do not include the common ion-transporting mechanisms located in the capillary endothelium at the blood-brain barrier and in the choroid plexus epithelium at the blood-CSF barrier. Future identification of these ion-transporting routes could provide a pharmacological target to prevent the rebound effect associated with the widely used osmotherapy.	[Oernbo, Eva Kjer; Lykke, Kasper; Steffensen, Annette Buur; Rath, Martin Fredensborg; MacAulay, Nanna] Univ Copenhagen, Dept Neurosci, Copenhagen, Denmark; [Toellner, Kathrin; Loescher, Wolfgang] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany; [Toellner, Kathrin; Loescher, Wolfgang] Ctr Syst Neurosci, Hannover, Germany; [Kruuse, Christina] Univ Copenhagen, Herlev Gentofte Hosp, Dept Neurol, Neurovasc Res Unit, Copenhagen, Denmark; [Lykke, Kasper] AJVaccines, Copenhagen, Denmark; [MacAulay, Nanna] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci, Blegdamsvej 3, DK-2200 Copenhagen, Denmark		MacAulay, N (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	macaulay@sund.ku.dk	Kruuse, Christina/AAI-1880-2019; Loscher, Wolfgang/G-9824-2016; Kruuse, Christina/F-2666-2014; Steffensen, Annette Buur B/J-9794-2018; Rath, Martin/AAL-9732-2021	Loscher, Wolfgang/0000-0002-9648-8973; Steffensen, Annette Buur B/0000-0003-0613-2410; Kruuse, Christina/0000-0002-4210-0523; MacAulay, Nanna/0000-0002-7800-6600; Rath, Martin/0000-0002-4047-6324	Independent Research Fund Denmark [0602-02344B FSS]; Deutsche Forschungsgemeinschaft (Bonn, Germany)German Research Foundation (DFG) [Lo 274/15-1]	This study was funded by the Independent Research Fund Denmark (Sapere Aude, 0602-02344B FSS, to NM) and the Deutsche Forschungsgemeinschaft (Bonn, Germany, Lo 274/15-1, to WL).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; BAIRAMIAN D, 1991, J NEUROCHEM, V56, P1623, DOI 10.1111/j.1471-4159.1991.tb02060.x; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Battison C, 2005, CRIT CARE MED, P33; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Brown PD, 2004, NEUROSCIENCE, V129, P957, DOI 10.1016/j.neuroscience.2004.07.003; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; CSERR HF, 1987, AM J PHYSIOL, V253, pF530, DOI 10.1152/ajprenal.1987.253.3.F530; CSERR HF, 1987, AM J PHYSIOL, V253, pF522, DOI 10.1152/ajprenal.1987.253.3.F522; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; Durham-Lee JC, 2011, J NEUROTRAUM, V28, P1319, DOI 10.1089/neu.2011.1921; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; GRAY WD, 1958, J PHARMACOL EXP THER, V124, P149; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Hawkins BT, 2006, J NEUROSCI METH, V151, P262, DOI 10.1016/j.jneumeth.2005.08.006; Hladky SB, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0040-3; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Karimy JK, 2015, J NEUROSCI METH, V241, P78, DOI 10.1016/j.jneumeth.2014.12.015; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kusche-Vihrog K, 2014, PFLUG ARCH EUR J PHY, V466, P851, DOI 10.1007/s00424-013-1356-3; Li MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep35055; Li YJ, 2011, J CHROMATOGR B, V879, P998, DOI 10.1016/j.jchromb.2011.02.018; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lykke K, 2019, J CEREBR BLOOD F MET, V39, P497, DOI 10.1177/0271678X17736715; Lykke K, 2016, EPILEPSY BEHAV, V59, P42, DOI 10.1016/j.yebeh.2016.03.021; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; MOLLER M, 1978, CELL TISSUE RES, V195, P1; Nakamura K, 2009, MICROVASC RES, V77, P327, DOI 10.1016/j.mvr.2008.12.001; Nordquist L, 2008, CLIN EXP HYPERTENS, V30, P151, DOI 10.1080/10641960801944231; O'Donnell ME, 2013, J CEREBR BLOOD F MET, V33, P225, DOI 10.1038/jcbfm.2012.160; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; POLLAY M, 1985, NEUROSURGERY, V17, P768, DOI 10.1227/00006123-198511000-00007; Pollay M, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-9; PULLEN RGL, 1987, AM J PHYSIOL, V253, pF538, DOI 10.1152/ajprenal.1987.253.3.F538; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Ropper Allan H, 2014, Pract Neurol, V14, P152, DOI 10.1136/practneurol-2014-000811; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; SCHELLER MS, 1991, J NEUROSURG ANESTH, V3, P291, DOI 10.1097/00008506-199112000-00009; Steffensen AB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04677-9; SUGRUE MF, 1990, BRIT J PHARMACOL, V99, P59, DOI 10.1111/j.1476-5381.1990.tb14654.x; Teiwes J, 2007, AM J HYPERTENS, V20, P109, DOI 10.1016/j.amjhyper.2006.05.022; Todd MM, 2013, ANESTHESIOLOGY, V118, P777, DOI 10.1097/ALN.0b013e3182815980; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; WALKER PC, 1989, DEV PHARMACOL THERAP, V12, P13, DOI 10.1159/000480977; Wang LC, 2013, ANESTHESIOLOGY, V118, P903, DOI 10.1097/ALN.0b013e31828156ff	55	4	4	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-8118			FLUIDS BARRIERS CNS	Fluids Barriers CNS	SEP 25	2018	15								27	10.1186/s12987-018-0111-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GV0XJ	WOS:000445788100001	30249273	Green Published, gold			2022-02-06	
J	Yu, J; Zhu, H; Taheri, S; Mondy, W; Perry, S; Kindy, MS				Yu, Jin; Zhu, Hong; Taheri, Saeid; Mondy, William; Perry, Stephen; Kindy, Mark S.			Impact of nutrition on inflammation, tauopathy, and behavioral outcomes from chronic traumatic encephalopathy	JOURNAL OF NEUROINFLAMMATION			English	Article						Animal model; Chronic traumatic encephalopathy; Concussion; Pathophysiology; Repetitive; Diet; Inflammation; Neurodegeneration; Behavior	BRAIN-INJURY; ANIMAL-MODEL; MOUSE MODEL; HEAD-INJURY; MICE; DEPRESSION; CONCUSSION; MOTOR; CONSEQUENCES; MEMORY	Background: Repetitive mild traumatic brain injuries (rmTBI) are associated with cognitive deficits, inflammation, and stress-related events. We tested the effect of nutrient intake on the impact of rmTBI in an animal model of chronic traumatic encephalopathy (CTE) to study the pathophysiological mechanisms underlying this model. We used a between group design rmTBI closed head injuries in mice, compared to a control and nutrient-treated groups. Methods: Our model allows for controlled, repetitive closed head impacts to mice. Briefly, 24-week-old mice were divided into five groups: control, rmTBI, and rmTBI with nutrients (2% of NF-216, NF-316 and NF-416). rmTBI mice received four concussive impacts over 7 days. Mice were treated with NutriFusion diets for 2 months prior to the rmTBI and until euthanasia (6 months). Mice were then subsequently euthanized for macro-and micro-histopathologic analysis for various times up to 6 months after the last TBI received. Animals were examined behaviorally, and brain sections were immunostained for glial fibrillary acidic protein (GFAP) for astrocytes, iba-1 for activated microglia, and AT8 for phosphorylated tau protein. Results: Animals on nutrient diets showed attenuated behavioral changes. The brains from all mice lacked macroscopic tissue damage at all time points. The rmTBI resulted in a marked neuroinflammatory response, with persistent and widespread astrogliosis and microglial activation, as well as significantly elevated phospho-tau immunoreactivity to 6 months. Mice treated with diets had significantly reduced inflammation and phospho-tau staining. Conclusions: The neuropathological findings in the rmTBI mice showed histopathological hallmarks of CTE, including increased astrogliosis, microglial activation, and hyperphosphorylated tau protein accumulation, while mice treated with diets had attenuated disease process. These studies demonstrate that consumption of nutrient-rich diets reduced disease progression.	[Yu, Jin; Zhu, Hong; Taheri, Saeid; Mondy, William; Kindy, Mark S.] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, 12901 Bruce B Downs Blvd,MDC 30, Tampa, FL 33612 USA; [Perry, Stephen] NutriFusion LLC, 10641 Airport Pulling Rd,Suite 31, Naples, FL 34109 USA; [Kindy, Mark S.] Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL 33620 USA; [Kindy, Mark S.] Univ S Florida, Dept Mol Pharmacol, Coll Med, Tampa, FL 33620 USA; [Kindy, Mark S.] Univ S Florida, Dept Physiol, Coll Med, Tampa, FL 33620 USA; [Kindy, Mark S.] Univ S Florida, Dept Pathol & Cell Biol, Coll Med, Tampa, FL 33620 USA; [Kindy, Mark S.] Univ S Florida, Dept Neurol, Coll Med, Tampa, FL 33620 USA; [Kindy, Mark S.] James A Haley VA Med Ctr, Tampa, FL 33612 USA; [Kindy, Mark S.] Shriners Hosp Children, Tampa, FL 33612 USA		Kindy, MS (corresponding author), Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, 12901 Bruce B Downs Blvd,MDC 30, Tampa, FL 33612 USA.; Kindy, MS (corresponding author), Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL 33620 USA.; Kindy, MS (corresponding author), James A Haley VA Med Ctr, Tampa, FL 33612 USA.; Kindy, MS (corresponding author), Shriners Hosp Children, Tampa, FL 33612 USA.	kindym@health.usf.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 ES016774-01, R21AG043718, 1P20GM109091, 2P20GM103444, 5P30GM103342]; National Science FoundationNational Science Foundation (NSF) [IIP-0903795]; AHA SFRN grant; VA Merit ReviewUS Department of Veterans Affairs; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES016774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103444, P30GM103342, P20GM109091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG043718] Funding Source: NIH RePORTER	This work was partially supported by grants from the National Institutes of Health (R01 ES016774-01, R21AG043718, 1P20GM109091, 2P20GM103444, and 5P30GM103342), VA Merit Award, a grant from the National Science Foundation (IIP-0903795), an AHA SFRN grant, and VA Merit Review (M.S.K.). Dr. Kindy is a Senior Research Career Scientist in the VA.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bilkei-Gorzo A, 2002, J NEUROSCI, V22, P10046; Conte V, 2004, J NEUROCHEM, V90, P758, DOI 10.1111/j.1471-4159.2004.02560.x; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hook GR, 2014, J NEUROTRAUM, V31, P515, DOI [10.1089/neu.2013.2944, 10.1089/NEU.2013.2944]; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lim S, 2016, BRAIN PATHOL, V26, P404, DOI 10.1111/bpa.12371; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Muller MB, 2001, EUR J NEUROSCI, V14, P1603, DOI 10.1046/j.0953-816x.2001.01784.x; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Stephenson J, 2018, IMMUNOLOGY, V154, P204, DOI 10.1111/imm.12922; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tang XD, 2002, SLEEP, V25, P691; Tang XD, 2007, BEHAV BRAIN RES, V180, P62, DOI 10.1016/j.bbr.2007.02.022; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yu J, 2015, NUTR NEUROSCI, V6, P154; Yu J, 2017, AGING-US, V9, P1041, DOI 10.18632/aging.101209; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	47	4	4	1	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	SEP 24	2018	15								277	10.1186/s12974-018-1312-4			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	GV0LV	WOS:000445753700002	30249250	Green Published, gold			2022-02-06	
J	Wang-Leandro, A; Hobert, MK; Kramer, S; Rohn, K; Stein, VM; Tipold, A				Wang-Leandro, Adriano; Hobert, Marc K.; Kramer, Sabine; Rohn, Karl; Stein, Veronika M.; Tipold, Andrea			The role of diffusion tensor imaging as an objective tool for the assessment of motor function recovery after paraplegia in a naturally-occurring large animal model of spinal cord injury	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article						MRI; Intervertebral discherniation; IVDH; Hemilaminectomy; Canine; SCI; DTI; Translational medicine; Follow-up studies	TRAUMATIC BRAIN-INJURY; INTERVERTEBRAL-DISK DEGENERATION; CLINICAL-APPLICATIONS; LOCOMOTOR RECOVERY; PAIN PERCEPTION; WHITE-MATTER; DOGS; HERNIATION; HEMILAMINECTOMY; FENESTRATION	Background: Traumatic spinal cord injury (SCI) results in sensory and motor function impairment and may cause a substantial social and economic burden. For the implementation of novel treatment strategies, parallel development of objective tools evaluating spinal cord (SC) integrity during motor function recovery (MFR) is needed. Diffusion tensor imaging (DTI) enables in vivo microstructural assessment of SCI. Methods: In the current study, temporal evolvement of DTI metrics during MFR were examined; therefore, values of fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were measured in a population of 17 paraplegic dogs with naturally-occurring acute SCI showing MFR within 4 weeks after surgical decompression and compared to 6 control dogs. MRI scans were performed preoperatively and 12 weeks after MFR was observed. DTI metrics were obtained at the lesion epicentre and one SC segment cranially and caudally. Variance analyses were performed to compare values between evaluated localizations in affected dogs and controls and between time points. Correlations between DTI metrics and clinical scores at follow-up examinations were assessed. Results: Before surgery, FA values at epicentres were higher than caudally (p = 0.0014) and control values (p = 0.0097); ADC values were lower in the epicentre compared to control values (p = 0.0035) and perilesional (p = 0.0448 cranially and p = 0.0433 caudally). In follow-up examinations, no significant differences could be found between DTI values from dogs showing MFR and control dogs. Lower ADC values at epicentres correlated with neuro-logical deficits at follow-up examinations (r = -0.705; p = 0.0023). Conclusions: Findings suggest that a tendency to the return of DTI values to the physiological situation after surgical decompression accompanies MFR after SCI in paraplegic dogs. DTI may represent a useful and objective clinical tool for follow-up studies examining in vivo SC recovery in treatment studies.	[Wang-Leandro, Adriano; Hobert, Marc K.; Kramer, Sabine; Stein, Veronika M.; Tipold, Andrea] Univ Vet Med Hannover, Dept Small Anim Med & Surg, Hannover, Lower Saxony, Germany; [Wang-Leandro, Adriano; Tipold, Andrea] Ctr Syst Neurosci, Hannover, Lower Saxony, Germany; [Rohn, Karl] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, Hannover, Lower Saxony, Germany; [Wang-Leandro, Adriano] Univ Zurich, Vetsuisse Fac, Dept Diagnost & Clin Serv, Clin Diagnost Imaging, Zurich, Switzerland; [Stein, Veronika M.] Univ Bern, Div Clin Neurol, Dept Vet Clin Sci, Vetsuisse Fac, Bern, Switzerland		Wang-Leandro, A (corresponding author), Univ Vet Med Hannover, Dept Small Anim Med & Surg, Hannover, Lower Saxony, Germany.	awang@vetclinics.uzh.ch			German Research FoundationGerman Research Foundation (DFG) [FOR 1103, TI 309/4-2]; Gesellschaft der Freunde der Tierarztlichen Hochschule Hannover; Akademie fur Tiergesundheit	The present project was partly supported by the German Research Foundation (FOR 1103, project TI 309/4-2). The first author received financial support from the "Gesellschaft der Freunde der Tierarztlichen Hochschule Hannover" and the "Akademie fur Tiergesundheit".	Auriat AM, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00226; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bergknut N, 2013, VET J, V195, P282, DOI 10.1016/j.tvjl.2012.10.024; Bergknut N, 2012, JAVMA-J AM VET MED A, V240, P1300, DOI 10.2460/javma.240.11.1300; Bock P, 2013, BRAIN PATHOL, V23, P82, DOI 10.1111/j.1750-3639.2012.00617.x; Brisson BA, 2004, JAVMA-J AM VET MED A, V224, P1808, DOI 10.2460/javma.2004.224.1808; Chang Y, 2007, VET REC, V160, P795, DOI 10.1136/vr.160.23.795; Charles YP, 2015, ORTHOP TRAUMATOL-SUR, V101, pS31, DOI 10.1016/j.otsr.2014.06.024; Cheran S, 2011, J NEUROTRAUM, V28, P1881, DOI 10.1089/neu.2010.1741; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; Chun KS, 2016, ANN REHABIL MED-ARM, V40, P126, DOI 10.5535/arm.2016.40.1.126; Cooper JJ, 2014, VET RADIOL ULTRASOUN, V55, P182, DOI 10.1111/vru.12114; D'souza MM, 2017, INJURY, V48, P880, DOI 10.1016/j.injury.2017.02.016; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Elizei SS, 2017, NEURAL REGEN RES, V12, P385, DOI 10.4103/1673-5374.202933; Facon D, 2005, AM J NEURORADIOL, V26, P1587; Fakhoury M, 2015, REV NEUROSCIENCE, V26, P397, DOI 10.1515/revneuro-2015-0001; Fluehmann G, 2006, J SMALL ANIM PRACT, V47, P582, DOI 10.1111/j.1748-5827.2006.00106.x; Gamanagatti S, 2015, WORLD J RADIOL, V7, P253, DOI 10.4329/wjr.v7.i9.253; Griffin JF, 2013, J MAGN RESON IMAGING, V37, P632, DOI 10.1002/jmri.23862; Guan XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117707; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; HANSEN H J, 1952, Acta Orthop Scand Suppl, V11, P1; HANSEN HANS-JORGEN, 1951, ACTA ORTHOPAED SCAND, V20, P280, DOI 10.3109/17453675108991175; Hendrix P, 2015, CLIN ANAT, V28, P88, DOI 10.1002/ca.22349; Hobert MK, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-36; Jang SH, 2016, NEURAL REGEN RES, V11, P1527, DOI 10.4103/1673-5374.191230; Jazayeri SB, 2015, EUR SPINE J, V24, P905, DOI 10.1007/s00586-014-3424-6; Jeffery ND, 2006, SPINAL CORD, V44, P584, DOI 10.1038/sj.sc.3101912; Jeffery ND, 2013, J VET INTERN MED, V27, P1318, DOI 10.1111/jvim.12183; Jeffery ND, 2016, JAVMA-J AM VET MED A, V248, P386, DOI 10.2460/javma.248.4.386; Kim JH, 2010, J NEUROTRAUM, V27, P587, DOI 10.1089/neu.2009.1063; Krishna V, 2014, J NEUROTRAUM, V31, P215, DOI 10.1089/neu.2013.2982; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Lerner A, 2014, WORLD NEUROSURG, V82, P96, DOI 10.1016/j.wneu.2013.07.083; Levine JM, 2009, J VET INTERN MED, V23, P1220, DOI 10.1111/j.1939-1676.2009.0393.x; Levine JM, 2011, J NEUROTRAUM, V28, P675, DOI 10.1089/neu.2010.1645; MCKEE WM, 1992, VET REC, V130, P296, DOI 10.1136/vr.130.14.296; Moore SA, 2017, J NEUROTRAUM, V34, P2007, DOI 10.1089/neu.2016.4745; Olby N, 2004, J NEUROTRAUM, V21, P49, DOI 10.1089/089771504772695940; Oliveri RS, 2014, NEUROBIOL DIS, V62, P338, DOI 10.1016/j.nbd.2013.10.014; Patterson EE, 2014, ILAR J, V55, P182, DOI 10.1093/ilar/ilu021; Priester WA, 1976, THERIOGENOLOGY, V6, P293, DOI DOI 10.1016/0093-691X(76)90021-2; Raspa A, 2016, BIOTECHNOL BIOENG, V113, P253, DOI 10.1002/bit.25689; Santarelli X, 2010, MAGN RESON IMAGING, V28, P70, DOI 10.1016/j.mri.2009.05.046; Sasiadek MJ, 2012, MED SCI MONITOR, V18, pRA73; Scott HW, 1997, J SMALL ANIM PRACT, V38, P488, DOI 10.1111/j.1748-5827.1997.tb03303.x; Shah LM, 2017, NEUROSURG CLIN N AM, V28, P1, DOI 10.1016/j.nec.2016.08.006; Sharp NJH, 2005, SMALL ANIMAL SPINAL, V2nd, P121; Smith PM, 2006, BRAIN PATHOL, V16, P99, DOI 10.1111/j.1750-3639.2006.00001.x; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Spitzbarth I, 2011, J NEUROPATH EXP NEUR, V70, P703, DOI 10.1097/NEN.0b013e3182270f8e; Ulrich R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095917; van der Star BJ, 2012, CNS NEUROL DISORD-DR, V11, P570, DOI 10.2174/187152712801661284; Vedantam A, 2014, NEUROSURGERY, V74, P1, DOI 10.1227/NEU.0000000000000171; Vos SB, 2017, MAGN RESON MED, V77, P285, DOI 10.1002/mrm.26124; Wang F, 2014, NEUROREPORT, V25, P1386, DOI 10.1097/WNR.0000000000000278; Wang-Leandro A, 2017, SPINAL CORD, V55, P1108, DOI 10.1038/sc.2017.83; Wang-Leandro A, 2017, J VET INTERN MED, V31, P842, DOI 10.1111/jvim.14715; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yoon H, 2017, J NEUROTRAUM, V34, P3041, DOI 10.1089/neu.2016.4886; Yoon H, 2016, VET J, V215, P110, DOI 10.1016/j.tvjl.2016.03.018; Yoshioka H, 2017, J MATH IND, V7, DOI 10.1186/s13362-017-0040-1	64	4	5	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1479-5876			J TRANSL MED	J. Transl. Med.	SEP 17	2018	16								258	10.1186/s12967-018-1630-4			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GT9ZP	WOS:000444907200002	30223849	Green Published, gold			2022-02-06	
J	Carron, SF; Yan, EB; Allitt, BJ; Rajan, R				Carron, Simone F.; Yan, Edwin B.; Allitt, Benjamin J.; Rajan, Ramesh			Immediate and Medium-term Changes in Cortical and Hippocampal Inhibitory Neuronal Populations after Diffuse TBI	NEUROSCIENCE			English	Article						diffuse traumatic brain injury; neural injury; interneurons; inhibition; cortex; hippocampus; time course	TRAUMATIC BRAIN-INJURY; GABAERGIC CELL SUBTYPES; NEUROPEPTIDE-Y; RAT HIPPOCAMPUS; IMMUNOREACTIVE NEURONS; SYNAPTIC CONNECTIONS; SELECTIVE VULNERABILITY; NONPYRAMIDAL CELLS; GRANULE CELLS; ANIMAL-MODEL	Changes in inhibition following traumatic brain injury (TBI) appear to be one of the major factors that contribute to excitation:inhibition imbalance. Neuron pathology, interneurons in particular evolves from minutes to weeks post injury and follows a complex time course. Previously, we showed that in the long-term in diffuse TBI (dTBI), there was select reduction of specific dendrite-targeting neurons in sensory cortex and hippocampus while in motor cortex there was up-regulation of specific dendrite-targeting neurons. We now investigated the time course of dTBI effects on interneurons in neocortex and hippocampus. Brains were labeled with antibodies against calbindin (CB), parvalbumin (PV), calretinin (CR) neuropeptide Y (NPY), and somatostatin (SOM) at 24 h and 2 weeks post dTBI. We found time-dependent, brain area-specific changes in inhibition at 24 h and 2 weeks. At 24 h post-injury, reduction of dendrite-targeting inhibitory neurons occurred in sensory cortex and hippocampus. At 2 weeks, we found compensatory changes in the somatosensory cortex and CA2/3 of hippocampus affected at 24 h, with affected interneuronal populations returning to sham levels. However, DG of hippocampus now showed reduction of dendrite-targeting inhibitory neurons. Finally, with respect to motor cortex, there was an upregulation of dendrite-targeting interneurons in the supragranular layers at 24 h returning to normal levels by 2 weeks. Overall, our findings reconfirm that dendritic inhibition is particularly susceptible to brain trauma, but also show that there are complex brain-area-specific changes in inhibitory neuronal numbers and in compensatory changes, rather than a simple monotonic progression of changes post-dTBI. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Carron, Simone F.; Yan, Edwin B.; Allitt, Benjamin J.; Rajan, Ramesh] Monash Univ, Dept Physiol, Melbourne, Vic 3800, Australia		Carron, SF (corresponding author), Monash Univ, Dept Physiol, Melbourne, Vic 3800, Australia.	simone.carron@monash.edu; Edwin.yan@monash.edu; Ben.allitt@monash.edu; Ramesh.Rajan@monash.edu	rajan, ramesh/L-4842-2019	Rajan, Ramesh/0000-0001-9862-0520	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1029311]	The author would like thank Richard Gillies for assisting with immunohistochemistry. The work represented here was funded by the National Health and Medical Research Council of Australia Project Grant No. APP1029311.	ADRIAN TE, 1983, NATURE, V306, P584, DOI 10.1038/306584a0; Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Allitt BJ, 2016, J NEUROTRAUM, V33, P375, DOI 10.1089/neu.2015.3946; Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Alwis DS, 2016, J NEUROTRAUM, V33, P1084, DOI 10.1089/neu.2014.3774; Baglietto-Vargas D, 2010, J ALZHEIMERS DIS, V21, P119, DOI 10.3233/JAD-2010-100066; Barinka F, 2010, PHYSIOL RES, V59, P665, DOI 10.33549/physiolres.931930; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; Corvino V, 2012, J NEUROCHEM, V122, P415, DOI 10.1111/j.1471-4159.2012.07770.x; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; DEMEULEMEESTER H, 1989, NEUROSCI LETT, V99, P6, DOI 10.1016/0304-3940(89)90255-3; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Guitierrez A, 2010, ALZHEIMERS DEMENT, V6, pS213; Gulyas AI, 1996, HIPPOCAMPUS, V6, P525, DOI 10.1002/(SICI)1098-1063(1996)6:5<525::AID-HIPO5>3.0.CO;2-H; HENDRY SHC, 1984, P NATL ACAD SCI-BIOL, V81, P6526, DOI 10.1073/pnas.81.20.6526; HENDRY SHC, 1984, J NEUROSCI, V4, P2497; Hestrin S, 1996, J NEUROSCI, V16, P5290; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Isaacs KR, 2000, EXP NEUROL, V163, P311, DOI 10.1006/exnr.2000.7347; Johansen F F, 1989, J Neurosurg Anesthesiol, V1, P339, DOI 10.1097/00008506-198912000-00007; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; KATSUMARU H, 1988, EXP BRAIN RES, V72, P347; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; KOHLER C, 1982, NEUROSCI LETT, V34, P259, DOI 10.1016/0304-3940(82)90185-9; KUBOTA Y, 1994, JPN J PHYSIOL, V44, pS145; Kuruba R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024493; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Long LL, 2011, INT J NEUROSCI, V121, P69, DOI 10.3109/00207454.2010.530007; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Malva JO, 2012, NEUROPEPTIDES, V46, P299, DOI 10.1016/j.npep.2012.09.001; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martinez A, 1999, J COMP NEUROL, V404, P438, DOI 10.1002/(SICI)1096-9861(19990222)404:4<438::AID-CNE2>3.0.CO;2-K; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; MIETTINEN R, 1992, NEUROSCIENCE, V48, P29, DOI 10.1016/0306-4522(92)90335-Y; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; NITSCH R, 1990, ANAT EMBRYOL, V181, P413, DOI 10.1007/BF02433788; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Paxinos G, 1997, RAT BRAIN STEREOTAXI; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Qi GX, 2015, JOVE-J VIS EXP, DOI 10.3791/52358; RESIBOIS A, 1992, NEUROSCIENCE, V46, P101, DOI 10.1016/0306-4522(92)90012-Q; ROGERS JH, 1992, BRAIN RES, V587, P147, DOI 10.1016/0006-8993(92)91439-L; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schwarzer C, 1996, N-S ARCH PHARMACOL, V354, P67; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Soontornniyomkij V, 2012, NEUROSCI LETT, V516, P161, DOI 10.1016/j.neulet.2012.03.092; SPERK G, 1992, NEUROSCIENCE, V50, P831, DOI 10.1016/0306-4522(92)90207-I; Sun CS, 2007, J COMP NEUROL, V500, P876, DOI 10.1002/cne.21207; TOTH K, 1992, NEUROSCIENCE, V49, P793, DOI 10.1016/0306-4522(92)90357-8; Toth Z, 1997, J NEUROSCI, V17, P8106; Turner CP, 2007, BRAIN RES, V1128, P50, DOI 10.1016/j.brainres.2006.10.039; VOLTERRA A, 1994, ANN NY ACAD SCI, V738, P153; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xapelli Sara, 2006, Recent Pat CNS Drug Discov, V1, P315, DOI 10.2174/157488906778773689; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yenari MA, 2001, STROKE, V32, P1028, DOI 10.1161/01.STR.32.4.1028; Yi F, 2014, NEUROCHEM J+, V8, P306, DOI 10.1134/S1819712414040126	86	4	4	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 15	2018	388						152	170		10.1016/j.neuroscience.2018.07.020			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GS5SR	WOS:000443731300013	30036662				2022-02-06	
J	Lajarin-Cuesta, R; Arribas, RL; Nanclares, C; Garcia-Frutos, EM; Gandia, L; de los Rios, C				Lajarin-Cuesta, Rocio; Arribas, Raquel L.; Nanclares, Carmen; Garcia-Frutos, Eva M.; Gandia, Luis; de los Rios, Cristobal			Design and synthesis of multipotent 3-aminomethylindoles and 7-azaindoles with enhanced protein phosphatase 2A-activating profile and neuroprotection	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY			English	Article						Gramine; Multi-target strategy; PP2A; Ca2+ channels; Neuroprotection; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; TAU-PHOSPHORYLATION; CA2+ CHANNELS; NEURODEGENERATIVE DISEASES; GRAMINE DERIVATIVES; INDOLE-DERIVATIVES; OXIDATIVE STRESS; DIRECTED LIGANDS; RATIONAL DESIGN	We report the synthesis and pharmacological evaluation of new 3-aminomethylindoles derivatives with neuroprotective properties designed to present multi-target activity centered on reducing the neuronal Ca2+ overload and preventing phosphatase 2A (PP2A) inhibition, which are two important early physiophathological events observed in neurodegenerative scenarios. Chemical syntheses of proposed compounds were achieved in two straightforward reaction steps with high yields. Most of the compounds mitigated the okadaic acid-provoked inhibition of PP2A and protected SH-SY5Y cells against toxic stimuli related to Tau-hyperphosphorylation and oxidative stress, similarly to the observed in Alzheimer's disease (AD). In addition, some of them mitigated the Ca2+ overload induced by depolarization. The derivative 1-(1-benzyl-5-chloro-1H-indo1-3-y1)-N,N-dimethylmethanamine (19) outstood by its high recovery of the PP2A activity and blockade of voltage-gated Ca2+ channels, accompanied by good neuroprotective profile. These findings make this compound eligible for further preclinical assays with the goal of positioning new innovative drugs for the treatment of AD. (C) 2018 Elsevier Masson SAS. All rights reserved.	[Lajarin-Cuesta, Rocio; Arribas, Raquel L.; Nanclares, Carmen; Gandia, Luis; de los Rios, Cristobal] Univ Autonoma Madrid, Inst Fdn Teofilo Hernando, C Arzobispo Morcillo 4, Madrid 28029, Spain; [Lajarin-Cuesta, Rocio; Arribas, Raquel L.; Nanclares, Carmen; Gandia, Luis; de los Rios, Cristobal] Univ Autonoma Madrid, Dept Farmacol & Terapeut, C Arzobispo Morcillo 4, Madrid 28029, Spain; [Garcia-Frutos, Eva M.] CSIC, Inst Ciencia Mat Madrid, C Sor Juan Ines Cruz S-N, Madrid 28049, Spain; [de los Rios, Cristobal] Hosp Univ Princesa, Inst Invest Sanitaria, C Diego de Leon 62, Madrid 28006, Spain		de los Rios, C (corresponding author), Univ Autonoma Madrid, Inst Fdn Teofilo Hernando, C Arzobispo Morcillo 4, Madrid 28029, Spain.; de los Rios, C (corresponding author), Univ Autonoma Madrid, Dept Farmacol & Terapeut, C Arzobispo Morcillo 4, Madrid 28029, Spain.	cristobal.delosrios@inv.uam.es	de los Rios, Cristobal/AAV-2315-2020; GANDIA, LUIS/L-2889-2013; de los Rios, Cristobal/E-9386-2010	GANDIA, LUIS/0000-0001-9597-8519; de los Rios, Cristobal/0000-0002-6456-7589	Proyectos de Investigacion en Salud (IS Carlos III) [PI13/00789, PI16/01041]; Proyectos de Investigacion en Salud - FEDER; Ministerio de Economia y Competitividad, Spain [SAF2016/78892-R]; Universidad Autonoma de Madrid (UAM); Comunidad de Madrid (Youth Employment Initiative)Comunidad de Madrid	This work was supported by the following grants: Proyectos de Investigacion en Salud (PI13/00789 and PI16/01041, IS Carlos III to C.d.I.R; co-funded by FEDER) and SAF2016/78892-R (Ministerio de Economia y Competitividad, Spain, to L.G.). R.L.C and R.L.A thank Universidad Autonoma de Madrid (UAM) for predoctoral fellowships. C.N. thanks Comunidad de Madrid for postdoctoral fellowships (Youth Employment Initiative). We thank the continued support of Prof. Antonio G. Garcia (UAM) and Fundacion Teofilo Hernando (Madrid, Spain).	Alam S, 2017, ACS CHEM NEUROSCI, V8, P1823, DOI 10.1021/acschemneuro.7b00270; Alonso E, 2017, ACS CHEM NEUROSCI, V8, P1358, DOI 10.1021/acschemneuro.7b00012; [Anonymous], 2016, LANCET, V388, P2713, DOI 10.1016/S0140-6736(16)32457-6; Arif M, 2014, P NATL ACAD SCI USA, V111, P1144, DOI 10.1073/pnas.1322614111; Arribas RL, 2018, BRIT J PHARMACOL, V175, P3220, DOI 10.1111/bph.14365; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bachurin SO, 2017, SCI REP-UK, V7, DOI 10.1038/srep45627; Bahn S, 2010, CHEM-EUR J, V16, P3590, DOI 10.1002/chem.200903144; Bassaco MM, 2014, RSC ADV, V4, P60785, DOI 10.1039/c4ra11571f; Berridge MJ, 2014, J PHYSIOL-LONDON, V592, P281, DOI 10.1113/jphysiol.2013.257527; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Cai P, 2017, ACS CHEM NEUROSCI, V8, P2496, DOI 10.1021/acschemneuro.7b00257; Cornec AS, 2017, J MED CHEM, V60, P5120, DOI 10.1021/acs.jmedchem.7b00475; de los Rios C, 2012, EXPERT OPIN THER PAT, V22, P853, DOI 10.1517/13543776.2012.701619; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dgachi Y, 2016, CHEMMEDCHEM, V11, P1318, DOI 10.1002/cmdc.201500539; Egea J, 2007, J NEUROCHEM, V102, P1842, DOI 10.1111/j.1471-4159.2007.04665.x; Evans DA, 2003, J AM CHEM SOC, V125, P10780, DOI 10.1021/ja036985c; Froldi G, 2004, PLANTA MED, V70, P373, DOI 10.1055/s-2004-818953; Garcia-Frutos EM, 2008, J AM CHEM SOC, V130, P9173, DOI 10.1021/ja8025399; Gauthier S, 2016, LANCET, V388, P2873, DOI 10.1016/S0140-6736(16)31275-2; Go ML, 2010, J MED CHEM, V53, P6838, DOI 10.1021/jm1002843; Gonzalez D, 2018, BIOORGAN MED CHEM, V26, P2551, DOI 10.1016/j.bmc.2018.04.019; Groschner K., BIOCH J, V318; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hong XH, 2017, ANGEW CHEM INT EDIT, V56, P3961, DOI 10.1002/anie.201612565; Jameel E, 2017, EUR J MED CHEM, V136, P36, DOI 10.1016/j.ejmech.2017.04.064; Jerabek J, 2017, EUR J MED CHEM, V127, P250, DOI 10.1016/j.ejmech.2016.12.048; Jung KJ, 2013, FREE RADICAL BIO MED, V61, P206, DOI 10.1016/j.freeradbiomed.2013.04.005; Kalev P, 2011, ANTI-CANCER AGENT ME, V11, P38, DOI 10.2174/187152011794941172; Kang S, 2013, J MED CHEM, V56, P4786, DOI 10.1021/jm4005048; Koh PO, 2012, J PINEAL RES, V52, P57, DOI 10.1111/j.1600-079X.2011.00918.x; Laha JK, 2016, CHEM COMMUN, V52, P4329, DOI 10.1039/c6cc00133e; Lajarin-Cuesta R, 2016, J MED CHEM, V59, P6265, DOI 10.1021/acs.jmedchem.6b00478; Lajarin-Cuesta R, 2016, EXPERT OPIN THER PAT, V26, P389, DOI 10.1517/13543776.2016.1135903; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; lqbal K., 2016, NEUROLOGY, V12, P15, DOI DOI 10.1038/NMEUR01.2015.225; Martinez-Sanz FJ, 2016, EUR J MED CHEM, V109, P114, DOI 10.1016/j.ejmech.2015.12.043; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; McAvoy Thomas, 2010, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1818s92; Medina M, 2015, EXPERT REV NEUROTHER, V15, P115, DOI 10.1586/14737175.2015.1000864; Medina M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00113; Medina M, 2013, MAR DRUGS, V11, P1656, DOI 10.3390/md11051656; Miranda S., 2007, OPEN ORG CHEM J, V1, P1; MORO MA, 1990, ANAL BIOCHEM, V185, P243, DOI 10.1016/0003-2697(90)90287-J; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P657, DOI 10.1038/nrd3842; Musella S, 2016, EUR J MED CHEM, V124, P773, DOI 10.1016/j.ejmech.2016.09.014; Na YM, 2003, EUR J MED CHEM, V38, P75, DOI 10.1016/S0223-5234(02)00005-3; Nakahata N, 1999, EUR J PHARMACOL, V382, P129, DOI 10.1016/S0014-2999(99)00591-9; Nepali K, 2017, EUR J MED CHEM, V127, P115, DOI 10.1016/j.ejmech.2016.12.039; NIEMEYER HM, 1984, BIOCHEM PHARMACOL, V33, P2973, DOI 10.1016/0006-2952(84)90596-3; Nimmrich V, 2013, BRIT J PHARMACOL, V169, P1203, DOI 10.1111/bph.12240; Nirogi R, 2017, J MED CHEM, V60, P1843, DOI 10.1021/acs.jmedchem.6b01662; Olgen S, 2011, CHEMOTHERAPY, V57, P1, DOI 10.1159/000317764; Orechoff A, 1935, BER DTSCH CHEM GES, V68, P436, DOI 10.1002/cber.19350680312; Palmieri A, 2010, ORG BIOMOL CHEM, V8, P1259, DOI 10.1039/b919891a; Park HJ, 2016, ANN CLIN TRANSL NEUR, V3, P769, DOI 10.1002/acn3.337; Perez EG, 2013, MEDCHEMCOMM, V4, P1166, DOI 10.1039/c3md00042g; Prati F, 2016, MOLECULES, V21, DOI 10.3390/molecules21040466; Pullagurla MR, 2003, BIOORG MED CHEM LETT, V13, P3355, DOI 10.1016/S0960-894X(03)00612-7; Rankovic Z, 2017, J MED CHEM, V60, P5943, DOI 10.1021/acs.jmedchem.6b01469; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; REEVE HL, 1994, EUR J NEUROSCI, V6, P943, DOI 10.1111/j.1460-9568.1994.tb00588.x; Romero A, 2010, J PINEAL RES, V49, P141, DOI 10.1111/j.1600-079X.2010.00778.x; Rosini M, 2016, FUTURE MED CHEM, V8, P697, DOI 10.4155/fmc-2016-0003; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Shaik JB, 2016, CHEM BIOL DRUG DES, V88, P43, DOI 10.1111/cbdd.12732; Sharifi A, 2001, MONATSH CHEM, V132, P875, DOI 10.1007/s007060170077; Shulda PK, 2015, BBA-PROTEINS PROTEOM, V1854, P269, DOI 10.1016/j.bbapap.2014.12.017; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Sun L, 2003, NEUROSCIENCE, V118, P1175, DOI 10.1016/S0306-4522(02)00697-8; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Ueda K, 1997, J NEUROCHEM, V68, P265; Voronkov M, 2011, FUTURE MED CHEM, V3, P821, DOI [10.4155/fmc.11.47, 10.4155/FMC.11.47]; Wang J, 2016, J ORG CHEM, V81, P10975, DOI 10.1021/acs.joc.6b02013; Wang XC, 2014, ACTA NEUROPATHOL, V127, P243, DOI 10.1007/s00401-013-1175-9; Wang Y, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-46; Wu PW, 2006, J AM CHEM SOC, V128, P14426, DOI 10.1021/ja064310e; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Yang TM, 2017, J MED CHEM, V60, P2745, DOI 10.1021/acs.jmedchem.6b01530; Yu LF, 2016, AM J PHYSIOL-CELL PH, V310, pC773, DOI 10.1152/ajpcell.00199.2015; Yu L, 2013, CHEM COMMUN, V49, P2368, DOI 10.1039/c3cc40389k; Zamponi GW, 2016, NAT REV DRUG DISCOV, V15, P19, DOI 10.1038/nrd.2015.5; Zhang MM, 2013, FEBS J, V280, P4739, DOI 10.1111/febs.12481	89	4	4	1	14	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0223-5234	1768-3254		EUR J MED CHEM	Eur. J. Med. Chem.	SEP 5	2018	157						294	309		10.1016/j.ejmech.2018.07.030			16	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Pharmacology & Pharmacy	GX1LY	WOS:000447480000022	30099252				2022-02-06	
J	Arikan, MK; Metin, B; Metin, SZ; Tulay, EE; Tarhan, N				Arikan, Mehmet Kemal; Metin, Baris; Metin, Sinem Zeynep; Tulay, Emine Elif; Tarhan, Nevzat			High Frequencies in QEEG Are Related to the Level of Insight in Patients With Schizophrenia	CLINICAL EEG AND NEUROSCIENCE			English	Article						schizophrenia; insight; qEEG; beta; gamma	TRAUMATIC BRAIN-INJURY; COGNITIVE INSIGHT; 1ST-EPISODE PSYCHOSIS; CORTICAL THICKNESS; ALZHEIMERS-DISEASE; SELF-AWARENESS; WORKING-MEMORY; EEG; POWER; OSCILLATIONS	Lack of insight is a neurocognitive problem commonly encountered in patients with psychotic disorders that negatively affects treatment compliance and prognosis. Measurement of insight is based on self-report scales, which are limited due to subjectivity. This study aimed to determine the correlation between resting state beta and gamma power in 23 patients with schizophrenia and insight. It was observed that as beta and gamma power measured via qualitative electroencephalography (qEEG) increased the level of insight decreased. Negative correlation was found in F3, C3, Cz for gamma activity and in F3 and C3 for beta activity. This finding indicates that resting state qEEG could be used to evaluate the level of insight in patients with schizophrenia.	[Arikan, Mehmet Kemal; Metin, Baris; Tarhan, Nevzat] Uskudar Univ, Fac Humanities Human & Social Sci, Dept Psychol, Istanbul, Turkey; [Metin, Sinem Zeynep; Tarhan, Nevzat] NPIstanbul Brain Hosp, Dept Psychiat, Istanbul, Turkey		Metin, B (corresponding author), Uskudar Univ, Dept Psychol, Haluk Turksoy Sok 14, Istanbul, Turkey.	baris.metin@uskudar.edu.tr	Tulay, Emine Elif/AAW-1048-2020; Tarhan, K. Nevzat/R-5911-2019; ARIKAN, Mehmet Kemal/AAH-6213-2020	Tulay, Emine Elif/0000-0003-0150-5476; Tarhan, K. Nevzat/0000-0002-6810-7096; 			AMADOR XF, 1991, SCHIZOPHRENIA BULL, V17, P113, DOI 10.1093/schbul/17.1.113; Andreasen N.C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Aron L, 2016, NATURE, V540, P207, DOI 10.1038/540207a; Barr MS, 2010, SCHIZOPHR RES, V121, P146, DOI 10.1016/j.schres.2010.05.023; Basar E, 2016, NEUROIMAGE-CLIN, V11, P106, DOI 10.1016/j.nicl.2016.01.015; Basar Erol, 2013, Dialogues Clin Neurosci, V15, P291; Basar Erol, 2013, Suppl Clin Neurophysiol, V62, P303; BasarEroglu C, 1996, INT J PSYCHOPHYSIOL, V24, P101, DOI 10.1016/S0167-8760(96)00051-7; Beck AT, 2004, SCHIZOPHR RES, V68, P319, DOI 10.1016/s0920-9964(03)00189-0; Buchy L, 2018, SCHIZOPHR RES, V193, P251, DOI 10.1016/j.schres.2017.06.048; Buchy L, 2016, SCHIZOPHR RES, V172, P16, DOI 10.1016/j.schres.2016.02.026; Chakraborty K., 2010, GER J PSYCHIAT, V13, P17; Clark SV, 2018, SCHIZOPHR RES, V193, P244, DOI 10.1016/j.schres.2017.06.043; DAVID AS, 1990, BRIT J PSYCHIAT, V156, P798, DOI 10.1192/bjp.156.6.798; Featherstone RE, 2015, ANN NY ACAD SCI, V1344, P12, DOI 10.1111/nyas.12745; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Headley DB, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00170; Lee Kwang-Hyuk, 2003, Cogn Neuropsychiatry, V8, P57, DOI 10.1080/713752240; Markova I., 2005, INSIGHT PSYCHIAT; McEvoy J. P., 2004, INSIGHT PSYCHOSIS, V2nd, P291; MCEVOY JP, 1989, J NERV MENT DIS, V177, P43, DOI 10.1097/00005053-198901000-00007; Mitra S, 2015, PSYCHIAT CLIN NEUROS, V69, P630, DOI 10.1111/pcn.12301; Pachou E, 2008, BRAIN TOPOGR, V21, P128, DOI 10.1007/s10548-008-0062-5; Poyraz BC, 2016, NORD J PSYCHIAT, V70, P528, DOI 10.1080/08039488.2016.1178328; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Snyder SM, 2006, J CLIN NEUROPHYSIOL, V23, P440, DOI 10.1097/01.wnp.0000221363.12503.78; Snyder SM, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.330; Thibodeau R, 2006, J ABNORM PSYCHOL, V115, P715, DOI 10.1037/0021-843X.115.4.715; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Uhlhaas Peter J, 2013, Dialogues Clin Neurosci, V15, P301; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Vohs JL, 2016, EXPERT REV NEUROTHER, V16, P1193, DOI 10.1080/14737175.2016.1199275; Wiffen Benjamin D R, 2010, Clin Schizophr Relat Psychoses, V4, P169, DOI 10.3371/CSRP.4.3.3; Williams S, 2010, J PSYCHIATR NEUROSCI, V35, P75, DOI 10.1503/jpn.100021	35	4	4	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	SEP	2018	49	5					316	320		10.1177/1550059418785489			5	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	GU9XO	WOS:000445710700004	29984595				2022-02-06	
J	Beadle, EJ; Ownsworth, T; Fleming, J; Shum, DHK				Beadle, Elizabeth Jane; Ownsworth, Tamara; Fleming, Jennifer; Shum, David H. K.			Relationship Between Neurocognitive Function and Self-Discrepancy After Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						awareness; cognition; executive functioning; identity change; self-concept; traumatic brain injury	AWARENESS DEFICITS; HEAD-INJURY; MEMORY; REHABILITATION; REFLECTIONS; DISEASE	Objective: Individuals with traumatic brain injury (TBI) often make unfavorable comparisons between their preinjury and postinjury selves. Although it is known that negative self-discrepancy is related to poorer emotional adjustment, the impact of neurocognitive function on self-discrepancy is unclear. This study aimed to investigate the relationship between current neurocognitive function (attention, memory, executive function, and self-awareness) and self-discrepancy after severe TBI. Design: Fifty-four adults with severe TBI were recruited from outpatient and community rehabilitation services and completed measures of self-discrepancy (Head Injury Semantic Differential Scale-III) and self-awareness (Awareness Questionnaire) and a battery of standardized tests of attention, memory, and executive functions. Results: More negative self-discrepancy was significantly associated with greater self-awareness (r = -0.40, P < .001) and better performance on tests of immediate memory (r = -0.43, P < .01), working memory (r = -0.35, P < .05), and verbal fluency (r = -0.34, P < .05). Self-awareness was the only neurocognitive factor significantly and uniquely related to self-discrepancy, accounting for 8.6% of the variance (P < .05). Furthermore, self-awareness was found to partially mediate the relationship between immediate memory and self-discrepancy. Conclusion: Better neurocognitive function is related to more negative self-discrepancy. These findings improve understanding of the process of identity reconstruction following TBI.	[Beadle, Elizabeth Jane; Ownsworth, Tamara; Shum, David H. K.] Griffith Univ, Menzies Hlth Inst Queensland, Sch Appl Psychol, Mt Gravatt, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Australia		Beadle, EJ (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia.	e.beadle@griffith.edu.au	Fleming, Jennifer/AAH-5108-2020; Ownsworth, Tamara/ABB-6961-2021; Shum, David H. K./A-3914-2008	Ownsworth, Tamara/0000-0003-1835-7094; Shum, David H. K./0000-0002-4810-9262	Centre for Research Excellence in Brain Recovery	Dr Beadle received a PhD scholarship funded by the Centre for Research Excellence in Brain Recovery.	Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Army Individual Test Battery, 1944, MAN DIR SCOR; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benton A., 1978, MULTILINGUAL APHASIA; BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Coste C, 2015, NEUROPSYCHOLOGIA, V71, P133, DOI 10.1016/j.neuropsychologia.2015.03.014; Curvis W, 2018, NEUROPSYCHOL REHABIL, V28, P142, DOI 10.1080/09602011.2016.1144515; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fleming J, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1758-6; Gracey F., 2012, THE SOCIAL CURE, P273; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P522, DOI 10.1080/09602010802141509; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hayes A.F., 2012, PROCESS VERSATILE CO; Helps Y, 2008, INJURY RES STAT SERI, V45; Huang J., 2014, UNDERSTANDING TRAUMA; Jones SJ., 2008, BRIT J OCCUP THER, V71, P44, DOI DOI 10.1177/030802260807100202; Levin H. S., 2014, UNDERSTANDING TRAUMA; Mograbi DC, 2009, CONSCIOUS COGN, V18, P989, DOI 10.1016/j.concog.2009.07.005; Naylor E, 2008, NEUROPSYCHOL REHABIL, V18, P590, DOI 10.1080/09602010701608681; Northoff G, 2011, CONSCIOUS COGN, V20, P52, DOI 10.1016/j.concog.2010.09.011; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-369; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Reddy A, 2017, NEUROPSYCHOL REHABIL, V27, P1103, DOI 10.1080/09602011.2015.1114499; Rosenberg M., 1965, SOC ADOLESCENT SELF; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STUSS D, 2001, FRONTAL LOBES NEUROP; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Tannenbaum P.H., 1957, MEASUREMENT MEANING; Toglia J, 2000, NEUROREHABILITATION, V15, P57; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432	51	4	4	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					E42	E50		10.1097/HTR.0000000000000360			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500006	29194178				2022-02-06	
J	Behrendt, F; Schuster-Amft, C				Behrendt, Frank; Schuster-Amft, Corina			Using an interactive virtual environment to integrate a digital Action Research Arm Test, motor imagery and action observation to assess and improve upper limb motor function in patients with neuromuscular impairments: a usability and feasibility study protocol	BMJ OPEN			English	Article						rehabilitation medicine; stroke; parkinson's disease; multiple sclerosis	HAND ACTIVITY INVENTORY; STROKE PATIENTS; BLOCK TEST; OUTCOME MEASURES; MENTAL PRACTICE; SAMPLE-SIZES; CHEDOKE ARM; RELIABILITY; VALIDITY; REALITY	Introduction In the recent past, training systems using an interactive virtual environment have been introduced to neurorehabilitation. Such systems can be applied to encourage purposeful limb movements and will increasingly be used at home by the individual patient. Therefore, an integrated valid and reliable assessment tool on the basis of such a system to monitor the recovery process would be an essential asset. Objectives The aim of the study is to evaluate usability, feasibility and validity of the digital version of the Action Research Arm Test using the Bi-Manu-Trainer system as a platform. Additionally, the feasibility and usability of the implementation of action observation and motor imagery tasks into the Bi-Manu-Trainer software will be evaluated. Patients and methods This observational study is planned as a single-arm trial for testing the new assessment and the action observation and motor imagery training module. Therefore, 75 patients with Parkinson's disease, multiple sclerosis, stroke, traumatic brain injury or Guillain-Barre syndrome will be included. 30 out of the 75 patients will additionally take part in a 4-week training on the enhanced Bi-Manu-Trainer system. Primary outcomes will be the score on the System Usability Scale and the correlation between the conventional and digital Action Research Arm Test scores. Secondary outcomes will be hand dexterity, upper limb activities of daily living and quality of life. Hypothesis We hypothesise that the digital Action Research Arm Test assessment is a valid and essential tool and that it is feasible to incorporate action observation and motor imagery into Bi-Manu-Trainer practice. The results are expected to give recommendations for necessary modifications and might also contribute knowledge concerning the application of action observation and motor imagery tasks using a training system such as the Bi-Manu-Trainer.	[Behrendt, Frank; Schuster-Amft, Corina] Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland; [Behrendt, Frank] Univ Childrens Hosp Basel, Basel, Switzerland; [Schuster-Amft, Corina] Bern Univ Appl Sci, Inst Rehabil & Performance Technol, Burgdorf, Switzerland; [Schuster-Amft, Corina] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland		Behrendt, F (corresponding author), Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland.; Behrendt, F (corresponding author), Univ Childrens Hosp Basel, Basel, Switzerland.	f.behrendt@reha-rhf.ch	Coish, Elizabeth/AAU-1245-2020; Schuster, Corina/B-6939-2008	Schuster-Amft, Corina/0000-0003-1120-4423; Behrendt, Frank/0000-0001-6967-0000	Commission for Technology and Innovation CTI (Bern, Switzerland) [18776.1PFLS-LS]	Commission for Technology and Innovation CTI (Bern, Switzerland) project no: 18776.1PFLS-LS.	Badarny S, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8V69GM4; Bangor A, 2009, J USABILITY STUD, V4, P114; Barreca SR, 2006, PHYS THER, V86, P245, DOI 10.1093/ptj/86.2.245; Barreca SR, 2005, ARCH PHYS MED REHAB, V86, P1616, DOI 10.1016/j.apmr.2005.03.017; Barreca Susan, 2004, Top Stroke Rehabil, V11, P31; Battaglia PJ, 2014, J MANIP PHYSIOL THER, V37, P190, DOI 10.1016/j.jmpt.2013.12.010; Braun S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00390; Brooke J., 1996, USABILITY EVALUATION, P189; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Celnik P, 2008, STROKE, V39, P1814, DOI 10.1161/STROKEAHA.107.508184; Cho HY, 2013, CLIN REHABIL, V27, P675, DOI 10.1177/0269215512464702; Clare HA, 2003, J MANIP PHYSIOL THER, V26, P476, DOI 10.1016/S0161-4754(03)00104-0; Connell LA, 2012, ARCH PHYS MED REHAB, V93, P221, DOI 10.1016/j.apmr.2011.09.015; Connelly Lynne M, 2008, Medsurg Nurs, V17, P411; Cramer GD, 2010, J MANIP PHYSIOL THER, V33, P220, DOI 10.1016/j.jmpt.2010.01.009; Cromwell F, 1965, OCCUPATIONAL THERAPI, P29; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; De Weerdt WJG., 1985, PHYSIOTHER CAN, V37, P65, DOI DOI 10.3138/PTC.37.2.065; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Del Din S, 2011, IEEE ENG MED BIO, P5839, DOI 10.1109/IEMBS.2011.6091444; DESROSIERS J, 1994, ARCH PHYS MED REHAB, V75, P751; Dijkerman HC, 2004, CLIN REHABIL, V18, P538, DOI 10.1191/0269215504cr769oa; Eftekharsadat B, 2015, NEUROL RES, V37, P539, DOI 10.1179/1743132815Y.0000000013; Eng K, 2007, MED BIOL ENG COMPUT, V45, P901, DOI 10.1007/s11517-007-0239-1; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Ferguson L., 2009, J PAIN, V10, pS73, DOI [DOI 10.1016/J.JPAIN.2009.01.258, 10.1016/j.jpain.2009.01.258]; GEISSER ME, 1994, PAIN, V59, P79, DOI 10.1016/0304-3959(94)90050-7; Guy W, 1976, ECDEU ASSESSMENT MAN, P218; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; Hester T, 2006, USING WEARABLE SENSO, P1; Hobart JC, 2012, J NEUROL, V259, P2681, DOI 10.1007/s00415-012-6570-y; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hosseini SA, 2012, J NEUROL SCI, V322, P263, DOI 10.1016/j.jns.2012.07.030; Houweling T, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0032-9; Hsieh CL, 1998, AGE AGEING, V27, P107, DOI 10.1093/ageing/27.2.107; Hsieh YW, 2009, STROKE, V40, P1386, DOI 10.1161/STROKEAHA.108.530584; Hsueh IP, 2002, CLIN REHABIL, V16, P617, DOI 10.1191/0269215502cr530oa; Ietswaart M, 2011, BRAIN, V134, P1373, DOI 10.1093/brain/awr077; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Julious SA, 2004, PHARM STAT, V3, P213, DOI 10.1002/pst.125; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Koo TK, 2011, J MANIP PHYSIOL THER, V34, P584, DOI 10.1016/j.jmpt.2011.05.009; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Lewis GN, 2011, DISABIL REHABIL-ASSI, V6, P453, DOI 10.3109/17483107.2011.574310; Lin KC, 2010, J REHABIL RES DEV, V47, P563, DOI 10.1682/JRRD.2009.09.0155; Lotze M, 2006, COGN BEHAV NEUROL, V19, P135, DOI 10.1097/01.wnn.0000209875.56060.06; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Merians Alma S, 2011, J Diabetes Sci Technol, V5, P301; Mirelman A, 2013, MOVEMENT DISORD, V28, P1597, DOI 10.1002/mds.25670; Mirelman A, 2011, J GERONTOL A-BIOL, V66, P234, DOI 10.1093/gerona/glq201; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Owens EF, 2004, J MANIP PHYSIOL THER, V27, P155, DOI 10.1016/j.jmpt.2003.12.019; Page SJ, 2005, NEUROREHAB NEURAL RE, V19, P27, DOI 10.1177/1545968304272701; Patel S, 2010, P IEEE, V98, P450, DOI 10.1109/JPROC.2009.2038727; Peres S. C., 2013, P HUM FACT ERG SOC A, P192, DOI [10.1177/1541931213571043, DOI 10.1177/1541931213571043]; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; Pinto EB, 2011, ARQ NEURO-PSIQUIAT, V69, P320, DOI 10.1590/S0004-282X2011000300010; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Porro CA, 2007, NEUROPSYCHOLOGIA, V45, P3114, DOI 10.1016/j.neuropsychologia.2007.06.016; Roalf DR, 2013, ALZHEIMERS DEMENT, V9, P529, DOI 10.1016/j.jalz.2012.10.001; Russell BS, 2012, J CHIROPR MED, V11, P145, DOI 10.1016/j.jcm.2012.02.002; Sakamoto M, 2009, NEUROSCI RES, V65, P23, DOI 10.1016/j.neures.2009.05.003; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Salter K, 2005, DISABIL REHABIL, V27, P315, DOI 10.1080/09638280400008545; Sauro J, 2011, MEASURING USABILITY; Schuster C, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-106; Schuster-Amft C, 2018, EFFECT 4 WEEK VIRTUA; Schuster-Amft C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-350; Song GB, 2015, J PHYS THER SCI, V27, P2057, DOI 10.1589/jpts.27.2057; Stefan K, 2005, J NEUROSCI, V25, P9339, DOI 10.1523/JNEUROSCI.2282-05.2005; Stephen Isaac WBM, 1995, HDB RES EVALUATION C; van Belle G, 2008, STATUS REV REPORT BL, P1; Villiger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072403; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WILLIAMS ME, 1982, J CHRON DIS, V35, P115, DOI 10.1016/0021-9681(82)90112-6; Wolfs CAG, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-33; Yozbatiran N, 2008, NEUROREHAB NEURAL RE, V22, P78, DOI 10.1177/1545968307305353	82	4	4	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	SEP	2018	8	7							e019646	10.1136/bmjopen-2017-019646			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV5YI	WOS:000446181900024	30012780	gold, Green Published			2022-02-06	
J	Cambier, Z; Boissonnault, JS; Hetzel, SJ; Plack, MM				Cambier, Ziadee; Boissonnault, Jill S.; Hetzel, Scott J.; Plack, Margaret M.			Physical Therapist, Physical Therapist Assistant, and Student Response to Inappropriate Patient Sexual Behavior: Results of a National Survey	PHYSICAL THERAPY			English	Article							TRAUMATIC BRAIN-INJURY; HARASSMENT; PREVALENCE; PEOPLE; WOMEN	Background. A recent survey found that 84% of physical therapist, physical therapist assistant, and student respondents experienced inappropriate patient sexual behavior (IPSB) over their careers and 47% over the prior 12 months. Prevalence data justify consideration of how to address IPSB. Objective. The objective was to determine how physical therapist clinicians (used here to mean physical therapists, physical therapist assistants, and students) address IPSB and examine strategy impact. Design. The design was observational and cross-sectional. Methods. Several sections of the American Physical Therapy Association and selected education programs fielded the electronic survey. Respondents reported on the frequency and effect of IPSB response strategy. Response-strategy impact was tested for statistical significance. Open-ended comments were analyzed using qualitative methods. Results. Of 1027 respondents, 396 had experienced IPSB over the prior 12 months; 391 provided data on the frequency and effect of response strategies used. Common informal responses included distraction, ignoring IPSB, and altering treatment to avoid physical contact or being alone. Common formal responses included reporting the behavior within the facility and documenting the behavior. Successful strategies included distraction, avoidance, direct confrontation, behavioral contracts, transfer of care, and chaperone use. Experienced clinicians were more likely to be direct, whereas novice clinicians were more likely to engage in unsuccessful actions of ignoring and joking. Limitations. Limitations included self-report, clinician memory, and convenience sampling. Conclusions. The first findings in 20 years on physical therapist, physical therapist assistant, and student response to IPSB provide direction for the profession. Results indicate a need for clear workplace policies coupled with training for managers and supervisors to support clinicians in resolving IPSB. Policies on using behavioral contracts, chaperones, and transfer of care could empower staff to consider these successful options. Professional education and training for all physical therapy professionals on assertive communication and redirection strategies with IPSB appears warranted.	[Cambier, Ziadee] Swedish Med Ctr, 500 17th Ave,Suite 100, Seattle, WA 98122 USA; [Boissonnault, Jill S.] Shenandoah Univ, Sch Hlth Profess, Div Phys Therapy, Leesburg, VA USA; [Boissonnault, Jill S.] Univ Wisconsin, Dept Orthoped & Rehabil, Phys Therapy Program, Madison, WI USA; [Hetzel, Scott J.] Univ Wisconsin Madison, Dept Biostat & Med Informat, Madison, WI USA; [Plack, Margaret M.] George Washington Univ, Dept Hlth Human Funct & Rehabil Sci, Washington, DC USA		Cambier, Z (corresponding author), Swedish Med Ctr, 500 17th Ave,Suite 100, Seattle, WA 98122 USA.	ziadee@comcast.net	Cambier, Ziadee/AAD-4767-2020	Plack, Margaret/0000-0001-9929-9708	APTA Section on Women's Health	The APTA Section on Women's Health provided grant funding for this work.	Alagiakrishnan K, 2005, POSTGRAD MED J, V81, P463, DOI 10.1136/pgmj.2004.028043; Alderman N, 2001, BRAIN DAM B, P175; American Physical Therapy Association, 2010, PROF PHYS THER COR V; American Physical Therapy Association, 2010, COD ETH PHYS THER; Ang A.Y.-C., 2010, NZ J PHYSIOTHER, V38, P106; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Bardell A, 2011, INT PSYCHOGERIATR, V23, P1182, DOI 10.1017/S1041610211000676; Bezeau SC, 2004, BRAIN INJURY, V18, P299, DOI 10.1080/02699050310001617398; BINGHAM SG, 1993, SEX ROLES, V29, P239, DOI 10.1007/BF00289938; Boissonnault JS, 2017, PHYS THER, V97, P1084, DOI 10.1093/ptj/pzx086; Bradburn N.M., 2004, ASKING QUESTIONS DEF, V1st; Bratuskins PA, 2013, MED J AUSTRALIA, V199, P454, DOI 10.5694/mja12.11855; Bronner G, 2003, J ADV NURS, V42, P637, DOI 10.1046/j.1365-2648.2003.02667.x; Bronner Gila, 2015, Handb Clin Neurol, V130, P297, DOI 10.1016/B978-0-444-63247-0.00017-1; Bruckner J., 1997, PHYS THER MAG, V5, P46; Cambier Z., 2013, J PHYS THER ED, V27, P7; Cipriani G, 2016, PSYCHOGERIATRICS, V16, P145, DOI 10.1111/psyg.12143; Cogin Julie, 2009, J Health Organ Manag, V23, P442; Creswell J.W ., 2007, QUAL INQ; Cummings N, 1992, J Am Coll Health, V40, P183; deMayo RA, 1997, PHYS THER, V77, P739, DOI 10.1093/ptj/77.7.739; Denzin N, HDB QUALITATIVE RES, P1194; Duncan S M, 2001, Can J Nurs Res, V32, P57; Erdreich B, 1994, SEXUAL HARASSMENT FE; Fallahi Khoshknab Masoud, 2015, Int J Community Based Nurs Midwifery, V3, P156; Firestone JM, 2003, GEND WORK ORGAN, V10, P42, DOI 10.1111/1468-0432.00003; Fowler F. J., 1995, IMPROVING SURVEY QUE, V38; GRAUERHOLZ E, 1989, SEX ROLES, V21, P789, DOI 10.1007/BF00289809; Greene DM, 1998, PSYCHOL WOMEN QUART, V22, P589, DOI 10.1111/j.1471-6402.1998.tb00179.x; Guba EG., 1989, 4 GENERATION EVALUAT; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; Higgins Agnes, 2004, Br J Nurs, V13, P1330; Higgins A, 2009, J ADV NURS, V65, P616, DOI 10.1111/j.1365-2648.2008.04899.x; HOLM S, 1979, SCAND J STAT, V6, P65; Ibrahim Chady, 2014, Psychiatr Danub, V26 Suppl 1, P36; Johnson C, 2006, BRAIN INJURY, V20, P687, DOI 10.1080/02699050600744137; Joller P, 2013, CAN FAM PHYSICIAN, V59, P255; Kamel Hosam K, 2004, J Am Med Dir Assoc, V5, pS48, DOI 10.1016/S1525-8610(04)70093-6; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kettl P, 1993, J Psychosoc Nurs Ment Health Serv, V31, P11; Kisa Adnan, 2002, J Health Soc Policy, V15, P77, DOI 10.1300/J045v15n01_05; Knight C, 2008, NEUROPSYCHOL REHABIL, V18, P129, DOI 10.1080/09602010701822381; KUZEL AJ, 1992, RES METH PR, V3, P31; Lawrie Barbara, 2004, Rehabil Nurs, V29, P9; Levin Karen, 2006, S Afr J Commun Disord, V53, P5; McComas J, 1995, Physiother Can, V47, P127; MCCOMAS J, 1993, PHYS THER, V73, P762, DOI 10.1093/ptj/73.11.762; Merriam S. B., 2002, QUALITATIVE RES PRAC; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Murphy Kathryn, 2015, Nursing, V45, P53, DOI 10.1097/01.NURSE.0000466448.57925.9a; O'Sullivan V, 1999, Physiother Res Int, V4, P28; Pennington A, 2000, J Dent Hyg, V74, P288; Raymond B, 1997, PT MAGAZINE PHYS THE, V5, P42; Robinson Karen M, 2003, Home Healthc Nurse, V21, P43, DOI 10.1097/00004045-200301000-00010; Rosen T, 2010, J AM GERIATR SOC, V58, P1970, DOI 10.1111/j.1532-5415.2010.03064.x; Rowe L, 2009, GEN PRACTICE SAFE PL; Sarnquist C, 2014, PEDIATRICS, V133, pE1226, DOI 10.1542/peds.2013-3414; Schlund MW, 1999, BRAIN INJURY, V13, P889; Schneider J., 1999, OCCUP THER INT, V6, P176, DOI [10.1002/oti.96, DOI 10.1002/OTI.96]; Series H., 2005, ADV PSYCHIAT TREATME, V11, P424, DOI DOI 10.1192/APT.11.6.424; Simpson G, SEXUALITY TRAUMATIC; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Weerakoon P., 1998, PHYSIOTHERAPY, V84, P491, DOI [10.1016/S0031-9406(05)65869-5, DOI 10.1016/S0031-9406(05)65869-5]; Williams TH, 1999, INT J LANG COMM DIS, V34, P99, DOI 10.1080/136828299247667; Zedeck S., 2011, APA HDB IND ORG PSYC, V3, P641, DOI DOI 10.1037/12171-018; Zook R, 2000, J Nurses Staff Dev, V16, P181, DOI 10.1097/00124645-200007000-00009	66	4	4	1	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	SEP	2018	98	9					804	814		10.1093/ptj/pzy067			11	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation	GS4AY	WOS:000443574500011	29893928	Bronze			2022-02-06	
J	Cinelli, I; Destrade, M; McHugh, P; Duffy, M				Cinelli, Ilaria; Destrade, Michel; McHugh, Peter; Duffy, Maeve			Effects of nerve bundle geometry on neurotrauma evaluation	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						coupled electromechanical modeling; diffuse axonal injury; electrothermal equivalence; finite element modeling; neurotrauma	TRAUMATIC BRAIN-INJURY; SPINAL-CORD AXONS; SQUID GIANT-AXON; WHITE-MATTER; MECHANICAL STRETCH; CORPUS-CALLOSUM; STRAIN; MICROENVIRONMENT; MYELINATION; MAGNITUDE	ObjectiveWe confirm that alteration of a neuron structure can induce abnormalities in signal propagation for nervous systems, as observed in brain damage. Here, we investigate the effects of geometrical changes and damage of a neuron structure in 2 scaled nerve bundle models, made of myelinated nerve fibers or unmyelinated nerve fibers. MethodsWe propose a 3D finite element model of nerve bundles, combining a real-time full electromechanical coupling, a modulated threshold for spiking activation, and independent alteration of the electrical properties for each fiber. With the inclusion of plasticity, we then simulate mechanical compression and tension to induce damage at the membrane of a nerve bundle made of 4 fibers. We examine the resulting changes in strain and neural activity by considering in turn the cases of intact and traumatized nerve membranes. ResultsOur results show lower strain and lower electrophysiological impairments in unmyelinated fibers than in myelinated fibers, higher deformation levels in larger bundles, and higher electrophysiological impairments in smaller bundles. ConclusionWe conclude that the insulation sheath of myelin constricts the membrane deformation and scatters plastic strains within the bundle, that larger bundles deform more than small bundles, and that small fibers tolerate a higher level of elongation before mechanical failure.	[Cinelli, Ilaria; McHugh, Peter] Natl Univ Ireland, Discipline Biomed Engn, Galway, Ireland; [Destrade, Michel] NUI, Sch Math Stat & Ap, Galway, Ireland; [Duffy, Maeve] Natl Univ Ireland, Elect & Elect Engn, Galway, Ireland		Cinelli, I (corresponding author), Natl Univ Ireland, Discipline Biomed Engn, Galway, Ireland.	i.cinelli1@nuigalway.ie	McHugh, Peter Edward/AAR-2574-2021; Cinelli, Ilaria/AAR-8760-2020; Destrade, Michel/V-3718-2018	McHugh, Peter Edward/0000-0001-9147-3652; Cinelli, Ilaria/0000-0003-1302-1188; Destrade, Michel/0000-0002-6266-1221	Galway University Foundation; Power Electronics Research Centre; Biomechanics Research Centre	Galway University Foundation; Power Electronics Research Centre; Biomechanics Research Centre	ALVAREZ O, 1978, BIOPHYS J, V21, P1, DOI 10.1016/S0006-3495(78)85505-2; Andersen SSL, 2009, PROG NEUROBIOL, V88, P104, DOI 10.1016/j.pneurobio.2009.03.002; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bercury KK, 2015, DEV CELL, V32, P447, DOI 10.1016/j.devcel.2015.01.016; Bjornholm L, 2017, NEUROIMAGE, V152, P108, DOI 10.1016/j.neuroimage.2017.02.056; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Cinelli I, 2017, P ANN INT IEEE EMBS, P978, DOI 10.1109/EMBC.2017.8036989; Cinelli I, 2017, I IEEE EMBS C NEUR E, P513, DOI 10.1109/NER.2017.8008402; Cinelli I, 2018, IEEE T BIO-MED ENG, V65, P1373, DOI 10.1109/TBME.2017.2752258; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Durand D. M., 2000, BIOMEDICAL ENG HDB, DOI [10. 1201/9781420049510, DOI 10.1201/9781420049510]; Einziger PD, 2005, IEEE T BIO-MED ENG, V52, P1632, DOI 10.1109/TBME.2005.856031; El Hady A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7697; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gallant PE, 1997, J NEUROTRAUM, V14, P811, DOI 10.1089/neu.1997.14.811; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Heimburg T, 2014, J PHYS CONF SER, V558, DOI 10.1088/1742-6596/558/1/012018; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hosmane S, 2011, LAB CHIP, V11, P3888, DOI 10.1039/c1lc20549h; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Lajtha A, 2009, SPRINGER REFERENCE, V281, DOI [10. 1016/j. jns. 2009. 03. 019, DOI 10.1016/J.JNS.2009.03.019]; Liewald D, 2014, BIOL CYBERN, V108, P541, DOI 10.1007/s00422-014-0626-2; Lytton William W, 2017, Brain Inform, V4, P219, DOI 10.1007/s40708-017-0067-5; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Mohagheghian F, 2015, 2015 IEEE 35TH INTERNATIONAL CONFERENCE ON ELECTRONICS AND NANOTECHNOLOGY (ELNANO), P378; Mosgaard LD, 2015, SOFT MATTER, V11, P7899, DOI 10.1039/c5sm01519g; Mueller JK, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/5/051001; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Platkiewicz J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000850; Plonsey R., 1988, BIOELECTRICITY QUANT, DOI [10.1007/978-0-387-48865-3., DOI 10.1007/978-0-387-48865-3]; Rattay F., 2005, FUNCTIONAL ELECT STI, P122; Rattay F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079256; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Smith DH, 1999, J NEUROSCI, V19, P4263; Tahayori B, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065006; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yu N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002664; Zhang PC, 2001, NATURE, V413, P428, DOI 10.1038/35096578; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Ziegler G, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00003	50	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	SEP	2018	34	9							e3118	10.1002/cnm.3118			16	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematical & Computational Biology; Mathematics	GS9VM	WOS:000444075700013	29908048	Green Submitted			2022-02-06	
J	Dickson, JM; Wang, X; St John, AE; Lim, EB; Stern, SA; White, NJ				Dickson, J. Michael; Wang, Xu; St John, Alexander E.; Lim, Esther B.; Stern, Susan A.; White, Nathan J.			Damage Control Resuscitation Supplemented with Vasopressin in a Severe Polytrauma Model with Traumatic Brain Injury and Uncontrolled Internal Hemorrhage	MILITARY MEDICINE			English	Article							LIMITED RESUSCITATION; FLUID RESUSCITATION; SHOCK; BLOOD; OXYGENATION; PRESSURE; VOLUME; SWINE; RATS	Introduction: Traumatic brain injury (TBI) and hemorrhagic shock (HS) are the leading causes of traumatic death worldwide and particularly on the battlefield. They are especially challenging when present simultaneously (polytrauma), and clear blood pressure end points during fluid resuscitation are not well described for this situation. The goal of this study is to evaluate for any benefit of increasing blood pressure using a vasopressor on brain blood flow during initial fluid resuscitation in a swine polytrauma model. Materials and Methods: We used a swine polytrauma model with simultaneous TBI, femur fracture, and HS with uncontrolled noncompressible internal bleeding from an aortic tear injury. Five animals were assigned to each of three experimental groups (hydroxyethyl starch only [HES], HES + 0.4 U/kg vasopressin, and no fluid resuscitation [No Fluids]). Fluids were given as two 10 mL/kg boluses according to tactical field care guidelines. Primary outcomes were mean arterial blood pressure (MAP) and brain blood flow at 60 min. Secondary outcomes were blood flows in the heart, intestine, and kidney; arterial blood lactate level; and survival at 6 hr. Organ blood flow was measured using injection of colored microspheres. Results: Five animals were tested in each of the three groups. There was a statistically significant increase in MAP with vasopressin compared with other experimental groups, but no significant increase in brain blood flow during the first 60 min of resuscitation. The vasopressin group also exhibited greater total internal hemorrhage volume and rate. There was no difference in survival at 6 hours. Conclusion: In this experimental swine polytrauma model, increasing blood pressure with vasopressin did not improve brain perfusion, likely due to increased internal hemorrhage. Effective hemostasis should remain the top priority for field treatment of the polytrauma casualty with TBI.	[Dickson, J. Michael] Univ Washington, Dept Emergency Med, Sch Med, Seattle, WA 98195 USA; [Dickson, J. Michael] 18D 19th Special Forces Grp Airborne, Jb Lewis Mcchord, WA 98433 USA; [Wang, Xu; St John, Alexander E.; Lim, Esther B.; Stern, Susan A.; White, Nathan J.] Univ Washington, Dept Emergency Med, Box 359702 325 9th Ave, Seattle, WA 98104 USA; [Wang, Xu; St John, Alexander E.; Lim, Esther B.; Stern, Susan A.; White, Nathan J.] Harborview Med Ctr, Box 359702 325 9th Ave, Seattle, WA 98104 USA		Dickson, JM (corresponding author), Univ Washington, Dept Emergency Med, Sch Med, Seattle, WA 98195 USA.; Dickson, JM (corresponding author), 18D 19th Special Forces Grp Airborne, Jb Lewis Mcchord, WA 98433 USA.			St. John, Alexander/0000-0001-6418-8629; White, Nathan/0000-0002-3752-310X	USAMRMC-SOCOM [W81XWH-141-0020]	This work was supported by grant W81XWH-141-0020 from USAMRMC-SOCOM.	Bein B, 2005, EUR J ANAESTH, V22, P62, DOI 10.1017/S026502150500013X; Brotfain E, 2012, SHOCK, V38, P630, DOI 10.1097/SHK.0b013e318272d59f; Chatrath Veena, 2015, J Anaesthesiol Clin Pharmacol, V31, P308, DOI 10.4103/0970-9185.161664; Cherkas David, 2011, Emerg Med Pract, V13, P1; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; Duan CY, 2015, INT J CLIN EXP MED, V8, P11645; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Jansen JO, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1778; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Ponschab M, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0114-9; Ramasamy A, 2008, J TRAUMA, V65, P910, DOI 10.1097/TA.0b013e3181848cf6; Rasmussen TE, 2015, ARMY AL T MAGAZINE, P80; Riberholt CG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154831; Risk Gregory, 2009, J Spec Oper Med, V9, P14; Stadlbauer KH, 2007, CRIT CARE, V11, DOI 10.1186/cc5977; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Westermann I, 2007, SHOCK, V28, P644, DOI 10.1097/shk.0b013e3180cab33f; White NJ, 2014, SHOCK, V42, P456, DOI 10.1097/SHK.0000000000000238; White NJ, 2013, SHOCK, V39, P210, DOI 10.1097/SHK.0b013e31827fd62b; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408	30	4	4	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2018	183	9-10					E460	E466		10.1093/milmed/usy001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8XG	WOS:000443018900035	29547998	Bronze			2022-02-06	
J	Elswick, CM; Wyrick, D; Gurien, LA; Rettiganti, M; Gowen, M; Pownall, A; Bahgat, D; Maxson, RT; Ocal, E; Alber, GW				Elswick, Clay M.; Wyrick, Deidre; Gurien, Lori A.; Rettiganti, Malik; Gowen, Marie; Pownall, Ambre; Bahgat, Diaa; Maxson, R. Todd; Ocal, Eylem; Alber, Gregory W.			Resource utilization and indications for helicopter transport of head-injured children	JOURNAL OF PEDIATRIC SURGERY			English	Article						Helicopter transport; Traumatic brain injury; Pediatric trauma	EMERGENCY MEDICAL-SERVICES; SCENE TRANSPORT; TRAUMA PATIENTS; SURVIVAL	Introduction: Helicopter emergency medical services (HEMS) have provided benefit for severely injured patients. However, HEMS are likely overused for the transportation of both adult and pediatric trauma patients. In this study, we aim to evaluate the degree of overuse of helicopter as a mode of transport for head-injured children. In addition, we propose criteria that can be used to determine if a particular patient is suitable for air versus ground transport. Materials and methods: We identified patients who were transported to our facility for head injuries. We included only those patients who were transported from another facility and who were seen by the neurosurgical service. We recorded a number of data points including age, gender, race, Glasgow Coma Score (GCS), and intubation status. We also collected data on a number of imaging findings such as mass effect, edema, intracranial hemorrhage, and skull fractures. Patients undergoing emergent nonneurosurgical intervention were excluded. Results: Of the 373 patients meeting inclusion criteria, 116 (31.1%) underwent a neurosurgical procedure or died and were deemed appropriate for helicopter transport. The remaining 68.9% of patients survived their injuries without neurosurgical intervention and were deemed nonappropriate for helicopter transport. Multivariable logistic regression identified GCS 3-8 and/or presence of mass effect, edema, epidural hematoma (EDH), and open-depressed skull fracture as appropriate indications for helicopter transport. Conclusions: The majority of patients transported to our facility by helicopter survived their head injury without need for neurosurgical intervention. Only those patients meeting clinical (GCS 3-8) or radiographic (mass effect, edema, EDH, open-depressed skull fracture) criteria should be transported by air. (C) 2018 Elsevier Inc. All rights reserved.	[Elswick, Clay M.] Wayne State Univ, Dept Neurosurg, Detroit, MI USA; [Wyrick, Deidre; Maxson, R. Todd] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Div Surg, Little Rock, AR 72205 USA; [Wyrick, Deidre; Maxson, R. Todd] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA; [Gurien, Lori A.] Univ Florida, Coll Med Jacksonville, Dept Surg, Jacksonville, FL USA; [Rettiganti, Malik; Gowen, Marie] Univ Arkansas Med Sci, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Pownall, Ambre; Ocal, Eylem; Alber, Gregory W.] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Div Neurosurg, Little Rock, AR 72205 USA; [Pownall, Ambre; Bahgat, Diaa; Ocal, Eylem; Alber, Gregory W.] Univ Arkansas Med Sci, Dept Neurosurg, Little Rock, AR 72205 USA; [Bahgat, Diaa] Univ Arkansas Med Sci, John L McClellan Mem Vet Hosp, Div Neurosurg, Little Rock, AR 72205 USA		Alber, GW (corresponding author), Arkansas Childrens Hosp, Div Neurosurg, 1 Childrens Way,Slot 838, Little Rock, AR 72202 USA.	galbert2@uams.edu					Bekelis K, 2015, ANN SURG, V261, P579, DOI 10.1097/SLA.0000000000000672; Bledsoe BE, 2006, J TRAUMA, V60, P1257, DOI 10.1097/01.ta.0000196489.19928.c0; Brown JB, 2016, J TRAUMA ACUTE CARE, V80, P702, DOI 10.1097/TA.0000000000000971; Delgado MK, 2013, ANN EMERG MED, V62, P351, DOI 10.1016/j.annemergmed.2013.02.025; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Knofsky M, 2013, J TRAUMA ACUTE CARE, V74, P917, DOI 10.1097/TA.0b013e31827e19a4; Missios S, 2014, J NEUROTRAUM, V31, P1321, DOI 10.1089/neu.2014.3325; Plevin RE, 2011, CURR OPIN CRIT CARE, V17, P596, DOI 10.1097/MCC.0b013e32834c5655; Polites SF, 2017, INJURY, V48, P1000, DOI 10.1016/j.injury.2016.12.010; Rose MK, 2012, AM SURGEON, V78, P794; Vercruysse GA, 2015, J TRAUMA ACUTE CARE, V78, P510, DOI 10.1097/TA.0000000000000553	11	4	4	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	SEP	2018	53	9					1795	1799		10.1016/j.jpedsurg.2018.04.032			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	GR5FS	WOS:000442653100028	29792280				2022-02-06	
J	Fiorin, FD; Santo, CCD; Santos, ARS; Fighera, MR; Royes, LFF				Fiorin, Fernando da Silva; do Espirito Santo, Caroline Cunha; Soares Santos, Adair Roberto; Fighera, Michele Rechia; Freire Royes, Luiz Fernando			Implication of surgical procedure in the induction of headache and generalized painful sensation in a fluid percussion injury model in rats	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Fluid percussion injury; Periorbital allodynia; Headache; Surgical procedure; Thermal hyperalgesia	TRAUMATIC BRAIN-INJURY; SENSORY INNERVATION; ALLODYNIA; STIMULATION; MIGRAINE	Background: This study demonstrated the effects of traumatic brain injury (TBI) and each step of the surgical procedure for a fluid percussion injury (FPI) model on periorbital allodynia. New method: Adult male Wistar rats were divided in naive, incision, scraping, sham-TBI and TBI groups. Periorbital allodynia was evaluated using von Frey filaments, and heat hyperalgesia of the hindpaws was evaluated by a Plantar Test Apparatus. Results: The statistical analyses revealed that the surgical procedure decreased von Frey filaments thresholds twenty-four hours after the surgery in all groups when compared to the naive group (p < 0.0001). Scraping, sham-TBI and TBI groups showed a decrease in the periorbital mechanical threshold for 35 days compared with the naive and incision groups (p < 0.0001). Only the TBI group demonstrated a significant difference in periorbital allodynia at 45 and 60 days after the injury (p < 0.01). A significant decrease in the thermal withdrawal latency of the hindpaw contralateral to the lesion was observed in the TBI group compared with the naive group at 7 days and 28 days after the lesion (p < 0.05). Comparison with existing methods: This study presented in detail the effects of each stage of the surgical procedure for a FPI model on periorbital allodynia over time and characterized the TBI model for this evaluation. Conclusion: The FPI model is relevant for the study of headache and generalized pain in both acute and chronic phases after an injury.	[Fiorin, Fernando da Silva; do Espirito Santo, Caroline Cunha; Soares Santos, Adair Roberto; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Catarina, Ctr Ciencias Biol, Programa Posgrad Neurocieneias, Florianopolis, SC, Brazil; [Fiorin, Fernando da Silva; do Espirito Santo, Caroline Cunha; Soares Santos, Adair Roberto] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Ciencias Fisiol, Lab Neurobiol Dor & Inflamacao, Florianopolis, SC, Brazil; [Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Lab Bioquim Exercicio, Santa Maria, RS, Brazil		Royes, LFF (corresponding author), Univ Fed Santa Catarina, Ctr Ciencias Biol, Programa Posgrad Neurocieneias, Florianopolis, SC, Brazil.; Royes, LFF (corresponding author), Univ Fed Santa Maria, Lab Bioquim Exercicio, Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Santos, Adair/C-5565-2013; da Silva Fiorin, Fernando/AAQ-9472-2021; Fighera, Michele R/J-9576-2014	Santos, Adair/0000-0002-6435-4698; da Silva Fiorin, Fernando/0000-0002-6517-7160; Fighera, Michele/0000-0002-3111-7530; do Espirito Santo, Caroline/0000-0001-8657-9532	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Programa de Apoio aos Nucleos de Excelencia (PRONEX-Project NENASC); Programa INCT-INOVAMED [465430/2014-7]; CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	The authors would like to acknowledge the financial support provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Programa de Apoio aos Nucleos de Excelencia (PRONEX-Project NENASC) and Programa INCT-INOVAMED (465430/2014-7). Fernando da Silva Fiorin and Caroline Cunha do Espirito Santo are recipients of CAPES fellowships. Adair RS Santos, Michele Rechia Fighera and Luiz Fernando Freire Royes are recipient of a productivity fellowship from CNPq.	Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Alder J., 2011, J VISUAL EXP JOVE, V54; Bree D., 2016, CEPHALALGIA; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 1998, J NEUROPHYSIOL, V79, P964, DOI 10.1152/jn.1998.79.2.964; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Fiorin FD, 2016, J NEUROTRAUM, V33, P1317, DOI 10.1089/neu.2015.4068; Flexman AM, 2010, CURR OPIN ANESTHESIO, V23, P551, DOI 10.1097/ACO.0b013e32833e15b9; Gerbatin R. R., 2016, MOL NEUROBIOL, P1; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kemp III W. J., 2011, SURG NEUROL INT, V2; Kosaras B, 2009, J COMP NEUROL, V515, P331, DOI 10.1002/cne.22049; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lucas S., 2014, CEPHALALGIA; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Maxwell CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015963; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meents JE, 2010, TRENDS MOL MED, V16, P153, DOI 10.1016/j.molmed.2010.02.004; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Old EA, 2015, HANDB EXP PHARMACOL, V227, P145, DOI 10.1007/978-3-662-46450-2_8; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Ossipov MH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/561761; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; SZOLCSANYI J, 1977, J PHYSIOL-PARIS, V73, P251; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; Wang ZJ, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0161-8; Zhao J, 2014, PAIN, V155, P1392, DOI 10.1016/j.pain.2014.04.019	37	4	4	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 1	2018	307						23	30		10.1016/j.jneumeth.2018.06.004			8	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GQ8ZN	WOS:000442055800004	29908224				2022-02-06	
J	Hohenberger, GM; Schwarz, AM; Maier, MJ; Grechenig, P; Dauwe, J; Grechenig, C; Krassnig, R; Gansslen, A; Weiglein, AH				Hohenberger, Gloria Maria; Schwarz, Angelika Maria; Maier, Marco Johannes; Grechenig, Peter; Dauwe, Jan; Grechenig, Christoph; Krassnig, Renate; Gaensslen, Axel; Weiglein, Andreas Heinrich			Safe zone for the posterior interosseous nerve with regard to the lateral and posterior approaches to the proximal radius	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Posterior interosseous nerve; Proximal radius fracture; Lateral approach radius; Posterior approach radius	ANATOMY; ANTERIOR; REPAIR; ELBOW	Purpose The posterior interosseous nerve (PIN) is at risk during the posterior and lateral approaches to the proximal radius. We aimed to define a safe zone for these approaches to avoid injury of the PIN and to evaluate their close and changing relationship to the nerve during forearm rotation. Methods The study collective consisted of 50 upper limbs. After performance of the lateral approach, the distance between the tip of the radial head and the PIN's exit point from the supinator (= distance 1) and the shortest interval between the nerve's exit to the radial margin of the ulna (= distance 2) were measured in maximum pronation and supination. Then, the dorsal approach was conducted and again distance 1 and the interval between the distal margin of the anconeus and the nerve's exit point (distance 2) were evaluated (pronation and supination). Results There were significantly shorter distances during supination in comparison to pronation. Regarding the lateral approach, distance 1 changed from a mean of 60.3 mm (supination) to 62.7 mm in pronation (p < 0.001). For the dorsal approach, distance 1 decreased significantly (p < 0.001) from 62.9 mm (pronation) to 60.2 mm (supination). Conclusion Supination during the lateral and dorsal approaches to the proximal radius needs to be avoided to protect the PIN. Furthermore, the nerve appeared at an interval between 45 and 84.1 mm (lateral approach) and 47.5-93 8 mm (dorsal approach), respectively. Therefore, care must be taken at this height during extension of the approaches in a distal direction.	[Hohenberger, Gloria Maria; Krassnig, Renate] Med Univ Graz, Dept Orthopaed & Trauma Surg, Auenbruggerpl 5, A-8036 Graz, Austria; [Schwarz, Angelika Maria] AUVA Trauma Hosp Graz, Gostinger Str 24, A-8020 Graz, Austria; [Grechenig, Peter; Grechenig, Christoph] Med Univ Graz, Auenbruggerpl 5, A-8036 Graz, Austria; [Dauwe, Jan] Univ Hosp Leuven, Dept Orthopaed Surg, Campus Pellenberg,Weligerveld 1, B-3212 Pellenberg, Belgium; [Gaensslen, Axel] Klinikum Wolfsburg, Trauma Dept, Sauerbruchstr 7, D-38440 Wolfsburg, Germany; [Weiglein, Andreas Heinrich] Med Univ Graz, Inst Anat, Harrachgasse 21, A-8010 Graz, Austria		Hohenberger, GM (corresponding author), Med Univ Graz, Dept Orthopaed & Trauma Surg, Auenbruggerpl 5, A-8036 Graz, Austria.	hohenberger.gloria@gmail.com	Dauwe, Jan/AAT-6852-2020; Maier, Marco J/E-6107-2012	Dauwe, Jan/0000-0003-4791-8663; Maier, Marco J/0000-0002-1715-7456			AO Foundation, 2017, AO SURG REF; Artico M, 2009, SURG RADIOL ANAT, V31, P101, DOI 10.1007/s00276-008-0412-8; Bhatia DN, 2016, SURG RADIOL ANAT, V38, P781, DOI 10.1007/s00276-016-1637-6; Diliberti T, 2000, J BONE JOINT SURG AM, V82A, P809, DOI 10.2106/00004623-200006000-00007; DUBERT T, 1990, Annales de Chirurgie de la Main et du Membre Superieur, V9, P15, DOI 10.1016/S0753-9053(05)80431-4; Elgafy H, 2000, J HAND SURG-AM, V25A, P930, DOI 10.1053/jhsu.2000.16359; Elgafy H, 2000, CLIN ORTHOP RELAT R, P242; Hackl M, 2015, INJURY, V46, P687, DOI 10.1016/j.injury.2015.01.028; Heidari N, 2011, SURG RADIOL ANAT, V33, P353, DOI 10.1007/s00276-010-0718-1; Hoppenfeld S, 2012, SURG EXPOSURES ORTHO, P122; Kelly EW, 2000, J BONE JOINT SURG AM, V82A, P1575, DOI 10.2106/00004623-200011000-00010; Loh YC, 1998, J BONE JOINT SURG BR, V80B, P629, DOI 10.1302/0301-620X.80B4.8478; Mekhail AO, 1996, J HAND SURG-AM, V21A, P794, DOI 10.1016/S0363-5023(96)80194-8; R Core Team, 2016, R LANG ENV STAT COMP; Raeburn K, 2015, SURG RADIOL ANAT, V37, P1155, DOI 10.1007/s00276-015-1487-7; Schimizzi A, 2009, J HAND SURG-AM, V34A, P1252, DOI 10.1016/j.jhsa.2009.04.026; Strauch R J, 1996, J Shoulder Elbow Surg, V5, P342, DOI 10.1016/S1058-2746(96)80064-4; Tejwani NC, 2007, J AM ACAD ORTHOP SUR, V15, P380, DOI 10.5435/00124635-200707000-00003; THIEL W, 1992, ANN ANAT, V174, P185, DOI 10.1016/S0940-9602(11)80346-8; Wada T, 1997, Handchir Mikrochir Plast Chir, V29, P129	20	4	4	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	SEP	2018	40	9			SI		1025	1030		10.1007/s00276-018-2004-6			6	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	GR6AZ	WOS:000442728000010	29619502				2022-02-06	
J	Honan, CA; Skromanis, S; Johnson, EG; Palmer, MA				Honan, Cynthia A.; Skromanis, Sarah; Johnson, Emma G.; Palmer, Matthew A.			Alcohol Intoxication Impairs Recognition of Fear and Sadness in Others and Metacognitive Awareness of Emotion Recognition Ability	EMOTION			English	Article						alcohol intoxication; emotion perception; facial expression; metacognition; social cognition	TRAUMATIC BRAIN-INJURY; FACIAL EXPRESSIONS; PERCEPTUAL CUES; DRINKING HISTORY; SOCIAL DRINKERS; CONSUMPTION; DEFICITS; CONFIDENCE; ACCURACY; ANGER	Alcohol intoxication is linked to negative social behaviors, but the mechanisms underlying this relationship are poorly understood. We investigated the effects of high-dose alcohol intoxication on the ability to perceive a range of basic emotions (sad, happy, anger, disgust, fear, and surprise) of different intensities, and on self-appraisals of emotion perception ability (i.e., metacognitive judgments). Sixtyfour participants consumed either an alcohol or placebo beverage. An emotion recognition task was used to assess emotion perception ability, and participants provided confidence ratings when providing each emotion recognition response. Alcohol-intoxicated individuals demonstrated a reduced ability to detect fear and sadness at moderate-to-high levels of emotion intensity and less overall insight into their ability to recognize emotions. These results provide new insights into the possible difficulties experienced by alcohol-intoxicated individuals in perceiving emotions in others and the limited capacity to monitor their emotion perception abilities, both of which may contribute to inappropriate social responding.	[Honan, Cynthia A.; Skromanis, Sarah; Palmer, Matthew A.] Univ Tasmania, Sch Med, Div Psychol, Launceston, Tas, Australia; [Johnson, Emma G.] Univ Sydney, Sch Psychol, Sydney, NSW, Australia		Honan, CA (corresponding author), Univ Tasmania, Div Psychol, Launceston, Tas 7250, Australia.	cynthia.honan@utas.edu.au	; Palmer, Matthew/J-7287-2014; Honan, Cynthia/O-6332-2017	Skromanis, Sarah/0000-0001-7981-7336; Palmer, Matthew/0000-0002-3467-3364; Honan, Cynthia/0000-0001-5735-4270; Johnson, Emma/0000-0002-2064-7130	Tasmania Police (Launceston); Australian Research CouncilAustralian Research Council [DP140103746]; School of Medicine, University of Tasmania	We thank Tasmania Police (Launceston) for their support and loan of breathalyzer equipment.; This work was supported by Australian Research Council Grant DP140103746 to Matthew A. Palmer and internal funding from the School of Medicine, University of Tasmania.	Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Attwood AS, 2009, J PSYCHOPHARMACOL, V23, P23, DOI 10.1177/0269881108089604; Attwood AS, 2014, J PSYCHOPHARMACOL, V28, P719, DOI 10.1177/0269881114536476; Attwood AS, 2009, PSYCHOPHARMACOLOGY, V204, P327, DOI 10.1007/s00213-009-1463-1; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; BARANSKI JV, 1994, PERCEPT PSYCHOPHYS, V55, P412, DOI 10.3758/BF03205299; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; BOTHWELL RK, 1987, J APPL PSYCHOL, V72, P691, DOI 10.1037/0021-9010.72.4.691; Bramham J, 2009, J NEUROPSYCHOL, V3, P125, DOI 10.1348/174866408X293994; Clements K, 2010, AGGRESS VIOLENT BEH, V15, P357, DOI 10.1016/j.avb.2010.06.004; COOPER ML, 1995, J PERS SOC PSYCHOL, V69, P990, DOI 10.1037/0022-3514.69.5.990; Craig LC, 2009, J PSYCHOPHARMACOL, V23, P258, DOI 10.1177/0269881108092126; Deffenbacher K.A., 1980, LAW HUMAN BEHAV, V4, P243, DOI [10.1007/bf01040617, DOI 10.1007/BF01040617, 10.1007/BF01040617]; Dolder PC, 2017, PSYCHOPHARMACOLOGY, V234, P41, DOI 10.1007/s00213-016-4431-6; Dry MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050977; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; Enders CK, 2011, REHABIL PSYCHOL, V56, P267, DOI 10.1037/a0025579; Felisberti F, 2015, HUM PSYCHOPHARM CLIN, V30, P384, DOI 10.1002/hup.2488; Fillmore MT, 2000, J STUD ALCOHOL, V61, P239, DOI 10.15288/jsa.2000.61.239; Fischer AH, 2007, J PERS SOC PSYCHOL, V93, P103, DOI 10.1037/0022-3514.93.1.103; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; GIGERENZER G, 1991, PSYCHOL REV, V98, P506, DOI 10.1037/0033-295X.98.4.506; Gorka SM, 2013, PSYCHOPHARMACOLOGY, V229, P141, DOI 10.1007/s00213-013-3090-0; HART JT, 1965, J EDUC PSYCHOL, V56, P208, DOI 10.1037/h0022263; Hertzog C, 2010, MEM COGNITION, V38, P771, DOI 10.3758/MC.38.6.771; Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333; Hoaken PNS, 2003, ADDICT BEHAV, V28, P1533, DOI 10.1016/j.addbeh.2003.08.033; Hooker CI, 2006, ORBITOFRONTAL CORTEX, P307, DOI [DOI 10.1093/ACPROF:OSO/9780198565741.003.0012, 10.1093/acprof:oso/9780198565741.001.0001/acprof-9780198565741-chapter-12]; JOSEPHS RA, 1990, J ABNORM PSYCHOL, V99, P115, DOI 10.1037/0021-843X.99.2.115; Kamboj SK, 2013, PSYCHOPHARMACOLOGY, V227, P31, DOI 10.1007/s00213-012-2940-5; Kano M, 2003, HUM PSYCHOPHARM CLIN, V18, P131, DOI 10.1002/hup.440; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; King AC, 2011, ARCH GEN PSYCHIAT, V68, P389, DOI 10.1001/archgenpsychiatry.2011.26; Koren D, 2006, SCHIZOPHRENIA BULL, V32, P310, DOI 10.1093/schbul/sbj035; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; Koriat A, 2004, J EXP PSYCHOL GEN, V133, P643, DOI 10.1037/0096-3445.133.4.643; Kornreich C, 2001, J STUD ALCOHOL, V62, P533, DOI 10.15288/jsa.2001.62.533; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Loeber S, 2009, ADDICTION, V104, P2013, DOI 10.1111/j.1360-0443.2009.02718.x; Marsh AA, 2007, EMOTION, V7, P239, DOI 10.1037/1528-3542.7.2.239; MARTIN CS, 1993, ALCOHOL CLIN EXP RES, V17, P140, DOI 10.1111/j.1530-0277.1993.tb00739.x; McDonald S, 2000, APHASIOLOGY, V14, P339, DOI 10.1080/026870300401397; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Padula CB, 2011, ALCOHOL ALCOHOLISM, V46, P547, DOI 10.1093/alcalc/agr066; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Palmer MA, 2017, MEMORY, V25, P1225, DOI 10.1080/09658211.2017.1282968; Palmer MA, 2013, J EXP PSYCHOL-APPL, V19, P55, DOI 10.1037/a0031602; Pearson, 2009, ADV CLIN SOLUTIONS W; Philippot P, 1999, ALCOHOL CLIN EXP RES, V23, P1031, DOI 10.1111/j.1530-0277.1999.tb04221.x; Rosenberg H, 2019, NEUROPSYCHOL REHABIL, V29, P232, DOI 10.1080/09602011.2016.1273118; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schirmer A, 2017, TRENDS COGN SCI, V21, P216, DOI 10.1016/j.tics.2017.01.001; SOBELL MB, 1986, ADDICT BEHAV, V11, P149, DOI 10.1016/0306-4603(86)90040-7; Sripada CS, 2011, NEUROIMAGE, V55, P371, DOI 10.1016/j.neuroimage.2010.11.062; STEELE CM, 1990, AM PSYCHOL, V45, P921, DOI 10.1037/0003-066X.45.8.921; TAYLOR SP, 1993, J STUD ALCOHOL, P78, DOI 10.15288/jsas.1993.s11.78; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V80, P86, DOI 10.1037//0022-3514.80.1.86; Toglia J, 2000, NEUROREHABILITATION, V15, P57; TUCKER JA, 1983, PSYCHOPHARMACOLOGY, V79, P215, DOI 10.1007/BF00427815; Valmas MM, 2014, ALCOHOL CLIN EXP RES, V38, P2998, DOI 10.1111/acer.12566; van Doorn EA, 2014, J EXP PSYCHOL GEN, V143, P980, DOI 10.1037/a0035226; Walter NT, 2011, ALCOHOL ALCOHOLISM, V46, P680, DOI 10.1093/alcalc/agr082; YANIV I, 1991, PSYCHOL BULL, V110, P611, DOI 10.1037/0033-2909.110.3.611	68	4	4	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1528-3542	1931-1516		EMOTION	Emotion	SEP	2018	18	6					842	854		10.1037/emo0000404			13	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	GR4NA	WOS:000442586900007	29265837				2022-02-06	
J	Humphries, DC; O'Neill, S; Scholefield, E; Dorward, DA; Mackinnon, AC; Rossi, AG; Haslett, C; Andrews, PJD; Rhodes, J; Dhaliwal, K				Humphries, Duncan C.; O'Neill, Stephen; Scholefield, Emma; Dorward, David A.; Mackinnon, Alison C.; Rossi, Adriano G.; Haslett, Christopher; Andrews, Peter J. D.; Rhodes, Jonathan; Dhaliwal, Kevin			Cerebral Concussion Primes the Lungs for Subsequent Neutrophil-Mediated Injury	CRITICAL CARE MEDICINE			English	Article						acid microaspiration; acute respiratory distress syndrome; concussion; inflammation; neutrophils; traumatic brain injury	TRAUMATIC BRAIN-INJURY; RESPIRATORY-DISTRESS-SYNDROME; TNF-ALPHA; MODEL; INFLAMMATION; RAT; TRANSPLANTATION; RESOLUTION; MOUSE; DEATH	Objectives: Mild traumatic brain injury in the form of concussion is extremely common, and the potential effects on pulmonary priming have been underestimated. The aim of this study was to characterize the pulmonary response following mild traumatic brain injury and assess the pulmonary susceptibility to lung injury after a subsequent innocuous pulmonary insult. Design: Experimental in vivo study. Setting: University research laboratory. Subjects: Male CD1 mice. Interventions: We developed a model of concussive traumatic brain injury in mice followed by pulmonary acid microaspiration. To assess the dependent role of neutrophils in mediating pulmonary injury, we specifically depleted neutrophils. Measurements and Main Results: Lateral fluid percussion to the brain resulted in neuronal damage and neutrophil infiltration as well as extensive pulmonary interstitial neutrophil accumulation but no alveolar injury. Following subsequent innocuous acid microaspiration, augmented alveolar neutrophil influx led to the development of pulmonary hemorrhage that was reduced following neutrophil depletion. Conclusions: This model shows for the first time that innocuous acid microaspiration is sufficient to induce neutrophil-mediated lung injury following mild concussion and that the extracranial effects of mild traumatic brain injury have been underestimated.	[Humphries, Duncan C.; O'Neill, Stephen; Scholefield, Emma; Dorward, David A.; Mackinnon, Alison C.; Rossi, Adriano G.; Haslett, Christopher; Dhaliwal, Kevin] Univ Edinburgh, MRC, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh, Midlothian, Scotland; [Andrews, Peter J. D.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Rhodes, Jonathan] Univ Edinburgh, Western Gen Hosp, Dept Anaesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland		Humphries, DC (corresponding author), Univ Edinburgh, MRC, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh, Midlothian, Scotland.	Duncan.Humphries@ed.ac.uk		Dhaliwal, Kevin/0000-0002-3925-3174; Humphries, Duncan/0000-0002-5551-6536	U.K. Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K013386/1]; Wellcome TrustWellcome TrustEuropean Commission [WT096497]; Wellcome Trust/Charity Open Access Fund; Research Councils UK (RCUK)UK Research & Innovation (UKRI); Wellcome TrustWellcome TrustEuropean Commission; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Edinburgh Molecular Imaging; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/K03197X/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601481] Funding Source: UKRI	Supported mainly by a U.K. Medical Research Council (MRC) PhD Studentship to Dr. Humphries. Also supported by the MRC (MR/K013386/1 [Drs. Rossi and Haslett]) and the Wellcome Trust WT096497 (Dr. Dorward).; Dr. Dorward received support for article research from Wellcome Trust/Charity Open Access Fund. Drs. Humphries and Haslett received support for article research from Research Councils UK (RCUK). Dr. Dorward's institution received funding from Wellcome Trust. Dr. Haslett's institution received funding from Medical Research Council studentship. Drs. Haslett and Dhaliwal received funding from Edinburgh Molecular Imaging. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; AUER RN, 1985, ACTA NEUROPATHOL, V67, P13, DOI 10.1007/BF00688120; Avlonitis VS, 2003, TRANSPLANTATION, V75, P1928, DOI 10.1097/01.TP.0000066351.87480.9E; BAIGELMAN W, 1981, NEUROSURGERY, V9, P729, DOI 10.1227/00006123-198112000-00021; Bopp C, 2008, CRIT CARE, V12, DOI 10.1186/cc6164; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carbonell WS, 1999, ANN NY ACAD SCI, V890, P287, DOI 10.1111/j.1749-6632.1999.tb08005.x; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Craven T, 2016, LANCET, V387, P31; Dhaliwal K, 2012, AM J RESP CRIT CARE, V186, P514, DOI 10.1164/rccm.201112-2132OC; Dinkel K, 2004, P NATL ACAD SCI USA, V101, P331, DOI 10.1073/pnas.0303510101; Dorward DA, 2016, THORAX, P1; Dorward DA, 2017, THORAX, V72, P928, DOI 10.1136/thoraxjnl-2017-210030; FOLKESSON HG, 1995, J CLIN INVEST, V96, P107, DOI 10.1172/JCI118009; FREVERT CW, 1995, J IMMUNOL, V154, P335; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kemp CD, 2008, J TRAUMA, V64, P1573, DOI 10.1097/TA.0b013e318068fc2f; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Locke LW, 2009, J NUCL MED, V50, P790, DOI 10.2967/jnumed.108.056127; Lopez-Aguilar J, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.02.24; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mascia L, 2010, JAMA-J AM MED ASSOC, V304, P2620, DOI 10.1001/jama.2010.1796; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Mrozek Segolene, 2015, World J Crit Care Med, V4, P163, DOI 10.5492/wjccm.v4.i3.163; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; SMART SJ, 1994, J IMMUNOL, V152, P4087; Theodore J, 1978, LANCET, V306, P749; Weaver LC, 2015, EXP NEUROL, V271, P409, DOI 10.1016/j.expneurol.2015.07.003; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Williams AE, 2016, THORAX, V10, P1; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	39	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2018	46	9					E937	E944		10.1097/CCM.0000000000003270			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ2VN	WOS:000441517100010	29957711	Green Published, hybrid			2022-02-06	
J	Kahan, M; Jones, KM; Balalla, S; McPherson, K; Stedman, E; Feigin, VL				Kahan, Michael; Jones, Kelly M.; Balalla, Shivanthi; McPherson, Kathryn; Stedman, Elisabeth; Feigin, Valery L.		BIONIC Study Grp	Return to Pre-Injury Work Following Mild Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						mild traumatic brain injury; return to work	FACTORS PREDICTING RETURN; EMPLOYMENT; MODERATE; SCALE; LIFE	Objective: Adults are at risk for unemployment following a moderate-severe traumatic brain injury (TBI). Less is known about employment patterns following mild TBI. This study aims to examine patterns of return to pre-injury job in adults following mild TBI over a 12-month post injury period, and to investigate factors associated with return to work. Methods: It is a prospective longitudinal study of 205 adults (aged >= 16 years at injury) identified as part of a larger population-based incidence study in the Waikato, New Zealand. In-person assessments were completed at baseline (within 14 days) and 1-, 6-, and 12-month post-injury. Results: A total of 159 (77.6%) adults returned to their pre-injury job at baseline and 185 (90.2%) returned within 12 months. Of those who did not return to their pre-injury job at baseline (n = 46), younger age at injury (<= 30 years, p = .02) and poor overall neurocognitive functioning at 1-month (p = .02) was associated with non-return to pre-injury job at 12 months. Conclusion: In a sample of employed adults, the majority returned to their pre-injury job shortly after injury. Cognitive functioning and younger age at time of injury may be associated with delayed return to work. Interventions to support younger workers may facilitate their return to work.	[Kahan, Michael; Jones, Kelly M.; Balalla, Shivanthi; Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, Auckland, New Zealand; [Kahan, Michael; Stedman, Elisabeth] Waikato Occupat Serv, Hamilton, New Zealand; [McPherson, Kathryn] Auckland Univ Technol, Sch Clin Sci, Ctr Person Ctr Res, Auckland, New Zealand; [McPherson, Kathryn] Hlth Res Council, Auckland, New Zealand		Kahan, M (corresponding author), Laura Ferguson Trust, POB 12089, Hamilton, New Zealand.	mkahan@wos.co.nz	Feigin, Valery/AAF-2313-2019; Jones, Kelly/I-5199-2019	Balalla, Shivanthi/0000-0001-5320-753X; Feigin, Valery L./0000-0002-6372-1740; McPherson, Kath/0000-0003-0487-8497	Health Research Council of New ZealandHealth Research Council of New Zealand [HRC 09/063A, HRC 13/408]; Health Research Council of New ZealandHealth Research Council of New Zealand	This work was supported by the Health Research Council of New Zealand HRC 09/063A and HRC 13/408. The funding for this studywas awarded before Kathryn McPherson became Chief Executive of the Health Research Council of New Zealand and she had no influence on the funding decision.	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Colantonio A, 2016, NEUROREHABILITATION, V39, P389, DOI 10.3233/NRE-161370; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P434; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pink B.N., 2006, AUSTR NZ STANDARD CL; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; World Health Organization, 1992, INT CLASS DIS REL HL, V1	35	4	4	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2018	19	2			SI		153	165		10.1017/Brimp.2018.7			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	GP2LS	WOS:000440665300004					2022-02-06	
J	Luo, QQ; Ding, LZ; Zhang, NJ; Jiang, ZL; Gao, CY; Xue, LH; Peng, B; Wang, GH				Luo, Qianqian; Ding, Lingzhi; Zhang, Nianjiao; Jiang, Zhenglin; Gao, Chunyi; Xue, Lihua; Peng, Bin; Wang, Guohua			A stable and easily reproducible model of focal white matter demyelination	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Lysophosphatidylcholine; Focal white matter demyelination; Remyelination; Multiple sclerosis; White matter injury	OLIGODENDROCYTE PRECURSOR CELLS; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; CORTICAL DEMYELINATION; HDAC INHIBITION; OPEN-FIELD; REMYELINATION; MYELIN; ANXIETY; LEUKODYSTROPHIES	Background: Demyelination is the end product of numerous pathological processes, and also is one of the main causes of neurological disability in Multiple sclerosis (MS). Research into the pathogenesis of MS is hampered by the conventional rodent models' inability to produce stable demyelination. New method: Focal demyelinating lesions were stereotactically targeted to the corpus callosum with a two-point injection of lysophosphatidylcholine (LPC-2) in mice. Three groups were analyzed (n = 8, each) and water maze, sensorimotor test, and compound action potential were included in functional tests. Electron microscopy was used for morphological analyses while western blot and immunohistochemistry were included for molecular detection. Results: Ten days after the LPC-2 injection, the expression of myelin basic protein (MBP) was reduced, while non-phosphorylated neurofilament (SMI-32) was increased. The amplitude of the N1 segment decreased and less well-defined myelin sheaths was found. Behavioral tests showed increased latency to escape and reduced time spent in target quadrant. Four weeks later, MBP expression still reduced, SMI-32 expression was increased, both spatial learning (D24-D27) and spatial memory (D28) were still significantly impaired in LPC-2 injection mice. Comparison with existing method(s): Compared with the classic single-point LPC-injection model, our studies showed that the two-point LPC-injection not only could induce demyelination in a short-term manner, but also could cause demyelination in a long-term manner with little remyelination in the mouse corpus callosum. Conclusions: We established a simple, reliable, and inexpensive model of demyelination in the corpus callosum in mice, with functional and morphological reproducibility, and good validity.	[Wang, Guohua] Nantong Univ, Inst Naut Med, Dept Neurophysiol & Neuropharmacol, 9 Seyuan Rd, Nantong 226019, Jiangsu, Peoples R China; Nantong Univ, Coinnovat Ctr Neuroregenerat, 9 Seyuan Rd, Nantong 226019, Jiangsu, Peoples R China		Wang, GH (corresponding author), Nantong Univ, Inst Naut Med, Dept Neurophysiol & Neuropharmacol, 9 Seyuan Rd, Nantong 226019, Jiangsu, Peoples R China.	wgh@ntu.edu.cn		Wang, Guohua/0000-0002-4810-8534	Chinese Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81471257, 31300973]; Natural Science Foundation of Jiangsu Province of ChinaNatural Science Foundation of Jiangsu Province [BK20161283]; Qing Lan ProjectJiangsu Polytech Institute	The authors also thank Tracey Fine, M.S. and E.L.S. for editing the manuscript. This work was supported by the Chinese Natural Science Foundation (Grants 81471257, 31300973), and Natural Science Foundation of Jiangsu Province of China (Grant BK20161283), and sponsored by Qing Lan Project (to G.W.).	Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; Basso AS, 2008, J CLIN INVEST, V118, P1532, DOI 10.1172/JCI33464; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; Degaonkar MN, 2005, MAGN RESON IMAGING, V23, P69, DOI 10.1016/j.mri.2004.11.010; Dehghan S, 2016, NEUROSCIENCE, V318, P178, DOI 10.1016/j.neuroscience.2016.01.028; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Ennaceur A, 2014, PHYSIOL BEHAV, V135, P55, DOI 10.1016/j.physbeh.2014.05.032; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gartner J, 2007, BUNDESGESUNDHEITSBLA, V50, P1531, DOI 10.1007/s00103-007-0388-2; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Joko Taisuke, 2003, Ryoikibetsu Shokogun Shirizu, P328; Kipp M, 2012, MULT SCLER RELAT DIS, V1, P15, DOI 10.1016/j.msard.2011.09.002; Kuboyama K, 2015, J NEUROSCI, V35, P12162, DOI 10.1523/JNEUROSCI.2127-15.2015; Kulesskaya N, 2014, PHYSIOL BEHAV, V133, P30, DOI 10.1016/j.physbeh.2014.05.006; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lemus HN, 2018, NEUROL CLIN, V36, P1, DOI 10.1016/j.ncl.2017.08.002; Li X, 2017, MOL NEUROBIOL, V54, P4365, DOI 10.1007/s12035-016-9994-z; Luo Q. Q., 2017, J CELL PHYSL; Marques SA, 2009, J NEUROSCI METH, V177, P183, DOI 10.1016/j.jneumeth.2008.10.015; Merkler D, 2006, BRAIN, V129, P1972, DOI 10.1093/brain/awl135; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Owens Trevor, 2006, Adv Neurol, V98, P77; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Sahel A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00077; Serra-de-Oliveira N, 2015, BEHAV BRAIN RES, V287, P265, DOI 10.1016/j.bbr.2015.03.038; Sleiman SF, 2009, EXPERT OPIN INV DRUG, V18, P573, DOI [10.1517/13543780902810345, 10.1517/13543780902810345 ]; Suzuki K, 2001, NEUROIMAG CLIN N AM, V11, P15; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2	39	4	4	4	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 1	2018	307						230	239		10.1016/j.jneumeth.2018.05.024			10	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GQ8ZN	WOS:000442055800024	29859880				2022-02-06	
J	Meng, DH; He, W; Huang, P; Liu, DH; Zhong, LL; Yu, RB; Li, JA				Meng, Dianhuai; He, Wei; Huang, Peng; Liu, Dinghua; Zhong, Lingling; Yu, Rongbin; Li, Jianan			Polymorphism of PARP-1 indicates an increased risk and a worse initial severity of ischemic stroke	PERSONALIZED MEDICINE			English	Article						DNA repair system; ischemic stroke; PARP-1; polymorphism; prognosis; susceptibility	TRAUMATIC BRAIN-INJURY; POLYMERASE-1; ASSOCIATION; XRCC1; DNA	Aim: Polymorphisms of DNA repair enzyme gene may alter the ability to repair damage and in turn may contribute to ischemic stroke susceptibility and outcome. Methods: We selected 316 ischemic stroke patients and 302 healthy controls. Then we genotyped SNPs of PARP-1 rs3219119, rs2271347 and APE1 rs1130409 in patient and control groups. Results: Polymorphism in PARP-1 rs2271347 was significantly associated with increased ischemic stroke risk (additive model: OR: 1.74; 95% CI: 1.03-2.93; p = 0.037). Patients harboring the PARP-1 rs2271347 GA/AA genotype had a worse initial stroke (additive model: OR: 1.85; 95% CI: 1.10-3.11; p = 0.021). Conclusion: Our study suggests that genetic variant of rs2271347 may contribute to the etiology of ischemic stroke.	[Meng, Dianhuai; Li, Jianan] Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China; [He, Wei; Huang, Peng; Yu, Rongbin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China; [He, Wei; Liu, Dinghua] Southeast Univ, Coll Med, Affiliated Jiangyin Peoples Hosp, Dept Neurol, Wuxi, Peoples R China; [Huang, Peng; Yu, Rongbin] Nanjing Med Univ, Sch Publ Hlth, Key Lab Infect Dis, Nanjing, Jiangsu, Peoples R China; [Zhong, Lingling] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Neurol, Huaian, Peoples R China		Yu, RB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China.; Yu, RB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Key Lab Infect Dis, Nanjing, Jiangsu, Peoples R China.	rongbinyu@njmu.edu.cn			Jiangsu province cadre health scientific research project [BJ15011]; Jiangsu provincial commission of health and family planning	The current study was supported by Jiangsu province cadre health scientific research project (grant number BJ15011), Jiangsu provincial commission of health and family planning. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alhadheq AM, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/8289293; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Gao XG, 2006, NEUROSCI LETT, V398, P172, DOI 10.1016/j.neulet.2005.12.078; He W, 2016, INT J ENV RES PUB HE, V13, P6; Jeffs B, 1997, NAT GENET, V16, P364, DOI 10.1038/ng0897-364; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kwiatkowski D, 2015, NEUROPSYCHOBIOLOGY, V71, P176, DOI 10.1159/000381985; Li PY, 2011, ANTIOXID REDOX SIGN, V14, P1905, DOI 10.1089/ars.2010.3451; Mahabir S, 2007, J EPIDEMIOL COMMUN H, V61, P737, DOI 10.1136/jech.2006.048934; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Sarnaik AA, 2010, J NEUROTRAUM, V27, P465, DOI 10.1089/neu.2009.1171; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Stanne TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114156; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Zhai LL, 2015, INT J CLIN EXP PATHO, V8, P7059; Zhao J, 2013, BRAIN RES, V1537, P312, DOI 10.1016/j.brainres.2013.08.061	21	4	4	0	6	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1741-0541	1744-828X		PERS MED	Pers. Med.	SEP	2018	15	5					355	360		10.2217/pme-2018-0007			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GZ3RX	WOS:000449304800004	30260276				2022-02-06	
J	Peterson, AL; Foa, EB; Blount, TH; McLean, CP; Shah, DV; Young-McCaughan, S; Litz, BT; Schobitz, RP; Castillo, DT; Rentz, TO; Yarvis, JS; Dondanville, KA; Fina, BA; Hall-Clark, BN; Brown, LA; DeBeer, BR; Jacoby, VM; Hancock, AK; Williamson, DE; Evans, WR; Synett, S; Straud, C; Hansen, HR; Meyer, EC; Javors, MA; Sharrieff, AFM; Lara-Ruiz, J; Koch, LM; Roache, JD; Mintz, J; Keane, TM				Peterson, Alan L.; Foa, Edna B.; Blount, Tabatha H.; McLean, Carmen P.; Shah, Dhiya, V; Young-McCaughan, Stacey; Litz, Brett T.; Schobitz, Richard P.; Castillo, Diane T.; Rentz, Timothy O.; Yarvis, Jeffrey S.; Dondanville, Katherine A.; Fina, Brooke A.; Hall-Clark, Brittany N.; Brown, Lily A.; DeBeer, Bryann R.; Jacoby, Vanessa M.; Hancock, Allison K.; Williamson, Douglas E.; Evans, Wyatt R.; Synett, Samantha; Straud, Casey; Hansen, Hunter R.; Meyer, Eric C.; Javors, Martin A.; Sharrieff, Allah-Fard M.; Lara-Ruiz, Jose; Koch, Lauren M.; Roache, John D.; Mintz, Jim; Keane, Terence M.		Consortium Alleviate PTSD	Intensive prolonged exposure therapy for combat-related posttraumatic stress disorder: Design and methodology of a randomized clinical trial	CONTEMPORARY CLINICAL TRIALS			English	Article						Posttraumatic stress disorder; PTSD; Prolonged exposure therapy; Intensive outpatient program; Military; Veterans	ACTIVE-DUTY MILITARY; COGNITIVE-PROCESSING THERAPY; INHIBITORY LEARNING APPROACH; SHEEHAN DISABILITY SCALE; TRAUMATIC BRAIN-INJURY; PRIMARY-CARE; PSYCHOMETRIC PROPERTIES; NICOTINE DEPENDENCE; FAGERSTROM TEST; LIFE EVENTS	Combat-related posttraumatic stress disorder (PTSD) is the most common psychological health condition in military service members and veterans who have deployed to the combat theater since September 11,2001. One of the highest research priorities for the Department of Defense and the Department of Veterans Affairs is to develop and evaluate the most efficient and efficacious treatments possible for combat-related PTSD. However, the treatment of combat-related PTSD in military service members and veterans has been significantly more challenging than the treatment of PTSD in civilians. Randomized clinical trials have demonstrated large post-treatment effect sizes for PTSD in civilian populations. However, recent randomized clinical trials of service members and veterans have achieved lesser reductions in PTSD symptoms. These results suggest that combat related PTSD is unique. Innovative approaches are needed to augment established evidence-based treatments with targeted interventions that address the distinctive elements of combat-related traumas. This paper describes the design, methodology, and protocol of a randomized clinical trial to compare two intensive prolonged exposure therapy treatments for combat-related PTSD in active duty military service members and veterans and that can be administered in an acceptable, efficient manner in this population. Both interventions include intensive daily treatment over a 3-week period and a number of treatment enhancements hypothesized to result in greater reductions in combat-related PTSD symptoms. The study is designed to advance the delivery of care for combat-related PTSD by developing and evaluating the most potent treatments possible to reduce PTSD symptomatology and improve psychological, social, and occupational functioning.	[Peterson, Alan L.; Blount, Tabatha H.; Shah, Dhiya, V; Young-McCaughan, Stacey; Dondanville, Katherine A.; Fina, Brooke A.; Hall-Clark, Brittany N.; Jacoby, Vanessa M.; Hancock, Allison K.; Evans, Wyatt R.; Straud, Casey; Hansen, Hunter R.; Javors, Martin A.; Lara-Ruiz, Jose; Koch, Lauren M.; Roache, John D.; Mintz, Jim] Univ Texas Hlth Sci Ctr San Antonio, 7550 Interstate 10 West,Suite 1325, San Antonio, TX 78229 USA; [Peterson, Alan L.; Rentz, Timothy O.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Peterson, Alan L.; Lara-Ruiz, Jose] Univ Texas San Antonio, San Antonio, TX USA; [Foa, Edna B.; Brown, Lily A.] Univ Penn, Philadelphia, PA 19104 USA; [McLean, Carmen P.] VA Palo Alto Hlth Care Syst, Menlo Pk, CA USA; [Litz, Brett T.; Keane, Terence M.] VA Boston Healthcare Syst, Boston, MA USA; [Litz, Brett T.; Keane, Terence M.] Boston Univ, Boston, MA 02215 USA; [Schobitz, Richard P.] Brooke Army Med Ctr, Joint Base San Antonio F, TX USA; [Castillo, Diane T.; DeBeer, Bryann R.; Synett, Samantha; Meyer, Eric C.] VA VISN 17 Ctr Excellence Res Returning War Vet, Waco, TX USA; [Yarvis, Jeffrey S.; Sharrieff, Allah-Fard M.] Carl R Darnall Army Med Ctr, Ft Hood, TX USA; [McLean, Carmen P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Williamson, Douglas E.] Duke Univ, Durham, NC USA; [Williamson, Douglas E.] Durham VA Hlth Care Syst, Durham, NC USA		Peterson, AL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, 7550 Interstate 10 West,Suite 1325, San Antonio, TX 78229 USA.	petersona3@uthscsa.edu; foa@pennmedicine.upenn.edu; blountt@uthscsa.edu; carmen.mclean4@va.gov; shahdv@uthscsa.edu; youngs1@uthscsa.edu; brett.litz@va.gov; richard.p.schobitz.mil@mail.mil; diane.castillo@va.gov; timothy.rentz@va.gov; jeffrey.s.yarvis.mil@mail.mil; dondanville@uthscsa.edu; fina@uthscsa.edu; hallclark@uthscsa.edu; lilybr@pennmedicine.upenn.edu; bryann.debeer@va.gov; jacobyv@uthscsa.edu; hancocka@uthscsa.edu; douglas.williamson@duke.edu; evanswr@uthscsa.edu; synett@uthscsa.edu; straud@uthscsa.edu; hansenhr@uthscsa.edu; eric.meyer2@va.gov; javors@uthscsa.edu; allah-fard.m.sharrieff.mil@mail.mil; lararuiz@uthscsa.edu; kochl@uthscsa.edu; roache@uthscsa.edu; mintz@uthscsa.edu; terence.keane@va.gov	; Keane, Terence/I-8253-2014	Roache, John/0000-0002-7010-8119; McLean, Carmen/0000-0003-4322-9318; Williamson, Douglas/0000-0002-5310-1716; Litz, Brett/0000-0002-0479-8887; Keane, Terence/0000-0002-0482-3149	U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service [I01CX001136-01]; Texas Health and Human Services Commission through its Texas Veterans + Family Alliance Grant Program [529-17-0058-0001]; U.S. Department of Defense, Defense Health Program [W81XWH-13-2-0065]; U.S. Department of Defense, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP) [W81XWH-13-2-0065]	This research was supported by Consortium to Alleviate PTSD award numbers W81XWH-13-2-0065 from the U.S. Department of Defense, Defense Health Program, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP), and I01CX001136-01 from the U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service. Additional funding has been provided by the Texas Health and Human Services Commission through its Texas Veterans + Family Alliance Grant Program, contract number 529-17-0058-0001.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arbuckle R, 2009, PSYCHIAT RES, V165, P163, DOI 10.1016/j.psychres.2007.11.018; Babor T.F., 2001, AUDIT THE ALCOHOL US; Barnes J. B., 2018, MIL MED; Beidel DC, 2017, J ANXIETY DISORD, V50, P23, DOI 10.1016/j.janxdis.2017.05.001; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; Blount TH, 2014, COGN BEHAV PRACT, V21, P89, DOI 10.1016/j.cbpra.2013.05.004; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Cigrang JA, 2017, FAM SYST HEALTH, V35, P450, DOI 10.1037/fsh0000315; Cigrang JA, 2015, J ANXIETY DISORD, V36, P110, DOI 10.1016/j.janxdis.2015.10.003; Cigrang JA, 2011, PSYCHOL SERV, V8, P104, DOI 10.1037/a0022740; Cohen J., 2013, STAT POWER ANAL BEHA; Coles T, 2014, NEUROPSYCH DIS TREAT, V10, P887, DOI 10.2147/NDT.S55220; Craske MG, 2008, BEHAV RES THER, V46, P5, DOI 10.1016/j.brat.2007.10.003; Craske MG, 2014, BEHAV RES THER, V58, P10, DOI 10.1016/j.brat.2014.04.006; Department of Defense Department of Veterans Affairs Department of Health and Human Services Department of Education National Research Action Plan, 2013, NON TRADITIONAL REF; Department of Veterans Affairs Report on VA Facility Specific Operation Enduring Freedom (OEF) Operation Iraqi Freedom (OW) and Operation New Dawn (OND), 2001, NON TRADITIONAL REF; DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536; Ebbert JO, 2006, ADDICT BEHAV, V31, P1716, DOI 10.1016/j.addbeh.2005.12.015; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Foa EB, 2018, JAMA-J AM MED ASSOC, V319, P354, DOI 10.1001/jama.2017.21242; Foa EB, 2016, PSYCHOL ASSESSMENT, V28, P1166, DOI 10.1037/pas0000258; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gragnani M. L., 2011, J AGGRESS MALTREAT T, V20, P530, DOI [10.1080/10926771.2011.588149, DOI 10.1080/10926771.2011.588149]; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Green JD, 2016, PSYCHOL TRAUMA-US, V8, P634, DOI 10.1037/tra0000086; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hendriks L, 2017, J CHILD PSYCHOL PSYC, V58, P1229, DOI 10.1111/jcpp.12756; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Institute of Medicine, 2014, TREATM POSTTR STRESS; Institute of Medicine, 2008, TREATM POSTTR STRESS; Johnson DC, 2011, MIL MED, V176, P161, DOI 10.7205/MILMED-D-10-00258; Kazis LE, 2004, HEALTH CARE FINANC R, V25, P43; Kazis LE, 2006, J AMBUL CARE MANAG, V29, P310, DOI 10.1097/00004479-200610000-00007; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kubany ES, 1996, PSYCHOL ASSESSMENT, V8, P428, DOI 10.1037/1040-3590.8.4.428; Marx B. P., NON TRADITIONAL REF; Marx B. P., 2011, ANN REPORT; Metalsky GI, 1997, COGNITIVE THER RES, V21, P359, DOI 10.1023/A:1021882717784; Meyers L, 2017, J TRAUMA STRESS, V30, P178, DOI 10.1002/jts.22174; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Nock MK, 2007, PSYCHOL ASSESSMENT, V19, P309, DOI 10.1037/1040-3590.19.3.309; Peterson A. L., 2011, TREATING PTSD MILITA, P42; Peterson AL, 2011, J CLIN PSYCHOL MED S, V18, P164, DOI 10.1007/s10880-011-9238-3; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Resick PA, 2017, JAMA PSYCHIAT, V74, P28, DOI 10.1001/jamapsychiatry.2016.2729; Resick PA, 2015, J CONSULT CLIN PSYCH, V83, P1058, DOI 10.1037/ccp0000016; Resick PA, 2012, J CONSULT CLIN PSYCH, V80, P201, DOI 10.1037/a0026602; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rodriguez P, 2012, J REHABIL RES DEV, V49, P649, DOI 10.1682/JRRD.2011.09.0162; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan D.V., 1983, ANXIETY DIS OVERCOME, P151; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sheehan KH, 2008, INT CLIN PSYCHOPHARM, V23, P70, DOI 10.1097/YIC.0b013e3282f2b4d6; Sobell LC, 2003, J STUD ALCOHOL, V64, P858, DOI 10.15288/jsa.2003.64.858; Spielberger CD., 1988, STATE TRAIT ANGER EX; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Stein NR, 2012, BEHAV MODIF, V36, P787, DOI 10.1177/0145445512446945; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Straus Murray A, 2004, Violence Vict, V19, P507; Sundin J, 2014, BRIT J PSYCHIAT, V204, P202, DOI 10.1192/bjp.bp.113.129569; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Weathers F.W., 1993, 9 ANN C ISTSS; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Weathers FW, 2013, NON TRADITIONAL REF; Weisman JS, 2018, CLIN PSYCHOL REV, V59, P41, DOI 10.1016/j.cpr.2017.10.010; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266	78	4	4	3	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	SEP	2018	72						126	136		10.1016/j.cct.2018.07.016			11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	GV5LN	WOS:000446143800015	30055335				2022-02-06	
J	Picha, K; Quintana, C; Glueck, A; Hoch, M; Heebner, NR; Abt, JP				Picha, Kelsey; Quintana, Carolina; Glueck, Amanda; Hoch, Matt; Heebner, Nicholas R.; Abt, John P.			Reliability of 5 Novel Reaction Time and Cognitive Load Protocols	JOURNAL OF SPORT REHABILITATION			English	Article						testing and measurement; clinical-evaluation; evaluation	TEST-RETEST RELIABILITY; CONCUSSION	Context: Reaction time (RT) is crucial to athletic performance. Therefore, when returning athletes to play following injury, it is important to evaluate RT characteristics ensuring a safe return. The Dynavision D2 (R) system may be utilized as an assessment and rehabilitation aid in the determination of RT under various levels of cognitive load. Previous research has demonstrated good reliability of simple protocols when assessed following a 24-to 48-hour test-retest window. Expanding reliable test-retest intervals may further refine novel RT protocols for use as a diagnostic and rehabilitation tool. Objective: To investigate the test-retest reliability of a battery of 5 novel RT protocols at different time intervals. Design: Repeated measures/reliability. Setting: Interdisciplinary sports medicine research laboratory. Participants: Thirty healthy individuals. Methods: Participants completed a battery of protocols increasing in difficulty in terms of reaction speed requirement and cognitive load. Prior to testing, participants were provided 3 familiarization trials. All protocols required participants to hit as many lights as quickly as possible in 60 seconds. After completing the initial testing session (session 1), participants waited 1 hour before completing the second session (session 2). Approximately 2 weeks later (average 14 [4] d), the participants completed the same battery of tasks for the third session (session 3). Main Outcome Measures: The intraclass correlation coefficient, standard error of measurement, minimal detectable change, and repeated-measures analysis of variance were calculated for RT. Results: The intraclass correlation coefficient values for each of the 5 protocols illustrated good to excellent reliability between sessions 1, 2, and 3 (.75-.90). There were no significant differences across time points (F < 0.105, P >.05). Conclusions: The 1-hour and 14-day test-retest intervals are reliable for clinical assessment, expanding the time frames previously reported in the literature of when assessments can be completed reliably. This study provides novel protocols that challenge cognition in unique ways.	[Picha, Kelsey; Quintana, Carolina; Glueck, Amanda; Hoch, Matt; Heebner, Nicholas R.; Abt, John P.] Univ Kentucky, Sports Med Res Inst, Coll Hlth Sci, Lexington, KY 40506 USA		Picha, K (corresponding author), Univ Kentucky, Sports Med Res Inst, Coll Hlth Sci, Lexington, KY 40506 USA.	kelsey.picha@uky.edu					Clark JF, 2015, JOVE-J VIS EXP, DOI 10.3791/52648; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; KLAVORA P, 1994, PERCEPT MOTOR SKILL, V79, P448, DOI 10.2466/pms.1994.79.1.448; KLAVORA P, 1995, PERCEPT MOTOR SKILL, V80, P607, DOI 10.2466/pms.1995.80.2.607; Kutner, 1990, APPL LINEAR STAT MOD; PAAS FGWC, 1994, PERCEPT MOTOR SKILL, V79, P419, DOI 10.2466/pms.1994.79.1.419; PAAS FGWC, 1994, EDUC PSYCHOL REV, V6, P351, DOI 10.1007/BF02213420; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Spiteri T, 2013, J STRENGTH COND RES, V27, P174, DOI 10.1519/JSC.0b013e318250381f; Taheri M, 2012, J SPORTS MED, V3, P15, DOI DOI 10.5812/ASJSM.34719; Vesia M, 2008, PERCEPT MOTOR SKILL, V107, P14, DOI 10.2466/PMS.107.1.14-20; Wells AJ, 2014, J SPORT SCI MED, V13, P145; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; YOUNGEN L, 1959, RES QUART, V30, P349, DOI 10.1080/10671188.1959.10613045	15	4	4	0	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	SEP	2018	27	5								10.1123/jsr.2018-0042			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GT3PC	WOS:000444414600002	29809102				2022-02-06	
J	Piegari, G; Iovane, V; Carletti, V; Fico, R; Costagliola, A; De Biase, D; Prisco, F; Paciello, O				Piegari, Giuseppe; Iovane, Valentina; Carletti, Vincenzo; Fico, Rosario; Costagliola, Alessandro; De Biase, Davide; Prisco, Francesco; Paciello, Orlando			Assessment of Google Glass for Photographic Documentation in Veterinary Forensic Pathology: Usability Study	JMIR MHEALTH AND UHEALTH			English	Article						Google Glass; necropsy; pictures; documentation; veterinary forensic pathology; mobile phone	SURGICAL EDUCATION; NECROPSY	Background: Google Glass is a head-mounted device designed in the shape of a pair of eyeglasses equipped with a 5.0-megapixel integrated camera and capable of taking pictures with simple voice commands. Objective: The objective of our study was to determine whether Google Glass is fit for veterinary forensic pathology purposes. Methods: A total of 44 forensic necropsies of 2 different species (22 dogs and 22 cats) were performed by 2 pathologists; each pathologist conducted 11 necropsies of each species and, for each photographic acquisition, the images were taken with a Google Glass device and a Nikon D3200 digital single-lens reflex (DSLR) camera. The pictures were collected, divided into 3 groups (based on the external appearance of the animal, organs, and anatomical details), and evaluated by 5 forensic pathologists using a 5-point score system. The parameters assessed were overall color settings, region of interest, sharpness, and brightness. To evaluate the difference in mean duration between necropsies conduced with Google Glass and DSLR camera and to assess the battery consumption of the devices, an additional number of 16 necropsies were performed by the 2 pathologists. In these cases, Google Glass was used for photographic reports in 8 cases (4 dogs and 4 cats) and a Nikon D3200 reflex camera in the other 8 cases. Statistical evaluations were performed to assess the differences in ratings between the quality of the images taken with both devices. Results: The images taken with Google Glass received significantly lower ratings than those acquired with reflex camera for all 4 assessed parameters (P<.001). In particular, for the pictures of Groups A and B taken with Google Glass, the sum of frequency of ratings 5 (very good) and 4 (good) was between 50% and 77% for all 4 assessed parameters. The lowest ratings were observed for the pictures of Group C, with a sum of frequency of ratings 5 and 4 of 21.1% (342/1602) for region of interest, 26% (421/1602) for sharpness, 35.5% (575/1602) for overall color settings, and 61.4% (995/1602) for brightness. Furthermore, we found a significant reduction in the mean execution time for necropsy conduced with the Google Glass with respect to the reflex group (P<.001). However, Google Glass drained the battery very quickly. Conclusions: These findings suggest that Google Glass is usable in veterinary forensic pathology. In particular, the image quality of Groups A and B seemed adequate for forensic photographic documentation purposes, although the quality was lower than that with the reflex camera. However, in this step of development, the high frequency of poor ratings observed for the pictures of Group C suggest that the device is not suitable for taking pictures of small anatomical details or close-ups of the injuries.	[Piegari, Giuseppe; Costagliola, Alessandro; De Biase, Davide; Prisco, Francesco; Paciello, Orlando] Univ Naples Federico II, Dept Vet Med & Anim Prod, Via F Delpino, Naples, Italy; [Iovane, Valentina] Univ Salerno, Dept Pharm, Fisciano, Italy; [Carletti, Vincenzo] Univ Salerno, Dept Informat & Elect Engn & Appl Math, Fisciano, Italy; [Fico, Rosario] Natl Ctr Forens Vet Med, Ist Zooprofilatt Sperimentale Reg Lazio & Tosc, Grosseto, Italy		Piegari, G (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Via F Delpino, Naples, Italy.	giuseppe.piegari@unina.it	De Biase, Davide/AAA-2546-2020	De Biase, Davide/0000-0002-8118-9807; Prisco, Francesco/0000-0002-0399-1239; iovane, valentina/0000-0002-0021-5920; Fico, Rosario/0000-0003-4846-4018; Piegari, Giuseppe/0000-0002-1637-4205; Paciello, Orlando/0000-0003-3091-0905			Albrecht UV, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3225; Aldaz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121179; Aquila I, 2014, FORENSIC SCI INT, V234, pE1, DOI 10.1016/j.forsciint.2013.08.024; Armstrong David G, 2014, J Diabetes Sci Technol, V8, P951, DOI 10.1177/1932296814535561; Brownlie HWB, 2016, VET PATHOL, V53, P919, DOI 10.1177/0300985816655851; Chaballout Basil, 2016, JMIR Med Educ, V2, pe2; Dolinak D., 2005, FORENSIC PATHOLOGY P; Dougherty B, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.8671; Frank C, 2015, VET CLIN N AM-EQUINE, V31, P233, DOI 10.1016/j.cveq.2015.04.002; Gerdin JA, 2013, VET PATHOL, V50, P994, DOI 10.1177/0300985813488895; Hashimoto DA, 2016, SURG ENDOSC, V30, P372, DOI 10.1007/s00464-015-4178-x; Henham A P, 1994, J Audiov Media Med, V17, P15, DOI 10.3109/17453059409018372; Kochendorfer-Lucius G, 2006, EQUITY DEV, P1, DOI [DOI 10.1002/0471667196.ESS1275.PUB2, 10.1596/978-0-8213-6105-4, DOI 10.1596/978-0-8213-6105-4]; Laricchiuta P, 2018, FOLIA MORPHOL, V77, P771, DOI 10.5603/FM.a2018.0025; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McDonough SP, 2015, VET PATHOL, V52, P5, DOI 10.1177/0300985814551582; McEwen BJ, 2016, VET PATHOL, V53, P1049, DOI 10.1177/0300985815625757; McEwen BJ, 2012, J FORENSIC SCI, V57, P1231, DOI 10.1111/j.1556-4029.2012.02123.x; Millins C, 2014, FORENSIC SCI MED PAT, V10, P357, DOI 10.1007/s12024-014-9568-1; Moshtaghi O, 2015, LARYNGOSCOPE, V125, P2295, DOI 10.1002/lary.25249; Munro HMC, 2001, J SMALL ANIM PRACT, V42, P279, DOI 10.1111/j.1748-5827.2001.tb02041.x; Nakhla J, 2017, WORLD NEUROSURG, V98, P711, DOI 10.1016/j.wneu.2016.11.122; Peterson GF, 2006, AM J FOREN MED PATH, V27, P200, DOI 10.1097/01.paf.0000243580.43150.3c; Rahimy E, 2015, JAMA OPHTHALMOL, V133, P710, DOI 10.1001/jamaophthalmol.2015.0465; Sahin Ned T, 2018, JMIR Hum Factors, V5, pe1, DOI 10.2196/humanfactors.8785; Salem NH, 2013, J FORENSIC LEG MED, V20, P763, DOI 10.1016/j.jflm.2013.04.015; Schaer R, 2015, IEEE ENG MED BIO, P315, DOI 10.1109/EMBC.2015.7318363; Siebert JN, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7379; Sinkin JC, 2016, PLAST RECONSTR SURG, V138, P298, DOI 10.1097/PRS.0000000000002307; Stern AW, 2016, VET PATHOL, V53, P1057, DOI 10.1177/0300985816643574; Wall Daniel, 2014, J Diabetes Sci Technol, V8, P1245, DOI 10.1177/1932296814543288; Wei NJ, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9409; Wobeser G, 1996, J WILDLIFE DIS, V32, P240, DOI 10.7589/0090-3558-32.2.240; Zhang YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep22237; 2010, FOR DENT 2 ED, P1	35	4	4	0	3	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	2291-5222			JMIR MHEALTH UHEALTH	JMIR mHealth uHealth	SEP	2018	6	9							e180	10.2196/mhealth.9975			11	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	GU6FB	WOS:000445401600001	30249586	Green Published, Green Submitted, gold			2022-02-06	
J	Theadom, A; Barker-Collo, S; Greenwood, A; Parmar, P; Jones, K; Starkey, N; McPherson, K; Feigin, VL				Theadom, Alice; Barker-Collo, Suzanne; Greenwood, Andrea; Parmar, Priya; Jones, Kelly; Starkey, Nicola; McPherson, Kathryn; Feigin, Valery L.		BIONIC Study Grp	Do Mild Traumatic Brain Injury Severity Sub-classification Systems Help to Identify People Who Go on to Experience Long-Term Symptoms?	BRAIN IMPAIRMENT			English	Article						mild traumatic brain injury; concussion; classification; post-concussion symptoms; adults	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; OUTCOME PREDICTION; NEW-ZEALAND; TASK-FORCE; TRACK-TBI; DEFINITION; PREVENTION; GUIDELINES; COMPLAINTS	Objective: To identify the systems available to sub-classify mild traumatic brain injury (TBI) and to determine their utility in predicting 1-year outcome. Methods: A systematic review to identify mild-TBI sub-classification systems was conducted until March 2016. The identified systems were applied to a cohort of N = 290 adults who had experienced a mild-TBI, and who had been assessed for post-concussion symptoms 1-year post injury. ANOVAs and regression models were used to determine whether each sub-classification system could distinguish between outcomes and to explore their contribution to explaining variance in post-concussion symptoms 1-year post injury. Results: Nineteen sub-classification systems for mild-TBI met the inclusion criteria for this review. The SaaI (1991) classification system significantly differentiated the experience of post-concussion symptoms in our cohort 1-year post injury (F = 2.39, p = 0.05). However, the findings did not remain significant following correction for multiple comparisons and inclusion of socio-demographic and contextual factors in the regression model. Conclusions: Current sub-classification systems fail to explain much of the variance in post-concussion symptoms 1 year following mild-TBI. Further research is needed to identify the factors (including socio-demographic and contextual factors) to determine, who may be at risk of developing persistent post-concussion symptoms.	[Theadom, Alice; Parmar, Priya; Jones, Kelly; Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, AUT North Shore Campus,AR417,90 Akoranga Dr, Auckland 1142, New Zealand; [Barker-Collo, Suzanne; Greenwood, Andrea] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [McPherson, Kathryn] Hlth Res Council New Zealand, Auckland, New Zealand		Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, AUT North Shore Campus,AR417,90 Akoranga Dr, Auckland 1142, New Zealand.	alice.theadom@aut.ac.nz	Feigin, Valery/AAF-2313-2019; Jones, Kelly/I-5199-2019; Starkey, Nicola/AAJ-3795-2020	Starkey, Nicola/0000-0002-4370-8186; Te Ao, Braden/0000-0002-1050-200X; Feigin, Valery L./0000-0002-6372-1740; McPherson, Kath/0000-0003-0487-8497	Health Research Council of New ZealandHealth Research Council of New Zealand [HRC 09/063A, 11/192]	The parent study from which the TBI sample and assessment data were extracted was funded by the Health Research Council of New Zealand (Grant reference numbers: HRC 09/063A and 11/192).	Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Andrade AF, 2011, INT J GEN MED, V4, P175, DOI 10.2147/IJGM.S13464; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Buck P. W., 2012, REHABILITATION REP, V7, P1; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Guskiewicz KM, 2001, ATHLET THER TODAY, V6, P18, DOI 10.1123/att.6.1.18; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jordan B. J., 1989, SPORTS NEUROLOGY, V227; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Maroon J C, 1980, Clin Neurosurg, V27, P414; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ruff RM, 1999, BRAIN INJURY, V13, P943; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Schneider R. C., 1973, HEAD NECK INJURIES F, P163; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Studerus-Germann AM, 2016, INT J NEUROSCI, V126, P289, DOI 10.3109/00207454.2015.1033620; TEASDALE G, 1974, LANCET, V2, P81; Tellier A, 1999, BRAIN INJURY, V13, P463; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Torg JS, 1991, ATHLETIC INJURIES HE, Vsecond; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	54	4	4	1	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2018	19	2			SI		119	132		10.1017/Brimp.2017.11			14	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	GP2LS	WOS:000440665300001					2022-02-06	
J	Toninato, J; Casey, H; Uppal, M; Abdallah, T; Bergman, T; Eckner, JT; Samadani, U				Toninato, Joseph; Casey, Hannah; Uppal, Mohit; Abdallah, Tessneem; Bergman, Thomas; Eckner, James T.; Samadani, Uzma			Traumatic brain injury reduction in athletes by neck strengthening (TRAIN)	CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS			English	Article						Concussion; Football; Sports; Student; Athlete; Brain injury; Head injuries; Neck strength; Prevention	STANDARDIZED ASSESSMENT; BOSTON ASSESSMENT; CONCUSSION; SPORTS; HEAD; INTERVIEW; RISK	Reporting of sports-related concussions (SRCs) has risen dramatically over the last decade, increasing awareness of the need for treatment and prevention of SRCs. To date most prevention studies have focused on equipment and rule changes to sports in order to reduce the risk of injury. However, increased neck strength has been shown to be a predictor of concussion rate. In the TRAIN study, student-athletes will follow a simple neck strengthening program over the course of three years in order to better understand the relationship between neck strength and SRCs. Neck strength of all subjects will be measured at baseline and biannually over the course of the study using a novel protocol. Concussion severity and duration in any subject who incurs an SRC will be evaluated using the Sports Concussion Assessment Tool 5th edition, a questionnaire based tool utilizing several tests that are commonly affected by concussion, and an automated eye tracking algorithm. Neck strength, and improvement of neck strength, will be compared between concussed and non-concussed athletes to determine if neck strength can indeed reduce risk of concussion. Neck strength will also be analyzed taking into account concussion severity and duration to find if a strengthening program can provide a protective factor to athletes. The study population will consist of student-athletes, ages 12-23, from local high schools and colleges. These athletes are involved in a range of both contact and non-contact sports.	[Toninato, Joseph; Casey, Hannah; Uppal, Mohit; Abdallah, Tessneem; Bergman, Thomas; Samadani, Uzma] Hennepin Cty Med Ctr, 701 Pk Ave South, Minneapolis, MN 55415 USA; [Toninato, Joseph; Casey, Hannah; Uppal, Mohit; Abdallah, Tessneem; Bergman, Thomas; Samadani, Uzma] Univ Minnesota, 100 Church St SE, Minneapolis, MN 55455 USA; [Eckner, James T.] Univ Michigan, 1301 Catherine St, Ann Arbor, MI 48109 USA		Toninato, J (corresponding author), Hennepin Cty Med Ctr, 701 Pk Ave South, Minneapolis, MN 55415 USA.	toni0015@d.umn.edu; casey372@umn.edu; Mohit.Uppal@hcemed.org; tessneem.abdallah@hcmed.org; thomas.bergman@hcmed.org; jeckner@med.umich.edu; uzma.samadani@hcmed.org		Abdallah, Tessneem/0000-0002-1604-9621; Casey, Hannah/0000-0002-6562-4020	Minnesota Spinal Cord Injury and Traumatic Brain Injury Research Grant; Rockswold Kaplan Endowment Fund; Charlene's 5 k Dog Run	Funding for this study comes from the Minnesota Spinal Cord Injury and Traumatic Brain Injury Research Grant, the Rockswold Kaplan Endowment Fund, and Charlene's 5 k Dog Run. Funds from each has contributed to all aspects of study expenses including salaries, travel, and equipment.	Babl FE, 2017, PEDIATRICS, V140; Ciuffreda K. J., 2007, OPTOMETRY, V78; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eckner JT, 2018, AM J PHYS MED REHAB, V97, P292, DOI 10.1097/PHM.0000000000000843; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Fortier CB, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000008; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Gorman M, 2017, APPL NEUROPSYCH-CHIL, V6, P364, DOI 10.1080/21622965.2016.1210011; Hildenbrand K. J., 2013, J STRENGTH CONDIT RE, V27; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; McAllister T., 2017, J ATHL TRAIN, V52; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Samadani U, 2015, J NEUROSURG, V122, P707, DOI 10.3171/2014.10.JNS14762; Sports Concussion Institute, 2012, CONC RES COACH ATH T; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	23	4	4	3	24	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	2451-8654			CONT CLIN TRIAL COMM	Contemp. Clin. Trials Commun.	SEP	2018	11						102	106		10.1016/j.conctc.2018.06.007			5	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	GS3FV	WOS:000443472200016	29998204	Green Published, gold			2022-02-06	
J	Thorsten, J; Burkhardt, S; Valentin, N; Rudolf, MM				Thorsten, Jentzsch; Burkhardt, Seifert; Valentin, Neuhaus; Rudolf, Moos M.			Predictors for shorter and longer length of hospital stay outliers: a retrospective case-control study of 8247 patients at a university hospital trauma department	SWISS MEDICAL WEEKLY			English	Article						length of stay (LOS) at the hospital; diagnosis related groups (DRG); outlier; inlier; trauma; fractures; complications	OF-STAY	BACKGROUND: Providing efficient healthcare is important for hospitals. Shorter and longer length of hospital stay (LOS) outliers influence financial results and reimbursement. The objective of this study was to identify independent diagnosis related group (DRG)-related risk factors for shorter and longer LOS outlier status. METHODS: A retrospective case-control study was conducted at a Swiss level 1 trauma centre between January 2012 and December 2014. The study included all patients with available information on LOS based on DRG. Many predictor variables were tested. The outcome variable was the DRG-based LOS. Logistic regression models were fitted for shorter and longer LOS outliers, with a significance level of < 1%. RESULTS: A total of 8247 patients were analysed, of whom inliers were more frequent than shorter and longer LOS outliers (n = 5838 [70.8%] vs n = 1996 [24.2%] vs n = 413 [5.0%]). Predictors for shorter LOS outliers were death (odds ratio [OR] 4.89, 95% confidence interval [CI] 3.27-7.31), concussion (OR 4.87, 95% CI 4.20-5.63) and psychiatric disease (OR 1.85, 95% CI 1.46-2.34). Predictors for longer LOS outliers were age >= 65 years (OR 1.74, 95% CI 1.31-2.30), number of diagnoses >= 5 (OR 2.07, 95% CI 1.52-2.81), comorbidity (OR 1.75, 95% CI 1.28-2.40), number of surgical procedures (OR 1.76, 95% CI 1.36-2.28), complication perioperatively (OR 1.69, 95% CI 1.24-2.30), infection (OR 2.66, 95% CI 1.57-4.49]), concussion (OR 1.52, 95% CI 1.14-2.01) and urinary tract infection (OR 2.34, 95% CI 1.61-3.41). CONCLUSION: This large study showed that LOS outliers, especially shorter LOS outliers, are relatively common. Patients who died, or had concussion or psychiatric disease were more commonly discharged early. Patients weremore often discharged late if they were aged >= 65 years, had more diagnoses, were comorbid, had more surgical procedures, complications perioperatively, infection, concussion and urinary tract infection. For hospitals, this can help raise awareness and lead to better management of specific diagnoses in order to avoid monetary deficits. For the public health sector, this information may be considered in future revisions of the DRG.	[Thorsten, Jentzsch; Valentin, Neuhaus] Univ Zurich, Univ Hosp Zurich, Dept Surg, Div Trauma Surg, Zurich, Switzerland; [Burkhardt, Seifert] Univ Zurich, Dept Biostat, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Rudolf, Moos M.] Univ Zurich, Univ Hosp Zurich, Med Directorate, Zurich, Switzerland		Thorsten, J (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Trauma, Epidemiol, Ramistr 100, CH-8091 Zurich, Switzerland.	thorsten.jentzsch@gmail.com	Jentzsch, Thorsten/AAR-6135-2020	Jentzsch, Thorsten/0000-0002-6133-3314; Seifert, Burkhardt/0000-0002-5829-2478			Cohen ME, 2009, ANN SURG, V250, P901, DOI 10.1097/SLA.0b013e3181b2a948; Cots F, 2004, HEALTH POLICY, V68, P159, DOI 10.1016/j.healthpol.2003.09.004; Felder S, 2009, INT J HEALTH CARE FI, V9, P279, DOI 10.1007/s10754-008-9051-1; Freitas A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-265; Hsiao W C, 1986, Health Aff (Millwood), V5, P32, DOI 10.1377/hlthaff.5.2.32; Jentzsch T, 2016, J SURG RES, V200, P236, DOI 10.1016/j.jss.2015.06.055; Mehra T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140874; Moos RM, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14334; Motte S, 2016, EUR RESPIR J, V47, P203, DOI 10.1183/13993003.00281-2015; Swiss DRG, 2017, SWISSDRG VERS 7 0 SY; Swiss DRG, WICHT BEGR GRENZV AU; Tecklenburg A, 2009, CHIRURG, V80, P768, DOI 10.1007/s00104-009-1693-0; Tokunaga J, 2002, INT J QUAL HEALTH C, V14, P493, DOI 10.1093/intqhc/14.6.493; World Health Organization, INT STAT CLASS DIS R	14	4	4	0	2	E M H SWISS MEDICAL PUBLISHERS LTD	MUTTENZ	FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND	1424-7860	1424-3997		SWISS MED WKLY	Swiss Med. Wkly.	AUG 13	2018	148								w14650	10.4414/smw.2018.14650			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX1QC	WOS:000447491700004		Green Accepted, gold, Green Submitted			2022-02-06	
J	Bukur, M; Teurel, C; Catino, J; Kurek, S				Bukur, Marko; Teurel, Candace; Catino, Joseph; Kurek, Stanley			The Price of Always Saying Yes: A Cost Analysis of Secondary Overtriage to an Urban Level I Trauma Center	AMERICAN SURGEON			English	Article							INTERFACILITY TRANSFERS; SEVERE INJURIES; BRAIN-INJURY; CENTER CARE; SYSTEM; SURGEONS; MORTALITY; MODERATE; PATIENT; BENEFIT	Level I trauma centers serve as a community resource, with most centers using an inclusive transfer policy that may result in overtriage. The financial burden this imparts on an urban trauma system has not been well examined. We sought to examine the incidence of secondary overtriage (SOT) at an urban Level I trauma center. This was a retrospective study from an urban Level I trauma center examining patients admitted as trauma transfers (TT) from 2010 to 2014. SOT was defined as patients not meeting the "Orange Book" transfer criteria and who had a length of stay of < 48 hours. Average ED and transport charges were calculated for total transfer charges. A total of 2397 TT were treated. The number of TT increased over the study interval. The mean age of TT was 59.7 years (SD +/- 26.4 years); patients were predominantly male (59.2%), white (83.2%), with at least one comorbidity (71.5%). Blunt trauma accounted for 96.8 per cent of admissions with a median Injury Severity Score of nine (IQR: 5-16). Predominant injuries were isolated closed head trauma (61.4%), skin/soft tissue injury (18.9%), and spinal injury (17.6%). SOT was 48.2 per cent and increased yearly (P < 0.001). The median trauma center charge for SOTwas ($27,072; IQR: $20,089-34,087), whereas ED charges were ($40,440; IQR: $26,150-65,125), resulting in a total cost of $67,512/patient. A liberal TT policy results in a high SOTrate adding significant unnecessary costs to the health-care system. Efforts to establish transfer guidelines may allow for significant cost savings without compromising care.	[Bukur, Marko] NYU, Bellevue Hosp Ctr, Sch Med, Div Acute Care Surg, New York, NY 10016 USA; [Teurel, Candace; Catino, Joseph] Delray Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, Delray Beach, FL USA; [Kurek, Stanley] Baylor Scott & White Hlth, Temple, TX USA; [Kurek, Stanley] Texas A&M Hlth Sci Ctr, Coll Med, Div Acute Care Surg, Bryan, TX USA		Bukur, M (corresponding author), Bellevue Hosp Ctr, Dept Surg, 550 First Ave,NBV 15S, New York, NY 10016 USA.	marko.bukur@nyumc.org		Bukur, Marko/0000-0002-1850-7147			American College of Surgeon Committee on Trauma, 2014, RES OPT CAR INJ PAT; Barmparas G, 2016, J SURG RES, V202, P58, DOI 10.1016/j.jss.2015.12.032; Bible JE, 2014, SPINE J, V14, P2877, DOI 10.1016/j.spinee.2014.01.065; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Ciesla DJ, 2008, J AM COLL SURGEONS, V206, P131, DOI 10.1016/j.jamcollsurg.2007.06.285; Con J, 2015, J SURG RES, V198, P462, DOI 10.1016/j.jss.2015.03.077; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Drolet BC, 2016, PLAST RECONSTR SURG, V137, P1927, DOI 10.1097/PRS.0000000000002147; Duchesne JC, 2008, J TRAUMA, V64, P7; Duchesne JC, 2008, J TRAUMA, V64, P92, DOI 10.1097/TA.0b013e31815dd4c4; Esposito TJ, 2006, J TRAUMA, V61, P1380, DOI 10.1097/01.ta.0000242862.68899.04; Esposito TJ, 2006, J TRAUMA, V60, P8, DOI 10.1097/01.ta.0000197425.87092.d5; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Gomez D, 2012, J TRAUMA ACUTE CARE, V73, P1288, DOI 10.1097/TA.0b013e318265cec2; Haas B, 2012, J TRAUMA ACUTE CARE, V72, P1510, DOI 10.1097/TA.0b013e318252510a; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Latifi Rifat, 2009, Am J Surg, V198, P905, DOI 10.1016/j.amjsurg.2009.08.011; Lehmann R, 2009, ARCH SURG-CHICAGO, V144, P853, DOI 10.1001/archsurg.2009.153; Lynch KT, 2016, J SURG RES, V204, P460, DOI 10.1016/j.jss.2016.05.035; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mohan D, 2015, ANN SURG, V261, P383, DOI 10.1097/SLA.0000000000000603; Mullins RJ, 1999, J TRAUMA, V47, pS59, DOI 10.1097/00005373-199909001-00013; Newgard CD, 2007, J TRAUMA, V63, P965, DOI 10.1097/TA.0b013e31803c5665; Osen HB, 2010, J TRAUMA, V69, P602, DOI 10.1097/TA.0b013e3181e7db37; Services CFMM, 2014, AR YOU HOSP INP OUTP; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Tang A, 2014, J TRAUMA ACUTE CARE, V77, P969, DOI 10.1097/TA.0000000000000462	30	4	4	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	AUG	2018	84	8					1368	1375					8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GS6SG	WOS:000443828300054	30185318				2022-02-06	
J	Burke, SL; Cadet, T; Maddux, M				Burke, Shanna L.; Cadet, Tamara; Maddux, Marlaina			Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults	JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; HEART-FAILURE; ALZHEIMERS-DISEASE; RISK-FACTORS; RACIAL DISPARITIES; ETHNIC DISPARITIES; B-VITAMINS; DEMENTIA; PREVALENCE; HYPERTENSION	Approximately 5.5 million individuals are diagnosed with Alzheimer's disease (AD) dementia, a number which includes those with mild cognitive impairment and asymptomatic individuals With biomarkers of AD. There is a higher incidence of mild cognitive impairment (MCI) in African American populations as compared to White populations, even when controlling for sociodemographic factors. The existing body of ethnically/racially targeted research on MCI has been limited by few studies with the ability to generalize to African American communities. This study sought to examine whether medical conditions which occur at a higher rate in African American individuals increase the hazard of subsequent MCI development. A secondary data analysis of the National Alzheimer's Coordinating Center Uniform Data Set was employed to examine the associations between health conditions (congestive heart failure, traumatic brain injury, diabetes. hypertension, hypercholestemlemia, B12 deficiency, thyroid disease) and their relationship to MCI. The analytic sample included 2847 participants with 9872 observations. Binary logistic generalized estimating equation modeling was used to examine repeated measures over the course of 1-11 observations. Education was associated With MCI development specifically those with some college or college graduates (p < 0.001) and more than college (p = 0.032). Female sex was associated with development of MCI (p < 0.001). African Americans with traumatic brain injury (TBI) were more likely to develop MCI (p < 0.001) compared to those with no reports of a TN. Inactive thyroid conditions decreased the risk a' MCI development (p = 0.005) compared to those without thyroid disease. Though vascular factors are often attributed to higher mortality and neurodegeneration in African Americans, congestive heart failure. diabetes, high cholesterol, hypertension. diabetes. nor seizures were associated with an increased risk of MCI development. Findings from this study provide Farmative data to develop targeted interventions for subsets of the African American community, including those with higher educational levels, those with TBI, and those with a history of thyroid disease. While it may not be possible to prevent MCl development, it is possible to modify lifestyle behaviors contributing to these health conditions,. such as falls that are otter experienced by older adults. Practitioners can increase awareress, knowledge. and resources relevant to clients.	[Burke, Shanna L.; Maddux, Marlaina] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Sch Social Work, 11200 SW 8th St,AHC5 564, Miami, FL 33199 USA; [Cadet, Tamara] Harvard Sch Dent Med, HSDM Oral Hlth Policy & Epidemiol, Simmons Coll Sch Social Work, Boston, MA USA		Burke, SL (corresponding author), Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Sch Social Work, 11200 SW 8th St,AHC5 564, Miami, FL 33199 USA.	sburke@fiu.edu	Burke, Shanna L/H-6440-2019	Burke, Shanna L/0000-0001-6969-3536	NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG016976]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017, P30 AG010161, P50 AG047366, P30 AG010129]; The NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG035982, P30 AG028383, P30 AG010124, P50 AG005133, P50 AG005142, P30 AG012300, P50 AG005136, P50 AG033514, P50 AG016573, P50 AG016570, P50 AG005131, P50 AG023501, P50 AG005681, P50 AG047270]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG010133, P50AG047366, P50AG016570, P30AG019610, P50AG005131, P30AG013854, P30AG008051, P30AG008017, P50AG025688, P50AG047266, P50AG005146, P50AG005134, P50AG016573, P30AG035982, P50AG005142, P50AG008702, P50AG005133, P50AG033514, P30AG013846, P30AG010161, P50AG047270, P30AG010129, P50AG016574, P50AG023501, P50AG005136, U01AG016976, P30AG012300, P50AG005138, P30AG028383, P50AG005681, P30AG010124] Funding Source: NIH RePORTER	The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA-funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Steven Ferris, PhD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG016570 (PI Marie-Francoise Chesselet, MD, PhD), P50 AG005131 (PI Douglas Galasko, MD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P50 AG005136 (PI Thomas Montine, MD, PhD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), and P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Akomolafe A, 2005, J NATL MED ASSOC, V97, P689; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Association A., 2017, ALZHEIMERS DEMENT, V13, P325, DOI DOI 10.1016/J.JALZ.2017.02.001; Barber S, 2016, SOC SCI MED, V153, P107, DOI 10.1016/j.socscimed.2016.02.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Bellinger JD, 2010, INT J ENV RES PUB HE, V7, P975, DOI 10.3390/ijerph7030975; Bibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265; Blair JEA, 2013, CURR CARDIOL REV, V9, P128, DOI 10.2174/1573403X11309020006; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Brown CS, 2014, GERONTOLOGIST, V54, P108, DOI 10.1093/geront/gnt103; Capatina C, 2015, J CLIN MED, V4, P1448, DOI 10.3390/jcm4071448; Centers for Disease Control and Prevention, 2015, TRAUM BRAIN INJ GAT; Centers for Disease Control and Prevention, 2016, FALLS AR LEAD CAUS I; Centers for Disease Control and Prevention, 2016, HLTH BLACK AFR AM NO; Centers for Disease Control and Prevention, 2012, EP AD ACC CAR UN, V45; Centers for Disease Control and Prevention, 2016, WHAT AR POT EFF TBI; de Jager CA, 2012, INT J GERIATR PSYCH, V27, P592, DOI 10.1002/gps.2758; England M, 2012, EPILEPSY SPECTRUM PR; Englander Jeffrey, 2014, Arch Phys Med Rehabil, V95, P1223, DOI 10.1016/j.apmr.2013.06.002; Faught E, 2012, NEUROLOGY, V78, P448, DOI 10.1212/WNL.0b013e3182477edc; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; FOLSTEIN MF, 1991, J GERONTOL, V46, pM132, DOI 10.1093/geronj/46.4.M132; Gan EH, 2012, J CLIN ENDOCR METAB, V97, P3438, DOI 10.1210/jc.2012-2284; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Griffith HR, 2006, J INT NEUROPSYCH SOC, V12, P166, DOI 10.1017/S1355617706060267; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.3.CO;2-X; Haan MN, 2007, AM J CLIN NUTR, V85, P511, DOI 10.1093/ajcn/85.2.511; HAERER AF, 1987, SOUTHERN MED J, V80, P339, DOI 10.1097/00007611-198703000-00016; Helfand M., 2004, SCREENING THYROID DI; Hollenbeak CS, 2011, ETHNIC DIS, V21, P210; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Johnson MA, 2010, J NUTR HEALTH AGING, V14, P339, DOI 10.1007/s12603-010-0077-y; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Katz MJ, 2012, ALZ DIS ASSOC DIS, V26, P335, DOI 10.1097/WAD.0b013e31823dbcfc; Kennedy Bernice Roberts, 2007, J Cult Divers, V14, P56; Kim S, 2015, COMPR PSYCHIAT, V62, P114, DOI 10.1016/j.comppsych.2015.07.002; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Kutner M., 2006, HLTH LITERACY AM ADU, V76; LaVeist TA, 2005, J URBAN HEALTH, V82, pIII26, DOI 10.1093/jurban/jti061; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Lin Katherine A, 2015, Alzheimers Dement (N Y), V1, P103; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1394, DOI 10.1001/archneur.60.10.1394; Manly J. J., 2004, CRIT PERSPECT, P95; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; Marshall MC, 2005, POSTGRAD MED J, V81, P734, DOI 10.1136/pgmj.2004.028274; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Menard S, 1995, APPL LOGISTIC REGRES, V106; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Miller LA, 2012, J CLIN EXP NEUROPSYC, V34, P509, DOI 10.1080/13803395.2012.663344; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; National Center for Injury Prevention and Control, 2013, REP C MILD TRAUM BRA; Nguyen HT, 2013, DIABETES RES CLIN PR, V101, P141, DOI 10.1016/j.diabres.2013.05.012; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; OSTERWEIL D, 1992, J AM GERIATR SOC, V40, P325, DOI 10.1111/j.1532-5415.1992.tb02130.x; Park YJ, 2010, ARCH GERONTOL GERIAT, V50, pE68, DOI 10.1016/j.archger.2009.05.015; Perkins P, 1997, NEUROLOGY, V49, P44, DOI 10.1212/WNL.49.1.44; Prineas R J, 1995, J Fla Med Assoc, V82, P805; Quadri P, 2005, CLIN CHEM LAB MED, V43, P1096, DOI 10.1515/CCLM.2005.191; Reitz C, 2007, ARCH NEUROL-CHICAGO, V64, P1734, DOI 10.1001/archneur.64.12.1734; Rhee CM, 2013, J CLIN ENDOCR METAB, V98, P2326, DOI 10.1210/jc.2013-1039; Rizos C V, 2011, Open Cardiovasc Med J, V5, P76, DOI 10.2174/1874192401105010076; Roberts LM, 2006, ANN INTERN MED, V145, P573, DOI 10.7326/0003-4819-145-8-200610170-00006; Roberts RO, 2014, ALZHEIMERS DEMENT, V10, P18, DOI 10.1016/j.jalz.2013.01.001; Ruitenberg A, 2001, NEUROBIOL AGING, V22, P575, DOI 10.1016/S0197-4580(01)00231-7; Sachs-Ericsson N, 2005, AM J GERIAT PSYCHIAT, V13, P968, DOI 10.1176/appi.ajgp.13.11.968; Sattler C, 2012, PSYCHIAT RES, V196, P90, DOI 10.1016/j.psychres.2011.11.012; Saxby BK, 2003, HEALTH PSYCHOL, V22, P587, DOI 10.1037/0278-6133.22.6.587; SCHOENBERG BS, 1985, ARCH NEUROL-CHICAGO, V42, P740, DOI 10.1001/archneur.1985.04210090004002; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shermer CR, 2007, J TRAUMA, V63, P1268; Shuey KM, 2008, RES AGING, V30, P200, DOI 10.1177/0164027507311151; Sierra C, 2012, CURR HYPERTENS REP, V14, P548, DOI 10.1007/s11906-012-0315-2; Sims RC, 2015, J AGING HEALTH, V27, P195, DOI 10.1177/0898264314543474; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sorrentino P, 2014, FEBS LETT, V588, P641, DOI 10.1016/j.febslet.2013.12.038; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Still C. N., 1990, J S C MED ASS, V86, P453; Still CH, 2015, J AM GERIATR SOC, V63, P2130, DOI 10.1111/jgs.13672; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Teresi JA, 1999, NEUROEPIDEMIOLOGY, V18, P309, DOI 10.1159/000026226; Vadikolias K, 2012, BRAIN BEHAV, V2, P620, DOI 10.1002/brb3.88; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Waldstein SR, 2005, ANN BEHAV MED, V29, P174, DOI 10.1207/s15324796abm2903_3; Washington RL, 1999, AM FAM PHYSICIAN, V59, P2211; Wessels AM, 2011, ALZHEIMERS DEMENT, V7, P418, DOI 10.1016/j.jalz.2010.07.003; Wharton W., 2015, ALZHEIMERS DEMENT J, V11, pP290; Whitfield KE, 1999, INT J AGING HUM DEV, V48, P73, DOI 10.2190/YGAQ-0D95-M0V4-820M; WOOLF PD, 1988, AM J MED, V84, P201, DOI 10.1016/0002-9343(88)90414-7; World Health Organization, 2016, INT STAT CLASS DIS R; Yancar Demir E, 2015, PSYCHOGERIATRICS, V15, P186, DOI 10.1111/psyg.12093	100	4	4	1	11	NATL MED ASSOC	WASHINGON	1012 10TH ST, N W, WASHINGON, DC 20001 USA	0027-9684	1943-4693		J NATL MED ASSOC	J. Natl. Med. Assoc.	AUG	2018	110	4					314	325		10.1016/j.jnma.2017.06.007			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ6XG	WOS:000441872100004	30126555	Green Accepted			2022-02-06	
J	Cadotte, DW; Akbar, MA; Fehlings, MG; Stroman, PW; Cohen-Adad, J				Cadotte, David W.; Akbar, M. Ali; Fehlings, Michael G.; Stroman, Patrick W.; Cohen-Adad, Julien			What Has Been Learned from Magnetic Resonance Imaging Examination of the Injured Human Spinal Cord: A Canadian Perspective	JOURNAL OF NEUROTRAUMA			English	Article						degenerative cervical myelopathy; functional MRI; MRI; quantitative MRI; spinal cord injury	CERVICAL SPONDYLOTIC MYELOPATHY; STATE FUNCTIONAL CONNECTIVITY; OF-THE-ART; THERMAL-STIMULATION; BRAIN-STEM; MRI; FMRI; ATLAS; SEGMENTATION; MOTION	Magnetic resonance imaging (MRI) has transformed the way surgeons and researchers study and treat spinal cord injury. In this narrative review, we explore the historical context of imaging the human spinal cord and describe how MRI has evolved from providing the first visualization of the human spinal cord in the 1980s to a remarkable set of imaging tools today. The article focuses in particular on the role of Canadian researchers to this field. We begin by outlining the clinical context of traumatic injury to the human spinal cord and describe why current MRI standards fall short when it comes to treating this disabling condition. Parts 2 and 3 of this work explore an exciting and dramatic shift in the use of MRI technology to aid in our understanding and treatment of traumatic injury to the spinal cord. We explore the use of functional imaging (part 2) and structural imaging (part 3) and explore how these techniques have evolved, how they are used, and the challenges that we face for continued refinement and application to patients who live with the neurological and functional deficits caused by injury to the delicate spinal cord.	[Cadotte, David W.] Univ Calgary, Foothills Med Ctr, Spine Program, Div Neurosurg,Dept Clin Neurosci, Calgary, AB, Canada; [Akbar, M. Ali; Fehlings, Michael G.] Univ Toronto, Toronto Western Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Akbar, M. Ali; Fehlings, Michael G.] Univ Toronto, Toronto Western Hosp, Spinal Program, Toronto, ON, Canada; [Stroman, Patrick W.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Cohen-Adad, Julien] Polytech Montreal, NeuroPoly Lab, Inst Biomed Engn, Montreal, PQ, Canada; [Cohen-Adad, Julien] Univ Montreal, Funct Neuroimaging Unit, CRIUGM, Montreal, PQ, Canada		Cadotte, DW (corresponding author), Univ Calgary, Foothills Med Ctr, Dept Clin Neurosci, Spine Program,Div Neurosurg, 1403-29 St Northwest, Calgary, AB T2N 2T9, Canada.	david.cadotte@ucalgary.ca			CIHRCanadian Institutes of Health Research (CIHR) [FDN-143263] Funding Source: Medline		Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Albrecht DS, 2018, PAIN, V159, P968, DOI 10.1097/j.pain.0000000000001171; Alexander Marcalee, 2017, Spinal Cord Ser Cases, V3, P16041, DOI 10.1038/scsandc.2016.41; AMBROSE J, 1973, BRIT J RADIOL, V46, P1023, DOI 10.1259/0007-1285-46-552-1023; Asman AJ, 2014, MED IMAGE ANAL, V18, P460, DOI 10.1016/j.media.2014.01.003; Awad A, 2015, J REHABIL MED, V47, P426, DOI 10.2340/16501977-1955; Barry RL, 2018, NEUROIMAGE, V168, P437, DOI 10.1016/j.neuroimage.2017.07.003; Barry RL, 2014, ELIFE, V3, DOI 10.7554/eLife.02812; Begin S, 2014, BIOMED OPT EXPRESS, V5, P4145, DOI 10.1364/BOE.5.004145; Blaiotta C, 2018, NEUROIMAGE, V166, P117, DOI 10.1016/j.neuroimage.2017.10.060; Bosma RL, 2014, MAGN RESON IMAGING, V32, P473, DOI 10.1016/j.mri.2014.01.007; Cadotte DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045560; Cadotte David W, 2011, Expert Opin Med Diagn, V5, P121, DOI 10.1517/17530059.2011.556111; Castellano A, 2016, BRAIN, V139, P1735, DOI 10.1093/brain/aww068; Chen CJ, 2001, RADIOLOGY, V221, P789, DOI 10.1148/radiol.2213010365; Chen YX, 2007, P ANN INT IEEE EMBS, P3388, DOI 10.1109/IEMBS.2007.4353058; Cohen-Adad J, 2011, MAGN RESON MED, V66, P1198, DOI 10.1002/mrm.22906; Cohen-Adad J., 2014, QUANTITATIVE MRI SPI, P59, DOI [10.1016/B978-0-12-396973-6.00005-8, DOI 10.1016/B978-0-12-396973-6.00005-8, 10.1016/B978-0-12-396973-6.00005-8.]; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Dandy WE, 1919, ANN SURG, V70, P397, DOI 10.1097/00000658-191910000-00004; De Leener B, 2018, NEUROIMAGE, V165, P170, DOI 10.1016/j.neuroimage.2017.10.041; De Leener B, 2017, NEUROIMAGE, V145, P24, DOI 10.1016/j.neuroimage.2016.10.009; Duval T, 2017, NEUROIMAGE, V145, P11, DOI 10.1016/j.neuroimage.2016.09.018; Duval T, 2015, NEUROIMAGE, V118, P494, DOI 10.1016/j.neuroimage.2015.06.038; Eippert F, 2017, NEUROIMAGE, V147, P589, DOI 10.1016/j.neuroimage.2016.12.072; Figley CR, 2008, AM J NEURORADIOL, V29, P1450, DOI 10.3174/ajnr.A1154; Figley CR, 2012, MAGN RESON IMAGING, V30, P471, DOI 10.1016/j.mri.2011.12.015; Figley CR, 2010, MAGN RESON IMAGING, V28, P1234, DOI 10.1016/j.mri.2010.01.005; Figley CR, 2009, NEUROIMAGE, V44, P421, DOI 10.1016/j.neuroimage.2008.08.040; Filous AR, 2018, AM J PATHOL, V188, P53, DOI 10.1016/j.ajpath.2017.09.005; Fonov VS, 2014, NEUROIMAGE, V102, P817, DOI 10.1016/j.neuroimage.2014.08.057; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Ghobrial George M, 2015, Neurosurgery, V62 Suppl 1, P62, DOI 10.1227/NEU.0000000000000816; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Grabher P, 2017, J NEUROTRAUM, V34, P2329, DOI 10.1089/neu.2017.4980; Grabher P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24636; Harita S, 2017, MAGN RESON MED, V78, P2149, DOI 10.1002/mrm.26606; Hawasli AH, 2018, J NEUROTRAUM, V35, P864, DOI 10.1089/neu.2017.5212; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1223; Hori M., 2018, SCI REP UK, V8; Huber E, 2018, NEUROLOGY, V90, pE1510, DOI 10.1212/WNL.0000000000005361; Ito T, 1996, SPINE, V21, P827, DOI 10.1097/00007632-199604010-00010; Kalsi-Ryan S, 2013, NEUROSCIENTIST, V19, P409, DOI 10.1177/1073858412467377; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kaushal M, 2017, J NEUROTRAUM, V34, P1278, DOI 10.1089/neu.2016.4649; Kharbanda HS, 2006, MAGN RESON MED, V56, P334, DOI 10.1002/mrm.20959; Kolesar TA, 2015, MAGN RESON INSIGHTS, V8, P31, DOI 10.4137/MRI.S23556; Kong YZ, 2014, P NATL ACAD SCI USA, V111, P18067, DOI 10.1073/pnas.1414293111; Kornelsen J, 2007, SPINAL CORD, V45, P485, DOI 10.1038/sj.sc.3102019; Levy S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189944; Martin AR, 2017, AM J NEURORADIOL, V38, P1257, DOI 10.3174/ajnr.A5163; Martin AR, 2017, AM J NEURORADIOL, V38, P1266, DOI 10.3174/ajnr.A5162; Martin AR, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019809; Martin AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195733; Massire A, 2016, NEUROIMAGE, V143, P58, DOI 10.1016/j.neuroimage.2016.08.055; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McCoy DB, 2017, AM J NEURORADIOL, V38, P410, DOI 10.3174/ajnr.A5044; Min YS, 2015, J NEUROTRAUM, V32, P1422, DOI 10.1089/neu.2014.3661; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Mohammadi S, 2013, NEUROIMAGE, V70, P377, DOI 10.1016/j.neuroimage.2012.12.058; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Nouri A, 2017, NEUROSURGERY, V80, P121, DOI 10.1227/NEU.0000000000001420; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; Peterson DJ, 2017, AM J NEURORADIOL, V38, P2015, DOI 10.3174/ajnr.A5334; Prados F, 2016, SCI REP-UK, V6, DOI 10.1038/srep36151; Sabre L, 2016, SPINAL CORD, V54, P65, DOI 10.1038/sc.2015.158; Saritas E.U., 2014, QUANTITATIVE MRI SPI, P91, DOI [10.1016/B978-0-12-396973-6.00007-1., DOI 10.1016/B978-0-12-396973-6.00007-1]; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Smith AC, 2018, ARCH PHYS MED REHAB, V99, P660, DOI 10.1016/j.apmr.2017.10.002; Smith S. A., 2014, QUANTITATIVE MRI SPI, P106; Standring S., 2008, GRAYS ANATOMY, P257; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Stroman PW, 2008, MAGN RESON IMAGING, V26, P809, DOI 10.1016/j.mri.2008.01.038; Stroman PW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167317; Stroman PW, 2016, J NEUROTRAUM, V33, P1450, DOI 10.1089/neu.2015.4257; Stroman PW, 2002, NEUROIMAGE, V17, P1854, DOI 10.1006/nimg.2002.1305; Stroman PW, 2004, SPINAL CORD, V42, P59, DOI 10.1038/sj.sc.3101559; Summers P, 2006, AM J NEURORADIOL, V27, P1952; Talairach J., 1988, COPLANAR STEREOTAXIC; Taso M., 2017, P INT SOC MAGN RES M; Taso M, 2016, NMR BIOMED, V29, P817, DOI 10.1002/nbm.3530; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tetreault LA, 2013, SPINE, V38, pS89, DOI 10.1097/BRS.0b013e3182a7eae0; Topfer R., 2017, P 25 ANN M ISMRM HON, P964; Topfer R, 2016, MAGN RESON MED, V76, P1604, DOI 10.1002/mrm.26354; Valsasina P., 2012, AM J NEURORADIOL, V33, P2195; Valsasina P, 2012, HUM BRAIN MAPP, V33, P2072, DOI 10.1002/hbm.21346; Van Huijzen C., 2007, HUMAN CENTRAL NERVOU; Vavasour IM, 2014, SPINE J, V14, P2344, DOI 10.1016/j.spinee.2014.01.036; Verma T, 2014, MAGN RESON MED, V72, P1629, DOI 10.1002/mrm.25075; WADA E, 1995, SPINE, V20, P2226, DOI 10.1097/00007632-199510001-00009; Weber KA, 2018, NEUROSCIENCE, V369, P40, DOI 10.1016/j.neuroscience.2017.10.035; Weber KA, 2016, NEUROIMAGE, V143, P267, DOI 10.1016/j.neuroimage.2016.09.015; Weber KA, 2016, NEUROIMAGE, V125, P233, DOI 10.1016/j.neuroimage.2015.10.014; Weidner N., 2017, NEUROLOGICAL ASPECTS; Wheeler-Kingshott CA, 2014, NEUROIMAGE, V84, P1082, DOI 10.1016/j.neuroimage.2013.07.014; Wrigley PJ, 2018, HUM BRAIN MAPP, V39, P588, DOI 10.1002/hbm.23868; Yiannakas MC, 2016, NEUROIMAGE-CLIN, V10, P71, DOI 10.1016/j.nicl.2015.11.001; YOUNG JS, 1978, PARAPLEGIA, V16, P39, DOI 10.1038/sc.1978.6; Zaimi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22181-4; Zaimi A, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00037; Zhang B, 2017, MAGN RESON MED, V78, P1623, DOI 10.1002/mrm.26538	102	4	4	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2018	35	16					1942	1957		10.1089/neu.2018.5903			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ2YY	WOS:000441527400012	30074873				2022-02-06	
J	Fokin, A; Wycech, J; Picard, E; Weisz, R; Puente, I				Fokin, Alexander; Wycech, Joanna; Picard, Eric; Weisz, Russell; Puente, Ivan			Is First Rib Fracture a Culprit or a Sign of Injury Severity? It Is Both	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						first rib fractures; subclavian structures' coinjuries; first thoracic vertebra injuries; clavicle fracture; chest trauma	SUBCLAVIAN ARTERY	Objectives: First rib fractures (first RFX) have been correlated with increased morbidity and mortality. Whether this is due to the fracture of the rib itself or due to an increased number of associated injuries remains debatable. Design: Retrospective cohort study. Setting: Level 1 trauma center. Patients: One thousand eighty-nine patients with rib fractures divided into 3 groups: group A (n = 44) with isolated first RFX, group B (n = 116) with first RFX combined with other rib fractures, and group C (n = 929) with rib fractures without first RFX. Intervention: None. Outcome measurements: Age, sex, Injury Severity Score, mortality, number of ribs fractured (RFX), incidences of flail chest, multiple coinjuries, hospital and intensive care unit lengths of stay, and duration of mechanical ventilation. Results: Group A, when compared with group B, had significantly lower Injury Severity Score, RFX, rates of flail chest, pulmonary coinjuries, and shorter hospital length of stay and intensive care unit length of stay. Group A compared with group C had significantly lower age, RFX, rates of flail chest, and hemopneumothorax. In group B, all outcome measurements were significantly higher than those in group C. Incidence of subclavian artery, brachial plexus, and first thoracic vertebra injuries was significantly higher in group A. Frequency of traumatic brain and orthopaedic coinjuries was comparable in both groups with first RFX. Conclusions: Isolated first RFX alone are associated with higher incidence of injuries to subclavian structures and the first thoracic vertebrae. When they are combined with fractures of other ribs, the overall severity of trauma expands significantly.	[Fokin, Alexander; Wycech, Joanna; Picard, Eric; Weisz, Russell; Puente, Ivan] Delray Med Ctr, Div Trauma & Crit Care Serv, 5352 Linton Blvd, Delray Beach, FL 33484 USA; [Wycech, Joanna; Puente, Ivan] Broward Hlth Med Ctr, Div Trauma & Crit Care Serv, Ft Lauderdale, FL USA; [Picard, Eric; Puente, Ivan] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Surg, Boca Raton, FL 33431 USA; [Puente, Ivan] Florida Int Univ, Herbert Wertheim Coll Med, Dept Surg, Miami, FL 33199 USA		Fokin, A (corresponding author), Delray Med Ctr, Div Trauma & Crit Care Serv, 5352 Linton Blvd, Delray Beach, FL 33484 USA.	Alexander.Fokin@tenethealth.com	Wycech, Joanna/AAC-1162-2019	Wycech, Joanna/0000-0002-8869-8575			ALBERS JE, 1982, ANN THORAC SURG, V33, P614, DOI 10.1016/S0003-4975(10)60822-3; BASSETT JS, 1968, J TRAUM, V8, P418, DOI 10.1097/00005373-196805000-00008; Cameron P, 1996, AUST NZ J SURG, V66, P530, DOI 10.1111/j.1445-2197.1996.tb00803.x; Chatterjee Souvik, 2011, Tanaffos, V10, P60; COSTA MC, 1988, J VASC SURG, V8, P71, DOI 10.1067/mva.1988.avs0080071; Flagel BT, 2005, SURGERY, V138, P717, DOI 10.1016/j.surg.2005.07.022; Gupta A, 1997, Cardiovasc Surg, V5, P48, DOI 10.1016/S0967-2109(97)00060-4; Legaye J, 2006, EUR J ORTHOP SURG TR, V16, P357; Lin YC, 2015, J EMERG MED, V49, P868, DOI 10.1016/j.jemermed.2015.07.031; MCADAM JG, 1986, INJURY, V17, P226, DOI 10.1016/0020-1383(86)90224-X; Mirza AK, 2017, J SURG CASE REP, V6, P1; PHILLIPS EH, 1981, SURGERY, V89, P42; RICHARDSON JD, 1975, ANN SURG, V181, P251, DOI 10.1097/00000658-197503000-00001; Rostas JW, 2017, AM J SURG, V213, P791, DOI 10.1016/j.amjsurg.2016.08.002; Sakellaridis T, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.009225; Sammy IA, 2017, EMERG MED J, V34, P205, DOI 10.1136/emermed-2016-206077; Stahl Daniel, 2017, J Orthop Trauma, V31, P225, DOI 10.1097/BOT.0000000000000758; YEE ES, 1981, ANN THORAC SURG, V32, P278, DOI 10.1016/S0003-4975(10)61051-X; Yonezawa N, 2017, CLIN CASE REP, V5, P260, DOI 10.1002/ccr3.823	19	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	AUG	2018	32	8					391	396		10.1097/BOT.0000000000001189			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HB8QI	WOS:000451355100013	29738402				2022-02-06	
J	Gerrish, AW; Hamill, ME; Love, KM; Lollar, DI; Locklear, TM; Dhiman, N; Nussbaum, MS; Collier, BR				Gerrish, Ashley W.; Hamill, Mark E.; Love, Katie M.; Lollar, Daniel I.; Locklear, Tonja M.; Dhiman, Nitasha; Nussbaum, Michael S.; Collier, Bryan R.			Postdischarge Mortality after Geriatric Low-Level Falls: A Five-Year Analysis	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting and Postgraduate Course Program of the Southeastern-Surgical-Congress	FEB 10-13, 2018	Tampa, FL	SE Surg Congress			TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; OUTCOMES; RISK; EPIDEMIOLOGY; PREVENTION; MANAGEMENT	Geriatric trauma patients with low-level falls often have multiple comorbidities and limited physiologic reserve. Our aim was to investigate postdischarge mortality in this population. We hypothesized that five-year mortality would be higher relative to other blunt mechanisms. The registry of our Level 1 trauma center was queried for patients evaluated between July 2008 and December 2012. Adult patients identified were matched with mortality data from 2008 to 2013 from the National Death Index. Low-level falls were identified by E Codes; other types of blunt trauma were based on registry classification. Patients with multiple admissions were excluded. Univariate analysis was performed using Fisher's exact and Wilcoxon tests. Kaplan-Meier curves were plotted to compare postdischarge mortality. Seven thousand nine hundred sixteen patients were evaluated, 35.1 per cent were females. Patients aged less than 65 years and penetrating trauma were excluded, yielding 1997 patients-63.7 per cent with low-level falls versus 36.3 per cent with other blunt traumas. Geriatric patients sustaining low-level falls were older, more likely female, had a higher inpatient mortality, and were less likely to return home at discharge. Injury severity score, hospital length of stay, and intensive care unit length of stay were similar. Survival analysis demonstrated increased postdischarge mortality in the low-level fall group with 25 per cent mortality at 120 days. Geriatric patients with other blunt trauma had a significantly lower postdischarge mortality. Geriatric patients injured in low-level falls have a higher inhospital mortality, are more likely to be functionally dependent on discharge, and have a high postdischarge mortality. Opportunities likely exist for injury prevention, consideration of palliative care, and postdischarge rehabilitation.	[Gerrish, Ashley W.; Hamill, Mark E.; Love, Katie M.; Lollar, Daniel I.; Dhiman, Nitasha; Nussbaum, Michael S.; Collier, Bryan R.] Virginia Tech, Carilion Sch Med, Dept Surg, 1906 Belleview Ave SE, Roanoke, VA 24014 USA; [Locklear, Tonja M.] Carilion Clin, Roanoke, VA USA; [Dhiman, Nitasha] John T Mather Mem Hosp, Port Jefferson, NY USA		Hamill, ME (corresponding author), Virginia Tech, Carilion Sch Med, Dept Surg, 1906 Belleview Ave SE, Roanoke, VA 24014 USA.	hamillm@mac.com	Hamill, Mark/I-5919-2019	Hamill, Mark/0000-0001-9566-0009			Ayoung-Chee P, 2014, J TRAUMA ACUTE CARE, V76, P498, DOI 10.1097/TA.0000000000000102; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Fallon WF, 2006, J TRAUMA, V61, P1040, DOI 10.1097/01.ta.0000238652.48008.59; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hayes WC, 1996, BONE, V18, pS77, DOI 10.1016/8756-3282(95)00383-5; Hollis S, 2006, J TRAUMA, V61, P1255, DOI 10.1097/01.ta.0000243889.07090.da; Landefeld CS, 2003, ANN INTERN MED, V139, P421, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00008; Lenartowicz M, 2012, ANN SURG, V256, P1098, DOI 10.1097/SLA.0b013e318270f27a; Lewis Michael C, 2007, Anesthesiol Clin, V25, P75, DOI 10.1016/j.atc.2006.11.002; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Reuben DB, 2017, J AM GERIATR SOC, V65, P2733, DOI 10.1111/jgs.15121; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tornetta P, 1999, J TRAUMA, V46, P702, DOI 10.1097/00005373-199904000-00024; Victorino GP, 2003, ARCH SURG-CHICAGO, V138, P1093, DOI 10.1001/archsurg.138.10.1093	19	4	4	0	2	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	AUG	2018	84	8					1272	1276					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	GS6SG	WOS:000443828300035	30185299				2022-02-06	
J	Hutchison, JS; Emery, C; Gagnon, I; Leger, C; Riopelle, R; Wellington, C; Wilson, E; Turgeon, AF				Hutchison, James S.; Emery, Carolyn; Gagnon, Isabelle; Leger, Caroline; Riopelle, Richard; Wellington, Cheryl; Wilson, Elisa; Turgeon, Alexis F.		Canadian Traumatic Brain Injury	The Canadian Traumatic Brain Injury Research Consortium: Epitomizing Collaborative Research in Canada	JOURNAL OF NEUROTRAUMA			English	Article						collaboration; investigator-led; programmatic approach; research network	CLINICAL-RESEARCH; CRITICAL-CARE; TRIALS GROUP; CHILDREN; EPIDEMIOLOGY; MORTALITY; BURDEN	Traumatic brain injury (TBI) is one of the leading causes of disability and mortality worldwide. The TBI pathogenesis can induce broad pathophysiological consequences and clinical outcomes attributed to the complexity of the brain. Thus, the diagnosis and prognosis are important issues for the management of mild, moderate, and severe forms of TBI. Metabolomics of readily accessible biofluids is a promising tool for establishing more useful and reliable biomarkers of TBI than using clinical findings alone. Metabolites are an integral part of all biochemical and pathophysiological pathways. Metabolomic processes respond to the internal and external stimuli resulting in an alteration of metabolite concentrations. Current high-throughput and highly sensitive analytical tools are capable of detecting and quantifying small concentrations of metabolites, allowing one to measure metabolite alterations after a pathological event when compared to a normal state or a different pathological process. Further, these metabolic biomarkers could be used for the assessment of injury severity, discovery of mechanisms of injury, and defining structural damage in the brain in TBI. Metabolic biomarkers can also be used for the prediction of outcome, monitoring treatment response, in the assessment of or prognosis of post-injury recovery, and potentially in the use of neuroplasticity procedures. Metabolomics can also enhance our understanding of the pathophysiological mechanisms of TBI, both in primary and secondary injury. Thus, this review presents the promising application of metabolomics for the assessment of TBI as a stand-alone platform or in association with proteomics in the clinical setting.	[Hutchison, James S.] Hosp Sick Children, Dept Crit Care, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Hutchison, James S.; Wilson, Elisa] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Res Program, Toronto, ON, Canada; [Hutchison, James S.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Hutchison, James S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Emery, Carolyn] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Emery, Carolyn] Univ Calgary, Hotchkiss Brain Inst, OBrien Inst Publ Hlth, Alberta Childrens Hosp,Res Inst,Cumming Sch Med, Calgary, AB, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Trauma Ctr, Montreal Childrens Hosp, Ctr Hlth, Montreal, PQ, Canada; [Leger, Caroline] Univ Laval, Res Ctr, Populat Hlth & Optimal Hlth Practices Res Unit Tr, CHU Quebec, Quebec City, PQ, Canada; [Riopelle, Richard] Ontario Neurotrauma Fdn, Toronto, ON, Canada; [Riopelle, Richard] Brain Injury Canada, Ottawa, ON, Canada; [Wellington, Cheryl] Univ British Columbia, Dept Pathol & Lab Med, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Turgeon, Alexis F.] Univ Laval, Div Crit Care Med, Dept Anesthesiol & Crit Care Med, Quebec City, PQ, Canada		Hutchison, JS (corresponding author), Hosp Sick Children, Dept Crit Care, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Turgeon, AF (corresponding author), Univ Laval, Div Crit Care Med, Dept Anesthesiol & Crit Care Med, CHU Quebec,Res Ctr, 18e Rue,Room Z-204, Quebec City, PQ G1J 1Z4, Canada.	jamie.hutchison@sickkids.ca; alexis.turgeon@fmed.ulaval.ca	Emery, Carolyn/AAI-2761-2020	Gagnon, Isabelle/0000-0003-2043-1644	CIHRCanadian Institutes of Health Research (CIHR) Funding Source: Medline		Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Carlozzi N. E., 2018, J HEAD TRAUMA REHABI; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; CIHI, 2007, BURD NEUR DIS DIS IN; Cook D, 2002, CRIT CARE MED, V30, P1636, DOI 10.1097/00003246-200207000-00039; Hall R, 2016, CAN J ANESTH, V63, P1215, DOI 10.1007/s12630-016-0719-6; Hall R, 2010, CAN J ANESTH, V57, P1051, DOI 10.1007/s12630-010-9385-2; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Marshall JC, 2009, CRIT CARE MED, V37, pS165, DOI 10.1097/CCM.0b013e3181921079; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077	20	4	4	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2018	35	16					1858	1863		10.1089/neu.2018.5871			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ2YY	WOS:000441527400003	30074867				2022-02-06	
J	Mishra, SK; Khushu, S; Gangenahalli, G				Mishra, Sushanta Kumar; Khushu, Subash; Gangenahalli, Gurudutta			Effects of iron oxide contrast agent in combination with various transfection agents during mesenchymal stem cells labelling: An in vitro toxicological evaluation	TOXICOLOGY IN VITRO			English	Article						Antioxidant enzyme; Fe-pro complex; Genotoxicity; IO-PLL complex; Mesenchymal stem cells; Ultrasmall superparamagnetic iron oxide nanoparticles	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; NANOPARTICLES; CANCER; DAMAGE; MRI; OPTIMIZATION; GENOTOXICITY; CYTOTOXICITY; ANTIOXIDANTS	The use of iron oxide nanoparticles for different biomedical applications, hold immense promise to develop negative tissue contrast in magnetic resonance imaging (MRI). Previously, we have optimized the labelling of mesenchymal stem cells (MSCs) with iron oxide nanoparticles complexed to different transfection agents like poly-L-lysine (IO-PLL) and protamine sulfate (Fe-Pro) on the basis of relaxation behaviour and its biological expressions. However, there is a distinct need to investigate the biocompatibility and biosafety concerns coupled with its cytotoxicity and genotoxicity. This study was prepared to evaluate the viability of cells, generation of ROS, changes in actin cytoskeleton, investigation of cell death, level of GSH and TAC, activities of SOD and GPx, and stability of DNA in MSCs after labelling. Results demonstrated a marginal alteration in toxicological parameters like ROS generation, cell length, actin cytoskeleton, total apoptosis and DNA damage was detected after stem cell labelling. Insignificant depletion of GSH and SOD level, and increase in GPx and TAC level in MSCs were measured after labelling with IO-PLL and Fe-Pro complexes, which later on recovered and normalized to its baseline. This MSCs labelling could provide a reference guideline for toxicological analysis and relaxometry based in vivo MRI detection.	[Mishra, Sushanta Kumar; Khushu, Subash] DRDO, INMAS, NMR Res Ctr, Delhi 54, India; [Mishra, Sushanta Kumar; Gangenahalli, Gurudutta] DRDO, INMAS, Div Stem Cell & Gene Therapy Res, Delhi 54, India		Khushu, S (corresponding author), DRDO, INMAS, NMR Res Ctr, Delhi 54, India.; Gangenahalli, G (corresponding author), DRDO, INMAS, Div Stem Cell & Gene Therapy Res, Delhi 54, India.	skhushu@yahoo.com; gugdutta@rediffmail.com	Mishra, Sushanta Kumar/N-5958-2019	Mishra, Sushanta/0000-0002-3403-6891	Defence Research and Development Organization (DRDO), Ministry of Defence, Govt. of IndiaDefence Research & Development Organisation (DRDO) [INM-311, 4.1]; Indian Council of Medical Research (ICMR)Indian Council of Medical Research (ICMR) [2014-25070]	The S & T project (INM-311, 4.1) was supported by funding from the Defence Research and Development Organization (DRDO), Ministry of Defence, Govt. of India, and the research team wishes to thank them for their valuable assistance. The authors also wish to express their gratitude to Dr. Anurag Agrawal and Bijay Ranjan Pattnaik (SRF), Translational research in asthma laboratory, IGIB for their unstinted support in the microscopy study and flow cytometric analysis. The authors also thank and acknowledge Dr. Sudhir Chandna (INMAS) and Dr. N. K. Choudhury (INMAS) for providing the facility to carry out comet assay. Mr. Sushanta Kumar Mishra acknowledges and sincerely thanks the Indian Council of Medical Research (ICMR) (2014-25070) for providing a research fellowship in support of the project.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Duan XH, 2012, EUR J RADIOL, V81, P2154, DOI 10.1016/j.ejrad.2011.06.050; Fan JJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt191; Gupta AK, 2004, J MATER SCI-MATER M, V15, P493, DOI 10.1023/B:JMSM.0000021126.32934.20; Gutierrez-Fernandez M, 2011, NEUROSCIENCE, V175, P394, DOI 10.1016/j.neuroscience.2010.11.054; Heyn C, 2005, MAGN RESON MED, V53, P312, DOI 10.1002/mrm.20356; Hong SC, 2011, INT J NANOMED, V6, P3219, DOI 10.2147/IJN.S26355; Hua P, 2015, MOL MED REP, V11, P113, DOI 10.3892/mmr.2014.2649; Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032; Jo J, 2010, J CONTROL RELEASE, V142, P465, DOI 10.1016/j.jconrel.2009.11.014; Johannsen M, 2010, INT J HYPERTHER, V26, P790, DOI 10.3109/02656731003745740; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; Khan MI, 2012, BIOMATERIALS, V33, P1477, DOI 10.1016/j.biomaterials.2011.10.080; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462; Mahmoudi M, 2010, COLLOID SURFACE B, V75, P300, DOI 10.1016/j.colsurfb.2009.08.044; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mesarosova M, 2014, TOXICOL LETT, V226, P303, DOI 10.1016/j.toxlet.2014.02.025; Miller IS, 2010, J BIOMED MATER RES A, V93A, P493, DOI 10.1002/jbm.a.32530; Mishra SK, 2017, EXP CELL RES, V351, P59, DOI 10.1016/j.yexcr.2016.12.025; Mishra SK, 2017, STEM CELL TRANSL MED, V6, P316, DOI 10.5966/sctm.2016-0087; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Mishra SK, 2016, CONTRAST MEDIA MOL I, V11, P350, DOI 10.1002/cmmi.1698; Mishra SK, 2015, EXP CELL RES, V339, P427, DOI 10.1016/j.yexcr.2015.11.010; Novotna B, 2012, TOXICOL LETT, V210, P53, DOI 10.1016/j.toxlet.2012.01.008; Pongrac IM, 2016, INT J NANOMED, V11, DOI 10.2147/IJN.S102730; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rai S, 2011, J BIOMED NANOTECHNOL, V7, P121, DOI 10.1166/jbn.2011.1231; Safi M, 2011, BIOMATERIALS, V32, P9353, DOI 10.1016/j.biomaterials.2011.08.048; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Soenen SJH, 2011, BIOMATERIALS, V32, P195, DOI 10.1016/j.biomaterials.2010.08.075; Stone V., 2013, NANOTOXICOLOGY, V52, P1, DOI [DOI 10.3109/17435390.2013.847505, 10.3109/17435390.2013.773464]; Thorek DLJ, 2008, BIOMATERIALS, V29, P3583, DOI 10.1016/j.biomaterials.2008.05.015; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wang JY, 2011, TOXICOL IN VITRO, V25, P242, DOI 10.1016/j.tiv.2010.11.010; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; Xu HY, 2011, BIOMATERIALS, V32, P9758, DOI 10.1016/j.biomaterials.2011.08.076; Yu M, 2012, INT J MOL SCI, V13, P5554, DOI 10.3390/ijms13055554; Zhu MT, 2010, J NANOSCI NANOTECHNO, V10, P8584, DOI 10.1166/jnn.2010.2488	44	4	4	0	26	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-2333			TOXICOL IN VITRO	Toxicol. Vitro	AUG	2018	50						179	189		10.1016/j.tiv.2018.03.009			11	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	GM1HA	WOS:000437815500019	29577976				2022-02-06	
J	Moffett, BS; Weingarten, MM; Schmees, LR; Galati, M; Erklauer, J; Riviello, JJ				Moffett, Brady S.; Weingarten, Mindl M.; Schmees, Lindsay R.; Galati, Marianne; Erklauer, Jennifer; Riviello, James J.			Fosphenytoin Population Pharmacokinetics in the Acutely Ill Pediatric Population*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						fosphenytoin; NONMEM; pediatrics; population pharmacokinetics	FREE PHENYTOIN CONCENTRATIONS; TRAUMATIC BRAIN-INJURY; ADULT PATIENTS; RENAL-DISEASE; CHILDREN; THERAPY	Objective: The purpose of this study is to describe the pharmacokinetics of phenytoin in pediatric patients receiving fosphenytoin. Design: Retrospective, population pharmacokinetic analysis. Setting: Emergency department or PICU of a large tertiary care children's hospital. Patients: Patients less than 19 years old who received fosphenytoin in the PICU or emergency center for treatment of seizures from January 2011 to June 2017 were included. Interventions: Population pharmacokinetic analysis was performed with NONMEM v7.3 (Icon Plc, Dublin, Ireland). Simulation was performed to determine optimal loading dose and maintenance dosing regimens. Measurements and Main Results: A total of 536 patients (55.4% male; median age, 3.4 yr [interquartile range, 0.92-8.5 yr]) met study criteria. Fosphenytoin was administered at median 15.1mg/kg/dose (interquartile range, 6.3-20.7mg/kg/dose). Mean serum concentrations of 17.57.8mg/L were at a median 4.2 hours (interquartile range, 2.5-7.8hr) after a dose. A pharmacokinetic model with two compartments, allometrically scaled fat-free mass on all parameters, and serum creatinine and concomitant phenobarbital use on clearance had the best fit. Simulation demonstrated that a 20mg/kg loading dose followed by 6mg/kg/dose every 8 hours had the greatest percentage of concentrations in the 10-20mg/L range, with reduced doses to achieve therapeutic in patients with reduced kidney function. Conclusions: A loading dose of 20mg/kg followed by 6mg/kg/dose every 8 hours based on fat-free mass is a reasonable empiric strategy for attainment and maintenance of therapeutic trough concentrations. Concomitant phenobarbital use may increase clearance of phenytoin and fosphenytoin dose reductions should occur in patients with reduced kidney function.	[Moffett, Brady S.; Weingarten, Mindl M.; Schmees, Lindsay R.] Texas Childrens Hosp, Dept Pharm, Houston, TX 77030 USA; [Moffett, Brady S.; Weingarten, Mindl M.; Schmees, Lindsay R.; Erklauer, Jennifer; Riviello, James J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Galati, Marianne] Texas Med Ctr Lib, Houston, TX USA		Moffett, BS (corresponding author), Texas Childrens Hosp, Dept Pharm, Houston, TX 77030 USA.; Moffett, BS (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	bsmoffet@texaschildrens.org		Weingarten, Mindl/0000-0003-3412-4047	Greenwich Pharmaceuticals	Dr. Weingarten received funding from Greenwich Pharmaceuticals. Drs. Weingarten and Riviello disclosed off-label product use in the article. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abend NS, 2008, PEDIATR EMERG CARE, V24, P705, DOI 10.1097/PEC.0b013e318188fcac; Al-Sallami HS, 2015, CLIN PHARMACOKINET, V54, P1169, DOI 10.1007/s40262-015-0277-z; Anderson BJ, 2011, PEDIATR ANESTH, V21, P222, DOI 10.1111/j.1460-9592.2011.03536.x; Anderson BJ, 2009, DRUG METAB PHARMACOK, V24, P25, DOI 10.2133/dmpk.24.25; [Anonymous], 2016, DRUG INFORM HDB; [Anonymous], 2011, CEREBYX R INTRAVENOU; Aweeka FT, 1999, EPILEPSIA, V40, P777, DOI 10.1111/j.1528-1157.1999.tb00778.x; Batchelor H, 2015, SEIZURE-EUR J EPILEP, V33, P8, DOI 10.1016/j.seizure.2015.10.006; Beal SL, 2002, J PHARMACOKINET PHAR, V29, P403, DOI 10.1023/A:1020909324909; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; BROWNE TR, 1988, NEUROLOGY, V38, P639, DOI 10.1212/WNL.38.4.639; BUCHANAN RA, 1969, PEDIATRICS, V43, P114; CUCINELL SA, 1965, CLIN PHARMACOL THER, V6, P420; Empey PE, 2013, CRIT CARE MED, V41, P2379, DOI 10.1097/CCM.0b013e318292316c; Fischer JH, 2003, CLIN PHARMACOKINET, V42, P33, DOI 10.2165/00003088-200342010-00002; Hennig S, 2015, J CLIN PHARMACOL, V55, P355, DOI 10.1002/jcph.417; Hooker AC, 2007, PHARM RES, V24, P2187, DOI 10.1007/s11095-007-9361-x; Messinger MM, 2015, THER DRUG MONIT, V37, P772, DOI 10.1097/FTD.0000000000000241; Nakazawa M, 2015, BRAIN DEV-JPN, V37, P418, DOI 10.1016/j.braindev.2014.06.009; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Ogutu BR, 2002, BRIT J CLIN PHARMACO, V54, P635, DOI 10.1046/j.1365-2125.2002.01689.x; Pellock JM, 1996, NEUROLOGY, V46, P14, DOI 10.1212/WNL.46.6_Suppl_1.14S; Prasad Asuri N, 2006, Adv Neurol, V97, P229; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Smetana KS, 2016, J CRIT CARE, V36, P116, DOI 10.1016/j.jcrc.2016.06.023; Soriano VV, 2017, ANN PHARMACOTHER, V51, P669, DOI 10.1177/1060028017707541; Stowe CD, 2000, J CLIN PHARMACOL, V40, P1452; Sutherland SM, 2015, CLIN J AM SOC NEPHRO, V10, P554, DOI 10.2215/CJN.01900214; Takeoka M, 1998, J CHILD NEUROL, V13, P537, DOI 10.1177/088307389801301102; Tanaka J, 2013, EUR J CLIN PHARMACOL, V69, P489, DOI 10.1007/s00228-012-1373-8; Voytko S M, 1997, Pediatr Nurs, V23, P503; Wheless JW, 1998, J CHILD NEUROL, V13, pS11, DOI 10.1177/0883073898013001041; Wolf GK, 2006, PEDIATR CRIT CARE ME, V7, P434, DOI 10.1097/01.PCC.0000235252.43921.DE; Yamamoto Y, 2015, THER DRUG MONIT, V37, P229, DOI 10.1097/FTD.0000000000000128	34	4	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	AUG	2018	19	8					748	754		10.1097/PCC.0000000000001627			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	GP5WF	WOS:000440946300017	29927880				2022-02-06	
J	Ouyang, W; Wu, WH; Fan, ZH; Wang, JH; Pan, HJ; Yang, WB				Ouyang, Wei; Wu, Wenhui; Fan, Zhiheng; Wang, Jihui; Pan, Huiju; Yang, Weibin			Modified device for fluid percussion injury in rodents	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						behavior changes; electrophysiological changes; fluid percussion device; neurological evaluation; percussion parameters; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ANIMAL-MODELS; ACUTE-PHASE; RAT; THETA; MICE; SEIZURES; NETWORK; IMPACT; HYPOACTIVITY	Fluid percussion (FP) injury model is a popular animal model of traumatic brain injury (TBI), but still there are some issues need to be addressed. To increase the validity and reliability of this technique, we adapted the FP device using electromagnetic protractor, stainless-steel cylinder, changing pressure transducer position, and foam pads to adjust the parameters of FP pulse. Besides, the adjusted FP device is more automatic. The FP pulse is promptly measured and displayed in a graphic user interface software. The modified device resulted in reliable FP pulse. The accuracy of the pendulum leveling was improved with using the electromagnetic protractor with slots. We then collected behavioral, cognition, electrophysiological, and immunohistochemical data to verify the percussion effects in TBI mice. Lateral fluid percussion injury (FPI) or sham treatment was administered at the right frontal motorsensory region of male C57BL/6J mice. TBI mice showed evident motor, cognitive, and functional impairments, characterized by evaluation of neurological, righting, geotaxis and cliff aversion reflexes, limb asymmetrical use, rotarod running, and Morris water maze testing. The neurobehavioral damages were scaled with histopathological findings. Further, the overall firing rates and theta powers in hippocampal CA1 were significantly reduced in TBI mice compared to sham mice at Days 2 and 3 after electrode implanting. The adapted device induced effects on behavior and biology in mice that agree with existing models. These findings confirmed the validity of adjustments, and the modified device may boost the interest in TBI studies.	[Ouyang, Wei; Fan, Zhiheng; Wang, Jihui; Pan, Huiju] Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, 688 Yingbing Ave, Jinhua 321004, Zhejiang, Peoples R China; [Wu, Wenhui] East China Jiaotong Univ, Sch Phys Educ & Hlth, Nanchang, Jiangxi, Peoples R China; [Yang, Weibin] Zhejiang Coll Sports, Affiliated Sports Med Hosp, Hangzhou, Zhejiang, Peoples R China		Ouyang, W (corresponding author), Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, 688 Yingbing Ave, Jinhua 321004, Zhejiang, Peoples R China.	wouyang@zjnu.cn		Ouyang, Wei/0000-0003-2866-491X	Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY15H090012]	Natural Science Foundation of Zhejiang Province, Grant/Award Number: LY15H090012	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Colgin LL, 2016, NAT REV NEUROSCI, V17, P239, DOI 10.1038/nrn.2016.21; de la Tremblaye PB, 2018, NEUROSCI BIOBEHAV R, V85, P160, DOI 10.1016/j.neubiorev.2017.05.022; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Groothuis J, 2014, BRAIN STIMUL, V7, P1, DOI 10.1016/j.brs.2013.07.001; Halford JJ, 2015, CLIN NEUROPHYSIOL, V126, P1661, DOI 10.1016/j.clinph.2014.11.008; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hyman JM, 2003, J NEUROSCI, V23, P11725; Johnstone MR, 2018, BRAIN INJURY, V32, P257, DOI 10.1080/02699052.2017.1394492; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Le Roy I, 1999, DEV PSYCHOBIOL, V34, P139, DOI 10.1002/(SICI)1098-2302(199903)34:2<139::AID-DEV7>3.0.CO;2-H; Lin YP, 2015, NEURAL REGEN RES, V10, P1088, DOI 10.4103/1673-5374.160100; Loscher W, 2016, EPILEPSY RES, V126, P157, DOI 10.1016/j.eplepsyres.2016.05.016; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Ramirez RL, 2010, PHARMACOL BIOCHEM BE, V95, P242, DOI 10.1016/j.pbb.2010.01.013; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Ten VS, 2003, BEHAV BRAIN RES, V145, P209, DOI 10.1016/S0166-4328(03)00146-3; Velazquez JLP, 2007, EPILEPSIA, V48, P1585, DOI 10.1111/j.1528-1167.2007.01120.x; Verleye M, 2003, NEUROSCI LETT, V353, P127, DOI 10.1016/j.neulet.2003.09.010; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Wahab RA, 2015, J NEUROSCI METH, V248, P16, DOI 10.1016/j.jneumeth.2015.03.010; Watts LT, 2015, J NEUROTRAUM, V32, P1001, DOI 10.1089/neu.2014.3737; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613; Yarnell A. M., 2016, CURRENT PROTOCOLS NE, V75; Young CK, 2009, CEREB CORTEX, V19, P24, DOI 10.1093/cercor/bhn055	57	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	AUG	2018	96	8					1412	1429		10.1002/jnr.24261			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GJ2GM	WOS:000435088300009	29775205				2022-02-06	
J	Ruan, MF; Li, L; Chen, C; Wu, X				Ruan, Mianfang; Li, Li; Chen, Chen; Wu, Xie			STRETCH COULD REDUCE HAMSTRING INJURY RISK DURING SPRINTING BY RIGHT SHIFTING THE LENGTH-TORQUE CURVE	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						angle-torque relationship; tension-length relationship; muscle strain Injures; biomechanics	CONTRACTION-INDUCED INJURY; PROFESSIONAL FOOTBALL; MUSCLE KINEMATICS; STRAIN INJURIES; EARLY STANCE; JOINT-ANGLE; PEAK TORQUE; PREVENTION; ELECTROMYOGRAPHY; EPIDEMIOLOGY	It was hypothesized that static stretch would shift the length-torque curve to the right, which may reduce the risk of muscle strain injuries. The purpose of this study was to evaluate the acute effects of static stretching of hamstring (SSH) on the risk of hamstring injury during sprinting indicated by the shift of the length-torque relationship. Twelve female college athletes (age: 20.8 +/- 0.7 years; height: 1.61 +/- 0.05 m; body mass: 54.25 +/- 4.22 kg) participated in this study. Subjects performed overground sprinting under 2 conditions: after warm-up with 4 x 30 seconds SSH or after warm-up without SSH. Three-dimensional kinematic and kinetic data and electromyography of biceps femoris long head (BFIh), rectus femoris, and vastus medialis were collected during testing. The maximum length of BFIh during late swing phase increased after SSH with large effect size and close to statistically significant (p = 0.05, d = 1.22), but the knee flexion torque at the peak length did not change significantly. Static stretching of hamstring significantly reduced peak values of both horizontal (d = 1.46) and vertical (d= 1.79) ground reaction forces, and BFIh's activation level during the preactivation (late swing) phase (p = 0.05, d = 2.16). The results indicated that the length of BFIh-knee torque relationship and the length of BFIh-hip torque relationships during the late swing phase and initial stance phase were shifted to the right after SSH, which may reduce risk of hamstring strain injuries. We suggest that preactivity static stretching should not be simply removed and participators should give priority to stretch muscles that are vulnerable to strain injuries.	[Ruan, Mianfang] Ningbo Univ, Fac Phys Educ, Ningbo, Zhejiang, Peoples R China; [Ruan, Mianfang; Chen, Chen; Wu, Xie] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Li, Li] Georgia Southern Univ, Dept Hlth Sci & Kinesiol, Statesboro, GA 30460 USA		Wu, X (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.	wuxie_sus@163.com	Li, Li/AAJ-2868-2020	/0000-0001-5902-9762	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81572213]; Shanghai City Committee of Science and Technology Key Project [17080503200]; K.C. Wong Magna Fund in Ningbo University	The research was conducted in biomechanics laboratory, Shanghai University of Sport, China. This study was supported by the National Natural Science Foundation of China (No. 81572213) and the Shanghai City Committee of Science and Technology Key Project (No. 17080503200). This study was sponsored by K.C. Wong Magna Fund in Ningbo University. The results of the present study do not constitute endorsement of the product by the authors or the NSCA.	ACSM, 2010, ACSMS RESOURCE MANUA; Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Askling CM, 2007, AM J SPORT MED, V35, P1716, DOI 10.1177/0363546507303563; Behm DG, 2016, APPL PHYSIOL NUTR ME, V41, P1, DOI 10.1139/apnm-2015-0235; Cohen J, 1988, STAT POWER ANAL BEHA; Cramer JT, 2005, EUR J APPL PHYSIOL, V93, P530, DOI 10.1007/s00421-004-1199-x; Ekstrand J, 2012, BRIT J SPORT MED, V46, P112, DOI 10.1136/bjsports-2011-090155; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Freckleton G, 2013, BRIT J SPORT MED, V47, P351, DOI 10.1136/bjsports-2011-090664; GARRETT WE, 1990, MED SCI SPORT EXER, V22, P436; Heiderscheit BC, 2005, CLIN BIOMECH, V20, P1072, DOI 10.1016/j.clinbiomech.2005.07.005; Henderson G, 2010, J SCI MED SPORT, V13, P397, DOI 10.1016/j.jsams.2009.08.003; HENNESSY L, 1993, BRIT J SPORT MED, V27, P243, DOI 10.1136/bjsm.27.4.243; Herda TJ, 2008, J STRENGTH COND RES, V22, P809, DOI 10.1519/JSC.0b013e31816a82ec; Herzog W, 2017, J SPORT HEALTH SCI, V6, P128, DOI 10.1016/j.jshs.2017.01.006; Hunter KD, 1997, J APPL PHYSIOL, V82, P278, DOI 10.1152/jappl.1997.82.1.278; Ishikawa M, 2007, J APPL PHYSIOL, V103, P1030, DOI 10.1152/japplphysiol.00277.2007; Kubo K, 2002, ACTA PHYSIOL SCAND, V175, P157, DOI 10.1046/j.1365-201X.2002.00976.x; LIEBER RL, 1993, J APPL PHYSIOL, V74, P520, DOI 10.1152/jappl.1993.74.2.520; Magnusson SP, 1996, AM J SPORT MED, V24, P622, DOI 10.1177/036354659602400510; Mara JK, 2017, J STRENGTH COND RES, V31, P1500, DOI 10.1519/JSC.0000000000001629; Marginson V, 1996, J SPORTS SCI, V19, P37; McHugh MP, 2010, SCAND J MED SCI SPOR, V20, P169, DOI 10.1111/j.1600-0838.2009.01058.x; McHugh MP, 2008, MED SCI SPORT EXER, V40, P566, DOI [10.1249/MSS.0b013e31815d2f8c, 10.1249/mss.0b013e31815d2f8c]; McHugh MP, 2003, J SPORT SCI, V21, P927, DOI 10.1080/0264041031000140400; Morin JB, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00404; Nelson AG, 2001, J STRENGTH COND RES, V15, P241; Nelson AG, 2001, RES Q EXERCISE SPORT, V72, P68, DOI 10.1080/02701367.2001.10608934; Opar DA, 2012, SPORTS MED, V42, P209, DOI 10.2165/11594800-000000000-00000; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard JW, 2012, BRIT J SPORT MED, V46, P88, DOI 10.1136/bjsports-2011-090127; Proske U, 2004, CLIN EXP PHARMACOL P, V31, P546, DOI 10.1111/j.1440-1681.2004.04028.x; Roberts TJ, 2010, J APPL PHYSIOL, V109, P396, DOI 10.1152/japplphysiol.01272.2009; Ruan MF, 2018, J SPORT HEALTH SCI, V7, P123, DOI 10.1016/j.jshs.2017.05.006; Ruan MF, 2017, J STRENGTH COND RES, V31, P1241, DOI 10.1519/JSC.0000000000001783; Ryan ED, 2008, J ORTHOP SPORT PHYS, V38, P632, DOI 10.2519/jospt.2008.2843; Saripalli AL, 2017, J APPL PHYSIOL, V122, P1218, DOI 10.1152/japplphysiol.01054.2016; Slawinski J, 2017, J SPORT SCI, V35, P858, DOI 10.1080/02640414.2016.1194525; Sun YL, 2015, MED SCI SPORT EXER, V47, P373, DOI 10.1249/MSS.0000000000000404; Theis N, 2013, CLIN BIOMECH, V28, P1061, DOI 10.1016/j.clinbiomech.2013.10.001; Thelen DG, 2005, MED SCI SPORT EXER, V37, P1931, DOI 10.1249/01.mss.0000176674.42929.de; Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092; Torres EM, 2008, J STRENGTH COND RES, V22, P1279, DOI 10.1519/JSC.0b013e31816eb501; Unick J, 2005, J STRENGTH COND RES, V19, P206; WARREN GL, 1993, J PHYSIOL-LONDON, V464, P457, DOI 10.1113/jphysiol.1993.sp019645; Witvrouw E, 2004, SPORTS MED, V34, P443, DOI 10.2165/00007256-200434070-00003; Yu B, 2017, J SPORT HEALTH SCI, V6, P137, DOI 10.1016/j.jshs.2017.02.003; Yu B, 2008, J BIOMECH, V41, P3121, DOI 10.1016/j.jbiomech.2008.09.005	48	4	4	2	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	AUG	2018	32	8					2190	2198		10.1519/JSC.0000000000002645			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GP5CT	WOS:000440891300013	29912857	Green Published, hybrid			2022-02-06	
J	Waqas, M; Malik, N; Shamim, MS; Nathani, KR; Abbasi, SA				Waqas, Muhammad; Malik, Noor; Shamim, Muhammad Shahzad; Nathani, Karim Rizwan; Abbasi, Sumia Andleeb			Quality of Life Among Patients Undergoing Decompressive Craniectomy for Traumatic Brain Injury Using Glasgow Outcome Scale Extended and Quality of Life After Brain Injury Scale	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; QOLIBRI; Quality of life; Severe traumatic brain injury	QOLIBRI; INFARCTION; SURVIVAL; DISEASE; TBI	OBJECTIVE: To assess quality of life of patients who underwent decompressive craniectomy (DC) for traumatic brain injury and satisfaction of caregivers with outcomes. METHODS: This cross-sectional study was conducted at a tertiary care urban center in Pakistan. All patients with severe traumatic brain injury who underwent DC and survived >6 months were included. Outcomes were assessed using 2 scales: Glasgow Outcome Scale Extended and Quality of Life After Traumatic Brain Injury (QOLIBRI). The proforma was translated and validated into the national language. Patient caregivers were interviewed to ask if they would opt for DC in a similar situation in future. RESULTS: The study comprised 40 patients, including 35 male (88%) and 5 female (12%) patients. Mean age of patients was 26.5 +/- 9.5 years. Mean Glasgow Coma Scale score at presentation was 8.34 +/- 3.22. Median follow-up was 12 months (range, 6-18 months). Mean Glasgow Outcome Scale Extended score was 5.35 +/- 1.9, which correlates with an unfavorable outcome. Mean QOLIBRI score was 59.65 +/- 21.27. Family members of 38 (95%) patients were content with their decision to give consent for DC in their patients. Spearman correlation for different domains of QOLIBRI and Glasgow Outcome Scale Extended was statistically significant for all parameters except social relationship. CONCLUSIONS: Mean QOLIBRI score of patients undergoing DC was 59.65 +/- 21.27. Most caregivers (95%) were satisfied with their decision to consent for DC. Patient-reported health-related quality of life assessment is necessary to assess impact of traumatic brain injury.	[Waqas, Muhammad; Malik, Noor; Shamim, Muhammad Shahzad; Nathani, Karim Rizwan] Aga Khan Univ Hosp Karachi, Sect Neurosurg, Karachi, Pakistan; [Abbasi, Sumia Andleeb] Aga Khan Univ Karachi, Dept Community Hlth Sci, Karachi, Pakistan		Shamim, MS (corresponding author), Aga Khan Univ Hosp Karachi, Sect Neurosurg, Karachi, Pakistan.	shahzad.shamim@aku.edu	Waqas, Muhammad/A-5673-2013	Waqas, Muhammad/0000-0003-4500-7954; Nathani, Karim/0000-0003-4134-7011			CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper DJ, 2012, J NEUROTRAUM, V29, P2595, DOI 10.1089/neu.2011.2279; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Ferri CP, 2016, ARQ NEURO-PSIQUIAT, V74, P67, DOI 10.1590/0004-282X20150182; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hyder AA, 1998, AM J PUBLIC HEALTH, V88, P196, DOI 10.2105/AJPH.88.2.196; JENNETT B, 1975, LANCET, V1, P480; Lonnqvist PA, 2017, BRIT J ANAESTH, V118, P286, DOI 10.1093/bja/aew474; Menon DK, 2017, BRIT J ANAESTH, V119, P1062, DOI 10.1093/bja/aex374; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Shamim MS, 2011, J NEUROSURG, V115, P1007, DOI 10.3171/2011.7.JNS101829; Skoglund TS, 2008, ACTA NEUROL SCAND, V117, P305, DOI 10.1111/j.1600-0404.2007.00967.x; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Walcott BP, 2013, WORLD NEUROSURG, V79, P80, DOI 10.1016/j.wneu.2012.11.014; Waqas M, 2016, BRIT J NEUROSURG, V30, P258, DOI 10.3109/02688697.2016.1139047; Waqas M, 2016, J NEURORADIOLOGY, V43, P25, DOI 10.1016/j.neurad.2015.07.003; Woertgen C, 2004, ACTA NEUROCHIR, V146, P691, DOI 10.1007/s00701-004-0280-x	25	4	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2018	116						E783	E790		10.1016/j.wneu.2018.05.092			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GN9GM	WOS:000439498500100	29852303	Green Published			2022-02-06	
J	Weiss, OE; Hendler, RM; Canji, EA; Morad, T; Foox, M; Francis, Y; Dubinski, Z; Merfeld, I; Hammer, L; Baranes, D				Weiss, Orly Eva; Hendler, Roni Mina; Canji, Eyal Aviv; Morad, Tzachy; Foox, Maytal; Francis, Yitshak; Dubinski, Zvy; Merfeld, Ido; Hammer, Liat; Baranes, Danny			Modulation of scar tissue formation in injured nervous tissue cultivated on surface-engineered coralline scaffolds	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						traumatic brain injury; scar tissue; biomaterial scaffolds; reactive astrocytes; coral	GLIAL SCAR; REACTIVE ASTROCYTES; WOUND CONTRACTION; PERIPHERAL-NERVES; STEM-CELLS; IN-VITRO; REGENERATION; MORPHOLOGY; ROUGHNESS; GROWTH	Following traumatic brain injury, there is no restoration of the lost nervous tissue, mainly due to the formation of a scar. One promising strategy to overcome this hurdle is grafting scaffolds that can disturb the scar blockade, enabling cell invasion into the wound. The aragonite skeleton of corals is useful scaffolds for testing this strategy, being supportive for neural cells in culture. The purpose of this work was to check if a contact between a coralline scaffold and an injured nervous tissue affects scar formation and if this effect can be regulated by engineering the scaffold's surface topology. To address that, hippocampal slices were cultivated on a coral skeleton having two distinct surface shapes: (1) intact skeleton pieces (ISP): porous, microrough surface; (2) grained skeleton (GS): nonporous, macrorough surface. On ISP, slices deformed by engulfing the scaffold's outer surface without penetrating the pores, yet, they preserved their coherence. By contrast, on GS slices were flat, but broken into interconnected small segments of tissue. In addition, whereas on ISP astrocytes were significantly more active and diffusely distributed, on GS reactive astrocytes tightened into a single <90 mu m wide scar-like stripe at the slice's periphery. Hence, by grafting coralline scaffolds of predesigned surface roughness and porosity into brain wounds, control over scar tissue formation can be gained, providing an opportunity for cell migration and damage repair. (C) 2017 Wiley Periodicals, Inc.	[Weiss, Orly Eva; Hendler, Roni Mina; Canji, Eyal Aviv; Morad, Tzachy; Merfeld, Ido; Hammer, Liat; Baranes, Danny] Ariel Univ, Dept Mol Biol, Ariel, Israel; [Foox, Maytal] Tel Aviv Univ, Dept Biomed Engn, Tel Aviv, Israel; [Francis, Yitshak] Ariel Sci Innovat, Ariel, Israel; [Dubinski, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Merfeld, Ido; Hammer, Liat] Qrons Inc, Miami, FL 33131 USA		Baranes, D (corresponding author), Ariel Univ, Dept Mol Biol, Ariel, Israel.	dannyb@ariel.ac.il		Baranes, Danny/0000-0002-4240-6725	Qrons Inc.	Qrons Inc.	Ahmed I, 2006, J BIOMED MATER RES A, V76A, P851, DOI 10.1002/jbm.a.30587; Baranes D, 2007, TISSUE ENG, V13, P473, DOI 10.1089/ten.2006.0052; Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569; Chen GB, 2013, CURR STEM CELL RES T, V8, P313, DOI 10.2174/1574888X11308040007; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; De Bartolo L, 2008, J MEMBRANE SCI, V325, P139, DOI 10.1016/j.memsci.2008.07.022; Donoso MG, 2007, INT BIODETER BIODEGR, V59, P245, DOI 10.1016/j.ibiod.2006.09.011; Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Jahani H, 2015, J BIOMED MATER RES A, V103, P1875, DOI 10.1002/jbm.a.35328; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Koyama Y, 2014, NEUROCHEM INT, V78, P35, DOI 10.1016/j.neuint.2014.08.005; Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019; Langer R, 2016, J PEDIATR SURG, V51, P8, DOI 10.1016/j.jpedsurg.2015.10.022; Lee SJ, 2004, BIOMATERIALS, V25, P4699, DOI 10.1016/j.biomaterials.2003.11.034; Li GN, 2008, TISSUE ENG PART B-RE, V14, P33, DOI 10.1089/teb.2007.0181; Li Y, 2012, PROG BRAIN RES, V201, P199, DOI 10.1016/B978-0-444-59544-7.00010-X; Martin AC, 2010, DEV BIOL, V341, P114, DOI 10.1016/j.ydbio.2009.10.031; Nava MM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/797410; Ohtake Y, 2015, BRAIN RES, V1619, P22, DOI 10.1016/j.brainres.2014.08.064; Peretz H, 2008, J TISSUE ENG REGEN M, V2, P463, DOI 10.1002/term.118; Peretz H, 2007, TISSUE ENG, V13, P461, DOI 10.1089/ten.2005.0522; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rog-Zielinska EA, 2016, TRENDS MOL MED, V22, P99, DOI 10.1016/j.molmed.2015.12.006; Shany B, 2006, TISSUE ENG, V12, P1763, DOI 10.1089/ten.2006.12.1763; Shany B, 2005, TISSUE ENG, V11, P585, DOI 10.1089/ten.2005.11.585; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SIVRON T, 1995, GLIA, V13, P157, DOI 10.1002/glia.440130302; Soller EC, 2012, BIOMATERIALS, V33, P4783, DOI 10.1016/j.biomaterials.2012.03.068; Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108; Tiryaki VM, 2012, INT J NANOMED, V7, P3891, DOI 10.2147/IJN.S32681; Tonazzini I, 2010, BIOPHYS J, V98, P2804, DOI 10.1016/j.bpj.2010.03.036; Vagaska B, 2010, PHYSIOL RES, V59, P309, DOI 10.33549/physiolres.931776; van Zuijlen PPM, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0017-5; Wang Z, 2016, APPL SURF SCI, V388, P223, DOI 10.1016/j.apsusc.2016.01.187; Wiese S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00120; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yannas IV, 2017, WOUND REPAIR REGEN, V25, P177, DOI 10.1111/wrr.12516; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058	41	4	4	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	AUG	2018	106	6					2295	2306		10.1002/jbm.b.34037			12	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GR8QD	WOS:000442988800021	29098785				2022-02-06	
J	Chen, H; Chan, YL; Linnane, C; Mao, YL; Anwer, AG; Sapkota, A; Annissa, TF; Herok, G; Vissel, B; Oliver, BG; Saad, S; Gorrie, CA				Chen, Hui; Chan, Yik Lung; Linnane, Claire; Mao, Yilin; Anwer, Ayad G.; Sapkota, Arjun; Annissa, Tiara F.; Herok, George; Vissel, Bryce; Oliver, Brian G.; Saad, Sonia; Gorrie, Catherine A.			L-Carnitine and extendin-4 improve outcomes following moderate brain contusion injury	SCIENTIFIC REPORTS			English	Article							SPINAL-CORD-INJURY; CIGARETTE-SMOKE EXPOSURE; PEPTIDE-1 RECEPTOR AGONIST; FOCAL CEREBRAL-ISCHEMIA; ACETYL-L-CARNITINE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; NEUROTROPHIC FACTOR; RENAL-DISEASE; FOOD-INTAKE	There is a need for pharmaceutical agents that can reduce neuronal loss and improve functional deficits following traumatic brain injury (TBI). Previous research suggests that oxidative stress and mitochondrial dysfunction play a major role in neuronal damage after TBI. Therefore, this study aimed to investigate two drugs known to have antioxidant effects, L-carnitine and exendin-4, in rats with moderate contusive TBI. L-carnitine (1.5 mM in drinking water) or exendin-4 (15 mu g/kg/day, ip) were given immediately after the injury for 2 weeks. Neurological function and brain histology were examined (24 h and 6 weeks post injury). The rats with TBI showed slight sensory, motor and memory functional deficits at 24 h, but recovered by 6 weeks. Both treatments improved sensory and motor functions at 24 h, while only exendin-4 improved memory. Both treatments reduced cortical contusion at 24 h and 6 weeks, however neither affected gliosis and inflammatory cell activation. Oxidative stress was alleviated and mitochondrial reactive oxygen species was reduced by both treatments, however only mitochondrial functional marker protein transporter translocase of outer membrane 20 was increased at 24 h post injury. In conclusion, L-carnitine and exendin-4 treatments immediately after TBI can improve neurological functional outcome and tissue integrity by reducing oxidative stress.	[Chen, Hui; Chan, Yik Lung; Linnane, Claire; Mao, Yilin; Sapkota, Arjun; Herok, George; Oliver, Brian G.; Saad, Sonia; Gorrie, Catherine A.] Univ Technol Sydney, Fac Sci, Sch Life Sci, Broadway, NSW 2007, Australia; [Chen, Hui] Chengdu Univ Tradit Chinese Med, Fac Basic Med Sci, Chengdu 610072, Sichuan, Peoples R China; [Anwer, Ayad G.] Macquarie Univ, ARC Ctr Excellence Nanoscale Biophoton, N Ryde, NSW 2109, Australia; [Annissa, Tiara F.] Republ Polytech, Sch Appl Sci, Singapore 738964, Singapore; [Vissel, Bryce] Univ Technol Sydney, Fac Sci, Ctr Neurosci & Regenerat Med, Broadway, NSW 2007, Australia; [Vissel, Bryce] St Vincent Hosp, Ctr Appl Med Res, Darlinghurst, NSW 2010, Australia; [Saad, Sonia] Univ Sydney, Kolling Inst Med Res, St Leonards, NSW 2065, Australia		Gorrie, CA (corresponding author), Univ Technol Sydney, Fac Sci, Sch Life Sci, Broadway, NSW 2007, Australia.	Catherine.Gorrie@uts.edu.au	Chen, Hui/D-2005-2014; Gorrie, Catherine/S-6591-2019; Oliver, Brian/E-7939-2010; Chen, Hui/R-6137-2019	Chen, Hui/0000-0001-6883-3752; Oliver, Brian/0000-0002-7122-9262; Chen, Hui/0000-0001-6883-3752; Gorrie, Catherine/0000-0001-5934-2492; Chan, Yik Lung/0000-0002-9605-4200; Saad, Sonia/0000-0001-8067-8046	Incentive Grant - Faculty of Science, University of Technology Sydney; UTS Postdoctoral Scholarship; Australian Research Training Scheme	This study was funded by an Incentive Grant awarded to Dr Hui Chen by the Faculty of Science, University of Technology Sydney. Yilin Mao was supported by a UTS Postdoctoral Scholarship and Australian Research Training Scheme.	Amadoro G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00018; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Binienda ZK, 2001, TOXICOL LETT, V125, P67, DOI 10.1016/S0378-4274(01)00415-5; Borges HL, 2008, CELL RES, V18, P17, DOI 10.1038/cr.2007.110; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan YL, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00306; Chan YL, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00033; Chan YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25881; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Chen H, 2014, J NEUROCHEM, V129, P297, DOI 10.1111/jnc.12623; Chen H, 2014, DIABETOLOGIA, V57, P614, DOI 10.1007/s00125-013-3132-5; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Darsalia V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103114; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DiNicolantonio JJ, 2014, REV CARDIOVASC MED, V15, P52, DOI 10.3909/ricm0710; Divakaruni Ajit S, 2014, Curr Protoc Toxicol, V60, DOI 10.1002/0471140856.tx2502s60; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Evans AM, 2003, CLIN PHARMACOKINET, V42, P941, DOI 10.2165/00003088-200342110-00002; Fagoe ND, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150141; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Ferrari R, 2004, ANN NY ACAD SCI, V1033, P79, DOI 10.1196/annals.1320.007; Gadoth N, 2010, OXIDATIVE STRESS FRE; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gultekin R, 2016, INJURY, V47, P516, DOI 10.1016/j.injury.2015.10.011; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hao M, 2012, NEUROCHEM INT, V61, P1, DOI 10.1016/j.neuint.2012.04.009; Hashimoto M, 2005, J NEUROSCI RES, V79, P476, DOI 10.1002/jnr.20368; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Jalal FY, 2010, ANN NY ACAD SCI, V1199, P95, DOI 10.1111/j.1749-6632.2009.05351.x; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Keller JN, 1998, J NEUROSCI, V18, P687; Kelly G S, 1998, Altern Med Rev, V3, P345; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liguz-Lecznar M, 2014, BEHAV BRAIN RES, V261, P202, DOI 10.1016/j.bbr.2013.12.027; Mack CM, 2006, INT J OBESITY, V30, P1332, DOI 10.1038/sj.ijo.0803284; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Matera M, 2003, J RENAL NUTR, V13, P2, DOI 10.1053/jren.2003.50010; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Mingrone G, 1999, J AM COLL NUTR, V18, P77, DOI 10.1080/07315724.1999.10718830; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Nakka VP, 2016, MOL NEUROBIOL, V53, P532, DOI 10.1007/s12035-014-9029-6; Nguyen LT, 2015, AM J PHYSIOL-RENAL, V308, pF689, DOI 10.1152/ajprenal.00417.2014; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Pekala J, 2011, CURR DRUG METAB, V12, P667, DOI 10.2174/138920011796504536; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rahbar AR, 2005, EUR J CLIN NUTR, V59, P592, DOI 10.1038/sj.ejcn.1602109; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stangenberg S, 2015, INT J BIOCHEM CELL B, V64, P81, DOI 10.1016/j.biocel.2015.03.017; Stirling D. P., 2013, BRAIN; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Yan H. Q., 2015, BRAIN NEUROTRAUMA MO, P471; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Yang WJ, 2015, NEUROCHEM INT, V80, P33, DOI 10.1016/j.neuint.2014.11.003; Zhang R, 2012, INT J MOL SCI, V13, P2078, DOI 10.3390/ijms13022078; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132; Zhou Y., 2010, FRONT MED-PRC, V4, P43, DOI [10.1007/s11684-010-0019-4, DOI 10.1007/S11684-010-0019-4]	82	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 25	2018	8								11201	10.1038/s41598-018-29430-6			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1DB	WOS:000439686700024	30046063	gold, Green Published			2022-02-06	
J	Angstman, NB; Frank, HG; Schmitz, C				Angstman, Nicholas B.; Frank, Hans-Georg; Schmitz, Christoph			Hypothermia ameliorates blast-related lifespan reduction of C-elegans	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; CAENORHABDITIS-ELEGANS; CAVITATION; MECHANISM	Blast-related mild traumatic brain injury induces significant long-term health issues, yet treatment procedures remain underdeveloped. Therapeutic hypothermia has been postulated as a potentially effective therapy. In a Caenorhabditis elegans model, we demonstrate a dose-dependent reduction in lifespan following exposure to blast-like shock waves. Using polyvinyl alcohol, we show that cavitation is a key injurious factor in the damaging shock wave component. Short and long lifespan C. elegans mutants demonstrated the interaction of genetic and environmental longevity-determining factors. Hypothermia reduced the long term effect of shock wave exposure. Thus, we present an effective C. elegans model of long term effects of blast-related mild traumatic brain injury, as well as evidence of the merit of therapeutic hypothermia as a therapy option following blast exposure.	[Angstman, Nicholas B.; Frank, Hans-Georg; Schmitz, Christoph] Ludwig Maximilians Univ Munchen, Inst Anat, Chair Neuroanat, Fac Med, Munich, Germany		Schmitz, C (corresponding author), Ludwig Maximilians Univ Munchen, Inst Anat, Chair Neuroanat, Fac Med, Munich, Germany.	christoph_schmitz@med.uni-muenchen.de	Frank, Hans-Georg/G-6038-2012	Frank, Hans-Georg/0000-0002-3562-138X			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Angstman NB, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00012; Dunkley S, 2017, NURS CRIT CARE, V22, P150, DOI 10.1111/nicc.12242; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kochanek PM, 2015, EXP NEUROL, V267, P13, DOI 10.1016/j.expneurol.2015.02.019; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Miyauchi T, 2014, J NEUROTRAUM, V31, P773, DOI 10.1089/neu.2013.3181; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; SCHELLING G, 1994, BIOPHYS J, V66, P133, DOI 10.1016/S0006-3495(94)80758-1; SULSTON JE, 1974, GENETICS, V77, P95	14	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 12	2018	8								10549	10.1038/s41598-018-28910-z			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7ET	WOS:000438343600059	30002423	gold, Green Published			2022-02-06	
J	Wilkes, S; McCormack, E; Kenney, O; Stephens, B; Passo, R; Harburg, L; Silverman, E; Moore, C; Bogoslovsky, T; Pham, D; Diaz-Arrastia, R				Wilkes, Sean; McCormack, Erin; Kenney, Ombra; Stephens, Brian; Passo, Ross; Harburg, Leah; Silverman, Erika; Moore, Carol; Bogoslovsky, Tanya; Dzung Pham; Diaz-Arrastia, Ramon			Evolution of Traumatic Parenchymal Intracranial Hematomas (ICHs): Comparison of Hematoma and Edema Components	FRONTIERS IN NEUROLOGY			English	Article						TBI; edema; hematoma; CT; neurotrauma	ACUTE INTRACEREBRAL HEMORRHAGE; CORTICAL IMPACT INJURY; DIFFUSE BRAIN INJURY; CEREBRAL CONTUSION; PROGRESSION; RATS; PATHOPHYSIOLOGY; MECHANISMS; EXPANSION; MODEL	This study seeks to quantitatively assess evolution of traumatic ICHs over the first 24 h and investigate its relationship with functional outcome. Early expansion of traumatic intracranial hematoma (ICH) is common, but previous studies have focused on the high density (blood) component. Hemostatic therapies may increase the risk of peri-hematoma infarction and associated increased cytotoxic edema. Assessing the magnitude and evolution of ICH and edema represented by high and low density components on computerized tomography (CT) may be informative for designing therapies targeted at traumatic ICH. CT scans from participants in the COBRIT (Citicoline Brain Injury Trial) study were analyzed using MIPAV software. CT scans from patients with non-surgical intraparenchymal ICHs at presentation and approximately 24 h later (+/- 12 h) were selected. Regions of high density and low density were quantitatively measured. The relationship between volumes of high and low density were compared to several outcome measures, including Glasgow Outcome Score- Extended (GOSE) and Disability Rating Score (DRS). Paired scans from 84 patients were analyzed. The median time between the first and second scan was 22.79 h (25%ile 20.11 h; 75%ile 27.49 h). Over this time frame, hematoma and edema volumes increased >50% in 34 (40%) and 46 (55%) respectively. The correlation between the two components was low (r = 0.39, p = 0.002). There was a weak correlation between change in edema volume and GOSE at 6 months (r = 0.268, p = 0.037), change in edema volume and DRS at 3 and 6 months (r = -0.248, p = 0.037 and r = 0.358, p = 0.005, respectively), change in edema volume and COWA at 6 months (r = 0.272, p = 0.049), and between final edema volume and COWA at 6 months (r = 0.302, p = 0.028). To conclude, both high density and low density components of traumatic ICHs expand significantly in the first 2 days after TBI. In our study, there does not appear to be a relationship between hematoma volume or hematoma expansion and functional outcome, while there is a weak relationship between edema expansion and functional outcome.	[Wilkes, Sean] Tripler Army Med Ctr, Dept Behav Hlth, Honolulu, HI 96859 USA; [McCormack, Erin; Kenney, Ombra; Stephens, Brian; Passo, Ross; Harburg, Leah; Moore, Carol; Bogoslovsky, Tanya; Dzung Pham] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Silverman, Erika; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA; [Bogoslovsky, Tanya] Acorda Therapeut, San Francisco, CA USA		Wilkes, S (corresponding author), Tripler Army Med Ctr, Dept Behav Hlth, Honolulu, HI 96859 USA.	sean.wilkes@post.harvard.edu	Wilkes, Sean/N-9279-2019; Pham, Dzung/AAR-8263-2020; Stephens, Brian/AAK-5134-2020	Wilkes, Sean/0000-0002-9768-6971; Stephens, Brian/0000-0002-5498-7969	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 HD42652]	This work was supported by NIH U01 HD42652.	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, ACT NEUR S, V70, P119; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; BULLOCK R, 1990, ACT NEUR S, V51, P286; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Maeda T, 2003, ACT NEUR S, V86, P329; Majidi S, 2016, J NEUROIMAGING, V26, P346, DOI 10.1111/jon.12306; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Stroop R, 1998, ACT NEUR S, V71, P303; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thiex Ruth, 2007, Neurosurg Focus, V22, pE6; Unterberg AW, 1997, ACT NEUR S, V70, P106; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Wilkes S, 2014, NEUROLOGY S10, V82; Wilkes S, 2014, NCA TBI 2014 C BETH; Wilkes S, 2015, NEUROLOGY S14, V84; Wilkes S, 2015, NCA TBI 2015 C BETH; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	33	4	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 4	2018	9								527	10.3389/fneur.2018.00527			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GL6PS	WOS:000437311400001	30022968	Green Published, gold			2022-02-06	
J	Cover, R; Roiger, T; Zwart, MB				Cover, Rebecca; Roiger, Trevor; Zwart, Mary Beth			The Lived Experiences of Retired Collegiate Athletes With a History of 1 or More Concussions	JOURNAL OF ATHLETIC TRAINING			English	Article						brain injuries; quality of life; concussion education	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SELF-REPORTED CONCUSSIONS; MILD HEAD-INJURY; FOOTBALL PLAYERS; FOLLOW-UP; SYMPTOMS; SPORT; KNOWLEDGE; IMPACT	Context: Concussions remain misunderstood, underreported, and undiagnosed. Although most concussion symptoms resolve within 2 weeks, some patients experience persistent symptoms that adversely affect physical, emotional, social, or cognitive functioning or a combination of these. Minimal evidence delineating the effect of concussions on recently retired collegiate athletes currently exists. Objective: To examine the lived experiences of retired collegiate athletes with a history of 1 or more concussions to discern individual concussion histories, knowledge and perceptions of concussions, and postconcussion quality of life. Design: Qualitative study. Setting: Telephone interviews. Patients or Other Participants: Former National Collegiate Athletic Association Division I athletes (n = 14) with a history of 1 or more concussions and retired from 1 to 5 years. Data Collection and Analysis: Fourteen semistructured telephone interviews (8 men and 6 women) were audiotaped. Interviews were transcribed and inductively analyzed by 3 athletic trainers with 34 combined years of professional experience. Themes were negotiated through consensual review. Participant checks were completed to ensure trustworthiness of the findings. Results: Participants sustained their first concussion during adolescence and often experienced difficulties transitioning back into the postconcussion academic environment. Judgments of injury severity were clearly evident in participants' knowledge and perceptions of concussions. Participants experienced an array of emotional, physical, cognitive, and social challenges during the immediate postconcussion period but did not feel their concussion history decreased their current quality of life. Conclusions: Adolescent exposure to concussions is of concern due to the risk imposed on the developing brain and the potential for adverse outcomes later in life. Although a graduated return to play is heavily emphasized in concussion management, researchers need to investigate barriers inhibiting the implementation of return-to-learn protocols. Concussion education should aim to modify indifferent attitudes toward concussive injuries. Additionally, investigators should continue to assess how a history of concussion affects quality of life in recently retired collegiate athletes.	[Cover, Rebecca; Roiger, Trevor; Zwart, Mary Beth] South Dakota State Univ, Dept Hlth & Nutr Sci, Box 2275A Wagner Hall 135, Brookings, SD 57007 USA		Roiger, T (corresponding author), South Dakota State Univ, Dept Hlth & Nutr Sci, Box 2275A Wagner Hall 135, Brookings, SD 57007 USA.	trevor.roiger@sdstate.edu					Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; [Anonymous], 2012, ED GUIDE CONCUSSIONS; [Anonymous], 2012, SCH ADM GUIDE ACAD C; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Conder Robert L, 2015, N C Med J, V76, P89; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Eiland L, 2013, NEUROSCIENCE, V249, P162, DOI 10.1016/j.neuroscience.2012.10.048; Essau CA, 2014, J AFFECT DISORDERS, V163, P125, DOI 10.1016/j.jad.2013.12.033; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; Irick E., 2015, NCAA SPORTS SPONSORS; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Pope C, 2002, QUAL SAF HEALTH CARE, V11, P148, DOI 10.1136/qhc.11.2.148; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	50	4	4	2	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2018	53	7					646	656		10.4085/1062-6050-338-17			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GS8PB	WOS:000443973200004	30095303	Green Published, gold			2022-02-06	
J	Erler, KS; Juengst, SB; Smith, DL; O'Neil-Pirozzi, TM; Novack, TA; Bogner, JA; Kaminski, J; Giacino, JT; Whiteneck, GG				Erler, Kimberly S.; Juengst, Shannon B.; Smith, Diane L.; O'Neil-Pirozzi, Therese M.; Novack, Thomas A.; Bogner, Jennifer A.; Kaminski, Jamie; Giacino, Joseph T.; Whiteneck, Gale G.			Examining Driving and Participation 5 Years After Traumatic Brain Injury	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						brain injury; participation; driving	COMMUNITY INTEGRATION; VALIDITY; REHABILITATION; PREDICTORS; EXPOSURE; ABILITY; HEALTH; RETURN	Participation is often considered a primary goal of traumatic brain injury (TBI) rehabilitation, but little is known about the influence of driving on participation after TBI. The objective of this study was to examine the independent contribution of driving status to participation at 5 years post TBI, after controlling for demographic, psychosocial, and functional factors. Participants (N = 2,456) were community-dwelling individuals with moderate to severe TBI, age 18 to 65 at time of injury, and enrolled in the TBI Model Systems (TBIMS) National Database (NDB). Hierarchical linear regressions for the dependent variable of participation at 5 years post TBI were performed. Findings showed that driving was a highly significant independent predictor of participation and was a stronger relative predictor of participation than FIM (R) Cognitive, FIM (R) Motor, and depression. The independent contribution of driving to participation suggests the need to develop evidenced-based occupational therapy assessments and interventions that facilitate safe engagement in the occupation of driving to address the long-term goal of improved participation.	[Erler, Kimberly S.; O'Neil-Pirozzi, Therese M.; Kaminski, Jamie; Giacino, Joseph T.] Spaulding Rehabil Hosp, Boston, MA 02129 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Smith, Diane L.] MGH Inst Hlth Profess, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Boston, MA 02115 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Birmingham, AL USA; [Bogner, Jennifer A.] Ohio State Univ, Columbus, OH 43210 USA; [Whiteneck, Gale G.] Craig Hosp, Englewood, CO USA		Erler, KS (corresponding author), Spaulding Rehabil Hosp, Boston, MA 02129 USA.	kerler@partners.org	Giacino, Joseph/AAF-1952-2021; Juengst, Shannon B/AAC-5891-2019	Giacino, Joseph/0000-0002-7916-9698; Juengst, Shannon B/0000-0003-4709-545X; Novack, Thomas/0000-0003-3043-7900	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0034, 90DP0039, 90DP0040, 90DP0044]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was conducted with support from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR; Grants 90DP0034, 90DP0039, 90DP0040, 90DP0044).	American Occupational Therapy Association-AOTA, 2014, AM J OCCUP THER, V68, ps01, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJOT.2014.682006]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Duquette J, 2010, AM J OCCUP THER, V64, P279, DOI 10.5014/ajot.64.2.279; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, pE77, DOI 10.1097/HTR.0000000000000386; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fisk GD, 1998, BRAIN INJURY, V12, P683; Griffen JA, 2009, TOP STROKE REHABIL, V16, P212, DOI 10.1310/tsr1603-212; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; Innes CRH, 2007, J NEUROL SCI, V260, P188, DOI 10.1016/j.jns.2007.04.052; Juengst SB, 2014, AM J PHYS MED REHAB, V93, P1086, DOI 10.1097/PHM.0000000000000163; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Labbe DR, 2014, J HEAD TRAUMA REHAB, V29, P185, DOI 10.1097/HTR.0b013e3182795211; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; Mezuk B, 2008, J GERONTOL B-PSYCHOL, V63, pS298, DOI 10.1093/geronb/63.5.S298; National Institute of Neurological Disorders and Stroke, 2016, NINDS COMM DAT EL HA; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; US Department of Transportation Federal Highway Administration, 2016, LIC DRIV AG SEX; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; World Health Organization, 2007, INT CLASS FUNCT DIS	44	4	4	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	JUL	2018	38	3					143	150		10.1177/1539449218757739			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	GK3RW	WOS:000436064000001	29457535				2022-02-06	
J	Flaherty, JM; Spencer, RJ; Drag, LL; Pangilinan, PH; Bieliauskas, LA				Flaherty, Jennifer M.; Spencer, Robert J.; Drag, Lauren L.; Pangilinan, Percival H.; Bieliauskas, Linas A.			Streamlining screening of emotional function in Veterans with traumatic brain injury	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						anxiety; depression; neurobehavioral; psychometric; sleep disturbance; traumatic brain injury	INSOMNIA SEVERITY INDEX; HOSPITAL ANXIETY; DEPRESSION SCALE; POSTCONCUSSIVE SYMPTOMS; PSYCHIATRIC-SYMPTOMS; VALIDITY; MILITARY; HADS; CARE; EXAGGERATION	ObjectivesThis study examined how depression, anxiety, and sleep items from the Neurobehavioral Symptom Inventory (NSI) predict results from longer inventories. MethodThis was a retrospective review from 484, predominantly male (96.1%) Veterans, mean age 29.7 years, who underwent brief neuropsychological screening during a comprehensive, multidisciplinary evaluation for mild traumatic brain injury (TBI). Participants completed the NSI, insomnia severity index (ISI), and hospital anxiety and depression scale (HADS). Results: Overall,97.1% who endorsed severe/very severe anxiety on the NSI had significant anxiety on the HADS; 85% reporting severe/very severe depression on the NSI, had significant depression on the HADS; and 97.7% reporting severe/very severe sleep problems on the NSI, had significant sleep difficulties on the ISI. ConclusionClose correspondence between severe/very severe symptoms on the NSI and lengthier checklists suggests additional checklists may be eliminated and individuals can be referred for mental health treatment. NSI reports of mild/moderate require further screening.	[Flaherty, Jennifer M.] Eastern Virginia Med Sch, Norfolk, VA 23501 USA; [Flaherty, Jennifer M.; Spencer, Robert J.; Pangilinan, Percival H.; Bieliauskas, Linas A.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Drag, Lauren L.] Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Pangilinan, Percival H.; Bieliauskas, Linas A.] Univ Michigan Hlth Syst, Ann Arbor, MI USA		Flaherty, JM (corresponding author), EVMS Neuropsychol Program, 721 Fairfax Ave,Ste 461, Norfolk, VA 23507 USA.	flaherjm@evms.edu					ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck AT, 1993, BECK ANXIETY INVENTO; Beck AT, 1987, MANUAL REVISED BECK; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Blozik E, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-198; Boxley L, 2016, J REHABIL RES DEV, V53, P873, DOI 10.1682/JRRD.2015.05.0088; Cameron IM, 2008, BRIT J GEN PRACT, V58, P32, DOI 10.3399/bjgp08X263794; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corson K, 2004, AM J MANAG CARE, V11, P10; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Department of Veterans Affairs, 2007, SCREEN EV POSS TRAUM; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Fitzpatrick R., 2009, OVERVIEW PATIENT REP; Flaherty JM, 2015, BRAIN INJURY, V29, P1630, DOI 10.3109/02699052.2015.1075249; Flint AJ, 2002, INT J GERIATR PSYCH, V17, P117, DOI 10.1002/gps.535; Golden J, 2007, J AFFECT DISORDERS, V100, P265, DOI 10.1016/j.jad.2006.10.020; Gough K, 2009, J PAIN SYMPTOM MANAG, V37, P797, DOI 10.1016/j.jpainsymman.2008.04.012; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IBM Corp, 2016, IBM SPSS STAT WIND V; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kraal AZ, 2015, REHABIL PSYCHOL, V60, P36, DOI 10.1037/rep0000017; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Leung C M, 1993, Int J Psychosom, V40, P29; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Martin C R, 2000, Psychol Health Med, V5, P193, DOI 10.1080/713690189; Martin CR, 2004, BRIT J CLIN PSYCHOL, V43, P51, DOI 10.1348/014466504772812968; McCrae M., 2008, MILD TRAUMATIC BRAIN; McCue P, 2003, Psychol Health Med, V8, P425, DOI 10.1080/1354850310001604568; Mccue P, 2006, BRIT J CLIN PSYCHOL, V45, P483, DOI 10.1348/014466505X82379; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Palmer GA, 2016, J LOSS TRAUMA, V21, P99, DOI 10.1080/15325024.2015.1072009; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Smith M. T., 2003, ARTHRITIS RHEUMATISM, V49, pS184, DOI DOI 10.1002/ART.11409; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Spencer RJ, 2012, NEUROPSYCHOLOGICAL P, P77; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stafford L, 2007, GEN HOSP PSYCHIAT, V29, P417, DOI 10.1016/j.genhosppsych.2007.06.005; Sukantarat KT, 2007, ANAESTHESIA, V62, P239, DOI 10.1111/j.1365-2044.2006.04948.x; Thompson DR., 1999, PSYCHOL HEALTH MED, V4, P369, DOI 10.1080/135485099106117; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4; Woolrich Rachel A, 2006, Psychol Health Med, V11, P80, DOI 10.1080/13548500500294211; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	57	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9762	1097-4679		J CLIN PSYCHOL	J. Clin. Psychol.	JUL	2018	74	7					1281	1292		10.1002/jclp.22595			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GJ3ZE	WOS:000435275800016	29508388	Green Published			2022-02-06	
J	Harshbarger, ND; Anderson, BE; Lam, KC				Harshbarger, Nicole D.; Anderson, Barton E.; Lam, Kenneth C.			Is There a Relationship Between the Functional Movement Screen, Star Excursion Balance Test, and Balance Error Scoring System?	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						clinical screening; injury prevention; postural stability	LOWER-EXTREMITY INJURY; QUALITY-OF-LIFE; INTERRATER RELIABILITY; POSTURAL STABILITY; FOOTBALL PLAYERS; HEALTHY; YOUNG; ASSESSMENTS; PERFORMANCE; CONCUSSION	Objective: To evaluate associations between the Functional Movement Screen (FMS), Star Excursion Balance Test (SEBT), and Balance Error Scoring System (BESS) scores. Design: Correlational. Setting: College athletic training facilities. Participants: Fifty-two intercollegiate athletes (men = 36 and women = 16) representing 8 sports and cleared for unrestricted sport participation. Interventions: Participants completed the EMS, SEBT, and BESS, in random order, during 1 testing session. Testing order was randomized to control for fatigue and learning effects. Main outcome Measures: Composite and item scores for the FMS. SEBT, and BESS. Results: A fair, negative correlation was found between EMS asymmetry and SEBT composite (r = -0.31, P = 0.03) scores. Fair, positive correlations were reported for FMS rotary stability task and SEBT anterior (r = 0.37-0.41, P <= 0.007) and posteromedial)r = 0.31, P = 0.03) reaches. Fair, negative correlations were reported for FMS deep squat and BESS single-leg firm (r = -0.33, P = - 0.02), double-leg foam (r = -0.34, P = 0.02) and tandem foam (r = -0.40, P = 0.003), FMS inline lunge and BESS single-leg firm (r = -0.39, P = 0.004), EMS trunk stability pushup and tandem foam (r = -0.31, P = 0.025), and FMS composite and BESS single-leg firm (r = -0.37, P = 0.007). Little-to-no correlations were reported for remaining comparisons. Conclusions: Results indicate that each instrument provides distinct information about function, with only small areas of overlap. Associations between the FMS asymmetry score and SEBT composite score may indicate a relationship between movement asymmetry and postural stability. Associations between the EMS deep squat and BESS foam tasks may be related to underlying neuromuscular control factors.	[Harshbarger, Nicole D.; Anderson, Barton E.; Lam, Kenneth C.] AT Still Univ, Dept Interdisciplinary Hlth Sci, Athlet Training Programs, Mesa, AZ 85206 USA		Lam, KC (corresponding author), AT Still Univ, Dept Interdisciplinary Hlth Sci, Arizona Sch Hlth Sci, 5850 E Still Circle, Mesa, AZ 85206 USA.	klam@atsu.edu	Lam, Kenny/ABB-9733-2020	Lam, Kenneth/0000-0002-2185-0990			Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Butler RJ, 2010, SPORT BIOMECH, V9, P270, DOI 10.1080/14763141.2010.539623; Chorba Rita S, 2010, N Am J Sports Phys Ther, V5, P47; Clifton DR, 2013, J STRENGTH COND RES, V27, P966, DOI 10.1519/JSC.0b013e318260b723; Cook Gray, 2006, N Am J Sports Phys Ther, V1, P62; Cook Gray, 2006, N Am J Sports Phys Ther, V1, P132; Coughlan GF, 2012, J ATHL TRAINING, V47, P366, DOI 10.4085/1062-6050-47.4.03; Filipa A, 2010, J ORTHOP SPORT PHYS, V40, P551, DOI 10.2519/jospt.2010.3325; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Frost D, 2013, ERGONOMICS, V56, P637, DOI 10.1080/00140139.2011.620177; Gabbe BJ, 2011, J TRAUMA, V70, P1532, DOI 10.1097/TA.0b013e31820e8546; Gribble PA, 2013, J ATHL TRAINING, V48, P621, DOI 10.4085/1062-6050-48.3.03; Gribble PA, 2013, J STRENGTH COND RES, V27, P978, DOI 10.1519/JSC.0b013e31825c32a8; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Gulgin H, 2014, INT J SPORTS PHYS TH, V9, P14; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Kiesel K, 2011, SCAND J MED SCI SPOR, V21, P287, DOI 10.1111/j.1600-0838.2009.01038.x; Kiesel Kyle, 2007, N Am J Sports Phys Ther, V2, P147; Kiesel KB, 2014, J SPORT REHABIL, V23, P88, DOI [10.1123/jsr.2012-0130, 10.1123/JSR.2012-0130]; Lockie RG, 2015, J HUM KINET, V47, P19, DOI 10.1515/hukin-2015-0058; Martin-Herz SP, 2012, CLIN CHILD FAM PSYCH, V15, P192, DOI 10.1007/s10567-012-0115-x; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Munro AG, 2010, PHYS THER SPORT, V11, P128, DOI 10.1016/j.ptsp.2010.07.002; O'Connor FG, 2011, MED SCI SPORT EXER, V43, P2224, DOI 10.1249/MSS.0b013e318223522d; Onate JA, 2012, J STRENGTH COND RES, V26, P408, DOI 10.1519/JSC.0b013e318220e6fa; Peate W F, 2007, J Occup Med Toxicol, V2, P3, DOI 10.1186/1745-6673-2-3; Plisky PJ, 2006, J ORTHOP SPORT PHYS, V36, P911, DOI 10.2519/jospt.2006.2244; Riemann BL, 1999, J SPORT REHABIL, V8, P171, DOI 10.1123/jsr.8.3.171; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Robinson RH, 2008, ARCH PHYS MED REHAB, V89, P364, DOI 10.1016/j.apmr.2007.08.139; Schneiders AG, 2011, INT J SPORTS PHYS TH, V6, P75; Sell TC, 2012, PHYS THER SPORT, V13, P80, DOI 10.1016/j.ptsp.2011.06.006; Shultz R, 2013, J ATHL TRAINING, V48, P331, DOI 10.4085/1062-6050-48.2.11; Teyhen DS, 2012, J ORTHOP SPORT PHYS, V42, P530, DOI 10.2519/jospt.2012.3838; Vikram M, 2012, CLIN TER, V163, P383; Watkins, 2007, FDN CLIN RES APPL PR; WINTER DA, 1990, MED PROG TECHNOL, V16, P31	41	4	4	1	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2018	28	4					389	394		10.1097/JSM.0000000000000465			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	GP1IO	WOS:000440569000014	28742602				2022-02-06	
J	Khetani, AM; Brooks, BL; Mikrogianakis, A; Barlow, KM				Khetani, Aneesh M.; Brooks, Brian L.; Mikrogianakis, Angelo; Barlow, Karen M.			Incorporating a Computerized Cognitive Battery Into the Emergency Department Care of Pediatric Mild Traumatic Brain InjuriesIs It Feasible?	PEDIATRIC EMERGENCY CARE			English	Article						computerized cognitive testing; feasibility; concussions; head injury; traumatic brain injury	CONCUSSION; INJURY; SENSITIVITY; SPORT	Objectives The use of computers to test cognitive function acutely after a concussion is becoming increasingly popular, especially after sport-related concussion. Although commonly performed in the community, it is not yet performed routinely in the emergency department (ED), where most injured children present. The challenges of performing computerized cognitive testing (CCT) in a busy ED are considerable. The aim of this study was to evaluate the feasibility of CCT in the pediatric ED after concussion. Methods Children, aged 8 to 18 years with mild traumatic brain injury, presenting to the ED were eligible for this prospective study. Exclusion criteria included the use of drugs, alcohol, and/or physical injury, which could affect CCT performance. A 30- or 15-minute CCT battery was performed. Feasibility measures included environmental factors (space, noise, waiting time), testing factors (time, equipment reliability, personnel), and patient factors (age, injury characteristics). Results Forty-nine children (28 boys; mean age, 12.6; SD, 2.5) participated in the study. All children completed CCT. Mean testing times for the 30- and 15-minute battery were 29.7 and 15.2 minutes, respectively. Noise-cancelling headphones were well tolerated. A shorter CCT was more acceptable to families and was associated with fewer noise disturbances. There was sufficient time to perform testing after triage and before physician assessment in over 90% of children. Conclusions Computerized cognitive testing is feasible in the ED. We highlight the unique challenges that should be considered before its implementation, including environmental and testing considerations, as well as personnel training.	[Khetani, Aneesh M.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Neurosci Brain Injury & Rehabil Program, Alberta Childrens Hosp, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Neurosci Brain Injury & Rehabil Program, Alberta Childrens Hosp, Dept Clin Neurosci, Calgary, AB, Canada; [Mikrogianakis, Angelo] Univ Calgary, Alberta Childrens Hosp, Sect Emergency Med, Dept Paediat,Cumming Sch Med, Calgary, AB, Canada; [Barlow, Karen M.] Univ Calgary, Alberta Childrens Hosp, Dept Neurosci, Res Inst Child & Maternal Hlth, Calgary, AB, Canada; [Barlow, Karen M.] Univ Calgary, Alberta Childrens Hosp, Dept Paediat, Res Inst Child & Maternal Hlth, Calgary, AB, Canada; [Barlow, Karen M.] Univ Calgary, Alberta Childrens Hosp, Traumat Brain Injury Rehabil Program, Calgary, AB, Canada		Barlow, KM (corresponding author), Alberta Childrens Prov Gen Hosp, C4-335,2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	karen.barlow@albertahealthservices.ca	Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014; Mikrogianakis, Angelo/AAW-5929-2021	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Mikrogianakis, Angelo/0000-0002-8854-0620	Alberta Children's Hospital Research Institute; McCarthy Tetrault Award; Psychological Assessment Resources, Inc.	Funding was provided by Alberta Children's Hospital Research Institute and the McCarthy Tetrault Award. B.L.B. receives funding from a test publisher (Psychological Assessment Resources, Inc.), book royalties from Oxford University Press, and in-kind test credits for research from the computerized test publisher (CNS Vital Signs).	Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Boudreaux ED, 2004, J EMERG MED, V26, P13, DOI 10.1016/j.jemermed.2003.04.003; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Canadian Association of Emergency Physicians, 2001, CJEM, V3, P82; Canadian Institute for Health Information, HLTH CAR CAN 2012 FO; De Monte VE, 2010, J CLIN EXP NEUROPSYC, V32, P28, DOI 10.1080/13803390902806519; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; National Center for Injury Prevention and Control, REP C MILD TRAUM BRA; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Taylor RG, 2015, PEDIATR EMERG CARE, V31, P348, DOI 10.1097/PEC.0000000000000368; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	26	4	4	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JUL	2018	34	7					501	506		10.1097/PEC.0000000000000959			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Pediatrics	GM9ED	WOS:000438545200018	28030519				2022-02-06	
J	Schmidt, J; Rubino, C; Boyd, LA; Virji-Babul, N				Schmidt, Julia; Rubino, Cristina; Boyd, Lara A.; Virji-Babul, Naznin			The Role of Physical Activity in Recovery From Concussion in Youth: A Neuroscience Perspective	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						children; exercise; mild traumatic brain injury; neuroimaging	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; DEFAULT-MODE NETWORK; TRANSCRANIAL MAGNETIC STIMULATION; WORKING-MEMORY; WHITE-MATTER; FUNCTIONAL CONNECTIVITY; EXERCISE; ACTIVATION; SYMPTOMS	Background and Purpose: Concussion is a major public health concern and one of the least understood neurological injuries. Children and youth are disproportionally affected by concussion, and once injured, take longer to recover. Current guidelines recommend a period of physical and cognitive rest with a gradual progressive return to activity. Although there is limited high-quality evidence (eg, randomized controlled trials) on the benefit of physical activity and exercise after concussion, most studies report a positive impact of exercise in facilitating recovery after concussion. In this article we characterize the complex and dynamic changes in the brain following concussion by reviewing recent results from neuroimaging studies and to inform physical activity participation guidelines for the management of a younger population (eg, 14-25 years of age) after concussion. Summary of Key Points: Novel imaging methods and tools are providing a picture of the changes in the structure and function of the brain following concussion. These emerging results will, in the future, assist in creating objective, evidence-based pathways for clinical decision-making. Until such time, physical therapists should be aware that current neuroimaging evidence supports participation in physical activity after an initial and brief period of rest, and consider how best to incorporate exercise into rehabilitation to enhance recovery following concussion. Recommendations for Clinical Practice: It is important that physical therapists understand the neurobiological impact of concussion injury and recovery, and be informed of the scientific rationale for the recommendations and guidelines for engagement in physical activity. Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A205).	[Schmidt, Julia; Rubino, Cristina; Boyd, Lara A.; Virji-Babul, Naznin] Univ British Columbia, Vancouver, BC, Canada; [Schmidt, Julia] La Trobe Univ, Melbourne, Vic, Australia		Virji-Babul, N (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Fac Med, Dept Phys Therapy, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	naznin.virji-babul@ubc.ca		Schmidt, Julia/0000-0003-2004-4871; Virji-Babul, Naznin/0000-0002-8984-5848	Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	J.S. has fellowship funding by the Michael Smith Foundation for Health Research; C.R. is funded by the Natural Sciences and Engineering Research Council of Canada.	Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; BC Injury and Prevention Unit, 2017, CONC AW TRAIN TOOL C; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Borich MR, 2015, J NEUROL PHYS THER, V39, P43, DOI 10.1097/NPT.0000000000000072; Bushbacher RM, 2000, DECONDITIONING CONDI; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Crabbe JB, 2004, PSYCHOPHYSIOLOGY, V41, P563, DOI 10.1111/j.1469-8986.2004.00176.x; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Deale A, 1998, J PSYCHOSOM RES, V45, P77, DOI 10.1016/S0022-3999(98)00021-X; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Leddy AL, 2016, J NEUROL PHYS THER, V40, P239, DOI 10.1097/NPT.0000000000000147; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Linder SM, 2017, AM J OCCUPATIONAL TH, V71, P1, DOI [10.5014/ajot.2017.020297, DOI 10.5014/AJOT.2017.020297]]; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Lohnberg JA, 2007, J CLIN PSYCHOL MED S, V14, P113, DOI 10.1007/s10880-007-9062-y; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Major BP, 2015, CLIN EXP PHARMACOL P, V42, P394, DOI 10.1111/1440-1681.12363; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mang CS, 2015, CLIN NEUROPHYSIOL, V126, P1959, DOI 10.1016/j.clinph.2014.12.018; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Mooney RA, 2016, EXP BRAIN RES, V234, P3669, DOI 10.1007/s00221-016-4767-5; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Parachute, 2017, PAR PREV INJ SAV LIV; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Porter S, 2017, EXPLORATION IDENTIFI; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Schmidt J, PEDIATRICS; SCHNEIDER KJ, 2017, BRIT J SPORT MED, V51; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; Sexton CE, 2016, NEUROIMAGE, V131, P81, DOI 10.1016/j.neuroimage.2015.09.071; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Snow NJ, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0146712, 10.1371/journal.pone.0150039]; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Stern JM, 2004, ATLAS EEG PATTERNS; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Themanson JR, 2006, NEUROSCIENCE, V141, P757, DOI 10.1016/j.neuroscience.2006.04.004; Themanson JR, 2009, FITNESS ACTION MONIT, V157, P319; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Turcotte K., 2013, CONCUSSION CHILDREN; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wiley GR, 2015, PLOS ONE, V10; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	93	4	4	2	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2018	42	3			SI		155	162		10.1097/NPT.0000000000000226			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GL1OM	WOS:000436873100007	29864097				2022-02-06	
J	Solomito, MJ; Kostyuna, RO; Wu, YH; Mueske, NM; Wren, TAL; Chou, LS; Ounpuu, S				Solomito, Matthew J.; Kostyuna, Regina O.; Wu, Yen-Hsun; Mueske, Nicole M.; Wren, Tishya A. L.; Chou, Li-Shan; Ounpuu, Sylvia			Motion analysis evaluation of adolescent athletes during dual-task walking following a concussion: A multicenter study	GAIT & POSTURE			English	Article						Concussion; Dynamic balance; Dual task; Return to sport; Biomechanics; Gait	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; BALANCE CONTROL; GAIT STABILITY; POSTURAL STABILITY; RECOVERY; RETURN; CHILDREN; DEFICITS; MANAGEMENT	Background: Research suggests that dynamic balance in adolescents is compromised following concussion and may worsen if patients return to sport (RTS) too soon. Understanding if there are ongoing dynamic balance deficits in adolescents at the time of RTS clearance would determine if more complex motor tasks are necessary to facilitate safe RTS decisions. Research question: The purpose of this study was to determine if there were remaining dynamic balance deficits in concussed adolescents at the time of clearance for RTS. Methods: Sixteen concussed adolescent athletes (age 14.6 +/- 1.8 years; 9 males; 57 +/- 46 days post injury) performed a simple walking task as well as two split attention gait tasks (reciting months backwards and audio Stroop). The center of mass (COM) movement and walking velocity during these tasks was compared to a control group of 15 healthy non-concussed adolescent athletes (age 13.8 +/- 1.4 years; 9 male). Results: The results indicated that there were no statistically significant differences between the two groups for any of the tasks. Height-normalized walking speed did not differ between groups during walking alone (control: 0.757 +/- 0.119, concussed: 0.739 +/- 0.108, p = 0.34), with the recitation task (control: 0.555 +/- 0.095, concussed: 0.557 +/- 0.143, p = 0.72), or with the Stroop task (control: 0.589 +/- 0.129, concussed: 0.567 +/- 0.141, p = 0.43). Similarly, height-normalized medial-lateral COM displacement did not differ between groups during walking alone (control: 0.027 +/- 0.007, concussed: 0.028 +/- 0.007, p = 0.98, with the recitation task (control: 0.037 +/- 0.012, concussed: 0.0.037 +/- 0.016, p = 0.82), or with the Stroop task (control: 0.032 +/- 0.014, concussed: 0.033 +/- 0.009, p = 0.891). Significance: These findings indicate that the patients were returned to sport when their dynamic balance was similar to controls suggesting that this cohort had recovered from their concussion. However, large variability in dynamic balance measures in both the patient and control groups may reflect ongoing neuromuscular development and requires further exploration.	[Solomito, Matthew J.; Kostyuna, Regina O.; Ounpuu, Sylvia] Connecticut Childrens Med Ctr, 399 Farmington Ave, Farmington, CT 06032 USA; [Wu, Yen-Hsun] Univ Hartford, 200 Bloomfield Ave, Hartford, CT 06117 USA; [Mueske, Nicole M.; Wren, Tishya A. L.] Childrens Hosp, 4650 Sunset Blvd, Los Angeles, CA 90027 USA; [Chou, Li-Shan] Univ Oregon, 1585 E 13th Ave, Eugen, OR 97403 USA		Solomito, MJ (corresponding author), Connecticut Childrens Med Ctr, 399 Farmington Ave, Farmington, CT 06032 USA.	msolomito@connecticutchildrens.org	Wren, Tishya/AAS-4196-2021				Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Castile L., 2011, BRIT J SPORT MED; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Clauser CE, 1969, WEIGHT VOLUME CTR MA; Cross M., 2015, BRIT J SPORT MED; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Law LSH, 2005, DEV MED CHILD NEUROL, V47, P321, DOI 10.1017/S0012162205000617; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Park BK, 1997, ARCH PHYS MED REHAB, V78, P471, DOI 10.1016/S0003-9993(97)90159-3; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE	30	4	4	1	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	JUL	2018	64						260	265		10.1016/j.gaitpost.2018.06.165			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	GL6NO	WOS:000437304400044	29966907				2022-02-06	
J	Vickers, ML; Coorey, CP; Milinovich, GJ; Eriksson, L; Assoum, M; Reade, MC				Vickers, Mark L.; Coorey, C. P.; Milinovich, G. J.; Eriksson, L.; Assoum, M.; Reade, M. C.			Bibliometric analysis of military trauma publications: 2000-2016	JOURNAL OF THE ROYAL ARMY MEDICAL CORPS			English	Article							BRAIN-INJURY; CARE; TRANSLATION; IMPACT; WAR	Introduction Bibliometric tools can be used to identify the authors, topics and research institutions that have made the greatest impact in a field of medicine.The aim of this research was to analyse military trauma publications over the last 16 years of armed conflict in order to highlight the most important lessons that have translated into civilian practice and military doctrine as well as identify emerging areas of importance. Methods A systematic search of research published between January 2000 and December 2016 was conducted using the Thompson Reuters Web of Science database. Both primary evidence and review publications were included. Results were categorised according to relevance and topic and the 30 most cited publications were reviewed in full. The h-index, impact factors, citation counts and citation analysis were used to evaluate results. Results A plateau in the number of annual publications on military trauma was found, as was a shift away from publications on wound and mortality epidemiology to publications on traumatic brain injury (TBI), neurosurgery or blast injury to the head. Extensive collaboration networks exist between highly contributing authors and institutions, but less collaboration between authors from different countries. The USA produced the majority of recent publications, followed by the UK, Germany and Israel. Conclusions In recent years, the number of publications on TBI, neurosurgery or blast injury to the head has increased. It is likely that the lessons of recent conflicts will continue to influence civilian medical practice, particularly regarding the long-term effects of blast-related TBI.	[Vickers, Mark L.; Coorey, C. P.; Milinovich, G. J.; Reade, M. C.] Univ Queensland, Fac Med, St Lucia, Qld 4072, Australia; [Eriksson, L.] Univ Queensland, Herston Hlth Sci Lib, St Lucia, Qld, Australia; [Assoum, M.] Univ Queensland, Ctr Child Hlth Res, South Brisbane, Qld, Australia; [Reade, M. C.] Australian Def Force, Joint Hlth Command, Canberra, ACT, Australia		Vickers, ML (corresponding author), Univ Queensland, Fac Med, St Lucia, Qld 4072, Australia.	mark.vickers@uq.net.au	Eriksson, Lars/B-9633-2008; Coorey, Craig/AAJ-7229-2021; Reade, Michael/G-7035-2012	Eriksson, Lars/0000-0001-5060-7706; Coorey, Craig/0000-0002-2696-5623; Reade, Michael/0000-0003-1570-0707; Vickers, Mark Leon/0000-0002-2831-404X			Asken B.M., 2017, BRAIN IMAGING BEHAV; Bahraini NH, 2017, J HEAD TRAUMA REHABI; Beckett A, 2013, CURR OPIN CRIT CARE, V19, P599, DOI 10.1097/MCC.0000000000000033; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P830, DOI 10.1002/asi.20806; Dolan RS, 2015, EMERG RADIOL, V22, P667, DOI 10.1007/s10140-015-1345-2; Ellegaard O, 2015, SCIENTOMETRICS, V105, P1809, DOI 10.1007/s11192-015-1645-z; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Haider AH, 2015, SURGERY, V158, P1687, DOI 10.1016/j.surg.2015.06.026; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Icasualties. org, 2017, IR AFGH COAL MIL FAT; Jett S, 2010, NURS FORUM, V45, P237, DOI 10.1111/j.1744-6198.2010.00195.x; Joshi S, 2017, MIL MED, V182, P124, DOI 10.7205/MILMED-D-16-00282; Kodumuri P, 2014, BONE JOINT J, V96B, P414, DOI 10.1302/0301-620X.96B3.32279; Kragh JF, 2008, J TRAUMA, V64, pS38, DOI 10.1097/TA.0b013e31816086b1; Lockey DJ, 2013, TRANSFUSION, V53, p17S, DOI 10.1111/trf.12031; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Ollerton JE, 2005, J TRAUMA, V58, P364, DOI 10.1097/01.TA.0000141882.31281.66; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS403, DOI 10.1097/TA.0b013e3182754834; Thorson CM, 2012, J TRAUMA ACUTE CARE, V73, pS483, DOI 10.1097/TA.0b013e31827546fb; van Dongen TTCF, 2017, J TRAUMA ACUTE CARE, V82, P596, DOI 10.1097/TA.0000000000001341; Wichkham H., 2009, ELEGANT GRAPHICS DAT; Zietlow John M, 2015, J Spec Oper Med, V15, P48	25	4	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0035-8665	2052-0468		J ROY ARMY MED CORPS	J. R. Army Med. Corps	JUL	2018	164	3					142	149		10.1136/jramc-2017-000858			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR2KO	WOS:000442400000003	29331949				2022-02-06	
J	Whiting, DL; Deane, FP; Simpson, GK; Ciarrochi, J; McLeod, HJ				Whiting, Diane L.; Deane, Frank P.; Simpson, Grahame K.; Ciarrochi, Joseph; McLeod, Hamish J.			Acceptance and Commitment Therapy delivered in a dyad after a severe traumatic brain injury: A feasibility study	CLINICAL PSYCHOLOGIST			English	Article						Acceptance and Commitment Therapy; feasibility; psychological flexibility; traumatic brain injury	CASE EXPERIMENTAL-DESIGNS; HOSPITAL ANXIETY; NEGATIVE AFFECT; N-OF-1 TRIALS; CHRONIC PAIN; SHORT-FORM; ACT; VALIDATION; ADJUSTMENT; QUALITY	ObjectiveThere is a high prevalence of complex psychological distress after a traumatic brain injury but limited evidence of effective interventions. We examined the feasibility of Acceptance and Commitment Therapy after a severe traumatic brain injury using the criteria, investigating a therapeutic effect, and reviewing the acceptability of measures, treatment protocol, and delivery method (in a dyad of two clients and a therapist). MethodTwo male outpatients with severe traumatic brain injury and associated psychological distress jointly engaged in a seven session treatment program based on Acceptance and Commitment Therapy principles. Pre- and post-treatment measures of mood, psychological flexibility, and participation were taken in addition to weekly measures. ResultsThe intervention showed a therapeutic effect with one participant, and appeared to be acceptable for both participants with regard to program content, measures, and delivery mode by in a dyad. One participant showed both significant clinical and reliable change across several outcome measures including measures of mood and psychological flexibility. The second participant did not show a reduction in psychological inflexibility, but did show a significant drop in negative affect. Significant changes pre- to post-treatment for measures of participation were not indicated. Qualitatively, both participants engaged in committed action set in accordance with their values. ConclusionsThis study suggests that Acceptance and Commitment Therapy may be feasible to be delivered in a dyad with individuals who have a severe traumatic brain injury. A further test of its potential efficacy in a phase II clinical trial is recommended.	[Whiting, Diane L.; Simpson, Grahame K.] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool, Merseyside, Australia; [Whiting, Diane L.; Deane, Frank P.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia; [Ciarrochi, Joseph] Australian Catholic Univ, Inst Posit Psychol & Educ, Strathfield, NSW, Australia; [McLeod, Hamish J.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland		Whiting, DL (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	diane.whiting@health.nsw.gov.au	Ciarrochi, Joseph/F-5823-2016; Simpson, Grahame K/W-1074-2019; Whiting, Diane/AAN-2522-2021	Ciarrochi, Joseph/0000-0003-0471-8100; Simpson, Grahame K/0000-0001-8156-9060; McLeod, Hamish/0000-0002-4225-1815; Deane, Frank/0000-0002-6247-7416; Whiting, Diane/0000-0003-1912-6626			Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Brown FJ, 2009, J INTELLECT DISABILI, V13, P195, DOI 10.1177/1744629509346173; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Ciarrochi J., 2008, CBT PRACTITIONERS GU; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Dahl J, 2004, BEHAV THER, V35, P785, DOI 10.1016/S0005-7894(04)80020-0; Evans JJ, 2014, NEUROPSYCHOL REHABIL, V24, P305, DOI 10.1080/09602011.2014.903198; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fledderus M, 2012, PSYCHOL MED, V42, P485, DOI 10.1017/S0033291711001206; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Graham CD, 2016, CLIN PSYCHOL REV, V46, P46, DOI 10.1016/j.cpr.2016.04.009; Graham CD, 2015, CLIN CASE STUD, V14, P83, DOI 10.1177/1534650114539386; Hann KEJ, 2014, J CONTEXT BEHAV SCI, V3, P217, DOI 10.1016/J.JCBS.2014.10.001; Hardy GE, 1999, PSYCHOL ASSESSMENT, V11, P159, DOI 10.1037/1040-3590.11.2.159; Hayes SC, 2003, ACCEPTANCE COMMITMEN; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kocovski NL, 2009, COGN BEHAV PRACT, V16, P276, DOI 10.1016/j.cbpra.2008.12.004; Kratochwill TR, 2013, REM SPEC EDUC, V34, P26, DOI 10.1177/0741932512452794; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; McCracken LM, 2013, J PAIN, V14, P1398, DOI 10.1016/j.jpain.2013.06.011; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; MOOREY S, 1991, BRIT J PSYCHIAT, V158, P255, DOI 10.1192/bjp.158.2.255; Moreland RL, 2010, SMALL GR RES, V41, P251, DOI 10.1177/1046496409358618; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Ossman WA, 2006, INT J PSYCHOL THER, V6, P397; Pankey J., 2003, INT J PSYCHOL THERAP, V3, P311; PERDICES M, 2005, BRAIN IMPAIRMENT, V0006, P00219; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Robey RR, 2004, J COMMUN DISORD, V37, P401, DOI 10.1016/j.jcomdis.2004.04.003; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Sylvester M., 2011, THESIS; Tate RL, 2014, NEUROPSYCHOL REHABIL, V24, P315, DOI 10.1080/09602011.2013.875043; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; Tindale R.S, 2001, BLACKWELL HDB SOCIAL, P1; Veehof MM, 2011, PAIN, V152, P533, DOI 10.1016/j.pain.2010.11.002; Vohra S, 2016, J CLIN EPIDEMIOL, V76, P9, DOI 10.1016/j.jclinepi.2015.05.004; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Westin V, 2008, BEHAV RES THER, V46, P1259, DOI 10.1016/j.brat.2008.08.008; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Whiting DL, 2015, PSYCHOL ASSESSMENT, V27, P415, DOI 10.1037/pas0000050; Whiting DL, 2012, BRAIN IMPAIR, V13, P360, DOI 10.1017/BrImp.2012.28; Williams KD, 2010, SMALL GR RES, V41, P268, DOI 10.1177/1046496409358619; Wilson K.G., 2009, MINDFULNESS 2 ACCEPT; Yalom I. D., 2005, THEORY PRACTICE GROU, V5th; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	59	4	4	2	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1328-4207	1742-9552		CLIN PSYCHOL-UK	Clin. Psychol.	JUL	2018	22	2			SI		230	240		10.1111/cp.12118			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GL4HD	WOS:000437109900014		Green Accepted			2022-02-06	
J	Zhang, JH; Gu, JW; Li, BC; Gao, FB; Liao, XM; Cui, SJ				Zhang, Jun-Hai; Gu, Jian-Wen; Li, Bing-Cang; Gao, Fa-Bao; Liao, Xiao-Ming; Cui, Shao-Jie			Establishment of a novel rat model of blast-related diffuse axonal injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						diffuse axonal injury; blast injury; animals; modelling	TRAUMATIC BRAIN-INJURY; ANGULAR-ACCELERATION; PATHOPHYSIOLOGY; BIOMECHANICS; MECHANISMS; EXPRESSION; EXPOSURE; PRIMATE; HEAD	Although studies concerning blast-related traumatic brain injury (bTBI) have demonstrated the significance of diffuse axonal injury (DAI), no standard models for this type of injury have been widely accepted. The present study investigated a mechanism of inducing DAI through real blast injury, which was achieved by performing instantaneous high-speed swinging of the rat head, thus establishing a stable animal model of blast DAI. Adult Sprague-Dawley rats weighing 150 +/- 10 g were randomly divided into experimental (n=16), control (n=10) and sham control (n=6) groups. The frontal, parietal and occipital cortex of the rats in the experimental group were exposed, whereas those of the control group were unexposed; the sham control group rats were anesthetized and attached to the craniocerebral blast device without experiencing a blast. The rats were subjected to craniocerebral blast injury through a blast equivalent to 400 mg of trinitrotoluene using an electric detonator. Biomechanical parameters, and physical and behavioural changes of the sagittal head swing were measured using a high-speed camera. Magnetic resonance imaging (MRI) scans were conducted at 2, 12, 24 and 48 h after craniocerebral injury, only the experimental group indicated brain stem injury. The rats were sacrificed immediately following the MRI at 48 h for pathological examination of the brain stem using haematoxylin and eosin staining. The results indicated that 14 rats (87.5%) in the experimental group exhibited blast DAI, while no DAI was observed in the control and sham control groups, and the difference between the groups was significant (P<0.05). The present results indicated that this experimental design may serve to provide a stable model of blast DAI in rats.	[Zhang, Jun-Hai; Gu, Jian-Wen; Cui, Shao-Jie] Peoples Liberat Army, Hosp 306, Dept Neurosurg, 9 Anxiang Beili, Beijing 100101, Peoples R China; [Li, Bing-Cang] Third Mil Med Univ, Res Inst Surg, State Key Lab Trauma Burns & Combined Injury, Chongqing 400042, Peoples R China; [Gao, Fa-Bao] Sichuan Univ, Dept Radiol, Chengdu 610041, Sichuan, Peoples R China; [Gao, Fa-Bao] Sichuan Univ, West China Hosp, Mol Imaging Ctr, Chengdu 610041, Sichuan, Peoples R China; [Liao, Xiao-Ming] Sichuan Univ, Coll Mat Sci & Engn, Profess Lab, Chengdu 610065, Sichuan, Peoples R China		Gu, JW (corresponding author), Peoples Liberat Army, Hosp 306, Dept Neurosurg, 9 Anxiang Beili, Beijing 100101, Peoples R China.	jianwengudoc@126.com			Key Medical Grant of 11th five years' plan from The Chinese People's Liberation Army [08Z011]; National Basic Research Program of ChinaNational Basic Research Program of China [2011CB935800]; Public Health Training Program of the Capital [Z151100003915125]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31770386]	The present study was supported by the Key Medical Grant of 11th five years' plan from The Chinese People's Liberation Army (grant no. 08Z011), the National Basic Research Program of China (grant no. 2011CB935800), the Public Health Training Program of the Capital (grant no. Z151100003915125) and the National Natural Science Foundation of China (grant no. 31770386).	Bell Monte K, 2008, Mil Med, V173, pv; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Edwards MJ, 2014, J TRAUMA ACUTE CARE, V76, P854, DOI 10.1097/TA.0b013e3182aa2e66; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Heinzelmann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00198; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Huo J, 2012, NEURAL REGEN RES, V7, P1729, DOI 10.3969/j.issn.1673-5374.2012.22.008; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Saljo A, J NEUROTRAUMA, V17, P719; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Zhao Y, 2015, CHIN J TRAUMATOL, V18, P201, DOI 10.1016/j.cjtee.2015.10.002; Zhao YL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4706915	32	4	4	3	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUL	2018	16	1					93	102		10.3892/etm.2018.6146			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GL4IZ	WOS:000437115500012	29977358	Green Published, gold, Green Submitted			2022-02-06	
J	Pandya, A; Chaput, KH; Schertzer, A; Moser, D; Guilfoyle, J; MacGillivray, S; Blackwood, J; Joffe, AR; Thompson, GC				Pandya, Anjli; Chaput, Kathleen Helen; Schertzer, Andrea; Moser, Diane; Guilfoyle, Jonathan; MacGillivray, Sherry; Blackwood, Jaime; Joffe, Ari R.; Thompson, Graham C.			Risk of Infection and Sepsis in Pediatric Patients with Traumatic Brain Injury Admitted to Hospital Following Major Trauma	SCIENTIFIC REPORTS			English	Article							SEVERITY SCORE; YOUNG-ADULTS; CHILDREN; ADOLESCENTS; DEATH	Head injury accounts for 29% of all traumatic deaths in children. Sepsis is significantly associated with an increased risk of mortality in adult traumatic brain injury patients. In the pediatric population, this relationship is not well understood. The objective of this study was to compare the proportion of pediatric traumatic brain injury (TBI) patients and trauma patients without brain injury (NTBI) who developed sepsis or any infection during their index hospital admission. We performed a retrospective study of all trauma patients <18 years of age, admitted to trauma centres in Alberta, Canada from January 1, 2003 to December 31, 2012. Patients who died within 24 hrs of trauma (n = 147) and those with burns as the primary mechanism of injury (n = 53) were excluded. Hospital admission data for the remaining 2556 patients was analyzed. 1727 TBI patients and 829 NTBI patients were included. TBI was associated with lower odds of developing sepsis (OR 0.32 95% CI 0.14-0.77 p = 0.011). TBI was not found to be independently associated with developing any infectious complication after adjusting for confounding by Injury Severity Score (OR 1.25 95% CI 0.90-1.74 p = 0.180). These relationships warrant further study.	[Pandya, Anjli; Thompson, Graham C.] Univ Calgart, Cumming Sch Med, Dept Emergency Med, Calgary, AB, Canada; [Chaput, Kathleen Helen; Thompson, Graham C.] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Schertzer, Andrea] Alberta Hlth Serv, Alberta Trauma Serv, Edmonton, AB, Canada; [Moser, Diane] Alberta Hlth Serv, Data Integrat Measurement & Reporting, Calgary, AB, Canada; [Guilfoyle, Jonathan; MacGillivray, Sherry; Blackwood, Jaime; Thompson, Graham C.] Univ Calgary, Dept Pediat, Cumming Sch Med, Calgary, AB, Canada; [Joffe, Ari R.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada		Thompson, GC (corresponding author), Univ Calgart, Cumming Sch Med, Dept Emergency Med, Calgary, AB, Canada.; Thompson, GC (corresponding author), Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada.; Thompson, GC (corresponding author), Univ Calgary, Dept Pediat, Cumming Sch Med, Calgary, AB, Canada.	graham.thompson@ahs.ca	Thompson, Graham/Y-4180-2019	Thompson, Graham/0000-0002-6781-4186			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BELL LM, 1992, J PEDIATR SURG, V27, P1394, DOI 10.1016/0022-3468(92)90184-9; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hietbrink F, 2013, SHOCK, V40, P21, DOI 10.1097/SHK.0b013e318295a40a; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LESCOHIER I, 1993, PEDIATRICS, V91, P721; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; National Center for Health Statistics, CLASS DIS FUNCT DIS; Newell E, 2012, PEDIATR CRIT CARE ME, V13, P222, DOI 10.1097/PCC.0b013e31822f12f6; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Weiss SL, 2014, CRIT CARE, V18, DOI [10.1186/s13054-015-1055-x, 10.1186/s13054-014-0623-9]	15	4	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 28	2018	8								9798	10.1038/s41598-018-28189-0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FC	WOS:000436546200019	29955138	gold, Green Published			2022-02-06	
J	Deb, S; Leeson, V; Aimola, L; Bodani, M; Li, LC; Weaver, T; Sharp, D; Crawford, M				Deb, Shoumitro; Leeson, Verity; Aimola, Lina; Bodani, Mayur; Li, Lucia; Weaver, Tim; Sharp, David; Crawford, Mike			Aggression Following Traumatic brain injury: Effectiveness of Risperidone (AFTER): study protocol for a feasibility randomised controlled trial	TRIALS			English	Article						Traumatic brain injury; Aggression; Pharmacological intervention; Risperidone; Feasibility RCT	ANTIPSYCHOTIC MEDICATION; BEHAVIOR PROBLEMS; HEAD-INJURY; MANAGEMENT; ADULTS; SERVICE; SCALE	Background: Traumatic brain injury (TBI) is a major public health concern and many people develop long-lasting physical and neuropsychiatric consequences following a TBI. Despite the emphasis on physical rehabilitation, it is the emotional and behavioural consequences that have greater impact on people with TBI and their families. One such problem behaviour is aggression which can be directed towards others, towards property or towards the self. Aggression is reported to be common after TBI (37-71%) and causes major stress for patients and their families. Both drug and non-drug interventions are used to manage this challenging behaviour, but the evidence-base for these interventions is poor and no drugs are currently licensed for the treatment of aggression following TBI. The most commonly used drugs for this purpose are antipsychotics, particularly second-generation drugs such as risperidone. Despite this widespread use, randomised controlled trials (RCTs) of antipsychotic drugs, including risperidone, have not been conducted. We have, therefore, set out to test the feasibility of conducting an RCT of this drug for people who have aggressive behaviour following TBI. Methods/design: We will examine the feasibility of conducting a placebo-controlled, double-blind RCT of risperidone for the management of aggression in adults with TBI and also assess participants' views about their experience of taking part in the study. We will randomise 50 TBI patients from secondary care services in four centres in London and Kent to up to 4 mg of risperidone orally or an inert placebo and follow them up 12 weeks later. Participants will be randomised to active or control treatment in a 1:1 ratio via an external and remote web-based randomisation service. Participants will be assessed at baseline and 12-week follow-up using a battery of assessment scales to measure changes in aggressive behaviour (MOAS, IRQ) as well as global functioning (GOS-E, CGI), quality of life (EQ-5D-5L, SF-12) and mental health (HADS). We will also assess the adverse effect profile with a standard scale (UKU) and collect available data from medical records on blood tests (serum glucose/HbA1c, lipid profile, prolactin), and check body weight and blood pressure. In addition completion of the MOAS and a check for any new or worsening side-effect will be completed weekly and used by the prescribing clinician to determine continuing dosage. Family carers' wellbeing will be assessed with CWSQ. Service use will be recorded using CSRI. A process evaluation will be carried out at the end of the trial using both qualitative and quantitative methodology. Discussion: Aggressive behaviour causes immense distress among some people with TBI and their families. By examining the feasibility of a double-blind, placebo-controlled RCT, we aim to discover whether this approach can successfully be used to test the effects of risperidone for the treatment of aggressive behaviour among people with aggression following TBI and improve the evidence base for the treatment of these symptoms. Our criteria for demonstrating success of the feasibility study are: (1) recruitment of at least 80% of the study sample, (2) uptake of intervention by at least 80% of participants in the active arm of the trial and (3) completion of follow-up interviews at 12 weeks by at least 75% of the study participants.	[Deb, Shoumitro; Leeson, Verity; Aimola, Lina; Crawford, Mike] Imperial Coll London, Div Brain Sci, Dept Med, Ctr Psychiat, 7th Floor Commonwealth Bldg, London W12 0NN, England; [Bodani, Mayur] Kent & Medway NHS & Social Care Partnership NHS T, Dept Neuropsychiat, Daren House, Sevenoaks TN13 3PG, Kent, England; [Li, Lucia; Sharp, David] Imperial Coll London, Dept Med, Div Brain Sci, Computat Cognit & Clin Neuroimaging C3NL, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England; [Weaver, Tim] Middlesex Univ, Sch Hlth & Educ, Dept Mental Hlth Res, London, England		Deb, S (corresponding author), Imperial Coll London, Div Brain Sci, Dept Med, Ctr Psychiat, 7th Floor Commonwealth Bldg, London W12 0NN, England.	s.deb@imperial.ac.uk	Sharp, David J/A-2119-2013	Crawford, Mike/0000-0003-3137-5772; Li, Lucia/0000-0001-7339-4854; Weaver, Tim/0000-0002-3437-3556; Deb, Shoumitro/0000-0002-1300-8103	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) ProgrammeNational Institute for Health Research (NIHR) [PB-PG-1013-32054]	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-1013-32054). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health, UK.	Agrawal N, 2008, PSYCHIATR BULL, V32, P288, DOI 10.1192/pb.bp.107.018424; Alderman N, 2002, BRAIN INJURY, V16, P469, DOI 10.1080/02699050110118458; Ballard CG, 2006, COCHRANE DB SYST REV, DOI [003410.001002/14651858.CD14003476.pub14651852, DOI 10.1002/14651858.CD003476.PUB2]; Beecham J, 2001, MEASURING MENTAL HLT; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; BROWNE RH, 1995, STAT MED, V14, P1933, DOI 10.1002/sim.4780141709; Craig KJ, 2008, PSYCHIAT RES, V159, P367, DOI 10.1016/j.psychres.2007.03.002; Deb S, 2007, J INTELL DISABIL RES, V51, P766, DOI 10.1111/j.1365-2788.2007.00950.x; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Deb S, 2016, NEUROPSYCH NEWS, V12, P22; Deb S., 2016, HDB EVIDENCE BASED P, P347, DOI DOI 10.1007/978-3-319-26583-4; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Falope ZF, 2006, NEUROREHAB NEURAL RE, V20, P90; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Fleminger S, 2006, PHARM MANAGEMENT AGI; Guy W., 1976, EARLY CLIN DRUG EVAL; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Leavy, 2006, PRACTICE QUALITATIVE; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; National Institute for Health and Care Excellence (NICE, 2013, TRIAG ASS INV EARL M; Oliver-Africano P, 2010, J INTELL DISABIL RES, V54, P17, DOI 10.1111/j.1365-2788.2009.01195.x; Quirk A, 2012, MENT HEALTH REV J, V17, P128, DOI 10.1108/13619321211287184; Ratey J. J., 1991, J NEUROPSYCHIATRY, V3, P557; Sadavoy J, 2008, CAMBRIDGE TEXTBOOK OF EFFECTIVE TREATMENTS IN PSYCHIATRY, P187, DOI 10.1017/CBO9780511544392.012; Silver JM, 2005, TXB TRAUMATIC BRAIN, P259; Stoffers J, 2010, COCHRANE DB SYST REV, DOI [10.1002/1465185.CD005653.pub2, 10.1002/14651858.CD005653.pub2]; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Unwin GL, 2011, RES DEV DISABIL, V32, P2121, DOI 10.1016/j.ridd.2011.07.031; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	4	4	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUN 21	2018	19								325	10.1186/s13063-018-2601-z			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	GK1HU	WOS:000435865800001	29929537	gold, Green Published, Green Accepted			2022-02-06	
J	Lah, S; Gott, C; Epps, A; Parry, L				Lah, Suncica; Gott, Chloe; Epps, Adrienne; Parry, Louise			Imagining the Future in Children with Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						autobiographical memory; event construction; prospection; retrograde memory	AUTOBIOGRAPHICAL MEMORY; DEVELOPMENTAL AMNESIA; EPISODIC MEMORY; THINKING; RECOGNITION; CHILDHOOD; DEFICITS; DAMAGE; TBI	Imagining future events is thought to rely on recombination and integration of past episodic memory traces into future events. Future and past events contain episodic and nonepisodic details. Children with severe traumatic brain injury (TBI) were found to have impaired recall of past episodic (but not semantic) event details. Here, we examined whether severe TBI impairs construction of future events. Children with severe TBI (n=15) and healthy controls (NC; n=33) 1) completed tests of anterograde (narrative and relational) memory and executive skills, 2) recalled past events and generated future events, and 3) rated events' phenomenological qualities. Events were scored for episodic (internal) and semantic (external) details. The groups did not differ in generating details of future events, although children with TBI recalled significantly fewer past internal (but not external) events' details relative to NCs. Moreover, the number of past internal details relative to future internal details was significantly higher in the NC group, but not in the TBI groups. Significant correlations between past and future were found for 1) internal details in both groups and 2) external details in the NC group. The TBI group rated their events as being less significant than did the NC group. The groups did not differ on ratings of visual intensity and rehearsal. Our study has shown that children who have sustained severe TBI had impoverished recall of past, but not generation of future, events. This unexpected dissociation between past and future event construction requires further research.	[Lah, Suncica; Gott, Chloe] Univ Sydney, Sch Psychol, Brennan MacCallum Bldg A18, Sydney, NSW 2006, Australia; [Lah, Suncica] ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Epps, Adrienne; Parry, Louise] Sydney Childrens Hosp, Rehab2Kids, Brain Injury Rehabil Program, Randwick, NSW, Australia		Lah, S (corresponding author), Univ Sydney, Sch Psychol, Brennan MacCallum Bldg A18, Sydney, NSW 2006, Australia.	suncica.lah@sydney.edu.au			Memory Node of the ARC Center of Excellence in Cognition and its Disorders; University of Sydney Thompson Fellowship	This work was, in part, supported by the Memory Node of the ARC Center of Excellence in Cognition and its Disorders and by The University of Sydney Thompson Fellowship awarded to S.L. We thank the staff from the Brain Injury Rehabilitation Program at Sydney Children's Hospital (Randwick) for their assistance with recruitment. We also express our gratitude to the families who participated in this study.	Addis DR, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00173; Adlam ALR, 2009, NEUROPSYCHOLOGIA, V47, P2207, DOI 10.1016/j.neuropsychologia.2009.01.038; Andelman F, 2010, NEUROCASE, V16, P426, DOI 10.1080/13554791003623318; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; Berryhill ME, 2010, NEUROPSYCHOLOGIA, V48, P1385, DOI 10.1016/j.neuropsychologia.2010.01.004; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Brandt KR, 2009, NEUROCASE, V15, P60, DOI 10.1080/13554790802613025; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Cooper JM, 2011, NEUROPSYCHOLOGIA, V49, P1843, DOI 10.1016/j.neuropsychologia.2011.03.008; Coste C, 2015, NEUROPSYCHOLOGIA, V71, P133, DOI 10.1016/j.neuropsychologia.2015.03.014; Coughlin C, 2014, COGNITIVE DEV, V30, P96, DOI 10.1016/j.cogdev.2014.02.001; de Haan M, 2006, TRENDS NEUROSCI, V29, P374, DOI 10.1016/j.tins.2006.05.008; de Vito S, 2012, NEUROPSYCHOLOGIA, V50, P1494, DOI 10.1016/j.neuropsychologia.2012.03.001; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eslinger PJ, 1999, DEV NEUROPSYCHOL, V15, P157, DOI 10.1080/87565649909540744; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; Gardiner JM, 2006, COGN NEUROPSYCHOL, V23, P930, DOI 10.1080/02643290600588442; Gott C, 2014, CHILD NEUROPSYCHOL, V20, P625, DOI 10.1080/09297049.2013.840362; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Irish M, 2013, CORTEX, V49, P2377, DOI 10.1016/j.cortex.2013.03.002; Irish M, 2012, NEUROPSYCHOLOGIA, V50, P3488, DOI 10.1016/j.neuropsychologia.2012.09.012; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Korkman M., 2007, NEPSY 2 CLIN INTERPR, V2nd ed ed; Kwan D, 2010, NEUROPSYCHOLOGIA, V48, P3179, DOI 10.1016/j.neuropsychologia.2010.06.011; Lah S, 2018, J NEUROTRAUM, V35, P2036; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Maguire EA, 2010, NEUROPSYCHOLOGIA, V48, P3187, DOI 10.1016/j.neuropsychologia.2010.06.037; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Partington J.E., 1949, PSYCHOL SERVICE CTR; Race E, 2011, J NEUROSCI, V31, P10262, DOI 10.1523/JNEUROSCI.1145-11.2011; Rasmussen KW, 2018, J NEUROPSYCHOL, V12, P78, DOI 10.1111/jnp.12108; Rasmussen KW, 2014, J NEUROPSYCHOL, V8, P34, DOI 10.1111/jnp.12003; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Squire LR, 2010, P NATL ACAD SCI USA, V107, P19044, DOI 10.1073/pnas.1014391107; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; Tedder J, 2016, CLIN NEUROPSYCHOL, V30, P334, DOI 10.1080/13854046.2016.1142612; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wang Q, 2014, J COGN DEV, V15, P625, DOI 10.1080/15248372.2013.784977; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 2005, WECHSLER INTELLIGENC; Willoughby KA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00053	59	4	4	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	17					2036	2043		10.1089/neu.2017.5250		JUN 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GQ7LU	WOS:000435036700001	29566641				2022-02-06	
J	Berger, S; Culpepper, N; Hidalgo, J; McKee, J; Wortzel, HS				Berger, Steven; Culpepper, Nickolas; Hidalgo, Jose; McKee, Jerry; Wortzel, Hal S.			AAPL Practice Resource for Prescribing in Corrections	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							BORDERLINE PERSONALITY-DISORDER; POSTTRAUMATIC-STRESS-DISORDER; EXTENDED-RELEASE NALTREXONE; PLACEBO-CONTROLLED TRIAL; AGGRESSIVE SCHIZOPHRENIC-PATIENTS; MEDICATION-ASSISTED TREATMENT; PSYCHIATRY WFSBP GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSIVE DISORDER; TRAUMATIC BRAIN-INJURY										Adeniji AA, 2016, J WOMENS HEALTH, V25, P638, DOI 10.1089/jwh.2015.5418; Alderman CP, 2009, ANN PHARMACOTHER, V43, P1220, DOI 10.1345/aph.1M009; Allan ER, 1996, J CLIN PSYCHIAT, V57, P455, DOI 10.4088/JCP.v57n1003; Allely CS, 2016, BRAIN INJURY, V30, P1161, DOI 10.1080/02699052.2016.1191674; Allen MH, 2000, J CLIN PSYCHIAT, V61, P11; American Psychiatric Association, 1999, TASK FORC SEX DANG O; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, PRACTICE GUIDELINE T; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; American Psychiatric Association (APA), 2009, RES DOC GUID PSYCH C; American Psychiatric Association (APA), PRACT GUID TREATM PA; American Psychiatric Association (APA), 2006, PRACT GUID TREATM SU, V163, pS3; American Psychiatric Association (APA), WORK GROUP PSYCH EV, DOI [10.1176/appi.books.9780890426760, DOI 10.1176/APPI.BOOKS.9780890426760]; American Psychiatric Association Practice Guidelines, 2016, HOM PAG; Andreoli SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088836; Andrisano C, 2013, INT CLIN PSYCHOPHARM, V28, P33, DOI 10.1097/YIC.0b013e32835a5d2e; [Anonymous], 2016, AM PSYCH ASS WORK GR; APA, 2009, PRACT GUID TREATM PA; APA, 2004, PRACT GUID TREATM PA; APA, 2005, GUID WATCH PRACT GUI; Appelbaum K MK, 2015, OXFORD TXB CORRECTIO, P200; Appelbaum KL, 2015, J AM ACAD PSYCHIATRY, V43, P406; Appelbaum Kenneth L, 2011, J Correct Health Care, V17, P218, DOI 10.1177/1078345811401356; Appelbaum KL, 2001, PSYCHIAT SERV, V52, P1343, DOI 10.1176/appi.ps.52.10.1343; Appelbaum KL, 2010, HDB CORRECTIONAL MEN, P91; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Ardino V, 2011, EUR J PSYCHOTRAMA S1, V2, P17; Aufderheide D., 2015, OXFORD TXB CORRECTIO, P46; Baillargeon J, 2000, PSYCHIATR SERV, V51, P1444, DOI 10.1176/appi.ps.51.11.1444; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Baillargeon J, 2010, AM J COMMUN PSYCHOL, V46, P361, DOI 10.1007/s10464-010-9345-6; Balbuena L, 2010, CAN J PSYCHIAT, V55, P50, DOI 10.1177/070674371005500108; Bandelow B, 2012, INT J PSYCHIAT CLIN, V16, P77, DOI 10.3109/13651501.2012.667114; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Beck AJ, 2012, SEXUAL VICTIMIZATION; Berger RH, 2015, OXFORD TXB CORRECTIO, P149; Bilodeau M, 2014, J ATTEN DISORD, V18, P169, DOI 10.1177/1087054712443157; Binswanger Hairston P., 2015, OXFORD TXB CORRECTIO, P247; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Binswanger IA, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-3; Bond DJ, 2012, ANN CLIN PSYCHIATRY, V24, P23; Bossini L, 2012, EXPERT OPIN PHARMACO, V13, P1707, DOI 10.1517/14656566.2012.699523; Briere J, 2016, PSYCHOL TRAUMA-US, V8, P439, DOI 10.1037/tra0000107; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Buckley PF, 1997, J AM ACAD PSYCHIATRY, V25, P173; Burns KA, 2009, J AM ACAD PSYCHIATRY, V37, P50; Burrow GF, 2006, CLIN PRACTICE CORREC, P426; Butler HD, 2014, CRIM JUSTICE BEHAV, V41, P1338, DOI 10.1177/0093854814535082; Cameron IM, 2014, J AFFECT DISORDERS, V166, P48, DOI 10.1016/j.jad.2014.04.078; Carson E. Ann, 2012, PRISONERS 2011; Casey P, 2009, CNS DRUGS, V23, P927, DOI 10.2165/11311000-000000000-00000; Caspi N, 2001, INT CLIN PSYCHOPHARM, V16, P111, DOI 10.1097/00004850-200103000-00006; Cassau JS, 2012, INT J LAW PSYCHIAT, V35, P231, DOI 10.1016/j.ijlp.2012.02.013; Chain S BB, 2015, OXFORD TXB CORRECTIO, V2015, P229; Chair Walton RB, 2009, NATL PRISON RAPE ELI; Chang Z, 2015, LANCET PSYCHIAT, V2, P891, DOI 10.1016/S2215-0366(15)00234-5; Chari AK, 2016, NATL SURVEY PRISON H; Cherek DR, 1999, PSYCHOPHARMACOLOGY, V142, P144, DOI 10.1007/s002130050873; Chiu T., 2010, ITS TIME AGING PRISO; Cislo AM, 2013, INT J LAW PSYCHIAT, V36, P304, DOI 10.1016/j.ijlp.2013.04.002; Cloyes KG, 2015, OXFORD TXB CORRECTIO, P326; COCCARO EF, 1990, J CLIN PSYCHOPHARM, V10, P373; Comai S, 2012, J CLIN PSYCHOPHARM, V32, P83, DOI 10.1097/JCP.0b013e31823f8770; Connery HS, 2015, HARVARD REV PSYCHIAT, V23, P63, DOI 10.1097/HRP.0000000000000075; Connor DF, 1997, J AM ACAD CHILD PSY, V36, P826, DOI 10.1097/00004583-199706000-00021; Coviello DM, 2012, SUBST ABUS, V33, P48, DOI 10.1080/08897077.2011.609438; Coviello DM, 2010, AM J ADDICTION, V19, P422, DOI 10.1111/j.1521-0391.2010.00070.x; COWDRY RW, 1988, ARCH GEN PSYCHIAT, V45, P111; Croft M, 2015, BRIT J PAIN, V9, P96, DOI 10.1177/2049463714540895; Cuijpers P, 2014, WORLD PSYCHIATRY, V13, P56, DOI 10.1002/wps.20089; Culpepper L, 2015, PRIM CARE COMPANION, V17; CZOBOR P, 1995, J CLIN PSYCHOPHARM, V15, P243, DOI 10.1097/00004714-199508000-00002; Daines MK, 2007, CORRECTIONAL PSYCHIA, P8; de Jongh A, 2016, DEPRESS ANXIETY, V33, P359, DOI 10.1002/da.22469; Deardorff WJ, 2015, DRUG AGING, V32, P537, DOI 10.1007/s40266-015-0273-x; Deiter Paul, 2008, Perm J, V12, P53; Del Paggio D, 2005, BAY AREA PSYCHOPHARM, V8, P1; Depakote ER, 2008, PRESCRIBING INFORM T; Dewa LH, 2015, SLEEP MED REV, V24, P13, DOI 10.1016/j.smrv.2014.12.002; Dickerson FB, 2011, J NERV MENT DIS, V199, P520, DOI 10.1097/NMD.0b013e318225ee78; Dickert J, 2015, PSYCHIAT SERV, V66, P975, DOI 10.1176/appi.ps.201400429; Dlugacz H, 2013, INT J LAW PSYCHIAT, V36, P213, DOI 10.1016/j.ijlp.2013.04.001; Doghramji PP, 2014, POSTGRAD MED, V126, P82, DOI 10.3810/pgm.2014.09.2802; Dolan KA, 2003, DRUG ALCOHOL DEPEN, V72, P59, DOI 10.1016/S0376-8716(03)00187-X; Downer AV, 2016, J AM ACAD PSYCHIATRY, V44, P9; Dunsieth NW, 2004, J CLIN PSYCHIAT, V65, P293; EBRAHIM GM, 1994, HOSP COMMUNITY PSYCH, V45, P271; Elger BS, 2008, MED SCI LAW, V48, P307, DOI 10.1258/rsmmsl.48.4.307; Elger BS, 2015, OXFORD TXB CORRECTIO, P85; Emilsson B, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-116; FAVA M, 1993, AM J PSYCHIAT, V150, P1158; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Felthous AR, 2015, J AM ACAD PSYCHIATRY, V43, P456; Finigan MW, 2011, J SUBST ABUSE TREAT, V41, P288, DOI 10.1016/j.jsat.2011.04.003; FINK M, 1984, AM J PSYCHIAT, V141, P1034; Fink M, 2014, J ECT, V30, P5, DOI 10.1097/YCT.0b013e3182a6ad0d; Fink M, 2010, J ECT, V26, P243, DOI 10.1097/YCT.0b013e3181feb69f; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fovet T, 2015, PSYCHIAT SERV, V66, P348, DOI 10.1176/appi.ps.201400104; Francesconi G, 2015, HUM PSYCHOPHARM CLIN, V30, P255, DOI 10.1002/hup.2476; Friedmann PD, 2012, SUBST ABUS, V33, P9, DOI 10.1080/08897077.2011.611460; Ghaemi SN, 2003, BIPOLAR DISORD, V5, P421, DOI 10.1046/j.1399-5618.2003.00074.x; Glancy G, 1996, J FORENSIC PSYCHIATR, V7, P387, DOI 10.1080/09585189608415023; Glancy G, 2016, AM PSYCH ASS 2016 AN; GLANCY GD, 2002, CPA B, V34, P19; GLANCY GD, 2002, CPA B, V34, P13; Glancy GD, 2003, AMERICAN ACAD PSYC 4, V28, P12; GLANCY GD, 2003, CPA B, V35, P13; Glancy GD, 2015, OXFORD TXB CORRECTIO, P95; Glancy Graham D, 2015, J Am Acad Psychiatry Law, V43, pS3; Goff Ashley, 2007, Crim Behav Ment Health, V17, P152; Goldberg JF, 2012, MANAGING SIDE EFFECT, P9; Gordon MS, 2008, ADDICTION, V103, P1333, DOI 10.1111/j.1360-0443.2008.002238.x; Gray R, 2008, J FORENSIC PSYCHI PS, V19, P335, DOI 10.1080/14789940802113493; GREENDYKE RM, 1986, J CLIN PSYCHIAT, V47, P423; Greenhalgh J, 2005, HEALTH TECHNOL ASSES, V9, P1; Griffiths EV, 2012, AUST NZ J PSYCHIAT, V46, P407, DOI 10.1177/0004867411433893; Groot E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157512; Group for the Advancement of Psychiatry, 2016, COMM PSYCH COMM AM P; Haas S, 1997, Ann Clin Psychiatry, V9, P145; Hanley MJ, 2008, AM J HEALTH-SYST PH, V65, P611, DOI 10.2146/ajhp070112; Harner HM, 2014, NURS RES, V63, P158, DOI 10.1097/NNR.0000000000000031; Hartling L, 2012, ANN INTERN MED, V157, P498, DOI 10.7326/0003-4819-157-7-201210020-00525; Haynes VS, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-222; Hermes E, 2014, EPIDEMIOL PSYCH SCI, V23, P281, DOI 10.1017/S2045796013000449; Herpertz SC, 2007, WORLD J BIOL PSYCHIA, V8, P212, DOI 10.1080/15622970701685224; Hilliard WT, 2013, J CORRECT HEALTH CAR, V19, P211, DOI 10.1177/1078345813486448; Hodgins S, 2010, CAN J PSYCHIAT, V55, P784, DOI 10.1177/070674371005501206; Hollander E, 2001, J CLIN PSYCHIAT, V62, P199, DOI 10.4088/JCP.v62n0311; HRW, 2012, OLD BARS AG PRIS POP; Institute for Healthcare Improvement, 2017, SCI IMPR IMPR; Ireland JL, 2006, J ADOLESCENT HEALTH, V38, P649, DOI 10.1016/j.jadohealth.2005.05.027; James D.J., 2006, MENTAL HLTH PROBLEMS; JAMES IP, 1967, BRIT J ADDICT, V62, P391; Jillani S, 2016, J AM ACAD PSYCHIATRY, V44, P158; John D, STATE PRISON HEALTHC; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; Jones RM, 2011, BRIT J PSYCHIAT, V198, P93, DOI 10.1192/bjp.bp.110.083030; Kaba F, 2014, AM J PUBLIC HEALTH, V104, P442, DOI 10.2105/AJPH.2013.301742; Kamath J, 2008, INT J OFFENDER THER, V52, P358, DOI 10.1177/0306624X07307367; Kamath J, 2016, INT J OFFENDER THER, V60, P1315, DOI 10.1177/0306624X15578228; Kamath J, 2013, INT J OFFENDER THER, V57, P251, DOI 10.1177/0306624X11427537; Karberg JC., 2005, SUBSTANCE DEPENDENCE; Katzman MA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-S1-S1; Keram EA, 2015, OXFORD TXB CORRECTIO, P365; Khalifa N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007667.pub2; Kinlock TW, 2008, CRIM JUSTICE BEHAV, V35, P34, DOI 10.1177/0093854807309111; Kitchiner N J, 2000, Br J Community Nurs, V5, P26; Knoll JL, 2015, OXFORD TXB CORRECTIO, P117; Knox CM, 2015, OXFORD TXB CORRECTIO, P159; Kreyenbuhl J, 2010, SCHIZOPHRENIA BULL, V36, P94, DOI 10.1093/schbul/sbp130; Kruszewse SP, 2009, J PSYCHIATR PRACT, V15, P314, DOI 10.1097/01.pra.0000358318.73684.df; Kumar A, 2015, PHARMACOL REP, V67, P195, DOI 10.1016/j.pharep.2014.09.004; Kunik ME, 1998, INT J GERIATR PSYCH, V13, P29, DOI 10.1002/(SICI)1099-1166(199801)13:1<29::AID-GPS726>3.0.CO;2-Z; Labbate LA, 2010, HDB PSYCHIAT DRUG TH; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Lapham SC, 2011, J ADDICT MED, V5, P163, DOI 10.1097/ADM.0b013e3181eb3b89; Larney S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004666; Larney S, 2012, ADDICTION, V107, P372, DOI 10.1111/j.1360-0443.2011.03618.x; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Lavan AH, 2016, THER ADV DRUG SAF, V7, P11, DOI 10.1177/2042098615615472; LEBERT F, 1994, J CLIN PSYCHIAT, V55, P536; Lee JD, 2016, NEW ENGL J MED, V374, P1232, DOI 10.1056/NEJMoa1505409; Lee JD, 2015, ADDICTION, V110, P1008, DOI 10.1111/add.12894; Legislative Analyst's Office, LOW STAT COST PRESCR; Lerner J, 2015, WESTCHESTER JAIL OVE; Li I, 2015, OXFORD TXB CORRECTIO, P155; Lindenmayer JP, 2000, J CLIN PSYCHIAT, V61, P123, DOI 10.4088/JCP.v61n0207; Lopez LV, 2015, J CLIN PSYCHIAT, V76, P1249, DOI 10.4088/JCP.15ac10243; Lubelczyk R, 2015, OXFORD TXB CORRECTIO, P90; Marcus SC, 2015, J MANAG CARE SPEC PH, V21, P754, DOI 10.18553/jmcp.2015.21.9.754; Martin A, 2008, AUST NZ J PSYCHIAT, V42, P141, DOI 10.1080/00048670701787529; Martinez-Gomez A, 2014, INTERPRETING, V16, P233, DOI 10.1075/intp.16.2.05mar; Maruschak LM, 2004, MED PROBLEMS PRISONE; Maschi T, 2014, INT J PRISON HEALTH, V10, P172, DOI 10.1108/IJPH-05-2013-0024; Mattes JA, 2005, J CLIN PSYCHOPHARM, V25, P575, DOI 10.1097/01.jcp.0000186739.22395.6b; Mattes JA, 2016, J AM ACAD PSYCHIATRY, V44, P151; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; McCall C, 2012, CURR PSYCHIAT REP, V14, P494, DOI 10.1007/s11920-012-0302-y; McCall WV, 2004, BRIT J PSYCHIAT, V185, P405, DOI 10.1192/bjp.185.5.405; McDermott BE, 2009, BEHAV SCI LAW, V27, P753, DOI 10.1002/bsl.892; McIntyre RS, 2015, J CLIN PSYCHIAT, V76, P398, DOI 10.4088/JCP.14m09410; McKee J, 2014, J CORRECT HEALTH CAR, V20, P249, DOI 10.1177/1078345814532419; Mela M, 2016, J AM ACAD PSYCHIATRY, V44, P82; Metzner JL, 2010, J AM ACAD PSYCHIATRY, V38, P104; Metzner JL, 2015, OXFORD TXB CORRECTIO, P112; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; Mojtabai R, 2008, ARCH GEN PSYCHIAT, V65, P962, DOI 10.1001/archpsyc.65.8.962; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Muller-Oerlinghausen B, 2010, NEUROPSYCHOBIOLOGY, V62, P43, DOI 10.1159/000314309; Namdari B, 2013, J ADDICT DIS, V32, P393, DOI 10.1080/10550887.2013.849974; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Association of State Alcohol and Drug Abuse Directors (NASADAD), 2011, CONS STAT US MED TRE; National Commission on Correctional Health Care, 2016, POS STAT SOL CONF IS; National Commission on Correctional Health Care (NCCHC), 2014, STAND HLTH SERV JAIL; National Commission on Correctional Health Care (NCCHC), 2014, STAND HLTH SERV PRIS; National Commission on Correctional Health Care (NCCHC), 2015, STAND MENT HLTH SERV; National Commission on Correctional Health Care (NCCHC), 2008, I03 NCCHC; National Drug Intelligence Center (NDIC), 2011, EC IMP ILL DRUG US A; National Hospice and Palliative Care Organization (NHPCO), 2009, QUAL GUID HOSP END O; National Institute for Health and Care Excellence (NICE), 2012, DRUG DIS AD; National Institute for Health and Care Excellence (NICE), 2016, BIP DIS ASS MAN; National Institute for Health and Care Excellence (NICE), 2011, GEN ANX DIS PAN DIS; National Institute for Health and Clinical Excellence, 2009, DEPR AD REC MAN; National Institute for Health and Clinical Excellence, 2009, NICE CLIN GUID, V78; National Institute for Health and Clinical Excellence, 2009, NICE CLIN GUID, V77; National Institute for Health and Clinical Excellence NICE, 2016, ATT DEF HYP DIS DIAG; *NICE, 2005, POSTTR STRESS DISORD; NIDA, PRINC DRUG ADD TREAT PRINC DRUG ADD TREAT, V3rd; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Ourada JD, 2015, OXFORD TXB CORRECTIO, P123; Oxelson E, 2010, GROUP PSYCHOTHERAPY, V24, P225; Pacini M, 2014, HEROIN ADDICT REL CL, V16, P35; Paparella S, 2010, J EMERG NURS, V36, P156, DOI 10.1016/j.jen.2009.11.019; Paterson B, 2003, J Psychiatr Ment Health Nurs, V10, P3, DOI 10.1046/j.1365-2850.2003.00523.x; Patterson RF, 2015, OXFORD TXB CORRECTIO, P382; Perrien M., 2015, OXFORD TXB CORRECTIO, P71; Perugi G, 2015, J AFFECT DISORDERS, V183, P119, DOI 10.1016/j.jad.2015.05.004; Picardi Angelo, 2014, Clin Pract Epidemiol Ment Health, V10, P140, DOI 10.2174/1745017901410010140; Pierre JM, 2004, AM J PSYCHIAT, V161, P1718, DOI 10.1176/appi.ajp.161.9.1718; Pilkinton PD, 2014, J CORRECT HEALTH CAR, V20, P95, DOI 10.1177/1078345813518629; Pittenger C, 2007, J CLIN PSYCHIAT, V68, P483, DOI 10.4088/JCP.v68n0320a; Pollock P H, 1997, J Psychiatr Ment Health Nurs, V4, P9, DOI 10.1111/j.1365-2850.1997.tb00171.x; Prommer EE, 2009, J PAIN SYMPTOM MANAG, V37, P3; Puetz TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126529; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Quaglio G, 2008, ADDICTION, V103, P1572, DOI 10.1111/j.1360-0443.2008.02266.x; Rand MR, ALCOHOL CRIME DATA 2; Rand MR, 2010, CRIMINAL VICTIMIZATI; Rasmussen K, 2002, J ECT, V18, P58, DOI 10.1097/00124509-200203000-00015; Reccoppa L, 2004, AM J ADDICTION, V13, P321, DOI 10.1080/10550490490460300; Reeves R, 2016, 9 AC HLTH POL C CORR; Reeves R, 2017, J AM ACAD PSYCHIATRY, V45; Reeves R, 2014, J AM ACAD PSYCHIATRY, V42, P484; Reeves R, 2012, J CORRECT HEALTH CAR, V18, P45, DOI 10.1177/1078345811421591; Rich JD, 2015, LANCET, V386, P350, DOI 10.1016/S0140-6736(14)62338-2; Risk Evaluation and Mitigation Strategy (REMS), SINGL SHAR SYST CLOZ; ROGERS R, 1994, LAW HUMAN BEHAV, V18, P543, DOI 10.1007/BF01499173; Rosenquist PB, 2006, J ECT, V22, P18, DOI 10.1097/00124509-200603000-00004; Royal College of General Practitioners (RCGP), 2011, SAF PRESCR PRIS GUID; Ruiz P., 2009, KAPLAN SADOCKS COMPR; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Saitman A, 2014, J ANAL TOXICOL, V38, P387, DOI 10.1093/jat/bku075; Saleh FM, 2015, OXFORD TXB CORRECTIO, P336; Salem A, 2015, J AM ACAD PSYCHIATRY, V43, P159; SALZMAN C, 1995, J CLIN PSYCHOPHARM, V15, P23, DOI 10.1097/00004714-199502000-00005; Sanford M, 2015, CNS DRUGS, V29, P253, DOI 10.1007/s40263-015-0234-2; Sarlon E, 2012, REV EPIDEMIOL SANTE, V60, P197, DOI 10.1016/j.respe.2011.11.001; Sattar SP, 2003, NEW ENGL J MED, V348, P764; Saxon AJ, 2001, PSYCHIATR SERV, V52, P959, DOI 10.1176/appi.ps.52.7.959; Scarff Jonathan R, 2011, P T, V36, P832; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Schwaebe C, 2005, INT J OFFENDER THER, V49, P614, DOI 10.1177/0306624X05275829; Schwartz Thomas L, 2013, Drugs Context, V2013, P212257, DOI 10.7573/dic.212257; Scott C, 2010, HDB CORRECTIONAL MEN; Scott CL, 2015, OXFORD TXB CORRECTIO, P8; Scott CL, 2010, HDB CORRECTIONAL MEN, P321; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Shelton D, 2010, J PSYCHIATR MENT HLT, V17, P603, DOI 10.1111/j.1365-2850.2010.01587.x; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Shorter D, 2015, AM J ADDICTION, V24, P705, DOI 10.1111/ajad.12306; Small Gary W, 2009, J Clin Psychiatry, V70, pe47, DOI 10.4088/JCP.8001tx20c; SMITH LD, 1989, HOSP COMMUNITY PSYCH, V40, P491; Soloff PH, 1998, B MENNINGER CLIN, V62, P195; Spivak B, 2003, J CLIN PSYCHIAT, V64, P755, DOI 10.4088/JCP.v64n0703; STEIN DJ, 1995, J CLIN PSYCHIAT, V56, P506; Stoffers J, 2010, COCHRANE DB SYST REV, DOI [10.1002/1465185.CD005653.pub2, 10.1002/14651858.CD005653.pub2]; Stoffers JM, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0534-0; Struckman-Johnson C, 2008, PRISON J, V80, P616; Stubbs J, 2008, INT PSYCHOGERIATR, V20, P616, DOI 10.1017/S1041610207006047; STUPPAECK CH, 1993, J NERV MENT DIS, V181, P519, DOI 10.1097/00005053-199308000-00010; Substance abuse and Mental Health Services Administration (SAMHSA), 2011, DRUG AB WARN NETW NA; Sullivan G, 1997, J PSYCHOPHARMACOL, V11, P93, DOI 10.1177/026988119701100119; Surya S, 2015, J ECT, V31, P150, DOI 10.1097/YCT.0000000000000263; Tamburello A, 2016, ANN M AM AC PSYCH LA; Tamburello AC, 2015, OXFORD TXB CORRECTIO, P165; Tamburello AC, 2017, J CORRECT HEALTH CAR, V23, P449, DOI 10.1177/1078345817727730; Tamburello AC, 2012, J AM ACAD PSYCHIATRY, V40, P502; TEPPER AM, 1984, LAW HUMAN BEHAV, V8, P205, DOI 10.1007/BF01044693; Thibaut F, 2010, WORLD J BIOL PSYCHIA, V11, P604, DOI 10.3109/15622971003671628; Torres R, 2016, SPRING C CORR HLTH C; Torrey EF, TREATMENT PERSONS ME; Trestman RL, 2000, J AM ACAD PSYCHIATRY, V28, P232; Trestman RL, 2015, OXFORD TXB CORRECTIO, P275; Vaslamatzis G, 2014, J NERV MENT DIS, V202, P138, DOI 10.1097/NMD.0000000000000083; Virdi S., 2015, OXFORD TXB CORRECTIO, P195; Volpe KD, 2005, PHARM PRACTICE NEWS, V32; Waghorn J, 2009, MENTAL HLTH PRACTICE, V12, P16, DOI DOI 10.7748/MHP2009.06.12.9.16.C7091; Wakeman SE, 2015, OXFORD TXB CORRECTIO, P260; Weber J, 2010, CNS DRUGS, V24, P713, DOI 10.2165/11200810-000000000-00000	293	4	4	0	5	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law	JUN 1	2018	46	2		S			S2	S50					49	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	GN5DZ	WOS:000439068300001	29884616				2022-02-06	
J	Castello, LM; Salmi, L; Zanotti, I; Gardino, CA; Baldrighi, M; Settanni, F; Avanzi, GC				Castello, Luigi M.; Salmi, Livia; Zanotti, Isabella; Gardino, Clara A.; Baldrighi, Marco; Settanni, Fabio; Avanzi, Gian C.			The increase in copeptin levels in mild head trauma does not predict the severity and the outcome of brain damage	BIOMARKERS IN MEDICINE			English	Article						biomarker; copeptin; copeptin prognostic value; TBI; traumatic brain injury	VASOPRESSIN V-1A; PROGNOSTIC VALUE; PLASMA COPEPTIN; ISCHEMIC-STROKE; INJURY; MICE	Aim: To investigate the copeptin prognostic role in mild head trauma. Methods: We enrolled 105 adult patients who entered the emergency room because of recent mild head trauma; we evaluated: clinical picture, imaging and laboratory data (including copeptin). Results: Copeptin resulted higher in mild head trauma patients compared with controls: 29.89 pmol/l versus 7.05 pmol/l (p = 0.0008). Copeptin failed in identifying patients with or without brain lesions detected by CT scan, and patients with or without adverse events during the 30 days follow-up. Conclusion: We confirmed that mild head trauma patients have a significantly higher copeptin plasma levels compared with controls. Nevertheless, we did not observe a significant role for copeptin in traumatic brain injury patients regarding brain damage and outcome.	[Castello, Luigi M.; Salmi, Livia; Gardino, Clara A.; Baldrighi, Marco; Avanzi, Gian C.] UPO, Dept Translat Med, Via Solaroli,17, I-28100 Novara, Italy; [Castello, Luigi M.; Zanotti, Isabella; Avanzi, Gian C.] AOU Maggiore Carita, Corso Mazzini,18, I-28100 Novara, Italy; [Settanni, Fabio] Univ Torino, Dept Med Sci, Div Endocrinol Diabetol & Metab, Corso AM Dogliotti,14, I-10126 Turin, Italy		Castello, LM (corresponding author), UPO, Dept Translat Med, Via Solaroli,17, I-28100 Novara, Italy.; Castello, LM (corresponding author), AOU Maggiore Carita, Corso Mazzini,18, I-28100 Novara, Italy.	luigi.castello@med.uniupo.it	Castello, Luigi Mario/AAC-7344-2022	Castello, Luigi Mario/0000-0001-8248-1976; Baldrighi, Marco/0000-0002-5595-6224			Choi KS, 2017, AM J EMERG MED, V35, P1444, DOI 10.1016/j.ajem.2017.04.038; De Marchis GM, 2013, NEUROLOGY, V80, P1278, DOI 10.1212/WNL.0b013e3182887944; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Lin C, 2013, PEPTIDES, V42, P43, DOI 10.1016/j.peptides.2013.01.015; Maisel A, 2013, J AM COLL CARDIOL, V62, P150, DOI 10.1016/j.jacc.2013.04.011; Molnar AH, 2008, ACTA NEUROCHIR, V150, P265, DOI 10.1007/s00701-007-1400-1; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Veisani Y, 2018, AM J EMERG MED, V36, P1307, DOI 10.1016/j.ajem.2017.11.026; Vetrone F, 2014, CLIN CHEM LAB MED, V52, P1457, DOI 10.1515/cclm-2014-0207; Winther JA, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0665-z; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017; Zhang AM, 2013, EXP THER MED, V5, P467, DOI 10.3892/etm.2012.804; Zhang JL, 2013, ACTA NEUROL SCAND, V128, P372, DOI 10.1111/ane.12132; Zhang X, 2012, PEPTIDES, V33, P336, DOI 10.1016/j.peptides.2012.01.011; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575	19	4	5	0	4	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1752-0363	1752-0371		BIOMARK MED	Biomark. Med.	JUN	2018	12	6					555	563		10.2217/bmm-2018-0041			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GK9SG	WOS:000436592800003	29620422	Green Submitted, hybrid			2022-02-06	
J	Davis, P; Waldock, R; Connorton, A; Driver, S; Anderson, S				Davis, Philip; Waldock, Robert; Connorton, Andrew; Driver, Sonny; Anderson, Sean			Comparison of amateur boxing before and after the 2013 rules change and the impact on boxers' safety	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						boxing; concussion; contact sports; injuries	PERFORMANCE; PROFILE	Objectives The effect of the rules change in 2013 on amateur boxing strategy, technique and safety in comparison with pre-2013 is unknown. Methods Pre-2013 and post-2013 3x3 min elite level amateur boxing was compared from video footage of 29 Olympic (pre-2013) and 50 World Championship bouts (post-2013) totalling 99 male boxers (mean +/- SD) age: 24.3 +/- 3.2 years, height: 177.3 +/- 11.3 cm and body mass: 70.7 +/- 16.4 kg. Result Many techniques that were dominant pre-2013 were used less post-2013, including: total punches thrown, rear hand punches, hook rear hand, punches landed, uppercut punches, total punches to the body (all < 0.05), while movement around the ring and defensive movements were higher post-2013 (both p < 0.004). Post-2013 boxers have increased their foot movement by 20% to move in and then away from their opponent, combined with long-range punches and deliberate defensive movements. The percentage of rounds where standing counts were issued changed from 9% to 3% pre-2013 to post-2013. However, pre-2013, 1.7% of bouts did not last the full duration due to referee stoppage, while post-2013, this increased to 4.2% as a result of two knockouts and eight technical knockouts. Discussion and conclusion Boxers should be aware of the large changes in technical demands of boxing. An increased risk of concussive or traumatic brain injury post-2013 is equivocal. However, an increase in skin splits and technical knockouts is apparent. It is likely that boxers believe head guard removal has made them more prone to knockouts.	[Davis, Philip; Waldock, Robert; Connorton, Andrew; Driver, Sonny; Anderson, Sean] Combat Sports Performance, 34 Sycamore Grove, Braintree CM7 2LT, Essex, England		Davis, P (corresponding author), Combat Sports Performance, 34 Sycamore Grove, Braintree CM7 2LT, Essex, England.	drdavisphilip@gmail.com					AIBA, 2015, AIB TECHN RUL; AIBA, 2015, OFF AM INT BOX ASS C; AIBA, 2015, TOURN STAT; AIBA, 2015, AIBA OP BOX AOB COMP; American Institute of Ultrasound in Medicine, 2013, AM INT BOX ASS OP BO, P1; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; Cohen J., 2013, STAT POWER ANAL BEHA; Corr DT, 2013, ADV WOUND CARE, V2, P37, DOI 10.1089/wound.2011.0321; Davis P., 2017, J STRENGTH COND RES, V1, DOI [10.1519/JSC.0000000000001864, DOI 10.1519/JSC.0000000000001864]; Davis P, 2016, INT J SPORT PHYSIOL, V11, P55, DOI 10.1123/ijspp.2014-0133; Davis P, 2015, INT J SPORT PHYSIOL, V10, P53, DOI 10.1123/ijspp.2013-0474; Davis P, 2013, INT J SPORT PHYSIOL, V8, P84, DOI 10.1123/ijspp.8.1.84; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Kapo S, 2008, HOMO SPORT, V10, P15; Loosemore M., 2016, ASPETAR SPORTS MED J, V5, P124; Loosemore Mike, 2008, Br J Sports Med, V42, P564; Martini Frederic H, 2014, FUNDAMENTALS ANATOMY; McCrory P, 2012, BRIT J SPORT MED, V46, P459, DOI 10.1136/bjsports-2012-091276; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1113, DOI 10.1136/bjsports-2015-095093; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1108, DOI 10.1136/bjsports-2015-095094; Sethi NK, 2018, CLIN J SPORT MED, V28, pE1, DOI 10.1097/JSM.0000000000000401; Smith MS, 2006, J SPORT SCI MED, V5, P74; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	24	4	4	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2018	52	11					741	746		10.1136/bjsports-2017-097667			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GH2KX	WOS:000433231900009	28954796	Bronze, Green Published			2022-02-06	
J	Haltmeier, T; Inaba, K; Schnuriger, B; Siboni, S; Benjamin, E; Lam, L; Clark, D; Demetriades, D				Haltmeier, Tobias; Inaba, Kenji; Schnuriger, Beat; Siboni, Stefano; Benjamin, Elizabeth; Lam, Lydia; Clark, Damon; Demetriades, Demetrios			Factors affecting the caloric and protein intake over time in critically ill trauma patients	JOURNAL OF SURGICAL RESEARCH			English	Article						Multiple trauma; Critical illness; Nutritional support; Caloric requirements; Protein requirements; Prospective study	RESTING METABOLIC-RATE; ENTERAL NUTRITION; SEVERE SEPSIS; GASTROINTESTINAL SURGERY; PARENTERAL-NUTRITION; PREDICTIVE EQUATIONS; ENERGY-REQUIREMENTS; CARE; SUPPORT; METAANALYSIS	Background: Major trauma leads to increased nutritional requirements. However, little is known about the actual amount of calories and protein administered and the factors affecting the intake over time in critically ill trauma patients. Methods: Prospective study including 100 trauma patients admitted to the Los Angeles County thorn University of Southern California Medical Center intensive care unit between March 2014 and October 2014. Inclusion criteria were age > 16 y, surgery at admission, and no oral nutrition. The caloric and protein intake was recorded, and requirements were calculated daily for 28 d. The nutritional intake and the impact of clinical factors on the intake over time were assessed using mixed model analysis. Results: The caloric and protein intake significantly increased over time, but the median intake did not meet the median calculated requirements at any time. Multivariable analysis revealed a smaller increase of the nutritional intake over time in patients with an injury severity score > 45, whereas penetrating injury and laparotomy were associated with a higher increase of the intake. Body mass index scores >= 30 kg/ m2, traumatic brain injury, and gastrointestinal tract injuries were associated with a smaller increase of the caloric intake over time. Conclusions: The median nutritional intake did not meet the median calculated requirements over time. A smaller increase of the nutritional intake over time was found in patients with a higher injury burden, whereas penetrating injury and laparotomy were associated with a higher increase of the intake. Higher body mass index scores, traumatic brain injury, and gastrointestinal tract injuries were associated with a smaller increase of the caloric intake over time. These clinical factors can help to adjust the nutritional support in critically ill trauma patients. (C) 2018 Elsevier Inc. All rights reserved.	[Haltmeier, Tobias; Inaba, Kenji; Siboni, Stefano; Benjamin, Elizabeth; Lam, Lydia; Clark, Damon; Demetriades, Demetrios] Los Angeles Cty, Dept Surg, Div Acute Care Surg & Surg Crit Care, Los Angeles, CA USA; [Haltmeier, Tobias; Inaba, Kenji; Siboni, Stefano; Benjamin, Elizabeth; Lam, Lydia; Clark, Damon; Demetriades, Demetrios] Univ Southern Calif, Med Ctr, Los Angeles, CA USA; [Haltmeier, Tobias; Schnuriger, Beat] Bern Univ Hosp, Inselspital, Dept Visceral Surg & Med, Div Acute Care Surg, Bern, Switzerland		Inaba, K (corresponding author), Univ Southern Calif, Dept Surg, Div Acute Care Surg & Surg Crit Care, LA Cty USC Med Ctr, 1200 N State St Inpatient Tower C Rm C5L100, Los Angeles, CA 90033 USA.	kinaba@surgery.usc.edu	Benjamin, Elizabeth/AAD-2457-2020; INABA, KENJI/AAC-8532-2020; Siboni, Stefano/AAF-5456-2019	Siboni, Stefano/0000-0003-0532-3135; Haltmeier, Tobias/0000-0001-6049-9235			Ahrens CL, 2005, CRIT CARE MED, V33, P2507, DOI 10.1097/01.CCM.0000186746.64572.8A; Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Arabi YM, 2015, NEW ENGL J MED, V372, P2398, DOI 10.1056/NEJMoa1502826; Arabi YM, 2011, AM J CLIN NUTR, V93, P569, DOI 10.3945/ajcn.110.005074; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Borel AL, 2014, AM J CLIN NUTR, V100, P859, DOI 10.3945/ajcn.114.088187; Campos Brenno Belazi Nery de Souza, 2012, Rev. bras. ter. intensiva, V24, P97, DOI 10.1590/S0103-507X2012000100015; Chapple LAS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1177-1; Collins Nancy, 2002, Adv Skin Wound Care, V15, P140, DOI 10.1097/00129334-200205000-00011; Compher C, 2017, CRIT CARE MED, V45, P156, DOI [10.1097/CCM.0000000000002083, 10.1097/ccm.0000000000002083]; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; DEVINE BJ, 1974, DRUG INTEL CLIN PHAR, V8, P650, DOI 10.1177/106002807400801104; Dey R, 2011, CRIT CARE S1, V15, pP382; Dissanaike S, 2007, CRIT CARE, V11, DOI 10.1186/cc6167; Donaldson-Andersen J., 1998, NUTR CLIN PRACT, V13, P25; Ferrie S, 2007, NUTR DIET, V64, P192, DOI 10.1111/j.1747-0080.2007.00124.x; Frankenfield D, 2004, JPEN-PARENTER ENTER, V28, P259, DOI 10.1177/0148607104028004259; Frankenfield DC, 2011, JPEN-PARENTER ENTER, V35, P563, DOI 10.1177/0148607111415859; Frankenfield DC, 2003, J AM DIET ASSOC, V103, P1152, DOI 10.1016/S0002-8223(03)00982-9; Grau T, 2007, CRIT CARE, V11, DOI 10.1186/cc5670; Grau T, 2009, CURR OPIN CLIN NUTR, V12, P175, DOI 10.1097/MCO.0b013e3283252f9e; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hasenboehler Erik, 2006, World J Emerg Surg, V1, P29, DOI 10.1186/1749-7922-1-29; Hill AG, 1998, BRIT J SURG, V85, P884; Hise ME, 2007, J AM DIET ASSOC, V107, P458, DOI 10.1016/j.jada.2006.12.012; Kan MN, 2003, CRIT CARE, V7, pR108, DOI 10.1186/cc2366; Kim H, 2012, J CRIT CARE, V27, P702, DOI 10.1016/j.jcrc.2012.07.019; Kim H, 2012, J CLIN NURS, V21, P2860, DOI 10.1111/j.1365-2702.2012.04218.x; Klein CJ, 1998, J AM DIET ASSOC, V98, P795, DOI 10.1016/S0002-8223(98)00179-5; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Kudsk KA, 2013, TRAUMA; Lewis SJ, 2001, BRIT MED J, V323, P773, DOI 10.1136/bmj.323.7316.773; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Mazaki T, 2008, J GASTROINTEST SURG, V12, P739, DOI 10.1007/s11605-007-0362-1; McClave SA, 1998, JPEN-PARENTER ENTER, V22, P375, DOI 10.1177/0148607198022006375; Miller MD, 2005, BRIT J NUTR, V94, P976, DOI 10.1079/BJN20051593; Nicolo M, 2016, JPEN-PARENTER ENTER, V40, P45, DOI 10.1177/0148607115583675; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Owais AE, 2014, CLIN NUTR, V33, P997, DOI 10.1016/j.clnu.2014.01.005; Peev MP, 2015, JPEN-PARENTER ENTER, V39, P21, DOI 10.1177/0148607114526887; Plank LD, 2003, P NUTR SOC, V62, P545, DOI 10.1079/PNS2003259; Plank LD, 2000, ANN NY ACAD SCI, V904, P592, DOI 10.1111/j.1749-6632.2000.tb06521.x; Plank LD, 2000, WORLD J SURG, V24, P630, DOI 10.1007/s002689910104; Rubinson L, 2004, CRIT CARE MED, V32, P350, DOI 10.1097/01.CCM.0000089641.06306.68; Rugeles SJ, 2013, INDIAN J CRIT CARE M, V17, P343, DOI 10.4103/0972-5229.123438; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Uehara M, 1999, CRIT CARE MED, V27, P1295, DOI 10.1097/00003246-199907000-00015; van Schijndel RJMS, 2009, CRIT CARE, V13, DOI 10.1186/cc7993; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Wade CE, 2015, JPEN-PARENTER ENTER, V39, P449, DOI 10.1177/0148607114523450; Walker RN, 2009, RESP CARE, V54, P509; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0701-z; Yeh DD, 2016, JPEN-PARENTER ENTER, V40, P37, DOI 10.1177/0148607115585142	53	4	4	1	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN	2018	226						64	71		10.1016/j.jss.2018.01.022			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GD1MH	WOS:000430263500010	29661290				2022-02-06	
J	Hill, CS; McLean, AL; Wilson, MH				Hill, Ciaran S.; McLean, Aaron L.; Wilson, Mark H.			Epidemiology of Pediatric Traumatic Brain Injury in a Dense Urban Area Served by a Helicopter Trauma Service	PEDIATRIC EMERGENCY CARE			English	Article						trauma; epidemiology; prehospital; brain injury	HEAD-INJURY; UNITED-KINGDOM; MAJOR TRAUMA; CHILDREN; UK; METAANALYSIS; INTUBATION; MORTALITY; OUTCOMES; AGE	Objective Pediatric traumatic brain injury is the most common cause of death and a major cause of morbidity in children and young adults worldwide. Despite this, our understanding of epidemiological factors relating to this type of injury is incomplete. The objective of this study was to explore a variety of factors relating to these injuries including mechanism, timing of emergency response, prehospital management, radiological diagnosis, neurosurgical care, and final outcomes. Methods A retrospective review of all pediatric traumas attending a single large, densely populated urban area within a 2-year period was undertaken, and all cases with significant pediatric traumatic brain injury, as defined by a computed tomography scan showing an intracranial injury, were included for further analysis. Various epidemiological and treatment factors were explored. Results One hundred sixteen patients fulfilled the inclusion criteria, and their injuries and management were explored further. A variety of key trends were identified. The most common mechanism of injury was pedestrian struck by car followed by falls from height. Males were injured 5 times more frequently than girls. A helicopter emergency trauma team attended 22% of the patients and intubated 11 in total. The most common intracranial injuries were skull fractures followed by contusions. Nineteen neurosurgical interventions were undertaken. Overall mortality in all patients was 8%. Conclusions An improved understanding of the epidemiology of pediatric brain injury will provide baselines for future outcome measurement and comparative analysis. This may improve service organization and delivery.	[Hill, Ciaran S.; McLean, Aaron L.] Royal London Hosp, Dept Neurosurg, Whitechapel Rd, London E1 1BB, England; [Hill, Ciaran S.; Wilson, Mark H.] Londons Air Ambulance, London, England; [Wilson, Mark H.] St Marys Hosp, Dept Neurosurg, London, England		Hill, CS (corresponding author), Royal London Hosp, Dept Neurosurg, Whitechapel Rd, London E1 1BB, England.	ciaran.hill@ucl.ac.uk					Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burrows P, 2015, ARCH DIS CHILD, V100, P1032, DOI 10.1136/archdischild-2014-307119; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Glass T, 2015, AM J EMERG MED, V33, P1458, DOI 10.1016/j.ajem.2015.06.069; Houston R, 2012, EMERG MED J, V29, P309, DOI 10.1136/emj.2011.112110; Johnson P, 2006, BRAIN COGNITION, V60, P205; Karamanos E, 2014, PREHOSP DISASTER MED, V29, P32, DOI 10.1017/S1049023X13008947; Lockey D, 2014, BRIT J ANAESTH, V113, P220, DOI 10.1093/bja/aeu227; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Pearson J, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-26; Pickering A, 2015, J TRAUMA ACUTE CARE, V78, P164, DOI 10.1097/TA.0000000000000483; Rados A, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-48; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Sobuwa Simpiwe, 2013, S Afr Med J, V103, P644, DOI 10.7196/samj.7035; Tasker RC, 2006, EMERG MED J, V23, P519, DOI 10.1136/emj.2005.028779; Tuma M, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/135986; Vandromme MJ, 2011, J TRAUMA, V71, P1615, DOI 10.1097/TA.0b013e31822a30a1	24	4	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JUN	2018	34	6					426	430		10.1097/PEC.0000000000000845			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	GJ4BD	WOS:000435291500020	29851919				2022-02-06	
J	Hoenig, HM; Amis, K; Edmonds, C; Morgan, MS; Landerman, L; Caves, K				Hoenig, Helen M.; Amis, Kristopher; Edmonds, Carol; Morgan, Michelle S.; Landerman, Lawrence; Caves, Kevin			Testing fine motor coordination via telehealth: Effects of video characteristics on reliability and validity	JOURNAL OF TELEMEDICINE AND TELECARE			English	Article						Telemedicine; coordination impairment; task performance and analysis; motor skills; psychometrics	TRAUMATIC BRAIN-INJURY; TO-NOSE TEST; PHYSICAL FUNCTION; TELEREHABILITATION; MOBILITY; ADULTS; TRIAL	Background: There is limited research about the effects of video quality on the accuracy of assessments of physical function. Methods: A repeated measures study design was used to assess reliability and validity of the finger-nose test (FNT) and the finger-tapping test (FTT) carried out with 50 veterans who had impairment in gross and/or fine motor coordination. Videos were scored by expert raters under eight differing conditions, including in-person, high definition video with slow motion review and standard speed videos with varying bit rates and frame rates. Results: FTT inter-rater reliability was excellent with slow motion video (ICC 0.98-0.99) and good (ICC 0.59) under the normal speed conditions. Inter-rater reliability for FNT 'attempts' was excellent (ICC 0.97-0.99) for all viewing conditions; for FNT 'misses' it was good to excellent (ICC 0.89) with slow motion review but substantially worse (ICC 0.44) on the normal speed videos. FTT criterion validity (i.e. compared to slow motion review) was excellent (beta = 0.94) for the in-person rater and good (beta = 0.77) on normal speed videos. Criterion validity for FNT 'attempts' was excellent under all conditions (r >= 0.97) and for FNT 'misses' it was good to excellent under all conditions (beta = 0.61-0.81). Conclusions: In general, the inter-rater reliability and validity of the FNT and FTT assessed via video technology is similar to standard clinical practices, but is enhanced with slow motion review and/or higher bit rate.	[Hoenig, Helen M.; Amis, Kristopher; Edmonds, Carol] Durham VA Hlth Care Syst, Phys Med & Rehabil Serv, Durham, NC USA; [Hoenig, Helen M.] Duke Univ, Med Ctr, Dept Med Geriatr, Durham, NC USA; [Morgan, Michelle S.; Landerman, Lawrence] Duke Univ, Ctr Aging & Human Dev, Durham, NC USA; [Caves, Kevin] Duke Univ, Med Ctr, Dept Surg, Speech & Audiol, Durham, NC 27710 USA		Hoenig, HM (corresponding author), Durham VA Hlth Care Syst, Rehabil Serv, Mail Code 117,508 Fulton St, Durham, NC 27705 USA.	Helen.Hoenig@va.gov			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG028716] Funding Source: Medline; RRD VA [I01 RX000900] Funding Source: Medline		Agostini M, 2015, J TELEMED TELECARE, V21, P202, DOI 10.1177/1357633X15572201; Arceneaux JM, 1997, INT J NEUROSCI, V89, P281, DOI 10.3109/00207459708988480; Christianson MK, 2004, NEW ZEAL J PSYCHOL, V33, P44; Chumbler NR, 2012, STROKE, V43, P2168, DOI 10.1161/STROKEAHA.111.646943; Dorsey ER, 2016, NEW ENGL J MED, V375, P154, DOI 10.1056/NEJMra1601705; Feys PG, 2003, ARCH PHYS MED REHAB, V84, P79, DOI 10.1053/apmr.2003.50068; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hoenig H, 2013, ARCH PHYS MED REHAB, V94, P998, DOI 10.1016/j.apmr.2013.01.009; Hooper J, 1998, ARCH PHYS MED REHAB, V79, P1076, DOI 10.1016/S0003-9993(98)90174-5; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Jackson JC, 2012, CRIT CARE MED, V40, P1088, DOI 10.1097/CCM.0b013e3182373115; Levy CE, 2015, J REHABIL RES DEV, V52, P361, DOI 10.1682/JRRD.2014.10.0239; Norman, 2003, HLTH MEASUREMENT SCA; Reitan R, 1985, HALSTEAD REITAN NEUR; Russell TG, 2011, J BONE JOINT SURG AM, V93A, P113, DOI 10.2106/JBJS.I.01375; Sanford JA, 2006, J AM GERIATR SOC, V54, P1641, DOI 10.1111/j.1532-5415.2006.00913.x; SAS Institute Inc, 2014, SAS STAT SOFTW VERS; Schein RM, 2010, ARCH PHYS MED REHAB, V91, P874, DOI 10.1016/j.apmr.2010.01.017; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Swaine Bonnie R., 2005, Physiotherapy Theory and Practice, V21, P271, DOI 10.1080/09593980500321119; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; Wang YC, 2011, J HAND THER, V24, P313, DOI 10.1016/j.jht.2011.05.001	23	4	4	1	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1357-633X	1758-1109		J TELEMED TELECARE	J. Telemed. Telecare	JUN	2018	24	5					365	372		10.1177/1357633X17700032			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	GK3PS	WOS:000436058200004	28350283	Green Accepted			2022-02-06	
J	Hsu, WC; Yu, CH; Kung, WM; Huang, KF				Hsu, Wei-Cherng; Yu, Chun-Hsien; Kung, Woon-Man; Huang, Kuo-Feng			Enhancement of matrix metalloproteinases 2 and 9 accompanied with neurogenesis following collagen glycosaminoglycan matrix implantation after surgical brain injury	NEURAL REGENERATION RESEARCH			English	Article						collagen glycosaminoglycan; matrix metalloproteinases; surgical brain trauma; neurogenesis; neural regeneration	EXTRACELLULAR-MATRIX; NEURAL STEM; PROGENITOR CELLS; DIFFERENTIATION; MIGRATION; MATRIX-METALLOPROTEINASE-9; IDENTIFICATION; CHEMOKINES	Surgical brain injury may result in irreversible neurological deficits. Our previous report showed that partial regeneration of a traumatic brain lesion is achieved by implantation of collagen glycosaminoglycan (CGM). Matrix metalloproteinases (MMPs) may play an important role in neurogenesis but there is currently a lack of studies displaying the relationship between the stimulation of MMPs and neurogenesis after collagen glycosaminoglycan implantation following surgical brain trauma. The present study was carried out to further examine the expression of MMP2 and MMP9 after implantation of collagen glycosaminoglycan (CGM) following surgical brain trauma. Using the animal model of surgically induced brain lesion, we implanted CGM into the surgical trauma. Rats were thus divided into three groups: (1) sham operation group: craniotomy only; (2) lesion (L) group: craniotomy + surgical trauma lesion; (3) lesion + CGM (L + CGM) group: CGM implanted following craniotomy and surgical trauma lesion. Cells positive for SOX2 (marker of proliferating neural progenitor cells) and matrix metalloproteinases (MMP2 and MMP9) in the lesion boundary zone were assayed and analyzed by immunofluorescence and ELISA commercial kits, respectively. Our results demonstrated that following implantation of CGM after surgical brain trauma, significant increases in MMP2(+)/SOX2(+) cells and MMP9(+)/SOX2(+) cells were seen within the lesion boundary zone in the L + CGM group. Tissue protein concentrations of MMP2 and MMP9 also increased after CGM scaffold implantation. 'these findings suggest that implantation of a CGM scaffold alone after surgical brain trauma can enhance the expression of MMP2 and MMP9 accompanied by neurogenesis.	[Hsu, Wei-Cherng] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Ophthalmol, New Taipei, Taiwan; [Hsu, Wei-Cherng; Yu, Chun-Hsien; Huang, Kuo-Feng] Buddhist Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yu, Chun-Hsien] Taipei Tzu Chi Hosp, Dept Pediat, Buddhist Tzu Chi Med Fdn, New Taipei, Taiwan; [Kung, Woon-Man; Huang, Kuo-Feng] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Surg, Div Neurosurg, New Taipei, Taiwan; [Kung, Woon-Man] Chinese Culture Univ, Dept Exercise & Hlth Promot, Coll Educ, Taipei, Taiwan		Huang, KF (corresponding author), Buddhist Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Huang, KF (corresponding author), Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Surg, Div Neurosurg, New Taipei, Taiwan.	kuofeng1234@gmail.com	Kung, Woon-Man/Q-3012-2019	Kung, Woon-Man/0000-0001-8311-2902	National Science Council of ChinaMinistry of Science and Technology, Taiwan [NSC 102-2314-B-303-004, NSC102-2314-B-303-004]; Tzu Chi Medical Mission Project, Buddhist Tzu Chi Medical Foundation [105-06]	This study was supported by grants from the National Science Council of China (NSC 102-2314-B-303-004) and the Tzu Chi Medical Mission Project 105-06, Buddhist Tzu Chi Medical Foundation.; This study was supported by grants from the National Science Council of China (NSC102-2314-B-303-004) and the Tzu Chi Medical Mission Project 105-06, Buddhist Tzu Chi Medical Foundation. None of the funding bodies play any role in the study other than to provide funding.	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Aizman I, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt418; Aizman I, 2013, STEM CELL TRANSL MED, V2, P223, DOI 10.5966/sctm.2012-0119; Barkho BZ, 2011, CURR STEM CELL RES T, V6, P327; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bikbaev A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14527; Brkic M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/620581; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Faissner A, 2015, GLIA, V63, P1330, DOI 10.1002/glia.22839; Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459; Fugate Jennifer E, 2015, Continuum (Minneap Minn), V21, P1425, DOI 10.1212/CON.0000000000000227; Fujioka H, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/789083; Gueye Y, 2011, GLIA, V59, P750, DOI 10.1002/glia.21146; Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598; Heikkinen A, 2014, PROG BRAIN RES, V214, P29, DOI 10.1016/B978-0-444-63486-3.00002-5; Hsu WC, 2000, INVEST OPHTH VIS SCI, V41, P2404; Hsu WC, 2008, GRAEF ARCH CLIN EXP, V246, P709, DOI 10.1007/s00417-007-0744-9; Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lei C, 2013, NEUROSCIENCE, V230, P86, DOI 10.1016/j.neuroscience.2012.11.008; Murase S, 2002, J NEUROSCI, V22, P3568; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Seipold L, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmol.2016.00149, 10.3389/fnmol.2015.00013]; Sellebjerg F, 2003, BRAIN RES BULL, V61, P347, DOI 10.1016/S0361-9230(03)00097-2; Shin Y, 2014, ADV HEALTHC MATER, V3, P1457, DOI 10.1002/adhm.201300569; Sirbulescu RF, 2015, MOL CELL NEUROSCI, V68, P9, DOI 10.1016/j.mcn.2015.03.015; Suzuki A, 2003, DEVELOPMENT, V130, P2513, DOI 10.1242/dev.00459; Verslegers M, 2013, MOL CELL NEUROSCI, V57, P63, DOI 10.1016/j.mcn.2013.10.001; Wojcik-Stanaszek L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022465; Wu WC, 2008, INVEST OPHTH VIS SCI, V49, P2673, DOI 10.1167/iovs.07-1594; YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933	31	4	4	1	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2018	13	6					1007	1012		10.4103/1673-5374.233443			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GL0AF	WOS:000436621100014	29926827	Green Published, gold			2022-02-06	
J	Ida, KK; Chisholm, KI; Malbouisson, LMS; Papkovsky, DB; Dyson, A; Singer, M; Duchen, MR; Smith, KJ				Ida, K. K.; Chisholm, K. I.; Malbouisson, L. M. S.; Papkovsky, D. B.; Dyson, A.; Singer, M.; Duchen, M. R.; Smith, K. J.			Protection of cerebral microcirculation, mitochondrial function, and electrocortical activity by small-volume resuscitation with terlipressin in a rat model of haemorrhagic shock	BRITISH JOURNAL OF ANAESTHESIA			English	Article						brain ischaemia; confocal microscopy; electrophysiology	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; HYPOTENSION; NOREPINEPHRINE; PERFUSION; HYPOXIA; MICRODIALYSIS; CIRCULATION; PRESSURE; FAILURE	Background: During early treatment of haemorrhagic shock, cerebral perfusion pressure can be restored by small-volume resuscitation with vasopressors. Whether this therapy is improved with additional fluid remains unknown. We assessed the value of terlipressin and lactated Ringer's solution (LR) on early recovery of microcirculation, tissue oxygenation, and mitochondrial and electrophysiological function in the rat cerebral cortex. Methods: Animals treated with LR replacing three times (3LR) the volume bled (n = 26), terlipressin (n = 27), terlipressin plus 1LR (n = 26), 2LR (n = 16), or 3LR (n = 15) were compared with untreated (n = 36) and sham-operated rats (n = 17). In vivo confocal microscopy was used to assess cortical capillary perfusion, changes in tissue oxygen concentration, and mitochondrial membrane potential and redox state. Electrophysiological function was assessed by cortical somatosensory evoked potentials, spinal cord dorsum potential, and peripheral electromyography. Results: Compared with sham treatment, haemorrhagic shock reduced the mean (SD) area of perfused vessels [82% (SD 10%) vs 38% (12%); P<0.001] and impaired oxygen concentration, mitochondrial redox state [99% (4%) vs 59% (15%) of baseline; P<0.001], and somatosensory evoked potentials [97%(13%) vs 27%(19%) of baseline]. Administration of terlipressin plus 1LR or 2LR was able to recover these measures, but terlipressin plus 3LR or 3LR alone were not as effective. Spinal cord dorsum potential was preserved in all groups, but no therapy protected electromyographic function. Conclusions: Resuscitation from haemorrhagic shock using terlipressin with small-volume LR was superior to high-volume LR, with regard to cerebral microcirculation, and mitochondrial and electrophysiological functions.	[Ida, K. K.; Chisholm, K. I.; Smith, K. J.] UCL, Inst Neurol, Queen Sq, London, England; [Ida, K. K.; Malbouisson, L. M. S.] Univ Sao Paulo, Sch Med, Postgrad Program Anaesthesiol, Lab Med Invest 8, Sao Paulo, Brazil; [Papkovsky, D. B.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Dyson, A.; Singer, M.] UCL, Bloomsbury Inst Intens Care Med, London, England; [Duchen, M. R.] UCL, Cell & Dev Biol, London, England		Ida, KK (corresponding author), UCL, Inst Neurol, Queen Sq, London, England.; Ida, KK (corresponding author), Univ Sao Paulo, Sch Med, Postgrad Program Anaesthesiol, Lab Med Invest 8, Sao Paulo, Brazil.	keila.ida@ulg.ac.be	Singer, Mervyn/Q-6142-2019; duchen, michael/A-2116-2009; Van Neer, Wim/E-4476-2012; Chisholm, Kim/N-7976-2016; Smith, Kenneth/I-9197-2014	Singer, Mervyn/0000-0002-1042-6350; duchen, michael/0000-0003-2548-4294; Chisholm, Kim/0000-0002-3192-8966; Smith, Kenneth/0000-0003-4408-7809; Ida, Keila/0000-0003-2200-4355	UK Multiple Sclerosis Society; National Multiple Sclerosis Society (USA)National Multiple Sclerosis Society; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [1064/61-24]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/14386-2]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [12/RC/2276]	UK Multiple Sclerosis Society, the National Multiple Sclerosis Society (USA), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Ciencia sem Fronteiras #1064/61-24), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #2011/14386-2), and Science Foundation Ireland (12/RC/2276).	Anwar M, 1996, CAN J PHYSIOL PHARM, V74, P157; Bayram B, 2012, AM J EMERG MED, V30, P1176, DOI 10.1016/j.ajem.2011.09.007; Beloncle F, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-13; Cavus E, 2008, J TRAUMA, V64, P641, DOI 10.1097/TA.0b013e3181637a6c; Cavus E, 2009, RESUSCITATION, V80, P567, DOI 10.1016/j.resuscitation.2009.01.013; Chisholm KI, 2016, ADV EXP MED BIOL, V876, P233, DOI 10.1007/978-1-4939-3023-4_29; Chisholm KI, 2016, J CEREBR BLOOD F MET, V36, P1955, DOI 10.1177/0271678X15606457; Cossu AP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/421291; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Dyson A, 2009, INTENS CARE MED, V35, P1783, DOI 10.1007/s00134-009-1577-2; Eefsen M, 2007, J HEPATOL, V47, P381, DOI 10.1016/j.jhep.2007.04.015; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Fullerton JN, 2011, SEMIN RESP CRIT CARE, V32, P581, DOI 10.1055/s-0031-1287866; GRAHAM DI, 1979, STROKE, V10, P724, DOI 10.1161/01.STR.10.6.724; GREGORY PC, 1979, STROKE, V10, P719, DOI 10.1161/01.STR.10.6.719; Gutierrez G, 2004, CRIT CARE, V8, P373, DOI 10.1186/cc2851; Guven H, 2002, J TRAUMA, V53, P66, DOI 10.1097/00005373-200207000-00014; Ida KK, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0825-9; Ida KKML, 2014, INTENSIVE CARE ME S1, V2, pO9; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Lee CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095821; LEE HB, 1985, J NUCL MED, V26, P72; MELDRUM BS, 1969, BRAIN RES, V13, P101, DOI 10.1016/0006-8993(69)90145-0; Meybohm P, 2007, ACTA NEUROCHIR, V149, P691, DOI 10.1007/s00701-007-1231-0; Meybohm P, 2008, ANESTH ANALG, V106, P795, DOI 10.1213/ane.0b013e31816173b4; Meybohm P, 2007, J TRAUMA, V62, P640, DOI 10.1097/01.ta.0000240962.62319.c8; Meybohm P, 2006, ANESTH ANALG, V103, P948, DOI 10.1213/01.ane.0000237125.42376.b5; O'Brien A, 2002, LANCET, V359, P1209, DOI 10.1016/S0140-6736(02)08225-9; Salluh JIF, 2007, ACTA ANAESTH SCAND, V51, P505, DOI 10.1111/j.1399-6576.2006.01252.x; Taccone FS, 2010, CRIT CARE MED, V38, P1008, DOI 10.1097/CCM.0b013e3181d16958; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Umbrello M, 2013, ANTIOXID REDOX SIGN, V19, P1690, DOI 10.1089/ars.2012.4979; Urbano J, 2012, RESUSCITATION, V83, P1159, DOI 10.1016/j.resuscitation.2012.02.003; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943	34	4	4	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	JUN	2018	120	6					1245	1254		10.1016/j.bja.2017.11.074			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GN4TA	WOS:000439024700016	29793592	Bronze			2022-02-06	
J	Jafari, M; Ala, S; Haddadi, K; Alipour, A; Mojtahedzadch, M; Ehteshami, S; Abediankenari, S; Shafizad, M; Salehifar, E; Khalili, F				Jafari, Marziye; Ala, Shahram; Haddadi, Kaveh; Alipour, Abbas; Mojtahedzadch, Mojtaba; Ehteshami, Saeid; Abediankenari, Saeid; Shafizad, Misagh; Salehifar, Ebrahim; Khalili, Foroogh			Cotreatment with Furosemide and Hypertonic Saline Decreases Serum Neutrophil Gelatinase-associated Lipocalin (NGAL) and Serum Creatinine Concentrations in Traumatic Brain Injury: A Randomized, Single-Blind Clinical Trial	IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH			English	Article						Neutrophil Gelatinase-associated Lipocalin; Serum Creatinine; Furosemide; Hypertonic saline; Traumatic brain injury	ACUTE KIDNEY INJURY; RESUSCITATION; OSMOLALITY	Acute kidney injury (AKI) occurs both after traumatic brain injury (TBI) and after hypertonic saline administration; furosemide may be useful in preventing AKI indirectly. Serum neutrophil gelatinase-associated lipocalin (sNGAL) is superior to serum creatinine (sCr) in diagnosing early AKI. We compared the administration of hypertonic saline plus furosemide (HTS+F) versus hypertonic saline (HTS), using sCr and sNGAL to investigate kidney injury in patients with TBI. This randomized, single-blind clinical trial was conducted from August 2016 to July 2017 in a neurosurgical intensive care unit, and included patients with a Glasgow Coma Score (GCS) 7-13 and brain edema. One group (n = 22) received hypertonic saline 5% (100 mL over 60 min then 20 mL/h) plus furosemide (40 mg over 60 min then 0.05 mg/kg per hour) for 72 h. The other group (n = 21) received only hypertonic saline 5%, in the same dose as noted above. The sCr and sNGAL concentrations, GCS. and length of stay were measured. Mean +/- SD differences were -51.15 (47.07) and 9.96 (64.23) ng/mL for sNGAL and -0.12 (0.22) and -0.005 (0.2) mg/dL for sCr in HTS+F group and HTS group respectively (both p < 0.001). The incidence of stage one AKI according to Improving Global Outcomes (KDIGO) criteria was 4.5% in the HTS+F group and 19.0% in the HTS group (p = 0.16). Hypokalemia was common in both groups. HTS+F group, compared with HTS group, was associated with lower concentrations of sCr and sNGAL. Incidence AKI (KDIGO criteria) did not have difference between groups.	[Jafari, Marziye; Ala, Shahram; Salehifar, Ebrahim; Khalili, Foroogh] Mazandaran Univ Med Sci, Fac Pharm, Dept Clin Pharm, Sari, Iran; [Haddadi, Kaveh; Shafizad, Misagh] Mazandaran Univ Med Sci, Emam Khomeini Hosp, Orthoped Res Ctr, Dept Neurosurg, Sari, Iran; [Alipour, Abbas] Mazandaran Univ Med Sci, Fac Med, Dept Community Med, Sari, Iran; [Mojtahedzadch, Mojtaba] Univ Tehran Med Sci, Dept Clin Pharm, Fac Pharm, Tehran, Iran; [Ehteshami, Saeid] Mazandaran Univ Med Sci, Emam Khomeini Hosp, Dept Neurosurg, Sari, Iran; [Abediankenari, Saeid] Mazandaran Univ Med Sci, Immunogenet Res Ctr, Sari, Iran		Ala, S (corresponding author), Mazandaran Univ Med Sci, Fac Pharm, Dept Clin Pharm, Sari, Iran.	sh204ala@yahoo.com	jafari, Marziye/AAS-1202-2020; Ala, Shahram/A-2313-2009	jafari, Marziye/0000-0002-7768-9833; 	Research, Mazandaran University of Medical Sciences	This research was supported by Vice Chancellor of Research, Mazandaran University of Medical Sciences. We thank our colleagues from Vice Chancellor of Research that greatly assisted the research. We thank Dr. Pouria Moshayedi from University of Pittsburgh Medical Center for comments that greatly improved the manuscript. We would like to thank Imam Khomeini Hospital ICU nurses for close cooperation and assistance. We would like to thank Editage (www.editage.com) for English language editing and Journalspecific formatting.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Case J, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/479730; Corry Jesse J, 2014, World J Crit Care Med, V3, P61, DOI 10.5492/wjccm.v3.i2.61; EIAMONG S, 1993, KIDNEY INT, V43, P1015, DOI 10.1038/ki.1993.143; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Haase-Fielitz A, 2014, ANN CLIN BIOCHEM, V51, P335, DOI 10.1177/0004563214521795; Ho KM, 2010, ANAESTHESIA, V65, P283, DOI 10.1111/j.1365-2044.2009.06228.x; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Kim Tiffany, 2015, BMC Res Notes, V8, P579, DOI 10.1186/s13104-015-1518-9; Li N, 2013, J NEPHROL, V26, P1083, DOI 10.5301/jn.5000282; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Maguigan KL, 2017, J CLIN NEUROSCI, V39, P147, DOI 10.1016/j.jocn.2017.01.025; Martensson J, 2014, BLOOD PURIFICAT, V37, P304, DOI 10.1159/000364937; Mayzler O, 2006, J NEUROSURG ANESTH, V18, P24, DOI 10.1097/01.ana.0000188358.41284.cb; McIlroy DR, 2010, CLIN J AM SOC NEPHRO, V5, P211, DOI 10.2215/CJN.04240609; MIYANOSHITA A, 1989, J PHARMACOL EXP THER, V251, P1155; MOON PF, 1995, CRIT CARE MED, V23, P323, DOI 10.1097/00003246-199502000-00019; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; Putzu A, 2017, JACC-CARDIOVASC INTE, V10, P355, DOI 10.1016/j.jcin.2016.11.006; RASTOGI SP, 1984, J LAB CLIN MED, V104, P271; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Solomon R, 2016, REANIMATION, V25, P591, DOI 10.1007/s13546-016-1231-2; Tecson KM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016028; Veltri Keith T, 2015, P T, V40, P185; Wan HY, 2016, INTERNAL MED, V55, P1433, DOI 10.2169/internalmedicine.55.6084; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	31	4	4	0	4	SHAHEED BEHESHTI UNIV, SCH PHARMACY	TEHRAN	NO 10 SHAMS ALLEY, VALI-E ASR ST, TEHRAN, 00000, IRAN	1735-0328	1726-6890		IRAN J PHARM RES	Iran. J. Pharm. Res.	SUM	2018	17	3					1130	1140					11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GM6WL	WOS:000438319600031	30127836				2022-02-06	
J	Jang, SH; Yeo, SS				Jang, Sung Ho; Yeo, Sang Seok			Injury of the Precommissural Fornix in a Patient with Subarachnoid Hemorrhage: A Case Report	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Postcommissural fornix; subarachnoid hemorrhage; memory; diffusion tensor imaging	DIFFUSION TENSOR TRACTOGRAPHY; TRAUMATIC BRAIN-INJURY; LESIONS	Objectives: We investigated injury of the pre- or postcommissural fornix in a patient with subarachnoid hemorrhage (SAH) using diffusion tensor imaging. Case Description: A 48-year-old male patient was diagnosed as SAH due to rupture of the right middle cerebral artery bifurcation aneurysm. After 9 weeks from onset, he was transferred to the rehabilitation department and he showed memory impairment. The whole fornix was reconstructed using single-tract fornix model based on a fiber assignment by continuous tracking, and separated fornices (pre- and postcommissural fornices) were reconstructed using 2-tract fornix model based on a probabilistic tractography method. The fractional anisotropy (FA), mean diffusivity, and fiber volume were measured in the patient and 6 normal control subjects. The integrities of both reconstructed whole fornices that were reconstructed using probabilistic tractography method were preserved. By contrast, in the results of 2-tract fornix model, the precommissural fornices showed discontinuations in both fornical cruses. In addition, the FA and fiber volume of both precommissural fornices in the patient were decreased by more than 2 standard deviations of those of normal control subjects. Conclusions: Separate evaluations of the pre-and postcommissural fornices using 2-tract fornix model would be useful for diagnosis in patients with memory impairment following SAH.	[Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Gyongsan, North Gyeongsan, South Korea; [Yeo, Sang Seok] Dankook Univ, Dept Phys Therapy, Coll Hlth Sci, 119 Dandae Ro, Cheonan Si 330714, Chungnam, South Korea		Yeo, SS (corresponding author), Dankook Univ, Dept Phys Therapy, Coll Hlth Sci, 119 Dandae Ro, Cheonan Si 330714, Chungnam, South Korea.	eangbul@hanmail.net			Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; HENDERSON J, 1977, BRAIN RES BULL, V2, P123, DOI 10.1016/0361-9230(77)90008-9; Hong JH, 2012, NEUROSURGERY, V70, P819, DOI 10.1227/NEU.0b013e3182367124; Kern KC, 2012, NEUROIMAGE, V59, P2932, DOI 10.1016/j.neuroimage.2011.09.071; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Mesulam MM, 2004, PROG BRAIN RES, V145, P67, DOI 10.1016/S0079-6123(03)45004-8; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Ross SR, 2003, CLIN NEUROPSYCHOL, V17, P581, DOI 10.1076/clin.17.4.581.27940; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Wolk DA, 2010, BEHAV NEUROL, V16, P15; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, J REHABIL MED, V45, P1078, DOI 10.2340/16501977-1232; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2013, YONSEI MED J, V54, P315, DOI 10.3349/ymj.2013.54.2.315; Yeo SS, 2012, INT J NEUROSCI, V122, P195, DOI 10.3109/00207454.2011.639469	20	4	4	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JUN	2018	27	6					E98	E101		10.1016/j.jstrokecerebrovasdis.2017.12.045			4	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	GG1ZS	WOS:000432489900004	29395645				2022-02-06	
J	Kumar, VA; Reddy, BU; Kumar, VAK; Pal, R; Kumar, RL; Jahnavi, M; Agrawal, A				Kumar, Valluri Anil; Reddy, Bobba Ushasree; Kumar, Veldurti Ananta Kiran; Pal, Ranabir; Kumar, R. Lakshman; Jahnavi, Mundlapudi; Agrawal, Amit			Speech and Swallowing Function Outcome Following Early Tracheostomy in Patients Who Underwent Neurosurgical Intervention	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Neurotrauma; tracheostomy; traumatic brain injury	PERCUTANEOUS TRACHEOSTOMY; MECHANICAL VENTILATION; COMPLICATIONS; INTUBATION; IMPACT; TRIAL	Background: Evaluation of late-onset speech and swallowing complications of tracheostomy on neurotrauma cases, as the most common intensive care unit procedure, needs to be evaluated. Objectives: A prospective study conducted in a tertiary care teaching hospital to find the late-onset speech and swallowing complications of tracheostomy in neurotrauma cases. Materials and Methods: This prospective observational study was conducted in the intensive care unit on intubated patients needing elective tracheostomy at a tertiary care teaching institute in South India with a dedicated referral trauma center. A data collection tool was prepared to find age, gender, date of admission, tracheostomy, and discharge, contact address and number, initial and final diagnosis, initial Glasgow Coma Scale (GCS) on admission and subsequent GCS before and after tracheostomy, ventilator settings before and after the tracheostomy, procedure and intraoperative complications, type of cannula used, details of decannulation, and respiratory difficulties. Results: In our study among 69 cases between 16 and 75 years' age range with mean 46.67 +/- 16.65, majority were males (75.36%) and 60 were cranial cases (86.96%). Of the alive cases (21 [30.43%]) who underwent tracheostomy; 18 were performed in operation theater and 3 as bedside procedure. Major problems reported were: Speech problems (not able to phonate) (9), feeble voice (6), pain while speaking (6), and reduced loudness (6), frequent throat clearing while speaking (4), cough while speaking (3); breathlessness while speaking (1), gasping while speaking (1) and vocal tiredness (1); aspirations (2) and painful swallowing (1). Conclusions: Our study suggested that though, majority of neurotrauma patients require tracheostomy for long term ventilator support and associated speech and swallowing problems are expected.	[Kumar, Valluri Anil] Narayana Med Coll Hosp, Dept Anesthesia, Nellore, Andhra Pradesh, India; [Reddy, Bobba Ushasree; Kumar, Veldurti Ananta Kiran; Kumar, R. Lakshman; Jahnavi, Mundlapudi; Agrawal, Amit] Narayana Med Coll Hosp, Dept Neurosurg, Nellore 524003, Andhra Pradesh, India; [Pal, Ranabir] MGM Med Coll & LSK Hosp, Dept Community Med, Kishanganj, Bihar, India		Kumar, VAK (corresponding author), Narayana Med Coll Hosp, Dept Neurosurg, Nellore 524003, Andhra Pradesh, India.	drananth21@gmail.com	Pal, Ranabir/M-6693-2013; Agrawal, Amit/C-1511-2011	Agrawal, Amit/0000-0002-3287-5448; Pal, Ranabir/0000-0002-8602-0162			AASS AS, 1975, ACTA ANAESTH SCAND, V19, P127, DOI 10.1111/j.1399-6576.1975.tb05232.x; Bickenbach J, 2011, MINERVA ANESTESIOL, V77, P1176; Bosel J, 2013, STROKE, V44, P21, DOI 10.1161/STROKEAHA.112.669895; Cheung NH, 2014, RESP CARE, V59, P895, DOI 10.4187/respcare.02971; Durbin CG, 2010, RESP CARE, V55, P76; HAZARD P, 1991, CRIT CARE MED, V19, P1018, DOI 10.1097/00003246-199108000-00008; Kiran S, 2015, INDIAN J CRIT CARE M, V19, P82, DOI 10.4103/0972-5229.151015; Norwood S, 2000, ANN SURG, V232, P233, DOI 10.1097/00000658-200008000-00014; Pinheiro BD, 2010, J BRAS PNEUMOL, V36, P84, DOI 10.1590/S1806-37132010000100014; Puentes W, 2016, ANAESTH INTENSIVE TH, V48, P89, DOI 10.5603/AIT.a2016.0016; Romero J, 2009, EUR SPINE J, V18, P1452, DOI 10.1007/s00586-009-1097-3; Siempos II, 2015, LANCET RESP MED, V3, P150, DOI 10.1016/S2213-2600(15)00007-7; Zirpe KG, 2017, INDIAN J CRIT CARE M, V21, P6, DOI 10.4103/0972-5229.198309	13	4	5	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	JUN	2018	22	6					427	430		10.4103/ijccm.IJCCM_31_18			4	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GK8SX	WOS:000436499200006	29962743	gold, Green Published			2022-02-06	
J	Murdaugh, DL; Ono, KE; Morris, SO; Burns, TG				Murdaugh, Donna L.; Ono, Kim E.; Morris, Sarah O.; Burns, Thomas G.			Effects of Developmental Age on Symptom Reporting and Neurocognitive Performance in Youth After Sports-Related Concussion Compared to Control Athletes	JOURNAL OF CHILD NEUROLOGY			English	Article						sports-related concussion; ImPACT; pediatric; age differences	YOUNG ATHLETE; TEST BATTERY; HEAD-INJURY; HIGH-SCHOOL; IMPACT; CHILDREN; RECOVERY; SPECIFICITY; SENSITIVITY; MEMORY	There is increased necessity to focus research on school-aged athletes with sports-related concussion (SRC). This study assessed differences in symptom reporting and neurocognitive performance in youth athletes who sustained a sports-related concussion. A total of 1345 concussed and 3529 nonconcussed athletes (ages 8-21) completed the Immediate Post-concussive Assessment and Cognitive Testing (ImPACT). Analyses of covariance were conducted in order to assess differences in neurocognitive performance and symptom reporting between the sports-related concussion and control groups across age ranges. Longitudinal hierarchical linear modeling was employed to examine age and its relationship with rates of sports-related concussion recovery in neurocognitive performance. Results revealed athletes aged 13 to 15 had significantly lower neurocognitive performance scores compared to same-aged athletes without a history of sports-related concussion. With respect to the hierarchical linear modeling results, age was identified as a unique predictor of symptom recovery, particularly for ages 8 to 12. Results provide a better understanding of typical symptom reporting and neurocognitive outcomes for younger athletes across different ages.	[Murdaugh, Donna L.; Ono, Kim E.; Morris, Sarah O.; Burns, Thomas G.] Childrens Healthcare Atlanta, 1547 Clifton Rd NE,Suite 200, Atlanta, GA 30322 USA		Murdaugh, DL (corresponding author), Childrens Healthcare Atlanta, 1547 Clifton Rd NE,Suite 200, Atlanta, GA 30322 USA.	dlmurdaugh@gmail.com		Murdaugh, Donna/0000-0001-8550-8353			Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cowan N, 1999, CHILD DEV, V70, P1082, DOI 10.1111/1467-8624.00080; Davis GA, 2018, NEUROSURGERY, V82, P232, DOI 10.1093/neuros/nyx344; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Hancock GR, 2006, QUANT METH EDUC BEHA, P1; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Korkman M, 2013, CHILD NEUROPSYCHOL, V19, P516, DOI 10.1080/09297049.2012.705822; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCory P, 2004, BRIT J SPORT MED, V38, P516; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Mckay CD, 2014, ARCH CLIN NEUROPSYCH, V29, P141, DOI 10.1093/arclin/act116; Metzl JD, 2006, PEDIATRICS, V117, P1813, DOI 10.1542/peds.2006-0480; Mous SE, 2017, APPL NEUROPSYCH-CHIL, V6, P22, DOI 10.1080/21622965.2015.1067214; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Putukian M., 2017, BR J SPORTS MED, V51, pA28; Raudenbush SW, 2004, HIERARCHICAL LINEAR; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12	32	4	4	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUN	2018	33	7					474	481		10.1177/0883073818766815			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	GF6OB	WOS:000432085800006	29667530				2022-02-06	
J	Onyemaechi, NOC; Nwankwo, OE; Ezeadawi, RA				Onyemaechi, N. O. C.; Nwankwo, O. E.; Ezeadawi, R. A.			Epidemiology of Injuries Seen in a Nigerian Tertiary Hospital	NIGERIAN JOURNAL OF CLINICAL PRACTICE			English	Article						Epidemiology; injuries; Nigeria; pattern; road traffic accidents	MORTALITY; BURDEN; TRAUMA; COUNTRIES; SEVERITY	Background: The study aimed to describe the pattern of injuries among patients presenting at a tertiary care hospital in Enugu southeast Nigeria. Patients and Methods: A retrospective review of records of all injured patients seen in our hospital over a 12-month period was done. Results: A total of 789 patients had complete medical records and were included in the study. Road traffic accident (RTA) was the most common cause of injury. Lacerations/ abrasions, fractures, and traumatic brain injury (TBI) were the most frequently seen injuries. The injury severity score (ISS) of the patients ranged from 1 to 50 with a mean score of 8.9 +/- 3.5. RTAs were responsible for 90.8% of patients with ISS > 15. Patients with ISS > 15 contributed to 64.1% of all deaths. The mortality rate was 4.5%. Most deaths resulted from RTA and were associated with TBI (P = 0.001). Conclusion: Lacerations and fractures were the most common injuries. RTA was the leading cause of injury. TBI was the most common cause of injury-related death.	[Onyemaechi, N. O. C.; Nwankwo, O. E.] Univ Nigeria, Coll Med, Dept Surg, Ituku Ozalla, Enugu, Nigeria; [Ezeadawi, R. A.] Enugu State Univ, Teaching Hosp, Dept Surg, Parklane, Enugu, Nigeria		Onyemaechi, NOC (corresponding author), Univ Nigeria, Coll Med, Dept Surg, Ituku Ozalla, Enugu, Nigeria.	ndubuisi.onyemaechi@unn.edu.ng	ONYEMAECHI, NDUBUISI/AAO-7745-2021		FIC NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43 TW010463] Funding Source: Medline		Adoga Adeyi A, 2014, J Emerg Trauma Shock, V7, P77, DOI 10.4103/0974-2700.130875; Bigdeli M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-406; Chalya Phillipo L, 2013, J Trauma Manag Outcomes, V7, P9, DOI 10.1186/1752-2897-7-9; Chiang WK, 2012, INT J GERONTOL, V6, P192, DOI 10.1016/j.ijge.2012.01.016; Egol Kenneth A, 2011, J Emerg Trauma Shock, V4, P178, DOI 10.4103/0974-2700.82202; Ekere AU, 2004, INT ORTHOP, V28, P187, DOI 10.1007/s00264-004-0548-z; Elachi Itodo C, 2015, Int J Crit Illn Inj Sci, V5, P99, DOI 10.4103/2229-5151.158404; Elachi Itodo C, 2014, Niger Med J, V55, P452, DOI 10.4103/0300-1652.144693; ELECHI EN, 1990, INJURY, V21, P234, DOI 10.1016/0020-1383(90)90011-I; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Huda N, 2012, J ORTHOP TRAUMA REHA, V5, P1; Lagarde E, 2007, PLOS MED, V4, P967, DOI 10.1371/journal.pmed.0040170; Madubueze CC, 2011, INT ORTHOP, V35, P743, DOI 10.1007/s00264-010-1080-y; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Onyemaechi NOC, 2015, INDIAN J SURG, V77, pS881, DOI 10.1007/s12262-014-1048-z; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Peden M., 2002, INJURY CHART BOOK GR; Prekker ME, 2009, J TRAUMA, V66, P1688, DOI 10.1097/TA.0b013e31817db0f1; Solagberu B A, 2003, West Afr J Med, V22, P177; Solagberu B. A., 2002, EUR J TRAUMA, V28, P365; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Tadesse B., 2014, E CENT AFR J SURG, V19, P73; Thanni L O A, 2006, Afr Health Sci, V6, P104; Wui Lim Woan, 2014, J Emerg Trauma Shock, V7, P174, DOI 10.4103/0974-2700.136860; Yadollahi M, 2017, CHIN J TRAUMATOL, V20, P27, DOI 10.1016/j.cjtee.2015.10.006	27	4	4	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1119-3077			NIGER J CLIN PRACT	Niger. J. Clin. Pract.	JUN	2018	21	6					752	757		10.4103/njcp.njcp_263_17			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN4XT	WOS:000439044700012	29888723	Green Accepted			2022-02-06	
J	Peacock, SH; Tomlinson, AD				Peacock, Sarah H.; Tomlinson, Amanda D.			Multimodal Neuromonitoring in Neurocritical Care	AACN ADVANCED CRITICAL CARE			English	Article						critical care; cerebral perfusion pressure; intracranial pressure; neuromonitoring; multimodal	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; INTENSIVE-CARE; MICRODIALYSIS; BLOOD; LIMITATIONS; STATEMENT; OXYGEN; DEPTH	Neuromonitoring is important for patients with acute brain injury. The bedside neurologic examination is standard for neurologic monitoring; however, a clinical examination may not reliably detect subtle changes in intracranial physiology. Changes found during neurologic examinations are often late signs. The assessment of multiple physiological variables in real time can provide new clinical insights into treatment decisions. No single monitoring modality is ideal for all patients. Simultaneous assessment of cerebral hemodynamics, oxygenation, and metabolism, such as in multimodal monitoring, allows an innovative approach to individualized patient care.	[Peacock, Sarah H.; Tomlinson, Amanda D.] Mayo Clin, Dept Crit Care Med, Coll Med, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Peacock, Sarah H.] Mayo Clin, Coll Med, Med, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Tomlinson, Amanda D.] Mayo Clin, Coll Med, Neurol, Jacksonville, FL 32224 USA		Peacock, SH (corresponding author), Mayo Clin, Dept Crit Care Med, Coll Med, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.; Peacock, SH (corresponding author), Mayo Clin, Coll Med, Med, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	Peacock.Sarah@mayo.edu					Aiolfi A, 2018, J NEUROSURG, V128, P828, DOI 10.3171/2016.11.JNS162198; Al-Rawi PG, 2013, MONITORING NEUROCRIT, P327; Behrens A, 2010, NEUROSURGERY, V66, P1050, DOI 10.1227/01.NEU.0000369519.35932.F2; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Chesnut RM, 2013, MONITORING NEUROCRIT, P338; Cipolla M.J., 2009, CEREBRAL CIRCULATION; Cohn SM, 2007, J TRAUMA, V62, P44, DOI 10.1097/TA.0b013e31802eb817; Czosnyka M, 2013, MONITORING NEUROCRIT, P445; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; Hajat Z, 2017, ANAESTHESIA, V72, P38, DOI 10.1111/anae.13739; Hanley DF, 2017, LANCET, V389, P603, DOI 10.1016/S0140-6736(16)32410-2; HANSEN HC, 1994, NEURO-OPHTHALMOLOGY, V14, P345, DOI 10.3109/01658109409024061; Horn P, 2013, MONITORING NEUROCRIT, P246; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kirkman Matthew A, 2016, Anesthesiol Clin, V34, P511, DOI 10.1016/j.anclin.2016.04.005; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Mangalore S, 2017, ANN INDIAN ACAD NEUR, V20, P252, DOI 10.4103/aian.AIAN_80_17; MATTA BF, 1994, ANESTH ANALG, V79, P745; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Muellner T, 1998, BRIT J NEUROSURG, V12, P136, DOI 10.1080/02688699845276; Muralidharan Rajanandini, 2015, Surg Neurol Int, V6, pS271, DOI 10.4103/2152-7806.157620; Myerson A, 1927, ARCH NEURO PSYCHIATR, V17, P807, DOI 10.1001/archneurpsyc.1927.02200360087006; Oddo M, 2013, MONITORING NEUROCRIT, P348; Pandit JJ, 2013, BRIT J ANAESTH, V110, P325, DOI 10.1093/bja/aet006; Prakash A, 2013, MONITORING NEUROCRIT, P320; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Rincon F, 2007, CURR OPIN CRIT CARE, V13, P115, DOI 10.1097/MCC.0b013e32808255c6; Roh D, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0659-0; Rose JC, 2004, NEUROCRIT CARE, V1, P287, DOI 10.1385/NCC:1:3:287; Schell RM, 2000, ANESTH ANALG, V90, P559, DOI 10.1097/00000539-200003000-00012; Shannon RJ, 2013, J PHARMACOKINET PHAR, V40, P343, DOI 10.1007/s10928-013-9306-4; Smith M, 2018, ANESTHESIOLOGY, V128, P401, DOI 10.1097/ALN.0000000000001885; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Tasneem N, 2017, CRIT CARE RES PRACT, V2017, DOI 10.1155/2017/6097265; Tsivgoulis G, 2009, CURR NEUROL NEUROSCI, V9, P46, DOI 10.1007/s11910-009-0008-7; Young GB, 2009, CAN J NEUROL SCI, V36, pS89; Zacharia BE, 2013, MONITORING NEUROCRIT, P2	43	4	4	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	SUM	2018	29	2					183	194		10.4037/aacnacc2018632			12	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	GI8KM	WOS:000434773500012	29875115				2022-02-06	
J	Steenstrup, SE; Mok, KM; McIntosh, AS; Bahr, R; Krosshaug, T				Steenstrup, Sophie Elspeth; Mok, Kam-Ming; McIntosh, Andrew S.; Bahr, Roald; Krosshaug, Tron			Reconstruction of head impacts in FIS World Cup alpine skiing	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						alpine skiing; head; helmet; injury prevention; concussion	INJURIES; SKIERS	Introduction Prior to the 2013/2014 season, the International Ski Federation (FIS) increased the helmet testing speed from 5.4 to 6.8 m/s for alpine downhill, super-G and giant slalom. Whether this increased testing speed reflects head impact velocities in real head injury situations on snow is unclear. We therefore investigated the injury mechanisms and gross head impact biomechanics in seven real head injury situations among World Cup (WC) alpine skiers. Methods We analysed nine head impacts from seven head injury videos from the FIS Injury Surveillance System, throughout nine WC seasons (2006-2015) in detail. We used commercial video-based motion analysis software to estimate head impact kinematics in two dimensions, including directly preimpact and postimpact, from broadcast video. The sagittal plane angular movement of the head was also measured using angle measurement software. Results In seven of nine head impacts, the estimated normal to slope preimpact velocity was higher than the current FIS helmet rule of 6.8 m/s (mean 8.1 (SD 0.6) m/s, range 1.9 +/- 0.8 to 12.1 +/- 0.4 m/s). The nine head impacts had a mean normal to slope velocity change of 9.3 +/- 1.0 m/s, range 5.2 +/- 1.1 to 13.5 +/- 1.3 m/s. There was a large change in sagittal plane angular velocity (mean 43.3 +/- 2.9 rad/s (range 21.2 +/- 1.5 to 64.2 +/- 3.0 rad/s)) during impact. Conclusion The estimated normal to slope preimpact velocity was higher than the current FIS helmet rule of 6.8 m/s in seven of nine head impacts.	[Steenstrup, Sophie Elspeth; Bahr, Roald; Krosshaug, Tron] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Dept Sports Med, N-0806 Oslo, Norway; [Mok, Kam-Ming] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Fac Med, Hong Kong, Hong Kong, Peoples R China; [McIntosh, Andrew S.] Fed Univ Australia, Australian Ctr Res Injury Sport & Its Prevent ACR, Ballarat, Vic, Australia		Steenstrup, SE (corresponding author), Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Dept Sports Med, N-0806 Oslo, Norway.	s.e.steenstrup@nih.no	Krosshaug, Tron/AAT-2390-2021; Mok, Kam-Ming/P-2269-2016	Mok, Kam-Ming/0000-0003-2185-6468	Royal Norwegian Ministry of Culture; South-Eastern Norway Regional Health Authority; International Olympic Committee; Norwegian Olympic Committee and Confederation of Sport; Norsk Tipping AS; International Ski Federation; DJO	The Oslo Sports Trauma Research Center has been established at the Norwegian School of Sport Sciences through generous grants from the Royal Norwegian Ministry of Culture, the South-Eastern Norway Regional Health Authority, the International Olympic Committee, the Norwegian Olympic Committee and Confederation of Sport, and Norsk Tipping AS. The FIS Injury Surveillance System is supported by the International Ski Federation and was established through a generous grant from DJO.	[Anonymous], 2013, FIS HELMET RULE 2013; ASTM International, 2011, F204011 ASTM INT; Bailly N, 2017, SCAND J MED SCI SPOR, V27, P964, DOI 10.1111/sms.12699; Bere T, 2014, BRIT J SPORT MED, V48, P36, DOI 10.1136/bjsports-2013-092206; Connor T.A., 2016, HEAD PROTECTION EURO; Florenes TW, 2012, SCAND J MED SCI SPOR, V22, P58, DOI 10.1111/j.1600-0838.2010.01147.x; Florenes TW, 2011, SCAND J MED SCI SPOR, V21, P196, DOI 10.1111/j.1600-0838.2009.01048.x; Florenes TW, 2009, BRIT J SPORT MED, V43, P973, DOI 10.1136/bjsm.2009.068759; International Ski Federation, 2016, FIS SPEC COMP EQ COM; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1108, DOI 10.1136/bjsports-2015-095094; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; Mecham MD, 1999, J APPL BIOMECH, V15, P27, DOI 10.1123/jab.15.1.27; Nakaguchi H, 2002, J NEUROSURG, V97, P542, DOI 10.3171/jns.2002.97.3.0542; Newman J, 2002, ACCIDENTAL INJURY BI; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Richards Darrin, 2008, Journal of ASTM International, V5, DOI 10.1520/JAI101406; Standardisation CSN, 2007, 10772007 EN STAND CS; Steenstrup SE, 2017, BRIT J SPORT MED, DOI [10. 1136/bjsports-2016-097086, DOI 10.1136/BJSP0RTS-2016-097086]; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; Yamazaki J, 2015, MED SCI SPORT EXER, V47, P1113, DOI 10.1249/MSS.0000000000000511	21	4	6	2	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2018	52	11					709	715		10.1136/bjsports-2017-098050			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GH2KX	WOS:000433231900004	29175825	Green Published, Bronze			2022-02-06	
J	Taylor, AM; Nigrovic, LE; Saillant, ML; Trudell, EK; Modest, JR; Kuhn, M; Vernacchio, L				Taylor, Alex M.; Nigrovic, Lise E.; Saillant, Meredith L.; Trudell, Emily K.; Modest, Jonathan R.; Kuhn, Madeleine; Vernacchio, Louis			Educational Initiative to Standardize Concussion Management in Pediatric Primary Care	CLINICAL PEDIATRICS			English	Article						ambulatory care; concussion; mild traumatic brain injury; minor head injury; pediatrics; primary care	SPORT-RELATED CONCUSSION; INTERRUPTED TIME-SERIES; MINOR HEAD-INJURY; INTERNATIONAL-CONFERENCE; EMERGENCY-DEPARTMENT; CONSENSUS STATEMENT; AMBULATORY-CARE; CHILDREN; QUALITY; KNOWLEDGE	Pediatric primary care providers report limited training and tools to manage concussion. We developed a learning community intervention for a large independent pediatric practice association affiliated with a university hospital to standardize concussion management and improve the use of consensus-based guidelines. The learning community included in-person and online didactics, followed by a web-based reinforcement platform to educate and train clinicians on our treatment algorithm and decision support tools. Chart reviews before and after the intervention demonstrated significant increases in the use of standardized symptom rating scales (19.6% to 69.3%; P < .001), balance assessment (2.3% to 37.6%; P < .001), and scheduled follow-up (41.8% to 61.2%; P < .001), with an increase in delivery of our entire best practice bundle from 3.5% to 28.1% (P < .001). A multimodal educational intervention can effect change among pediatric primary care providers and help align their management practices with consensus-based guidelines.	[Taylor, Alex M.] Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA; [Taylor, Alex M.] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA; [Nigrovic, Lise E.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Saillant, Meredith L.; Trudell, Emily K.; Modest, Jonathan R.; Kuhn, Madeleine] Boston Childrens Hosp, Pediat Phys Org, Boston, MA USA; [Vernacchio, Louis] Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA		Taylor, AM (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	alex.taylor@childrens.harvard.edu	ARSLAN, Okan/AAA-3232-2020	Nigrovic, Lise/0000-0002-6369-3997; Correa, Emily/0000-0003-1985-405X	Provider-Payor Quality Initiative at Boston Children's Hospital [76315]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported in part by a grant from the Provider-Payor Quality Initiative at Boston Children's Hospital (#76315).	[Anonymous], 2013, Br J Sports Med, V47, P259; [Anonymous], 2013, Br J Sports Med, V47, P263; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Centers for Disease Control and Prevention, HEADS; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Gioia GA, 2010, J INT NEUROPSYCH SOC, V16, P178; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hill C, BALANCE ERROR SCORIN; Jordan K, 2004, FAM PRACT, V21, P396, DOI 10.1093/fampra/cmh409; Kerfoot BP, 2007, MED EDUC, V41, P23, DOI 10.1111/j.1365-2929.2006.02644.x; Kerfoot BP, 2009, ANN SURG, V249, P744, DOI 10.1097/SLA.0b013e31819f6db8; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Massachusetts Department of Public Health, HEAD INJ CONC EXTR A; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Nelson EC, 2007, QUALITY DESIGN CLIN; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Reisner A, 2017, J PEDIATR-US, V184, P26, DOI 10.1016/j.jpeds.2017.01.045; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Soto CM, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-22; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	42	4	4	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JUN	2018	57	7					806	814		10.1177/0009922817734363			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GF6BQ	WOS:000432052200006	29027478				2022-02-06	
J	Wilu, AW; Coello, Y; El Haj, M				Wilu, Amina Wili; Coello, Yann; El Haj, Mohamad			Destination memory in traumatic brain injuries	NEUROLOGICAL SCIENCES			English	Article						Binding; Destination memory; Memory; Traumatic brain injuries	WORKING-MEMORY; TEMPORAL-ORDER; SOCIAL OUTCOMES; CONTEXT MEMORY; SHORT-TERM; RETRIEVAL; BEHAVIOR; INFORMATION; PREDICTORS; RECALL	Destination memory, which is socially driven, refers to the ability to remember to whom one has sent information. Our study investigated destination memory in patients with traumatic brain injuries (TBIs). Patients and control participants were invited to tell proverbs (e.g., "the pen is mightier than the sword") to pictures of celebrities (e.g., Barack Obama). Then they were asked to indicate to which celebrity they had previously told the proverbs. Besides the assessment of destination memory, participants performed a binding task in which they were required to associate letters with their corresponding location. Analysis demonstrated less destination memory and binding in patients with TBIs than in controls. In both populations, significant correlations were observed between destination memory and performances on the binding task. These findings demonstrate difficulty in the ability to attribute information to its appropriate destination in TBI patients, perhaps owing to difficulties in binding separate information together to form a coherent representation of an event in memory.	[Wilu, Amina Wili; Coello, Yann; El Haj, Mohamad] Univ Lille, CNRS, CHU Lille, UMR 9193,SCALab,Sci Cognit & Sci Affect, F-59000 Lille, France; [El Haj, Mohamad] Ctr Hosp Tourcoing, Unite Geriatrie, Tourcoing, France		El Haj, M (corresponding author), Univ Lille, CNRS, CHU Lille, UMR 9193,SCALab,Sci Cognit & Sci Affect, F-59000 Lille, France.; El Haj, M (corresponding author), Ctr Hosp Tourcoing, Unite Geriatrie, Tourcoing, France.	mohamad.elhaj@univ-lille3.fr		el haj, mohamad/0000-0001-7635-7557			Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen J., 2013, STAT POWER ANAL BEHA; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; Coste C, 2011, CORTEX, V47, P771, DOI 10.1016/j.cortex.2010.07.004; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; El Haj M, BEHAV BRAIN SCI ACCE; El Haj M., 2017, PSYCHOL RES; El Haj M, 2018, BEHAV BRAIN SCI, V41, DOI 10.1017/S0140525X17001339; El Haj M, 2017, EXP AGING RES, V43, P355, DOI 10.1080/0361073X.2017.1333821; El Haj M, 2017, Q J EXP PSYCHOL, V70, P1166, DOI 10.1080/17470218.2016.1173079; El Haj M, 2015, CURR ALZHEIMER RES, V12, P796, DOI 10.2174/1567205012666150710112802; El Haj M, 2016, MEMORY, V24, P526, DOI 10.1080/09658211.2015.1021257; El Haj M, 2015, J ALZHEIMERS DIS, V48, P529, DOI 10.3233/JAD-150467; El Haj M, 2015, AGING CLIN EXP RES, V27, P337, DOI 10.1007/s40520-014-0286-z; El Haj M, 2015, EXP AGING RES, V41, P204, DOI 10.1080/0361073X.2015.1001658; El Haj M, 2014, GERIATR PSYCHOL NEUR, V12, P432, DOI 10.1684/pnv.2014.0499; El Haj M, 2013, DEMENT GER COGN D EX, V3, P342, DOI 10.1159/000354187; El Haj M, 2014, J CLIN EXP NEUROPSYC, V36, P127, DOI 10.1080/13803395.2013.869309; Ellis PD, 2010, THE ESSENTIAL GUIDE; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Haj ME, 2017, PSYCHOL RES, P1; Kessels RPC, 2012, NEUROPSYCHOL REV, V22, P117, DOI 10.1007/s11065-012-9202-5; KORIAT A, 1988, J MEM LANG, V27, P23, DOI 10.1016/0749-596X(88)90046-0; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Ries M, 2006, NEUROPSYCHOLOGIA, V44, P2233, DOI 10.1016/j.neuropsychologia.2006.05.021; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	47	4	4	2	3	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2018	39	6					1035	1040		10.1007/s10072-018-3321-6			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GH0KT	WOS:000433091600008	29550983				2022-02-06	
J	Xiao, YN; Huang, HL; Peng, Y; Wang, XH				Xiao, Yingni; Huang, Helai; Peng, Yong; Wang, Xinghua			A STUDY ON MOTORCYCLISTS HEAD INJURIES IN CAR-MOTORCYCLE ACCIDENTS BASED ON REAL-WORLD DATA AND ACCIDENT RECONSTRUCTION	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Motorcycle helmet; head injury prevention; epidemiological analysis; accident reconstruction	GROUND IMPACT; BRAIN-INJURY; HELMET USE; COLLISIONS; PROTECTION; MODEL; RISK; NECK	Accident data had shown that as one of the most vulnerable road users, the risk of motorcyclist casualties due to head injuries is extremely high in motorcycle accidents. The objective of this study was to analyze motorcyclist head injury based on epidemiological statistical analysis and car-motorcycle accident reconstruction using real world accident data, and obtain a comprehensive understanding about safety effects of helmets on motorcyclists head injury. In epidemiological data analysis of this study, odds ratios (ORs) was applied to identify differences in injuries between helmeted and unhelmeted motorcyclists. Two vehicle-motorcycle collisions with detailed information were reconstructed by using PC-Crash simulation and MADYMO reconstruction. Furthermore, the head injury reconstruction using MADYMO outputs as boundary conditions was accomplished and analyzed with respect to 1st principal strain, Von Mises stress, coup pressure, countercoup pressure at the cerebrum. The results indicated that unhelmeted motorcyclists were more likely to suffer head injury, serious and fatal injury, and tend to take equal responsibility or more. 1st principal strain was reduced from 0.44 to 0.25 for Case 1, and from 0.16 to 0.10 for case 2 when including a helmet. Von Mises stress were reduced from 30.37 kpa to 19.51 kpa for Case 1 and from 3.42 kpa to 3.03 kpa for case when including a helmet, which meant a reduction of the risk of concussion. But the motorcyclist in Case 2 experienced a lower percentage increase in coup pressure and countercoup pressure. This study provided comprehensive knowledge on motorcyclists head injuries and the effectiveness of helmets as well as contributing to develop the injury prevention measures and protection devices of motorcyclists.	[Xiao, Yingni; Huang, Helai; Peng, Yong; Wang, Xinghua] Cent S Univ, Sch Traff & Transportat Engn, Changsha 410075, Hunan, Peoples R China; [Peng, Yong] Cent S Univ, Minist Educ, Key Lab Traff Safety Track, Changsha 410075, Hunan, Peoples R China; [Wang, Xinghua] Joint Int Res Lab Key Technol Rail Traff Safety, Changsha 410075, Hunan, Peoples R China; [Peng, Yong] Natl & Local Joint Engn Res Ctr Safety Technol Ra, Changsha 410075, Hunan, Peoples R China		Peng, Y (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha 410075, Hunan, Peoples R China.; Peng, Y (corresponding author), Cent S Univ, Minist Educ, Key Lab Traff Safety Track, Changsha 410075, Hunan, Peoples R China.; Peng, Y (corresponding author), Natl & Local Joint Engn Res Ctr Safety Technol Ra, Changsha 410075, Hunan, Peoples R China.	yong_peng@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [71561167001]; Urban Transportation Research Center of Central South University	This study was sponsored by National Natural Science Foundation of China (Grant No. 71561167001), and supported by Urban Transportation Research Center of Central South University.	Amarasingha N, 2014, J SAFETY RES, V49, P113, DOI 10.1016/j.jsr.2014.03.004; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Chen JG, 2013, INT CONF MEAS, P570, DOI 10.1109/ICMTMA.2013.142; Crocetta G, 2015, ACCIDENT ANAL PREV, V79, P56, DOI 10.1016/j.aap.2015.03.009; Curnow WJ, 2003, ACCIDENT ANAL PREV, V35, P287, DOI 10.1016/S0001-4575(02)00012-X; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Fildes B, 2004, 2004 INT C BIOM IMP; Gilchrist A, 1996, ACCIDENT ANAL PREV, V28, P525, DOI 10.1016/0001-4575(96)00030-9; GOLDSTEIN JP, 1986, EVALUATION REV, V10, P355, DOI 10.1177/0193841X8601000306; Haworth N, 2012, ACCIDENT ANAL PREV, V44, P12, DOI 10.1016/j.aap.2010.10.031; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koomstra M, 2003, SUNFLOWER COMP STUDY; Li F, 2017, CURR PHARM DESIGN, V23, P2177, DOI 10.2174/1381612823666161118144829; Liu B. C., 2004, COCHRANE DB SYST REV; Martinez L, 2007, 20 ESV C LYON FRANC; McNally DS, 2013, ACCIDENT ANAL PREV, V60, P15, DOI 10.1016/j.aap.2013.07.011; MOHAN Dinesh, 2002, J TRANSPORT INFRASTR, V9, P79; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Otte D, 2001, P IRCOBI C ISL MAN; Peng Y, 2015, INT J AUTO TECH-KOR, V16, P791, DOI 10.1007/s12239-015-0080-8; Peng Y, 2013, TRAFFIC INJ PREV, V14, P639, DOI 10.1080/15389588.2012.733841; Peng Y, 2012, INT J CRASHWORTHINES, V17, P553, DOI 10.1080/13588265.2012.698578; Peng Y, 2012, SAFETY SCI, V50, P1749, DOI 10.1016/j.ssci.2012.03.005; Peng Y, 2012, INT J CRASHWORTHINES, V17, P415, DOI 10.1080/13588265.2012.661659; Rice TM, 2016, ACCIDENT ANAL PREV, V91, P200, DOI 10.1016/j.aap.2016.03.002; Rogers N, 2008, JOINT OECD ITF TRANS; Roudsari Bahman S, 2005, Traffic Inj Prev, V6, P185; Scott Long J., 1997, REGRESSION MODELS CA, V7; Sui B, 2017, INT TECHN C ENH SAF; Suriyawongpaisal Paibul, 2003, Inj Control Saf Promot, V10, P95, DOI 10.1076/icsp.10.1.95.14110; Thibault L. E., 1993, P IRCOBI C EINDH NET, P3; TNO, 2001, MADYMO HUM MOD MAN V; Wang BY, 2015, J MECH MED BIOL, V15, DOI 10.1142/S0219519415500165; Wang XH, 2017, J ENG MED, V231; World Health Organization (WHO), 2013, 358 WHO; Xu J, 2016, ACCIDENT ANAL PREV, V89, P128, DOI 10.1016/j.aap.2016.01.013; Xu J, 2016, ACCIDENT ANAL PREV, V87, P102, DOI 10.1016/j.aap.2015.10.022; Yang JK, 2008, CHIN J MECH ENG-EN, V21, P81, DOI 10.3901/CJME.2008.04.081; Yang KH, 2004, J MECH MED BIOL, V4, P447, DOI 10.1142/S021951940400120X; Yao Jianfeng, 2007, Traffic Inj Prev, V8, P94, DOI 10.1080/15389580600944243; Yin S, 2017, ACCIDENT ANAL PREV, V106, P285, DOI 10.1016/j.aap.2017.06.005; Yu CJ, 2009, J SAFETY TECHNOL, V5, P76; Zhang W, 2017, BIOMECH METHODOL PLO, V12	44	4	4	2	47	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	JUN	2018	18	4							1850036	10.1142/S0219519418500367			19	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering	GL6YI	WOS:000437340800001					2022-02-06	
J	Liu, J; Xue, XS; Wu, Y; Yang, CH; Li, N; Li, HP				Liu, Jie; Xue, Xinsheng; Wu, Ying; Yang, Chaohua; Li, Ning; Li, Huiping			Efficacy and safety of electro-acupuncture treatment in improving the consciousness of patients with traumatic brain injury: study protocol for a randomized controlled trial	TRIALS			English	Article						Electro-acupuncture; Traumatic brain injury; Consciousness; Mismatch; Negativity	CEREBRAL ISCHEMIA/REPERFUSION INJURY; VEGETATIVE STATE; MAGNETIC STIMULATION; DISORDERS; EPIDEMIOLOGY; AWARENESS; ACUPOINT	Background: Traumatic brain injury (TBI) has become a leading cause of death among young people worldwide. Survivors may live with a long-term TBI-related disability or even develop a disorder of consciousness resulting in poor life quality and shortened life expectancy. Thus far, very few approaches have been found to be effective in the consciousness recovery of these patients. Acupuncture has long been used in the treatment of neurological disorders in China. However, its efficacy and safety in consciousness recovery remain to be proved. Methods: Here, we present a study design and protocol of a randomized, blinded, controlled study to evaluate the efficacy and safety of electro-acupuncture in the consciousness recovery of patients with TBI. A total of 150 patients with initial Glasgow coma scale score of less than 8 points will be recruited in the trial and randomized into acupuncture or control groups. Patients in the control group will receive routine pharmacological treatment alone while patients in the acupuncture group will receive electro-acupuncture treatment for 10 days in addition to routine treatment. The efficacy will be assessed with the changes in Glasgow coma scale score and mismatch negativity of event-related brain potentials before and after treatment. Moreover, Glasgow outcome scale and Barthel index of activities of daily living will be compared between the two groups at 3 months after treatment. The secondary outcome measures are the length of stay in ICU and hospital, expenses in ICU and hospital, as well as the incidence of coma-related complications. The safety of electro-acupuncture will be assessed by monitoring the incidence of adverse events and changes in vital signs during the study. Discussion: Results from this trial will significantly add to the current body of evidence on the role of electroacupuncture in the consciousness recovery of patients with severe TBI. In addition, a more convenient and consistent electro-acupuncture method can be set up for clinical practice. If found to be effective and safe, electro-acupuncture will be a valuable complementary option for comatose patients with TBI.	[Liu, Jie; Li, Ning] Sichuan Univ, Dept Tradit Chinese Med & Western Med, West China Hosp, Guoxuexiang 37, Chengdu 610041, Sichuan, Peoples R China; [Xue, Xinsheng; Li, Huiping] Sichuan Univ, Dept Crit Care Med, West China Hosp, Guoxuexiang 37, Chengdu 610041, Sichuan, Peoples R China; [Wu, Ying] Sichuan Univ, West China Hosp, Dept Neurol, Guoxuexiang 37, Chengdu 610041, Sichuan, Peoples R China; [Yang, Chaohua] Sichuan Univ, West China Hosp, Dept Neurosurg, Guoxuexiang 37, Chengdu 610041, Sichuan, Peoples R China		Li, HP (corresponding author), Sichuan Univ, Dept Crit Care Med, West China Hosp, Guoxuexiang 37, Chengdu 610041, Sichuan, Peoples R China.	huipingli2154@hotmail.com			Administration of Traditional Chinese Medicine of Sichuan, Jinjiangqu, Chengdu City, China [2016C053]	This report is supported by the Administration of Traditional Chinese Medicine of Sichuan (2016C053), Yongxingxiang 15, Jinjiangqu, Chengdu City, China, 610016.	Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Deng SZ, 2015, EXP THER MED, V10, P1247, DOI 10.3892/etm.2015.2653; Fridman EA, 2010, BRAIN INJURY, V24, P636, DOI 10.3109/02699051003610433; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Li YM, 2015, BRAIN INJURY, V29, P981, DOI 10.3109/02699052.2014.989405; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marwick C, 1997, JAMA-J AM MED ASSOC, V278, P1725, DOI 10.1001/jama.1997.03550210021013; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Piccione F, 2011, NEUROREHAB NEURAL RE, V25, P98, DOI 10.1177/1545968310369802; Quirico PE, 2014, NEUROL SCI, V35, pS129, DOI 10.1007/s10072-014-1754-0; Schnakers C, 2017, CURR OPIN NEUROL, V30, P573, DOI 10.1097/WCO.0000000000000495; Shi XM, 2009, SHI XUEMIN PRACTICAL, P264; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Ugoya SO, 2010, CLIN NEUROPHARMACOL, V33, P279, DOI 10.1097/WNF.0b013e3182011070; Wang WB, 2016, NEURAL REGEN RES, V11, P1099, DOI 10.4103/1673-5374.187042; Wang Y, 2016, NEURAL REGEN RES, V11, P957, DOI 10.4103/1673-5374.184495; Yamamoto T, 2010, EUR J NEUROSCI, V32, P1145, DOI 10.1111/j.1460-9568.2010.07412.x; Yang A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004131.pub3; Yu HL, 2016, NEURAL REGEN RES, V11, P1141, DOI 10.4103/1673-5374.187053	23	4	5	0	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1745-6215			TRIALS	Trials	MAY 29	2018	19								296	10.1186/s13063-018-2687-3			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GH5JO	WOS:000433457500001	29843761	Green Published, gold			2022-02-06	
J	Acuna, SA; Tyler, ME; Danilov, YP; Thelen, DG				Acuna, Samuel A.; Tyler, Mitchell E.; Danilov, Yuri P.; Thelen, Darryl G.			Abnormal muscle activation patterns are associated with chronic gait deficits following traumatic brain injury	GAIT & POSTURE			English	Article						Walking; Balance; Muscle coordination; Temporal activation patterns; EMG	SPINAL-CORD-INJURY; WALKING SPEED; BALANCE; LOCOMOTION; ACCELEROMETERS; CLASSIFICATION; ADULTS; FALLS	Background: Gait and balance disorders are common among individuals who have experienced a mild to moderate traumatic brain injury (TBI). However, little is known about how the neuromuscular control of gait is altered following a TBI. Research question: Investigate the relationship between lower limb muscle activation patterns and chronic gait deficits in individuals who previously experienced a mild to moderate TBI. Methods: Lower extremity electromyographic (EMG) signals were collected bilaterally during treadmill and overground walking in 44 ambulatory individuals with a TBI > 1 year prior and 20 unimpaired controls. Activation patterns of TBI muscles were cross-correlated with normative data from control subjects to assess temporal phasing of muscle recruitment. Clinical assessments of gait and balance were performed using dynamic posturography, the dynamic gait index, six-minute walk test, and preferred walking speed. Results: TBI subjects exhibited abnormal activation patterns in the tibialis anterior, medial gastrocnemius, and rectus femoris muscles during both overground and treadmill walking. Activation patterns of the vastus lateralis and soleus muscles did not differ from normal. There was considerable heterogeneity in performance on clinical balance and gait assessments. Abnormal muscle activation patterns were significantly correlated with variations in the dynamic gait index among the TBI subjects. Significance: Individuals who have experienced a prior TBI do exhibit characteristic changes in the temporal coordination of select lower extremity muscles, which may contribute to impairments during challenging walking tasks.	[Acuna, Samuel A.; Thelen, Darryl G.] Univ Wisconsin, Dept Mech Engn, 1513 Univ Ave, Madison, WI 53706 USA; [Tyler, Mitchell E.; Danilov, Yuri P.] Univ Wisconsin, Dept Kinesiol, Madison, WI USA; [Thelen, Darryl G.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Thelen, Darryl G.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI USA		Thelen, DG (corresponding author), Univ Wisconsin, Dept Mech Engn, 1513 Univ Ave, Madison, WI 53706 USA.	dgthelen@wisc.edu	Danilov, Yuri/P-7917-2018	Danilov, Yuri/0000-0002-3123-4016; Acuna, Samuel/0000-0002-0428-5416	Department of DefenseUnited States Department of Defense [W81XWH-13-1-0081]; National Institutes of Health training grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25GM08325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	Development of the TBI training and testing methods used in this study were supported by the Department of Defense [W81XWH-13-1-0081]. SAA's participation in the EMG collection and analysis was supported by a National Institutes of Health training grant [R25GM08325]. The authors would like to thank the staff of the Tactile Communication and Neurorehabilitation Laboratory, Holly Shoenberg, Michael Schmidt, Kristen Rasske, and Emily Keuler for assistance in data collection.	Albani G, 2003, FUNCT NEUROL, V18, P165; Anderson FC, 2003, GAIT POSTURE, V17, P159, DOI 10.1016/S0966-6362(02)00073-5; [Anonymous], 1995, GAIT POSTURE; Balance Manager Systems, 2011, CLIN OP GUID; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Buster TW, 2016, BRAIN INJURY, V30, P1249, DOI 10.1080/02699052.2016.1183822; CALANCIE B, 1994, BRAIN, V117, P1143, DOI 10.1093/brain/117.5.1143; Casanova C, 2011, EUR RESPIR J, V37, P150, DOI 10.1183/09031936.00194909; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Chow JW, 2010, BRAIN INJURY, V24, P1575, DOI 10.3109/02699052.2010.523053; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Danilov Y, 2015, BRAIN NEUROTRAUMA MO, P605, DOI DOI 10.1201/B18126-51; Den Otter AR, 2007, GAIT POSTURE, V25, P342, DOI 10.1016/j.gaitpost.2006.04.007; Enright Paul L, 2003, Respir Care, V48, P783; FORSSBERG H, 1985, EXP BRAIN RES, V57, P480; Grech C, 2016, J ORTHOP, V13, P148, DOI 10.1016/j.jor.2016.03.011; Herman T, 2009, GAIT POSTURE, V29, P237, DOI 10.1016/j.gaitpost.2008.08.013; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; JACOBS R, 1993, MED SCI SPORT EXER, V25, P1163; Jasiewicz JM, 2006, GAIT POSTURE, V24, P502, DOI 10.1016/j.gaitpost.2005.12.017; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Meinert I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152435; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Schmitz A, 2009, J ELECTROMYOGR KINES, V19, P1085, DOI 10.1016/j.jelekin.2008.10.008; Schwartz MH, 2016, DEV MED CHILD NEUROL, V58, P1139, DOI 10.1111/dmcn.13126; Selles RW, 2005, IEEE T NEUR SYS REH, V13, P81, DOI 10.1109/TNSRE.2004.843176; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Steele KM, 2015, DEV MED CHILD NEUROL, V57, P1176, DOI 10.1111/dmcn.12826; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tyler ME, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-79; van Ingen Schenau G. J., 1994, Human Movement Science, V13, P495, DOI 10.1016/0167-9457(94)90051-5; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688; Wang P, 2013, RES DEV DISABIL, V34, P1226, DOI 10.1016/j.ridd.2012.12.013; Whitney SL, 2006, ARCH PHYS MED REHAB, V87, P402, DOI 10.1016/j.apmr.2005.11.002; Williams G, 2015, J HEAD TRAUMA REHAB, V30, pE13, DOI 10.1097/HTR.0000000000000038; Williams G, 2013, BRAIN INJURY, V27, P434, DOI 10.3109/02699052.2012.750754; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2009, GAIT POSTURE, V29, P454, DOI 10.1016/j.gaitpost.2008.11.005; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; WINTER DA, 1989, J MOTOR BEHAV, V21, P337; WINTER DA, 1987, ELECTROEN CLIN NEURO, V67, P402, DOI 10.1016/0013-4694(87)90003-4; Wren TAL, 2006, J BIOMECH, V39, P2714, DOI 10.1016/j.jbiomech.2005.09.006; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	50	4	4	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	MAY	2018	62						510	517		10.1016/j.gaitpost.2018.04.012			8	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	GG6WT	WOS:000432840100077	29684885	Green Accepted			2022-02-06	
J	Albicini, M; McKinlay, A				Albicini, Michelle; McKinlay, Audrey			Anxiety Disorders in Adults With Childhood Traumatic Brain Injury: Evidence of Difficulties More Than 10 Years Postinjury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; anxiety disorders; brain injuries; child; concussion	POSTTRAUMATIC-STRESS-DISORDER; TERM BEHAVIOR PROBLEMS; PSYCHIATRIC-DISORDERS; GENDER-DIFFERENCES; HEAD-INJURY; EMOTION REGULATION; CHILDREN; OUTCOMES; ADOLESCENTS; PREDICTORS	Objective: To explore long-term psychiatric outcomes in individuals with a history of childhood traumatic brain injury (TBI) or orthopedic injury (OI). Setting: Hospital emergency department, medical admission records and outpatient settings. Participants: There were 95 males (M = 22.78 years, SD = 3.44 years) and 74 females (M = 22.27 years, SD = 3.09 years), 65 with mild TBI (M = 23.25 years, SD = 3.58 years), 61 with moderate-severe TBI (M = 22.34 years, SD = 2.79 years), and 43 with OI (M = 21.81 years, SD = 3.36 years). Design: Longitudinal, between-subjects, cross-sectional design using retrospective and current data. Main Measures: Semistructured interview to obtain psychiatric diagnoses and background information, and medical records for identification of TBI. Results: Group with moderate-severe TBI presented with significantly higher rates of any anxiety disorder ((2)(2) = 6.81, P = .03) and comorbid anxiety disorder ((2)(2) = 6.12, P < .05). Group with overall TBI presented with significantly higher rates of any anxiety disorder ((2)(1) = 5.36, P = .02), panic attacks ((2)(1) = 4.43, P = .04), specific phobias ((2)(1) = 4.17, P = .04), and depression ((2)(1) = 3.98, P < .05). Prediction analysis revealed a statistically significant model ((2)(7) = 41.84, P < .001) explaining 23% to 37% of the variance in having any anxiety disorder, with significant predictors being group (TBI) and gender (female). Conclusions: Children who have sustained a TBI may be vulnerable to persistent anxiety, panic attacks, specific phobias, and depression, even 13 years after the injury event.	[Albicini, Michelle] Monash Univ, Sch Psychol Sci, Fac Med Nursing & Hlth Sci, Wellington Rd, Melbourne, Vic 3800, Australia; [Albicini, Michelle] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic, Australia; [McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia		Albicini, M (corresponding author), Monash Univ, Sch Psychol Sci, Fac Med Nursing & Hlth Sci, Wellington Rd, Melbourne, Vic 3800, Australia.	michelle.albicini@monash.edu			Health Research Council/Accident Compensation Corporation of New Zealand	The study was part of a larger study that was supported by a postdoctoral fellowship from the Health Research Council/Accident Compensation Corporation of New Zealand.	Albicini M, 2015, FRESH LOOK ANXIETY D, P199; Albicini M., 2014, TRAUMATIC BRAIN INJU, P3; Albicini M, 2015, J CLIN EXP NEUROPSYC, V37, P776, DOI 10.1080/13803395.2015.1053843; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V., 2012, DEV SOCIAL NEUROSCIE, P3; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Angold A, 1998, PSYCHOL MED, V28, P51, DOI 10.1017/S003329179700593X; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beyond Blue, 2016, WHO DOES IT AFF; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Centers for Disease Control and Injury Prevention, 2006, HEADS FACTS PHYS MIL; Centers for Disease Control and Prevention, 2013, TRAUMATIC BRAIN INJU; Cisler JM, 2012, CURR PSYCHIAT REP, V14, P182, DOI 10.1007/s11920-012-0262-2; Cisler JM, 2010, J PSYCHOPATHOL BEHAV, V32, P68, DOI 10.1007/s10862-009-9161-1; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Fergusson DM, 2007, ARCH GEN PSYCHIAT, V64, P1089, DOI 10.1001/archpsyc.64.9.1089; Fergusson DM, 2009, ARCH GEN PSYCHIAT, V66, P260, DOI 10.1001/archgenpsychiatry.2008.543; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jonsson CA, 2013, BRAIN INJURY, V27, P831, DOI 10.3109/02699052.2013.775493; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lewinsohn PM, 1998, J ABNORM PSYCHOL, V107, P109, DOI 10.1037/0021-843X.107.1.109; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2017, DISABIL REHABIL, V39, P1296, DOI 10.1080/09638288.2016.1193905; McKinlay A, 2014, AUST PSYCHOL, V49, P323, DOI 10.1111/ap.12084; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rosema S, 2015, J NEUROTRAUM, V32, P976, DOI 10.1089/neu.2014.3567; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Seeman M, 1997, AM J PSYCHIAT, V154, P501; SUSMAN EJ, 1985, J YOUTH ADOLESCENCE, V14, P245, DOI 10.1007/BF02090322; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; World Health Organization, 1990, COMP INT DIAGN INT C; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	54	4	4	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					191	199		10.1097/HTR.0000000000000312			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500124	28520662				2022-02-06	
J	Chen, H; Jia, F; Zhu, CC; Xu, JM; Hua, XB; Xi, ZH; Shen, L; Zhao, SC; Cen, L				Chen, Hong; Jia, Feng; Zhu, Chengcheng; Xu, Jumei; Hua, Xiaobin; Xi, Zhenhao; Shen, Liang; Zhao, Shicheng; Cen, Lian			Controllable preparation of SB-3CT loaded PLGA microcapsules for traumatic-brain-injury pharmaco-therapy	CHEMICAL ENGINEERING JOURNAL			English	Article						TBI; SB-3CT; PLGA; Encapsulation; Microfluidics	OF-THE-ART; ATTENUATES BEHAVIORAL IMPAIRMENTS; CONTROLLED CORTICAL IMPACT; DRUG-DELIVERY; SOLVENT EXTRACTION/EVAPORATION; CONTROLLED-RELEASE; HIPPOCAMPAL LOSS; MICROSPHERES; EMULSION; MICROPARTICLES	This study is to explore controllable preparation of poly (lactic-co-glycolic acid) (PLGA) microcapsules to load 2-[[(4-phenoxyphenyl)sulfonyl]methyl]-thiirane (SB-3CT) for traumatic brain injury (TBI) pharmacological therapy. Capillary-based microfluidic method was proposed to prepare SB-3CT loaded PLGA microcapsules. Drug loading and release behavior of the corresponding PLGA microcapsules were evaluated and correlated with their degradation profile. The obtained PLGA microcapsules had a golf-featured morphology and high monodispersion. Precise control on the size and size distribution of the microcapsules could be achieved by varying the geometry of the capillary device and operation parameters to yield uniform and reproducible PLGA microcapsules in the range of 35-65 mu m. A high drug encapsulation efficiency of 99% within the obtained PLGA microcapsules with a releasing duration of around 50 d was ensured. Pharmacological therapy of TBI was tried by local injection of PLGA-SB-3CT suspension in rats at the trauma site after TBI. The protection on brain tissue upon administration was demonstrated by accelerated behavioral recovery (beam balance and beam walk latencies, and spatial memory ability) and reduction in the neuronal cell apoptosis in CA2 and hilus hippocampus as well as the injury cortical region. Hence, PLGA-SB-3CT could serve as a promising pharmaco-therapeutic option for TBI treatment.	[Chen, Hong; Zhu, Chengcheng; Xu, Jumei; Hua, Xiaobin; Xi, Zhenhao; Shen, Liang; Zhao, Shicheng; Cen, Lian] East China Univ Sci & Technol, Sch Chem Engn, Shanghai Key Lab Multiphase Mat Chem Engn, Dept Prod Engn,State Key Lab Chem Engn, 130 Mei Long Rd, Shanghai 200237, Peoples R China; [Jia, Feng] Shanghai Jiao Tong Univ, Shanghai Renji Hosp, Sch Med, Dept Neurosurg, 1630 Dong Fang Rd, Shanghai, Peoples R China		Zhao, SC; Cen, L (corresponding author), East China Univ Sci & Technol, Sch Chem Engn, Shanghai Key Lab Multiphase Mat Chem Engn, Dept Prod Engn,State Key Lab Chem Engn, 130 Mei Long Rd, Shanghai 200237, Peoples R China.	zhaosc@ecust.edu.cn; liancen@ecust.edu.cn		Xi, Zhenhao/0000-0002-4747-126X	National "973" Project FoundationNational Basic Research Program of China [2010CB944804]; National Nature Science FoundationNational Natural Science Foundation of China (NSFC) [81471855, 21676083]; Open Funding Project of the State Key Laboratory of Bioreactor Engineering	This study is financially supported by National "973" Project Foundation (2010CB944804) and National Nature Science Foundation (81471855, 21676083), and "Open Funding Project of the State Key Laboratory of Bioreactor Engineering".	Abidian MR, 2009, ADV FUNCT MATER, V19, P573, DOI 10.1002/adfm.200801473; Abu-Awwad HAM, 2017, ACTA BIOMATER, V57, P225, DOI 10.1016/j.actbio.2017.04.028; Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3; Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20; Carli P, 2004, LANCET, V363, P584, DOI 10.1016/S0140-6736(04)15626-2; Chen WL, 2017, MOL PHARMACEUT, V14, P459, DOI 10.1021/acs.molpharmaceut.6b00896; Choi SW, 2009, ADV FUNCT MATER, V19, P2943, DOI 10.1002/adfm.200900763; Datta SS, 2014, ADV MATER, V26, P2205, DOI 10.1002/adma.201305119; Dawes GJS, 2009, J MATER SCI-MATER M, V20, P1089, DOI 10.1007/s10856-008-3666-0; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faden AI, 1996, JAMA-J AM MED ASSOC, V276, P569, DOI 10.1001/jama.276.7.569; Fan YL, 2017, AAPS PHARMSCITECH, V18, P2648, DOI 10.1208/s12249-017-0745-x; Fattahi P, 2013, I IEEE EMBS C NEUR E, P953, DOI 10.1109/NER.2013.6696093; Fattahi P, 2013, ADV MATER, V25, P4555, DOI 10.1002/adma.201301033; Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015; Gao F, 2009, LANGMUIR, V25, P3832, DOI 10.1021/la804173b; Grill A. E., 2017, DRUG DELIV TRANSL RE, V2, P1; Han FY, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00185; Han HJ, 2010, ADV FUNCT MATER, V20, P409, DOI 10.1002/adfm.200901293; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Kang SW, 2008, BIOMATERIALS, V29, P1109, DOI 10.1016/j.biomaterials.2007.11.004; Keohane K, 2014, INT J PHARMACEUT, V467, P60, DOI 10.1016/j.ijpharm.2014.03.051; Kim MR, 2010, CHEM COMMUN, V46, P7433, DOI 10.1039/c0cc01738h; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Langert KA, 2017, J NEUROCHEM, V140, P334, DOI 10.1111/jnc.13892; Lee JH, 2013, MATER LETT, V105, P136, DOI 10.1016/j.matlet.2013.04.082; McDonald CJ, 2002, ADV COLLOID INTERFAC, V99, P181, DOI 10.1016/S0001-8686(02)00034-9; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Ralay R. H., 2011, J NEUROTRAUM, V28, P1757, DOI DOI 10.1089/NEU.2011.1799; Ramazani F, 2016, INT J PHARMACEUT, V499, P358, DOI 10.1016/j.ijpharm.2016.01.020; Ranasinghe HS, 2012, DEV NEUROSCI-BASEL, V34, P417, DOI 10.1159/000343257; Shah RK, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70053-1; Shahani K, 2011, J PHARM SCI-US, V100, P2599, DOI 10.1002/jps.22475; Shahani K, 2010, CANCER RES, V70, P4443, DOI 10.1158/0008-5472.CAN-09-4362; Shi DQ, 2016, ACS NANO, V10, P1292, DOI 10.1021/acsnano.5b06663; Shum HC, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3670365; Siepmann J, 2005, BIOMACROMOLECULES, V6, P2312, DOI 10.1021/bm050228k; Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P229, DOI 10.1016/S0169-409X(01)00116-8; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Takahara YK, 2005, J AM CHEM SOC, V127, P6271, DOI 10.1021/ja043581r; Tanaka T, 2010, LANGMUIR, V26, P3848, DOI 10.1021/la903309t; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Versypt ANF, 2013, J CONTROL RELEASE, V165, P29, DOI 10.1016/j.jconrel.2012.10.015; Vladisavljevic GT, 2012, LANGMUIR, V28, P12948, DOI 10.1021/la302092f; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xu QB, 2009, SMALL, V5, P1575, DOI 10.1002/smll.200801855; Yang YY, 2001, BIOMATERIALS, V22, P231, DOI 10.1016/S0142-9612(00)00178-2; Zieringer MA, 2015, SMALL, V11, P2903, DOI 10.1002/smll.201403175	51	4	4	7	61	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1385-8947	1873-3212		CHEM ENG J	Chem. Eng. J.	MAY 1	2018	339						346	358		10.1016/j.cej.2018.01.140			13	Engineering, Environmental; Engineering, Chemical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FZ5GF	WOS:000427619400038					2022-02-06	
J	Fleming, CJE; Kholodkov, T; Dillon, KH; Belvet, B; Crawford, EF				Fleming, C. J. Eubanks; Kholodkov, Tatyana; Dillon, Kirsten H.; Belvet, Benita; Crawford, Eric F.			Actuarial Prediction of Psychotherapy Retention Among Iraq-Afghanistan Veterans With Posttraumatic Stress Disorder	PSYCHOLOGICAL SERVICES			English	Article						OEF/OIF/OND veterans; PTSD; psychotherapy; retention; dropout	MENTAL-HEALTH-CARE; PROLONGED EXPOSURE THERAPY; COGNITIVE PROCESSING THERAPY; DIALECTICAL BEHAVIOR-THERAPY; PSYCHOMETRIC PROPERTIES; SERVICE UTILIZATION; TREATMENT ENGAGEMENT; OEF/OIF VETERANS; PTSD; MILITARY	The present study aimed to identify predictors of treatment retention in a sample of Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) veterans with postraumatic stress disorder (PTSD) who were referred for PTSD-focused treatment through completion of a Veterans Affairs (VA) specialty clinic introductory information session. A total of 124 returning veterans (89% male, 53% Caucasian, 40% African American, 2% Latino; average age = 37 years) participated in an introductory session intended to facilitate informed decision making about treatment selection for PTSD. To evaluate patient, therapist, and system characteristics that were associated with risk of prematurely dropping out of psychotherapy for PTSD, we used recursive partitioning or "classification tree" methods commonly used to derive actuarial models of risk for high or low scores on a particular outcome when the set of independent or predictor variables is large. Findings revealed interactions among predictors involving access to care, readiness for change, histories of traumatic brain injury, and previous PTSD treatment. Results from the exploratory reclusive model indicated that participation in therapy was highest when veterans entered psychotherapy within 68 days of the information session, believed that they needed help, and had a history of traumatic brain injury, while participation was lowest when entry into treatment exceeded 68 days and belief in needing help was low. Effects associated with partitions in the reclusive model were substantial, with Cohen's d statistics ranging from .60 to 1.75. Results of the present effectiveness study implicate the importance of access to care as well as motivation for treatment in the returning cohort of OEF/OIF/OND veterans seeking help for PTSD.	[Fleming, C. J. Eubanks] Elon Univ, Dept Psychol, Campus Box 2337, Elon, NC 27244 USA; [Fleming, C. J. Eubanks; Kholodkov, Tatyana; Dillon, Kirsten H.; Crawford, Eric F.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Belvet, Benita] Durham Vet Affairs VA Med enter, Durham, NC USA; [Crawford, Eric F.] VA Midatlantic Reg Mental Illness Res Educ & Clin, Durham, NC USA		Fleming, CJE (corresponding author), Elon Univ, Dept Psychol, Campus Box 2337, Elon, NC 27244 USA.	pinkfreud27@gmail.com			Durham Veterans Affairs (VA) Medical Center; VA Mid-Atlantic Region Mental Illness Research, Education, and Clinical Center	This article is the result of work supported with resources and the use of facilities at the Durham Veterans Affairs (VA) Medical Center and VA Mid-Atlantic Region Mental Illness Research, Education, and Clinical Center. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the U.S. Department of Veterans Affairs, the U.S. Department of Defense, or the U.S. government.	*AM PSYCH ASS, 2000, DAIGN STAT MAN MENT; ANDERSON J G, 1973, Journal of Health and Social Behavior, V14, P348, DOI 10.2307/2136779; [Anonymous], 2009, DEPRESS ANXIETY, V26, P493, DOI 10.1002/da.20581; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; Crawford EF, 2015, J TRAUMA STRESS, V28, P118, DOI 10.1002/jts.21993; DeViva JC, 2014, PSYCHOL SERV, V11, P179, DOI 10.1037/a0035077; Di Leone BAL, 2013, PSYCHOL SERV, V10, P145, DOI 10.1037/a0032088; Drag L, 2013, J HEAD TRAUMA REHAB, V28, P39, DOI 10.1097/HTR.0b013e318263bb61; Elbogen EB, 2013, PSYCHIAT SERV, V64, P134, DOI 10.1176/appi.ps.004792011; Elhai JD, 2008, J PSYCHIATR RES, V42, P858, DOI 10.1016/j.jpsychires.2007.09.006; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Foa E.B., 2007, PROLONGED EXPOSURE T, DOI [10.1093/med:psych/9780195308501.001.0001, DOI 10.1093/MED:PSYCH/9780195308501.001.0001]; Foa EB., 2006, PATHOLOGICAL ANXIETY, P3; Gallegos AM, 2015, WOMEN HEALTH ISS, V25, P542, DOI 10.1016/j.whi.2015.04.008; Garcia HA, 2011, PSYCHOL SERV, V8, P1, DOI 10.1037/a0022705; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; Harpaz-Rotem I, 2014, J NERV MENT DIS, V202, P97, DOI 10.1097/NMD.0000000000000078; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hunt YM, 2006, J TRAUMA STRESS, V19, P915, DOI 10.1002/jts.20161; Imel ZE, 2013, J CONSULT CLIN PSYCH, V81, P394, DOI 10.1037/a0031474; Jakupcak M, 2013, J TRAUMA STRESS, V26, P165, DOI 10.1002/jts.21768; Jeffreys MD, 2014, J ANXIETY DISORD, V28, P108, DOI 10.1016/j.janxdis.2013.04.010; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; Kroger C, 2014, BEHAV RES THER, V60, P46, DOI 10.1016/j.brat.2014.07.001; Kroger C, 2013, BEHAV RES THER, V51, P411, DOI 10.1016/j.brat.2013.04.008; MAGUEN S, 2007, PSYCHOL SERV, V4, P168, DOI DOI 10.1037/1541-1559.4.3.168; MCCONNAUGHY EA, 1983, PSYCHOTHER-THEOR RES, V20, P368, DOI 10.1037/h0090198; Meyers LL, 2013, MIL MED, V178, P95, DOI 10.7205/MILMED-D-12-00302; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Murphy RT, 2009, PSYCHOL SERV, V6, P264, DOI 10.1037/a0017577; Oliva EM, 2013, PSYCHIAT SERV, V64, P722, DOI 10.1176/appi.ps.201300145; Peterson A. L., 2011, TREATING PTSD MILITA, P42; Resick P. A., 2008, COGNITIVE PROCESSING; Sayer NA, 2011, J TRAUMA STRESS, V24, P699, DOI 10.1002/jts.20693; Seal KH, 2012, GEN HOSP PSYCHIAT, V34, P450, DOI 10.1016/j.genhosppsych.2012.04.007; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Szafranski D. D., 2015, MILITARY BEHAV HLTH, V4, P25, DOI DOI 10.1080/21635781.2015.1093976; Trusz SG, 2011, PSYCHIATRY, V74, P207, DOI 10.1521/psyc.2011.74.3.207; Tuerk PW, 2013, PSYCHOL SERV, V10, P401, DOI 10.1037/a0030549; U. S. Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; U. S. Department of Veterans Affairs and National Center for PTSD, 2015, COGN PROC THER EFF T; U. S. Department of Veterans Affairs and National Center for PTSD, 2015, PROL EXP EMBR YOUR L; van Minnen A, 2002, BEHAV RES THER, V40, P439, DOI 10.1016/S0005-7967(01)00024-9; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029	54	4	4	0	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	MAY	2018	15	2			SI		172	180		10.1037/ser0000139			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GP4OP	WOS:000440847300006	29723019				2022-02-06	
J	Forrest, G; Deike, D				Forrest, George; Deike, Dawn			The impact of inpatient rehabilitation on outcomes for patients with cancer	JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY			English	Article							SPINAL-CORD-INJURY; FUNCTIONAL OUTCOMES; BRAIN-TUMORS; ACUTE STROKE; SURVIVAL; CARE; COMPRESSION; DISABILITY; DISCHARGE; DISEASE	Background Patients with cancer have challenges around mobility, activities of daily living, and self-care. Objective To report outcomes of patients who received radiation therapy while on an inpatient rehabilitation facility (IRF). Methods 61 patients admitted to an IRF with either a primary malignant brain tumor, tumor metastatic to the brain, tumor metastatic to the spine with spinal cord injury, or tumor metastatic to bone. Each patient required radiation therapy. The study notes the outcomes of 69 patients admitted with stroke and 23 patients admitted with a traumatic spinal cord injury. Each patient was offered therapy in accordance with the Center for Medicare and Medicaid Services guidelines. Level of function was assessed using Functional Independence Measure. Outcome measures were improvement in function, functional level at discharge, length of stay, and percent discharged to home. Results The patients in the cancer group had significant improvement in function. More than 75% of the patients with cancer returned to their homes. The functional level achieved by patients with primary malignancies of the brain or tumors metastatic to the brain was not significantly different than that of patients with stroke. The functional level achieved by patients with cancer metastatic to the spine was not significantly different than that of patients with a traumatic spinal cord injury. The percent of patients with cancer discharged to home was not significantly different than that of patients without cancer. Limitations The study reports outcomes from only 1 IRF. Conclusions Comprehensive care that includes radiation and rehabilitation at the IRF level benefits appropriately selected patients with cancer.	[Forrest, George; Deike, Dawn] Albany Med Coll, Dept Phys Med & Rehabil, Albany, NY 12208 USA		Forrest, G (corresponding author), Albany Med Coll, Dept Phys Med & Rehabil, Albany, NY 12208 USA.	georgemcv78@gmail.com	Deike, Dawn/AAA-5677-2020; Deike, Dawn/AAK-2123-2020	Deike, Dawn/0000-0003-2784-1902			American Cancer Society, 2016, CANC FACTS FIGURES 2, P1; Asher A, 2014, PM&R, V6, P808, DOI 10.1016/j.pmrj.2014.01.009; Bartolo M, 2012, J NEURO-ONCOL, V107, P537, DOI 10.1007/s11060-011-0772-5; Bottemiller KL, 2006, REHABIL NURS, V31, P22, DOI 10.1002/j.2048-7940.2006.tb00006.x; Buckner JC, 2007, MAYO CLIN PROC, V82, P1271, DOI 10.4065/82.10.1271; Centers for Medicare & Medicaid Services, 2012, INP REH FAC; Cheville AL, 2011, REHABIL, V90, P27; Cohen ME, 2000, ARCH PHYS MED REHAB, V81, pS21, DOI 10.1053/apmr.2000.20620; Cole RP, 2000, ARCH PHYS MED REHAB, V81, P623, DOI 10.1053/mr.2000.3861; DIETZ JH, 1969, MED CLIN N AM, V53, P607; Eriks IE, 2004, SPINAL CORD, V42, P235, DOI 10.1038/sj.sc.3101555; Forrest G, 2002, AM J PHYS MED REHAB, V81, P57, DOI 10.1097/00002060-200201000-00010; Gallegos-Kearin V, 2018, AM J PHYS MED REHAB, V97, P514, DOI 10.1097/PHM.0000000000000911; Greenberg E, 2006, AM J PHYS MED REHAB, V85, P568, DOI 10.1097/01.phm.0000223218.38152.53; Guo Y, 2011, AM J PHYS MED REHAB, V90, P265, DOI [10.1097/PHM.0b013e3182063ba6, 10.1097/PHM.0b013e31820be1a4]; Huang ME, 1998, ARCH PHYS MED REHAB, V79, P1386, DOI 10.1016/S0003-9993(98)90232-5; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; Hunter Elizabeth G, 2013, J Appl Gerontol, V32, P443, DOI 10.1177/0733464811432632; LEHMANN JF, 1978, ARCH PHYS MED REHAB, V59, P410; Marciniak CM, 1996, ARCH PHYS MED REHAB, V77, P54, DOI 10.1016/S0003-9993(96)90220-8; Marciniak CM, 2001, ARCH PHYS MED REHAB, V82, P457, DOI 10.1053/apmr.2001.21862; McKinley WO, 2000, AM J PHYS MED REHAB, V79, P138, DOI 10.1097/00002060-200003000-00005; Memorial Sloan Kettering Cancer Center, MET BRAIN TUM SEC BR; MURRAY PK, 1985, CANCER, V55, P197, DOI 10.1002/1097-0142(19850101)55:1<197::AID-CNCR2820550131>3.0.CO;2-F; New PW, 2005, ARCH PHYS MED REHAB, V86, P250, DOI 10.1016/j.apmr.2004.04.028; Ng AH, 2017, PM&R, V9, P1135, DOI 10.1016/j.pmrj.2017.04.006; Nguyen VQC, 2015, ARCH PHYS MED REHAB, V96, P1297, DOI 10.1016/j.apmr.2015.03.007; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, P1530, DOI 10.1016/S0003-9993(98)90414-2; OTOOLE DM, 1991, WESTERN J MED, V155, P384; Parsch D, 2003, SPINAL CORD, V41, P205, DOI 10.1038/sj.sc.3101426; Reistetter TA, 2010, ARCH PHYS MED REHAB, V91, P345, DOI 10.1016/j.apmr.2009.11.010; Tang V, 2007, SPINAL CORD, V45, P671, DOI 10.1038/sj.sc.3102024; Tang V, 2008, J NEUROL, V255, P820, DOI 10.1007/s00415-008-0695-z; White AP, 2006, J AM ACAD ORTHOP SUR, V14, P587, DOI 10.5435/00124635-200610000-00001	34	4	4	0	1	FRONTLINE MEDICAL COMMUNICATIONS	THE WOODLANDS	WRIGHTS MEDIA, 2407 TIMBERLOCH PLACE, SUITE B, THE WOODLANDS, TX 77386 USA	2330-7749	2330-7757		J COMMUNITY SUPPORT	J. Community Support. Oncol.	MAY-JUN	2018	16	3					E138	E144		10.12788/jcso.0409			7	Oncology	Emerging Sources Citation Index (ESCI)	Oncology	HH7OC	WOS:000455919200004					2022-02-06	
J	Hudnut, AW; Lash-Rosenberg, L; Xin, A; Doblado, JAL; Zurita-Lopez, C; Wang, QM; Armani, AM				Hudnut, Alexa W.; Lash-Rosenberg, Lian; Xin, An; Doblado, Juan A. Leal; Zurita-Lopez, Cecilia; Wang, Qiming; Armani, Andrea M.			Role of Extracellular Matrix in the Biomechanical Behavior of Pancreatic Tissue	ACS BIOMATERIALS SCIENCE & ENGINEERING			English	Article						3D printing; biomechanics; elastography; polarimetry; Young's modulus; FEA modeling	TRAUMATIC BRAIN-INJURY; STRAIN-ENERGY; SOFT-TISSUE; ELASTOGRAPHY; COMPRESSION; MICROSCOPY; MECHANICS; DISEASES	Correlating the biomechanical properties of tissue with its function is an emerging area of research with potential impact in diagnostics, therapeutics, and prognostics. A critical stepping-stone in developing structure-function models is creating methods that can correlate the tissue structure with its mechanical behavior. As an initial step in addressing this challenge, we have characterized the mechanical behavior of unprocessed pancreatic tissue using optical fiber polarimetric elastography. To correlate the observed behavior to physiologically relevant structural features, a series of architectures are designed and fabricated using 3D printing. The mechanical response of the 3D printed elastomeric structures is analyzed using compressive testing and modeled using finite element analysis. The biomechanical behavior and buckling point of the 3D printed structures is used to create a calibration curve to understand the measured response of the resected pancreatic tissue. Based on the modeling and biomimetic results, the biomechanical behavior of pancreatic tissue is likely due to the collagen IV network.	[Hudnut, Alexa W.; Armani, Andrea M.] Univ Southern Calif, Dept Biomed Engn, 1002 Childs Way,MCB 495, Los Angeles, CA 90089 USA; [Lash-Rosenberg, Lian] Univ Southern Calif, Dept Mech Engn, 1002 Childs Way,MCB 495, Los Angeles, CA 90089 USA; [Armani, Andrea M.] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, 1002 Childs Way,MCB 495, Los Angeles, CA 90089 USA; [Xin, An; Wang, Qiming] Univ Southern Calif, Dept Civil Engn, 920 Downey Way,BHE 222, Los Angeles, CA 90089 USA; [Doblado, Juan A. Leal; Zurita-Lopez, Cecilia] Calif State Univ Los Angeles, Dept Chem & Biochem, 617 Charles E Young Dr E,Room 251, Los Angeles, CA 90095 USA		Armani, AM (corresponding author), Univ Southern Calif, Dept Biomed Engn, 1002 Childs Way,MCB 495, Los Angeles, CA 90089 USA.; Armani, AM (corresponding author), Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, 1002 Childs Way,MCB 495, Los Angeles, CA 90089 USA.	armani@usc.edu	Armani, Andrea/X-7611-2019; Zurita-Lopez, Cecilia I./AAC-6509-2020	Armani, Andrea/0000-0001-9890-5104; Leal Doblado, Juan/0000-0002-1398-0920	Office of Naval ResearchOffice of Naval Research [N00014-11-1-0910, N00014-17-2270]; National Science Foundation [NSF]National Science Foundation (NSF) [1649093]; A. E. Mann Graduate Research Fellowship; Zumberge Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM061331, SC2GM118202] Funding Source: NIH RePORTER	This work was supported by the Office of Naval Research [N00014-11-1-0910, N00014-17-2270], the National Science Foundation [NSF Grant No. 1649093], A. E. Mann Graduate Research Fellowship, and the Zumberge Research Fund.	Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Ayyildiz M, 2015, J MECH BEHAV BIOMED, V49, P235, DOI 10.1016/j.jmbbm.2015.05.011; Babaei B, 2017, J MECH BEHAV BIOMED, V69, P193, DOI 10.1016/j.jmbbm.2016.12.013; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Baskin DG, 2015, J HISTOCHEM CYTOCHEM, V63, P543, DOI 10.1369/0022155415589119; BATESMITH EC, 1949, J PHYSIOL-LONDON, V110, P47, DOI 10.1113/jphysiol.1949.sp004420; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cecelja M, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012016; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Drifka CR, 2016, J HISTOCHEM CYTOCHEM, V64, P519, DOI 10.1369/0022155416659249; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fu HR, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4913848; Fung Y., 1981, BIOMECHANICS MECH PR, DOI [10.1118/1.595186, DOI 10.1118/1.595186]; Gibson RF, 2010, COMPOS STRUCT, V92, P2793, DOI 10.1016/j.compstruct.2010.05.003; Gress TM, 1998, DIGESTION, V59, P625, DOI 10.1159/000007567; Harrison MC, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921243; Hudnut AW, 2017, BIOMED OPT EXPRESS, V8, P4663, DOI 10.1364/BOE.8.004663; Hudnut AW, 2017, APPL PHYS LETT, V110, DOI 10.1063/1.4985709; Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001; Jiang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34147; Kasper D., 2015, HARRISONS PRINCIPLES, DOI [10.1212/01.WNL.0000161672.02235.A0, DOI 10.1212/01.WNL.0000161672.02235.A0]; Kennedy BF, 2011, OPT EXPRESS, V19, P6623, DOI 10.1364/OE.19.006623; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Laklai H, 2016, NAT MED, V22, P497, DOI 10.1038/nm.4082; Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005; Li YW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7798; Liska R, 2005, J APPL POLYM SCI, V97, P2286, DOI 10.1002/app.22025; Middendorf JM, 2017, J BIOMECH, V64, P77, DOI 10.1016/j.jbiomech.2017.09.007; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Mulliken AD, 2006, INT J SOLIDS STRUCT, V43, P1331, DOI 10.1016/j.ijsolstr.2005.04.016; Ohlund D, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-154; Park J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1929; Schenke-Layland K, 2008, J BIOPHOTONICS, V1, P451, DOI 10.1002/jbio.200810045; Shahzad M, 2015, MATER RES-IBERO-AM J, V18, P918, DOI 10.1590/1516-1439.320414; Shan SC, 2015, ADV MATER, V27, P4296, DOI 10.1002/adma.201501708; Shima H, 2012, MATERIALS, V5, P47, DOI 10.3390/ma5010047; Spek AL, 2009, ACTA CRYSTALLOGR D, V65, P148, DOI 10.1107/S090744490804362X; Vigier S, 2017, CURR RES TRANSL MED, V65, P31, DOI 10.1016/j.retram.2016.10.001; YEOH OH, 1993, RUBBER CHEM TECHNOL, V66, P754, DOI 10.5254/1.3538343; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	42	4	4	0	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2373-9878			ACS BIOMATER SCI ENG	ACS Biomater. Sci. Eng.	MAY	2018	4	5					1916	1923		10.1021/acsbiomaterials.8b00349			15	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	GG1VR	WOS:000432476200046	31828218	Green Accepted			2022-02-06	
J	Leetch, AN; Wilson, B				Leetch, Aaron N.; Wilson, Bryan			Pediatric Major Head Injury Not a Minor Problem	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Intracranial hemorrhage; Blunt head injury; Abusive head trauma	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; RANDOMIZED CONTROLLED-TRIAL; RAPID-SEQUENCE INTUBATION; RAISED INTRACRANIAL-PRESSURE; CEREBRAL PERFUSION-PRESSURE; SHAKEN INFANT SYNDROME; EMERGENCY-DEPARTMENT; BLOOD-PRESSURE; DECOMPRESSIVE CRANIECTOMY	Traumatic brain injury is a highly prevalent and devastating cause of morbidity and mortality in children. A rapid, stepwise approach to the traumatized child should proceed, addressing life-threatening problems first. Management focuses on preventing secondary injury from physiologic extremes such as hypoxemia, hypotension, prolonged hyperventilation, temperature extremes, and rapid changes in cerebral blood flow. Initial Glasgow Coma Score, hyperglycemia, and imaging are often prognostic of outcome. Surgically amenable lesions should be evacuated promptly. Reduction of intracranial pressure through hyperosmolar therapy, decompressive craniotomy, and seizure prophylaxis may be considered after stabilization. Nonaccidental trauma should be considered when evaluating pediatric trauma patients.	[Leetch, Aaron N.; Wilson, Bryan] Univ Arizona, Dept Emergency Med, POB 245057, Tucson, AZ 85724 USA; [Leetch, Aaron N.; Wilson, Bryan] Univ Arizona, Dept Pediat, POB 245057, Tucson, AZ 85724 USA		Leetch, AN (corresponding author), Univ Arizona, Dept Emergency Med, POB 245057, Tucson, AZ 85724 USA.	aleetch@aemrc.arizona.edu					Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Adams H, 2016, NEUROSURG CLIN N AM, V27, P519, DOI 10.1016/j.nec.2016.05.007; Adelson P, 2003, PEDIATR CRIT CARE ME, V4, P1; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Agbeko RS, 2012, PEDIATR CRIT CARE ME, V13, pE39, DOI 10.1097/PCC.0b013e31820ac2ad; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; American Academy of Pediatrics ACoEP, 2012, APLS PED EM MED RES; American Heart Association, 2017, PEDIAT ADV LIFE SUPP, V1st; Atwal GS, 1998, FORENSIC SCI INT, V96, P215, DOI 10.1016/S0379-0738(98)00126-1; Atzema C, 2002, ACAD EMERG MED, V9, P451; Babbitt CJ, 2013, PEDIATR EMERG CARE, V29, P279, DOI 10.1097/PEC.0b013e3182850409; Bao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090956; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Bray RJ, 1998, PAEDIATR ANAESTH, V8, P491; Brenkert TE, 2013, PEDIATR EMERG CARE, V29, P71, DOI 10.1097/PEC.0b013e31827b54c3; BRUCE DA, 1979, CHILD BRAIN, V5, P174; CAFFEY J, 1974, PEDIATRICS, V54, P396; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang WTW, 2014, EMERG MED CLIN N AM, V32, P889, DOI 10.1016/j.emc.2014.07.008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; Cook TM, 1998, BRIT J ANAESTH, V81, P338, DOI 10.1093/bja/81.3.338; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Crompton EM, 2017, CRIT CARE MED, V45, P575, DOI 10.1097/CCM.0000000000002205; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Dieckmann RA, 2010, PEDIATR EMERG CARE, V26, P312, DOI 10.1097/PEC.0b013e3181d6db37; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Esposito TJ, 2005, J TRAUMA, V59, P1314, DOI 10.1097/01.ta.0000198375.83830.62; Gaither JB, 2017, PREHOSP EMERG CARE, V21, P575, DOI 10.1080/10903127.2017.1308609; Gardner A, 1973, SURY ANESTHESIOL, V17, P320; GIBBS JM, 1972, BRIT J ANAESTH, V44, P1298, DOI 10.1093/bja/44.12.1298; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kenefake ME, 2013, EMERG MED CLIN N AM, V31, P627, DOI 10.1016/j.emc.2013.04.004; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lazoritz S, 1997, CHILD ABUSE NEGLECT, V21, P1009, DOI 10.1016/S0145-2134(97)00061-6; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MERTEN DF, 1984, PEDIATR RADIOL, V14, P272, DOI 10.1007/BF01601874; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murphy S, 2017, J NEUROTRAUMA; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Patanwala AE, 2016, PHARMACOTHERAPY, V36, P57, DOI 10.1002/phar.1683; PATEL R, 1994, CAN J ANAESTH, V41, P771, DOI 10.1007/BF03011582; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Pouraghaei Mahboob, 2014, Anesth Pain Med, V4, pe14618, DOI 10.5812/aapm.14618; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Sakles JC, 2016, INTERN EMERG MED, V11, P983, DOI 10.1007/s11739-016-1396-8; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; SHAPIRO HM, 1972, BRIT J ANAESTH, V44, P1200, DOI 10.1093/bja/44.11.1200; Shein SL, 2016, PEDIATR CRIT CARE ME, V17, P236, DOI 10.1097/PCC.0000000000000610; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Stiell I.G., 2000, ACAD EMERG MED, V7, P572; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; WALLS RM, 1993, ANN EMERG MED, V22, P1008, DOI 10.1016/S0196-0644(05)82743-X; Welch TP, 2016, CRIT CARE MED, V44, P809, DOI 10.1097/CCM.0000000000001558; Wing R, 2013, EMERG MED CLIN N AM, V31, P653, DOI 10.1016/j.emc.2013.05.007; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	91	4	5	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	MAY	2018	36	2					459	+		10.1016/j.emc.2017.12.012			15	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GE3EW	WOS:000431097600014	29622334				2022-02-06	
J	Ongun, EA; Dursun, O				Ongun, Ebru Atike; Dursun, Oguz			Prediction of mortality in pediatric traumatic brain injury: Implementations from a tertiary pediatric intensive care facility	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Brain edema therapy; children; mortality; pediatric critical care; Rotterdam-CT score; traumatic brain injury	HEAD COMPUTED-TOMOGRAPHY; INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; ORGAN DONATION; CHILDREN; TRACHEOSTOMY; THERAPY; CT; CLASSIFICATION; HYPERTENSION	BACKGROUND: To explore the mortality risk factors of traumatic brain injury in pediatric intensive care unit admissions. METHODS: Eighty-eight children (categorized using the Glasgow Coma Scale) between September 2014 and December 2016 were analyzed. Emergency department and intensive care course, treatment strategies, axonal injury, intubation and tracheostomy rates, length of intensive care and hospitalization, Rotterdam-CT scores, injury severity scores, and PRISM-Ill scores were recorded. RESULTS: Older age was associated with trauma severity (p=0.010). Target serum osmolality was reached at 8.5 (3.5-40) hours in patients undergoing anti-edema therapy. ICP-monitoring rates was 8%; in absence of ICP-monitorization clinical follow-up was performed through repeated brain tomographies. Axonal injury was associated with prolonged intubation, intensive care and hospital stay (p<0.001, p<0.00 I , p=0.030). Six children required tracheostomy at 14.33 +/- 1.03 days; decannulations were performed within 6 months in five children. CONCLUSION: Mortality rate was 12.5%; six patients progressed to brain death with organ donor approvals in five. Initial hypotension, lung contusion, injury severity scores and Rotterdam-CT scores were related with mortality. Rotterdam-CT score was determined as the independent risk factor for mortality; one increment in the score increased the odd of recovery by 20.334 times (%95 CI 1.999-206.879). ISS score was also borderline significant (p=0.052; OR:1.195 %95 CI 0.999-1.430).	[Ongun, Ebru Atike; Dursun, Oguz] Akdeniz Univ, Fac Med, Dept Pediat Crit Care, Antalya, Turkey		Ongun, EA (corresponding author), Univ Hastanesi, A2 Blok,1 Kat Konyaalti, TR-07070 Antalya, Turkey.	ebruongun@akdeniz.edu.tr	Dursun, Oguz/L-6205-2019; ongun, ebru atike/L-5719-2015; temel, Ebru/AAF-4980-2020; dursun, oguz/C-1604-2016	Dursun, Oguz/0000-0001-5482-3780; ongun, ebru atike/0000-0002-1248-8635; dursun, oguz/0000-0001-5482-3780			Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Centers for Disease Control and Prevention, 2015, WISCARS LEAD CAUS DE, P1999; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Dursun O, 2011, PEDIATR INT, V53, P202, DOI 10.1111/j.1442-200X.2010.03208.x; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Gencpinar P, 2015, TURKIYE KLINIKLERI J, V35, P60; Gomez MP, 2012, TRANSPL P, V44, P1592, DOI 10.1016/j.transproceed.2012.04.005; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Gunduz RC, 2014, TURKISH J PEDIATR, V56, P597; Hardcastle N, 2014, PEDIATR ANESTH, V24, P703, DOI 10.1111/pan.12415; Hill EP, 2017, J TRAUMA ACUTE CARE, V82, P896, DOI 10.1097/TA.0000000000001406; Holscher CM, 2014, J PEDIATR SURG, V49, P590, DOI 10.1016/j.jpedsurg.2013.09.002; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Khalili H, 2017, WORLD NEUROSURG, V103, P88, DOI 10.1016/j.wneu.2017.02.060; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Li Q, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0119-4; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maguigan KL, 2017, J CLIN NEUROSCI, V39, P147, DOI 10.1016/j.jocn.2017.01.025; Mtaweh H, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0348-3; Neff LP, 2015, J TRAUMA ACUTE CARE, V78, P22, DOI 10.1097/TA.0000000000000488; Ozturk NY, 2016, J PEDIAT EMERG INTEN, V3, P11; Picetti E, 2017, ACTA NEUROCHIR, V159, P615, DOI 10.1007/s00701-017-3118-z; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schonfeld D, 2015, POSTGRAD MED J, V91, P634, DOI 10.1136/postgradmedj-2013-305004rep; Shein SL, 2016, PEDIATR CRIT CARE ME, V17, P236, DOI 10.1097/PCC.0000000000000610; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Su E, 2016, TRANSLATIONAL RES TR; Tasker RC, 2011, BRIT J NEUROSURG, V25, P68, DOI 10.3109/02688697.2010.538770; Turkish Statistics Institution (TUIK), 2016, IST COC IST COC; Turkish Transplant Foundation, 2013, DON ACT TURK	40	4	4	1	3	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAY	2018	24	3					199	206		10.5505/tjtes.2017.37906			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GG8YA	WOS:000432984700003	29786813	Bronze			2022-02-06	
J	Penttila, N; Korpijaakko-Huuhka, AM; Kent, RD				Penttila, Nelly; Korpijaakko-Huuhka, Anna-Maija; Kent, Ray D.			Auditory-Perceptual Assessment of Fluency in Typical and Neurologically Disordered Speech	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							HIGHLY EXPERIENCED JUDGES; DYSARTHRIC SPEECH; STUTTERING RESEARCH; VOICE QUALITY; MOTOR CONTROL; BRAIN-INJURY; APRAXIA; DISFLUENCY; APHASIA; JUDGMENTS	Purpose: The aim of this study is to investigate how speech fluency in typical and atypical speech is perceptually assessed by speech-language pathologists (SLPs). Our research questions were as follows: (a) How do SLPs rate fluency in speakers with and without neurological communication disorders? (b) Do they differentiate the speaker groups? and (c) What features do they hear impairing speech fluency? Method: Ten SLPs specialized in neurological communication disorders volunteered as expert judges to rate 90 narrative speech samples on a Visual Analogue Scale (see Kempster, Gerratt, Verdolini Abbott, Barkmeier-Kraemer, & Hillman, 2009; p. 127). The samples-randomly mixed-were from 70 neurologically healthy speakers (the control group) and 20 speakers with traumatic brain injury, 10 of whom had neurogenic stuttering (designated as Clinical Groups A and B). Results: The fluency rates were higher for typical speakers than for speakers with traumatic brain injury; however, the agreement among the judges was higher for atypical fluency. Auditory-perceptual assessment of fluency was significantly impaired by the features of stuttering and something else but not by speech rate. Stuttering was also perceived in speakers not diagnosed as stutterers. A borderline between typical and atypical fluency was found. Conclusions: Speech fluency is a multifaceted phenomenon, and on the basis of this study, we suggest a more general approach to fluency and its deviations that will take into account, in addition to the motor and linguistic aspects of fluency, the metalinguistic component of expression as well. The results of this study indicate a need for further studies on the precise nature of borderline fluency and its different disfluencies.	[Penttila, Nelly; Korpijaakko-Huuhka, Anna-Maija] Univ Tampere, Fac Social Sci, Tampere, Finland; [Kent, Ray D.] Univ Wisconsin, Waisman Ctr, Madison, WI 53706 USA		Penttila, N (corresponding author), Univ Tampere, Fac Social Sci, Tampere, Finland.	nelly.penttila@uta.fi	Kent, Raymond D/AAI-1928-2020	Penttila, Nelly/0000-0002-6086-2310	Emil Aaltonen Foundation [25.4.2016 / 20 025e]	This research was supported by a grant from the Emil Aaltonen Foundation (25.4.2016 / 20 025e), awarded to Nelly Tenttila. The authors thank all the participants who volunteered their time for recording the speech samples and for acting as evaluators in the study. The authors would also like to gratefully acknowledge the statistician Juho Luoma for his advice on the statistical designs of this study.	Ambrose NG, 1999, J SPEECH LANG HEAR R, V42, P895, DOI 10.1044/jslhr.4204.895; Bailey DJ, 2017, AM J SPEECH-LANG PAT, V26, P641, DOI 10.1044/2017_AJSLP-16-0108; Bainbridge LA, 2015, J SPEECH LANG HEAR R, V58, P278, DOI 10.1044/2015_JSLHR-S-14-0200; Basso A, 2003, APHASIA ITS THERAPY; BELLAIRE K, 1986, J COMMUN DISORD, V19, P271, DOI 10.1016/0021-9924(86)90033-X; Benson D. F., 1967, CORTEX MILANO, V3, P373, DOI DOI 10.1016/S0010-9452(67)80025-X; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Boersma P, 2005, PRAAT DOING PHONETIC; Bortfeld H, 2001, LANG SPEECH, V44, P123, DOI 10.1177/00238309010440020101; Bothe AK, 2008, J SPEECH LANG HEAR R, V51, P867, DOI 10.1044/1092-4388(2008/063); Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Brundage SB, 2006, J FLUENCY DISORD, V31, P271, DOI 10.1016/j.jfludis.2006.07.002; Campbell J. H., 1994, SYSTEMATIC DISFLUENC; Cannito MP, 1997, J SPEECH LANG HEAR R, V40, P627, DOI 10.1044/jslhr.4003.627; CANTER GJ, 1971, BRIT J DISORD COMMUN, V6, P139; Chan KMK, 2002, J SPEECH LANG HEAR R, V45, P111, DOI 10.1044/1092-4388(2002/009); Conture E. G., 1990, ASHA REPORTS, V18, P2; CORDES AK, 1995, J SPEECH HEAR RES, V38, P33, DOI 10.1044/jshr.3801.33; COSTELLO AD, 1989, CORTEX, V25, P103; Cucchiarini C, 2000, J ACOUST SOC AM, V107, P989, DOI 10.1121/1.428279; Dagenais PA, 1999, J MED SPEECH-LANG PA, V7, P91; de Jong NH, 2009, BEHAV RES METHODS, V41, P385, DOI 10.3758/BRM.41.2.385; Deger K, 2002, J PHONETICS, V30, P321, DOI 10.1006/jpho.2001.0163; Derwing TM, 2004, LANG LEARN, V54, P655, DOI 10.1111/j.1467-9922.2004.00282.x; Duffy, 2005, MOTOR SPEECH DISORDE; Eadie T, 2011, J VOICE, V25, P420, DOI 10.1016/j.jvoice.2009.12.009; FEYEREISEN P, 1986, J CLIN EXP NEUROPSYC, V8, P393, DOI 10.1080/01688638608401329; Finn P, 1997, J SPEECH LANG HEAR R, V40, P867, DOI 10.1044/jslhr.4004.867; GERRATT BR, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P77; Goodglass H, 1983, ASSESSMENT APHASIA R; Gordon JK, 2006, APHASIOLOGY, V20, P188, DOI 10.1080/02687030500472777; Gordon JK, 1998, APHASIOLOGY, V12, P673, DOI 10.1080/02687039808249565; Green JR, 2004, J MED SPEECH-LANG PA, V12, P149; GREGORY HH, 1993, J FLUENCY DISORD, V18, P389, DOI 10.1016/0094-730X(93)90017-X; Guenther F., 2006, SPEECH PRODUCTION MO, P27; Guitar B., 2006, STUTTERING INTEGRATE, V3rd; Haley KL, 2012, J SPEECH LANG HEAR R, V55, pS1502, DOI 10.1044/1092-4388(2012/11-0318); Harmon TG, 2016, APHASIOLOGY, V30, P922, DOI 10.1080/02687038.2015.1077925; Hoffman L, 2014, INT J SPEECH-LANG PA, V16, P317, DOI 10.3109/17549507.2014.898097; Jacks A, 2015, J SPEECH LANG HEAR R, V58, P1670, DOI 10.1044/2015_JSLHR-S-14-0277; JOHNS DF, 1970, J SPEECH HEAR RES, V13, P556, DOI 10.1044/jshr.1303.556; Kempster GB, 2009, AM J SPEECH-LANG PAT, V18, P124, DOI 10.1044/1058-0360(2008/08-0017); Kent R. D., 1996, AM J SPEECH LANGUAGE, V5, P7, DOI [10.1044/1058-0360.0503.07, DOI 10.1044/1058-0360.0503.07]; Kent RD, 2000, J COMMUN DISORD, V33, P391, DOI 10.1016/S0021-9924(00)00023-X; Kerschensteiner M, 1972, Cortex, V8, P233; Korpijaakko-Huuhka A.-M., 1994, P 3 C INT CLIN PHON, P91; Korpijaakko-Huuhka AM, 2012, J INTERACT RES COM D, V3, P47, DOI 10.1558/jircd.v3i1.47; KREIMAN J, 1990, J SPEECH HEAR RES, V33, P103, DOI 10.1044/jshr.3301.103; KREIMAN J, 1993, J SPEECH HEAR RES, V36, P21, DOI 10.1044/jshr.3601.21; KREINDLER A, 1980, BRAIN LANG, V9, P199, DOI 10.1016/0093-934X(80)90140-6; Krishnan G, 2013, J NEUROLINGUIST, V26, P252, DOI 10.1016/j.jneuroling.2012.09.001; Laine M., 1997, BOSTONIN NIMENTATEST; Lehtonen J., 1976, AFINLAN VUOSIKIRJA, V8, P53; LENNON P, 1990, LANG LEARN, V40, P387, DOI 10.1111/j.1467-1770.1990.tb00669.x; LOVE LR, 1971, J SPEECH HEAR RES, V14, P229, DOI 10.1044/jshr.1402.229; Lundgren K, 2010, J NEUROLINGUIST, V23, P447, DOI 10.1016/j.jneuroling.2009.08.008; Lundie M, 2014, S AFR J COMMUN DISOR, V61, DOI 10.4102/sajcd.v61i1.64; Luria A.R., 1973, WORKING BRAIN; MAZZUCCHI A, 1981, BRIT J DISORD COMMUN, V16, P19; McCauley R, 1989, J SPEECH LANGUAGE PA, V13, P29; McNeil M., 2011, APHASIA RELATED NEUR, P27; MEYERS SC, 1986, J FLUENCY DISORD, V11, P293, DOI 10.1016/0094-730X(86)90017-3; MOSSHOLDER KW, 1995, J MANAGE, V21, P335, DOI 10.1016/0149-2063(95)90061-6; Myers FL, 2012, J FLUENCY DISORD, V37, P9, DOI 10.1016/j.jfludis.2011.10.001; Nicolosi L., 1987, TERMINOLOGY COMMUNIC; Park H, 2011, APHASIOLOGY, V25, P998, DOI 10.1080/02687038.2011.570770; Pietila M.-L, 2005, W APHASIA BATTERY; QUESAL RW, 1988, J SPEECH HEAR DISORD, V53, P349, DOI 10.1044/jshd.5303.349; Rohrer JD, 2010, NEUROLOGY, V75, P603, DOI 10.1212/WNL.0b013e3181ed9c6b; Rosen K, 2010, CLIN LINGUIST PHONET, V24, P141, DOI 10.3109/02699200903440983; ROSENBEK J, 1980, J FLUENCY DISORD, V5, P233, DOI 10.1016/0094-730X(80)90030-3; Segalowitz N.S., 2010, COGNITIVE BASES 2 LA; Shriberg LD, 2003, CLIN LINGUIST PHONET, V17, P575, DOI 10.1080/0269920031000138141; St Louis KO, 2004, J FLUENCY DISORD, V29, P213, DOI 10.1016/j.jfludis.2004.07.002; Susca M, 2001, J SPEECH LANG HEAR R, V44, P61, DOI 10.1044/1092-4388(2001/006); Tani T, 2011, J FLUENCY DISORD, V36, P1, DOI 10.1016/j.jfludis.2010.12.002; Togher L., 2000, BRAIN DAM B, P1; Tree JEF, 1995, J MEM LANG, V34, P709, DOI 10.1006/jmla.1995.1032; Van Borsel J, 2001, J COMMUN DISORD, V34, P385, DOI 10.1016/S0021-9924(01)00057-0; Van Borsel J., 1997, J CLIN SPEECH LANGUA, V7, P16; Van Borsel J, 2014, J NEUROLINGUIST, V27, P41, DOI 10.1016/j.jneuroling.2013.09.003; Van Lieshout PHHM, 2007, CLIN LINGUIST PHONET, V21, P159, DOI 10.1080/02699200600812331; Weismer G., 1992, INTELLIGIBILITY SPEE, P68; Xu Y., 2005, PROSODYPRO PRAAT; Yaruss J. S., 1997, CONT ISSUES COMMUNIC, V24, P33, DOI DOI 10.1044/jslhr.4102.249; YORKSTON KM, 1990, J SPEECH HEAR DISORD, V55, P550, DOI 10.1044/jshd.5503.550; YOUNG M, 1984, NATURE TREATMENT STU, P13	87	4	4	1	6	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	MAY	2018	61	5					1086	1103		10.1044/2018_JSLHR-S-17-0326			18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	GG7ML	WOS:000432882300003	29710314	Green Accepted			2022-02-06	
J	Salis, C; Murray, L; Bakas, K				Salis, Christos; Murray, Laura; Bakas, Katrina			An International Survey of Assessment Practices for Short-Term and Working Memory Deficits in Aphasia	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							SPEECH-LANGUAGE PATHOLOGISTS; TRAUMATIC BRAIN-INJURY; SENTENCE COMPREHENSION; COGNITIVE ASSESSMENT; EXECUTIVE FUNCTION; EVERYDAY LIFE; QUESTIONNAIRE; RELIABILITY; STROKE; VALIDITY	Purpose: Recent research has highlighted the clinical relevance of understanding the nature of short-term memory (STM) and working memory (WM) deficits in persons with aphasia and the way these deficits affect linguistic processing and functional communication in activities of daily living. The psychometric properties of tests commonly used to identify STM/WM problems in individuals with aphasia, however, have been questioned. No previous study has sought to investigate assessment practices and attitudes by speech-language pathologists involved in aphasia management. Accordingly, the aims of this study were (a) to investigate both attitudes toward STM/WM assessment in individuals with aphasia, as well as the types and frequency of STM/WM tests used with individuals with aphasia, and (b) to explore factors (e.g., educational background) that may influence STM/WM assessment practices. Method: Respondents recruited via professional and aphasia support organizations completed an online survey. The survey elicited information about the respondents' demographic and clinical backgrounds and STM/WM assessment clinical practices and views, including frequency and preferred use of specific STM/WM tests. Results: The majority of respondents reported regular use of STM/WM tests as part of aphasia management. Positive attitudes toward STM/WM assessments were also reported. The most popular rankings of tests were the Cognitive Linguistic Quick Test (Helm-Estabrooks, 2001), the Comprehensive Aphasia Test (Swinburn, Porter, & Howard, 2005), and the Token Test (McNeil & Prescott, 1978). Results suggested limited knowledge about measures that assess self-perceptions of functional memory abilities. Regression analyses showed that the frequency of reported STM/WM test use was similar between clinicians and dual-role researchers/clinicians, but their attitudes toward the value of STM/WM differed. U.S. and UK respondents reported similar assessment practices. Conclusions: It is reassuring that STM/WM is taken into consideration by clinicians when providing aphasia management. Two of the most popular tests, however, have poor psychometric properties, and caution should be exercised in clinical decision making. The different value placed on STM/WM testing by clinicians and researchers/clinicians has implications for continuing professional development.	[Salis, Christos] Newcastle Univ, Speech & Language Sci, King George VI Bldg,Queen Victoria Rd, Newcastle Upon Tyne, Tyne & Wear, England; [Murray, Laura] Western Univ, Elborn Coll, Sch Commun Sci & Disorders, London, ON, Canada; [Bakas, Katrina] Univ Cincinnati, Commun Sci & Disorders, Cincinnati, OH 45221 USA		Salis, C (corresponding author), Newcastle Univ, Speech & Language Sci, King George VI Bldg,Queen Victoria Rd, Newcastle Upon Tyne, Tyne & Wear, England.	christos.salis@ncl.ac.uk		Murray, Laura/0000-0002-7773-1843			Agresti A., 2007, INTRO CATEGORICAL DA, V2nd; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Baldo JV, 2012, APHASIOLOGY, V26, P338, DOI 10.1080/02687038.2011.602391; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; BERRY JM, 1989, DEV PSYCHOL, V25, P701, DOI 10.1037/0012-1649.25.5.701; Boyatzis R. E., 1998, TRANSFORMING QUALITA; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burns M., 1997, BURNS BRIEF INVENTOR; Cahana-Amitay D., 2015, REDEFINING RECOVERY; Caplan D, 2013, COGN NEUROPSYCHOL, V30, P77, DOI 10.1080/02643294.2013.803958; Code C, 2011, INT J SPEECH-LANG PA, V13, P3, DOI 10.3109/17549507.2010.520090; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; CROVITZ HF, 1979, CORTEX, V15, P131, DOI 10.1016/S0010-9452(79)80013-1; De Renzi E, 1975, Cortex, V11, P341; DeDe G, 2014, APHASIOLOGY, V28, P692, DOI 10.1080/02687038.2014.895973; Delis D.C., 2000, CALIFORNIA VERBAL LE; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Doyle PJ, 2004, J CLIN EPIDEMIOL, V57, P997, DOI 10.1016/j.jclinepi.2003.11.016; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Eling P, 2015, CORTEX, V63, P16, DOI 10.1016/j.cortex.2014.08.002; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Guo YE, 2014, DISABIL REHABIL, V36, P691, DOI 10.3109/09638288.2013.804597; Harnish SM, 2015, AM J SPEECH-LANG PAT, V24, pS880, DOI 10.1044/2015_AJSLP-14-0153; Harris L, 2014, NEUROPSYCHOL REHABIL, V24, P678, DOI 10.1080/09602011.2014.892885; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hilari K, 2003, STROKE, V34, P1944, DOI 10.1161/01.STR.0000081987.46660.ED; Howard D., 1990, NEUROPSYCHOLOGICAL I, P287, DOI DOI 10.1017/CB09780511665547.016; Huber W, 1984, Adv Neurol, V42, P291; Huber W., 1983, AACHENER APHASIE TES; Kalbe E, 2005, J CLIN EXP NEUROPSYC, V27, P779, DOI 10.1080/13803390490918273; Katz RC, 2000, INT J LANG COMM DIS, V35, P303; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Kay J., 1992, PSYCHOLINGUISTIC ASS; Keho Y., 2012, BASICS LINEAR PRINCI; Kemp, 1998, NEPSY DEV NEUROPSYCH; Kinnear P., 2008, SPSS 15 MADE SIMPLE; Klein E. R., 2007, FOCUS FUNCTION GAINI; Kroker C., 2006, APHASIE SCHNELL TEST; Lang CJG, 2012, J NEUROL, V259, P1655, DOI 10.1007/s00415-011-6394-1; Leach L., 2000, KAPLAN BAYCREST NEUR; Lehman MT, 1998, APHASIOLOGY, V12, P771, DOI 10.1080/02687039808249572; Mansbach WE, 2012, J CLIN EXP NEUROPSYC, V34, P183, DOI 10.1080/13803395.2011.630649; Martin N, 2004, BRAIN LANG, V89, P464, DOI 10.1016/j.bandl.2003.12.004; Martin Randi C., 2008, Seminars in Speech and Language, V29, P201, DOI 10.1055/s-0028-1082884; Mayer JF, 2012, J COMMUN DISORD, V45, P325, DOI 10.1016/j.jcomdis.2012.06.002; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; McNeil MR, 1978, REVISED TOKEN TEST; Meyers JE., 1995, REY COMPLEX FIGURE T; Milman L. H., 2012, SCALES COGNITIVE COM; Carrasco PM, 2012, SPAN J PSYCHOL, V15, P768, DOI 10.5209/rev_SJOP.2012.v15.n2.38888; Morgan G.A, 2010, IBM SPSS INTRO STAT; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Murray H. A, 1943, THEMATIC APPERCEPTIO; Murray L. L., 2015, NEUROGENIC DISORDERS; Murray L. L., 2016, APHASIA RELATED NEUR, P129; Murray L, 2018, NEUROPSYCHOL REHABIL, V28, P309, DOI 10.1080/09602011.2016.1174718; Murray LL, 2012, APHASIOLOGY, V26, P317, DOI 10.1080/02687038.2011.589894; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Paradis M., 1987, ASSESSMENT BILINGUAL; Pena J., 1990, PROGRAMA INTEGRADO E; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Powell T., 2013, BRAIN INJURY WORKBOO; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Randolph C., 2012, REPEATABLE BATTERY A; Rappolt Susan, 2002, J Contin Educ Health Prof, V22, P170, DOI 10.1002/chp.1340220306; Raven J., 2003, MANUAL RAVENS PROGR; Reinvang I., 1980, NORSK GRUNNTEST AFAS; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P629; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reynolds C.R., 1994, TEST MEMORY LEARNING; Richter K., 2006, BIELEFELDER APHASIE; Risse T., 2009, HNO, V57, P943; ROBSON P, 1989, PSYCHOL MED, V19, P513, DOI 10.1017/S003329170001254X; Roid GH., 2011, LEITER INT PERFORMAN; Ross-Swain D, 1986, ROSS INFORM PROCESSI; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Salis C, 2015, INT J LANG COMM DIS, V50, P721, DOI 10.1111/1460-6984.12172; Schmidt M., 1996, REY AUDITORY VERBAL; Schuell H., 1965, MINNESOTA TEST DIFFE; Schuell H., 1964, APHASIA ADULTS DIAGN; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Suleman S, 2015, APHASIOLOGY, V29, P1409, DOI 10.1080/02687038.2015.1049584; Swinburn K., 2005, COMPREHENSIVE APHASI; Tabachnik BG, 2014, USING MULTIVARIATE S; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tomoeda C., 1993, ARIZONA BATTERY COMM; Tulsky DS, 2014, J INT NEUROPSYCH SOC, V20, P599, DOI 10.1017/S135561771400040X; Vallat-Azouvi C, 2012, NEUROPSYCHOL REHABIL, V22, P634, DOI 10.1080/09602011.2012.681110; VANDERLINDEN M, 1989, ACTA NEUROL BELG, V89, P236; Visser-Keizer AC, 2002, J CLIN EXP NEUROPSYC, V24, P1032, DOI 10.1076/jcen.24.8.1032.8383; Vogel AP, 2010, J EVAL CLIN PRACT, V16, P1183, DOI 10.1111/j.1365-2753.2009.01291.x; Warrington E. K., 1996, CAMDEN MEMORY TESTS; WARRINGTON EK, 1969, BRAIN, V92, P885, DOI 10.1093/brain/92.4.885; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2000, WAIS 3 MANUEL ECHELL; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2010, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; World Health Organization, 2007, INT CLASS FUNCT DIS; Zakarias L, 2018, NEUROPSYCHOL REHABIL, V28, P369, DOI 10.1080/09602011.2016.1159579	103	4	4	1	14	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2018	27	2					574	591		10.1044/2017_AJSLP-17-0057			18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	GI1UE	WOS:000434155300005	29466549	Green Submitted			2022-02-06	
J	Schober, ME; Requena, DF; Rodesch, CK				Schober, Michelle E.; Requena, Daniela F.; Rodesch, Christopher K.			EPO improved neurologic outcome in rat pups late after traumatic brain injury	BRAIN & DEVELOPMENT			English	Article						Controlled cortical impact; Erythropoietin; Developmental; Apoptosis; Neurocognitive impairment	RECOMBINANT-HUMAN-ERYTHROPOIETIN; FUNCTIONAL RECOVERY; OBJECT RECOGNITION; COGNITIVE FUNCTION; CLINICAL-TRIAL; DOUBLE-BLIND; MEMORY; TERM; CHILDREN; VOLUME	In adult rats, erythropoietin improved outcomes early and late after traumatic brain injury, associated with increased levels of Brain Derived Neurotrophic Factor. Using our model of pediatric traumatic brain injury, controlled cortical impact in 17-day old rats, we previously showed that erythropoietin increased hippocampal neuronal fraction in the first two days after injury. Erythropoietin also decreased activation of caspase3, an apoptotic enzyme modulated by Brain Derived Neurotrophic Factor, and improved Novel Object Recognition testing 14 days after injury. Data on long-term effects of erythropoietin on Brain Derived Neurotrophic Factor expression, histology and cognitive function after developmental traumatic brain injury are lacking. We hypothesized that erythropoietin would increase Brain Derived Neurotrophic Factor and improve long-term object recognition in rat pups after controlled cortical impact, associated with increased neuronal fraction in the hippocampus. Methods: Rats pups received erythropoietin or vehicle at 1, 24, and 48 h and 7 days after injury or sham surgery followed by histology at 35 days, Novel Object Recognition testing at adulthood, and Brain Derived Neurotrophic Factor measurements early and late after injury. Results: Erythropoietin improved Novel Object Recognition performance and preserved hippocampal volume, but not neuronal fraction, late after injury. Conclusions: Improved object recognition in erythropoietin treated rats was associated with preserved hippocampal volume late after traumatic brain injury. Erythropoietin is approved to treat various pediatric conditions. Coupled with exciting experimental and clinical studies suggesting it is beneficial after neonatal hypoxic ischemic brain injury, our preliminary findings support further study of erythropoietin use after developmental traumatic brain injury. (C) 2018 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Schober, Michelle E.; Requena, Daniela F.] Univ Utah, Dept Pediat, Div Crit Care, Salt Lake City, UT 84132 USA; [Rodesch, Christopher K.] Univ Utah, Core Facil, Salt Lake City, UT 84132 USA; [Rodesch, Christopher K.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA		Schober, ME (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Crit Care, POB 581289, Salt Lake City, UT 84158 USA.	michelle.schober@hsc.utah.edu			CHRCDA (NIH) [K 12HD001410]; Divisions of Neonatology and Pediatric Critical Care Medicine, Department of Pediatrics, University of Utah, Salt Lake City UT; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001410] Funding Source: NIH RePORTER	Funding for this study provided by the CHRCDA (NIH K 12HD001410) and from the Divisions of Neonatology and Pediatric Critical Care Medicine, Department of Pediatrics, University of Utah, Salt Lake City UT.	Alnaceli M, 2012, ANAT RES INT, V7012; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Dame C, 2001, BIOL NEONATE, V79, P228; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dzietko M, 2004, NEUROBIOL DIS, V15, P177, DOI 10.1016/j.nbd.2003.10.006; Gonzalez FF, 2009, DEV NEUROSCI-BASEL, V31, P403, DOI 10.1159/000232558; Juul SE, 2015, CLIN PERINATOL, V42, P469, DOI 10.1016/j.clp.2015.04.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Lieutaud T, 2008, J NEUROTRAUM, V25, P1179, DOI 10.1089/neu.2008.0591; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Marvizon JCG, 2007, NEUROSCIENCE, V148, P250, DOI 10.1016/j.neuroscience.2007.05.036; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Mulkey SB, 2017, J PEDIATR-US, V186, P196, DOI 10.1016/j.jpeds.2017.03.053; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Osborne AL, 2017, NEUROPSYCHOPHARMACOL, V42, P1447, DOI 10.1038/npp.2017.40; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Paxinos G, RAT BRAIN STEREOTAXI; Pierce DR, 2011, BRAIN RES, V1378, P54, DOI 10.1016/j.brainres.2011.01.028; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Robinson S, 2016, J NEUROSURG-PEDIATR, V17, P739, DOI 10.3171/2015.10.PEDS15554; Schober ME, 2014, J NEUROTRAUM, V31, P358, DOI 10.1089/neu.2013.2922; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sola A, 2005, PEDIATR RES, V57, p110R, DOI 10.1203/01.PDR.0000159571.50758.39; Statler PA, 2007, PEDIATR RES, V61, P671, DOI 10.1203/pdr.0b013e31805341dc; van de Looij Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095643; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Wu YW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0191; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zagrebelsky M, 2014, NEUROPHARMACOLOGY, V76, P628, DOI 10.1016/j.neuropharm.2013.05.029; Zhang J, 2014, J CLIN NEUROSCI, V21, P1283, DOI 10.1016/j.jocn.2013.10.040; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	42	4	5	3	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	MAY	2018	40	5					367	375		10.1016/j.braindev.2018.01.003			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	GF8OW	WOS:000432233200001	29429559	Green Accepted			2022-02-06	
J	Slatore, CG; Falvo, MJ; Nugent, S; Carlson, K				Slatore, Christopher G.; Falvo, Michael J.; Nugent, Shannon; Carlson, Kathleen			Afghanistan and Iraq War Veterans: Mental Health Diagnoses are Associated with Respiratory Disease Diagnoses	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; US MILITARY PERSONNEL; OBSTRUCTIVE PULMONARY-DISEASE; COGNITIVE-BEHAVIORAL THERAPY; REPORTED PHYSICAL HEALTH; TRAUMATIC BRAIN-INJURY; RETROSPECTIVE COHORT; DEPRESSIVE SYMPTOMS; LUNG-DISEASE; DEPLOYMENT	Introduction: Many veterans of the wars in Afghanistan and Iraq have concomitant respiratory conditions and mental health conditions. We wanted to evaluate the association of mental health diagnoses with respiratory disease diagnoses among post-deployment veterans. Methods: We conducted a retrospective cohort study of all Afghanistan and Iraq War veterans who were discharged from the military or otherwise became eligible to receive Veterans Health Administration services. The primary exposure was receipt of a mental health diagnosis and the primary outcome was receipt of a respiratory diagnosis as recorded in the electronic health record. We used multivariable adjusted logistic regression to measure the associations of mental health diagnoses with respiratory diagnoses and conducted several analyses exploring the timing of the diagnoses. Results: Among 182,338 post-deployment veterans, 14% were diagnosed with a respiratory condition, 77% of whom had a concomitant mental health diagnosis. The incidence rates were 5,363/100,000 person-years (p-y), 587/100,000 p-y, 1,450/100,000 p-y, and 233/100,000 p-y for any respiratory disease diagnosis, bronchitis, asthma, and chronic obstructive lung disease diagnoses, respectively, after the date of first Veterans Health Administration utilization. Any mental health diagnosis was associated with increased odds for any respiratory diagnosis (adjusted odds ratio 1.41, 95% confidence interval 1.37-1.46). The association of mental health diagnoses and subsequent respiratory disease diagnoses was stronger and more consistent than the converse. Conclusion: Many Afghanistan and Iraq War veterans are diagnosed with both respiratory and mental illnesses. Comprehensive plans that include care coordination with mental health professionals and treatments for mental illnesses may be important for many veterans with respiratory diseases.	[Slatore, Christopher G.; Nugent, Shannon; Carlson, Kathleen] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, R&D 66,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Slatore, Christopher G.] VA Portland Hlth Care Syst, Sect Pulm & Crit Care Med, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Slatore, Christopher G.] Oregon Hlth & Sci Univ, Dept Med, Div Pulm & Crit Care Med, OHSU Div Pulm & Crit Care Med, 3181 SW Sam Jackson Pk Rd,Mail Code UHN6, Portland, OR 97239 USA; [Falvo, Michael J.] Vet Affairs New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, Dept Vet Affairs, 385 Tremont Ave,Mail Stop 129, East Orange, NJ 07018 USA; [Falvo, Michael J.] State Univ New Jersey, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Stanley S Bergen Bldg,65 Bergen St, Newark, NJ 07103 USA; [Carlson, Kathleen] Oregon Hlth & Sci Univ, Sch Publ Hlth, 3181 SW Sam Jackson Pk Rd,MC GH230, Portland, OR 97239 USA		Slatore, CG (corresponding author), VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, R&D 66,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.; Slatore, CG (corresponding author), VA Portland Hlth Care Syst, Sect Pulm & Crit Care Med, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.; Slatore, CG (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Pulm & Crit Care Med, OHSU Div Pulm & Crit Care Med, 3181 SW Sam Jackson Pk Rd,Mail Code UHN6, Portland, OR 97239 USA.			Falvo, Michael/0000-0001-9348-6676	VA HSR&D Career Development Awards [CDA 09-025, CDP 11-227, CDA 08-025]	This study was supported by VA HSR&D Career Development Awards to Dr. Slatore (CDA 09-025 and CDP 11-227) and Dr. Carlson (CDA 08-025). It was also supported by resources from the VA Portland Health Care System, Portland, Oregon. The Department of Veterans Affairs did not have a role in the conduct of the study, in the collection, management, analysis, interpretation of data, or in the preparation of the manuscript.	Abraham Joseph H, 2014, US Army Med Dep J, P33; Abraham JH, 2014, MIL MED, V179, P540, DOI 10.7205/MILMED-D-13-00443; Abraham JH, 2012, J OCCUP ENVIRON MED, V54, P740, DOI 10.1097/JOM.0b013e318252969a; Andersen BL, 2008, CANCER-AM CANCER SOC, V113, P3450, DOI 10.1002/cncr.23969; Baird Coleen P, 2011, US Army Med Dep J, P80; Barrett DH, 2002, PSYCHOSOMATICS, V43, P195, DOI 10.1176/appi.psy.43.3.195; BORSON S, 1992, PSYCHOSOMATICS, V33, P190, DOI 10.1016/S0033-3182(92)71995-1; Carlson KF, 2016, NEUROREHABILITATION, V39, P351, DOI 10.3233/NRE-161367; Carroll D, 2011, PSYCHOSOM MED, V73, P716, DOI 10.1097/PSY.0b013e31822ff9e8; Coventry PA, 2008, BRIT J HEALTH PSYCH, V13, P381, DOI 10.1348/135910707X203723; DelVecchio SP, 2015, J ASTHMA, V52, P363, DOI 10.3109/02770903.2014.973502; Eagan TML, 2005, INT J TUBERC LUNG D, V9, P603; Edmondson D, 2013, AM HEART J, V166, P806, DOI 10.1016/j.ahj.2013.07.031; Eisner MD, 2010, THORAX, V65, P229, DOI 10.1136/thx.2009.126201; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2015, AN VA HLTH CAR UT OP; Falvo MJ, 2016, J OCCUP ENVIRON MED, V58, P325, DOI 10.1097/JOM.0000000000000675; Galovski TE, 2009, J TRAUMA STRESS, V22, P197, DOI 10.1002/jts.20418; Guglani L, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-45; Harrison SL, 2016, PATIENT EDUC COUNS, V99, P348, DOI 10.1016/j.pec.2015.10.013; IOM (Institute of Medicine), 2011, LONG TERM HLTH CONS; Jeon Y, 2016, AM J RESP CRITICAL C; Katz PP, 2010, PRIM CARE RESP J, V19, P223, DOI 10.4104/pcrj.2010.00012; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb; King MS, 2011, NEW ENGL J MED, V365, P222, DOI 10.1056/NEJMoa1101388; Kunik ME, 2005, CHEST, V127, P1205, DOI 10.1378/chest.127.4.1205; Lavoie KL, 2006, CHEST, V130, P1039, DOI 10.1378/chest.130.4.1039; Luft BJ, 2012, PSYCHOL MED, V42, P1069, DOI 10.1017/S003329171100256X; Maurer J, 2008, CHEST, V134, p43S, DOI 10.1378/chest.08-0342; Morris MJ, 2014, AM J RESP CRIT CARE, V190, P77, DOI 10.1164/rccm.201402-0372OC; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Patten SB, 1999, CAN J PSYCHIAT, V44, P151, DOI 10.1177/070674379904400205; Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9; Pugh MJ, 2016, MIL MED, V181, P476, DOI 10.7205/MILMED-D-15-00035; Roop SA, 2007, MIL MED, V172, P1264, DOI 10.7205/MILMED.172.12.1264; Rose C, 2012, J OCCUP ENVIRON MED, V54, P746, DOI 10.1097/JOM.0b013e31825297ba; Rosenberg SL, 2014, J ALLERGY CLIN IMMUN, V134, P1009, DOI 10.1016/j.jaci.2014.07.005; Schmitz N, 2007, PSYCHOSOM MED, V69, P332, DOI 10.1097/PSY.0b013e31804259e0; Schnurr P P, 1999, Semin Clin Neuropsychiatry, V4, P295; Schnurr PP, 1999, J NERV MENT DIS, V187, P353, DOI 10.1097/00005053-199906000-00004; Schnurr PP, 2000, J NERV MENT DIS, V188, P496, DOI 10.1097/00005053-200008000-00004; Scott KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080573; Sharkey JM, 2016, MIL MED, V181, P265, DOI 10.7205/MILMED-D-14-00690; Shorr AF, 2004, JAMA-J AM MED ASSOC, V292, P2997, DOI 10.1001/jama.292.24.2997; Slatore CG, 2013, AM J RESP CRIT CARE, V188, P1147, DOI 10.1164/rccm.201309-1656ST; Smith B, 2012, J OCCUP ENVIRON MED, V54, P708, DOI 10.1097/JOM.0b013e31825107f9; Smith B, 2009, AM J EPIDEMIOL, V170, P1433, DOI 10.1093/aje/kwp287; Szema Anthony M, 2013, Occup Med Health Aff, V1, DOI 10.4172/2329-6879.1000117; Szema AM, 2011, J OCCUP ENVIRON MED, V53, P961, DOI 10.1097/JOM.0b013e31822c9f05; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thornton LM, 2009, PSYCHOSOM MED, V71, P715, DOI 10.1097/PSY.0b013e3181b0545c; Usmani ZA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008483.pub2; Zhang MWB, 2011, GEN HOSP PSYCHIAT, V33, P217, DOI 10.1016/j.genhosppsych.2011.03.009	52	4	4	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2018	183	5-6					E249	E257		10.1093/milmed/usx108			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF9BQ	WOS:000432271500017	29420832	Bronze			2022-02-06	
J	Thiara, S; Griesdale, DE; Henderson, WR; Sekhon, MS				Thiara, Sonny; Griesdale, Donald E.; Henderson, William R.; Sekhon, Mypinder S.			Effect of Cerebral Perfusion Pressure on Acute Respiratory Distress Syndrome	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Acute respiratory distress syndrome; Cerebral perfusion pressure; Neuromonitoring; Driving pressure	TRAUMATIC BRAIN-INJURY; END-EXPIRATORY PRESSURE; SEVERE HEAD-INJURY; ACUTE LUNG INJURY; INTRACRANIAL-PRESSURE; NEUROCRITICAL CARE; BERLIN DEFINITION; REACTIVITY; MANAGEMENT; PEEP	Background: Increased cerebral perfusion pressure (CPP) > 70 mmHg has been associated with acute respiratory distress syndrome (ARDS) after traumatic brain injury (TBI). Since this reported association, significant changes in ventilation strategies and fluid management have been accepted as routine critical care. Recently, individualized perfusion targets using autoregulation monitoring suggest CPP titration > 70 mmHg. Given these clinical advances, the association between ARDS and increased CPP requires further delineation. Objective: To determine the association between ARDS and increased CPP after TBI. Methods: We conducted a single-center historical cohort study investigating the association of increased CPP and ARDS after TBI. We collected demographic data and physiologic data for CPP, intracranial pressure, mechanical ventilation, cumulative fluid balance and delta/driving pressure (Delta P). We collected outcomes measures pertaining to duration of ventilation, intensive care unit admission length, hospitalization length and 6-month neurological outcome. Results: In total, 113 patients with severe TBI and multimodal neuromonitoring were included. In total, 16 patients (14%) developed ARDS according to the Berlin definition. There was no difference in the mean CPP during the first 7 days of admission between patients who developed ARDS (74 mmHg SD 18 vs. 73 mmHg SD 18, p= 0.86) versus those who did not. Patients who developed ARDS had a higher Delta P (15 mmHg [5] vs. 12 mmHg [4], p= 0.016) and lower lung compliance (35 ml/cmH(2)O [10] vs. 49 ml/cmH(2)O [18], p = 0.024) versus those who did not. Conclusion: We did not observe an association between increased CPP and ARDS. Patients with ARDS had higher Delta P and lower lung compliance.	[Thiara, Sonny; Griesdale, Donald E.; Sekhon, Mypinder S.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Griesdale, Donald E.] Univ British Columbia, Vancouver Gen Hosp, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Griesdale, Donald E.] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Henderson, William R.] Univ British Columbia, Vancouver Gen Hosp, Dept Emergency Med, Div Crit Care Med, Vancouver, BC, Canada		Sekhon, MS (corresponding author), Vancouver Gen Hosp, Crit Care Med, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada.	mypindersekhon@gmail.com					Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; BURCHIEL KJ, 1981, NEUROSURGERY, V8, P443, DOI 10.1227/00006123-198104000-00007; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Go SL, 2013, CRIT CARE, V17, DOI 10.1186/cc11389; Guerin C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1556-2; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Meng LZ, 2015, ANESTHESIOLOGY, V122, P196, DOI 10.1097/ALN.0000000000000506; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Sekhon MS, 2017, CAN J NEUROL SCI, V44, P350, DOI 10.1017/cjn.2017.25; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; Smielewski P, 2012, EUR J ANAESTH, V29, pA34; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Tejerina E, 2017, J CRIT CARE, V38, P341, DOI 10.1016/j.jcrc.2016.11.010; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Videtta W, 2002, ACT NEUR S, V81, P93	31	4	4	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2018	45	3					313	319		10.1017/cjn.2017.292			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF8MQ	WOS:000432227200010	29455690	Bronze			2022-02-06	
J	Ziaeirad, M; Alimohammadi, N; Irajpour, A; Aminmansour, B				Ziaeirad, Marzieh; Alimohammadi, Nasrollah; Irajpour, Alireza; Aminmansour, Bahram			Association between Outcome of Severe Traumatic Brain Injury and Demographic, Clinical, Injury-related Variables of Patients	IRANIAN JOURNAL OF NURSING AND MIDWIFERY RESEARCH			English	Article						Head trauma; Iran; patients; traumatic brain injury		Background: Traumatic brain injury (TBI) is a main health problem among communities. There exists a variety of effective factors on the outcome of patients with TBI. We describe the demographic, clinical, and injury related variables of the patients with severe TBI, and determine the predictors of outcome. Materials and Methods: We did this cross-sectional study on all 267 adult patients with severe TBI admitted to three trauma centers of Isfahan University of Medical Sciences (IUMS) from March 20, 2014 to March 19, 2015. Data were extracted from patients' profiles. We considered the patients' outcome as discharged and died. We analyzed the collected data using descriptive (frequency, mean, and standard deviation) and analytical (independent t-test, Mann-Whitney U-test, Kruskal-Wallis test and logistic regression) statistics in Statistical Package for the Social Sciences (SPSS) 16.0. We considered p < 0.05 as the significance level. Results: The mean (SD) age of patients was 43.86 (18.40) years. The majority of the population was men (87.27%). Road traffic accidents (RTAs) were the most common mechanism of trauma (79.40%). The mean (SD) of Glasgow coma scale (GCS) was 6.03 (3.11). In 50.19% of the patients, the pupillary reflex was absent. One hundred and twenty-four patients (46.44%) died before discharge. We found age, gender, GCS, pupillary reflex, hypernatremia, and increased intracranial pressure (IICP) as the predictors of death in severe TBI. Conclusions: In this study, the mortality rate of patients with severe TBI was high. In addition, some factors were determined as the significant predictors of outcome. The findings can assist in planning to enhance the quality of care and reduce the mortality rate in the patients with severe TBI.	[Ziaeirad, Marzieh] Isfahan Univ Med Sci, Student Res Ctr, Sch Nursing & Midwifery, Esfahan, Iran; [Ziaeirad, Marzieh] Islamic Azad Univ, Nursing & Midwifery Fac, Dept Nursing, Isfahan Khorasgan Branch, Esfahan, Iran; [Alimohammadi, Nasrollah] Isfahan Univ Med Sci, Sch Nursing & Midwifery, Hezarjarib Ave, Esfahan, Iran; [Irajpour, Alireza] Isfahan Univ Med Sci, Nursing & Midwifery Fac, Nursing & Midwifery Care Res Ctr, Dept Crit Care Nursing, Esfahan, Iran; [Aminmansour, Bahram] Isfahan Univ Med Sci, Sch Med, Dept Neurosurg, Esfahan, Iran		Alimohammadi, N (corresponding author), Isfahan Univ Med Sci, Sch Nursing & Midwifery, Hezarjarib Ave, Esfahan, Iran.	alimohammadi@nm.mui.ac.ir	ziaeirad, marzieh/T-2799-2017		Isfahan University of Medical Sciences	Isfahan University of Medical Sciences.	Atci IB, 2015, ACTA MEDICA MEDITERR, V31, P825; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chalya PL, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-61; Settervall CHC, 2011, REV LAT-AM ENFERM, V19, P1337, DOI 10.1590/S0104-11692011000600009; Damkliang J, 2013, AUSTRALAS EMERG NURS, V16, P127, DOI 10.1016/j.aenj.2013.09.001; Ebrahimi FH, 2010, ARAK U MED SCI J, V12, P1; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fazel M, 2007, FEYZ J KASHAN U MED, V12, P21; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Grigorakos L., 2016, J NEUROSCI CLIN RES, V1, P1; Guerrier G, 2015, AUST NZ J PUBL HEAL, V39, P188, DOI 10.1111/1753-6405.12362; Haji Maghsoudi M, 2016, J SAFETY PROMOT INJU, V4, P33; Haller CS, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14177; Hejini ES, 2015, J COMMUNITY HLTH, V9, P37; Hijar M, 2012, REV PANAM SALUD PUBL, V32, P70, DOI 10.1590/S1020-49892012000700011; Iba J, 2014, ACUTE MED SURG, V1, P31, DOI 10.1002/ams2.5; Kasmaei VM, 2015, EMERGENCY, V3, P141; Kulesza B, 2015, JPCCR, V9, P163; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Modaghegh MHS, 2013, ARCH IRAN MED, V16, P576, DOI 0131610/AIM.005; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rejeb I, 2015, J ACUTE DIS, V4, P68, DOI 10.1016/S2221-6189(14)60087-1; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saini NS, 2012, INDIAN J NEUROTRAUM, V9, P45, DOI 10.1016/j.ijnt.2012.04.009; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Zand S, 2010, IJCCN, V3, P7	28	4	4	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1735-9066	2228-5504		IRAN J NURS MIDWIFE	Iran. J. Nurs. Midwifery Res.	MAY-JUN	2018	23	3					211	216		10.4103/ijnmr.IJNMR_65_17			6	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VJ1YZ	WOS:000552769000010	29861760	gold, Green Published			2022-02-06	
J	McCaskey, MA; Wirth, B; Schuster-Amft, C; de Bruin, ED				McCaskey, Michael A.; Wirth, Brigitte; Schuster-Amft, Corina; de Bruin, Eling D.			Dynamic multi-segmental postural control in patients with chronic non-specific low back pain compared to pain-free controls: A cross-sectional study	PLOS ONE			English	Article							MOVEMENT VARIABILITY; CEREBRAL CONCUSSION; JOINT COORDINATION; GLOBAL BURDEN; QUIET STANCE; PRESSURE; INDIVIDUALS; RELIABILITY; ADAPTATION; MANAGEMENT	Reduced postural control is thought to contribute to the development and persistence of chronic non-specific low back pain (CNLBP). It is therefore frequently assessed in affected patients and commonly reported as the average amount of postural sway while standing upright under a variety of sensory conditions. These averaged linear outcomes, such as mean centre of pressure (CP) displacement or mean CP surface areas, may not reflect the true postural status. Adding nonlinear outcomes and multi-segmental kinematic analysis has been reported to better reflect the complexity of postural control and may detect subtler postural differences. In this cross-sectional study, a combination of linear and nonlinear postural parameters were assessed in patients with CNLBP (n = 24, 24-75 years, 9 females) and compared to symptom-free controls (CG, n = 34, 22-67 years, 11 females). Primary outcome was postural control measured by variance of joint configurations (uncontrolled manifold index, UI), confidence ellipse surface areas (CEA) and approximate entropy (ApEn) of CP dispersion during the response phase of a perturbed postural control task on a swaying platform. Secondary outcomes were segment excursions and clinical outcome correlates for pain and function. Non-parametric tests for group comparison with P-adjustment for multiple comparisons were conducted. Principal component analysis was applied to identify patterns of segmental contribution in both groups. CNLBP and CG performed similarly with respect to the primary outcomes. Comparison of joint kinematics revealed significant differences of hip (P < .001) and neck (P < .025) angular excursion, representing medium to large group effects (r's = .36 - .51). Significant (P's < .05), but moderate correlations of ApEn (r = -.42) and Ul (r = -.46) with the health-related outcomes were observed. These findings lend further support to the notion that averaged linear outcomes do not suffice to describe subtle postural differences in CNLBP patients with low to moderate pain status.	[McCaskey, Michael A.; de Bruin, Eling D.] Swiss Fed Inst Technol, Inst Human Movement Sci, Dept Hlth Sci & Technol, Zurich, Switzerland; [McCaskey, Michael A.; Schuster-Amft, Corina] Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland; [Schuster-Amft, Corina] Bern Univ Appl Sci, Inst Rehabil & Performance Technol, Burgdorf, Switzerland; [Wirth, Brigitte] Univ Zurich, Balgrist Univ Hosp, Dept Chiropract Med, Zurich, Switzerland; [de Bruin, Eling D.] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden		McCaskey, MA (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci, Dept Hlth Sci & Technol, Zurich, Switzerland.; McCaskey, MA (corresponding author), Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland.	michael.mccaskey@hest.ethz.ch	McCaskey, Michael Alexander/Q-8055-2019; de Bruin, Eling D./A-4751-2011; Schuster, Corina/B-6939-2008	McCaskey, Michael Alexander/0000-0002-6152-8816; de Bruin, Eling D./0000-0002-6542-7385; Schuster-Amft, Corina/0000-0003-1120-4423	cantonal department of health and social services of the Canton of Argovia, Switzerland; Reha Rheinfelden, Switzerland; ETH ZurichETH Zurich	MM and CS were partially funded by a grant from the cantonal department of health and social services of the Canton of Argovia (www.ag.ch/dgs), Switzerland. Internal funding was provided by MM and CS' employer, Reha Rheinfelden, Switzerland. BW and EdB were funded by their employers, ETH Zurich, as part of their teaching activity (PhD supervision). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and the authors had unrestricted access to the data. There was no additional external funding received for this study.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black DP, 2007, EXP BRAIN RES, V183, P511, DOI 10.1007/s00221-007-1066-1; Brumagne S, 2008, GAIT POSTURE, V28, P657, DOI 10.1016/j.gaitpost.2008.04.015; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Churchill AJG, 2002, COMPUT METH PROG BIO, V69, P197, DOI 10.1016/S0169-2607(01)00191-2; Claeys K, 2015, J ELECTROMYOGR KINES, V25, P329, DOI 10.1016/j.jelekin.2014.10.013; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Fairbank J C, 1980, Physiotherapy, V66, P271; Fernandes RJ, 2012, J HUM KINET, V33, P15, DOI 10.2478/v10078-012-0040-6; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hodges PW, 2003, J ELECTROMYOGR KINES, V13, P361, DOI 10.1016/S1050-6411(03)00042-7; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Hsu WL, 2013, AGE, V35, P1299, DOI 10.1007/s11357-012-9422-x; Janda V, 2006, REHABILITATION SPINE, P203; Krishnamoorthy V, 2005, EXP BRAIN RES, V164, P1, DOI 10.1007/s00221-004-2205-6; Krishnamoorthy V, 2003, BIOL CYBERN, V89, P152, DOI 10.1007/s00422-003-0419-5; Lamoth CJC, 2004, CLIN BIOMECH, V19, P551, DOI 10.1016/j.clinbiomech.2003.10.006; Langevin HM, 2007, MED HYPOTHESES, V68, P74, DOI 10.1016/j.mehy.2006.06.033; Latash M.L., 2008, NEUROPHYSIOLOGICAL B; Latash ML, 2010, MOTOR CONTROL, V14, P294; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; Mannion AF, 2006, EUR SPINE J, V15, P55, DOI 10.1007/s00586-004-0815-0; Mazaheri M, 2013, GAIT POSTURE, V37, P12, DOI 10.1016/j.gaitpost.2012.06.013; McCaskey MA, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1104-4; Merskey H, 1994, CLASSIFICATION CHRON; Meucci RD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005874; Moseley GL, 2004, EUR J PAIN, V8, P39, DOI 10.1016/S1090-3801(03)00063-6; Panjabi MM, 2006, EUR SPINE J, V15, P668, DOI 10.1007/s00586-005-0925-3; Park S, 2004, EXP BRAIN RES, V154, P417, DOI 10.1007/s00221-003-1674-3; PARKER EMILY, 2016, ENVIRON TOXICOL, P1; Peterka R J, 1990, J Vestib Res, V1, P87; Pijnenburg M, 2015, BRAIN CONNECT, V5, P303, DOI 10.1089/brain.2014.0309; Rasev E., 2011, THESIS; Rocchi MBL, 2005, ITAL J SPORT SCI, V12, P169; Ruhe A, 2011, EUR SPINE J, V20, P358, DOI 10.1007/s00586-010-1543-2; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Sipko T, 2013, EUR J PAIN, V17, P612, DOI 10.1002/j.1532-2149.2012.00226.x; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Tajali S, 2013, BIOMED ENG-APP BAS C, V25, DOI 10.4015/S1016237213500105; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang TY, 2015, HUM MOVEMENT SCI, V40, P284, DOI 10.1016/j.humov.2015.01.002; Winter D. A., 2009, BIOMECHANICS MOTOR C, DOI 10.1002/9780470549148; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	51	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194512	10.1371/journal.pone.0194512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	WOS:000429522200011	29634749	gold, Green Submitted, Green Published, Green Accepted			2022-02-06	
J	Allain, M; Kuczer, V; Longo, C; Batard, E; Le Conte, P				Allain, M.; Kuczer, V; Longo, C.; Batard, E.; Le Conte, P.			Place of simulation in the initial training of french emergency physicians: national observational and descriptive study	ANNALES FRANCAISES DE MEDECINE D URGENCE			French	Article						Simulation; Initial training; Emergency medicine; National study; DES	PATIENT SIMULATION; MANAGEMENT; MEDICINE; VALIDATION; SKILLS	Background: Simulation appears to be now an essential tool for the training of both technical and nontechnical medical skills. It allows to respect the ethical statement: "Never the first time on a real patient". Currently, integration of simulation in training programs is not harmonized between French medicine faculties. The corresponding framework remains to be defined in anticipation of the creation of the diploma of Emergency Medical Specialty (DES) planned for fall 2017. Objective: This investigation addressed the use of simulation in French initial formation in emergency medicine. It was intended as a first step toward establishing a simulation-based training program. Method: This observational study was multicentric. A questionnaire was sent by e-mail to all coordinators of Emergency Medicine initial formation in France. Data were compiled with Excel software (Microsoft Inc.). They included both quantitative and qualitative items that concerned the general context, the structure, and the content of the simulation-based training. Results: Twenty-five out of 29 universities answered the questionnaire. Among those, 23 (92%) used simulation, 22 of them used high-fidelity simulation, and 21 used procedural simulation. The most involved application fields were: cardiac arrest (22), shock state (21), chest pain, tachycardia (20), severe trauma and traumatic brain injury (17). The most practiced technical procedures were: intubation (22), difficult intubation (21), mechanical ventilation and intraosseous access (18). Median time was 2-3 days of simulation by year. In 12 centers (52%), the training staff had dedicated time duty and 15 centers (65%) benefited from remunerated staff. Finally, only 12 centers (52%) felt they essentially complied with the statement "Never the first time on a real patient". Discussion: Simulation use in French emergency physician's initial training is heterogeneous. The main limitation of our study was the absence of response from 4 faculties. Generally, responding coordinators agreed on the main situations and techniques to be taught. As in other countries, promotion of simulation seems to be consensual. However, effective deployment remains difficult due to material investment, formation and availability of staff. This study could provide a basis for the establishment of a national simulation-based training program.	[Allain, M.; Kuczer, V; Longo, C.; Batard, E.] CHU Nantes, Serv Urgences Samu 44, 1 Pl Alexis Ricordeau, F-44000 Nantes, France; [Longo, C.; Batard, E.] CESU, 44 Quai Moncousu, F-44093 Nantes, France; [Batard, E.; Le Conte, P.] Univ Nantes, Fac Med, 1 Quai Tourville, F-44000 Nantes, France		Allain, M (corresponding author), CHU Nantes, Serv Urgences Samu 44, 1 Pl Alexis Ricordeau, F-44000 Nantes, France.	milena.allain@chu-nantes.fr					Boet S., 2013, SIMULATION SANTE THE; Boet S, 2011, CRIT CARE MED, V39, P1377, DOI 10.1097/CCM.0b013e31820eb8be; Boulet JR, 2008, ACAD EMERG MED, V15, P1017, DOI 10.1111/j.1553-2712.2008.00228.x; Fanning Ruth M, 2007, Simul Healthc, V2, P115, DOI 10.1097/SIH.0b013e3180315539; Gaba D. M., 2001, Simulation & Gaming, V32, P175, DOI 10.1177/104687810103200206; Giroux M, 2009, PEDAGOGIE MED, V10, P193; Granry J-C, 2012, HAUTE AUTORITE SANTE; Harvey A, 2010, MED EDUC, V44, P587, DOI 10.1111/j.1365-2923.2010.03634.x; Haute Autorite de sante, 2015, SEC PAT GER RISQ GUI; Haute Autorite de sante, 2012, EV AM PRAT GUID BONN; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; Issenberg SB, 1999, JAMA-J AM MED ASSOC, V282, P861, DOI 10.1001/jama.282.9.861; Jabre P, 2011, ANN FR MED URGENCE, V1, P379, DOI 10.1007/s13341-011-0122-4; KOHN LT, 2000, ERR IS HUMAN BUILDIN, P180; Levraut J, 2012, ANN FR MED URGENCE, V2, P361, DOI 10.1007/s13341-012-0259-9; McCoy CE, 2011, J EMERG MED, V40, P448, DOI 10.1016/j.jemermed.2010.02.026; Ministere de l'Education nationale, 2015, ARR 13 NOV 2015 FIX; Ministere de l'Education nationale, 2017, ARR 21 AVR 2017 REL; Morgan PJ, 2004, BRIT J ANAESTH, V92, P388, DOI 10.1093/bja/aeh081; Nguyen HB, 2009, RESUSCITATION, V80, P674, DOI 10.1016/j.resuscitation.2009.02.021; Nguyen L, 2011, ANN FR MED URGENCE, V1, P91, DOI 10.1007/s13341-011-0029-4; Okuda Y, 2008, ACAD EMERG MED, V15, P1113, DOI 10.1111/j.1553-2712.2008.00195.x; Oriot D, 2012, SIMUL HEALTHC, V7, P171, DOI 10.1097/SIH.0b013e31824a5c20; Owen H, 2006, RESUSCITATION, V71, P204, DOI 10.1016/j.resuscitation.2006.04.007; Patterson PD, 2012, PREHOSP EMERG CARE, V16, P98, DOI 10.3109/10903127.2011.616260; Riou B, 2017, ANN FR MED URGENCE, V7, P149, DOI 10.1007/s13341-017-0750-4; Schwartz LR, 2007, ACAD EMERG MED, V14, P130, DOI 10.1197/j.aem.2006.09.052; Shapiro MJ, 2008, ACAD EMERG MED, V15, P1088, DOI 10.1111/j.1553-2712.2008.00251.x; Wiel E, 2009, ANN FR ANESTH, V28, P542, DOI 10.1016/j.annfar.2009.04.005; Yee B, 2005, ANESTHESIOLOGY, V103, P241, DOI 10.1097/00000542-200508000-00006	30	4	4	0	1	LAVOISIER	CACHAN	14, RUE DE PROVIGNY, 94236 CACHAN, FRANCE	2108-6524	2108-6591		ANN FR MED URGENCE	Ann. Fr. Med. Urgence	APR	2018	8	2					75	82		10.3166/afmu-2018-0042			8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	IC5VT	WOS:000471037600002		Bronze			2022-02-06	
J	Badke, GL; Araujo, JLV; Miura, FK; Guirado, VMD; Saade, N; Paiva, ALC; Avelar, TM; Pedrozo, CAG; Veiga, JCE				Badke, Guilherme Lellis; Vitorino Araujo, Joao Luiz; Miura, Flavio Key; de Paula Guirado, Vinicius Monteiro; Saade, Nelson; Campos Paiva, Aline Lariessy; Avelar, Tiago Marques; Grander Pedrozo, Charles Alfred; Esteves Veiga, Jose Carlos			Analysis of direct costs of decompressive craniectomy in victims of traumatic brain injury	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						decompressive craniectomy; brain injuries; cost and cost analysis; intracranial pressure	HEAD-INJURIES; MANAGEMENT; EDEMA	Background: Decompressive craniectomy is a procedure required in some cases of traumatic brain injury (TBI). This manuscript evaluates the direct costs and outcomes of decompressive craniectomy for TBI in a developing country and describes the epidemiological profile. Methods: A retrospective study was performed using a five-year neurosurgical database, taking a sample of patients with TBI who underwent decompressive craniectomy. Several variables were considered and a formula was developed for calculating the total cost. Results: Most patients had multiple brain lesions and the majority (69.0%) developed an infectious complication. The general mortality index was 68.8%. The total cost was R$ 2,116,960.22 (US$ 661,550.06) and the mean patient cost was R$ 66,155.00 (US$ 20,673.44). Conclusions: Decompressive craniectomy for TBI is an expensive procedure that is also associated with high morbidity and mortality. This was the first study performed in a developing country that aimed to evaluate the direct costs. Prevention measures should be a priority.	[Badke, Guilherme Lellis; Vitorino Araujo, Joao Luiz; Miura, Flavio Key; de Paula Guirado, Vinicius Monteiro; Saade, Nelson; Campos Paiva, Aline Lariessy; Avelar, Tiago Marques; Grander Pedrozo, Charles Alfred; Esteves Veiga, Jose Carlos] Santa Casa Sao Paulo, Fac Ciencias Med, Discipline Neurocirurgia, Rua Dr Cesario Motta Jr 112, BR-01221020 Sao Paulo, SP, Brazil; [Vitorino Araujo, Joao Luiz] Hosp Israelista Albert Einstein, Sao Paulo, SP, Brazil; [Vitorino Araujo, Joao Luiz] Inst Canc Arnaldo Vieira de Carvalho, Sao Paulo, SP, Brazil		Paiva, ALC (corresponding author), Santa Casa Sao Paulo, Fac Ciencias Med, Discipline Neurocirurgia, Rua Dr Cesario Motta Jr 112, BR-01221020 Sao Paulo, SP, Brazil.	lariessy@hotmail.com	Veiga, Jose/AAV-1687-2020; de Paula Guirado, Vinicius Monteiro/AAG-7299-2019	de Paula Guirado, Vinicius Monteiro/0000-0002-7782-3609; Marques Avelar, Tiago/0000-0002-7141-5815			Cherian I, 2016, WORLD NEUROSURG, V89, P51, DOI 10.1016/j.wneu.2016.01.072; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Jorge Maria Helena Prado de Mello, 2004, Rev. bras. epidemiol., V7, P228; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kshettry Varun R, 2007, Neurosurg Focus, V23, pE8; Lemcke J, 2010, ACTA NEUROCHIR SUPPL, V106, P231, DOI 10.1007/978-3-211-98811-4_43; Malmivaara K, 2011, EUR J NEUROL, V18, P656, DOI 10.1111/j.1468-1331.2010.03294.x; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Mauldin PD, 2010, ANTIMICROB AGENTS CH, V54, P109, DOI 10.1128/AAC.01041-09; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Ng E, 2012, ANN ACAD MED SINGAP, V41, P189; Panourias IG, 2005, NEUROSURGERY, V57, P181, DOI 10.1227/01.NEU.0000163416.66374.48; Park J, 2009, J NEUROSURG, V110, P101, DOI 10.3171/2008.4.17540; Pestotnik SL, 1996, ANN INTERN MED, V124, P884, DOI 10.7326/0003-4819-124-10-199605150-00004; PICKARD JD, 1990, BRIT MED J, V301, P629, DOI 10.1136/bmj.301.6753.629; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962	30	4	4	0	3	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	APR	2018	76	4					257	264		10.1590/0004-282X20180016			8	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	GF2HY	WOS:000431760400009	29742246	gold			2022-02-06	
J	Cheever, C; Barbosa-Leiker, C				Cheever, Chong (Sherry); Barbosa-Leiker, Celestina			Impact of Alcohol Screening for Traumatic Brain Injury Patients Being Admitted to Neurosurgical Intensive Care Unit	JOURNAL OF NEUROSCIENCE NURSING			English	Article						Abbreviated Injury Score; alcohol abused; alcohol screening; emergency department; Glasgow Coma score; neurosurgical intensive care unit; traumatic brain injury	GLASGOW COMA SCALE; WITHDRAWAL SYNDROME; BRIEF INTERVENTION; CENTERS; VISITS	Objective: The aims of this study were to determine the prevalence and describe the importance of alcohol screening for all patients with traumatic brain injury (TBI) and examine the relationship between gender, age, Abbreviated Injury Scale (AIS), emergent decompressive craniectomy, Glasgow Coma Scale (GCS) from the emergency department (ED), and the length of stay with alcohol screening. Method: This is a retrospective analysis of de-identified data from the 2012 TBI registry of a level 1 trauma center in the Pacific Northwest. Measurements and Main Results: Of 1591 patients with TBI, 1273 (80%) were screened for alcohol use and 318 (20%) were not screened. There was a significant association between alcohol screening and AIS (chi(2)(5) = 15.46, P < .001), ED GCS (chi(2)(12) = 22.13, P = .04), sex (chi(2)(1) = 7.86, P <= .001), and age (r = 0.23, P < .001). Women and patients with high AIS (critical), low (mild) AIS, and midrange GCS scores were less likely to be screened, as were younger patients. Urgent decompressive craniectomy (chi(2)(1) = 1.94, P = .16) and length of stay (r = -0.04, P = .14) did not display a significant association with alcohol screening. Conclusion: This study uncovered a systemic bias per sex and age for alcohol screening, as well as skewed AIS and GCS scores due to an unknown alcohol intoxication status. An updated ED's triage process and screening tool is recommended to achieve a targeted 100% alcohol screening rate for all head trauma patients in the ED before admission to the neurosurgical intensive care unit.	[Cheever, Chong (Sherry)] Univ Washington, Harborview Med Ctr, Neurosurg Intens Care Unit, 325 9Th Ave, Seattle, WA 98104 USA; [Barbosa-Leiker, Celestina] Washington State Univ, Coll Nursing, Program Excellence Addict Res, Spokane, WA USA		Cheever, C (corresponding author), Univ Washington, Harborview Med Ctr, Neurosurg Intens Care Unit, 325 9Th Ave, Seattle, WA 98104 USA.						Aseltine RH, 2007, ANN EMERG MED, V50, P699, DOI 10.1016/j.annemergmed.2007.06.486; Bendtsen Preben, 2007, Accid Emerg Nurs, V15, P3, DOI 10.1016/j.aaen.2006.09.004; Bernstein E, 2008, ANN EMERG MED, V51, P751, DOI 10.1016/j.annemergmed.2008.01.325; Carlson RW, 2012, CRIT CARE CLIN, V28, P549, DOI 10.1016/j.ccc.2012.07.004; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Centers for Disease Control and Prevention, SEV TBI; Cunningham RM, 2010, ANN EMERG MED, V55, P556, DOI 10.1016/j.annemergmed.2010.03.004; Dunham CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047999; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Forsythe M, 2012, INT EMERG NURS, V20, P167, DOI 10.1016/j.ienj.2011.09.006; Jawa RS, 2014, AM J SURG, V208, P781, DOI 10.1016/j.amjsurg.2014.04.007; Johnson JA, 2013, ANN EMERG MED, V62, P262, DOI 10.1016/j.annemergmed.2013.04.011; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; MacLeod JBA, 2011, INJURY, V42, P922, DOI 10.1016/j.injury.2010.01.098; Rehman Tausif, 2008, Cases J, V1, P203, DOI 10.1186/1757-1626-1-203; Sarff M, 2010, CRIT CARE MED, V38, pS494, DOI 10.1097/CCM.0b013e3181ec5412; Shahin H, 2012, TRAUMA, V14, P233, DOI 10.1177/1460408611434382; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Terrell F, 2008, J AM COLL SURGEONS, V207, P630, DOI 10.1016/j.jamcollsurg.2008.05.021	21	4	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2018	50	2					83	87		10.1097/JNN.0000000000000345			5	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	FZ7QC	WOS:000427795000007	29521730				2022-02-06	
J	Kramer, N; Lebowitz, D; Walsh, M; Ganti, L				Kramer, Nicholas; Lebowitz, David; Walsh, Michael; Ganti, Latha			Rapid Sequence Intubation in Traumatic Brain-injured Adults	CUREUS			English	Article						rapid sequence intubation; traumatic brain injury (tbi); intubation; ketamine; emergency medicine; rocuronium; succinylcholine; pretreatment; induction agents; intracranial pressure	INTRACRANIAL-PRESSURE; ATRIAL MYOCARDIUM; INDUCTION AGENT; BLOOD-PRESSURE; DOUBLE-BLIND; HEAD-INJURY; KETAMINE; ETOMIDATE; SUCCINYLCHOLINE; PROPOFOL	Deciding on proper medication administration for the traumatic brain injury (TBI) patient undergoing intubation can be daunting and confusing. Pretreatment with lidocaine and/or vecuronium is no longer recommended; however, high-dose fentanyl can be utilized to help blunt the sympathetic stimulation of intubation. Induction with etomidate is recommended; however, ketamine can be considered in the proper patient population, such as those with hypotension. Paralysis can be performed with either succinylcholine or rocuronium, with the caveat that rocuronium can lead to delays in proper neurological examinations due to prolonged paralysis. Recommendations for post-intubation continuous sedation medications include a combination propofol and fentanyl in the normotensive/hypertensive patient population. A combination midazolam and fentanyl or ketamine alone can be considered in the hypotensive patient.	[Kramer, Nicholas] Univ Cent Florida, Emergency Med, Orlando, FL 32816 USA; [Lebowitz, David] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Walsh, Michael] Univ Cent Florida, Pharm, Orlando, FL 32816 USA; [Ganti, Latha] Univ Cent Florida, Clin Sci, Orlando, FL 32816 USA		Kramer, N (corresponding author), Univ Cent Florida, Emergency Med, Orlando, FL 32816 USA.	nicholas.kramer@ucf.edu	Ganti, Latha/AAF-6268-2020	Ganti, Latha/0000-0001-7717-3864			Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; [Anonymous], 2017, NEUROMUSCULAR BLOCKI; [Anonymous], 2015, PRETREATMENT AGENTS; [Anonymous], 2017, INDUCTION AGENTS RAP; [Anonymous], 2018, PERIOPERATIVE USES I; BACHOFEN M, 1988, ANAESTHESIST, V37, P156; Benson M, 2000, J CLIN MONITOR COMP, V16, P183, DOI 10.1023/A:1009937510028; Camps AS, 2000, CRIT CARE MED, V28, P3612, DOI 10.1097/00003246-200011000-00009; CHUNG KS, 1992, CAN J ANAESTH, V39, P774, DOI 10.1007/BF03008287; Clancy M, 2001, EMERG MED J, V18, P373, DOI 10.1136/emj.18.5.373; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; CORK RC, 1984, ANESTH ANALG, V63, P60; DAHLGREN N, 1981, ANAESTHESIA, V36, P1022, DOI 10.1111/j.1365-2044.1981.tb08676.x; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; Filanovsky Y, 2010, CAN J EMERG MED, V12, P154; Flower O, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/637171; Fuchs-Buder T, 1998, BRIT J ANAESTH, V80, P504, DOI 10.1093/bja/80.4.504; Green SM, 2011, ANN EMERG MED, V57, P449, DOI 10.1016/j.annemergmed.2010.11.030; Grover VK, 1999, NEUROL INDIA, V47, P118; Guldner G, 2003, ACAD EMERG MED, V10, P134, DOI 10.1111/j.1553-2712.2003.tb00030.x; Hanouz JL, 2005, ANESTHESIOLOGY, V102, P1190, DOI 10.1097/00000542-200506000-00019; Hanouz JL, 2004, ANESTH ANALG, V99, P1689, DOI 10.1213/01.ANE.0000136466.85913.3C; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P131, DOI 10.1053/j.jvca.2009.05.008; Jellish WS, 1997, J CLIN ANESTH, V9, P36, DOI 10.1016/S0952-8180(96)00211-5; Johnson EG, 2015, J EMERG MED, V49, P43, DOI 10.1016/j.jemermed.2014.12.028; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kerr ME, 1997, NURS RES, V46, P195, DOI 10.1097/00006199-199707000-00003; Kim JT, 2007, ANAESTH INTENS CARE, V35, P20, DOI 10.1177/0310057X0703500102; Kuzak Nick, 2006, CJEM, V8, P80; Langsjo JW, 2003, ANESTHESIOLOGY, V99, P614, DOI 10.1097/00000542-200309000-00016; LANIER WL, 1989, ANESTHESIOLOGY, V71, P87, DOI 10.1097/00000542-198907000-00016; Lin CC, 2008, AM J EMERG MED, V26, P845, DOI 10.1016/j.ajem.2007.11.027; MINTON MD, 1986, ANESTHESIOLOGY, V65, P165, DOI 10.1097/00000542-198608000-00006; Na HS, 2012, ACTA ANAESTH SCAND, V56, P558, DOI 10.1111/j.1399-6576.2012.02648.x; Oglesby AJ, 2004, EMERG MED J, V21, P655, DOI 10.1136/emj.2003.009043; Pantawala AE, 2016, PHARMACOTHERAPY, V36, P57, DOI [10.1002/phar.1683, DOI 10.1002/PHAR.1683]; Patanwala AE, 2011, ACAD EMERG MED, V18, P11, DOI 10.1111/j.1553-2712.2010.00954.x; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Robinson N, 2001, EMERG MED J, V18, P453, DOI 10.1136/emj.18.6.453; RUDY EB, 1991, HEART LUNG, V20, P667; Samaha T, 1996, ANN FR ANESTH, V15, P36, DOI 10.1016/0750-7658(96)89400-7; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; Tong JL, 2005, ANAESTHESIA, V60, P754, DOI 10.1111/j.1365-2044.2005.04238.x; Tran DTT, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub3; Upchurch CP, 2017, ANN EMERG MED, V69, P24, DOI 10.1016/j.annemergmed.2016.08.009; WHITE PF, 1982, ANESTHESIOLOGY, V57, P242, DOI 10.1097/00000542-198209000-00019; Xue FS, 2006, ANAESTHESIA, V61, P444, DOI 10.1111/j.1365-2044.2006.04584.x; YANO M, 1986, ANESTHESIOLOGY, V64, P651, DOI 10.1097/00000542-198605000-00019	49	4	5	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	APR	2018	10	4							e2530	10.7759/cureus.2530			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HB3GQ	WOS:000450939400128	29946498	Green Published, gold			2022-02-06	
J	Lee, SH; Lim, D; Kim, DH; Kim, SC; Kim, TY; Kang, C; Jeong, JH; Park, YJ; Lee, SB; Kim, RB				Lee, Soo Hoon; Lim, Daesung; Kim, Dong Hoon; Kim, Seong Chun; Kim, Tae Yun; Kang, Changwoo; Jeong, Jin Hee; Park, Yong Joo; Lee, Sang Bong; Kim, Rock Bum			PREDICTOR OF ISOLATED TRAUMA IN HEAD: A NEW SIMPLE PREDICTOR FOR SURVIVAL OF ISOLATED TRAUMATIC BRAIN INJURY	JOURNAL OF EMERGENCY MEDICINE			English	Article						traumatic brain injury; prognosis; survival probability; emergency department	CRASH PROGNOSTIC MODELS; GLASGOW COMA SCALE; EXTERNAL VALIDATION; PRACTICAL SCALE; SEVERITY SCORE; BLOOD-PRESSURE; IMPACT; MORTALITY; MODERATE; COHORT	Background: Mortality prediction in patients with brain trauma during initial management in the emergency department (ED) is essential for creating the foundation for a better prognosis. Objective: This study aimed to create a simple and useful survival predictive model for patients with isolated blunt traumatic brain injury that is easily available in the ED. Methods: This is a retrospective study based on the trauma registry data of an academic teaching hospital. The inclusion criteria were age >= 15 years, blunt and not penetrating mechanism of injury, and Abbreviated Injury Scale (AIS) scores between 1 and 6 for head and 0 for all other body parts. The primary outcome was 30-day survival probability. Internal and external validation was performed. Results: After univariate logistic regression analysis based on the derivation cohort, the final Predictor of Isolated Trauma in Head (PITH) model for survival prediction of isolated traumatic brain injury included Glasgow Coma Scale (GCS), age, and coded AIS of the head. In the validation cohort, the area under the curve of the PITH score was 0.970 (p < 0.0001; 95% confidence interval 0.960-0.978). Sensitivity and specificity were 95% and 81.7% at the cutoff value of 0.9 (probability of survival 90 %), respectively. Conclusions: The PITH model performed better than the GCS; Revised Trauma Score; and mechanism of injury, GCS, age, and arterial pressure. It will be a useful triage method for isolated traumatic brain injury in the early phase of management. (C) 2018 Elsevier Inc. All rights reserved.	[Lee, Soo Hoon; Kim, Dong Hoon; Kim, Tae Yun; Kang, Changwoo; Jeong, Jin Hee; Lee, Sang Bong; Kim, Rock Bum] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Sch Med, Dept Emergency Med, Jinju, Gyeongsangnam D, South Korea; [Lim, Daesung; Kim, Seong Chun; Park, Yong Joo] Gyeongsang Natl Univ, Dept Emergency Med, Changwon Hosp, Sch Med, Chang Won, Gyeongsangnam D, South Korea; [Kim, Rock Bum] Gyeongsang Natl Univ Hosp, Ctr Reg Cardiocerebrovasc Dis, Jinju, Gyeongsangnam D, South Korea		Lee, SH (corresponding author), Gyeongsang Natl Univ Hosp, Dept Emergency Med, Gangnam Ro 79, Jinju 52727, Gyeongsangnam D, South Korea.			Lee, Soo Hoon/0000-0002-2512-5905	Korea Centers for Disease Control and Prevention	Korea Centers for Disease Control and Prevention provided financial support for data collection.	BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Castano-Leon AM, 2016, J NEUROTRAUM, V33, P1598, DOI 10.1089/neu.2015.4182; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; JENNETT B, 1975, LANCET, V1, P480; Kuhls DA, 2002, J AM COLL SURGEONS, V194, P695, DOI 10.1016/S1072-7515(02)01211-5; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Moon JH, 2013, J KOREAN NEUROSURG S, V54, P42, DOI 10.3340/jkns.2013.54.1.42; Moore L, 2010, J TRAUMA, V68, P698, DOI 10.1097/TA.0b013e3181aa093d; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reisner A, 2014, J NEUROTRAUM, V31, P906, DOI 10.1089/neu.2013.3128; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	20	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	APR	2018	54	4					427	434		10.1016/j.jemermed.2018.01.001			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GF6YI	WOS:000432114100012	29478860				2022-02-06	
J	Letzkus, L; Addison, N; Turner, L; Conaway, M; Quatrara, B				Letzkus, Lisa; Addison, Nancy; Turner, Lauren; Conaway, Mark; Quatrara, Beth			Paroxysmal Sympathetic Hyperactivity and Environmental Factors: A Pilot Study	JOURNAL OF NEUROSCIENCE NURSING			English	Article						brain injury; paroxysmal sympathetic hyperactivity; pediatrics; symptoms	TRAUMATIC BRAIN-INJURY; AUTONOMIC INSTABILITY; DYSAUTONOMIA	Problem: Paroxysmal sympathetic hyperactivity (PSH) is a complicated phenomenon that presents as autonomic instability and muscle overactivity in individuals who experience severe brain injury. Identifying potential modifiable environmental nociceptive stimuli is necessary for developing interventions that impact clinical outcomes. Objective: The aim of this study was to identify physical environmental nociceptive stimuli that could hinder recovery for children who experience PSH after severe brain injury. Methodology: This study measured quantitative physical characteristics coupled with data from semistructured interviews, with parents and clinical nurses, to explore the elusive PSH phenomenon after severe brain injury in children. Results: Eight subjects were enrolled in the cohort study. Temperature showed a statistically significant association with PSH (P = .02), with lower temperatures associated with an increased chance of PSH. Blankets were also associated with PSH (P = .009), with the use of blankets associated with a greater chance of PSH. Persons, gown, position, head-of-bed elevation, incontinence of urine and stool, light level, and noise level did not point to a statistically significant association with PSH. Six nursing interviews were conducted with 2 guardian interviews. Themes that are emerging from the qualitative interviews included the priorities of strategies to target auditory, tactile, and visual stimuli. Conclusion: Paroxysmal sympathetic hyperactivity environmental strategies need to be explored further in subsequent studies. Environmental interventions could complement pharmacological strategies for the management of this elusive phenomenon with the goal of improving outcomes in children who experience severe brain injury and show PSH.	[Letzkus, Lisa] Univ Virginia Hlth Syst, Nursing Res, Charlottesville, VA 22903 USA; [Letzkus, Lisa; Conaway, Mark] Univ Virginia Hlth Syst, Charlottesville, VA 22903 USA; [Addison, Nancy] Locus Hlth, Charlottesville, VA USA; [Turner, Lauren] Virginia Commonwealth Univ, Richmond, VA USA; [Quatrara, Beth] Univ Virginia Hlth Syst, Sch Nursing, Charlottesville, VA USA		Letzkus, L (corresponding author), Univ Virginia Hlth Syst, Nursing Res, Charlottesville, VA 22903 USA.; Letzkus, L (corresponding author), Univ Virginia Hlth Syst, Charlottesville, VA 22903 USA.	lmc8c@virginia.edu					Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Cohen MZ, 2000, HERMENEUTIC PHENOMEN; Creswell JW., 1998, QUAL INQ; De Tanti A, 2005, BRAIN INJURY, V19, P1277, DOI 10.1080/02699050500309270; Dennis CM, 2010, J NEUROSCI NURS, V42, P217, DOI 10.1097/JNN.0b013e3181e26c20; Kenner C, 2004, DEV CARE NEWBORNS IN; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Krach LE, 1997, J NEUROL REHABIL, V11, P41; Letzkus L, 2016, BRAIN INJURY, V30, P1181, DOI 10.1080/02699052.2016.1184757; Linder LA, 2011, CANCER NURS, V34, P176, DOI 10.1097/NCC.0b013e3181fc52d0; Liu WF, 2007, J PERINATOL, V27, pS48, DOI 10.1038/sj.jp.7211844; McNett MM, 2010, J NEUROSCI NURS, V42, P71, DOI 10.1097/JNN.0b013e3181ce5b8a; Plusbuyer, 2014, PHON; Pyle, 2014, PHOT; Rabinstein AA, 2004, ARCH NEUROL-CHICAGO, V61, P1625, DOI 10.1001/archneur.61.10.1625-a; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Symington A, 2003, COCHRANE COLLABORATI; U.S. Environmental Protection Agency, 1974, INF LEV ENV NOIS REQ	19	4	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2018	50	2					88	92		10.1097/JNN.0000000000000349			5	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	FZ7QC	WOS:000427795000008	29521731				2022-02-06	
J	Lindborg, CM; Brennan, TA; Wang, HT; Kaplan, FS; Pignolo, RJ				Lindborg, Carter M.; Brennan, Tracy A.; Wang, Haitao; Kaplan, Frederick S.; Pignolo, Robert J.			Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP)	BONE			English	Article						Fibrodysplasia ossificans progressiva (FOP); Heterotopic ossification; Cartilage-derived retinoic acid-sensitive protein (CD-RAP); RAR gamma agonists; Biomarker; ACVR1	MELANOMA INHIBITORY-ACTIVITY; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; MATRIX PROTEIN; SERUM MARKER; RISK-FACTORS; RECEPTOR; ARTHROPLASTY; PREVALENCE; HIP	Background: Genesis of a cartilaginous scaffold is an obligate precursor to bone formation in heterotopic endochondral ossification (HEO). We tested the hypothesis that cartilage-derived retinoic acid-sensitive protein (CD-RAP) can serve as a plasma biomarker for the pre-osseous cartilaginous stage of HEO. Palovarotene, a retinoic acid receptor-gamma (RAR gamma) agonist, has been proposed as a possible treatment for fibrodysplasia ossificans progressiva (FOP) and is a potent inhibitor of HEO in mouse models. Current drug development for FOP mandates the identification of stage-specific biomarkers to facilitate the evaluation of clinical trial endpoints. Results: Here we show in an injury-induced, constitutively-active transgenic mouse model of FOP that CD-RAP levels peaked between day-7 and day-10 during the zenith of histologically-identified chondrogenesis, preceded radiographically apparent HEO, and were diminished by palovarotene. Cross-sectional analysis of CD-RAP levels in plasma samples from FOP patients demonstrated a statistically non-significant trend toward higher levels in the recent flare-up period (three weeks to three months within onset of symptoms). However, in a longitudinal subgroup analysis of patients followed for at least six months after resolution of flare-up symptoms, there was a statistically significant decrease of CD-RAP when compared to levels in the same patients at the time of active or recent exacerbations. Conclusions: These data support the further exploration of CD-RAP as a stage-specific biomarker of HEO in FOP. (C) 2017 Elsevier Inc. All rights reserved.	[Lindborg, Carter M.; Brennan, Tracy A.; Kaplan, Frederick S.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Haitao; Kaplan, Frederick S.] Univ Penn, Dept Orthopaed Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Haitao; Kaplan, Frederick S.] Univ Penn, Ctr Res FOP & Related Disorders, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pignolo, Robert J.] Mayo Clin, Sch Med, Dept Med, Rochester, MN 55905 USA		Pignolo, RJ (corresponding author), Mayo Clin, Coll Med, 200 First St SW, Rochester, MN 55905 USA.	cml274@georgetown.edu; tabrenna@verizon.net; whaitao@mail.med.upenn.edu; frederick.kaplan@uphs.upenn.edu; pignolo.robert@mayo.edu	Wang, Haitao/AAG-8784-2020		Clementia Pharmaceuticals, Inc.; Cali-Weldon Preclinical Drug Testing and Biomarker Development Program at the University of Pennsylvania; Ian Cali Distinguished Clinician-Scientist award; Robert and Arlene Professorship in Geriatric Medicine at the Mayo Clinic; Radiant Hope Foundation; Center for Research in FOP and Related Disorders at the University of Pennsylvania Perelman School of Medicine; Ian Cali Endowment for FOP Research; Whitney Weldon Endowment for FOP Research; Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine; Penn Center for Musculoskeletal Disorders [NIH P30-AR050950]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH R01-AR41916]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P30AR050950, R01AR041916] Funding Source: NIH RePORTER	This work was supported by Clementia Pharmaceuticals, Inc., the Cali-Weldon Preclinical Drug Testing and Biomarker Development Program at the University of Pennsylvania, the Ian Cali Distinguished Clinician -Scientist award, the Robert and Arlene Professorship in Geriatric Medicine at the Mayo Clinic, and the Radiant Hope Foundation (to RJP); the Center for Research in FOP and Related Disorders at the University of Pennsylvania Perelman School of Medicine; the Ian Cali Endowment for FOP Research; the Whitney Weldon Endowment for FOP Research and the Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine (to FSK). This work was also supported by the Penn Center for Musculoskeletal Disorders (NIH P30-AR050950), and the National Institutes of Health (NIH R01-AR41916).	Bosserhoff AK, 1997, CANCER RES, V57, P3149; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Covey Dana C, 2006, J Am Acad Orthop Surg, V14, pS10; Covey Dana C, 2010, Instr Course Lect, V59, P427; Dalury DF, 2004, J ARTHROPLASTY, V19, P447, DOI 10.1016/j.arth.2003.12.064; Dietz UH, 1996, J BIOL CHEM, V271, P3311, DOI 10.1074/jbc.271.6.3311; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; HSU JD, 1975, CLIN ORTHOP RELAT R, P165; Jamil F, 2002, SPINAL CORD, V40, P388, DOI 10.1038/sj.sc.3101305; Joshi AB, 2002, J ARTHROPLASTY, V17, P427, DOI 10.1054/arth.2002.32170; Kan LX, 2011, J CELL BIOCHEM, V112, P2759, DOI 10.1002/jcb.23259; Kaplan FS, 2007, EXPERT OPIN BIOL TH, V7, P705, DOI 10.1517/14712598.7.5.705; KAPLAN FS, 1994, J BONE JOINT SURG AM, V76A, P425, DOI 10.2106/00004623-199403000-00013; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Keenan MAE, 1996, J HEAD TRAUMA REHAB, V11, P8, DOI 10.1097/00001199-199608000-00004; Kolanczyk M, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-82; Muller-Ladner U, 1999, RHEUMATOLOGY, V38, P148, DOI 10.1093/rheumatology/38.2.148; Neidhart M, 2000, OSTEOARTHR CARTILAGE, V8, P222, DOI 10.1053/joca.1999.0293; ORZEL JA, 1985, J NUCL MED, V26, P125; Pignolo RJ, 2005, CLIN REV BONE MINER, V3, P261, DOI 10.1385/BMM:3:3-4:261; Pignolo RJ, 2016, J BONE MINER RES, V31, P650, DOI 10.1002/jbmr.2728; Pignolo RJ, 2013, PEDIATR ENDOCR REV P, V10, P437; Pignolo RJ, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-80; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Sakano S, 1999, J BONE MINER RES, V14, P1891, DOI 10.1359/jbmr.1999.14.11.1891; Schmidt-Rohlfing B, 2002, RHEUMATOL INT, V22, P165, DOI 10.1007/s00296-002-0215-x; Schubert T, 2010, EXP MOL MED, V42, P166, DOI 10.3858/emm.2010.42.3.017; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Tscheudschilsuren G, 2006, EXP CELL RES, V312, P63, DOI 10.1016/j.yexcr.2005.09.017; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	35	4	4	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	APR	2018	109				SI		153	157		10.1016/j.bone.2017.09.016			5	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	GB5DK	WOS:000429082400025	28963080	Green Accepted			2022-02-06	
J	Rand, D; Givon, N; Bar, MA				Rand, Debbie; Givon, Noa; Bar, Michal Avrech			A video-game group intervention: Experiences and perceptions of adults with chronic stroke and their therapists	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Neurology; Occupational therapy; Qualitative research; Rehabilitation; Video games	TRAUMATIC BRAIN-INJURY; VIRTUAL-REALITY; GAMING TECHNOLOGY; REHABILITATION; PEOPLE; PROGRAMS; PARTICIPATION; RECOVERY; VALIDITY; BALANCE	Background. Ongoing physical activity is important for maintaining the functional level of individuals with chronic stroke. Video games in a group setting might be a cost-effective way for providing mobility and preventing physical inactivity. Purpose. This study explores the experiences and perceptions of individuals with chronic stroke who participated in a novel community-based video-game group intervention and their therapists. Method. A qualitative study, nested in a randomized controlled trial, was conducted using semistructured interviews with eight individuals with chronic stroke (four men and four women) ages 29 to 69 and a focus group of their three occupational therapists, following a video-game intervention. Data were analyzed using content analysis. Findings. Three main categories were identified by the study participants: (a) using video games, (b) the group/team experience, and (c) intervention outcomes/evolving understandings following the intervention. Implications. Playing video games was perceived not as treatment but as a motivating tool to facilitate whole-body movement. Therefore, this intervention might be suitable to be used in the community for ongoing intervention.	[Rand, Debbie; Givon, Noa; Bar, Michal Avrech] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Occupat Therapy, IL-69978 Tel Aviv, Israel		Rand, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Occupat Therapy, IL-69978 Tel Aviv, Israel.	drand@post.tau.ac.il	Avrech-Bar, Michal/AAH-8549-2021	Avrech Bar, Michal/0000-0001-9656-4780	European Commission, Seventh Framework Programme [277023]	This study was supported through a grant from the European Commission, Seventh Framework Programme (No. 277023).	Annema JH, 2013, INT J ARTS TECHNOL, V6, P106, DOI 10.1504/IJART.2013.050695; Barker RN, 2005, DISABIL REHABIL, V27, P1213, DOI 10.1080/09638280500075717; Broeks JG, 1999, DISABIL REHABIL, V21, P357; Brown EVD, 2015, DISABIL HEALTH J, V8, P507, DOI 10.1016/j.dhjo.2015.03.007; Celinder D, 2012, SCAND J OCCUP THER, V19, P457, DOI 10.3109/11038128.2012.655307; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd edition; Combs SA, 2012, DISABIL REHABIL, V34, P1291, DOI 10.3109/09638288.2011.641660; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Cyarto EV, 2006, J SCI MED SPORT, V9, P402, DOI 10.1016/j.jsams.2006.06.020; Farrow S., 2004, TECHNOL DISABIL, V16, P69, DOI [10.3233/TAD-2004-16201, DOI 10.3233/TAD-2004-16201]; Foley N., 2013, UPPER EXTREMITY INTE; Fritz SL, 2013, TOP STROKE REHABIL, V20, P218, DOI 10.1310/tsr2003-218; Givon N, 2016, CLIN REHABIL, V30, P383, DOI 10.1177/0269215515584382; Glegg SMN, 2013, CYBERPSYCH BEH SOC N, V16, P385, DOI 10.1089/cyber.2013.1506; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Guba E. G., 1998, LANDSCAPE QUALITATIV, P195; Hartman-Maeir A, 2007, DISABIL REHABIL, V29, P559, DOI 10.1080/09638280600924996; Jensen MP, 2005, ARCH PHYS MED REHAB, V86, P116, DOI 10.1016/j.apmr.2004.01.040; Lange B, 2012, DISABIL REHABIL, V34, P1863, DOI 10.3109/09638288.2012.670029; Laver K, 2011, AUST OCCUP THER J, V58, P215, DOI 10.1111/j.1440-1630.2010.00897.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LAWTON MP, 1982, J GERONTOL, V37, P91, DOI 10.1093/geronj/37.1.91; Levac DE, 2013, PHYSIOTHER THEOR PR, V29, P504, DOI 10.3109/09593985.2012.762078; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; Lewis GN, 2011, DISABIL REHABIL-ASSI, V6, P453, DOI 10.3109/17483107.2011.574310; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; Oxford Dictionaries, 2016, VID GAM; Page SJ, 2004, ARCH PHYS MED REHAB, V85, P1377, DOI 10.1016/j.apmr.2003.12.031; Peng W, 2013, HEALTH EDUC BEHAV, V40, P171, DOI 10.1177/1090198112444956; Peters DM, 2013, J NEUROL PHYS THER, V37, P105, DOI 10.1097/NPT.0b013e31829ee9bc; Rand D, 2015, J STROKE CEREBROVASC, V24, P274, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.039; Rand D, 2014, NEUROREHAB NEURAL RE, V28, P733, DOI 10.1177/1545968314521008; Rand Debbie, 2008, J Neurol Phys Ther, V32, P155, DOI 10.1097/NPT.0b013e31818ee779; Rand D, 2009, STROKE, V40, P163, DOI 10.1161/STROKEAHA.108.523621; Richards L., 2007, README 1 USERS GUIDE, V2nd Edn; Ryan R.M., 2009, HELL J PSYCHOL, V6, P107, DOI [DOI 10.1080/17509840701827437, 10.1080/17509840701827437]; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979; Saunders DH, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub6; Shkedi A, 2011, MEANING WORDS METHOD; Shkedi A., 2005, MULTIPLE CASE NARRAT; Simpson LA, 2011, INT J THER REHABIL, V18, P520, DOI 10.12968/ijtr.2011.18.9.520; Strauss A., 1990, BASICS QUALITATIVE R; Strauss A., 1994, HDB QUALITATIVE RES, V17, P273, DOI DOI 10.1007/BF00988593; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Weiss P. L., 2014, TXB NEURAL REPAIR RE, V2, P918; Weiss PL, 2009, PHYS THER REV, V14, P307, DOI 10.1179/108331909X12488667117339	49	4	4	2	26	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	APR	2018	85	2					158	168		10.1177/0008417417733274			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GD0YV	WOS:000430228100011	29614877				2022-02-06	
J	Van Horn, JD; Irimia, A; Torgerson, CM; Bhattrai, A; Jacokes, Z; Vespa, PM				Van Horn, John Darrell; Irimia, Andrei; Torgerson, Carinna M.; Bhattrai, Avnish; Jacokes, Zachary; Vespa, Paul M.			Mild cognitive impairment and structural brain abnormalities in a sexagenarian with a history of childhood traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; mild cognitive impairment; aging	GOODNESS-OF-FIT; CAVUM SEPTUM PELLUCIDUM; ALZHEIMERS-DISEASE; OLDER-ADULTS; EARLIER AGE; EARLY-ONSET; RESERVE; CHILDREN; EDUCATION; SEVERITY	In this report, we present a case study involving an older, female patient with a history of pediatric traumatic brain injury (TBI). Magnetic resonance imaging and diffusion tensor imaging volumes were acquired from the volunteer in question, her brain volumetrics and morphometrics were extracted, and these were then systematically compared against corresponding metrics obtained from a large sample of older healthy control (HC) subjects as well as from subjects in various stages of mild cognitive impairment (MCI) and Alzheimer disease (AD). Our analyses find the patient's brain morphometry and connectivity most similar to those of patients classified as having early-onset MCI, in contrast to HC, late MCI, and AD samples. Our examination will be of particular interest to those interested in assessing the clinical course in older patients having suffered TBI earlier in life, in contradistinction to those who experience incidents of head injury during aging.	[Van Horn, John Darrell; Irimia, Andrei; Torgerson, Carinna M.; Bhattrai, Avnish; Jacokes, Zachary] Univ Southern Calif, USC Mark & Mary Stevens Neuroimaging & Informat I, 2025 Zonal Ave, Los Angeles, CA 90033 USA; [Vespa, Paul M.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA		Van Horn, JD (corresponding author), Univ Southern Calif, USC Mark & Mary Stevens Neuroimaging & Informat I, 2025 Zonal Ave, Los Angeles, CA 90033 USA.	jvanhorn@usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Van Horn, John/0000-0003-1537-0816	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R44 NS081792-03A1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS081792] Funding Source: NIH RePORTER	This work was supported by NIH grant R44 NS081792-03A1 to J.V.H.	Akinola RA, 2014, ACTA RADIOL OPEN, V3, DOI 10.1177/2047981614530288; Apostolova L. G., 2010, STAT MAP BASED CLASS; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Bennet AM, 2011, J ALZHEIMERS DIS, V24, P475, DOI 10.3233/JAD-2011-101848; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Bigler ED, 2014, NEUROLOGY, V82, P1641, DOI 10.1212/WNL.0000000000000395; Bodensteiner JB, 1997, SPORTS MED, V24, P361, DOI 10.2165/00007256-199724060-00002; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; Boyle P, 1997, INT J EPIDEMIOL, V26, P651, DOI 10.1093/ije/26.3.651; Carnero-Pardo C, 2007, NEUROLOGIA, V22, P860; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Celsis P, 2000, ANN MED, V32, P6, DOI 10.3109/07853890008995904; Cheng ST, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0721-2; CHOI JW, 1989, BIOMETRICS, V45, P979, DOI 10.2307/2531697; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Elkana O, 2016, J ALZHEIMERS DIS, V49, P607, DOI 10.3233/JAD-150562; Fisher MJ, 2011, AUST CRIT CARE, V24, P133, DOI 10.1016/j.aucc.2011.01.005; Friston KJ, 2008, NEUROIMAGE, V39, P181, DOI 10.1016/j.neuroimage.2007.08.013; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Gupta A, 2015, NEUROIMAGE-CLIN, V7, P506, DOI 10.1016/j.nicl.2015.01.005; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Henderson VW, 2014, CLIMACTERIC, V17, P510, DOI 10.3109/13697137.2014.931618; Hermans L., 2016, NEUROREHABILITATION, V31, P228; Hua X, 2008, NEUROIMAGE, V41, P19, DOI 10.1016/j.neuroimage.2008.02.010; Hua X, 2011, NEUROIMAGE, V57, P5, DOI 10.1016/j.neuroimage.2011.01.079; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Jack CR, 2010, ALZHEIMERS DEMENT, V6, P212, DOI 10.1016/j.jalz.2010.03.004; Johnston JE, 2006, PERCEPT MOTOR SKILL, V103, P412, DOI 10.2466/PMS.103.2.412-414; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kowoll ME, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00062; Kvalseth TO, 2004, PERCEPT MOTOR SKILL, V98, P967; Lalli MA, 2014, ALZHEIMERS DEMENT, V10, pS277, DOI 10.1016/j.jalz.2013.09.005; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Mathews PM, 2000, MOL MED, V6, P878, DOI 10.1007/BF03401825; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Miller LS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00506; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Moussard A, 2016, BRAIN RES, V1642, P146, DOI 10.1016/j.brainres.2016.03.028; Nestor SM, 2008, BRAIN, V131, P2443, DOI 10.1093/brain/awn146; Newman M, 2014, HUM MOL GENET, V23, P602, DOI 10.1093/hmg/ddt448; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Poulin P, 2002, BRAIN COGNITION, V49, P220, DOI 10.1006/brcg.2001.1471; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; REIJNEVELD SA, 1990, AM J PHYS ANTHROPOL, V83, P181, DOI 10.1002/ajpa.1330830206; Rencher Alvan C., 2002, METHODS MULTIVARIATE; Ringman JM, 2011, NEUROSCI LETT, V487, P287, DOI 10.1016/j.neulet.2010.10.039; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Sakka P, 2015, ADV EXP MED BIOL, V821, P125, DOI 10.1007/978-3-319-08939-3_16; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Silk T, 2013, PSYCHIAT RES-NEUROIM, V213, P186, DOI 10.1016/j.pscychresns.2013.03.001; Sobral M, 2015, ARQ NEURO-PSIQUIAT, V73, P480, DOI 10.1590/0004-282X20150044; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thompson PM, 2007, ANN NY ACAD SCI, V1097, P183, DOI 10.1196/annals.1379.017; Van Horn JD, 2009, CURR OPIN NEUROL, V22, P370, DOI 10.1097/WCO.0b013e32832d92de; VansHorn J. D., 2009, IMAGING AGING BRAIN; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Walther A, 2016, NEUROIMAGE, V137, P188, DOI 10.1016/j.neuroimage.2015.12.012; Weiner MW, 2014, ALZHEIMERS DEMENT, V10, pS226, DOI 10.1016/j.jalz.2014.04.005; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Weiner Michael W, 2013, Alzheimers Dement, V9, pe111, DOI [10.1016/j.jalz.2011.09.172, 10.1016/j.jalz.2013.05.1769]; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446	77	4	4	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		652	660		10.1002/jnr.24084			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FV2DK	WOS:000424374300015	28543689	Green Accepted			2022-02-06	
J	Diakogeorgiou, E; Miyashita, TL				Diakogeorgiou, Eleni; Miyashita, Theresa L.			Effect of Head Impact Exposures on Changes in Cognitive Testing	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; cognitive testing; accelerometer; hit count	COLLEGIATE FOOTBALL PLAYERS; CONCUSSION; SPORTS; MANAGEMENT; IMPAIRMENT; STATEMENT; SYMPTOMS	Background: Gaining a better understanding of head impact exposures may lead to better comprehension of the possible effects of repeated impact exposures not associated with clinical concussion. Purpose: To assess the correlation between head impacts and any differences associated with cognitive testing measurements pre- and postseason. Study Design: Case-control study; Level of evidence, 3. Methods: A total of 34 National Collegiate Athletic Association Division I men's lacrosse players wore lacrosse helmets instrumented with an accelerometer during the 2014 competitive season and were tested pre- and postseason with the Sport Concussion Assessment Tool (SCAT 3) and Concussion Vital Signs (CVS) computer-based neurocognitive tests. The number of head impacts >20g and results from the 2 cognitive tests were analyzed for differences and correlation. Results: There was no significant difference between pre- and postseason SCAT 3 scores, although a significant correlation between pre- and postseason cognitive scores on the SCAT 3 and total number of impacts sustained was noted (r = -0.362, P = .035). Statistically significant improvements on half of the CVS testing components included visual reaction time (P = .037, d = 0.37), reaction time (P = .001, d = 0.65), and simple reaction time (P = .043, d = 0.37), but no correlation with head impacts was noted. Conclusion: This study did not find declines in SCAT 3 or CVS scores over the course of a season among athletes who sustained multiple head impacts but no clinical concussion. Thus, it could not be determined whether there was no cognitive decline among these athletes or whether there may have been subtle declines that could not be measured by the SCAT 3 or CVS.	[Diakogeorgiou, Eleni; Miyashita, Theresa L.] Sacred Heart Univ, 5151 Pk Ave, Fairfield, CT 06825 USA		Diakogeorgiou, E (corresponding author), Sacred Heart Univ, 5151 Pk Ave, Fairfield, CT 06825 USA.	diakogeorgioue@sacredheart.edu					Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512	25	4	4	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR 29	2018	6	3							2325967118761031	10.1177/2325967118761031			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	GC6LW	WOS:000429904300001	29623281	Green Published, gold			2022-02-06	
J	Buchmann, I; Jung, R; Liepert, J; Randerath, J				Buchmann, Ilka; Jung, Rebecca; Liepert, Joachim; Randerath, Jennifer			Assessing Anosognosia in Apraxia of Common Tool-Use With the VATA-NAT	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						anosognosia; tool-use apraxia; VATA-NAT; psychometric properties; stroke	TRAUMATIC BRAIN-INJURY; RIGHT-HEMISPHERE; MOTOR AWARENESS; HEMIPLEGIA; STROKE; SELF; UNAWARENESS; IMPAIRMENT; DISORDERS; DISEASE	In neurological patients, a lack of insight into their impairments can lead to possibly dangerous situations and non-compliance in rehabilitation therapy with worse rehabilitation outcomes as a result. This so called anosognosia is a multifaceted syndrome that can occur after brain damage affecting different neurological or cognitive functions. To our knowledge no study has investigated anosognosia for apraxia of common tool-use (CTU) so far. CTU-apraxia is a disorder frequently occurring after stroke that affects the use of familiar objects. Here, we introduce a new questionnaire to diagnose anosognosia for CTU-apraxia, the Visual Analogue Test assessing Anosognosia for Naturalistic Action Tasks (VATA-NAT). This assessment is adapted from a series of VATA-questionnaires that evaluate insight into motor (VATA-M) or language (VATA-L) impairment and take known challenges such as aphasia into account. Fifty one subacute stroke patients with left (LBD) or right (RBD) brain damage were investigated including patients with and without CTU-apraxia. Patients were assessed with the VATA-L,-M and -NAT before and after applying a diagnostics session for each function. Interrater reliability, composite reliability as well as convergent and divergent validity were evaluated for the VATA-NAT. Seven percent of the LBD patients with CTU-apraxia demonstrated anosognosia. After tool-use diagnostics this number increased to 20 percent. For the VATA-NAT, psychometric data revealed high interrater-reliability (t >= 0.828), composite reliability (CR >= 0.809) and convergent validity (tau = -0.626). When assessing patients with severe aphasia, the possible influence of language comprehension difficulties needs to be taken into account for interpretation. Overall, close monitoring of anosognosia over the course of rehabilitation is recommended. With the VATA-NAT we hereby provide a novel assessment for anosognosia in patients with CTU-apraxia. For diagnosing anosognosia we recommend to combine this new tool with the existing VATA-M and -L subtests, particularly in patients who demonstrate severe functional deficits.	[Buchmann, Ilka; Jung, Rebecca; Randerath, Jennifer] Univ Konstanz, Dept Psychol, Constance, Germany; [Buchmann, Ilka; Liepert, Joachim; Randerath, Jennifer] Univ Konstanz, Schmieder Fdn Sci & Res, Lurija Inst Rehabil & Hlth Sci, Allensbach, Germany; [Liepert, Joachim] Kliniken Schmieder, Allensbach, Germany		Randerath, J (corresponding author), Univ Konstanz, Dept Psychol, Constance, Germany.; Randerath, J (corresponding author), Univ Konstanz, Schmieder Fdn Sci & Res, Lurija Inst Rehabil & Hlth Sci, Allensbach, Germany.	j_randerath@hotmail.com	Randerath, Jennifer/AAC-1530-2019	Randerath, Jennifer/0000-0002-0794-5571	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [RA2492/3-1]; EU FP7 Marie Curie Zukunftskolleg Incoming Fellowship Programme at the University of Konstanz [291784]; Landesgraduiertenforderungsgesetz (LGFG) in Baden-Wurttemberg	This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG) (Grant No. RA2492/3-1) and the EU FP7 Marie Curie Zukunftskolleg Incoming Fellowship Programme at the University of Konstanz (Grant No. 291784) awarded to Dr. Jennifer Randerath and the Landesgraduiertenforderungsgesetz (LGFG) in Baden-Wurttemberg awarded to M.Sc. Ilka Buchmann.	Anton G., 1893, Z HEILKUNDE, P313; Babinski J.F.F., 1914, REV NEUROL, DOI [DOI 10.1016/J.CORTEX.2014.04.019, 10.1016/j.cortex.2014.04.019]; Baier B, 2005, J NEUROL NEUROSUR PS, V76, P358, DOI 10.1136/jnnp.2004.036731; Baier B, 2014, CORTEX, V61, P120, DOI 10.1016/j.cortex.2014.07.017; Berlingeri M, 2015, CONSCIOUS COGN, V37, P160, DOI 10.1016/j.concog.2015.08.010; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; BREIER JI, 1995, NEUROLOGY, V45, P65, DOI 10.1212/WNL.45.1.65; Buchmann I, 2017, CORTEX, V94, P49, DOI 10.1016/j.cortex.2017.06.001; Canzano L, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00039; Canzano L, 2014, CORTEX, V61, P148, DOI 10.1016/j.cortex.2014.05.015; Celesia GG, 1997, NEUROLOGY, V49, P88, DOI 10.1212/WNL.49.1.88; Cho E, 2016, ORGAN RES METHODS, V19, P651, DOI 10.1177/1094428116656239; Cocchini G, 2012, ACTA NEUROPSYCHOL, V10, P419, DOI 10.5604/17307503.1023693; Cocchini G, 2010, CLIN NEUROPSYCHOL, V24, P1379, DOI 10.1080/13854046.2010.524167; Cocchini G, 2010, NEUROPSYCHOLOGIA, V48, P1489, DOI 10.1016/j.neuropsychologia.2010.01.019; Cocchini G, 2009, NEUROPSYCHOLOGY, V23, P223, DOI 10.1037/a0014266; COHEN L, 1991, J NEUROL NEUROSUR PS, V54, P842, DOI 10.1136/jnnp.54.9.842; Cotelli M, 2014, J CLIN EXP NEUROPSYC, V36, P843, DOI 10.1080/13803395.2014.948389; CUTTING J, 1978, J NEUROL NEUROSUR PS, V41, P548, DOI 10.1136/jnnp.41.6.548; Dean MP, 2017, APHASIOLOGY, V31, P725, DOI 10.1080/02687038.2016.1239014; Della Sala S, 2009, CLIN NEUROPSYCHOL, V23, P406, DOI 10.1080/13854040802251393; Dovern A, 2011, FORTSCHR NEUROL PSYC, V79, P345, DOI 10.1055/s-0029-1246097; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Gambina G, 2015, AM J ALZHEIMERS DIS, V30, P635, DOI 10.1177/1533317515577185; Garbarini F, 2013, J NEUROL NEUROSUR PS, V84, P416, DOI 10.1136/jnnp-2012-302838; Gasquoine PG, 2016, NEUROPSYCHOL REHABIL, V26, P261, DOI 10.1080/09602011.2015.1011665; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Goldenberg G., 2011, APRAXIEN; Hanna-Pladdy B, 2003, NEUROLOGY, V60, P487, DOI 10.1212/WNL.60.3.487; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hartman-Maeir A, 2001, NEUROREHAB NEURAL RE, V15, P213, DOI 10.1177/154596830101500309; Huber W., 1983, AACHENER APHASIE TES; Jenkinson PM, 2014, CORTEX, V61, P1, DOI 10.1016/j.cortex.2014.10.005; Karnath H. O., 2012, KOGNITIVE NEUROWISSE, V3, P202; Katz JM, 2004, NEUROLOGY, V63, P2440, DOI 10.1212/01.WNL.0000149192.60937.B3; Kertesz A, 1970, Cortex, V6, P362; Kertesz A, 2010, STUDY ANOSOGNOSIA, P113; Langer KG, 2014, CORTEX, V61, P5, DOI 10.1016/j.cortex.2014.04.019; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEBRUN Y, 1987, CORTEX, V23, P251, DOI 10.1016/S0010-9452(87)80035-7; MAHER LM, 1994, BRAIN LANG, V46, P402, DOI 10.1006/brln.1994.1022; Mattioli F, 2012, NEUROPSYCHOL REHABIL, V22, P501, DOI 10.1080/09602011.2012.662340; Morin A, 2017, LATERALITY, V22, P105, DOI 10.1080/1357650X.2016.1173049; Moro V, 2011, BEHAV BRAIN RES, V225, P259, DOI 10.1016/j.bbr.2011.07.010; Nurmi ME, 2014, CORTEX, V61, P43, DOI 10.1016/j.cortex.2014.04.008; Orfei MD, 2009, CEREBROVASC DIS, V27, P280, DOI 10.1159/000199466; Orfei MD, 2008, NEUROSCIENTIST, V14, P203, DOI 10.1177/1073858407309995; Orfei MD, 2010, AM J GERIAT PSYCHIAT, V18, P1133, DOI 10.1097/JGP.0b013e3181dd1c50; Orfei MD, 2010, STUDY ANOSOGNOSIA, P429; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Ownsworth T., 2014, SELF IDENTITY BRIAN; Pedersen PM, 1996, ARCH PHYS MED REHAB, V77, P25, DOI 10.1016/S0003-9993(96)90215-4; Peskine A, 2007, BEHAVIORAL AND COGNITIVE NEUROLOGY OF STROKE, P198, DOI 10.1017/CBO9780511544880.011; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Plummer P, 2003, PHYS THER, V83, P732, DOI 10.1093/ptj/83.8.732; Poeck K., 2006, KLINISCHE NEUROPSYCH, V6, P227; Prigatano G., 2008, COGNITIVE NEUROREHAB, P218; Prigatano G.P., 2010, STUDY ANOSOGNOSIA; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rubens A. B., 1991, AWARENESS DEFICIT BR, V3rd, P40; Schachter D. L., 1991, CLIN THEORETICAL ISS, P127; Spalletta G, 2012, J ALZHEIMERS DIS, V29, P761, DOI 10.3233/JAD-2012-111886; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P719, DOI 10.1136/jnnp.2005.085373; Starkstein SE, 2010, CAN J PSYCHIAT, V55, P355, DOI 10.1177/070674371005500604; Turnbull OH, 2014, CORTEX, V61, P18, DOI 10.1016/j.cortex.2014.10.008; Vallar G, 2003, PROG BRAIN RES, V142, P285; Vocat R, 2010, BRAIN, V133, P3578, DOI 10.1093/brain/awq297; Von Monakow A, 1885, ARCH PSYCHIAT, V16, P151, DOI DOI 10.1007/BF02227304; Wang YC, 2014, WORK, V47, P553, DOI 10.3233/WOR-131627; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wu AJ, 2014, TOP STROKE REHABIL, V21, P211, DOI 10.1310/tsr2103-211	71	4	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAR 27	2018	12								119	10.3389/fnhum.2018.00119			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GA6MY	WOS:000428448300001	29636672	Green Published, gold			2022-02-06	
J	Weeks, JJ; Carlson, LJ; Radabaugh, HL; de la Tremblaye, PB; Bondi, CO; Kline, AE				Weeks, Jillian J.; Carlson, Lauren J.; Radabaugh, Hannah L.; de la Tremblaye, Patricia B.; Bondi, Corina O.; Kline, Anthony E.			Intermittent treatment with haloperidol or quetiapine does not disrupt motor and cognitive recovery after experimental brain trauma	BEHAVIOURAL BRAIN RESEARCH			English	Article						Antipsychotic drugs; Behavioral outcome; Controlled cortical impact; Functional recovery; Learning and memory; Morris water maze; Traumatic brain injury	DOPAMINE-D-2 RECEPTOR OCCUPANCY; WATER MAZE PERFORMANCE; ENVIRONMENTAL ENRICHMENT; ATYPICAL ANTIPSYCHOTICS; WORKING-MEMORY; UNITED-STATES; CORTEX INJURY; RATS; RISPERIDONE; BEHAVIOR	Traumatic brain injury (TBI)-induced agitation and aggression pose major obstacles to clinicians in the acute hospital and rehabilitation settings. Thus, management of these symptoms is crucial. Antipsychotic drugs (APDs) are a common treatment approach for alleviating these symptoms. However, previous pre-clinical TBI studies have indicated that daily and chronic administration of these drugs (e.g., haloperidol; HAL) can exacerbate cognitive and motor deficits. Quetiapine (QUE) is an atypical APD that differs from many typical APDs, such as HAL, in its relatively rapid dissociation from the D-2 receptor. The goal of this study was to test the hypotheses that intermittent HAL and QUE would not hinder recovery of cognitive and motor function following TBI and that daily QUE would also not impair functional recovery, which would be in contrast to HAL. Seventy anesthetized male rats received either a controlled cortical impact or sham injury and were then randomly assigned to TBI and sham groups receiving HAL (0.5 mg/kg) or QUE (10 mg/kg) intraperitoneally once per day or once every other day and compared to each other and vehicle (VEH) controls. Motor function was assessed by beam balance/walk tests on post-operative days 1-5 and cognitive function was evaluated with a Morris water maze task on days 14-19. No differences were revealed among the sham groups in any task, and hence the data were pooled. No overall differences were detected among the TBI groups, regardless of treatment or administration paradigm [p > 0.05], but all were impaired vs. SHAM controls [p < 0.05]. The SHAM controls also performed significantly better in the cognitive test vs. all TBI groups [p < 0.05]. Moreover, the TBI + continuous HAL group performed worse than the TBI + continuous VEH, TBI + continuous QUE, and TBI + intermittent QUE groups [p < 0.05], which did not differ from one another. Overall, the data suggest that QUE does not exacerbate TBI-induced cognitive and motor deficits, which supports the hypothesis. QUE may prove useful as an alternative APD treatment for management of agitation and aggression after clinical TBI. HAL may also be safe, but only if used sparingly. (C) 2016 Elsevier B.V. All rights reserved.	[Weeks, Jillian J.; Carlson, Lauren J.; Radabaugh, Hannah L.; de la Tremblaye, Patricia B.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Weeks, Jillian J.; Carlson, Lauren J.; Radabaugh, Hannah L.; de la Tremblaye, Patricia B.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 Fifth Ave Suite 201, Pittsburgh, PA 15213 USA; [Weeks, Jillian J.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA		Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 Fifth Ave Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Phys Med & Rehabil Crit Care Med Psychol, 3471 Fifth Ave Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060005, HD069620, HD069620-S1, NS084967, NS094950]; University of Pittsburgh Physicians/UPMC Academic Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS094950, R01NS060005, R01NS084967] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health grants NS060005, HD069620, HD069620-S1, NS084967 (AEK), NS094950 (COB), and the University of Pittsburgh Physicians/UPMC Academic Foundation (COB).	Amin SN, 2014, J INTEGR NEUROSCI, V13, P669, DOI 10.1142/S0219635214500253; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Daniels JP, 2008, J CLIN PSYCHIAT, V69, P497, DOI 10.4088/JCP.v69n0324a; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Faul M, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Folweiler K., 2016, J NEUROTRAUMA; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; He J, 2006, BEHAV BRAIN RES, V172, P39, DOI 10.1016/j.bbr.2006.04.009; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; HOVDA DA, 1985, P W PHARMACOL SOC, V28, P209; Ichikawa J, 2002, BRAIN RES, V956, P349, DOI 10.1016/S0006-8993(02)03570-9; Jibson MD, 1998, J PSYCHIAT RES, V32, P215, DOI 10.1016/S0022-3956(98)00023-5; Johnsen E, 2013, EUR PSYCHIAT, V28, P174, DOI 10.1016/j.eurpsy.2011.10.003; Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161; Kapur S, 2000, ARCH GEN PSYCHIAT, V57, P553, DOI 10.1001/archpsyc.57.6.553; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Leary L. B., 2016, J NEUROTRAUMA; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Ma L, 2015, BRAIN RES, V1622, P443, DOI 10.1016/j.brainres.2015.07.012; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nikiforuk A., EFFECTS QUETIAPINE S; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rosengarten H, 2002, PROG NEURO-PSYCHOPH, V26, P1047, DOI 10.1016/S0278-5846(02)00221-X; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Silverstone P H, 2012, Front Psychiatry, V3, P82, DOI 10.3389/fpsyt.2012.00082; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wadenberg MLG, 2001, NEUROPSYCHOPHARMACOL, V25, P633, DOI 10.1016/S0893-133X(01)00261-5; Wang HN, 2010, PHYSIOL RES, V59, P263, DOI 10.33549/physiolres.931756; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB	49	4	4	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		159	164		10.1016/j.bbr.2016.09.049			6	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400018	27664299	Green Accepted			2022-02-06	
J	Lazar, DJ; Lichtenstein, JD; Tybor, DJ				Lazar, Damien J.; Lichtenstein, Jonathan D.; Tybor, David J.			Concussion Prevalence in Competitive Ultimate Frisbee Players	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; ultimate; ultimate Frisbee	UNITED-STATES; EPIDEMIOLOGY; SPORTS; INJURY; IMPACT	Background: Ultimate Frisbee (ultimate) is a fast-growing, popular sport played nationally by over 4 million athletes. While several studies have examined injury rates in ultimate, no work has investigated the prevalence of concussions specifically or players' knowledge and management of those injuries. Purpose: To estimate the lifetime prevalence of concussions in ultimate and to assess players' knowledge of concussions as well as their concussion management behaviors. Study Design: Descriptive epidemiology study. Methods: From June to November 2015, we collected ultimate-related concussion data via an anonymous web-based survey, the Concussion in Ultimate Frisbee Survey, from a convenience sample of 787 male and female ultimate players across the United States. Results: There were 553 male and 234 female respondents included in the analysis; 26.58% of men and 24.79% of women reported that they had sustained at least 1 concussion while playing ultimate, with 45.58% and 43.10% of those men and women, respectively, reporting multiple concussions. A total of 67.81% of men and 78.21% of women stated that they would remove themselves from play after sustaining a given concussion, although 45.99% of men and 37.62% of women indicated that they had returned to play in the same game or practice. Conclusion: Our preliminary data suggest that concussions do commonly occur in competitive ultimate and that better education and management of concussions in ultimate athletes are needed. This study is an important first step in deepening our understanding of these issues.	[Lazar, Damien J.; Lichtenstein, Jonathan D.; Tybor, David J.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Lazar, Damien J.; Tybor, David J.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Dept Psychiat, Pediat, Hanover, NH USA; [Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Dartmouth Inst, Hanover, NH USA		Lichtenstein, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Psychiat, One Med Ctr Dr, Lebanon, NH 03756 USA.	jonathan.d.lichtenstein@dartmouth.edu		Tajudin, Muhd/0000-0001-7026-4173			Atlanta Flying Disc Club, US; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marfleet P, 1991, Br J Sports Med, V25, P235; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Northwest Ultimate Association, HISTORY; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Shuttleworth-Edwards AB, 2008, J CLIN EXP NEUROPSYC, V30, P870, DOI 10.1080/13803390701846914; Sports & Fitness Industry Association, ULT FRISB PART REP 2; USA Ultimate, ANN REP 2015; Yen LE, 2010, CLIN J SPORT MED, V20, P300, DOI 10.1097/JSM.0b013e3181ea8b1c; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	18	4	4	2	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR 8	2018	6	3							2325967118759051	10.1177/2325967118759051			13	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FY7LG	WOS:000427043100001	29552572	gold, Green Published			2022-02-06	
J	Allen, CJ; Baldor, DJ; Hanna, MM; Namias, N; Bullock, MR; Jagid, JR; Proctor, KG				Allen, Casey J.; Baldor, Daniel J.; Hanna, Mena M.; Namias, Nicholas; Bullock, M. Ross; Jagid, Jonathan R.; Proctor, Kenneth G.			Early Craniectomy Improves Intracranial and Cerebral Perfusion Pressure after Severe Traumatic Brain Injury	AMERICAN SURGEON			English	Article							HEAD COMPUTED-TOMOGRAPHY; DECOMPRESSIVE CRANIECTOMY; NEUROLOGIC CHANGE; PROPENSITY SCORE; TRACK-TBI; HYPERTENSION; MANAGEMENT; TRIAL; MULTICENTER; CRANIOTOMY	y After traumatic brain injury, decompressive craniectomy (DC) is a second-tier, late therapy for refractory intracranial hypertension. We hypothesize that early DC, based on CT evidence of intracranial hypertension, improves intracranial pressure (ICP) and cerebral perfusion pressure (CPP). From September 2008 to January 2015, 286 traumatic brain injury patients requiring invasive ICP monitoring at a single Level I trauma center were reviewed. DC and non-DC patients were propensity scorematched 1: 1, based on demographics, hemodynamics, injury severity score (ISS), Glasgow Coma Scale (GCS), transfusion requirements, and need for vasopressor therapy. Data are presented as M +/- SD or median (IQR) and compared at P <= 0.05. The study populationwas 42 +/- 17 years, 84 per centmale, ISS = 29 +/- 11, GCS = 6 (5), length of stay (LOS) = 32(40) days, and 28 per centmortality. There were 116/286 (41%) DC, of which 105/116 (91%) were performed at the time of ICP placement. For 50 DC propensity matched to 50 non-DC patients, the midline shift was 7(11) versus 0(5) mm (P < 0.001), abnormal ICP (hours > 20 mm Hg) was 1(10) versus 8(16) (P = 0.017), abnormal CPP (hours < 60 mm Hg) was 0(6) versus 4(9) (P = 0.008), daily minimum CPP (mm Hg) was 67(13) versus 62(17) (P = 0.010), and daily maximum ICP (mm Hg) was 18(9) versus 22(11) (P < 0.001). However, LOS [33(37) versus 25(34) days], mortality (24 versus 30%), and Glasgow Outcome Score Extended [3.0(3.0) versus 3.0(4.0)] did not improve significantly. Early DC for CT evidence of intracranial hypertension decreased abnormal ICP and CPP time and improved ICP and CPP thresholds, but had no obvious effect on the outcome.	[Allen, Casey J.; Baldor, Daniel J.; Hanna, Mena M.; Namias, Nicholas; Proctor, Kenneth G.] Univ Miami, Miller Sch Med, Dewitt Daughtry Dept Surg, Div Trauma, Miami, FL 33136 USA; [Allen, Casey J.; Baldor, Daniel J.; Hanna, Mena M.; Namias, Nicholas; Proctor, Kenneth G.] Univ Miami, Miller Sch Med, Dewitt Daughtry Dept Surg, Div Surg Crit Care, Miami, FL 33136 USA; [Allen, Casey J.; Baldor, Daniel J.; Hanna, Mena M.; Namias, Nicholas; Proctor, Kenneth G.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA		Proctor, KG (corresponding author), Univ Miami, Sch Med, Ryder Trauma Ctr, Dept Surg,Div Trauma,Surg, 1800 NW 10th Ave, Miami, FL 33124 USA.; Proctor, KG (corresponding author), Univ Miami, Sch Med, Ryder Trauma Ctr, Dept Surg,Div Surg Crit Care,Surg, 1800 NW 10th Ave, Miami, FL 33124 USA.	kproctor@miami.edu	Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628; Namias, Nicholas/0000-0001-7021-2250	Office of Naval Research, Naval Medical Research Center; U.S. Army Medical Research & Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	Supported in part by: Grants from the Office of Naval Research, Naval Medical Research Center and U.S. Army Medical Research & Material Command.	Alali AS, 2014, CRIT CARE MED, V42, P2235, DOI 10.1097/CCM.0000000000000500; Austin PC, 2010, AM J EPIDEMIOL, V172, P1092, DOI 10.1093/aje/kwq224; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bullock MR, 2007, J NEUROTRAUM, V24, pvii; Bullock MR, 2007, J NEUROTRAUMA, V24; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; Garcia Vicente E, 2013, CASE REP CRIT CARE, V2013; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kurland DB, 2015, NEUROCRIT CARE; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mhanna MJ, 2015, J NEUROSURG PEDIAT, V16, P1; Nambiar M, 2015, CRIT CARE RESUSC, V17, P67; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Ryan ML, 2011, J TRAUMA, V70, P1371, DOI 10.1097/TA.0b013e31821858e6; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Salim A, 2013, J TRAUMA ACUTE CARE, V74, P973; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Sinha S, 2015, NEUROL INDIA, V63, P175, DOI 10.4103/0028-3886.156277; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Tanrikulu L, 2015, CLIN NEUROL NEUROSUR, V135, P15, DOI 10.1016/j.clineuro.2015.04.019; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; Van Haren RM, 2013, J TRAUMA ACUTE CARE, V75, P1030; Van Haren RM, 2013, J TRAUMA ACUTE CARE, V75, P1024, DOI 10.1097/TA.0b013e3182a99d48; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	39	4	4	0	2	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	MAR	2018	84	3					443	450					8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GB0FH	WOS:000428720300032	29559063				2022-02-06	
J	Arnould, A; Rochat, L; Dromer, E; Azouvi, P; Van der Linden, M				Arnould, Annabelle; Rochat, Lucien; Dromer, Emilie; Azouvi, Philippe; Van der Linden, Martial			Does multitasking mediate the relationships between episodic memory, attention, executive functions and apathetic manifestations in traumatic brain injury?	JOURNAL OF NEUROPSYCHOLOGY			English	Article						apathy; initiative; interest; multitasking; executive functions; episodic memory; traumatic brain injury	MULTIDIMENSIONAL APPROACH; BEHAVIORAL SYNDROMES; COGNITIVE FUNCTIONS; ALZHEIMERS-DISEASE; BASAL GANGLIA; FRONTAL LOBES; TASK; SCHIZOPHRENIA; DEPRESSION; DYSFUNCTION	Apathy is frequently described in patients with traumatic brain injury (TBI); its negative consequences particularly affect functional independence. Among apathetic manifestations, lack of initiative and lack of interest have mainly been associated with cognitive impairments. However, few studies have been conducted to precisely identify the underlying cognitive processes. Our aims were (1) to determine the best predictor of apathy from among several cognitive processes, including episodic memory and attention/executive mechanisms and multitasking, and (2) to examine to what extent multitasking could mediate the relationships between specific cognitive processes and lack of initiative/interest. Seventy participants (34 patients with TBI matched with 36 control participants) were given a questionnaire to assess anxio-depressive symptoms, four tasks to assess specific cognitive processes, and one task to assess real-life multitasking. Participants' relatives completed an apathy questionnaire. Multitasking, as assessed by the number of goals not achieved, was the only significant predictor of apathetic manifestations. In addition, the mediation analyses revealed that multitasking performance mediated the relationships between verbal episodic memory and lack of initiative/interest, whereas executive and attentional functions were only indirectly related to lack of initiative/interest due to their significant impacts on multitasking. These results shed new light on the aetiology of apathetic manifestations in patients with TBI, indicating how specific cognitive deficits are expressed in real-life multitasking, and consequently, how they may lead to the development and/or maintenance of apathetic manifestations.	[Arnould, Annabelle; Rochat, Lucien; Van der Linden, Martial] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, Geneva, Switzerland; [Arnould, Annabelle; Dromer, Emilie; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, 104 Blvd Raymond Poincare, F-92380 Garches, France; [Arnould, Annabelle; Dromer, Emilie; Azouvi, Philippe] Univ Versailles St Quentin En Yvelines, EA HANDIReSP 4047, Versailles, France; [Rochat, Lucien; Van der Linden, Martial] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Van der Linden, Martial] Univ Liege, Cognit Psychopathol Unit, Liege, Belgium		Arnould, A (corresponding author), Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, 104 Blvd Raymond Poincare, F-92380 Garches, France.	annabelle.arnould@aphp.fr		Rochat, Lucien/0000-0002-9992-2720			Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Arnould A, 2015, BRAIN INJURY, V29, P1597, DOI 10.3109/02699052.2015.1075156; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Baudic S, 2006, DEMENT GERIATR COGN, V21, P316, DOI 10.1159/000091523; Brown RG, 2000, TRENDS NEUROSCI, V23, P412, DOI 10.1016/S0166-2236(00)01626-X; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; BURGESS PW, 1996, MODIFIED 6 ELEMENT T; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Esposito F, 2014, ARCH GERONTOL GERIAT, V58, P43, DOI 10.1016/j.archger.2013.09.002; Esposito F, 2012, DEMENT GER COGN D EX, V2, P456, DOI 10.1159/000345037; Esposito F, 2010, ALZ DIS ASSOC DIS, V24, P131, DOI 10.1097/WAD.0b013e3181c9c168; Finset A, 2000, BRAIN INJURY, V14, P887; Frisch S, 2012, J NEUROPSYCHOL, V6, P257, DOI 10.1111/j.1748-6653.2012.02026.x; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Garnier C, 1998, REV NEUROPSYCHOL, V8, P385; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Heaton, 2010, NEUROPSYCHOLOGY EVER, P5; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P207, DOI 10.1080/09084282.2011.643956; Kashdan TB, 2009, J RES PERS, V43, P987, DOI 10.1016/j.jrp.2009.04.011; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kirsch-Darrow L, 2006, NEUROLOGY, V67, P33, DOI 10.1212/01.wnl.0000230572.07791.22; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Laloyaux J, 2014, PSYCHIAT RES, V217, P163, DOI 10.1016/j.psychres.2014.03.026; Laloyaux J, 2013, PSYCHIAT RES, V210, P465, DOI 10.1016/j.psychres.2013.06.032; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; Lengenfelder J, 2015, APPL NEUROPSYCH-ADUL, V22, P7, DOI 10.1080/23279095.2013.816703; Levaux M. N., 2012, CASE REPORTS PSYCHIA, V2012; Levaux MN, 2012, ALTER, V6, P267, DOI 10.1016/j.alter.2012.08.003; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Levy ML, 1998, J NEUROPSYCH CLIN N, V10, P314, DOI 10.1176/jnp.10.3.314; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Liemburg EJ, 2015, SCHIZOPHR RES, V161, P367, DOI 10.1016/j.schres.2014.11.028; Logie RH, 2011, MEM COGNITION, V39, P1561, DOI 10.3758/s13421-011-0120-1; Mackinlay R, 2006, BRAIN COGNITION, V61, P14, DOI 10.1016/j.bandc.2005.12.006; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAlister C, 2013, AGING NEUROPSYCHOL C, V20, P735, DOI 10.1080/13825585.2013.781990; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; Muller U, 2006, BRAIN INJURY, V20, P157, DOI 10.1080/02699050500443467; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Pachalska M., 2002, MED SCI MONITOR, V8, P1; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Reitan R, 1985, HALSTEAD REITAN NEUR; Rempfer MV, 2003, PSYCHIAT RES, V117, P103, DOI 10.1016/S0165-1781(02)00318-9; Robert PH, 2006, EUR J NEUROL, V13, P729, DOI 10.1111/j.1468-1331.2006.01088.x; Rochat L, 2013, NEUROLOGY, V81, P1674, DOI 10.1212/01.wnl.0000435290.49598.1d; Rochat L, 2013, CORTEX, V49, P90, DOI 10.1016/j.cortex.2011.08.004; Rose NS, 2015, CAN J EXP PSYCHOL, V69, P252, DOI 10.1037/cep0000054; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; Semkovska M, 2004, SCHIZOPHR RES, V69, P289, DOI 10.1016/j.schres.2003.07.005; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345; Wolfson, 1993, HALSTEAD REITAN NEUR; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann P., 1995, TEST ATTENTION PERFO	78	4	4	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2018	12	1					101	119		10.1111/jnp.12107			19	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FY2GG	WOS:000426632900006	27231036	Green Submitted			2022-02-06	
J	Bahraini, NH; Monteith, LL; Gerber, HR; Forster, JE; Hostetter, TA; Brenner, LA				Bahraini, Nazanin H.; Monteith, Lindsey L.; Gerber, Holly R.; Forster, Jeri E.; Hostetter, Trisha A.; Brenner, Lisa A.			The Association Between Posttraumatic Stress Disorder and Perceptions of Deployment-Related Injury in Veterans With and Without Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						deployment; mild traumatic brain injury; military Veterans; posttraumatic stress disorder	QUESTIONNAIRE; HEALTH; IRAQ; RELIABILITY; COMPLAINTS; SYMPTOMS	Objectives: To examine whether the association between posttraumatic stress disorder (PTSD) and injury perceptions (ie, consequences, emotional representations, and coherence) differs for Veterans with mild traumatic brain injury (mTBI) compared with Veterans with non-TBI (ie, orthopedic). Participants: Eighty Veterans injured during post-9/11 deployments. Design: Observational, 2x2 factorial design. Main Measures: Injury histories ascertained using the Ohio State University TBI-Identification Method and Deployment Injury Questionnaire; Injury Perception Questionnaire-Revised (injury perceptions); Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (PTSD diagnosis); and PTSD Symptom Checklist-Civilian Version (PTSD symptoms). Results: The association between PTSD diagnosis and injury perceptions did not differ between Veterans with mTBI and those with non-TBIs, adjusting for age, subjective pain, and depressive symptoms. PTSD symptom severity was significantly associated with injury consequences (P <.0001) and emotional representations (P <.0001), irrespective of injury type (mTBI vs non-TBI). Only injury coherence was associated with a significant interaction between PTSD symptom severity and mTBI (P =.04). Conclusion: PTSD symptom severity influences perceptions about mTBI and non-TBIs sustained during deployment. Altering injury perceptions may be an important treatment target for Veterans with co-occurring PTSD and deployment-related injuries.	[Bahraini, Nazanin H.; Monteith, Lindsey L.; Gerber, Holly R.; Forster, Jeri E.; Hostetter, Trisha A.; Brenner, Lisa A.] Rocky Mt Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs, Denver, CO USA; [Bahraini, Nazanin H.; Monteith, Lindsey L.; Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Psychiat, Aurora, CO USA; [Bahraini, Nazanin H.; Forster, Jeri E.; Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Phys Med & Rehabil, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Neurol, Aurora, CO USA		Bahraini, NH (corresponding author), Rocky Mt MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	nazanin.bahraini@va.gov	Brenner, Lisa A./AAG-2442-2019; Monteith, Lindsey L./X-3658-2019	Monteith, Lindsey L./0000-0002-8104-5280	Department of Veterans Affairs, Rehabilitation Research & Development ServiceUS Department of Veterans Affairs	This study was funded by the Department of Veterans Affairs, Rehabilitation Research & Development Service. The authors are solely responsible for the content of this article, which does not necessarily reflect the views of the Department of Veterans Affairs.	AFFLECK G, 1992, J CONSULT CLIN PSYCH, V60, P119, DOI 10.1037/0022-006X.60.1.119; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Leventhal H, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P19; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; SAS Institute Inc, 2013, SAS V9 4; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Spitzer R, 1995, STRUCTURED CLIN INTE; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Ware J., 2000, SCORE VERSION 2 SF 3; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Weathers F., 1993, 9 ANN C ISTSS SAN AN; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	27	4	4	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					E7	E15		10.1097/HTR.0000000000000307			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200002	28422900				2022-02-06	
J	Bolzenius, JD; Wade, BSC; Velez, CS; Drennon, AM; Cooper, DB; Kennedy, JE; Reid, MW; Bowles, AO; Thompson, PM; Gutman, B; Lewis, JD; Ritter, JL; York, GE; Bigler, ED; Tate, DF				Bolzenius, Jacob D.; Wade, Benjamin S. C.; Velez, Carmen S.; Drennon, Ann Marie; Cooper, Douglas B.; Kennedy, Jan E.; Reid, Matthew W.; Bowles, Amy O.; Thompson, Paul M.; Gutman, Boris; Lewis, Jeffrey D.; Ritter, John L.; York, Gerald E.; Bigler, Erin D.; Tate, David F.			Relationships Between Subcortical Shape Measures and Subjective Symptom Reporting in US Service Members With Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						magnetic resonance imaging; mild traumatic brain injury; military; mTBI; service members; shape analyses; subcortical structures; volumetric measures	POSTTRAUMATIC-STRESS-DISORDER; EMOTION REGULATION; PTSD SYMPTOMS; VOLUME LOSS; PERFORMANCE; BLAST; COMPLAINTS; EXPOSURE; CONNECTIVITY; ASSOCIATIONS	Objective: To assess interactions of subcortical structure with subjective symptom reporting associated with mild traumatic brain injury (mTBI), using advanced shape analysis derived from volumetric MRI. Participants: Seventy-six cognitively symptomatic individuals with mTBI and 59 service members sustaining only orthopedic injury. Design: Descriptive cross-sectional study. Main Measures: Self-report symptom measures included the PTSD Checklist-Military, Neurobehavioral Symptom Inventory, and Symptom Checklist-90-Revised. High-dimensional measures of shape characteristics were generated from volumetric MRI for 7 subcortical structures in addition to standard volume measures. Results: Several significant interactions between group status and symptom measures were observed across the various shape measures. These interactions were revealed in the right thalamus and globus pallidus for each of the shape measures, indicating differences in structure thickness and expansion/contraction for these regions. No relationships with volume were observed. Conclusion: Results provide evidence for the sensitivity of shape measures in differentiating symptomatic mTBI individuals from controls, while volumetric measures did not exhibit this same sensitivity. Disruptions to thalamic nuclei identified here highlight the role of the thalamus in the spectrum of symptoms associated with mTBI. Additional work is needed to prospectively, and longitudinally, assess these measures along with cognitive performance and advanced multimodal imaging methods to extend the utility of shape analysis in relation to functional outcomes in this population.	[Bolzenius, Jacob D.; Wade, Benjamin S. C.; Velez, Carmen S.; Tate, David F.] Univ Missouri St Louis, Missouri Inst Mental Hlth, Berkeley, MO 63134 USA; [Wade, Benjamin S. C.] Univ Calif Los Angeles, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90024 USA; [Drennon, Ann Marie; Cooper, Douglas B.; Kennedy, Jan E.; Reid, Matthew W.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Bowles, Amy O.] Brooke Army Med Ctr, Dept Rehabil Med, San Antonio, TX USA; [Thompson, Paul M.; Gutman, Boris] Univ Southern Calif, Imaging Genet Ctr, Marina Del Rey, CA USA; [Lewis, Jeffrey D.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Neurol, Bethesda, MD 20814 USA; [Ritter, John L.] Brooke Army Med Ctr, Dept Radiol, San Antonio, TX USA; [York, Gerald E.] Alaska Radiol Associates, TBI Imaging & Res, Anchorage, AK USA; [Bigler, Erin D.] Dept Psychol, Provo, UT USA; [Bigler, Erin D.] Ctr Neurosci, Provo, UT USA		Tate, DF (corresponding author), Univ Missouri St Louis, Missouri Inst Mental Hlth, Berkeley, MO 63134 USA.	David.Tate@mimh.edu	Ritter, John/AAG-8899-2020; Tate, David F/I-3963-2013	Tate, David F/0000-0003-0213-1920; Wade, Benjamin/0000-0003-2461-6101	Defense and Veterans Brain Injury Centers; US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0025]; Chronic Effects of Neurotrauma Consortium (CENC) [PT108802-SC104835]	This work is supported in part by the Defense and Veterans Brain Injury Centers, the US Army Medical Research and Materiel Command (USAMRMC; W81XWH-13-2-0025), and the Chronic Effects of Neurotrauma Consortium (CENC; PT108802-SC104835).	ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Brenner LA, 2015, REHABIL PSYCHOL, V60, P277, DOI 10.1037/rep0000048; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Christensen JF, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2837; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; DEROGATIS LR, 1992, SCL 90R ADM SCORING; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guidelines VDCP, 2016, MAN CONC MILD TRAUM; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; LIPSEY JR, 1983, BRIT J PSYCHIAT, V143, P266, DOI 10.1192/bjp.143.3.266; Peters SK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00104; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; Tate DF, 2017, BRAIN IMAGING BEHAV; Tate DF, 2017, INT BRAIN INJ ASS 20; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Weathers FW, 1993, ANN M INT SOC TRAUMA; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310	40	4	4	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					113	122		10.1097/HTR.0000000000000379			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200012	29517591	Green Accepted			2022-02-06	
J	Bounes, FV; Faure, G; Rouget, A; Conil, JM; Georges, B; Geeraerts, T; Fourcade, O; Minville, V; Delmas, C				Bounes, Fanny Vardon; Faure, Geraldine; Rouget, Antoine; Conil, Jean-Marie; Georges, Bernard; Geeraerts, Thomas; Fourcade, Olivier; Minville, Vincent; Delmas, Clement			Plasma free carnitine in severe trauma: Influence of the association with traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Carnitine; Severe trauma; Nutrition; Brain trauma	TOTAL PARENTERAL-NUTRITION; PROPOFOL INFUSION SYNDROME; CRITICALLY-ILL PATIENTS; EARLY ENTERAL NUTRITION; ACETYL-L-CARNITINE; INTESTINAL PERMEABILITY; INFECTIOUS MORBIDITY; METABOLIC-RESPONSE; RANDOMIZED-TRIAL; CRITICAL ILLNESS	Background: Metabolic response to severe trauma requires early nutritional resuscitation. Carnitine is essential for lipolysis, the energy source during this hypercatabolic phase. However L-carnitine is not present in nutritional replacement solutions. Furthermore, free carnitine depletion, defined as carnitine plasma level under 36 mu mol/L, was not adequately reported in adult patients with severe trauma. The aim of this study was to assess plasma free carnitine levels and factors of variation in severe trauma. Method: Our observational study concerned 38 trauma patients including 18 with traumatic brain injury (TBI). On the third day after trauma, plasma free carnitine concentration was determined (by enzymatic method) while patients received artificial nutrition. Results: Low plasmatic free carnitine concentration was evidenced in 95% of the patients with a median value of 18 mu mol/L (11-47). Univariate analysis showed that mean arterial pressure, serum urea, CKD-EPI and patients with TBI were significantly associated with plasma free carnitine concentration less than 18 mu mol/L. Lower plasma free carnitine concentration was observed in the group of patients with TBI with 17.72 mu mol/L (11-36) versus 21.5 mu mol/L (11-47) for others patients (p = 0.031). Logistic regression analysis showed that severe trauma with TBI and CKD-EPI above 94 mL/min/1.73 m2 appeared to be independent predictor of lower free carnitine plasmatic concentration (Goodness of fit = 0.87 and AUC = 0.89). Conclusion: Our observations support hypotheses that plasma free carnitine concentration is lowered in severe injured patients especially for TBI patients and patients with estimated GFR above 94 mL/min/1.73 m(2). (C) 2017 Elsevier Ltd. All rights reserved.	[Bounes, Fanny Vardon; Faure, Geraldine; Rouget, Antoine; Conil, Jean-Marie; Georges, Bernard; Geeraerts, Thomas; Fourcade, Olivier; Minville, Vincent; Delmas, Clement] Toulouse Univ Hosp, Crit Care Unit, Ave Pr Jean Poulhes, F-31059 Toulouse, France; [Bounes, Fanny Vardon; Minville, Vincent; Delmas, Clement] Univ Paul Sabatier, INSERM U1048, Inst Malad Metab & Cardiovasc, Ave Pr Jean Poulhes, F-31059 Toulouse, France		Bounes, FV (corresponding author), Toulouse Univ Hosp, Dept Anesthesiol & Crit Care, 1 Ave Pr J Poulhes, F-31059 Toulouse, France.	Bounes.f@chu-toulouse.fr; Faure.g@chu-toulouse.fr; Rouget.a@chu-toulouse.fr; Conil.jm@chu-toulouse.fr; Georges.b@chu-toulouse.fr; Geeraerts.t@chu-toulouse.fr; Fourcade.o@chu-toulouse.fr; Minville.v@chu-toulouse.fr; Delmas.clement@chu-toulouse.fr	Bounes, Fanny/ABG-6128-2021; Minville, Vincent/ABE-4286-2020	Minville, Vincent/0000-0003-0516-4939; Delmas, Clement/0000-0001-9180-9128; Vardon Bounes, Fanny/0000-0003-2505-848X			Ahmad S, 2001, SEMIN DIALYSIS, V14, P209, DOI 10.1046/j.1525-139X.2001.00055.x; ARDUINI A, 1992, J BIOL CHEM, V267, P12673; Biolo G, 1997, NUTRITION, V13, pS52, DOI 10.1016/S0899-9007(97)00206-2; BOWYER BA, 1986, AM J CLIN NUTR, V43, P85, DOI 10.1093/ajcn/43.1.85; Bray RJ, 1998, PAEDIATR ANAESTH, V8, P491; Cederblad G, 1984, Clin Nutr, V2, P143, DOI 10.1016/0261-5614(84)90017-7; CEDERBLAD G, 1983, METABOLISM, V32, P383, DOI 10.1016/0026-0495(83)90048-3; CEJKA J, 1992, CLIN CHEM, V38, P304; Conejero R, 2002, NUTRITION, V18, P716, DOI 10.1016/S0899-9007(02)00847-X; Conil JM, 2007, BRIT J CLIN PHARMACO, V63, P583, DOI 10.1111/j.1365-2125.2006.02807.x; DAVIS AT, 1988, AM J CLIN NUTR, V48, P1400, DOI 10.1093/ajcn/48.6.1400; Doig GS, 2009, INTENS CARE MED, V35, P2018, DOI 10.1007/s00134-009-1664-4; Flanagan JL, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-30; Garcia-de-Lorenzo A, 2003, NUTRITION, V19, P805, DOI 10.1016/S0899-9007(03)00103-5; Green B, 2004, BRIT J CLIN PHARMACO, V58, P119, DOI 10.1111/j.1365-2125.2004.02157.x; Hadley JS, 2002, CURR OPIN PHARMACOL, V2, P700, DOI 10.1016/S1471-4892(02)00217-5; Hasenboehler Erik, 2006, World J Emerg Surg, V1, P29, DOI 10.1186/1749-7922-1-29; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4; Houdijk APJ, 1998, LANCET, V352, P772, DOI 10.1016/S0140-6736(98)02007-8; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kompan L, 1999, INTENS CARE MED, V25, P157, DOI 10.1007/s001340050809; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Laquay N, 2010, ANN FR ANESTH, V29, P377, DOI 10.1016/j.annfar.2010.02.030; Lefrant J-Y, 2014, ANN FR ANESTH, P202; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MARQUIS NR, 1964, J LIPID RES, V5, P184; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Minville V, 2011, CRIT CARE, V15, DOI 10.1186/cc10013; NANNI G, 1985, JPEN-PARENTER ENTER, V9, P483, DOI 10.1177/0148607185009004483; PARKE TJ, 1992, BRIT MED J, V305, P613, DOI 10.1136/bmj.305.6854.613; PICHARD C, 1989, AM J CLIN NUTR, V49, P283, DOI 10.1093/ajcn/49.2.283; Preiser JC, 2014, BRIT J ANAESTH, V113, P945, DOI 10.1093/bja/aeu187; Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003; REBOUCHE CJ, 1992, FASEB J, V6, P3379, DOI 10.1096/fasebj.6.15.1464372; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Seron-Arbeloa C, 2011, CLIN NUTR, V30, P346, DOI 10.1016/j.clnu.2010.11.004; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; TANPHAICHITR V, 1981, JPEN-PARENTER ENTER, V5, P505, DOI 10.1177/0148607181005006505; Uezono S, 2005, ANESTHESIOLOGY, V103, P909, DOI 10.1097/00000542-200510000-00046; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Wolf A, 2001, LANCET, V357, P606, DOI 10.1016/S0140-6736(00)04064-2; Zanelli SA, 2005, ANN NY ACAD SCI, V1053, P153, DOI 10.1196/annals.1344.013	44	4	4	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAR	2018	49	3					538	542		10.1016/j.injury.2017.11.005			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	GB6ZB	WOS:000429223200011	29162266				2022-02-06	
J	Brett, BL; Solomon, GS; Hill, J; Schatz, P				Brett, Benjamin L.; Solomon, Gary S.; Hill, Jennifer; Schatz, Philip			Two-year Test-Retest Reliability in High School Athletes Using the Four- and Two-Factor ImPACT Composite Structures: The Effects of Learning Disorders and Headache/Migraine Treatment History	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Childhood brain insult; Developmental and learning disabilities; Assessment; Practice effects/reliable change; Norms/normative studies; Sports concussion	SPORT-RELATED CONCUSSION; NEUROCOGNITIVE TEST-PERFORMANCE; ICE HOCKEY PLAYERS; TEST BATTERY; CLINICAL NEUROPSYCHOLOGY; INTERPRETING CHANGE; CONSTRUCT-VALIDITY; ASSESSMENT TOOLS; ONLINE VERSION; NORMATIVE DATA	Objective: This study examined the test-retest reliability of the four-and two-factor structures (i.e., Memory and Speed) of ImPACT over a 2-year interval across multiple groups with premorbid conditions, including those with a history of special education or learning disorders (LD; n = 114), treatment history for headache/migraine (n = 81), and a control group (n = 792). Methods: Nine hundred and eighty seven high school athletes completed baseline testing using online ImPACT across a 2-year interval. Paired-samples t-tests documented improvement from initial to follow-up assessments. Test stability was examined using Regression-based measures (RBM) and Reliable change indices (RCI). Reliability was examined using intraclass correlation coefficients (ICC). Results: Significant improvement on all four composites were observed for the control group over a 2-year interval; whereas significant differences were observed only on Visual Motor Speed for the LD and headache/migraine treatment history groups. ICCs ranges were similar across groups and greater or comparable reliability was observed for the two-factor structure on Memory (0.67-0.73) and Speed (0.76-0.78) composites. RCIs and RBMs demonstrated stability for the four-and two-factor structures, with few cases falling outside the range of expected change within a healthy sample at the 90% and 95% CIs. Conclusion: Typical practices of obtaining new baselines every 2 years in the high school population can be applied to athletes with a history of special education or LD and headache/migraine treatment. The two-factor structure has potential to increase test-retest reliability. Further research regarding clinical utility is needed.	[Brett, Benjamin L.] Univ Memphis, Dept Counseling Educ Psychol & Res, 100 Ball Hall, Memphis, TN 38152 USA; [Brett, Benjamin L.; Solomon, Gary S.] Vanderbilt Sports Concuss Ctr, Nashville, TN USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Hill, Jennifer; Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Brett, BL (corresponding author), Univ Memphis, Dept Counseling Educ Psychol & Res, 100 Ball Hall, Memphis, TN 38152 USA.	blbrett@memphis.edu	Solomon, Gary/K-9011-2019				Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Brett BL, 2017, J CLIN EXP NEUROPSYC, V39, P286, DOI 10.1080/13803395.2016.1224322; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; CDC, 2015, FAQS BAS TEST; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cohen J., 2013, STAT POWER ANAL BEHA; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; DIKMEN SS, 1991, J INT NEUROPSYCH SOC, V5, P346; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2016, APPL NEUROPSYCH-CHIL, V5, P294, DOI 10.1080/21622965.2015.1077334; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Gerrard PB, 2017, ARCH CLIN NEUROPSYCH, V32, P117, DOI 10.1093/arclin/acw097; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Immediate Post- Concussion Assessment and Cognitive Testing (ImPACT), 2012, IMM POSTC ASS TEST I; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; L?ders H., 1993, CLIN NEUROPSYCHOL, V7, P300, DOI DOI 10.1080/13854049308401901; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell M. R., 2007, IMPACT VERSION 6 0 U; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P69, DOI 10.1080/87565641.2015.1014089; McCaffrey R. J., 1993, CLIN NEUROPSYCHOL, V6, P32; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P., 2017, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-09769, DOI 10.1136/BJSPORTS-2017-09769]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Roebuck-Spencer T, 2007, ARCH CLIN NEUROPSYCH, V22, pS79, DOI 10.1016/j.acn.2006.10.011; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Spreen E., 2006, COMPENDIUM NEUROPSYC, P1; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Wojtowicz M., 2017, AM AC NEUR BOST MA; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Womble MN, 2016, ARCH CLIN NEUROPSYCH, V31, P305, DOI 10.1093/arclin/acw011; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	60	4	4	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2018	33	2					216	226		10.1093/arclin/acx059			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FY4QD	WOS:000426808700008	28666316	Bronze			2022-02-06	
J	Delgado, RE; Peacock, K; Elizondo, B; Wells, M; Grafman, JH; Pugh, MJ				Delgado, Roxana E.; Peacock, Kimberly; Elizondo, Barbara; Wells, Margaret; Grafman, Jordan H.; Pugh, Mary J.			A Family's Affair: Caring for Veterans with Penetrating Traumatic Brain Injury	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium (MHSRS)	2016	FL				CAREGIVER BURDEN; HEALTH; STRESS	Approximately 1.1 million family members are primary caregivers to post 9/11 veterans. These military caregivers assume a role that requires a long-term commitment that may affect their own health status; however, the impact on health among military caregivers is underestimated and underrepresented. As part of a larger retrospective cohort study that aimed to assess the health-related outcomes of post 9/11 veterans with penetrating traumatic brain injury (pTBI), we examined the health impact of caregiving on caregivers. Caregivers (n = 66) of veterans with pTBI completed a survey that captured the veterans' and their own health-related outcomes. Surveys included veteran and caregiver sociodemographics, caregiver role, tasks, burden, and caregiver-reported measures of veterans' health and quality of life. The participants were spouses (58%) and parents (32%) providing full-time assistance for more than 5 yr (74%). In their caregiver role, they provided assistance with activities of daily living and emotional/social support. Forty-eight percent of these caregivers met the definition of experiencing clinically significant burden. Veterans with pTBI had other comorbidities (e.g., depression, cognitive dysfunction, and anger), which were associated with caregiver burden. The findings further confirm the impact of caregiving on health status of caregivers, specifically when assisting veterans with pTBI.	[Delgado, Roxana E.; Peacock, Kimberly; Elizondo, Barbara; Wells, Margaret] Univ Texas Hlth Sci Ctr San Antonio, Gen & Hosp Med Div, Dept Med, San Antonio, TX 78229 USA; [Delgado, Roxana E.] Univ Texas Hlth Sci Ctr San Antonio, Mil Hlth Inst, San Antonio, TX 78229 USA; [Pugh, Mary J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Elizondo, Barbara; Wells, Margaret; Pugh, Mary J.] South Texas Vet Healthcare Syst, Res, San Antonio, TX 78229 USA; [Grafman, Jordan H.] Northwestern Univ, Weinberg Coll Arts & Sci, Neurol Cognit Neurol & Alzheimers Ctr, Dept Phys Med & Rehabil,Dept Psychiat,Feinberg Sc, Chicago, IL 60611 USA; [Grafman, Jordan H.] Northwestern Univ, Weinberg Coll Arts & Sci, Dept Psychol, Chicago, IL 60611 USA		Delgado, RE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Gen & Hosp Med Div, Dept Med, San Antonio, TX 78229 USA.; Delgado, RE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Mil Hlth Inst, San Antonio, TX 78229 USA.		Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763	Frankel Foundation; VA Health Services Research and Development ServiceUS Department of Veterans Affairs	This study was funded by grants from the Frankel Foundation and VA Health Services Research and Development Service. The funding agency had no role in data collection, analysis, or manuscript development.	[Anonymous], 2016, SURV CAS DEF 13 0 NE; Brundage JF, 2015, MSMR, V22, P20; Dillman DA., 2014, INTERNET PHONE MAIL, V4th; Howell Alison, 2011, WAR COMES HOME TOLL; Lew HL, 2013, J REHABIL RES DEV, V50, pXI, DOI 10.1682/JRRD.2013.09.0212; LoboPrabhu SM, 2006, SUPPORTING CAREGIVER; Patel BR, 2015, SOC WORK, V60, P9, DOI 10.1093/sw/swu043; Paulson D, 2011, CLIN GERONTOLOGIST, V34, P132, DOI 10.1080/07317115.2011.539518; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Ramchand R., 2014, HIDDEN HEROES AM MIL; Razani J, 2007, J AM GERIATR SOC, V55, P1415, DOI 10.1111/j.1532-5415.2007.01307.x; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Tanielian T, 2013, MILITARY CAREGIVERS, P20; Tooth L, 2005, BRAIN INJURY, V19, P963, DOI 10.1080/02699050500110785	14	4	4	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183			S			379	385		10.1093/milmed/usx156			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GC0JM	WOS:000429463600053	29635565	Bronze			2022-02-06	
J	Farjah, GH; Fazli, F; Karimipour, M; Pourheidar, B; Heshmatiyan, B; Pourheidar, M				Farjah, Gholam Hossein; Fazli, Farzaneh; Karimipour, Mojtaba; Pourheidar, Bagher; Heshmatiyan, Behnam; Pourheidar, Maryam			The effect of bone marrow mesenchymal stem cells on recovery of skeletal muscle after neurotization surgery in rat	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Bone marrow mesenchymal; stem cells; Motor end plate; Nerve regeneration; Neurotization Rat model	PERIPHERAL-NERVE REGENERATION; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; STROMAL CELLS; FUNCTIONAL RECOVERY; DENERVATED MUSCLE; MUSCULAR NEUROTIZATION; ADULT RATS; TRANSPLANTATION; DIFFERENTIATION	Objective(s): When the nerve is injured near its entrance to the muscle belly, we cannot perform conventional methods. One useful method in such a situation is neurotization surgery. In this study, Bone marrow mesenchymal stem cells (BMSCs) implanted into the paralyzed muscle after neurotization surgery. These cells can stimulate axon growth and motor endplate formation, also prevent muscle atrophy. Materials and Methods: Thirty-six adult male Sprague-Dawley rats were randomized into six groups: intact group, sham surgery group, control group, DMEM group, cell+DMEM group, denervated group. The motor nerve of the lateral head of gastrocnemius muscle was cut, and the proximal portion of the severed nerve was transplanted to the proximal third of the muscle paralysis. BMSCs with/or DMEM was injected into the site of injury. All animals were evaluated by withdrawal reflex latency (WRL), electromyography, muscle weight, histology and immunohistochemistry. Results: The WRL difference between the control and cell+DMEM groups at weeks 4 and 12 post-operation was statistically significant (P<0.05). The mean number of motor end plates in cell+DMEM group was more than control group (P<0.05). At 12 weeks post-operation, the difference of the mean nerve conduction velocity (NCV) between cell treated group and sham surgery groups were not statistically significant (P>0.05). In weeks 4 and 12 post-operation, the mean fiber diameters in cell+DMEM group were more than control group (P<0.05). Conclusion: The results of this study demonstrate that transplantation of BMSCs after neurotization surgery, prevent muscle atrophy and improve muscle function.	[Farjah, Gholam Hossein; Pourheidar, Bagher] Urmia Univ Med Sci, Dept Anat, Neurophysiol Res Ctr, Fac Med, Orumiyeh, Iran; [Fazli, Farzaneh; Pourheidar, Maryam] Urmia Univ Med Sci, Fac Med, Orumiyeh, Iran; [Karimipour, Mojtaba] Urmia Univ Med Sci, Dept Anat, Fac Med, Orumiyeh, Iran; [Heshmatiyan, Behnam] Urmia Univ Med Sci, Dept Physiol, Neurophysiol Res Ctr, Fac Med, Orumiyeh, Iran		Farjah, GH (corresponding author), Urmia Univ Med Sci, Dept Anat, Neurophysiol Res Ctr, Fac Med, Orumiyeh, Iran.	hfarjah@hotmail.com			Urmia University of Medical Sciences in Urmia, Iran [1655]	This article was derived from an MSs thesis in the Urmia University of Medical Sciences. Funding for this research project was supported by grant no. 1655 from the Urmia University of Medical Sciences in Urmia, Iran.	Azizi S, 2012, VET RES FORUM, V1, P107; Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030; Bhagavati S, 2004, BIOCHEM BIOPH RES CO, V318, P119, DOI 10.1016/j.bbrc.2004.03.192; Bielecki M, 2004, Rocz Akad Med Bialymst, V49, P10; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; BRUNELLI G, 1985, J HAND SURG-AM, V10A, P993, DOI 10.1016/S0363-5023(85)80022-8; Cantinieaux D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069515; Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; CHIU DTW, 1991, J HAND SURG-BRIT EUR, V16B, P505, DOI 10.1016/0266-7681(91)90104-V; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Dadon- Nachum M, 2004, EXPERT OPINBIOL THER, V11, P1591; Delk NA, 2012, AUTOPHAGY, V8, P650, DOI 10.4161/auto.19226; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dow DE, 2006, RESTOR NEUROL NEUROS, V24, P41; Farjah GH, 2015, IRAN J VET RES, V16, P167; Farjah GH, 2013, IRAN J BASIC MED SCI, V16, P901; Fukuda A, 2005, MUSCLE NERVE, V31, P229, DOI 10.1002/mus.20254; He JG, 2013, DIFFERENTIATION, V86, P57, DOI 10.1016/j.diff.2013.07.002; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Inoue M, 2003, GLIA, V44, P111, DOI 10.1002/glia.10285; Isaacs J, 2013, J NEUROSURG, V119, P914, DOI 10.3171/2013.5.JNS121837; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Kang SB, 2012, TISSUE ENG PT A, V18, P1912, DOI [10.1089/ten.TEA.2011.0225, 10.1089/ten.tea.2011.0225]; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Konya D, 2008, REGEN MED, V3, P309, DOI 10.2217/17460751.3.3.309; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lee B, 2015, J BIOMECH, V48, P171, DOI 10.1016/j.jbiomech.2014.11.005; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lopes FRP, 2006, EXP NEUROL, V198, P457, DOI 10.1016/j.expneurol.2005.12.019; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Manganelli F, 2016, EUR J NEUROL, V23, P1566, DOI 10.1111/ene.13079; Mu LC, 2011, NEUROSURGERY, V69, P208, DOI 10.1227/NEU.0b013e31822ed596; Noordin S, 2008, ACTA ORTHOP, V79, P126, DOI 10.1080/17453670710014879; Ozdal-Kurt F, 2016, BIOTECH HISTOCHEM, V91, P412, DOI 10.1080/10520295.2016.1183819; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Prockop DJ, 1999, OSTEOARTHR CARTILAGE, V7, P364, DOI 10.1053/joca.1998.0213; Ritfeld GJ, 2012, CELL TRANSPLANT, V21, P1561, DOI 10.3727/096368912X640484; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Song S, 2004, EXP NEUROL, V185, P191, DOI 10.1016/j.expneurol.2003.09.003; Uchida N, 2017, HUM GENE THER CL DEV, V28, P136, DOI 10.1089/humc.2017.029; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; Vathana T, 2014, J NEUROSURG, V120, P1125, DOI 10.3171/2014.1.JNS122241; VIRTANEN P, 1992, J APPL PHYSIOL, V72, P2069, DOI 10.1152/jappl.1992.72.6.2069; Vogel G, 2000, SCIENCE, V287, P1418, DOI 10.1126/science.287.5457.1418; Wakao S, 2010, EXP NEUROL, V223, P537, DOI 10.1016/j.expneurol.2010.01.022; Watson JA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005290; Wehbe J, 2004, PAN ARAB J ORTH TRAU, V8, P69; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zarbakhsh S, 2012, CELL J, V14, P39; Zhen GH, 2010, CYTOTHERAPY, V12, P605, DOI 10.3109/14653241003745888	55	4	4	0	3	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	MAR	2018	21	3					236	243		10.22038/ijbms.2018.22327.5699			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GB0EO	WOS:000428718100002	29511489				2022-02-06	
J	Frizzell, ERA; Arnold, GP; Wang, WJ; Abboud, RJ; Drew, TS				Frizzell, Erin R. A.; Arnold, Graham P.; Wang, Weijie; Abboud, Rami J.; Drew, Tim S.			Comparison of branded rugby headguards on their effectiveness in reducing impact on the head	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article								Aim To compare the available brands of rugby headguards and evaluate their impact attenuation properties at various locations on the cranium, with regard to concussion prevention. Methods Seven different branded headguards were fitted onto a rigid headform and drop-tested in three different positions. An accelerometer measured the linear acceleration the headform experienced on impact with the ground. Each test involved dropping the headform from a height that generated 103.8 g on average when bare, which is the closest acceleration to the upper limit of the concussion threshold of 100 g. A mean peak acceleration for each drop position was calculated and compared with the bare baseline measurement. Results Each headguard demonstrated a significant decrease in the mean peak acceleration from the baseline value (all p=0.01). Overall the Canterbury Ventilator was the most effective headguard, decreasing the impact force on average by 47%. The least effective was the XBlades Elite headguard, averaging a force reduction of 27%. In five of the seven headguards, the right side of the headwear was the most effective at reducing impact force. Conclusion Overall, the results indicate that it would be beneficial to wear a headguard during rugby in order to reduce the impact forces involved in head collisions. There was also a clear difference in performance between the tested brands, establishing the Canterbury headguard as the most effective. However, only one model of headguard from each brand was tested, so further research evaluating all other models should be considered.	[Abboud, Rami J.] Univ Dundee, IMAR, Ninewells Hosp Med Sch, Dept Orthopaed & Trauma Surg,TORT Ctr, Dundee, Scotland; Univ Dundee, Sch Med, Dundee, Scotland		Abboud, RJ (corresponding author), Univ Dundee, IMAR, Ninewells Hosp Med Sch, Dept Orthopaed & Trauma Surg,TORT Ctr, Dundee, Scotland.	r.j.abboud@dundee.ac.uk	Wang, Weijie W/A-6670-2010	Wang, Weijie W/0000-0003-3987-9270			Aylwin M., 2017, RUGBY UNIONS NEW TAC; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bey T, 2009, WEST J EMERG MED, V10, P6; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cross M, 2016, BRIT J SPORT MED, V50, P1; Eager D, 2014, 8 AUSTR C APPL MECH, V8, P244; England Professional Rugby Injury Surveillance Project Steering Group, 2017, ENGL PROF RUGB INJ S; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hebert O, 2016, J SCI MED SPORT, V19, P789, DOI 10.1016/j.jsams.2015.12.517; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Jones SJ, 2004, BRIT J SPORT MED, V38, P159, DOI 10.1136/bjsm.2002.002584; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Landesman P., 2015, CONCUSSION; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mueller FO, 2001, J ATHL TRAINING, V36, P312; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pettersen JA, 2002, BRIT J SPORT MED, V36, P19, DOI 10.1136/bjsm.36.1.19; Rugby Football Union, 2015, 100 NEW ART PITCH GR; Schofield D., 2015, RUGBY CONCUSSIONS SO; Scottish Rugby Union, 2015, COND APPR GRANT ART; World Rugby, 2017, WORLD RUGB CONC MAN	36	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	MAR	2018	4	1							e000361	10.1136/bmjsem-2018-000361			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VJ4QA	WOS:000596798200070	30498572	gold, Green Published			2022-02-06	
J	Hasanaj, L; Thawani, SP; Webb, N; Drattell, JD; Serrano, L; Nolan, RC; Raynowska, J; Hudson, TE; Rizzo, JR; Dai, WW; McComb, B; Goldberg, JD; Rucker, JC; Galetta, SL; Balcer, LJ				Hasanaj, Lisena; Thawani, Sujata P.; Webb, Nikki; Drattell, Julia D.; Serrano, Liliana; Nolan, Rachel C.; Raynowska, Jenelle; Hudson, Todd E.; Rizzo, John-Ross; Dai, Weiwei; McComb, Bryan; Goldberg, Judith D.; Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.			Rapid Number Naming and Quantitative Eye Movements May Reflect Contact Sport Exposure in a Collegiate Ice Hockey Cohort	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article							KING-DEVICK TEST; FOOTBALL PLAYERS; RECURRENT CONCUSSION; SCREENING TOOL; HEAD TRAUMA; SACCADES; DEPRESSION; INJURY; TESTS	Background: The King-Devick (K-D) test of rapid number naming is a reliable visual performance measure that is a sensitive sideline indicator of concussion when time scores worsen (lengthen) from preseason baseline. Within cohorts of youth athletes,18 years old, baseline K-D times become faster with increasing age. We determined the relation of rapid number-naming time scores on the K-D test to electronic measurements of saccade performance during preseason baseline assessments in a collegiate ice hockey team cohort. Within this group of young adult athletes, we also sought to examine the potential role for player age in determining baseline scores. Methods: Athletes from a collegiate ice hockey team received preseason baseline testing as part of an ongoing study of rapid rink-side performance measures for concussion. These included the K-D test (spiral-bound cards and tablet computer versions). Participants also performed a laboratory-based version of the K-D test with simultaneous infrared-based video-oculographic recordings using an Eye-Link 1000+. This allowed measurement of the temporal and spatial characteristics of eye movements, including saccadic velocity, duration, and intersaccadic interval (ISI). Results: Among 13 male athletes, aged 18-23 years (mean 20.5 +/- 1.6 years), prolongation of the ISI (a combined measure of saccade latency and fixation duration) was the measure most associated with slower baseline time scores for the EyeLink-paired K-D (mean 38.2 +/- 6.2 seconds, r = 0.88 [95% CI 0.63-0.96], P = 0.0001), the K-D spiral-bound cards (36.6 +/- 5.9 seconds, r = 0.60 [95% CI 0.08-0.87], P = 0.03), and K-D computerized tablet version (39.1 +/- 5.4 seconds, r = 0.79 [95% CI 0.42-0.93], P = 0.001). In this cohort, older age was a predictor of longer (worse) K-D baseline time performance (age vs EyeLink-paired K-D: r = 0.70 [95% CI 0.24-0.90], P = 0.008; age vs K-D spiral-bound cards: r = 0.57 [95% CI 0.03-0.85], P = 0.04; age vs K-D tablet version: r = 0.59 [95% CI 0.06-0.86], P = 0.03) as well as prolonged ISI (r = 0.62 [95% CI 0.11-0.87], P = 0.02). Slower baseline K-D times were not associated with greater numbers of reported prior concussions. Conclusions: Rapid number-naming performance using the K-D at preseason baseline in this small cohort of collegiate ice hockey players is best correlated with ISI among eye movement-recording measures. Baseline K-D scores notably worsened with increasing age, but not with numbers of prior concussions in this small cohort. While these findings require further investigation by larger studies of contact and noncontact sports athletes, they suggest that duration of contact sports exposure may influence preseason test performance. (C) 2017 by North American Neuro-Ophthalmology Society	[Hasanaj, Lisena; Thawani, Sujata P.; Serrano, Liliana; Nolan, Rachel C.; Raynowska, Jenelle; Hudson, Todd E.; Rizzo, John-Ross; Dai, Weiwei; Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA; [McComb, Bryan; Goldberg, Judith D.; Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Ophthalmol, New York, NY USA; [Hudson, Todd E.; Rizzo, John-Ross; Goldberg, Judith D.] NYU, Sch Med, Dept Phys Med & Rehabil, New York, NY USA; [Webb, Nikki] NYU, Dept Athlet, New York, NY USA		Balcer, LJ (corresponding author), NYU, Sch Med, Dept Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA.	laura.balcer@nyumc.org		Rucker, Janet/0000-0002-0397-0999; Goldberg, Judith D./0000-0003-3758-6976; Rizzo, John-Ross/0000-0002-4084-0085	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD001097] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER		CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Roos JCP, 2008, EXP BRAIN RES, V187, P283, DOI 10.1007/s00221-008-1304-1; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5	31	4	4	3	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	MAR	2018	38	1					24	29		10.1097/WNO.0000000000000533			6	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	GG1EU	WOS:000432428800008	28746058	Green Accepted			2022-02-06	
J	Jadischke, R; Viano, DC; McCarthy, J; King, AI				Jadischke, Ron; Viano, David C.; McCarthy, Joe; King, Albert I.			Concussion with primary impact to the chest and the potential role of neck tension	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article								Objectives Most biomechanical research on brain injury focuses on direct blows to the head. There are a few older studies that indicate craniocervical stretch could be a factor in concussion by causing strain in the upper spinal cord and brainstem. The objectives of this study are to assess the biomechanical response and estimate the strain in the upper cervical spine and brainstem from primary impact to the chest in American football. Methods Impact testing was conducted to the chest of a stationary unhelmeted and helmeted anthropomorphic test device (ATD) as well as the laboratory reconstruction of two NFL game collisions resulting in concussion. A finite element (FE) study was also conducted to estimate the elongation of the cervical spine under tensile and flexion loading conditions. Results The helmeted ATD had a 40% (t=9.84, p<0.001) increase in neck tensile force and an 8% (t=7.267, p<0.001) increase in neck flexion angle when compared with an unhelmeted ATD. The case studies indicated that the neck tension in the injured players exceeded tolerable levels from volunteer studies. The neck tension was combined with flexion of the head relative to the torso. The FE analysis, combined with a spinal cord coupling ratio, estimated that the strain along the axis of the upper cervical spinal cord and brainstem was 10%-20% for the combined flexion and tension loading in the two cases presented. Conclusion Strain in the upper spinal cord and brainstem from neck tension is a factor in concussion.	[Jadischke, Ron; McCarthy, Joe] McCarthy Engn, Windsor, ON, Canada; [Jadischke, Ron; Viano, David C.; King, Albert I.] Wayne State Univ, Dept Biomed Engn, Detroit, MI USA; [Viano, David C.] ProBiomechanics, Bloomfield Hills, MI USA		Jadischke, R (corresponding author), McCarthy Engn, Windsor, ON, Canada.; Jadischke, R (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI USA.	ronjadischke@yahoo.ca			Institute for Injury Research; McCarthy Engineering	Funding for this research has been received from McCarthy Engineering and from the Institute for Injury Research.	Breig, 1960, BIOMECHANICS CENTRAL; Chancey Valeta Carol, 2003, Stapp Car Crash J, V47, P135; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DVORAK J, 1991, J ORTHOPAED RES, V9, P828, DOI 10.1002/jor.1100090608; Endo K, 2014, ASIAN SPINE J, V8, P747, DOI 10.4184/asj.2014.8.6.747; Fice JB, 2011, ANN BIOMED ENG, V39, P2152, DOI 10.1007/s10439-011-0315-4; Friede R., 1961, PATHOLOGY MECH EXPT, P61; FRIEDE RL, 1960, J NEUROPATH EXP NEUR, V19, P266, DOI 10.1097/00005072-196004000-00007; Hodgson VR, 1979, P 23 STAPP CAR CRASH, P589; Hodgson VR, 1981, WRIGHT PATTERSON AIR; Hutchinson MG, 2011, THESIS; Jadischke R, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034306; King AI, 1979, AG C 253 MOD AN EV H; Kroeker SG, 2013, J BIOMECH, V46, P773, DOI 10.1016/j.jbiomech.2012.11.012; Kuwazawa Y, 2006, SPINE, V31, pE579, DOI 10.1097/01.brs.0000229228.62627.75; Maiman D J, 1989, J Spinal Disord, V2, P14; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Margulies S, 1992, P INT RES COUNC BIOM, V20, P213; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mertz H. J., 1971, P 15 STAPP CAR CRASH; Mertz HJ, 1967, P 11 STAPP CAR CRASH, P175; Ommaya AK, 1966, P 10 STAPP CAR CRASH, V10, P314; Ommaya AK, 1965, TRAUMA NERVOUS SYSTE, P317; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Sances A, 1981, 25 STAPP CAR CRASH C; Singh A, 2009, J NEUROTRAUM, V26, P627, DOI 10.1089/neu.2008.0621; SMITH CG, 1956, RADIOLOGY, V66, P259, DOI 10.1148/66.2.259; Stapp JP, 1951, GRAVITATIONAL STRESS, P165; Thunnissen J, 1995, P 39 STAPP CAR CRASH, P439, DOI [DOI 10.4271/952721, 10.4271/952721]; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Yliniemi EM, 2005, DYNAMIC TENSILE NECK; Yliniemi EM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3078151; Yoganandan N, 1996, MED ENG PHYS, V18, P289, DOI 10.1016/1350-4533(95)00054-2; Yuan Q, 1998, SPINE, V23, P1677, DOI 10.1097/00007632-199808010-00012	36	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	MAR	2018	4	1							e000362	10.1136/bmjsem-2018-000362			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VJ4QA	WOS:000596798200071	30364582	gold, Green Published			2022-02-06	
J	Martinez, M; Pergami, P; Murnick, J; Pearl, MS				Martinez, Mesha; Pergami, Paola; Murnick, Jonathan; Pearl, Monica S.			Embolization of a traumatic arteriovenous fistula between the middle meningeal artery and middle meningeal vein in a child with pulsatile tinnitus	CHILDS NERVOUS SYSTEM			English	Article						Middle meningeal artery; Arteriovenous fistula; Coil embolization; Pediatric	VESSELS	Traumatic arteriovenous fistulas (AVFs) involving the middle meningeal artery (MMA) are uncommon lesions and rare in the pediatric population. An adolescent with headaches developed a bruit and a rhythmic "swooshing" noise in the left ear 9 weeks after a traumatic brain injury involving a left temporal bone fracture. An MRA of the brain demonstrated an enlarged left MMA and arterialized flow in the left middle meningeal vein (MMV), suggestive of an AVF. Cerebral angiography confirmed and characterized the left MMA-MMV fistula, which drained into the pterygoid plexus. The patient underwent transarterial coil embolization, with successful obliteration of the fistulous connection, and her tinnitus resolved. This case illustrates the importance of recognizing a post-traumatic AVF in a pediatric patient with pulsatile tinnitus, and that endovascular treatment by coil embolization is a safe and effective treatment option.	[Martinez, Mesha; Pearl, Monica S.] Johns Hopkins Univ, Sch Med, Div Intervent Neuroradiol, Baltimore, MD 21218 USA; [Pergami, Paola] Childrens Natl Med Ctr, Dept Neurol, 111 Michigan Ave NW, Washington, DC 20010 USA; [Murnick, Jonathan; Pearl, Monica S.] Childrens Natl Med Ctr, Dept Radiol, Washington, DC 20010 USA; [Pearl, Monica S.] Johns Hopkins Univ Hosp, Bloomberg Bldg Room 7218,1800 Orleans St, Baltimore, MD 21287 USA		Pearl, MS (corresponding author), Johns Hopkins Univ, Sch Med, Div Intervent Neuroradiol, Baltimore, MD 21218 USA.; Pearl, MS (corresponding author), Childrens Natl Med Ctr, Dept Radiol, Washington, DC 20010 USA.; Pearl, MS (corresponding author), Johns Hopkins Univ Hosp, Bloomberg Bldg Room 7218,1800 Orleans St, Baltimore, MD 21287 USA.	msmit135@jhmi.edu					BETZ H, 1974, RADIOLOGE, V14, P528; FINCHER EF, 1951, ANN SURG, V133, P886, DOI 10.1097/00000658-195106000-00015; FRECKMANN N, 1981, ACTA NEUROCHIR, V55, P273, DOI 10.1007/BF01808443; HANDA J, 1970, Clinical Radiology, V21, P39, DOI 10.1016/S0009-9260(70)80137-4; KITAHARA T, 1977, EUR NEUROL, V16, P136, DOI 10.1159/000114891; Ko JH, 2014, INTERV NEURORADIOL, V20, P352, DOI 10.15274/NRJ-2014-10025; LESLIE EV, 1962, RADIOLOGY, V78, P930, DOI 10.1148/78.6.930; NAKAMURA K, 1966, J NEUROSURG, V25, P424, DOI 10.3171/jns.1966.25.4.0424; ROSKI RA, 1982, SURG NEUROL, V17, P200, DOI 10.1016/0090-3019(82)90280-4; Vassilyadi M, 2009, CAN J NEUROL SCI, V36, P751, DOI 10.1017/S0317167100008386; WILSON CB, 1964, JAMA-J AM MED ASSOC, V188, P953; Yu JL, 2017, INTERV NEURORADIOL, V23, P90, DOI 10.1177/1591019916673584	12	4	5	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2018	34	3					571	575		10.1007/s00381-017-3665-x			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FV6QT	WOS:000424707300031	29170838				2022-02-06	
J	Mayer, AR; Hanlon, FM; Claus, ED; Dodd, AB; Miller, B; Mickey, J; Quinn, DK; Hagerty, SL; Seaman, B; Hutchison, KE				Mayer, Andrew R.; Hanlon, Faith M.; Claus, Eric D.; Dodd, Andrew B.; Miller, Brittny; Mickey, Jessica; Quinn, Davin K.; Hagerty, Sarah L.; Seaman, Brandi; Hutchison, Kent E.			An Examination of Behavioral and Neuronal Effects of Comorbid Traumatic Brain Injury and Alcohol Use	BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING			English	Article						Alcohol use disorders; Alcohol-cue reactivity; Limbic; Prefrontal; Structure; Traumatic brain injury	YOUNG-ONSET DEMENTIA; CUE REACTIVITY; USE DISORDER; INTOXICATION; RISK; CONSUMPTION; ACTIVATION; ADDICTION; ABUSE; NEUROBIOLOGY	BACKGROUND: Chronic alcohol use disorders (AUDs) and traumatic brain injury (TBI) are highly comorbid and share commonly affected neuronal substrates (i.e., prefrontal cortex, limbic system, and cerebellum). However, no studies have examined how combined physical trauma and heavy drinking affect neurocircuitry relative to heavy drinking alone. METHODS: The current study investigated whether comorbid AUDs and mild or moderate TBI (AUDs+TBI) would negatively affect maladaptive drinking behaviors (n = 90 AUDs+TBI; n = 62 AUDs) as well as brain structure (i.e., increased atrophy; n = 62 AUDs+TBI; n = 44 AUDs) and function (i.e., activation during gustatory cue reactivity; n = 55 AUDs+TBI; n = 37 AUDs) relative to AUDs alone. RESULTS: Participants reported a much higher incidence of trauma (59.2%) compared with the general population. There were no differences in demographic and clinical measures between groups, suggesting that they were well matched. Although maladaptive drinking behaviors tended to be worse for the AUDs+TBI group, effect sizes were small and not statistically significant. Increased alcohol-cue reactivity was observed in bilateral anterior insula and orbitofrontal cortex, anterior cingulate cortex, medial prefrontal cortex, posterior cingulate cortex, dorsal striatum, thalamus, brainstem, and cerebellum across both groups relative to a carefully matched appetitive control. However, there were no significant differences in structural integrity or functional activation between AUDs+TBI and AUDs participants, even when controlling for AUD severity. CONCLUSIONS: Current results indicate that a combined history of mild or moderate TBI was not sufficient to alter drinking behaviors and/or underlying neurocircuitry at detectable levels relative to heavy drinking alone. Future studies should examine the potential long-term effects of combined alcohol and trauma on brain functioning.	[Mayer, Andrew R.; Hanlon, Faith M.; Claus, Eric D.; Dodd, Andrew B.; Miller, Brittny; Mickey, Jessica] Univ New Mexico, Sch Med, Mind Res Network Lovelace Biomed & Environm Res I, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Claus, Eric D.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Quinn, Davin K.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Seaman, Brandi] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Hagerty, Sarah L.; Hutchison, Kent E.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA		Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domen Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org	Claus, Eric/AAQ-5035-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD086704-01, 3R01AA014886-05S1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098494] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (Grant No. 1R01HD086704-01 to ARM and Grant No. 3R01AA014886-05S1 to KEH).	Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Brust JCM, 2010, INT J ENV RES PUB HE, V7, P1540, DOI 10.3390/ijerph7041540; Cherpitel CJ, 2007, DRUG ALCOHOL REV, V26, P201, DOI 10.1080/09595230601146686; Chopra K, 2012, BRIT J CLIN PHARMACO, V73, P348, DOI 10.1111/j.1365-2125.2011.04111.x; Claus ED, 2013, J STUD ALCOHOL DRUGS, V74, P141, DOI 10.15288/jsad.2013.74.141; Claus ED, 2011, NEUROPSYCHOPHARMACOL, V36, P2086, DOI 10.1038/npp.2011.99; Courtney KE, 2016, ADDICT BIOL, V21, P3, DOI 10.1111/adb.12314; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, TRAUMATIC BRAIN INJU; Filbey FM, 2008, NEUROPSYCHOPHARMACOL, V33, P1391, DOI 10.1038/sj.npp.1301513; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jasinska AJ, 2014, NEUROSCI BIOBEHAV R, V38, P1, DOI 10.1016/j.neubiorev.2013.10.013; Johnson LA, 2015, MIL MED, V180, P208, DOI 10.7205/MILMED-D-14-00268; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kareken DA, 2004, ALCOHOL CLIN EXP RES, V28, P550, DOI 10.1097/01.ALC.0000122764.60626.AF; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koike H, 2006, CURR OPIN NEUROL, V19, P481, DOI 10.1097/01.wco.0000245371.89941.eb; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Littlewood RA, 2015, PSYCHOPHARMACOLOGY, V232, P1261, DOI 10.1007/s00213-014-3757-1; Mayer AR, 2017, BRAIN IMAGING BEHAV, V11, P698, DOI 10.1007/s11682-016-9546-1; Mayfield J, 2013, CURR OPIN NEUROBIOL, V23, P513, DOI 10.1016/j.conb.2013.01.024; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; Myrick H, 2008, ARCH GEN PSYCHIAT, V65, P466, DOI 10.1001/archpsyc.65.4.466; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Nordstrom P, 2013, JAMA INTERN MED, V173, P1612, DOI 10.1001/jamainternmed.2013.9079; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Picard C, 2011, ALZ DIS ASSOC DIS, V25, P203, DOI 10.1097/WAD.0b013e3182056be7; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rosenbloom M, 2003, ALCOHOL RES HEALTH, V27, P146; Schacht JP, 2013, ADDICT BIOL, V18, P121, DOI 10.1111/j.1369-1600.2012.00464.x; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Schneider F, 2001, AM J PSYCHIAT, V158, P1075, DOI 10.1176/appi.ajp.158.7.1075; Sher KJ, 2005, ANNU REV CLIN PSYCHO, V1, P493, DOI 10.1146/annurev.clinpsy.1.102803.144107; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Tang DW, 2012, PHYSIOL BEHAV, V106, P317, DOI 10.1016/j.physbeh.2012.03.009; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thayer RE, 2016, HUM BRAIN MAPP, V37, P2276, DOI 10.1002/hbm.23172; Vollstadt-Klein S, 2011, BIOL PSYCHIAT, V69, P1060, DOI 10.1016/j.biopsych.2010.12.016; Weil ZM, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00135; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604	61	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-9022	2451-9030		BIOL PSYCHIAT-COGN N	Biol. Psychiat.-Cogn. Neurosci. Neuroimag.	MAR	2018	3	3					294	302		10.1016/j.bpsc.2017.09.012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ7NR	WOS:000494340900015	29486871	Green Accepted			2022-02-06	
J	Scheetz, LJ; Horst, MA; Arbour, RB				Scheetz, Linda J.; Horst, Michael A.; Arbour, Richard B.			Early neurological deterioration in older adults with traumatic brain injury	INTERNATIONAL EMERGENCY NURSING			English	Article						Brain injuries; Glasgow Coma Scale; Aged; Elderly; Emergency medical services	GLASGOW COMA SCALE; MORTALITY PREDICTION MODEL; GERIATRIC TRAUMA; OUTCOMES; SCORES; ANTICOAGULATION; AGREEMENT; WARFARIN; IMPACT; LEVEL	Introduction: Traumatic brain injuries (TBIs) and resulting fatalities among older adults increased considerably in recent years. Neurological deterioration often goes unrecognized at the injury scene and patients arrive at emergency departments with near-normal Glasgow Coma Scale (GCS) scores. This study examined the proportion of older adults experiencing early neurological deterioration (prehospital to emergency department), associated factors, and association of the magnitude of neurological deterioration with TBI severity. Methods: This secondary analysis of National Trauma Data Bank Research Datasets included patients who were age >= 65, sustained a TBI, and transported from the injury scene to an emergency department. Data analysis included chi-square analysis, t-tests, and logistic regression. Long-term anticoagulant/antiplatelet therapy was not associated with deterioration. Results: Of the sample of 91,886 patients, 13,913 (15.1%) experienced early neurological deterioration. Adjusting for covariates, age, gender, head AIS(max) injury severity, and probability of death were associated with early deterioration. Patients with severe and critical head injuries had the highest odds of early neurological deterioration (OR = 1.41 [CI = 1.22-1.63] and OR = 1.98 [CI = 1.63-2.40], p < 0.001). Discussion/conclusions: Prehospital providers, nurses, physicians, and other providers have opportunities to optimize outcomes from older adult TBI through early recognition of neurological deterioration, rapid transport to facilities for definitive treatment, and targeted rehabilitation. (c) 2016 Elsevier Ltd. All rights reserved.	[Scheetz, Linda J.] CUNY, Lehman Coll, Dept Nursing, 250 Bedford Pk Blvd West, Bronx, NY 10468 USA; [Scheetz, Linda J.] CUNY, Grad Ctr, 250 Bedford Pk Blvd West, Bronx, NY 10468 USA; [Horst, Michael A.] Lancaster Gen Hosp, Lancaster Gen Res Inst, Res Data & Biostat, Lancaster, PA USA; [Arbour, Richard B.] Lancaster Gen Hosp, Lancaster, PA USA		Scheetz, LJ (corresponding author), CUNY, Lehman Coll, Dept Nursing, 250 Bedford Pk Blvd West, Bronx, NY 10468 USA.; Scheetz, LJ (corresponding author), CUNY, Grad Ctr, 250 Bedford Pk Blvd West, Bronx, NY 10468 USA.	linda.scheetz@lehman.cuny.edu	Scheetz, Linda J./A-8160-2009; Scheetz, Linda/AAH-7479-2019	Scheetz, Linda J./0000-0002-1947-5052; 	George N. Shuster Fellowship Fund, Lehman College, City University of New York	This work was supported by a grant from the George N. Shuster Fellowship Fund, Lehman College, City University of New York. This funding source had no role in the study design, data collection, analysis and interpretation, writing this manuscript, or decision to submit this manuscript.	American College of Emergency Physicians, 2014, Ann Emerg Med, V63, pe7, DOI 10.1016/j.annemergmed.2014.02.008; American College of Surgeons Committee on Trauma, 2014, NAT TRAUM DAT BANK R; American College of Surgeons Committee on Trauma, 2015, NAT TRAUM DAT BANK R; Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Arbour RB, 2013, CRIT CARE NURS CLIN, V25, P297, DOI 10.1016/j.ccell.2013.02.010; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Centers for Disease Control and Prevention, 2018, TRAUM BRAIN INJ CONC; Cook Alan, 2014, J Trauma Acute Care Surg, V76, P47, DOI 10.1097/TA.0b013e3182ab0d5d; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Dinh MM, 2013, EMERG MED AUSTRALAS, V25, P457, DOI 10.1111/1742-6723.12126; Fuller G, 2014, PREHOSP EMERG CARE, V18, P60, DOI 10.3109/10903127.2013.831507; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Haider AH, 2012, J TRAUMA ACUTE CARE, V72, P1695, DOI 10.1097/TA.0b013e318256a010; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Joosse P, 2014, HEALTH INF MANAG J, V43, P17, DOI 10.1177/183335831404300203; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Leth PM, 2010, J TRAUMA, V68, P1413, DOI 10.1097/TA.0b013e3181b251b8; Majidi S, 2013, AM J EMERG MED, V31, P1215, DOI 10.1016/j.ajem.2013.05.026; McNett MM, 2016, J NEUROSCI NURS, V48, P207, DOI 10.1097/JNN.0000000000000225; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Newgard CD, 2011, J AM COLL SURGEONS, V213, P709, DOI 10.1016/j.jamcollsurg.2011.09.012; Osler T, 2008, ANN SURG, V247, P1041, DOI 10.1097/SLA.0b013e31816ffb3f; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Sasser SM, 2011, MMWR-MORBID MORTAL W, V61, P1; Scheetz LJ, 2012, J EMERG MED, V43, P1020, DOI 10.1016/j.jemermed.2011.09.036; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	38	4	4	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1755-599X	1878-013X		INT EMERG NURS	Int. Emerg. Nurs.	MAR	2018	37				SI		29	34		10.1016/j.ienj.2016.11.003			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	GA0HT	WOS:000427994800006	28082072				2022-02-06	
J	Shen, YT; Radford, K; Daylight, G; Cumming, R; Broe, TGA; Draper, B				Shen, Yu-Tang; Radford, Kylie; Daylight, Gail; Cumming, Robert; Broe, Tony G. A.; Draper, Brian			Depression, Suicidal Behaviour, and Mental Disorders in Older Aboriginal Australians	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						late-life; depression; aboriginal; childhood; mental health; resilience	LATE-LIFE DEPRESSION; ADVERSE CHILDHOOD EXPERIENCES; TRAUMATIC BRAIN-INJURY; STRAIT ISLANDER PEOPLE; RISK-FACTORS; PSYCHOMETRIC PROPERTIES; COMMUNITY-SAMPLE; PARENTAL DEATH; HEALTH; RESILIENCE	Aboriginal Australians experience higher levels of psychological distress, which may develop from the long-term sequelae of social determinants and adversities in early and mid-life. There is little evidence available on the impact of these on the mental health of older Aboriginal Australians. This study enrolled 336 Aboriginal Australian participants over 60 years from 5 major urban and regional areas in NSW, utilizing a structured interview on social determinants, and life-time history of physical and mental conditions; current psychosocial determinants and mental health. Univariate and multivariate analyses were utilized to examine the link between these determinants and current depressive scores and suicidality. There was a high rate of life-time depression (33.3%), current late-life depression (18.1%), and suicidal ideation (11.1%). Risk factors strongly associated with late-life depression included sleep disturbances, a history of suicidal behaviour, suicidal ideation in late-life and living in a regional location. This study supports certain historical and psychosocial factors predicting later depression in old age, and highlights areas to target for prevention strategies.	[Shen, Yu-Tang] St Vincents Hosp, Sydney, NSW 2010, Australia; [Radford, Kylie; Daylight, Gail; Broe, Tony G. A.; Draper, Brian] Neurosci Res Australia, Sydney, NSW 2010, Australia; [Radford, Kylie; Broe, Tony G. A.; Draper, Brian] Univ New South Wales, Fac Med, Sydney, NSW 2010, Australia; [Cumming, Robert] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2010, Australia		Shen, YT (corresponding author), St Vincents Hosp, Sydney, NSW 2010, Australia.; Radford, K; Draper, B (corresponding author), Neurosci Res Australia, Sydney, NSW 2010, Australia.; Radford, K; Draper, B (corresponding author), Univ New South Wales, Fac Med, Sydney, NSW 2010, Australia.	dr.yutang.shen@gmail.com; k.radford@neura.edu.au; cliffdaylight@gmail.com; robert.cumming@sydney.edu.au; t.broe@neura.edu.au; B.Draper@unsw.edu.au	Radford, Kylie/D-5338-2011	Radford, Kylie/0000-0001-8095-5314	Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [510347]; NHMRC-ARC Dementia Research Development FellowshipAustralian Research CouncilNational Health and Medical Research Council of Australia [1103312]	This study was supported by an Australian National Health and Medical Research Council (NHMRC) project grant (510347). Kylie Radford is supported by a NHMRC-ARC Dementia Research Development Fellowship (1103312). The other authors had no conflicts of interest to report. This work also relied on the support of many individuals and organizations. We are particularly grateful to our participants; our local Elder guidance groups; KGOWS Aboriginal Reference Group; the Aboriginal Health and Medical Research Council; and our Aboriginal community partners who continue to support our research: Durri Aboriginal Corporation Medical Service and Booroongen Djugun in Kempsey, Darrimba Maarra Aboriginal Health Clinic in Nambucca, Galambila Aboriginal Health Service in Coffs Harbour, La Perouse Local Aboriginal Land Council, La Perouse Aboriginal Community Health Centre, and Tharawal Aboriginal Corporation in Campbelltown. We wish to recognize the hard work of our research team including Aboriginal research assistants, investigators, project officers and interviewers, medical doctors, knowledge translation and support team (Koori Dementia Care Project). We also acknowledge Kerry Arabena for her steadfast support and critical appraisal of our research throughout, particularly in relation to the importance of early life factors for growing old well for Aboriginal Australians.	Adams KB, 2004, AGING MENT HEALTH, V8, P475, DOI 10.1080/13607860410001725054; Almeida OP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094983; Almeida OP, 2012, BRIT J PSYCHIAT, V201, P466, DOI 10.1192/bjp.bp.112.110130; Australian Bureau of Statistics, 2015, CAUS DEATH DEATHS AB; Australian Bureau of Statistics, 2013, LIF TABL AB TORR STR; Australian Bureau of Statistics, 2015, CAUS DEATH INT SELF; Australian Bureau of Statistics, 2010, HLTH WELF AUSTR AB T; Aziz R, 2013, PSYCHIAT CLIN N AM, V36, P497, DOI 10.1016/j.psc.2013.08.001; Bentley KH, 2016, CLIN PSYCHOL REV, V43, P30, DOI 10.1016/j.cpr.2015.11.008; Berg L, 2016, J CHILD PSYCHOL PSYC, V57, P1092, DOI 10.1111/jcpp.12560; Berger M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41760; Brown R, 2001, Aust N Z J Ment Health Nurs, V10, P33, DOI 10.1046/j.1440-0979.2001.00189.x; Calabria B, 2014, ADDICT SCI CLIN PRAC, V9, DOI 10.1186/1940-0640-9-17; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Choi NG, 2017, INT PSYCHOGERIATR, V29, P359, DOI 10.1017/S1041610216001800; Choi NG, 2011, AGING MENT HEALTH, V15, P720, DOI 10.1080/13607863.2010.551343; Comijs HC, 2013, J AFFECT DISORDERS, V147, P241, DOI 10.1016/j.jad.2012.11.010; Cosgrave C, 2015, AUST J RURAL HEALTH, V23, P272, DOI 10.1111/ajr.12205; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; Draper B, 2008, J AM GERIATR SOC, V56, P262, DOI 10.1111/j.1532-5415.2007.01537.x; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Esler D, 2008, AUST NZ J PUBL HEAL, V32, P317, DOI 10.1111/j.1753-6405.2008.00247.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goins RT, 2013, RES AGING, V35, P123, DOI 10.1177/0164027511431989; Gubhaju L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-661; Hinton R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007938; Holvast F, 2015, J AFFECT DISORDERS, V185, P1, DOI 10.1016/j.jad.2015.06.036; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Jeon HJ, 2014, J NERV MENT DIS, V202, P870, DOI 10.1097/NMD.0000000000000217; Keilp JG, 2012, J AFFECT DISORDERS, V140, P75, DOI 10.1016/j.jad.2012.01.045; Kenny D. T., 2011, PSYCHIAT PSYCHOL LAW, V14, P294; Krieg Anthea, 2009, Australas Psychiatry, V17 Suppl 1, pS28, DOI 10.1080/10398560902948621; Lamond AJ, 2008, J PSYCHIATR RES, V43, P148, DOI 10.1016/j.jpsychires.2008.03.007; Liu DWY, 2016, CRISIS, V37, P130, DOI 10.1027/0227-5910/a000364; Liu DWY, 2014, ARCH SUICIDE RES, V18, P453, DOI 10.1080/13811118.2013.833881; Lue BH, 2010, ARCH GERONTOL GERIAT, V50, pS34, DOI 10.1016/S0167-4943(10)70010-8; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Markwick A, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0091-5; Panagioti M, 2014, INT J CHRONIC OBSTR, V9, P1289, DOI 10.2147/COPD.S72073; Paradies YC, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-9; Patten SB, 2016, EPIDEMIOL PSYCH SCI, V25, P160, DOI 10.1017/S2045796015000104; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Pigeon WR, 2008, SLEEP, V31, P481, DOI 10.1093/sleep/31.4.481; Priest NC, 2011, MED J AUSTRALIA, V194, P546; Prince MJ, 1997, PSYCHOL MED, V27, P323, DOI 10.1017/S0033291796004485; Radford K, 2017, AM J GERIAT PSYCHIAT, V25, P1097, DOI 10.1016/j.jagp.2017.05.008; Radford K, 2015, DEMENT GERIATR COGN, V40, P22, DOI 10.1159/000377673; Radford K, 2014, INT PSYCHOGERIATR, V26, P1033, DOI 10.1017/S1041610213002561; Richardson JD, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1372-5; Sarnyai Z, 2016, AUSTRALAS PSYCHIATRY, V24, P72, DOI 10.1177/1039856215620025; Savikko N, 2006, INT J OLDER PEOPLE N, V1, P17, DOI 10.1111/j.1748-3743.2006.00001.x; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Turale S., 1994, AUSTR J MENTAL HLTH, V3, P16; Turpin M, 2007, AUST J RURAL HEALTH, V15, P131, DOI 10.1111/j.1440-1584.2007.00870.x; Valkanova V, 2013, BIOL PSYCHIAT, V73, P406, DOI 10.1016/j.biopsych.2012.10.028; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Zhang H, 2013, COMPR PSYCHIAT, V54, P790, DOI 10.1016/j.comppsych.2013.03.004	58	4	4	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2018	15	3							447	10.3390/ijerph15030447			14	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	GA7II	WOS:000428509200054	29510527	Green Submitted, gold, Green Published			2022-02-06	
J	Skytioti, M; Sovik, S; Elstad, M				Skytioti, Maria; Sovik, Signe; Elstad, Maja			Dynamic cerebral autoregulation is preserved during isometric handgrip and head-down tilt in healthy volunteers	PHYSIOLOGICAL REPORTS			English	Article						Dynamic cerebral autoregulation; head-down tilt; isometric handgrip; wavelet analysis	ARTERIAL-BLOOD PRESSURE; RESPIRATORY SINUS ARRHYTHMIA; PHASE COHERENCE ANALYSIS; TRAUMATIC BRAIN-INJURY; STROKE VOLUME; FLOW VELOCITY; CEREBROVASCULAR AUTOREGULATION; TRENDELENBURG POSITION; STATIC EXERCISE; CARDIAC-OUTPUT	In healthy humans, cerebral blood flow (CBF) is autoregulated against changes in arterial blood pressure. Spontaneous fluctuations in mean arterial pressure (MAP) and CBF can be used to assess cerebral autoregulation. We hypothesized that dynamic cerebral autoregulation is affected by changes in autonomic activity, MAP, and cardiac output (CO) induced by handgrip (HG), head-down tilt (HDT), and their combination. In thirteen healthy volunteers, we recorded blood velocity by ultrasound in the internal carotid artery (ICA), HR, MAP and CO-estimates from continuous finger blood pressure, and end-tidal CO2. Instantaneous ICA beat volume (ICABV, mL) and ICA blood flow (ICABF, mL/min) were calculated. Wavelet synchronization index gamma (0-1) was calculated for the pairs: MAP-ICABF, CO-ICABF and HR-ICABV in the low (0.05-0.15 Hz; LF) and high (0.15-0.4 Hz; HF) frequency bands. ICABF did not change between experimental states. MAP and CO were increased during HG (+16% and +15%, respectively, P<0.001) and during HDT+HG (+12% and +23%, respectively, P<0.001). In the LF interval, median gamma for the MAP-ICABF pair (baseline: 0.23 [0.12-0.28]) and the CO-ICABF pair (baseline: 0.22 [0.15-0.28]) did not change with HG, HDT, or their combination. High gamma was observed for the HR-ICABV pair at the respiratory frequency, the oscillations in these variables being in inverse phase. The unaltered ICABF and the low synchronization between MAP and ICABF in the LF interval suggest intact dynamic cerebral autoregulation during HG, HDT, and their combination.	[Skytioti, Maria; Elstad, Maja] Univ Oslo, Inst Basic Med Sci, Div Physiol, POB 1113 Blindern, N-0317 Oslo, Norway; [Sovik, Signe] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Sovik, Signe] Akershus Univ Hosp, Dept Anaesthesia & Intens Care, Lorenskog, Norway		Skytioti, M (corresponding author), Univ Oslo, Inst Basic Med Sci, Div Physiol, POB 1113 Blindern, N-0317 Oslo, Norway.	maria.skytioti@medisin.uio.no	Sovik, Signe/O-4185-2016	Sovik, Signe/0000-0003-4524-2268	University of Oslo; Research Council of NorwayResearch Council of Norway [230354]	The study was funded by the University of Oslo and the Research Council of Norway (Grant 230354).	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Addison P.S., 2015, IEEE REV BIOMED ENG, V8, P78, DOI DOI 10.1109/RBME.2015.2436978; Baden JR, 2014, AVIAT SPACE ENVIR MD, V85, P1222, DOI 10.3357/ASEM.4085.2014; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bogert LWJ, 2005, EXP PHYSIOL, V90, P437, DOI 10.1113/expphysiol.2005.030262; Bracic M, 1998, B MATH BIOL, V60, P919, DOI 10.1006/bulm.1998.0047; Brothers RM, 2014, EXP PHYSIOL, V99, P1499, DOI 10.1113/expphysiol.2014.081190; Brys M, 2003, AM J PHYSIOL-HEART C, V285, pH1048, DOI 10.1152/ajpheart.00062.2003; Claassen JAHR, 2007, J APPL PHYSIOL, V102, P870, DOI 10.1152/japplphysiol.00906.2006; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Cohen MA, 2002, J PHYSIOL-LONDON, V542, P669, DOI 10.1113/jphysiol.2002.017483; Cooke WH, 2003, J APPL PHYSIOL, V95, P1439, DOI 10.1152/japplphysiol.00524.2003; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; de Jong DLK, 2017, J PHYSIOL-LONDON, V595, P5623, DOI 10.1113/JP274304; Deegan BM, 2010, J APPL PHYSIOL, V109, P1424, DOI 10.1152/japplphysiol.01262.2009; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Donnelly J, 2015, EXPERT REV NEUROTHER, V15, P169, DOI 10.1586/14737175.2015.996552; Elstad M, 2009, ACTA PHYSIOL, V195, P289, DOI 10.1111/j.1748-1716.2008.01887.x; Elstad M, 2001, J PHYSIOL-LONDON, V536, P251, DOI 10.1111/j.1469-7793.2001.t01-1-00251.x; Fisher N.I., 1995, STAT ANAL CIRCULAR D; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Gao YJ, 2015, BEHAV BRAIN RES, V278, P330, DOI 10.1016/j.bbr.2014.10.019; Hamner JW, 2014, STROKE, V45, P1771, DOI 10.1161/STROKEAHA.114.005293; Hilz MJ, 2013, STROKE, V44, P1062, DOI 10.1161/STROKEAHA.111.680256; Hollander M, 1999, NONPARAMETRIC STAT M; Holme NLA, 2016, EUR J APPL PHYSIOL, V116, P2187, DOI 10.1007/s00421-016-3471-2; Iatsenko D, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0622; Immink RV, 2005, STROKE, V36, P2595, DOI 10.1161/01.STR.0000189624.06836.03; Kalmar AF, 2012, BRIT J ANAESTH, V108, P478, DOI 10.1093/bja/aer448; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; Kvandal P, 2013, J CLIN MONIT COMPUT, V27, P375, DOI 10.1007/s10877-013-9484-z; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Latka M, 2005, AM J PHYSIOL-HEART C, V289, pH2272, DOI 10.1152/ajpheart.01307.2004; Lewis NCS, 2015, CLIN SCI, V129, P169, DOI 10.1042/CS20140751; Marmarelis VZ, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0180; Mitsis GD, 2004, IEEE T BIO-MED ENG, V51, P1932, DOI 10.1109/TBME.2004.834272; Montero D, 2016, AEROSP MED HUM PERF, V87, P682, DOI 10.3357/AMHP.4546.2016; Morlet J., 1983, NATO ASI SERIES, P233, DOI [10.1007/978-3-642-82002-1_12, DOI 10.1007/978-3-642-82002-1_12]; Nogueira RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070821; Ogoh S, 2005, J PHYSIOL-LONDON, V569, P697, DOI 10.1113/jphysiol.2005.095836; Ogoh S, 2010, J APPL PHYSIOL, V108, P1701, DOI 10.1152/japplphysiol.01031.2009; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Panerai RB, 2014, MED ENG PHYS, V36, P576, DOI 10.1016/j.medengphy.2013.09.004; Peebles K, 2007, J PHYSIOL-LONDON, V584, P347, DOI 10.1113/jphysiol.2007.137075; Peng TY, 2010, IEEE T BIO-MED ENG, V57, P960, DOI 10.1109/TBME.2009.2024265; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Rubenfire M, 2002, ATHEROSCLEROSIS, V160, P241, DOI 10.1016/S0021-9150(01)00572-X; Sato K, 2012, J PHYSIOL-LONDON, V590, P3277, DOI 10.1113/jphysiol.2012.230425; Schramm P, 2014, ANAESTHESIA, V69, P58, DOI 10.1111/anae.12477; Secher NH, 2012, EXP PHYSIOL, V97, P59, DOI 10.1113/expphysiol.2011.057679; Skytioti M, 2017, EUR J APPL PHYSIOL, V117, P2237, DOI 10.1007/s00421-017-3711-0; Skytioti M, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12969; Strik C, 2002, ACT NEUR S, V81, P139; Tan CO, 2014, EXP PHYSIOL, V99, P3, DOI 10.1113/expphysiol.2013.072355; Tan CO, 2012, J APPL PHYSIOL, V113, P1194, DOI 10.1152/japplphysiol.00783.2012; Tian FH, 2016, NEUROIMAGE-CLIN, V11, P124, DOI 10.1016/j.nicl.2016.01.020; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; TOSKA K, 1993, J PHYSIOL-LONDON, V472, P501, DOI 10.1113/jphysiol.1993.sp019958; Vianna LC, 2012, CLIN PHYSIOL FUNCT I, V32, P59, DOI 10.1111/j.1475-097X.2011.01055.x; Wallin BG, 2007, MUSCLE NERVE, V36, P595, DOI 10.1002/mus.20831; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Yamamoto M, 2006, ULTRASOUND OBST GYN, V28, P853, DOI 10.1002/uog.3847; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE	67	4	4	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2051-817X			PHYSIOL REP	PHYSIOL. REP.	MAR	2018	6	6							e13656	10.14814/phy2.13656			15	Physiology	Emerging Sources Citation Index (ESCI)	Physiology	GB2NS	WOS:000428890500011	29595918	Green Published, gold			2022-02-06	
J	Tschiffely, AE; Haque, A; Haran, FJ; Cunningham, CA; Mehalick, ML; May, T; Stuessi, K; Walker, PB; Norris, JN				Tschiffely, Anna E.; Haque, Ashraful; Haran, Francis J.; Cunningham, Craig A.; Mehalick, Melissa L.; May, Todd; Stuessi, Keith; Walker, Peter B.; Norris, Jacob N.			Recovery from Mild Traumatic Brain Injury Following Uncomplicated Mounted and Dismounted Blast: A Natural History Approach	MILITARY MEDICINE			English	Article							CONCUSSIVE BLAST; ASSOCIATION; MECHANISM	Objective: The purpose of this study is to utilize a natural history approach to describe and understand symptom recovery in personnel diagnosed with a blast-related mild traumatic brain injury (mTBI) resulting from an improvised explosive device blast. Participants and Design: The population included military personnel who experienced a blast mTBI while mounted (vehicle; n = 176) or dismounted (on foot; n = 37) (N = 213). Patients had no co-morbid psychiatric or muscle-skeletal issues and were treated within 72 h of injury. Prevalence and duration of self-reported symptoms were separately analyzed by injury context (mounted vs dismounted). Results: Headache was prominently reported in both mounted (85%) and dismounted (75%) populations. The mean time from injury to return to full duty was between 7.8 d (mounted) and 8.5 d (dismounted). The dismounted population reported visual changes that lasted 0.74 d longer. Conclusion: Our analysis implicates that headache is a common and acutely persistent symptom in mTBI regardless of injury context. Additionally, patients in mounted vs dismounted injury did not report significant differences in symptom prevalence. Although knowing the injury context (i.e., dismounted vs mounted) may be beneficial for providers to understand symptom presentations and deliver accurate anticipatory guidance for patients with blast-related mTBI, no significant differences were observed in this population. This may be due to the population characteristic as the trajectory of recovery may vary for patients who were not able to return to full duty within 30 d or required higher levels of care.	[Tschiffely, Anna E.; Haque, Ashraful; Mehalick, Melissa L.; Walker, Peter B.; Norris, Jacob N.] US Navy, Med Res Ctr, Dept Neurotrauma, Operat & Undersea Med Directorate, Silver Spring, MD 20910 USA; [Haque, Ashraful] Henry M Jackson Fdn, Bethesda, MD 20817 USA; [Haran, Francis J.] Naval Submarine Base New London, Naval Submarine Med Res Lab, Groton, CT 06349 USA; [Cunningham, Craig A.] Naval Med Ctr Portsmouth, Nursing Res & Consultat Serv, Portsmouth, VA 23708 USA; [May, Todd] Intermt Healthcare Layton Hosp, Sports Med, Layton, UT 84041 USA; [Stuessi, Keith] Naval Hosp Camp Pendleton, DVBIC, Oceanside, CA 92058 USA; [Norris, Jacob N.] SPAWAR Syst Ctr Pacific, Adv Concepts & Appl Res Branch, San Diego, CA 92152 USA		Tschiffely, AE (corresponding author), US Navy, Med Res Ctr, Dept Neurotrauma, Operat & Undersea Med Directorate, Silver Spring, MD 20910 USA.				 [CDMRP: W81XWH-13-DMRDP-CRI-IIIRA]	CDMRP: W81XWH-13-DMRDP-CRI-IIIRA.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; [Anonymous], 2016, NAT GUID C VA DOD CL; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Doll RADM, 2015, COMMUNICATION; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Haran FJ, 2016, J HEAD TRAUMA REHAB, V31, P329, DOI 10.1097/HTR.0000000000000172; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Kontos Anthony P, 2015, J Trauma Acute Care Surg, V79, pS146, DOI 10.1097/TA.0000000000000667; Lemonick DM, 2011, AM J CLIN MED, V8, P134; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McHugh T, 2006, BRAIN COGNITION, V60, P209; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Norris JN, 2015, BRAIN INJURY, V29, P898, DOI 10.3109/02699052.2015.1022879; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Risling M, 2012, FRONT NEUROL, V3, P338; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Tanielin T, 2008, INVISIBLE WOUNDS WAR; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	29	4	4	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183	3-4					E140	E147		10.1093/milmed/usx036			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF9BF	WOS:000432270400008	29514349	Bronze			2022-02-06	
J	Wang, JL; Qi, W; Shen, XZ; Tao, S; Liu, YJ				Wang, Junliang; Qi, Wei; Shen, Xuezhen; Tao, Sheng; Liu, Yujie			Results of arthroscopic fixation of Mason type II radial head fractures using Kirschner wires	MEDICINE			English	Article						arthroscopy; Kirschner wire; outcome; radial head fracture	INTERNAL-FIXATION; OPEN REDUCTION; REPLACEMENT; INJURIES	The goals of this study are to report an arthroscopic technique for the treatment of Mason type II radial head fractures using Kirschner wires (K-wires), and investigate the feasibility and evaluate the results. We retrospectively review 18 cases of closed Mason type II radial head fractures treated in our institution from August 2010 to May 2015. There were 13 males and 5 females with an average age of 30.6 (17-45 years) years. Injuries were caused by falling in 8 cases, by traffic accidents in 5 cases, and by sports in 5 cases. The average time from injury to admission was 3.9 days (1-11 days). All radial head fractures were confirmed on x-ray and computed tomography. The fracture fragments were fixed with percutaneous K-wires under arthroscopy. All surgical wounds healed with primary closure, and no complication occurred, such as neurovascular injury, infection, or hardware failure. All patients were followed up for a mean period of 19 months (range: 14-29 months). Bone union was achieved for all patients with a mean time of 11 weeks. At final follow-up, range of motion of the elbow has no significant difference in comparison to the uninjured side. The mean Visual Analog Scale for these patients was 1.7 (range 0-3). According to the Broberg-Morrey score, there were 7 excellent, 9 good, 2 fair, and 0 poor results (with good or excellent results in 89%). Mayo elbow performance score and the disabilities of the arm, shoulder, and hand score were significantly improved postoperatively. The present study demonstrates that arthroscopic fixation of Mason type II radial head fractures using K-wires provided a stable fixation with good clinical outcomes and patient satisfaction.	[Wang, Junliang; Qi, Wei; Shen, Xuezhen; Tao, Sheng; Liu, Yujie] Chinese Peoples Liberat Army PLA, Gen Hosp, Dept Orthoped, Beijing 10086, Peoples R China		Wang, JL (corresponding author), Chinese Peoples Liberat Army PLA, Gen Hosp, Dept Orthoped, Beijing 10086, Peoples R China.	junliangzq@126.com					Atesok K, 2011, KNEE SURG SPORT TR A, V19, P320, DOI 10.1007/s00167-010-1298-7; Bhatia DN, 2016, ARTHROSC TEC, V5, pE705, DOI 10.1016/j.eats.2016.02.033; Chen X, 2011, INT ORTHOP, V35, P1071, DOI 10.1007/s00264-010-1107-4; Coleman DA., 1985, IOWA ORTHOP J, V5, P48; Dei Giudici L, 2016, EFORT OPEN REV, V1, P325, DOI 10.1302/2058-5241.1.160016; Guzzini M, 2016, G CHIR, V37, P200, DOI 10.11138/gchir/2016.37.5.200; Kaas L, 2010, ACTA ORTHOP, V81, P373, DOI 10.3109/17453674.2010.483988; Kodde IF, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0603-5; Kovar FM, 2013, WORLD J ORTHOP, V4, P80, DOI 10.5312/wjo.v4.i2.80; Liu R, 2015, MED SCI MONITOR, V21, P90, DOI 10.12659/MSM.893048; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; Michels F, 2007, KNEE SURG SPORT TR A, V15, P1244, DOI 10.1007/s00167-007-0378-9; Pearce MS, 1996, J ROY SOC MED, V89, pP340, DOI 10.1177/014107689608900616; Pike JM, 2014, CLIN ORTHOP RELAT R, V472, P2120, DOI 10.1007/s11999-014-3519-8; Rolla PR, 2006, ARTHROSCOPY, V22, P233, DOI 10.1016/j.arthro.2005.10.003; Ruan HJ, 2009, INT ORTHOP, V33, P249, DOI 10.1007/s00264-007-0453-3; Yoon A, 2014, CLIN ORTHOP RELAT R, V472, P2105, DOI 10.1007/s11999-014-3541-x	17	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAR	2018	97	12							e0201	10.1097/MD.0000000000010201			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4OV	WOS:000429041100041	29561446	gold, Green Published			2022-02-06	
J	Zogas, A				Zogas, Anna			Thinking about Thinking Mild Traumatic Brain Injury and Finding Continuity in US Military Veterans' Embodied Minds	CAMBRIDGE JOURNAL OF ANTHROPOLOGY			English	Article						cognitive impairment; complex embodiment; institutions; metacognition; mild traumatic brain injury; military veterans	SERVICE MEMBERS; IRAQ; AFGHANISTAN; DISABILITY; COMBAT	This article examines American military veterans' metacognition - their 'thinking about thinking'. After sustaining mild traumatic brain injuries (mild TBI), some veterans experience impaired memory, poor concentration and other cognitive problems that surface when they begin attending colleges and trade schools. In response, clinicians at a specialized TBI clinic at a Department of Veterans Affairs (VA) Medical Centre created a programme that encourages veterans to become reflexive about their cognition. Symptoms that veterans experience as cognitive impairments are reframed by clinicians as conflicts between their military-minded bodies and their new civilian environments. We have seen the growing influence of the neuro-disciplines on the government of populations, but newly materialist understandings of the mind also shift the boundaries of what constitutes 'the body', suggesting new terrains for the disciplinary techniques of institutions. Analysing veterans' experiences of their injuries and clinicians' efforts to help them reveals cognition as a site of discipline.	[Zogas, Anna] Univ Washington, Seattle, WA 98195 USA		Zogas, A (corresponding author), Univ Washington, Seattle, WA 98195 USA.			Zogas, Anna/0000-0001-8080-2158	National Science FoundationNational Science Foundation (NSF); Wenner-Gren Foundation; Mellon/ACLS Dissertation Completion Fellowship	I am grateful to the veterans and clinicians at the Western VA Medical Centre for their interest and engagement in this research. My thanks to Patrick McKearney, Tyler Zoanni and two anonymous reviewers, who read earlier versions of this article and whose insights and thoughtful comments were very welcome. This research was funded by the National Science Foundation, the Wenner-Gren Foundation, and the Mellon/ACLS Dissertation Completion Fellowship.	Castro CA, 2014, STATE AM VETERAN LOS; Cifu D. X., 2011, OVERCOMING POST DEPL, DOI [10.1097/PHM.0b013e3181e722ad, DOI 10.1097/PHM.0B013E3181E722AD]; Cifu DX, 2010, AM J PHYS MED REHAB, V89, P688, DOI 10.1097/PHM.0b013e3181e722ad; Finley EP, 2011, FIELDS COMBAT UNDERS; Foucault M., 2007, SECURITY TERRITORY P; Foucault M., 1995, DISCIPLINE PUNISH BI; Garland-Thomson R, 2011, HYPATIA, V26, P591, DOI 10.1111/j.1527-2001.2011.01206.x; Gerber DA, 2012, CORPOREALITIES DISCO, P1; HAHN H, 1988, J SOC ISSUES, V44, P39, DOI 10.1111/j.1540-4560.1988.tb02047.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kintzle S., 2016, STATE AM VETERAN CHI; Linton S., 1998, CLAIMING DISABILITY, DOI [10.1080/01459741003715383, DOI 10.1080/01459741003715383]; MacLeish KT, 2012, MED ANTHROPOL Q, V26, P49, DOI 10.1111/j.1548-1387.2011.01196.x; Messinger S. D., 2014, 113 ANN M AM ANTHR A; Messinger SD, 2013, ANTHROPOL CONSCIOUS, V24, P191, DOI 10.1111/anoc.12013; Messinger SD, 2010, MED ANTHROPOL Q, V24, P281, DOI 10.1111/j.1548-1387.2010.01105.x; Messinger SD, 2010, MED ANTHROPOL, V29, P150, DOI 10.1080/01459741003715383; Morrison D.R., 2012, DSQ, V32, DOI 10.18061/dsq.v32i2.3189; Mundey L., 2015, UNDERSTANDING US WAR, P175; Pitts-Taylor V., 2016, BRAINS BODY NEUROSCI; Rose N, 2003, SOCIETY, V41, P46, DOI 10.1007/BF02688204; Rose N., 2013, NEUR NEW BRAIN, DOI 10.1176/appi.ps.61.6.589; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Shakespeare Tom, 2006, DISABILITY RIGHTS WR; Shay J, 2014, PSYCHOANAL PSYCHOL, V31, P182, DOI 10.1037/a0036090; Siebers Tobin, 2008, DISABILITY THEORY; Sorensen BR, 2015, CURR ANTHROPOL, V56, pS231, DOI 10.1086/683298; Taylor B., 2015, FISCAL YEAR 2014 VA; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terry J., 2009, WOMENS STUDIES Q, V37, P200, DOI DOI 10.1353/WSQ.0.0143; US Department of Defense, 2008, DEM REP; US Department of Defense, 2017, DOD NUMB TRAUM BRAIN; US Department of Veterans Affairs, 2016, CLIN PRACT GUID MAN; US Department of Veterans Affairs, 2015, INT AGR REF NUMB VA7; Wool, 2015, WAR WEIGHT LIFE WALT	36	4	4	1	3	BERGHAHN JOURNALS	BROOKLYN	20 JAY ST, SUITE 512, BROOKLYN, NY 11201 USA	0305-7674	2047-7716		CAMB J ANTHROPOL	Cambr. J. Anthropol.	SPR	2018	36	1			SI		80	98		10.3167/cja.2018.360106			19	Anthropology	Emerging Sources Citation Index (ESCI)	Anthropology	GG9XL	WOS:000433054300006					2022-02-06	
J	Obembe, AO; Goldsmith, CH; Simpson, LA; Sakakibara, BM; Eng, JJ				Obembe, Adebimpe O.; Goldsmith, Charlie H.; Simpson, Lisa A.; Sakakibara, Brodie M.; Eng, Janice J.			Support service utilization and out-of-pocket payments for health services in a population-based sample of adults with neurological conditions	PLOS ONE			English	Article							SOCIAL SUPPORT; STROKE; PEOPLE; LIFE; CARE; HOME	Background Social support can help to deal with the consequences of neurological conditions and promote functional independence and quality of life. Our aim was to evaluate the impact of neurological conditions on the use of support and health-care services in a population-based sample of community-dwelling adults with neurological conditions. Methods Data were from the Survey of Living with Neurological Conditions in Canada, which was derived from a representative sample of household residents. Formal and informal support received and out-of-pocket payments were assessed by personal interviews. Logistic regression was used to explore the association between support service utilization and six common neurological conditions (Stroke, Parkinson's disease, Alzheimer's disease/dementias, traumatic brain injury, spinal cord injury and multiple sclerosis) with stroke as the reference category. Results The sample contained 2,410 respondents and equate to an estimated 459,770 when sample weights were used. A larger proportion of people within each of the neurological conditions received informal support than formal support (at least twice as much). Samples with the non-stroke conditions were more likely to receive formal assistance for personal (odds ratios 2.7 to 5.6; P < 0.05) and medical (odds ratios 2.4 to 4.4; P < 0.05) care compared to the stroke group. Also, the non-stroke conditions were more likely to receive informal assistance (odds ratios 2.7 to 17.9; P < 0.05) and less likely to make out-of-pocket payments for rehabilitation therapy (odds ratios 0.2 to 0.3; P < 0.05) than the stroke group. The Alzheimer's disease/dementia group had the highest proportion who received formal and informal support services. Conclusions Our findings suggest that Canadians with neurological conditions receive more informal assistance than formal assistance. Furthermore, it appears that stroke survivors receive less support services, while those with Alzheimer's disease/dementia receive the most compared to other adult neurological conditions. Such data can help inform the development of support services in the community.	[Obembe, Adebimpe O.; Sakakibara, Brodie M.; Eng, Janice J.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Obembe, Adebimpe O.; Simpson, Lisa A.; Sakakibara, Brodie M.; Eng, Janice J.] Vancouver Coastal Hlth Res Inst, GF Strong Rehab Ctr, Rehabil Res Program, Vancouver, BC, Canada; [Goldsmith, Charlie H.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Goldsmith, Charlie H.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC, Canada; [Simpson, Lisa A.] Univ British Columbia, Grad Program Rehabil Sci, Vancouver, BC, Canada		Eng, JJ (corresponding author), Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada.; Eng, JJ (corresponding author), Vancouver Coastal Hlth Res Inst, GF Strong Rehab Ctr, Rehabil Res Program, Vancouver, BC, Canada.	janice.eng@ubc.ca		Obembe, Adebimpe/0000-0003-1282-304X	Canadian Research Data Centre Network (CRDCN) from the Social Sciences and Humanities Research Council (SSHRC); Canadian Institute for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Canadian Foundation for Innovation (CFI)Canada Foundation for Innovation; Statistics Canada; Canada Research Chairs ProgramCanada Research Chairs; Michael Smith Foundation for Health Research Trainee AwardMichael Smith Foundation for Health Research	This research was supported by funds to the Canadian Research Data Centre Network (CRDCN) from the Social Sciences and Humanities Research Council (SSHRC), the Canadian Institute for Health Research (CIHR), the Canadian Foundation for Innovation (CFI), and Statistics Canada. Although the research and analysis are based on data from Statistics Canada, the opinions expressed do not represent the views of Statistics Canada. This work was also supported in part by the Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). AOO is also supported by the Michael Smith Foundation for Health Research Trainee Award (http://www.msfhr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler G, 2008, TRAFFIC INJ PREV, V9, P299, DOI 10.1080/15389580801895186; Akinwuntan AE, 2012, J STROKE CEREBROVASC, V21, P478, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.001; Anderson C, 2000, STROKE, V31, P1032, DOI 10.1161/01.STR.31.5.1032; [Anonymous], 2011, WORLD REP DIS; Chard Sarah E, 2006, NeuroRx, V3, P525, DOI 10.1016/j.nurx.2006.07.002; Clarke A, 2001, EUR J PUBLIC HEALTH, V11, P166, DOI 10.1093/eurpub/11.2.166; Fargen KM, 2015, J NEUROSURG, V122, P870, DOI 10.3171/2014.12.JNS14646; Guerriere DN, 2008, HEALTH SOC CARE COMM, V16, P126, DOI 10.1111/j.1365-2524.2007.00732.x; Heart and Stroke Foundation, 2015, HEART STROK FDN 2015; Hogg-Johnson Sheilah, 2011, Healthc Policy, V6, pe93; Howe Edmund, 2008, Psychiatry (Edgmont), V5, P51; Jacoby WG, 2000, ELECT STUD, V19, P577, DOI 10.1016/S0261-3794(99)00028-1; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Mitchell LA, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1010-1; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; Newsom JT, 1996, PSYCHOL AGING, V11, P34, DOI 10.1037/0882-7974.11.1.34; Piersma D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149566; Public Health Agency of Canada National Population Health Study of Neurological Conditions (Canada)., 2014, MAPP CONN UND NEUR C; Romanow RJ, 2002, SHAPE FUTURE HLTH CA; Sarnak D., 2016, 2015 INT PROFILES HL; Singhpoo K, 2012, J STROKE CEREBROVASC, V21, P776, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.005; Statistics Canada, 2020, SURV LIV NEUR COND C; Sunnerhagen KS, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-66; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Van Buuren S., 2012, FLEXIBLE IMPUTATION; Verbeeten D., 2015, UNDERSTANDING HLTH S; Verdonschot MML, 2009, J INTELL DISABIL RES, V53, P303, DOI 10.1111/j.1365-2788.2008.01144.x; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wong SL, 2014, HEALTH REP, V25, P10	30	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192911	10.1371/journal.pone.0192911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	WOS:000426049500047	29474391	Green Submitted, gold, Green Published			2022-02-06	
J	Thoma, RJ; Cook, JA; McGrew, C; King, JH; Pulsipher, DT; Yeo, RA; Monnig, MA; Mayer, A; Pommy, J; Campbell, RA				Thoma, Robert J.; Cook, Julia A.; McGrew, Christopher; King, John H.; Pulsipher, Dalin T.; Yeo, Ronald A.; Monnig, Mollie A.; Mayer, Andrew; Pommy, Jessica; Campbell, Richard A.			Convergent and discriminant validity of the ImPACT with traditional neuropsychological measures	COGENT PSYCHOLOGY			English	Article						head injury; traumatic brain injury; concussion; test construction	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; TEST-RETEST RELIABILITY; NORMATIVE DATA; HEAD-INJURY; VALIDATION; DAMAGE; MANAGEMENT; CONSTRUCT	Neuropsychological assessment of cognitive sequelae secondary to sports concussion is limited by lengthy administration times and lack of readily available neuropsychologists. Brief computerized test batteries are now under development to address this, but the validity of these measures is not yet established. The validity of one such computerized test battery, the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), was administered to 93 healthy NCAA Division I athletes, aged 18-24, along with a battery of traditional, well-described neuropsychological tests. Convergent and discriminant validity between the ImPACT and traditional measures was investigated using multitrait-multimethod matrix (MTMM) analysis. As an example, the ImPACT Visual Motor Speed composite demonstrated reasonably good convergent validity secondary to moderate correlations with traditional measures of processing speed, but it demonstrated relatively poor discriminant validity as it significantly correlated with the Reaction Time composite score. MTMM results were variable across ImPACT composites and data for each are presented. The ImPACT composite's validity was further investigated using exploratory factor analysis (EFA). Six principal components were termed processing speed, visual memory, verbal memory, attention & working memory, and verbal fluency, based upon traditional test loadings, and a sixth loaded only on the ImPACT Reaction Time composite. EFA indicated content validity of moderate strength for the Visual Motor Speed and Visual Memory composites, but revealed problems with specificity for the other composites. Based upon the present findings, validity problems render the interpretability of the ImPACT composites somewhat questionable, and more research is necessary prior to using the ImPACT for assessment of clinical populations.	[Thoma, Robert J.; King, John H.; Campbell, Richard A.] Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA; [Thoma, Robert J.; Cook, Julia A.; Yeo, Ronald A.; Pommy, Jessica] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Thoma, Robert J.; Yeo, Ronald A.; Mayer, Andrew] Mind Res Network, Albuquerque, NM 87106 USA; [Cook, Julia A.] Indiana Univ Sch Med, Div Plast & Reconstruct Surg, Indianapolis, IN 46202 USA; [McGrew, Christopher] Univ New Mexico, Hlth Sci Ctr, Dept Family & Community Med, Albuquerque, NM 87131 USA; [McGrew, Christopher] Univ New Mexico, Hlth Sci Ctr, Dept Orthoped & Rehabil, Albuquerque, NM 87131 USA; [Pulsipher, Dalin T.] Akron Childrens Hosp, Neuro Dev Sci Ctr, Akron, OH USA; [Monnig, Mollie A.] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA		Thoma, RJ (corresponding author), Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA.; Thoma, RJ (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.; Thoma, RJ (corresponding author), Mind Res Network, Albuquerque, NM 87106 USA.	rjthoma@salud.unm.edu; juacook@iupui.edu; cmcgrew@salud.unm.edu; jhking@salud.unm.edu; dalin.pulsipher@my.rfums.org; ryeo@unm.edu; mollie_monnig@brown.edu; amayer@mrn.org; jpommy@salud.unm.edu; Rcampbell@salud.unm.edu		Pulsipher, Dalin/0000-0002-1809-6288; Cook, Julia/0000-0003-0212-937X	University of New Mexico Health Sciences Center, Research Allocation Committee; NIGMS COBRE [P20RR021938]	This research was made possible by a grant from the University of New Mexico Health Sciences Center, Research Allocation Committee Grant to Dr Campbell. Dr Thoma was supported by NIGMS COBRE # P20RR021938 (PI: Vince Calhoun, Ph.D).	Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; FALSSTEWART W, 1992, PERCEPT MOTOR SKILL, V74, P39, DOI 10.2466/PMS.74.1.39-42; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; HAYASHI T, 1987, BEHAV RES METH INSTR, V19, P345, DOI 10.3758/BF03202573; Hill CR, 2007, SCHOOL PSYCHOL QUART, V22, P380, DOI 10.1037/1045-3830.22.3.380; ImPACT, 2012, TECHN MAN ONL VERS 2; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Lacritz LH, 1998, ARCH CLIN NEUROPSYCH, V13, P623, DOI 10.1016/S0887-6177(98)00004-3; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Luciana M, 2005, CHILD DEV, V76, P697, DOI 10.1111/j.1467-8624.2005.00872.x; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Randolph C, 2005, J ATHL TRAINING, V40, P139; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; REITAN RM, 1958, J PSYCHOL, V46, P339, DOI 10.1080/00223980.1958.9916299; Robbins R. N., 2008, CULTURAL NEUROPSYCHO; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; SNOW WG, 1988, CAN J SURG, V31, P191; Sunderland J., 2008, GENDER LANGUAGE RES; Topolinski S, 2012, J EXP PSYCHOL GEN, V141, P260, DOI 10.1037/a0025658; Wechsler, 2008, WAIS 4 ADM SCORING M	40	4	5	0	6	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	2331-1908			COGENT PSYCHOL	Cogent Psychol.	FEB 20	2018	5	1							1430199	10.1080/23311908.2018.1430199			16	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	FX5PQ	WOS:000426132500001	32999895	Green Accepted, gold, Green Published			2022-02-06	
J	Brotfain, E; Kutz, R; Grinshpun, J; Gruenbaum, BF; Gruenbaum, SE; Frenkel, A; Zhumadilov, A; Zeldetz, V; Bichovsky, Y; Boyko, M; Klein, M; Zlotnik, A				Brotfain, Evgeni; Kutz, Ruslan; Grinshpun, Julia; Gruenbaum, Benjamin F.; Gruenbaum, Shaun E.; Frenkel, Amit; Zhumadilov, Agzam; Zeldetz, Vladimir; Bichovsky, Yoav; Boyko, Matthew; Klein, Moti; Zlotnik, Alexander			Blood Glutamate Reducing Effect of Hemofiltration in Critically Ill Patients	NEUROTOXICITY RESEARCH			English	Article						Hemofiltration; Glutamate; Brain injury; GOT; GPT	TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; OXALOACETATE TRANSAMINASE; RAT MODEL; PERITONEAL-DIALYSIS; CEREBROSPINAL-FLUID; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; CLINICAL-TRIALS; AMINO-ACIDS	Glutamate toxicity plays a well-established role in secondary brain damage following acute and chronic brain insults. Previous studies have demonstrated the efficacy of hemodialysis and peritoneal dialysis in reducing blood glutamate levels. However, these methods are not viable options for hemodynamically unstable patients. Given more favorable hemodynamics, longer treatment, and less needed anticoagulation, we investigated whether hemofiltration could be effective in lowering blood glutamate levels. Blood samples were taken from 10 critically ill patients immediately before initiation of hemofiltration and after 1, 2, 4, 6, and 12 h, for a total of 6 blood samples. Samples were sent for determination of glutamate, glutamate oxaloacetate transaminase (GOT), glutamate pyruvate transaminase (GPT), hemoglobin, hematocrit, urea, creatinine, glucose, sodium, potassium, platelet, and white blood cell (WBC) levels. There was a statistically significant reduction in blood glutamate levels at all time points compared to baseline levels. There was no difference in levels of GOT or GPT. Hemofiltration can be a promising method of reducing blood glutamate levels, especially in critically ill patients where hemodialysis and peritoneal dialysis may be contraindicated.	[Brotfain, Evgeni; Kutz, Ruslan; Grinshpun, Julia; Frenkel, Amit; Bichovsky, Yoav; Boyko, Matthew; Klein, Moti; Zlotnik, Alexander] Ben Gurion Univ Negev, Dept Anesthesiol & Crit Care, Soroka Univ Med Ctr, Fac Hlth Sci, Beer Sheva, Israel; [Gruenbaum, Benjamin F.; Gruenbaum, Shaun E.] Yale Univ, Dept Anesthesiol, Sch Med, New Haven, CT 06525 USA; [Zhumadilov, Agzam] Natl Res Ctr Oncol & Transplantat, Dept Anesthesiol & Oncol, Astana, Kazakhstan; [Zeldetz, Vladimir] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Univ Med Ctr, Dept Emergent Med, Beer Sheva, Israel		Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Dept Anesthesiol & Crit Care, Soroka Univ Med Ctr, Fac Hlth Sci, Beer Sheva, Israel.	AleksZl@clalit.org.il	Boyko, Matthew/AAC-7341-2021; klein, moti/AAR-6552-2021	Boyko, Matthew/0000-0003-3116-1643; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM086287] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM086287] Funding Source: Medline		Aliprandi A, 2005, J CEREBR BLOOD F MET, V25, P513, DOI 10.1038/sj.jcbfm.9600039; Barton I K, 1993, Clin Intensive Care, V4, P16; BERL S, 1962, J BIOL CHEM, V237, P2562; Boyko M, 2014, J NEURAL TRANSM, V121, P971, DOI 10.1007/s00702-014-1181-7; Boyko M, 2012, NEUROTHERAPEUTICS, V9, P649, DOI 10.1007/s13311-012-0129-6; Boyko M, 2012, NEUROCHEM RES, V37, P2198, DOI 10.1007/s11064-012-0843-9; Boyko M, 2011, EUR J NEUROSCI, V34, P1432, DOI 10.1111/j.1460-9568.2011.07864.x; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Godino MD, 2013, J CLIN INVEST, V123, P4359, DOI 10.1172/JCI67284; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; Forni LG, 1997, NEW ENGL J MED, V336, P1303, DOI 10.1056/NEJM199705013361807; Friedrich JO, 2012, CRIT CARE, V16, DOI 10.1186/cc11458; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; MCCULLOCH J, 1992, BRIT J CLIN PHARMACO, V34, P106, DOI 10.1111/j.1365-2125.1992.tb04118.x; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nagy D, 2010, CELL MOL NEUROBIOL, V30, P1101, DOI 10.1007/s10571-010-9542-8; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Patel P, 2010, NEUROCRIT CARE, V13, P286, DOI 10.1007/s12028-010-9386-6; Rogachev B, 2013, J NEUROSURG ANESTH, V25, P262, DOI 10.1097/ANA.0b013e318283f86a; Rogachev B, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.07.002; Ronco C, 2003, ARTIF ORGANS, V27, P792, DOI 10.1046/j.1525-1594.2003.07289.x; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Soupart A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017903.77985.CD; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Zauner A, 1996, ACT NEUR S, V67, P40; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2012, J NEUROSURG ANESTH, V24, P30, DOI 10.1097/ANA.0b013e318232deaa; Zlotnik A, 2011, BIOL REPROD, V84, P581, DOI 10.1095/biolreprod.110.088120; Zlotnik A, 2011, J NEUROSURG ANESTH, V23, P45, DOI 10.1097/ANA.0b013e3181f82a8f	41	4	4	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	FEB	2018	33	2					300	308		10.1007/s12640-017-9791-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FS8DN	WOS:000422640700007	28836163	Green Accepted			2022-02-06	
J	Cavalcante, LP; Ferreira, SG; Pereira, DR; de Moraes, SR; Simas, R; Sannomiya, P; Breithaupt-Faloppa, AC; Moreira, LFP				Cavalcante, Leonardo Pessoa; Ferreira, Sueli Gomes; Pereira, Daniel Romano; de Moraes, Sergio Rodrigues; Simas, Rafael; Sannomiya, Paulina; Breithaupt-Faloppa, Ana Cristina; Pinho Moreira, Luiz Felipe			Acute administration of oestradiol or progesterone in a spinal cord ischaemia-reperfusion model in rats	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Animal model; Aortic operation; Ischaemia-reperfusion injury; Spinal cord; Paraplegia; Related subjects; Surgery; Complication	BRAIN-INJURY; ENDOVASCULAR REPAIR; AORTIC-ANEURYSMS; NEUROPROTECTION; STROKE; OCCLUSION; PROTECTS; RISK	OBJECTIVES: Despite research into protective pharmacological adjuncts, paraplegia persists as a dreaded complication after thoracic and thoracoabdominal aortic interventions. Reports on gender-related neurological outcomes after ischaemic and traumatic brain injuries have led to increased interest in hormonal neuroprotective effects and have generated other studies seeking to prove the neuroprotective effects of the therapeutic administration of 17 beta-oestradiol and of progesterone. We hypothesised that acute administration of oestradiol or progesterone would prevent or attenuate spinal cord ischaemic injury induced by occlusion of the descending thoracic aorta. METHODS: Male rats were divided into groups receiving 280 A mu g/kg of 17 beta-oestradiol or 4 mg/kg of progesterone or vehicle 30 min before transitory endovascular occlusion of the proximal descending thoracic aorta for 12 min. Hindlimb motor function was assessed by a functional grading scale (that of Basso, Beattie and Bresnahan) for 14 days after reperfusion. On the 14th day, a segment of the thoracolumbar spinal cord was harvested and prepared for histological and immunohistochemical analyses. RESULTS: There was significant impairment of the motor function of the hindlimb in the 3 study groups, with partial improvement noticed over time, but no difference was detected between the groups. On Day 1 of assessment, the 17 beta-oestradiol group had a functional score of 9.8 (0.0-16.5); the progesterone group, a score of 0.0 (0-17.1) and the control group, a score of 6.5 (0-16.9); on the 14th day, the 17 beta-oestradiol group had a functional score of 18.0 (4.4-19.4); the progesterone group had a score of 7.5 (0-18.5) and the control group had a score of 17.0 (0-19.9). Analysis of the grey matter showed that the number of viable neurons per section was not different between the study groups on the 14th day. Immunostaining of the spinal cord grey matter was also similar among the 3 groups. CONCLUSIONS: Acute administration of oestradiol or of progesterone 30 min before transitory occlusion of the proximal descending thoracic aorta of male rats could not prevent or attenuate spinal cord ischaemic injury based on an analysis of functional and histological outcomes.	[Cavalcante, Leonardo Pessoa; Ferreira, Sueli Gomes; Pereira, Daniel Romano; de Moraes, Sergio Rodrigues; Simas, Rafael; Sannomiya, Paulina; Breithaupt-Faloppa, Ana Cristina; Pinho Moreira, Luiz Felipe] Univ Sao Paulo, Fac Med, Heart Inst Incor, Lab Cardiovasc Surg & Circulat Pathophysiol,LIM 1, Av Dr Eneas Carvalho de Aguiar 44, BR-05403000 Sao Paulo, Brazil		Moreira, LFP (corresponding author), Univ Sao Paulo, Fac Med, Heart Inst Incor, Lab Cardiovasc Surg & Circulat Pathophysiol,LIM 1, Av Dr Eneas Carvalho de Aguiar 44, BR-05403000 Sao Paulo, Brazil.	luiz.moreira@incor.usp.br	Breithaupt-Faloppa, Ana Cristina/O-9094-2017; CAVALCANTE, LEONARDO PESSOA/U-8969-2019; Simas, Rafael/F-4609-2015; Cirurgia Toracica e Cardiovascular, Teses - Pos-Graduacao/AAY-2301-2021; Moreira, Luiz Felipe Pinho/F-9882-2012	Breithaupt-Faloppa, Ana Cristina/0000-0003-0554-0674; CAVALCANTE, LEONARDO PESSOA/0000-0002-3231-2004; Simas, Rafael/0000-0003-4315-1303; Moreira, Luiz Felipe Pinho/0000-0003-0179-4976; Cavalcante, Leonardo/0000-0002-1390-6712	Brazilian National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [481031/2013-8]	This work was supported by the Brazilian National Council for Scientific and Technological Development (CNPq) [481031/2013-8].	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Breithaupt-Faloppa AC, 2014, SHOCK, V41, P208, DOI 10.1097/SHK.0000000000000092; Brown CM, 2009, SEMIN REPROD MED, V27, P240, DOI 10.1055/s-0029-1216277; Elkabes S, 2014, EXP NEUROL, V259, P28, DOI 10.1016/j.expneurol.2014.01.008; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gravereaux EC, 2001, J VASC SURG, V34, P997, DOI 10.1067/mva.2001.119890; Institute for Laboratory Animal Resources, 1996, GUIDE CARE USE LAB A; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Jacobs MJ, 2015, EUR J VASC ENDOVASC, V49, P410, DOI 10.1016/j.ejvs.2015.01.003; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Judas GI, 2014, INTERACT CARDIOV TH, V18, P757, DOI 10.1093/icvts/ivu021; Kanellopoulos GK, 1997, STROKE, V28, P2532, DOI 10.1161/01.STR.28.12.2532; Khalaj L, 2011, NEUROCHEM RES, V36, P268, DOI 10.1007/s11064-010-0314-0; KOYANAGI I, 1993, NEUROSURGERY, V33, P277; Maeda T, 2012, J ANESTH, V26, P805, DOI 10.1007/s00540-012-1434-2; Messe SR, 2008, NEUROCRIT CARE, V9, P344, DOI 10.1007/s12028-008-9104-9; Morishita K, 2003, ANN THORAC SURG, V76, P1967, DOI 10.1016/S0003-4975(03)01254-2; Ramsey JBG, 2010, J NEUROTRAUM, V27, P1709, DOI 10.1089/neu.2010.1382; Saito T, 2011, ANESTH ANALG, V113, P565, DOI 10.1213/ANE.0b013e318224ac35; Simon FHP, 2016, J VASC SURG, V64, P1797, DOI 10.1016/j.jvs.2015.10.011; Singer CA, 1996, NEUROSCI LETT, V212, P13, DOI 10.1016/0304-3940(96)12760-9; Sousa PTR, 2017, J VASC SURG, DOI [10.1016/j.jvs.2016.12.125., DOI 10.1016/J.JVS.2016.12.125]; Suzuki S, 2009, FRONT NEUROENDOCRIN, V30, P201, DOI 10.1016/j.yfrne.2009.04.007; Taira Y, 1996, STROKE, V27, P1850, DOI 10.1161/01.STR.27.10.1850; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Umehara S, 2010, ANESTH ANALG, V110, P1133, DOI 10.1213/ANE.0b013e3181cdb06b; Vandenberk N, 2013, AM J EMERG MED, V31, P581, DOI 10.1016/j.ajem.2012.09.025; Wilson ME, 2002, MOL BRAIN RES, V102, P48, DOI 10.1016/S0169-328X(02)00181-X; Wise PM, 2000, BIOL REPROD, V63, P982, DOI 10.1095/biolreprod63.4.982; Wynn M, 2016, J VASC SURG, V64, P289, DOI 10.1016/j.jvs.2015.12.060	31	4	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	FEB	2018	26	2					196	201		10.1093/icvts/ivx314			6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	FU8XZ	WOS:000424141100005	29049608	Bronze			2022-02-06	
J	Horner, D; Altshuler, D; Droege, C; Feih, J; Ferguson, K; Fiorenza, M; Greathouse, K; Hamilton, L; Pfaff, C; Roller, L; Stollings, J; Wong, A				Horner, Deanna; Altshuler, Diana; Droege, Chris; Feih, Joel; Ferguson, Kevin; Fiorenza, Mallory; Greathouse, Kasey; Hamilton, Leslie; Pfaff, Caitlin; Roller, Lauren; Stollings, Joanna; Wong, Adrian			Major publications in the critical care pharmacotherapy literature: January-December 2016	JOURNAL OF CRITICAL CARE			English	Article						Communicable diseases; Critical care; Delirium; Drug therapy; Neurology; Review	VENTILATOR-ASSOCIATED PNEUMONIA; MOLECULAR-WEIGHT HEPARIN; PROTHROMBIN COMPLEX CONCENTRATE; CLINICAL-PRACTICE GUIDELINES; HIGH-DOSE ERYTHROPOIETIN; TRAUMATIC BRAIN-INJURY; SUSTAINED NEUROMUSCULAR BLOCKADE; INFECTIOUS-DISEASES SOCIETY; IMPROVES PLATELET ACTIVITY; BLOOD-PRESSURE REDUCTION	Purpose: To summarize select critical care pharmacotherapy guidelines and studies published in 2016. Summary: The Critical Care Pharmacotherapy Literature Update (CCPLU) Group screened 31 journals monthly for relevant pharmacotherapy articles and selected 107 articles for review over the course of 2016. Of those included in the monthly CCPLU, three guidelines and seven primary literature studies are reviewed here. The guideline updates included are as follows: hospital-acquired pneumonia and ventilator-associated pneumonia management, sustained neuromuscular blocking agent use, and reversal of antithrombotics in intracranial hemorrhage (ICH). The primary literature summaries evaluate the following: dexmedetomidine for deliriumprevention in post-cardiac surgery, dexmedetomidine for delirium management in mechanically ventilated patients, high-dose epoetin alfa after out-of-hospital cardiac arrest, ideal blood pressure targets in ICH, hydrocortisone in severe sepsis, procalcitonin-guided antibiotic de-escalation, and empiric micafungin therapy. Conclusion: The review provides a synopsis of select pharmacotherapy publications in 2016 applicable to clinical practice. (C) 2017 Elsevier Inc. All rights reserved.	[Horner, Deanna] United Healthcare Medicare & Retirement Part D S, 2441 Warrenville Rd,5th Floor, Lisle, IL 60532 USA; [Altshuler, Diana] NYU, Langone Med Ctr, 550 First Ave, New York, NY 10016 USA; [Droege, Chris] Univ Cincinnati, UC Hlth, Med Ctr, Crit Care Pharm Residency PGY2, 234 Goodman St, Cincinnati, OH 45219 USA; [Feih, Joel] Froedtert & Med Coll Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Ferguson, Kevin] Tampa Gen Hosp, Crit Care, 1 Tampa Gen Circle, Tampa, FL 33606 USA; [Fiorenza, Mallory] Lee Hlth, 2776 Cleveland Ave, Ft Myers, FL 33901 USA; [Greathouse, Kasey] Northwestern Mem Hosp, 251 E Huron St, Chicago, IL 60611 USA; [Hamilton, Leslie] Univ Tennessee, Coll Pharm, Hlth Sci Ctr, 1924 Alcoa Highway,Box 117, Knoxville, TN 37920 USA; [Pfaff, Caitlin] West Chester Hosp, UC Hlth, Emergency Med, 7700 Univ Dr, W Chester, OH 45069 USA; [Roller, Lauren] Touro Univ Calif, 1310 Club Dr, Vallejo, CA 94592 USA; [Stollings, Joanna] Vanderbilt Univ, Med Ctr, ICU Recovery Ctr, 1211 Med Ctr Dr, Nashville, TN 37232 USA; [Wong, Adrian] MCPHS Univ, Brigham & Womens Hosp, Outcomes Res & Pharm Informat, 75 Francis St, Boston, MA 02115 USA		Horner, D (corresponding author), United Healthcare Medicare & Retirement Part D S, 2441 Warrenville Rd,5th Floor, Lisle, IL 60532 USA.	deanna_horner@uhc.com; diana.altshuler@nyumc.org; christopher.droege@uchealth.com; joel.feih@froedtert.com; kferguson@tgh.org; mallory.fiorenza@LeeHealth.org; kgreatho@nm.org; lhamilt4@uthsc.edu; caitlin.pfaff@UCHealth.com; lauren.roller@tu.edu; joanna.stollings@vanderbilt.edu; awong22@partners.org	Hamilton, Leslie/I-8886-2019	Hamilton, Leslie/0000-0002-7570-7380			ABRAMSON NS, 1991, NEW ENGL J MED, V324, P1225; ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; Adnet F, 2001, INTENS CARE MED, V27, P1729, DOI 10.1007/s00134-001-1112-6; Alderazi YJ, 2014, J STROKE CEREBROVASC, V23, pE207, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.009; Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Annane D, 2016, SEMIN RESP CRIT CARE, V37, P51, DOI 10.1055/s-0035-1570355; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bailly S, 2015, AM J RESP CRIT CARE, V191, P1139, DOI 10.1164/rccm.201409-1701OC; Bottiger BW, 2008, NEW ENGL J MED, V359, P2651, DOI 10.1056/NEJMoa070570; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Byrne M, 2012, BLOOD COAGUL FIBRIN, V23, P772, DOI 10.1097/MBC.0b013e328358e8af; Campbell PG, 2010, WORLD NEUROSURG, V74, P279, DOI 10.1016/j.wneu.2010.05.030; Cariou A, 2008, RESUSCITATION, V76, P397, DOI 10.1016/j.resuscitation.2007.10.003; Cariou A, 2016, J AM COLL CARDIOL, V68, P40, DOI 10.1016/j.jacc.2016.04.040; Charles PE, 2003, INTENS CARE MED, V29, P2162, DOI 10.1007/s00134-003-2002-x; Cherfan A, 2007, PHARMACOTHERAPY, V27, P755, DOI 10.1592/phco.27.5.755; CHUANG YC, 2014, BMC INFECT DIS, V14; Corbonnois G, 2013, THROMB HAEMOSTASIS, V109, P560, DOI 10.1160/TH12-08-0575; Crowther M, 2015, ARTERIOSCL THROM VAS, V35, P1736, DOI 10.1161/ATVBAHA.114.303402; Culic S, 2017, PEDIAT BLOOD CANC, V49, P332; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; de Jong E, 2016, LANCET INFECT DIS, V16, P819, DOI 10.1016/S1473-3099(16)00053-0; Delcourt C, 2012, NEUROLOGY, V79, P314, DOI 10.1212/WNL.0b013e318260cbba; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Desmurs-Clavel H, 2009, THROMB RES, V123, P796, DOI 10.1016/j.thromres.2008.07.007; Dimopoulos G, 2013, CHEST, V144, P1759, DOI 10.1378/chest.13-0076; Doshi NM, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-45; Ducruet AF, 2010, NEUROL RES, V32, P706, DOI 10.1179/174313209X459129; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Ezra DG, 2005, BRIT J OPHTHALMOL, V89, P1068, DOI 10.1136/bjo.2004.062406; Firozvi K, 2006, AM J HEMATOL, V81, P582, DOI 10.1002/ajh.20652; Flaherty ML, 2007, NEUROLOGY, V68, P116, DOI 10.1212/01.wnl.0000250340.05202.8b; Forel JM, 2006, CRIT CARE MED, V34, P2749, DOI 10.1097/01.CCM.0000239435.87433.0D; FREDRIKSSON K, 1992, STROKE, V23, P972, DOI 10.1161/01.STR.23.7.972; Freire AT, 2010, DIAGN MICR INFEC DIS, V68, P140, DOI 10.1016/j.diagmicrobio.2010.05.012; French KF, 2012, NEUROCRIT CARE, V17, P107, DOI 10.1007/s12028-012-9681-5; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Frontera JA, 2014, NEUROCRIT CARE, V21, P397, DOI 10.1007/s12028-014-9972-0; Gainnier M, 2004, CRIT CARE MED, V32, P113, DOI 10.1097/01.CCM.0000104114.72614.BC; Garnacho-Montero J, 2007, CRIT CARE MED, V35, P1888, DOI 10.1097/01.CCM.0000275389.31974.22; Gatt A, 2008, THROMB HAEMOSTASIS, V100, P350, DOI 10.1160/TH07-05-0357; Grauls CMJEV, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00005; Grmec S, 2009, RESUSCITATION, V80, P631, DOI 10.1016/j.resuscitation.2009.03.010; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hedrick Traci L, 2007, Surg Infect (Larchmt), V8, P589, DOI 10.1089/sur.2006.021; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hu QY, 2004, MAYO CLIN PROC, V79, P827; Hung A, 2000, BRIT J HAEMATOL, V109, P537, DOI 10.1046/j.1365-2141.2000.02001.x; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Jaeschke R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a744; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Joshi M, 2006, RESP MED, V100, P1554, DOI 10.1016/j.rmed.2006.01.004; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Kalina M, 2008, AM SURGEON, V74, P858; Kapapa T, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/298767; Keh D, 2016, JAMA-J AM MED ASSOC, V316, P1775, DOI 10.1001/jama.2016.14799; Kesler SM, 2009, INTENS CARE MED, V35, P157, DOI 10.1007/s00134-008-1267-5; Kiraly A, 2013, AM J THER, V20, P300, DOI 10.1097/MJT.0b013e3182878d18; Kofteridis DP, 2010, CLIN INFECT DIS, V51, P1238, DOI 10.1086/657242; Komori M, 2014, CIRC J, V78, P1335, DOI 10.1253/circj.CJ-13-1534; Korbila IP, 2010, CLIN MICROBIOL INFEC, V16, P1230, DOI 10.1111/j.1469-0691.2009.03040.x; Kumar A, 2010, CRIT CARE MED, V38, P1773, DOI 10.1097/CCM.0b013e3181eb3ccd; Kumar R, 2015, J INTENSIVE CARE MED, V30, P462, DOI 10.1177/0885066614527417; Leatherman JW, 1996, AM J RESP CRIT CARE, V153, P1686, DOI 10.1164/ajrccm.153.5.8630621; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; Lenart S B, 2000, Am J Crit Care, V9, P188; Lerma FA, 2001, J CHEMOTHERAPY, V13, P70, DOI 10.1179/joc.2001.13.1.70; Leuchter RHV, 2014, JAMA-J AM MED ASSOC, V312, P817, DOI 10.1001/jama.2014.9645; Levy JH, 2016, J THROMB HAEMOST, V14, P623, DOI 10.1111/jth.13227; Li XW, 2013, J NEUROSURG, V118, P94, DOI 10.3171/2012.9.JNS112286; Luporsi P, 2011, Acute Card Care, V13, P93, DOI 10.3109/17482941.2011.567281; Makris M, 2000, BRIT J HAEMATOL, V108, P884, DOI 10.1111/j.1365-2141.2000.1902_2.x; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; Murray MJ, 2016, CRIT CARE MED, V44, P2079, DOI 10.1097/CCM.0000000000002027; Murray MJ, 2002, CRIT CARE MED, V30, P142, DOI 10.1097/00003246-200201000-00021; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Ng HJ, 2003, ANN HEMATOL, V82, P257, DOI 10.1007/s00277-003-0633-1; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; NollaSalas J, 1997, INTENS CARE MED, V23, P23, DOI 10.1007/s001340050286; Ostrosky-Zeichner L, 2014, CLIN INFECT DIS, V58, P1219, DOI 10.1093/cid/ciu074; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Park SY, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-308; Parry-Jones AR, 2015, ANN NEUROL, V78, P54, DOI 10.1002/ana.24416; Paul M, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003344.PUB2; Pollac Jr C V, 2015, J MED, V373, P511; Pugh R, 2015, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD007577.PUB3; Qureshi AI, 2016, NEW ENGL J MED, V375, P1033, DOI 10.1056/NEJMoa1603460; Qureshi AI, 2010, ARCH NEUROL-CHICAGO, V67, P570, DOI 10.1001/archneurol.2010.61; Qureshi Ai, 2012, J Vasc Interv Neurol, V5, P6; Rattanaumpawan P, 2010, J ANTIMICROB CHEMOTH, V65, P2645, DOI 10.1093/jac/dkq360; READE MC, 2009, CRIT CARE, V13; Reade MC, 2016, JAMA-J AM MED ASSOC, V315, P1460, DOI 10.1001/jama.2016.2707; Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rodriguez-Luna D, 2013, EUR J NEUROL, V20, P1277, DOI 10.1111/ene.12180; Rosenberg JB, 2008, CRIT CARE MED, V36, P3151, DOI 10.1097/CCM.0b013e31818f0ee7; Sakamoto Y, 2013, STROKE, V44, P1846, DOI 10.1161/STROKEAHA.113.001212; Schuetz P, 2012, CLIN INFECT DIS, V55, P651, DOI 10.1093/cid/cis464; Schulman S, 2014, BRIT J HAEMATOL, V164, P308, DOI 10.1111/bjh.12620; Schuster MG, 2008, ANN INTERN MED, V149, P83, DOI 10.7326/0003-4819-149-2-200807150-00004; Shepherd SJ, 2016, CRIT CARE MED, V44, P1198, DOI 10.1097/CCM.0000000000001652; Sieger B, 1997, CRIT CARE MED, V25, P1663, DOI 10.1097/00003246-199710000-00015; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singh T, 2013, CLIN J AM SOC NEPHRO, V8, P1533, DOI 10.2215/CJN.01570213; Sivasankar S, 2006, INDIAN J CRIT CARE M, V10, P11, DOI 10.4103/0972-5229.24683; SLADEN RN, 1995, J CARDIOTHOR VASC AN, V9, P147, DOI 10.1016/S1053-0770(05)80185-5; Sorce LR, 2009, PEDIATR CRIT CARE ME, V10, P171, DOI 10.1097/PCC.0b013e3181956ccf; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Stangier J, 2010, CLIN PHARMACOKINET, V49, P259, DOI 10.2165/11318170-000000000-00000; Su X, 2016, LANCET, V388, P1893, DOI 10.1016/S0140-6736(16)30580-3; Timsit JF, 2016, JAMA-J AM MED ASSOC, V316, P1555, DOI 10.1001/jama.2016.14655; Tumbarello M, 2013, CHEST, V144, P1768, DOI 10.1378/chest.13-1018; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; van Veen JJ, 2011, BLOOD COAGUL FIBRIN, V22, P565, DOI 10.1097/MBC.0b013e3283494b3c; Vavra KA, 2010, ANN PHARMACOTHER, V44, P718, DOI 10.1345/aph.1M447; Veltkamp R, 2013, SEMIN THROMB HEMOST, V39, P963, DOI 10.1055/s-0033-1357506; Voils SA, 2012, THROMB RES, V130, P833, DOI 10.1016/j.thromres.2012.10.001; Wang CH, 2012, INT UROL NEPHROL, V44, P1091, DOI 10.1007/s11255-011-0104-x; Warkentin TE, 2002, CAN J ANAESTH, V49, pS11; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Watson HG, 2001, BRIT J HAEMATOL, V115, P145, DOI 10.1046/j.1365-2141.2001.03070.x; Xu JS, 2016, J THORAC DIS, V8, pE886, DOI 10.21037/jtd.2016.09.13; Yaghi S, 2015, JAMA NEUROL, V26, P1; Yapici N, 2011, HEART SURG FORUM, V14, pE93, DOI 10.1532/HSF98.201011102; Yasaka M, 2006, THROMB RES, V118, P290, DOI 10.1016/j.thromres.2005.08.009; Zhang YH, 2008, J HYPERTENS, V26, P1446, DOI 10.1097/HJH.0b013e328300a24a; Zhou W, 2013, STROKE, V44, P771, DOI 10.1161/STROKEAHA.112.675231	135	4	4	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2018	43						327	339		10.1016/j.jcrc.2017.09.178			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ7DK	WOS:000418522800055	28974331				2022-02-06	
J	Keays, G; Friedman, D; Gagnon, I				Keays, Glenn; Friedman, Debbie; Gagnon, Isabelle			Rates of concussions and minor head injuries in Quebec, 2003 and 2016, in children under 18 years old, and comparisons with Ontario's rates of mild traumatic brain injuries	CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE			English	Article						Adolescents; Children; Mild traumatic brain injury; Concussion	EMERGENCY-DEPARTMENTS; SURVEILLANCE SYSTEM; EPIDEMIOLOGY; MANAGEMENT; SPORTS; TRENDS; STATEMENT; DIAGNOSIS; VISITS; CARE	Objectives Increases of mild traumatic brain injuries in children have been reported in the USA and Ontario over the past decade. The main objective of this study is to calculate the pediatric rates of mild traumatic brain injury in Quebec, and our second objective is to compare them with those in Ontario. Methods Analysts from the R,gie de l'Assurance Maladie du Qu,bec (RAMQ, Quebec Health Insurance Board) compiled tables, by age and sex, of all medical services for mild traumatic brain injuries (concussions and minor head injuries) between 2003 and 2016. Quebec's population rates were calculated and yearly graphs were plotted by age and sex. Results In Quebec, there were statistically significant increases in rates of mild traumatic brain injury (concussion and minor head injury) in older children: a 2.0-fold increase for those aged 13-17 years, and 1.4-fold increase for those aged 9-12 years. When only considering concussions, girls (13-17 years) had more concussions than boys in 2015 and 2016. The increase in the rates of concussion was significantly higher in Ontario than in Quebec: 4.4- vs. 2.2-fold increase. Conclusions The recent increase in rates of mild traumatic brain injuries reported in the scientific literature has also been observed in Quebec. The fact that the rate of visits for mild traumatic brain injury, per person, remained the same from 2003 to 2016 suggests that the increase was not the result of parents seeking more medical services, but that more of them consulted when their child injured his/her head.	[Keays, Glenn; Friedman, Debbie] Montreal Childrens Hosp, CHIRPP, Room BS1-2766-1,1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada; [Friedman, Debbie] McGill Univ, Canadian Hosp Injury Reporting & Prevent Program, Montreal Childrens Hosp, Hlth Ctr,Hlth Canada, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Dept Pediat & Pediat Surg, Fac Med, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy Pediat, 3654 Prom Sir William Osler, Montreal, PQ H3G 1Y5, Canada		Keays, G (corresponding author), Montreal Childrens Hosp, CHIRPP, Room BS1-2766-1,1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada.	glenn.keays@muhc.mcgill.ca		Gagnon, Isabelle/0000-0003-2043-1644			[Anonymous], 2014, TRAUM BRAIN INJ CONC; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Birchard M., 2014, MOURI J HLTH PHYS ED, V74; Blue Cross Shields, 2016, STEEP RIS CONC DIAGN; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2014, TRAUM BRAIN INJ US F; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Greenhow A, 2015, NEUROETHICS-NETH, V8, P65, DOI 10.1007/s12152-014-9216-1; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Institut de la Statistque du Quebec, 2017, QUEB POP EST AG SEX; Keays G, 2010, CAN J PUBLIC HEALTH, V101, P115, DOI 10.1007/BF03404354; Kostylova A, 2005, INJURY PREV, V11, P186, DOI 10.1136/ip.2004.006585; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Mackenzie S G, 1999, Inj Prev, V5, P208; Mannix R., 2016, NATURE REV NEUROLOGY; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ministere de la Sante du Quebec, 2017, EL QUEB HLTH INS PLA; Ministere de la Sante du Quebec, 2017, REG ASS MAL QUEB; Moscote-Salazar L. R., 2016, ARCH MED, V1, P18; Pabian PS, 2017, PHYS THER SPORT, V23, P123, DOI 10.1016/j.ptsp.2016.09.006; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schlosser A. J., 2016, CONCUSSION KNOWLEDGE; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Wolfe C., 2015, TRAUMATIC BRAIN INJU; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R. L., 2017, J PEDIAT, V181; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zonfrillo M., 2015, ACAD EMERG MED, V22, P872	43	4	4	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0008-4263	1920-7476		CAN J PUBLIC HEALTH	Can. J. Public Health-Rev. Can. Sante Publ.	FEB	2018	109	1					52	60		10.17269/s41997-018-0037-6			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GD2JC	WOS:000430324900008	29981067	Green Published			2022-02-06	
J	Kennard, M; McLellan, T; McKinlay, A				Kennard, Megan; McLellan, Tracey; McKinlay, Audrey			Sports Media Representations of Concussions in the National Rugby League	AUSTRALIAN PSYCHOLOGIST			English	Article						brain injury; concussion guidelines; media representation; rule compliance; sports concussion; terminology	TRAUMATIC BRAIN-INJURY; TERMINOLOGY; MISCONCEPTIONS; INFORMATION	ObjectiveConcussion is poorly understood by the general public who are regularly exposed to this type of injury via televised sports such as the National Rugby League (NRL). This study investigated media representations of concussion by examining the terminology used by the commentators during the 2010 and 2011 NRL seasons. MethodData was obtained through a surveillance design where commentary statements were recorded for each observable concussion. ResultsDramatic terminology was the most frequently used followed by entertaining and humorous terminology. Commentators often portrayed the way the incident had occurred and the player's reaction to being concussed. However, information about a player sustaining an injury that required medical attention was rarely conveyed. ConclusionMedia tend to trivialise concussion and this may have an impact on the public's knowledge of, and influence their response to, concussion.	[Kennard, Megan] Monash Univ, Sch Psychol, Clayton, Vic, Australia; [McLellan, Tracey; McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch, New Zealand; [McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Grattan St, Melbourne, Vic 3010, Australia		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Grattan St, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514			Appel M, 2011, MEDIA PSYCHOL, V14, P144, DOI 10.1080/15213269.2011.573461; Bandura A, 2001, MEDIA PSYCHOL, V3, P265, DOI 10.1207/S1532785XMEP0303_03; Brodie M, 2001, HEALTH AFFAIR, V20, P192, DOI 10.1377/hlthaff.20.1.192; BRYANT J, 1977, J COMMUN, V27, P140, DOI 10.1111/j.1460-2466.1977.tb02140.x; BRYANT J, 1982, J COMMUN, V32, P109, DOI 10.1111/j.1460-2466.1982.tb00482.x; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Desmarais F., 2009, INT J SPORT COMMUNIC, V2, P129, DOI DOI 10.1123/IJSC.2.2.129; Desmarais F, 2010, J LANG SOC PSYCHOL, V29, P338, DOI 10.1177/0261927X10368836; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gerbner G., 1998, MASS COMMUNICATION S, V3, DOI [DOI 10.1080/15205436.1998.9677855, 10.1207/s15327825mcs0103&4_4]; Grilli R., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000389; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Lang A, 2013, MEDIA PSYCHOL, V16, P129, DOI 10.1080/15213269.2013.764707; Lee MJ, 2009, HOWARD J COMMUN, V20, P95, DOI 10.1080/10646170802665281; Mastro D, 2012, J MASS COMMUN Q, V89, P458, DOI 10.1177/1077699012447922; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; NRL, 2012, STAT GAM 2012; NRL, 2011, STAT OF THE GAM; Riddle K, 2010, MEDIA PSYCHOL, V13, P155, DOI 10.1080/15213261003800140; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Wills SM, 2001, BRAIN INJURY, V15, P645, DOI 10.1080/02699050010010502; Zhou ShuHua, 2013, International Journal of Sport Communication, V6, P173	30	4	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	FEB	2018	53	1					97	102		10.1111/ap.12272			6	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	FS9DC	WOS:000422714900011					2022-02-06	
J	King, PR; Beehler, GP; Vest, BM; Donnelly, K; Wray, LO				King, Paul R.; Beehler, Gregory P.; Vest, Bonnie M.; Donnelly, Kerry; Wray, Laura O.			Qualitative Exploration of Traumatic Brain Injury-Related Beliefs Among US Military Veterans	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; TBI; qualitative content analysis; veterans; illness perception model	COMMON-SENSE MODEL; MENTAL-HEALTH; ILLNESS REPRESENTATIONS; MISCONCEPTIONS; STIGMA; CARE; MANAGEMENT; CHECKLIST; BARRIERS; SOLDIERS	Purpose/Objective: Explore cognitive, affective, and experiential factors that inform veterans' traumatic brain injury (TBI)-related beliefs. Research Method/Design: Qualitative descriptive study of 22 veterans who received care for TBI at a VA Medical Center in the Northeastern United States using directed content analysis. Measures included a semistructured interview, demographic survey, the Alcohol Use Disorders Identification Test-Consumption Items (AUDIT-C), Patient Health Questionnaire-9 (PHQ-9), PTSD Checklist (PCL), Neurobehavioral Symptom Inventory (NSI), and Insomnia Severity Index (ISI). Results: Results were organized according to Leventhal et al.'s (1997) illness perception model, including veterans' self-reports regarding: (a) knowledge of TBI, labels, and symptoms (identity); (b) etiology (cause); (c) the biopsychosocial impact of TBI (consequences); (d) symptom chronicity (timeline); and (e) recovery expectancy and management strategies (controllability). Participants identified common causes of TBI, as well as acute symptoms. Uncertainty was present with regard to TBI nomenclature, recovery expectancies and trajectories, and the impact of co-occurring mental health diagnoses. Conclusions/Implications: Opportunity exists to improve TBI-related education in the course of routine, patient-centered care. Clinicians should take into account the subjective beliefs and experiences, including co-occurring mental health conditions, that inform patients' illness representations to improve patient-provider communication and the quality of TBI care.	[King, Paul R.; Beehler, Gregory P.; Wray, Laura O.] VA Western New York Healthcare Syst Buffalo, Ctr Integrated Healthcare, Buffalo, NY USA; [King, Paul R.; Donnelly, Kerry] State Univ New York Univ Buffalo, Dept Counseling Sch & Educ Psychol, Buffalo, NY USA; [Beehler, Gregory P.] State Univ New York Univ Buffalo, Sch Publ Hlth & Hlth Profess, Buffalo, NY USA; [Vest, Bonnie M.] State Univ New York Univ Buffalo, Dept Family Med, Buffalo, NY USA; [Donnelly, Kerry] VA Western New York Healthcare Syst Buffalo, Behav VA Careline, Buffalo, NY USA; [Donnelly, Kerry] State Univ New York Univ Buffalo, Dept Psychiat, Buffalo, NY USA; [Wray, Laura O.] State Univ New York Univ Buffalo, Div Geriatr Gerontol, Dept Med, Buffalo, NY USA		King, PR (corresponding author), VA Western New York Hlth Care Syst, Ctr Integrated Hlth Care, 116N,3495 Bailey Ave, Buffalo, NY 14215 USA.	paul.king2@va.gov		Vest, Bonnie/0000-0002-3401-7367	VA Center for Integrated Health Care pilot grant program; Department of Veterans Affairs Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs	Research reported in this article was supported by the VA Center for Integrated Health Care pilot grant program. Preparation of this article was supported in part by the Department of Veterans Affairs Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, and with the use of facilities and resources at the VA Western New York Health care System at Buffalo and University at Buffalo.	Acosta J. D., 2014, MENTAL HLTH STIGMA M; Babor TF., 2001, ALCOHOL USE DISORDER, V2a ed.; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Defense and Veterans Brain Injury Center, 2016, RESOURCES; Department of Veterans Affairs, POL TBI SYST CAR; Department of Veterans Affairs, 2016, POL TBI SYST CAR; Department of Veterans Affairs and Department of Defense (VA/DoD) The Management of MDD Working Group, 2008, VA DOD CLIN PRACT GU; Department of Veterans Affairs and Department of Defense (VA/DOD) & the Management of Post-Traumatic Stress Working Group, 2010, VA DOD CLIN PRACT GU; Department of Veterans Affairs and Department of Defense (VA/DoD) The Management of Substance Use Disorders Working Group, 2009, VA DOD CLIN PRACT GU; Department of Veterans Affairs Veterans Health Initiative, 2010, TRAUM BRAIN INJ VHI; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hamblen J. L., 2013, INT SOC TRAUM STRESS; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kehle-Forbes SM, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000227; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; King PR, 2015, MIL MED, V180, P863, DOI 10.7205/MILMED-D-14-00472; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; King PR, 2013, MIL BEHAV HLTH, V1, P74, DOI DOI 10.1080/21635781.2012.759168; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Leventhal H, 1997, PERCEPTIONS HLTH ILL, P19; Makris UE, 2014, PAIN MED, V15, P938, DOI 10.1111/pme.12397; McAndrew LM, 2008, BRIT J HEALTH PSYCH, V13, P195, DOI 10.1348/135910708X295604; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Office of the Surgeon General. U.S. Army Medical Command Joint Mental Health Advisory Team 7 (J-MHAT 7), 2011, OP END FREED 2010 AF; Olmsted KLR, 2011, MIL PSYCHOL, V23, P52, DOI 10.1080/08995605.2011.534414; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Quinn C, 2017, AGING MENT HEALTH, V21, P553, DOI 10.1080/13607863.2015.1128882; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Shiloh S, 2016, J HEALTH PSYCHOL, V21, P1516, DOI 10.1177/1359105314557876; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Weathers F.W., 1993, ANN M INT SOC TRAUM; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	45	4	4	0	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2018	63	1					121	130		10.1037/rep0000165			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FZ6YK	WOS:000427746300012	29553787	Bronze			2022-02-06	
J	Lier, H; Bernhard, M; Hilbert-Carius, P				Lier, H.; Bernhard, M.; Hilbert-Carius, P.			The Coagulation system in the German S3 guideline on treatment of polytrauma and severely injured patients 2016. Update on the latest concepts for sufficient hemostasis	NOTFALL & RETTUNGSMEDIZIN			German	Article						Hemorrhage; Blood transfusion; massive; Tranexamic acid; Fresh frozen plasma; Point-of-care testing	RANDOMIZED-CLINICAL-TRIAL; TRAUMA PATIENTS; PLATELET-FUNCTION; COAGULOPATHY; TRANSFUSION; RESUSCITATION; MORTALITY; PLASMA; MANAGEMENT; THERAPY	Traumatic brain injury and massive bleeding are the most frequent causes of death in severely injured patients. Uncontrolled hemorrhage is still a major cause of preventable death after trauma. The current German S3 trauma guideline on the treatment of polytrauma and severely injured patients emphasize the importance of early bleeding control in various areas. Besides uncontrolled hemorrhage, subsequent trauma-induced coagulopathy (TIC) is a second frequent problem after trauma; therefore, the current guideline addresses TIC in a separate and dedicated chapter. The key factors in management of TIC are early detection and aggressive therapy. Apart from standard coagulation tests and parameters indicating shock, viscoelastic tests are of increasing interest in the diagnostics of TIC. Trauma centers are urged to establish massive transfusion and coagulation protocols, which are individually adapted to the structure of the hospital. For treatment an optimization of the preconditions of coagulation, such as normothermia, normovolemia, normocalcemia and prevention of acidosis must be considered, even if sometimes hard to establish. Besides damage control resuscitation, two therapeutic approaches are possible: a ratio-driven and a coagulation factor-based regimen for treatment of TIC. Independent of the preferred concept, the early use of tranexamic acid should be taken into consideration for bleeding trauma patients. The present article summarizes the coagulation chapter of the current German guideline and gives a brief overview of current publications on this topic.	[Lier, H.] Univ Klinikum Koln AoR, Klin Anasthesiol & Operat Intens Med, Kerpener Str 62, D-50937 Cologne, Germany; [Lier, H.; Bernhard, M.; Hilbert-Carius, P.] Deutsch Gesell Anasthesiol & Intens Med, Arbeitskreis Trauma & Schockraummanagement, Nurnberg, Germany; [Lier, H.] DIVI Sekt Hamotherapie & Hamostasemanagement, Berlin, Germany; [Bernhard, M.] Univ KlinikumLeipzig, Zentrale Notaufnahme, Leipzig, Germany; [Hilbert-Carius, P.] Bergmannstrost BG Klinikum Halle gGmbH, Klin Anasthesiol, Intens, Notfallmed,Schmerztherapie, Halle, Saale, Germany		Lier, H (corresponding author), Univ Klinikum Koln AoR, Klin Anasthesiol & Operat Intens Med, Kerpener Str 62, D-50937 Cologne, Germany.	heiko.lier@uk-koeln.de	Lier, Heiko/J-3005-2019	Lier, Heiko/0000-0001-7374-4324			Arbeitsgemeinschaft Der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF, 2016, UB S3 LEITL POL SCHW; Arbeitsgemeinschaft Der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF Association of Scientific Medical Societies in Germany, 2011, S3 LEITL 012 019 POL; Boffard KD, 2009, TRANSFUSION, V49, p240S, DOI 10.1111/j.1537-2995.2008.01987.x; Brooke M, 2016, J SURG RES, V204, P139, DOI 10.1016/j.jss.2016.04.015; Bundesarztekammer (BAK German Medical Association, 2014, QUERSCHN BAK THER BL; Cannon WB, 1918, J AMER MED ASSOC, V70, P618; Christie SA, 2017, J TRAUMA ACUTE CARE, V82, P1055, DOI 10.1097/TA.0000000000001423; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Grottke O, 2017, ANAESTHESIST; Gustafson ML, 2015, AM J EMERG MED, V33, P607, DOI 10.1016/j.ajem.2015.01.030; Hess JR, 2015, TRANSFUSION, V55, P1362, DOI 10.1111/trf.13118; Hodgetts TJ, 2006, EMERG MED J, V23, P745, DOI 10.1136/emj.2006.039610; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Innerhofer P, 2017, LANCET HAEMATOL, V4, pE258, DOI 10.1016/S2352-3026(17)30077-7; Klein AA, 2016, ANAESTHESIA, V71, P829, DOI 10.1111/anae.13489; Kozek-Langenecker SA, 2021, GEMATOL TRANSFUZIOL, V66, P88, DOI 10.1097/EJA.0000000000000630; Levy JH, 2017, ANESTH ANALG, V124, P1268, DOI 10.1213/ANE.0000000000001897; Lier H, 2013, HAMOSTASEOLOGIE, V33, P51, DOI 10.5482/HAMO-12-05-0011; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Meledeo MA, 2017, J TRAUMA ACUTE CARE, V82, pS33, DOI 10.1097/TA.0000000000001431; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Pierce Albert, 2014, Adv Anesth, V32, P1; Ramsey MT, 2016, J TRAUMA ACUTE CARE, V80, P726, DOI 10.1097/TA.0000000000001017; Roberts DJ, 2016, ANN SURG, V263, P1018, DOI 10.1097/SLA.0000000000001347; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schlimp CJ, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0221-8; Schochl H, 2014, CRIT CARE, V18, DOI 10.1186/cc13982; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Sondeen JL, 2003, J TRAUMA, V54, pS110, DOI 10.1097/01.TA.0000047220.81795.3D; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Stein P, 2017, ANAESTHESIA, V72, P1317, DOI 10.1111/anae.13920; Stein P, 2017, SEMIN THROMB HEMOST, V43, P367, DOI 10.1055/s-0037-1598062; Tonglet ML, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.33377; Winearls J, 2016, ANESTH ANALG, V123, P910, DOI 10.1213/ANE.0000000000001516; Wirtz MR, 2017, SEMIN THROMB HEMOST, V43, P375, DOI 10.1055/s-0037-1598057	36	4	4	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	FEB	2018	21	1					14	21		10.1007/s10049-017-0361-z			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FV1QB	WOS:000424338400004					2022-02-06	
J	Marquardt, CA; Goldman, DJ; Cuthbert, BN; Lissek, S; Sponheim, SR				Marquardt, Craig A.; Goldman, Daniel J.; Cuthbert, Bruce N.; Lissek, Shmuel; Sponheim, Scott R.			Symptoms of Posttraumatic Stress Rather Than Mild Traumatic Brain Injury Best Account for Altered Emotional Responses in Military Veterans	JOURNAL OF TRAUMATIC STRESS			English	Article							BLAST-RELATED CONCUSSION; HEART-RATE; DIMENSIONAL MODELS; COMBAT VETERANS; STARTLE REFLEX; DISORDER; MODULATION; FEAR; PSYCHOPHYSIOLOGY; PSYCHOPATHOLOGY	Emotional dysfunction is evident in posttraumatic stress disorder (PTSD), yet it is unclear what aspects of the disorder most directly relate to aberrant emotional responding. Also, the frequent co-occurrence of blast-related mild traumatic brain injuries (mTBIs) among recently deployed U.S. military personnel complicates efforts to understand the basis for emotional disruption. We studied a cross-sectional sample (enriched for PTSD and mTBI) of 123 U.S. veterans of wars in Iraq and Afghanistan. We measured subjective affective evaluations and peripheral psychophysiological responses to images with pleasant, neutral, unpleasant, and combat-related aversive content. When compared with other postdeployment participants, those who had combat-related PTSD rated pleasant image content as less positive (<mml:msubsup>p2</mml:msubsup> = .04) and less arousing (<mml:msubsup>p2</mml:msubsup> = .06), and exhibited heightened physiological responsivity to combat image content (<mml:msubsup>p2</mml:msubsup> = .07). Symptoms of PTSD were associated with elevated skin conductance responses ( = .28), reduced heart rate deceleration ( = .44 to .47), and increased corrugator facial muscle electromyography ( = .47). No effects for blast-related mTBI were observed across any affective modulation measures. These findings point to a greater impact of PTSD symptomatology than blast-related mTBI on emotional functioning and highlight the utility of dimensional assessments of psychopathology for understanding the effects of combat-stress conditions on adjustment to civilian life.	[Marquardt, Craig A.; Lissek, Shmuel; Sponheim, Scott R.] Univ Minnesota Twin Cities, Dept Psychol, Minneapolis, MN USA; [Marquardt, Craig A.; Sponheim, Scott R.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Goldman, Daniel J.] Midwestern Neuropsychol PLLC, Edina, MN USA; [Cuthbert, Bruce N.] NIMH, Bethesda, MD 20892 USA; [Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA		Sponheim, SR (corresponding author), Minneapolis VA Hlth Care Syst, 116B,One Vet Dr, Minneapolis, MN 55417 USA.	sponh001@umn.edu		Marquardt, Craig/0000-0003-2714-6168; Lissek, Shmuel/0000-0001-7384-371X	National Science FoundationNational Science Foundation (NSF) [00039202]; Congressionally Directed Medical Research ProgramUnited States Department of Defense; Department of DefenseUnited States Department of Defense [PT074550]; Veterans AffairsUS Department of Veterans Affairs [I01RX000622] Funding Source: NIH RePORTER	This work was supported by the National Science Foundation Graduate Research Fellowship Program (CAM; 00039202); the Congressionally Directed Medical Research Program (SRS); and the Department of Defense (SRS; PT074550). The funding sources were not involved in the choice of topics, study design, data analysis or interpretation, or preparation/submission of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation, the Department of Defense, the Department of Veterans Affairs, or the Department of Health and Human Services. The authors wish to thank Kevin Roberts and Russell Bacon for assistance with selection of the combat images. The authors are indebted to the U.S. military veteran participants whose involvement made this work possible.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Buchanan TW, 2004, BEHAV NEUROSCI, V118, P429, DOI 10.1037/0735-7044.118.2.429; Cook E. W., 1987, PSYCHOPHYSIOLOGY, V24, P726, DOI [10.1111/j.1469-8986.1987, DOI 10.1111/J.1469-8986.1987]; Cuthbert BN, 2005, J ABNORM PSYCHOL, V114, P565, DOI 10.1037/0021-843X.114.4.565; Cuthbert BN, 2003, PSYCHOPHYSIOLOGY, V40, P407, DOI 10.1111/1469-8986.00043; Disner SG, 2017, CLIN PSYCHOL SCI, V5, P650, DOI 10.1177/2167702617703436; Elsesser K, 2006, COGNITION EMOTION, V20, P1092, DOI 10.1080/02699930500375712; Elsesser K, 2004, J ABNORM PSYCHOL, V113, P289, DOI 10.1037/0021-843X.113.2.289; First M., 1995, STRUCTURED CLIN INTE, V9, P92; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kashdan TB, 2006, BEHAV RES THER, V44, P457, DOI 10.1016/j.brat.2005.03.001; Koenen KC, 2003, J CONSULT CLIN PSYCH, V71, P980, DOI 10.1037/0022-006X.71.6.980; LANG PJ, 1992, PSYCHOL SCI, V3, P44, DOI 10.1111/j.1467-9280.1992.tb00255.x; Lang PJ, 2005, A6 U FLOR CTR RES PS; Libkuman TM, 2007, BEHAV RES METHODS, V39, P326, DOI 10.3758/BF03193164; Lindauer RTL, 2006, PSYCHOSOM MED, V68, P33, DOI 10.1097/01.psy.0000188566.35902.e7; Lissek S., 2012, OXFORD HDB TRAUMATIC, DOI [10.1093/oxfordhb/9780195399066.013.0013, DOI 10.1093/OXFORDHB/9780195399066.013.0013]; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; McTeague LM, 2012, DEPRESS ANXIETY, V29, P264, DOI 10.1002/da.21891; McTeague LM, 2010, BIOL PSYCHIAT, V67, P346, DOI 10.1016/j.biopsych.2009.08.023; Miller MW, 2004, J ABNORM PSYCHOL, V113, P451, DOI 10.1037/0021-843x.113.3.451; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Vaidyanathan U, 2009, PSYCHOL BULL, V135, P909, DOI 10.1037/a0017222; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yufik T, 2010, J ABNORM PSYCHOL, V119, P764, DOI 10.1037/a0020981	47	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	FEB	2018	31	1					114	124		10.1002/jts.22259			11	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	FY4JV	WOS:000426789700012	29513916	Bronze			2022-02-06	
J	McCartney, CSE; MacLeod, JA; Greer, PA; Davies, PL				McCartney, Christian-Scott E.; MacLeod, James A.; Greer, Peter A.; Davies, Peter L.			An easy-to-use FRET protein substrate to detect calpain cleavage in vitro and in vivo	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Calpain; Substrate; Cysteine protease; Cleavage specificity; Substrate optimization; Fret	RESONANCE ENERGY-TRANSFER; TRAUMATIC BRAIN-INJURY; MU-CALPAIN; CONDITIONAL DISRUPTION; PROTEOLYTIC-ENZYME; FLUORESCENT-PROBES; SMALL-SUBUNIT; ACTIVE-SITE; II-SPECTRIN; ACTIVATION	Calpain-1 and-2 are Ca2+-activated intracellular cysteine proteases that regulate a wide range of cellular functions through the cleavage of their protein substrates. Unlike degradative proteases, calpains make limited, transformative cleavages, typically in accessible sequences linking discrete subdomains, to irreversibly alter substrate functions. The biological roles of calpain and their interplay with calcium signaling are of significant biomedical interest as biomarkers and potential therapeutic targets in a growing number of diseases including Alzheimer's, cancer and fibrosis. Unfortunately, many of the colorimetric and fluorimetric assays that have been developed to study calpain activity suffer from low sensitivity and/or poor calpain specificity. To address the need for a highly sensitive and calpain-specific substrate suitable for in vitro and in vivo calpain activity analysis, we have developed a protein FRET probe. We inserted the optimized calpain cleavage sequence PLFAAR between cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) and modulated its flanking sequences for optimal calpain cleavage. We demonstrate greater sensitivity and calpain-specificity of an optimal 16-residue PLFAAR-based FRET substrate compared to a standard a-spectrin-based probe. The 16-residue PLFAAR protein FRET substrate is not significantly cleaved by trypsin, chymotrypsin, cathepsin-L or caspase-3, and is highly sensitive to both calpain-1 and-2. After transfection of the substrate gene into breast cancer cells the PLFAAR protein FRET product was cut in lysed wild-type cells but not in those with a calpain knock-out phenotype. Blockage of substrate cleavage in the lysates by endogenous and exogenous calpastatin was observed, and was overcome by adding extra calpain.	[McCartney, Christian-Scott E.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [MacLeod, James A.; Greer, Peter A.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada		Davies, PL (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	peter.davies@queensu.ca			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 74681]	Funding for this work was provided by the Canadian Institutes of Health Research (CIHR) (MOP 74681). PLD holds the Canada Research Chair in Protein Engineering.	Amini M, 2013, J NEUROSCI, V33, P5773, DOI 10.1523/JNEUROSCI.4247-12.2013; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; BANIK NL, 1994, J NEUROSCI RES, V37, P489, DOI 10.1002/jnr.490370408; Betts R, 2004, BIOCHEMISTRY-US, V43, P2596, DOI 10.1021/bi0359832; Betts R, 2003, J BIOL CHEM, V278, P7800, DOI 10.1074/jbc.M208350200; Chou JS, 2011, BBA-PROTEINS PROTEOM, V1814, P864, DOI 10.1016/j.bbapap.2011.04.007; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Cuerrier D, 2007, J BIOL CHEM, V282, P9600, DOI 10.1074/jbc.M610372200; Duan WW, 2016, PROTEOMICS, V16, P60, DOI 10.1002/pmic.201500356; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; He LS, 2004, AM J PATHOL, V164, P1901, DOI 10.1016/S0002-9440(10)63751-0; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Huang Z, 2013, J IMMUNOL, V191, P3778, DOI 10.4049/jimmunol.1300972; Huber EM, 2015, J AM CHEM SOC, V137, P7835, DOI 10.1021/jacs.5b03688; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kelly JC, 2009, BBA-PROTEINS PROTEOM, V1794, P1505, DOI 10.1016/j.bbapap.2009.06.013; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Kovacs L, 2016, AM J RESP CELL MOL, V54, P384, DOI 10.1165/rcmb.2015-0151OC; Li FZ, 2015, BBA-MOL BASIS DIS, V1852, P1796, DOI 10.1016/j.bbadis.2015.06.008; Liu ZX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Low KE, 2014, BBA-GEN SUBJECTS, V1840, P3367, DOI 10.1016/j.bbagen.2014.08.014; MCDERMOTT JR, 1985, LIFE SCI, V37, P725, DOI 10.1016/0024-3205(85)90542-9; Mittoo S, 2003, ANAL BIOCHEM, V319, P234, DOI 10.1016/S0003-2697(03)00324-5; Moldoveanu T, 2004, J BIOL CHEM, V279, P6106, DOI 10.1074/jbc.M310460200; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Neefjes J, 2004, NAT REV DRUG DISCOV, V3, P58, DOI 10.1038/nrd1282; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Polster BM, 2006, J PEPT RES THERAP, V13, P83; Rao SS, 2017, CLIN EXP ALLERGY, V47, P176, DOI 10.1111/cea.12805; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Rubenstein R., 2016, BEHAV BRAIN RES; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Sandmann S, 2001, BRIT J PHARMACOL, V132, P767, DOI 10.1038/sj.bjp.0703860; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SASAKI T, 1984, J BIOL CHEM, V259, P2489; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shields DC, 1999, P NATL ACAD SCI USA, V96, P11486, DOI 10.1073/pnas.96.20.11486; Shimada M, 2008, J BIOL CHEM, V283, P21002, DOI 10.1074/jbc.M710354200; Shiryaev SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054290; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Stockholm D, 2005, J MOL BIOL, V346, P215, DOI 10.1016/j.jmb.2004.11.039; Storr SJ, 2015, PATHOBIOLOGY, V82, P133, DOI 10.1159/000430464; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Sun HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065733; Takatsuka K, 2005, BIOCHEM BIOPH RES CO, V336, P316, DOI 10.1016/j.bbrc.2005.08.089; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Trager N, 2014, J NEUROCHEM, V130, P268, DOI 10.1111/jnc.12659; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Yamashita T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2303; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053	65	4	4	1	25	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	FEB	2018	1865	2					221	230		10.1016/j.bbamcr.2017.10.013			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FU5LB	WOS:000423893100001	29104086	Bronze			2022-02-06	
J	Morris, NA; Robinson, D; Schmidt, JM; Frey, HP; Park, S; Agarwal, S; Connolly, ES; Claassen, J				Morris, Nicholas A.; Robinson, David; Schmidt, J. Michael; Frey, Hans Peter; Park, Soojin; Agarwal, Sachin; Connolly, E. Sander; Claassen, Jan			Hunt-Hess 5 subarachnoid haemorrhage presenting with cardiac arrest is associated with larger volume bleeds	RESUSCITATION			English	Article						Cardiac arrest; Subarachnoid haemorrhage; Multimodality monitoring; Cerebral perfusion pressure; Mortality	TRAUMATIC BRAIN-INJURY; CEREBRAL BLOOD-FLOW; HYPOTHERMIA TREATMENT; COMPUTED-TOMOGRAPHY; PERFUSION-PRESSURE; RESUSCITATION; MANAGEMENT; ABNORMALITIES; COMPLICATIONS; OXYGENATION	Aims: The mechanism, effects, and outcomes of cardiac arrest (CA) caused by subarachnoid haemorrhage (SAH) remain unclear. We compared SAH patients presenting with CA to other high-grade SAH patients presenting without CA in order to better understand (1) the cause of CA, (2) cerebral pathophysiology following CA, and (3) outcomes of CA in patients with SAH. Methods: We performed a retrospective analysis of a prospectively collected observational cohort. 31 Hunt-Hess 5 patients that presented with CA were compared to 146 Hunt-Hess 5 patients that presented without CA. Clinical and imaging findings were predefined and adjudicated. Cerebral physiology measures were available for a subset of patients, matched 1:1 by age. Results: Twenty-two (71%) CA patients had pulseless electrical activity/asystole compared to 2 (6%) with a shockable rhythm. The CA patients were younger (OR 0.96, 95% CI 0.93-0.99, p = 0.009), had more SAH on CT (OR 1.07, 95% CI 1.01-1.13, p = 0.02), and had higher in-hospital mortality (87% vs. 58%, OR 6.2 (2.1-26.6), p = 0.004). There were no differences in aneurysm location, cerebral herniation, or ictal seizures. Despite similar cerebral perfusion pressure, CA patients had pathologically lower brain tissue oxygenation, lower glucose, and higher lactate to pyruvate ratios. Conclusions: CA in SAH is associated with larger volume bleeds. Despite normal cerebral perfusion pressures, CA patients show compromised cerebral physiology. (C) 2017 Published by Elsevier Ireland Ltd.	[Morris, Nicholas A.] Univ Maryland, Dept Neurol, Program Trauma, Med Ctr, Baltimore, MD 21201 USA; [Robinson, David; Schmidt, J. Michael; Frey, Hans Peter; Park, Soojin; Agarwal, Sachin; Claassen, Jan] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Connolly, E. Sander] Columbia Univ, Dept Neurosurg, Med Ctr, New York, NY USA		Claassen, J (corresponding author), Milstein Hosp, Div Crit Care Neurol, Bldg 177 Ft Washington Ave,8-300 Ctr, New York, NY 10032 USA.	jc1439@cumc.columbia.edu	Claassen, Jan/AAA-5451-2020; Morris, Nicholas/S-7475-2019	Morris, Nicholas/0000-0002-1270-9805; Robinson, David/0000-0003-3221-3599	DANA Foundation; National Library of Medicine of the National Institutes of Health (NIH) [R01 LM011826]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01 ES026833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026833] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM011826] Funding Source: NIH RePORTER	Drs. Robinson and Claassen had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis. N.A.M., D.R., J.M.S., H.P.F.S.P., S.A., and E.S.C. report no disclosures. J.C. reports receiving honoraria from serving on the advisory board for SAGE Pharmaceuticals for study development. Funding for the research was provided by the DANA Foundation (JC); grant R01 LM011826 from the National Library of Medicine of the National Institutes of Health (NIH) (JC); and grant K01 ES026833 from the NIH (SP).	Anei R, 2010, NEUROL MED-CHIR, V50, P879, DOI 10.2176/nmc.50.879; Arnaout M, 2015, CRIT CARE MED, V43, P453, DOI 10.1097/CCM.0000000000000722; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Bederson JB, 1995, STROKE, V26, P91; Bell DD, 2005, CAN J ANAESTH, V52, P309, DOI 10.1007/BF03016069; Bouzat P, 2013, RESUSCITATION, V84, P1540, DOI 10.1016/j.resuscitation.2013.05.014; BROUWERS PJAM, 1993, STROKE, V24, P809, DOI 10.1161/01.STR.24.6.809; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Claassen J, 2004, CRIT CARE MED, V32, P832, DOI 10.1097/01.CCM.0000114830.48833.8A; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Fukui S, 2002, NEUROLOGY, V59, P134, DOI 10.1212/WNL.59.1.134; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; Hutchinson P, 2014, NEUROCRIT CARE, V21, P148, DOI 10.1007/s12028-014-0035-3; Inamasu J, 2011, NEUROL MED-CHIR, V51, P619, DOI 10.2176/nmc.51.619; Inamasu J, 2009, RESUSCITATION, V80, P977, DOI 10.1016/j.resuscitation.2009.05.010; Kurkciyan I, 2001, RESUSCITATION, V51, P27, DOI 10.1016/S0300-9572(01)00381-1; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; Mitsuma W, 2011, RESUSCITATION, V82, P1294, DOI 10.1016/j.resuscitation.2011.05.019; Mullner M, 1996, STROKE, V27, P59, DOI 10.1161/01.STR.27.1.59; Nordmark J, 2009, RESUSCITATION, V80, P573, DOI 10.1016/j.resuscitation.2009.02.003; NORNES H, 1973, J NEUROSURG, V39, P226, DOI 10.3171/jns.1973.39.2.0226; POLLICK C, 1988, J AM COLL CARDIOL, V12, P600, DOI 10.1016/S0735-1097(88)80044-5; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Ristagno G, 2007, CRIT CARE MED, V35, P2145, DOI 10.1097/01.CCM.0000280427.76175.D2; Shapiro S, 1996, STROKE, V27, P1780, DOI 10.1161/01.STR.27.10.1780; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Sundgreen C, 2001, STROKE, V32, P128, DOI 10.1161/01.STR.32.1.128; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; VANGIJN J, 1985, J NEUROSURG, V63, P355, DOI 10.3171/jns.1985.63.3.0355; Vergouwen MDI, 2011, STROKE, V42, P3093, DOI 10.1161/STROKEAHA.111.619510; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Yamashina Y, 2015, J CARDIOL, V65, P508, DOI 10.1016/j.jjcc.2014.07.022; Yasui N, 2002, ACT NEUR S, V82, P93; Zaroff JG, 1999, NEUROSURGERY, V44, P34, DOI 10.1097/00006123-199901000-00013	39	4	4	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	FEB	2018	123						71	76		10.1016/j.resuscitation.2017.12.015			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	FR7BZ	WOS:000419222600017	29253648	Green Accepted			2022-02-06	
J	Useche, JN; Bermudez, S				Nicolas Useche, Juan; Bermudez, Sonia			Conventional Computed Tomography and Magnetic Resonance in Brain Concussion	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Head injury, closed; Craniocerebral trauma; Brain injuries traumatic; Contrecoup injury; Brain concussion; Brain contusion; Multidetector computed tomography; Magnetic resonance imaging	DIFFUSE AXONAL INJURY; BLUNT HEAD TRAUMA; UNITED-STATES; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; COST-EFFECTIVENESS; SPORT HELD; CT; MANAGEMENT; MR	Conventional neuroimaging is still the mainstay in the assessment of the acute, follow-up, and chronic settings of concussion and mild traumatic brain injury (mTBI). Computed tomography (CT) is preferred for the initial assessment of acute mTBI, repeat evaluation in acute mTBI with neurologic deterioration, and cautious use in children with mTBI. Clinical rules have been developed to identify pediatric and adult patients with mTBI who can safely forego CT. MR imaging is mostly used in patients with acute mTBI when initial or follow-up CT is normal and there are persistent neurologic findings and in subacute or chronic mTBI.	[Nicolas Useche, Juan; Bermudez, Sonia] El Bosque Univ, Hosp Univ Fdn Santa Fe Bogota, Diagnost & Intervent Imaging Dept, Calle 119 7-75, Bogota 110111, DC, Colombia		Useche, JN (corresponding author), El Bosque Univ, Hosp Univ Fdn Santa Fe Bogota, Diagnost & Intervent Imaging Dept, Calle 119 7-75, Bogota 110111, DC, Colombia.	nicolas.useche@radiologiafsfb.org	Bermudez, Sonia/I-9324-2019	Bermudez, Sonia/0000-0003-4027-4391			Basamh M, 2016, CAN J NEUROL SCI, V43, P74, DOI 10.1017/cjn.2015.232; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Bodanapally UK, 2013, NEURORADIOLOGY, V55, P771, DOI 10.1007/s00234-013-1166-5; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chern JJ, 2014, J NEUROSURG-PEDIATR, V14, P306, DOI 10.3171/2014.6.PEDS13682; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; David-Ferdon C, 2013, MMWR-MORBID MORTAL W, V62, P545; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Glass T, 2015, AM J EMERG MED, V33, P1458, DOI 10.1016/j.ajem.2015.06.069; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1133; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Image Gently, 2014, ALL RAD SAF PED IM I; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kahn J, 2016, ACTA RADIOL, V57, P362, DOI 10.1177/0284185115580839; Kara A, 2008, TURK NEUROSURG, V18, P1; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Klang E, 2017, J AM COLL RADIOL, V14, P171, DOI 10.1016/j.jacr.2016.08.032; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Reljic T, 2014, J NEUROTRAUM, V31, P78, DOI 10.1089/neu.2013.2873; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Rose SC, 2017, BRAIN INJURY, V31, P1; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Stone JL, 2014, NEUROSURGERY, V75, P3; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; TEASDALE G, 1974, LANCET, V2, P81; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061; US Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wei SC, 2010, AM J NEURORADIOL, V31, P334, DOI 10.3174/ajnr.A1824; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zafonte R, 2012, BRAIN IMAGING BEHAV, V6, P355, DOI 10.1007/s11682-012-9182-3	71	4	4	1	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2018	28	1					15	+		10.1016/j.nic.2017.09.006			16	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FR3UA	WOS:000418990900004	29157850				2022-02-06	
J	Seth, N; Simmons, HA; Masood, F; Graham, WA; Rosene, DL; Westmoreland, SV; Cummings, SM; Gwardjan, B; Sejdic, E; Hoggatt, AF; Schalk, DR; Abdullah, HA; Sledge, JB; Nesathurai, S				Seth, Nitin; Simmons, Heather A.; Masood, Farah; Graham, William A.; Rosene, Douglas L.; Westmoreland, Susan, V; Cummings, Sheila M.; Gwardjan, Basia; Sejdic, Ervin; Hoggatt, Amber F.; Schalk, Dane R.; Abdullah, Hussein A.; Sledge, John B.; Nesathurai, Shanker			Model of Traumatic Spinal Cord Injury for Evaluating Pharmacologic Treatments in Cynomolgus Macaques (Macaca fasicularis)	COMPARATIVE MEDICINE			English	Article							PRIMATE MODEL; VITAMIN-E; CONTUSION; SELENIUM; FASCICULARIS; PREVENTION; MONKEY; BRAIN; RISK; RAT	Here we present the results of experiments involving cynomolgus macaques, in which a model of traumatic spinal cord injury (TSCI) was created by using a balloon catheter inserted into the epidural space. Prior to the creation of the lesion, we inserted an EMG recording device to facilitate measurement of tail movement and muscle activity before and after TSCI. This model is unique in that the impairment is limited to the tail: the subjects do not experience limb weakness, bladder impairment, or bowel dysfunction. In addition, 4 of the 6 subjects received a combination treatment comprising thyrotropin releasing hormone, selenium, and vitamin E after induction of experimental TSCI. The subjects tolerated the implantation of the recording device and did not experience adverse effects due the medications administered. The EMG data were transformed into a metric of volitional tail moment, which appeared to be valid measure of initial impairment and subsequent natural or treatment-related recovery. The histopathologic assessment demonstrated widespread axon loss at the site of injury and areas cephalad and caudad. Histopathology revealed evidence of continuing inflammation, with macrophage activation. The EMG data did not demonstrate evidence of a statistically significant treatment effect.	[Seth, Nitin; Masood, Farah; Abdullah, Hussein A.] Univ Guelph, Sch Engn, Guelph, ON, Canada; [Simmons, Heather A.; Schalk, Dane R.; Nesathurai, Shanker] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Graham, William A.; Gwardjan, Basia; Nesathurai, Shanker] McMaster Univ, Dept Med, Div Phys Med & Rehabil, Hamilton, ON, Canada; [Rosene, Douglas L.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02215 USA; [Westmoreland, Susan, V] Harvard Med Sch, Boston, MA USA; [Cummings, Sheila M.] Sanofi, Framingham, MA USA; [Sejdic, Ervin] Univ Pittsburgh, Swanson Sch Engn, Pittsburgh, PA USA; [Hoggatt, Amber F.] Brigham & Womens Hosp, Ctr Comparat Med, 75 Francis St, Boston, MA 02115 USA; [Sledge, John B.] Lafayette Bone & Joint Clin, Lafayette, LA USA; [Nesathurai, Shanker] St Josephs Hamilton Healthcare, Hamilton Hlth Sci, Dept Phys Med & Rehabil, Hamilton, ON, Canada		Nesathurai, S (corresponding author), Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.; Nesathurai, S (corresponding author), McMaster Univ, Dept Med, Div Phys Med & Rehabil, Hamilton, ON, Canada.; Nesathurai, S (corresponding author), St Josephs Hamilton Healthcare, Hamilton Hlth Sci, Dept Phys Med & Rehabil, Hamilton, ON, Canada.	nesathurai@hhsc.ca	Simmons, Heather/U-6081-2019	Rosene, Douglas/0000-0001-8719-1441	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P51OD011106]; University of Wisconsin-Madison; Research Facilities Improvement ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR15459-01, RR020141-01]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P51RR000168]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR020141, P51RR000168, C06RR015459] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P51OD011106] Funding Source: NIH RePORTER	Research reported in this publication was supported in part by the Office of The Director, National Institutes of Health, under Award Number P51OD011106 to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. The New England Primate Research Center was the recipient of NIH Grant 5P51RR000168. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Algotar AM, 2013, PROSTATE, V73, P328, DOI 10.1002/pros.22573; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; BUNGE RP, 1993, ADV NEUROL, V59, P75; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Chamberlain JD, 2015, NEUROEPIDEMIOLOGY, V44, P182, DOI 10.1159/000382079; Chang HT, 2007, SPINAL CORD, V45, P174, DOI 10.1038/sj.sc.3101910; Dargahi N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070078; EIDELBERG E, 1981, BRAIN, V104, P647, DOI 10.1093/brain/104.4.647-a; EIDELBERG E, 1980, EXP BRAIN RES, V40, P241; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fulton JF, 1932, J PHYSIOL-LONDON, V75, P17, DOI 10.1113/jphysiol.1932.sp002869; Goossens ME, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-8; Graham W. A., 2013, Open Journal of Veterinary Medicine, V3, P86, DOI 10.4236/ojvm.2013.31014; GRAND TI, 1972, J MAMMAL, V53, P198, DOI 10.2307/1378849; ILAR (Institute for Laboratory Animal Research), 2011, GUIDE CARE USE LAB A, V8th; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Love S., 2008, GREENFIELDS NEUROPAT; Ma ZW, 2016, EXP NEUROL, V279, P261, DOI 10.1016/j.expneurol.2016.02.008; Mckay WB, 2011, SPINAL CORD, V49, P421, DOI 10.1038/sc.2010.145; Meguerditchian A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01794; National Institutes of Health, 2016, SEL DIET FACT SHEE S; Nesathurai S, 2013, REHABILITATION PEOPL; Nesathurai S, 2006, J MED PRIMATOL, V35, P397, DOI 10.1111/j.1600-0684.2006.00161.x; Nesathurai S, 2006, J MED PRIMATOL, V35, P401, DOI 10.1111/j.1600-0684.2006.00162.x; Norreel JC, 2003, J NEUROSCI, V23, P1924; Nout YS, 2012, NEUROTHERAPEUTICS, V9, P380, DOI 10.1007/s13311-012-0114-0; OJHA P R, 1974, Mammalia, V38, P163, DOI 10.1515/mamm.1974.38.2.163; PITTS LH, 1995, J NEUROTRAUM, V12, P235, DOI 10.1089/neu.1995.12.235; RIVLIN AS, 1978, SURG NEUROL, V10, P39; RODMAN PS, 1979, AM J PHYS ANTHROPOL, V51, P51, DOI 10.1002/ajpa.1330510107; SAUNDERS RD, 1987, J NEUROCHEM, V49, P24, DOI 10.1111/j.1471-4159.1987.tb03388.x; Seth N., 2015, Open Journal of Veterinary Medicine, V5, P161, DOI 10.4236/ojvm.2015.57022; Sledge J, 2013, MED HYPOTHESES, V81, P747, DOI 10.1016/j.mehy.2013.07.040; Sledge J, 2016, AM J PHYS MED REHAB, V95, pE108, DOI 10.1097/PHM.0000000000000486; Torkildsen O, 2016, EUR J NEUROL, V23, P18, DOI 10.1111/ene.12883; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	42	4	4	0	4	AMER ASSOC LABORATORY ANIMAL SCIENCE	MEMPHIS	9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA	1532-0820			COMPARATIVE MED	Comparative Med.	FEB	2018	68	1					63	73					11	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	GP3PI	WOS:000440762300009	29460723				2022-02-06	
J	Weber, AM; Torres, C; Rauscher, A				Weber, Alexander Mark; Torres, Carlos; Rauscher, Alexander			Imaging the Role of Myelin in Concussion	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Myelin water imaging; Mild traumatic brain injury; White matter; Brain	TRAUMATIC BRAIN-INJURY; MAGNETIZATION-TRANSFER RATIO; ANISOTROPIC WATER DIFFUSION; MULTIPLE-SCLEROSIS BRAIN; WHITE-MATTER; AXONAL INJURY; OPTIC-NERVE; CORPUS-CALLOSUM; OLIGODENDROCYTE; DEGENERATION	Myelin water imaging (MWI) provides mild traumatic brain injury (mTBI) researchers with a specific myelin biomarker and helps to further elucidate microstructural and microarchitectural changes of white matter after mTBI. Improvement of scanner hardware and software with the implementation of MWI across scanner platforms will likely result in increased research regarding the role of myelin in traumatic brain injury (TBI). Future research should include detailed investigation of myelin between 2 weeks and 2 months after injury, the use of MWI in moderate and severe TBI, and investigation of the role of myelin in chronic TBI.	[Weber, Alexander Mark; Rauscher, Alexander] Univ British Columbia, Fac Med, Dept Pediat, Div Neurol, M10 Purdy Pavil,2221 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada; [Torres, Carlos] Univ Ottawa, Dept Radiol, 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada; [Torres, Carlos] Ottawa Hosp, Dept Med Imaging, 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada		Weber, AM (corresponding author), Univ British Columbia, Fac Med, Dept Pediat, Div Neurol, M10 Purdy Pavil,2221 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	alex.weber@ubc.ca		Weber, Alexander/0000-0001-7295-0775			Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Benarroch EE, 2009, NEUROLOGY, V72, P1779, DOI 10.1212/WNL.0b013e3181a6b123; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; CAHILL GM, 1989, BRAIN RES, V479, P65, DOI 10.1016/0006-8993(89)91336-X; Chen JT, 2005, NEUROIMAGE, V25, P1272, DOI 10.1016/j.neuroimage.2004.12.046; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; FOSTER RE, 1982, DEV BRAIN RES, V3, P371, DOI 10.1016/0165-3806(82)90005-0; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GUTIERREZ R, 1995, NEUROSCI LETT, V195, P93, DOI 10.1016/0304-3940(94)11789-L; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Laule C, 2008, NEUROIMAGE, V40, P1575, DOI 10.1016/j.neuroimage.2007.12.008; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lehto LJ, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3678; Li X, 2016, J MAGN RESON IMAGING, V43, P463, DOI 10.1002/jmri.24976; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; MacKay Alex L, 2016, Brain Plast, V2, P71, DOI 10.3233/BPL-160033; Maxwell WL, 2015, J NEUROTRAUM, V32, P780, DOI 10.1089/neu.2014.3369; McCrea M.A., 2007, MILD TRAUMATIC BRAIN; Meyers SM, 2013, J MAGN RESON IMAGING, V38, P1445, DOI 10.1002/jmri.24106; Meyers SM, 2009, MAGN RESON IMAGING, V27, P1096, DOI 10.1016/j.mri.2009.02.001; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miyamoto N, 2013, STROKE, V44, P3516, DOI 10.1161/STROKEAHA.113.002813; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Nordengen K, 2015, BRAIN STRUCT FUNCT, V220, P899, DOI 10.1007/s00429-013-0691-7; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prasloski T, 2012, NEUROIMAGE, V63, P533, DOI 10.1016/j.neuroimage.2012.06.064; Pukropski A, 2017, 25 ANN M EXH INT SOC; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Schmierer K, 2007, J MAGN RESON IMAGING, V26, P41, DOI 10.1002/jmri.20984; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Stanisz GJ, 1999, MAGN RESON MED, V42, P1128, DOI 10.1002/(SICI)1522-2594(199912)42:6<1128::AID-MRM18>3.0.CO;2-9; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Weickert J, 2007, VISUALIZATION PROCES; Wiggermann V, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3727; Wiggermann V, 2013, NEUROLOGY, V81, P211, DOI 10.1212/WNL.0b013e31829bfd63; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215	63	4	4	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2018	28	1					83	+		10.1016/j.nic.2017.09.005			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FR3UA	WOS:000418990900009	29157855				2022-02-06	
J	Korman, M; Shaklai, S; Cisamariu, K; Gal, C; Maaravi-Hesseg, R; Levy, I; Keren, O; Karni, A; Sacher, Y				Korman, Maria; Shaklai, Sharon; Cisamariu, Keren; Gal, Carmit; Maaravi-Hesseg, Rinatia; Levy, Ishay; Keren, Ofer; Karni, Avi; Sacher, Yaron			Atypical Within-Session Motor Procedural Learning after Traumatic Brain Injury but Well-Preserved Between-Session Procedural Memory Consolidation	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						procedural learning; motor sequence; atypical consolidation; training schedule; long-term memory; fatigue; TBI; memorydeficits	CLOSED-HEAD INJURY; SKILL ACQUISITION; COGNITIVE FATIGUE; MENTAL FATIGUE; FUNCTIONAL MRI; SLEEP PATTERNS; TIME-COURSE; PERFORMANCE; SEQUENCE; EPIDEMIOLOGY	Using the finger-to-thumb opposition sequence (FOS) learning task, we characterized motor skill learning in sub-acute patients hospitalized for rehabilitation following traumatic brain injury (TBI). Ten patients (Trained TBI) and 11 healthy participants (Trained Healthy) were trained using amulti-session protocol: a single session was afforded in the first week of the study, and four daily sessions were afforded during the second week. Intensity of practice was adapted to patients. Performance speed and accuracy were tested before and after each session. Retention was tested 1 month later. Ten patients (Control TBI) had no FOS training and were tested only at the beginning and the end of the 6 week period. Although baseline performance on the FOS was very slow, all three phases of skill learning found in healthy adults (acquisition, between-session consolidation gains, and long-term retention) could be identified in patients with TBI. However, their time-course of learning was atypical. The Trained TBI group improved in speed about double the spontaneous improvements observed in the Control TBI group, with no speed-accuracy tradeoff. Normalized to their initial performance on the FOS, the gains accrued by the Trained TBI group after a first training were comparable to those accrued by healthy adults. Only during the second week with daily training, the rate of improvement of the Trained TBI group lagged behind that of the Trained Healthy group, due to increasing within-sessions losses in performance speed; no such losses were found in healthy participants. The Functional Independence Measure scores at the start of the study correlated with the total gains attained at the end of the study; no correlations were found with severity of injury or explicit memory impairments. Despite within-sessions losses in performance, which we propose reflect cognitive fatigue, training resulted in robust overall learning and long-term retention in patients with moderate-severe TBI. Given that the gains in performance evolved mainly between sessions, as delayed, offline, gains, our results suggest that memory consolidation processes can be effectively engaged in patients with TBI. However, practice protocols and schedules may need to be optimized to better engage the potential for long-term plasticity in these patients.	[Korman, Maria; Gal, Carmit; Levy, Ishay; Karni, Avi] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Haifa, Israel; [Shaklai, Sharon; Cisamariu, Keren; Sacher, Yaron] Loewenstein Hosp & Rehabil Ctr, Raanana, Israel; [Shaklai, Sharon; Keren, Ofer; Sacher, Yaron] Tel Aviv Univ, Sackler Med Fac, Tel Aviv, Israel; [Gal, Carmit; Maaravi-Hesseg, Rinatia; Levy, Ishay; Karni, Avi] Univ Haifa, Sagol Dept Neurobiol, Brain Behav Res Ctr, Haifa, Israel; [Keren, Ofer; Karni, Avi] Sheba Med Ctr, Ramat Gan, Israel		Korman, M (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Haifa, Israel.; Shaklai, S (corresponding author), Loewenstein Hosp & Rehabil Ctr, Raanana, Israel.; Shaklai, S (corresponding author), Tel Aviv Univ, Sackler Med Fac, Tel Aviv, Israel.	korman.maria@gmail.com; sharons5@clalit.org.il	Korman, Maria/N-6515-2019	Korman, Maria/0000-0003-1895-0189	Edmond J. Safra Brain Research Center for the Study of Learning Disabilities	The Edmond J. Safra Brain Research Center for the Study of Learning Disabilities is gratefully acknowledged for partially funding this project.	Abd-Elfattah HM, 2015, J ADV RES, V6, P351, DOI 10.1016/j.jare.2015.01.011; Adi-Japha E, 2011, RES DEV DISABIL, V32, P1011, DOI 10.1016/j.ridd.2011.01.048; Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Albouy G, 2016, SCI REP-UK, V6, DOI 10.1038/srep34948; Albouy G, 2013, HIPPOCAMPUS, V23, P985, DOI 10.1002/hipo.22183; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Borragan G, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00086; Borragan G, 2015, BRAIN COGNITION, V95, P54, DOI 10.1016/j.bandc.2015.01.011; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Dorffierger S, 2009, BEHAV BRAIN RES, V198, P165, DOI 10.1016/j.bbr.2008.10.033; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Engel-Yeger B, 2009, NEUROPSYCHOL REHABIL, V19, P662, DOI 10.1080/09602010802622730; Feys H, 2000, Physiother Res Int, V5, P1, DOI 10.1002/pri.180; Filoteo JV, 2010, PSYCHOL SCI, V21, P415, DOI 10.1177/0956797610362646; Fox O, 2016, RES DEV DISABIL, V51-52, P135, DOI 10.1016/j.ridd.2016.01.014; Friedman J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00623; Hauptmann B, 2005, COGNITIVE BRAIN RES, V24, P181, DOI 10.1016/j.cogbrainres.2005.01.012; Hillier SL, 1997, BRAIN INJURY, V11, P649; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; KATZ N, 1989, AM J OCCUP THER, V43, P184, DOI 10.5014/ajot.43.3.184; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Korman M, 2015, NEUROSCI LETT, V606, P173, DOI 10.1016/j.neulet.2015.08.051; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Landry S, 2014, J CLIN SLEEP MED, V10, P491, DOI 10.5664/jcsm.3692; Lohse KR, 2014, NEUROPSYCHOLOGIA, V59, P130, DOI 10.1016/j.neuropsychologia.2014.05.001; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McDowall J, 1996, NEW ZEAL J PSYCHOL, V25, P2; Mednick SC, 2008, BEHAV NEUROSCI, V122, P267, DOI 10.1037/0735-7044.122.2.267; Michimata A, 2008, TOHOKU J EXP MED, V214, P257, DOI 10.1620/tjem.214.257; Nissley HM, 2002, NEUROPSYCHOLOGY, V16, P111, DOI 10.1037//0894-4105.16.1.111; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Parsons LC, 1997, J NEUROTRAUM, V14, P549, DOI 10.1089/neu.1997.14.549; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Roy RN, 2013, IEEE ENG MED BIO, P6607, DOI 10.1109/EMBC.2013.6611070; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Seel RT, 2007, J HEAD TRAUMA REHAB, V22, P267, DOI 10.1097/01.HTR.0000290971.56130.c8; Shelton FDAP, 2001, NEUROREHAB NEURAL RE, V15, P229, DOI 10.1177/154596830101500311; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 2002, BRAIN COGNITION, V50, P304, DOI 10.1016/S0278-2626(02)00515-8; Vakil E, 2014, J CLIN EXP NEUROPSYC, V36, P447, DOI 10.1080/13803395.2014.901299; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Wilhelm I, 2012, DEVELOPMENTAL SCI, V15, P506, DOI 10.1111/j.1467-7687.2012.01146.x; Wiseman KA, 2000, BRAIN COGNITION, V44, P14; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	62	4	4	0	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JAN 30	2018	12								10	10.3389/fnhum.2018.00010			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FU1AV	WOS:000423582500002	29441005	Green Published, gold			2022-02-06	
J	Gao, M; Dong, Q; Lu, YZ; Yao, H; Zou, MM; Yang, Y; Zhu, JW; Yang, ZJ; Xu, MH; Xu, RX				Gao, Mou; Dong, Qin; Lu, Yingzhou; Yao, Hui; Zou, Mingming; Yang, Yang; Zhu, Jianwei; Yang, Zhijun; Xu, Minhui; Xu, Ruxiang			Induced neural stem cell-derived astrocytes modulate complement activation and mediate neuroprotection following closed head injury	CELL DEATH & DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; NERVOUS-SYSTEM; PROGENITOR CELLS; PROTEIN CRRY; EXPRESSION; IMMUNE; MODEL; TRANSPLANTATION; NEUROGENESIS; INHIBITION	The complement system is a crucial component of immunity, and its activation has critical roles in neuroinflammatory response and cellular damage following closed head injury (CHI). We previously demonstrated that systemically injected induced neural stem cells (iNSCs) could modulate complement activation to ameliorate neuronal apoptosis in mouse CHI models. However, it remains unknown whether iNSC derivatives can regulate complement activation. In the present study, after CHI mouse serum treatment, we found dramatic decreases in the cellular viabilities of differentiated iNSCs. Interestingly, following CHI mouse serum treatment, the death of astrocytes derived from iNSCs which were pre-treated with CHI mouse serum was significantly decreased. Meanwhile, the deposition of C3 (C3d) and C5b-9 in these astrocytes was substantially reduced. Remarkably, we detected increased expression of complement receptor type 1-related protein y (Crry) in these astrocytes. Moreover, these astrocytes could reduce the numbers of apoptotic neurons via Crry expression post-CHI mouse serum treatment. Additionally, intracerebral-transplanted iNSCs, pre-treated with CHI mouse serum, significantly increased the levels of Crry expression in astrocytes to reduce the accumulation of C3d and C9 and the death of neurons in the brains of CHI mice. In summary, iNSCs receiving CHI mouse serum pre-treatment could enhance the expression of Crry in iNSC-derived astrocytes to modulate complement activation and mediate neuroprotection following CHI.	[Gao, Mou; Xu, Minhui] Third Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Chongqing 400042, Peoples R China; [Gao, Mou; Yao, Hui; Zou, Mingming; Yang, Yang; Zhu, Jianwei; Yang, Zhijun; Xu, Ruxiang] PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China; [Dong, Qin] Capital Med Univ, Fu Xing Hosp, Dept Neurol, Beijing 100038, Peoples R China; [Lu, Yingzhou] Capital Med Univ, Fu Xing Hosp, Dept Obstet, Beijing 100038, Peoples R China		Xu, MH (corresponding author), Third Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Chongqing 400042, Peoples R China.; Xu, RX (corresponding author), PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China.	dpmhxu@126.com; jzprofxu@126.com	Yang, Yang/AAL-1670-2020	Yang, Yang/0000-0001-6645-2454	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81671189]; Military Medical Innovation Project of the Army [16CXZ001]	This work was supported by grants from the National Natural Science Foundation of China (NSFC) (No. 81671189), and the Military Medical Innovation Project of the Army (No. 16CXZ001). The authors thank Dr. Cuiying Wu, Ms. Chen Chen, Ms. Ning Liu and Ms. Qinqin Wang for technical support.	Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Briggs DT, 2007, GLIA, V55, P1405, DOI 10.1002/glia.20551; Canova C, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-22; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Coulthard LG, 2017, J NEUROSCI, V37, P5395, DOI 10.1523/JNEUROSCI.0525-17.2017; Davoust N, 1999, J IMMUNOL, V163, P6551; Davoust N, 1999, GLIA, V27, P162, DOI 10.1002/(SICI)1098-1136(199908)27:2<162::AID-GLIA6>3.0.CO;2-K; Dooley D, 2014, PHARMACOL THERAPEUT, V141, P21, DOI 10.1016/j.pharmthera.2013.08.001; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Gao M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45989; Gao M, 2017, BRAIN BEHAV IMMUN, V59, P288, DOI 10.1016/j.bbi.2016.09.020; Gao M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29955; Griesemer A, 2014, IMMUNOL REV, V258, P241, DOI 10.1111/imr.12152; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kim H, 2014, CYTOTHERAPY, V16, P357, DOI 10.1016/j.jcyt.2013.10.011; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Koutsoudaki PN, 2016, GLIA, V64, P763, DOI 10.1002/glia.22959; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Rocha-Ferreira E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00056; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Shinjyo N, 2016, MOL NEUROBIOL, V53, P3076, DOI 10.1007/s12035-015-9204-4; Shinjyo N, 2009, STEM CELLS, V27, P2824, DOI 10.1002/stem.225; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Woodruff TM, 2010, NEUROMOL MED, V12, P179, DOI 10.1007/s12017-009-8085-y; Yao H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137211; Zeng SM, 2016, J PATHOL, V238, P446, DOI 10.1002/path.4669	45	4	4	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JAN 24	2018	9								101	10.1038/s41419-017-0172-7			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FZ2CV	WOS:000427385100004	29367701	Green Published, gold			2022-02-06	
J	Belatar, B; Laidi, F; El Abidi, A; Eljaoudi, R; Mamouch, F; Kabbaj, S; Maazouzi, W				Belatar, Bahia; Laidi, Fatna; El Abidi, Abdelah; Eljaoudi, Rachid; Mamouch, Fouzia; Kabbaj, Saad; Maazouzi, Wajdi			Serum levels of Selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: case-control study	PAN AFRICAN MEDICAL JOURNAL			English	Article						Severe brain injury; selenium; coma; C-reactive protein; comatose patients; serum selenium; serum C-reactive protein	ACUTE-PHASE; SELENOPROTEIN; ANTIOXIDANT; DISEASE	Introduction: Mortality and morbidity related to traumatic brain injuries still remain high in patients. Many authors reported the importance of Selenium in maintaining the integrity of brain functions. This fact is supported by clinical evidence that therapy with selenium supplementation could help patients suffering from brain disorders like neurodegenerative diseases. The aim of our study was to assess the relationship between Selenium concentration in serum and evolution of comatose patients with severe traumatic brain injury, in the first week of admission, and the correlation between selenium and C-reactive protein. Methods: This case-control study was conducted with 64 comatose patients with TBI, in the Department of Anesthesiology and Reanimation, IbnSina University Hospital and Hospital of specialties in Rabat-Morocco, and healthy volunteers recruited in Blood transfusion center of Rabat. Blood sampling was collected from TBI patients, in the first week (3h after admission and each 48h during one week), and from healthy volunteers one time. Concentration of Se in serum was determined by electrochemical atomic absorption spectrometry. Statistical analysis was performed using Statistical software (SPSS) and the cases and controls were compared using the Mann-Whitney U test. A P-value < 0.05 was considered to be statistically significant. Results: Comparison selenium concentration in the first day (D0), third day (D2) and fifth day according to the death and survival statue in patients did not show statistical significance (p > 0.05). Selenium concentration of D0 in patients and Selenium concentration in control group also did not show statistical significance (p > 0.05). Similarly, we did not report a correlation between selenium and C-reactive protein. Conclusion: According to our data selenium and CRP may not play a role in progression of coma state in patients with severe traumatic brain injury.	[Belatar, Bahia; Kabbaj, Saad; Maazouzi, Wajdi] Univ Mohammed V Rabat, Fac Med & Pharm, Res Unit Cerebral Monitoring Neuroreanimat, Rabat, Morocco; [Laidi, Fatna] Univ Mohammed V Rabat, Fac Dent Med, Fac Med & Pharm, Oral Biomech & Biotechnol Res Unit, Rabat, Morocco; [El Abidi, Abdelah] Natl Inst Hlth, Dept Toxicol, Rabat, Morocco; [Eljaoudi, Rachid] Univ Mohammed V Rabat, Fac Med & Pharm, Pharmacol & Toxicol Dept, Rabat, Morocco; [Mamouch, Fouzia] Univ Mohammed V Rabat, Fac Med & Pharm, Res Unit Oncol, Rabat, Morocco; [Kabbaj, Saad; Maazouzi, Wajdi] Ibn Sina Univ Hosp, Hosp Specialties, Serv Anesthesiol & Reanimat, Rabat, Morocco		Belatar, B (corresponding author), Univ Mohammed V Rabat, Fac Med & Pharm, Res Unit Cerebral Monitoring Neuroreanimat, Rabat, Morocco.			Eljaoudi, Rachid/0000-0002-0692-2036			Angelova EA, 2008, EUR NEUROL, V60, P298, DOI 10.1159/000157884; ARTHUR JR, 1994, P NUTR SOC, V53, P615, DOI 10.1079/PNS19940070; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; BERR C, 1993, J AM GERIATR SOC, V41, P143, DOI 10.1111/j.1532-5415.1993.tb02048.x; Brown K M, 2001, Public Health Nutr, V4, P593; Chen J, 2003, J NEUROCHEM, V86, P1, DOI 10.1046/j.1471-4159.2003.01854.x; Foaud HM, 2014, J CLINDIAGN RES, V8; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Hao S, 2016, J AGR FOOD CHEM, V64, P1385, DOI 10.1021/acs.jafc.5b05621; Imam SZ, 1999, BRAIN RES, V818, P575, DOI 10.1016/S0006-8993(98)01311-0; KIREMIDJIANSCHUMACHER L, 1994, BIOL TRACE ELEM RES, V41, P115, DOI 10.1007/BF02917222; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee YH, 2016, J THORAC DIS, V8, P2068, DOI 10.21037/jtd.2016.07.60; Maehira F, 2002, CLIN CHIM ACTA, V316, P137, DOI 10.1016/S0009-8981(01)00744-6; Meyer CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147716; Mishra V, 2007, CLIN NUTR, V26, P41, DOI 10.1016/j.clnu.2006.10.003; Naghibi T, 2016, TURK J MED SCI, V46, P1, DOI 10.3906/sag-1404-125; Rayman MP, 1997, BRIT MED J, V314, P387, DOI 10.1136/bmj.314.7078.387; Solovyev ND, 2015, J INORG BIOCHEM, V153, P1, DOI 10.1016/j.jinorgbio.2015.09.003; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Sun Rong-qing, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P681, DOI 10.3760/cma.j.issn.2095-4352.2013.11.011; Vahter M, 1997, J TRACE ELEM MED BIO, V11, P215, DOI 10.1016/S0946-672X(97)80016-8; Yoshida S, 2016, CHEM PHARM BULL, V64, P52, DOI 10.1248/cpb.c15-00689	23	4	4	0	2	AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET	KAMPALA	PO BOX 12874, KAMPALA, 00000, UGANDA	1937-8688			PAN AFR MED J	Pan Afr. Med. J.	JAN 16	2018	29								36	10.11604/pamj.2018.29.36.10945			9	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	FX5FG	WOS:000426102900001	29875918	Green Published, Green Submitted, gold			2022-02-06	
J	Howard, SW; Zhang, ZD; Buchanan, P; Bernell, SL; Williams, C; Pearson, L; Huetsch, M; Gill, J; Pineda, JA				Howard, Steven W.; Zhang, Zidong; Buchanan, Paula; Bernell, Stephanie L.; Williams, Christine; Pearson, Lindsey; Huetsch, Michael; Gill, Jeff; Pineda, Jose A.			The cost of a pediatric neurocritical care program for traumatic brain injury: a retrospective cohort study	BMC HEALTH SERVICES RESEARCH			English	Article						Traumatic brain injury; Child health; Cost of care; Guidelines; Neurocritical care	EVIDENCE-BASED MEDICINE; US CHILDREN; OUTCOMES; MORTALITY; IMPLEMENTATION; HEALTH; MANAGEMENT; CHARGES	Background: Inpatient care for children with severe traumatic brain injury (sTBI) is expensive, with inpatient charges averaging over $70,000 per case (Hospital Inpatient, Children Only, National Statistics. Diagnoses-clinical classification software (CCS) principal diagnosis category 85 coma, stupor, and brain damage, and 233 intracranial injury. Diagnoses by Aggregate charges [https://hcupnet.ahrq.gov/#setup]). This ranks sTBI in the top quartile of pediatric conditions with the greatest inpatient costs (Hospital Inpatient, Children Only, National Statistics. Diagnoses-clinical classification software (CCS) principal diagnosis category 85 coma, stupor, and brain damage, and 233 intracranial injury. Diagnoses by Aggregate charges [https://hcupnet.ahrq.gov/#setup]). The Brain Trauma Foundation developed sTBI intensive care guidelines in 2003, with revisions in 2012 (Kochanek, Carney, et. al. PCCM 3:S1-S2, 2012). These guidelines have been widely disseminated, and are associated with improved health outcomes (Pineda, Leonard. et. al. LN 12:45-52, 2013), yet research on the cost of associated hospital care is limited. The objective of this study was to assess the costs of providing hospital care to sTBI patients through a guideline-based Pediatric Neurocritical Care Program (PNCP) implemented at St. Louis Children's Hospital, a pediatric academic medical center in the Midwest United States. Methods: This is a retrospective cohort study. We used multi-level regression to estimate pre-/post-implementation effects of the PNCP program on inflation adjusted total cost of in-hospital sTBI care. The study population included 58 pediatric patient discharges in the pre-PNCP implementation group (July 15, 1999 - September 17, 2005), and 59 post-implementation patient discharges (September 18, 2005 - January 15, 2012). Results: Implementation of the PNCP was associated with a non-significant difference in the cost of care between the pre- and post-implementation periods (e(ss) = 1.028, p = 0.687). Conclusions: Implementation of the PNCP to support delivery of guideline-based care for children with sTBI did not change the total per-patient cost of in-hospital care. A key strength of this study was its use of hospital cost data rather than charges. Future research should consider the longitudinal post-hospitalization costs of this approach to sTBI care.	[Howard, Steven W.] St Louis Univ, Hlth Management & Policy, Salus Ctr 374, 3545 Lafayette Ave, St Louis, MO 63104 USA; [Zhang, Zidong] St Louis Univ, Sch Med, St Louis, MO USA; [Buchanan, Paula] St Louis Univ, Ctr Outcomes Res, St Louis, MO 63103 USA; [Bernell, Stephanie L.] Oregon State Univ, Sch Social & Behav Hlth Sci, Corvallis, OR 97331 USA; [Williams, Christine] United Healthcare, Minneapolis, MN USA; [Pearson, Lindsey] St Lukes Hlth Syst, Kansas City, MO USA; [Huetsch, Michael] Barnes Jewish Coll, Goldfarb Sch Nursing, St Louis, MO USA; [Gill, Jeff] Washington Univ St Louis, Sch Med, Div Biostat, St Louis, MO USA; [Pineda, Jose A.] Washington Univ St Louis, Sch Med, St Louis, MO USA; [Gill, Jeff] Amer Univ, Dept Govt, Washington, DC 20016 USA		Howard, SW (corresponding author), St Louis Univ, Hlth Management & Policy, Salus Ctr 374, 3545 Lafayette Ave, St Louis, MO 63104 USA.	Steven.Howard@SLU.edu	Howard, Steven/K-6062-2019; Pineda, Jose/W-2806-2019	Zhang, Zidong/0000-0002-1084-9732	St. Louis Children's Hospital Foundation	This research was predominantly conducted in-kind, but was supported in part by the St. Louis Children's Hospital Foundation.	Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Brolliar SMMM, 2016, J NEUROTRAUM, V33, P7; Carey K, 2002, HLTH SERV OUTCOMES R, V3, P41, DOI DOI 10.1023/A:1021530924455; Chan E, 2002, ARCH PEDIAT ADOL MED, V156, P504, DOI 10.1001/archpedi.156.5.504; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Eddy DM, 2005, HEALTH AFFAIR, V24, P9, DOI 10.1377/hlthaff.24.1.9; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Figaji AA, 2009, CHILD NERV SYST, V25, P1335, DOI 10.1007/s00381-009-0821-y; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; Frees E. W., 1996, DATA ANAL USING REGR; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Graves JM, 2016, PEDIATR CRIT CARE ME, V17, P438, DOI 10.1097/PCC.0000000000000698; Griswold M, 2004, BIOSTATISTICS, V1, P1; Hospital Inpatient, DIAGN CLIN CLASS SOF; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kurz JE, 2016, PEDIATR CRIT CARE ME, V17, P649, DOI 10.1097/PCC.0000000000000765; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; March A., 2006, COMMONWEALTH FUND FA; Markham C, 2017, CURR OPIN PEDIATR, V29, P266, DOI 10.1097/MOP.0000000000000497; Murphy S, 2012, NEUROTHERAPEUTICS, V9, P3, DOI 10.1007/s13311-011-0093-6; O'Lynnger TM, 2016, J NEUROSURG-PEDIATR, V17, P19, DOI 10.3171/2015.5.PEDS1544; Pagano E, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1241-1; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Roumeliotis N, 2015, CHILD NERV SYST, V31, P4; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Scaife ER, 2010, CURR OPIN PEDIATR, V22, P339, DOI 10.1097/MOP.0b013e3283395f2b; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Tasker RC, 2009, CURR OPIN PEDIATR, V21, P724, DOI 10.1097/MOP.0b013e328331e813; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Timbie JW, 2012, HEALTH AFFAIR, V31, P2168, DOI 10.1377/hlthaff.2012.0150; Vitaz TW, 2001, J TRAUMA, V51, P369, DOI 10.1097/00005373-200108000-00025	39	4	4	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	JAN 12	2018	18								20	10.1186/s12913-017-2768-0			9	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	FS8WF	WOS:000422694700001	29329548	gold, Green Published			2022-02-06	
J	Ahmad, S; Afzal, A; Rehman, L; Javed, F				Ahmad, Shakeel; Afzal, Ali; Rehman, Lal; Javed, Farrukh			Impact of depressed skull fracture surgery on outcome of head injury patients	PAKISTAN JOURNAL OF MEDICAL SCIENCES			English	Article						Depressed skull fracture; Head injury; Glasgow Outcome Scale	TRAUMATIC BRAIN-INJURY; SAGITTAL SINUS	Objective: To assess outcomes in surgically managed patients with depressed skull fractures and associated moderate to severe head injury. Methods: The study was conducted in the Department of Neurosurgery Jinnah Postgraduate Medical Centre, Karachi, from January 2016 to December 2017. We analyzed 90 patients with depressed skull fracture managed surgically from January 2015 to December 2016. The patients selected for this study belonged to all age groups with clinically palpable depressed skull fracture confirmed by CT brain with bone window. Outcome was assessed by Glasgow outcome score. Results: Total 90 patients were included in the study. Sixty (66.7%) were male and 30 (33.3%) were female with mean age of years 27.58 + 11.329. Among 90 patients, 38.8% were aged between 21 and 30 years. Road traffic accident was seen in 72 (80%) patients. The commonest site of fracture was frontal region in 50 patients (55.6%). GCS improved post operatively on comparison to preoperative. Five patients expired. Conclusion: Depressed skull fracture is common neuro surgical issue. Timely surgical management gives excellent results by decreasing morbidity and mortality.	[Ahmad, Shakeel; Afzal, Ali; Rehman, Lal; Javed, Farrukh] Jinnah Postgrad Med Ctr, Dept Neurosurg, Rafiqui Shaheed Rd, Karachi, Pakistan		Javed, F (corresponding author), Jinnah Postgrad Med Ctr, Dept Neurosurg, Rafiqui Shaheed Rd, Karachi, Pakistan.	farrukhjavedkhi@gmail.com	Afzal, Ali/Q-9205-2019; Javeed, Farrukh/AAU-5414-2021	Javeed, Farrukh/0000-0002-7433-4834			Al-Haddad SA, 2002, ANN ROY COLL SURG, V84, P196; Ali M, 2003, J POSTGRAD MED I, V17, P116; BRAAKMAN R, 1972, J NEUROL NEUROSUR PS, V35, P395, DOI 10.1136/jnnp.35.3.395; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Fitzsimmons-Francis C, 2001, SURGINT, V52, P25; Foreman PM, 2017, CEREBROVASC DIS EXTR, V7, P72, DOI 10.1159/000455391; Geisler FH, 2012, PRINCIPLES NEUROLOGI, P365; Kim YJ, 2007, J KOREAN NEUROSURG S, V42, P346, DOI 10.3340/jkns.2007.42.4.346; Mehdi SA, 2010, PROFESSIONAL MED J, V17, P616; Meltzer H, 2000, J TRAUMA, V49, P981, DOI 10.1097/00005373-200011000-00035; Miyake Shigeta, 2016, No Shinkei Geka, V44, P599, DOI 10.11477/mf.1436203337; Ozer FD, 2005, J EMERG MED, V29, P137, DOI 10.1016/j.jemermed.2005.03.006; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Qureshi Nazer H, 2017, SKULL FRACTURE; Rolekar Nikita G, 2014, IJMHS, V3, DOI [10.5455/ijmsph.2014.271020141, DOI 10.5455/IJMSPH.2014.271020141]; Sendjaja AN, 2016, J SURG, V2968, DOI [10.17352/2455, DOI 10.17352/2455]; Tripathi AK, 2016, IND J ANAT SUR HEAD, V2, P32; Uzan M, 1998, J NEUROSURG, V88, P598, DOI 10.3171/jns.1998.88.3.0598; Yuan Q, 2012, INJURY, V43, P2094, DOI 10.1016/j.injury.2012.03.028; Zahed Hossain M, 2008, TAJ, V21, P140	20	4	4	0	1	PROFESSIONAL MEDICAL PUBLICATIONS	SADDAR	PANORAMA CENTRE, RM 522, 5TH FLOOR, BLDG 2, RAJA GHAZANFAR ALI RD, PO BOX 8766, SADDAR, KARACHI 00000, PAKISTAN	1682-024X			PAK J MED SCI	Pak. J. Med. Sci.	JAN-FEB	2018	34	1					130	134		10.12669/pjms.341.13184			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5JH	WOS:000428369200027	29643893	Green Submitted, Green Published, gold			2022-02-06	
J	Vieira, RDA; Paiva, WS; de Oliveira, DV; Guirado, VMD; Lanca, EDC; de Sousa, RMC				Almeida Vieira, Rita de Cassia; Paiva, Wellingson Silva; de Oliveira, Daniel Vieira; de Paula Guirado, Vinicius Monteiro; Caetano Lanca, Ellen de Fatima; Cardoso de Sousa, Regina Marcia			Recovery of Patients with Pure Diffuse Axonal Injury Who Remained in a Coma for 6 Hours or More	WORLD NEUROSURGERY			English	Article						Diffuse axonal injury; Glasgow Outcome Scale; Head trauma; Recovery; Severe traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; GLASGOW OUTCOME SCALE; MODEL; TOMOGRAPHY; PREDICTION; PROGNOSIS	BACKGROUND: Diffuse axonal injury (DAI) is a traumatic brain injury and one of the most common causes of unfavorable outcome and death. The aim of this study was to investigate the recovery of patients with pure DAI who remained in a coma for 6 hours or longer after brain injury. METHODS: This was a follow-up study of 75 patients diagnosed with pure DAI, aged 18-60 years, with a Glasgow Coma Scale score <= 8 at hospital admission. Patient data were collected at hospital admission, hospital discharge, and 3 and 6 months after DAI. Recovery was assessed by score changes in the Katz Index of Independence in Activities of Daily Living and Extended Glasgow Outcome Scale. RESULTS: The percentage of patients in a coma for 6-24 hours, >24 hours without brainstem signs, and >24 hours with brainstem signs was 42.7%, 20%, and 37.3%, respectively. The 6-month mortality rate was 32.0%, and the mean Extended Glasgow Outcome Scale score among survivors decreased from 3.8 at discharge (SD = 1.2) to 2.1 at 3 months (SD = 1.6) and 1.2 at 6 months (SD = 1.6). The mean Katz Index of Independence in Activities of Daily Living scores were 8.5 (SD = 5.5), 3.5 (SD = 5.8), and 1.8 (SD = 4.5) at discharge and 3 and 6 months after trauma, respectively. Statistically significant differences were observed among the 3 evaluation periods. CONCLUSIONS: Mortality was high among patients with DAI, but almost all survivors had favorable outcomes at 6 months. Functional improvement was more pronounced in the first 3 months.	[Almeida Vieira, Rita de Cassia; Cardoso de Sousa, Regina Marcia] Univ Sao Paulo, Nursing Sch, Sao Paulo, Brazil; [Paiva, Wellingson Silva; de Oliveira, Daniel Vieira; de Paula Guirado, Vinicius Monteiro] Univ Sao Paulo, Dept Neurol, Fac Med, Sao Paulo, Brazil; [Caetano Lanca, Ellen de Fatima] Univ Fed Amazonas, Nursing Sch, Manaus, Amazonas, Brazil		Vieira, RDA (corresponding author), Univ Sao Paulo, Nursing Sch, Sao Paulo, Brazil.	ritavieira@usp.br	Sousa, Regina M/H-1108-2012; Paiva, Wellingson S/G-5517-2013; de Oliveira, Daniel Vieira/AAH-1071-2019; Vieira, Rita de Cassia/E-3262-2013; de Paula Guirado, Vinicius Monteiro/AAG-7299-2019	Sousa, Regina M/0000-0002-2575-7937; Paiva, Wellingson S/0000-0002-5165-7040; de Oliveira, Daniel Vieira/0000-0002-6768-3286; Vieira, Rita de Cassia/0000-0002-7981-9822; de Paula Guirado, Vinicius Monteiro/0000-0002-7782-3609; Vieira, Rita de Cassia/0000-0001-9210-4445	Coordination for the Improvement of Higher Education Personnel (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21804-0]; Conselho Nacional de Desenvolvimento Cientiifico and Tecnoloigico Universal MCTI-CNPq [444855/214-9]	This project was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES); the Sao Paulo Research Foundation (FAPESP; 2013/21804-0); and the Conselho Nacional de Desenvolvimento Cientiifico and Tecnoloigico Universal MCTI-CNPq (444855/214-9).	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Association for the Advancement of Automotive Medicine (AAAM), 2005, ABBR INJ SCAL AIS 20; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Currie S., 2016, MED J, V92, P41, DOI [10.1136/postgradmedj-2014-133211, DOI 10.1136/POSTGRADMEDJ-2014-133211]; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Gennarelli TA, 1987, HEAD INJURY; Gennarelli TA, 1993, HEAD INJURY; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jeong JH, 2010, J NEUROSURG, V113, P532, DOI 10.3171/2009.10.JNS091152; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Liew B S, 2009, Med J Malaysia, V64, P280; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Lino VTS, 2008, CAD SAUDE PUBLICA, V24, P103, DOI 10.1590/S0102-311X2008000100010; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; Sousa RMC, 1996, REV ESC ENF USP, V30, P484, DOI DOI 10.1590/S0080-62341996000300010; Sousa RMC, 2006, REV ESC ENFERM USP, V40, P203, DOI DOI 10.1590/S0080-62342006000200008; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tomei G, 1991, J Neurosurg Sci, V35, P61; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Yoganandan N, 2009, J TRAUMA, V66, P309, DOI 10.1097/TA.0b013e3181692104; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zhao L, 2016, THER CLIN RISK MANAG, V12, DOI 10.2147/TCRM.S109482	39	4	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2018	109						140	146		10.1016/j.wneu.2017.09.101			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FR4DD	WOS:000419015000131	28962952				2022-02-06	
J	Azios, JH; Archer, B				Azios, Jamie H.; Archer, Brent			Singing behaviour in a client with traumatic brain injury: a conversation analysis investigation	APHASIOLOGY			English	Article						Traumatic brain injury; conversation analysis; therapy; facework; singing	TALK-IN-INTERACTION; APHASIA THERAPY; SOCIAL-INTERACTION; GOOD-NEWS; BAD-NEWS; SPEAKING; DISCOURSE; COUPLES; PEOPLE; PARTICIPATION	Background: Traumatic brain injury (TBI) is associated with pragmatic communication difficulties that lead to difficulty in social interaction. Research on conversation abilities in persons with TBI is limited, but has revealed unique patterns of behaviour that result in success or breakdown in conversation. Only a handful of studies have examined real-world conversations of persons with TBI to better understand how these behaviours might be motivated by conversation moves of partners.Aims: This study involved an exploration of a particular behaviour in a man with TBI, singing, to better understand the interactional environment, and goals associated with the behaviour.Methods & Procedures: Over 7h of conversation data were videorecorded from 10 therapy sessions in which a man with TBI recurrently employed singing during conversation. Instances of singing were identified and transcribed according to principles of conversation analysis (CA). A total of 39 instances were included and analysed independently, focusing on explaining the sequential context of the device and the interactional work that was achieved.Outcomes & Results: Data analysis revealed four distinct sequences involving instances of singing. These included a normative sequence in which the participant inserted singing in ways similar to neurotypical speakers. The other three sequences comprised of unusual instances of singing that allowed the participant to nominate new topics, demonstrate disalignment, and close topics in conversation.Conclusions: CA revealed that the participant produced singing in response to the actions of his conversation partners. All sequences were jointly produced and dependent upon the conversation turns before and after the instance of singing. The findings suggest that conversational partners pursue various interactional agendas during conversation in therapy sessions and the participant uses singing to perform facework in this context.	[Azios, Jamie H.] Lamar Univ, Dept Speech & Hearing Sci, Beaumont POB 10076, Beaumont, TX 77710 USA; [Archer, Brent] Bowling Green State Univ, Dept Commun Sci & Disorders, Bowling Green, OH 43403 USA		Azios, JH (corresponding author), Lamar Univ, Dept Speech & Hearing Sci, Beaumont POB 10076, Beaumont, TX 77710 USA.	jamie.azios@lamar.edu	Azios, Jamie/AAP-4142-2020		Lamar University	This work was partially supported by Lamar University through a summer research fellowship.	Aaltonen T., 2010, COMMUNICATION MED, V7, P115, DOI DOI 10.1558/cam.v7i2.115; Antaki C, 1988, ANAL EVERYDAY EXPLAN; Arundale RB, 2010, J PRAGMATICS, V42, P2078, DOI 10.1016/j.pragma.2009.12.021; Atkinson JM, 1999, APHASIOLOGY, V13, P243, DOI 10.1080/026870399402073; BECKMAN HB, 1984, ANN INTERN MED, V101, P692, DOI 10.7326/0003-4819-101-5-692; Beeke S., 2018, BETTER CONVERSATIONS; Beeke S, 2007, INT J LANG COMM DIS, V42, P629, DOI 10.1080/13682820601160087; Beeke Suzanne, 2007, Seminars in Speech and Language, V28, P136, DOI 10.1055/s-2007-970571; Beukelman D.R., 1984, ASSESSMENT INTELLIGI; BILMES J, 1985, DISCOURSE PROCESS, V8, P319, DOI 10.1080/01638538509544620; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Bull, 1989, CONVERSATION INTERDI, P21; BUTTON G, 1985, HUM STUD, V8, P3, DOI 10.1007/BF00143022; Church Amelia, 2004, RASK INT J LANGUAGE, V21, P111; Clark HH, 2002, COGNITION, V84, P73, DOI 10.1016/S0010-0277(02)00017-3; Croteau C, 2004, APHASIOLOGY, V18, P291, DOI 10.1080/02687030344000616; Croteau C, 2006, APHASIOLOGY, V20, P327, DOI 10.1080/02687030500475051; Damico J, 2015, APHASIOLOGY, V29, P400, DOI 10.1080/02687038.2014.945388; Denman A, 2011, DISABIL REHABIL, V33, P243, DOI 10.3109/09638288.2010.511686; Denzin NK., 1999, DOING INTERNET RES C, P107, DOI 10.4135/9781452231471.n5; Drew P, 1997, J PRAGMATICS, V28, P69, DOI 10.1016/S0378-2166(97)89759-7; Drew P, 1998, LANG SOC, V27, P495, DOI 10.1017/S0047404500020200; Enfield N. J., 2017, CONCEPT ACTION; Enfield NJ., 2013, RELATIONSHIP THINKIN; Frankel T, 2007, APHASIOLOGY, V21, P1039, DOI 10.1080/02687030701198395; Freese J, 1998, LANG SOC, V27, P195, DOI 10.1017/S0047404500019850; Frick M, 2013, PRAGMATICS, V23, P243, DOI 10.1075/prag.23.2.03fri; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Geertz C., 1973, INTERPRETATION CULTU; Goffman E., 1967, INTERACTION RITUAL; Goffman E., 1963, STIGMA NOTES MANAGEM; Goffman E., 1974, FRAME ANAL; Goffman E., 1956, PRESENTATION SELF EV; Goffman E, 1955, PSYCHIATR, V18, P213, DOI 10.1080/00332747.1955.11023008; Goodwin, 2004, J LINGUIST ANTHROPOL, V14, P151, DOI DOI 10.1525/JLIN.2004.14.2.151; Goodwin C, 2003, POINTING: WHERE LANGAUAGE, CULTURE, AND COGNITON MEET, P217; Goodwin C, 2002, CURR ANTHROPOL, V43, pS19, DOI 10.1086/339566; GOODWIN C, 1995, RES LANG SOC INTERAC, V28, P233, DOI 10.1207/s15327973rlsi2803_4; Goodwin C, 2000, J PRAGMATICS, V32, P1489, DOI 10.1016/S0378-2166(99)00096-X; GOODWIN C, 1987, SOC PSYCHOL QUART, V50, P115, DOI 10.2307/2786746; GOODWIN C, 1990, ANNU REV ANTHROPOL, V19, P283, DOI 10.1146/annurev.an.19.100190.001435; Goodwin C., 1981, CONVERSATIONAL ORG I; Goodwin C., 2006, ROOTS HUMAN SOCIALIT, P97; Goodwin C., 2003, CONVERSATION BRAIN D, P90; Goodwin C, 2007, DISCOURSE SOC, V18, P53, DOI 10.1177/0957926507069457; Goodwin C, 2010, STUD DISCOURSE GRAMM, V23, P373; Hanson EK, 2013, AUGMENT ALTERN COMM, V29, P310, DOI 10.3109/07434618.2013.848934; Hayano K., 2013, HDB CONVERSATION ANA, P395, DOI [10.1002/9781118325001.ch19, DOI 10.1002/9781118325001.CH19]; Heeschen C, 1999, APHASIOLOGY, V13, P365, DOI 10.1080/026870399402145; Heeschen C., 2003, CONVERSATION BRAIN D, P231; Hellermann J., 2009, IRAL-INT REV APPL LI, V47, P95, DOI DOI 10.1515/IRAL.2009.005; Heritage J, 2005, LEA COMMUN SER, P103; Heritage J, 2008, NEW BLACKWELL COMPAN, P300, DOI DOI 10.1002/9781444304992.CH15; Jefferson G., 1973, SEMIOTICA, V9, P47, DOI DOI 10.1515/SEMI.1973.9.1.47; Jefferson Gail., 1979, EVERYDAY LANGUAGE ST; Klippi A, 2015, APHASIOLOGY, V29, P337, DOI 10.1080/02687038.2013.878451; Kovarsky D, 1999, CONSTRUCTING (IN) COMPETENCE, P291; Kovarsky Dana, 2007, Commun Med, V4, P53, DOI 10.1515/CAM.2007.029; Kovarsky D, 2011, TOP LANG DISORD, V31, P325, DOI 10.1097/TLD.0b013e3182358e98; Kovarsky Dana, 2009, Seminars in Speech and Language, V30, P27, DOI 10.1055/s-0028-1104532; Lerner GH, 1996, SOC PSYCHOL QUART, V59, P303, DOI 10.2307/2787073; Lerner GH, 2002, LANGUAGE TURN SEQUEN; Lock S, 2001, INT J LANG COMM DIS, V36, P25, DOI 10.3109/13682820109177853; Maynard DW, 1997, RES LANG SOC INTERAC, V30, P93, DOI 10.1207/s15327973rlsi3002_1; Merrison Andrew John, 2011, DISCURSIVE APPROACHE, P221; Mikesell L., 2010, DISCOURSE SOCIALITY, P85; Mikesell L, 2010, DISCOURSE STUD, V12, P465, DOI 10.1177/1461445610370127; Mikesell L, 2009, RES LANG SOC INTERAC, V42, P135, DOI 10.1080/08351810902864552; NYSTRAND M, 1991, RES TEACH ENGL, V25, P261; Oelschlaeger ML, 1998, CLIN LINGUIST PHONET, V12, P459, DOI 10.3109/02699209808985238; Oelschlaeger ML, 1998, APHASIOLOGY, V12, P971, DOI 10.1080/02687039808249464; Pomerantz A., 2013, HDB CONVERSATION ANA, P210; Pomerantz A., 1984, STRUCTURES SOCIAL AC, P57, DOI DOI 10.1017/CBO9780511665868.008; Psathas G., 1995, CONVERSATION ANAL ST; Purves BA, 2009, APHASIOLOGY, V23, P914, DOI 10.1080/02687030802514946; Rasmussen G, 2013, J INTERACT RES COM D, V4, P273, DOI 10.1558/jircd.v4i2.273; Raymond G, 2003, AM SOCIOL REV, V68, P939, DOI 10.2307/1519752; Ross-Swain D., 1996, RIPA 2 ROSS INFORM P; Roter DL, 1992, DOCTORS TALKING PATI; Schegloff E. A., 1999, DISCOURSE STUD, V1, P405, DOI [10.1177/1461445699001004002, DOI 10.1177/1461445699001004002]; Schegloff E. A., 1973, SEMIOTICA, V8, P289, DOI [10.1515/semi.1973.8.4.289, DOI 10.1515/SEMI.1973.8.4.289]; Schegloff E. A., 1990, CONVERSATIONAL ORG I, P51; SCHEGLOFF EA, 1987, SOC PSYCHOL QUART, V50, P101, DOI 10.2307/2786745; Schegloff EA, 2007, SEQUENCE ORGANIZATION IN INTERACTION: A PRIMER IN CONVERSATION ANALYSIS I, P1, DOI 10.2277/ 0521532795; SCHEGLOFF EA, 1968, AM ANTHROPOL, V70, P1075, DOI 10.1525/aa.1968.70.6.02a00030; Schegloff EA, 2009, RES LANG SOC INTERAC, V42, P91, DOI 10.1080/08351810902864511; Schegloff Emanuel A., 1982, ANAL DISCOURSE TEXT, P71; Schegloff Emanuel A., 2006, ROOTS HUMAN SOCIALIT, P70; Sidnell J., 2011, CONVERSATION ANAL IN; Simmons-Mackie N, 1999, AM J SPEECH-LANG PAT, V8, P218, DOI 10.1044/1058-0360.0803.218; Simmons-Mackie N., 2013, CONSTRUCTING IN COMP, P313; Simmons-Mackie N, 2008, INT J LANG COMM DIS, V43, P5, DOI 10.1080/13682820701697889; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; SimmonsMackie NN, 1997, APHASIOLOGY, V11, P761, DOI 10.1080/02687039708250455; Stevanovic M, 2014, SOC SEMIOT, V24, P495, DOI 10.1080/10350330.2014.929394; Stivers T, 2005, RES LANG SOC INTERAC, V38, P131, DOI 10.1207/s15327973rlsi3802_1; Stivers T, 2008, RES LANG SOC INTERAC, V41, P31, DOI 10.1080/08351810701691123; Turner S, 2006, APHASIOLOGY, V20, P483, DOI 10.1080/02687030600589991; Wilkinson R., 2003, CONVERSATION BRAIN D, P59; Wilkinson R, 2007, J PRAGMATICS, V39, P542, DOI 10.1016/j.pragma.2006.07.010; Wilkinson R, 2015, APHASIOLOGY, V29, P257, DOI 10.1080/02687038.2014.974138; Wilkinson R, 2010, J INTERACT RES COM D, V1, P45, DOI 10.1558/jircd.v1i1.45; Wilkinson R, 2010, APHASIOLOGY, V24, P869, DOI 10.1080/02687030903501958	105	4	4	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2018	32	8					944	966		10.1080/02687038.2018.1466106			23	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	GH3IS	WOS:000433296600005					2022-02-06	
J	Balakrishnan, B; Zhang, LY; Simpson, PM; Hanson, SJ				Balakrishnan, Binod; Zhang, Liyun; Simpson, Pippa M.; Hanson, Sheila J.			Impact of the Timing of Placement of an Intracranial Pressure Monitor on Outcomes in Children with Severe Traumatic Brain Injury	PEDIATRIC NEUROSURGERY			English	Article						Severe traumatic brain injury; Intracranial pressure monitoring; Pediatric intensive care unit	PROPENSITY SCORE ANALYSIS; MANAGEMENT; GUIDELINES; MORTALITY	Background: Severe traumatic brain injury (sTBI) is the leading cause of morbidity and mortality from trauma. Brain Trauma Foundation guidelines recommend intracranial pressure (ICP) monitoring in sTBI. We hypothesized that early ICP monitor placement was associated with better outcomes in children. Methods: This was a retrospective study of children with sTBI admitted to the participating pediatric intensive care units (PICUs) and entered into the Virtual Pediatric Systems (VPS), LLC, database between 1 January 2010 and 31 December 2015. We compared outcomes of patients who had an ICP monitor placed early (<= 6 h from PICU admission) to those with later placement (>6 to <72 h). We collected demographics, diagnoses, procedure data, illness severity scores, outcomes, and site data. Multivariable regression analysis was used to identify variables independently associated with outcomes. Results: Twenty-seven percent of 3,608 patients with sTBI underwent ICP monitoring, 355 in the early and 156 in the later ICP monitoring groups, respectively. A higher proportion of patients in the early ICP monitoring group had worse markers of illness/injury severity; unadjusted analysis showed higher mortality in this group (31.3 vs. 21.8%, p = 0.029). Multivariable regression analysis showed that ICP monitoring was not independently associated with any of the outcomes. Conclusion: Time to ICP monitoring was not associated with outcomes after pediatric sTBI. (C) 2018 S. Karger AG, Basel	[Balakrishnan, Binod; Hanson, Sheila J.] Childrens Hosp Wisconsin, Sect Crit Care, Milwaukee, WI 53201 USA; [Balakrishnan, Binod; Zhang, Liyun; Simpson, Pippa M.; Hanson, Sheila J.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Zhang, Liyun; Simpson, Pippa M.] Med Coll Wisconsin, Sect Quantitat Hlth Sci, Milwaukee, WI 53226 USA		Hanson, SJ (corresponding author), Childrens Hosp Wisconsin, 9000 W Wisconsin Ave, Milwaukee, WI 53226 USA.	shanson@mcw.edu					Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Ali MS, 2015, J CLIN EPIDEMIOL, V68, P122, DOI 10.1016/j.jclinepi.2014.08.011; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Davidson GH, 2012, J TRAUMA ACUTE CARE, V73, P162, DOI 10.1097/TA.0b013e31825699b4; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Elze MC, 2017, J AM COLL CARDIOL, V69, P345, DOI 10.1016/j.jacc.2016.10.060; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Forsyth RJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub3; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; O'Lynnger TM, 2016, J NEUROSURG-PEDIATR, V17, P19, DOI 10.3171/2015.5.PEDS1544; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	25	4	4	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2018	53	6					379	386		10.1159/000494028			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HF4CH	WOS:000454180300003	30404096				2022-02-06	
J	Binder, LM; Chafetz, MD				Binder, Laurence M.; Chafetz, Michael D.			Determination of the smoking gun of intent: significance testing of forced choice results in social security claimants	CLINICAL NEUROPSYCHOLOGIST			English	Article						Malingering; binomial theorem; forced choice tests; Social Security Disability	SYMPTOM VALIDITY TEST; TRAUMATIC BRAIN-INJURY; DISABILITY CONSULTATIVE EXAM; NEUROPSYCHOLOGICAL ASSESSMENT; CLASSIFICATION ACCURACY; MEMORY IMPAIRMENT; AMERICAN ACADEMY; TEST-PERFORMANCE; RESPONSE BIAS; CHILDREN	Objective: Significantly below-chance findings on forced choice tests have been described as revealing "the smoking gun of intent" that proved malingering. The issues of probability levels, one-tailed vs. two-tailed tests, and the combining of PVT scores on significantly below-chance findings were addressed in a previous study, with a recommendation of a probability level of .20 to test the significance of below-chance results. The purpose of the present study was to determine the rate of below-chance findings in a Social Security Disability claimant sample using the previous recommendations. Method: We compared the frequency of below-chance results on forced choice performance validity tests (PVTs) at two levels of significance, .05 and .20, and when using significance testing on individual subtests of the PVTs compared with total scores in claimants for Social Security Disability in order to determine the rate of the expected increase. Results: The frequency of significant results increased with the higher level of significance for each subtest of the PVT and when combining individual test sections to increase the number of test items, with up to 20% of claimants showing significantly below-chance results at the higher p-value. Conclusions: These findings are discussed in light of Social Security Administration policy, showing an impact on policy issues concerning child abuse and neglect, and the importance of using these techniques in evaluations for Social Security Disability.				brain.resource@yahoo.com	Chafetz, Michael/AAC-2579-2020				Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P147, DOI 10.1080/23279095.2014.880842; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Binder L. M., 2007, PORTLAND DIGIT RECOG; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Binder LM, 2014, CLIN NEUROPSYCHOL, V28, P1366, DOI 10.1080/13854046.2014.978383; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Bush S.S., 2013, MILD TRAUMATIC BRAIN, P57; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Cassar JR, 1996, J AM ACAD CHILD PSY, V35, P700, DOI 10.1097/00004583-199606000-00005; Chafetz M, 2015, INTELLECTUAL DISABIL; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Chafetz M, 2014, CHILD ABUSE NEGLECT, V38, P1755, DOI 10.1016/j.chiabu.2014.08.015; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; Chafetz MD, 2012, CLIN NEUROPSYCHOL, V26, P1358, DOI 10.1080/13854046.2012.730674; Chafetz MD, 2010, CLIN NEUROPSYCHOL, V24, P1045, DOI 10.1080/13854046.2010.481637; Frazier TW, 2008, ARCH CLIN NEUROPSYCH, V23, P501, DOI 10.1016/j.acn.2008.04.001; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 1995, THE WORD MEMORY TEST; Green P., 2004, MANUAL GREENS MED SY; Green P., 2008, ADV INTERPRETATION S; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoskins LL, 2010, ARCH CLIN NEUROPSYCH, V25, P591, DOI 10.1093/arclin/acq060; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larson JCG, 2015, ARCH CLIN NEUROPSYCH, V30, P192, DOI 10.1093/arclin/acv012; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; PANKRATZ L, 1990, CLIN NEUROPSYCHOL, V4, DOI DOI 10.1080/13854049008401832; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Schroeder RW, 2012, COGN BEHAV NEUROL, V25, P139, DOI 10.1097/WNN.0b013e31826b71c1; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Slick DJ, 2003, CLIN NEUROPSYCHOL, V17, P390, DOI 10.1076/clin.17.3.390.18090; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Social Security Administration (SSA), 2016, SSI ANN STAT REP 201; Social Security Administration (SSA), 2016, ANN STAT REP SOC SEC; Thompson G. B., 2005, VSVT VICTORIA SYMPTO; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1	46	4	4	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	1					132	144		10.1080/13854046.2017.1337931			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GD3XB	WOS:000430436000011	28617092				2022-02-06	
J	Bogue, R				Bogue, Robert			Rehabilitation robots	INDUSTRIAL ROBOT-THE INTERNATIONAL JOURNAL OF ROBOTICS RESEARCH AND APPLICATION			English	Article						Rehabilitation; Robot; Exoskeleton; Neuroplasticity; Brain-computer interface; Strokes		Purpose - This paper aims to provide an insight into the emerging use of robots in the rehabilitation of sufferers from strokes and other neurological impediments. Design/methodology/approach - This considers research, clinical trials and commercial products. Following an introduction, it explains brain neuroplasticity and its role in rehabilitation and then discusses the use of robots in the restoration of upper limb and hand movement in stroke and traumatic injury patients. Robotic techniques aimed at restoring ambulatory ability are then discussed, followed by examples of the application of brain-computer interface technology to robotic rehabilitation. Finally, concluding comments are drawn. Findings - Research has shown that robotic techniques can assist in the restoration of functionality to partially or fully paralysed upper and lower limbs. A growing number of commercial exoskeleton and end-effector robotic products have been launched which are augmenting conventional rehabilitation therapies. These systems frequently include interactive computer games and tasks which encourage repetitive use and allow patients to monitor their progress. Trials which combine robotics with brain-computer interface technology have yielded encouraging and unexpectedly positive results. Originality/value - This provides details of the increasingly important role played by robots in the rehabilitation of patients suffering from strokes and other neurological disorders.				robbogue@aol.com	Coish, Elizabeth/AAU-1245-2020				Ang Kai Keng, 2014, Front Neuroeng, V7, P30, DOI 10.3389/fneng.2014.00030; Donati ARC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30383; Hesse S, 2012, J REHABIL RES DEV, V49, P613, DOI 10.1682/JRRD.2011.08.0142; Keller U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126948; Kim GaYeong, 2017, J Phys Ther Sci, V29, P1108, DOI 10.1589/jpts.29.1108; Klamroth-Marganska V, 2014, LANCET NEUROL, V13, P159, DOI 10.1016/S1474-4422(13)70305-3; McConnell A.C., 2017, J REHABILITATION MED, V49	7	4	4	4	14	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	0143-991X	1758-5791		IND ROBOT	Ind. Robot.		2018	45	3					301	306		10.1108/IR-03-2018-0046			6	Engineering, Industrial; Robotics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Robotics	GO3ZO	WOS:000439939500001					2022-02-06	
J	Boselli, M; Aquilani, R; Maestri, R; Achilli, MP; Arrigoni, N; Pasini, E; Condino, AM; Boschi, F; Dossena, M; Buonocore, D; Verri, M				Boselli, Mirella; Aquilani, Roberto; Maestri, Roberto; Achilli, Maria Pia; Arrigoni, Nadia; Pasini, Evasio; Condino, Anna Maria; Boschi, Federica; Dossena, Maurizia; Buonocore, Daniela; Verri, Manuela			Inflammation and rehabilitation outcomes in patients with nontraumatic intracranial haemorrhage	NEUROREHABILITATION			English	Article						Heamorrhagic stroke; inflammation; rehabilitation; functional recovery rate	MARKED NEUROPROTECTIVE EFFICACY; SUBACUTE ISCHEMIC-STROKE; LONG-TERM POTENTIATION; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; ALBUMIN THERAPY; BRAIN-INJURY; PROTEIN SUPPLEMENTATION; CYTOKINES; RATS	BACKGROUND: Systemic inflammation and its impact on rehabilitation for patients with non-traumatic haemorrhagic injury (HBI) sequelae has not yet been adequately documented. OBJECTIVE AND METHODS: We therefore considered 31 patients with HBI, to determine the serum levels of inflammatory markers (C-Reactive Protein, CRP and or interleukine-6,IL-6) to establish their impact on functional status (Functional Independence Measure, FIM:18 indicating the worst performance and 126, a normal score). RESULTS: The results showed an inflammation prevalence (CRP >0.5 mg/dl and/or IL 6 >7 pg/ml) of 74.2% at admission to Rehab. FIM reduction was more pronounced in inflamed compared to non-inflamed subjects (p< 0.05) and significantly correlated with blood variables sensitive to inflammation, such as alpha 1 globulin (r=-0.565) and neutrophil/ lymphocyte ratio (r=-0.52), CRP (r=-0.365). At discharge from Rehab, the inflammation rate diminished. Inflamed patients showed similar gains in FIM score as their controls. In the entire population, the FIM gam was significantly associated with a gain in serum albumin, only (r=+0.56). CONCLUSIONS: We conclude that systemic inflammation is prevalent in HBI patients and contributes to reduce patient functional status. However, during the Rehab stage, inflammation does not hinder the improvement rate of functional capacity.	[Boselli, Mirella; Achilli, Maria Pia; Arrigoni, Nadia] IRCCS Montescano, Unita Riabil Neuromotoria Gravi Cerebroles Acquis, Ist Clin Sci Maugeri Spa Soc Benefit, Pavia, Italy; [Boselli, Mirella; Aquilani, Roberto; Dossena, Maurizia; Buonocore, Daniela; Verri, Manuela] Univ Pavia, Dipartimento Biol & Biotecnol Lazzaro Spallanzani, Via Ferrata 9, I-27100 Pavia, Italy; [Maestri, Roberto] IRCCS Montescano, Dipartimento Ingn Biomed, Ist Clin Sci Maugeri Spa Soc Benefit, Pavia, Italy; [Pasini, Evasio] IRCCS Lumezzane, Ist Clin Sci Maugeri, Div Riabil Cardiaca, Brescia, Italy; [Condino, Anna Maria; Boschi, Federica] Univ Pavia, Dipartimento Sci Farmaco, Pavia, Italy		Boselli, M (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol Lazzaro Spallanzani, Via Ferrata 9, I-27100 Pavia, Italy.	manuela.verri@unipv.it	Maestri, Roberto/AAA-7585-2019; Maestri, Roberto/J-8168-2016; Pasini, Evasio/AAC-1798-2020; Achilli, Maria Pia/AAE-1142-2021	Maestri, Roberto/0000-0002-2873-0430; Maestri, Roberto/0000-0002-2873-0430; Pasini, Evasio/0000-0003-2836-4490; Boselli, Mirella/0000-0003-4545-5271; Achilli, Maria Pia/0000-0003-1918-2388			*AM HEART ASS, 1996, HEART STROK FACTS; Aquilani R, 1999, EURA MEDICOPHYS, V35, P75; Aquilani R, 2014, BIOMED RESEARCH INTE, V2014; Aquilani R, 2015, INT J IMMUNOPATH PH, V28, P576, DOI 10.1177/0394632015608249; Aquilani R, 2014, BRAIN INJURY, V28, P161, DOI 10.3109/02699052.2013.860470; Aquilani R, 2010, NUTR NEUROSCI, V13, P129, DOI 10.1179/147683010X12611460764002; Aquilani R, 2008, NUTR NEUROSCI, V11, P235, DOI 10.1179/147683008X301586; Aquilani R, 2008, CLIN REHABIL, V22, P1042, DOI 10.1177/0269215508094244; Badjatia N, 2010, JPEN-PARENTER ENTER, V34, P64, DOI 10.1177/0148607109348797; Belayev L, 1998, STROKE, V29, P2587, DOI 10.1161/01.STR.29.12.2587; Belayev L, 1999, BRAIN RES, V845, P107, DOI 10.1016/S0006-8993(99)01952-6; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boselli M, 2012, NUTR CLIN PRACT, V27, P99, DOI 10.1177/0884533611431068; Chang HR, 1998, JPEN-PARENTER ENTER, V22, P156, DOI 10.1177/0148607198022003156; Davalos A, 1996, STROKE, V27, P1028, DOI 10.1161/01.STR.27.6.1028; DAVERAT P, 1991, STROKE, V22, P1, DOI 10.1161/01.STR.22.1.1; Davis JP, 2004, STROKE, V35, P1930, DOI 10.1161/01.STR.0000135227.10451.c9; Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4; Doutheil J, 1999, MOL BRAIN RES, V63, P225, DOI 10.1016/S0169-328X(98)00276-9; ELHAG A, 1987, J IMMUNOL, V139, P2406; Esper DH, 2006, JPEN-PARENTER ENTER, V30, P71, DOI 10.1177/014860710603000271; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; Mathers CD, 2000, MED J AUSTRALIA, V172, P592, DOI 10.5694/j.1326-5377.2000.tb124125.x; Rosenorn J, 1987, Br J Neurosurg, V1, P33, DOI 10.3109/02688698709034339; SAVELAND H, 1986, J NEUROSURG, V64, P191, DOI 10.3171/jns.1986.64.2.0191; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646; Zoico E, 2002, NUTR REV, V60, P39, DOI 10.1301/00296640260085949	37	4	4	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	4					449	456		10.3233/NRE-172362			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GL1RG	WOS:000436883100007	29966209				2022-02-06	
J	Brett, BL; Kuhn, AW; Yengo-Kahn, AM; Kerr, ZY; Bonfield, CM; Solomon, GS; Zuckerman, SL				Brett, Benjamin L.; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Kerr, Zachary Y.; Bonfield, Christopher M.; Solomon, Gary S.; Zuckerman, Scott L.			Initial symptom presentation after high school football-related concussion varies by time point in a season: an initial investigation	SPORTS MEDICINE-OPEN			English	Article						Sport-related concussion; Symptoms; Modifying factors; Neurocognitive function; ImPACT testing; Sport injury	SPORT-RELATED CONCUSSION; SELF-REPORTED CONCUSSIONS; POSTCONCUSSION SYNDROME; BASE-LINE; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SEX-DIFFERENCES; COLLEGIATE; INJURY	Background: Schedule-based and in-season factors (e.g., competition type) have been shown to be associated with symptom reporting patterns and injury severity in sport-related concussion (SRC). To determine if acute neurocognitive and symptom presentation following SRC differ by time point within a high school football season. Methods: Multicenter ambispective cohort of high school football players who sustained a SRC (N = 2594). Timing (early, mid, and late season) of SRC was based on median dates for the start of the pre-season, regular season, and playoffs of each states football schedules. Analysis of covariance (ANCOVA) investigated differences across season period groups for (1) neurocognitive test scores, (2) total symptom scores (TSS), and (3) individual symptom increases from baseline within 1 week post-injury. Results: Significant group differences were observed in TSS, F(2, 2589) = 15.40, p < 0.001, eta(2)(p)= 0.01, and individual symptom increases from baseline, F(2, 2591) = 16.40, p < 0.001, eta(2)(p)= 0.01. Significant increases were seen from baseline to both midseason and late season in both TSS, chi(2 )= 24.40, p < 0.001, phi=0.10 and individual symptoms, chi(2 )= 10.32, p = 0.006, phi=0.10. Post hoc tests indicated a linear trend, with late-season injured athletes reporting approximately twice the TSS (13.10 vs. 6.77) and new symptoms (5.70 vs. 2.68) as those with early-season injuries. Conclusion: In a cohort of American high school football student-athletes, those suffering SRC in the late-season time period had increased acute symptom burden. SRC sustained later in-season may require more conservative management.	[Brett, Benjamin L.] Vet Affairs Connecticut Healthcare Syst, Dept Psychol, West Haven, CT USA; [Brett, Benjamin L.] Univ Memphis, Dept Counseling Educ Psychol & Res, Memphis, TN 38152 USA; [Brett, Benjamin L.; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Bonfield, Christopher M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Yengo-Kahn, Aaron M.; Bonfield, Christopher M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA.; Zuckerman, SL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA.	scott.zuckerman@vanderbilt.edu	Kuhn, Andrew W/AAM-4820-2020; Yengo-Kahn, Aaron/AAV-7647-2020	Kuhn, Andrew W/0000-0003-1836-7575; Yengo-Kahn, Aaron/0000-0002-5989-3064			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; [Anonymous], 2012, IMMEDIATE POSTCONCUS; [Anonymous], 2016, NATIONALB 2014 15 HI; [Anonymous], 2008, NATIONALA REPORT TRE; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Collins CL, 2016, AM J SPORT MED, V44, P1382, DOI 10.1177/0363546516629626; Coombs WT, 1996, REV EDUC RES, V66, P137, DOI 10.3102/00346543066002137; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gardner RM, 2017, PHYSICIAN SPORTSMED, V45, P1, DOI 10.1080/00913847.2017.1248221; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Institute o Medicine, 2015, SPORTS RELATED CONCU; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jones CM, 2017, SPORTS MED, V47, P943, DOI 10.1007/s40279-016-0619-5; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Knox CL, 2006, PEDIATRICS, V118, P549, DOI 10.1542/peds.2005-2913; Kuhn AW, 2017, NEUROSURGERY, V64, P211, DOI 10.1093/neuros/nyx294; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; National C Athletic Association, 2015, 2014 15 SPORTS MED H; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Steiner ME, 2016, SPORTS HEALTH, V8, P217, DOI 10.1177/1941738115626689; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593; Zuckerman SL, 2016, NEUROSURGERY S1, V63, P169	60	4	4	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open		2018	4								8	10.1186/s40798-018-0121-8			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	VI8CS	WOS:000514831000008	29387986	Green Published, gold			2022-02-06	
J	Brokaw, EB; Fine, MS; Kindschi, KE; Santago, AC; Lum, PS; Higgins, M				Brokaw, E. B.; Fine, M. S.; Kindschi, K. E.; Santago, A. C., II; Lum, P. S.; Higgins, M.			Cross-sectional evaluation of visuomotor tracking performance following subconcussive head impacts	TECHNOLOGY AND HEALTH CARE			English	Article						Subconcussive; lacrosse; visuomotor tracking; head injury	FOOTBALL PLAYERS; CONCUSSION; EXPOSURE; DEFICITS; INJURY; SPORTS	BACKGROUND: Repeated mild traumatic brain injury (mTBI) has been associated with increased risk of degenerative neurological disorders. While the effects of mTBI and repeated injury are known, studies have only recently started examining repeated subconcussive impacts, impacts that do not result in a clinically diagnosed mTBI. In these studies, repeated subconcussive impacts have been connected to cognitive performance and brain imaging changes. OBJECTIVE: Recent research suggests that performance on a visuomotor tracking (VMT) task may help improve the identification of mTBI. The goal of this study was to investigate if VMT performance is sensitive to the cumulative effect of repeated subconcussive head impacts in collegiate men's lacrosse players. METHODS: A cross-sectional, prospective study was completed with eleven collegiate men's lacrosse players. Participants wore helmet-mounted sensors and completed VMT and reaction time assessments. The relationship between cumulative impact metrics and VMT metrics were investigated. RESULTS: In this study, VMT performance correlated with repeated subconcussive head impacts; individuals approached clinically diagnosed mTBI-like performance as the cumulative rotational velocity they experienced increased. CONCLUSION: This suggests that repeated subconcussive impacts can result in measurable impairments and indicates that visuomotor tracking performance may be a useful tool for monitoring the effects of repeated subconcussive impacts.	[Brokaw, E. B.; Fine, M. S.; Santago, A. C., II] Mitre Corp, Emerging Technol Dept, Mclean, VA USA; [Kindschi, K. E.] MedStar Hlth Union Mem Hosp, Dept Sports Med, Baltimore, MD USA; [Lum, P. S.] MedStar Hlth Natl Rehabil Hosp, Ctr Appl Biomech & Rehabil Res, Washington, DC USA; [Lum, P. S.] Catholic Univ Amer, Dept Biomed Engn, Washington, DC 20064 USA; [Higgins, M.] Towson Univ, Kinesiol Dept, Towson, MD USA		Brokaw, EB (corresponding author), 7525 Colshire Dr,M-S J710, Mclean, VA 22102 USA.	ebrokaw@mitre.org		Fine, Michael/0000-0001-5717-179X	MITRE Corporation; Towson University	This research was internally funded by the MITRE Corporation, which is a not-for-profit organization that operates federally funded research and development centers, and Towson University. The authors' time was supported by their respective organizations.	Allison MA, 2014, ANN BIOMED ENG; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Davenport EM, 2014, J NEUROTRAUM, V8, P1; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Duma SM, 2009, IEEE ENG MED BIO, P1123, DOI 10.1109/IEMBS.2009.5333423; Fine MS, 2007, J NEUROPHYSIOL, V98, P1392, DOI 10.1152/jn.00196.2007; Fine MS, 2016, EXP BRAIN RES, V234, P3173, DOI 10.1007/s00221-016-4714-5; Forbes JA, 2012, NEUROSURG FOCUS, V33; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Massy-westropp NM, 2011, BMC RES NOTES; McAllister TW, 2012, NEUROLOGY, V79, P393; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Munce TA, 2016, MED SCI SPORTS EXERC, V2014; Press JN, 2016, CLIN J SPORT MED OFF, P1; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2010, J NEUROTRAUM, V338; Tsao JW, 2013, J CHEM INF MODEL, V53, P1689; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Zhang MR, 2013, PLOS ONE, V8, P8	37	4	4	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0928-7329	1878-7401		TECHNOL HEALTH CARE	Technol. Health Care		2018	26	1					109	118		10.3233/THC-171079			10	Health Care Sciences & Services; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Engineering	FZ0WR	WOS:000427295500011	29125529				2022-02-06	
J	Calati, R; Maller, JJ; Meslin, C; Lopez-Castroman, J; Ritchie, K; Courtet, P; Artero, S				Calati, Raffaella; Maller, Jerome J.; Meslin, Chantal; Lopez-Castroman, Jorge; Ritchie, Karen; Courtet, Philippe; Artero, Sylvaine			Repatriation is associated with isthmus cingulate cortex reduction in community-dwelling elderly	WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY			English	Article						Stress; brain imaging; biological psychiatry	STRESSFUL LIFE EVENTS; SURFACE-BASED ANALYSIS; CORTICAL THICKNESS; MAJOR DEPRESSION; VOLUME CHANGES; DSM-IV; DISORDER; CHILDHOOD; RISK; PREVALENCE	Objectives: The impact of stressful life events (SLEs) on brain anatomy is poorly understood, particularly its long-term neural consequences. We tested the hypothesis that a serious SLE (repatriation of French citizens living in Algeria in 1962) is associated with changes in brain regions previously implicated in psychopathology (hippocampus, amygdala, corpus callosum, prefrontal cortex, anterior, posterior and isthmus cingulate cortex (ICC)) in a large elderly population.Methods: Structural magnetic resonance imaging was used to acquire anatomical scans from 82 subjects repatriated from Algeria and 339 subjects without this experience or any other trauma. We derived quantitative regional estimates of subcortical volume using FreeSurfer Software. The General Linear Model was used to test the association between repatriation and changes in brain volume adjusted for confounders (gender, age, education, total brain volume, traumatic brain injury, Mini Mental State Examination score at baseline, current and lifetime major depression and recent SLEs).Results: Repatriation to France was associated with reduced volume in a number of areas; however, only left and right ICC survived to false discovery rate correction.Conclusions: In the elderly a previous (approximately 40 years before) serious SLE could be associated with long-term volume reduction in the ICC, independently of psychopathology.	[Calati, Raffaella; Lopez-Castroman, Jorge; Ritchie, Karen; Courtet, Philippe; Artero, Sylvaine] Univ Montpellier UM1, La Colombiere Hosp, INSERM, U1061, Montpellier, France; [Calati, Raffaella; Courtet, Philippe] FondaMental Fdn, Creteil, France; [Calati, Raffaella; Courtet, Philippe] CHRU, Lapeyronie Hosp, Dept Emergency Psychiat & Post Acute Care, Montpellier, France; [Maller, Jerome J.] Alfred & Monash Univ, Cent Clin Sch, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [Maller, Jerome J.] Gen Elect Healthcare, Melbourne, Vic, Australia; [Meslin, Chantal] Australian Natl Univ, Ctr Mental Hlth Res, Canberra, ACT, Australia; [Lopez-Castroman, Jorge] CHRU, Dept Adult Psychiat, Nimes, France		Calati, R (corresponding author), Univ Montpellier UM1, INSERM, U1061, Montpellier, France.	raffaella.calati@gmail.com	Calati, Raffaella/J-9931-2018; Ritchie, Karen/G-3571-2013; Artero, Sylvaine/AAE-6059-2020; Maller, Jerome J/H-4963-2014	Calati, Raffaella/0000-0001-8130-437X; Ritchie, Karen/0000-0002-0688-8982; Maller, Jerome J/0000-0003-4685-1508; Artero, Sylvaine/0000-0002-1671-226X	FondaMental Foundation, Creteil, France; ServierServier; AstraZenecaAstraZeneca; Bristol-Myers-SquibbBristol-Myers Squibb; JanssenJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc; LillyEli Lilly; LundbeckLundbeck Corporation; OtsukaOtsuka Pharmaceutical; RocheRoche Holding	Dr Raffaella Calati received a grant from the FondaMental Foundation, Creteil, France. Professor Philippe Courtet received research grants from Servier, and fees for presentations at congresses or participation in scientific boards from AstraZeneca, Bristol-Myers-Squibb, Janssen, Lilly, Lundbeck, Otsuka, Roche and Servier.	Ahmed F, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00568; Arnone D, 2012, EUR NEUROPSYCHOPHARM, V22, P1, DOI 10.1016/j.euroneuro.2011.05.003; Artero S, 2011, BRIT J PSYCHIAT, V199, P43, DOI 10.1192/bjp.bp.110.087924; Assareh AA, 2015, NEUROSCI BIOBEHAV R, V49, P171, DOI 10.1016/j.neubiorev.2014.12.013; Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Bandelow B, 2013, INT J PSYCHIAT CLIN, V17, P56, DOI 10.3109/13651501.2012.735244; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Bogic M, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0064-9; Bremner J Douglas, 2007, Expert Rev Neurother, V7, P393, DOI 10.1586/14737175.7.4.393; Brietzke E, 2012, REV BRAS PSIQUIATR, V34, P480, DOI 10.1016/j.rbp.2012.04.009; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; BROWN GW, 1993, PSYCHOSOM MED, V55, P248, DOI 10.1097/00006842-199305000-00003; Chaouloff F, 2013, CELL TISSUE RES, V354, P179, DOI 10.1007/s00441-013-1606-x; Chou Kee-Lee, 2012, J Clin Psychiatry, V73, pe1365, DOI 10.4088/JCP.12m07946; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Corp IBM, 2013, IBM SPSS STAT WIND V; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duval ER, 2015, THER CLIN RISK MANAG, V11, P115, DOI 10.2147/TCRM.S48528; Eckart C, 2011, J PSYCHIATR NEUROSCI, V36, P176, DOI 10.1503/jpn.100010; Molina ME, 2010, WORLD J BIOL PSYCHIA, V11, P493, DOI 10.3109/15622970701472094; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujino J, 2015, J AFFECT DISORDERS, V174, P397, DOI 10.1016/j.jad.2014.12.009; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Harwood RH, 1998, AGE AGEING, V27, P707, DOI 10.1093/ageing/27.6.707; Horesh N, 2008, PSYCHOPATHOLOGY, V41, P300, DOI 10.1159/000141925; Hughes MM, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw001; Ke J, 2016, ACTA RADIOL, V57, P1387, DOI 10.1177/0284185115585848; Kendler KS, 2004, PSYCHOL MED, V34, P1475, DOI 10.1017/S003329170400265X; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kennis M, 2015, HUM BRAIN MAPP, V36, P99, DOI 10.1002/hbm.22615; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kikinis Z, 2010, SCHIZOPHR RES, V123, P153, DOI 10.1016/j.schres.2010.07.027; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Li L, 2014, NEUROSCI BIOBEHAV R, V43, P163, DOI 10.1016/j.neubiorev.2014.04.003; Lim HK, 2012, NEUROPSYCHOPHARMACOL, V37, P838, DOI 10.1038/npp.2011.264; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; Mandelli L, 2015, EUR PSYCHIAT, V30, P665, DOI 10.1016/j.eurpsy.2015.04.007; MARK LP, 1993, AM J NEURORADIOL, V14, P349; McCrory Eamon, 2011, Front Psychiatry, V2, P48, DOI 10.3389/fpsyt.2011.00048; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; McLaren ME, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.49; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Papagni SA, 2011, STRESS, V14, P227, DOI 10.3109/10253890.2010.522279; Rinne-Albers MAW, 2013, EUR CHILD ADOLES PSY, V22, P745, DOI 10.1007/s00787-013-0410-1; Ritchie K, 2004, BRIT J PSYCHIAT, V184, P147, DOI 10.1192/bjp.184.2.147; Schmidt U, 2015, PSYCHONEUROENDOCRINO, V51, P444, DOI 10.1016/j.psyneuen.2014.08.020; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shin LM, 2009, ARCH GEN PSYCHIAT, V66, P1099, DOI 10.1001/archgenpsychiatry.2009.138; Siriwardhana Chesmal, 2014, Confl Health, V8, P13, DOI 10.1186/1752-1505-8-13; Sleijpen M, 2016, ETHNIC HEALTH, V21, P158, DOI 10.1080/13557858.2015.1044946; Szymkowicz SM, 2016, INT J GERIATR PSYCH, V31, P325, DOI 10.1002/gps.4324; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; van der Werff SJA, 2013, HUM PSYCHOPHARM CLIN, V28, P529, DOI 10.1002/hup.2336; WATSON CG, 1991, J CLIN PSYCHOL, V47, P179, DOI 10.1002/1097-4679(199103)47:2<179::AID-JCLP2270470202>3.0.CO;2-P; Watson IPB, 2016, NEUROSCI BIOBEHAV R, V68, P134, DOI 10.1016/j.neubiorev.2016.05.010; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wood KH, 2015, NEUROIMAGE, V119, P371, DOI 10.1016/j.neuroimage.2015.06.086; World Health Organization, 2004, ICD 10 INT STAT CLAS; Zannas AS, 2013, J PSYCHIATR RES, V47, P829, DOI 10.1016/j.jpsychires.2013.02.008; Zhang HW, 2014, PROG NEURO-PSYCHOPH, V53, P61, DOI 10.1016/j.pnpbp.2014.03.002	69	4	4	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1562-2975	1814-1412		WORLD J BIOL PSYCHIA	World J. Biol. Psychiatry		2018	19	6					421	430		10.1080/15622975.2016.1258490			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GS7XD	WOS:000443917000003	27844618				2022-02-06	
J	Curvis, W; Simpson, J; Hampson, N				Curvis, William; Simpson, Jane; Hampson, Natalie			Social anxiety following traumatic brain injury: an exploration of associated factors	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; social anxiety; stigma; psychological	HOSPITAL ANXIETY; SELF-ESTEEM; PSYCHOSOCIAL ADJUSTMENT; PSYCHOMETRIC PROPERTIES; PSYCHIATRIC-DISORDERS; FUNCTIONAL RECOVERY; LIFE SATISFACTION; PHOBIA INVENTORY; DEPRESSION SCALE; PANIC DISORDER	Social anxiety (SA) following traumatic brain injury (TBI) has the potential to affect an individual's general psychological well-being and social functioning, however little research has explored factors associated with its development. The present study used hierarchical multiple regression to investigate the demographic, clinical and psychological factors associated with SA following TBI. A sample of 85 people who experienced TBI were recruited through social media websites and brain injury services across the North-West of England. The overall combined biopsychosocial model was significant, explaining 52-54.3% of the variance in SA (across five imputations of missing data). The addition of psychological variables (self-esteem, locus of control, self-efficacy) made a significant contribution to the overall model, accounting for an additional 12.2-13% of variance in SA above that explained by demographic and clinical variables. Perceived stigma was the only significant independent predictor of SA (B=.274, p=.005). The findings suggest that psychological variables are important in the development of SA following TBI and must be considered alongside clinical factors. Furthermore, the significant role of stigma highlights the need for intervention at both an individualised and societal level.	[Curvis, William; Simpson, Jane] Univ Lancaster, Div Hlth Res, Lancaster, England; [Hampson, Natalie] Salford Royal NHS Fdn Trust, Dept Clin Neuropsychol, Salford, Lancs, England		Curvis, W (corresponding author), Univ Lancaster, Furness Coll, Div Hlth Res, Clin Psychol, Floor C, Lancaster L1 4YG, England.	wcurvis@gmail.com		Simpson, Jane/0000-0001-5071-4077			Alonso J, 2008, ACTA PSYCHIAT SCAND, V118, P305, DOI 10.1111/j.1600-0447.2008.01241.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anderson KN, 2015, AM J ORTHOPSYCHIAT, V85, P131, DOI 10.1037/ort0000046; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; Antony MM, 2006, BEHAV RES THER, V44, P1177, DOI 10.1016/j.brat.2005.08.013; Banerjee R, 2001, SOC DEV, V10, P558, DOI 10.1111/1467-9507.00180; Bedard M, 2005, J COGN REHABIL, V23, P8, DOI DOI 10.1080/0963828031000090489; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Beyenburg S, 2005, EPILEPSY BEHAV, V7, P161, DOI 10.1016/j.yebeh.2005.05.014; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bowerman B.L., 1990, LINEAR STAT MODELS A, V2nd ed.; British Psychological Society, 2011, GOOD PRACT GUID US P; British Psychological Society, 2008, COND RES PEOPL NOT H; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Clark DM., 1995, SOCIAL PHOBIA DIAGNO, P69; CLOITRE M, 1992, COGNITIVE THER RES, V16, P569, DOI 10.1007/BF01175142; Coe R, 2002, BRIT EDUCATIONAL RES; Cohen J., 2013, STAT POWER ANAL BEHA; Connor KM, 2000, BRIT J PSYCHIAT, V176, P379, DOI 10.1192/bjp.176.4.379; Department of Health, 2005, **NON-TRADITIONAL**; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Guindon MH, 2002, J COUNS DEV, V80, P204, DOI 10.1002/j.1556-6678.2002.tb00184.x; Hair JF., 2006, MULTIVARIATE DATA AN, V6; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Jones JM, 2012, BRIT J HEALTH PSYCH, V17, P798, DOI 10.1111/j.2044-8287.2012.02074.x; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kennedy BL, 1998, J CLIN PSYCHOL, V54, P509, DOI 10.1002/(SICI)1097-4679(199806)54:4<509::AID-JCLP12>3.3.CO;2-B; Kervick RB, 2005, BRAIN INJURY, V19, P881, DOI 10.1080/02699050400025273; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; LEARY MR, 1986, J SOC CLIN PSYCHOL, V4, P256, DOI 10.1521/jscp.1986.4.3.256; Linden MA, 2010, BRAIN INJURY, V24, P642, DOI 10.3109/02699051003601689; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; Menard S.W., 1995, APPL LOGISTIC REGRES; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; National Institute for Health and Care Excellence, 2013, SOC ANX DIS NICE GUI; Neuro QOL, 2010, NEUR REP IT BANK DEV; Neuro QOL, 2012, AD IT BANKS; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Ohayon MM, 2010, J PSYCHOSOM RES, V68, P235, DOI 10.1016/j.jpsychores.2009.07.018; Oliver M., 1983, SOCIAL WORK DISABLED; Oliver M., 2004, IMPLEMENTING SOCIAL, P18; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Poder K, 2009, MULT SCLER J, V15, P393, DOI 10.1177/1352458508099143; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Qualtrics, 2013, QUALTR SURV SOFTW; Rao D, 2009, QUAL LIFE RES, V18, P585, DOI 10.1007/s11136-009-9475-1; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rapee RM, 2004, CLIN PSYCHOL REV, V24, P737, DOI 10.1016/j.cpr.2004.06.004; REEVE D, 2012, ROUTLEDGE HDB DISABI, P78, DOI DOI 10.4324/9780429430817-8; Ritter V, 2013, COGNITIVE THER RES, V37, P1101, DOI 10.1007/s10608-013-9553-0; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Rosenberg M., 1979, CONCEIVING SELF; Rosenberg M., 1965, SOC ADOLESCENT SELF; Rubin D.B., 1987, MULTIPLE IMPUTATION; Schafer JL, 1997, ANAL INCOMPLETE MULT; Scheutzow MH, 1999, BRAIN INJURY, V13, P705; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Simpson J, 2015, DISABIL REHABIL, V37, P1299, DOI 10.3109/09638288.2014.961656; Simpson J, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/608562; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Soo C., 2012, DEV SOCIAL NEUROSCIE, P370; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; Waldron B, 2010, SPINAL CORD, V48, P598, DOI 10.1038/sc.2009.182; WALLSTON KA, 1994, J PERS ASSESS, V63, P534, DOI 10.1207/s15327752jpa6303_10; Wallston KA, 2005, J HEALTH PSYCHOL, V10, P623, DOI 10.1177/1359105305055304; Wells A., 2013, COGNITIVE THERAPY AN; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; WILSON BA, 2009, NEUR REH THEOR MOD, P1; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	96	4	4	1	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	4					527	547		10.1080/09602011.2016.1175359			21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GA4CA	WOS:000428276000003	27186650	Green Accepted			2022-02-06	
J	Daverio, M; Babl, FE; Barker, R; Gregori, D; Da Dalt, L; Bressan, S				Daverio, Marco; Babl, Franz E.; Barker, Ruth; Gregori, Dario; Da Dalt, Liviana; Bressan, Silvia		Paediat Res Emergency Dept Int	Helmet use in preventing acute concussive symptoms in recreational vehicle related head trauma	BRAIN INJURY			English	Article						Head trauma; traumatic brain injury; paediatric; concussion; helmet	HIGH-SCHOOL FOOTBALL; DECISION RULES; CHILDREN; INJURY; ACCURACY; SPORT	Objectives: Helmets use has proved effective in reducing head trauma (HT) severity in children riding non-motorised recreational vehicles. Scant data are available on their role in reducing concussive symptoms in children with HT while riding non-motorised recreational vehicles such as bicycles, push scooters and skateboards (BSS). We aimed to investigate whether helmet use is associated with a reduction in acute concussive symptoms in children with BSS-related-HT.Methods: Prospective study of children <18years who presented with a BSS related-HT between April 2011 and January 2014 at a tertiary Paediatric Emergency Department (ED).Results: We included 190 patients. Median age 9.4years (IQR 4.8-13.8). 66% were riding a bicycle, 23% a push scooter, and 11% a skateboard. 62% were wearing a helmet and 62% had at least one concussive symptom. Multivariate logistic regression analysis adjusting for age, gender, and type of vehicle showed that patients without a helmet presented more likely with headache (adjusted odds-ratio (aOR) 2.54, 95% CI 1.27-5.06), vomiting (aOR 2.16, 95% CI 1.00-4.66), abnormal behaviour (aOR 2.34, 95% CI 1.08-5.06), or the presence of at least one concussive symptom (aOR 2.39, 95% CI 1.20-4.80).Conclusions: In children presenting to the ED following a wheeled BSS-related HT helmet use was associated with less acute concussive symptoms.ABBREVIATIONS: aOR, adjusted odds ratio; APHIRST, Australasian Paediatric Head Injury Rules Study; BSS, bicycles, push scooters and skateboards; CI, confidence interval; CT, computed tomography; ED, emergency department; HT, head trauma; IQR, interquartile range; OR, odds ratio; RCH, Royal Children's Hospital; RV, recreational vehicle.	[Daverio, Marco; Babl, Franz E.; Bressan, Silvia] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Daverio, Marco; Da Dalt, Liviana; Bressan, Silvia] Univ Padua, Dept Womans & Childs Hlth, Dept Paediat, Padua, Italy; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, 50 Flemington Rd, Melbourne, Vic 3052, Australia; [Babl, Franz E.] Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Barker, Ruth] Mater Med Res Inst, Queensland Injury Surveillance Unit, South Brisbane, Qld, Australia; [Gregori, Dario] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Unit Biostat Epidemiol & Publ Hlth, Padua, Italy		Babl, FE (corresponding author), Royal Childrens Hosp, Emergency Dept, 50 Flemington Rd, Melbourne, Vic 3052, Australia.	franz.babl@rch.org.au	Barker, Ruth Andrea/Q-3717-2016; Daverio, Marco/AAB-1646-2019	Barker, Ruth Andrea/0000-0002-1355-4614; Daverio, Marco/0000-0002-3127-8836	National Health and Medical Research Council, CanberraNational Health and Medical Research Council of Australia [GNT1046727]; National Health and Medical Research Council (Centre of Research Excellence for Paediatric Emergency Medicine), Canberra [GNT1058560]; ACT, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia	The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, ACT, Australia and the Victorian Government's Infrastructure Support Program, Melbourne, Australia.	Auguie B., 2017, MISCELLANEOUS FUNCTI; Australian Bureau of Statistics, 2011 CENS QUICK STAT; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Bressan S, 2016, EMERG MED AUSTRALAS, V28, P425, DOI 10.1111/1742-6723.12617; Bressan S, 2016, J PAEDIATR CHILD H, V52, P151, DOI 10.1111/jpc.12967; Collins CL, 2016, AM J SPORT MED, V44, P1382, DOI 10.1177/0363546516629626; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Faul M, 2010, TRAUMATIC BRAIN INJU; Forjuoh SN, 2002, ARCH PEDIAT ADOL MED, V156, P656, DOI 10.1001/archpedi.156.7.656; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P726, DOI 10.1016/j.jpeds.2013.03.073; National Road Transport Commission, AUSTR ROAD RUL PART; Page JL, 2012, INJURY PREV, V18, P94, DOI 10.1136/injuryprev-2011-040029; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Wesson DE, 2008, PEDIATRICS, V122, P605, DOI 10.1542/peds.2007-1776; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2015, INT J SPORTS MED, V36, P419, DOI 10.1055/s-0034-1395587	24	4	4	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	3					335	341		10.1080/02699052.2018.1426107			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FU3PV	WOS:000423764700008	29355399				2022-02-06	
J	Dionne, JP; Levine, J; Makris, A				Dionne, J. P.; Levine, J.; Makris, A.			Acceleration-based methodology to assess the blast mitigation performance of explosive ordnance disposal helmets	SHOCK WAVES			English	Article						Blast; Traumatic brain injury (TBI); Personal protective equipment (PPE); Helmet; Test methodologies; EOD	INJURY	To design the next generation of blast mitigation helmets that offer increasing levels of protection against explosive devices, manufacturers must be able to rely on appropriate test methodologies and human surrogates that will differentiate the performance level of various helmet solutions and ensure user safety. Ideally, such test methodologies and associated injury thresholds should be based on widely accepted injury criteria relevant within the context of blast. Unfortunately, even though significant research has taken place over the last decade in the area of blast neurotrauma, there currently exists no agreement in terms of injury mechanisms for blast-induced traumatic brain injury. In absence of such widely accepted test methods and injury criteria, the current study presents a specific blast test methodology focusing on explosive ordnance disposal protective equipment, involving the readily available Hybrid III mannequin, initially developed for the automotive industry. The unlikely applicability of the associated brain injury criteria (based on both linear and rotational head acceleration) is discussed in the context of blast. Test results encompassing a large number of blast configurations and personal protective equipment are presented, emphasizing the possibility to develop useful correlations between blast parameters, such as the scaled distance, and mannequin engineering measurements (head acceleration). Suggestions are put forward for a practical standardized blast testing methodology taking into account limitations in the applicability of acceleration-based injury criteria as well as the inherent variability in blast testing results.	[Dionne, J. P.; Levine, J.; Makris, A.] 2400 St Laurent Blvd, Ottawa, ON K1G 6C4, Canada		Dionne, JP (corresponding author), 2400 St Laurent Blvd, Ottawa, ON K1G 6C4, Canada.	Jean-Philippe.Dionne@safariland.com		Dionne, Jean-Philippe/0000-0002-1127-2787			Baker W.E., 1973, EXPLOSIONS AIR; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bass Cameron R Dale, 2005, Int J Occup Saf Ergon, V11, P347; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bulmash G., 1984, ARBRLTR02555; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Dionne J. P., 2016, P 2016 PERS ARM SYST; Dionne J. P., 2012, P 2012 PERS ARM SYST; Dionne J. P., 2014, P 22 MIL ASP BLAST S; Haladuick T., 2012, PERS ARM SYST S PASS; Kimpara, 2011, INT J AUTOMOT ENG, V2, P13, DOI [10.20485/jsaeijae.2.2_13, DOI 10.20485/JSAEIJAE.2.2_13]; King A. I., 2003, P ANN C INT RES COUN; Levine J., 2014, P 2014 PERS ARM SYST; Levine J., 2016, P 23 MIL ASP BLAST S; Levine J., 2012, P 21 MIL ASP BLAST S; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; MITAL NK, 1979, J APPL MECH-T ASME, V46, P925, DOI 10.1115/1.3424679; Nerenberg J., 2002, EVALUATION ABS LPU E; Newman J, 2000, P INT RES COUNC BIOM; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman J.A., 1986, P IRCOBI C, P121; Ohrt A. P., 2014, P 22 MIL ASP BLAST S; Ommaya A. K., 1984, GG SNIV MEM LECT DEN; Ouellet S., 2012, P 2012 PERS ARM SYST; Public Safety Bomb Suit Standard, 2012, 011701 NIJ US DEP JU; SAE (Society of Automotive Engineers), 1995, J2111 SAE; Simmonds K., 2004, NRL REV, P156; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; THIBAULT LE, 1990, 34 ANN C ASS ADV AUT; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]	31	4	4	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	JAN	2018	28	1					5	18		10.1007/s00193-017-0737-5			14	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FU0TF	WOS:000423562600002					2022-02-06	
J	Divani, AA; Phan, JA; Salazar, P; SantaCruz, KS; Bachour, O; Mahmoudi, J; Zhu, XH; Pomper, MG				Divani, Afshin A.; Phan, Jenny-Ann; Salazar, Pascal; SantaCruz, Karen S.; Bachour, Ornina; Mahmoudi, Javad; Zhu, Xiao-Hong; Pomper, Martin G.			Changes in [F-18]Fluorodeoxyglucose Activities in a Shockwave-Induced Traumatic Brain Injury Model Using Lithotripsy	JOURNAL OF NEUROTRAUMA			English	Article						blast traumatic brain injury; cerebral metabolism; FDG; head injury; lithotripsy; PET; shockwave	POSITRON-EMISSION-TOMOGRAPHY; WAVE LITHOTRIPSY; RENAL INJURY; RAT-BRAIN; IN-VITRO; GLUCOSE; BLOOD; PET; MICRODIALYSIS; METABOLISM	We present a longitudinal study of cerebral metabolism using [F-18]fluorodeoxyglucose (FDG) positron emission tomography (PET) in a rat model of shockwave-induced traumatic brain injury (SW-TBI). Anesthetized rats received 5 or 10 SW pulses to the right anterior lateral or dorsal frontal regions using SW lithotripsy. Animals were scanned for FDG uptake at baseline, 3h post-injury, and 3 days post-injury, using a small animal PET/computed tomography (CT) scanner. FDG uptake at all time-points was quantified as the ratio of brain activity relative to peripheral activity in the left ventricle (LV) in the heart (A(brain)/A(LV)) for the entire brain, each hemisphere, and four cortices (motor, cingulate, somatosensory, and retrosplenial). The mixed-designed models analysis of variance (ANOVA) for the hemispheric and global FDG uptake ratio showed a significant effect of the time-of-scan (p=0.038) and measured region (p=6.12e-09). We also observed a significant effect of the time-of-scan (p=0.046) and measured region (p=2.28e-09) for the FDG uptake ratio in four cortical regions. None of the measurements (global or local) showed a significant effect for the number of SW pulses (5 or 10) or SW location (lateral or dorsal frontal regions). Our data suggest that SW-TBI causes hypermetabolism on the impact side of the rat brain at 3h post-injury compared with the baseline measurements. However, the increase in FDG uptake by day 3 post-injury was not significant. Further studies on post-TBI metabolic changes are needed to understand better the pathophysiology of the injury.	[Divani, Afshin A.] Univ Minnesota, Dept Neurol, 420 Delaware St SE MMC 295, Minneapolis, MN 55455 USA; [Divani, Afshin A.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Divani, Afshin A.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA; [Bachour, Ornina] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA; [Zhu, Xiao-Hong] Univ Minnesota, Dept Radiol, Ctr Magnet Imaging Res, Minneapolis, MN 55455 USA; [Phan, Jenny-Ann] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Phan, Jenny-Ann] Aarhus Univ Hosp, Dept Nucl Med, Aarhus, Denmark; [Phan, Jenny-Ann] Aarhus Univ Hosp, PET Ctr, Aarhus, Denmark; [Salazar, Pascal] Vital Images Inc, Minnetonka, MN USA; [SantaCruz, Karen S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Mahmoudi, Javad] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran; [Pomper, Martin G.] Johns Hopkins Med Sch, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA		Divani, AA (corresponding author), Univ Minnesota, Dept Neurol, 420 Delaware St SE MMC 295, Minneapolis, MN 55455 USA.	divani@umn.edu	Mahmoudi, Javad/M-4680-2017	Phan, Jenny-Ann/0000-0003-3658-002X			Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Connors BA, 2009, BJU INT, V104, P1004, DOI 10.1111/j.1464-410X.2009.08520.x; Divani AA, 2015, J NEUROTRAUM, V32, P1109, DOI 10.1089/neu.2014.3686; Evan AP, 2007, BJU INT, V100, P624, DOI 10.1111/j.1464-410X.2007.07007.x; GJEDDE A, 1981, J NEUROCHEM, V36, P1463, DOI 10.1111/j.1471-4159.1981.tb00587.x; Green LA, 1998, J NUCL MED, V39, P729; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Rubins DJ, 2003, NEUROIMAGE, V20, P2100, DOI 10.1016/j.neuroimage.2003.07.011; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Sweis BM, 2016, BEHAV BRAIN RES, V296, P149, DOI 10.1016/j.bbr.2015.09.015; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Xiong GM, 2012, PHYS MED BIOL, V57, P8041, DOI 10.1088/0031-9155/57/23/8041; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	26	4	4	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					187	194		10.1089/neu.2017.5208			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000419569700020	28922962				2022-02-06	
J	Driver, S; Stork, R				Driver, Sangeeta; Stork, Ryan			Pharmacological management of sleep after traumatic brain injury	NEUROREHABILITATION			English	Article						Brain injury; sleep; medications; pharmacology; therapy	PRIMARY INSOMNIA; CONTROLLED-TRIAL; DOUBLE-BLIND; HEAD-INJURY; MELATONIN; PLACEBO; DISORDERS; TRAZODONE; RECOVERY; DISTURBANCE	Sleep-wake disturbances (SWD) are prevalent in the traumatic brain injury (TBI) population and may exacerbate related neurobehavioral impairments. As such, it is important to recognize and treat SWD early to allow for optimal cognitive recovery following a TBI. A number of medications are currently available for treatment of SWD. However, most research in this area has historically focused on neurologically intact populations. This article reviews key pharmacologic treatment principles and agents to consider for use in the treatment of TBI-related SWD. In addition, it highlights available research literature that has examined the use of sleep medications in this unique population.	[Driver, Sangeeta] Shirley Ryan Abilitylab, Brain Injury Med & Rehabil Program, 355 E Erie St, Chicago, IL 60611 USA; [Driver, Sangeeta] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Stork, Ryan] Univ Michigan, Dept Phys Med & Rehabil, Med Sch, Ann Arbor, MI 48109 USA		Driver, S (corresponding author), Shirley Ryan Abilitylab, Brain Injury Med & Rehabil Program, 355 E Erie St, Chicago, IL 60611 USA.	sdriver@sralab.org					Barker MJ, 2005, J INT NEUROPSYCH SOC, V11, P281, DOI 10.1017/S1355617705050332; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Brower KJ, 2008, ALCOHOL CLIN EXP RES, V32, P1429, DOI 10.1111/j.1530-0277.2008.00706.x; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Erman M, 2006, SLEEP MED, V7, P17, DOI 10.1016/j.sleep.2005.09.004; Erman MK, 2008, J CLIN SLEEP MED, V4, P229; Flanagan SR, 2007, J HEAD TRAUMA REHAB, V22, P67, DOI 10.1097/00001199-200701000-00009; FUDGE JL, 1990, J AFFECT DISORDERS, V18, P275, DOI 10.1016/0165-0327(90)90079-N; GOLDSTEIN LB, 1995, J NEUROL NEUROSUR PS, V58, P753, DOI 10.1136/jnnp.58.6.753; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Karsten J, 2017, J PSYCHOPHARMACOL, V31, P327, DOI 10.1177/0269881116681399; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Killgore WD, 2017, SLEEP, V40, pA426, DOI 10.1093/sleepj/zsx050.1142; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Lequerica A, 2015, ARCH PHYS MED REHAB, V96, P1802, DOI 10.1016/j.apmr.2015.05.011; Malec J. F., 1991, J CONSULT CLIN PSYCH, V3, P82, DOI DOI 10.1037/1040-3590.3.1.82; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Miljatovic AM, 2012, EUROPEAN PSYCHIAT S1, V27, P1; Minkel J, 2013, SLEEP MED CLIN, V8, P333, DOI 10.1016/j.jsmc.2013.06.002; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Pandi-Perumal SR, 2007, CNS DRUGS, V21, P995, DOI 10.2165/00023210-200721120-00004; Pevet P, 2011, J PHYSIOL-PARIS, V105, P170, DOI 10.1016/j.jphysparis.2011.07.001; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Shan RSLP, 2004, AM J PHYS MED REHAB, V83, P421, DOI 10.1097/00002060-200406000-00003; Stahl SM, 2009, CNS SPECTRUMS, V14, P536, DOI 10.1017/S1092852900024020; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Yi XY, 2018, SLEEP MED, V45, P25, DOI 10.1016/j.sleep.2018.01.010; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397	32	4	4	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	3					347	353		10.3233/NRE-182536			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HA8FK	WOS:000450524200010	30347630				2022-02-06	
J	Drummond, M; Douglas, J; Olver, J				Drummond, Melanie; Douglas, Jacinta; Olver, John			A Prospective Analysis of Olfactory Impairment Recovery After Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; olfaction; olfactory impairment; posttraumatic anosmia; rehabilitation; smell; traumatic brain injury	OF-PENNSYLVANIA SMELL; FOLLOW-UP; CONSEQUENCES; DYSFUNCTION; DISORDERS; IMPACT; TASTE; LIFE; ANOSMIA	Objective: To investigate the natural progression of olfactory impairment (OI) in individuals with traumatic brain injury (TBI) at 6 months postinjury. Participants: Forty-seven adults (mean age = 43.1 years, SD = 18.2), with predominantly severe TBI (mean posttraumatic amnesia [PTA] duration = 25.5 days, SD = 22.8). Design: Consecutive admission longitudinal study. Main Measures: Participants were evaluated using the University of Pennsylvania Smell Identification Test (UPSIT) at resolution of PTA and at 6 months post-initial injury. Each participant was also interviewed to explore his or her experience of having an OI. Standard multiple regression was used to assess the ability of age, PTA duration, presence of facial fractures, and initial UPSIT score to predict olfactory performance at 6 months. Results: Thirty-five participants (74%) continued to demonstrate OI at 6 months. Thirty-two participants (68%) showed some improvement, but only 12 of these individuals achieved scores within the normal range. The remaining 15 participants either produced a poorer performance (23%) or demonstrated no change (9%). Initial UPSIT score uniquely accounted for 73.5% of the variance in UPSIT performance at 6 months. Conclusions: Olfactory impairment persists in a substantial proportion of adults who experience it post-TBI and has the potential to impact a broad spectrum of everyday activities.	[Drummond, Melanie; Douglas, Jacinta] La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia; [Drummond, Melanie; Olver, John] Epworth HealthCare, Epworth Monash Rehabil Med Unit, Richmond, Vic, Australia; [Drummond, Melanie; Olver, John] Epworth HealthCare, Epworth Rehabil, Richmond, Vic, Australia; [Douglas, Jacinta] Univ New South Wales, NHMRC Clin Ctr Res Excellence Brain Recovery, Sch Psychol, Sydney, NSW, Australia; [Douglas, Jacinta] Summer Fdn, Blackburn, Vic, Australia		Drummond, M (corresponding author), BSpPath, Epworth Rehabil Execut Team, 25 Burwood Rd, Hawthorn, Vic 3122, Australia.	melanie.drummond@epworth.org.au	Douglas, Jacinta M/C-2380-2009	Olver, John/0000-0001-7069-1191	Victorian Brain Injury Recovery Association Scholarship; Epworth Health Care Scholarship Program; Epworth Monash Rehabilitation Medicine Unit; La Trobe University Post Graduate Support Grant; Health Sciences Post Graduate Program	Financial assistance was received from the Victorian Brain Injury Recovery Association Scholarship, Epworth Health Care Scholarship Program, Epworth Monash Rehabilitation Medicine Unit, and La Trobe University Post Graduate Support Grant and Health Sciences Post Graduate Program. The authors thank the participants for their generous contribution to this research. The authors also thank Epworth HealthCare speech pathologists Chloe Douglas and Hayley Dell'Oro for their invaluable assistance with recruitment and data collection.	Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; Blomqvist EH, 2004, RHINOLOGY, V42, P189; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; DAVIDSON TM, 1995, POSTGRAD MED, V98, P107, DOI 10.1080/00325481.1995.11946020; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Deecke L., 2003, CHEM SENSES, V28, pE27, DOI 10.1007/s12078-012-9127-7; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Drummond M., 2007, BRAIN IMPAIR, V8, P31; Drummond M, 2015, BRAIN IMPAIR, V16, P196, DOI 10.1017/BrImp.2015.27; Drummond M, 2013, BRAIN INJURY, V27, P332, DOI 10.3109/02699052.2012.750743; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; FERRIS AM, 1989, ANN NY ACAD SCI, V561, P113, DOI 10.1111/j.1749-6632.1989.tb20975.x; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Haxel BR, 2012, HNO, V60, P432, DOI 10.1007/s00106-011-2448-z; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hirsh A., 2003, TASTE AND SMELL; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Keller A, 2013, BMC EAR NOSE THROAT, V13, DOI 10.1186/1472-6815-13-8; Menco B. P., 2003, HDB OLFACTION GUSTAT, V2nd, P17; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Nordin S, 2011, ACTA OTO-LARYNGOL, V131, P826, DOI 10.3109/00016489.2010.539625; Pink B.N., 2006, AUSTR NZ STANDARD CL; Ponsford J, 2010, BRAIN IMPAIR, V11, P253, DOI 10.1375/brim.11.3.253; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Renzi G, 2002, ANN PLAS SURG, V48, P355, DOI 10.1097/00000637-200204000-00003; Schiffman S, 1990, CHICAGO TRIBUNE, P23; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Shu CH, 2011, RHINOLOGY, V49, P337, DOI 10.4193/Rhino10.130; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Van Toller S, 1999, CHEM SENSES, V24, P705, DOI 10.1093/chemse/24.6.705; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	41	4	4	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					53	61		10.1097/HTR.0000000000000283			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300014	28195960				2022-02-06	
J	Fresson, M; Dardenne, B; Meulemans, T				Fresson, Megan; Dardenne, Benoit; Meulemans, Thierry			Diagnosis threat and underperformance: The threat must be relevant and implicit	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Contrast effect; diagnosis threat; domain identification; neuropsychological assessment; stereotype threat	TRAUMATIC BRAIN-INJURY; STEREOTYPE THREAT; TEST-PERFORMANCE; WORKING-MEMORY; COGNITIVE PERFORMANCE; NEGATIVE STEREOTYPES; SELF-EFFICACY; HEAD-INJURY; METAANALYSIS; IDENTIFICATION	Introduction: The diagnosis threat (DT) phenomenon shows that, in some cases, reminding people with mild traumatic brain injury (mTBI) about their past neurological history diminishes subsequent cognitive performance. The aim of the present study was to investigate the role of personal relevance (i.e., domain identification) and type of threat (i.e., implicit vs. explicit) as moderating variables. We investigated intrusive thoughts as a potential mediator. Method: Control (non-mTBI) and mTBI participants were recruited and completed a domain identification questionnaire. Under either an implicit or an explicit DT condition, they completed neuropsychological tasks assessing working memory, episodic memory, and executive processing, as well as measures of intrusive thoughts. Results: As expected, the main results showed that, for working memory and episodic memory, high identifier mTBI participants scored worse in the implicit DT condition than in the explicit condition. The implicit DT condition also led high identifier mTBI participants to score worse than low identifiers for working memory. Conversely, the explicit DT condition led high identifier mTBI participants to perform better than low identifiers for both working and episodic memory. Unexpectedly, low identifier mTBI participants scored better on working memory tasks in the implicit DT condition than in the explicit condition. We found no evidence of mediation by intrusive thoughts. Conclusions: Domain identification and the explicit or implicit nature of the DT must be taken into account, as they can impact mTBI participants' cognitive performance. This study suggests the influence of DT as a factor biasing neuropsychological assessment.	[Fresson, Megan; Dardenne, Benoit; Meulemans, Thierry] Univ Liege, Psychol & Neurosci Cognit Unit, B33 Trifacultaire Quartier Agora,Pl Orateurs 1, B-4000 Liege, Belgium		Fresson, M (corresponding author), Univ Liege, Psychol & Neurosci Cognit Unit, B33 Trifacultaire Quartier Agora,Pl Orateurs 1, B-4000 Liege, Belgium.	megan.fresson@ulg.ac.be		Dardenne, Benoit/0000-0002-4001-7101			Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V46, P610, DOI 10.1037/0022-3514.46.3.610; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beilock SL, 2007, J EXP PSYCHOL GEN, V136, P256, DOI 10.1037/0096-3445.136.2.256; Biernat M., 2005, STANDARDS EXPECTANCI; Blaine H, 2013, J NEUROTRAUM, V30, P1405, DOI 10.1089/neu.2013.2865; Cadinu M, 2005, PSYCHOL SCI, V16, P572, DOI 10.1111/j.0956-7976.2005.01577.x; Cadinu M, 2003, EUR J SOC PSYCHOL, V33, P267, DOI 10.1002/ejsp.145; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Dardenne B, 2007, J PERS SOC PSYCHOL, V93, P764, DOI 10.1037/0022-3514.93.5.764; Delis DC, 1987, CALIFORNIA VERBAL LE; Desrichard O, 2005, EUR J SOC PSYCHOL, V35, P537, DOI 10.1002/ejsp.249; DIXON RA, 1983, J GERONTOL, V38, P682, DOI 10.1093/geronj/38.6.682; Dumont M, 2010, SEX ROLES, V62, P545, DOI 10.1007/s11199-008-9582-4; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fernandez-Ballesteros R, 2015, EXP AGING RES, V41, P410, DOI 10.1080/0361073X.2015.1053757; Fimm, 2010, TEST ATTENTIONAL PER; Fresson M, 2017, J CLIN EXP NEUROPSYC, V39, P913, DOI 10.1080/13803395.2017.1280450; Gallagher A. M., 2005, GENDER DIFFERENCES M, P189; Geurten M, 2016, CAN J BEHAV SCI, V48, P328, DOI 10.1037/cbs0000057; Godefroy A, 2008, FONCTIONS EXECUTIVES; Good C, 2008, J APPL DEV PSYCHOL, V29, P17, DOI 10.1016/j.appdev.2007.10.004; Grimm LR, 2009, J PERS SOC PSYCHOL, V96, P288, DOI 10.1037/a0013463; Hayes, 2018, INTRO MEDIATION MODE; Hess TM, 2003, J GERONTOL B-PSYCHOL, V58, pP3, DOI 10.1093/geronb/58.1.P3; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson Grant L, 2007, Pain Pract, V7, P94, DOI 10.1111/j.1533-2500.2007.00116.x; Keller J, 2007, BRIT J EDUC PSYCHOL, V77, P323, DOI 10.1348/000709906X113662; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Kit KA, 2014, J INT NEUROPSYCH SOC, V20, P157, DOI 10.1017/S1355617713001264; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kray LJ, 2001, J PERS SOC PSYCHOL, V80, P942, DOI 10.1037/0022-3514.80.6.942; Lamont RA, 2015, PSYCHOL AGING, V30, P180, DOI 10.1037/a0038586; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Logel C, 2009, J EXP SOC PSYCHOL, V45, P299, DOI 10.1016/j.jesp.2008.07.016; Martiny SE, 2012, EUR J SOC PSYCHOL, V42, P65, DOI 10.1002/ejsp.840; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mazerolle M, 2012, PSYCHOL SCI, V23, P723, DOI 10.1177/0956797612437607; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mrazek MD, 2011, J EXP SOC PSYCHOL, V47, P1243, DOI 10.1016/j.jesp.2011.05.011; Nguyen HHD, 2008, J APPL PSYCHOL, V93, P1314, DOI 10.1037/a0012702; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Pennington CR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146487; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schmader T, 2003, J PERS SOC PSYCHOL, V85, P440, DOI 10.1037/0022-3514.85.3.440; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Schuster CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126118; Seibt B, 2004, J PERS SOC PSYCHOL, V87, P38, DOI 10.1037/0022-3514.87.1.38; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stawarczyk D, 2014, ACTA PSYCHOL, V148, P25, DOI 10.1016/j.actpsy.2014.01.007; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Trontel HG, 2013, J CLIN EXP NEUROPSYC, V35, P960, DOI 10.1080/13803395.2013.844770; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wheeler SC, 2001, PSYCHOL BULL, V127, P797, DOI 10.1037//0033-2909.127.6.797; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298	63	4	4	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2018	40	7					682	697		10.1080/13803395.2017.1420143			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GK8AR	WOS:000436438200004	29316843				2022-02-06	
J	Galvagno, SM; Mabry, RL; Maddry, J; Kharod, CU; Walrath, BD; Powell, E; Shackelford, S				Galvagno, Samuel M., Jr.; Mabry, Robert L.; Maddry, Joseph; Kharod, Chetan U.; Walrath, Benjamin D.; Powell, Elizabeth; Shackelford, Stacy			Measuring US Army medical evacuation: Metrics for performance improvement	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						MEDEVAC; helicopter emergency medical services; process improvement; quality improvement; tactical combat casualty care; military evacuation; air medical transport; quality assurance; aeromedical evacuation; en route care; critical care air transport; paramedic	DEATH; OPERATIONS	BACKGROUND The US Army medical evacuation (MEDEVAC) community has maintained a reputation for high levels of success in transporting casualties from the point of injury to definitive care. This work served as a demonstration project to advance a model of quality assurance surveillance and medical direction for prehospital MEDEVAC providers within the Joint Trauma System. METHODS A retrospective interrupted time series analysis using prospectively collected data was performed as a process improvement project. Records were reviewed during two distinct periods: 2009 and 2014 to 2015. MEDEVAC records were matched to outcomes data available in the Department of Defense Trauma Registry. Abstracted deidentified data were reviewed for specific outcomes, procedures, and processes of care. Descriptive statistics were applied as appropriate. RESULTS A total of 1,008 patients were included in this study. Nine quality assurance metrics were assessed. These metrics were: airway management, management of hypoxemia, compliance with a blood transfusion protocol, interventions for hypotensive patients, quality of battlefield analgesia, temperature measurement and interventions, proportion of traumatic brain injury (TBI) patients with hypoxemia and/or hypotension, proportion of traumatic brain injury patients with an appropriate assessment, and proportion of missing data. Overall survival in the subset of patients with outcomes data available in the Department of Defense Trauma Registry was 97.5%. CONCLUSION The data analyzed for this study suggest overall high compliance with established tactical combat casualty care guidelines. In the present study, nearly 7% of patients had at least one documented oxygen saturation of less than 90%, and 13% of these patients had no documentation of any intervention for hypoxemia, indicating a need for training focus on airway management for hypoxemia. Advances in battlefield analgesia continued to evolve over the period when data for this study was collected. Given the inherent high-risk, high-acuity nature of prehospital advanced life support and emphasis on the use of nonphysician practitioners in an out-of-hospital setting, the need for ongoing medical oversight and quality improvement assessment is crucial. LEVEL OF EVIDENCE Care management, level IV.	[Galvagno, Samuel M., Jr.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Anesthesiol,Program Trauma,Shock Trauma Ctr, 22 South Greene St,T3N08, Baltimore, MD 21201 USA; [Mabry, Robert L.] Robert Wood Johnson Fdn, Hlth Policy Fellows Program, Princeton, NJ 08540 USA; [Maddry, Joseph] 59th MDW ST Chief Scientists Off, USAF En Route Care Res Ctr, San Antonio, TX USA; [Maddry, Joseph] 59th MDW ST Chief Scientists Off, Clin Resuscitat Emergency Sci & Toxicol Res Progr, San Antonio, TX USA; [Maddry, Joseph] US Army Inst Surg Res, San Antonio, TX USA; [Maddry, Joseph] USUHS, F Edward Hebert Sch Med, Bethesda, MD USA; [Kharod, Chetan U.] Joint Base San Antonio Ft Sam Houston, Mil EMS & Disaster Med Fellowship, Houston, TX USA; [Walrath, Benjamin D.] NMCSD Emergency Med Staff Phys, Navy Med West, San Diego, CA USA; [Powell, Elizabeth] Univ Cincinnati, Univ Cincinnati Air Care & Mobile Care, Dept Emergency Med, Cincinnati, OH USA; [Shackelford, Stacy] Joint Trauma Syst, Educ & Performance Improvement, San Antonio, TX USA		Galvagno, SM (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Anesthesiol,Program Trauma,Shock Trauma Ctr, 22 South Greene St,T3N08, Baltimore, MD 21201 USA.	sgalvgno@anes.umm.edu		Kharod, Chetan/0000-0003-4352-8887; Powell, Elizabeth/0000-0003-1258-5272			Air Medical Physician Association, 2002, Prehosp Emerg Care, V6, P461; [Anonymous], 2008, CLIN PRACTICE GUIDEL; [Anonymous], 2013, CRITICAL CARE AIR TR; Apodaca A, 2013, J TRAUMA ACUTE CARE, V75, pS157, DOI 10.1097/TA.0b013e318299da3e; Apodaca AN, 2013, SHOCK, V40, P5, DOI 10.1097/SHK.0b013e31829793d7; Baker Bruce C, 2007, Anesthesiol Clin, V25, P131, DOI 10.1016/j.anclin.2006.12.003; Barnard Ed B G, 2014, J Spec Oper Med, V14, P35; Blackbourne Lorne H, 2008, US Army Med Dep J, P50; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Gerhardt RT, 2012, COMBAT CASUALTY CARE, P88; Harcke HT, 2011, MIL MED, V176, P824, DOI 10.7205/MILMED-D-10-00271; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Kotwal RS, 2015, JAMA SURG, V30, P1; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Mabry RL, 2012, J TRAUMA ACUTE CARE, V73, pS32, DOI 10.1097/TA.0b013e3182606001; Malsby RF, 2013, MIL MED, V178, P785, DOI 10.7205/MILMED-D-13-00047; Sauer Samual W, 2015, J Spec Oper Med, V15, P25; Schauer SG, 2015, MIL MED, V180, P60, DOI 10.7205/MILMED-D-14-00384; Simpson N, 2012, EMERG MED J, V29, P243, DOI 10.1136/emj.2010.094789; Sollid SJM, 2010, SCAND J TRAUMA RESUS, V18, P1; Thompson C B, 1995, Air Med J, V14, P55	23	4	4	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2018	84	1					150	156		10.1097/TA.0000000000001715			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FS0JG	WOS:000419459600023	29267184				2022-02-06	
J	Garlanger, KL; Beck, LA; Cheville, AL				Garlanger, Kristin L.; Beck, Lisa A.; Cheville, Andrea L.			Functional outcomes in patients with co-occurring traumatic brain injury and spinal cord injury from an inpatient rehabilitation facility's perspective	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injury; Traumatic brain injury; Dual diagnosis; Functional outcomes; Cord injury rehabilitation	CLOSED HEAD-INJURY; NEUROLOGICAL CLASSIFICATION; INTERNATIONAL STANDARDS; INDEPENDENCE MEASURE; SYSTEM; PERFORMANCE; SPECTRUM; DISEASE; IMPACT; COSTS	Objective: To examine the occurrence and severity of co-occurring traumatic brain injury (TBI) in persons with traumatic spinal cord injury (SCI), i.e. dual diagnosis (DD), and to describe differences in functional outcomes between persons with DD and SCI only from an inpatient rehabilitation facility (IRF) perspective. Design: Retrospective clinical chart review. Setting: Acute Midwest SCI inpatient rehabilitation facility. Participants: 256 persons age 18-80 years with acute traumatic SCI (AIS A-E, C1-S3 level of injury) from 2002-2012. Interventions: Neuroimaging and electronic medical records were reviewed to identify those with co-occurring TBI. Outcomes were then compared between the SCI only and DD groups. Outcome Measures: Length of stay (LOS), discharge location and functional independence measures (FIM) Results: Forty-one percent of persons with traumatic SCI experienced co-occurring TBI. Rehabilitation LOS for the DD groups did not differ significantly from the SCI only group. Those with Moderate-Severe DD had significantly lower Total admission FIM (P < 0.001), Cognitive admission and discharge FIM (both P < 0.001) and Motor FIM efficiency scores (P = 0.03) compared to those with SCI only and were significantly less likely to discharge home (P = 0.05). Conclusions: Persons admitted to IRFs with Moderate-Severe DD compared to those with SCI only are less efficient in obtaining motor skills and may require ongoing rehabilitation to safely return home. It is therefore imperative to initiate early discharge planning and educate rehabilitation team members and families on the additional time and resources necessary to achieve more successful outcomes in those with Moderate-Severe DD.	[Garlanger, Kristin L.; Beck, Lisa A.; Cheville, Andrea L.] Mayo Clin, Dept Phys Med & Rehabil, Coll Med, Rochester, MN 55905 USA		Garlanger, KL (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.	garlanger.kristin@mayo.edu					Beck L A, 1999, SCI Nurs, V16, P127; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P733, DOI 10.1016/S0003-9993(99)90219-8; Cifu DX, 1999, J NEUROTRAUM, V16, P805, DOI 10.1089/neu.1999.16.805; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P785, DOI 10.1016/S0003-9993(99)90228-9; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Friedland DP, 2013, J SPINE S, VS4, P5; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1471, DOI 10.1016/S0003-9993(99)90260-5; Kirshblum S, 2014, PHYS MED REH CLIN N, V25, P505, DOI 10.1016/j.pmr.2014.04.001; Kohler F, 2009, EUR J PHYS REHAB MED, V45, P479; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mallinson TR, 2008, ARCH PHYS MED REHAB, V89, P2066, DOI 10.1016/j.apmr.2008.05.014; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; Nott Melissa T, 2014, Top Spinal Cord Inj Rehabil, V20, P225, DOI 10.1310/sci2003-225; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Schuld C, 2016, J SPINAL CORD MED, V39, P504, DOI 10.1080/10790268.2016.1180831; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; SILVER JR, 1980, INJURY, V12, P219, DOI 10.1016/0020-1383(80)90011-X; Steudel W I, 1988, Acta Neurochir Suppl (Wien), V43, P85; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Young JS, 1982, SPINAL CORD INJURY S, P14; Zorowitz RD, 2009, EUR J PHYS REHAB MED, V45, P259	31	4	4	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.		2018	41	6					718	730		10.1080/10790268.2018.1465744			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA9FH	WOS:000450602200013	29714644	Green Published			2022-02-06	
J	Gauvreau, CA; Kairy, D; Mazer, B; Guindon, A; Le Dorze, G				Gauvreau, Christine Alary; Kairy, Dahlia; Mazer, Barbara; Guindon, Andreanne; Le Dorze, Guylaine			Rehabilitation strategies enhancing participation in shopping malls for persons living with a disability	DISABILITY AND REHABILITATION			English	Article						Rehabilitation; strategies; intervention; participation; shopping; disability	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION; NOMINAL GROUP; STROKE; BARRIERS; FACILITATORS; PERFORMANCE; POSTSTROKE; MODERATE; PEOPLE	Purpose: After rehabilitation, it is not clear the extent to which persons living with a disability return to their former activities in the community, such as going to shopping malls. Rehabilitation professionals are faced with the challenge to adequately prepare their clients to resume community participation. The purpose of this study was to identify rehabilitation strategies aimed at preparing clients to engage in activities in shopping malls. Method: Twenty-two participants including 16 rehabilitation clinicians and 6 persons living with a disability participated in four nominal group sessions. Participants were questioned on current or potential rehabilitation strategies carried out to enhance participation in shopping malls for persons living with a disability. Discussions were audio-recorded and qualitative content analysis was conducted. Results: Participants mentioned strategies that were either carried out by the clinician, or in collaboration with other parties. The latter type of strategies was either carried out with the collaboration of the client, the interdisciplinary team, the relatives, or community organizations. Conclusions: Rehabilitation clinicians have a role to play in preparing persons living with a disability to resume activities in a shopping mall. Additionally, therapeutic interventions in community settings may enhance the participation of rehabilitation clients in their everyday activities.	[Gauvreau, Christine Alary; Kairy, Dahlia; Mazer, Barbara; Guindon, Andreanne; Le Dorze, Guylaine] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Gauvreau, Christine Alary; Le Dorze, Guylaine] Univ Montreal, Sch Speech Language Pathol & Audiol, Montreal, PQ, Canada; [Gauvreau, Christine Alary; Mazer, Barbara] Jewish Rehabil Hosp, Ctr Integre Sante & Serv Sociaux CISSS Laval, Laval, PQ, Canada; [Kairy, Dahlia] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Mazer, Barbara] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada		Le Dorze, G (corresponding author), Univ Montreal, Fac Med, Ecole Orthophonie & Audiol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	guylaine.le.dorze@umontreal.ca	Le Dorze, Guylaine/A-1790-2014	Mazer, Barbara/0000-0003-0557-2457	Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal - Rehabilitation Living Lab - Fonds de recherche du Quebec - Sante [24499]	This work was supported by the Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal - Rehabilitation Living Lab, funded by the Fonds de recherche du Quebec - Sante [grant number 24499].	Allen Jane, 2004, Br J Community Nurs, V9, P110; Bhogal Sanjit K, 2003, Top Stroke Rehabil, V10, P107; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Dahan-Oliel N, 2016, DISABIL REHABIL, V38, P2102, DOI 10.3109/09638288.2015.1114033; Devos H, 2009, NEUROREHAB NEURAL RE, V23, P699, DOI 10.1177/1545968309334208; Doig E, 2011, DISABIL REHABIL, V33, P1203, DOI 10.3109/09638288.2010.525286; Fleming J, 2014, J HEAD TRAUMA REHAB, V29, P125, DOI 10.1097/HTR.0b013e318286545d; Fong KNK, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-19; Gardner P, 2014, DISABIL REHABIL, V36, P1249, DOI 10.3109/09638288.2013.837970; Gassaway J, 2011, J SPINAL CORD MED, V34, P176, DOI 10.1179/107902611X12971826988138; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hartman-Maeir A, 2007, NEUROREHABILITATION, V22, P295; Harvey N, 2012, INT J NURS PRACT, V18, P188, DOI 10.1111/j.1440-172X.2012.02017.x; Hollander JA, 2004, J CONTEMP ETHNOGR, V33, P602, DOI 10.1177/0891241604266988; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Iwarsson S, 2003, DISABIL REHABIL, V25, P57, DOI 10.1080/0963828021000007969; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kang YJ, 2008, CYBERPSYCHOL BEHAV, V11, P329, DOI 10.1089/cpb.2007.0116; Kehayia E, 2014, ALTER, V8, P151, DOI 10.1016/j.alter.2014.03.006; Le Dorze G, 2014, APHASIOLOGY, V28, P421, DOI 10.1080/02687038.2013.869305; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; LMG, 2008, SAGE ENCY QUALITATIV, P697, DOI DOI 10.4135/9781412963909.N349; Meyers AR, 2002, SOC SCI MED, V55, P1435, DOI 10.1016/S0277-9536(01)00269-6; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Office des personnes handicapees du Quebec, 2009, EQ EV RESP RIGHTS AR; Rand D, 2007, DISABIL REHABIL, V29, P1710, DOI 10.1080/09638280601107450; Rand D, 2009, AM J OCCUP THER, V63, P535, DOI 10.5014/ajot.63.5.535; Recio AC, 2013, AM J PHYS MED REHAB, V92, P1104, DOI 10.1097/PHM.0000000000000012; Richards H, 2000, FAM PRACT, V17, P71, DOI 10.1093/fampra/17.1.71; Robinson CA, 2011, PHYS THER, V91, P1865, DOI 10.2522/ptj.20100216; Roth EJ, 2007, TOP STROKE REHABIL, V14, P48, DOI 10.1310/tsr1401-48; Skempes D, 2015, ARCH PHYS MED REHAB, V96, P163, DOI 10.1016/j.apmr.2014.07.410; Swaine B, 2014, ALTER, V8, P217, DOI 10.1016/j.alter.2014.04.003; Tessier A., 2012, ETMIS, V8, P1; United Nations General Assembly, 2007, CONV RIGHTS PERS DIS; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; VANDEVEN AH, 1972, AM J PUBLIC HEALTH N, V62, P337, DOI 10.2105/AJPH.62.3.337; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wiles R, 2004, SOC SCI MED, V59, P1263, DOI 10.1016/j.socscimed.2003.12.022; Wolfenden B, 2009, INT J REHABIL RES, V32, P93, DOI 10.1097/MRR.0b013e328325a358; World Health Organization, 2007, INT CLASS FUNCT DIS	43	4	4	2	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	8					917	925		10.1080/09638288.2017.1280093			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FY5YB	WOS:000426913400007	28129706				2022-02-06	
J	Harris, LL; Chernoff, MC; Nichols, SL; Williams, PL; Garvie, PA; Yildirim, C; McCauley, SR; Woods, SP				Harris, Lynnette L.; Chernoff, Miriam C.; Nichols, Sharon L.; Williams, Paige L.; Garvie, Patricia A.; Yildirim, Cenk; McCauley, Stephen R.; Woods, Steven Paul		Memory & Executive Functioning Stu	Prospective memory in youth with perinatally-acquired HIV infection	CHILD NEUROPSYCHOLOGY			English	Article						prospective memory; perinatal HIV; children; adolescents; executive functioning	TRAUMATIC BRAIN-INJURY; SELF-REPORT MEASURES; ANTIRETROVIRAL THERAPY; MEDICATION ADHERENCE; YOUNG-ADULTS; NEUROCOGNITIVE DISORDERS; PEDIATRIC HIV; SUBSTANCE USE; VIRAL LOAD; CHILDREN	Youth with perinatal HIV infection (PHIV) are at increased risk for neurocognitive impairment (NCI). Prospective memory (PM) is a complex neurocognitive function that has been shown to be impaired in adults with HIV disease and independently associated with poorer daily living skills, including medication nonadherence. The current study sought to determine the presence and extent of PM deficits in youth with PHIV. Participants included 173 youth with PHIV and 85 youth perinatally HIV-exposed but uninfected (PHEU), mean age 14.1 years, 75% black, 18% Hispanic. Among youth with PHIV, 26% had a past AIDS-defining condition (Centers for Disease Control and Prevention [CDC], Class C), 74% did not (non-C). Adjusted generalized estimating equation models were used to compare groups (PHIV/C, PHIV/non-C, and PHEU) on the Naturalistic Event-Based Prospective Memory Test (NEPT) and the Prospective Memory Assessment for Children & Youth (PROMACY). Secondarily, subgroups defined by HIV serostatus and global NCI were compared (PHIV/NCI, PHIV/non-NCI, PHEU). PHIV/C had significantly lower NEPT scores than PHEU, with decreases of 40% in mean scores, but did not differ from PHIV/non-C. PHIV/NCI had 11-32% lower PROMACY scores and 33% lower NEPT scores compared to PHIV/non-NCI (all p < .05); significantly, lower scores for PHIV/NCI versus PHEU also were observed for PROMACY and NEPT indices. Findings suggest a subset of youth with PHIV (those with a prior AIDS-defining diagnosis) is vulnerable to PM deficits. The extent to which PM deficits interfere with development and maintenance of independent living and health-related behaviors during transition to adulthood requires further study.	[Harris, Lynnette L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Chernoff, Miriam C.; Williams, Paige L.; Yildirim, Cenk] Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA USA; [Nichols, Sharon L.; Woods, Steven Paul] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Williams, Paige L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Garvie, Patricia A.] Childrens Diagnost & Treatment Ctr, Res Dept, Ft Lauderdale, FL USA; [McCauley, Stephen R.] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Neurol, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Pediat, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Woods, Steven Paul] Univ Houston, Dept Psychol, 126 Heyne Bldg,Suite 204, Houston, TX 77004 USA		Woods, SP (corresponding author), Univ Houston, Dept Psychol, 126 Heyne Bldg,Suite 204, Houston, TX 77004 USA.	spwoods@uh.edu			Division of Intramural Research, National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 MH084794]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission; National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); Office of AIDS ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Heart Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); National Institute of Dental and Craniofacial ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism, through Harvard T.H. Chan School of Public Health [HD052102]; National Institute on Alcohol Abuse and Alcoholism, through Tulane University School of Medicine [HD052104]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH084794]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD052102, U01HD052104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH084794, R01MH073419] Funding Source: NIH RePORTER	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases: [Grant Number R01 MH084794]. The Pediatric HIV/AIDS Cohort Study (PHACS) was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development with co-funding from the National Institute on Drug Abuse, the National Institute of Allergy and Infectious Diseases, the Office of AIDS Research, the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute on Deafness and Other Communication Disorders, the National Heart Lung and Blood Institute, the National Institute of Dental and Craniofacial Research, and the National Institute on Alcohol Abuse and Alcoholism, through cooperative agreements with the Harvard T.H. Chan School of Public Health (HD052102) (PI: George Seage; Project Director: Julie Alperen) and the Tulane University School of Medicine (HD052104) (PI: Russell Van Dyke; Co-PIs: Kenneth Rich, Ellen Chadwick; Project Director: Patrick Davis). The PHACS PH201 substudy was supported by the National Institute of Mental Health (R01 MH084794) (PI: Sharon Nichols). Data analysis services were provided by the Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health (PI: Paige Williams, Ph.D.); data management services were provided by Frontier Science and Technology Research Foundation (PI: Suzanne Siminski); and regulatory services and logistical support were provided by Westat, Inc. (PI: Julie Davidson).	Alperen J, 2014, J ADOLESCENT HEALTH, V54, P341, DOI 10.1016/j.jadohealth.2013.09.003; Altgassen M, 2010, J NEURODEV DISORD, V2, P2, DOI 10.1007/s11689-009-9030-y; Altgassen M, 2009, BRAIN IMPAIR, V10, P52, DOI 10.1375/brim.10.1.52; BELMAN AL, 1990, BRAIN IN PEDIATRIC AIDS, P45; Bisiacchi PS, 2000, BRAIN COGNITION, V43, P49; Brouwers P, 1995, CHILD NEUROPSYCHOL, V1, P93, DOI 10.1080/09297049508402241; Carey CL, 2006, J CLIN EXP NEUROPSYC, V28, P536, DOI 10.1080/13803390590949494; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Delis DC., 2001, DELIS KAPLAN EXECUTI; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Doyle KL, 2015, NEUROPSYCHOLOGY, V29, P909, DOI 10.1037/neu0000180; Einstein, 2007, PROSPECTIVE MEMORY O; Elkington KS, 2009, J ADOLESCENT HEALTH, V45, P133, DOI 10.1016/j.jadohealth.2009.01.004; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Farley JJ, 2008, J DEV BEHAV PEDIATR, V29, P377, DOI 10.1097/DBP.0b013e3181856d22; Faytell MP, 2017, NEUROPSYCHOL REHABIL, V27, P1142, DOI 10.1080/09602011.2015.1122636; Faytell MP, 2018, NEUROPSYCHOL REHABIL, V28, P1038, DOI 10.1080/09602011.2016.1236733; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Garvie PA, 2017, PEDIATR INFECT DIS J, V36, P751, DOI [10.1097/INF.0000000000001573, 10.1097/inf.0000000000001573]; Garvie PA, 2014, PEDIATR INFECT DIS J, V33, pE232, DOI 10.1097/INF.0000000000000314; Gongvatana A, 2009, J NEUROVIROL, V15, P187, DOI 10.1080/13550280902769756; Gosling A, 2004, CLIN CHILD PSYCHOL P, V9, P25, DOI DOI 10.1177/1359104504039168; Hazra R, 2010, ANNU REV MED, V61, P169, DOI 10.1146/annurev.med.050108.151127; Hinkin CH, 2002, NEUROLOGY, V59, P1944, DOI 10.1212/01.WNL.0000038347.48137.67; Jeremy RJ, 2005, PEDIATRICS, V115, P380, DOI 10.1542/peds.2004-1108; Kacanek D, 2015, AIDS, V29, P1227, DOI 10.1097/QAD.0000000000000697; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P162, DOI 10.1076/chin.7.3.162.8744; Kliegel M, 2006, CHILD NEUROPSYCHOL, V12, P407, DOI 10.1080/09297040600696040; Koekkoek S, 2008, EUR J PAEDIATR NEURO, V12, P290, DOI 10.1016/j.ejpn.2007.09.002; Loft S, 2014, J CLIN EXP NEUROPSYC, V36, P761, DOI 10.1080/13803395.2014.942255; LYMAN WD, 1990, AIDS, V4, P917, DOI 10.1097/00002030-199009000-00014; Martin EM, 2007, J CLIN EXP NEUROPSYC, V29, P496, DOI 10.1080/13803390600800970; Martin SC, 2006, DEV NEUROPSYCHOL, V30, P633, DOI 10.1207/s15326942dn3002_1; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCauley SR, 2011, J CLIN EXP NEUROPSYC, V33, P639, DOI 10.1080/13803395.2010.547844; McCauley SR, 2010, CHILD NEUROPSYCHOL, V16, P293, DOI 10.1080/09297041003601470; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Morgan EE, 2012, J CLIN EXP NEUROPSYC, V34, P416, DOI 10.1080/13803395.2012.654764; Naar-King S, 2009, J PEDIATR PSYCHOL, V34, P187, DOI 10.1093/jpepsy/jsn065; Nichols SL, 2015, PEDIATR INFECT DIS J, V34, P969, DOI 10.1097/INF.0000000000000809; Osipoff J. N., 2012, INT J PEDIAT ENDOCRI, V29, P1; Pearlstein SL, 2014, J PEDIATR PSYCHOL, V39, P294, DOI 10.1093/jpepsy/jst077; PIZZO PA, 1990, J INFECT DIS, V161, P316, DOI 10.1093/infdis/161.2.316; Pontali Emanuele, 2005, Paediatr Drugs, V7, P137, DOI 10.2165/00148581-200507030-00001; Raskin S., 2010, MEMORY INTENTIONS TE; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Smith R, 2015, CHILD NEUROPSYCHOL, V21, P234, DOI 10.1080/09297049.2014.898744; Smith R, 2012, PEDIATR INFECT DIS J, V31, P592, DOI 10.1097/INF.0b013e318253844b; Tassiopoulos K, 2013, CLIN INFECT DIS, V56, P283, DOI 10.1093/cid/cis816; Usitalo A, 2014, AIDS CARE, V26, P107, DOI 10.1080/09540121.2013.802280; Ward H, 2005, CHILD NEUROPSYCHOL, V11, P527, DOI 10.1080/09297040490920186; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Wechsler D., 2003, MANUAL WECHSLER INTE; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Williams PL, 2006, PEDIATRICS, V118, pE1745, DOI 10.1542/peds.2006-0493; Wolters PL, 2005, NEUROLOGY AIDS; Wood SM, 2009, AIDS, V23, P1859, DOI 10.1097/QAD.0b013e32832d924f; Woods SP, 2008, ARCH CLIN NEUROPSYCH, V23, P257, DOI 10.1016/j.acn.2007.12.006; Woods SP, 2008, NEUROPSYCHOLOGY, V22, P110, DOI 10.1037/0894-4105.22.1.110; Woods SP, 2007, ARCH CLIN NEUROPSYCH, V22, P187, DOI 10.1016/j.acn.2006.12.006; Woods SP, 2014, J INT NEUROPSYCH SOC, V20, P652, DOI 10.1017/S1355617714000435; Woods SP, 2010, J CLIN EXP NEUROPSYC, V32, P398, DOI 10.1080/13803390903130737; Woods SP, 2009, J INT NEUROPSYCH SOC, V15, P42, DOI 10.1017/S1355617708090012; World Health Organ- ization, 2016, HIV AIDS FACT SHEET; Zogg JB, 2012, J BEHAV MED, V35, P47, DOI 10.1007/s10865-011-9341-9; Zogg JB, 2011, ARCH CLIN NEUROPSYCH, V26, P250, DOI 10.1093/arclin/acr020	68	4	4	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2018	24	7					938	958		10.1080/09297049.2017.1360854			21	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GO4IS	WOS:000439970300004	28782457	Green Accepted			2022-02-06	
J	Herren, K; Schmid, S; Rogan, S; Radlinger, L				Herren, Kaspar; Schmid, Stefan; Rogan, Slavko; Radlinger, Lorenz			Effects of Stochastic Resonance Whole-Body Vibration in Individuals with Unilateral Brain Lesion: A Single-Blind Randomized Controlled Trial: Whole-Body Vibration and Neuromuscular Function	REHABILITATION RESEARCH AND PRACTICE			English	Article							CHRONIC STROKE; MUSCLE STRENGTH; MOTOR FUNCTION; BALANCE DISABILITY; GAIT PERFORMANCE; POSTURAL CONTROL; ANKLE JOINT; INJURY; FATIGUE; RECOVERY	Introduction. Stochastic resonance whole-body vibration (SR-WBV) devices are promising sensorimotor interventions to address muscle weakness and to improve balance and mobility particularly in the elderly. However, it remains inconclusive whether individuals with stroke or traumatic brain injury (TBI) can profit from this method. The aim of this prospective single-blind randomized controlled trial was to investigate the effects of SR-WBV on muscle strength as well as gait and balance performance in this population. Methods. Forty-eight individuals with stroke or TBI were randomly allocated to an experimental and a sham group. Participants were exposed daily to 5 consecutives 1-minute SR-WBV sessions, whereas the experimental group trained in a standing position with 5 Hz and the sham group in a seated position with 1 Hz. Isometric muscle strength properties of the paretic knee extensor muscles as well as balance and gait performance were measured at baseline, after the first session and after two weeks of SR-WBV. Results. Both groups showed short- and long-term effects in gait performance. However, no between-group effects could be found at the three measurement points. Discussion. Complementary SR-WBV showed no beneficial effects immediately after the intervention and after two weeks of conventional rehabilitation therapy. Future research is needed to identify the potential efficacy of SR-WBV in individuals with stroke and TBI using shorter and less exhausting test procedures and a generally prolonged intervention time.	[Herren, Kaspar] Bern Univ Hosp, Dept Physiotherapy, Inseispital Bern, Bern, Switzerland; [Herren, Kaspar] Hosp Langenthal, SRO AG, Langenthal, Switzerland; [Schmid, Stefan; Rogan, Slavko; Radlinger, Lorenz] Bern Univ Appl Sci, Dept Hlth Profess, Bern, Switzerland; [Rogan, Slavko] Acad Physiotherapy & Training Educ, Grenzach Wyhlen, Germany		Rogan, S (corresponding author), Bern Univ Appl Sci, Dept Hlth Profess, Bern, Switzerland.	slavko.rogan@bfh.ch	Rogan, Slavko/M-9794-2017; Schmid, Stefan/E-8534-2010	Rogan, Slavko/0000-0003-0865-2575; Schmid, Stefan/0000-0001-5138-9800	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [13DPD6_127280]; team of physical therapists of the Department of Physiotherapy at the Bern University Hospital	This study was funded by the Swiss National Science Foundation (no. 13DPD6_127280) and supported by the team of physical therapists of the Department of Physiotherapy at the Bern University Hospital.	Abercromby AFJ, 2007, MED SCI SPORT EXER, V39, P1794, DOI 10.1249/mss.0b013e3181238a0f; Adamson Joy, 2004, J Stroke Cerebrovasc Dis, V13, P171, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.003; Arias P, 2009, MOVEMENT DISORD, V24, P891, DOI 10.1002/mds.22468; ASTROM M, 1992, STROKE, V23, P527, DOI 10.1161/01.STR.23.4.527; Batchelor FA, 2012, INT J STROKE, V7, P482, DOI 10.1111/j.1747-4949.2012.00796.x; BESSOU P, 1988, J PHYSIOL-PARIS, V83, P102; BOHANNON RW, 1988, INT J REHABIL RES, V11, P181, DOI 10.1097/00004356-198806000-00012; Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067; Brogardh C, 2012, PM&R, V4, P901, DOI 10.1016/j.pmrj.2012.09.1157; Brogardh C, 2012, ARCH PHYS MED REHAB, V93, P253, DOI 10.1016/j.apmr.2011.09.005; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burke JF, 2012, STROKE, V43, P2207, DOI 10.1161/STROKEAHA.112.656967; Cardinale M, 2003, MED SPORT, V56, P287; Cardinale M, 2010, BRIT J SPORT MED, V44, P284, DOI 10.1136/bjsm.2007.043232; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; Chan KS, 2012, CLIN REHABIL, V26, P1087, DOI 10.1177/0269215512446314; Choi Eon-Tak, 2016, J Phys Ther Sci, V28, P3149; Choi SJ, 2014, J PHYS THER SCI, V26, P1411, DOI 10.1589/jpts.26.1411; Cochrane DJ, 2010, EUR J APPL PHYSIOL, V108, P311, DOI 10.1007/s00421-009-1215-2; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; De Ruiter CJ, 2000, PFLUG ARCH EUR J PHY, V440, P163, DOI 10.1007/s004240000284; Di Carlo A, 2009, AGE AGEING, V38, P4, DOI 10.1093/ageing/afn282; Dickstein R, 1994, CLIN REHABIL, V8, P91, DOI [10.1177/026921559400800201., DOI 10.1177/026921559400800201]; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Dobkin BH, 2008, NEUROREHAB NEURAL RE, V22, P105, DOI 10.1177/1545968308315046; Dobkin BHK, 2014, J REHABIL RES DEV, V51, P39, DOI 10.1682/JRRD.2013.04.0080; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Eng Janice J, 2007, Expert Rev Neurother, V7, P1417, DOI 10.1586/14737175.7.10.1417; Evers SMAA, 2004, STROKE, V35, P1209, DOI 10.1161/01.STR.0000125860.48180.48; Flansbjer UB, 2005, CLIN REHABIL, V19, P514, DOI 10.1191/0269215505cr854oa; FREEMAN MAR, 1967, ACTA ANAT, V68, P321; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Goldstein LB, 1997, STROKE, V28, P307, DOI 10.1161/01.STR.28.2.307; Guo C, 2015, CNS NEUROL DISORD-DR, V14, P1110, DOI 10.2174/1871527315666151111124937; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Harris Jocelyn E, 2004, Physiother Can, V56, P171, DOI 10.2310/6640.2004.00017; Hermens H.J., 1999, EUROPEAN RECOMMENDAT, V8, P13, DOI 10.1016/S1050-6411(00)00027-4; Herren K, 2009, PHYSOSCIENCE, V5, P13, DOI 10.1055/s-0028-1109140; Herren K., 2011, PHYSIOTHERAPY, P97; Huang MZ, 2018, J BIOMECH, V73, P80, DOI 10.1016/j.jbiomech.2018.03.022; Hwang KJ, 2016, J PHYS THER SCI, V28, P473, DOI 10.1589/jpts.28.473; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; Jansa J, 2004, NEUROREHAB NEURAL RE, V18, P37, DOI 10.1177/0888439003262287; Kempen GIJM, 2008, AGE AGEING, V37, P45, DOI 10.1093/ageing/afm157; Kessler J, 2014, ARCH GERONTOL GERIAT, V59, P305, DOI 10.1016/j.archger.2014.06.005; Kim CM, 2003, PHYS THER, V83, P49, DOI 10.1093/ptj/83.1.49; Kong SW, 2015, J PHYS THER SCI, V27, P2171, DOI 10.1589/jpts.27.2171; Lau RWK, 2012, MED SCI SPORT EXER, V44, P1409, DOI 10.1249/MSS.0b013e31824e4f8c; Lee G, 2015, J PHYS THER SCI, V27, P1133, DOI 10.1589/jpts.27.1133; Liao LR, 2016, MED SCI SPORT EXER, V48, P1227, DOI 10.1249/MSS.0000000000000909; Liao LR, 2015, PHYS THER, V95, P966, DOI 10.2522/ptj.20140295; Liao LR, 2014, PHYS THER REHABIL J, V94, P1232, DOI 10.2522/ptj.20130366; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Lu J, 2015, TOP STROKE REHABIL, V22, P161, DOI 10.1179/1074935714Z.0000000005; Madou KH, 2008, HONG KONG PHYSIOTHER, V26, P24, DOI 10.1016/S1013-7025(09)70005-3; Marin PJ, 2013, AM J PHYS MED REHAB, V92, P881, DOI 10.1097/PHM.0b013e318292336c; Marin PJ, 2009, J STRENGTH COND RES, V23, P2311, DOI 10.1519/JSC.0b013e3181b8d637; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Mebes C, 2008, ARTHRIT RHEUM-ARTHR, V59, P1665, DOI 10.1002/art.24196; Merkert J, 2011, Z GERONTOL GERIATR, V44, P256, DOI 10.1007/s00391-011-0170-9; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Nadeau S, 1999, AM J PHYS MED REHAB, V78, P123, DOI 10.1097/00002060-199903000-00007; Newman M, 1972, STROKE, V3, P702, DOI 10.1161/01.STR.3.6.702; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Pang MYC, 2013, EUR J PHYS REHAB MED, V49, P439; Patterson SL, 2007, ARCH PHYS MED REHAB, V88, P115, DOI 10.1016/j.apmr.2006.10.025; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Petit PD, 2010, J ELECTROMYOGR KINES, V20, P1186, DOI 10.1016/j.jelekin.2010.08.002; Prisby RD, 2008, AGEING RES REV, V7, P319, DOI 10.1016/j.arr.2008.07.004; Prosiegel M., 1996, NEUROL REHABIL, V2, P7; Roelants M, 2006, J STRENGTH COND RES, V20, P124, DOI 10.1519/R-16674.1; Rogan S, 2016, J GERONTOL GERIATR R, V5, P1; Rogan S., 2013, INT J KINESIOL SPORT, V1, P1; Rogan S., 2015, EUROPEAN REV AGING P, V12; Rogan S, 2017, ARCH GERONTOL GERIAT, V73, P95, DOI 10.1016/j.archger.2017.07.022; Rogan S, 2016, EUR REV AGING PHYS A, V13, DOI 10.1186/s11556-016-0164-0; Rogan S, 2014, AGING CLIN EXP RES, V26, P519, DOI 10.1007/s40520-014-0212-4; Rogan S, 2014, RES SPORTS MED, V22, P294, DOI 10.1080/15438627.2014.919504; Schillinger A, 2015, TIDSSKR NORSKE LAEGE, V135, P331, DOI 10.4045/tidsskr.14.0271; Sievanen H, 2014, AGING CLIN EXP RES, V26, P511, DOI 10.1007/s40520-014-0206-2; Silva AT, 2014, AM J PHYS MED REHAB, V93, P310, DOI 10.1097/PHM.0000000000000042; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Tankisheva E, 2014, ARCH PHYS MED REHAB, V95, P439, DOI 10.1016/j.apmr.2013.09.009; Tihanyi J, 2010, ACTA PHYSIOL HUNG, V97, P172, DOI 10.1556/APhysiol.97.2010.2.3; Tihanyi TK, 2007, CLIN REHABIL, V21, P782, DOI 10.1177/0269215507077814; Torvinen S, 2002, INT J SPORTS MED, V23, P374, DOI 10.1055/s-2002-33148; Tyson SF, 2006, PHYS THER, V86, P30, DOI 10.1093/ptj/86.1.30; van Nes IJW, 2004, AM J PHYS MED REHAB, V83, P867, DOI 10.1097/01.PHM.0000140801.23135.09; van Nes IJW, 2006, STROKE, V37, P2331, DOI 10.1161/01.STR.0000236494.62957.f3; WADE DT, 1985, J NEUROL NEUROSUR PS, V48, P7, DOI 10.1136/jnnp.48.1.7; Williams G, 2016, J PHYSIOTHER, V62, P164, DOI 10.1016/j.jphys.2016.04.003; Williams GP, 2013, J HEAD TRAUMA REHAB, V28, P371, DOI 10.1097/HTR.0b013e31824a1d40; Yang XT, 2015, CLIN REHABIL, V29, P627, DOI 10.1177/0269215514552829	94	4	4	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2867	2090-2875		REHABIL RES PRACT	Rehabil. Res. Pract.		2018	2018								9319258	10.1155/2018/9319258			11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	GQ3TI	WOS:000441589300001	30155308	Green Published, gold, Green Submitted			2022-02-06	
J	Hildenbrand, K; Richards, KAR; Wright, PM				Hildenbrand, Kasee; Richards, K. Andrew R.; Wright, Paul M.			Physical Education Teachers' Awareness and Understanding of Concussions, and Concussion Policies and Protocols	RESEARCH QUARTERLY FOR EXERCISE AND SPORT			English	Article						Return to learn; return to play; school health; teacher knowledge	KNOWLEDGE; COACHES; SPORT	Purpose: Our primary aim was to determine physical educators' current level of understanding of concussion symptoms and response guidelines. Method: Participants included 404 in-service physical educators (137 male, 266 female, 1 other) recruited through 3 SHAPE America - Society of Health and Physical Educators communication outlets. Participants were asked to complete an online survey. The survey included 8 questions related to previous concussion training, 6 items to measure awareness of concussion policies, 20 items related to concussion symptoms, and 14 items for concussion knowledge. Analyses included descriptive statistics and 2x2 (Coaching x Concussion) factorial analyses of variance to examine differences in study variables by coaching status and participants' personal concussion experiences. Results: Participants reported they did not have any formal role or responsibility related to concussion management, and more than half reported their districts did not require concussion training. Nevertheless, many physical educators were receiving training (n=291, 72%). Participants who also coached were more aware of concussion policies and systems than were their counterparts, but there were no differences related to concussion facts. Conclusion: School districts are generally not requiring concussion management training for physical education teachers or giving them specific responsibilities in the management process, yet many physical educators are getting trained. This training often occurs online and may be required for secondary responsibilities such as coaching. Participants reported being aware of concussion policies and procedures but were less likely to agree that this awareness has resulted in changes in how they teach physical education. Participants also knew more about concussion facts than about the legitimacy of symptoms.	[Hildenbrand, Kasee] Washington State Univ, Pullman, WA 99164 USA; [Richards, K. Andrew R.] Univ Alabama, Tuscaloosa, AL 35487 USA; [Wright, Paul M.] Northern Illinois Univ, De Kalb, IL 60115 USA		Hildenbrand, K (corresponding author), Washington State Univ, Athlet Training Program, Smith Gym 211C, Pullman, WA 99164 USA.	khildenbrand@wsu.edu	Richards, Kevin/Q-9165-2019	Richards, Kevin/0000-0003-3045-6001			Corbin J., 2015, BASICS QUALITATIVE R; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Onate JA., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; Potteiger AJ, 2016, STRATEGIES, V29, P48; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Roetert E. P., 2014, PRINCIPAL LEADERSHIP, V14, P18; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Schmies H, 2014, J PHYS EDUC RECREAT, V85, P5, DOI 10.1080/07303084.2014.946845; Schutz R. W., 2004, DEV SPORT EXERCISE P, P73; Tabachnick B.G., 2013, USING MULTIVARIATE S; Warner R. M, 2012, APPL STAT BIVARIATE	17	4	4	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0270-1367	2168-3824		RES Q EXERCISE SPORT	Res. Q. Exerc. Sport		2018	89	3					361	366		10.1080/02701367.2018.1472735			6	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	GR5EN	WOS:000442649800011	29889625				2022-02-06	
J	Howell, DR; Meehan, WP; Foss, KDB; Reches, A; Weiss, M; Myer, GD				Howell, David R.; Meehan, William P., III; Foss, Kim D. Barber; Reches, Amit; Weiss, Michal; Myer, Gregory D.			Reduced dual-task gait speed is associated with visual Go/No-Go brain network activation in children and adolescents with concussion	BRAIN INJURY			English	Article						Locomotion; mild traumatic brain injury; electroencephalography; attention	BALANCE CONTROL; EXECUTIVE DYSFUNCTION; RESPONSE-INHIBITION; SINGLE-TASK; ATTENTION; INJURY; YOUNG; PERFORMANCE; STABILITY; RECOVERY	Objective: To investigate the association between dual-task gait performance and brain network activation (BNA) using an electroencephalography (EEG)-based Go/No-Go paradigm among children and adolescents with concussion. Methods: Participants with a concussion completed a visual Go/No-Go task with collection of electroencephalogram brain activity. Data were treated with BNA analysis, which involves an algorithmic approach to EEG-ERP activation quantification. Participants also completed a dual-task gait assessment. The relationship between dual-task gait speed and BNA was assessed using multiple linear regression models. Results: Participants (n=20, 13.9 +/- 2.3years of age, 50% female) were tested at a mean of 7.0 +/- 2.5days post-concussion and were symptomatic at the time of testing (post-concussion symptom scale=40.4 +/- 21.9). Slower dual-task average gait speed (mean=82.2 +/- 21.0cm/s) was significantly associated with lower relative time BNA scores (mean=39.6 +/- 25.8) during the No-Go task (=0.599, 95% CI=0.214, 0.985, p=0.005, R-2=0.405), while controlling for the effect of age and gender. Conclusion: Among children and adolescents with a concussion, slower dual-task gait speed was independently associated with lower BNA relative time scores during a visual Go/No-Go task. The relationship between abnormal gait behaviour and brain activation deficits may be reflective of disruption to multiple functional abilities after concussion.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, 13123 E 16th Ave,B060, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Howell, David R.; Meehan, William P., III; Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg & Pediat, Boston, MA USA; [Foss, Kim D. Barber; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, SPORT Ctr, Cincinnati, OH 45229 USA; [Reches, Amit; Weiss, Michal] ElMindA Ltd, Herzliyya, Israel; [Myer, Gregory D.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Univ Penn, Dept Orthopaed, Philadelphia, PA 19104 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu	Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422			[Anonymous], 1995, GAIT POSTURE; Barry RJ, 2016, CLIN NEUROPHYSIOL, V127, P2273, DOI 10.1016/j.clinph.2016.02.010; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Corp DT, 2016, EXP BRAIN RES, V234, P443, DOI 10.1007/s00221-015-4479-2; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Eckner JT, 2016, BRAIN INJURY, V30, P1075, DOI 10.3109/02699052.2016.1160152; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Holste KG, 2016, MOTOR CONTROL, V20, P380, DOI 10.1123/mc.2014-0047; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Kiefer AW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00243; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Reches A., 2013, FUNCT NEUROL REHABIL, V3, P295; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; van Dinteren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087347; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	42	4	4	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	9					1129	1134		10.1080/02699052.2018.1482424			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GL0ZJ	WOS:000436823600010	29851513				2022-02-06	
J	Hunter, LE; Ifrah, C; Zimmerman, ME; Kim, M; Lipton, RB; Stewart, WF; Lipton, ML				Hunter, Liane E.; Ifrah, Chloe; Zimmerman, Molly E.; Kim, Mimi; Lipton, Richard B.; Stewart, Walter F.; Lipton, Michael L.			Heading and unintentional head impacts have opposing associations with Patient Reported Outcomes in amateur soccer players	RESEARCH IN SPORTS MEDICINE			English	Article						soccer; traumatic brain injuries; Patient Reported Outcomes	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TESTS; SLEEP DISTURBANCE; CONCUSSIONS; SYMPTOMS; EXPOSURE; ACCELERATION; CALIBRATION; TBI	The effects of soccer-related head impacts, beyond overt concussions, on Patient Reported Outcomes (PROs) have not been explored to date. Generalized estimating equations were employed to determine the association between soccer-related head impacts (headers in the prior 2weeks, unintentional head impacts in the prior 2weeks, headers in the prior 12months and lifetime concussions) on PROs including depression, anxiety, sleep disturbance and sleep impairment. Compared to players with no unintentional head impacts in the prior 2weeks, players with one unintentional exposure reported more symptoms of anxiety (p=0.002) and players with 2+exposures reported more symptoms of depression (p=0.006) and anxiety (p<0.001). In contrast, players in the 3rd Quartile of 12 mo. headers reported less anxiety (p=0.001), sleep disturbance (p=0.002) and sleep impairment (p<0.001) compared to those in the 1st quartile. Unintentional head impacts are associated with worse PROs while more headers are paradoxically associated with better PROs.	[Hunter, Liane E.; Ifrah, Chloe; Lipton, Michael L.] Albert Einstein Coll Med, Gruss Magnet Resonance Imaging Ctr, Bronx, NY 10467 USA; [Hunter, Liane E.; Ifrah, Chloe; Kim, Mimi; Lipton, Richard B.; Lipton, Michael L.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Zimmerman, Molly E.] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA; [Kim, Mimi; Lipton, Richard B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Lipton, Richard B.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Stewart, Walter F.] Sutter Hlth Res Ctr, Walnut Creek, CA USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA		Hunter, LE (corresponding author), Albert Einstein Coll Med, Gruss Magnet Resonance Imaging Ctr, Bronx, NY 10467 USA.; Hunter, LE (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.	michael.lipton@einstein.yu.edu	Lipton, Richard B/B-5060-2011; Lipton, Richard Bruce/AAY-2818-2021		National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5F31NS098799-02, R01NS082432]; Dana Foundation David Mahoney Neuroimaging Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS098799, R01NS082432] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke [5F31NS098799-02,R01NS082432]; The Dana Foundation David Mahoney Neuroimaging Program.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hardin J.W., 2005, GEN ESTIMATING EQUAT; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Hiles SA, 2017, PSYCHOL MED, V47, P1466, DOI 10.1017/S0033291716003548; Hinami K, 2015, J HOSP MED, V10, P294, DOI 10.1002/jhm.2366; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lingsma H, 2017, NEUROLOGY, V88, P822, DOI 10.1212/WNL.0000000000003679; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mollayeva T, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0657-2; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Sbordone RJ, 2014, APPL NEUROPSYCH-ADUL, V21, P98, DOI 10.1080/09084282.2012.762630; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P25, DOI 10.1007/s12207-010-9068-x; Snyder CF, 2013, MED CARE, V51, pS73, DOI 10.1097/MLR.0b013e31829b1d84; Stewart W. F., FRONTIERS NEUROLOGY; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	33	4	4	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2018	26	4					390	400		10.1080/15438627.2018.1492396			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GS7VH	WOS:000443911800001	30003822	Green Accepted			2022-02-06	
J	De la Blanca, MAIP; Mondejar, EF; Jimenez, FJG; Morales, JMA; Lombardo, MDQ; Rodriguez, JLV				Ibaez Perez De la Blanca, Ma. Angustias; Fernandez Mondejar, Enrique; Gomez Jimenez, Francisco Javier; Alonso Morales, Jose Maria; Quijano Lombardo, Ma. Dolores; Viso Rodriguez, Juan Luis			Risk factors for intracranial lesions and mortality in older patients with mild traumatic brain injuries	BRAIN INJURY			English	Article						Score- Traumatic brain injury; over 60 years; neuroprotectors	MINOR HEAD-INJURY; SEROTONIN REUPTAKE INHIBITORS; COMPUTED-TOMOGRAPHY; SCANDINAVIAN GUIDELINES; EMERGENCY-DEPARTMENT; INITIAL MANAGEMENT; ADULTS; AGE; METAANALYSIS; VALIDATION	Primary Objective: To identify risk factors for intracerebral lesion (ICL) in older adults with mild traumatic brain injury (MTBI) and evaluate the influence of comorbidities on outcomes. Research Design: Prospective cohort study. Methods and Procedures: Information was gathered on clinical history/examination, cranial computed tomography, admission Glasgow Coma Scale (GCS) score, analytical and coagulation findings, and mortality at 1 week post-discharge. Bivariate and multivariate logistic regression analyses were performed, calculating odds ratios for ICL with 95% confidence interval. P < 0.05 was considered significant. Main Outcomes and Results: Data were analyzed on 504 patients with mean +/- SD age of 79.37 +/- 8.06 years. Multivariate analysis showed that traffic accident, GCS score of 14/15, transient consciousness loss, nausea, and receipt of antiplatelets were predictors of ICL, while SRRI and/or benzodiazepine intake was a protective factor. A score was assigned to patients by rounding OR values, and a score >= 1 indicated moderate/high risk of ICL. Conclusions: MTBI management should be distinct in over-60 year-olds, who may not present typical symptoms, with frequent comorbidities. Knowledge of risk factors for post-MTBI ICL, associated with higher mortality, is important to support clinical decision-making. Further research is warranted to verify our novel finding that benzodiazepines and/or SSRI inhibitors may act as neuroprotectors.	[Ibaez Perez De la Blanca, Ma. Angustias; Alonso Morales, Jose Maria; Quijano Lombardo, Ma. Dolores; Viso Rodriguez, Juan Luis] Complejo Hosp Univ Granada, Emergency Unit, Granada, Spain; [Fernandez Mondejar, Enrique] Complejo Hosp Univ Granada, Crit Care Unit, Granada, Spain; [Gomez Jimenez, Francisco Javier] Univ Granada, Dept Internal Med, Granada, Spain		De la Blanca, MAIP (corresponding author), Avd Juan Pablo II, Granada 18014, Spain.	iangustias@yahoo.es					Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Chattopadhayay A., 2007, SEROTONIN RECEPTOR N; Cowman J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12235; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Depreitere B, 2012, Acta Neurochir Suppl, V114, P289, DOI 10.1007/978-3-7091-0956-4_56; Duaso E, 2009, EMERGENCIAS, V21, P362; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Fabbri A, 2010, J NEUROL NEUROSUR PS, V81, P1275, DOI 10.1136/jnnp.2009.197467; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Hackam DG, 2012, NEUROLOGY, V79, P1862, DOI 10.1212/WNL.0b013e318271f848; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Leiblich A, 2005, J NEURORADIOLOGY, V26, P603; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nagurney JT, 1998, ACAD EMERG MED, V5, P678, DOI 10.1111/j.1553-2712.1998.tb02485.x; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; RAKIER A, 1995, BRAIN INJURY, V9, P187, DOI 10.3109/02699059509008191; Rochelle D, 1998, J CEREBRAL BLOOD FLO, V18, P548; ROMSTEDT K, 1985, THROMB RES, V38, P361, DOI 10.1016/0049-3848(85)90135-5; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROY CW, 1986, INJURY, V17, P220, DOI 10.1016/0020-1383(86)90222-6; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Serebruany VL, 2006, AM J MED, V119, P113, DOI 10.1016/j.amjmed.2005.03.044; Shin JY, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3517; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Timiras P., 2003, PHYSL BASIS AGING GE, P99, DOI DOI 10.1161/01.ATV.0000173418.42264.19; Timmons T, 2010, CLIN GERIATR MED, V04, P20; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633	44	4	4	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	1					99	104		10.1080/02699052.2017.1382716			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7VS	WOS:000427072300011	29156999				2022-02-06	
J	Kelmendi, FM; Morina, AA; Mekaj, AY; Blyta, A; Alimehmeti, R; Dragusha, S; Ahmeti, F; Morina, Q; Kotori, A				Kelmendi, Fatos M.; Morina, Arsim A.; Mekaj, Agon Y.; Blyta, Afrim; Alimehmeti, Ridvan; Dragusha, Shefki; Ahmeti, Feti; Morina, Qamile; Kotori, Afrim			Serum S100B Levels Can Predict Computed Tomography Findings in Paediatric Patients with Mild Head Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; PROTEIN; MANAGEMENT; RADIATION; BIOMARKERS; CHILDHOOD; CHILDREN; SCANS; RISK	Introduction. Traumatic brain injuries (TBIs) are very common in paediatric populations, in which they are also a leading cause of death. Computed tomography (CT) overuse in these populations results in ionization radiation exposure, which can lead to lethal malignancies. The aims of this study were to investigate the accuracy of serum S100B levels with respect to the detection of cranial injury in children with mild TBI and to determine whether decisions regarding the performance of CT can be made based on biomarker levels alone. Materials and Methods. This was a single-center prospective cohort study that was carried out from December 2016 to December 2017. A total of 80 children with mild TBI who met the inclusion criteria were included in the study. The patients were between 2 and 16 years of age. We determined S100B protein levels and performed head CTs in all the patients. Results. Patients with cranial injury, as detected by CT, had higher S100B protein levels than those without cranial injury (P < 0.0001). We found that patients with cranial injury (head CT+) had higher mean S100B protein levels (0.527 mu gL(-1), 95% confidence interval (CI) 0.447-0.607 mu gL(-1)) than did patients without cranial injury (head CT-) (0.145 mu gL(-1), 95% CI 0.138-0.152 mu gL(-1)). Receiver operating characteristic (ROC) curve analysis clearly showed that S100B protein levels differed between patients with and without cranial injury at 3 hours after TBI (AUC = 0.893, 95% CI 0.786-0.987, P = 0.0001). Conclusion. Serum S100B levels cannot replace clinical examinations or CT as tools for identifying paediatric patients with mild head injury; however, serum S100B levels can be used to identify low-risk patients to prevent such patients from being exposed to radiation unnecessarily.	[Kelmendi, Fatos M.; Morina, Arsim A.; Mekaj, Agon Y.; Dragusha, Shefki; Ahmeti, Feti] Univ Clin Ctr Kosovo, Clin Neurosurg, Pristina 10000, Kosovo; [Blyta, Afrim] Univ Clin Ctr Kosovo, Clin Neurol, Pristina 10000, Kosovo; [Alimehmeti, Ridvan] Univ Hosp Ctr Mother Theresa, Serv Neurosurg, 370 Dibra St, Tirana, Albania; [Morina, Qamile] Univ Clin Ctr Kosovo, Clin Anesthesiol, Pristina 10000, Kosovo; [Kotori, Afrim] Univ Clin Ctr Kosovo, Clin Med Biochem, Pristina 10000, Kosovo		Mekaj, AY (corresponding author), Univ Clin Ctr Kosovo, Clin Neurosurg, Pristina 10000, Kosovo.	agon.mekaj@uni-pr.edu		mekaj, agon/0000-0003-1094-5182			Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Astrand R, 2011, CLIN CHIM ACTA, V412, P2190, DOI 10.1016/j.cca.2011.08.009; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Da Dalt L, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-017-0442-0; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Farrell CA, 2013, PAED CHILD HEALT-CAN, V18, P253, DOI 10.1093/pch/18.5.253; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kuppermann N, 2014, LANCET, V383, P308; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Osmond M. H., 2006, ACAD EMERG MED, V13, pS11, DOI DOI 10.1197/j.aem.2006.03.008; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Raabe A, 2005, ANESTHESIOLOGY, V102, P713, DOI 10.1097/00000542-200504000-00003; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Singh J, 2015, J PHARMACOL PHARMACO, V6, P185, DOI 10.4103/0976-500X.162004; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Woertgen C, 2002, BRAIN INJURY, V16, P807, DOI 10.1080/02699050210128933; World Medical Association[WMA], 2013, WMA DECL HELS ETH PR	33	4	5	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2018	2018								6954045	10.1155/2018/6954045			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	GD6EY	WOS:000430603100001	29850551	Green Published, Green Submitted, gold			2022-02-06	
J	Kim, HH; Choi, SC; Chae, MK; Min, YG				Kim, Hyuk-Hoon; Choi, Sang Chun; Chae, Minjung Kathy; Min, Young-Gi			Neuroprotective effect of ethanol in acute carbon monoxide intoxication A retrospective study	MEDICINE			English	Article						brain injury; carbon monoxide; ethanol; magnetic resonance imaging; retrospective studies	TRAUMATIC BRAIN-INJURY; DELAYED NEUROLOGICAL SEQUELAE; DAMAGE	In acute carbon monoxide (CO) intoxication, treatment of neurologic injury and prevention of neurological sequelae are primary concerns. Ethanol is the one of the frequent substances which is co-ingested in intentional CO poisoning. Neuroprotective effect of ethanol was highlighted and demonstrated in isolated brain injury recently. We assessed the neuroprotective effect of ethanol in acute CO intoxication using magnetic resonance imaging (MRI). We retrospectively reviewed medical records for patients who visited an emergency medical center of a university-affiliated hospital during a period of 73 months, from March 2009 to April 2015. Enrolled patients were divided into 2 groups, patients with or without abnormal brain lesion in brain MRI. Multivariate logistic regression analysis was performed to assess the factors associated with brain injury in MRI. A total of 109 patients with acute CO intoxication were evaluated of which 66 (60.55%) tested positive in brain MRI. MRI lesion-positive patients were more likely to have electrocardiogram change, elevation of serum troponin I and s100 protein level and lower serum ethanol level. Serum ethanol positivity was an independent factor for prevalence of brain injury in MRI in acute CO poisoning. This study revealed that ethanol which is co-ingested in acute CO intoxication may work the neuroprotective effect and could consequence more favorable neurological outcome in acute CO intoxication.	[Kim, Hyuk-Hoon; Choi, Sang Chun; Chae, Minjung Kathy; Min, Young-Gi] Ajou Univ, Dept Emergency Med, Sch Med, Suwon, South Korea		Min, YG (corresponding author), Ajou Univ, Dept Emergency Med, Sch Med, Suwon, South Korea.	youngmd@me.com					Beppu T, 2014, AM J NEURORADIOL, V35, P625, DOI 10.3174/ajnr.A3489; Bjork JM, 2014, NEUROPHARMACOLOGY, V84, P101, DOI 10.1016/j.neuropharm.2013.07.039; Budygin EA, 2001, J PHARMACOL EXP THER, V297, P27; Collins MA, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00008; Crews FT, 1998, PHARMACOL BIOCHEM BE, V59, P981, DOI 10.1016/S0091-3057(97)00538-8; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Hampson NB, 2005, UNDERSEA HYPERBAR M, V32, P21; Hampson NB, 2013, J EMERG MED, V44, P625, DOI 10.1016/j.jemermed.2012.08.033; Hu MH, 2012, J CLIN TOXICOL, V2, P124; Kao LW, 2004, EMERG MED CLIN N AM, V22, P985, DOI 10.1016/j.emc.2004.05.003; Kwon OY, 2004, EMERG MED J, V21, P250, DOI 10.1136/emj.2002.002014; Lo CP, 2007, AM J ROENTGENOL, V189, pW205, DOI 10.2214/AJR.07.2425; MACLENNAN AJ, 1995, NEUROSCI LETT, V197, P105; MONTOLIU C, 1994, J NEUROCHEM, V63, P1855; O'Donnell P, 2000, CLIN RADIOL, V55, P273, DOI 10.1053/crad.1999.0369; Oh S, 2015, NEURAL REGEN RES, V10, P36, DOI 10.4103/1673-5374.150644; Park E, 2012, CLIN TOXICOL, V50, P183, DOI 10.3109/15563650.2012.658918; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Schilaty ND, 2014, J PHARMACOL EXP THER, V349, P559, DOI 10.1124/jpet.113.211490; Sener RN, 2003, AM J NEURORADIOL, V24, P1475; THORN SR, 1995, ANN EMERG MED, V25, P474, DOI 10.1016/S0196-0644(95)70261-X; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Weaver LK, 1999, CRIT CARE CLIN, V15, P297, DOI 10.1016/S0749-0704(05)70056-7	24	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN	2018	97	1							e9569	10.1097/MD.0000000000009569			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8CQ	WOS:000424080300036	29505539	Green Published, gold			2022-02-06	
J	Kinnunen, L; Niemela, M; Hakko, H; Miettunen, J; Merikukka, M; Karttunen, V; Ristikari, T; Gissler, M; Rasanen, S				Kinnunen, Lotta; Niemela, Mika; Hakko, Helina; Miettunen, Jouko; Merikukka, Marko; Karttunen, Vesa; Ristikari, Tiina; Gissler, Mika; Rasanen, Sami			Psychiatric diagnoses of children affected by their parents' traumatic brain injury: the 1987 Finnish Birth Cohort study	BRAIN INJURY			English	Article						Children; psychiatric diagnoses; mental health; parental TBI; offspring; traumatic brain injury	ADVERSE CHILDHOOD EXPERIENCES; CLOSED-HEAD-INJURY; QUALITATIVE-ANALYSIS; MARITAL ADJUSTMENT; MENTAL-DISORDERS; FOLLOW-UP; DEPRESSION; TBI; RISK; DEATH	Objective: To investigate whether parental TBI increases the overall risk for psychiatric disorders and the risk for specific psychiatric diagnoses in the children affected by parental TBI.Methods: The 1987 Finnish Birth Cohort (n=59 476) were followed up through national registers from birth to the end of 2008. The diagnoses of cohort members and their parents were obtained from the Care Register of Health Care, provided by the National Institute of Health and Welfare.Results: During the 21-year follow-up, the likelihood for psychiatric diagnoses being assessed in psychiatric care was significantly increased in males with any mental disorder (odds ratio (OR)=1.43), substance-use-related disorders (OR=1.71) and behavioural and emotional disorders (OR=1.75), and in females with disorders of psychological development (OR=1.85).Conclusions: Children affected by parental TBI are at increased risk for psychiatric disorders: males for externalizing disorders and females for developmental disorders. Observed gender interactions in the association between parental TBI and the psychiatric disorders of children warrant further study.	[Kinnunen, Lotta; Miettunen, Jouko] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Kinnunen, Lotta; Miettunen, Jouko] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Kinnunen, Lotta; Miettunen, Jouko] Univ Oulu, Oulu, Finland; [Niemela, Mika; Merikukka, Marko; Ristikari, Tiina] Natl Inst Hlth & Welf, Dept Welf, Oulu, Finland; [Hakko, Helina; Rasanen, Sami] Oulu Univ Hosp, Dept Psychiat, Oulu, Finland; [Karttunen, Vesa] Oulu Univ Hosp, Dept Neurol, Oulu, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Informat Serv Dept, Helsinki, Finland; [Gissler, Mika] Univ Turku, Res Ctr Child Psychiat, Turku, Finland; [Gissler, Mika] Karolinska Inst, Div Family Med, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden		Kinnunen, L (corresponding author), Univ Oulu, Ctr Life Course Hlth Res, Licentiate Med, POB 5000, Oulu 90014, Finland.	lotta.kinnunen@student.oulu.fi	Miettunen, Jouko/AAC-4334-2019	Miettunen, Jouko/0000-0003-0575-2669; Gissler, Mika/0000-0001-8254-7525; Kinnunen, Lotta/0000-0001-5428-6938	National Institute for Health and Welfare, Finland; Juho Vainio Foundation [201610329]; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science [00160427]; Academy of FinlandAcademy of FinlandEuropean Commission [268336, 288960]; Academy of FinlandAcademy of FinlandEuropean Commission; Alma and K. A. Snellman Foundation, Oulu, Finland	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. "This work was supported by National Institute for Health and Welfare, Finland; Juho Vainio Foundation [201610329]; Finnish Cultural Foundation [00160427]; The Academy of Finland [268336, 288960]; The Academy of Finland funded PSYCOHORTS consortium; The Alma and K. A. Snellman Foundation, Oulu, Finland.	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Appel CW, 2013, EPIDEMIOLOGY, V24, P608, DOI 10.1097/EDE.0b013e3182915df8; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Barnes J, 2003, NEW OXFORD TXB PSYCH, V2, P1848; Berg L, 2016, J CHILD PSYCHOL PSYC, V57, P1092, DOI 10.1111/jcpp.12560; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Boyd A, 2015, J AFFECT DISORDERS, V173, P245, DOI 10.1016/j.jad.2014.11.002; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brent D, 2009, AM J PSYCHIAT, V166, P786, DOI 10.1176/appi.ajp.2009.08081244; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Franulic A, 2000, BRAIN INJURY, V14, P431; Giallo R, 2014, RES DEV DISABIL, V35, P814, DOI 10.1016/j.ridd.2014.01.017; Gissler M, 2004, NORSK EPIDEMIOLOGI, V14, P113; Gladstone BM, 2011, EARLY INTERV PSYCHIA, V5, P271, DOI 10.1111/j.1751-7893.2011.00287.x; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Guldin MB, 2015, JAMA PSYCHIAT, V72, P1227, DOI 10.1001/jamapsychiatry.2015.2094; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hammond FM, 2012, BRAIN INJURY, V26, P1287, DOI 10.3109/02699052.2012.706352; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hoofien D, 2001, BRAIN INJURY, V15, P189; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kalil A., 2016, HDB LIFE COURSE, V2, P341, DOI DOI 10.1007/978-3-319-20880-0_15; Keskimaki I, 1991, INT J HLTH SCI, V2, P15; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; McGrath JJ, 2014, JAMA PSYCHIAT, V71, P301, DOI 10.1001/jamapsychiatry.2013.4081; Muntaner C, 1998, SOC SCI MED, V47, P2043, DOI 10.1016/S0277-9536(98)00309-8; Najman JM, 2010, AM J PUBLIC HEALTH, V100, P1719, DOI 10.2105/AJPH.2009.180943; Niemela M, 2014, GEN HOSP PSYCHIAT, V36, P337, DOI 10.1016/j.genhosppsych.2013.12.012; Oladeji BD, 2010, BRIT J PSYCHIAT, V196, P186, DOI 10.1192/bjp.bp.109.063677; Paananen R, 2012, INT J EPIDEMIOL, V41, P941, DOI 10.1093/ije/dyr035; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Partovi D, 2012, THESIS; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; Riecher-Rossler A, 2010, EUR PSYCHIAT, V25, P189, DOI 10.1016/j.eurpsy.2009.03.002; Ristikari T, 2016, 9 NAT I HLTH WELF; Rohleder P, 2017, BRAIN INJURY, V31, P199, DOI 10.1080/02699052.2016.1225985; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Schilling EA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-30; Siegel K, 1996, J AM ACAD CHILD PSY, V35, P442, DOI 10.1097/00004583-199604000-00010; Sieh DS, 2010, CLIN CHILD FAM PSYCH, V13, P384, DOI 10.1007/s10567-010-0074-z; Silver JM, 2010, ESSENTIALS NEUROPSYC, P223; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tiar AMV, 2015, BRAIN INJURY, V29, P1005, DOI 10.3109/02699052.2014.976272; Unsworth DJ, 2017, J CLIN EXP NEUROPSYC, V39, P547, DOI 10.1080/13803395.2016.1248812; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; World Health Organization, 1992, ICD 10 CLASSIFICATIO	78	4	4	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	7					933	940		10.1080/02699052.2018.1470331			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GH6GT	WOS:000433542900015	29738275	Green Accepted			2022-02-06	
J	Leiton, CV; Chen, E; Cutrone, A; Conn, K; Mellanson, K; Malik, DM; Klingener, M; Lamm, R; Cutrone, M; Petrie, J; Sheikh, J; DiBua, A; Cohen, B; Floyd, TF				Leiton, Cindy, V; Chen, Elyssa; Cutrone, Alissa; Conn, Kristy; Mellanson, Kennelia; Malik, Dania M.; Klingener, Michael; Lamm, Ryan; Cutrone, Michael; Petrie, John; Sheikh, Joher; DiBua, Adriana; Cohen, Betsy; Floyd, Thomas F.			Astrocyte HIF-2 alpha supports learning in a passive avoidance paradigm under hypoxic stress	HYPOXIA			English	Article						astrocyte; hypoxia; HIF; learning; LTP; tripartite synapse; memory; glia; cognitive function	INDUCIBLE FACTOR-I; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; COGNITIVE IMPAIRMENT; INTERMITTENT HYPOXIA; ERYTHROPOIETIN PROTECTS; ATHEROSCLEROSIS RISK; SYNAPTIC PLASTICITY; SECRETED PROTEINS; FACTOR EXPRESSION	Background: The brain is extensively vascularized, uses similar to 20% of the body's oxygen, and is highly sensitive to changes in oxygen. While synaptic plasticity and memory are impaired in healthy individuals by exposure to mild hypoxia, aged individuals appear to be even more sensitive. Aging is associated with progressive failure in pulmonary and cardiovascular systems, exposing the aged to both chronic and superimposed acute hypoxia. The HIF proteins, the "master regulators" of the cellular response to hypoxia, are robustly expressed in neurons and astrocytes. Astrocytes support neurons and synaptic plasticity via complex metabolic and trophic mechanisms. The activity of HIF proteins in the brain is diminished with aging, and the increased exposure to chronic and acute hypoxia with aging combined with diminished HIF activity may impair synaptic plasticity. Purpose: Herein, we test the hypothesis that astrocyte HIF supports synaptic plasticity and learning upon hypoxia. Materials and Methods: An Astrocyte-specific HIF loss-of-function model was employed, where knock-out of HIF-1 alpha or HIF-2 alpha in GFAP expressing cells was accomplished by cremediated recombination. Animals were tested for behavioral (open field and rotarod), learning (passive avoidance paradigm), and electrophysiological (long term potentiation) responses to mild hypoxic challenge. Results: In an astrocyte-specific HIF loss-of-function model followed by mild hypoxia, we identified that the depletion of HIF-2 alpha resulted in an impaired passive avoidance learning performance. This was accompanied by an attenuated response to induction in long-term potentiation (LTP), suggesting that the hippocampal circuitry was perturbed upon hypoxic exposure following HIF-2 alpha loss in astrocytes, and not due to hippocampal cell death. We investigated HIF-regulated trophic and metabolic target genes and found that they were not regulated by HIF-2 alpha, suggesting that these specific targets may not be involved in mediating the phenotypes observed. Conclusion: Together, these results point to a role for HIF-2 alpha in the astrocyte's regulatory role in synaptic plasticity and learning under hypoxia and suggest that even mild, acute hypoxic challenges can impair cognitive performance in the aged population who harbor impaired HIF function.	[Leiton, Cindy, V] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Leiton, Cindy, V; Chen, Elyssa; Conn, Kristy] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Cutrone, Alissa] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Mellanson, Kennelia] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Malik, Dania M.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Klingener, Michael] SUNY Stony Brook, Dept Genet, Stony Brook, NY 11794 USA; [Lamm, Ryan] Thomas Jefferson Univ Hosp, Dept Gen Surg, Philadelphia, PA 19107 USA; [Cutrone, Michael] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Petrie, John] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA; [Sheikh, Joher] Georgetown Univ, Dept Physiol & Biophys, Washington, DC USA; [DiBua, Adriana] Hofstra Univ, Dept Chem, Hempstead, NY 11550 USA; [Cohen, Betsy] Swarthmore Coll, Comp Sci Dept, Swarthmore, PA 19081 USA; [Floyd, Thomas F.] Univ Texas Southwestern, Dept Anesthesiol & Pain Management, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Floyd, Thomas F.] Univ Texas Southwestern, Dept Cardiothorac Surg, Dallas, TX 75390 USA; [Floyd, Thomas F.] Univ Texas Southwestern, Dept Radiol, Dallas, TX 75390 USA		Floyd, TF (corresponding author), Univ Texas Southwestern, Dept Anesthesiol & Pain Management, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Thomas.Floyd@UTSouthwestern.edu	Floyd, Thomas/AAD-7818-2019	Mellanson, Kennelia/0000-0003-4795-2503; Malik, Dania/0000-0003-3049-8009; Leiton, Cindy/0000-0003-2204-5341	Department of Anesthesiology, Stony Brook University; Research Foundation of the State University of New York at Stony Brook, Stony Brook, NY, USA	The authors thank Ying Wang, PhD, for help in the characterization of the physiology and recombination of the animal models described herein, thank Ted Abel, PhD, at the University of Pennsylvania, Smilow Center for Translational Research (Philadelphia, PA, USA) for consultation on the passive avoidance paradigm and for helpful conversations on the other behavioral and LTP tests, and specially thank Laurie Levine at the Division for Laboratory Animal Resources at SBU for help in animal maintenance, breeding, and caretaking. The authors would like to thank Lucia Roa-Pena, MD, and Yan Ji, BS, MBA, from the Histopathology Core at the Department of Pathology, Stony Brook University, for help in processing tissue and optimizing the cleaved caspase-3 antibody and immunohistochemistry conditions. The authors would like to thank the laboratory of Dr. Holly Colognato for the development of protocols to establish mixed glial cultures used for generation of primary cortical astrocytes. This research was sponsored by the Department of Anesthesiology, Stony Brook University, and the Research Foundation of the State University of New York at Stony Brook, Stony Brook, NY, USA.	Adamcio B, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-37; Al-Qahtani JM, 2014, NEUROCHEM RES, V39, P161, DOI 10.1007/s11064-013-1201-2; Albert RK, 2016, NEW ENGL J MED, V375, P1617, DOI 10.1056/NEJMoa1604344; Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053; Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI 10.1089/neu.2008-0765; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Baek SH, 2016, BMB REP, V49, P245, DOI 10.5483/BMBRep.2016.49.5.053; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bell M, 2011, ADV EXP MED BIOL, V701, P327, DOI 10.1007/978-1-4419-7756-4_44; Benderro GF, 2011, BRAIN RES, V1389, P50, DOI 10.1016/j.brainres.2011.03.016; Bolanos Juan P., 2004, Molecular Aspects of Medicine, V25, P61, DOI 10.1016/j.mam.2004.02.009; Bosch-Marce M, 2007, CIRC RES, V101, P1310, DOI 10.1161/CIRCRESAHA.107.153346; BOVOLENTA P, 1987, DEV BRAIN RES, V33, P113, DOI 10.1016/0165-3806(87)90181-7; Bressler J, 2017, J CARD FAIL, V23, P47, DOI 10.1016/j.cardfail.2016.11.002; Bruce A.S., 2009, NEUROPSYCHOLOGICAL A, P336; Burman MA, 2014, J NEUROSCI METH, V222, P111, DOI 10.1016/j.jneumeth.2013.11.005; Cable GG, 2003, AVIAT SPACE ENVIR MD, V74, P169; Cannon JA, 2017, J CARD FAIL, V23, P464, DOI 10.1016/j.cardfail.2017.04.007; Casper KB, 2007, GENESIS, V45, P292, DOI 10.1002/dvg.20287; Chavez JC, 2003, ADV EXP MED BIOL, V510, P337; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chow LML, 2008, TRANSGENIC RES, V17, P919, DOI 10.1007/s11248-008-9185-4; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Costenla AR, 1999, BRAIN RES, V851, P228, DOI 10.1016/S0006-8993(99)02194-0; Cranston JM, 2005, COCHRANE DATABASE SY, V14; Daulatzai MA, 2015, J NEUROSCI RES, V93, P1778, DOI 10.1002/jnr.23634; Dayyat EA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-77; Detrait ERAY, 2009, BEHAV RES METHODS, V41, P805, DOI 10.3758/BRM.41.3.805; Dienel GA, 2013, NEUROCHEM INT, V63, P244, DOI 10.1016/j.neuint.2013.06.015; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; Dlugaj M, 2016, J ALZHEIMERS DIS, V49, P1031, DOI 10.3233/JAD-150434; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; DUNWIDDIE TV, 1981, DEV NEUROSCI-BASEL, V4, P165, DOI 10.1159/000112753; Dzietko M, 2004, NEUROBIOL DIS, V15, P177, DOI 10.1016/j.nbd.2003.10.006; FEINSTEIN DL, 1992, J NEUROSCI RES, V32, P1, DOI 10.1002/jnr.490320102; Filosa JA, 2007, EXP PHYSIOL, V92, P641, DOI 10.1113/expphysiol.2006.036368; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frenkel-Denkberg G, 1999, FEBS LETT, V462, P341, DOI 10.1016/S0014-5793(99)01552-5; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Giulio C., 2005, RESP PHYSIOL NEUROBI, V147, P31, DOI [10.1016/j.resp.2005.01.006, DOI 10.1016/J.RESP.2005.01.006]; Gozal D, 2003, J NEUROCHEM, V86, P1545, DOI 10.1046/j.1471-4159.2003.01973.x; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hennigan A, 2009, BEHAV BRAIN RES, V197, P371, DOI 10.1016/j.bbr.2008.09.037; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Holthoff K, 2000, GLIA, V29, P288, DOI 10.1002/(SICI)1098-1136(20000201)29:3<288::AID-GLIA10>3.0.CO;2-8; Hornbein TF, 2001, J EXP BIOL, V204, P3129; Huang YY, 2006, LEARN MEMORY, V13, P298, DOI 10.1101/lm.166906; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Ingraham JP, 2008, J GERONTOL A-BIOL, V63, P12, DOI 10.1093/gerona/63.1.12; Jahn-Eimermacher A, 2011, BEHAV BRAIN RES, V221, P271, DOI 10.1016/j.bbr.2011.03.007; JANICKE B, 1987, NEUROBIOL AGING, V8, P495, DOI 10.1016/0197-4580(87)90123-0; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; JESSEN KR, 1984, J NEUROCYTOL, V13, P923, DOI 10.1007/BF01148594; Jha MK, 2018, PROG NEUROBIOL, V162, P37, DOI 10.1016/j.pneurobio.2017.12.003; Jung F, 2000, CIRC RES, V86, P319, DOI 10.1161/01.RES.86.3.319; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Katschinski DM, 2006, EXP GERONTOL, V41, P482, DOI 10.1016/j.exger.2005.12.003; Kim C-H, 2011, EFFECTS HYPOXIA EXER; Kim H, 2003, MECH AGEING DEV, V124, P941, DOI 10.1016/S0047-6374(03)00166-0; Knabe W, 2004, ANAT EMBRYOL, V207, P503, DOI 10.1007/s00429-003-0365-y; Ko CY, 2011, CELL DEATH DIFFER, V18, P1757, DOI 10.1038/cdd.2011.44; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Krypotos AM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00189; Kumar A, 2004, J NEUROPHYSIOL, V91, P2437, DOI 10.1152/jn.01148.2003; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Lahiri S, 2006, PROG BIOPHYS MOL BIO, V91, P249, DOI 10.1016/j.pbiomolbio.2005.07.001; Lahousse L, 2015, RESP MED, V109, P1371, DOI 10.1016/j.rmed.2015.07.014; LaManna JC, 2007, ESSAYS BIOCHEM, V43, P139; LAMBERTY Y, 1990, PHYSIOL BEHAV, V47, P1137, DOI 10.1016/0031-9384(90)90364-A; Larson J, 2014, J EXP BIOL, V217, P1024, DOI 10.1242/jeb.085381; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Li M, 2010, ANESTHESIOLOGY, V113, P845, DOI 10.1097/ALN.0b013e3181eaaef9; Liu RQ, 2006, J NEUROCHEM, V96, P1101, DOI 10.1111/j.1471-4159.2005.03597.x; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Malle C, 2013, AVIAT SPACE ENVIR MD, V84, P773, DOI 10.3357/ASEM.3482.2013; Mamczur P, 2015, GLIA, V63, P328, DOI 10.1002/glia.22753; Marina N, 2018, GLIA, V66, P1185, DOI 10.1002/glia.23283; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McLaren AT, 2009, CAN J ANAESTH, V56, P502, DOI 10.1007/s12630-009-9104-z; Nakazawa MS, 2016, NAT REV CANCER, V16, P663, DOI 10.1038/nrc.2016.84; Ndubuizu OI, 2009, AM J PHYSIOL-REG I, V297, pR158, DOI 10.1152/ajpregu.90829.2008; Neuhaus C, 2014, PSYCHOL RES BEHAV MA, V7, P297, DOI 10.2147/PRBM.S51844; Ogren SO, 2010, EUR J PHARMACOL, V626, P9, DOI 10.1016/j.ejphar.2009.09.070; Olney JW, 2002, DEV BRAIN RES, V133, P115, DOI 10.1016/S0165-3806(02)00279-1; Ota Y, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/185463; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; Pinho J, 2017, NEUROPHARMACOLOGY, V114, P12, DOI 10.1016/j.neuropharm.2016.11.017; Pittman R. N, 2011, REGULATION TISSUE OX; Popa-Wagner A, 2015, J NEURAL TRANSM, V122, P47, DOI 10.1007/s00702-013-1129-3; Powell FL, 2009, ADV EXP MED BIOL, V648, P369, DOI 10.1007/978-90-481-2259-2_42; Prabhakar NR, 2015, PHYSIOLOGY, V30, P340, DOI 10.1152/physiol.00022.2015; Qiu CX, 2015, NAT REV CARDIOL, V12, P267, DOI 10.1038/nrcardio.2014.223; Rabie T, 2011, INT J DEV NEUROSCI, V29, P655, DOI 10.1016/j.ijdevneu.2011.06.003; Rapino C, 2005, AGING CELL, V4, P177, DOI 10.1111/j.1474-9726.2005.00161.x; Risher WC, 2012, MATRIX BIOL, V31, P170, DOI 10.1016/j.matbio.2012.01.004; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; Ryan HE, 2000, CANCER RES, V60, P4010; Sakers K, 2017, P NATL ACAD SCI USA, V114, pE3830, DOI 10.1073/pnas.1617782114; Sakr HF, 2015, J PHYSIOL PHARMACOL, V66, P191; Sardinha VM, 2017, GLIA, V65, P1944, DOI 10.1002/glia.23205; SARTHY PV, 1989, DNA-J MOLEC CELL BIO, V8, P437, DOI 10.1089/dna.1.1989.8.437; Schega L, 2013, GERONTOLOGY, V59, P316, DOI 10.1159/000350927; Schneider ALC, 2016, J GERONTOL A-BIOL, V71, P772, DOI 10.1093/gerona/glv158; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schousboe A, 2011, J NEUROSCI RES, V89, P1926, DOI 10.1002/jnr.22746; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; Sonmez A, 2007, SURG NEUROL, V68, P297, DOI 10.1016/j.surneu.2006.11.045; Stogsdill JA, 2017, CURR OPIN NEUROBIOL, V42, P1, DOI 10.1016/j.conb.2016.09.016; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Suzuki H, 2016, CIRC J, V80, P1773, DOI 10.1253/circj.CJ-16-0367; Tamura MK, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0226-6; Tarantini S, 2017, EXP GERONTOL, V94, P52, DOI 10.1016/j.exger.2016.11.004; Tazangi PE, 2015, PHARMACOL BIOCHEM BE, V130, P15, DOI 10.1016/j.pbb.2014.12.011; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Tran PV, 2008, J NUTR, V138, P2495, DOI 10.3945/jn.108.091553; Tsuboi I, 2015, J CELL PHYSIOL, V230, P1534, DOI 10.1002/jcp.24899; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Vallon M, 2014, CELL MOL LIFE SCI, V71, P3489, DOI 10.1007/s00018-014-1625-0; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang MS, 2018, P NATL ACAD SCI USA, V115, pE1647, DOI 10.1073/pnas.1711692115; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Weiskopf RB, 2002, ANESTHESIOLOGY, V96, P871, DOI 10.1097/00000542-200204000-00014; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023; Wenger RH, 2000, J EXP BIOL, V203, P1253; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Yeo EJ, 2008, ANN HEMATOL, V87, P11, DOI 10.1007/s00277-007-0359-6; Yohannes AM, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.01.014; Zhao J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.565; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	145	4	4	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		2324-1128		HYPOXIA	Hypoxia		2018	6						35	56		10.2147/HP.S173589			22	Physiology	Emerging Sources Citation Index (ESCI)	Physiology	HS6TE	WOS:000464003400001	30519596	Green Published, gold			2022-02-06	
J	Leung, J; Fereday, S; Sticpewich, B; Hanna, J				Leung, Joan; Fereday, Sarah; Sticpewich, Bridget; Hanna, Joe			Extra practice outside therapy sessions to maximize training opportunity during inpatient rehabilitation after traumatic brain injury	BRAIN INJURY			English	Article						Exercise; family; physiotherapy; self-management; survey; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; LENGTH-OF-STAY; STROKE REHABILITATION; PHYSICAL-ACTIVITY; PHYSIOTHERAPY; EXPERIENCE; INTENSITY; RECOVERY; TIME	Objective: To determine if extra practice outside therapy sessions can be conducted for patients with traumatic brain injury and identify factors that influence their participation.Methods: A purpose-designed survey was conducted on consecutive eligible patients with traumatic brain injury and their relatives on discharge from inpatient rehabilitation.Results: In total, 68 of the 69 of patients who took part in the survey reported that they participated in extra practice outside therapy sessions. Also, 58% reported that they conducted extra practice more than three times a week on average and 70% reported no barriers in conducting extra practice. Patients with poor motivation, reduced executive functioning and less severe brain injury are less likely to participate in extra practice and may require more support. Relatives tended to be involved in extra practice for patients who were dependent. A wide range of barriers were identified with poor motivation and lack of confidence being the main ones.Conclusion: With appropriate support, extra practice outside therapy sessions is generally feasible to maximize training opportunity for patients with traumatic brain injury. Motivation, perception of being listened to, executive functioning and severity of injury are factors that influence participation in extra practice. Strategies that improve motivation, interaction and confidence are likely to enhance participation. Relatives are a useful source of support for the more dependent patients.	[Leung, Joan; Hanna, Joe] Royal Rehab, Dept Brain Injury Unit, Sydney, NSW, Australia; [Fereday, Sarah; Sticpewich, Bridget] Inst Royal Rehab, Dept Physiotherapy, Sydney, NSW, Australia		Leung, J (corresponding author), Royal Rehab, Brain Injury Unit, 235 Morrison Rd, Ryde, NSW 2112, Australia.	joan.leung@royalrehab.com.au	Leung, Joan/AAC-8623-2019	Leung, Joan/0000-0003-0888-558X			Access Economics , 2009, EC COST SPIN CORD IN; Ada L, 1999, AUST J PHYSIOTHER, V45, P33; Australian Bureau of Statistics, 2003, SURV DIS AG CAR; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Brusco NK, 2007, AUST J PHYSIOTHER, V53, P75, DOI 10.1016/S0004-9514(07)70039-9; Clissett P, 2001, Nurs Stand, V15, P39; Cooke EV, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-60; Davies-Avery A, 1978, HLTH MED CARE SERV R, V1, P3; De Weerdt W, 2001, AUST J PHYSIOTHER, V47, P53, DOI 10.1016/S0004-9514(14)60298-1; English C, 2015, INT J STROKE, V10, P465, DOI 10.1111/ijs.12474; English C, 2015, INT J STROKE, V10, P594, DOI 10.1111/ijs.12470; Esmonde Tim, 1997, Aust J Physiother, V43, P43; Foley N, 2012, DISABIL REHABIL, V34, P2132, DOI 10.3109/09638288.2012.676145; Galvin R, 2011, STROKE, V42, P681, DOI 10.1161/STROKEAHA.110.594689; Galvin R, 2009, INT J REHABIL RES, V32, P238, DOI 10.1097/MRR.0b013e32832b083c; Han C, 2013, CLIN REHABIL, V27, P75, DOI 10.1177/0269215512447223; Hartley SL, 2006, J INTELL DISABIL RES, V50, P813, DOI 10.1111/j.1365-2788.2006.00844.x; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwakkel G, 2016, NEUROREHAB NEURAL RE, V30, P804, DOI 10.1177/1545968315624784; Lohse KR, 2014, STROKE, V45, P2053, DOI 10.1161/STROKEAHA.114.004695; Mackey F, 1996, ARCH PHYS MED REHAB, V77, P1066, DOI 10.1016/S0003-9993(96)90070-2; Oyesanya T, 2017, BRAIN INJURY, V31, P151, DOI 10.1080/02699052.2016.1225987; Partridge C, 2000, Physiother Res Int, V5, P230, DOI 10.1002/pri.203; Peiris CL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-198; Ruff RM, 1999, AM J PHYS MED REHAB, V78, P143, DOI 10.1097/00002060-199903000-00011; Scrivener K, 2015, J PHYSIOTHER, V61, P61, DOI 10.1016/j.jphys.2015.02.017; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Ware J E Jr, 1978, Health Med Care Serv Rev, V1, P3; Wellwood I, 2004, CLIN REHABIL, V18, P529, DOI 10.1191/0269215504cr768oa	30	4	4	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	7					915	925		10.1080/02699052.2018.1469046			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GH6GT	WOS:000433542900013	29718728				2022-02-06	
J	Lichtenstein, JD; Linnea, KS; Maerlender, AC				Lichtenstein, Jonathan D.; Linnea, Kate S.; Maerlender, Arthur C.			Patterns of referral in high school concussion management programs: A pilot study of consultants from different disciplines	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Computerized neuropsychological tests; concussion management; consultation; ImPACT; sport-related concussion	SPORT-RELATED CONCUSSION; NEUROPSYCHOLOGICAL ASSESSMENT; NEUROCOGNITIVE PERFORMANCE; PROLONGED RECOVERY	School-based concussion management programs cover thousands of young athletes, yet there is little in the way of research to assess program processes or outcomes. This study examined the referral patterns of consultants working with ten high school concussion management programs. In addition to the number of referrals made to specialists, other potential outcome variables were explored. The sample included over 5,000 athlete-seasons and 298 concussions managed directly by certified athletic trainers. All programs used computerized neuropsychological testing (both baseline and post injury). Two groups were compared: five programs used a clinical neuropsychologist (NP) as the testing consultant and five used nonneuropsychologists (non-NP) with advanced clinical degrees as the testing consultant. There was no significant difference in concussion incidence rates between groups. Referrals to outside specialists were significantly higher for the non-NP group: X-2(1) = 16.474, p < .0001. Further, concussions in the non-NP group took longer to recover overall (Mann-Whitney U, p = .013) and had significantly more cases taking longer than 2 weeks to complete their testing protocol: X-2(1) = 9.672, p = .003. The findings of this pilot study support the idea that neuropsychologists are best suited for the role of testing consultant to high school concussion management programs.	[Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Neuropsychol Sect, Dept Psychiat, Lebanon, NH USA; [Linnea, Kate S.] Harvard Med Sch, Bostons Childrens Hosp, Dept Dev Med, Boston, MA USA; [Maerlender, Arthur C.] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE USA		Lichtenstein, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Psychiat, HB 7750,One Med Ctr Dr, Lebanon, NH 03756 USA.	jonathan.d.lichtenstein@dartmouth.edu					Broglio SP, 2007, J ATHL TRAINING, V42, P504; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P611, DOI 10.1037/0894-4105.21.5.611; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Lewinsohn PM, 1997, J ABNORM PSYCHOL, V106, P365, DOI 10.1037/0021-843X.106.3.365; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511	15	4	4	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2018	7	4					334	341		10.1080/21622965.2017.1340158			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GS6WE	WOS:000443839800005	28657773	Green Published			2022-02-06	
J	Liu, ML; Niu, XF; Zhou, G; Jia, ZT; Li, P; Fan, YB				Liu, Meili; Niu, Xufeng; Zhou, Gang; Jia, Zhengtai; Li, Ping; Fan, Yubo			Potential effect of mechano growth factor E-domain peptide on axonal guidance growth in primary cultured cortical neurons of rats	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						mechano growth factor; axonal guidance growth; Netrin-1; DCC; nerve regeneration	PERIPHERAL-NERVE REGENERATION; EXPRESSION; BRAIN; INJURY; SCAFFOLDS; VARIANTS; ISCHEMIA; PROTEINS; DELIVERY; REPAIR	Establishing appropriate synaptic connections and plasticity is a critical need in neuronal regeneration and development. Mechano growth factor (MGF) and its C-terminal E-domain peptide with 24 amino acids, MGF-Ct24E, are potential neuroprotective agents. Our preliminary study indicates that Netrin-1 can guide axonal growth and its expression is sensitive to MGF, but how MGF regulates the expression of Netrin-1 and its receptor DCC is still unclear. Here, we investigate the effect of MGF-Ct24E on the expression of Netrin-1 and DCC in primary cultured cortical neurons in vitro and the adult rat brain in vivo. MTT assay shows that MGF-Ct24E can significantly protect primary cortical neurons against nerve injury. There is a significant increase in axonal elongation after MGF-Ct24E treatment at concentrations of 0.5 and 1.0 mu g/ml. Real-time polymerase chain reaction assay indicates that MGF-Ct24E can effectively promote the expression of Netrin-1 and DCC in primary cultured cortical neurons. To identify the certain mechanism of MGF-Ct24E on neuronal guidance and growth, adult rats are subjected to intramuscular injection of MGF-Ct24E after traumatic brain injury. Rats injected with MGF-Ct24E start eating and drinking within 14days, indicating that MGF-Ct24E can promote rehabilitation. HE staining and immunohistochemistry assays of brain section slices reveal that MGF-Ct24E treatment can significantly inhibit the haemorrhage of traumatic brain injury and promote expression of Netrin-1. Further investigation of protein expression by Western blot assay shows that MGF-Ct24E promotes expression of Netrin-1 and DCC after nerve injury. MGF-Ct24E can effectively improve axonal guidance through upregulation of Netrin-1/DCC signalling in neuronal regeneration. Copyright (C) 2016 John Wiley & Sons, Ltd.	[Liu, Meili; Niu, Xufeng; Zhou, Gang; Jia, Zhengtai; Li, Ping; Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing 100191, Peoples R China; [Fan, Yubo] Natl Res Ctr Rehabil Tech Aids, Beijing 100176, Peoples R China		Fan, YB (corresponding author), Sch Biol Sci & Med Engn, 37 XueYuan Rd, Beijing 100191, Peoples R China.	yubofan@buaa.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31470901, 31470915, 31100666, 61227902, 31300769]; National Basic Research Program of China (973 program)National Basic Research Program of China [2011CB710901]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [YWF-16-BJ-Y-04, YWF-15-YG-033]; 111 ProjectMinistry of Education, China - 111 Project [B13003]; International Joint Research Center of Aerospace Biotechnology and Medical Engineering, Ministry of Science and Technology of China	This study was supported by funds from National Natural Science Foundation of China (Nos 31470901, 31470915, 31100666, 61227902, 31300769), National Basic Research Program of China (973 program, 2011CB710901), the Fundamental Research Funds for the Central Universities (No. YWF-16-BJ-Y-04, YWF-15-YG-033), the 111 Project (No. B13003), and also the International Joint Research Center of Aerospace Biotechnology and Medical Engineering, Ministry of Science and Technology of China. The authors would also like to thank M.S. Michael Anderson (Johns Hopkins University, School of Medicine, Department of Neuroscience) for his assistance in language editing.	Aperghis M, 2004, BRAIN RES, V1009, P213, DOI 10.1016/j.brainres.2004.02.049; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Beresewicz M, 2010, INT J DEV NEUROSCI, V28, P91, DOI 10.1016/j.ijdevneu.2009.09.002; Borgens RB, 1999, NEUROSCIENCE, V91, P251, DOI 10.1016/S0306-4522(98)00584-3; Chen JQ, 2014, ASIAN PAC J TROP MED, V7, P991, DOI 10.1016/S1995-7645(14)60174-7; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Dai ZQ, 2010, GROWTH HORM IGF RES, V20, P275, DOI 10.1016/j.ghir.2010.03.005; Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje; Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383; Goldspink G, 2005, PHYSIOLOGY, V20, P232, DOI 10.1152/physiol.00004.2005; Kang JG, 2014, J TISSUE ENG REGEN M, V8, P402; Kemp SWP, 2008, NEUROL RES, V30, P1030, DOI 10.1179/174313208X362505; Kofler J, 2014, J TISSUE ENG REGEN M, V8, P11; Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002; Kravchenko IV, 2012, MOL CELL BIOCHEM, V363, P347, DOI 10.1007/s11010-011-1187-5; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Liu M, 2013, PLOS ONE, V8; Liu ML, 2008, NEUROSCI LETT, V444, P236, DOI 10.1016/j.neulet.2008.08.029; Liu ML, 2012, NANOSCALE, V4, P3201, DOI 10.1039/c2nr30072a; LOHRKE S, 1995, J NEUROCYTOL, V24, P283, DOI 10.1007/BF01186541; Luo ZW, 2015, BIOMATERIALS, V52, P463, DOI 10.1016/j.biomaterials.2015.01.001; Matheny RW, 2010, ENDOCRINOLOGY, V151, P865, DOI 10.1210/en.2009-1217; Niu XF, 2014, INT J PHARMACEUT, V469, P214, DOI 10.1016/j.ijpharm.2014.04.054; Pena JR, 2015, BIOMATERIALS, V46, P26, DOI 10.1016/j.biomaterials.2014.12.050; Pfister BJ, 2004, J NEUROSCI, V24, P7978, DOI 10.1523/JNEUROSCI.1974-04.2004; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; Riddoch-Contreras J, 2009, EXP NEUROL, V215, P281, DOI 10.1016/j.expneurol.2008.10.014	29	4	5	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	JAN	2018	12	1					70	79		10.1002/term.2364			10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Engineering	FT8VL	WOS:000423431200063	27863093				2022-02-06	
J	Liu, Q; Zhang, H; Xu, J; Zhao, D				Liu, Qi; Zhang, Hang; Xu, Jian; Zhao, Dong			Neuritin provides neuroprotection against experimental traumatic brain injury in rats	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Traumatic brain injury; neuritin; apoptosis; caspase-3; neuroprotection	CELL-DEATH; CPG15; PATHWAYS; GROWTH; CASPASE-3; IDENTIFICATION; MECHANISMS; PLASTICITY; APOPTOSIS; NEURONS	Objectives: Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Neuritin is a neurotrophic factor that regulates neural growth and development. However, the role of neuritin in alleviating TBI has not been investigated.Methods: In this study, Sprague Dawley rats (n = 144) weighing 300 50g were categorized into control, sham, TBI and TBI + neuritin groups. The neurological scores and the ultrastructure of cortical neurons, apoptotic cells and caspase-3 were measured by using Garcia scoring system, transmission electron microscopy, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling, Western blot analysis and real-time RT-PCR at various time points post-TBI.Conclusions: Our findings indicated that neuritin plays a protective role in TBI by improving neurological scores, repairing injured neurons and protecting the cortical neurons against apoptosis through inhibition of caspase-3 expression. Further investigation of the molecular mechanisms underlying caspase-3 inhibition by neuritin will provide a research avenue for potential TBI therapeutics.	[Liu, Qi; Zhang, Hang; Xu, Jian; Zhao, Dong] Shihezi Univ, Affiliated Hosp 1, Dept Neurosurg, Coll Med, Shihezi, Xinjiang, Peoples R China; [Liu, Qi; Zhang, Hang; Xu, Jian; Zhao, Dong] Shihezi Univ, Key Lab Xinjiang Endem & Ethn Dis, Coll Med, Shihezi, Xinjiang, Peoples R China		Zhao, D (corresponding author), Shihezi Univ, Affiliated Hosp 1, Dept Neurosurg, Coll Med, Shihezi, Xinjiang, Peoples R China.; Zhao, D (corresponding author), Shihezi Univ, Key Lab Xinjiang Endem & Ethn Dis, Coll Med, Shihezi, Xinjiang, Peoples R China.	zhanghang@stu.shzu.edu.cn		zhang hang, hang/0000-0002-8657-4966	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81360185]; Research and Innovation Project of Graduate Students in Xinjiang Uygur Autonomous Region [XJGRI2017041]; International Cooperation Project of Shihezi University [GJHZ201704]	This study was supported by grants from National Natural Science Foundation of China [grant number 81360185]; Research and Innovation Project of Graduate Students in Xinjiang Uygur Autonomous Region [grant number XJGRI2017041]; International Cooperation Project of Shihezi University [grant number GJHZ201704].	Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Cappelletti G, 2007, J NEUROSCI RES, V85, P2702, DOI 10.1002/jnr.21235; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Connolly PF, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00149; Di Giovanni S, 2004, FASEB J, V18, P153, DOI 10.1096/fj.04-2694fje; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Guimares JS, 2009, REV NEUROLOGIA, V48, P304, DOI 10.33588/rn.4806.2008512; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Han Y, 2007, J NEUROTRAUM, V24, P722, DOI 10.1089/neu.2006.0174; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Ju WJ, 2007, P NATL ACAD SCI USA, V104, P14294, DOI 10.1073/pnas.0702251104; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Mangiola A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/736104; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Putz U, 2005, NAT NEUROSCI, V8, P322, DOI 10.1038/nn1407; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Roth KA, 2000, P NATL ACAD SCI USA, V97, P466, DOI 10.1073/pnas.97.1.466; Schoch KM, 2012, NEUROTHERAPEUTICS, V9, P323, DOI 10.1007/s13311-012-0107-z; Shindler KS, 1997, J NEUROSCI, V17, P3112; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Wall DM, 2014, CELL MICROBIOL, V16, P1746, DOI 10.1111/cmi.12368; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X	43	4	5	3	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.		2018	128	9					811	820		10.1080/00207454.2018.1424155			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GL6ZR	WOS:000437345100004	29334295				2022-02-06	
J	Maneyapanda, MB; Stork, R; Ingraham, B; Lonini, L; Jayaraman, A; Shawen, N; Ripley, D				Maneyapanda, Mithra B.; Stork, Ryan; Ingraham, Benjamin; Lonini, Luca; Jayaraman, Arun; Shawen, Nicholas; Ripley, David			Association of sleep with neurobehavioral impairments during inpatient rehabilitation after traumatic brain injury	NEUROREHABILITATION			English	Article						Sleep; actigraphy; traumatic brain injury	NEUROREHABILITATION ADMISSIONS; HEAD-INJURY; POLYSOMNOGRAPHY; DISTURBANCES; ACTIGRAPHY; PREVALENCE; PARAMETERS; DISORDERS; VETERANS; PATTERNS	BACKGROUND: Sleep disturbance is a common sequela after traumatic brain injury (TBI). Many of the impairments following TBI may be exacerbated by impaired sleep-wake cycle regulation. OBJECTIVE: To investigate the relationship between total sleep time (TST), measured by wrist actigraphy and observational sleep logs, and neurobehavioral impairments during inpatient rehabilitation after TBI. METHODS: Twenty-five subjects undergoing inpatient rehabilitation for traumatic brain injury were included. TST was measured using wrist actigraphy and observational sleep logs. Neurobehavioral impairments were assessed using the Neurobehavioral Rating Scale-Revised (NRS-R), a multidimensional clinician-based assessment. RESULTS: Of 25 subjects enrolled, 23 subjects completed the study. A significant negative correlation was found between total NRS-R and TST calculated by observational sleep logs (r = -0.28, p = 0.007). The association between total NRS-R and TST, as calculated by actigraphy, was not significantly correlated (R = -0.01, p = 0.921). CONCLUSIONS: Sleep disturbance during inpatient rehabilitation is associated with neurobehavioral impairments after TBI. TST measured by actigraphy may be limited by sleep detection algorithms that have not been validated in certain patient populations. Considerations should be made regarding the feasibility of using wearable sensors in patients with cognitive and behavioral impairments. Challenges regarding actigraphy for sleep monitoring in the brain injury population are discussed.	[Maneyapanda, Mithra B.] Bryn Mawr Rehab Hosp, Brain Injury Program, Malvern, PA USA; [Maneyapanda, Mithra B.] Thomas Jefferson Univ, Dept Rehabil Med, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Stork, Ryan] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Ingraham, Benjamin; Lonini, Luca; Jayaraman, Arun; Ripley, David] Northwestern Feinberg Sch Med, Shirley Ryan AbilityLab, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Lonini, Luca; Jayaraman, Arun; Shawen, Nicholas] Shirley Ryan AbilityLab, Max Nader Lab Rehabil Technol & Outcomes Res, Chicago, IL USA		Ripley, D (corresponding author), Northwestern Feinberg Sch Med, Shirley Ryan AbilityLab, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	dripley@sralab.org	Lonini, Luca/AAI-7032-2020	Lonini, Luca/0000-0002-9358-1718; Ripley, David/0000-0002-5349-1830			Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; Edwards G B, 1993, Am J Crit Care, V2, P125; FONTAINE DK, 1989, HEART LUNG, V18, P402; Freedman NS, 1999, AM J RESP CRIT CARE, V159, P1155, DOI 10.1164/ajrccm.159.4.9806141; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Krahn L E, 1997, Ann Clin Psychiatry, V9, P203; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Liu XF, 2014, REAL TIM SYST SYMP P, P346, DOI 10.1109/RTSS.2014.30; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Nazem S, 2016, J HEAD TRAUMA REHAB, V31, P136, DOI 10.1097/HTR.0000000000000225; ORTON DI, 1989, BRIT MED J, V298, P21, DOI 10.1136/bmj.298.6665.21; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; PARSONS LC, 1982, NURS RES, V31, P260; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Towns SJ, 2016, PM&R, V8, P1046, DOI 10.1016/j.pmrj.2016.04.005; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697; Zinkhan M, 2014, SLEEP MED, V15, P1107, DOI 10.1016/j.sleep.2014.04.015; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	25	4	4	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	3					319	325		10.3233/NRE-182533			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HA8FK	WOS:000450524200008	30347627				2022-02-06	
J	Matias, M; Silvestre, S; Falcao, A; Alves, G				Matias, Mariana; Silvestre, Samuel; Falcao, Amilcar; Alves, Gilberto			Considerations and Pitfalls in Selecting the Drug Vehicles for Evaluation of New Drug Candidates: Focus on &ITin vivo&IT Pharmaco-Toxicological Assays Based on the Rotarod Performance Test	JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; P-GLYCOPROTEIN EFFLUX; ANTICONVULSANT ACTIVITY; DIMETHYL-SULFOXIDE; PROPYLENE-GLYCOL; NERVOUS-SYSTEM; IN-SILICO; DERIVATIVES; DMSO; SOLUBILITY	Purpose - During the discovery and development of new drugs, compounds with low aqueous solubility pose special challenges in their pharmacological evaluation and, therefore, the selection of appropriate vehicles to administer the compounds of interest is determinant for the quality of the results generated during the in vivo non-clinical studies. This work aimed to evaluate the motor deficit (as a surrogate of neurotoxicity) of several administration/delivery vehicles through the rotarod performance test. Methods - Trained male CD-1 mice were intraperitoneally administered with the following vehicles: dimethyl sulfoxide (DMSO), aqueous sodium chloride (NaCl) 0.9%, aqueous carboxymethylcellulose (CMC) 0.5%, polyethylene glycol (PEG)-400, propylene glycol (PG), and solutions of these vehicles containing 5% and 10% DMSO. Results - It was observed that the aqueous vehicles (NaCl 0.9% and CMC 0.5%) did not affect the performance of the animals on the rod. On the other hand, a vehicle consisting solely of DMSO led to significant motor impairment and only a small improvement was recorded over time. Additionally, a strong neuromotor toxicity was observed in the early evaluation points of the experiment using vehicles constituted by PG and PEG-400 or by mixtures of PG/DMSO (5% and 10%) and PEG-400/DMSO (5% and 10%). Conclusion - This study provides useful data about the neurotoxicity inherent to several vehicles frequently used in non-clinical pharmaco-toxicological assays, aiming to draw especial attention to the need of a careful selection of drug vehicles in order to avoid the impact of such confounding variables on the accuracy of the results and in decision-making processes.	[Matias, Mariana; Silvestre, Samuel; Alves, Gilberto] Univ Beira Interior, CICS UBI Hlth Sci Res Ctr, Covilha, Portugal; [Matias, Mariana; Silvestre, Samuel; Falcao, Amilcar; Alves, Gilberto] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Falcao, Amilcar] Univ Coimbra, Fac Pharm, Pharmacol Dept, Polo Ciencias Saude, Coimbra, Portugal		Alves, G (corresponding author), Univ Beira Interior, CICS UBI Hlth Sci Res Ctr, Fac Hlth Sci, Av Infante D Henrique, P-6200506 Covilha, Portugal.	gilberto@fcsaude.ubi.pt	Alves, Gilberto/L-9639-2014; Silvestre, Samuel/A-4822-2017; Matias, Mariana/G-7966-2019; Falcao, Amilcar/G-6611-2013	Alves, Gilberto/0000-0002-4213-0714; Silvestre, Samuel/0000-0003-4297-5108; Matias, Mariana/0000-0002-7649-7418; Falcao, Amilcar/0000-0002-3854-6549	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal)Portuguese Foundation for Science and Technology [SFRH/BD/85279/2012]; POPH-QREN - FSE; POPH-QREN - MECGerman Research Foundation (DFG)National Health and Medical Research Council of Australia; FEDER funds through the POCI - COMPETE - Operational Programme Competitiveness and Internationalisation in Axis I - Strengthening research, technological development and innovation [007491]; FCT - Foundation for Science and TechnologyPortuguese Foundation for Science and Technology [UID/Multi/00709/2013]	The authors are grateful to Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) for the PhD fellowship of Mariana Matias (SFRH/BD/85279/2012), involving the POPH-QREN, which is co-funded by FSE and MEC. The authors also acknowledge the support provided by FEDER funds through the POCI - COMPETE 2020 - Operational Programme Competitiveness and Internationalisation in Axis I - Strengthening research, technological development and innovation (Project No. 007491) and National Funds by FCT - Foundation for Science and Technology (Project UID/Multi/00709/2013).	Abbasi M, 2014, J MOL LIQ, V197, P171, DOI 10.1016/j.molliq.2014.05.004; Alam O, 2010, EUR J MED CHEM, V45, P2467, DOI 10.1016/j.ejmech.2010.02.031; Alves G, 2008, FUND CLIN PHARMACOL, V22, P529, DOI 10.1111/j.1472-8206.2008.00617.x; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Amir M, 2013, ARCH PHARM RES, V36, P61, DOI 10.1007/s12272-013-0004-y; Aniket Kshirsagar, 2009, International Journal of ChemTech Research, V1, P696; Auta J, 2010, PHARMACOL BIOCHEM BE, V95, P383, DOI 10.1016/j.pbb.2010.02.016; Authier N, 2002, TOXICOL LETT, V132, P117, DOI 10.1016/S0378-4274(02)00052-8; Bagal Sharan, 2014, Drug Discov Today Technol, V12, pe79, DOI 10.1016/j.ddtec.2014.03.008; Bakar B, 2012, INJURY, V43, P315, DOI 10.1016/j.injury.2011.08.021; Banfor PN, 2016, J PHARMACOL TOX MET, V82, P62, DOI 10.1016/j.vascn.2016.07.002; Bao DS, 2014, CARBOHYD POLYM, V110, P113, DOI 10.1016/j.carbpol.2014.03.095; Cao XD, 2016, J MED CHEM, V59, P2942, DOI 10.1021/acs.jmedchem.5b01416; Caron G, 2017, DRUG DISCOV TODAY, V22, P835, DOI 10.1016/j.drudis.2016.11.017; Castel-Branco M, 2003, EUR J PHARMACOL, V482, P163, DOI 10.1016/j.ejphar.2003.09.065; Castel-Branco MM, 2002, FUND CLIN PHARMACOL, V16, P331, DOI 10.1046/j.1472-8206.2002.00096.x; Cavaletti G, 2000, TOXICOL LETT, V118, P103, DOI 10.1016/S0378-4274(00)00269-1; Colucci M, 2008, PHARMACOL RES, V57, P419, DOI 10.1016/j.phrs.2008.04.004; Cui LJ, 2005, BIOL PHARM BULL, V28, P1216, DOI 10.1248/bpb.28.1216; Dawood KM, 2006, BIOORGAN MED CHEM, V14, P3672, DOI 10.1016/j.bmc.2006.01.033; Di L, 2012, DRUG DISCOV TODAY, V17, P486, DOI 10.1016/j.drudis.2011.11.007; Elder D, 2013, INT J PHARMACEUT, V453, P3, DOI 10.1016/j.ijpharm.2012.10.041; Fortuna A, 2013, EPILEPSY RES, V107, P37, DOI 10.1016/j.eplepsyres.2013.08.013; Fortuna A, 2012, EPILEPSIA, V53, P529, DOI 10.1111/j.1528-1167.2012.03409.x; Gad SC, 2006, INT J TOXICOL, V25, P499, DOI 10.1080/10915810600961531; Galvao J, 2014, FASEB J, V28, P1317, DOI 10.1096/fj.13-235440; Goodfellow VS, 2013, J MED CHEM, V56, P8032, DOI 10.1021/jm401094t; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Harada A, 2017, J PHARMACOL EXP THER, V360, P75, DOI 10.1124/jpet.116.237388; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Hasebe M, 2008, INT J DEV NEUROSCI, V26, P409, DOI 10.1016/j.ijdevneu.2008.03.007; Julien C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040020; Kashaw SK, 2009, EUR J MED CHEM, V44, P4335, DOI 10.1016/j.ejmech.2009.05.008; Kikuchi R, 2013, DRUG METAB DISPOS, V41, P2012, DOI 10.1124/dmd.113.053868; Kumar D, 2013, EXCLI J, V12, P628; Larsen J, 1996, TOXICOL APPL PHARM, V140, P296, DOI 10.1006/taap.1996.0225; Lau K, 2012, PEDIATR RES, V71, P54, DOI 10.1038/pr.2011.12; Li SC, 2013, MAR DRUGS, V11, P5159, DOI 10.3390/md11125159; Loh ZH, 2015, ASIAN J PHARM SCI, V10, P255, DOI 10.1016/j.ajps.2014.12.006; Lu CB, 2001, EXP NEUROL, V170, P180, DOI 10.1006/exnr.2001.7686; Matias M, 2017, EUR J PHARM SCI, V102, P264, DOI 10.1016/j.ejps.2017.03.014; Mozaffari S, 2012, MED CHEM RES, V21, P3797, DOI 10.1007/s00044-011-9924-6; Pandeya SN, 2000, EUR J MED CHEM, V35, P879, DOI 10.1016/S0223-5234(00)01169-7; Partap S, 2018, BIOORG CHEM, V77, P74, DOI 10.1016/j.bioorg.2018.01.001; RAMMLER DH, 1967, ANN NY ACAD SCI, V141, P13, DOI 10.1111/j.1749-6632.1967.tb34861.x; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Stegemann S, 2007, EUR J PHARM SCI, V31, P249, DOI 10.1016/j.ejps.2007.05.110; Stella VJ, 2007, ADV DRUG DELIVER REV, V59, P677, DOI 10.1016/j.addr.2007.05.013; Thackaberry EA, 2014, XENOBIOTICA, V44, P235, DOI 10.3109/00498254.2013.845706; Thore SN, 2015, J HETEROCYCLIC CHEM, V52, P142, DOI 10.1002/jhet.1989; Torregrosa R, 2015, BIOORGAN MED CHEM, V23, P3655, DOI 10.1016/j.bmc.2015.04.014; Vafaeezadeh M, 2015, J MOL LIQ, V207, P73, DOI 10.1016/j.molliq.2015.03.003; Wang X, 2014, J NEUROSCI, V34, P7253, DOI 10.1523/JNEUROSCI.4936-13.2014; Waybright TJ, 2009, J BIOMOL SCREEN, V14, P708, DOI 10.1177/1087057109335670; Xie C, 2014, MED CHEM RES, V23, P2161, DOI 10.1007/s00044-013-0811-1; Yang HN, 2015, CARBOHYD POLYM, V122, P265, DOI 10.1016/j.carbpol.2014.12.073; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447; Zar T, 2007, SEMIN DIALYSIS, V20, P217, DOI 10.1111/j.1525-139X.2007.00280.x; Zhang LM, 2014, NEUROPHARMACOLOGY, V81, P116, DOI 10.1016/j.neuropharm.2013.09.016; Zhang WB, 2012, MED CHEM RES, V21, P2587, DOI 10.1007/s00044-011-9771-5	60	4	5	2	6	CANADIAN SOC PHARMACEUTICAL SCIENCES	EDMONTON	3118 DENTISTRY-PHARMACY CENTRE UNIV ALBERTA CAMPUS, EDMONTON, ALBERTA T6G2N8, CANADA	1482-1826			J PHARM PHARM SCI	J. Pharm. Pharm. Sci.		2018	21						110	118		10.18433/jpps29656			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GB4VR	WOS:000429060600010	29543586	gold			2022-02-06	
S	Morse, AM; Kothare, SV		Hainline, B; Stern, RA		Morse, Anne Marie; Kothare, Sanjeev V.			Sleep disorders and concussion	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; WAKE DISTURBANCES; PHYSICAL-ACTIVITY; INSOMNIA; MILD; RECOVERY; ASSOCIATION; DEPRESSION; COMPLAINTS	Sleep disorders are a common sequel of sports-related concussion. Sleep-wake dysfunction can vary among patients, independent of cause or severity of concussive injury. The pathogenesis of postconcussive sleep disorder is unclear, but may be related to impaired signaling in neurons involved in normal sleep-wake control and circadian rhythm maintenance. Standardized methods of assessment for sleep disorders following concussion are important for diagnosis and management. Appropriate management is key because sleep dysfunction can have deleterious effects on concussion recovery. Management is patient-specific, based on sleep pathology and comorbid postconcussive symptomatology.	[Morse, Anne Marie] Geisinger Med Ctr, Dept Child Neurol & Sleep Med, Danville, PA 17822 USA; [Kothare, Sanjeev V.] Cohen Childrens Med Ctr, Dept Pediat, Pediat Neurol & Pediat Sleep Program, Lake Success, NY USA		Kothare, SV (corresponding author), Northwell Hlth, Cohen Childrens Med Ctr, 2001 Marcus Ave,Suite W290, Lake Success, NY 11042 USA.	skothare@northwell.edu		Kothare, Sanjeev/0000-0001-7849-6649			Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; Annest JJ, 2005, PSYCHOL REP, V96, P891, DOI 10.2466/PR0.96.4.891-898; Aurora RN, 2010, J CLIN SLEEP MED, V6, P389; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bessot N, 2017, HEALTHY AGEING LONG, V7, P323, DOI 10.1007/978-3-319-64543-8_14; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; de Lecea L, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00016; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Gioia G, 2007, ACUTE CONCUSSION EVA; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hong CT, 2015, J NEUROL SCI, V358, P385, DOI 10.1016/j.jns.2015.09.376; Hou LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055400; Howie EK, 2012, J SPORT HEALTH SCI, V1, P160, DOI 10.1016/j.jshs.2012.09.003; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lakin-Thomas PL, 2000, TRENDS GENET, V16, P135, DOI 10.1016/S0168-9525(99)01945-9; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lettieri CJ, 2016, CHEST, V149, P483, DOI 10.1378/chest.15-0693; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Menn SJ, 2014, J CLIN SLEEP MED, V10, P1181, DOI 10.5664/jcsm.4196; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; Ohayon MM, 2005, J PSYCHIAT RES, V39, P151, DOI 10.1016/j.jpsychires.2004.07.001; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pandi-Perumal SR, 2007, PROG NEURO-PSYCHOPH, V31, P1, DOI 10.1016/j.pnpbp.2006.06.020; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Singh K, 2016, PEDIATR NEUROL, V60, P30, DOI 10.1016/j.pediatrneurol.2016.02.013; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	55	4	6	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						127	134		10.1016/B978-0-444-63954-7.00013-6			8	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100015	30482340				2022-02-06	
J	Naganawa, S; Nakane, T; Kawai, H; Taoka, T				Naganawa, Shinji; Nakane, Toshiki; Kawai, Hisashi; Taoka, Toshiaki			Differences in Signal Intensity and Enhancement on MR Images of the Perivascular Spaces in the Basal Ganglia versus Those in White Matter	MAGNETIC RESONANCE IN MEDICAL SCIENCES			English	Article						gadolinium; glymphatic system; magnetic resonance imaging; perivascular space	VIRCHOW-ROBIN SPACES; SMALL-VESSEL DISEASE; HEAVILY T-2-WEIGHTED 3D-FLAIR; TRAUMATIC BRAIN-INJURY; CONTRAST ENHANCEMENT; FLUID; PATHWAY; COGNITION; SYSTEM	Purpose: To elucidate differences between the perivascular space (PVS) in the basal ganglia (BG) versus that found in white matter (WM) using heavily T-2-weighted FLAIR (hT(2)-FL) in terms of 1) signal intensity on non-contrast enhanced images, and 2) the degree of contrast enhancement by intravenous single dose administration of gadolinium based contrast agent (IV-SD-GBCA). Materials and Methods: Eight healthy men and 13 patients with suspected endolymphatic hydrops were included. No subjects had renal insufficiency. All subjects received IV-SD-GBCA. MR cisternography (MRC) and hT(2)-FL images were obtained prior to and 4 h after IV-SD-GBCA. The signal intensity of the PVS in the BG, subinsular WM, and the cerebrospinal fluid (CSF) in Ambient cistern (CSFAC) and CSF in Sylvian fissure (CSFSyl) was measured as well as that of the thalamus. The signal intensity ratio (SIR) was calculated by dividing the intensity by that of the thalamus. We used 5% as a threshold to determine the significance of the statistical test. Results: In the pre-contrast scan, the SIR of the PVS in WM (Mean +/- standard deviation, 1.83 +/- 0.46) was significantly higher than that of the PVS in the BG (1.05 +/- 0.154), CSFSyl (1.03 +/- 0.15) and the CSFAC (0.97 +/- 0.29). There was no significant difference between the SIR of the PVS in the BG compared to the CSFAC and CSFSyl. For the evaluation of the contrast enhancement effect, significant enhancement was observed in the PVS in the BG, the CSFAC and the CSFSyl compared to the pre-contrast scan. No significant contrast enhancement was observed in the PVS in WM. Conclusion: The signal intensity difference between the PVS in the BG versus WM on pre-contrast images suggests that the fluid composition might be different between these PVSs. The difference in the contrast enhancement between the PVSs in the BG versus WM suggests a difference in drainage function.	[Naganawa, Shinji; Nakane, Toshiki; Kawai, Hisashi; Taoka, Toshiaki] Nagoya Univ, Grad Sch Med, Dept Radiol, Shouwa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan		Naganawa, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Radiol, Shouwa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	naganawa@med.nagoya-u.ac.jp	Taoka, Toshiaki/A-1637-2016; Naganawa, Shinji/I-1572-2012	Taoka, Toshiaki/0000-0001-9227-0240; Naganawa, Shinji/0000-0002-0214-613X			Adachi M, 2017, MAGN RESON MED SCI, V16, P238, DOI 10.2463/mrms.mp.2016-0063; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Groeschel S, 2006, NEURORADIOLOGY, V48, P745, DOI 10.1007/s00234-006-0112-1; Hurford R, 2014, J NEUROL NEUROSUR PS, V85, P522, DOI 10.1136/jnnp-2013-305815; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Ishikawa M, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0010-1; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jost G, 2017, EUR RADIOL, V27, P2877, DOI 10.1007/s00330-016-4654-2; Kanda T, 2015, RADIOLOGY, V276, P228, DOI 10.1148/radiol.2015142690; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Kwee RM, 2007, RADIOGRAPHICS, V27, P1071, DOI 10.1148/rg.274065722; Naganawa S, 2017, MAGN RESON MED SCI, V16, P89, DOI 10.2463/mrms.ci.2016-0114; Naganawa S, 2017, MAGN RESON MED SCI, V16, P61, DOI 10.2463/mrms.mp.2016-0039; Naganawa S, 2016, MAGN RESON MED SCI, V15, P308, DOI 10.2463/mrms.mp.2015-0121; Naganawa S, 2015, MAGN RESON MED SCI, V14, P203, DOI [10.2463/mrms.2014-0112, 10.2463/mrms.mp.2015-0065]; Naganawa S, 2014, MAGN RESON MED SCI, V13, P7, DOI 10.2463/mrms.2013-0056; Naganawa S, 2010, MAGN RESON MED SCI, V9, P73, DOI 10.2463/mrms.9.73; Ohashi T, 2018, MAGN RESON MED SCI, V17, P67, DOI 10.2463/mrms.mp.2017-0001; Song CJ, 2000, RADIOLOGY, V214, P671, DOI 10.1148/radiology.214.3.r00mr17671; Tomimoto H, 2007, EUR J NEUROL, V14, P95, DOI 10.1111/j.1468-1331.2006.01567.x; van Veluw SJ, 2016, J CEREBR BLOOD F MET, V36, P576, DOI 10.1177/0271678X15620434; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Yao M, 2014, CEREBROVASC DIS, V37, P155, DOI 10.1159/000356982; Zeppenfeld DM, 2017, JAMA NEUROL, V74, P91, DOI 10.1001/jamaneurol.2016.4370	28	4	4	0	1	JPN SOC MAGNETIC RESONANCE MEDICINE	TOKYO	GOTANDA PARK SIDE BLDG 4F, 5 24 9 HIGASHI-GOTANDA, SHINAGAWA-KU, TOKYO, 141-0022, JAPAN	1347-3182	1880-2206		MAGN RESON MED SCI	Magn. Reson. Med. Sci.		2018	17	4					301	307		10.2463/mrms.mp.2017-0137			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	GW5VF	WOS:000447007900007	29343658	Green Published, Green Submitted, gold			2022-02-06	
J	O'Brien, AM; Casey, JE; Salmon, RM				O'Brien, Amanda M.; Casey, Joseph E.; Salmon, Rachel M.			Short-term test-retest reliability of the ImPACT in healthy young athletes	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Baseline testing; children; concussion testing; psychometrics	SPORT-RELATED CONCUSSION; COMPUTERIZED NEUROPSYCHOLOGICAL ASSESSMENT; BASE-LINE; INTERNATIONAL-CONFERENCE; HIGH-SCHOOL; PSYCHOMETRIC ISSUES; CONSENSUS STATEMENT; TEST-PERFORMANCE; SEPARATE NORMS; NORMATIVE DATA	The present study examined the short-term test-retest reliability of the Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) variables with healthy 11- to 14-year-old athletes. 53 young athletes (M-ag(e) = 12.4 years, 9 female) were administered the ImPACT on two separate occasions two weeks apart. Participants were instructed to complete the Post-Concussion Symptom Scale (PCSS) and the baseline computerized neurocognitive test during both the baseline and retest phases. Intraclass correlation (ICC), standard error of measurement (SEM), and reliable change index (RCI) were used as reliability metrics. PCSS Total Symptoms and Visual-Motor Speed were the only scores to reach clinical reliability standards (i.e., R > 0.7). None of the scores exceeded RCI cut-offs. Results indicate that the composite scores of the ImPACT are differentially reliable in a preadolescent sample across a two-week retest period, with only motor processing speed and self-reported symptoms exceeding clinical reliability standards. The findings support the view that neurocognitive testing should not be the sole determining factor in concussion assessment. This study highlights the importance of continuing research with younger athletes to assess the reliability of neurocognitive measures in concussion management programs. Future research should focus on a larger, heterogeneous sample, including children with learning disabilities and ADHD.	[O'Brien, Amanda M.; Casey, Joseph E.; Salmon, Rachel M.] Univ Windsor, Dept Psychol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada		Casey, JE (corresponding author), Univ Windsor, Dept Psychol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	jecasey@uwindsor.ca	O'Brien, Amanda M./AAJ-2998-2020	Darroch, Amanda/0000-0001-8746-5553			Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barker C, 2015, RES METHODS CLIN PSY; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HOPKINS KD, 1990, EDUC PSYCHOL MEAS, V50, P717, DOI 10.1177/0013164490504001; ImPACT Applications, 2011, TECHNICAL MANUAL ONL; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kegel NE, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P117, DOI 10.1007/978-0-387-89545-1_10; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Lovell M. R., 2002, IMPACT BEST APPROACH; Lovell M. R., 2007, IMPACT IMMEDIATE POS; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Moser RS, 2017, APPL NEUROPSYCH-CHIL, V6, P166, DOI 10.1080/21622965.2016.1138310; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Resch JE, 2013, CLIN NEUROPSYCHOL, V27, P1265, DOI 10.1080/13854046.2013.845247; Reynolds E, 2016, APPL NEUROPSYCH-CHIL, V5, P283, DOI 10.1080/21622965.2015.1057637; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Urbina S, 1997, PSYCHOL TESTING; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2008, WAIS 4 TECHNICAL INT; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	55	4	4	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2018	7	3					208	216		10.1080/21622965.2017.1290529			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GR5KM	WOS:000442669800003	28631965				2022-02-06	
J	Olsen, DC; Hays, CC; Orff, HJ; Jak, AJ; Twamley, EW				Olsen, Donald C.; Hays, Chelsea C.; Orff, Henry J.; Jak, Amy J.; Twamley, Elizabeth W.			Correlates of employment and postsecondary education enrolment in Afghanistan and Iraq veterans with traumatic brain injuries	BRAIN INJURY			English	Article						postconcussive symptoms; unemployment; reintegration; disability	MILD HEAD-INJURY; SYMPTOMS; MILITARY; METAANALYSIS; POPULATION	Primary Objective: About 20% of Iraq and Afghanistan Veterans have sustained a traumatic brain injury (TBI), which can result in postconcussive symptoms and difficulty transitioning from the military to civilian employment and postsecondary education. To better inform programs help Veterans transition back into civilian life, we evaluated correlates of employment and postsecondary education enrolment among treatment-seeking Veterans with a history of TBI. Research Design: A cross-sectional design, using an archival database of VA medical records, was used to answer these research questions.Methods and Procedures: We examined demographic, TBI-related, postconcussive, psychiatric, and neuropsychological factors in 390 Veterans (86% with mild TBI) to determine what factors were associated with employment or enrolment in postsecondary education. Bivariate correlations and multivariate regression were used.Main Outcomes and Results: age, minority status, and service connected disability ratings were significantly associated with employment and postsecondary education enrolment in a multivariate context, whereas TBI-related factors and neurocognitive, postconcussive, and psychiatric symptom severity were not associated with employment or postsecondary education outcomes.Conclusions: Further research is needed to confirm these findings and to evaluate the contribution of age, minority status, and disability on successful return to work and/or school for Veterans with a history of TBI.	[Olsen, Donald C.] Alliant Int Univ, Clin Psychol PhD Program, San Diego, CA USA; [Hays, Chelsea C.] SDSU UCSD Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Orff, Henry J.; Jak, Amy J.; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Orff, Henry J.; Jak, Amy J.; Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA		Twamley, EW (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr 116A, San Diego, CA 92161 USA.	etwamley@ucsd.edu			RRD VA [IK2 RX001512] Funding Source: Medline; Veterans AffairsUS Department of Veterans Affairs [IK2RX001512] Funding Source: NIH RePORTER		Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beck AT, 1993, BECK ANXIETY INVENTO; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Broshek DK, 2000, NEUROPSYCHOLOGICAL A; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COHANY SR, 1990, MON LABOR REV, V113, P22; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fischer Hannah, 2009, US MILITARY CASUALTY; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Grant DA, 2000, WISCONSIN CARD SORTI; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Orff HJ, 2013, FOCUS J LIFE LONG LE, V11, P328; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tombaugh T.N., 1996, TEST MEMORY MALINGER; US Bureau of Labor, 2011, EMPL SIT VET 2011 EC; US Census Bureau, 2012, ENR STAT POP 3 YEARS; US Department of Veterans Affairs, 2016, VA DOD POST 9 11 GI; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Veterans for Common Sense, 2011, VCS FACT SHEETS REP; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2008, WECHSLER ADULT INTEL; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	46	4	4	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					544	549		10.1080/02699052.2018.1431845			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200003	29370539				2022-02-06	
B	Ownsworth, T		Haslam, C; Kessels, RPC		Ownsworth, Tamara			ERRORS: FRIEND OR FOE? The theory and evidence base for error-based learning	ERRORLESS LEARNING IN NEUROPSYCHOLOGICAL REHABILITATION: MECHANISMS, EFFICACY AND APPLICATION	Current Issues in Neuropsychology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; MEMORY-IMPAIRED PATIENTS; SELF-AWARENESS; EXECUTIVE FUNCTION; PSYCHOSOCIAL ADJUSTMENT; METACOGNITIVE SKILLS; NATURALISTIC ACTION; VIDEO FEEDBACK; REHABILITATION; INTERVENTION		[Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Clin Neuropsychol, Nathan, Qld, Australia; [Ownsworth, Tamara] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia		Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Clin Neuropsychol, Nathan, Qld, Australia.; Ownsworth, T (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia.		Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094			Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; Bertens D, 2015, J INT NEUROPSYCH SOC, V21, P639, DOI 10.1017/S1355617715000764; Bertens D, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-64; Bettcher BM, 2008, J INT NEUROPSYCH SOC, V14, P199, DOI 10.1017/S1355617708080193; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Burgess P, 1996, BEHAV ASSESSMENT DYS; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Efklides A., 2002, METACOGNITION, P19, DOI 10.1007/978-1-4615-1099-4_2; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Ford JM, 2001, PSYCHOL AGING, V16, P161, DOI 10.1037/0882-7974.16.1.161; Giovannetti T, 2002, J INT NEUROPSYCH SOC, V8, P633, DOI 10.1017/S135561770280131X; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Haslam C, 2017, NEUROPSYCHOL REHABIL, V27, P60, DOI 10.1080/09602011.2015.1053947; Katz Noomi, 2002, Can J Occup Ther, V69, P281; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Mathalon DH, 2003, NEUROBIOL AGING, V24, P675, DOI 10.1016/S0197-4580(02)00154-9; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T., 2015, FUNCTIONAL SIGNIFICA; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-369; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Robertson I., 1996, GOAL MANAGEMENT TRAI; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Schmidt J, 2015, NEUROREHABILITATION, V36, P175, DOI 10.3233/NRE-151205; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Tanguay AN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00272; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; [No title captured]	54	4	4	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-95925-5; 978-1-315-66073-8; 978-1-138-95924-8	CURR ISS NEUROPSYCH			2018							164	179			10.4324/9781315660738		16	Psychology, Clinical; Neurosciences; Psychology; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Rehabilitation	BL9FJ	WOS:000457355600011					2022-02-06	
J	Pastore, V; Galbiati, S; Recla, M; Colombo, K; Beretta, E; Strazzer, S				Pastore, Valentina; Galbiati, Susanna; Recla, Monica; Colombo, Katia; Beretta, Elena; Strazzer, Sandra			Psychological and behavioural difficulties following severe TBI in adolescence: a comparison with a sample of peers with brain lesions of other origin and with a control group	BRAIN INJURY			English	Article						Brain injuries; adolescent; behavioural symptoms; psychological adjustment	QUALITY-OF-LIFE; DEFICIT HYPERACTIVITY DISORDER; PROBLEM-SOLVING SKILLS; SCHOOL-AGED PATIENTS; 1ST 6 MONTHS; ADJUSTMENT PROBLEMS; PRACTICAL SCALE; INJURY EVIDENCE; CHILDREN; CHILDHOOD	Objective: To describe behavioural and adjustment problems in a group of 57 adolescents with severe traumatic brain injury (TBI) and compare them with a clinical group of peers with brain lesions of other origin (N=33) and a control group of healthy adolescents (N=48).Methods: All subjects received an age-appropriate assessment, including the child behaviour checklist (CBCL) 4/18, the strengths and difficulties questionnaire (SDQ) and the vineland adaptive behaviour scales (VABS).Results: Compared with healthy peers, adolescents with TBI presented with more marked behavioural problems on most CBCL scales (Internalization and Externalization domains were both affected) and on the SDQ Hyperactivity and Peer problems scales. They also showed a more impaired functioning in most VABS domains. Compared with adolescents with brain lesions of other aetiology, patients with TBI showed more conduct problems on the SDQ scale, but no significant differences were found on the CBCL scales. Regarding the VABS, patients with other lesions presented with the worst outcome in the Motor and Daily Living Skills domains.Conclusions: Adolescents with TBI are exposed at a very high risk to develop behavioural and psychological disturbances with the potential to severely affect their social re-entry. Further knowledge is needed to plan early and well-timed interventions.	[Pastore, Valentina; Galbiati, Susanna; Recla, Monica; Colombo, Katia; Beretta, Elena; Strazzer, Sandra] Eugenio Medea Sci Inst, Neurophysiat Dept, I-23842 Lecce, Bosisio Parini, Italy		Pastore, V (corresponding author), Eugenio Medea Sci Inst, Neurophysiat Dept, I-23842 Lecce, Bosisio Parini, Italy.	valentina.pastore@bp.lnf.it	Recla, Monica/ABG-1905-2020; Beretta, Elena/AAH-5369-2019; Galbiati, Susanna/AAH-6883-2019; Strazzer, Sandra/AAH-5712-2019; Colombo, Katia/ABE-5754-2020; Pastore, Valentina/AAH-6831-2019	Recla, Monica/0000-0002-3001-8872; Beretta, Elena/0000-0002-8036-7624; Galbiati, Susanna/0000-0001-7209-4251; Strazzer, Sandra/0000-0001-8414-6565; Colombo, Katia/0000-0002-5390-106X; Pastore, Valentina/0000-0002-3170-3070	RICERCA CORRENTE [-RICERCA CORRENTE 2011-2013. 'E.MEDEA' SCIENTI, RICERCA CORRENTE 2014-2016. 'E. MEDEA' SCIEN]	This work was supported by the RICERCA CORRENTE [-RICERCA CORRENTE 2011-2013. 'E.MEDEA' SCIENTI, RICERCA CORRENTE 2014-2016. 'E. MEDEA' SCIEN].	Achenbach T. M., 1983, CHILD BEHAV CHECKLIS; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Anderson VA, 2014, DEV MED CHILD NEUROL, V56, P329, DOI 10.1111/dmcn.12387; Bardoni A, 2013, BRAIN INJURY, V27, P1395, DOI 10.3109/02699052.2013.823652; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carraro E, 2008, EURA MEDICOPHYS, V44, P1; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Di Battista A, 2014, J REHABIL MED, V46, P975, DOI 10.2340/16501977-1883; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Graham JE, 2014, AM J PHYS MED REHAB, V93, P231, DOI 10.1097/PHM.0b013e3182a92c58; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Heverly-Fitt S, 2014, J INT NEUROPSYCH SOC, V20, P684, DOI 10.1017/S1355617714000393; Hillis AE, 2014, BRAIN, V137, P981, DOI 10.1093/brain/awt317; Hollingshead A. B., 1975, UNPUB; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108167; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; JENNETT B, 1975, LANCET, V1, P480; Ladd GW, 2006, CHILD DEV, V77, P822, DOI 10.1111/j.1467-8624.2006.00905.x; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Liao CC, 2012, J TRAUMA ACUTE CARE, V73, P1327, DOI 10.1097/TA.0b013e31826fc87f; Max JE, 1998, BRAIN INJURY, V12, P41; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Pastore V, 2015, BRAIN INJURY, V29, P937, DOI 10.3109/02699052.2015.1008045; Pastore V, 2014, J CHILD NEUROL, V29, P1664, DOI 10.1177/0883073813513329; Pastore V, 2013, BRAIN INJURY, V27, P677, DOI 10.3109/02699052.2013.775482; Pastore V, 2011, DISABIL REHABIL, V33, P675, DOI 10.3109/09638288.2010.506239; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Recla M, 2013, BRAIN INJURY, V27, P862, DOI 10.3109/02699052.2013.775499; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Ross KA, 2011, BRAIN INJURY, V25, P1206, DOI 10.3109/02699052.2011.609519; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Slifer KJ, 2009, DEV DISABIL RES REV, V15, P144, DOI 10.1002/ddrr.60; Swensen A, 2004, J ADOLESCENT HEALTH, V35, P1; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tomaszewski W, 2014, ANN AGR ENV MED, V21, P649, DOI 10.5604/12321966.1120620; Tonks J, 2010, NEUROPSYCHOL REHABIL, V20, P922, DOI 10.1080/09602011.2010.519209; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	67	4	4	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		1011	1020		10.1080/02699052.2018.1469041			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400008	29738269				2022-02-06	
J	Petley, L; Bardouille, T; Chiasson, D; Froese, P; Patterson, S; Newman, A; Omisade, A; Beyea, S				Petley, Lauren; Bardouille, Tim; Chiasson, Darrell; Froese, Patrick; Patterson, Steve; Newman, Aaron; Omisade, Antonina; Beyea, Steven			Attentional dysfunction and recovery in concussion: effects on the P300m and contingent magnetic variation	BRAIN INJURY			English	Article						Mtbi; visual attention; magnetoencephalography; MEG; attention network test; ANT	TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; HEAD-INJURY; NEGATIVE-VARIATION; COMPONENTS; RELIABILITY; SYMPTOMS; CHILDREN; NETWORKS; DEFICITS	Primary objective: To examine the effect of concussion on indices of attention using magnetoencephalography.Methods and procedures: Thirteen patients were recruited from the emergency department and scanned within 3-6days of injury. Five returned for follow-up scans one and three months post-injury. Thirteen healthy controls also completed testing. During MEG acquisition, participants performed the Attention Network Test (ANT). Cognitive evoked responses to this task include a cue-evoked P300m, a contingent magnetic variation (CMV) and a target-evoked P300m. The Rivermead Postconcussion Symptom Questionnaire and Sport Concussion Assessment Tool (SCAT3) were administered in all sessions.Results: Patients suffering from concussion had slower response times and benefitted more from spatial cues than did controls. Global activation for all three evoked responses was lower for patients than controls. In a small sample of patients who returned for follow-up, the CMV and target P300m improved with recovery.Conclusions: MEG-evoked responses to the ANT reveal neurophysiological evidence of attentional dysfunction within days of injury. A pattern of improvement was also observed over the course of three months for the P300m, while behavioural performance did not change significantly. Further development of this method may yield a useful adjunct to neurological examination for concussion diagnosis and monitoring.	[Petley, Lauren; Bardouille, Tim; Beyea, Steven] IWK Hlth Ctr, Biomed Translat Imaging Ctr BIOTIC, Halifax, NS, Canada; [Petley, Lauren; Bardouille, Tim; Patterson, Steve; Newman, Aaron; Beyea, Steven] Dalhousie Univ, Halifax, NS, Canada; [Petley, Lauren; Chiasson, Darrell; Froese, Patrick; Omisade, Antonina; Beyea, Steven] QEII Hlth Sci Ctr, Nova Scotia Hlth Author, Halifax, NS, Canada		Petley, L (corresponding author), 2150 Shattuck Ave,Ste 408, Berkeley, CA 94704 USA.	lauren.petley.phd@gmail.com	Newman, Aaron/A-6835-2011	Newman, Aaron/0000-0001-5290-8342; Beyea, Steven/0000-0001-7851-0017	Atlantic Innovation Fund (AIF) grant from the Atlantic Canada Opportunities Agency (ACOA)	All work described herein was supported by an Atlantic Innovation Fund (AIF) grant from the Atlantic Canada Opportunities Agency (ACOA) for industry-partnered research. All or a portion of the reported results could contribute to the future development of a commercial product.	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; BRUNIA CHM, 1988, BIOL PSYCHOL, V26, P165, DOI 10.1016/0301-0511(88)90018-X; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaetz M, 2000, BRAIN INJURY, V14, P815; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hamano T, 1997, EVOKED POTENTIAL, V104, P257, DOI 10.1016/S0168-5597(97)96107-4; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Ishigami Y, 2013, J NEUROSCI METH, V216, P1, DOI 10.1016/j.jneumeth.2013.02.013; Ishigami Y, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00017; Ishigami Y, 2010, J NEUROSCI METH, V190, P117, DOI 10.1016/j.jneumeth.2010.04.019; Johnson KA, 2008, J CHILD PSYCHOL PSYC, V49, P1339, DOI 10.1111/j.1469-7610.2008.01936.x; Kelly JP, 1997, NEUROLOGY, V48, P581; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Konrad K, 2006, BIOL PSYCHIAT, V59, P643, DOI 10.1016/j.biopsych.2005.08.013; KUTAS M, 1980, BRAIN RES, V202, P95, DOI 10.1016/S0006-8993(80)80037-0; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Meeren HKM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071408; Missonnier P, 2013, NEURODEGENER DIS, V12, P59, DOI 10.1159/000338815; Muller A, 2015, NEUROREPORT, V26, P952, DOI 10.1097/WNR.0000000000000447; Neuhaus AH, 2007, J PSYCHIATR RES, V41, P635, DOI 10.1016/j.jpsychires.2006.06.012; Oberlin BG, 2005, BEHAV BRAIN RES, V165, P1, DOI 10.1016/j.bbr.2005.06.041; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmese CA, 2000, BRAIN INJURY, V14, P535; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; ROHRBAUGH JW, 1976, SCIENCE, V191, P1055, DOI 10.1126/science.1251217; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Trujillo LT, 2009, SLEEP, V32, P1285, DOI 10.1093/sleep/32.10.1285; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Wang K, 2005, SCHIZOPHR RES, V78, P235, DOI 10.1016/j.schres.2005.01.019	53	4	4	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	4					464	473		10.1080/02699052.2018.1429022			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FV9WZ	WOS:000424942400010	29355389				2022-02-06	
J	Raskin, SA; Shum, DHK; Ellis, J; Pereira, A; Mills, G				Raskin, Sarah A.; Shum, David H. K.; Ellis, Judi; Pereira, Antonia; Mills, Ginger			A comparison of laboratory, clinical, and self-report measures of prospective memory in healthy adults and individuals with brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Assessment; brain injury; episodic memory; prospective memory; self-report	COMPREHENSIVE ASSESSMENT; RETROSPECTIVE MEMORY; NORMATIVE DATA; EVENT; TIME; PERFORMANCE; INTENTIONS; AWARENESS; CUE; SCHIZOPHRENIA	Individuals with traumatic brain injury (TBI) have demonstrated deficits in prospective memory (PM) functioning when compared to healthy adults. These deficits have been measured using laboratory measures, clinical measures, and self-report questionnaires. However, PM has been shown to involve multiple cognitive processes and have a variety of stages. Thus, it is not known whether these measures all assess the same aspects of PM. Thus, this study was designed to measure the convergent validity of the three types of PM measures in both healthy adults and individuals with TBI. We aimed to investigate the convergent validity of the three types of tasks in two ways. First, we sought to investigate whether the PM deficits experienced by people with TBI are consistent across tasks. Second, we sought to examine the relationship between the three types of tasks. Results demonstrated that while all three types of measures were sensitive to PM deficits in TBI, there were differences in the aspects/processes of PM being measured. Data from the laboratory measure suggested a specific difficulty with detecting the correct cue. Data from the clinical measure suggested that TBI has a greater effect on time-based cues than event-based cues and that the primary deficit is a prospective intention retrieval deficit rather than the retrospective memory component. In addition, those with TBI did not differ from healthy adults when the time delay was short enough, suggesting that PM is not universally impaired. Data from the self-report questionnaire suggested that those with TBI are more sensitive to difficulties with basic activities of daily living rather than instrumental activities on daily living. These results are discussed in terms of rehabilitation techniques that could focus first on cue detection and use basic activities of daily living as outcome measures.	[Raskin, Sarah A.] Trinity Coll, Dept Psychol & Neurosci Program, Hartford, CT 06106 USA; [Shum, David H. K.] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Gold Coast, Qld, Australia; [Shum, David H. K.] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, CAS Key Lab Mental Hlth, Beijing, Peoples R China; [Ellis, Judi] Univ Reading, Dept Psychol, Reading, Berks, England; [Pereira, Antonia] Univ Chichester, Dept Psychol, Chichester, England; [Mills, Ginger] Univ Hartford, Dept Clin Physiol, Hartford, CT USA		Raskin, SA (corresponding author), Trinity Coll, Dept Psychol & Neurosci Program, Hartford, CT 06106 USA.	sarah.raskin@trincoll.edu	Pereira, Antonina/AAA-4225-2021; Raskin, Sarah/T-1420-2019; Pereira, Antonina/H-1241-2016; Shum, David H. K./A-3914-2008	Pereira, Antonina/0000-0001-5206-4063; Raskin, Sarah/0000-0002-4310-4278; Pereira, Antonina/0000-0001-5206-4063; Shum, David H. K./0000-0002-4810-9262			Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Beck AT, 1987, MANUAL REVISED BECK; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Carey CL, 2004, CLIN NEUROPSYCHOL, V18, P234, DOI 10.1080/13854040490501448; Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Chi SY, 2014, J INT NEUROPSYCH SOC, V20, P1015, DOI 10.1017/S1355617714000964; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; d'Ydewalle G, 2001, AM J PSYCHOL, V114, P411, DOI 10.2307/1423688; Delprado J, 2012, J INT NEUROPSYCH SOC, V18, P295, DOI 10.1017/S135561771100172X; Dobbs AR, 1996, PROSPECTIVE MEMORY T, P199; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Elliott J, 2008, POPULAR FEMINIST FICTION AS AMERICAN ALLEGORY: REPRESENTING NATIONAL TIME, P1, DOI 10.1057/9780230612808; Fleming J, 2000, BRAIN IMPAIR, V1, P141, DOI DOI 10.1375/brim.1.2.141; Fleming J, 2009, BRAIN IMPAIR, V10, P34, DOI 10.1375/brim.10.1.34; Fleming JM, 1996, BRAIN INJURY, V10, P1; Foster ER, 2009, NEUROPSYCHOLOGY, V23, P347, DOI 10.1037/a0014692; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Huang J, 2014, NEUROPSYCHOL REHABIL, V24, P61, DOI 10.1080/09602011.2013.854723; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kvavilashvili L, 2013, Q J EXP PSYCHOL, V66, P864, DOI 10.1080/17470218.2012.721379; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Man DWK, 2011, NEUROPSYCHOL REHABIL, V21, P884, DOI 10.1080/09602011.2011.627270; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Maylor EA, 2002, MEM COGNITION, V30, P871, DOI 10.3758/BF03195773; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Mitchell MB, 2011, GERONTOLOGIST, V51, P179, DOI 10.1093/geront/gnq087; Molander B, 1998, SCAND J PSYCHOL, V39, P275, DOI 10.1111/1467-9450.00087; Nelson D. L., 1998, U S FLORIDA WORD ASS; Neulinger K., 2015, AGING NEUROPSYCHOL C, V25, P1; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pavawalla SP, 2012, NEUROPSYCHOLOGY, V26, P91, DOI 10.1037/a0025866; Paxton J, 2014, J INT NEUROPSYCH SOC, V20, P673, DOI 10.1017/S1355617714000575; Pereira A, 2012, CONSCIOUS COGN, V21, P1257, DOI 10.1016/j.concog.2012.04.012; Radford KA, 2011, CLIN NEUROPSYCHOL, V25, P127, DOI 10.1080/13854046.2010.529463; Raskin S., 2010, MEMORY INTENTIONS TE; Raskin SA, 2019, NEUROPSYCHOL REHABIL, V29, P289, DOI 10.1080/09602011.2017.1294082; Raskin SA, 2014, NEUROPSYCHOLOGY, V28, P359, DOI 10.1037/neu0000040; Raskin SA, 2012, NEUROPSYCHOL REHABIL, V22, P40, DOI 10.1080/09602011.2011.632908; Raskin SA, 2011, NEUROPSYCHOLOGY, V25, P201, DOI 10.1037/a0020999; Raskin SA, 2009, BRAIN IMPAIR, V10, P76, DOI 10.1375/brim.10.1.76; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Rendell PG, 2009, BRAIN IMPAIR, V10, P14, DOI 10.1375/brim.10.1.14; Rendell PG, 1999, J GERONTOL B-PSYCHOL, V54, pP256, DOI 10.1093/geronb/54B.4.P256; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Scullin MK, 2013, COGNITIVE PSYCHOL, V67, P55, DOI 10.1016/j.cogpsych.2013.07.001; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Shum D, 2004, SCHIZOPHRENIA BULL, V30, P693, DOI 10.1093/oxfordjournals.schbul.a007123; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Steer, 1990, MANUAL BECK ANXIETY; TEASDALE G, 1974, LANCET, V2, P81; Twamley EW, 2008, SCHIZOPHR RES, V106, P42, DOI 10.1016/j.schres.2007.10.030; Uttl B, 2011, CAN J EXP PSYCHOL, V65, P57, DOI 10.1037/a0022843; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Waugh N., 1999, THESIS; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Woods S, 2010, ARCH CLIN NEUROPSYCH, V25, P543; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263; Woods SP, 2009, J INT NEUROPSYCH SOC, V15, P42, DOI 10.1017/S1355617708090012; [No title captured]	69	4	4	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2018	40	5					423	436		10.1080/13803395.2017.1371280			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GE9RS	WOS:000431568400001	28946819	Green Accepted			2022-02-06	
J	Rhea, EM; Bullock, KM; Banks, WA				Rhea, Elizabeth M.; Bullock, Kristin M.; Banks, William A.			Effect of controlled cortical impact on the passage of pituitary adenylate cyclase activating polypeptide (PACAP) across the blood-brain barrier	PEPTIDES			English	Article						Traumatic brain injury; Controlled cortical impact; PACAP38; Blood-brain barrier	CEREBRAL-ARTERY OCCLUSION; INJURY; TRANSPORT; MICE; PERMEABILITY; DEATH; RATS	Injuries to the central nervous system can affect the blood-brain barrier (BBB), including disruption and influencing peptide transport across the BBB. Pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) is a potent neurotrophic and neuroprotective peptide currently being investigated for its therapeutic role following injury to the central nervous system and can cross the BBB in a saturable manner. The goal of the current study was to investigate for the first time PACAP38 uptake by the brain following traumatic brain injury (TBI). Using radioactively labeled PACAP38, we measured the levels of PACAP38 present in the injured, ipsilateral cortex in Sham-treated mice compared to mice receiving a controlled cortical impact (CCI), a model of TBI. Experiments were conducted at 6 different time points (from 2 h up to 4 weeks) following CCI to determine temporal changes in PACAP38 transport. PACAP38 uptake was increased at 2 and 72 h post-CCI compared to Sham. We did not detect changes in PACAP38 uptake in the contralateral cortex and cerebellum between Sham and CCI-treatment. The rate of PACAP38 transport into the ipsilateral cortex following CCI was increased 3.6-fold 72 h after compared to 2 h post-CCI. In addition, the rate of transport into the cerebellum was greater than that of the cortices. The data presented here shows PACAP38 transport is temporally altered following CCI-treatment and PACAP38 uptake is greater in the cerebellum compared to the cortices.	[Rhea, Elizabeth M.; Banks, William A.] Univ Washington, Sch Med, Div Gerontol & Geriatr Med, Seattle, WA USA; [Rhea, Elizabeth M.; Bullock, Kristin M.; Banks, William A.] VA Puget Sound, Geriatr Res & Educ Clin Ctr, Seattle, WA USA		Rhea, EM (corresponding author), VA Puget Sound, Res & Dev, Seattle, WA 98108 USA.		Meredith, Elizabeth/AAM-4574-2021; Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AG000057, RO1AG046619]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG046619, T32AG000057] Funding Source: NIH RePORTER	This study was supported by the National Institute of Health (T32AG000057 to E.M.R. and RO1AG046619 to W.A.B.).	Banks W. A., 2016, CONSEQUENCES DIS STA; BANKS WA, 1993, J PHARMACOL EXP THER, V267, P690; Banks WA, 1998, EXP NEUROL, V151, P116, DOI 10.1006/exnr.1998.6786; BANKS WA, 1994, PEPTIDES, V15, P23, DOI 10.1016/0196-9781(94)90165-1; Banks WA, 1996, ANN NY ACAD SCI, V805, P270; Banks WA, 1996, ANN NY ACAD SCI, V805, P277; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Bukovics P, 2014, PEPTIDES, V60, P18, DOI 10.1016/j.peptides.2014.07.001; Friess SH, 2015, J NEUROTRAUM, V32, P791, DOI 10.1089/neu.2014.3564; Liu Y. L., 2017, ACTA PHARM SIN, V3; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Matsumoto M, 2016, J MOL NEUROSCI, V59, P270, DOI 10.1007/s12031-016-0731-x; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Miyamoto K, 2014, J MOL NEUROSCI, V54, P370, DOI 10.1007/s12031-014-0309-4; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Mizushima H, 1999, PEPTIDES, V20, P1337, DOI 10.1016/S0196-9781(99)00143-6; Nonaka N, 2002, PEPTIDES, V23, P2197, DOI 10.1016/S0196-9781(02)00248-6; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Reglodi D, 2000, STROKE, V31, P1411, DOI 10.1161/01.STR.31.6.1411; Shioda S, 2015, PEPTIDES, V72, P202, DOI 10.1016/j.peptides.2015.08.006; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Somogyvari-Vigh A, 2000, REGUL PEPTIDES, V91, P89, DOI 10.1016/S0167-0115(00)00123-3; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491	25	4	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JAN	2018	99						8	13		10.1016/j.peptides.2017.10.013			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	FS1HD	WOS:000419525600002	29107653	Green Accepted, Bronze			2022-02-06	
J	Ringrose, H; Brown, M; Walton, K; Sivan, M				Ringrose, Hollie; Brown, Mary; Walton, Krystyna; Sivan, Manoj			Association between Paroxysmal Sympathetic Hyperactivity and tracheostomy weaning in Traumatic Brain Injury	NEUROREHABILITATION			English	Article						Paroxysmal autonomic instability; dystonia; intensive care; neurorehabilitation	DYSAUTONOMIA	BACKGROUND: Rehabilitation following severe Traumatic Brain Injury (TBI) often involves the use of temporary tracheostomies. Tracheostomy weaning is influenced by physiological parameters, which are abnormal in the concomitant complication of Paroxysmal Sympathetic Hyperactivity (PSH). OBJECTIVE: To investigate the association between PSH and tracheostomy weaning in severe TBI. METHODS: This was a retrospective cohort study of consecutive patients with TBI and tracheostomy admitted to a Hyper-Acute Neurorehabilitation Unit over a 34-month period. Duration of tracheostomy wean and influencing characteristics were statistically compared between those with and without PSH. RESULTS: Fifty-one patients admitted with TBI required a tracheostomy. Of these, 10 patients were also diagnosed with PSH. The mean tracheostomy wean in the PSH group was longer compared to the non-PSH group (72.3, SD 61.0 versus 30.0 days, SD 16.2). This difference was statistically significant (p = 0.007, using Mann Whitney U test). The PSH group had more respiratory and oral secretions, but this was not statistically significant (p = 0.16 and 0.29). CONCLUSIONS: This is the first study to demonstrate that PSH is associated with prolonged tracheostomy weaning in severe TBI. Awareness of this association should enable those planning rehabilitation to set realistic goals for a patient's tracheostomy	[Ringrose, Hollie; Brown, Mary; Walton, Krystyna; Sivan, Manoj] Salford Royal Hosp, Dept Rehabil Med Neurol, Salford, Lancs, England; [Ringrose, Hollie] Burnley Gen Hosp, Rakehead Rehabil Ctr, Burnley, Lancs, England; [Sivan, Manoj] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England; [Sivan, Manoj] Univ Leeds, Acad Dept Rehabil Med, Leeds, W Yorkshire, England		Ringrose, H (corresponding author), Burnley Gen Teaching Hosp, Rakehead Rehabil Ctr, Rehabil Med, Casterton Ave, Burnley BB10 2PQ, Lancs, England.	hollie.ringrose@nhs.net		Sivan, Manoj/0000-0002-0334-2968			Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; British Society of Rehabilitation Medicine, 2015, SPEC NEUR SERV PROV; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Friedland D, 2013, ACNR, V13; GORDON E, 1995, J NEUROSURG ANESTH, V7, P235, DOI 10.1097/00008506-199510000-00001; Hinson HE, 2015, BRAIN INJURY, V29, P455, DOI 10.3109/02699052.2014.995229; Hughes J. D, 2013, EARLY DIAGNOSIS PSH; Intensive Care Society, 2014, STAND CAR AD PAT TEM; Laxe S, 2013, BRAIN INJURY, V27, P1383, DOI 10.3109/02699052.2013.823648; Mitton K, 2017, BRAIN INJURY, V31, P267, DOI 10.1080/02699052.2016.1250951; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Richard I, 2005, ANN FR ANESTH, V24, P659, DOI 10.1016/j.annfar.2005.03.010; Rogers DF, 2002, CURR OPIN PHARMACOL, V2, P249, DOI 10.1016/S1471-4892(02)00146-7; Zanata ID, 2014, INT ARCH OTORHINOLAR, V18, P108, DOI 10.1055/s-0033-1363467	16	4	5	1	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	2					207	212		10.3233/NRE-172276			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FZ0WT	WOS:000427295800010	29562563	Green Accepted			2022-02-06	
B	Roebuck-Spencer, T; Desire, N; Beauchamp, M		Donders, J; Hunter, SJ		Roebuck-Spencer, Tresa; Desire, Naddley; Beauchamp, Miriam			Traumatic Brain Injury	NEUROPSYCHOLOGICAL CONDITIONS ACROSS THE LIFESPAN			English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSION SYMPTOMS; COLLEGIATE FOOTBALL PLAYERS; POST-CONCUSSIVE SYMPTOMS; IMPAIRED SELF-AWARENESS; COMMON DATA ELEMENTS; HEAD-INJURY; COGNITIVE INTERVENTION; OUTCOME PREDICTION; ANXIETY DISORDERS		[Roebuck-Spencer, Tresa] Jefferson Neurobehav Grp, Metairie, LA 70002 USA; [Desire, Naddley] Alberta Childrens Prov Gen Hosp, CHU St Justine, Res Ctr, Calgary, AB, Canada; [Beauchamp, Miriam] Univ Montreal, Montreal, PQ, Canada		Roebuck-Spencer, T (corresponding author), Jefferson Neurobehav Grp, Metairie, LA 70002 USA.						Albrecht MA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00105; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barr RG, 2009, PEDIATRICS, V123, P972, DOI 10.1542/peds.2008-0908; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Bryck RL, 2012, AM PSYCHOL, V67, P87, DOI 10.1037/a0024657; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2015, REPORT C TRAUMATIC B; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen RA, 1999, J NEUROPSYCH CLIN N, V11, P444, DOI 10.1176/jnp.11.4.444; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Defense and Veterans Brain Injury Center, 2016, DOD NUMBERS TRAUMATI; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Doig E, 2014, AM J OCCUP THER, V68, P578, DOI 10.5014/ajot.2014.010785; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Eren S, 2014, SOCIAL CARE NEURODIS, V5, P135, DOI [10.1108/SCN-06-2013-0022, DOI 10.1108/SCN-06-2013-0022]; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Institute of Medicine, 2009, GULF WAR HLTH VOLUME, V7; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kenny DT, 2007, CONT ISSUES CRIME JU, V107, P1; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin H.S., 2014, UNDERSTANDING TRAUMA; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Marr A., 2004, CENTRAL NERVOUS SYST; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Masten SV, 2011, JAMA-J AM MED ASSOC, V306, P1098, DOI 10.1001/jama.2011.1277; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Milders M, 1998, MEMORY, V6, P21, DOI 10.1080/741941597; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Paniak C, 2000, BRAIN INJURY, V14, P219; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Pinchuk D, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00025; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Randolph C, 2005, J ATHL TRAINING, V40, P139; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Sauber-Schatz EK, 2015, MMWR SURVEILL SUMM, V64, P1, DOI 10.15585/mmwr.ss6408a1; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Sawyer Q, 2016, J ATHL TRAINING, V51, P739, DOI 10.4085/1062-6050-51.12.01; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Segev S, 2016, NEUROPSYCHOLOGY, V30, P800, DOI 10.1037/neu0000299; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 2010, J HEAD TRAUMA REHAB, V25, P92, DOI 10.1097/HTR.0b013e3181c9d887; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Waldron-Perrine B, 2015, BRAIN INJURY, V29, P1051, DOI 10.3109/02699052.2015.1004742; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; WEHMAN PH, 1991, ARCH PHYS MED REHAB, V72, P101; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	135	4	4	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-1-107-19001-6				2018							139	161			10.1017/9781316996751		23	Clinical Neurology; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BQ7BX	WOS:000614258300009					2022-02-06	
J	Fernandez, IS; Sansevere, AJ; Gainza-Lein, M; Buraniqi, E; Tasker, RC; Loddenkemper, T				Sanchez Fernandez, Ivan; Sansevere, Arnold J.; Gainza-Lein, Marina; Buraniqi, Ersida; Tasker, Robert C.; Loddenkemper, Tobias			Time to continuous electroencephalogram in repeated admissions to the pediatric intensive care unit	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Critical care; Electroencephalogram; Intensive care unit; Pediatric; Seizures	REFRACTORY STATUS EPILEPTICUS; CRITICALLY-ILL CHILDREN; TRAUMATIC BRAIN-INJURY; ELECTROGRAPHIC SEIZURES; NONCONVULSIVE SEIZURES; PERIODIC DISCHARGES; COMATOSE CHILDREN; EEG; STATES; PRESSURE	Purpose: Describe timing from intensive care unit (ICU) admission to initiation of continuous electroencephalogram (cEEG) in repeated ICU admissions. Method: We performed a retrospective observational study in pediatric patients who underwent repeated ICU admissions with cEEG from 2011 to 2013. The main outcome measure was time from ICU admission to cEEG. Results: There were 41 patients (54% males) with at least 2 ICU admissions with cEEG (median (p25-p75) age at first admission: 3.3 (0.3-8.4) years, at second admission: 3.9 (1.1-9.4) years), 7 patients (57% males, 9.9 (2.9-11.5) years) with at least 3 ICU admissions, and 5 patients (60% males, 10.1 (4-10.5) years) with at least 4 ICU admissions. One patient had 21 ICU admissions. The median (p25-p75) time from ICU admission to cEEG was not different during the first and second ICU admissions [10.7 (1.9-22.9) hours versus 13 (0.2-36.7) hours; p = 0.908]. Among patients with electrographic seizures on first admission, time to cEEG was not different during the first and second admissions [7.9 (0.5-23.4) hours versus 14.5 (-2 to 44.5) hours; p=0.636]. Among patients with status epilepticus during the first admission, time to cEEG was not different between the first and second admissions [15.3 (9-79) hours versus 40.7 (19.3-42.6) hours; p=0.75]. Conclusions: The time from ICU admission to the initiation of cEEG did not decrease in second or subsequent ICU admissions, even in patients with seizures or status epilepticus on the first admission. (C) 2017 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Sanchez Fernandez, Ivan; Sansevere, Arnold J.; Gainza-Lein, Marina; Buraniqi, Ersida; Loddenkemper, Tobias] Harvard Med Sch, Boston Childrens Hosp, Div Epilepsy & Clin Neurophysiol, Dept Neurol, Boston, MA USA; [Sanchez Fernandez, Ivan] Univ Barcelona, Hosp St Joan de Deu, Dept Child Neurol, Barcelona, Spain; [Gainza-Lein, Marina] Univ Austral Chile, Fac Med, Valdivia, Chile; [Tasker, Robert C.] Harvard Med Sch, Boston Childrens Hosp, Div Crit Care, Dept Neurol, Boston, MA USA; [Tasker, Robert C.] Harvard Med Sch, Boston Childrens Hosp, Div Crit Care, Dept Anesthesiol, Boston, MA USA; [Tasker, Robert C.] Harvard Med Sch, Boston Childrens Hosp, Div Crit Care, Dept Perioperat Med, Boston, MA USA; [Tasker, Robert C.] Harvard Med Sch, Boston Childrens Hosp, Div Crit Care, Dept Pain Med, Boston, MA USA		Loddenkemper, T (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Epilepsy & Clin Neurophysiol, Fegan 9,300 Longwood Ave, Boston, MA 02115 USA.	tobias.loddenkemper@childrens.harvard.edu	Tasker, Robert C/R-5837-2019	Loddenkemper, Tobias/0000-0003-2074-0674; Tasker, Robert/0000-0003-3647-8113	Fundacion Alfonso Martin Escudero; HHV6 Foundation; Epilepsy Research Fund; American Epilepsy Society; Epilepsy Foundation of America; Epilepsy Therapy Project; PCORIPatient-Centered Outcomes Research Institute - PCORI; Pediatric Epilepsy Research Foundation; CURE; HHV-6 Foundation; LundbeckLundbeck Corporation; EisaiEisai Co Ltd; Upsher-Smith; Acorda; PfizerPfizer	Ivan Sanchez Fernandez has received fundin from Fundacion Alfonso Martin Escudero and the HHV6 Foundation.; Tobias Loddenkemper serves on the Laboratory Accreditation Board for Long Term (Epilepsy and Intensive Care Unit) Monitoring, on the Council (and as Treasurer) of the American Clinical Neurophysiology Society, on the American Board of Clinical Neurophysiology, as an Associate Editor for Seizure, as Contributing Editor for Epilepsy Currents, and as an Associate Editor for Wyllie's Treatment of Epilepsy 6th edition. He is part of pending patent applications to detect and predict seizures and to diagnose epilepsy. He receives research support from the Epilepsy Research Fund, the American Epilepsy Society, the Epilepsy Foundation of America, the Epilepsy Therapy Project, PCORI, the Pediatric Epilepsy Research Foundation, CURE, HHV-6 Foundation, and received research grants from Lundbeck, Eisai, Upsher-Smith, Acorda, and Pfizer. He serves as a consultant for Zogenix, Upsher Smith and Lundbeck. He performs video electroencephalogram long-term and ICU monitoring, electroencephalograms, and other electrophysiological studies at Boston Children's Hospital and affiliated hospitals and bills for these procedures and he evaluates pediatric neurology patients and bills for clinical care. He has received speaker honorariums from national societies including the AAN, AES and ACNS, and for grand rounds at various academic centers. His wife, Dr. Karen Stannard, is a pediatric neurologist and she performs video electroencephalogram long-term and ICU monitoring, electroencephalograms, and other electrophysiological studies and bills for these procedures and she evaluates pediatric neurology patients and bills for clinical care.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2013, LANCET NEUROL, V12, P1170, DOI 10.1016/S1474-4422(13)70246-1; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0330-3; Chin RFM, 2004, J NEUROL NEUROSUR PS, V75, P1584, DOI 10.1136/jnnp.2003.032797; Claassen J, 2014, ANN NEUROL, V75, P771, DOI 10.1002/ana.24166; Fernandez IS, 2017, NEUROLOGY, V88, P386, DOI 10.1212/WNL.0000000000003550; Foreman B, 2012, NEUROLOGY, V79, P1951, DOI 10.1212/WNL.0b013e3182735cd7; Gainza-Lein M, 2017, J NEUROL, V264, P1165, DOI 10.1007/s00415-017-8510-3; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Gwer S, 2012, ARCH DIS CHILD, V97, P343, DOI 10.1136/archdischild-2011-300935; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hosain SA, 2005, PEDIATR NEUROL, V32, P162, DOI 10.1016/j.pediatrneurol.2004.09.008; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; Lambrechtsen FACP, 2008, EPILEPSIA, V49, P615, DOI 10.1111/j.1528-1167.2007.01465.x; LOTHMAN E, 1990, NEUROLOGY, V40, P13; McBride MC, 2000, NEUROLOGY, V55, P506, DOI 10.1212/WNL.55.4.506; Ney JP, 2013, NEUROLOGY, V81, P2002, DOI 10.1212/01.wnl.0000436948.93399.2a; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Pisani F, 2007, NEUROLOGY, V69, P2177, DOI 10.1212/01.wnl.0000295674.34193.9e; R Core Team, 2018, R LANGUAGE ENV STAT; Saengpattrachai M, 2006, EPILEPSIA, V47, P1510, DOI 10.1111/j.1528-1167.2006.00624.x; Fernandez IS, 2017, EPILEPSIA, V58, P420, DOI 10.1111/epi.13653; Fernandez IS, 2015, NEUROLOGY, V84, P2304, DOI 10.1212/WNL.0000000000001673; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Warnes GR, 2015, GMODELS VARIOUS R PR; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams RP, 2016, EPILEPSIA, V57, P786, DOI 10.1111/epi.13354; Young GB, 1996, NEUROLOGY, V47, P83	36	4	4	0	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	JAN	2018	54						19	26		10.1016/j.seizure.2017.11.013			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV8RI	WOS:000424854100004	29182970	Bronze			2022-02-06	
J	Sander, AM; Clark, AN; van Veldhoven, LM; Hanks, R; Hart, T; Novelo, LL; Ngan, E; Arciniegas, DB				Sander, Angelle M.; Clark, Allison N.; van Veldhoven, Laura M.; Hanks, Robin; Hart, Tessa; Novelo, Luis Leon; Ngan, Esther; Arciniegas, David B.			Factor analysis of the everyday memory questionnaire in persons with traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury; memory impairment; memory assessment; everyday memory functioning	COMPONENTS; FAILURES; ADULTS; TBI	Objectives: To investigate the factor structure of the Everyday Memory Questionnaire (EMQ) in persons with traumatic brain injury (TBI). Method: This was a secondary analysis of baseline data from two clinical trials targeting memory impairment after TBI. Participants were 169 persons with complicated mild, moderate, or severe TBI at an average of 41months post-injury. They completed the EMQ via clinical interview. Exploratory factor analysis was conducted using a three-factor principal axis factoring estimation method with a polychoric correlation matrix and oblique rotation. Results: The three factors accounted for 49.2% of the variance, with moderate correlations observed among the factors. The three factors appeared to represent general everyday memory (prospective and episodic), conversational memory, and spatial or action memory. The three factors added significantly to the variance in age-corrected objective learning test scores predicted by injury severity, education, and sex. Conclusions: The three factors of the EMQ are consistent with the heterogeneity of memory impairments observed after TBI. The factor scores may be used to target treatments for impaired memory and to evaluate their effectiveness.	[Sander, Angelle M.; Clark, Allison N.; van Veldhoven, Laura M.; Arciniegas, David B.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.; Clark, Allison N.; van Veldhoven, Laura M.; Arciniegas, David B.] Harris Hlth Syst, Houston, TX 77054 USA; [Sander, Angelle M.; Clark, Allison N.; Arciniegas, David B.] Brain Injury Res Ctr, Houston, TX 77025 USA; [Sander, Angelle M.; Arciniegas, David B.] Baylor Coll Med, Dept Psychiat, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA; [Hanks, Robin] Wayne State Univ, Rehabil Inst Michigan, Dept Phys Med & Rehabil, Detroit, MI USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Novelo, Luis Leon; Ngan, Esther] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA		Sander, AM (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA.; Sander, AM (corresponding author), Harris Hlth Syst, Houston, TX 77054 USA.; Sander, AM (corresponding author), Brain Injury Res Ctr, Houston, TX 77025 USA.; Sander, AM (corresponding author), Baylor Coll Med, Dept Psychiat, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA.	asander@bcm.edu					Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bernaards CA, 2005, EDUC PSYCHOL MEAS, V65, P770, DOI 10.1177/0013164404272507; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Catell RE, 1978, SCI USE FACTOR ANAL; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; Corcoran R, 1992, Seizure, V1, P37, DOI 10.1016/1059-1311(92)90053-4; Cornish IM, 2000, BRIT J PSYCHOL, V91, P427, DOI 10.1348/000712600161916; Czuba KJ, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000170; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Efklides A, 2002, EUR J PSYCHOL ASSESS, V18, P63, DOI 10.1027//1015-5759.18.1.63; GOLDSTEIN LH, 1992, CORTEX, V28, P189, DOI 10.1016/S0010-9452(13)80047-0; Hoofien D, 2001, BRAIN INJURY, V15, P189; KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Pettersson E, 2010, J RES PERS, V44, P407, DOI 10.1016/j.jrp.2010.03.002; Rey A, 1958, EXAMIN CLIN PSYCHOL; RICHARDSON JTE, 1995, MEMORY, V3, P187, DOI 10.1080/09658219508258965; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; SANDER AM, 2014, HDB NEUROPSYCHOLOGY, P173, DOI DOI 10.1007/978-1-4939-0784-7_9; Stewart FM, 1996, BRIT J CLIN PSYCHOL, V35, P369, DOI 10.1111/j.2044-8260.1996.tb01191.x; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Sunderland A, 1996, BRIT J CLIN PSYCHOL, V35, P463, DOI 10.1111/j.2044-8260.1996.tb01200.x; Symonds CP, 1928, BRIT MED J, V1928, P829, DOI 10.1136/bmj.2.3540.829; Tabachnick B.G., 2001, USING MULTIVARIATE S; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Tinson D J, 1987, Int Disabil Stud, V9, P6; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432; [No title captured]; [No title captured]	42	4	4	2	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	3					495	509		10.1080/13854046.2017.1368714			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FZ4KL	WOS:000427561000011	28849703				2022-02-06	
J	Sasaoka, K; Nakamura, K; Osuga, T; Morita, T; Yokoyama, N; Morishita, K; Sasaki, N; Ohta, H; Takiguchi, M				Sasaoka, K.; Nakamura, K.; Osuga, T.; Morita, T.; Yokoyama, N.; Morishita, K.; Sasaki, N.; Ohta, H.; Takiguchi, M.			Transcranial Doppler Ultrasound Examination in Dogs with Suspected Intracranial Hypertension Caused by Neurologic Diseases	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Article						CNS disorders; Intracranial pressure; Repeatability; Ultrasonography	CODED DUPLEX SONOGRAPHY; TRAUMATIC BRAIN-INJURY; NERVE SHEATH DIAMETER; CEREBRAL-BLOOD-FLOW; OPHTHALMIC ARTERY; PULSATILITY INDEX; CLINICAL SIGNS; WAVE-FORM; PRESSURE; ULTRASONOGRAPHY	Background: Transcranial Doppler ultrasound examination (TCD) is a rapid, noninvasive technique used to evaluate cerebral blood flow and is useful for the detection of intracranial hypertension in humans. However, the clinical usefulness of TCD in diagnosing intracranial hypertension has not been demonstrated for intracranial diseases in dogs. Objectives: To determine the association between the TCD variables and intracranial hypertension in dogs with intracranial diseases. Animals: Fifty client-owned dogs with neurologic signs. Methods: Cross-sectional study. All dogs underwent TCD of the basilar artery under isoflurane anesthesia after magnetic resonance imaging (MRI). Dogs were classified into 3 groups based on MRI findings: no structural diseases (group I), structural disease without MRI evidence of intracranial hypertension (group II), and structural disease with MRI evidence of intracranial hypertension (group III). The TCD vascular resistance variables (resistive index [RI], pulsatility index [PI], and the ratio of systolic to diastolic mean velocity [Sm/Dm]) were measured. Results: Fifteen, 22, and 13 dogs were classified into groups I, II, and III, respectively. Dogs in group III had significantly higher Sm/Dm (median, 1.78; range, 1.44-2.58) than those in group I (median, 1.63; range, 1.43-1.75) and group II (median, 1.62; range, 1.27-2.10). No significant differences in RI and PI were identified among groups. Conclusions and Clinical Importance: Our findings suggest that increased Sm/Dm is associated with MRI findings of suspected intracranial hypertension in dogs with intracranial diseases and that TCD could be a useful tool to help to diagnose intracranial hypertension.	[Sasaoka, K.; Osuga, T.; Morita, T.; Yokoyama, N.; Sasaki, N.; Ohta, H.; Takiguchi, M.] Hokkaido Univ, Lab Vet Internal Med, Dept Vet Clin Sci, Sapporo, Hokkaido, Japan; [Nakamura, K.; Morishita, K.] Hokkaido Univ, Vet Teaching Hosp, Grad Sch Vet Med, Sapporo, Hokkaido, Japan		Takiguchi, M (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Internal Med, N18 W9, Sapporo, Hokkaido 0600818, Japan.	mtaki@vetmed.hokudai.ac.jp	Nakamura, Kensuke/H-4654-2019; Sasaoka, Kazuyoshi/ABA-2872-2021	Nakamura, Kensuke/0000-0002-1010-3228; Sasaoka, Kazuyoshi/0000-0002-2990-7808; Morita, Tomoya/0000-0003-2798-5113			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Anvari A, 2015, RADIOGRAPHICS, V35, P1789, DOI 10.1148/rg.2015150112; Armasu M, 2014, VET J, V202, P292, DOI 10.1016/j.tvjl.2014.08.008; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Bittermann S, 2014, VET J, V201, P101, DOI 10.1016/j.tvjl.2014.04.020; Carvalho CF, 2012, CAN VET J, V53, P855; Chetboul V, 2004, J VET PHARMACOL THER, V27, P49, DOI 10.1046/j.0140-7783.2003.00543.x; Chung WJ, 2006, J VET MED SCI, V68, P597, DOI 10.1292/jvms.68.597; Duque FJ, 2009, VET RADIOL ULTRASOUN, V50, P530, DOI 10.1111/j.1740-8261.2009.01577.x; Duque J, 2011, VET RADIOL ULTRASOUN, V52, P111, DOI 10.1111/j.1740-8261.2010.01750.x; Fukushima U, 2000, J VET MED SCI, V62, P353, DOI 10.1292/jvms.62.353; GOH D, 1992, PEDIATR RADIOL, V22, P246, DOI 10.1007/BF02019849; Gura M, 2011, TURK NEUROSURG, V21, P210, DOI 10.5137/1019-5149.JTN.3574-10.1; HASSLER W, 1989, J NEUROSURG, V71, P195, DOI 10.3171/jns.1989.71.2.0195; Haubrich C, 2007, STROKE, V38, P2677, DOI 10.1161/STROKEAHA.107.485847; Hong SP, 2014, KOREAN CIRC J, V44, P406, DOI 10.4070/kcj.2014.44.6.406; Ilie LA, 2015, AM J VET RES, V76, P724, DOI 10.2460/ajvr.76.8.724; KORNEGAY JN, 1983, J AM VET MED ASSOC, V182, P1111; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Madison AM, 2015, AM J VET RES, V76, P667, DOI 10.2460/ajvr.76.8.667; Maruyoshi H, 2010, CIRC J, V74, P1251, DOI 10.1253/circj.CJ-09-0866; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Nagai H, 1997, STROKE, V28, P603, DOI 10.1161/01.STR.28.3.603; Pinto LA, 2012, INVEST OPHTH VIS SCI, V53, P2448, DOI 10.1167/iovs.11-9388; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Saito M, 2003, VET RADIOL ULTRASOUN, V44, P687, DOI 10.1111/j.1740-8261.2003.tb00532.x; Scrivani PV, 2013, VET RADIOL ULTRASOUN, V54, P263, DOI 10.1111/vru.12023; SHAPIRO HM, 1975, ANESTHESIOLOGY, V43, P445, DOI 10.1097/00000542-197510000-00010; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Sturges BK, 2014, SMALL ANIMAL CRITICA, P436; Sturges BK, 2014, SMALL ANIMAL CRITICA, P998; THUOMAS KA, 1993, ACTA RADIOL, V34, P289; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; Treib J, 1998, EUR NEUROL, V40, P212, DOI 10.1159/000007982; Walmsley GL, 2006, VET J, V172, P258, DOI 10.1016/j.tvjl.2005.05.012	37	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-1676			J VET INTERN MED	J. Vet. Intern. Med.	JAN-FEB	2018	32	1					314	323		10.1111/jvim.14900			10	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	FX1MC	WOS:000425814500038	29265506	Green Published, gold			2022-02-06	
J	Saunders, BJ; Lansdell, G; Eriksson, A; Bunn, R				Saunders, Bernadette J.; Lansdell, Gaye; Eriksson, Anna; Bunn, Rebecca			Friend or foe: the media's power to inform and shape societal attitudes towards people with acquired brain injury	DISABILITY & SOCIETY			English	Article						Acquired brain injury; traumatic brain injury; disability; media; criminal justice; deviance; qualitative content analysis	REPRESENTATION; DISABILITIES; POPULATION; PREVALENCE; CHILDHOOD; ABUSE	Media representations play an integral role in modern society, informing the public about a range of issues affecting their communities. Using qualitative content analysis, this article reports on the study of a sample of Australian media coverage, spanning 30years, covering issues associated with acquired brain injury (ABI) and related cognitive disabilities. The analysis explores how the media both portray and actively shape public perceptions about people living with ABI, the lived experience of the condition, and its broader social implications. The authors identify a range of themes arising in the sample that communicate specific ideas about ABI, disability, and deviance. Importantly, they identify how these themes are able to either construct or reinforce dominant understandings of disability and deviance through both their content and structure.	[Saunders, Bernadette J.] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Lansdell, Gaye; Bunn, Rebecca] Monash Univ, Fac Law, Melbourne, Vic, Australia; [Eriksson, Anna] Monash Univ, Fac Arts, Melbourne, Vic, Australia		Saunders, BJ (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia.	bernadette.saunders@monash.edu		Eriksson, Anna/0000-0002-6105-2299; Saunders, Bernadette/0000-0003-3830-9874	Office of the Public Advocate, Victoria [MU-001]	This work was supported by the Office of the Public Advocate, Victoria [fund number MU-001].	Allen R, 1997, AUST NZ J PSYCHIAT, V31, P375, DOI 10.3109/00048679709073847; Altheide D., 2017, QUALITATIVE MEDIA AN, DOI [10.4135/9781452270043, DOI 10.4135/9781452270043]; [Anonymous], 2016, THE MERCURY; [Anonymous], 2013, AGE; [Anonymous], 2016, CANBERRA TIMES  0918; Australian Institute of Health and Welfare, 2007, BULLETIN, V55; Australian Institute of Health and Welfare, 2015, HLTH AUSTR PRIS; Barnes C., 1993, 1 BRIT COUNC ORG DIS; Barry E., 2009, SUNDAY HERALD SUN; Beaumont L., 2003, AGE; Berryessa Colleen M, 2014, Int J Criminol Sociol, V3, P46; BOGDAN R, 1977, SOC POLICY, V7, P14; Butterworth R., 2011, SUNDAY AGE      0814; Caldwell F., 2011, QUEENSLAND TIME 0625; Clogston J. S., 1990, DISABILITY COVERAGE; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Dahl M, 1993, CANADIAN J COMMUNICA, V18, DOI [10.22230/cjc.1993v18n1a718, DOI 10.22230/CJC.1993V18N1A718]; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Devotta K, 2013, DISABIL REHABIL, V35, P1859, DOI 10.3109/09638288.2012.760658; Disabilities Trust Foundation, 2018, BRAIN INJ HOM; Duffy M., 2005, SYDNEY MORNING HERAL; Elder J., 1999, SUNDAY AGE      0404; Ellis K, 2015, MEDIA INT AUST, P78, DOI 10.1177/1329878X1515400111; ERICSON RV, 1987, VISUALIZING DEVIANCE; Farnall O, 1999, JOURNALISM MASS COMM, V76, P659, DOI 10.1177/107769909907600404; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Haller B., 1997, 83 ANN M NAT COMM AS; Haller Beth A., 2010, REPRESENTING DISABIL; Heasley A., 2002, AGE; Hewitt S., 2003, SUNDAY HERALD SUN; Hinde S., 2008, SUNDAY HERALD SUN; Horin A., 2012, SYDNEY MORN HERALD; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hutson S., 1994, YOUTH HOMELESSNESS C, DOI [10.1007/978-1-349-23535-3, DOI 10.1007/978-1-349-23535-3]; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Jacks Timna, 2015, AGE; Jackson M., 2011, CORRECTIONS RES PAPE; Jewkes Yvonne., 2015, MEDIA CRIME; Jones SC, 2009, DISABIL SOC, V24, P5, DOI 10.1080/09687590802535345; Kearney N., 2003, HERALD SUN; Kearney N., 2005, THE HERALD SUN  0219; Kehn M, 2011, DISABIL HEALTH J, V4, P121, DOI 10.1016/j.dhjo.2010.09.001; Kelly G., 2012, ISSUES INEQUITIES FA; Lee J., 2014, AGE; Lunn S., 2007, AUSTRALIAN; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Martain T., 2016, THE MERCURY; May J, 2014, AGE; McArthur G., 2007, HERALD SUN; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McPherson G, 2016, DISABIL SOC, V31, P659, DOI 10.1080/09687599.2016.1197823; Medew J., 2008, AGE; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Mounce L., 2012, NOBODY MADE CONNECTI; Nairn R., 2006, AUSTR NZ J PSYCHIAT, V13, P243, DOI DOI 10.1375/pplt.13.2.243; Pardun C. J., 2005, CHANGING ATTITUDES C; Petrie A., 2012, AGE; Ralph A, 2013, BRAIN INJURY, V27, P1475, DOI 10.3109/02699052.2013.823653; Roos P., 1972, PRINCIPLE NORMALISAT; Rushworth, 2011, OUT SIGHT OUT MIND P; Rushworth N., 2010, PARITY; Saunders B.J., 2013, EXAMINATION IMPACT U; Saunders B, 2014, AUST J SOC ISSUES, V49, P45, DOI 10.1002/j.1839-4655.2014.tb00299.x; Saunders BJ, 2001, CHILDHOOD, V8, P443, DOI 10.1177/0907568201008004003; Schneider, 2010, SUBMISSION PRODUCTIV; Sheridan J., 2009, SUNDAY AGE      1101; Shiel F., 1997, AGE; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Sieff E., 2009, J MENTAL HLTH, V12, P259, DOI [DOI 10.1080/0963823031000118249, 10.1080/0963823031000118249]; Silvester John., 2014, AGE; Silvester John, 2010, AGE; Spencer B., 2005, AGE; Stark J., 2007, SYDNEY MORNING HERAL; Stephens A, 2014, AUST J PUBL ADMIN, V73, P260, DOI 10.1111/1467-8500.12073; Swan J, 2012, SYDNEY MORNING HERAL; Tang C., 2016, THE EXAMINER; Tang C., 2015, THE EXAMINER; Tanhane A., 2008, SUNDAY AGE      0525; Tippet G., 2005, SUNDAY AGE      0123; Wertheimer A., 1988, ACCORDING PAPERS PRE; West M. B., 2010, THESIS, P269; Wilkinson P, 2009, J APPL RES INTELLECT, V22, P65, DOI 10.1111/j.1468-3148.2008.00453.x; Williams H., 2012, REPAIRING SHATTERED; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; Wilson, 1989, JOURNALISM JUSTICE C; Wondemaghen M, 2014, INT J COMP APPL CRIM, V38, P343, DOI 10.1080/01924036.2013.848219	86	4	4	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0968-7599	1360-0508		DISABIL SOC	Disabil. Soc.		2018	33	6					932	953		10.1080/09687599.2018.1466692			22	Rehabilitation; Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Rehabilitation; Social Sciences - Other Topics	GI4GD	WOS:000434328200007					2022-02-06	
J	Sharland, MJ; Waring, SC; Johnson, BP; Taran, AM; Rusin, TA; Pattock, AM; Palcher, JA				Sharland, Michael J.; Waring, Stephen C.; Johnson, Brian P.; Taran, Allise M.; Rusin, Travis A.; Pattock, Andrew M.; Palcher, Jeanette A.			Further examination of embedded performance validity indicators for the Conners' Continuous Performance Test and Brief Test of Attention in a large outpatient clinical sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity; attention; forensics; effort; malingering	TRAUMATIC BRAIN-INJURY; TEST-II; TEST FAILURE; CLASSIFICATION ACCURACY; SYMPTOM EXAGGERATION; AMERICAN ACADEMY; CROSS-VALIDATION; SUSPECT EFFORT; RESPONSE BIAS; HEAD-INJURY	Objective: Assessing test performance validity is a standard clinical practice and although studies have examined the utility of cognitive/memory measures, few have examined attention measures as indicators of performance validity beyond the Reliable Digit Span. The current study further investigates the classification probability of embedded Performance Validity Tests (PVTs) within the Brief Test of Attention (BTA) and the Conners' Continuous Performance Test (CPT-II), in a large clinical sample. Method: This was a retrospective study of 615 patients consecutively referred for comprehensive outpatient neuropsychological evaluation. Non-credible performance was defined two ways: failure on one or more PVTs and failure on two or more PVTs. Classification probability of the BTA and CPT-II into non-credible groups was assessed. Sensitivity, specificity, positive predictive value, and negative predictive value were derived to identify clinically relevant cut-off scores. Results: When using failure on two or more PVTs as the indicator for non-credible responding compared to failure on one or more PVTs, highest classification probability, or area under the curve (AUC), was achieved by the BTA (AUC = .87 vs. .79). CPT-II Omission, Commission, and Total Errors exhibited higher classification probability as well. Conclusion: Overall, these findings corroborate previous findings, extending them to a large clinical sample. BTA and CPT-II are useful embedded performance validity indicators within a clinical battery but should not be used in isolation without other performance validity indicators.	[Sharland, Michael J.; Rusin, Travis A.] Essentia Hlth, Dept Neurol, Duluth, MN 55805 USA; [Waring, Stephen C.; Johnson, Brian P.; Taran, Allise M.; Palcher, Jeanette A.] Essentia Inst Rural Hlth, Div Res, Duluth, MN USA; [Pattock, Andrew M.] Univ Minnesota, Med Sch, Minneapolis, MN 55455 USA		Sharland, MJ (corresponding author), Essentia Hlth, Dept Neurol, Duluth, MN 55805 USA.	michael.sharland@essentiahealth.org	Waring, Stephen/AAR-6870-2021	Waring, Stephen/0000-0002-9674-0083	Essentia Health Duluth Clinic Foundation [A1307]	This work was supported by The Essentia Health Duluth Clinic Foundation [grant number A1307].	Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; BRANDT J, 1988, CLIN ASSESSMENT MALI, P65; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; CONDER R, 1992, COMPUTERIZED ASSESSM; Conners C. K., 2000, CONNERS CONTINUOUS P; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Delis D.C., 2000, CALIFORNIA VERBAL LE; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Doss R.C., 1999, J FORENSIC NEUROPSYC, V1, P5, DOI [https://doi.org/10.1300/J151v01n04_02, DOI 10.1300/J151V01N04_02, 10.1300/J151v01n04_02]; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2004, USERS MANUAL; Greenberg LM., 1996, TEST VARIABLES ATTEN; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Harrison AG, 2016, CLIN NEUROPSYCHOL, V30, P265, DOI 10.1080/13854046.2016.1154188; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry GK, 2005, CLIN NEUROPSYCHOL, V19, P121, DOI 10.1080/13854040490516604; Hunter B, 2014, ARCH CLIN NEUROPSYCH, V29; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Rey A., 1964, EXAMEN CLIN PSYCHOL; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Schretlen D., 1996, BRIEF TEST ATTENTION; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick D., 1997, VSVT VICTORIA SYMPTO; Slick DJ, 2003, CLIN NEUROPSYCHOL, V17, P390, DOI 10.1076/clin.17.3.390.18090; Strauss E, 1999, CLIN NEUROPSYCHOL, V13, P420, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT420; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Webb JW, 2012, CLIN NEUROPSYCHOL, V26, P1377, DOI 10.1080/13854046.2012.728248; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	51	4	4	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	1					98	108		10.1080/13854046.2017.1332240			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GD3XB	WOS:000430436000008	28548557				2022-02-06	
J	Songwathana, P; Kitrungrote, L; Anumas, N; Nimitpan, P				Songwathana, Praneed; Kitrungrote, Luppana; Anumas, Narumol; Nimitpan, Pinwanan			Predictive Factors for Health-Related Quality of Life among Thai Traumatic Brain Injury Patients	INTERNATIONAL JOURNAL OF BEHAVIORAL SCIENCE			English	Article						quality of life; traumatic brain injury; predictive factors	HOSPITAL ANXIETY; DEPRESSION SCALE; SOCIAL SUPPORT; HEAD-INJURY; FOLLOW-UP; QOLIBRI; SATISFACTION; VALIDITY; OUTCOMES	Factors related to health-related quality of life (HRQoL) have been studied widely but there is limited research about traumatic brain injury (TBI) survivors living in low and middle income countries where social context and care environment are different. This cross-sectional study aimed to determine the factors predicting HRQoL among Thai TBI survivors. Sample included 200 people who had TBI and were selected through purposive sampling at least 1 month after discharge based on their medical records from two tertiary care hospitals in southern Thailand. They were interviewed using the Quality of Life after Traumatic Brain Injury (QOLIBRI) instrument. The selected factors examined as independent variables included Glasgow coma scale (GCS), functional and disability, anxiety/ depression, social support and community integration, and some demographic factors. Results revealed that the significant positive relationships existed between HRQoL and GCS, community integration and social support; while a negative relationship with anxiety and depression was reported. A hierarchical multiple regression analysis indicated that all of five factors could significantly predict HRQoL at 58.3%. In conclusion, five important factors (GCS, social support, anxiety, depression, and community integration) predicted HRQoL which required comprehensive interventions. For improving patient's HRQoL after discharge, it is suggested to provide more support, strengthen their involvement in the community, and reduce the patient's anxiety and depression in particular to those without social support at home.	[Songwathana, Praneed] Prince Songkla Univ, Fac Nursing, Hat Yai, Thailand; [Anumas, Narumol] Hatyai Hosp, Neurosurg Intens Care Unit, Songkhla, Thailand; [Nimitpan, Pinwanan] Songklanagarind Hosp, Trauma Ward, Songkhla, Thailand		Songwathana, P (corresponding author), Prince Songkla Univ, Fac Nursing, Hat Yai, Thailand.	praneed.sw@gmail.com		Kitrungrote, Luppana/0000-0002-5913-3305	Higher Education Research Promotion; National Research University Project of Thailand, Office of the Higher Education Commission	This study was partially supported by the Higher Education Research Promotion and the National Research University Project of Thailand, Office of the Higher Education Commission. Sincere thanks also are given to all participants in this study. I am also appreciative of Dr. Patricia Liehr, who helps editing the final manuscript during a visit to the Christine E. Lynn College of Nursing, Florida Atlantic University.	Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; [Anonymous], 2012, 2 GLOB STAT REP ROAD; Arandon K., 2016, PRINCESS NARADHIWAS, V8, P1; Asai MO, 2005, SOC WORK, V50, P111, DOI 10.1093/sw/50.2.111; Bellon K, 2012, J HEAD TRAUMA REHAB, V27, P449, DOI 10.1097/HTR.0b013e31826674d6; Bureau of Non Communicable Diseases of Thailand, 2016, NONC DIS INF; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Cohen J., 2013, STAT POWER ANAL BEHA; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Dillahunt A. C., 2013, PLOS ONE, V8, P1, DOI [10.1371/jounal.pone.0082896, DOI 10.1371/JOUNAL.PONE.0082896]; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; JENNETT B, 1975, LANCET, V1, P480; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kespichayawattana J., 1999, THESIS; Kim J H, 2000, J Transcult Nurs, V11, P264, DOI 10.1177/104365960001100404; Kliangta R., 2010, P 4 GRAD STUD C SILP; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Laplante L., 2007, TRANSLATION PROCESS; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petchprapai N., 2007, THESIS; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Rungpueng A., 2013, WEEKLY EPIDEMIOLOGIC, V44, P481; Samartkit N, 2010, PAC RIM INT J NURS R, V14, P297; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sukraeny N., 2014, SONGKLANAGARIND NU S, V34, P119; Tabish S. A., 2015, EMERGEN MED, V5, P1, DOI [10.4172/2165-7548.10000229, DOI 10.4172/2165-7548.10000229]; Thomas MD, 2009, BRAIN INJURY, V23, P516, DOI 10.1080/02699050902926333; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; UNESCO, 2017, ED SUST DEV GOALS LE, P7; Upadhyay D., 2007, WORLD APPL SCI J, V2, P687; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; World Health Organization, 2013, MORT ROAD TRAFF DEAT; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	4	4	0	2	BEHAVIORAL SCIENCE RESEARCH INST, SRINAKHARINWIROT UNIV	BANGKOK	114 SUKHUMVIT 23, WATTANA, BANGKOK, 10110, THAILAND	1906-4675			INT J BEHAV SCI	Int. J. Behav. Sci.	JAN	2018	13	1					82	92					11	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	GB0JB	WOS:000428730900007					2022-02-06	
J	Su, TM; Lan, CM; Lee, TH; Shih, FY; Hsu, SW; Lu, CH				Su, Tsung-Ming; Lan, Chu-Mei; Lee, Tsung-Han; Shih, Fu-Yuan; Hsu, Shih-Wei; Lu, Cheng-Hsien			Posttraumatic Cerebral Infarction After Decompressive Craniectomy for Traumatic Brain Injury: Incidence, Risk Factors and Outcome	TURKISH NEUROSURGERY			English	Article						Decompressive craniectomy; Posttraumatic cerebral infarction; Traumatic brain injury	SUBARACHNOID HEMORRHAGE; ARTERIAL SPASM	AIM: To investigate the incidence, timing, risk factors of posttraumatic cerebral infarction (PTCI) and its influence on mortality in patients with moderate to severe traumatic brain injury (TBI). MATERIAL and METHODS: After reviewing the medical records and radiographs over a 6-year period, 173 patients with moderate to severe TBI were enrolled to determine the risk factors for the development of PTCI following unilateral decompressive craniectomy (DC). RESULTS: The incidence of PTCI following DC was 31.2%. Infarction in the posterior cerebral artery territory was the most common site of PTCI. The PTCI group had a significantly increased mortality (p<0.001) and unfavorable outcome (p<0.001). After stepwise logistic regression analysis, preoperative Glasgow Coma Scale (GCS) score (p<0.001, odds ratio [OR]=0.536, 95% confidence interval [CI]=0.407-0.706), pupillary dilation (p=0.016, OR=3.2, 95% CI=1.24-8.28), subdural hematoma (p=0.01, OR=16.87, 95% CI=1.97-144.30) and craniectomy size (p=0.017, OR=1.02, 95% CI=1.0-1.04) remained independently associated with PTCI development following DC. CONCLUSION: PTCI is a severe complication in patients with acute TBI. We recommend repeating computed tomography within 3 days of trauma to detect the occurrence of PTCI in patients with subdural hematoma who have low preoperative GCS score and pupillary dilation, irrespective of neurological status. More studies are necessary to clarify the role and benefit of DC in patients with a GCS score of 5 or less.	[Su, Tsung-Ming; Lee, Tsung-Han; Shih, Fu-Yuan; Hsu, Shih-Wei; Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Su, Tsung-Ming; Lee, Tsung-Han; Shih, Fu-Yuan] Chang Gung Univ, Coll Med, Dept Neurosurg, Kaohsiung, Taiwan; [Lan, Chu-Mei] Chang Jung Christian Univ, Dept Hlth Psychol, Tainan, Taiwan; [Hsu, Shih-Wei] Chang Gung Univ, Coll Med, Dept Radiol, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, Dept Neurol, Kaohsiung, Taiwan		Lu, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan.; Lu, CH (corresponding author), Chang Gung Univ, Coll Med, Dept Neurol, Kaohsiung, Taiwan.	hlu99@ms44.url.com.tw					Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; De Bonis P, J NEUROTRAUMA, V27, P1965; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Ham HY, 2011, J KOREAN NEUROSURG S, V50, P370, DOI 10.3340/jkns.2011.50.4.370; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MIRVIS SE, 1990, AM J NEURORADIOL, V11, P355; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; ROTHFUS WE, 1987, AM J NEURORADIOL, V8, P1073; Server A, 2001, ACTA RADIOL, V42, P254; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5	20	4	6	0	3	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2018	28	4					582	588		10.5137/1019-5149.JTN.20761-17.1			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GL5YI	WOS:000437251200011		Bronze			2022-02-06	
J	Thibaut, A; Wannez, S; Deltombe, T; Martens, G; Laureys, S; Chatelle, C				Thibaut, A.; Wannez, S.; Deltombe, T.; Martens, G.; Laureys, S.; Chatelle, C.			Physical therapy in patients with disorders of consciousness: Impact on spasticity and muscle contracture	NEUROREHABILITATION			English	Article						Spasticity; hypertonicity; upper motor neuron; muscle contracture; disorders of consciousness; minimally conscious state; vegetative state/unresponsive wakefulness syndrome; non-pharmacological treatment; physical therapy	MODIFIED ASHWORTH SCALE; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; UPPER-LIMB; STROKE; RELIABILITY; DISABILITY; STATE	BACKGROUND: Spasticity is a frequent complication after severe brain injury, which may prevent the rehabilitation process and worsen the patients' quality of life. OBJECTIVES: In this study, we investigated the correlation between spasticity, muscle contracture, and the frequency of physical therapy (PT) in subacute and chronic patients with disorders of consciousness (DOC). METHODS: 109 patients with subacute and chronic disorders of consciousness (Vegetative state/Unresponsive wakefulness syndrome - VS/UWS; minimally conscious state - MCS and patients who emerged from MCS - EMCS) were included in the study (39 female; mean age: 40 +/- 13.5y; 60 with traumatic etiology; 35 VS/UWS, 68 MCS, 6 EMCS; time since insult: 38 +/- 42months). The number of PT sessions (i.e., 20 to 30 minutes of conventional stretching of the four limbs) was collected based on patients' medical record and varied between 0 to 6 times per week (low PT = 0-3 and high PT = 4-6 sessions per week). Spasticity was measured with the Modified Ashworth Scale (MAS) on every segment for both upper (UL) and lower limbs (LL). The presence of muscle contracture was assessed in every joint. We tested the relationship between spasticity and muscle contracture with the frequency of PT as well as other potential confounders such as time since injury or anti-spastic medication intake. RESULTS: We identified a negative correlation between the frequency of PT and MAS scores as well as the presence of muscle contracture. We also identified that patients who received less than four sessions per week were more likely to be spastic and suffer from muscle contracture than patients receiving 4 sessions or more. When separating subacute (3 to 12 months post-insult) and chronic (>12months post-insult) patients, these negative correlations were only observed in chronic patients. A logit regression model showed that frequency of PT influenced spasticity, whereas neither time since insult nor medication had a significant impact on the presence of spasticity. On the other hand, PT, time since injury and medication seemed to be associated with the presence of muscle contracture. CONCLUSION: Our results suggest that, in subacute and chronic patients with DOC, PT could have an impact on patients' spasticity and muscles contractures. Beside PT, other factors such as time since onset and medication seem to influence the development of muscle contractures. These findings support the need for frequent PT sessions and regular re-evaluation of the overall spastic treatment for patients with DOC.	[Thibaut, A.; Wannez, S.; Martens, G.; Laureys, S.; Chatelle, C.] Univ Liege, Coma Sci Grp, Dept Neurol, GIGA Consciousness, Liege, Belgium; [Thibaut, A.; Wannez, S.; Martens, G.; Laureys, S.; Chatelle, C.] Univ Hosp Liege, Liege, Belgium; [Thibaut, A.] Harvard Med Sch, Spaulding Rehabil Hosp, Spaulding Neuromodulat Ctr, Boston, MA USA; [Deltombe, T.] Catholic Univ Louvain, Dept Phys Med & Rehabil, CHU UCL Namur Site Mt Godinne, Yvoir, Belgium; [Chatelle, C.] Massachusetts Gen Hosp, Lab NeuroImaging Coma & Consciousness, Boston, MA 02114 USA		Thibaut, A (corresponding author), Quartier Hop, GIGA Consciousness, B-34,Ave Hop 11, B-4000 Liege, Belgium.	athibaut@ulg.ac.be	Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021; Martens, Geraldine/ABF-1147-2020; Thibaut, Aurore/U-8101-2019	Laureys, Steven/0000-0002-3096-3807; Martens, Geraldine/0000-0001-7038-7165; Chatelle, Camille/0000-0002-7526-2107	Belgian Funds for Scientific Research (FRS)Fonds de la Recherche Scientifique - FNRS; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; EU Luminous Project; EU Human Brain Project; McDonnell Foundation; European Space AgencyEuropean Space AgencyEuropean Commission; BelspoBelgian Federal Science Policy Office; Fondazione Europea di Ricerca Biomedica; BIAL FoundationBial Foundation; Wallonia-Brussels Federation Concerted Research Action; Belgian American Educational Foundation (BAEF); Leon Fredericq Foundation; Wallonie Bruxelles International (WBI)	This research was supported by the Belgian Funds for Scientific Research (FRS), European Commission, EU Luminous Project, EU Human Brain Project, McDonnell Foundation, European Space Agency, Belspo, "Fondazione Europea di Ricerca Biomedica", BIAL Foundation, Wallonia-Brussels Federation Concerted Research Action, the Belgian American Educational Foundation (BAEF), the Leon Fredericq Foundation, and Wallonie Bruxelles International (WBI).	Ada L, 2006, DISABIL REHABIL, V28, P891, DOI 10.1080/09638280500535165; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Autti-Ramo I, 2006, AM J PHYS MED REHAB, V85, P89, DOI 10.1097/01.phm.0000179442.59847.27; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Borisova Y, 2009, CLIN REHABIL, V23, P681, DOI 10.1177/0269215509334841; Brainin M, 2013, NEUROLOGY, V80, pS1, DOI 10.1212/WNL.0b013e3182762379; Cruse D, 2011, LANCET, DOI [10.1016/S0140-6736(11): 61224-5, DOI 10.1016/S0140-6736(11):61224-5]; Demertzi A, 2011, J NEUROL, V258, P1058, DOI 10.1007/s00415-010-5882-z; Diserens K, 2007, J NEUROL SCI, V253, P18, DOI 10.1016/j.jns.2006.10.021; Diserens K, 2012, CLIN REHABIL, V26, P451, DOI 10.1177/0269215511425541; Doan QV, 2012, PM&R, V4, P4, DOI 10.1016/j.pmrj.2011.10.001; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P155, DOI 10.1097/00001199-200403000-00007; Farmer SE, 2001, DISABIL REHABIL, V23, P549; Ganapathy Vaidyanathan, 2015, Clin Interv Aging, V10, P1793, DOI 10.2147/CIA.S91123; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2012, BRAIN INJURY, V26, P1493, DOI 10.3109/02699052.2012.695426; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Jung YJ, 2011, NEUROREHABILITATION, V29, P53, DOI 10.3233/NRE-2011-0677; Kaneko F, 2003, CLIN NEUROPHYSIOL, V114, P2397, DOI 10.1016/S1388-2457(03)00245-1; Lance J. W., 1980, SPASTICITY DISORDERS; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Mehrholz J, 2005, CLIN REHABIL, V19, P751, DOI 10.1191/0269215505cr889oa; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Svensson J, 2014, ACTA NEUROL SCAND, V129, P13, DOI 10.1111/ane.12139; Thibaut A, 2014, EUR J PHYS REHABIL M; Thibaut A, 2013, BRAIN INJURY, V27, P1093, DOI 10.3109/02699052.2013.804202; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991	29	4	4	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	2					199	205		10.3233/NRE-172229			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FZ0WT	WOS:000427295800009	29562552	Green Published			2022-02-06	
J	Thielen, P; Mehoke, T; Gleason, J; Iwaskiw, A; Paulson, J; Merkle, A; Wester, B; Dymond, J				Thielen, P.; Mehoke, T.; Gleason, J.; Iwaskiw, A.; Paulson, J.; Merkle, A.; Wester, B.; Dymond, J.			Exploration of the molecular basis of blast injury in a biofidelic model of traumatic brain injury	SHOCK WAVES			English	Article						Blast injury; Traumatic brain injury; Biofidelic headform; Caenorhabditis elegans; Transcriptomics	UNFOLDED PROTEIN RESPONSE; NERVOUS-SYSTEM	Biological response to blast overpressure is complex and results in various and potentially non-concomitant acute and long-term deficits to exposed individuals. Clinical links between blast severity and injury outcomes remain elusive and have yet to be fully described, resulting in a critical inability to develop associated protection and mitigation strategies. Further, experimental models frequently fail to reproduce observed physiological phenomena and/or introduce artifacts that confound analysis and reproducibility. New models are required that employ consistent mechanical inputs, scale with biological analogs and known clinical data, and permit high-throughput examination of biological responses for a range of environmental and battlefield- relevant exposures. Here we describe a novel, biofidelic headform capable of integrating complex biological samples for blast exposure studies. We additionally demonstrate its utility in detecting acute transcriptional responses in the model organism Caenorhabditis elegans after exposure to blast overpressure. This approach enables correlation between mechanical exposure and biological outcome, permitting both the enhancement of existing surrogate and computational models and the high-throughput biofidelic testing of current and future protection systems.	[Thielen, P.; Mehoke, T.; Gleason, J.; Iwaskiw, A.; Paulson, J.; Merkle, A.; Wester, B.; Dymond, J.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA		Wester, B; Dymond, J (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA.	brock.wester@jhuapl.edu; jessica.dymond@jhuapl.edu		Thielen, Peter/0000-0003-1807-2785			[Anonymous], 2016, TRIM GAL; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carneal C., 2016, P PERS ARM SYST S AM, P632; Cernak I., 2015, BRAIN NEUROTRAUMA MO; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; Dimitriadi M, 2010, NEUROBIOL DIS, V40, P4, DOI 10.1016/j.nbd.2010.05.012; Eddings MA, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/6/067001; Faul M, 2010, TRAUMATIC BRAIN INJU; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Krajewska M, 2011, BRAIN RES, V1370, P227, DOI 10.1016/j.brainres.2010.11.015; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Merkle AC, 2010, IFMBE PROC, V32, P22, DOI 10.1007/978-3-642-14998-6_6; Merkle A. C., INJURY BIOMECHANICS, V2012, P1; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Onate M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21709; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Roberts JC, 2012, J BIOMECH, V45, P2899, DOI 10.1016/j.jbiomech.2012.07.027; Valenzuela V, 2016, BRAIN RES, V1648, P617, DOI 10.1016/j.brainres.2016.04.053; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	25	4	4	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	JAN	2018	28	1					115	126		10.1007/s00193-017-0769-x			12	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FU0TF	WOS:000423562600009					2022-02-06	
J	Trimmel, H; Majdan, M; Wodak, A; Herzer, G; Csomor, D; Brazinova, A				Trimmel, Helmut; Majdan, Marek; Wodak, Andrea; Herzer, Guenther; Csomor, Daniel; Brazinova, Alexandra			Citicoline in severe traumatic brain injury: indications for improved outcome	WIENER KLINISCHE WOCHENSCHRIFT			English	Article						Traumatic brain injury; Neuroprotective agents; Citicoline; Outcome; Intensive care medicine	REDUCED EVOKED RELEASE; CDP-CHOLINE; CARE; ACETYLCHOLINE; STROKE; IMPACT; TRIAL; SCALE; EPIDEMIOLOGY; MECHANISMS	Goal-oriented management of traumatic brain injury (TBI) can save the lives and/or improve the long-term outcome of millions of affected patients worldwide. Additionally, enhancing quality of life will save enormous socio-economic costs; however, promising TBI treatment strategies with neuroprotective agents, such as citicoline (CDP-choline), lacked evidence or produced contradictory results in clinical trials. During a prehospital TBI project to optimize early TBI care within 14 Austrian trauma centers, data on 778 TBI patients were prospectively collected. As preceding evaluations suggested a beneficial outcome in TBI patients treated at the Wiener Neustadt Hospital (WNH), we aimed to investigate the potential role of citicoline administration, solely applied in WNH, in those patients. In a retrospective subgroup analysis we compared 67 patients from WNH with citicoline administration and 67 matched patients from other Austrian centers without citicoline use. Patients with Glasgow Coma Scale score < 13 on site and/or Abbreviated Injury Scale of the region "head" > 2 were included. Our analysis revealed significantly reduced rates of intensive care unit (ICU) mortality (5% vs. 24%, p < 0.01), in-hospital mortality (9% vs. 24%, p = 0.035) and 6-month mortality (13% vs. 28%, p = 0.031), as well as of unfavorable outcome (34% vs. 57%, p = 0.015) and observed vs. expected ratio for mortality (0.42 vs. 0.84) in the WNH (citicoline receivers) group. Despite the limitations of a retrospective subgroup analysis our findings suggest a possible correlation between early and consequent citicoline administration and beneficial outcomes. Therefore, we aim to set up an initiative for a prospective, multicenter randomized controlled trial with citicoline in sTBI (severe TBI) patients.	[Trimmel, Helmut; Wodak, Andrea; Herzer, Guenther; Csomor, Daniel] Gen Hosp Wiener Neustadt, Dept Anesthesiol Emergency Med & Intens Care, Wiener Neustadt, Austria; [Trimmel, Helmut; Wodak, Andrea; Herzer, Guenther; Csomor, Daniel] Gen Hosp Wiener Neustadt, Karl Landsteiner Inst Emergency Med, Wiener Neustadt, Austria; [Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Brazinova, Alexandra] INRO, Vienna, Austria		Trimmel, H (corresponding author), Gen Hosp Wiener Neustadt, Dept Anesthesiol Emergency Med & Intens Care, Wiener Neustadt, Austria.; Trimmel, H (corresponding author), Gen Hosp Wiener Neustadt, Karl Landsteiner Inst Emergency Med, Wiener Neustadt, Austria.	helmut.trimmel@wienerneustadt.lknoe.at	Majdan, Marek/K-5017-2012; Brazinova, Alexandra/C-4265-2016	Majdan, Marek/0000-0001-8037-742X; Brazinova, Alexandra/0000-0003-0625-256X	Austrian Ministry of Health; Austrian Worker's Compensation Board (AUVA) [FK 11/2008, FK 11/2010]; AUVA [FK 09/13]; Neurotrauma Foundation	The INRO prehospital project was funded jointly by the Austrian Ministry of Health (Contract Oct. 15, 2008) and by the Austrian Worker's Compensation Board (AUVA; FK 11/2008 and FK 11/2010). Data analysis was supported by a grant from AUVA (FK 09/13). INRO is supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham through the Neurotrauma Foundation, and by small donations from various sources. Chiesi Pharmaceuticals provided a non-educational grant to facilitate initial data analysis at INRO and writing assistance.	Adibhatla Rao Muralikrishna, 2013, Nat Rev Neurol, V9, P173, DOI 10.1038/nrneurol.2012.166-c1; Adibhatla RM, 2002, J NEUROSCI RES, V70, P133, DOI 10.1002/jnr.10403; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Blount PJ, 2002, J HEAD TRAUMA REHAB, V17, P314, DOI 10.1097/00001199-200208000-00005; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brazinova A, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0133-z; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bustamante A, 2012, J NEUROCHEM, V123, P217, DOI 10.1111/j.1471-4159.2012.07891.x; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; Committee on Trauma, 2014, RES OPT CAR INJ PAT; Conant Richard, 2004, Altern Med Rev, V9, P17; COVIELLA ILG, 1992, J NEUROCHEM, V59, P338, DOI 10.1111/j.1471-4159.1992.tb08909.x; COVIELLA ILG, 1987, NEUROCHEM INT, V11, P293, DOI 10.1016/0197-0186(87)90049-0; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DORMAN RV, 1983, J NEUROCHEM, V40, P276, DOI 10.1111/j.1471-4159.1983.tb12682.x; FRESTA M, 1995, PHARMACEUT RES, V12, P1769, DOI 10.1023/A:1016234226404; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; GCOVIELLA IL, 1992, J NUTR BIOCHEM, V3, P313, DOI 10.1016/0955-2863(92)90039-L; Grieb P, 2014, CNS DRUGS, V28, P185, DOI 10.1007/s40263-014-0144-8; Herzer G, 2016, WIEN KLIN WOCHENSCHR, V128, P649, DOI 10.1007/s00508-016-1027-4; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Lazowski T, 2003, CRITICAL CARE, V7, P1; Le Poncin-Lafitte M, 1986, Agressologie, V27, P413; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Leon-Carrion J, 2000, NEUROREHABILITATION, V14, P33; LEVIN HS, 1991, J NEUROL SCI, V103, pS39; LOZANO R, 1991, J NEUROL SCI, V103, pS43; Ma XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079584; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; MALDONADO VC, 1991, J NEUROL SCI, V103, pS15; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Phillips JP, 2003, J HEAD TRAUMA REHAB, V18, P342, DOI 10.1097/00001199-200307000-00005; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; SAVCI V, 1995, J NEUROCHEM, V64, P378; Secades JJ., 2014, J TRAUMA TREAT, V4, P4; Secades JJ, 2012, REV NEUROLOGIA, V54, P173, DOI 10.33588/rn.5403.2011490; Secades JJ, 2011, REV NEUROLOGIA, V52, pS1, DOI 10.33588/rn.52S02.2010787; Spiers PA, 1999, J INT NEUROPSYCH SOC, V5, P260, DOI 10.1017/S1355617799533092; Tayebati SK, 2013, CLIN CHEM LAB MED, V51, P513, DOI 10.1515/cclm-2012-0559; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zweifler Richard M, 2002, Curr Med Res Opin, V18 Suppl 2, ps14, DOI 10.1185/030079902125000679	57	4	4	1	11	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	JAN	2018	130	1-2					37	44		10.1007/s00508-017-1240-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT0GD	WOS:000422799700006	28752349				2022-02-06	
J	Vickers, KL; Schultheis, MT; Manning, KJ				Vickers, Kayci L.; Schultheis, Maria T.; Manning, Kevin J.			Driving after brain injury: Does dual-task modality matter?	NEUROREHABILITATION			English	Article						Brain injuries; chronic; TBI (traumatic brain injury); CVA (cerebrovascular accident); automobile driving; cognition	ON-ROAD; DRIVER PERFORMANCE; PREDICTION; REHABILITATION; INTERFERENCE; MULTITASKING; BEHAVIORS; ATTENTION; VALIDITY; ABILITY	BACKGROUND: Virtual reality technology allows neuropsychologists to examine complex, real-world behaviors with high ecological validity and can provide an understanding of the impact of demanding dual-tasks on driving performance. OBJECTIVE: We hypothesized that a task imposing high cognitive and physical demands (coin-sorting) would result in the greatest reduction in driving maintenance performance. METHODS: Twenty participants with acquired brain injury and 28 healthy controls were included in the current study. All participants were licensed and drove regularly. Participants completed two standardized VRDS drives: (1) a baseline drive with no distractions, and (2) the same route with three, counterbalanced dual-tasks representing differing demands. RESULTS: A series of 3 (Task) x 2 (Group) ANOVAs revealed that the ABI group tended to go slower than the HC group in the presence of a dual-task, F (1, 111) = 6.24, p = 0.01. Importantly, the ABI group also showed greater variability in speed, F (1, 110) = 10.97, p < 0.01, and lane position, F (1, 108) = 7.81, p < 0.01, an effect driven by dual-tasks with both a cognitive and motor demand. CONCLUSIONS: These results indicate that long-term driving difficulties following ABI are subtle and likely due to reduced cognitive resources.	[Vickers, Kayci L.; Schultheis, Maria T.] Drexel Univ, Dept Psychol, 3201 Chestnut St,Suite 118-119, Philadelphia, PA 19104 USA; [Manning, Kevin J.] Univ Connecticut, Dept Psychol, Storrs, CT USA		Schultheis, MT (corresponding author), Drexel Univ, Dept Psychol, 3201 Chestnut St,Suite 118-119, Philadelphia, PA 19104 USA.	schultheis@drexel.edu		Schultheis, Maria/0000-0002-6558-548X			Aslaksen PM, 2013, EUR J NEUROL, V20, P1227, DOI 10.1111/ene.12172; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Ball K. K., 2002, GERONTECHNOLOGY, V1, P217; Bedard M, 2010, AM J OCCUP THER, V64, P336, DOI 10.5014/ajot.64.2.336; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; Bourlon C, 2014, GAIT POSTURE, V39, P188, DOI 10.1016/j.gaitpost.2013.07.002; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; CHAPARRO A, 2004, P HUM FACT ERG SOC A, V48, P2319, DOI DOI 10.1177/154193120404801924; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Engum E. S., 1988, COGNITIVE REHABILITA, V6, P34; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fisher DL, 2007, TRANSPORT RES REC, P80, DOI 10.3141/2018-11; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fleming J, 1999, BRAIN INJURY, V13, P417; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; HANDLER BS, 1995, J REHABIL, V61, P43; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Horrey WJ, 2009, J SAFETY RES, V40, P7, DOI 10.1016/j.jsr.2008.10.011; Lansdown T, 2004, ERGONOMICS, V47, P91, DOI 10.1080/00140130310001629775; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Lee HC, 2003, ACCIDENT ANAL PREV, V35, P797, DOI 10.1016/S0001-4575(02)00083-0; Levy J, 2008, APPL COGNITIVE PSYCH, V22, P507, DOI 10.1002/acp.1378; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mathias JL, 2009, INT PSYCHOGERIATR, V21, P637, DOI 10.1017/S1041610209009119; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McGehee DV, 2004, TRANSPORT RES F-TRAF, V7, P181, DOI 10.1016/j.trf.2004.08.001; McKeever JD, 2013, TRAFFIC INJ PREV, V14, P132, DOI 10.1080/15389588.2012.699695; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Parmet Y, 2015, HUM FACTORS, V57, P311, DOI 10.1177/0018720814548220; Pollatsek A, 2006, HUM FACTORS, V48, P447, DOI 10.1518/001872006778606787; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis Maria T, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4921; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Shinar D, 2005, ACCIDENT ANAL PREV, V37, P315, DOI 10.1016/j.aap.2004.09.007; Smith A., 2013, SYMBOL DIGIT MODALIT; Wechsler D., 2014, WECHSLER ADULT INTEL, Vfourth; Yang YR, 2007, GAIT POSTURE, V25, P185, DOI 10.1016/j.gaitpost.2006.03.007	48	4	4	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	2					213	222		10.3233/NRE-172301			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FZ0WT	WOS:000427295800011	29562565				2022-02-06	
J	Wilde, EA; Provenzale, JM; Taylor, BA; Boss, M; Zuccolotto, A; Hachey, R; Pathak, S; Tate, DF; Abildskov, TJ; Schneider, W				Wilde, Elisabeth A.; Provenzale, James M.; Taylor, Brian A.; Boss, Michael; Zuccolotto, Anthony; Hachey, Rebecca; Pathak, Sudhir; Tate, David F.; Abildskov, Tracy J.; Schneider, Walter			Assessment of quantitative magnetic resonance imaging metrics in the brain through the use of a novel phantom	BRAIN INJURY			English	Article						Phantom; diffusion tensor imaging; traumatic brain injury; diffuse axonal injury; quantitative MRI; metrology	WHITE-MATTER; STATISTICAL-METHODS; QUALITY-ASSURANCE; DIFFUSION PHANTOM; REPRODUCIBILITY; INJURY; MRI; MULTICENTER; BIOMARKERS; SCANNERS	Objective: Multisite and longitudinal neuroimaging studies are important in uncovering trajectories of recovery and neurodegeneration following traumatic brain injury (TBI) and concussion through the use of diffusion tensor imaging (DTI) and other imaging modalities. This study assessed differences in anisotropic diffusion measurement across four scanners using a human and a novel phantom developed in conjunction with the Chronic Effects of Neurotrauma Consortium.Method: Human scans provided measurement within biological tissue, and the novel physical phantom provided measures of anisotropic intra-tubular diffusion to serve as a model for intra-axonal water diffusion. Intra- and inter-scanner measurement variances were compared, and the impact on effect size was calculated.Results: Intra-scanner test-retest reliability estimates for fractional anisotropy (FA) demonstrated relative stability over testing intervals. The human tissue and phantom showed similar FA ranges, high linearity and large within-device effect sizes. However, inter-scanner measures of FA indicated substantial differences, some of which exceeded typical DTI effect sizes in mild TBI.Conclusion: The diffusion phantom may be used to better elucidate inter-scanner variability in DTI-based measurement and provides an opportunity to better calibrate results obtained from scanners used in multisite and longitudinal studies. Novel solutions are being evaluated to understand and potentially overcome these differences.	[Wilde, Elisabeth A.] VA Salt Lake City Hlth Care Syst, Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Wilde, Elisabeth A.; Abildskov, Tracy J.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Provenzale, James M.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Taylor, Brian A.] Virginia Commonwealth Univ, Coll Engn, Dept Biomed Engn, Richmond, VA USA; [Boss, Michael] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Boss, Michael] NIST, Boulder, CO USA; [Zuccolotto, Anthony; Schneider, Walter] Phantom Metr Div Psychol Software Tools In, Pittsburgh, PA USA; [Hachey, Rebecca; Pathak, Sudhir; Schneider, Walter] Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Abildskov, Tracy J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Schneider, Walter] Univ Pittsburgh, Dept Psychol, Med Ctr, Pittsburgh, PA 15260 USA; [Schneider, Walter] Univ Pittsburgh, Med Ctr, Dept Engn, Pittsburgh, PA USA; [Schneider, Walter] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA; [Schneider, Walter] Univ Pittsburgh, Dept Radiol, Med Ctr, Pittsburgh, PA 15260 USA		Wilde, EA (corresponding author), Univ Utah, 729 Arapeen Dr, Salt Lake City, UT 84112 USA.	Elisabeth.wilde@hsc.utah.edu	Tate, David F/I-3963-2013; Boss, Michael/I-2904-2019	Tate, David F/0000-0003-0213-1920; Boss, Michael/0000-0002-9492-767X; Taylor, Brian/0000-0001-9745-1075	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R43NS103729] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R44 MH072020] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R43 NS103729] Funding Source: Medline		Andersson J, 2007, TR07JA2 FMRIB U OXF, V2, P1; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Bisdas S, 2008, AM J NEURORADIOL, V29, P1128, DOI 10.3174/ajnr.A1044; Bjornholm L, 2017, NEUROIMAGE, V152, P108, DOI 10.1016/j.neuroimage.2017.02.056; Brander A, 2010, ACTA RADIOL, V51, P800, DOI 10.3109/02841851.2010.495351; Chen B, 2008, MAGN RESON IMAGING, V26, P103, DOI 10.1016/j.mri.2007.05.003; Chen CC, 2004, J DIGIT IMAGING, V17, P279, DOI 10.1007/s10278-004-1023-5; Chenevert TL, 2011, J MAGN RESON IMAGING, V34, P983, DOI 10.1002/jmri.22363; Cho GY, 2012, MAGN RESON MED, V67, P1710, DOI 10.1002/mrm.23193; D'Souza WD, 2001, MED PHYS, V28, P688, DOI 10.1118/1.1354998; Dabrowski W, 1997, MED PHYS, V24, P687, DOI 10.1118/1.597991; Fan QY, 2018, NEUROIMAGE, V182, P469, DOI 10.1016/j.neuroimage.2018.01.004; Huber JS, 2009, IEEE T NUCL SCI, V56, P2722, DOI 10.1109/TNS.2009.2028073; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kessler LG, 2015, STAT METHODS MED RES, V24, P9, DOI 10.1177/0962280214537333; Kranz GS, 2017, NEUROIMAGE, V150, P60, DOI 10.1016/j.neuroimage.2017.02.027; Lavdas I, 2013, J MAGN RESON IMAGING, V38, P173, DOI 10.1002/jmri.23950; Liewald D, 2014, BIOL CYBERN, V108, P541, DOI 10.1007/s00422-014-0626-2; Malyarenko D, 2013, J MAGN RESON IMAGING, V37, P1238, DOI 10.1002/jmri.23825; Marenco S, 2006, PSYCHIAT RES-NEUROIM, V147, P69, DOI 10.1016/j.pscychresns.2006.01.008; Mattila S, 2007, MAGN RESON MED, V57, P754, DOI 10.1002/mrm.21218; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Obuchowski NA, 2015, STAT METHODS MED RES, V24, P68, DOI 10.1177/0962280214537390; Ota M, 2013, NEUROPSYCHOBIOLOGY, V68, P205, DOI 10.1159/000355298; Pagani E, 2010, J MAGN RESON IMAGING, V31, P1458, DOI 10.1002/jmri.22186; Palacios EM, 2017, AM J NEURORADIOL, V38, P537, DOI 10.3174/ajnr.A5025; Pathak S, 2015, IMPROVED QUANTIFICAT; Raunig DL, 2015, STAT METHODS MED RES, V24, P27, DOI 10.1177/0962280214537344; Reischauer C, 2009, J MAGN RESON IMAGING, V29, P692, DOI 10.1002/jmri.21665; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schneider W, 2017, MHSRS KISS FL; Takao H, 2012, HUM BRAIN MAPP, V33, P466, DOI 10.1002/hbm.21225; Teipel SJ, 2011, PSYCHIAT RES-NEUROIM, V194, P363, DOI [10.1016/j.pscychresns2011.05.012, 10.1016/j.pscychresns.2011.05.012]; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Venkatraman VK, 2015, NEUROIMAGE, V119, P406, DOI 10.1016/j.neuroimage.2015.06.078; Wang ZYJ, 2011, MED PHYS, V38, P4415, DOI 10.1118/1.3595111; Wilde EA, 2016, BRAIN INJURY, V30, P1442, DOI 10.1080/02699052.2016.1219063; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Zhu T, 2011, NEUROIMAGE, V56, P1398, DOI 10.1016/j.neuroimage.2011.02.010; Zuccolotto AP, 2015, UNIVERSAL MODULAR TE	41	4	4	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1266	1276		10.1080/02699052.2018.1494855			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200013	30169993				2022-02-06	
J	Wintermann, GB; Rosendahl, J; Weidner, K; Strauss, B; Petrowski, K				Wintermann, Gloria-Beatrice; Rosendahl, Jenny; Weidner, Kerstin; Strauss, Bernhard; Petrowski, Katja			Predictors of Major Depressive Disorder following Intensive Care of Chronically Critically Ill Patients	CRITICAL CARE RESEARCH AND PRACTICE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; CONFUSION ASSESSMENT METHOD; ACUTE LUNG INJURY; CRITICAL ILLNESS; PROSPECTIVE COHORT; UNIT SURVIVORS; BRAIN-ICU; SYMPTOMS; DISTRESS	Objective. Major depressive disorder (MDD) is a common condition following treatment in the Intensive Care Unit (ICU). Long-term data on MDD in chronically critically ill (CCI) patients are scarce. Hence, the primary aim of the present study was to investigate the frequency and predictors of MDD after intensive care of CCI patients. Materials and Methods. In a prospective cohort study, patients with long-term mechanical ventilation requirements (n = 131) were assessed with respect to a diagnosis of MDD, using the Structured Clinical Interview for DSM-IV, three and six months after the transfer from acute ICU to post-acute ICU. Sociodemographic, psychological, and clinical risk factors with p values <= 0.1 were identified in a univariate logistic regression analysis and entered in a multivariable logistic regression model. A mediator analysis was run using the bootstrapping method, testing the mediating effect of perceived helplessness during the ICU stay, between the recalled traumatic experience from the ICU and a post-ICU MDD. Results. 17.6% (n = 23) of the patients showed a full- or subsyndromal MDD. Perceived helplessness, recalled experiences of a traumatic event from the ICU, symptoms of acute stress disorder, and the diagnosis of posttraumatic stress disorder (PTSD) after ICU could be identified as significant predictors of MDD. In a mediator analysis, perceived helplessness could be proved as a mediator. Conclusions. Every fifth CCI patient suffers from MDD up to six months after being discharged from ICU. Particularly, perceived helplessness during the ICU stay seems to mainly affect the long-term evolvement of MDD. CCI patients with symptoms of acute stress disorder/PTSD should also be screened for MDD.	[Wintermann, Gloria-Beatrice; Weidner, Kerstin; Petrowski, Katja] Tech Univ Dresden, Dept Psychotherapy & Psychosomat Med, Med Fak Carl Gustav Carus, Dresden, Germany; [Rosendahl, Jenny] Friedrich Schiller Univ, Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Rosendahl, Jenny; Strauss, Bernhard] Friedrich Schiller Univ, Jena Univ Hosp, Inst Psychosocial Med & Psychotherapy, Jena, Germany; [Petrowski, Katja] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Psychol & Med Sociol, Clin & Polyclin Psychosomat Med & Psychotherapy, Mainz, Germany		Wintermann, GB (corresponding author), Tech Univ Dresden, Dept Psychotherapy & Psychosomat Med, Med Fak Carl Gustav Carus, Dresden, Germany.	gloria.wintermann@uniklinikum-dresden.de	Rosendahl, Jenny/AAX-3240-2020; Wintermann, Gloria-Beatrice/AAN-3318-2021	Rosendahl, Jenny/0000-0001-7535-7571; Wintermann, Gloria-Beatrice/0000-0002-6292-0852	German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [01EO1002]	This study was supported by the German Federal Ministry of Education and Research (Grant no. 01EO1002). The authors would like to kindly thank Professor Frank Oehmichen and Professor Markus Pohl for their conceptual and scientific advice of the present study. The authors would also like to thank Stefan Rueckriem, Sara Wuestemann, Clara L. Buck, Christine Schier, and Corinna Klotzsche for their support in patient enrollment and data assessment. Finally, the authors thank Cynthia Heflebower for proofreading the manuscript and correcting the English editing.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Bienvenu OJ, 2013, PSYCHOL MED, V43, P2657, DOI 10.1017/S0033291713000214; Boer KR, 2008, INTENS CARE MED, V34, P664, DOI 10.1007/s00134-007-0941-3; Cox CE, 2007, CRIT CARE, V11, DOI 10.1186/cc5667; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd; Davydow DS, 2013, AM J GERIAT PSYCHIAT, V21, P887, DOI 10.1016/j.jagp.2013.01.017; Davydow DS, 2009, INTENS CARE MED, V35, P796, DOI 10.1007/s00134-009-1396-5; Duggan MC, 2017, J CRIT CARE, V37, P72, DOI 10.1016/j.jcrc.2016.08.023; Eaton WW, 2000, ARCH GEN PSYCHIAT, V57, P217, DOI 10.1001/archpsyc.57.3.217; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Falcone T., 2010, CURRENT CLIN MED; Foa EB, 2006, J CLIN PSYCHIAT, V67, P15; Griffiths J, 2007, INTENS CARE MED, V33, P1506, DOI 10.1007/s00134-007-0730-z; Harvey MA, 2016, CRIT CARE MED, V44, P381, DOI 10.1097/CCM.0000000000001531; Helfricht S, 2009, J TRAUMA STRESS, V22, P476, DOI 10.1002/jts.20445; Hinz A, 2005, PSYCHOTHER PSYCH MED, V55, P221, DOI 10.1055/s-2004-834630; Hopkins RO, 2010, GEN HOSP PSYCHIAT, V32, P147, DOI 10.1016/j.genhosppsych.2009.11.003; Jackson JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5707; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; Katon Wayne J, 2011, Dialogues Clin Neurosci, V13, P7; Klugkist M, 2008, ANAESTHESIST, V57, P464, DOI 10.1007/s00101-008-1356-4; Krishnadas R, 2016, BRAIN BEHAV IMMUN, V51, P29, DOI 10.1016/j.bbi.2015.08.005; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Myhren H, 2010, CRIT CARE, V14, DOI 10.1186/cc8870; Nelson BJ, 2000, CRIT CARE MED, V28, P3626, DOI 10.1097/00003246-200011000-00013; Nelson JE, 2004, CRIT CARE MED, V32, P1527, DOI 10.1097/01.CCM.0000129485.08835.5A; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Nixon RDV, 2004, J AFFECT DISORDERS, V82, P315, DOI 10.1016/j.jad.2004.01.008; OSullivan S., 2006, PHYS REHABILITATION, VFifth; Preacher K. J, 2016, CALCULATION SOBEL TE; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rabiee A, 2016, CRIT CARE MED, V44, P1744, DOI 10.1097/CCM.0000000000001811; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rollnik JD, 2011, REHABILITATION, V50, P408, DOI 10.1055/s-0031-1273728; Samuelson KAM, 2007, ACTA ANAESTH SCAND, V51, P671, DOI 10.1111/j.1399-6576.2007.01292.x; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Sukantarat K, 2007, BRIT J HEALTH PSYCH, V12, P65, DOI 10.1348/135910706X94096; Wade DM, 2012, CRIT CARE, V16, DOI 10.1186/cc11677; Weinert CR, 1997, AM J RESP CRIT CARE, V156, P1120, DOI 10.1164/ajrccm.156.4.9611047; Wintermann GB, 2017, J NERV MENT DIS, V205, P780, DOI 10.1097/NMD.0000000000000714; Wintermann GB, 2015, CRIT CARE MED, V43, P1213, DOI 10.1097/CCM.0000000000000936; Wittchen H.-U., 1997, STRUKTURIERTES KLIN; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; Zink W, 2009, NAT REV NEUROL, V5, P372, DOI 10.1038/nrneurol.2009.75	50	4	4	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1305	2090-1313		CRIT CARE RES PRACT	Crit. Care Res. Pract.		2018	2018								1586736	10.1155/2018/1586736			9	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GQ3QM	WOS:000441581300001	30155292	Green Published, Green Submitted, gold			2022-02-06	
S	Wolff, CS; Cantu, RC; Kucera, KL		Hainline, B; Stern, RA		Wolff, Catherine S.; Cantu, Robert C.; Kucera, Kristen L.			Catastrophic neurologic injuries in sport	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							CERVICAL-SPINE INJURIES; PREVENTING SUDDEN-DEATH; HIGH-SCHOOL; UNITED-STATES; AMERICAN FOOTBALL; TRAUMATIC BRAIN; CORD-INJURY; EPIDEMIOLOGY; FATALITIES; HEAD	Tens of millions of children and adults participate in organized sport in the United States each year. Although uncommon, fatal and severe nonfatal brain and spine injuries can occur during these activities. These "catastrophic" injuries have been noted in contact sports such as football, rugby, and ice hockey, as well as in noncontact sports including baseball, cheerleading, swimming and diving, equestrian, gymnastics, pole vault, rodeo, snow skiing, snowboarding, and wrestling. They happen at all levels of play, from youth to professional. Among all sports, football has the highest number of fatal brain and cervical spine injuries. While these injuries are more frequent in high school football, the rate is higher amongst college football athletes. Patterns exist in the types of brain and spine injuries most often occurring as a result of traumatic impacts in sport, but incidence and mechanisms of injury vary dramatically between sports. Understanding these patterns is essential to informing prevention efforts; football, pole vault, and cheer are all examples of sports benefiting from successful catastrophic injury prevention efforts. Participating in sport provides many benefits to physical and mental health. Despite these benefits, rare devastating injuries can be traumatic for the athletes, their families, and communities and can raise safety concerns that may reduce participation in sport. Understanding and preventing these types of injuries are critical to fostering participation in sport and ensuring both children and adults reap the physical, social, and mental benefits of sport.	[Wolff, Catherine S.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Cantu, Robert C.] Emerson Hosp, Dr Robert C Cantu Concuss Ctr, Concord, MA USA; [Kucera, Kristen L.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA		Kucera, KL (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA.	kkucera@email.unc.edu					Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Berry JG, 2006, AUST NZ J PUBL HEAL, V30, P268, DOI 10.1111/j.1467-842X.2006.tb00869.x; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Boden BP, 2006, AM J SPORT MED, V34, P1223, DOI 10.1177/0363546506288306; Boden Barry P, 2005, Curr Sports Med Rep, V4, P45; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Boden BP, 2012, AM J SPORT MED, V40, P1488, DOI 10.1177/0363546512446682; Boden BP, 2009, PHYS MED REH CLIN N, V20, P55, DOI 10.1016/j.pmr.2008.10.014; Boden BP, 2004, AM J SPORT MED, V32, P1189, DOI 10.1177/0363546503262161; Boden BP, 2005, J AM ACAD ORTHOP SUR, V13, P445, DOI 10.5435/00124635-200511000-00004; Boden BP, 2002, AM J SPORT MED, V30, P791, DOI 10.1177/03635465020300060601; Boden BP, 2001, AM J SPORT MED, V29, P50, DOI 10.1177/03635465010290011301; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Butterwick DJ, 2011, CLIN J SPORT MED, V21, P243, DOI 10.1097/JSM.0b013e318218acdd; Cantu RC, 2000, NEUROSURGERY, V47, P673, DOI 10.1097/00006123-200009000-00029; Cantu RC, 2003, NEUROSURGERY, V53, P358, DOI 10.1227/01.NEU.0000073422.01886.88; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Carll KE., 2010, SEMIN SPINE SURG, V22, P168; Casa DJ, 2013, J ATHL TRAINING, V48, P546, DOI 10.4085/1062-6050-48.4.12; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Chomiak J, 2000, AM J SPORT MED, V28, pS58; Comstock RD, 2015, SUMMARY REPORT NATL; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dennis S, 2017, UNDERGRADUATE RES DA; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Franz T, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038166; Gouttebarge V, 2015, J SPORT MED PHYS FIT, V55, P1376; HADDON W, 1980, PUBLIC HEALTH REP, V95, P411; Haddon W, 1973, HUM FACTORS, V15, P355; Hutton MJ, 2016, GLOB SPINE J, V6, P721, DOI 10.1055/s-0036-1586744; Irick E., 2016, NCAA SPORTS SPONSORS; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kirkham A, 2016, WOUNDS MIDDLE AGES; Kleisiaris CF, 2014, J MED ETHICS HIST ME, V7; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Kucera KL, 2016, CATASTROPHIC SPORTS; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Mall NA, 2012, AM J SPORT MED, V40, P1755, DOI 10.1177/0363546512448355; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meehan WP, 2013, PEDIATR EMERG CARE, V29, P624, DOI 10.1097/PEC.0b013e31828e9cea; Mueller F O, 1991, Exerc Sport Sci Rev, V19, P261; Mueller FO, 2011, FOOTBALL FATALITIES; Mueller FO, 2009, CATASTROPHIC SPORTS; National Collegiate Athletic Association, 2017, NCAA CAT SPORT INJ R; National Federation of State High School Associations, 2017, SPORT PART STAT; National Spinal Cord Injury Statistical Center, 2016, FACTS FIG GLANC FACTS FIG GLANC; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Singh S, 2008, PEDIATRICS, V121, pE954, DOI 10.1542/peds.2007-0767; Tator CH, 2016, CLIN J SPORT MED, V26, P232, DOI 10.1097/JSM.0000000000000232; Thomas KE, 2006, BRIT J SPORT MED, V40, P619, DOI 10.1136/bjsm.2006.025858; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3439, DOI 10.1001/jama.254.24.3439; TORG JS, 1977, J AM COLL HEALTH ASS, V25, P224; Walters BS, 2014, J EMERG MED, V46, P650, DOI 10.1016/j.jemermed.2013.11.081; Weber CD, 2016, EUR J TRAUMA EMERG S, V42, P741, DOI 10.1007/s00068-015-0596-7; Zuckerman SL, 2015, WORLD NEUROSURG, V83, P1098, DOI 10.1016/j.wneu.2014.12.030; [No title captured]	60	4	4	1	4	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						25	37		10.1016/B978-0-444-63954-7.00004-5			13	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100006	30482353				2022-02-06	
J	Ye, H; Wang, WW; Ding, Y; Liu, XL; Jia, WJ; Luo, WL; Fan, HJ; Zhou, HQ; Wang, J; Ju, JL; Zhou, DM; Bao, TH; Zhu, YH				Ye, Hong; Wang, WeiWei; Ding, Yu; Liu, XiaoLei; Jia, WenJi; Luo, WeiLi; Fan, HuiJuan; Zhou, HongQun; Wang, Jin; Ju, JianLong; Zhou, DongMing; Bao, TianHao; Zhu, YuHong			Spontaneous running wheel improves neuroprotection efficacy of ischemic postconditioning in mice following ischemia/reperfusion injury	BIOCELL			English	Article						Ischemic postconditioning; ischemia/reperfusion; running wheel; apoptosis; PI3K; STAT3	TRAUMATIC BRAIN-INJURY; PI3K/AKT; ACTIVATION; APOPTOSIS; EXERCISE	Ischemic postconditioning (IP) has been shown to provide protection for ischemia/reperfusion (IR) injury, but its efficacy is limited. In this study we hypothesized that spontaneous running wheel (RW) could improve neuroprotection efficacy of IP for IR. We established mouse models of IR and showed that compared to Sham group, IR group had obvious brain infract and neurological dysfunction. In IR+IP group, brain infract and neurological dysfunction improved compared to IR group. However, in IR+IP+RW group brain infract and neurological dysfunction improved much better. TUNEL assay showed that IP but not RW significantly reduced the number of apoptotic cells after IR. However, the number of apoptotic cells was significantly reduced in RW+IP group. In addition, the levels of pro-apoptotic factors increased in IR group but significantly reduced in IR+IP+RW group, while the levels of anti-apoptotic factors decreased in IR group but significantly increased in IR+IP+RW group. Moreover, in IR+IP+RW group, MDA level was further decreased and SOD level was further increased compared to IR+IP group. Finally, both PI3K inhibitor and STAT3 inhibitor significantly worsened brain infract and neurological dysfunction and promoted apoptosis in IR mice. In conclusion, RW combined with IP reduces brain infract and neurological dysfunction in mice after IR, and this is associated with enhanced anti-apoptotic and anti-oxidant benefits via the activation of PI3K and STAT3 pathways.	[Ye, Hong; Jia, WenJi; Luo, WeiLi; Fan, HuiJuan; Zhou, HongQun; Wang, Jin; Ju, JianLong; Bao, TianHao; Zhu, YuHong] Kunming Med Univ, Affiliated Hosp 2, Dept Neurol, Kunming, Yunnan, Peoples R China; [Wang, WeiWei] Kunming Med Univ, Affiliated Hosp 2, Dept Cardiol, Kunming, Yunnan, Peoples R China; [Ding, Yu] Kunming Med Univ, Affiliated Hosp 2, Dept Ultrasound, Kunming, Yunnan, Peoples R China; [Liu, XiaoLei] Kunming Med Univ, Affiliated Hosp 1, Dept Neurol, Kunming, Yunnan, Peoples R China; [Bao, TianHao] Kunming Med Univ, Mental Hlth Ctr, Kunming, Yunnan, Peoples R China; [Ye, Hong] Kunming Med Univ, Kunming, Yunnan, Peoples R China; [Zhou, DongMing] Univ Alberta, Biomed Engn, Edmonton, AB, Canada		Bao, TH; Zhu, YH (corresponding author), Kunming Med Univ, Affiliated Hosp 2, Dept Neurol, Kunming, Yunnan, Peoples R China.; Bao, TH (corresponding author), Kunming Med Univ, Mental Hlth Ctr, Kunming, Yunnan, Peoples R China.	baotianhao@126.com; yuhong_lilin@aliyun.com			Joint Fund for Yunnan Provincial Science and Technology Department-Kunming Medical University [2017FE467-152]; Yunnan Provincial Workstation of XunMing Ji (2018); National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81060102]; Yunnan Provincial Medical and Health Units set up research institutes for scientific research projects [2014NS077, 2016NS262, 2016NS263, 2017NS286, 2017NS287]; Chinese stroke high-risk population intervention suitable technology research and promotion project [GN-2016R0005]	This study was supported by the Joint Fund for Yunnan Provincial Science and Technology Department-Kunming Medical University (No. 2017FE467-152), Yunnan Provincial Workstation of XunMing Ji (2018), National Natural Science Foundation of China (Regional Fund Project) (No. 81060102), Yunnan Provincial Medical and Health Units set up research institutes for scientific research projects (No. 2014NS077, 2016NS262, 2016NS263, 2017NS286, 2017NS287), Chinese stroke high-risk population intervention suitable technology research and promotion project (No. GN-2016R0005).	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Arunsundar M, 2015, NEUROTOX RES, V27, P143, DOI 10.1007/s12640-014-9492-x; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dezfulian C, 2013, TRANSL STROKE RES, V4, P19, DOI 10.1007/s12975-012-0224-3; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Gao GS, 2017, EXP THER MED, V14, P3926, DOI 10.3892/etm.2017.4934; Gidday J, 2015, BRAIN CIRC, V1, P97, DOI [DOI 10.4103/2394-8108.166379, 10.4103/2394-8108.166379]; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Gurusamy R, 2017, CMC-COMPUT MATER CON, V53, P91; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Kobayashi A, 2017, CMES-COMP MODEL ENG, V113, P117; Koo HM, 2013, J PHYS THER SCI, V25, P1103, DOI 10.1589/jpts.25.1103; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lu YJ, 2008, CELL PHYSIOL BIOCHEM, V21, P305, DOI 10.1159/000129389; Qin M, 2015, VASC PHARMACOL, V70, P23, DOI 10.1016/j.vph.2015.03.002; Tsubokawa T, 2007, STROKE, V38, P1057, DOI 10.1161/01.STR.0000257978.70312.1d; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Xie F, 2017, BIOCELL, V41, P45; Xue R, 2016, CLIN SCI, V130, P377, DOI 10.1042/CS20150496; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348	21	4	4	1	17	INST HISTOL EMBRIOL-CONICET	MENDOZA	FAC CIENCIAS MED-UNIV NAC CUYO CASILLA DE CORREO 56, 5500 MENDOZA, ARGENTINA	0327-9545	1667-5746		BIOCELL	Biocell		2018	42	3					79	85		10.32604/biocell.2018.04615			7	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	HK9AL	WOS:000458281100002					2022-02-06	
S	Zaninotto, ALC; Costa, BT; Ferreira, IS; French, M; Paiva, WS; Fregni, F		Fregni, F		Zaninotto, Ana Luiza C.; Costa, Beatriz Teixeira; Ferreira, Isadora Santos; French, Melanie; Paiva, Wellingson Silva; Fregni, Felipe			Traumatic Brain Injury	CLINICAL TRIALS IN NEUROLOGY	Neuromethods		English	Article; Book Chapter						Traumatic brain injury; Research; Review; Trauma; TBI	RANDOMIZED CONTROLLED-TRIAL; EXCESSIVE DAYTIME SLEEPINESS; INTRACRANIAL HYPERTENSION; MILD HYPOTHERMIA; CYCLOSPORINE-A; REHABILITATION IMPROVE; COGNITIVE FUNCTION; CLINICAL-TRIAL; DOUBLE-BLIND; THERAPY	Traumatic brain injury (TBI) is one of the leading causes of disabilities and young adults' death. Considering all the challenges faced in research involving this field, this book chapter analyses the 100 most cited TBI trials in order to provide methodological recommendations for designing future trials in TBI. A literature review of 100 most cited clinical trials in TBI between 2010 and 2015 was conducted using the web engine: Web of Science. Based on the CONSORT guidelines, a comprehensive discussion of the main findings is provided as to guide and help investigators in this field to design TBI clinical trials.	[Zaninotto, Ana Luiza C.; Costa, Beatriz Teixeira; Ferreira, Isadora Santos; French, Melanie; Fregni, Felipe] Harvard Med Sch, Spaulding Rehabil Hosp, Ctr Clin Res Learning, Lab Neuromodulat, Boston, MA 02115 USA; [Paiva, Wellingson Silva] Univ Sao Paulo HC FMUSP, Hosp Clin, Dept Neurol, Sao Paulo, Brazil; [Fregni, Felipe] Harvard Med Sch, Spaulding Res Inst, Spaulding Rehabil Hosp, Charlestown, MA USA		Zaninotto, ALC (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Ctr Clin Res Learning, Lab Neuromodulat, Boston, MA 02115 USA.		Paiva, Wellingson S/G-5517-2013; Zaninotto, Ana Luiza C./I-4095-2016	Paiva, Wellingson S/0000-0002-5165-7040; Zaninotto, Ana Luiza C./0000-0003-0639-0612; Fregni, Felipe/0000-0001-9359-8643			Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Administration USFaD, 2015, STEP 3 CLIN RES; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chittester B, 2014, MED DEVICE CLIN TRIA; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Empey PE, 2006, J NEUROTRAUM, V23, P109, DOI 10.1089/neu.2006.23.109; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Food and Drug Administration, WHAT DOES IT MEAN FD; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Katz-Leurer M, 2009, CLIN REHABIL, V23, P714, DOI 10.1177/0269215509335293; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Marmarou A, 2005, J NEUROTRAUM, V22, P1444, DOI 10.1089/neu.2005.22.1444; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Surgeons AAoN, 2015, TRAUM BRAIN INJ; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wilson M., 2014, SCAND J TRAUMA RE S1, V22, pA7, DOI [10.1186/1757-7241-22-S1-A7, DOI 10.1186/1757-7241-22-S1-A7]; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Wright J, 2011, ENCY CLIN NEUROPSYCH, P1150, DOI DOI 10.1007/978-0-387-79948-3; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	97	4	4	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-7880-9; 978-1-4939-7879-3	NEUROMETHODS	Neuromethods		2018	138						105	138		10.1007/978-1-4939-7880-9_4	10.1007/978-1-4939-7880-9		34	Cell Biology; Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL6RK	WOS:000454651100006					2022-02-06	
J	Zhang, XJ; Li, ZY; Zhang, QS; Chen, L; Huang, XJ; Zhang, Y; Liu, XJ; Liu, WL; Li, WP				Zhang, Xiejun; Li, Zongyang; Zhang, Qiusheng; Chen, Lei; Huang, Xianjian; Zhang, Yuan; Liu, Xiaojia; Liu, Wenlan; Li, Weiping			Mechanisms Underlying H2O2-Evoked Carbonyl Modification of Cytoskeletal Protein and Axon Injury in PC-12 Cells	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Traumatic brain injury; Oxidative stress; Cytoskeletal protein; Carbonylation; Axonal injury; Proteasome beta 5 subunit	TRAUMATIC BRAIN-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TO-MESENCHYMAL TRANSITION; OXIDATIVE-STRESS; 20S PROTEASOME; INHIBITION; ACTIN; INACTIVATION; ACCUMULATION; FIBROBLASTS	Background/Aims: To investigate the mechanism that enables oxidative stress and cytoskeleton protein carbonylation to contribute to axonal dysfunction in traumatic brain injury (TBI). Methods: We created an in vitro model of neuronal oxidative damage by exposing a neuron-like cell line (PC-12) to different concentrations (100 mu M, 200 mu M, and 300 mu M) of H202 for 24 h or 48 h. Carbonyl modification of cytoskeletal proteins (beta-actin and beta-tubulin) and its impact on beta-actin/beta-tubulin filament dynamics were determined by enzyme-linked immunosorbent assay, immunostaining, and western blotting. Depolymerization of beta-actin/beta-tubulin filaments was evaluated using the monomer/polymer ratio of each protein via western blotting. Phosphorylation of the neurofilament heavy chain (P-NFH) was used as an axonal injury marker and detected by immunostaining. Results: Our results showed that H2O2 treatment led to increased oxidative stress in PC-12 cells, as indicated by the increased generation of malondialdehyde and 8-hydroxydeoxyguanosine and decreased intracellular glutathione levels. H2O2 treatment also increased carbonyl modification of total proteins and cytoskeleton proteins beta-actin/beta-tubulin, which occurred concurrently with the suppression of proteasome activity. Moreover, H2O2 treatment increased the generation of the axonal injury marker P-NFH, and depolymerization of the beta-actin/beta-tubulin filaments was indicated by increased monomer/polymer ratios of each protein. Lastly, overexpression of the proteasome beta 5 subunit in PC-12 cells significantly reduced the H2O2-induced accumulation of carbonylated beta-actin/beta-tubulin, P-NFH, and beta-actin/beta-tubulin depolymerization. Conclusions: We concluded that carbonylation of cytoskeleton proteins could lead to depolymerization of their filaments and axonal injury, and proteasome suppression contributes to the accumulation of carbonylated proteins under oxidative conditions. (C) 2018 The Author(s) Published by S. Karger AG, Basel	[Zhang, Xiejun; Zhang, Qiusheng; Chen, Lei; Huang, Xianjian; Liu, Xiaojia; Li, Weiping] Anhui Med Univ, Affilated Hosp 1, Shenzhen Peoples Hosp 2, Dept Neurosurg,Shenzhen Univ,Clin Coll, Shenzhen, Peoples R China; [Zhang, Xiejun; Li, Zongyang; Zhang, Qiusheng; Chen, Lei; Huang, Xianjian; Zhang, Yuan; Liu, Wenlan; Li, Weiping] Shenzhen Key Lab Neurosurg, Shenzhen, Peoples R China; [Li, Zongyang; Zhang, Yuan; Liu, Wenlan] Anhui Med Univ, Affilated Hosp 1, Shenzhen Peoples Hosp 2, Cent Lab,Shenzhen Univ,Clin Coll, Shenzhen, Peoples R China		Liu, WL; Li, WP (corresponding author), Shenzhen Univ, Aff Hosp 1, Shenzhen Peoples Hosp 2, Dept Neurosurg,Shenzhen Key Lab Neurosurg, Shenzhen 518035, Peoples R China.	wlliu@szu.edu.cn; wpli@szu.edu.cn			National Natural Science Foundation ChinaNational Natural Science Foundation of China (NSFC) [81301062]; Shenzhen Science & Technology Commission grants [ZDSYS20140509173142601, GCZX2015050411225563, JC1120140414170821242]	This study was supported by a grant from the National Natural Science Foundation China (Grant No. 81301062) and Shenzhen Science & Technology Commission grants (Grant Nos. ZDSYS20140509173142601, GCZX2015050411225563 and JC1120140414170821242).	Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Brettschneider J, 2006, MULT SCLER J, V12, P143, DOI 10.1191/135248506ms1263oa; Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Butterfield DA, 2012, ANTIOXID REDOX SIGN, V17, P1610, DOI 10.1089/ars.2011.4109; Castro JP, 2013, J PROTEOMICS, V92, P171, DOI 10.1016/j.jprot.2013.05.006; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Farout L, 2006, ARCH BIOCHEM BIOPHYS, V453, P135, DOI 10.1016/j.abb.2006.02.003; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Jamart C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-166; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507; Lu CY, 2015, BIOSCI TRENDS, V9, P138, DOI 10.5582/bst.2015.01066; Michelot A, 2013, DEV CELL, V24, P182, DOI 10.1016/j.devcel.2012.12.008; Miraldi ER, 2008, BIOPHYS J, V95, P2470, DOI 10.1529/biophysj.107.126219; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Petzold A, 2004, J NEUROL NEUROSUR PS, V75, P1178, DOI 10.1136/jnnp.2003.017236; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Rodrigo R, 2013, DIS MARKERS, V2013, P773, DOI 10.1155/2013/974358; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Tang X, 2015, CELL PHYSIOL BIOCHEM, V35, P816, DOI 10.1159/000369740; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tourtellotte WG, 2016, AM J PATHOL, V186, P489, DOI 10.1016/j.ajpath.2015.10.022; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Zhang J, 2016, CELL PHYSIOL BIOCHEM, V40, P347, DOI 10.1159/000452550; Zhang L, 2015, CELL PHYSIOL BIOCHEM, V37, P43, DOI 10.1159/000430332; [张秋生 Zhang Qiusheng], 2015, [中华神经医学杂志, Chinese Journal of Neuromedicine], V14, P469; Zheng JZ, 2010, J NEUROCHEM, V115, P1556, DOI 10.1111/j.1471-4159.2010.07062.x; Zheng JZ, 2010, J NEUROSCI RES, V88, P3376, DOI 10.1002/jnr.22488	39	4	4	1	6	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2018	48	3					1088	1098		10.1159/000491975			11	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	GS4KY	WOS:000443612500019	30041238	gold			2022-02-06	
J	Zhang, ZJ; Wang, ZZ; Zhang, B; Liu, Y				Zhang, Zhijie; Wang, Zhenzhong; Zhang, Bo; Liu, Yan			Downregulation of microRNA-155 by preoperative administration of valproic acid prevents postoperative seizures by upregulating SCN1A	MOLECULAR MEDICINE REPORTS			English	Article						microRNA-155; valproic acid; sodium voltage-gated channel subunit 1	TRAUMATIC BRAIN-INJURY; STATUS EPILEPTICUS; NEONATAL SEIZURES; CHILDREN; COMPLICATIONS; CRANIOPLASTY; EPILEPSY	The risk of seizure is increased following brain surgery such as cranioplasty. Patients with seizures that are treated with valproic acid (VPA) may have a decreased risk of further seizures. To verify microRNA (miR)-155 as a potential biomarker for the occurrence of seizures, reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used. Computational analysis and luciferase reporter assay was performed to identify the putative target of miR-155. RT-qPCR and western blot analyses were used to determine the expression level of miR-155, sodium voltage-gated channel subunit 1 (SCN1A) mRNA and protein. RT-qPCR analysis indicated that miR-155 levels in patients who experienced seizures increased 2.45-fold compared with patient who did not experience seizures, indicating miR-155 may be a potential biomarker for the occurrence of seizures. SCN1A was identified as a target gene of miR-155; the luciferase reporter assay revealed a negative regulatory relationship between miR-155 and SCN1A. The expression of SCN1A mRNA of patients receiving VPA was higher compared with the control group patients. Furthermore, the expression levels of SCN1A mRNA and protein were reduced or elevated following transfection with miR-155 mimics or inhibitors, respectively, compared with the scramble control. Furthermore, a concentration-dependent effect of miR-155 on the expression of SCN1A was observed. In conclusion, miR-155 may be associated with the risk of seizure and SCN1A may be a target gene of miR-155. Downregulation of microRNA-155 by preoperative administration of VPA may prevent postoperative seizure by upregulating the expression of SCN1A.	[Zhang, Zhijie; Wang, Zhenzhong; Zhang, Bo] Ningbo Univ, Affiliated Yangming Hosp, Dept Neurosurg, Ningbo 315100, Zhejiang, Peoples R China; [Liu, Yan] Ningbo Yinzhou Dist 2 Hosp, Dept Neurosurg, 2 Qianhe Rd, Ningbo 315100, Zhejiang, Peoples R China		Liu, Y (corresponding author), Ningbo Yinzhou Dist 2 Hosp, Dept Neurosurg, 2 Qianhe Rd, Ningbo 315100, Zhejiang, Peoples R China.	925403713@qq.com					Ashhab MU, 2013, J MOL NEUROSCI, V51, P950, DOI 10.1007/s12031-013-0013-9; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bin Goh WW, 2012, BIOINFORMATICS, V28, P453, DOI 10.1093/bioinformatics/btr693; Cai ZX, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2016.00129; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cranley MR, 2016, J ROY ARMY MED CORPS, V162, P109, DOI 10.1136/jramc-2014-000392; Creutzfeldt CJ, 2014, J NEUROL NEUROSUR PS, V85, P721, DOI 10.1136/jnnp-2013-305678; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filip Agata, 2007, Postepy Biochem, V53, P413; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Guarnieri DJ, 2008, ANN MED, V40, P197, DOI 10.1080/07853890701771823; Hatfield S, 2008, CELL TISSUE RES, V331, P57, DOI 10.1007/s00441-007-0530-3; Hesdorffer DC, 2009, EPILEPSIA, V50, P1102, DOI 10.1111/j.1528-1167.2008.01945.x; Hunsberger JG, 2012, AM J TRANSL RES, V4, P316; Klimek M, 2010, CURR OPIN ANESTHESIO, V23, P564, DOI 10.1097/ACO.0b013e32833e14f2; Krause-Titz UR, 2016, NEUROSURG REV, V39, P133, DOI 10.1007/s10143-015-0678-3; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; Lee L, 2013, BRIT J NEUROSURG, V27, P629, DOI 10.3109/02688697.2013.815313; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; MEYER FB, 1989, BRAIN RES REV, V14, P227, DOI 10.1016/0165-0173(89)90002-7; Mizrahi E M, 1987, Epilepsia, V28 Suppl 1, pS46, DOI 10.1111/j.1528-1157.1987.tb05757.x; Nicoloso MS, 2008, BRAIN PATHOL, V18, P122, DOI 10.1111/j.1750-3639.2007.00119.x; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Ronen GM, 2007, NEUROLOGY, V69, P1816, DOI 10.1212/01.wnl.0000279335.85797.2c; Sankar R, 2005, NEUROLOGY, V64, P776, DOI 10.1212/01.WNL.0000157320.78071.6D; Wang LL, 2015, CELL PHYSIOL BIOCHEM, V37, P2012, DOI 10.1159/000438561; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	31	4	6	1	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JAN	2018	17	1					1375	1381		10.3892/mmr.2017.8004			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FT8WG	WOS:000423433300178	29115566	Bronze			2022-02-06	
J	Sebastiani, A; Golz, C; Sebastiani, PG; Bobkiewicz, W; Behl, C; Mittmann, T; Thal, SC; Engelhard, K				Sebastiani, Anne; Goelz, Christina; Sebastiani, Philipp G.; Bobkiewicz, Wiesia; Behl, Christian; Mittmann, Thomas; Thal, Serge C.; Engelhard, Kristin			Sequestosome 1 Deficiency Delays, but Does Not Prevent Brain Damage Formation Following Acute Brain Injury in Adult Mice	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; protein degradation; autophagy; SQSTM1; p62; BAG3; mouse model	SELECTIVE AUTOPHAGY; CELL-DEATH; DEGRADATION; P62; DISEASE; RATS; INHIBITION; IMPAIRMENT; EXPRESSION; PROTEINS	Neuronal degeneration following traumatic brain injury (TBI) leads to intracellular accumulation of dysfunctional proteins and organelles. Autophagy may serve to facilitate degradation to overcome protein debris load and therefore be an important pro-survival factor. On the contrary, clearing may serve as pro-death factor by removal of essential or required proteins involved in pro-survival cascades. Sequestosome 1 (SQSTM1/p62) is a main regulator of the autophagic pathway that directs ubiquinated cargoes to autophagosomes for degradation. We show that SQSTM1 protein levels are suppressed 24 h and by trend 5 days after trauma. In line with these data the expression of Sqstm1 mRNA is reduced by 30% at day 3 after and stays depressed until day 5 after injury, indicating an impaired autophagy post controlled cortical impact (CCI). To determine the potential role of SQSTM1-dependent autophagy after TBI, mice lacking SQSTM1 (SQSTM1-KO) and littermates (WT) were subjected to CCI and brain lesion volume was determined 24 h and 5 days after insult. Lesion volume is 17% smaller at 24 h and immunoblotting reveals a reduction by trend of cell death marker alpha II-spectrin cleavage. But there is no effect on brain damage and cell death markers 5 days after trauma in SQSTM1-KO compared with WT. In line with these data neurofunctional testing does not reveal any differences. Additionally, gene expression of inflammatory (Tnf-alpha, iNos, Il-6, and Il-1 beta) and protein degradation markers (Bag1 and Bag3) were quantified by real-time PCR. Protein levels of LC3, BAG1, and BAG3 were analyzed by immunoblotting. Real-time PCR reveals minor changes in inflammatory marker gene expression and reduced Bag3 mRNA levels 5 days after trauma. Immunoblotting of autophagy markers LC3, BAG1, and BAG3 does not show any difference between KO and WT 24 h and 5 days after TBI. In conclusion, genetic ablation of SQSTM1-dependent autophagy leads to a delay but shows no persistent effect on post-traumatic brain damage formation. SQSTM1 therefore only plays a minor role for secondary brain damage formation and autophagic clearance of debris after TBI.	[Sebastiani, Anne; Goelz, Christina; Sebastiani, Philipp G.; Bobkiewicz, Wiesia; Thal, Serge C.; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Behl, Christian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem & Pathobiochem, Mainz, Germany; [Mittmann, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol, Mainz, Germany		Sebastiani, A; Golz, C; Sebastiani, PG; Bobkiewicz, W; Thal, SC; Engelhard, K (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany.; Behl, C (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem & Pathobiochem, Mainz, Germany.; Mittmann, T (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol, Mainz, Germany.	annesebastiani@web.de; chrgoelz@uni-mainz.de; philipp.sebastiani@gmx.net; wieslawa.bobkiewicz@unimedizin-mainz.de; cbehl@uni-mainz.de; mittmann@uni-mainz.de; thal@uni-mainz.de; engelhak@uni-mainz.de	Thal, Serge/D-6593-2011; Mittmann, Thomas/AAM-9047-2020	Thal, Serge/0000-0002-1222-8729; Behl, Christian/0000-0001-8453-2378	German Research FoundationGerman Research Foundation (DFG) [CRC1080/A9, TP C07, TP C02]	This work was supported by the German Research Foundation (CRC1080/A9) to CB, KE, and TM (TP C07 and TP C02). Some data shown in this manuscript are part of a doctoral thesis presented by PS to the Medical Faculty, University Medical Center of the Johannes Gutenberg University Mainz, Germany. The study is content of the professorial dissertation (Habilitation) of AS presented to the Johannes Gutenberg-University Mainz, Germany.	Au AK, 2017, NEUROCRIT CARE, V26, P348, DOI 10.1007/s12028-016-0351-x; Belaid A, 2014, AUTOPHAGY, V10, P201, DOI 10.4161/auto.27198; Chen HC, 2013, J SURG RES, V179, pE203, DOI 10.1016/j.jss.2012.02.023; Cho KO, 2012, GLIA, V60, P1915, DOI 10.1002/glia.22407; Evans TD, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2298; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Geng JF, 2017, AUTOPHAGY, V13, P639, DOI 10.1080/15548627.2017.1280646; Giza CC, 2001, J ATHL TRAINING, V36, P228; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jackson KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169291; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Moscat J, 2016, CELL, V167, P606, DOI 10.1016/j.cell.2016.09.030; Niida M, 2010, MOL IMMUNOL, V47, P2378, DOI 10.1016/j.molimm.2010.05.004; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rusten TE, 2010, NAT CELL BIOL, V12, P207, DOI 10.1038/ncb0310-207; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sandilands E, 2012, EMBO REP, V13, P733, DOI 10.1038/embor.2012.92; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sebastiani A, 2015, J NEUROTRAUM, V32, P1599, DOI 10.1089/neu.2014.3751; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang B, 2016, AUTOPHAGY, V12, P1215, DOI 10.1080/15548627.2016.1179401; Wang Z, 2011, AUTOPHAGY, V7, P401, DOI 10.4161/auto.7.4.14397; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xu Y, 2016, J NEUROCHEM, V139, P795, DOI 10.1111/jnc.13851; Zheng SL, 2017, J MOL NEUROSCI, V62, P43, DOI 10.1007/s12031-017-0909-x	40	4	4	0	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 19	2017	11								678	10.3389/fnins.2017.00678			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ4AG	WOS:000418299400001	29311767	gold, Green Published			2022-02-06	
J	Edwards, D; Sommerhage, F; Berry, B; Nummer, H; Raquet, M; Clymer, B; Stancescu, M; Hickman, JJ				Edwards, Darin; Sommerhage, Frank; Berry, Bonnie; Nummer, Hanna; Raquet, Martina; Clymer, Brad; Stancescu, Maria; Hickman, James J.			Comparison of NMDA and AMPA Channel Expression and Function between Embryonic and Adult Neurons Utilizing Microelectrode Array Systems	ACS BIOMATERIALS SCIENCE & ENGINEERING			English	Article						hippocampal neurons; adult neurons; embryonic neurons; microelectrode array; electrophysiology; in vitro	CENTRAL-NERVOUS-SYSTEM; SERUM-FREE MEDIUM; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; IN-VITRO; POSTNATAL-DEVELOPMENT; SYNAPTIC PLASTICITY; CORTICAL CULTURES; NETWORK ACTIVITY; DEFINED SYSTEM	Microelectrode arrays (MEAs) are innovative tools used to perform electrophysiological experiments for the study of electrical activity and connectivity in populations of neurons from dissociated cultures. Reliance upon neurons derived from embryonic tissue is a common limitation of neuronal/MEA hybrid systems and perhaps of neuroscience research in general, and the use of adult neurons could model fully functional in vivo parameters more closely. Spontaneous network activity was concurrently recorded from both embryonic and adult rat neurons cultured on MEAs for up to 10 weeks in vitro to characterize the synaptic connections between cell types. The cultures were exposed to synaptic transmission antagonists against NMDA and AMPA channels, which revealed significantly different receptor profiles of adult and embryonic networks in vitro. In addition, both embryonic and adult neurons were evaluated for NMDA and AMPA channel subunit expression over five weeks in vitro. The results established that neurons derived from embryonic tissue did not express mature synaptic channels for several weeks in vitro under defined conditions. Consequently, the embryonic response to synaptic antagonists was significantly different than that of neurons derived from adult tissue sources. These results are especially significant because most studies reported with embryonic hippocampal neurons do not begin at two to four weeks in culture. In addition, the utilization of MEAs in lieu of patch-clamp electrophysiology avoided a large-scale, labor-intensive study. These results establish the utility of this unique hybrid system derived from adult hippocampal tissue in combination with MEAs and offer a more appropriate representation of in vivo function for drug discovery. It has application for neuronal development and regeneration as well as for investigations into neurodegenerative disease, traumatic brain injury, and stroke.	[Edwards, Darin; Sommerhage, Frank; Berry, Bonnie; Nummer, Hanna; Raquet, Martina; Clymer, Brad; Stancescu, Maria; Hickman, James J.] Univ Cent Florida, NanoSci Technol Ctr, 12424 Res Pkwy, Orlando, FL 32826 USA; [Edwards, Darin; Berry, Bonnie; Hickman, James J.] Univ Cent Florida, UCF Coll Med, Burnett Sch Biomed Sci, 6850 Lake Nona Blvd, Orlando, FL 32827 USA		Hickman, JJ (corresponding author), Univ Cent Florida, NanoSci Technol Ctr, 12424 Res Pkwy, Orlando, FL 32826 USA.; Hickman, JJ (corresponding author), Univ Cent Florida, UCF Coll Med, Burnett Sch Biomed Sci, 6850 Lake Nona Blvd, Orlando, FL 32827 USA.	jhickman@ucf.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 EB005459]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB005459] Funding Source: NIH RePORTER	This work was supported by NIH Grant R01 EB005459 and a gift from Unither Therapeutics.	Abe K, 2008, DEV GROWTH DIFFER, V50, P261, DOI [10.1111/j.1440-169x.2008.00999.x, 10.1111/j.1440-169X.2008.00999.x]; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; Amin H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02635-x; BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brewer LD, 2007, BRAIN RES, V1151, P20, DOI 10.1016/j.brainres.2007.03.020; Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X; Charkhkar H, 2015, BRAIN RES, V1629, P1, DOI 10.1016/j.brainres.2015.09.036; CHENG B, 1995, J NEUROCHEM, V65, P2525; Chiappalone M, 2003, BIOSENS BIOELECTRON, V18, P627, DOI 10.1016/S0956-5663(03)00041-1; Das M, 2005, IN VITRO CELL DEV-AN, V41, P343; Edwards D, 2013, ACS CHEM NEUROSCI, V4, P1174, DOI 10.1021/cn300206k; Edwards D, 2010, J NEUROSCI METH, V190, P155, DOI 10.1016/j.jneumeth.2010.04.030; Esposti F, 2009, IEEE T NEUR SYS REH, V17, P364, DOI 10.1109/TNSRE.2009.2022832; Gavello D., 2016, CHANNELS AUSTIN, P1; Golan H, 2000, NEURAL PLAST, V7, P31, DOI 10.1155/NP.2000.31; Gonzalez-Sulser A, 2011, NEUROPHARMACOLOGY, V60, P1142, DOI 10.1016/j.neuropharm.2010.10.007; Gross GW, 1997, EUR J CELL BIOL, V74, P36; GROSS GW, 1995, BIOSENS BIOELECTRON, V10, P553, DOI 10.1016/0956-5663(95)96931-N; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Hofmann F, 2006, J PHYSIOL-PARIS, V99, P125, DOI 10.1016/j.jphysparis.2005.12.005; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kamioka H, 1996, NEUROSCI LETT, V206, P109, DOI 10.1016/S0304-3940(96)12448-4; Kamphuis W, 2003, EUR J NEUROSCI, V18, P1085, DOI 10.1046/j.1460-9568.2003.02841.x; Keefer EW, 2001, BIOSENS BIOELECTRON, V16, P513, DOI 10.1016/S0956-5663(01)00165-8; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Liu JP, 2010, J ALZHEIMERS DIS, V22, P541, DOI 10.3233/JAD-2010-100948; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; MATTSON MP, 1993, J NEUROSCI, V13, P4575; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Napoli A, 2016, J CELL BIOCHEM, V117, P559, DOI 10.1002/jcb.25312; Opitz T, 2002, J NEUROPHYSIOL, V88, P2196, DOI 10.1152/jn.00316.2002; Ravenscroft MS, 1998, J AM CHEM SOC, V120, P12169, DOI 10.1021/ja973669n; Safronov BV, 1999, J PHYSIOL-LONDON, V514, P729, DOI 10.1111/j.1469-7793.1999.729ad.x; Sasmal DK, 2016, J AM CHEM SOC, V138, P8789, DOI 10.1021/jacs.6b03496; Schaffner AE, 1995, J NEUROSCI METH, V62, P111, DOI 10.1016/0165-0270(95)00063-1; Stead JDH, 2006, J NEUROSCI, V26, P345, DOI 10.1523/JNEUROSCI.2755-05.2006; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Texido L, 2011, CELL CALCIUM, V49, P184, DOI 10.1016/j.ceca.2011.02.001; Travaglia A, 2016, NEUROBIOL LEARN MEM, V135, P125, DOI 10.1016/j.nlm.2016.08.005; Varghese K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008643; Vassallo A, 2017, NEUROTOXICOLOGY, V60, P280, DOI 10.1016/j.neuro.2016.03.019; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Wille M, 2015, INT J MOL SCI, V16, P21454, DOI 10.3390/ijms160921454	50	4	4	1	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2373-9878			ACS BIOMATER SCI ENG	ACS Biomater. Sci. Eng.	DEC	2017	3	12					3525	3533		10.1021/acsbiomaterials.7b00596			9	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	FQ1IO	WOS:000418110600047	29250595	Green Published, hybrid			2022-02-06	
J	Gatin, L; Schnitzler, A; Cale, F; Genet, G; Denormandie, P; Genet, F				Gatin, Laure; Schnitzler, Alexis; Cale, Fabien; Genet, Guillaume; Denormandie, Philippe; Genet, Francois			Soft Tissue Surgery for Adults With Nonfunctional, Spastic Hands Following Central Nervous System Lesions: A Retrospective Study	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Spastic hands; soft tissue surgery; neuro-orthopaedic surgery	FLEXOR CARPI ULNARIS; CEREBRAL-PALSY; WRIST ARTHRODESIS; UPPER EXTREMITY; REHABILITATION; DEFORMITY; PATIENT; ORIGIN	Purpose Soft tissue surgery for upper extremity contractures can improve hygiene, pain, and appearance in adults with central nervous system lesions. The goal of such interventions is highly individual; thus, goal attainment scaling (GAS; a method of scoring the extent to which patient's individual goals are achieved [5 levels] in the course of intervention and using T score values) is pertinent to evaluate outcome. The objective of this study was to assess the effect of soft tissue surgery for upper extremity muscle contractures in patients with central nervous system lesions using GAS. Methods Retrospective data from 70 interventions were included (63 patients; 23 women). The mean age was 51.3 +/- 16.2 years (range, 24.2-87.0 years). The primary goal was to improve hygiene (n = 58), pain (n = 10), or appearance (n = 2). The etiologies were stroke (n = 35), traumatic brain injury (n = 16), cerebral anoxia (n = 4), neurodegenerative disease (n = 6), and cerebral palsy (n = 2). The GAS score was calculated before surgery and 3 months after surgery. Results The T score (which took into account the weight of each goal) was 52.3 at 3 months (38.5 before surgery), corresponding to a "better than expected" outcome. The mean of the differences of the GAS score for each goal before and after surgery increased by 1.27 for hygiene, 1.06 for pain, and 1.00 for appearance. Conclusions Soft tissue surgery can safely and effectively improve hygiene, pain, and appearance in adults with cerebral damage. The preoperative evaluation should be multidisciplinary. The GAS is a useful tool to assess the effectiveness of orthopedic surgery for these patients. Copyright (C) 2017 by the American Society for Surgery of the Hand. All rights reserved.	[Gatin, Laure; Cale, Fabien; Denormandie, Philippe] Hop Raymond Poincare, AP HP, Serv Chirurg Orthoped & Traumatol, Garches, France; [Schnitzler, Alexis; Genet, Francois] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Schnitzler, Alexis] Univ Versailles St Quentin En Yvelines, HANDI ReSP EA4047, Montigny Le Bretonneux, France; [Genet, Guillaume; Denormandie, Philippe; Genet, Francois] Univ Versailles St Quentin En Yvelines, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France		Genet, F (corresponding author), CHU R Poincare, Serv Med Phys & Readaptat, 104 Bd R Poincare, F-92380 Garches, France.	francois.genet@aphp.fr			Allergan SA (Courbevoie, France); Merz Pharma (Paris La Defense, France); Ipsen Pharma (Boulogne Billancourt, France)	The authors received financial support from Allergan SA (Courbevoie, France), Merz Pharma (Paris La Defense, France), and Ipsen Pharma (Boulogne Billancourt, France).	Allieu Y, 2011, CHIR MAIN, V30, P159, DOI 10.1016/j.main.2011.03.003; BRAUN R, 1971, CALIF MED, V115, P11; Carlson MG, 2006, J HAND SURG-AM, V31A, P483, DOI 10.1016/j.jhsa.2005.12.013; El-Said NS, 2001, J BONE JOINT SURG BR, V83B, P259, DOI 10.1302/0301-620X.83B2.10763; GREEN WT, 1962, J BONE JOINT SURG AM, V44, P1343, DOI 10.2106/00004623-196244070-00006; Hargreaves DG, 2000, J HAND SURG-BRIT EUR, V25B, P193, DOI 10.1054/jhsb.2000.0366; Hayden RJ, 2005, HAND CLIN, V21, P631, DOI 10.1016/j.hcl.2005.08.004; HOFFER MM, 1986, J HAND SURG-AM, V11A, P836, DOI 10.1016/S0363-5023(86)80232-5; HOUSE JH, 1981, J BONE JOINT SURG AM, V63, P216, DOI 10.2106/00004623-198163020-00006; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Koman LA, 2010, ORTHOP CLIN N AM, V41, P519, DOI 10.1016/j.ocl.2010.06.003; Kong KH, 2012, ARCH PHYS MED REHAB, V93, P143, DOI 10.1016/j.apmr.2011.06.027; Krasny-Pacini A., 2013, Annals of Physical and Rehabilitation Medicine, V56, P212, DOI 10.1016/j.rehab.2013.02.002; Libberecht K, 2011, J HAND SURG-EUR VOL, V36E, P141, DOI 10.1177/1753193410384691; Omer G E, 1976, J Hand Surg Am, V1, P197; Pomerance JF, 1996, J HAND SURG-AM, V21A, P828, DOI 10.1016/S0363-5023(96)80199-7; Rockwood K, 2000, J AM GERIATR SOC, V48, P1080, DOI 10.1111/j.1532-5415.2000.tb04783.x; Saintyves G, 2011, CHIR MAIN, V30, P46, DOI 10.1016/j.main.2011.01.008; Thevenin-Lemoine C, 2013, J BONE JOINT SURG AM, V95A, P446, DOI 10.2106/JBJS.K.00190; Thibaut A, 2013, BRAIN INJURY, V27, P1093, DOI 10.3109/02699052.2013.804202; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Van Heest AE, 1999, J HAND SURG-AM, V24A, P323; Van Heest AE, 2009, J HAND SURG-AM, V34A, P1216, DOI 10.1016/j.jhsa.2009.03.006; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	24	4	4	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	DEC	2017	42	12							UNSP 1035.e1	10.1016/j.jhsa.2017.08.003			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	FO7GB	WOS:000417039600016	28935338				2022-02-06	
J	Giritharan, S; Cox, J; Heal, CJ; Hughes, D; Gnanalingham, K; Kearney, T				Giritharan, Sumithra; Cox, Joanna; Heal, Calvin J.; Hughes, David; Gnanalingham, Kanna; Kearney, Tara			The prevalence of growth hormone deficiency in survivors of subarachnoid haemorrhage: results from a large single centre study	PITUITARY			English	Article						Subarachnoid haemorrhage; Hypopituitarism; Growth hormone deficiency	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; ANTERIOR-PITUITARY FUNCTION; GH DEFICIENCY; LONG-TERM; NEUROENDOCRINE DYSFUNCTION; BODY-COMPOSITION; ACUTE-PHASE; HIGH-RISK; HYPOPITUITARISM	Objective The variation in reported prevalence of growth hormone deficiency (GHD) post subarachnoid haemorrhage (SAH) is mainly due to methodological heterogeneity. We report on the prevalence of GHD in a large cohort of patients following SAH, when dynamic and confirmatory pituitary hormone testing methods are systematically employed. Design In this cross-sectional study, pituitary function was assessed in 100 patients following SAH. Baseline pituitary hormonal profile measurement and glucagon stimulation testing (GST) was carried out in all patients. Isolated GHD was confirmed with an Arginine stimulation test and ACTH deficiency was confirmed with a short synacthen test. Results The prevalence of hypopituitarism in our cohort was 19% and the prevalence of GHD was 14%. There was no association between GHD and the clinical or radiological severity of SAH at presentation, treatment modality, age, or occurrence of vasospasm. There were statistically significant differences in terms of Glasgow Outcome Scale (GOS; p = 0.03) between patients diagnosed with GHD and those without. Significant inverse correlations between GH peak on GST with body mass index (BMI) and waist hip ratio (WHR) was also noted (p < 0.0001 and p < 0.0001 respectively). Conclusion Using the current testing protocol, the prevalence of GHD detected in our cohort was 14%. It is unclear if the BMI and WHR difference observed is truly due to GHD or confounded by the endocrine tests used in this protocol. There is possibly an association between the development of GHD and worse GOS score. Routine endocrine screening of all SAH survivors with dynamic tests is time consuming and may subject many patients to unnecessary side-effects. Furthermore the degree of clinical benefit derived from growth hormone replacement in this patient group, remains unclear. Increased understanding of the most appropriate testing methodology in this patient group and more importantly which SAH survivors would derive most benefit from GHD screening is required.	[Giritharan, Sumithra; Kearney, Tara] Salford Royal NHS Fdn Trust, Dept Endocrinol, Stott Lane, Salford M6 8HD, Greater Manches, England; [Cox, Joanna; Kearney, Tara] Salford Royal NHS Fdn Trust, Vasc Res Network, Stott Lane, Salford M6 8HD, Greater Manches, England; [Heal, Calvin J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Biostat, Fac Biol Med & Hlth, Manchester, Lancs, England; [Hughes, David] Salford Royal NHS Fdn Trust, Dept Neuroradiol, Stott Lane, Salford M6 8HD, Greater Manches, England; [Gnanalingham, Kanna] Salford Royal NHS Fdn Trust, Dept Neurosurg, Stott Lane, Salford M6 8HD, Greater Manches, England; [Gnanalingham, Kanna] Univ Manchester, MAHSC, Manchester, Lancs, England; [Giritharan, Sumithra] Salford Royal NHS Fdn Trust, Dept Endocrinol & Diabet, Stott Lane, Salford M6 8HD, Greater Manches, England		Giritharan, S (corresponding author), Salford Royal NHS Fdn Trust, Dept Endocrinol, Stott Lane, Salford M6 8HD, Greater Manches, England.; Giritharan, S (corresponding author), Salford Royal NHS Fdn Trust, Dept Endocrinol & Diabet, Stott Lane, Salford M6 8HD, Greater Manches, England.	sumithra@doctors.org.uk			Investigator-Initiated Research (IIR) award from Pfizer Ltd.	This study was partly funded by an Investigator-Initiated Research (IIR) award from Pfizer Ltd.	Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Andersen M, 2015, GROWTH HORM IGF RES, V25, P108, DOI 10.1016/j.ghir.2015.03.001; Bengtsson BA, 1998, GROWTH HORM IGF RES, V8, P77, DOI 10.1016/S1096-6374(98)80014-2; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Can A, 2016, NEUROSURGERY, V79, P253, DOI 10.1227/NEU.0000000000001157; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Dichtel LE, 2014, J CLIN ENDOCR METAB, V99, P4712, DOI 10.1210/jc.2014-2830; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; DRAKE CG, 1988, J NEUROSURG, V68, P985; Dutta P, 2012, NEUROL INDIA, V60, P390, DOI 10.4103/0028-3886.100729; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Flaherty Matthew L, 2005, J Stroke Cerebrovasc Dis, V14, P267, DOI 10.1016/j.jstrokecerebrovasdis.2005.07.004; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Gross BA, 2015, WORLD NEUROSURG, V83, P1039, DOI 10.1016/j.wneu.2015.01.034; Hannon MJ, 2015, CLIN ENDOCRINOL, V82, P115, DOI 10.1111/cen.12533; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; Ioachimescu AG, 2015, WORLD NEUROSURG, V83, P1026, DOI 10.1016/j.wneu.2015.01.044; JENNETT B, 1975, LANCET, V1, P480; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khajeh L, 2016, EUR J NEUROL, V23, P1269, DOI 10.1111/ene.13014; Khajeh L, 2015, J NEUROL NEUROSUR PS, V86, P905, DOI 10.1136/jnnp-2014-307897; Klose M, 2015, J CLIN MED, V4, P1480, DOI 10.3390/jcm4071480; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kopczak A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010002; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kronvall E, 2016, WORLD NEUROSURG, V88, P83, DOI 10.1016/j.wneu.2015.12.057; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Lammert A, 2012, PITUITARY, V15, P505, DOI 10.1007/s11102-011-0357-5; Lissett CA, 1999, CLIN ENDOCRINOL, V51, P551, DOI 10.1046/j.1365-2265.1999.00836.x; National Institute for Health and Clinical Excellence, 2003, HUM GROWTH HORM SOM; NICE, QUAL LIF ASS GH DEF; Noble AJ, 2008, NEUROSURGERY, V63, P1095, DOI 10.1227/01.NEU.0000327580.91345.78; Parenti G, 2011, J ENDOCRINOL INVEST, V34, P361, DOI [10.1007/BF03347460, 10.3275/7242]; Quinn AC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003932; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Ronne-Engstrom E, 2013, ACTA NEUROCHIR, V155, P587, DOI 10.1007/s00701-012-1612-x; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Scott RB, 2010, STROKE, V41, P1743, DOI 10.1161/STROKEAHA.110.585240; Svensson J, 1997, CLIN ENDOCRINOL, V46, P579, DOI 10.1046/j.1365-2265.1997.1851001.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tjahjadi M, 2013, WORLD NEUROSURG, V79, P296, DOI 10.1016/j.wneu.2012.10.009; Toogood AA, 1998, CLIN ENDOCRINOL, V48, P569, DOI 10.1046/j.1365-2265.1998.00440.x; Vahl N, 1997, AM J PHYSIOL-ENDOC M, V272, pE1108, DOI 10.1152/ajpendo.1997.272.6.E1108; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277; Wong GKC, 2011, NEUROSURGERY, V68, P1556, DOI 10.1227/NEU.0b013e31820cd40d	49	4	4	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	DEC	2017	20	6					624	634		10.1007/s11102-017-0825-7			11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	FK9AP	WOS:000413803200003	28822018	Green Published, hybrid			2022-02-06	
J	Harbinson, M; Zarshenas, S; Cullen, NK				Harbinson, Meredith; Zarshenas, Sareh; Cullen, Nora K.			Long-Term Functional and Psychosocial Outcomes After Hypoxic-Ischemic Brain Injury: A Case-Controlled Comparison to Traumatic Brain Injury	PM&R			English	Article							QUALITY-OF-LIFE; CARDIAC-ARREST SURVIVORS; DISABILITY RATING-SCALE; INDEPENDENCE MEASURE; NEUROLOGICAL REHABILITATION; ASSESSING DEPRESSION; COGNITIVE SEQUELAE; DAMAGE; NEUROPATHOLOGY; RESUSCITATION	Background: Despite the increasing rate of survival from hypoxic-ischemic brain injury (HIBI), there is a paucity of evidence on the long-term functional outcomes after inpatient rehabilitation among these nontrauma patients compared to patients with traumatic brain injury (TBI). Objectives: To compare functional and psychosocial outcomes of patients with HIBI to those of case-matched patients with TBI 4-11 years after brain insult. Design: Retrospective, matched case-controlled study. Methods: Data at the time of rehabilitation admission and discharge were collected as part of a larger acquired brain injury (ABI) database at Toronto Rehabilitation Institute (TRI) between 1999 and 2009. This study consisted of 11 patients with HIBI and 11 patients with TBI that attended the neuro-rehabilitation day program at TRI during a similar time frame and were matched on age, admission Functional Independence Measure (FIM) scores, and acute care length of stay (ALOS). At 4-11 years following brain insult, patients were reassessed using the FIM, Disability Rating Scale (DRS), Personal Health Questionnaire Depression Scale (PHQ-9), and the Mayo-Portland Adaptability Inventory 4 (MPAI-4). Results: At follow-up, patients with HIBI had significantly lower FIM motor and cognitive scores than patients with TBI (75.3 +/- 20.6 versus 88.1 +/- 4.78, P < .05, and 25.5 +/- 5.80 versus 32.7 +/- 2.54, P <. 05, respectively) despite having a similar time frame postinsult (ie, 4-11 years). In addition, there were significant differences in motor and total FIM change from admission to follow-up between HIBI and TBI patients (P < .05). Patients with HIBI also had significantly lower scores on the DRS, PHQ-9, and total MPAI-4 at follow-up (P < .05). Conclusions: The study results suggest that patients with HIBI achieve less long-term functional improvements compared to patients with TBI. Further research is warranted to compare the components of inpatient rehabilitation while adjusting for demographics and clinical characteristics between these 2 groups of patients.	[Harbinson, Meredith] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Zarshenas, Sareh] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Cullen, Nora K.] Univ Toronto, Brain & Spine Program, Toronto Rehabil Inst, Univ Hlth Network,Fac Med,Rehabil Sci Inst, Toronto, ON, Canada; [Cullen, Nora K.] West Pk Healthcare Ctr, 82 Buttonwood Ave, Toronto, ON M6M 2J5, Canada		Cullen, NK (corresponding author), Univ Toronto, Brain & Spine Program, Toronto Rehabil Inst, Univ Hlth Network,Fac Med,Rehabil Sci Inst, Toronto, ON, Canada.; Cullen, NK (corresponding author), West Pk Healthcare Ctr, 82 Buttonwood Ave, Toronto, ON M6M 2J5, Canada.	nora.cullen@uhn.ca		Cullen, Nora/0000-0001-6359-9418	Physicians' Services Incorporated (PSI) Foundation	The authors thank the staff of the Toronto Rehabilitation Institute (TRI), Acquired Brain Injury service, for their assistance in data collection, and acknowledge TRI for their support of the ABI Database. The authors also thank the Physicians' Services Incorporated (PSI) Foundation for providing funding for this study.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Alkadri ME, 2009, OCHSNER J, V9, P278; Anderson CA, 2010, NEUROREHABILITATION, V26, P47, DOI 10.3233/NRE-2010-0535; Busl KM, 2010, NEUROREHABILITATION, V26, P5, DOI 10.3233/NRE-2010-0531; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2003, PSYCHOSOMATICS, V44, P161; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Geocadin RG, 2008, NEUROL CLIN, V26, P487, DOI 10.1016/j.ncl.2008.03.015; Granja C, 2002, RESUSCITATION, V55, P37, DOI 10.1016/S0300-9572(02)00203-4; Greer DM, 2006, SEMIN NEUROL, V26, P373, DOI 10.1055/s-2006-948317; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Gualtieri CT, 2002, BRAIN INJURY MENTAL; Guo MF, 2011, FOLIA NEUROPATHOL, V49, P79; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Harve H, 2007, ACTA ANAESTHSIOL SCA, V51, P37; Heinz Ute E, 2015, BMC Res Notes, V8, P243, DOI 10.1186/s13104-015-1175-z; Hofgren C, 2008, BRAIN INJURY, V22, P972, DOI 10.1080/02699050802491289; Hollenberg J, 2008, CIRCULATION, V118, P389, DOI 10.1161/CIRCULATIONAHA.107.734137; Hopkins RO, 2012, NEUROREHABILITATION, V31, P319, DOI 10.3233/NRE-2012-0799; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Lecours A, 2012, J HEAD TRAUMA REHAB, V27, P379, DOI 10.1097/HTR.0b013e31823b2385; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Lu-Emerson C, 2010, NEUROREHABILITATION, V26, P35, DOI 10.3233/NRE-2010-0534; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P1603, DOI 10.1016/j.apmr.2012.04.003; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Middelkamp W, 2007, CLIN REHABIL, V21, P425, DOI 10.1177/0269215507075307; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Moulaert VRMP, 2010, J REHABIL MED, V42, P553, DOI 10.2340/16501977-0547; Moulaert VRMP, 2009, RESUSCITATION, V80, P297, DOI 10.1016/j.resuscitation.2008.10.034; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Pusswald G, 2000, RESUSCITATION, V47, P241, DOI 10.1016/S0300-9572(00)00240-9; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ravaud JF, 1999, SCAND J REHABIL MED, V31, P31; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Smania N, 2013, J HEAD TRAUMA REHAB, V28, P131, DOI 10.1097/HTR.0b013e31823c0127; Smith PM, 1996, ARCH PHYS MED REHAB, V77, P431, DOI 10.1016/S0003-9993(96)90029-5; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Sunnerhagen KS, 1996, RESUSCITATION, V31, P135, DOI 10.1016/0300-9572(95)00903-5; UDS Data Management Service, 1995, GUID UN DAT SYST MED; van Alem AP, 2004, AM HEART J, V148, P416, DOI 10.1016/j.ahj.2004.01.031	50	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	DEC	2017	9	12					1200	1207		10.1016/j.pmrj.2017.04.015			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FQ7CT	WOS:000418521100003	28512065				2022-02-06	
J	Ilie, G; Wickens, CM; Vingilis, ER; Mann, RE; Hamilton, H; Toplak, M; Adlaf, EM; Kolla, N; Ialomiteanu, AR; van der Mass, M; Asbridge, M; Rehm, J; Cusimano, MD				Ilie, Gabriela; Wickens, Christine M.; Vingilis, Evelyn R.; Mann, Robert E.; Hamilton, Hayley; Toplak, Maggie; Adlaf, Edward M.; Kolla, Nathan; Ialomiteanu, Anca R.; van der Mass, Mark; Asbridge, Mark; Rehm, Jurgen; Cusimano, Michael D.			Associations between a history of traumatic brain injuries and conduct disorder during youth in a population sample of Canadian adults	PSYCHIATRY RESEARCH			English	Article						Traumatic brain injury; Adults; Conduct disorder during youth; Lifetime history of traumatic brain injury	CHILDHOOD; SYMPTOMS; OUTCOMES; CONSEQUENCES; AGGRESSION; DELINQUENT; DEPRESSION; BEHAVIORS; MINI	This study describes the association between history of traumatic brain injury (TBI) and childhood symptoms of conduct disorder (CD). Data were based on telephone interviews with 6048 respondents derived from the 2011-2013 cycles of a representative cross-sectional survey of adults aged 18+ years in Ontario, Canada. TBI was defined as loss of consciousness for at least 5 min or overnight hospitalization due to injury symptoms. Symptoms of CD before 15 years of age were assessed using five items based on the DSM-IV. Adults who reported a history of TBI reported odds 3 times higher for possible CD before 15 years of age. Odds remained significant even when age, sex, marital status, income, and education were statistically controlled. The nature of this data precludes determining if TBI occurred before or following CD symptoms. Nonetheless, the co-occurrence of a history of TBI with symptoms of CD supports the recommendation that practitioners be vigilant in assessing the history of both CD and TBI when diagnosing and treating one of these conditions. These findings do not exclude the possibility that TBI during childhood or youth may be interfering with brain development and could co-occur with conduct behaviors in both the short and long term.	[Ilie, Gabriela; Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Wickens, Christine M.; Mann, Robert E.; Hamilton, Hayley; Ialomiteanu, Anca R.; van der Mass, Mark; Rehm, Jurgen] Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, 33 Russell St, Toronto, ON M5S 2S1, Canada; [Wickens, Christine M.; Mann, Robert E.; Hamilton, Hayley; Adlaf, Edward M.; Kolla, Nathan; Rehm, Jurgen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Vingilis, Evelyn R.; Adlaf, Edward M.] Univ Western Ontario, Dept Family Med, Populat & Community Hlth Unit, London, ON, Canada; [Toplak, Maggie] York Univ, Dept Psychol, Toronto, ON, Canada; [Toplak, Maggie] LaMarsh Ctr Child & Youth Res, Toronto, ON, Canada; [Kolla, Nathan] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Cusimano, Michael D.] St Michael Hosp, Div Neurosurg, Toronto, ON, Canada		Wickens, CM (corresponding author), Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, 33 Russell St, Toronto, ON M5S 2S1, Canada.	christine.wickens@camh.ca	van der Maas, Mark/AAL-5601-2020; Kolla, Nathan/W-4671-2019; Ilie, Gabriela/AAM-9122-2021; Wickens, Christine M./Q-2014-2017; Cusimano, Michael/X-4059-2019	van der Maas, Mark/0000-0001-9606-0187; Wickens, Christine M./0000-0002-9865-850X; 	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP102537]; CIHR Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; AUTO21 [B502:BAB]; CIHRCanadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research Council (SSHRC)Social Sciences and Humanities Research Council of Canada (SSHRC); Industry Canada	This research was supported by a Canadian Institutes for Health Research (CIHR) grant (MOP102537) and a CIHR Strategic Team Grant in Applied Injury Research (TIR-103946). Additional funding was obtained from a grant from AUTO21 (B502:BAB), a member of the Networks of Centres of Excellence (NCE) program that is administered and funded by the CIHR, Natural Sciences and Engineering Research Council (NSERC), and the Social Sciences and Humanities Research Council (SSHRC), in partnership with Industry Canada. The funding organizations did not play any role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript.	Adlaf E. M., 2013, CAMH MONITOR 2012 ME; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Bardone AM, 1998, J AM ACAD CHILD PSY, V37, P594, DOI 10.1097/00004583-199806000-00009; Butterworth P, 2004, J CLIN EPIDEMIOL, V57, P742, DOI 10.1016/j.jclinepi.2003.10.015; Canino G, 2010, SOC PSYCH PSYCH EPID, V45, P695, DOI 10.1007/s00127-010-0242-y; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Dicker BG, 1989, HEAD TRAUMA REHABIL, V4, P73; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Due P, 2005, EUR J PUBLIC HEALTH, V15, P128, DOI 10.1093/eurpub/cki105; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Faul M, 2010, TRAUMATIC BRAIN INJU; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fergusson DM, 1998, J CHILD PSYCHOL PSYC, V39, P1097, DOI 10.1111/1469-7610.00414; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P837, DOI 10.1111/j.1469-7610.2004.00387.x; Frances A., 2000, DSM 4 CLASS PSYCH; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Hux D, 1998, BRAIN INJURY, V12, P667; Ialomiteanu A.R., 2011, CAMH RES DOCUMENT SE, V37; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108167; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Karam RG, 2015, PSYCHOL MED, V45, P2045, DOI 10.1017/S0033291714003183; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Laub JH, 2000, AM J PSYCHIAT, V157, P96, DOI 10.1176/ajp.157.1.96; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; LYNSKEY MT, 1995, J ABNORM CHILD PSYCH, V23, P281, DOI 10.1007/BF01447558; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, https://doi.org/10.1300/J076v27n03_01]; Odgers CL, 2007, ARCH GEN PSYCHIAT, V64, P476, DOI 10.1001/archpsyc.64.4.476; Olino TM, 2010, J ABNORM CHILD PSYCH, V38, P1139, DOI 10.1007/s10802-010-9427-9; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Rutter M., 2008, RUTTERS CHILD ADOLES; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Scott S, 2008, ADV PSYCHIAT TREATME, V14, P61, DOI DOI 10.1192/APT.BP.106.002626; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks J, 2010, NEUROPSYCHOL REHABIL, V20, P922, DOI 10.1080/09602011.2010.519209; Tsai MC, 2014, J PEDIATR-US, V164, P136, DOI 10.1016/j.jpeds.2013.08.042; Vitola ES, 2012, CNS SPECTRUMS, V17, P94, DOI 10.1017/S1092852912000478; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wickens C.M., 2017, J TRANSPORT IN PRESS; Wickens CM, 2015, ACCIDENT ANAL PREV, V78, P87, DOI 10.1016/j.aap.2015.02.013	54	4	4	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	DEC	2017	258						184	188		10.1016/j.psychres.2017.08.011			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FN7FQ	WOS:000416184500029	28867408				2022-02-06	
J	Ko, A; Harada, MY; Barmparas, G; Smith, EJT; Birch, K; Barnard, ZR; Yim, DA; Ley, EJ				Ko, Ara; Harada, Megan Y.; Barmparas, Galinos; Smith, Eric J. T.; Birch, Kurtis; Barnard, Zachary R.; Yim, Dorothy A.; Ley, Eric J.			Limit Crystalloid Resuscitation after Traumatic Brain Injury	AMERICAN SURGEON			English	Article							FLUID RESUSCITATION; HEAD-INJURY; VOLUME; COAGULOPATHY; IMMEDIATE; MORTALITY; DURATION; MODEL	Patients with traumatic brain injury (TBI) are often resuscitated with crystalloids in the emergency department (ED) to maintain cerebral perfusion. The purpose of this study was to evaluate whether crystalloid resuscitation volume impacts mortality in TBI patients. This was a retrospective study of trauma patients with head abbreviated injury scale score >= 2, who received crystalloids during ED resuscitation between 2004 and 2013. Clinical characteristics and volume of crystalloids received in the ED were collected. Patients who received < 2 L of crystalloids were categorized as low volume (LOW), whereas those who received >= 2 L were considered high volume (HIGH). Mortality and outcomes were compared. Multivariable regression analysis was used to determine the odds of mortality while controlling for confounders. Over 10 years, 875 patients met inclusion criteria. Overall mortality was 12.5 per cent. Seven hundred and forty-two (85%) were in the LOW cohort and 133 (15%) in the HIGH cohort. Gender and age were similar between the groups. The HIGH cohort had lower admission systolic blood pressure (128 vs 138 mm Hg, P = 0.001), lower Glasgow coma scale score (10 vs 12, P < 0.001), higher head abbreviated injury scale (3.8 vs 3.3, P < 0.001), and higher injury severity score (25 vs 18, P < 0.001). The LOW group had a lower unadjusted mortality (10 vs 26%, P < 0.001). Multivariable analysis adjusting for confounders demonstrated that those resuscitated with >= 2 L of crystalloids had increased odds of mortality (adjusted odds ratio 2.25, P = 0.005). Higher volume crystalloid resuscitation after TBI is associated with increased mortality, thus limited resuscitation for TBI patients may be indicated.	[Ko, Ara; Harada, Megan Y.; Barmparas, Galinos; Smith, Eric J. T.; Yim, Dorothy A.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Birch, Kurtis; Barnard, Zachary R.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Suite 8215NT, Los Angeles, CA 90048 USA.	Eric.Ley@cshs.org	Barmparas, Galinos/L-6530-2019				Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cotton BA, 2009, J TRAUMA, V67, P389, DOI 10.1097/TA.0b013e3181a8b26f; Faul M, 2010, TRAUMATIC BRAIN INJU; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Harada MY, 2017, INT J SURG, V38, P78, DOI 10.1016/j.ijsu.2016.12.073; Haut ER, 2011, ANN SURG, V253, P371, DOI 10.1097/SLA.0b013e318207c24f; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Kaafarani HMA, 2014, SCAND J SURG, V103, P81, DOI 10.1177/1457496914524388; Kasotakis G, 2013, J TRAUMA ACUTE CARE, V74, P1215, DOI 10.1097/TA.0b013e3182826e13; Kellum JA, 1998, SHOCK, V9, P364, DOI 10.1097/00024382-199805000-00009; Leenen M, 2014, INJURY, V45, pS59, DOI 10.1016/j.injury.2014.08.019; Ley EJ, 2011, J TRAUMA, V70, P398, DOI 10.1097/TA.0b013e318208f99b; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Pepe Paul E, 2002, Prehosp Emerg Care, V6, P81, DOI 10.1080/10903120290938887; Sakles JC, 1997, ANN EMERG MED, V29, P392, DOI 10.1016/S0196-0644(97)70352-4; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Wang CH, 2014, CRIT CARE MED, V42, P954, DOI 10.1097/CCM.0000000000000050	23	4	4	0	2	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	DEC	2017	83	12					1447	1452					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FW3NZ	WOS:000425216300034	29336770				2022-02-06	
J	Kobe, IO; Qureshi, MM; Hassan, S; Oluoch-Olunya, DL				Kobe, Isaac O.; Qureshi, Mahmoud M.; Hassan, Saidi; Oluoch-Olunya, David L.			The impact of the introduction of PECARN head CT rules on the utilisation of head CT scans in a private tertiary hospital in Sub-Saharan Africa	CHILDS NERVOUS SYSTEM			English	Article						Head CT (computed tomography) scan; PECARN (Paediatric Emergency Care Applied Research Network); Mild head injury	TRAUMATIC BRAIN-INJURY; RADIATION-EXPOSURE; CHILDREN; RISK; MANAGEMENT; CHILDHOOD	The decision to order head CT scans to rule out clinically significant traumatic brain injury in mild head injury in children is made on the basis of clinical decision rules of which the Paediatric Emergency Care Applied Research Network (PECARN) CT head rules have been found to be most sensitive. The purpose of this study is to determine the proportion of head CT scans done for children with mild head injury and to determine disposition of patients from casualty after the introduction of PECARN head CT rules compared to the period before. The research question is "will introduction of the PECARN CT head rules reduce the proportion of head CT scans requested for children under 18 years with mild head injury at the AKUHN?" A before and after quasi experimental study with a study population including all children under 18 years presenting to the AKUHN with mild head injury and a Glasgow coma scale of 14 and above on presentation. Sample size was 85. A total of 42 patients files were analysed in the before study while 43 patients were selected for the after study. The median age was 5 years. The proportion of head CT scans reduced from 56% in the before group to 33% in the after group with no missed clinically significant traumatic brain injury. More patients were discharged home after evaluation in the after group (81%) than in the before group (58%). The number of head CT scans ordered reduced without missing any clinically significant traumatic brain injury.	[Kobe, Isaac O.; Qureshi, Mahmoud M.; Hassan, Saidi; Oluoch-Olunya, David L.] Aga Khan Univ Hosp, Dept Surg, POB 30270-00100, Nairobi, Kenya		Kobe, IO (corresponding author), Aga Khan Univ Hosp, Dept Surg, POB 30270-00100, Nairobi, Kenya.	kobeisaac@yahoo.com; mahmoud.qureshi@aku.edu; hsaid2ke@yahoo.com; dloolunya@yahoo.ca			Aga Khan University Resident research fund	Financial support was obtained from the Aga Khan University Resident research fund upon approval by the Aga Khan University Hospital, Nairobi (AKUHN) Research and Ethics Committee. The funds were allocated to Dr. Isaac Kobe, the corresponding author. Parts of the study were presented as powerpoint in the Faculty Seminar Series presentation at the Aga Khan University Hospital as part of qualifying requirement for the corresponding authors's Master of Medicine dissertation.	Babl F, 2014, BMC PAEDIATRICS, P1; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Chodick G, 2007, ISR MED ASSOC J, V9, P584; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Korir GK, 2012, J APPL CLIN MED PHYS, V13, P187, DOI 10.1120/jacmp.v13i1.3457; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Population reference bureau, 2011, KEN POP DAT SHEET, P8; Tobias JD, 2011, SAUDI J ANAESTH, V5, P395, DOI 10.4103/1658-354X.87270	13	4	4	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2017	33	12					2147	2152		10.1007/s00381-017-3577-9			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FL3ST	WOS:000414144400015	28856440				2022-02-06	
J	LaDuke, C; DeMatteo, D; Heilbrun, K; Gallo, J; Swirsky-Sacchetti, T				LaDuke, Casey; DeMatteo, David; Heilbrun, Kirk; Gallo, Jennifer; Swirsky-Sacchetti, Thomas			The Neuropsychological Assessment of Justice-Involved Men: Descriptive Analysis, Preliminary Data, and a Case for Group-Specific Norms	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Forensic neuropsychology; Assessment; Norms/normative studies; Head injury; Traumatic brain injury	CLINICAL NEUROPSYCHOLOGISTS; ANTISOCIAL-BEHAVIOR; UNITED-STATES; VALIDITY; PERFORMANCE; AMERICAN; TRAIL; RATES; EDUCATION; ISSUES	Objective: Neuropsychological expertise has played an increasing role in legal decision-making in criminal contexts. Valid neuropsychological evidence in criminal forensic contexts requires normative data that are representative of justice-involved individuals. Unfortunately, existing normative data appear unlikely to represent justice-involved individuals due to significant demographic and clinical factors specific to this population. As a result, the interpretation of neuropsychological performance with justice-involved individuals using existing normative data may increase the risk of inaccurate description, invalid clinical conceptualization, misdiagnosis of impairment, and misattribution of deficits in functional-legal capacities. The current study aimed to examine the use of neuropsychological assessment with justice-involved men. Method: A sample of incarcerated men (N = 95) was assessed using a battery of demographic, clinical, and neuropsychological measures. Results: Descriptive analyses showed the demographic and clinical diversity of justice-involved men. Inferential statistical analyses, effect size calculations, and clinical analyses demonstrated that a sample of justice-involved men performed significantly differently and was more impaired than commonly referenced normative samples across multiple measures of intellectual functioning, attention, verbal fluency, and executive functioning. Preliminary data are provided to aid the use of the selected neuropsychological measures with justice-involved men. Conclusions: Justice-involved men appear to represent a distinct neuropsychological population. Group-specific normative data will be useful to help ensure that opinions about these individuals are relevant, valid, and admissible within legal decision-making in criminal contexts. The current data can guide future efforts to develop substantive normative data on neuropsychological measures likely to be used in the assessment of justice-involved men.	[LaDuke, Casey; DeMatteo, David; Heilbrun, Kirk; Gallo, Jennifer] Drexel Univ, Dept Psychol, 3201 Chestnut St, Philadelphia, PA 19104 USA; [DeMatteo, David] Drexel Univ, Thomas R Kline Law Sch, 3320 Market St, Philadelphia, PA 19104 USA; [Swirsky-Sacchetti, Thomas] Jefferson Med Coll, Dept Psychiat & Human Behav, 1015 Walnut St, Philadelphia, PA 19107 USA; [LaDuke, Casey] Univ Virginia Hlth Syst, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA		LaDuke, C (corresponding author), Univ Virginia Hlth Syst, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA.	claduke3@gmail.com	DeMatteo, David/ABF-9266-2020; LaDuke, Casey/AAC-9100-2019; LaDuke, Casey/L-6606-2019	LaDuke, Casey/0000-0002-5415-713X; DeMatteo, David/0000-0002-0266-5749	Society for the Psychological Study of Social Issues; American Psychological Foundation	This work was supported by the Society for the Psychological Study of Social Issues Grants-In-Aid Program (with a matching contribution from the department of the first author), and the American Psychological Foundation Visionary Grant Program.	American Psychological Association, 2002, GUIDELINES MULTICULT; American Psychological Association, 2013, SPEC GUID FOR PSYCH; American Psychological Association, 2010, AM PSYCH ASS ETH PRI; Barkley R.A., 2011, BARKLEY ADULT ADHD R; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bureau of Justice Statistics, 2015, PROB PAR US 2014; Bureau of Justice Statistics, 2016, PRIS IN 2015; Bureau of Justice Statistics, 2015, PRISONERS IN 2014; Bureau of Justice Statistics, 2016, PROB PAR US 2015; Bureau of Justice Statistics, 2016, AG STAT PRIS POP 199; Burgess P, 1996, BEHAV ASSESSMENT DYS; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cagigas X. E., 2014, CLIN NEUROPSYCHOLOGY; Cahill BS, 2012, BEHAV SCI LAW, V30, P154, DOI 10.1002/bsl.2004; Center for Substance Abuse Treatment, 1994, TREATMENT IMPROVEMEN, V11; Centers for Disease Control and Prevention, 2007, TRAUM BRAIN INJ PRIS; Centre for Substance Abuse Treatment, 1994, DHHS PUBLICATION, VSMA 94- 2094; Delis DC., 2001, DELIS KAPLAN EXECUTI; DENNEY RL, 2008, CLIN NEUROPSYCHOLOGY; Farahany NA, 2015, J LAW BIOSCI, V2, P485, DOI 10.1093/jlb/lsv059; FISHBEIN D, 2000, SCI TREATMENT PREVEN; Gasquoine PG, 2017, CLIN NEUROPSYCHOL, V31, P587, DOI 10.1080/13854046.2016.1277786; Hancock M, 2010, AGGRESSIVE BEHAV, V36, P338, DOI 10.1002/ab.20353; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heilbrun K, 2003, ASSESSMENT, V10, P329, DOI 10.1177/1073191103258591; Institute of Behavioral Research, 2007, TCU DRUG SCREEN 2 TC; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; KAUFMANN PM, 2008, CLIN NEUROPSYCHOLOGY, P55; LaDuke C., 2016, THESIS; LaDuke C., 2015, SCITECH LAWYER, V11, P18; LaDuke C., 2016, 2016 NAT AC NEUR C S; LaDuke C, 2012, PROF PSYCHOL-RES PR, V43, P503, DOI 10.1037/a0028161; Larrabee G.J., 2011, FORENSIC NEUROPSYCHO; Manly JJ, 2008, NEUROPSYCHOL REV, V18, P179, DOI 10.1007/s11065-008-9068-8; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; MARTELL DA, 1992, LAW HUMAN BEHAV, V16, P313, DOI 10.1007/BF01044772; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; MELTON GB, 2007, PSYCHOL EVALUATIONS; Miles H., 2009, FORENSIC NEUROPSYCHO, P193; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Morse SJ, 2016, J LAW BIOSCI, V3, P336, DOI 10.1093/jlb/lsw025; *NAT AC NEUR, 2003, POS PAP IND COURT OR; National Center for PTSD, 1994, PCL C FOR DSM 4; National Center for PTSD, 2004, LIF STRESS CHECKL RE; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Porteus S. D, 1959, MAZE TEST CLIN PSYCH; Porteus S.D., 1965, PORTEUS MAZE TEST 50; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rabin LA, 2014, PROF PSYCHOL-RES PR, V45, P368, DOI 10.1037/a0037987; Rasmussen K, 2001, J AM ACAD PSYCHIATRY, V29, P186; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; RUFF RM, 1992, PERCEPT MOTOR SKILL, V75, P1311, DOI 10.2466/PMS.75.8.1311-1319; Salazar X.F., 2007, ASSESSMENT FEIGNED C, P405; Sayegh P, 2014, ARCH CLIN NEUROPSYCH, V29, P731, DOI 10.1093/arclin/acu059; Schroeder R. W., 2016, CLIN NEUROPSYCHOL, V30, P1; She P., 2006, RES BRIEF REV DISABI; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Smith A., 1991, SYMBOL DIGIT MODALIT; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P18, DOI 10.1076/1385-4046(200002)14:1;1-8;FT018; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Vanderhoff Holly, 1800, J Correct Health Care, V17, P51, DOI 10.1177/1078345810385914; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wolff N, 2012, INT J ENV RES PUB HE, V9, P1908, DOI 10.3390/ijerph9051908; Wolff N, 2009, VIOLENCE VICTIMS, V24, P469, DOI 10.1891/0886-6708.24.4.469	71	4	4	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2017	32	8					929	942		10.1093/arclin/acx042			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FN7AS	WOS:000416170000002	28520974	Bronze			2022-02-06	
J	Ma, L; Yang, Y; Sun, XC; Jiang, ML; Ma, Y; Yang, XL; Guo, ZW				Ma, Ling; Yang, Yue; Sun, Xuechen; Jiang, Meiling; Ma, Yang; Yang, Xilun; Guo, Zhiwei			Propofol regulates the expression of TLR4 through miR-21 in human umbilical vein endothelial cells	MOLECULAR MEDICINE REPORTS			English	Article						propofol; Toll-like receptor 4; microRNA-21	MEDIATED INNATE IMMUNITY; TRAUMATIC BRAIN-INJURY; TUMOR PROGRESSION; ANESTHESIA; CANCER; INHIBITION; ACTIVATION; SUPPRESSOR; INDUCTION; RESPONSES	Propofol (2,6-diisopropylphenol) is one of the most commonly used intravenous anesthetics. Anesthetics can regulate the inflammatory process; however, the mechanism remains to be fully elucidated. The present study aimed to investigate whether and how propofol affects the inflammatory reaction in human umbilical vein endothelial cells (HUVECs). The expression levels of Toll-like receptor 4 (TLR4) and cluster of differentiation 14 (CD14) were determined in HUVECs treated with propofol and lipopolysaccharide (LPS) using western blot and reverse transcription-quantitative polymerase chain reaction analyses. In addition, whether propofol regulated the expression of TLR4 though microRNA (miR)-21 was examined. The results showed that LPS promoted the expression levels of TLR4, CD14 and tumor necrosis factor alpha (TNF alpha), and suppressed the expression of miR-21 in HUVECs. Propofol suppressed the expression levels of TLR4, CD14 and TNF alpha, and upregulated the expression of miR-21 in a concentration-dependent manner. miR-21 downregulated the expression of TLR4 at the mRNA and protein levels, whereas the miR-21 mimic reversed the effect of LPS on the expression of TLR4. In addition, the miR-21 inhibitor inhibited the downregulatory effect of propofol on the expression of TLR4. TargetScan analysis showed that TLR4 was included in the list of targets of miR-21. Fluorescent reporter assays showed that the miR-21 mimic and propofol treatment reduced the fluorescence intensity in cells transfected with a reporter vector containing the wild-type TLR4 3'-untranslated region. Taken together, the results of the present study demonstrated that propofol regulated the expression of TLR4 in HUVECs through miR-21.	[Ma, Ling; Yang, Yue; Sun, Xuechen; Jiang, Meiling; Ma, Yang; Yang, Xilun; Guo, Zhiwei] China Med Univ, Dept Anesthesiol, Shengjing Hosp, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China		Ma, L (corresponding author), China Med Univ, Dept Anesthesiol, Shengjing Hosp, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China.	maling_sj@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81302534]; Doctor Start-up Funding Program of the Science and Technology Department of Liaoning Province [20111098]	This study was supported by the National Natural Science Foundation of China (grant no. 81302534) and the Doctor Start-up Funding Program of the Science and Technology Department of Liaoning Province (grant no. 20111098).	Bamford S, 2007, CELL MICROBIOL, V9, P532, DOI 10.1111/j.1462-5822.2006.00808.x; Calil IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090013; Chang GJ, 2015, ONCOTARGET, V6, P38578, DOI 10.18632/oncotarget.6161; Chen Yijiao, 2015, Zhonghua Yi Xue Za Zhi, V95, P3440; Chen ZF, 2015, ONCOL LETT, V10, P329, DOI 10.3892/ol.2015.3179; Dong GZ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0057-x; Gong Shumin, 2015, Yichuan, V37, P554, DOI 10.16288/j.yczz.15-020; Inada Takefumi, 2009, Immunopharmacol Immunotoxicol, V31, P150, DOI 10.1080/08923970802590415; Ji Xiang, 2009, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V21, P278; Jiang LH, 2015, LAB INVEST, V95, P1398, DOI 10.1038/labinvest.2015.105; Kang WK, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0227-0; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Krejsek J, 2005, Cas Lek Cesk, V144, P790; Kushida A, 2007, IMMUNOPHARM IMMUNOT, V29, P477, DOI 10.1080/08923970701675085; Leavy O, 2011, NAT REV IMMUNOL, V11, P502, DOI 10.1038/nri3031; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Liu C, 2011, INT J BIOL SCI, V7, P347, DOI 10.7150/ijbs.7.347; Liu F, 2016, NEUROPEPTIDES, V58, P1, DOI 10.1016/j.npep.2016.03.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez CB, 2004, J IMMUNOL, V173, P6882, DOI 10.4049/jimmunol.173.11.6882; Ma B, 2017, J TISSUE ENG REGEN M, V11, P1779, DOI 10.1002/term.2075; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Mannavola F, 2016, EXPERT REV CLIN IMMU, V12, P79, DOI 10.1586/1744666X.2016.1100965; Nakanuno Ryuichi, 2015, Hiroshima Journal of Medical Sciences, V64, P31; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Ouchi K, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0006-z; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Rachagani S, 2015, ONCOTARGET, V6, P40295, DOI 10.18632/oncotarget.5641; Rashidi Nesa, 2015, J Reprod Infertil, V16, P72; Sharma J, 2011, CELL IMMUNOL, V269, P69, DOI 10.1016/j.cellimm.2011.03.023; Siampalioti A, 2015, EUR REV MED PHARMACO, V19, P2493; Vogel SN, 2012, J IMMUNOL, V188, P5207, DOI 10.4049/jimmunol.1201050; Wang JQ, 2016, FUND CLIN PHARMACOL, V30, P511, DOI 10.1111/fcp.12217; Xie FL, 2015, PLANT BIOTECHNOL J, V13, P355, DOI 10.1111/pbi.12296; Yan LX, 2016, INT J ONCOL, V48, P471, DOI 10.3892/ijo.2015.3287; Zhang J, 2015, CANCER RES, V75, P1859, DOI 10.1158/0008-5472.CAN-14-1254; Zivkovic A, 2011, J IMMUNOL, V186, P1608, DOI 10.4049/jimmunol.1001665	38	4	4	1	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	DEC	2017	16	6					9074	9080		10.3892/mmr.2017.7765			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FQ3AM	WOS:000418229200156	29039542	Bronze			2022-02-06	
J	Sommer, JB; Bach, A; Mala, H; Gynther, M; Bjerre, AS; Gram, MG; Marschner, L; Stromgaard, K; Mogensen, J; Pickering, DS				Sommer, Jens Bak; Bach, Anders; Mala, Hana; Gynther, Mikko; Bjerre, Ann-Sofie; Gram, Marie Gajhede; Marschner, Linda; Stromgaard, Kristian; Mogensen, Jesper; Pickering, Darryl S.			Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in Rats	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; PSD-95; Neuroprotection; Excitotoxicity; Controlled cortical impact	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; POSTSYNAPTIC DENSITY PROTEIN-95; NITRIC-OXIDE SYNTHASE; IN-VITRO; CEREBROSPINAL-FLUID; SECONDARY ISCHEMIA; SYNAPTIC PROTEINS; OXIDATIVE STRESS; NMDA RECEPTORS	Therapeutic effects of PSD-95 inhibition have been demonstrated in numerous studies of stroke; however only few studies have assessed the effects of PSD-95 inhibitors in traumatic brain injury (TBI). As the pathophysiology of TBI partially overlaps with that of stroke, PSD-95 inhibition may also be an effective therapeutic strategy in TBI. The objectives of the present study were to assess the effects of a dimeric inhibitor of PSD-95, UCCB01-144, on excitotoxic cell death in vitro and outcome after experimental TBI in rats in vivo. In addition, the pharmacokinetic parameters of UCCB01-144 were investigated in order to assess uptake of the drug into the central nervous system of rats. After a controlled cortical impact rats were randomized to receive a single injection of either saline or two different doses of UCCB01-144 (10 or 20 mg/kg IV) immediately after injury. Spatial learning and memory were assessed in a water maze at 2 weeks post-trauma, and at 4 weeks lesion volumes were estimated. Overall, UCCB01-144 did not protect against NMDA-toxicity in neuronal cultures or experimental TBI in rats. Important factors that should be investigated further in future studies assessing the effects of PSD-95 inhibitors in TBI are discussed.	[Sommer, Jens Bak; Bach, Anders; Stromgaard, Kristian; Pickering, Darryl S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Jagtvej 160, DK-2100 Copenhagen, Denmark; [Sommer, Jens Bak; Mala, Hana; Bjerre, Ann-Sofie; Gram, Marie Gajhede; Marschner, Linda; Mogensen, Jesper] Univ Copenhagen, Dept Psychol, UCN, Fac Social Sci, Copenhagen, Denmark; [Gynther, Mikko] Univ Eastern Finland, Sch Pharm, Kuopio, Finland		Sommer, JB (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Jagtvej 160, DK-2100 Copenhagen, Denmark.; Sommer, JB (corresponding author), Univ Copenhagen, Dept Psychol, UCN, Fac Social Sci, Copenhagen, Denmark.	jens.sommer@sund.ku.dk	Gynther, Mikko/AAK-2827-2020; Gynther, Mikko/AAU-2199-2021	Gynther, Mikko/0000-0002-8606-7489; Bjerre, Ann-Sofie/0000-0001-6032-6502; Mogensen, Jesper/0000-0003-1959-581X; Stromgaard, Kristian/0000-0003-2206-4737; Bach, Anders/0000-0003-4305-9910; Rytter, Hana Mala/0000-0002-2910-372X	Aase og Ejnar Danielsens Fond; Gangstedfonden	This work was supported by grants from Aase og Ejnar Danielsens Fond and Gangstedfonden. The funding sources had no involvement in any parts of the study. We gratefully acknowledge and are indebted to Heidi Marie Nielsen and Shahrokh Khazraie Padrah for their valuable assistance and technical expertise.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Bach A, 2017, SPR SER TRANSL STROK, P203, DOI 10.1007/978-3-319-45345-3_8; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bratane BT, 2011, STROKE, V42, P3265, DOI 10.1161/STROKEAHA.111.618801; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P557, DOI 10.1080/10408440802014287; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Carpenter KLH, 2008, ACTA NEUROCHIR SUPPL, V102, P207, DOI 10.1007/978-3-211-85578-2_41; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Contestabile A, 2004, NEUROCHEM INT, V45, P903, DOI 10.1016/j.neuint.2004.03.021; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fan J, 2009, J NEUROSCI, V29, P10928, DOI 10.1523/JNEUROSCI.2491-09.2009; Fang M, 2003, J BIOL CHEM, V278, P36669, DOI 10.1074/jbc.M303520200; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gardoni F, 2006, EUR J NEUROSCI, V24, P2694, DOI 10.1111/j.1460-9568.2006.05140.x; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hanell Anders, 2012, Front Neurol, V3, P29, DOI 10.3389/fneur.2012.00029; Hawkins RD, 1998, PROG BRAIN RES, V118, P155; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hlatky R, 2002, ACT NEUR S, V81, P331; Hoque A, 2016, PHARMACOL THERAPEUT, V160, P159, DOI 10.1016/j.pharmthera.2016.02.009; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jensen JB, 1998, NEUROCHEM INT, V32, P505, DOI 10.1016/S0197-0186(97)00130-7; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kochanek PM, 2007, BRAIN INJURY MED PRI, P81; Kucharz K, 2017, J CEREBR BLOOD F MET, V37, P1820, DOI 10.1177/0271678X16645595; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Marschner L, 2016, IN VIVO, V30, P77; Martel MA, 2009, CHANNELS, V3, P12, DOI 10.4161/chan.3.1.7864; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mesenge C, 1996, J NEUROTRAUM, V13, P11, DOI 10.1089/neu.1996.13.11; Montaner J, 2013, DRUG FUTURE, V38, P485, DOI 10.1358/dof.2013.038.07.1980497; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Otani N, 2002, J NEUROTRAUM, V19, P1587, DOI 10.1089/089771502762300247; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Rangel-Castilla L, 2007, INTENSIVE CARE MED, P739, DOI [10.1007/978-0-387-49518-7_66, DOI 10.1007/978-0-387-49518-7_66]; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Shear D, 2011, 2011 SOC NEUR C, P12; Shear D, 2009, J NEUROTRAUM, V26, pA26; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Sommer JB, 2017, EUR J NEUROSCI, V45, P238, DOI 10.1111/ejn.13483; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Srejic LR, 2013, J CEREBR BLOOD F MET, V33, P1937, DOI 10.1038/jcbfm.2013.153; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sun HS, 2008, STROKE, V39, P2544, DOI 10.1161/STROKEAHA.107.506048; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Teves LM, 2016, J CEREBR BLOOD F MET, V36, P555, DOI 10.1177/0271678X15612099; Tisdall MM, 2013, NEUROCRIT CARE, V19, P65, DOI 10.1007/s12028-011-9633-5; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walls AB, 2014, NEUROMETHODS, V90, P73, DOI 10.1007/978-1-4939-1059-5_4; Watanabe Y, 2003, BIOCHEM J, V372, P465, DOI 10.1042/BJ20030380; Wen WY, 2006, CURR TOP MED CHEM, V6, P711, DOI 10.2174/156802606776894474; Yan XB, 2004, NEUROSCI LETT, V355, P197, DOI 10.1016/j.neulet.2003.11.001; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhou HH, 2015, STROKE, V46, P1352, DOI 10.1161/STROKEAHA.115.008886	89	4	4	0	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	DEC	2017	42	12					3401	3413		10.1007/s11064-017-2381-y			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FN0GT	WOS:000415657000006	28828633				2022-02-06	
J	van Markus-Doornbosch, F; Meesters, J; Kraaij, L; Wolterbeek, R; Vliet Vlieland, T				van Markus-Doornbosch, Frederike; Meesters, Jorit; Kraaij, Laurika; Wolterbeek, Ron; Vliet Vlieland, Thea			Fatigue and its relationship with physical activity in adolescents and young adults with traumatic brain injury: a cross-sectional study	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Traumatic brain injuries; Adolescent; Fatigue; Physical activity; Young adult	POST-CONCUSSION SYMPTOMS; FOLLOW-UP; EXERCISE; HEALTH; REHABILITATION; INDIVIDUALS; PERFORMANCE; CHILDREN; BENEFITS; VALIDITY	BACKGROUND: Physical activity (PA) in patients with traumatic brain injury (TBI) may be impaired leading to secondary health issues and limitations in participation. AIM: This study aims to determine the level of PA and its determinants in adolescents and young adults with TBI. DESIGN: Cross-sectional survey study. SETTING: Outpatient clinic of a rehabilitation center. POPULATION : Discharged patients aged 12-39 years with a diagnosis of TBI > 6 months treated in the rehabilitation center between 2009-2012. METHODS: The Activity Questionnaire for Adults and Adolescents (AQuAA) measuring PA, with results dichotomized for meeting or not meeting Dutch recommendations for health-enhancing physical activity (D-HEPA) and the Checklist Individual Strength questionnaire (CIS; range 20-140, higher scores represent higher levels of fatigue), measuring fatigue, were administered. RESULTS : Fifty (47%) of the 107 invited patients completed the questionnaire. Mean age was 25.0 +/- 7.2 years and 22 (44%) were male. Eighteen (36%) had a mild injury, 13 (26%) a moderate injury and 19 (38%) a severe injury. Median time spent on moderate-vigorous physical activity was 518 minutes/week (IQR 236-1725) (males performing significantly more minutes on moderate-vigorous activity than women) and on sedentary activity 2728 minutes/week (IQR 1637-3994). Thirty-two (64%) participants met the D-HEPA. According to the CIS, 19 participants (38%) were severely fatigued. Both the CIS total score and the subscales motivation and physical activity were associated with meeting the D-HEPA. CONCLUSIONS: The proportion of individuals with TBI meeting D-HEPA was similar to the general population, with the PA level being associated with self-reported fatigue. CLINICAL REHABILITATION IMPACT : Physical activity programs are continuously being developed to increase the percentage of individuals meeting public health recommendations for PA; when developing programs for individuals with TBI extra consideration should be taken for the presence of fatigue. As in the general population, females with TBI are less active, PA programs should probably consider gender differences in their development.	[van Markus-Doornbosch, Frederike; Meesters, Jorit; Kraaij, Laurika; Vliet Vlieland, Thea] Sophia Rehabil Ctr, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands; [van Markus-Doornbosch, Frederike; Meesters, Jorit; Vliet Vlieland, Thea] Leiden Univ, Med Ctr, Dept Orthoped Rehabil & Phys Therapy, Leiden, Netherlands; [Wolterbeek, Ron] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; [Vliet Vlieland, Thea] Rijnlands Rehabil Ctr, Leiden, Netherlands		van Markus-Doornbosch, F (corresponding author), Sophia Rehabil Ctr, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands.	f.vanmarkus@sophiarevalidatie.nl					AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; American Heart Association, 2015, AM HEART ASS REC PHY; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Benelux P, 2017, WECHSLER ADULT INTEL; Birch A, 1997, DEV PSYCHOL, P220; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Chinapaw MJM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-58; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Committee PAGA, 2008, PHYS ACT GUID ADV CO; Corporation I, 2015, IBM SPSS STAT WIND V; Curtin R, 2000, PUBLIC OPIN QUART, V64, P413, DOI 10.1086/318638; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; Dillard C, 2017, DISABIL REHABIL, V39, P544, DOI 10.3109/09638288.2016.1152602; Donkervoort M, 2007, DISABIL REHABIL, V29, P453, DOI 10.1080/09638280600836018; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; Fleming J, 2011, BRAIN INJURY, V25, P806, DOI 10.3109/02699052.2011.585508; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hassett L, 2015, J HEAD TRAUMA REHAB, V30, pE55, DOI 10.1097/HTR.0000000000000047; Hildebrandt VH, TNO TRENDS REPORT PH; Hildebrandt VH, 2013, TNO TRENDS REPORT PH; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Jones TM, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0039-x; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Knittle K, 2016, ARTHRIT CARE RES, V68, P203, DOI 10.1002/acr.22647; Maatta S, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0123-2; Meessen JMTA, 2017, RHEUMATOL INT, V37, P219, DOI 10.1007/s00296-016-3598-9; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Moore DL, 2000, SURVEY NONRESPONSE, P197; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Novack TA, 2000, BRAIN INJURY, V14, P987; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rimmer JH, 2008, J REHABIL RES DEV, V45, P315, DOI 10.1682/JRRD.2007.02.0042; Rockette-Wagner B, 2017, CHILD OBES, V13, P72, DOI 10.1089/chi.2015.0151; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Statistics Netherland (CBS), 2017, PEOPL LENGTH WEIGHT; Stiggelbout M., 2000, TIJDSCHR SOC GEZONDH, V78, P180; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; TEASDALE G, 1974, LANCET, V2, P81; ter Wolbeek M, 2006, PEDIATRICS, V117, pE1078, DOI 10.1542/peds.2005-2575; van Buuren S, 2004, Ned Tijdschr Geneeskd, V148, P1967; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Visser-Keizer AC, 2015, ARCH PHYS MED REHAB, V96, P1056, DOI 10.1016/j.apmr.2014.12.010; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; WHO, 2020, PHYS ACTIVITY; WHO (World Health Organization), 2016, BMI CLASSIFICATION; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009	61	4	4	0	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	DEC	2017	53	6					900	909		10.23736/S1973-9087.17.04517-8			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	FR7OB	WOS:000419258700010	28417612				2022-02-06	
J	Watson, CE; Clous, EA; Jaeger, M; D'Amours, SK				Watson, C. E.; Clous, E. A.; Jaeger, M.; D'Amours, S. K.			Introduction of the Abbreviated Westmead Post-Traumatic Amnesia Scale and Impact on Length of Stay	SCANDINAVIAN JOURNAL OF SURGERY			English	Article						Post-traumatic amnesia; mild traumatic brain injury; A-WPTAS; length of stay	TRAUMATIC BRAIN-INJURY; LONG-TERM OUTCOMES; MILD; IMPAIRMENT	Background and Aims: Mild traumatic brain injury is a common presentation to Emergency Departments. Early identification of patients with cognitive deficits and provision of discharge advice are important. The Abbreviated Westmead Post-traumatic Amnesia Scale provides an early and efficient assessment of post-traumatic amnesia for patients with mild traumatic brain injuries, compared with the previously used assessment, the Modified Oxford Post-traumatic Scale. Material and Methods: This retrospective cohort study reviewed 270 patients with mild traumatic brain injury assessed for post-traumatic amnesia over a 2-year period between February 2011 and February 2013. It identified those assessed with Abbreviated Westmead Post-traumatic Amnesia Scale versus Modified Oxford Post-traumatic Scale, the outcomes of these post-traumatic amnesia assessments, the hospital length of stay for patients, and their readmission rates. Results: The Abbreviated Westmead Post-traumatic Amnesia Scale was used in 91% of patient cases (and the Modified Oxford Post-traumatic Scale in 7%), and of those assessed with the Abbreviated Westmead Post-traumatic Amnesia Scale, 94% cleared post-traumatic amnesia testing within 4h. Of those assessed with the Abbreviated Westmead Post-traumatic Amnesia Scale, 56% had a shorter length of stay than had they been assessed with the Modified Oxford Post-traumatic Scale, resulting in 295 bed-days saved. Verbal and written discharge advice was provided to those assessed for post-traumatic amnesia to assist their recovery. In all, 1% of patients were readmitted for monitoring of mild post-concussion symptoms. Conclusion: The Abbreviated Westmead Post-traumatic Amnesia Scale provides an effective and timely assessment of post-traumatic amnesia for patients presenting to the Emergency Department with mild traumatic brain injury compared with the previously used assessment tool. It helps identify patients with cognitive impairment and the need for admission and further investigation, resulting in appropriate access to care. It also results in a decreased length of stay and decreased hospital admissions, with subsequent cost savings to the hospital.	[Watson, C. E.] Liverpool Hosp, Occupat Therapy Dept, Liverpool, NSW, Australia; [Clous, E. A.; D'Amours, S. K.] Liverpool Hosp, Trauma Dept, Liverpool, NSW, Australia; [Clous, E. A.] Acad Medisch Centrum, Dept Surg, Trauma Unit, Amsterdam, Netherlands; [Jaeger, M.] Liverpool Hosp, Neurosurg Dept, Liverpool, NSW, Australia; [Jaeger, M.] Wollongong Hosp, Neurosurg Dept, Wollongong, NSW, Australia		Watson, CE (corresponding author), Liverpool Hosp, Occupat Therapy Dept, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	catherine.watson@sswahs.nsw.gov.au					Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Jagnoor J, 2015, INJURY, V46, P1871, DOI 10.1016/j.injury.2014.08.044; Konigs M, 2012, J NEUROL NEUROSUR PS, V83, P1048, DOI 10.1136/jnnp-2012-302635; Leach K, 2006, BRAIN INJURY, V20, P1241, DOI 10.1080/02699050601049874; Meares S, 2012, IMPACT ABBREVIATED W; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Motor Accidents Authority, 2008, GUID MILD TRAUM BRAI; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Reed D, 2011, ADULT TRAUMA CLIN PR; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Stuart B, 2012, J EMERG NURS, V38, P435, DOI 10.1016/j.jen.2011.04.006; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684	17	4	4	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1457-4969	1799-7267		SCAND J SURG	Scand. J. Surg.	DEC	2017	106	4					356	360		10.1177/1457496917698642			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FN5CB	WOS:000416023000012	28385102	Bronze			2022-02-06	
J	Zhang, SH; Xie, HY; Wang, YY; Li, DK; Du, L; Wu, Y; Yang, GY				Zhang, Shehong; Xie, Hongyu; Wang, Yuyang; Li, Dake; Du, Liang; Wu, Yi; Yang, Guo-Yuan			Enriched environment improves behavioral performance and attenuates inflammatory response induced by TNF-alpha in healthy adult mice	EUROPEAN JOURNAL OF INFLAMMATION			English	Article						behavior; enriched environment; inflammation; mice; TNF-alpha	BRAIN; HIPPOCAMPUS; MEMORY; EXPRESSION; NEUROGENESIS; DYSFUNCTION; PLASTICITY; MICROGLIA; CYTOKINES; RESTORES	Several studies have demonstrated the neuroprotective effect of enriched environment (EE) and its positive effect on cognitive performance in pathological conditions, such as neurodegenerative diseases, epilepsy, and traumatic brain injury. However, the immunomodulatory effect of EE in normal rodents is not well characterized. To assess the immunomodulatory effect of EE, we randomly assigned normal mice to EE housing or standard environmental (SE) housing for 3 weeks. Behavioral alterations were evaluated by open field, fear conditioning, and Morris water maze tests. Immunohistochemical staining was performed to assess the expression of behavioral-related proteins, and enzyme-linked immunosorbent assay (ELISA) for brain-derived neurotrophic factor (BDNF), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1 beta (IL-1 beta) was also performed. We also measured the levels of RIP1 and RIP3 proteins using western blotting. EE significantly improved the cognitive performance which was associated with the increased expressions of BDNF, ionized calcium-binding adapter molecule 1 (Iba1), and glial fibrillary acidic protein (GFAP); EE did not influence any morphological changes in the brain tissue in adult mice; however, increased resistance to inflammation induced by TNF-alpha was observed. These findings indicate that EE can positively influence cognitive and behavioral performance in healthy adult mice by exerting environ-immuno effect on neural function.	[Zhang, Shehong; Xie, Hongyu; Wang, Yuyang; Du, Liang; Wu, Yi] Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai 200040, Peoples R China; [Li, Dake] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China; [Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurol, Shanghai 200025, Peoples R China; [Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Med X Res Inst, Neurosci & Neuroengn Res Ctr, Shanghai, Peoples R China; [Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China		Wu, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai 200040, Peoples R China.; Yang, GY (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurol, Shanghai 200025, Peoples R China.	wuyi@fudan.edu.cn; gyyang0626@163.com			Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81472150]; Key Projects of Shanghai Science and Technology on Biomedicine [13411951000]; Key Construction Projects of Shanghai Health and Family Planning on Weak Discipline [2015ZB0401]	This study was supported by the Natural Science Foundation of China (NSFC, nos. 81472150), the Key Projects of Shanghai Science and Technology on Biomedicine (nos. 13411951000), and the Key Construction Projects of Shanghai Health and Family Planning on Weak Discipline (nos. 2015ZB0401).	Baamonde C, 2011, DEV NEUROSCI-BASEL, V33, P442, DOI 10.1159/000329425; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; Doulames V, 2014, INT J NEUROSCI, V124, P369, DOI 10.3109/00207454.2013.848441; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Goshen I, 2009, J NEUROSCI, V29, P3395, DOI 10.1523/JNEUROSCI.5352-08.2009; Huang J, 2013, STROKE, V44, P190, DOI 10.1161/STROKEAHA.112.670299; Huttenrauch M, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00062; Jadavji NM, 2006, NEUROSCIENCE, V140, P1127, DOI 10.1016/j.neuroscience.2006.03.027; Kim YK, 2016, PROG NEURO-PSYCHOPH, V64, P277, DOI 10.1016/j.pnpbp.2015.06.008; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Livingston-Thomas J, 2016, NEUROTHERAPEUTICS, V13, P395, DOI 10.1007/s13311-016-0423-9; Ma K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050733; Ma YY, 2017, PROG NEUROBIOL, V157, P247, DOI 10.1016/j.pneurobio.2016.01.005; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Miki K, 2009, J NEUROSCI RES, V87, P1270, DOI 10.1002/jnr.21925; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Piazza F, 2014, METAB BRAIN DIS, V29, P93, DOI 10.1007/s11011-013-9467-2; Ron-Hare N, 2011, BRAIN BEHAV IMMUN, V25, P1036, DOI 10.1016/j.bbi.2010.12.011; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Singhal G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00097; Smith BL, 2017, PSYCHONEUROENDOCRINO, V77, P37, DOI 10.1016/j.psyneuen.2016.11.040; Tanaka S, 2011, J NEUROSCI RES, V89, P506, DOI 10.1002/jnr.22582; Veena J, 2009, NEUROSCI LETT, V455, P178, DOI 10.1016/j.neulet.2009.03.059; Williamson LL, 2012, BRAIN BEHAV IMMUN, V26, P500, DOI 10.1016/j.bbi.2012.01.003; Williamson LL, 2011, J NEUROSCI, V31, P15511, DOI 10.1523/JNEUROSCI.3688-11.2011; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zhang Shehong, 2016, Medicines (Basel), V3, DOI 10.3390/medicines3030016; Zhang XQ, 2016, MOL MED REP, V14, P2231, DOI 10.3892/mmr.2016.5470; Zheng JJ, 2014, NAT NEUROSCI, V17, P391, DOI 10.1038/nn.3634	37	4	4	1	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2058-7392	1721-727X		EUR J INFLAMM	Eur. J. Inflamm.	DEC	2017	15	3					200	209		10.1177/1721727X17730471			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FR3JA	WOS:000418961800007		gold			2022-02-06	
J	Damar, U; Gersner, R; Johnstone, JT; Kapur, K; Collins, S; Schachter, S; Rotenberg, A				Damar, Ugur; Gersner, Roman; Johnstone, Joshua T.; Kapur, Kush; Collins, Stephen; Schachter, Steven; Rotenberg, Alexander			Alterations in the Timing of Huperzine A Cerebral Pharmacodynamics in the Acute Traumatic Brain Injury Setting	JOURNAL OF NEUROTRAUMA			English	Article						cerebral pharmacodynamics; epilepsy; huperzine A; transcranial magnetic stimulation; traumatic brain injury	TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL INHIBITION; RECEPTOR SUBUNITS; EXPRESSION; THALAMUS; SEIZURES; PROGRESS; DRUGS; GABA	Traumatic brain injury (TBI) may affect the pharmacodynamics of centrally acting drugs. Paired-pulse transcranial magnetic stimulation (ppTMS) is a safe and noninvasive measure of cortical gamma-aminobutyric acid (GABA)-mediated cortical inhibition. Huperzine A (HupA) is a naturally occurring acetylcholinesterase inhibitor with newly discovered potent GABA-mediated antiepileptic capacity, which is reliably detected by ppTMS. To test whether TBI alters cerebral HupA pharmacodynamics, we exposed rats to fluid percussion injury (FPI) and tested whether ppTMS metrics of cortical inhibition differ in magnitude and temporal pattern in injured rats. Anesthetized adult rats were exposed to FPI or sham injury. Ninety minutes post-TBI, rats were injected with HupA or saline (0.6mg/kg, intraperitoneally). TBI resulted in reduced cortical inhibition 90min after the injury (N=18) compared to sham (N=13) controls (p=0.03). HupA enhanced cortical inhibition after both sham injury (N=6; p=0.002) and TBI (N=6; p=0.02). The median time to maximum HupA inhibition in sham and TBI groups were 46.4 and 76.5min, respectively (p=0.03). This was consistent with a quadratic trend comparison that projects HupA-mediated cortical inhibition to last longer in injured rats (p=0.007). We show that 1) cortical GABA-mediated inhibition, as measured by ppTMS, decreases acutely post-TBI, 2) HupA restores lost post-TBI GABA-mediated inhibition, and 3) HupA-mediated enhancement of cortical inhibition is delayed post-TBI. The plausible reasons of the latter include 1) low HupA volume of distribution rendering HupA confined in the intravascular compartment, therefore vulnerable to reduced post-TBI cerebral perfusion, and 2) GABAR dysfunction and increased AChE activity post-TBI.	[Damar, Ugur; Gersner, Roman; Kapur, Kush; Rotenberg, Alexander] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA USA; [Johnstone, Joshua T.; Collins, Stephen] Biscayne Neurotherapeut Inc, Miami, FL USA; [Schachter, Steven] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA USA; [Schachter, Steven] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA		Rotenberg, A (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	Alexander.Rotenberg@childrens.harvard.edu	Kapur, Kush/AAQ-3437-2020	Kapur, Kush/0000-0001-9022-913X	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS088583]; Boston Children's Hospital Translational Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088583] Funding Source: NIH RePORTER	This study was supported by NIH/NINDS 5R01NS088583 (to A.R.) and the Boston Children's Hospital Translational Research Program(to A.R.). Dr. Steven Schachter is the inventor on a patent for the use of Huperzine A for treatment of epilepsy, which is licensed by Harvard Medical School to Biscayne Neurotherapeutics, Inc., in which he holds less than 5% equity and for which he serves as chair of the scientific advisory board. Drs. Joshua T. Johnstone and Stephen Collins are the employees of Biscayne Neurotherapeutics, Inc.	Santos MA, 2016, FUTURE MED CHEM, V8, P2113, DOI 10.4155/fmc-2016-0103; Bialer M, 2015, EPILEPSY RES, V111, P85, DOI 10.1016/j.eplepsyres.2015.01.001; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Damar U, 2017, MED HYPOTHESES, V99, P57, DOI 10.1016/j.mehy.2016.12.006; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Gersner R, 2015, EPILEPSY RES, V117, P97, DOI 10.1016/j.eplepsyres.2015.08.012; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hameed MQ, 2014, NEUROREPORT, V25, P532, DOI 10.1097/WNR.0000000000000132; Hoffmeister PG, 2011, NEUROMOL MED, V13, P44, DOI 10.1007/s12017-010-8136-4; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Hsieh TH, 2012, J NEUROPHYSIOL, V107, P966, DOI 10.1152/jn.00690.2011; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Li YX, 2007, EUR J DRUG METAB PH, V32, P183, DOI 10.1007/BF03191002; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Lu HY, 2015, NEUROPSYCH DIS TREAT, V11, P2649, DOI 10.2147/NDT.S92158; Majidi S, 2017, NEUROCRIT CARE, V27, P90, DOI 10.1007/s12028-016-0363-6; Park P, 2010, NEUROSCI LETT, V470, P6, DOI 10.1016/j.neulet.2009.12.033; Pascarella A, 2016, J NEUROL, V263, P2048, DOI 10.1007/s00415-016-8232-y; Rafii MS, 2011, NEUROLOGY, V76, P1389, DOI 10.1212/WNL.0b013e318216eb7b; Rotenberg A, 2010, BRAIN TOPOGR, V22, P257, DOI 10.1007/s10548-009-0116-3; Shao ZQ, 2015, INT J CLIN EXP MED, V8, P2944; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Vahabzadeh-Hagh AM, 2012, NEUROMODULATION, V15, P296, DOI 10.1111/j.1525-1403.2012.00482.x; Vahabzadeh-Hagh AM, 2011, J NEUROPHYSIOL, V105, P615, DOI 10.1152/jn.00660.2010; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Yu D, 2013, P NATL ACAD SCI USA, V110, pE746, DOI 10.1073/pnas.1300083110; Zhu SZ, 2016, NEUROSCI LETT, V631, P70, DOI 10.1016/j.neulet.2016.07.009	29	4	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					393	397		10.1089/neu.2017.5258		NOV 2017	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000417143800001	29054135	Green Published			2022-02-06	
J	Strigo, IA; Spadoni, AD; Inslicht, SS; Simmons, AN				Strigo, Irina A.; Spadoni, Andrea D.; Inslicht, Sabra S.; Simmons, Alan N.			Repeated Exposure to Experimental Pain Differentiates Combat Traumatic Brain Injury with and without Post-Traumatic Stress Disorder	JOURNAL OF NEUROTRAUMA			English	Article						avoidance; emotion; imaging; insula; salience	PREFRONTAL CORTEX; US VETERANS; AVOIDANCE; PTSD; FEAR; INSULA; ANTICIPATION; ASSOCIATION; ACTIVATION; DEPRESSION	Mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) are highly comorbid conditions that often co-occur with chronic pain. We have shown that women with PTSD subsequent to intimate partner violence show attenuated brain response to repeated experimental pain that was related to symptoms of avoidance. The aim of this study was to extend our past findings to males with combat trauma and to examine brain response to experimental pain in men with and without PTSD who sustained mTBI during combat. Seventy male veterans performed an experimental pain paradigm during functional magnetic resonance imaging fMRI. Of the 70 total subjects, 46 self-reported a history of mTBI during combat (46 of 70). Of those with mTBI, 26 also met criteria for PTSD (26 of 46). As in our previous study, we examined change in brain activity to repeated heat pain with linear mixed-effects modeling for group by administration interaction effects. We observed a significant group by administration interaction to repeated heat pain within insular, frontal, and parietal cortices, such that the control group showed increased activation over time, whereas mTBI groups (mTBI-only, mTBI + PTSD) showed decreased activation within bilateral anterior insulas (AIs) between administrations. Importantly, change in the right AI response was inversely correlated with avoidance symptoms, but only in those with comorbid mTBI + PTSD. Further, in the comorbid group, greater AI attenuation was associated with decreased connectivity with anterior cingulate (ACC). The current study provides further evidence that repeated exposure to brief painful stimuli results in attenuation of insula activation over time in traumatized individuals. Further, in PTSD, AI shows greatest attenuation in those with the highest level of avoidance-a finding that was replicated across diverse samples. Thus, this mechanism may be a generalized mechanism of maladaptive response to experimental pain in those with significant trauma.	[Strigo, Irina A.; Inslicht, Sabra S.] Vet Affairs San Francisco Healthcare Syst, San Francisco, CA USA; [Strigo, Irina A.; Inslicht, Sabra S.] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Spadoni, Andrea D.; Simmons, Alan N.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Spadoni, Andrea D.; Simmons, Alan N.] Univ Calif San Diego, La Jolla, CA 92093 USA		Strigo, IA (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco VA Healthcare Syst, Res Serv, 4150 Clement St,Bldg 203,MC 116H, San Francisco, CA 94121 USA.	irina.strigo@ucsf.edu	Inslicht, Sabra S/O-3697-2017; Simmons, Alan N/A-9815-2008; strigo, irina A/L-9882-2016	Inslicht, Sabra S/0000-0002-2456-1625; Simmons, Alan N/0000-0003-3963-2112; strigo, irina A/0000-0002-8799-716X; Spadoni, Andrea/0000-0002-8367-6406	United States (U.S.) Department of Veterans Affairs Clinical Sciences Research and Development Service [I01-CX-000816, I01-CX000292, I01-CX000715, IK2 CX000864, I01CX000720]	This work was supported, in part, by I01-CX-000816(IAS), I01-CX000292 & I01-CX000715(ANS), IK2 CX000864(ADS), and I01CX000720(SSI) from the United States (U.S.) Department of Veterans Affairs Clinical Sciences Research and Development Service.	Andersen TE, 2016, EUR J PAIN, V20, P1241, DOI 10.1002/ejp.848; Asmundson GJG, 2009, DEPRESS ANXIETY, V26, P888, DOI 10.1002/da.20600; Badour CL, 2012, BEHAV RES THER, V50, P610, DOI 10.1016/j.brat.2012.06.006; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bernstein D., 1998, MANUAL CHILDHOOD TRA; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bravo-Rivera C, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00184; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Christenfeld N, 1997, HEALTH PSYCHOL, V16, P327, DOI 10.1037/0278-6133.16.4.327; Cox R.W, 2016, 065862 BIORXIV; Cox Robert W, 2017, Proc Natl Acad Sci U S A, V114, pE3370, DOI 10.1073/pnas.1614961114; Craig A. D., 2015, DO YOU FEEL INTEROCE; Defrin R, 2017, J PAIN, V18, P1, DOI 10.1016/j.jpain.2016.09.005; Defrin R, 2015, J PAIN, V16, P961, DOI 10.1016/j.jpain.2015.06.010; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Engstrom M, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01071; First M., 1997, STRUCTURED CLIN INTE; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Geuze E, 2007, ARCH GEN PSYCHIAT, V64, P76, DOI 10.1001/archpsyc.64.1.76; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holschneider DP, 2016, NEUROBIOL STRESS, V3, P8, DOI 10.1016/j.ynstr.2015.12.003; Hopper JW, 2007, J TRAUMA STRESS, V20, P713, DOI 10.1002/jts.20284; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Krypotos AM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00189; Kucyi A, 2013, P NATL ACAD SCI USA, V110, P18692, DOI 10.1073/pnas.1312902110; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Linnman C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-8; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McNally GP, 2004, J NEUROSCI, V24, P6912, DOI 10.1523/JNEUROSCI.1828-04.2004; Moeller-Bertram T, 2012, NEUROPHARMACOLOGY, V62, P586, DOI 10.1016/j.neuropharm.2011.04.028; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morey RA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.196; Mueller SC, 2010, NEUROPSYCHOLOGIA, V48, P3037, DOI 10.1016/j.neuropsychologia.2010.06.013; Nahin RL, 2017, J PAIN, V18, P247, DOI 10.1016/j.jpain.2016.10.021; Pamplona FA, 2011, J PSYCHIATR RES, V45, P354, DOI 10.1016/j.jpsychires.2010.06.015; Pieritz Karoline, 2015, Neuropsychiatr Dis Treat, V11, P2109, DOI 10.2147/NDT.S87703; Pineles SL, 2011, J ABNORM PSYCHOL, V120, P240, DOI 10.1037/a0022123; Ploner M, 2010, P NATL ACAD SCI USA, V107, P355, DOI 10.1073/pnas.0906186106; Reitan R, 1985, HALSTEAD REITAN NEUR; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Simmons AN, 2008, BIOL PSYCHIAT, V64, P681, DOI 10.1016/j.biopsych.2008.05.027; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Strigo IA, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.15; Strigo IA, 2008, ARCH GEN PSYCHIAT, V65, P1275, DOI 10.1001/archpsyc.65.11.1275; Strigo IA, 2008, PSYCHOSOM MED, V70, P338, DOI 10.1097/PSY.0b013e3181656a48; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Strigo IA, 2010, BIOL PSYCHIAT, V68, P442, DOI 10.1016/j.biopsych.2010.03.034; Strigo IA, 2010, PSYCHOSOM MED, V72, P316, DOI 10.1097/PSY.0b013e3181d07873; Taber KH, 2010, PTSD RES Q, V21, P1; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Touroutoglou A, 2012, NEUROIMAGE, V60, P1947, DOI 10.1016/j.neuroimage.2012.02.012; Vlaeyen JWS, 2016, PAIN, V157, P1588, DOI 10.1097/j.pain.0000000000000574; Wechsler D., 1997, WECHSLER ADULT IINTE; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Yehuda R, 2001, DEV PSYCHOPATHOL, V13, P733, DOI 10.1017/S0954579401003170	70	4	4	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					297	307		10.1089/neu.2017.5061		NOV 2017	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000417130500001	28931334				2022-02-06	
J	Hashimoto, K; Ikeda, N; Nakashima, M; Ikeshima-Kataoka, H; Miyamoto, Y				Hashimoto, Kei; Ikeda, Natsumi; Nakashima, Mari; Ikeshima-Kataoka, Hiroko; Miyamoto, Yasunori			Vitronectin Regulates the Fibrinolytic System during the Repair of Cerebral Cortex in Stab-Wounded Mice	JOURNAL OF NEUROTRAUMA			English	Article						cerebral cortex; fibrinolytic system; stab wound; vitronectin	PLASMINOGEN-ACTIVATOR INHIBITOR; HEPARIN-BINDING DOMAIN; EXTRACELLULAR-MATRIX; PROTEIN VITRONECTIN; IN-VIVO; BRAIN; DIFFERENTIATION; INTEGRINS; EXPRESSION; UROKINASE	Vitronectin (VN), one of the serum proteins, is known to be involved in the regulation of blood coagulation, fibrinolysis, and cell migration. It has been proposed that the regulation of fibrinolysis by VN promotes the blood-brain barrier (BBB) recovery from brain injuries such as traumatic injury and subarachnoid hemorrhage. The effects of VN on fibrinolysis in the injured brain remain unclear, however. We examined the effects of VN on the fibrinolytic system in the stab-wounded cerebral cortex of VN-knockout (KO) mice. First, hemorrhage and recovery from BBB breakdown in the wounded regions were assessed by serum immunoglobulin G (IgG) extravasation. The level of IgG extravasation increased 3-7 days after the stab wound (D3-7) in the cortex of VN-KO mice, compared with that in wild type mice, indicating that VN deficiency inhibited the recovery from BBB breakdown. The VN deficiency decreased fibrin fiber deposition at D1-3, suggesting that VN deficiency tilts the balance between fibrinogenesis and fibrinolysis toward fibrinolysis. Next, the effects of VN deficiency on the fibrinolytic factors were analyzed in the stab-wounded cortex. The VN deficiency impaired the activity of plasminogen activator inhibitor-1, an inhibitor of the fibrinolytic system, at D3-5. Further, VN deficiency up-regulated the mRNA and protein expression levels of tissue-type plasminogen activator, and urokinase-type plasminogen activator. These results demonstrate that VN contributes to the regulation of the fibrinolytic system and recovery from BBB breakdown in the wounded brain.	[Hashimoto, Kei; Ikeda, Natsumi; Nakashima, Mari; Miyamoto, Yasunori] Ochanomizu Univ, Bunkyo Ku, Grad Sch Humanities & Sci, Tokyo, Japan; [Hashimoto, Kei; Nakashima, Mari; Miyamoto, Yasunori] Ochanomizu Univ, Bunkyo Ku, Inst Human Life Innovat, 2-1-1 Otsuka, Tokyo 1128610, Japan; [Hashimoto, Kei; Miyamoto, Yasunori] Ochanomizu Univ, Bunkyo Ku, Program Leading Grad Sch, Tokyo, Japan; [Hashimoto, Kei] Japan Soc Promot Sci, Chiyoda Ku, Kojimachi, Tokyo, Japan; [Ikeshima-Kataoka, Hiroko] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Ikeshima-Kataoka, Hiroko] Keio Univ, Sch Med, Dept Pharmacol & Neurosci, Shinjuku Ku, Shinanomachi, Tokyo, Japan		Miyamoto, Y (corresponding author), Ochanomizu Univ, Bunkyo Ku, Inst Human Life Innovat, 2-1-1 Otsuka, Tokyo 1128610, Japan.	miyamoto.yasunori@ocha.ac.jp	Miyamoto, Yasunori/M-4825-2019	Miyamoto, Yasunori/0000-0001-9192-4281	Leading Graduate School Promotion Center, Ochanomizu University; Japan Society for the Promotion of Science (JSPS) KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [17K07105, 17J02956]	The authors wish to thank Prof. David Ginsburg (University of Michigan) for providing the VN-KO mice, and Prof. Masao Hayashi (Ochanomizu University) for providing the anti-VN antibody. The authors gratefully acknowledge the work of past and present members of Miyamoto laboratory. We would like to thank Editage (www.editage.jp) for English language editing. This work was supported by grants from Leading Graduate School Promotion Center, Ochanomizu University and by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 17K07105 and 17J02956 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; CAMIOLO SM, 1971, P SOC EXP BIOL MED, V138, P277; Chow S, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15054; Dietzmann K, 2000, PATHOL RES PRACT, V196, P15, DOI 10.1016/S0344-0338(00)80017-5; Furutani Y, 2012, J BIOL CHEM, V287, P39041, DOI 10.1074/jbc.M112.383851; Gamble M., 2002, THEORY PRACTICE HIST, P125; Hashimoto K, 2016, MOL CELL NEUROSCI, V70, P76, DOI 10.1016/j.mcn.2015.11.013; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hultman K, 2010, J NEUROSCI RES, V88, P2441, DOI 10.1002/jnr.22412; Ikeshima-Kataoka H, 2008, IN VIVO, V22, P409; Ikeshima-Kataoka H, 2013, MOL CELL NEUROSCI, V56, P65, DOI 10.1016/j.mcn.2013.02.002; Jang YC, 2000, SURGERY, V127, P696, DOI 10.1067/msy.2000.105858; Kataoka K, 2000, BRAIN RES, V887, P187, DOI 10.1016/S0006-8993(00)03042-0; Katic J, 2014, J NEUROSCI, V34, P14606, DOI 10.1523/JNEUROSCI.3280-13.2014; Koukoulis GK, 2001, HUM PATHOL, V32, P1356, DOI 10.1053/hupa.2001.29675; Lazar MH, 2004, AM J RESP CELL MOL, V31, P672, DOI 10.1165/rcmb.2004-0025OC; Martinez-Morales JR, 1997, DEVELOPMENT, V124, P5139; MARTINEZMORALES JR, 1995, NEUROSCIENCE, V68, P245, DOI 10.1016/0306-4522(95)00089-2; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; McCarty JH, 2009, CELL ADHES MIGR, V3, P211, DOI 10.4161/cam.3.2.7767; NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708; Nosaka M, 2011, J CLIN INVEST, V121, P2911, DOI 10.1172/JCI40782; Pons S, 2000, DEVELOPMENT, V127, P333; PREISSNER KT, 1987, J BIOL CHEM, V262, P12247; RIJKEN DC, 1982, J BIOL CHEM, V257, P2920; Sakane F, 2013, DEV NEUROBIOL, V73, P518, DOI 10.1002/dneu.22077; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SEIFFERT D, 1995, DEV DYNAM, V203, P71, DOI 10.1002/aja.1002030108; SEIFFERT D, 1995, FEBS LETT, V368, P155, DOI 10.1016/0014-5793(95)00630-R; SEIFFERT D, 1994, J BIOL CHEM, V269, P2659; SEIFFERT D, 1994, J BIOL CHEM, V269, P19836; Seiffert D, 1996, J BIOL CHEM, V271, P29644, DOI 10.1074/jbc.271.47.29644; SEIFFERT D, 1991, BIOCHIM BIOPHYS ACTA, V1078, P23, DOI 10.1016/0167-4838(91)90087-G; THORSEN S, 1972, THROMB DIATH HAEMOST, V28, P65; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; VENSTROM K, 1995, MOL BIOL CELL, V6, P419, DOI 10.1091/mbc.6.4.419; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; ZANETTI A, 1994, BLOOD, V84, P1116, DOI 10.1182/blood.V84.4.1116.bloodjournal8441116; Zheng XX, 1995, P NATL ACAD SCI USA, V92, P12426, DOI 10.1073/pnas.92.26.12426; Zhu JW, 2002, DEVELOPMENT, V129, P2891	41	4	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3183	3191		10.1089/neu.2017.5008			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000014	28683586				2022-02-06	
J	Li, L; Chopp, M; Ding, GL; Li, QJ; Mahmood, A; Jiang, Q				Li, Lian; Chopp, Michael; Ding, Guangliang; Li, Qingjiang; Mahmood, Asim; Jiang, Quan			Chronic global analysis of vascular permeability and cerebral blood flow after bone marrow stromal cell treatment of traumatic brain injury in the rat: A long-term MRI study	BRAIN RESEARCH			English	Article						Traumatic brain injury; Bone marrow stromal cells; Intervention; Vascular permeability; Cerebral blood flow; MRI	CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; BARRIER PERMEABILITY; UNITED-STATES; MURINE MODEL; ADULT RATS; PERFUSION; TRANSPLANTATION; DISRUPTION; PERSPECTIVE	Vascular permeability and hemodynamic alteration in response to the transplantation of human bone marrow stromal cells (hMSCs) after traumatic brain injury (TBI) were longitudinally investigated in non directly injured and normal-appearing cerebral tissue using magnetic resonance imaging (MRI). Male Wistar rats (300-350 g, n = 30) subjected to controlled cortical impact TBI were intravenously injected with 1 ml of saline (at 6-h or 1-week post-injury, n = 5/group) or with hMSCs in suspension (similar to 3 x 10(6) hMSCs, at 6-h or 1-week post-injury, n = 10/group). MRI measurements of T2-weighted imaging, cerebral blood flow (CBF) and blood-to-brain transfer constant (Ki) of gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA), and neurological behavioral estimates were performed on all animals at multiple time points up to 3-months post-injury. Our long-term imaging data show that blood-brain barrier (BBB) breakdown and hemodynamic disruption after TBI, as revealed by Ki and CBF, respectively, affect both hemispheres of the brain in a diffuse manner. Our data reveal a sensitive vascular permeability and hemodynamic reaction in response to the time-dependent transplantation of hMSCs. A more rapid reduction of Ki following cell treatment is associated with a higher level of CBF in the injured brain, and acute (6 h) cell administration leads to enhanced therapeutic effects on both the recovery of vascular integrity and stabilization of cerebral perfusion compared to delayed (1 w) cell engraftment. Our results indicate that cell-enhanced BBB reconstitution plays an important role in underlying the restoration of CBF in the injured brain, which in turn, contributes to the improvement of functional outcome. (C) 2017 Elsevier B.V. All rights-reserved.	[Li, Lian; Chopp, Michael; Ding, Guangliang; Li, Qingjiang; Jiang, Quan] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA; [Mahmood, Asim] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48208 USA; [Li, Lian; Chopp, Michael; Ding, Guangliang; Li, Qingjiang; Mahmood, Asim] Henry Ford Hosp, Dept Neurol, B126,Educ & Res Bldg,2799 West Grand Blvd, Detroit, MI 48202 USA		Jiang, Q (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA.	lli2@hfhs.org; MCHOPPl@hfhs.org; gding1@hfhs.org; QLI1@hfhs.org; AMAHM002@hfhs.org; QJIANG1@hfhs.org		Li, Lian/0000-0003-0097-1184; Ding, Guangliang/0000-0003-1286-5901	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS064134]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064134] Funding Source: NIH RePORTER	We thank Dr. Changsheng Qu for animal experiment assistance. This work was supported by National Institutes of Health RO1 NS064134.	Aertker B.M., 2015, EXP NEUROL; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Borlongan CV, 2004, BRAIN RES, V1009, P26, DOI 10.1016/j.brainres.2004.02.050; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Chen M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0284-x; Chen X, 2013, ACTA RADIOL, V54, P313, DOI 10.1258/ar.2012.120605; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Dori I., 2016, HISTOL HISTOPATHOL, P11864; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Ewing JR, 2013, NMR BIOMED, V26, P1028, DOI 10.1002/nbm.2996; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Garbuzova-Davis S, 2014, J COMP NEUROL, V522, P3120, DOI 10.1002/cne.23582; Garbuzova-Davis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063553; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Izumi Y, 2002, J CLIN NEUROSCI, V9, P289, DOI 10.1054/jocn.2001.0966; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li L, 2006, J CEREBR BLOOD F MET, V26, P1366, DOI 10.1038/sj.jcbfm.9600288; Li L, 2017, J NEUROTRAUM, V34, P182, DOI 10.1089/neu.2015.4315; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114173; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Long JA, 2015, J CEREBR BLOOD F MET, V35, P1852, DOI 10.1038/jcbfm.2015.143; Luh WM, 1999, MAGNET RESON MED, V41, P1246, DOI 10.1002/(SICI)1522-2594(199906)41:6<1246::AID-MRM22>3.0.CO;2-N; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mahmood A, 2011, J NEUROTRAUM, V28, P1199, DOI 10.1089/neu.2010.1694; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; Opydo-Chanek M, 2007, ACTA NEUROBIOL EXP, V67, P187; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Park HJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0180-4; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Rolfe A, 2015, BRAIN NEUROTRAUMA MO; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Taguchi A, 2015, STEM CELLS DEV, V24, P2207, DOI 10.1089/scd.2015.0160; Tang GH, 2014, STEM CELLS, V32, P3150, DOI 10.1002/stem.1808; Tang HL, 2013, CELL REPROGRAM, V15, P435, DOI 10.1089/cell.2012.0081; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wong EC, 1998, MAGNET RESON MED, V40, P348, DOI 10.1002/mrm.1910400303; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yu YM, 2010, RADIOLOGY, V257, P47, DOI 10.1148/radiol.10092169; Ziegler DW, 2016, J NEUROTRAUMA	75	4	4	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 15	2017	1675						61	70		10.1016/j.brainres.2017.09.007			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FK6IY	WOS:000413608600007	28899758	Green Accepted			2022-02-06	
J	El-Menyar, A; Consunji, R; Al-Thani, H; Mekkodathil, A; Jabbour, G; Alyafei, KA				El-Menyar, Ayman; Consunji, Rafael; Al-Thani, Hassan; Mekkodathil, Ahammed; Jabbour, Gaby; Alyafei, Khalid A.			Pediatric Traumatic Brain Injury: a 5-year descriptive study from the National Trauma Center in Qatar	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Trauma; Head injury; Pediatric; Brain injury; Road traffic; Falls	HEAD TRAUMA; CHILDREN; EPIDEMIOLOGY; DISABILITY	Background: The epidemiologic characteristics and outcomes of pediatric traumatic brain injury (pTBI) have not been adequately documented from the rapidly developing countries in the Arab Middle East. We aimed to describe the hospital-based epidemiologic characteristics, injury mechanisms, clinical presentation, and outcomes of pTBI and analyze key characteristics and determinant of pTBI that could help to make recommendations for policies to improve their care. Methods: We conducted a retrospective observational study in a level 1 trauma center (2010-2014) for all pTBI patients. Data were analyzed and compared according to different patient age groups. Results: Out of 945 traumatic brain injury patients, 167 (17.7%) were <= 18 years old with a mean age of 10.6 +/- 5.9 and 81% were males. The rate of pTBI varied from 5 to 14 cases per 100,000 children per year. The most affected group was teenagers (15-18 years; 40%) followed by infants/ toddlers (<= 4 years; 23%). Motor vehicle crash (MVC; 47. 3%) was the most frequent mechanism of injury followed by falls (21.6%). MVC accounted for a high proportion of pTBI among teenagers (77.3%) and adolescents (10-14 years; 48.3%). Fall was a common cause of pTBI for infants/toddlers (51.3%) and 5-9 years old group (30.3%). The proportion of brain contusion was significantly higher in adolescents (61.5%) and teenagers (58.6%). Teenagers had higher mean Injury Severity Scoring of 24.2 +/- 9.8 and lower median (range) Glasgow Coma Scale of 3 (3-15) (P = 0.001 for all). The median ventilatory days and intensive care unit and hospital length of stay were significantly prolonged in the teenage group. Also, pTBI in teenage group showed higher association with pneumonia (46.4%) and sepsis (17.3%) than other age groups (P = 0.01). The overall mortality rate was 13% (n = 22); 11 died within the first 24 h, 7 died between the second and seventh day and 4 died one week post-admission. Among MVC victims, a decreasing trend of case fatality rate (CFR) was observed with age; teenagers had the highest CFR (85.7) followed by adolescents (75.0), young children (33.3), and infants/toddlers (12.5). Conclusions: This local experience to describe the burden of pTBI could be a basis to adopt and form an efficient, tailored strategy for safety in the pediatric population.	[El-Menyar, Ayman] Hamad Gen Hosp, Trauma Surg Sect, Clin Res, Doha, Qatar; [El-Menyar, Ayman; Mekkodathil, Ahammed] Weill Cornell Med Sch, Clin Med, Doha, Qatar; [Consunji, Rafael] Hamad Gen Hosp, Trauma Surg Sect, Hamad Injury Prevent Program, Doha, Qatar; [Al-Thani, Hassan; Jabbour, Gaby] Hamad Gen Hosp, Trauma Surg Sect, Doha, Qatar; [Alyafei, Khalid A.] Hamad Med Corp, Div Pediat Emergency Med, Dept Pediat, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Gen Hosp, Trauma Surg Sect, Clin Res, Doha, Qatar.; El-Menyar, A (corresponding author), Weill Cornell Med Sch, Clin Med, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X			Alhabdan S, 2013, ANN SAUDI MED, V33, P52, DOI 10.5144/0256-4947.2013.52; Alharthy Nesrin, 2015, J Emerg Trauma Shock, V8, P88, DOI 10.4103/0974-2700.155504; Alyafei Khalid A, 2015, Int J Crit Illn Inj Sci, V5, P21, DOI 10.4103/2229-5151.152312; Assiry KA, 2014, ONLINE J MED MED SCI, V5, P44; Cassidy LD, 2003, J PEDIATR SURG, V38, P482, DOI 10.1053/jpsu.2003.50084; Consunji RJ, 2015, INJURY PREV, V21, pE105, DOI 10.1136/injuryprev-2013-040939; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; El-Matbouly M, 2013, SCI WORLD J, DOI 10.1155/2013/354920; El-Menyar A, 2016, TRAFFIC INJ PREV, V17, P284, DOI 10.1080/15389588.2015.1069820; Fakharian E, 2014, CHIN J TRAUMATOL, V17, P153, DOI 10.3760/cma.j.issn.1008-1275.2014.03.006; Faul M, 2010, TRAUMATIC BRAIN INJU; Gofin R, 2007, ISR MED ASSOC J, V9, P531; Grivna M, 2008, EPIDEMIOLOGY PREVENT; Grivna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068636; Hefny AF, 2012, ASIAN J SURG, V35, P74, DOI 10.1016/j.asjsur.2012.04.021; Iranmanesh F, 2009, INDIAN J PEDIATR, V76, P929, DOI 10.1007/s12098-009-0143-9; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Klimo P, 2015, NEUROSURGERY, V77, P1, DOI 10.1227/NEU.0000000000000743; Lotfi-Sadigh S, 2015, ANAL RES CLIN MED, V3, P57; Malik S, 2015, J LOCAL GLOBAL HLTH, P40; Parchani A, 2013, BRAIN INJURY, V27, P1450, DOI 10.3109/02699052.2013.823664; Raman S. R., INT J INJ C IN PRESS; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Yagmur F, 2016, AM J FOREN MED PATH, V37, P35, DOI 10.1097/PAF.0000000000000213; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	28	4	4	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	NOV 7	2017	12								48	10.1186/s13017-017-0159-9			10	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Surgery	FM2DE	WOS:000414793700001	29151847	Green Published, gold			2022-02-06	
J	Sedlacik, J; Kjorstad, A; Nagy, Z; Buhk, JH; Behem, CR; Trepte, CJ; Fiehler, J; Temme, F				Sedlacik, Jan; Kjorstad, Asmund; Nagy, Zsuzsanna; Buhk, Jan-Hendrik; Behem, Christoph R.; Trepte, Constantin J.; Fiehler, Jens; Temme, Fabian			Feasibility Study of a Novel High-Flow Cold Air Cooling Protocol of the Porcine Brain Using MRI Temperature Mapping	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article						cerebral cooling; upper airways; nasal cavity; nasopharyngeal cooling; mild traumatic brain injury; hypothermia; targeted temperature management	THERAPEUTIC HYPOTHERMIA; INJURY; INDUCTION; ARREST	Early, prehospital cooling seeks to reduce and control the body temperature as early as possible to protect the brain and improve patient outcome in cardiac arrest, stroke, and traumatic brain injury. In this study, we investigate the feasibility of localized cooling of the porcine brain by using a novel high-flow cold air protocol, which utilizes the close proximity between the nasal cavity and the brain. Five adult pigs were anesthetized and temperature change was mapped before, during, and after cooling by using the proton resonance frequency method on a 3 T Siemens Magnetom Skyra system. Cooling was performed by inserting a tube blowing high-flow (250L/min) cold air (-10 degrees C) through the nasal cavity for 5-20 minutes. The brain temperature change was measured by using an MRI phase mapping technique utilizing the temperature-dependent proton resonance frequency change. MRI maps showed significant temperature reduction of the porcine brain. On average, a mean whole-brain cooling effect of -0.33 degrees C +/- 0.30 degrees C was found after 5 minutes of cooling. The anterior part of the brain was directly exposed to the cold and showed a significantly larger temperature drop (-0.83 degrees C +/- 0.51 degrees C) than the posterior part (-0.03 degrees C +/- 0.21 degrees C). However, a large variability of the temperature drop was observed between the animals. This variability may be caused by not well-controlled factors confounding the MRI temperature mapping, for example, subject movement, or cooling effectiveness, for example, core temperature or nasal patency. The results indicate that the proposed high-flow cold air protocol allows for localized cooling of the frontal porcine brain, which may be clinically relevant for traumatic injuries of the frontal brain where systemic cooling is unfavorable.	[Sedlacik, Jan; Kjorstad, Asmund; Nagy, Zsuzsanna; Buhk, Jan-Hendrik; Fiehler, Jens; Temme, Fabian] Univ Med Ctr Hamburg Eppendorf, Dept Neuroradiol, Martinistr 52,Bldg Ost 22, D-20246 Hamburg, Germany; [Behem, Christoph R.; Trepte, Constantin J.] Univ Med Ctr Hamburg Eppendorf, Dept Anaesthesiol, Hamburg, Germany		Sedlacik, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neuroradiol, Martinistr 52,Bldg Ost 22, D-20246 Hamburg, Germany.	j.sedlacik@uke.uni-hamburg.de		Trepte, Constantin/0000-0001-5791-3212	Federal Ministry of Education and Research (BMBF) GermanyFederal Ministry of Education & Research (BMBF) [031A530]	The study was funded by the Federal Ministry of Education and Research (BMBF) Germany (grant number 031A530). Equipment was provided free of charge by MecoTec GmbH (Bitterfeld-Wolfen, Germany: CryoAir cold air therapy device) and by Drager Medical GmbH (Luebeck, Germany: Fabius MRI Anaesthesia Machine).	[Anonymous], 2015, KALTL THER LOK ANW D; Arrich J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub4; Castren M, 2010, CIRCULATION, V122, P729, DOI 10.1161/CIRCULATIONAHA.109.931691; Caulfield AF, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/690506; Covaciu L, 2011, INTENS CARE MED, V37, P1277, DOI 10.1007/s00134-011-2264-7; Doll H, 2009, J NEUROTRAUM, V26, P235, DOI 10.1089/neu.2008.0741; Giuliani E, 2016, NEUROCRIT CARE, V25, P464, DOI 10.1007/s12028-016-0257-7; Harris B, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16450; Howes D, 2010, RESUSCITATION, V81, P388, DOI 10.1016/j.resuscitation.2009.12.025; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Kandzari DE, 2004, AM J CARDIOL, V93, P636, DOI 10.1016/j.amjcard.2003.11.038; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Maier F, 2015, MAGN RESON MED, V73, P1662, DOI 10.1002/mrm.25279; McDannold N, 2005, INT J HYPERTHER, V21, P533, DOI 10.1080/02656730500096073; Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Polderman KH, 2015, CIRCULATION, V124; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Schwartz BG, 2012, AM J CARDIOL, V110, P461, DOI 10.1016/j.amjcard.2012.03.048; Siewert C, 2014, Z MED PHYS, V24, P6, DOI 10.1016/j.zemedi.2013.11.001; Winter L, 2016, INT J HYPERTHER, V32, P63, DOI 10.3109/02656736.2015.1108462; Wolfson MR, 2008, NEUROCRIT CARE, V8, P437, DOI 10.1007/s12028-008-9064-0; Yokobori S, 2011, THER HYPOTHERMIA TEM, V1, P185, DOI 10.1089/ther.2011.0012	23	4	4	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	MAR	2018	8	1					45	52		10.1089/ther.2017.0031		NOV 2017	8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY1GT	WOS:000414562700001	29099343				2022-02-06	
J	Albrecht, JS; Slejko, JF; Stein, DM; Smith, GS				Albrecht, Jennifer S.; Slejko, Julia F.; Stein, Deborah M.; Smith, Gordon S.			Treatment Charges for Traumatic Brain Injury Among Older Adults at a Trauma Center	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						costs; older adults; trauma center; traumatic brain injury	TREATMENT COSTS; OUTCOMES; SEVERITY; UNDERTRIAGE; CARE	Objective: To provide charge estimates of treatment for traumatic brain injury (TBI), including both hospital and physician charges, among adults 65 years and older treated at a trauma center. Methods: We identified older adults treated for TBI during 2008-2012 (n = 1843) at Maryland's Primary Adult Resource Center and obtained hospital and physician charges separately. Analyses were stratified by sex and all charges were inflated to 2012 dollars. Total TBI charges were modeled as a function of covariates using a generalized linear model. Results: Women comprised 48% of the sample. The mean unadjusted total TBI hospitalization charge for adults 65 years and older was $36 075 (standard deviation, $63 073). Physician charges comprised 15% of total charges. Adjusted mean charges were lower in women than in men (adjusted difference, -$894; 95% confidence interval, -$277 to -$1512). Length of hospital and intensive care unit stay were associated with the highest charges. Conclusions: This study provides the first estimates of hospital and physician charges associated with hospitalization for TBI among older adults at a trauma center that will aid in resource allocation, triage decisions, and healthcare policy.	[Albrecht, Jennifer S.; Smith, Gordon S.] Univ Maryland, Dept Epidemiol & Publ Hlth, Sch Med, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA; [Slejko, Julia F.] Univ Maryland, Dept Pharmaceut Hlth Serv Res, Sch Pharm, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA; [Stein, Deborah M.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Surg,Div Surg Crit Care, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, Shock Trauma & Anesthesiol Res Organized Res Ctr, Natl Study Ctr Trauma & Emergency Med Serv, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA		Albrecht, JS (corresponding author), Univ Maryland, Dept Epidemiol & Publ Hlth, Sch Med, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA.	jalbrecht@epi.umaryland.edu	Slejko, Julia/M-9335-2019	Albrecht, Jennifer/0000-0003-4838-2274; Stein, Deborah/0000-0003-3683-3963; Smith, Gordon/0000-0002-2911-3071	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12HD43489-13]; Agency for Healthcare Quality and ResearchUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1K01HS024560]; US National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA18707]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD043489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018707, R01AA018313] Funding Source: NIH RePORTER	Dr Albrecht was supported by National Institutes of Health grant K12HD43489-13 and Agency for Healthcare Quality and Research grant 1K01HS024560. Dr Smith was supported by US National Institute on Alcohol Abuse and Alcoholism grant R01AA18707.	[Anonymous], 1971, JAMA, V215, P277; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Centers for Disease Control and Prevention, 2001, RAT TBI REL HOSP AG; Centers for Medicare & Medicaid Services, FY 2012 STAT AV OP C; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cost to Charge Ratio Files, 2015, COST CHARG RAT FIL H; Curtis K, 2014, AUSTRALAS J AGEING, V33, P264, DOI 10.1111/ajag.12059; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Faul M, 2010, TRAUMATIC BRAIN INJU; Grossmann FF, 2012, ANN EMERG MED, V60, P317, DOI 10.1016/j.annemergmed.2011.12.013; Kodadek LM, 2015, J SURG RES, V199, P220, DOI 10.1016/j.jss.2015.05.017; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Marr A., 2004, CENTRAL NERVOUS SYST; Maryland Institute for Emergency Medical Services Systems, 2012, 2012 2013 ANN REP; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Nakamura Y, 2012, ANN EMERG MED, V60, P335, DOI 10.1016/j.annemergmed.2012.04.006; Peterson C, 2015, MED CARE, V53, P840, DOI 10.1097/MLR.0000000000000410; Rochette LM, 2009, J SAFETY RES, V40, P353, DOI 10.1016/j.jsr.2009.08.003; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Scheetz LJ, 2015, INT EMERG NURS, V23, P162, DOI 10.1016/j.ienj.2014.09.003; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Thurman DJ., 1995, GUIDELINES SURVEILLA; Weir S, 2010, EXPERT REV PHARM OUT, V10, P187, DOI [10.1586/erp.10.8, 10.1586/ERP.10.8]	30	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					E45	E53		10.1097/HTR.0000000000000297			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100006	28195959	Green Submitted, Green Accepted			2022-02-06	
J	Barnes, SM; Monteith, LL; Gerard, GR; Hoffberg, AS; Homaifar, BY; Brenner, LA				Barnes, Sean M.; Monteith, Lindsey L.; Gerard, Georgia R.; Hoffberg, Adam S.; Homaifar, Beeta Y.; Brenner, Lisa A.			. Problem-Solving Therapy for Suicide Prevention in Veterans With Moderate-to-Severe Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; problem-solving therapy; suicide prevention; safety planning; Veterans	NEUROPSYCHIATRIC INTERVIEW MINI; RANDOMIZED CONTROLLED-TRIAL; DELIBERATE SELF-HARM; BRIEF INTERVENTION; EVENTUAL SUICIDE; HOPELESSNESS; IDEATION; ATTEMPTERS; RELIABILITY; OUTPATIENTS	Objective: Develop and test the acceptability and feasibility of Problem-Solving Therapy for Suicide Prevention (PST-SP), a group intervention aimed at improving problem solving and preventing suicide, among Veterans with hopelessness and moderate-to-severe traumatic brain injury (TBI). Research Method: Following treatment development, 16 U.S. Veterans with moderate-to-severe TBI and a Beck Hopelessness Scale score >= 4 participated in an acceptability and feasibility pilot study of PST-SP at a Veterans Affairs Medical Center. Participants completed the Client Satisfaction Questionnaire-8 (CSQ-8) and Narrative Evaluation of Intervention Interview (NEII) after participating in PST-SP. Results: PST-SP was developed for Veterans with moderate-to-severe TBI and hopelessness. 75% (n = 12) of participants enrolled in the pilot study attended >= 80% of PST-SP sessions. Participants reported high satisfaction with PST-SP (CSQ-8 M = 27.8 out of 32; SD = 4.78; range 14-32) and described the intervention as valuable, beneficial, and without negative effects (NEII). Conclusions/Implications: Results from measures of acceptability and attendance suggest that PST-SP is an acceptable and feasible intervention for Veterans with hopelessness and moderate-to-severe TBI. Findings support readiness to examine efficacy of the intervention in a Phase II randomized controlled trial.	[Barnes, Sean M.; Monteith, Lindsey L.; Gerard, Georgia R.; Hoffberg, Adam S.; Homaifar, Beeta Y.; Brenner, Lisa A.] VA Rocky Mt Mental Illness Res Educ & Clin Ctr, 1055 Clermont St, Denver, CO 80220 USA; [Barnes, Sean M.; Monteith, Lindsey L.; Homaifar, Beeta Y.; Brenner, Lisa A.] Univ Colorado, Anschutz Med Ctr, Boulder, CO 80309 USA		Barnes, SM (corresponding author), VA Rocky Mt Mental Illness Res Educ & Clin Ctr, 1055 Clermont St, Denver, CO 80220 USA.	Sean.Barnes2@va.gov	Monteith, Lindsey L./X-3658-2019; Brenner, Lisa A./AAG-2442-2019	Monteith, Lindsey L./0000-0002-8104-5280; Hoffberg, Adam/0000-0002-7036-936X	Military Suicide Research Consortium, through the Office of the Assistant Secretary of Defense for Health Affairs; Rocky Mountain Mental Illness, Research, Education, and Clinical Center; Denver VA Medical Center Grant [W81XWH-10-2-0178]	Preliminary analyses were presented at the IASR/AFSP International Summit on Suicide Research: Preventing Suicide: Progress Through Research, October 11-14, 2015, New York, NY; The 11th World Congress on Brain Injury. March 2-5, 2016, The Hague, the Nether-lands; and The Military Health System Research Symposium, August 15-18, 2016, Kissimmee, Florida. This research was funded by the Military Suicide Research Consortium, through the Office of the Assistant Secretary of Defense for Health Affairs, and the Rocky Mountain Mental Illness, Research, Education, and Clinical Center. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Military Suicide Research Consortium, Department of Defense, Department of Veterans Affairs, or the U.S. Government. Denver VA Medical Center Grant W81XWH-10-2-0178. We thank the following consultants on this project for their valuable contributions and support: Arthur Nezu, Christine Nezu, Theodore Tsaousides, Teresa Ashman, Joshua Cantor, and Grahame Simpson.	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arean P. A., 2013, HIGH QUALITY PSYCHOT; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Attkisson C. C., 1996, OUTCOME ASSESSMENT I; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Beck A.T., 1988, MANUAL FOR THE BECK; BECK AT, 1989, J CONSULT CLIN PSYCH, V57, P309, DOI 10.1037/0022-006X.57.2.309; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Bell KR, 2015, CONTEMP CLIN TRIALS, V40, P54, DOI 10.1016/j.cct.2014.11.001; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Brenner LA, 2015, ARCH PHYS MED REHAB, V96, P1411, DOI 10.1016/j.apmr.2015.04.010; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brown G., 2015, SAFETY PLANNING INTE; Chang EC, 2015, COGNITIVE THER RES, V39, P403, DOI 10.1007/s10608-014-9664-2; Choi NG, 2016, SUICIDE LIFE-THREAT, V46, P323, DOI 10.1111/sltb.12195; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; D'Zurilla TJ., 2013, PROBLEM SOLVING THER; Department of Veterans Affairs Department of Defense., 2013, VA DOD CLIN PRACT GU; DIXON WA, 1991, J COUNS PSYCHOL, V38, P51, DOI 10.1037/0022-0167.38.1.51; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Feeley N, 2009, CAN J NURS RES, V41, P84; Fong KNK, 2009, AM J OCCUP THER, V63, P525, DOI 10.5014/ajot.63.5.525; GASTON L, 1992, EVAL PROGRAM PLANN, V15, P227, DOI 10.1016/0149-7189(92)90085-9; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Greene C. J., 2011, MOVING FORWARD OVERC; Gustavson KA, 2016, AM J GERIAT PSYCHIAT, V24, P11, DOI 10.1016/j.jagp.2015.07.010; Hasson-Ohayon I., 2006, PSYCHOL SERV, V3, P262, DOI [DOI 10.1037/1541-1559.3.4.262, 10.1037/1541-1559.3.4.262]; Hatcher S, 2015, BRIT J PSYCHIAT, V206, P229, DOI 10.1192/bjp.bp.113.135780; Hawton K, 1998, BRIT MED J, V317, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Husain N, 2014, BRIT J PSYCHIAT, V204, P462, DOI 10.1192/bjp.bp.113.138370; Karlin, 2008, SAFETY PLAN TREATMEN; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KLEIN K, 1994, SOC COGNITION, V12, P187, DOI 10.1521/soco.1994.12.3.187; Knox KL, 2012, AM J PUBLIC HEALTH, V102, pS33, DOI 10.2105/AJPH.2011.300501; Nguyen T D, 1983, Eval Program Plann, V6, P299, DOI 10.1016/0149-7189(83)90010-1; Pollock LR, 2004, PSYCHOL MED, V34, P163, DOI 10.1017/S0033291703008092; Pollock LR, 2001, SUICIDE LIFE-THREAT, V31, P386, DOI 10.1521/suli.31.4.386.22041; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; RUDD MD, 1994, AM J ORTHOPSYCHIAT, V64, P136, DOI 10.1037/h0079492; SALAZAR AM, 1995, NEUROSURG CLIN N AM, V6, P715; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Stanley B, 2016, PSYCHIAT SERV, V67, P679, DOI 10.1176/appi.ps.201500082; Stanley B, 2012, COGN BEHAV PRACT, V19, P256, DOI 10.1016/j.cbpra.2011.01.001; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Townsend E, 2001, PSYCHOL MED, V31, P979, DOI 10.1017/S0033291701004238; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Williams M., 2015, MINDFULNESS TRANSFOR	53	4	4	0	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					600	608		10.1037/rep0000154			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT1CK	WOS:000422871400021	28795831				2022-02-06	
J	Cordingley, DM; Girardin, R; Morissette, MP; Reimer, K; Leiter, J; Russell, K; Ellis, MJ				Cordingley, Dean M.; Girardin, Richard; Morissette, Marc P.; Reimer, Karen; Leiter, Jeff; Russell, Kelly; Ellis, Michael J.			Graded Aerobic Treadmill Testing in Adolescent Traumatic Brain Injury Patients	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						adolescent; exercise intolerance; graded aerobic exercise testing; safety; traumatic brain injury	POSTCONCUSSION SYNDROME; WALK TEST; EXERCISE; CONCUSSION; RELIABILITY; CAPACITY; RECOVERY; MANAGEMENT; INDIVIDUALS; CHILDREN	Purpose: To examine the safety and tolerability of clinical graded aerobic treadmill testing in recovering adolescent moderate and severe traumatic brain injury (TBI) patients referred to a multidisciplinary pediatric concussion program. Methods: We completed a retrospective case series of two moderate and five severe TBI patients (mean age, 17.3 years) who underwent initial Buffalo Concussion Treadmill Testing at a mean time of 71.6 days (range, 55-87) postinjury. Results: Six patients completed one graded aerobic treadmill test each and one patient underwent initial and repeat testing. There were no complications. Five initial treadmill tests were completely tolerated and allowed an accurate assessment of exercise tolerance. Two initial tests were terminated early by the treatment team because of neurological and cardiorespiratory limitations. As a result of testing, two patients were cleared for aerobic exercise as tolerated and four patients were treated with individually tailored submaximal aerobic exercise programs resulting in subjective improvement in residual symptoms and/or exercise tolerance. Repeat treadmill testing in one patient performed after 1 month of treatment with submaximal aerobic exercise prescription was suggestive of improved exercise tolerance. One patient was able to tolerate aerobic exercise following surgery for posterior glottic stenosis. Conclusions: Preliminary results suggest that graded aerobic treadmill testing is a safe, well tolerated, and clinically useful tool to assess exercise tolerance in appropriately selected adolescent patients with TBI. Future prospective studies are needed to evaluate the effect of tailored submaximal aerobic exercise prescription on exercise tolerance and patient outcomes in recovering adolescent moderate and severe TBI patients.	[Cordingley, Dean M.; Girardin, Richard; Morissette, Marc P.; Reimer, Karen; Leiter, Jeff; Ellis, Michael J.] Univ Manitoba, Pan Am Concuss Program, Winnipeg, MB, Canada; [Cordingley, Dean M.; Girardin, Richard; Morissette, Marc P.; Leiter, Jeff] Univ Manitoba, Pan Am Clin Fdn, Winnipeg, MB, Canada; [Reimer, Karen] Univ Manitoba, Dept Rehabil Sci, Winnipeg, MB, Canada; [Leiter, Jeff; Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Russell, Kelly; Ellis, Michael J.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Russell, Kelly; Ellis, Michael J.] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Cordingley, Dean M.; Girardin, Richard; Morissette, Marc P.; Reimer, Karen; Leiter, Jeff; Russell, Kelly; Ellis, Michael J.] Canada North Concuss Network, Winnipeg, MB, Canada		Ellis, MJ (corresponding author), Pan Am Clin Fdn, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com		Russell, Kelly/0000-0002-9159-9201; Morissette, Marc/0000-0002-5342-8938	Pan Am Clinic Foundation; Winnipeg Jets True North Foundation	All phases of this study were supported by a grant from the Pan Am Clinic Foundation, Winnipeg Jets True North Foundation and a generous donation by Leonard and Susan Asper.; DMC, RG, JL, MPM, K. Reimer, K. Russell, and MJE report grants from Pan Am Clinic Foundation, grants from Winnipeg Jets True North Foundation, and grants from Donation to Pan Am Clinic Foundation by Leonard and Susan Asper, during the conduct of the study.	Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; American College of Sports Medicine, 2010, ACSMS GUIDELINES EXE; Amonette WE, 2013, J HEAD TRAUMA REHAB, V28, pE13, DOI 10.1097/HTR.0b013e31826463a1; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bhambhani Y, 2003, ARCH PHYS MED REHAB, V84, P1629, DOI 10.1053/S0003-9993(03)00343-5; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Chin LMK, 2015, J HEAD TRAUMA REHAB, V30, P382, DOI 10.1097/HTR.0000000000000062; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2014, BRAIN INJURY, V29, P1; Grassi GP, 2006, J SPORT MED PHYS FIT, V46, P412; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; Jamnik VK, 2011, APPL PHYSIOL NUTR ME, V36, pS3, DOI [10.1139/h11-044, 10.1139/H11-044]; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Kitagawa RS, 2013, J NEUROSURG, V119, P324, DOI 10.3171/2013.5.JNS1397; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Mossberg KA, 2005, AM J PHYS MED REHAB, V84, P492, DOI 10.1097/01.phm.0000166883.97562.cd; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2008, J CLIN ENDOCR METAB, V93, P2581, DOI 10.1210/jc.2008-0368; Mossberg KA, 2008, PHYS THER, V88, P77, DOI 10.2522/ptj.20070022; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Mossberg KA, 2012, PHYS THER, V92, P726, DOI 10.2522/ptj.20110157; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Ravindra VM, 2015, J NEUROSURG-PEDIATR, V15, P599, DOI 10.3171/2014.11.PEDS14397; Scaife ER, 2010, CURR OPIN PEDIATR, V22, P339, DOI 10.1097/MOP.0b013e3283395f2b; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	52	4	4	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2017	44	6					684	691		10.1017/cjn.2017.209			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FP5JF	WOS:000417655100008	28849757	Bronze			2022-02-06	
J	Flores, G; Vicenty, JC; Pastrana, EA				Flores, Gabriel; Vicenty, Juan C.; Pastrana, Emil A.			Post-operative seizures after burr hole evacuation of chronic subdural hematomas: is prophylactic anti-epileptic medication needed?	ACTA NEUROCHIRURGICA			English	Article						Chronic; Subdural; Hematoma; Seizures; Prophylaxis; Post-operative	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC SEIZURES; CONTROLLED-TRIAL; EPILEPSY; TUMORS	There are limited data with regards to the associated risk of post-operative seizures in patients with surgically treated chronic subdural hematomas (CSDHs). The use of anti-epileptic drugs (AEDs) is associated with significant side effects. A retrospective chart review was performed on patients operated via burr hole for CSDH in our institution from 2004 to 2013. Post-operative seizures at 1-year follow-up were identified. Demographic data, medical history, and imaging characteristics were recorded. A total of 220 patients were included in the study. Post-operative seizures occurred in 2.3%. The mean time of onset of seizures was 8.4 days. No difference in age and gender between seizing and non-seizing groups was identified p > 0.05. Mean midline shift was 4.6 mm in seizing group vs. 4.2 mm in non-seizing group, p > 0.05. Mean thickness was 14.6 mm in patients without post-operative seizures and 18.4 mm in patients with post-operative seizures, p > 0.05. There was no significant difference in post-operative seizure incidence related to the side or location of the CSDHs. The incidence of post-operative seizures in patients with CSDH evacuated via burr holes was low. Prophylactic AEDs should not be routinely administered if no other risk factor for seizure exists. Demographic and clinical factors did not appear to influence post-operative seizures.	[Flores, Gabriel; Vicenty, Juan C.; Pastrana, Emil A.] Univ Puerto Rico Med Sci Campus, Dept Surg, Neurosurg Sect, POB 365067, San Juan, PR 00936 USA		Pastrana, EA (corresponding author), Univ Puerto Rico Med Sci Campus, Dept Surg, Neurosurg Sect, POB 365067, San Juan, PR 00936 USA.	emil.pastrana@upr.edu					Chang EF, 2008, J NEUROSURG, V108, P227, DOI 10.3171/JNS/2008/108/2/0227; Chari A, 2014, J NEUROSURG, V121, P176, DOI 10.3171/2014.4.JNS131212; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Glantz MJ, 1996, NEUROLOGY, V46, P985, DOI 10.1212/WNL.46.4.985; GRISOLI F, 1988, NEUROSURGERY, V23, P616, DOI 10.1227/00006123-198811000-00012; Grobelny BT, 2009, J NEUROSURG, V111, P1257, DOI 10.3171/2009.6.JNS0928; Hirakawa K, 1972, Neurol Med Chir (Tokyo), V12, P71, DOI 10.2176/nmc.12.71; Karibe Hiroshi, 2011, No Shinkei Geka, V39, P1149; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7; Schneck Michael J, 2004, J Stroke Cerebrovasc Dis, V13, P192, DOI 10.1016/j.jstrokecerebrovasdis.2004.08.003; Singh AK, 2014, NEUROL INDIA, V62, P169, DOI 10.4103/0028-3886.132364; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4	17	4	5	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2017	159	11					2033	2036		10.1007/s00701-017-3298-6			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FJ4ZZ	WOS:000412754600001	28808801				2022-02-06	
J	Holdnack, JA; Iverson, GL; Silverberg, ND; Tulsky, DS; Heinemann, AW				Holdnack, James A.; Iverson, Grant L.; Silverberg, Noah D.; Tulsky, David S.; Heinemann, Allen W.			NIH Toolbox Cognition Tests Following Traumatic Brain Injury: Frequency of Low Scores	REHABILITATION PSYCHOLOGY			English	Article						multivariate base rates; cognition; NIH Toolbox; traumatic brain injury; cognitive impairment	CLOSED-HEAD-INJURY; REHABILITATION PSYCHOLOGY; BEHAVIORAL FUNCTION; HEALTHY-ADULTS; OLDER-ADULTS; BATTERY; MODERATE; OUTCOMES; PREVALENCE; ATTENTION	Purpose/Objective: To apply multivariate base rate analyses to the National Institutes of Health Toolbox Cognition Battery (NIHTB-CB) to facilitate the identification of cognitive impairment in individuals with traumatic brain injury (TBI). Research Method/Design: In a multisite cross-sectional design, 158 participants who sustained a complicated mild or moderate TBI (n = 74) or severe TBI (n = 84) at least 1 year earlier were administered the NIHTB-CB. The NIHTB-CB is comprised of 2 crystallized cognition tests (reflecting premorbid ability) and 5 fluid cognition tests, measuring processing speed, memory, and executive functioning. Base rates for obtaining 0 to 5 low fluid cognition scores were calculated across a range of cutoffs for defining a low test score (<= 25th to 5th percentiles). Base rates of low scores in the TBI sample were compared to the NIHTB-CB normative sample using diagnostic accuracy statistics. Results: The proportion of the TBI sample obtaining low scores decreased as the cutoff for defining a low score decreased. Individuals with lower premorbid cognitive ability, as measured by NIHTB-CB Crystallized Composite score, tended to produce more low scores on the NIHTB-CB fluid cognition tests, even when using fully demographically adjusted scores. Certain patterns of low scores were associated with TBI (defined as likelihood ratio >2.0), whereas others were nonspecific, occurring almost as often in participants without TBI. Conclusions/Implications: Premorbid ability stratified base rate tables provided in this article can guide researchers and clinicians in the interpretation of NIHTB-CB performance in adults with TBI.	[Holdnack, James A.] Univ Delaware, Ctr Hlth Assessment Res & Translat, 5 Rose Hill Dr, Bear, DE 19701 USA; [Iverson, Grant L.] Havard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Dept Med, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Dept Phys Therapy, Bear, DE 19701 USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Dept Psychol & Brain Sci, Bear, DE 19701 USA; [Heinemann, Allen W.] Shirley Ryan Abil Lab, Chicago, IL USA; [Heinemann, Allen W.] Northwestern Univ, Dept Phys Med & Rehabil, Evanston, IL 60208 USA		Holdnack, JA (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, 5 Rose Hill Dr, Bear, DE 19701 USA.	jhold@udel.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Iverson, Grant/0000-0001-7348-9570; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090024, H122G070138]; Institutional Development Award (IDeA) from National Institute of General Medical Sciences of the National Institutes of Health [U54-GM104941]; Mooney-Reed Charitable Foundation; Heinz Family Foundation; ImPACT Applications, Inc.; ImPACT Applications Systems; CNS Vital Signs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104941] Funding Source: NIH RePORTER	Standardization data from NIH Toolbox used with permission. This research was supported by Grants H133B090024, H122G070138 from the National Institute on Disability, Independent Living, and Rehabilitation Research. Support for James A. Holdnack was also provided by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant U54-GM104941 (PI: Binder-Macleod). Grant L. Iverson acknowledges support from the Mooney-Reed Charitable Foundation, the Heinz Family Foundation, and ImPACT Applications, Inc. This work is related in part to the TBI Endpoints Development Initiative and a grant titled Development and Validation of a Cognition Endpoint for Traumatic Brain Injury Clinical Trials.; Grant L. Iverson has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical practice in forensic neuropsychology involving individuals who have sustained mild TBIs. He has received honorariums for serving on research panels that provide scientific peer review of programs. He is a coinvestigator, collaborator, or consultant on grants relating to mild TBI funded by several organizations. He has received research support from test publishing companies in the past, including ImPACT Applications Systems and CNS Vital Signs. He receives royalties for one neuropsychological test (Wisconsin Card Sorting Test-64 Card Version).	Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Brooks BL, 2013, PRACT RESOUR MENT, P75, DOI 10.1016/B978-0-12-386934-0.00002-X; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P182, DOI 10.1093/arclin/acq005; Brooks BL, 2009, ARCH CLIN NEUROPSYCH, V24, P647, DOI 10.1093/arclin/acp061; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Di Paola M, 2015, J HEAD TRAUMA REHAB, V30, P402, DOI 10.1097/HTR.0000000000000063; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dunn DS, 2016, REHABIL PSYCHOL, V61, P1, DOI 10.1037/rep0000082; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Holdnack JA, 2017, ARCH CLIN NEUROPSYCH, V32, P574, DOI 10.1093/arclin/acx032; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2012, NEUROPSYCHOLOGICAL A, P360; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Martin RM, 2017, J NEUROSURG, V126, P796, DOI 10.3171/2016.3.JNS151781; MEARNS J, 1993, J CLIN PSYCHOL, V49, P714, DOI 10.1002/1097-4679(199309)49:5<714::AID-JCLP2270490515>3.0.CO;2-H; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SHONTZ FC, 1980, PROF PSYCHOL, V11, P919; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Tulsky D. S., 2017, USING NIH TOOL UNPUB; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; Wright BA., 1972, REHABIL PSYCHOL, V19, P38, DOI DOI 10.1037/H0090869	43	4	4	0	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					474	484		10.1037/rep0000145			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT1CK	WOS:000422871400008	29265868	Green Accepted, Bronze			2022-02-06	
J	Kizilay, YO; Aytan, O				Kizilay, Yusuf Onur; Aytan, Onur			Low-Energy Hawkins Type III Talar Neck Fracture-Dislocation With Neurovascular and Tendon Entrapment in a Pediatric Patient	JOURNAL OF FOOT & ANKLE SURGERY			English	Article						avascular necrosis; children; neurovascular entrapment; talus fracture; tendon entrapment	MINIMALLY DISPLACED NECK; AVASCULAR NECROSIS; TALUS FRACTURE; CHILD; COMPLICATIONS; INJURY; BODY	Several serious complications can occur after talar neck fractures. However, these fractures are extremely rare in children. We present a pediatric low-energy Hawkins type III fracture-dislocation that had excessive displacement accompanied by neurovascular and tendon entrapment. A 9-year-old male patient referred to our hospital 5 hours after jumping off a swing in a children's playground. An excessively displaced talar neck fracture-dislocation was observed at the initial evaluation. The patient underwent urgent surgery. The tibialis posterior flexor digitorum longus tendons, posterior tibial artery, and tibial nerve were entrapped at the fracture site. The talar neck fracture was reduced using open reduction. The neurovascular structures and tendons were removed from the fracture site. The fracture was fixed using two 4.5-mm cannulated screws. The patient was able to bear full weight at 10 weeks postoperatively. At 6 months, the patient was able to walk unassisted with full ankle range of motion. However, at 2 years, his American Orthopaedic Foot and Ankle Society Ankle-Hindfoot scale score had decreased to 72 points, and we observed avascular necrosis in the talar head. In conclusion, talar fractures are rare but can lead to serious complications. In the pediatric population, even low-energy trauma, such as had occurred in our patient, can result in severe displaced fracture-dislocations. After severe displaced fracture-dislocations, important soft tissue structures can become entrapped between fracture fragments, and surgeons should be aware of this situation when considering using closed reduction. (C) 2017 by the American College of Foot and Ankle Surgeons. All rights reserved.	[Kizilay, Yusuf Onur; Aytan, Onur] Turan & Turan Bone & Joint Surg Clin, Muradiye Mahallesi Bahribaba Vakif Ishani Cekirge, TR-16050 Osmangazi, Bursa, Turkey		Kizilay, YO (corresponding author), Turan & Turan Bone & Joint Surg Clin, Muradiye Mahallesi Bahribaba Vakif Ishani Cekirge, TR-16050 Osmangazi, Bursa, Turkey.	onurkizilay@yahoo.com	Kizilay, Yusuf Onur/J-7669-2019	Kizilay, Yusuf Onur/0000-0001-8373-3426			ANDERSON H, 1919, MED SURG ASPECTS AVI; Burton P D, 1992, J Orthop Trauma, V6, P248, DOI 10.1097/00005131-199206000-00021; CANALE ST, 1978, J BONE JOINT SURG AM, V60, P143, DOI 10.2106/00004623-197860020-00001; Dougall TW, 1997, INJURY, V28, P551, DOI 10.1016/S0020-1383(97)00060-0; Du Jun-feng, 2015, Zhongguo Gu Shang, V28, P567; Ebraheim N A, 1995, Am J Orthop (Belle Mead NJ), VSuppl, P22; Fortin P T, 2001, J Am Acad Orthop Surg, V9, P114; Haverkort JJM, 2015, INT J SURG CASE REP, V16, P106, DOI 10.1016/j.ijscr.2015.09.025; HAWKINS LG, 1970, J BONE JOINT SURG AM, VA 52, P991, DOI 10.2106/00004623-197052050-00013; Herring JA, 2007, TACHDJIANS PEDIAT OR, P2760; Hildanus F., 1608, FRACOFURTI MOENUM BE, V67, P140; Jarde O, 2001, Acta Orthop Belg, V67, P60; Lindvall E, 2004, J BONE JOINT SURG AM, V86A, P2229, DOI 10.2106/00004623-200410000-00014; Mao Jian-Shui, 2015, Zhongguo Gu Shang, V28, P368; McKeever F M, 1963, Clin Orthop Relat Res, V30, P45; NIAZI TBM, 1992, INJURY, V23, P280, DOI 10.1016/S0020-1383(05)80021-X; PENNY JN, 1980, J TRAUMA, V20, P1029, DOI 10.1097/00005373-198012000-00004; PETERSON L, 1977, ACTA ORTHOP SCAND, V48, P696, DOI 10.3109/17453677708994820; Prasad KSRK, 2004, INJURY, V35, P1216, DOI 10.1016/j.injury.2004.02.016; Rammelt S, 2000, FOOT ANKLE INT, V21, P1030, DOI 10.1177/107110070002101209; RIEDL K, 1975, Z ORTHOP GRENZGEB, V113, P696; Smith JT, 2010, J PEDIATR ORTHOPED, V30, P779, DOI 10.1097/BPO.0b013e3181f73e6e; Talkhani IS, 2000, INJURY, V31, P63, DOI 10.1016/S0020-1383(99)00227-2; Thermann H, 1998, UNFALLCHIRURG, V101, P2, DOI 10.1007/s001130050225; Vallier HA, 2004, J BONE JOINT SURG AM, V86A, P1616, DOI 10.2106/00004623-200408000-00003; Wang Kun-Chuang, 2004, Chang Gung Med J, V27, P56; Wen S L, 1980, Zhonghua Wai Ke Za Zhi, V18, P521	27	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1067-2516	1542-2224		J FOOT ANKLE SURG	J. Foot Ankle Surg.	NOV-DEC	2017	56	6					1288	1291		10.1053/j.jfas.2017.05.007			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	FL4SU	WOS:000414222400030	28778631				2022-02-06	
J	Nguyen, T; Mao, YL; Sutherland, T; Gorrie, CA				Nguyen, Tara; Mao, Yilin; Sutherland, Theresa; Gorrie, Catherine Anne			Neural progenitor cells but not astrocytes respond distally to thoracic spinal cord injury in rat models	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; contusion; spinal cord; neuroinflammatory; ependymal cell; glial fibrillary acidic protein; microglia; nestin; neuroaxis; tanycyte; third ventricle; trauma; neural regeneration	CENTRAL-NERVOUS-SYSTEM; LEVEL NEUROPATHIC PAIN; CNS STEM-CELLS; ADULT-RAT; INFLAMMATORY CYTOKINES; INTERMEDIATE FILAMENT; CONTUSION INJURY; EPENDYMAL CELLS; NEUROGENESIS; MICROGLIA	Traumatic spinal cord injury (SCI) is a detrimental condition that causes loss of sensory and motor function in an individual. Many complex secondary injury cascades occur after SCI and they offer great potential for therapeutic targeting. In this study, we investigated the response of endogenous neural progenitor cells, astrocytes, and microglia to a localized thoracic SCI throughout the neuroaxis. Twenty-five adult female Sprague-Dawley rats underwent mild-contusion thoracic SCI (n = 9), sham surgery (n = 8), or no surgery (n = 8). Spinal cord and brain tissues were fixed and cut at six regions of the neuroaxis. Immunohistochemistry showed increased reactivity of neural progenitor cell marker nestin in the central canal at all levels of the spinal cord. Increased reactivity of astrocyte-specific marker glial fibrillary acidic protein was found only at the lesion epicenter. The number of activated microglia was significantly increased at the lesion site, and activated microglia extended to the lumbar enlargement. Phagocytic microglia and macrophages were significantly increased only at the lesion site. There were no changes in nestin, glial fibrillary acidic protein, microglia and macrophage response in the third ventricle of rats subjected to mild-contusion thoracic SCI compared to the sham surgery or no surgery. These findings indicate that neural progenitor cells, astrocytes and microglia respond differently to a localized SCI, presumably due to differences in inflammatory signaling. These different cellular responses may have implications in the way that neural progenitor cells can be manipulated for neuroregeneration after SCI. This needs to be further investigated.	[Nguyen, Tara; Mao, Yilin; Sutherland, Theresa; Gorrie, Catherine Anne] Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW, Australia		Gorrie, CA (corresponding author), Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW, Australia.	Catherine.gorrie@uts.edu.au	Gorrie, Catherine/S-6591-2019	Gorrie, Catherine/0000-0001-5934-2492; Sutherland, Theresa C./0000-0002-2919-1504; Mao, Yilin/0000-0002-3573-6486	UTS Faculty of Science Early Career Research Grant	This study was supported by UTS Faculty of Science Early Career Research Grant to CAG.	Ahadi R, 2015, SPINE, V40, pE823, DOI 10.1097/BRS.0000000000000654; Alfaro-Cervello C, 2012, J COMP NEUROL, V520, P3528, DOI 10.1002/cne.23104; Ayoub AE, 2003, J NEUROSCI, V23, P7759; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Blasko J, 2012, CENT EUR J BIOL, V7, P397, DOI 10.2478/s11535-012-0027-2; Cawsey T, 2015, J NEUROTRAUM, V32, P1393, DOI 10.1089/neu.2014.3575; Chan WM, 2013, TRANSL STROKE RES, V4, P447, DOI 10.1007/s12975-012-0249-7; Cizkova D, 2009, CELL MOL NEUROBIOL, V29, P999, DOI 10.1007/s10571-009-9387-1; Cunha JD, 2007, WOUND REPAIR REGEN, V15, P134, DOI 10.1111/j.1524-475X.2006.00194.x; Decimo I, 2011, STEM CELLS, V29, P2062, DOI 10.1002/stem.766; Detloff MR, 2008, EXP NEUROL, V212, P337, DOI 10.1016/j.expneurol.2008.04.009; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Foret A, 2010, J NEUROCHEM, V112, P762, DOI 10.1111/j.1471-4159.2009.06500.x; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Goodman T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00387; Gorrie CA, 2010, BRAIN RES, V1337, P8, DOI 10.1016/j.brainres.2010.04.019; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Gregoire CA, 2015, GLIA, V63, P1469, DOI 10.1002/glia.22851; Guo YJ, 2014, BIOCHEM BIOPH RES CO, V446, P830, DOI 10.1016/j.bbrc.2014.02.103; Gwak YS, 2009, NEUROSCIENCE, V161, P895, DOI 10.1016/j.neuroscience.2009.03.055; Haan N, 2013, J NEUROSCI, V33, P6170, DOI 10.1523/JNEUROSCI.2437-12.2013; Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Ke Y, 2006, STEM CELLS, V24, P1011, DOI 10.1634/stemcells.2005-0249; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li Wei, 2006, Neurosci Bull, V22, P34; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; Mao YL, 2016, NEURAL REGEN RES, V11, P1075, DOI 10.4103/1673-5374.187035; Mao Y, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00058; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mokry Jaroslav, 2008, Acta Medica (Hradec Kralove), V51, P173; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Mortazavi MM, 2015, CLIN ANAT, V28, P27, DOI 10.1002/ca.22432; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008; Ohtake Y, 2016, NEURAL REGEN RES, V11, P1050, DOI 10.4103/1673-5374.187022; PAXINOS G, 1996, RAT BRAIN STEROTAXIC; Petit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024538; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Prieto M, 2000, EXP NEUROL, V161, P27, DOI 10.1006/exnr.1999.7223; RAFOLS JA, 1985, ANAT REC, V211, P75, DOI 10.1002/ar.1092110112; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Schwindt TT, 2009, AN ACAD BRAS CIENC, V81, P443, DOI 10.1590/S0001-37652009000300009; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; Shihabuddin Lamya S., 2008, V438, P55, DOI 10.1007/978-1-59745-133-8_6; Stammers AT, 2012, J NEUROSCI RES, V90, P782, DOI 10.1002/jnr.22820; Stenudd M, 2015, JAMA NEUROL, V72, P235, DOI 10.1001/jamaneurol.2014.2927; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Sutherland TC, 2017, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00310; Takahashi M, 2003, J NEUROPATH EXP NEUR, V62, P185, DOI 10.1093/jnen/62.2.185; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Tureyen K, 2005, NEUROSURGERY, V57, P1254, DOI 10.1227/01.NEU.0000186040.96929.8A; Weiss S, 1996, J NEUROSCI, V16, P7599; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Zhou X, 2014, NEURAL REGEN RES, V9, P1787, DOI 10.4103/1673-5374.143423	65	4	4	1	5	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	NOV	2017	12	11					1885	1894		10.4103/1673-5374.219051			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	FP8GQ	WOS:000417880400027	29239336	Green Published, gold			2022-02-06	
J	Ren, WB; Ma, XF; Liu, XZ; Li, YX; Jiang, ZM; Zhao, YJ; Li, C; Li, X				Ren, Wenbo; Ma, Xiaofang; Liu, Xiaozhi; Li, Yanxia; Jiang, Zhongmin; Zhao, Yujun; Li, Chen; Li, Xin			Moderate hypothermia induces protein SUMOylation in bone marrow stromal cells and enhances their tolerance to hypoxia	MOLECULAR MEDICINE REPORTS			English	Article						small ubiquitin-like modifiers; SUMOylation; moderate hypothermia; bone marrow stromal stem cells; infarction; cerebral ischemic penumbra	MESENCHYMAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; SUMO; THERAPY; TRANSPLANTATION; MODIFIER; REPAIR; RATS; NEUROPROTECTION	Acute cerebral infarction can progress rapidly, and there are limited specific and effective treatments. Small ubiquitin-like modifiers (SUMOs) provide an important post-translational modification of proteins. Following cerebral infarction, multiple proteins can combine with SUMOs to protect nerve cells. Furthermore, moderate hypothermia (core body temperature, 33-34 degrees C) can increase the level of SUMOylation on multiple proteins. In the present study, it was examined whether moderate hypothermia increases the survival rate of bone marrow stromal stem cells (BMSCs) implanted in the cerebral ischemic penumbra via SUMOylation of multiple proteins. Firstly, BMSCs were exposed to oxygen-glucose deprivation (OGD) under moderate hypothermic (33 degrees C) conditions. Subsequently, adult rats with middle cerebral artery occlusion were treated with a combination of BMSCs and moderate hypothermia (32-34 degrees C). The results demonstrated that hypothermia promoted the combination of multiple proteins with SUMOs in BMSCs, and induced transport of SUMOs from the cytoplasm to the nucleus. Moderate hypothermia additionally reduced damage to BMSCs following OGD and improved BMSC survival following transplantation into the penumbra. These data suggest that moderate hypothermia may protect against BMSC injury via rapid SUMOylation of intracellular proteins. Thus, BMSC transplantation combined with moderate hypothermia may be a potential therapeutic strategy to treat cerebral infarction.	[Ren, Wenbo; Li, Xin] Tianjin Med Univ, Hosp 2, Dept Neurol, 23 Pingjiang Rd, Tianjin 300211, Peoples R China; [Ren, Wenbo; Zhao, Yujun; Li, Chen] Fifth Cent Hosp Tianjin, Dept Neurol, Tianjin 300450, Peoples R China; [Ma, Xiaofang; Liu, Xiaozhi; Li, Yanxia] Fifth Cent Hosp Tianjin, Cent Lab, Tianjin 300450, Peoples R China; [Jiang, Zhongmin] Fifth Cent Hosp Tianjin, Dept Pathol, Tianjin 300450, Peoples R China		Li, X (corresponding author), Tianjin Med Univ, Hosp 2, Dept Neurol, 23 Pingjiang Rd, Tianjin 300211, Peoples R China.	jessielx@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471175]; Tianjin Health Bureau Science and Technology Projects [2014KY23]; Tanggu Science and Technology Promotion Projects [201 3KJXQ03]	The current study was supported by the National Natural Science Foundation of China (grant no. 81471175), Tianjin Health Bureau Science and Technology Projects (grant no. 2014KY23) and Tanggu Science and Technology Promotion Projects (grant no. 201 3KJXQ03).	An HY, 2015, STROKE, V46, P982, DOI 10.1161/STROKEAHA.114.008154; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Black IB, 2001, BLOOD CELL MOL DIS, V27, P632, DOI 10.1006/bcmd.2001.0423; Bleilevens C, 2013, EXP BRAIN RES, V224, P155, DOI 10.1007/s00221-012-3296-0; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Campos F, 2012, NEUROCHEM INT, V60, P495, DOI 10.1016/j.neuint.2012.02.003; Chen JR, 2008, J ANAT, V213, P249, DOI 10.1111/j.1469-7580.2008.00948.x; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Cui LL, 2010, PHARMACOL BIOCHEM BE, V96, P469, DOI 10.1016/j.pbb.2010.07.007; Deng J, 2006, STEM CELLS, V24, P1054, DOI 10.1634/stemcells.2005-0370; Eckert MA, 2013, J CEREBR BLOOD F MET, V33, P1322, DOI 10.1038/jcbfm.2013.91; Froehler MT, 2010, EXPERT REV CARDIOVAS, V8, P593, DOI [10.1586/erc.09.129, 10.1586/ERC.09.129]; Iwabuchi M, 2014, J CEREBR BLOOD F MET, V34, P425, DOI 10.1038/jcbfm.2013.210; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Keusekotten K, 2012, METHODS MOL BIOL, V832, P111, DOI 10.1007/978-1-61779-474-2_6; Kirton A, 2013, STROKE, V44, P3265, DOI 10.1161/STROKEAHA.113.000739; Kurwale NS, 2015, J NEUROSCI RURAL PRA, V6, P152, DOI 10.4103/0976-3147.153218; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025852; Maltman DJ, 2011, NEUROCHEM INT, V59, P347, DOI 10.1016/j.neuint.2011.06.008; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Shinozuka K, 2013, BRAIN SCI, V3, P239, DOI 10.3390/brainsci3010239; Shinozuka Kazutaka, 2013, J Stem Cell Res Ther, V4, P12912; Silveirinha V, 2013, J NEUROCHEM, V127, P580, DOI 10.1111/jnc.12347; Sindberg GM, 2014, J MED PRIMATOL, V43, P231, DOI 10.1111/jmp.12122; Sommer S, 2015, CHEMBIOCHEM, V16, P1183, DOI 10.1002/cbic.201500011; Titova EM, 2014, NEUROSCIENCE, V283, P231, DOI 10.1016/j.neuroscience.2014.09.028; Trappe K, 2013, EUR HEART J, V34, P147, DOI 10.1093/eurheartj/ehr269; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; van Rooy MJ, 2014, CURR MED CHEM, V21, P2121; Wang LL, 2012, J NEUROCHEM, V123, P349, DOI 10.1111/j.1471-4159.2012.07916.x; Yang W, 2008, J NEUROCHEM, V106, P989, DOI 10.1111/j.1471-4159.2008.05404.x; Yang W, 2013, J BIOMOL SCREEN, V18, P621, DOI 10.1177/1087057113479971; Yang W, 2012, J PROTEOME RES, V11, P1108, DOI 10.1021/pr200834f; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006; Zhang Y, 2016, CNS NEUROSCI THER, V22, P824, DOI 10.1111/cns.12584	36	4	6	1	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	NOV	2017	16	5					7006	7012		10.3892/mmr.2017.7425			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FM0ZU	WOS:000414698900165	28901483	Bronze			2022-02-06	
J	Tao, XG; Chen, XT; Hou, ZG; Hao, SY; Liu, BY				Tao, Xiaogang; Chen, Xuetao; Hou, Zonggang; Hao, Shuyu; Liu, Baiyun			Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-kappa B in a Mouse Model of Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Calpain; NF-kappa B; PARP; Traumatic brain injury	ADP-RIBOSE POLYMERASE-1; CEREBRAL-ISCHEMIA; MICROGLIAL ACTIVATION; CEREBROSPINAL-FLUID; NITRIC-OXIDE; INFLAMMATION; MICE; RATS; EXPRESSION; APOPTOSIS	OBJECTIVES: Poly(ADP-ribose) polymerase (PARP), calpain, and nuclear factor-kappa B (NF-kappa B) are reported to participate in inflammatory reactions in pathologic conditions and are involved in traumatic brain injury. The objective of this study was to investigate whether PARP participates in inflammation related to calpain and NF-kB in a mouse model of controlled cortical impact (CCI). METHODS: PJ34 (10 mg/kg), a selective PARP inhibitor, was administered intraperitoneally 5 minutes and 8 hours after experimental CCI. We then performed a histopathologic analysis, and we measured calpain activity and protein levels in all animals. The cytosolic, mitochondria, and nuclear fractions were prepared and used to determine the levels of PARP, calpastatin, NF-kappa B p65, inhibitory-kappa B-alpha, tumor necrosis factor-a, interleukin-1 beta, intracellular adhesion molecule-1, inducible nitric oxide synthase, and cyclooxygenase-2. We then measured blood-brain barrier disruption using electron microscopy at 6 and 24 hours after CCI. RESULTS: Treatment with PJ34 markedly reduced the extent of both cerebral contusion and edema, improved neurologic scores, and attenuated blood-brain barrier damage resulting from CCI. Our data showed that the cytosolic and nuclear fractions of calpain and NF-kappa B were up-regulated in the injured cortex and that these changes were reversed by PJ34. Moreover, PJ34 significantly enhanced the calpastatin and inhibitory-kappa B levels and decreased the levels of inflammatory mediators. CONCLUSIONS: PARP inhibition by PJ34 suppresses the overactivation of calpain and the production of inflammatory factors that are caused by NF-kappa B activation and attenuates neuronal cell death in a mouse model of CCI.	[Tao, Xiaogang; Chen, Xuetao; Hou, Zonggang; Hao, Shuyu; Liu, Baiyun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Dept Neurotrauma, Beijing, Peoples R China; [Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Liu, Baiyun] Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Neurotrauma, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China.; Liu, BY (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.	liubaiyun1963@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171144, 81471238]	This study was supported by research grants from the National Natural Science Foundation of China (nos. 81171144, 81471238).	Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Besson VC, 2005, BRAIN RES, V1041, P149, DOI 10.1016/j.brainres.2005.01.096; Blenn C, 2011, CELL MOL LIFE SCI, V68, P1455, DOI 10.1007/s00018-010-0533-1; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Camins A, 2009, CURR DRUG METAB, V10, P433, DOI 10.2174/138920009788898028; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cuzzocrea S, 2000, AM J PATHOL, V157, P2065, DOI 10.1016/S0002-9440(10)64845-6; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Fink EL, 2008, J CEREBR BLOOD F MET, V28, P1523, DOI 10.1038/jcbfm.2008.52; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Haddad M, 2006, BRIT J PHARMACOL, V149, P23, DOI 10.1038/sj.bjp.0706837; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Jasinska M, 2006, ACTA NEUROBIOL EXP, V66, P99; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Khorooshi R, 2008, J IMMUNOL, V181, P7284, DOI 10.4049/jimmunol.181.10.7284; Koh SH, 2004, EUR J NEUROSCI, V20, P1461, DOI 10.1111/j.1460-9568.2004.03632.x; Komjati K, 2005, CNS NEUROL DISORD-DR, V4, P179, DOI 10.2174/1568007053544138; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Lescot T, 2010, J NEUROTRAUM, V27, P1069, DOI 10.1089/neu.2009.1188; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Lian H, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-47; Liu S, 2014, BRAIN INJURY, V28, P133, DOI 10.3109/02699052.2013.860479; Lorente L, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.30165; Ma M, 2013, NEUROBIOL DIS, V56, P34, DOI 10.1016/j.nbd.2013.03.009; Ma M, 2012, J NEUROTRAUM, V29, P2555, DOI 10.1089/neu.2012.2473; Marzocco S, 2004, SHOCK, V21, P38, DOI 10.1097/01.shk.0000095056.62263.b2; McDonald MC, 2001, FASEB J, V15, P171, DOI 10.1096/fj.99-0645com; McGinnis KM, 1999, BIOCHEM BIOPH RES CO, V263, P94, DOI 10.1006/bbrc.1999.1315; Milligan SA, 1996, ARCH BIOCHEM BIOPHYS, V335, P388, DOI 10.1006/abbi.1996.9998; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Newcomb JK, 1999, J NEUROTRAUM, V16, P1, DOI 10.1089/neu.1999.16.1; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Ponnappan Subramaniam, 2005, Immun Ageing, V2, P15, DOI 10.1186/1742-4933-2-15; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sarnaik AA, 2010, J NEUROTRAUM, V27, P465, DOI 10.1089/neu.2009.1171; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Sun YX, 2013, NEUROL SCI, V34, P345, DOI 10.1007/s10072-012-1007-z; Tao X, 2015, NEUROSCIENCE, V291, P26, DOI 10.1016/j.neuroscience.2015.01.070; Tissier S, 2004, SHOCK, V21, P352, DOI 10.1097/00024382-200404000-00010; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	69	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2017	107						888	899		10.1016/j.wneu.2017.06.076			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2XV	WOS:000415860500123	28642177				2022-02-06	
J	Zheng, ZT; Dong, XL; Li, YD; Gao, WW; Zhou, Y; Jiang, RC; Yue, SY; Zhou, ZW; Zhang, JN				Zheng, Zhi-tong; Dong, Xin-long; Li, Ya-dan; Gao, Wei-wei; Zhou, Yuan; Jiang, Rong-cai; Yue, Shu-yuan; Zhou, Zi-wei; Zhang, Jian-ning			Electrical stimulation improved cognitive deficits associated with traumatic brain injury in rats	BRAIN AND BEHAVIOR			English	Article						angiogenesis; cognitive deficit; electrical stimulation; endothelial progenitor cell; traumatic brain injury	ENDOTHELIAL PROGENITOR CELLS; PROMOTES ANGIOGENESIS; FUNCTIONAL RECOVERY; CONTROLLED-TRIAL; HEAD-INJURY; MODEL; NEOVASCULARIZATION; TRANSPLANTATION; ERYTHROPOIETIN; VASCULOGENESIS	IntroductionCognitive deficits associated with traumatic brain injury (TBI) reduce patient quality of life. However, to date, there have been no effective treatments for TBI-associated cognitive deficits. In this study, we aimed to determine whether electrical stimulation (ES) improves cognitive deficits in TBI rats. MethodsRats were randomly divided into three groups: the Sham control group, electrical stimulation group (ES group), and No electrical stimulation control group (N-ES group). Following fluid percussion injury, the rats in the ES group received ES treatment for 3weeks. Potent cognitive function-relevant factors, including the escape latency, time percentage in the goal quadrant, and numbers of CD34(+) cells, von Willebrand Factor(+) (vWF(+)) vessels, and circulating endothelial progenitor cells (EPCs), were subsequently assessed using the Morris water maze (MWM) test, immunohistochemical staining, and flow cytometry. ResultsCompared with the rats in the N-ES group, the rats in the ES group exhibited a shorter escape latency on day 3 (p=.025), day 4 (p=.011), and day 5 (p=.003), as well as a higher time percentage in the goal quadrant (p=.025) in the MWM test. After 3weeks of ES, there were increased numbers of CD34(+) cells (p=.008) and vWF(+) vessels (p=.000) in the hippocampus of injured brain tissue in the ES group compared with those in the N-ES group. Moreover, ES also significantly increased the number of EPCs in the peripheral blood from days 3 to 21 after TBI in the ES group (p<.05). ConclusionsTaken together, these findings suggest that ES may improve cognitive deficits induced by TBI, and this protective effect may be a result, in part, of enhanced angiogenesis, which may be attributed to the increased mobilization of EPCs in peripheral blood.	[Zheng, Zhi-tong; Dong, Xin-long; Gao, Wei-wei; Zhou, Yuan; Jiang, Rong-cai; Yue, Shu-yuan; Zhou, Zi-wei; Zhang, Jian-ning] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin, Peoples R China; [Zheng, Zhi-tong; Dong, Xin-long; Gao, Wei-wei; Zhou, Yuan; Jiang, Rong-cai; Zhou, Zi-wei; Zhang, Jian-ning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Zheng, Zhi-tong; Dong, Xin-long; Gao, Wei-wei; Zhou, Yuan; Jiang, Rong-cai; Zhou, Zi-wei; Zhang, Jian-ning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Li, Ya-dan] Tianjin Huanhu Hosp, Intens Care Units, Tianjin, Peoples R China		Zhou, ZW; Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin, Peoples R China.	ziweizhou2009@hotmail.com; jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029]; Natural Science Foundations of TianjinNatural Science Foundation of Tianjin [13JCZDJC30800]; Natural Science Foundations of Tianjin Medical University General Hospital [303071901401]	National Natural Science Foundation of China, Grant/Award Number: 81330029; Natural Science Foundations of Tianjin, Grant/Award Number: 13JCZDJC30800; Natural Science Foundations of Tianjin Medical University General Hospital, Grant/Award Number: 303071901401	Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cheng X, 2012, BRAIN RES BULL, V89, P124, DOI 10.1016/j.brainresbull.2012.07.009; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Edwards P, 2005, LANCET, V365, P1957; Franulic A, 2000, BRAIN INJURY, V14, P431; Gale JT, 2013, STEREOT FUNCT NEUROS, V91, P355, DOI 10.1159/000351523; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Jahanshahi A, 2013, EXP BRAIN RES, V231, P165, DOI 10.1007/s00221-013-3680-4; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Pellegrini L, 2013, NEUROL RES, V35, P937, DOI 10.1179/1743132813Y.0000000235; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Safar P, 2001, NEW ENGL J MED, V345, P66; Schier R, 2014, BRIT J ANAESTH, V113, P652, DOI 10.1093/bja/aeu135; Sebastian A, 2011, WOUND REPAIR REGEN, V19, P693, DOI 10.1111/j.1524-475X.2011.00736.x; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Zhang P, 2011, CELL BIOCHEM BIOPHYS, V59, P19, DOI 10.1007/s12013-010-9107-y; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073	30	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	NOV	2017	7	11							e00667	10.1002/brb3.667			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FN5QR	WOS:000416063200001	29201537	gold, Green Published			2022-02-06	
J	Annamalai, K; Nanda, A				Annamalai, Kalyan; Nanda, Arnab			Biological Aging and Life Span Based on Entropy Stress via Organ and Mitochondrial Metabolic Loading	ENTROPY			English	Article						biological aging; entropy stress; mitochondria; life span; bio-markers	RESTING ENERGY-EXPENDITURE; MAMMALS; TISSUE; LEVEL; MASS	The energy for sustaining life is released through the oxidation of glucose, fats, and proteins. A part of the energy released within each cell is stored as chemical energy of Adenosine Tri-Phosphate molecules, which is essential for performing life-sustaining functions, while the remainder is released as heat in order to maintain isothermal state of the body. Earlier literature introduced the availability concepts from thermodynamics, related the specific irreversibility and entropy generation rates to metabolic efficiency and energy release rate of organ k, computed whole body specific entropy generation rate of whole body at any given age as a sum of entropy generation within four vital organs Brain, Heart, Kidney, Liver (BHKL) with 5th organ being the rest of organs (R5) and estimated the life span using an upper limit on lifetime entropy generated per unit mass of body, sigma(M),(life). The organ entropy stress expressed in terms of lifetime specific entropy generated per unit mass of body organs (kJ/(K kg of organ k)) was used to rank organs and heart ranked highest while liver ranked lowest. The present work includes the effects of (1) two additional organs: adipose tissue (AT) and skeletal muscles (SM) which are of importance to athletes; (2) proportions of nutrients oxidized which affects blood temperature and metabolic efficiencies; (3) conversion of the entropy stress from organ/cellular level to mitochondrial level; and (4) use these parameters as metabolism-based biomarkers for quantifying the biological aging process in reaching the limit of sigma(M life). Based on the 7-organ model and Elia constants for organ metabolic rates for a male of 84 kg steady mass and using basic and derived allometric constants of organs, the lifetime energy expenditure is estimated to be 2725 MJ/kg body mass while lifetime entropy generated is 6050 kJ/(K kg body mass) with contributions of 190; 1835.0; 610; 290; 700; 1470 and 95 kJ/K contributed by AT-BHKL-SM-R7 to 1 kg body mass over life time. The corresponding life time entropy stresses of organs are: 1.2; 60.5; 110.5; 110.5; 50.5; 3.5; 3.0 MJ/K per kg organ mass. Thus, among vital organs highest stress is for heart and kidney and lowest stress is for liver. The 5-organ model (BHKL and R5) also shows similar ranking. Based on mitochondrial volume and 5-organ model, the entropy stresses of organs expressed in kJ/K per cm(3) of Mito volume are: 12,670; 5465; 2855; 4730 kJ/cm(3) of Mito for BHKL indicating brain to be highly stressed and liver to be least stressed. Thus, the organ entropy stress ranking based on unit volume of mitochondria within an organ (kJ/(K cm(3) of Mito of organ k)) differs from entropy stress based on unit mass of organ. Based on metabolic loading, the brains of athletes already under extreme mitochondrial stress and facing reduced metabolic efficiency under concussion are subjected to more increased stress. In the absence of non-intrusive measurements for estimating organ-based metabolic rates which can serve as metabolism-based biomarkers for biological aging (BA) of whole body, alternate methods are suggested for estimating the biological aging rate.	[Annamalai, Kalyan; Nanda, Arnab] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA		Annamalai, K (corresponding author), Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.	kannamalai@tamu.edu; arnab229@gmail.com			Texas AM University	The authors wish to thank (1) three anonymous reviewers for bringing attention to review articles in this area, a few more pertinent references and many useful discussions which have been incorporated in the manuscript; and (2) Jothi Sukkawala MD for bringing attention to recent aging research of Mayo Clinic [47]. The principal author close to retirement recently started translating results from combustion and thermodynamics to biology and hence wish to acknowledge the funding provided through Paul Pepper Professorship and the James J. Cain Chair in Mechanical Engineering at Texas A&M University, which partially supported the graduate student(s) and the open access fees for the publication of this manuscript.	ABRAHAMS S, 1991, AM J PHYSIOL, V261, pR719, DOI 10.1152/ajpregu.1991.261.3.R719; Andresen B, 2002, P NATL ACAD SCI USA, V99, P5822, DOI 10.1073/pnas.082633699; Annamalai K., 2017, P 10 US NAT COMB M C; Annamalai K., 2006, COMBUSTION SCI ENG; Annamalai K., 2011, ADV THERMODYNAMICS E; Annamalai K., 2017, J COMBUST IN PRESS; Annamalai K, 2012, ENTROPY-SWITZ, V14, P2550, DOI 10.3390/e14122550; AOKI I, 1994, AGE, V17, P29, DOI 10.1007/BF02435047; CALDER WA, 1981, ANNU REV PHYSIOL, V43, P301, DOI 10.1146/annurev.ph.43.030181.001505; DAVIES M, 1961, J CELL COMPAR PHYSL, V57, P135, DOI 10.1002/jcp.1030570302; ELIA M, 1992, ENERGY METABOLISM, P61; ELSE PL, 1985, AM J PHYSIOL, V248, pR415, DOI 10.1152/ajpregu.1985.248.4.R415; Flatt Thomas, 2012, Frontiers in Genetics, V3, P148, DOI 10.3389/fgene.2012.00148; Floyd RA, 2001, EXP GERONTOL, V36, P619, DOI 10.1016/S0531-5565(00)00231-X; Gemma C., 2007, BRAIN AGING MODELS M; Guachalla LM, 2009, AGING-US, V1, P303, DOI 10.18632/aging.100030; Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034; Hershey D., 1980, NEW AGE SCALE HUMANS; HOPPELER H, 1984, RESP PHYSIOL, V55, P131, DOI 10.1016/0034-5687(84)90018-5; Huaxiong H., RETIREMENT SPENDING; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kummitha CM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12159; Lee CP, 1996, FASEB J, V10, P345, DOI 10.1096/fasebj.10.2.8641569; Lee D, 2015, AGING CELL, V14, P8, DOI 10.1111/acel.12277; Longevity Sacher G., 1978, GERONTOLOGIST, V18, p[112, 120], DOI [10.1093/geront/18.2.112640450, DOI 10.1093/GERONT/18.2.112640450]; MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x; Miller J., 2014, THESIS; Mostafavi H, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002458; Nanda N., 2017, THESIS; Pinker S., 2016, WALL STREET J; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; Segolene M., 2012, ANESTHESIOL RES PRAC, V2012, p[1, 13]; Silva C., 2009, J THERMODYN, V2009, P1, DOI [DOI 10.1155/2009/186723, 10.1155/2009/186723]; Silva C, 2008, ENTROPY-SWITZ, V10, P100, DOI 10.3390/entropy-e10020100; Singer D, 2006, THERMOCHIM ACTA, V446, P20, DOI 10.1016/j.tca.2006.05.006; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Wang Z., 2012, INT SCH RES NETW ISR, V9, DOI [DOI 10.5402/2012/673050, 10.5402/2012/673050]; Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885; Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539, DOI 10.1152/ajpendo.2000.279.3.E539; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Wenger B. C., TEMPERATURE REGULATI	41	4	4	1	12	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1099-4300			ENTROPY-SWITZ	Entropy	OCT	2017	19	10							566	10.3390/e19100566			36	Physics, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Physics	FM2QQ	WOS:000414845100060		gold, Green Submitted			2022-02-06	
J	Armstead, WM; Riley, J; Vavilala, MS				Armstead, William M.; Riley, John; Vavilala, Monica S.			K Channel Impairment Determines Sex and Age Differences in Epinephrine-mediated Outcomes after Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						K-ATP K-Ca channels; autoregulation; traumatic brain injury; pressor support	ACTIVATED PROTEIN-KINASE; CEREBRAL AUTOREGULATION; UP-REGULATION; HIPPOCAMPAL NECROSIS; JUVENILE PIGS; ERK MAPK; HYPOTENSION; ATP; CEREBROVASODILATION; NOREPINEPHRINE	Traumatic brain injury (TBI) is the leading cause of injury-related death in children, with boys and children under 4 years having particularly poor outcomes. Activation of ATP- and calcium-sensitive (K-ATP and K-Ca) channels produces cerebrovasodilation and contributes to autoregulation, both of which are impaired after TBI, contributing to poor outcomes. Upregulation of the c-Jun-terminal kinase (JNK) isoform of mitogen-activated protein kinase produces K channel function impairment after CNS injury. Vasoactive agents can be used to normalize cerebral perfusion pressure. Epinephrine (EPI) prevents impairment of cerebral autoregulation and hippocampal neuronal cell necrosis after TBI in female and male newborn and female juvenile but not male juvenile pigs via differential modulation of JNK. The present study used anesthetized pigs equipped with a closed cranial window to address the hypothesis that differential K channel impairment contributes to age and sex differences in EPI-mediated outcomes after brain injury. Results show that pial artery dilation in response to the K-ATP and K-Ca channel agonists cromakalim and NS 1619 was impaired after TBI and that such impairment was prevented by EPI in female and male newborn and female juvenile but not male juvenile pigs. Using vasodilation as an index of function, these data indicate that EPI protects cerebral autoregulation and limits histopathology after TBI through protection of K channel function via blockade of JNK in an age-and sex-dependent manner. (C) 2017 Wiley Periodicals, Inc.	[Armstead, William M.; Riley, John] Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS090998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090998] Funding Source: NIH RePORTER	This study was supported by RO1 NS090998 from the National Institutes of Health.	Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead WM, 2017, J NEUROTRAUM, V34, P1666, DOI 10.1089/neu.2016.4770; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Armstead WM, 2016, PEDIATR CRIT CARE ME, V17, pe130, DOI 10.1097/PCC.0000000000000603; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2012, NEUROL RES, V34, P530, DOI 10.1179/1743132812Y.0000000039; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2011, J NEUROTRAUM, V28, P105, DOI 10.1089/neu.2010.1581; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 1999, BRAIN RES, V816, P158, DOI 10.1016/S0006-8993(98)01146-9; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dobbing J., 1981, SCI F PAEDIATRICS, P744; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Ishikawa S, 2009, ANESTH ANALG, V108, P1631, DOI 10.1213/ane.0b013e31819d94e3; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS24, DOI 10.1097/PCC.0b013e31823f4450; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Newacheck PW, 2004, PEDIATRICS, V114, P79, DOI 10.1542/peds.114.1.79; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Otani N, 2002, J NEUROTRAUM, V19, P1587, DOI 10.1089/089771502762300247; Ross J, 2005, BRAIN RES, V1054, P95, DOI 10.1016/j.brainres.2005.06.065; Salvucci A, 2000, BRAIN RES, V887, P406, DOI 10.1016/S0006-8993(00)03079-1; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6	29	4	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	OCT	2017	95	10					1917	1926		10.1002/jnr.24063			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG1EC	WOS:000409535900004	28397372	Green Accepted			2022-02-06	
